PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Harris, JB; LaRocque, RC; Charles, RC; Mazumder, RN; Khan, AI; Bardhan, PK				Harris, Jason B.; LaRocque, Regina C.; Charles, Richelle C.; Mazumder, Ramendra N.; Khan, Azharul I.; Bardhan, Pradip K.			Cholera's western front	LANCET			English	Editorial Material							TETRACYCLINE; VACCINES		[Harris, Jason B.; LaRocque, Regina C.; Charles, Richelle C.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Harris, Jason B.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [LaRocque, Regina C.; Charles, Richelle C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Mazumder, Ramendra N.; Khan, Azharul I.; Bardhan, Pradip K.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; International Centre for Diarrhoeal Disease Research (ICDDR)	Harris, JB (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	jbharris@partners.org	Harris, Jason/ABF-2684-2020; Charles, Richelle/W-4342-2019	Harris, Jason/0000-0003-3642-5126; Charles, Richelle/0000-0002-8881-1849	FOGARTY INTERNATIONAL CENTER [K01TW007409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089721] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW007409] Funding Source: Medline; NIAID NIH HHS [K08 AI089721] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1473; [Anonymous], 2010, WORLD HLTH STAT 2010; Hossain MS, 2002, J HEALTH POPUL NUTR, V20, P18; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; *PAN AM HLTH ORG, 2010, EP AL UPD SIT HAIT; RABBANI GH, 1989, ANTIMICROB AGENTS CH, V33, P1447, DOI 10.1128/AAC.33.9.1447; Ryan ET, 2000, AM J TROP MED HYG, V63, P12, DOI 10.4269/ajtmh.2000.63.12; Sack DA, 2006, NEW ENGL J MED, V355, P649, DOI 10.1056/NEJMp068144; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; *VACC RES LIB, 2010, CHOL OUTBR TRAIN SHI; *WHO, 2004, 1 STEPS MAN OUTBR AC; WHO/UNICEF Joint Water Supply and Sanitation Monitoring Programme, 2015, PROGR SAN DRINK WAT; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P117; World Health Organization, 2005, TREATM DIARRH MAN PH	15	36	39	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					1961	1965		10.1016/S0140-6736(10)62172-1	http://dx.doi.org/10.1016/S0140-6736(10)62172-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	701GZ	21112083	Green Accepted			2022-12-24	WOS:000285807700004
J	Raveh, A; Cooper, A; Guy-David, L; Reuveny, E				Raveh, Adi; Cooper, Ayelet; Guy-David, Liora; Reuveny, Eitan			Nonenzymatic Rapid Control of GIRK Channel Function by a G Protein-Coupled Receptor Kinase	CELL			English	Article							G-BETA-GAMMA; PLECKSTRIN HOMOLOGY DOMAIN; SHORT-TERM DESENSITIZATION; K+-CURRENT; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CONFORMATIONAL REARRANGEMENTS; MUTATIONAL ANALYSIS; POTASSIUM CHANNEL; ACTIVATION; MEMBRANE	G protein-coupled receptors (GPCRs) respond to agonists to activate downstream enzymatic pathways or to gate ion channel function. Turning off GPCR signaling is known to involve phosphorylation of the GPCR by GPCR kinases (GRKs) to initiate their internalization. The process, however, is relatively slow and cannot account for the faster desensitization responses required to regulate channel gating. Here, we show that GRKs enable rapid desensitization of the G protein-coupled potassium channel (GIRK/Kir3.x) through a mechanism independent of their kinase activity. On GPCR activation, GRKs translocate to the membrane and quench channel activation by competitively binding and titrating G protein beta gamma subunits away from the channel. Of interest, the ability of GRKs to effect this rapid desensitization depends on the receptor type. The findings thus reveal a stimulus-specific, phosphorylation-independent mechanism for rapidly downregulating GPCR activity at the effector level.	[Raveh, Adi; Cooper, Ayelet; Guy-David, Liora; Reuveny, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il			Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF) [207/09]; Minerva Foundation; Human Frontier Science Program	Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation; Human Frontier Science Program(Human Frontier Science Program)	The authors like to thank Ruth Meller and Elisha Shalgi for technical help, and the Reuveny laboratory for helpful comments. We are grateful to Drs. J.L. Benovic for GRK2 and GRK6, W.C. Claycomb for HL-1 cells, D.E. Logothetis for PtdIns(4,5)P2 GIRK mutants, C. Barlot for G alpha<INF>s</INF> mutant, S. Nakanishi for the mGluR2, Z. Vogel for mu OR, and R. Tsien for mCherry cDNAs. The work was supported in part by the Josef Cohn Center for Biomembrane Research, The Israeli Science Foundation (ISF grant 207/09), The Minerva Foundation, and the Human Frontier Science Program.	Aragay AM, 1998, FEBS LETT, V430, P37, DOI 10.1016/S0014-5793(98)00495-5; Bender K, 2001, J BIOL CHEM, V276, P28873, DOI 10.1074/jbc.M102328200; Berlot CH, 2002, J BIOL CHEM, V277, P21080, DOI 10.1074/jbc.M201330200; Blanchet C, 2002, P NATL ACAD SCI USA, V99, P4674, DOI 10.1073/pnas.072075399; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cordeaux Y, 2004, BRIT J PHARMACOL, V143, P705, DOI 10.1038/sj.bjp.0705925; Dang VC, 2009, J NEUROSCI, V29, P3322, DOI 10.1523/JNEUROSCI.4749-08.2009; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Doupnik CA, 2008, J RECEPT SIG TRANSD, V28, P83, DOI [10.1080/10799890801941970, 10.1080/10799890801941970 ]; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; GARCIAHIGUERA I, 1994, J BIOL CHEM, V269, P1348; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Keselman I, 2007, CHANNELS, V1, P113, DOI 10.4161/chan.4321; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Koike-Tani M, 2005, J PHYSIOL-LONDON, V564, P489, DOI 10.1113/jphysiol.2004.079285; KONG GH, 1994, J BIOL CHEM, V269, P13084; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Li JL, 2003, J BIOL CHEM, V278, P30219, DOI 10.1074/jbc.M302385200; Lleres David, 2007, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1210s42; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Meyer T, 2001, J BIOL CHEM, V276, P5650, DOI 10.1074/jbc.M009179200; Murga C, 1998, NEUROSCIENCE, V87, P631, DOI 10.1016/S0306-4522(98)00145-6; Nikolov EN, 2004, J BIOL CHEM, V279, P23630, DOI 10.1074/jbc.M312861200; Nobles M, 2010, PFLUG ARCH EUR J PHY, V460, P99, DOI 10.1007/s00424-010-0799-z; Palczewski K, 1997, EUR J BIOCHEM, V248, P261, DOI 10.1111/j.1432-1033.1997.00261.x; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Raveh Adi, 2008, V491, P199, DOI 10.1007/978-1-59745-526-8_16; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Sadja R, 2009, CHANNELS, V3, P205, DOI 10.4161/chan.3.3.9136; Shui Z, 1998, J PHYSIOL-LONDON, V507, P325, DOI 10.1111/j.1469-7793.1998.325bt.x; Sickmann T, 2003, J NEUROPHYSIOL, V90, P2494, DOI 10.1152/jn.00112.2003; Sickmann T, 2008, NEUROSCI LETT, V436, P102, DOI 10.1016/j.neulet.2008.02.067; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; TOUHARA K, 1995, J BIOL CHEM, V270, P17000, DOI 10.1074/jbc.270.28.17000; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	63	46	47	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					750	760		10.1016/j.cell.2010.10.018	http://dx.doi.org/10.1016/j.cell.2010.10.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111235	Bronze			2022-12-24	WOS:000284583500017
J	Reid, WV; Chen, D; Goldfarb, L; Hackmann, H; Lee, YT; Mokhele, K; Ostrom, E; Raivio, K; Rockstrom, J; Schellnhuber, HJ; Whyte, A				Reid, W. V.; Chen, D.; Goldfarb, L.; Hackmann, H.; Lee, Y. T.; Mokhele, K.; Ostrom, E.; Raivio, K.; Rockstrom, J.; Schellnhuber, H. J.; Whyte, A.			Earth System Science for Global Sustainability: Grand Challenges	SCIENCE			English	Editorial Material							FRAMEWORK		[Reid, W. V.] David & Lucile Packard Fdn, Los Altos, CA 94022 USA; [Chen, D.; Goldfarb, L.; Lee, Y. T.; Raivio, K.] Int Council Sci ICSU, F-75116 Paris, France; [Hackmann, H.] Int Social Sci Council, F-75732 Paris, France; [Mokhele, K.] Natl Res Fdn S Africa, ZA-0001 Pretoria, South Africa; [Ostrom, E.] Indiana Univ, Bloomington, IN 47408 USA; [Rockstrom, J.] Stockholm Environm Inst, SE-10691 Stockholm, Sweden; [Schellnhuber, H. J.] Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; [Whyte, A.] Int Dev Res Ctr, Ottawa, ON K1G 3H9, Canada	National Research Foundation - South Africa; Indiana University System; Indiana University Bloomington; Stockholm Environment Institute; Potsdam Institut fur Klimafolgenforschung	Reid, WV (corresponding author), David & Lucile Packard Fdn, Los Altos, CA 94022 USA.	wreid@packard.org	Chen, Deliang/A-5107-2013; Schellnhuber, Hans Joachim/B-2607-2012; currie, morgan/G-1449-2011; Lee, Yuan-Tseh/F-7914-2012; Schellnhuber, Hans Joachim/O-3873-2019	Chen, Deliang/0000-0003-0288-5618; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Rockstrom, Johan/0000-0001-8988-2983				CLARK WC, 2004, EARTH SYSTEM ANAL SU, P1; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Reid WV, 2009, SCIENCE, V325, P245, DOI 10.1126/science.1178591; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Schellnhuber H. J., 2002, GLOBAL CHANGE NEWSLE, V49, P20; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Walker B, 2009, SCIENCE, V325, P1345, DOI 10.1126/science.1175325	8	345	378	10	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					916	917		10.1126/science.1196263	http://dx.doi.org/10.1126/science.1196263			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	678XY	21071651				2022-12-24	WOS:000284118000023
J	Mulder, AM; Yoshioka, C; Beck, AH; Bunner, AE; Milligan, RA; Potter, CS; Carragher, B; Williamson, JR				Mulder, Anke M.; Yoshioka, Craig; Beck, Andrea H.; Bunner, Anne E.; Milligan, Ronald A.; Potter, Clinton S.; Carragher, Bridget; Williamson, James R.			Visualizing Ribosome Biogenesis: Parallel Assembly Pathways for the 30S Subunit	SCIENCE			English	Article							ESCHERICHIA-COLI; RNA; PROTEINS; RECONSTITUTION; LANDSCAPE; COMPLEXES; DYNAMICS	Ribosomes are self-assembling macromolecular machines that translate DNA into proteins, and an understanding of ribosome biogenesis is central to cellular physiology. Previous studies on the Escherichia coli 30S subunit suggest that ribosome assembly occurs via multiple parallel pathways rather than through a single rate-limiting step, but little mechanistic information is known about this process. Discovery single-particle profiling (DSP), an application of time-resolved electron microscopy, was used to obtain more than 1 million snapshots of assembling 30S subunits, identify and visualize the structures of 14 assembly intermediates, and monitor the population flux of these intermediates over time. DSP results were integrated with mass spectrometry data to construct the first ribosome-assembly mechanism that incorporates binding dependencies, rate constants, and structural characterization of populated intermediates.	[Beck, Andrea H.; Bunner, Anne E.; Williamson, James R.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Beck, Andrea H.; Bunner, Anne E.; Williamson, James R.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Beck, Andrea H.; Bunner, Anne E.; Williamson, James R.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Mulder, Anke M.; Yoshioka, Craig; Milligan, Ronald A.; Potter, Clinton S.; Carragher, Bridget] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Williamson, JR (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	jrwill@scripps.edu	Williamson, James R/B-2891-2009; Williamson, James/AAL-2104-2021; Yoshioka, Craig/ABH-3720-2020	Williamson, James R/0000-0002-8772-468X; Williamson, James/0000-0002-8772-468X; Carragher, Bridget/0000-0002-0624-5020; Bunner, Anne/0000-0002-0305-1300	NIH [RR175173, R37-GM-53757, GM-52468]; NSF; NIH through the National Center for Research Resources [RR175173, RR023093]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR023093, P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053757, R37GM052468, R01GM052468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (grants RR175173, R37-GM-53757, and GM-52468) and the NSF (graduate research fellowship to A. M. M.). The EM data collection and analysis were conducted at the National Resource for Automated Molecular Microscopy, which is supported by the NIH through the National Center for Research Resources P41 program (grants RR175173 and RR023093). We thank N. R. Voss and members of the Automated Molecular Imaging and Williamson laboratories for critical discussion of experiments. MAP, structure factors, and layer-line data have been deposited at EMDB with accession code EMD-1783.	Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Bunner AE, 2010, J MOL BIOL, V398, P1, DOI 10.1016/j.jmb.2010.02.036; Bunner AE, 2010, P NATL ACAD SCI USA, V107, P5417, DOI 10.1073/pnas.0912007107; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2006, 3 DIMENSIONAL ELECT; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; MANDIYAN V, 1991, P NATL ACAD SCI USA, V88, P8174, DOI 10.1073/pnas.88.18.8174; MIZUSHIMA S, 1970, NATURE, V226, P1214, DOI 10.1038/2261214a0; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; NOMURA M, 1973, SCIENCE, V179, P864, DOI 10.1126/science.179.4076.864; PAULING L, 1968, P NATL ACAD SCI USA, V60, P59, DOI 10.1073/pnas.60.1.59; POWERS T, 1993, J MOL BIOL, V232, P362, DOI 10.1006/jmbi.1993.1396; Ruiz Teresa, 2006, V319, P403; SERDYUK IN, 1983, J MOL BIOL, V169, P409, DOI 10.1016/S0022-2836(83)80058-8; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Zhang W, 2008, STRUCTURE, V16, P1770, DOI 10.1016/j.str.2008.10.011	17	144	148	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					673	677		10.1126/science.1193220	http://dx.doi.org/10.1126/science.1193220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030658	Green Accepted			2022-12-24	WOS:000283580600049
J	Moreno, JD				Moreno, Jonathan D.			Long shadow of the stem-cell ruling	NATURE			English	Editorial Material									Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Moreno, JD (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.								0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1031	1032		10.1038/4671031a	http://dx.doi.org/10.1038/4671031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671XW	20981069				2022-12-24	WOS:000283548600013
J	Smoot, GF				Smoot, George F.			Thinking in aeons	NATURE			English	Editorial Material									Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Smoot, GF (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S12	S12		10.1038/467S12a	http://dx.doi.org/10.1038/467S12a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944612	Bronze			2022-12-24	WOS:000282898700011
J	Nijhout, HF; Grunert, LW				Nijhout, H. Frederik; Grunert, Laura W.			The Cellular and Physiological Mechanism of Wing-Body Scaling in Manduca sexta	SCIENCE			English	Article							PROTHORACIC GLAND; TOBACCO HORNWORM; CRITICAL WEIGHT; IMAGINAL DISKS; SIZE; DROSOPHILA; GROWTH; ECDYSONE; INSECTS; NUTRITION	In animals, appendages develop in proportion to overall body size; when individual size varies, appendages covary proportionally. In insects with complete metamorphosis, adult appendages develop from precursor tissues called imaginal disks that grow after somatic growth has ceased. It is unclear, however, how the growth of these appendages is matched to the already established body size. We studied the pattern of cell division in the tobacco hornworm Manduca sexta and found that both the rate of cell division and the duration of growth of the wing imaginal disks depend on the size of the body in which they develop. Moreover, we found that both of these processes are controlled by the level and duration of secretion of the steroid hormone ecdysone. Thus, proportional growth is under hormonal control and indirectly regulated by the central nervous system.	[Nijhout, H. Frederik; Grunert, Laura W.] Duke Univ, Dept Biol, Durham, NC 27705 USA	Duke University	Nijhout, HF (corresponding author), Duke Univ, Dept Biol, Durham, NC 27705 USA.	hfn@duke.edu			NSF [IOS-0641144, IOS-0744952]	NSF(National Science Foundation (NSF))	We thank C. Shreve, V. Callier, R. Dilling, K. Preuss, and I. Jalli for assistance and helpful discussions. Supported by NSF grants IOS-0641144 and IOS-0744952.	ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Champlin DT, 1998, DEVELOPMENT, V125, P2009; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; KATO Y, 1987, DEVELOPMENT, V100, P227; Kingan TG, 2000, J EXP BIOL, V203, P3011; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Leopold P, 2006, SCIENCE, V312, P1317, DOI 10.1126/science.1128343; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2009, DEVELOPMENT, V136, P2345, DOI 10.1242/dev.032672; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43; Nijhout H.F., 1994, INSECT HORMONES; Nijhout HF, 2007, DEV BIOL, V302, P569, DOI 10.1016/j.ydbio.2006.10.023; NIJHOUT HF, 1979, J INSECT PHYSIOL, V25, P277, DOI 10.1016/0022-1910(79)90055-6; NIJHOUT HF, 1984, J INSECT PHYSIOL, V30, P629, DOI 10.1016/0022-1910(84)90047-7; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Orme MH, 2005, CELL METAB, V2, P277, DOI 10.1016/j.cmet.2005.10.005; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SCHWARTZ LM, 1983, DEV BIOL, V99, P103, DOI 10.1016/0012-1606(83)90257-9; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Stern DL, 1999, DEVELOPMENT, V126, P1091; TRUMAN JW, 1981, AM ZOOL, V21, P655; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	34	55	55	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1693	1695		10.1126/science.1197292	http://dx.doi.org/10.1126/science.1197292			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21109634				2022-12-24	WOS:000285390500071
J	Schindler, D				Schindler, David			Tar sands need solid science	NATURE			English	Editorial Material							EARLY-LIFE STAGES; CYP1A INDUCTION; ATHABASCA RIVER; OIL		Univ Alberta, Edmonton, AB T6G 2E9, Canada	University of Alberta	Schindler, D (corresponding author), Univ Alberta, Edmonton, AB T6G 2E9, Canada.	d.schindler@ualberta.ca						Chen, 2009, CANC INCIDENCE FORT; Colavecchia MV, 2007, J TOXICOL ENV HEAL A, V70, P1542, DOI 10.1080/15287390701384726; Colavecchia MV, 2006, J TOXICOL ENV HEAL A, V69, P967, DOI 10.1080/15287390500362154; Kelly EN, 2010, P NATL ACAD SCI USA, V107, P16178, DOI 10.1073/pnas.1008754107; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; *LIB PART CAN, 2010, HIDD DIM WAT OIL SAN; *NEW DEM PART CAN, 2010, MISS ACT FED GOV PRO; Rosenberg, 2004, OIL SANDS REGIONAL A; Squires Allison J., 2010, Integrated Environmental Assessment and Management, V6, P119, DOI 10.1897/IEAM_2008-081.1; Timoney Kevin P., 2009, Open Conservation Biology Journal, V3, P65, DOI 10.2174/1874839200903010065	10	96	96	0	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					499	501		10.1038/468499a	http://dx.doi.org/10.1038/468499a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684WA	21107404	Bronze			2022-12-24	WOS:000284584200016
J	Someya, S; Yu, W; Hallows, WC; Xu, JZ; Vann, JM; Leeuwenburgh, C; Tanokura, M; Denu, JM; Prolla, TA				Someya, Shinichi; Yu, Wei; Hallows, William C.; Xu, Jinze; Vann, James M.; Leeuwenburgh, Christiaan; Tanokura, Masaru; Denu, John M.; Prolla, Tomas A.			Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric Restriction	CELL			English	Article							GLUTATHIONE REDOX STATE; DIETARY RESTRICTION; CELL-DEATH; RAT-LIVER; LIFE-SPAN; MICE; DISEASE; STRESS; MITOCHONDRIA; DEACETYLASE	Caloric restriction (CR) extends the life span and health span of a variety of species and slows the progression of age-related hearing loss (AHL), a common age-related disorder associated with oxidative stress. Here, we report that CR reduces oxidative DNA damage in multiple tissues and prevents AHL in wild-type mice but fails to modify these phenotypes in mice lacking the mitochondrial deacetylase Sirt3, a member of the sirtuin family. In response to CR, Sirt3 directly deacetylates and activates mitochondrial isocitrate dehydrogenase 2 (Idh2), leading to increased NADPH levels and an increased ratio of reduced-to-oxidized glutathione in mitochondria. In cultured cells, overexpression of Sirt3 and/or Idh2 increases NADPH levels and protects from oxidative stress-induced cell death. Therefore, our findings identify Sirt3 as an essential player in enhancing the mitochondrial glutathione antioxidant defense system during CR and suggest that Sirt3-dependent mitochondrial adaptations may be a central mechanism of aging retardation in mammals.	[Yu, Wei; Hallows, William C.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Someya, Shinichi; Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Someya, Shinichi; Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Someya, Shinichi; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Xu, Jinze; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr, Gainesville, FL 32611 USA; [Xu, Jinze; Leeuwenburgh, Christiaan] Univ Florida, Inst Aging, Gainesville, FL 32611 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Denu, JM (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	jmdenu@wisc.edu; taprolla@wisc.edu	YU, WEI/G-4128-2013; Xu, Jinze/G-7868-2011; YU, WEI/C-3822-2012	YU, WEI/0000-0001-9898-4607; Leeuwenburgh, Christiaan/0000-0003-0826-4257; Tanokura, Masaru/0000-0001-5072-2480	NIH [AG021905, GM065386]; Ministry of Education, Culture, Sports, Science, and Technologies of Japan; Marine Bio Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740, R01AG021905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technologies of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Marine Bio Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Kinoshita for histological processing. This research was supported by NIH grants AG021905 (T.A.P.) and GM065386 (J.M.D.), the National Projects on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science, and Technologies of Japan, and Marine Bio Foundation.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Halliwell B.G.J.M.C., 2007, FREE RADICALS BIOL M; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014; HUNTER KP, 1987, HEARING RES, V30, P207, DOI 10.1016/0378-5955(87)90137-7; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Johnson KR, 2010, HEARING RES, V268, P85, DOI 10.1016/j.heares.2010.05.002; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; KORNBERG A, 1955, METHOD ENZYMOL, V1, P705, DOI 10.1016/0076-6879(55)01122-1; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McFadden SL, 1999, NEUROBIOL AGING, V20, P1, DOI 10.1016/S0197-4580(99)00018-4; McNeill DR, 2007, MOL CANCER RES, V5, P61, DOI 10.1158/1541-7786.MCR-06-0329; Meira LB, 2009, P NATL ACAD SCI USA, V106, P888, DOI 10.1073/pnas.0807030106; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; OLAFSDOTTIR K, 1988, BIOCHIM BIOPHYS ACTA, V964, P377, DOI 10.1016/0304-4165(88)90038-4; Paeratakul S, 2002, INT J OBESITY, V26, P1205, DOI 10.1038/sj.ijo.0802026; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Rebrin I, 2008, ADV DRUG DELIVER REV, V60, P1545, DOI 10.1016/j.addr.2008.06.001; Rebrin I, 2007, BRAIN RES, V1127, P10, DOI 10.1016/j.brainres.2006.10.040; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024; Someya S, 2010, MECH AGEING DEV, V131, P480, DOI 10.1016/j.mad.2010.04.006; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; STEEL KP, 1983, ARCH OTOLARYNGOL, V109, P22; STEEL KP, 1996, HEARING RES, V28, P227; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; SWEET RJ, 1988, AUDIOLOGY, V27, P305; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weindruch R., 1988, RETARDATION AGING DI; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhu HY, 1999, BRAIN RES, V842, P224, DOI 10.1016/S0006-8993(99)01827-2	63	842	886	7	141	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					802	812		10.1016/j.cell.2010.10.002	http://dx.doi.org/10.1016/j.cell.2010.10.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21094524	Green Accepted, Bronze			2022-12-24	WOS:000284583500021
J	Dhruva, SS; Redberg, RF				Dhruva, Sanket S.; Redberg, Rita F.			Accelerated Approval and Possible Withdrawal of Midodrine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Redberg, Rita F.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Sch Med, Dept Med, 505 Parnassus Ave,Ste M-1180, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu						Fleming TR, 2005, HEALTH AFFAIR, V24, P67, DOI 10.1377/hlthaff.24.1.67; *GEN, 2010, GEN PROV UPD AV ADV; HARRIS G, 2010, NY TIMES        0903; NAINGGOLAN L, FDA DOES U TURN MIDO; POLLACK A, 2010, NY TIMES        0917; Temple R, 1999, JAMA-J AM MED ASSOC, V282, P790, DOI 10.1001/jama.282.8.790; U.S. Government Accounting Office, 2009, NEW DRUG APPR FDA NE; *US FDA, 2010, FDA PROP WITHDR LOW; *US FDA, 2010, MID UPD SEPT 10	9	29	29	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2172	2173		10.1001/jama.2010.1695	http://dx.doi.org/10.1001/jama.2010.1695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21081731				2022-12-24	WOS:000284269800029
J	Hillman, M				Hillman, Mayer			Personal View More daylight, better health: why we shouldn't be putting the clocks back this weekend	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Westminster, Policy Studies Inst, London W1R 8AL, England	University of Westminster	Hillman, M (corresponding author), Univ Westminster, Policy Studies Inst, London W1R 8AL, England.	mayer.hillman@blueyonder.co.uk						Hillman M, 2010, MAKING MOST DAYLIGHT; HILLMAN M, 1988, MAKING MOST DAYLIGHT	2	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2010	341								c5964	10.1136/bmj.c5964	http://dx.doi.org/10.1136/bmj.c5964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YY	20980369				2022-12-24	WOS:000283790400010
J	da Fonseca, PCA; Kong, EH; Zhang, ZG; Schreiber, A; Williams, MA; Morris, EP; Barford, D				da Fonseca, Paula C. A.; Kong, Eric H.; Zhang, Ziguo; Schreiber, Anne; Williams, Mark. A.; Morris, Edward P.; Barford, David			Structures of APC/C-Cdh1 with substrates identify Cdh1 and Apc10 as the D-box co-receptor	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; DESTRUCTION BOX; CRYSTAL-STRUCTURE; CYCLIN-B; KEN BOX; RECOGNITION; SUBUNIT; BINDING; YEAST; COMPLEX/CYCLOSOME	The ubiquitylation of cell-cycle regulatory proteins by the large multimeric anaphase-promoting complex (APC/C) controls sister chromatid segregation and the exit from mitosis(1,2). Selection of APC/C targets is achieved through recognition of destruction motifs, predominantly the destruction (D)-box(3) and KEN (Lys-Glu-Asn)-box(4). Although this process is known to involve a coactivator protein (either Cdc20 or Cdh1) together with core APC/C subunits(1,2), the structural basis for substrate recognition and ubiquitylation is not understood. Here we investigate budding yeast APC/C using single-particle electron microscopy and determine a cryo-electron microscopy map of APC/C in complex with the Cdh1 co-activator protein (APC/C-Cdh1) bound to a D-box peptide at similar to 10 angstrom resolution. We find that a combined catalytic and substrate-recognition module is located within the central cavity of the APC/C assembled from Cdh1, Apc10-a core APC/C subunit previously implicated in substrate recognition(5-7)-and the cullin domain of Apc2. Cdh1 and Apc10, identified from difference maps, create a co-receptor for the D-box following repositioning of Cdh1 towards Apc10. Using NMR spectroscopy we demonstrate specific D-box-Apc10 interactions, consistent with a role for Apc10 in directly contributing towards D-box recognition by the APC/C-Cdh1 complex. Our results rationalize the contribution of both co-activator and core APC/C subunits to D-box recognition(8,9) and provide a structural framework for understanding mechanisms of substrate recognition and catalysis by the APC/C.	[da Fonseca, Paula C. A.; Kong, Eric H.; Zhang, Ziguo; Schreiber, Anne; Morris, Edward P.; Barford, David] Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; [Williams, Mark. A.] Univ London, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 7HX, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Birkbeck University London	Barford, D (corresponding author), Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk		Morris, Edward/0000-0003-3544-0041; da Fonseca, Paula/0000-0001-8656-5747; Williams, Mark/0000-0002-1645-2189	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK grant to D. B. We thank F. Beuron for help with the early stages of this project and for EM support. We are grateful to J. Kirkpatrick for the use of the facilities of the UCL/Birkbeck Institute of Structural Molecular Biology (ISMB) Biomolecular NMR Centre.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Baryshnikova OK, 2008, J BIOMOL NMR, V41, P5, DOI 10.1007/s10858-008-9234-6; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	38	147	149	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					274	+		10.1038/nature09625	http://dx.doi.org/10.1038/nature09625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21107322	Green Accepted			2022-12-24	WOS:000287144200047
J	Harris, KM; Maurer, J; Kellermann, AL				Harris, Katherine M.; Maurer, Juergen; Kellermann, Arthur L.			Influenza Vaccine -- Safe, Effective, and Mistrusted.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Harris, Katherine M.; Maurer, Juergen; Kellermann, Arthur L.] RAND Corp, Arlington, VA USA	RAND Corporation	Harris, KM (corresponding author), RAND Corp, Arlington, VA USA.			/0000-0002-3923-677X				Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080; MOYER CS, 2010, AM MED NEWS     0719; SteelFisher GK, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1005102	5	40	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2183	2185		10.1056/NEJMp1012333	http://dx.doi.org/10.1056/NEJMp1012333			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688EP	21105831				2022-12-24	WOS:000284832900002
J	Matsuki, T; Matthews, RT; Cooper, JA; van der Brug, MP; Cookson, MR; Hardy, JA; Olson, EC; Howell, BW				Matsuki, Tohru; Matthews, Russell T.; Cooper, Jonathan A.; van der Brug, Marcel P.; Cookson, Mark R.; Hardy, John A.; Olson, Eric C.; Howell, Brian W.			Reelin and Stk25 Have Opposing Roles in Neuronal Polarization and Dendritic Golgi Deployment	CELL			English	Article							MATRIX PROTEIN GM130; APOE RECEPTOR 2; TYROSINE PHOSPHORYLATION; TAU PHOSPHORYLATION; BRAIN-DEVELOPMENT; CORTICAL-NEURONS; VLDL RECEPTOR; SAD KINASES; POLARITY; MOUSE	The Reelin ligand regulates a Dab1-dependent signaling pathway required for brain lamination and normal dendritogenesis, but the specific mechanisms underlying these actions remain unclear. We find that Stk25, a modifier of Reelin-Dab1 signaling, regulates Golgi morphology and neuronal polarization as part of an LKB1-Stk25-Golgi matrix protein 130 (GM130) signaling pathway. Overexpression of Stk25 induces Golgi condensation and multiple axons, both of which are rescued by Reelin treatment. Reelin stimulation of cultured neurons induces the extension of the Golgi into dendrites, which is suppressed by Stk25 overexpression. In vivo, Reelin and Dab1 are required for the normal extension of the Golgi apparatus into the apical dendrites of hippocampal and neocortical pyramidal neurons. This demonstrates that the balance between Reelin-Dab1 signaling and LKB1-Stk25-GM130 regulates Golgi dispersion, axon specification, and dendrite growth and provides insights into the importance of the Golgi apparatus for cell polarization.	[Matsuki, Tohru; Matthews, Russell T.; Olson, Eric C.; Howell, Brian W.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [van der Brug, Marcel P.; Cookson, Mark R.; Hardy, John A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Cooper, Jonathan A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Fred Hutchinson Cancer Center	Howell, BW (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.	howellb@upstate.edu	Hardy, John/C-2451-2009; Cookson, Mark/AAW-2516-2021	Hardy, John/0000-0002-3122-0423; Cookson, Mark/0000-0002-1058-3831; Matsuki, Tohru/0000-0003-1832-2406; Howell, Brian/0000-0002-0204-0773	NINDS; SUNY Upstate Medical University; NIH [NS066071, NS069660, CA41072]; NIA; NATIONAL CANCER INSTITUTE [R37CA041072, R01CA041072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066071, R01NS069660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000947] Funding Source: NIH RePORTER; Medical Research Council [G0701075] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); SUNY Upstate Medical University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Zainab Mansaray and Kristin Giamanco for experimental assistance, Michael Zuber for comments on the manuscript, Hans Clevers for cell lines, Louis Cantley and Jun-ichi Miyazaki for DNA vectors, Arvydas Matiukas and Melissa Pepling for assistance with confocal microscopy, and Bonnie Lee Howell for editing. This work was supported by funds from the NINDS intramural program and SUNY Upstate Medical University to B.W.H.; NIH grants NS066071 to E.C.O., NS069660 to R.T.M., and CA41072 to J.A.C.; and NIA intramural funds for M.R.C.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Asada N, 2007, J NEUROSCI, V27, P11769, DOI 10.1523/JNEUROSCI.1938-07.2007; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Brich J, 2003, J NEUROSCI, V23, P187; CAVINESS VS, 1973, J COMP NEUROL, V147, P235, DOI 10.1002/cne.901470206; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Anda FC, 2010, J NEUROSCI, V30, P10391, DOI 10.1523/JNEUROSCI.0381-10.2010; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; Nichols AJ, 2010, CEREB CORTEX, V20, P2213, DOI 10.1093/cercor/bhp303; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Sanchez-Ponce D, 2008, MOL CELL NEUROSCI, V37, P832, DOI 10.1016/j.mcn.2008.01.010; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sutterlin C, 2010, J CELL BIOL, V188, P621, DOI 10.1083/jcb.200910001; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	57	113	117	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					826	836		10.1016/j.cell.2010.10.029	http://dx.doi.org/10.1016/j.cell.2010.10.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111240	Green Accepted, Bronze			2022-12-24	WOS:000284583500023
J	Nakagawa, K; Hirota, Y; Sawada, N; Yuge, N; Watanabe, M; Uchino, Y; Okuda, N; Shimomura, Y; Suhara, Y; Okano, T				Nakagawa, Kimie; Hirota, Yoshihisa; Sawada, Natsumi; Yuge, Naohito; Watanabe, Masato; Uchino, Yuri; Okuda, Naoko; Shimomura, Yuka; Suhara, Yoshitomo; Okano, Toshio			Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme	NATURE			English	Article							DIETARY PHYLLOQUINONE; GENE; VITAMIN-K-2; CONVERSION; ACCUMULATION; METABOLISM; MUTATIONS; TISSUES; RATS	Vitamin K occurs in the natural world in several forms, including a plant form, phylloquinone (PK), and a bacterial form, menaquinones (MKs). In many species, including humans, PK is a minor constituent of hepatic vitamin K content, with most hepatic vitamin K content comprising long-chain MKs. Menaquinone-4 (MK-4) is ubiquitously present in extrahepatic tissues, with particularly high concentrations in the brain, kidney and pancreas of humans and rats(1-3). It has consistently been shown that PK is endogenously converted to MK-4 (refs 4-8). This occurs either directly within certain tissues or by interconversion to menadione (K-3), followed by prenylation to MK-4 (refs 9-12). No previous study has sought to identify the human enzyme responsible for MK-4 biosynthesis. Previously we provided evidence for the conversion of PK and K3 into MK-4 in mouse cerebra(13). However, the molecular mechanisms for these conversion reactions are unclear. Here we identify a human MK-4 biosynthetic enzyme. We screened the human genome database for prenylation enzymes and found UbiA prenyltransferase containing 1 (UBIAD1), a human homologue of Escherichia coli prenyltransferase menA. We found that short interfering RNA against the UBIAD1 gene inhibited the conversion of deuterium-labelled vitamin K derivatives into deuterium-labelled-MK-4 (MK-4-d(7)) in human cells. We confirmed that the UBIAD1 gene encodes an MK-4 biosynthetic enzyme through its expression and conversion of deuterium-labelled vitamin K derivatives into MK-4-d(7) in insect cells infected with UBIAD1 baculovirus. Converted MK-4-d(7) was chemically identified by H-2-NMR analysis. MK-4 biosynthesis by UBIAD1 was not affected by the vitamin K antagonist warfarin. UBIAD1 was localized in endoplasmic reticulum and ubiquitously expressed in several tissues of mice. Our results show that UBIAD1 is a human MK-4 biosynthetic enzyme; this identification will permit more effective decisions to be made about vitamin K intake and bone health.	[Nakagawa, Kimie; Hirota, Yoshihisa; Sawada, Natsumi; Yuge, Naohito; Watanabe, Masato; Uchino, Yuri; Okuda, Naoko; Shimomura, Yuka; Suhara, Yoshitomo; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Okano, T (corresponding author), Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	t-okano@kobepharma-u.ac.jp	Hirota, Yoshihisa/R-6741-2019	Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Sugiura and A. Takeuchi for technical support with <SUP>2</SUP>H-NMR analysis and LC-APCI-MS/MS analysis. This work was supported in part by priority areas from the Ministry of Education, Culture, Sports, Science and Technology (to K.N. and T.O.).	BILLETER M, 1960, BIOCHEM Z, V333, P430; Booth SL, 1998, J NUTR, V128, P785, DOI 10.1093/jn/128.5.785; Davidson RT, 1998, J NUTR, V128, P220, DOI 10.1093/jn/128.2.220; DIALAMEH G H, 1970, Biochimica et Biophysica Acta, V223, P332; GUILLAUMONT M, 1992, INT J VITAM NUTR RES, V62, P15; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Igarashi M, 2007, MOL CELL BIOL, V27, P7947, DOI 10.1128/MCB.00813-07; Lin E. C. C., 1987, ESCHERICHIA COLI SAL, P202; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; MARTIUS C, 1961, AM J CLIN NUTR, V9, P97, DOI 10.1093/ajcn/9.4.97; MARTIUS C, 1959, BIOCHEM Z, V331, P1; MEGANATHAN R, 1996, ESCHERICHIA COLI SAL, P642; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Ronden JE, 1998, BBA-GEN SUBJECTS, V1379, P69, DOI 10.1016/S0304-4165(97)00089-5; Shearer M.J., 1988, CURRENT ADV VITAMIN, P437; Shearer MJ, 2008, THROMB HAEMOSTASIS, V100, P530, DOI 10.1160/TH08-03-0147; Spronk HMH, 2003, J VASC RES, V40, P531, DOI 10.1159/000075344; Suhara Y, 2009, BIOORG MED CHEM LETT, V19, P1054, DOI 10.1016/j.bmcl.2009.01.021; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; TAGGART WV, 1969, BIOCHEMISTRY-US, V8, P1141, DOI 10.1021/bi00831a047; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Thijssen HHW, 1996, BRIT J NUTR, V75, P121, DOI 10.1079/BJN19960115; THIJSSEN HHW, 1994, BRIT J NUTR, V72, P415, DOI 10.1079/BJN19940043; Thijssen HHW, 1996, J NUTR, V126, P537, DOI 10.1093/jn/126.2.537; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; [No title captured]	30	214	234	2	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					117	+		10.1038/nature09464	http://dx.doi.org/10.1038/nature09464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20953171				2022-12-24	WOS:000283786900047
J	Srivastava, R				Srivastava, Ranjana			The Power Proxy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Melbourne, Vic, Australia.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1786	1789		10.1056/NEJMp1003221	http://dx.doi.org/10.1056/NEJMp1003221			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YK	21047221				2022-12-24	WOS:000283787800003
J	Pang, SS; Berry, R; Chen, ZJ; Kjer-Nielsen, L; Perugini, MA; King, GF; Wang, C; Chew, SH; La Gruta, NL; Williams, NK; Beddoe, T; Tiganis, T; Cowieson, NP; Godfrey, DI; Purcell, AW; Wilce, MCJ; McCluskey, J; Rossjohn, J				Pang, Siew Siew; Berry, Richard; Chen, Zhenjun; Kjer-Nielsen, Lars; Perugini, Matthew A.; King, Glenn F.; Wang, Christina; Chew, Sock Hui; La Gruta, Nicole L.; Williams, Neal K.; Beddoe, Travis; Tiganis, Tony; Cowieson, Nathan P.; Godfrey, Dale I.; Purcell, Anthony W.; Wilce, Matthew C. J.; McCluskey, James; Rossjohn, Jamie			The structural basis for autonomous dimerization of the pre-T-cell antigen receptor	NATURE			English	Article							ANALYTICAL ULTRACENTRIFUGATION; SEDIMENTATION-VELOCITY; ALPHA; TCR; BETA; SELECTION; ANGSTROM; OPINION; CHAINS; PHENIX	The pre-T-cell antigen receptor (pre-TCR), expressed by immature thymocytes, has a pivotal role in early T-cell development, including TCR beta-selection, survival and proliferation of CD4(-)CD8(-) double-negative thymocytes, and subsequent ab T-cell lineage differentiation(1-3). Whereas alpha beta TCR ligation by the peptide-loaded major histocompatibility complex initiates T-cell signalling(4), preTCR-induced signalling occurs by means of a ligand-independent dimerization event(5). The pre-TCR comprises an invariant a-chain (pre-T alpha) that pairs with any TCR beta-chain (TCR beta) following successful TCR beta-gene rearrangement(6). Here we provide the basis of pre-T alpha-TCR beta assembly and pre-TCR dimerization. The pre-T alpha chain comprised a single immunoglobulin-like domain that is structurally distinct from the constant (C) domain of the TCR alpha-chain(7); nevertheless, the mode of association between pre-T alpha and TCRb mirrored that mediated by the C alpha-C beta domains of the abTCR. The pre-TCR had a propensity to dimerize in solution, and the molecular envelope of the pre-TCR dimer correlated well with the observed head-to-tail pre-TCR dimer. This mode of pre-TCR dimerization enabled the pre-T alpha domain to interact with the variable (V) beta domain through residues that are highly conserved across the V beta and joining (J) beta gene families, thus mimicking the interactions at the core of the alpha beta TCR's V alpha-V beta interface. Disruption of this pre-T alpha-V beta dimer interface abrogated pre-TCR dimerization in solution and impaired pre-TCR expression on the cell surface. Accordingly, we provide a mechanism of pre-TCR self-association that allows the pre-T alpha chain to simultaneously 'sample' the correct folding of both the V and C domains of any TCR beta-chain, regardless of its ultimate specificity, which represents a critical checkpoint in T-cell development. This unusual dual-chaperone-like sensing function of pre-T alpha represents a unique mechanism in nature whereby developmental quality control regulates the expression and signalling of an integral membrane receptor complex.	[Chen, Zhenjun; Kjer-Nielsen, Lars; La Gruta, Nicole L.; Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Pang, Siew Siew; Berry, Richard; Wang, Christina; Chew, Sock Hui; Williams, Neal K.; Beddoe, Travis; Tiganis, Tony; Cowieson, Nathan P.; Wilce, Matthew C. J.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Prot Crystallog Unit, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Perugini, Matthew A.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Perugini, Matthew A.; Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [King, Glenn F.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia	University of Melbourne; Monash University; University of Melbourne; University of Melbourne; University of Queensland	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	jamesm1@unimelb.edu.au; jamie.rossjohn@monash.edu	Beddoe, Travis/F-3415-2014; King, Glenn F/J-5059-2012; Purcell, Anthony/AAH-1942-2019; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; Tiganis, Tony/AAV-3495-2020	Beddoe, Travis/0000-0003-4550-2277; King, Glenn F/0000-0002-2308-2200; Purcell, Anthony/0000-0003-0532-8331; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Tiganis, Tony/0000-0002-8065-9942; La Gruta, Nicole/0000-0001-5358-9363; Godfrey, Dale/0000-0002-3009-5472; berry, richard/0000-0001-7043-0469	Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank S. Turner for discussions; S. Ramarathinam for technical assistance; the staff at the Australian synchrotron (MX and SAXS/WAXS beamlines) and Berkeley Advanced Light Source (SIBYLS beamline) for assistance with data collection; and T. Caradoc-Davies for advice on processing of merohedral twinned X-ray data. This research was supported by grants from the Australian Research Council and the National Health and Medical Research Council of Australia. A.W.P., T.T. and M.C.J.W. are supported by NHMRC Senior Research Fellowships, and D.I.G. is supported by an NHMRC Principal Research Fellowship. M.A.P. is supported by an ARC Future Fellowship and J.R. is supported by an ARC Federation Fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Burger R, 1999, LEUKEMIA RES, V23, P19, DOI 10.1016/S0145-2126(98)00133-7; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dave VP, 2009, IMMUNOL REV, V232, P22, DOI 10.1111/j.1600-065X.2009.00835.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HIRANO T, 1979, J IMMUNOL, V123, P1133; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yamasaki S, 2007, TRENDS IMMUNOL, V28, P39, DOI 10.1016/j.it.2006.11.006; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	30	59	66	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					844	U110		10.1038/nature09448	http://dx.doi.org/10.1038/nature09448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944746				2022-12-24	WOS:000282898700067
J	Barnett, BP; Hwang, YS; Taylor, MS; Kirchner, H; Pfluger, PT; Bernard, V; Lin, YY; Bowers, EM; Mukherjee, C; Song, WJ; Longo, PA; Leahy, DJ; Hussain, MA; Tschop, MH; Boeke, JD; Cole, PA				Barnett, Brad P.; Hwang, Yousang; Taylor, Martin S.; Kirchner, Henriette; Pfluger, Paul T.; Bernard, Vincent; Lin, Yu-yi; Bowers, Erin M.; Mukherjee, Chandrani; Song, Woo-Jin; Longo, Patti A.; Leahy, Daniel J.; Hussain, Mehboob A.; Tschoep, Matthias H.; Boeke, Jef D.; Cole, Philip A.			Glucose and Weight Control in Mice with a Designed Ghrelin O-Acyltransferase Inhibitor	SCIENCE			English	Article							DES-ACYL GHRELIN; INSULIN-SECRETION; OBESITY; GOAT; HORMONE; ADIPOSITY; PHENOTYPE; RELEASE; PEPTIDE; HUMANS	Ghrelin is a gastric peptide hormone that stimulates weight gain in vertebrates. The biological activities of ghrelin require octanoylation of the peptide on Ser(3), an unusual posttranslational modification that is catalyzed by the enzyme ghrelin O-acyltransferase (GOAT). Here, we describe the design, synthesis, and characterization of GO-CoA-Tat, a peptide-based bisubstrate analog that antagonizes GOAT. GO-CoA-Tat potently inhibits GOAT in vitro, in cultured cells, and in mice. Intraperitoneal administration of GO-CoA-Tat improves glucose tolerance and reduces weight gain in wild-type mice but not in ghrelin-deficient mice, supporting the concept that its beneficial metabolic effects are due specifically to GOAT inhibition. In addition to serving as a research tool for mapping ghrelin actions, GO-CoA-Tat may help pave the way for clinical targeting of GOAT in metabolic diseases.	[Barnett, Brad P.; Hwang, Yousang; Taylor, Martin S.; Bowers, Erin M.; Mukherjee, Chandrani; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Barnett, Brad P.; Taylor, Martin S.; Bernard, Vincent; Lin, Yu-yi; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Barnett, Brad P.; Taylor, Martin S.; Bernard, Vincent; Lin, Yu-yi; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Kirchner, Henriette; Pfluger, Paul T.; Tschoep, Matthias H.] Univ Cincinnati, Dept Internal Med, Metab Dis Inst, Obes Res Ctr, Cincinnati, OH 45237 USA; [Song, Woo-Jin; Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21205 USA; [Song, Woo-Jin; Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Metab, Baltimore, MD 21205 USA; [Song, Woo-Jin; Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Div Metab, Baltimore, MD 21205 USA; [Longo, Patti A.; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Lin, Yu-yi] Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan; [Kirchner, Henriette; Tschoep, Matthias H.] German Inst Human Nutr, Dept Pharmacol, D-14558 Nuthetal, Germany	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Taiwan University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Cole, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	pcole@jhmi.edu	Tschoep, Matthias H/I-5443-2014; Barnett, Bradley/AAN-1628-2020; Barnett, Brad/AAY-2578-2020; song, woojin/G-3357-2013; Kirchner, Henriette/D-6699-2011; Pfluger, Paul T/A-3770-2019	Barnett, Bradley/0000-0002-8301-404X; Pfluger, Paul T/0000-0002-8118-7588; Tschoep, Matthias/0000-0002-4744-371X; Bernard, Vincent/0000-0003-1555-608X; Taylor, Martin/0000-0003-1560-9276; song, woojin/0000-0003-3197-6682; Boeke, Jef/0000-0001-5322-4946; Taylor, Martin/0000-0001-5824-142X	NIH; Pfeiffer Foundation; Kaufman Foundation; Keck Foundation; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081472, P60DK079637, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfeiffer Foundation; Kaufman Foundation; Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Shamblott, S. Bhat, A. Chambers, C. Schrum, J. Hembree, N. Forbes, M. Li, J. McClellan, M. Miller, K. O'Donnell-Mendell, J. Jabbari, W. Gibson, J. Liu, and D. Gladowski for advice and assistance; G. Ronnett, J. Liu, and R. Alani for critical reading of the manuscript; and the NIH Common Fund, Pfeiffer Foundation, Kaufman Foundation, and Keck Foundation for financial support. The authors (P. A. C., J. D. B., Y.H., and B. P. B.) and Johns Hopkins University have filed a patent on the GOAT inhibitors described here. The inhibitors have been licensed to the biotechnology company Acylin Therapeutics, Inc. P. A. C., J. D. B., and M. H. T. are on the Scientific Advisory Board and have equity in Acylin Therapeutics. M. H. T. also has equity in and is a member of the Scientific Advisory Boards of Marcadia Biotech, Inc., and Ambrx, Inc.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Ariyasu H, 2005, ENDOCRINOLOGY, V146, P355, DOI 10.1210/en.2004-0629; Broglio F, 2004, J CLIN ENDOCR METAB, V89, P3062, DOI 10.1210/jc.2003-031964; Dezaki K, 2008, PHARMACOL THERAPEUT, V118, P239, DOI 10.1016/j.pharmthera.2008.02.008; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Granata R, 2010, J MOL ENDOCRINOL, V45, P107, DOI 10.1677/JME-10-0019; Gualillo O, 2008, TRENDS PHARMACOL SCI, V29, P398, DOI 10.1016/j.tips.2008.06.003; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lu SC, 2009, MOL PHARMACOL, V75, P901, DOI 10.1124/mol.108.052852; Parang K, 2001, NAT STRUCT BIOL, V8, P37; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Tong J, 2010, DIABETES, V59, P2145, DOI 10.2337/db10-0504; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Yada T, 2008, CURR DIABETES REV, V4, P18, DOI 10.2174/157339908783502352; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang WZ, 2008, ENDOCRINOLOGY, V149, P4710, DOI 10.1210/en.2008-0263; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	28	198	207	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1689	1692		10.1126/science.1196154	http://dx.doi.org/10.1126/science.1196154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21097901	Green Accepted			2022-12-24	WOS:000285390500070
J	Reiter, NJ; Osterman, A; Torres-Larios, A; Swinger, KK; Pan, T; Mondragon, A				Reiter, Nicholas J.; Osterman, Amy; Torres-Larios, Alfredo; Swinger, Kerren K.; Pan, Tao; Mondragon, Alfonso			Structure of a bacterial ribonuclease P holoenzyme in complex with tRNA	NATURE			English	Article							PRECURSOR TRANSFER-RNA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; 2-METAL-ION MECHANISM; THERMOTOGA-MARITIMA; PROTEIN-COMPONENT; CONSERVED CORE; BINDING-SITE; ACTIVE-SITE; SUBSTRATE	Ribonuclease (RNase) P is the universal ribozyme responsible for 5'-end tRNA processing. We report the crystal structure of the Thermotoga maritima RNase P holoenzyme in complex with tRNA(Phe). The 154 kDa complex consists of a large catalytic RNA (P RNA), a small protein cofactor and a mature tRNA. The structure shows that RNA-RNA recognition occurs through shape complementarity, specific intermolecular contacts and base-pairing interactions. Soaks with a pre-tRNA 5' leader sequence with and without metal help to identify the 5' substrate path and potential catalytic metal ions. The protein binds on top of a universally conserved structural module in P RNA and interacts with the leader, but not with the mature tRNA. The active site is composed of phosphate backbone moieties, a universally conserved uridine nucleobase, and at least two catalytically important metal ions. The active site structure and conserved RNase P-tRNA contacts suggest a universal mechanism of catalysis by RNase P.	[Reiter, Nicholas J.; Osterman, Amy; Torres-Larios, Alfredo; Swinger, Kerren K.; Mondragon, Alfonso] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Mondragon, A (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu		Torres-Larios, Alfredo/0000-0002-0702-350X	NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087055, R01GM058443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Sontheimer and O. Uhlenbeck for comments and suggestions, N. Pace for the gift of the T. maritima RNase P protein plasmid, Obiter Research, A. Davis and M. E. Duban for advice and preparation of iridium hexammine, and A. Samelson for discussions and assistance. In addition, we are grateful for data collection assistance from S. Anderson, Z. Wawrzak, and staff at LS-CAT. Research was supported by the NIH. N.J.R. is an NRSA postdoctoral fellow.	Biswas R, 2000, J MOL BIOL, V296, P19, DOI 10.1006/jmbi.1999.3443; BROWN JW, 1990, CELL, V62, P407, DOI 10.1016/0092-8674(90)90003-W; Buck AH, 2005, NAT STRUCT MOL BIOL, V12, P958, DOI 10.1038/nsmb1004; Buck AH, 2005, EMBO J, V24, P3360, DOI 10.1038/sj.emboj.7600805; BURKARD U, 1988, NUCLEIC ACIDS RES, V16, P11617, DOI 10.1093/nar/16.24.11617; Chen JL, 1997, RNA, V3, P557; Chen Y, 1997, BIOCHEMISTRY-US, V36, P2425; Christian EL, 2000, RNA, V6, P511, DOI 10.1017/S1355838200000042; Christian EL, 2006, RNA, V12, P1463, DOI 10.1261/rna.158606; Crary SM, 2002, RNA, V8, P933, DOI 10.1017/S1355838202025025; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ferre-D'Amare AR, 1998, J MOL BIOL, V279, P621, DOI 10.1006/jmbi.1998.1789; Gaur RK, 1996, RNA, V2, P674; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hsieh J, 2010, J MOL BIOL, V400, P38, DOI 10.1016/j.jmb.2010.04.050; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Kazantsev AV, 2009, RNA, V15, P266, DOI 10.1261/rna.1331809; Kazantsev AV, 2005, P NATL ACAD SCI USA, V102, P13392, DOI 10.1073/pnas.0506662102; Kazantsev AV, 2003, P NATL ACAD SCI USA, V100, P7497, DOI 10.1073/pnas.0932597100; KIRSEBOM LA, 1994, EMBO J, V13, P4870, DOI 10.1002/j.1460-2075.1994.tb06814.x; Kirsebom LA, 2010, PROTEIN REV, V10, P113, DOI 10.1007/978-1-4419-1142-1_7; Koutmou KS, 2010, J MOL BIOL, V396, P195, DOI 10.1016/j.jmb.2009.11.039; Krasilnikov AS, 2004, SCIENCE, V306, P104, DOI 10.1126/science.1101489; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Krivenko AA, 2002, ACTA CRYSTALLOGR D, V58, P1234, DOI 10.1107/S0907444902007965; Krummel DAP, 2000, J MOL BIOL, V295, P1113, DOI 10.1006/jmbi.1999.3424; Kurz JC, 1998, BIOCHEMISTRY-US, V37, P2393, DOI 10.1021/bi972530m; LAGRANDEUR TE, 1994, EMBO J, V13, P3945, DOI 10.1002/j.1460-2075.1994.tb06710.x; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LIU F, 2010, PROTEIN REV, V10; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mondragon A, 2010, PROTEIN REV, V10, P63, DOI 10.1007/978-1-4419-1142-1_4; Niranjanakumari S, 1998, P NATL ACAD SCI USA, V95, P15212, DOI 10.1073/pnas.95.26.15212; Pan T, 1995, P NATL ACAD SCI USA, V92, P12510, DOI 10.1073/pnas.92.26.12510; PECKMILLER KA, 1991, J MOL BIOL, V221, P1; REICH C, 1988, SCIENCE, V239, P178, DOI 10.1126/science.3122322; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; Stams T, 1998, SCIENCE, V280, P752, DOI 10.1126/science.280.5364.752; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Sun L, 2006, EMBO J, V25, P3998, DOI 10.1038/sj.emboj.7601290; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Torres-Larios A, 2006, CURR OPIN STRUC BIOL, V16, P327, DOI 10.1016/j.sbi.2006.04.002; Tsai HY, 2003, J MOL BIOL, V325, P661, DOI 10.1016/S0022-2836(02)01267-6; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Warnecke JM, 1996, P NATL ACAD SCI USA, V93, P8924, DOI 10.1073/pnas.93.17.8924	50	204	205	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					784	789		10.1038/nature09516	http://dx.doi.org/10.1038/nature09516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21076397	Green Accepted			2022-12-24	WOS:000285093700037
J	McKnight, SL				McKnight, Steven L.			On Getting There from Here	SCIENCE			English	Editorial Material							FAMILY; HIF; PROTEIN; CANCER; DOMAIN	Studies on a variety of interesting biological problems, ranging from circadian rhythm to cancer cell growth to longevity, have begun to give evidence that the physiological state of cells and tissues reflects both the cell's regulatory systems and its state of intermediary metabolism. It is appreciated that the regulatory state of a cell or tissue, as driven by transcription factors and signaling pathways, can impose itself upon the dynamics of metabolic state. It follows that the reciprocal must also be the case, that metabolic state will feed back to impose itself on regulatory state. An appreciation and understanding of this reciprocity may be required to crack open problems in biological research that have heretofore been insoluble.	Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu						Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	16	80	81	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1338	1339		10.1126/science.1199908	http://dx.doi.org/10.1126/science.1199908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127243				2022-12-24	WOS:000284902100032
J	Gray, MW; Lukes, J; Archibald, JM; Keeling, PJ; Doolittle, WF				Gray, Michael W.; Lukes, Julius; Archibald, John M.; Keeling, Patrick J.; Doolittle, W. Ford			Irremediable Complexity?	SCIENCE			English	Editorial Material							EVOLUTION; INTRONS		[Gray, Michael W.; Archibald, John M.; Doolittle, W. Ford] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada; [Lukes, Julius] Univ S Bohemia, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	Dalhousie University; University of South Bohemia Ceske Budejovice; University of British Columbia	Gray, MW (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada.	ford@dal.ca	Lukes, Julius/H-6760-2012	Lukes, Julius/0000-0002-0578-6618; Gray, Michael/0000-0001-7125-2625; Keeling, Patrick/0000-0002-7644-0745; Doolittle, W. Ford/0000-0002-4675-8832				AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; COVELLO PS, 1993, TRENDS GENET, V9, P265, DOI 10.1016/0168-9525(93)90011-6; Fox GE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003483; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lynch M, 2007, ORIGINS GENOME ARCHI; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Paukstelis PJ, 2008, P NATL ACAD SCI USA, V105, P6010, DOI 10.1073/pnas.0801722105; Sancar A, 2008, NAT STRUCT MOL BIOL, V15, P23, DOI 10.1038/nsmb0108-23; Speijer D, 2006, IUBMB LIFE, V58, P91, DOI 10.1080/15216540600551355; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Szathmary E, 1995, MAJOR TRANSITIONS EV	13	168	168	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					920	921		10.1126/science.1198594	http://dx.doi.org/10.1126/science.1198594			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071654				2022-12-24	WOS:000284118000026
J	Rogowski, K; van Dijk, J; Magiera, MM; Bosc, C; Deloulme, JC; Bosson, A; Peris, L; Gold, ND; Lacroix, B; Grau, MB; Bec, N; Larroque, C; Desagher, S; Holzer, M; Andrieux, A; Moutin, MJ; Janke, C				Rogowski, Krzysztof; van Dijk, Juliette; Magiera, Maria M.; Bosc, Christophe; Deloulme, Jean-Christophe; Bosson, Anouk; Peris, Leticia; Gold, Nicholas D.; Lacroix, Benjamin; Grau, Montserrat Bosch; Bec, Nicole; Larroque, Christian; Desagher, Solange; Holzer, Max; Andrieux, Annie; Moutin, Marie-Jo; Janke, Carsten			A Family of Protein-Deglutamylating Enzymes Associated with Neurodegeneration	CELL			English	Article							PURKINJE-CELL-DEGENERATION; LIGHT-CHAIN KINASE; BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATION; ALPHA-TUBULIN; POLYGLUTAMYLATION; MOUSE; GLUTAMYLATION; EXPRESSION; TISSUES	Polyglutamylation is a posttranslational modification that generates glutamate side chains on tubulins and other proteins. Although this modification has been shown to be reversible, little is known about the enzymes catalyzing deglutamylation. Here we describe the enzymatic mechanism of protein deglutamylation by members of the cytosolic carboxypeptidase (CCP) family. Three enzymes (CCP1, CCP4, and CCP6) catalyze the shortening of polyglutamate chains and a fourth (CCP5) specifically removes the branching point glutamates. In addition, CCP1, CCP4, and CCP6 also remove gene-encoded glutamates from the carboxyl termini of proteins. Accordingly, we show that these enzymes convert detyrosinated tubulin into Delta 2-tubulin and also modify other substrates, including myosin light chain kinase 1. We further analyze Purkinje cell degeneration (pcd) mice that lack functional CCP1 and show that microtubule hyperglutamylation is directly linked to neurodegeneration. Taken together, our results reveal that controlling the length of the polyglutamate side chains on tubulin is critical for neuronal survival.	[Rogowski, Krzysztof; van Dijk, Juliette; Magiera, Maria M.; Gold, Nicholas D.; Lacroix, Benjamin; Grau, Montserrat Bosch; Janke, Carsten] Univ Montpellier 2 & 1, CNRS, UMR 5237, CRBM, F-34293 Montpellier, France; [Bosc, Christophe; Deloulme, Jean-Christophe; Bosson, Anouk; Peris, Leticia; Andrieux, Annie; Moutin, Marie-Jo] Univ Grenoble 1, CEA IRTSV GPC, Grenoble Inst Neurosci, INSERM U836, F-38042 Grenoble, France; [Bec, Nicole; Larroque, Christian] INSERM, Inst Rech Cancerol Montpellier, CRLC Val Aurelle, F-34298 Montpellier, France; [Desagher, Solange] Univ Montpellier 2, IGMM, CNRS, UMR 5535, F-34293 Montpellier, France; [Holzer, Max] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Leipzig University	Rogowski, K (corresponding author), Univ Montpellier 2 & 1, CNRS, UMR 5237, CRBM, F-34293 Montpellier, France.	krzysztof.rogowski@crbm.cnrs.fr; carsten.janke@curie.fr	Magiera, Maria M./Y-8754-2019; Holzer, Max/A-1729-2008; Moutin, Marie-Jo/P-7518-2017; peris, leticia/P-9249-2017; Bosc, Christophe/Q-8877-2019; Janke, Carsten/A-7279-2011; ANDRIEUX, ANNIE/B-2134-2017; Bosc, Christophe/P-3401-2017; Lacroix, Benjamin/AAL-8428-2020; Deloulme, Jean Christophe/P-6858-2017	Magiera, Maria M./0000-0003-4847-3053; Holzer, Max/0000-0003-1754-9932; Moutin, Marie-Jo/0000-0003-2681-9818; peris, leticia/0000-0002-0668-1252; Bosc, Christophe/0000-0002-3195-6692; Janke, Carsten/0000-0001-7053-2000; ANDRIEUX, ANNIE/0000-0002-4022-6405; Bosc, Christophe/0000-0002-3195-6692; Lacroix, Benjamin/0000-0003-2533-9150; Deloulme, Jean Christophe/0000-0002-2234-5865; Rogowski, Krzysztof/0000-0002-0206-3289; Bosch Grau, Montserrat/0000-0002-8990-9485; bec, nicole/0000-0001-7608-2434	CNRS; Universities Montpellier; Institut Curie; Association pour la Recherche sur le Cancer (ARC) [3140, 4892, 7927]; French National Research Agency (ANR) [05-JCJC-0035, 08-JCJC-0007]; Fondation pour la Recherche Medicale (FRM) [DEQ20081213977]; HFSP [RGP 23/2008]; EMBO [R07Job, ASTF 157-2007, ALTF 546-2006]; Alzheimer Forschung Initiative [06825]; La Ligue contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universities Montpellier; Institut Curie; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); French National Research Agency (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); HFSP(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Alzheimer Forschung Initiative; La Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the CNRS, the Universities Montpellier 2 and 1, the Institut Curie, the Association pour la Recherche sur le Cancer (ARC) award 3140 to C.J. and awards 4892 and 7927 to A.A., the French National Research Agency (ANR) awards 05-JCJC-0035 and 08-JCJC-0007 to C.J. and "Tyr-Tips" to A.A., the Fondation pour la Recherche Medicale (FRM) research grant DEQ20081213977, the HFSP program grant RGP 23/2008, and the EMBO Young Investigator Program grant to C.J., the La Ligue contre le cancer research grant R07Job to A.A., and the Alzheimer Forschung Initiative project 06825 to M.H. B.L. was supported by a fellowship from the La Ligue contre le Cancer and the EMBO short-term fellowship ASTF 157-2007. K.R. received two postdoctoral fellowships from the La Ligue contre le Cancer and the EMBO long-term fellowship ALTF 546-2006.	AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; BRE MH, 1994, CELL MOTIL CYTOSKEL, V27, P337, DOI 10.1002/cm.970270406; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Gao Y, 2001, IUBMB LIFE, V51, P337; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; Redeker V, 2004, BIOCHEMISTRY-US, V43, P12265, DOI 10.1021/bi049070z; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; Rusconi F, 1997, BIOCHEMISTRY-US, V36, P11021, DOI 10.1021/bi970752e; Smith AF, 1998, AM J PHYSIOL-CELL PH, V274, pC1188, DOI 10.1152/ajpcell.1998.274.5.C1188; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wloga D, 2010, EUKARYOT CELL, V9, P184, DOI 10.1128/EC.00176-09; WOLFF A, 1992, EUR J CELL BIOL, V59, P425	36	208	219	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					564	578		10.1016/j.cell.2010.10.014	http://dx.doi.org/10.1016/j.cell.2010.10.014			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074048	Green Submitted, Bronze			2022-12-24	WOS:000284149100014
J	Maertens, GN; Hare, S; Cherepanov, P				Maertens, Goedele N.; Hare, Stephen; Cherepanov, Peter			The mechanism of retroviral integration from X-ray structures of its key intermediates	NATURE			English	Article							VIRUS INTEGRASE; DNA INTEGRATION; AMINO-ACID; SITES; TRANSPOSITION; INTASOME; COMPLEX; HIV-1	To establish productive infection, a retrovirus must insert a DNA replica of its genome into host cell chromosomal DNA(1,2). This process is operated by the intasome, a nucleoprotein complex composed of an integrase tetramer (IN) assembled on the viral DNA ends(3,4). The intasome engages chromosomal DNA within a target capture complex to carry out strand transfer, irreversibly joining the viral and cellular DNA molecules. Although several intasome/transpososome structures from the DDE(D) recombinase superfamily have been reported(4-6), the mechanics of target DNA capture and strand transfer by these enzymes remained unclear. Here we report crystal structures of the intasome from prototype foamy virus in complex with target DNA, elucidating the pre-integration target DNA capture and post-catalytic strand transfer intermediates of the retroviral integration process. The cleft between IN dimers within the intasome accommodates chromosomal DNA in a severely bent conformation, allowing widely spaced IN active sites to access the scissile phosphodiester bonds. Our results resolve the structural basis for retroviral DNA integration and provide a framework for the design of INs with altered target sequences.	[Maertens, Goedele N.; Hare, Stephen; Cherepanov, Peter] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, London W2 1PG, England	Imperial College London	Cherepanov, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, St Marys Campus,Norfolk Pl, London W2 1PG, England.	p.cherepanov@imperial.ac.uk	Maertens, Goedele/D-8628-2015; Cherepanov, Peter P/F-6859-2010	Maertens, Goedele/0000-0002-1963-8026; Cherepanov, Peter P/0000-0002-0634-538X; Hare, Stephen/0000-0003-2951-1595	UK Medical Research Council; MRC [G0900116] Funding Source: UKRI; Medical Research Council [G0900116] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Engelman and F. Dyda for critical reading of the manuscript, J. Sanchez-Weatherby for assistance with X-ray data collection at the I02 beamline of the Diamond Light Source and J. Moore for help with crystallization screening and the X-ray generator. This work was funded by the UK Medical Research Council.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Craigie R, 2002, MOBILE DNA, P613; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Harper AL, 2003, J VIROL, V77, P3838, DOI 10.1128/JVI.77.6.3838-3845.2003; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Johnson RC, 2008, RSC BIOMOL SCI, P176; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konsavage WM, 2005, J VIROL, V79, P4691, DOI 10.1128/JVI.79.8.4691-4699.2005; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lim KI, 2010, P NATL ACAD SCI USA, V107, P12475, DOI 10.1073/pnas.1001402107; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Trobridge GD, 2006, P NATL ACAD SCI USA, V103, P1498, DOI 10.1073/pnas.0510046103; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005	26	240	242	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					326	U217		10.1038/nature09517	http://dx.doi.org/10.1038/nature09517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068843	Green Accepted, Green Submitted			2022-12-24	WOS:000284051000055
J	Mitrovich, QM; Tuch, BB; De La Vega, FM; Guthrie, C; Johnson, AD				Mitrovich, Quinn M.; Tuch, Brian B.; De La Vega, Francisco M.; Guthrie, Christine; Johnson, Alexander D.			Evolution of Yeast Noncoding RNAs Reveals an Alternative Mechanism for Widespread Intron Loss	SCIENCE			English	Article							SMALL NUCLEOLAR RNAS; CANDIDA-ALBICANS; SNORNAS; GENOME	The evolutionary forces responsible for intron loss are unresolved. Whereas research has focused on protein-coding genes, here we analyze noncoding small nucleolar RNA ( snoRNA) genes in which introns, rather than exons, are typically the functional elements. Within the yeast lineage exemplified by the human pathogen Candida albicans, we find-through deep RNA sequencing and genome-wide annotation of splice junctions-extreme compaction and loss of associated exons, but retention of snoRNAs within introns. In the Saccharomyces yeast lineage, however, we find it is the introns that have been lost through widespread degeneration of splicing signals. This intron loss, perhaps facilitated by innovations in snoRNA processing, is distinct from that observed in protein-coding genes with respect to both mechanism and evolutionary timing.	[Mitrovich, Quinn M.; Guthrie, Christine; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Mitrovich, Quinn M.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Tuch, Brian B.; De La Vega, Francisco M.] Life Technol, Res & Dev, Genet Syst Div, Foster City, CA 94404 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Thermo Fisher Scientific	Guthrie, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	christineguthrie@gmail.com; ajohnson@cgl.ucsf.edu	De La Vega, Francisco/H-3832-2011		NIH [GM021119, GM37049]; Life Technologies Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM021119, R37GM021119] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Technologies Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Barbacioru, O. Homann, S. Kuersten, S. Ledoux, I. Listerman, T. Lowe, C. Maeder, K. Pande, A. Price, S. Roy, J. Steitz, and members of the Guthrie and Johnson laboratories for helpful discussions and support; and M. Barker and C. Monighetti for providing sequence reads. This work was supported by NIH grants GM021119 (C. G.) and GM37049 (A. D. J.) and by Life Technologies Corp. C. G. is an American Cancer Society Research Professor of Molecular Genetics. Sequence data are available at the Gene Expression Omnibus (accession number GSE21291).	Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Brown JWS, 2008, TRENDS PLANT SCI, V13, P335, DOI 10.1016/j.tplants.2008.04.010; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Liu N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-515; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Marck C, 2006, NUCLEIC ACIDS RES, V34, P1816, DOI 10.1093/nar/gkl085; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Penny D, 2009, J MOL EVOL, V69, P527, DOI 10.1007/s00239-009-9279-5; Piekna-Przybylska D, 2007, RNA, V13, P305, DOI 10.1261/rna.373107; Qu LH, 1999, MOL CELL BIOL, V19, P1144; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Tuch BB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001070; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2	21	29	420	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					838	841		10.1126/science.1194554	http://dx.doi.org/10.1126/science.1194554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051641	Green Accepted			2022-12-24	WOS:000283855700048
J	Avorn, J				Avorn, Jerry			Medication Use in Older Patients Better Policy Could Encourage Better Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Avorn, Jerry] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA USA; [Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Ste 3030,1620 Tremont St, Boston, MA 02120 USA.	javorn@medsoc.harvard.edu						Avorn J, 2005, POWERFUL MED BENEFIT; Avorn J, 2003, GERIATRIC MED EVIDEN, P65; Boult C, 2010, HEALTH AFFAIR, V29, P811, DOI 10.1377/hlthaff.2010.0095; Boult C, 2009, J AM GERIATR SOC, V57, P2328, DOI 10.1111/j.1532-5415.2009.02571.x; *FUT HLTH CAR WORK, 2008, RET AG AM BUILD HLTH; *IND DRUG INF SERV, BAL DAT MED; Peterson JF, 2005, ARCH INTERN MED, V165, P802, DOI 10.1001/archinte.165.7.802; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; SCHONDELMEYER SW, 2010, RX PRICE WATCH REPOR; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233	10	30	31	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1606	1607		10.1001/jama.2010.1495	http://dx.doi.org/10.1001/jama.2010.1495			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940388				2022-12-24	WOS:000282816500027
J	Chakraborty, A; Koldobskiy, MA; Bello, NT; Maxwell, M; Potter, JJ; Juluri, KR; Maag, D; Kim, S; Huang, AS; Dailey, MJ; Saleh, M; Snowman, AM; Moran, TH; Mezey, E; Snyder, SH				Chakraborty, Anutosh; Koldobskiy, Michael A.; Bello, Nicholas T.; Maxwell, Micah; Potter, James J.; Juluri, Krishna R.; Maag, David; Kim, Seyun; Huang, Alex S.; Dailey, Megan J.; Saleh, Masoumeh; Snowman, Adele M.; Moran, Timothy H.; Mezey, Esteban; Snyder, Solomon H.			Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain	CELL			English	Article							PROTEIN-KINASE-B; MICE LACKING; PPAR-GAMMA; FAT MASS; PHOSPHORYLATION; ACTIVATION; MTOR; PHOSPHOINOSITIDES; RESISTANCE; MEMBRANE	The inositol pyrophosphate IP7 (5-diphosphoinositolpentakisphosphate), formed by a family of three inositol hexakisphosphate kinases (IP6Ks), modulates diverse cellular activities. We now report that IP7 is a physiologic inhibitor of Akt, a serine/threonine kinase that regulates glucose homeostasis and protein translation, respectively, via the GSK3 beta and mTOR pathways. Thus, Akt and mTOR signaling are dramatically augmented and GSK3b signaling reduced in skeletal muscle, white adipose tissue, and liver of mice with targeted deletion of IP6K1. IP7 affects this pathway by potently inhibiting the PDK1 phosphorylation of Akt, preventing its activation and thereby affecting insulin signaling. IP6K1 knockout mice manifest insulin sensitivity and are resistant to obesity elicited by high-fat diet or aging. Inhibition of IP6K1 may afford a therapeutic approach to obesity and diabetes.	[Chakraborty, Anutosh; Koldobskiy, Michael A.; Maxwell, Micah; Juluri, Krishna R.; Maag, David; Kim, Seyun; Huang, Alex S.; Saleh, Masoumeh; Snowman, Adele M.; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Bello, Nicholas T.; Dailey, Megan J.; Moran, Timothy H.; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Potter, James J.; Mezey, Esteban] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Kim, Seyun/B-3387-2012	Bello, Nicholas/0000-0001-5300-5604	U.S. Public Health Service [MH18501, DA-000266]; Research Scientist Award [DA00074]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266, K05DA000074] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Robert Luo for providing the pCDNA-TOPO-V5/His full-length and Delta PH Akt constructs; Susan Aja for the Oxymax experiments; Cory Brayton for histological analysis; Molee Chakraborty, Nadine Forbes, Kent Werner, and Gary Ho for technical support; and Asif Mustafa for helpful discussions. This work was supported by U.S. Public Health Service Grants MH18501 and DA-000266 and Research Scientist Award DA00074 (to S.H.S.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; BENNETT M, 2000, NAT REV MOL CELL BIO, V1, P11; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; CURRIE RA, 2001, BIOCHEM J, V337, P575; DEPINTO FL, 2010, LIVER INT, V30, P603; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Downes CP, 2005, BIOCHEM SOC T, V33, P1303, DOI 10.1042/BST0331303; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; FRUMAN DA, 1985, BIOCHEM SOC T, V27, P624; Funai K, 2006, AM J PHYSIOL-REG I, V290, pR1080, DOI 10.1152/ajpregu.00277.2005; Hand CE, 2007, BIOORG MED CHEM LETT, V17, P183, DOI 10.1016/j.bmcl.2006.09.066; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoffler U, 2009, ENDOCRINE, V36, P311, DOI 10.1007/s12020-009-9224-9; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Ito M, 2008, J ENDOCRINOL, V198, P309, DOI 10.1677/JOE-08-0087; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shao J, 2000, J ENDOCRINOL, V167, P107, DOI 10.1677/joe.0.1670107; Shay KP, 2009, BIOGERONTOLOGY, V10, P443, DOI 10.1007/s10522-008-9187-x; Shears SB, 2007, BIOCHEM SOC SYMP, V74, P211, DOI 10.1042/BSS2007c18; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Welsh GL, 2005, BIOCHEM SOC T, V33, P346, DOI 10.1042/BST0330346; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	65	240	255	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					897	910		10.1016/j.cell.2010.11.032	http://dx.doi.org/10.1016/j.cell.2010.11.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145457	Bronze, Green Accepted			2022-12-24	WOS:000285182600008
J	Fornoni, A				Fornoni, Alessia			Proteinuria, the Podocyte, and Insulin Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GLOMERULAR PODOCYTE		[Fornoni, Alessia] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Fornoni, Alessia] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA	University of Miami; University of Miami	Fornoni, A (corresponding author), Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA.		Fornoni, Alessia/F-8350-2013	fornoni, Alessia/0000-0002-1313-7773				Coward RJM, 2005, DIABETES, V54, P3095, DOI 10.2337/diabetes.54.11.3095; Engel H, 1996, J NUCL MED, V37, P441; MOGENSEN CE, 1980, DIABETOLOGIA, V18, P453; Musso C, 2006, CLIN J AM SOC NEPHRO, V1, P616, DOI 10.2215/CJN.01271005; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015	6	34	45	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2010	363	21					2068	2069		10.1056/NEJMcibr1008395	http://dx.doi.org/10.1056/NEJMcibr1008395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	681KC	21083394				2022-12-24	WOS:000284310000015
J	Law, RHP; Lukoyanova, N; Voskoboinik, I; Caradoc-Davies, TT; Baran, K; Dunstone, MA; D'Angelo, ME; Orlova, EV; Coulibaly, F; Verschoor, S; Browne, KA; Ciccone, A; Kuiper, MJ; Bird, PI; Trapani, JA; Saibil, HR; Whisstock, JC				Law, Ruby H. P.; Lukoyanova, Natalya; Voskoboinik, Ilia; Caradoc-Davies, Tom T.; Baran, Katherine; Dunstone, Michelle A.; D'Angelo, Michael E.; Orlova, Elena V.; Coulibaly, Fasseli; Verschoor, Sandra; Browne, Kylie A.; Ciccone, Annette; Kuiper, Michael J.; Bird, Phillip I.; Trapani, Joseph A.; Saibil, Helen R.; Whisstock, James C.			The structural basis for membrane binding and pore formation by lymphocyte perforin	NATURE			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; GRANZYME-B; CRYSTAL-STRUCTURE; HUMAN-COMPLEMENT; 9TH COMPONENT; CELL-DEATH; T-CELLS; DOMAIN; CYTOTOXICITY; IDENTIFICATION	Natural killer cells and cytotoxic T lymphocytes accomplish the critically important function of killing virus-infected and neoplastic cells. They do this by releasing the pore-forming protein perforin and granzyme proteases from cytoplasmic granules into the cleft formed between the abutting killer and target cell membranes. Perforin, a 67-kilodalton multidomain protein, oligomerizes to form pores that deliver the pro-apoptopic granzymes into the cytosol of the target cell(1-6). The importance of perforin is highlighted by the fatal consequences of congenital perforin deficiency, with more than 50 different perforin mutations linked to familial haemophagocytic lymphohistiocytosis (type 2 FHL)(7). Here we elucidate the mechanism of perforin pore formation by determining the X-ray crystal structure of monomeric murine perforin, together with a cryo-electron microscopy reconstruction of the entire perforin pore. Perforin is a thin 'key-shaped' molecule, comprising an amino-terminal membrane attack complex perforin-like (MACPF)/cholesterol dependent cytolysin (CDC) domain(8,9) followed by an epidermal growth factor (EGF) domain that, together with the extreme carboxy-terminal sequence, forms a central shelf-like structure. A C-terminal C2 domain mediates initial, Ca2+-dependent membrane binding. Most unexpectedly, however, electron microscopy reveals that the orientation of the perforin MACPF domain in the pore is inside-out relative to the subunit arrangement in CDCs10,11. These data reveal remarkable flexibility in the mechanism of action of the conserved MACPF/CDC fold and provide new insights into how related immune defence molecules such as complement proteins assemble into pores.	[Voskoboinik, Ilia; Baran, Katherine; Verschoor, Sandra; Browne, Kylie A.; Ciccone, Annette; Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; [Law, Ruby H. P.; Dunstone, Michelle A.; D'Angelo, Michael E.; Coulibaly, Fasseli; Bird, Phillip I.; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Law, Ruby H. P.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3800, Australia; [Lukoyanova, Natalya; Orlova, Elena V.; Saibil, Helen R.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Voskoboinik, Ilia] Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; [Caradoc-Davies, Tom T.] Australian Synchrotron, Melbourne, Vic 3168, Australia; [Dunstone, Michelle A.] Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia; [Kuiper, Michael J.] Victorian Partnership Adv Comp, Dept Life Sci, Carlton, Vic 3053, Australia; [Trapani, Joseph A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Peter Maccallum Cancer Center; Monash University; Monash University; University of London; Birkbeck University London; University of Melbourne; Monash University; University of Melbourne	Trapani, JA (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, St Andrews Pl, Melbourne, Vic 3002, Australia.	joe.trapani@petermac.org; h.saibil@mail.cryst.bbk.ac.uk; james.whisstock@monash.edu	Orlova, Elena/CAF-8290-2022; Dunstone, Michelle/I-2895-2014	Lukoyanova, Natalya/0000-0002-2051-0812; Trapani, Joseph/0000-0003-0983-1532; Coulibaly, Fasseli/0000-0003-3380-2117; Voskoboinik, Ilia/0000-0002-6410-009X; law, ruby/0000-0001-5432-5781; Whisstock, James/0000-0003-4200-5611; Orlova, Elena/0000-0003-3371-415X; Bird, Phillip/0000-0002-6695-606X; D'Angelo, Michael/0000-0001-9342-0132; Dunstone, Michelle/0000-0002-6026-648X	NHMRC; ARC; UK BBSRC; Wellcome Trust; BBSRC [BB/D008573/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D008573/1] Funding Source: researchfish	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J.C.W. is an Australian Research Council Federation Fellow and Honorary National Health and Medical Research Council of Australia Principal Research Fellow. I.V., F.C. and M.A.D. are NHMRC Career Development Fellows. K.B. is an NHMRC C.J. Martin overseas training fellow. J.A.T. acknowledges the support of an NHMRC Senior Principal Research Fellowship during the course of the work. The authors thank the NHMRC, the ARC, the UK BBSRC and the Wellcome Trust for grant support. We thank the Australian synchrotron beamline scientists for technical support and access to the MX-2 Microfocus Beamline; we thank D. Clare and L. Wang for electron microscopy support, and D. Houldershaw, R. Westlake and K. Mahmood for computing support. We thank D. Steer and the Monash University Proteomics Unit for technical support.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baran K, 2009, IMMUNITY, V30, P684, DOI 10.1016/j.immuni.2009.03.016; Bird CH, 2005, MOL CELL BIOL, V25, P7854, DOI 10.1128/MCB.25.17.7854-7867.2005; BRICKNER A, 1985, BIOCHEMISTRY-US, V24, P4603, DOI 10.1021/bi00338a019; Bricogne G, 2009, BUSTER VERSION 2 8 0; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dang TX, 2005, J STRUCT BIOL, V150, P100, DOI 10.1016/j.jsb.2005.02.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DOURMASHKIN RR, 1980, CLIN EXP IMMUNOL, V42, P554; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Grobler JA, 1997, NAT STRUCT BIOL, V4, P261, DOI 10.1038/nsb0497-261; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAWASAKI A, 1990, INT IMMUNOL, V2, P677, DOI 10.1093/intimm/2.7.677; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Moreno RU, 2009, BLOOD, V113, P338, DOI 10.1182/blood-2008-08-172924; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; Ramachandran R, 2005, P NATL ACAD SCI USA, V102, P7139, DOI 10.1073/pnas.0500556102; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; SHINKAI Y, 1988, NATURE, V334, P525, DOI 10.1038/334525a0; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Sutton VR, 2008, METHODS, V44, P241, DOI 10.1016/j.ymeth.2007.11.011; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P150, DOI 10.1073/pnas.83.1.150; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429	57	281	291	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					447	U277		10.1038/nature09518	http://dx.doi.org/10.1038/nature09518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21037563				2022-12-24	WOS:000284313100045
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling Screening for early detection of lung cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				2010, BRIT MED J, V341, pC6480, DOI DOI 10.1136/BMJ.C6480	1	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 17	2010	341								c6544	10.1136/bmj.c6544	http://dx.doi.org/10.1136/bmj.c6544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684WO	21084372				2022-12-24	WOS:000284586200015
J	Yudkin, JS; Richter, B; Gale, EAM				Yudkin, John S.; Richter, Bernd; Gale, Edwin A. M.			Intensified glucose control in type 2 diabetes-whose agenda?	LANCET			English	Editorial Material							SURVIVAL; TIME		[Yudkin, John S.] UCL, London WC1E 6BT, England; [Richter, Bernd] Univ Dusseldorf, Cochrane Metab & Endocrine Disorders Review Grp, Dusseldorf, Germany; [Gale, Edwin A. M.] Univ Bristol, Bristol, Avon, England	University of London; University College London; Heinrich Heine University Dusseldorf; University of Bristol	Yudkin, JS (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008	Richter, Bernd/0000-0002-7117-3983				*AM DIAB ASS, 2010, AM DIABETES ASS  SPR, P14; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gerstein HC, 1996, LANCET, V347, P949, DOI 10.1016/S0140-6736(96)91420-8; Hauber A, 2006, DIABETOLOGIA, V49, P247, DOI 10.1007/s00125-005-0108-0; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Royal College of Physicians, 2009, INN HLTH PAT PHYS PH; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	18	27	27	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1220	1222		10.1016/S0140-6736(10)61112-9	http://dx.doi.org/10.1016/S0140-6736(10)61112-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	751DI	21093903				2022-12-24	WOS:000289597300008
J	Bennett, EJ; Rush, J; Gygi, SP; Harper, JW				Bennett, Eric J.; Rush, John; Gygi, Steven P.; Harper, J. Wade			Dynamics of Cullin-RING Ubiquitin Ligase Network Revealed by Systematic Quantitative Proteomics	CELL			English	Article							NEDD8; ACTIVATION; JAB1/CSN5; INHIBITOR; CSN; SCF	Dynamic reorganization of signaling systems frequently accompanies pathway perturbations, yet quantitative studies of network remodeling by pathway stimuli are lacking. Here, we report the development of a quantitative proteomics platform centered on multiplex absolute quantification (AQUA) technology to elucidate the architecture of the cullin-RING ubiquitin ligase (CRL) network and to evaluate current models of dynamic CRL remodeling. Current models suggest that CRL complexes are controlled by cycles of CRL deneddylation and CAND1 binding. Contrary to expectations, acute CRL inhibition with MLN4924, an inhibitor of the NEDD8-activating enzyme, does not result in a global reorganization of the CRL network. Examination of CRL complex stoichiometry reveals that, independent of cullin neddylation, a large fraction of cullins are assembled with adaptor modules, whereas only a small fraction are associated with CAND1. These studies suggest an alternative model of CRL dynamicity where the abundance of adaptor modules, rather than cycles of neddylation and CAND1 binding, drives CRL network organization.	[Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bennett, Eric J.; Gygi, Steven P.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rush, John] Cell Signaling Technol, Danvers, MA 01923 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	Millennium Pharmaceuticals; National Institutes of Health; Stewart Trust; Damon Runyon Cancer Research Foundation [DRG 1974-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565, R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stewart Trust; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Woong Kim, Ryan Kunz, and Fiona McAllister from the Gygi laboratory (Harvard Medical School) for assistance with the AQUA analysis, Harper lab members John Lydeard for reagents, Mat Sowa for bioinformatics assistance, and Brenda O'Connell for a critical reading of the manuscript. This work was supported by grants to J.W.H. from Millennium Pharmaceuticals, the National Institutes of Health, and the Stewart Trust. E.J.B. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG 1974-08). J.W.H. is a consultant for Millennium Pharmaceuticals. J.R. is an employee of Cell Signaling Technologies.	Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bosu DR, 2010, DEV BIOL, V346, P113, DOI 10.1016/j.ydbio.2010.07.020; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Olma MH, 2009, J CELL SCI, V122, P1035, DOI 10.1242/jcs.043539; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Siergiejuk E, 2009, EMBO J, V28, P3845, DOI 10.1038/emboj.2009.354; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhang WJ, 2008, P NATL ACAD SCI USA, V105, P8470, DOI 10.1073/pnas.0804144105; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	29	263	265	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					951	965		10.1016/j.cell.2010.11.017	http://dx.doi.org/10.1016/j.cell.2010.11.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145461	Green Accepted, Bronze			2022-12-24	WOS:000285182600012
J	Ko, M; Huang, Y; Jankowska, AM; Pape, UJ; Tahiliani, M; Bandukwala, HS; An, J; Lamperti, ED; Koh, KP; Ganetzky, R; Liu, XS; Aravind, L; Agarwal, S; Maciejewski, JP; Rao, A				Ko, Myunggon; Huang, Yun; Jankowska, Anna M.; Pape, Utz J.; Tahiliani, Mamta; Bandukwala, Hozefa S.; An, Jungeun; Lamperti, Edward D.; Koh, Kian Peng; Ganetzky, Rebecca; Liu, X. Shirley; Aravind, L.; Agarwal, Suneet; Maciejewski, Jaroslaw P.; Rao, Anjana			Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2	NATURE			English	Article							DNA METHYLATION; MUTATIONS; MALIGNANCIES; THERAPY; COMMON; HYPOMETHYLATION; MYELOFIBROSIS; EPIGENETICS; CONVERSION; NEOPLASMS	TET2 is a close relative of TET1, an enzyme that converts 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA(1,2). The gene encoding TET2 resides at chromosome 4q24, in a region showing recurrent microdeletions and copy-neutral loss of heterozygosity (CN-LOH) in patients with diverse myeloid malignancies(3). Somatic TET2 mutations are frequently observed in myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), MDS/MPN overlap syndromes including chronic myelomonocytic leukaemia (CMML), acute myeloid leukaemias (AML) and secondary AML (sAML)(4-12). We show here that TET2 mutations associated with myeloid malignancies compromise catalytic activity. Bone marrow samples from patients with TET2 mutations displayed uniformly low levels of 5hmC in genomic DNA compared to bone marrow samples from healthy controls. Moreover, small hairpin RNA (shRNA)-mediated depletion of Tet2 in mouse haematopoietic precursors skewed their differentiation towards monocyte/macrophage lineages in culture. There was no significant difference in DNA methylation between bone marrow samples from patients with high 5hmC versus healthy controls, but samples from patients with low 5hmC showed hypomethylation relative to controls at the majority of differentially methylated CpG sites. Our results demonstrate that Tet2 is important for normal myelopoiesis, and suggest that disruption of TET2 enzymatic activity favours myeloid tumorigenesis. Measurement of 5hmC levels in myeloid malignancies may prove valuable as a diagnostic and prognostic tool, to tailor therapies and assess responses to anticancer drugs.	[Ko, Myunggon; Huang, Yun; Pape, Utz J.; Tahiliani, Mamta; Bandukwala, Hozefa S.; An, Jungeun; Lamperti, Edward D.; Koh, Kian Peng; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA; [Ko, Myunggon; Huang, Yun; Pape, Utz J.; Tahiliani, Mamta; Bandukwala, Hozefa S.; An, Jungeun; Lamperti, Edward D.; Koh, Kian Peng; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Jankowska, Anna M.; Ganetzky, Rebecca; Maciejewski, Jaroslaw P.] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44195 USA; [Jankowska, Anna M.; Ganetzky, Rebecca; Maciejewski, Jaroslaw P.] Cleveland Clin, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44195 USA; [Pape, Utz J.; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Pape, Utz J.; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Agarwal, Suneet] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet] Harvard Stem Cell Inst, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	maciejj@ccf.org; arao@idi.harvard.edu	Koh, Kian Peng/S-6279-2016	Koh, Kian Peng/0000-0003-2523-5175; Huang, Yun/0000-0001-5950-9168; Ko, Myunggon/0000-0002-6007-2570; Aravind, L/0000-0003-0771-253X; Ganetzky, Rebecca/0000-0001-6238-8109	NIH [R01 AI44432, RC1 DA028422, K24 HL077522, R01 HL098522, R01 HG4069]; Aplastic Anemia MDS Foundation; Bob Duggan Memorial Research Fund; Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH) [1 UL1 RR 025758-02]; GlaxoSmithKline-Immune Disease Institute (GSK-IDI) Alliance; Leukemia and Lymphoma Society of America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA042471] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150, K24HL077522] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aplastic Anemia MDS Foundation; Bob Duggan Memorial Research Fund; Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline-Immune Disease Institute (GSK-IDI) Alliance; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01 AI44432 and RC1 DA028422 (to A.R.), NIH grants K24 HL077522 and R01 HL098522, an Established Investigator award from the Aplastic Anemia & MDS Foundation, and an award from the Bob Duggan Memorial Research Fund (to J.P.M), NIH grant R01 HG4069 (to X.S.L.) and a pilot grant from Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH Grant #1 UL1 RR 025758-02, to S.A.). Y.H. was supported by postdoctoral fellowships from the GlaxoSmithKline-Immune Disease Institute (GSK-IDI) Alliance and the Leukemia and Lymphoma Society of America. H.S.B. is supported by a postdoctoral fellowship from the GSK-IDI Alliance.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lengauer C, 2003, SCIENCE, V300, P442, DOI 10.1126/science.1084468; Levine RL, 2009, NEW ENGL J MED, V360, P2355, DOI 10.1056/NEJMe0902257; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mullighan CG, 2009, NAT GENET, V41, P766, DOI 10.1038/ng0709-766; Smith LT, 2007, TRENDS GENET, V23, P449, DOI 10.1016/j.tig.2007.07.005; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Tefferi A, 2008, LEUKEMIA LYMPHOMA, V49, P2231, DOI 10.1080/10428190802578866; Viguie F, 2005, LEUKEMIA, V19, P1411, DOI 10.1038/sj.leu.2403818; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413	26	983	1032	1	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					839	843		10.1038/nature09586	http://dx.doi.org/10.1038/nature09586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21057493	Green Accepted			2022-12-24	WOS:000285093700049
J	Burden, AD; Boon, MH; Leman, J; Wilson, H; Richmond, R; Ormerod, AD				Burden, A. D.; Boon, M. Hilton; Leman, J.; Wilson, H.; Richmond, R.; Ormerod, A. D.		Guideline Dev Grp	Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							MYOCARDIAL-INFARCTION; EPIDEMIOLOGY; DISEASES; RISK		[Boon, M. Hilton] Scottish Intercollegiate Guidelines Network, Glasgow, Lanark, Scotland; [Burden, A. D.] Univ Glasgow, Western Infirm, Alan Lyell Ctr Dermatol, Glasgow G11 6NT, Lanark, Scotland; [Leman, J.] Western Infirm & Associated Hosp, Glasgow G11 6NT, Lanark, Scotland; [Wilson, H.] Stobhill Hosp, Glasgow G21 3UW, Lanark, Scotland; [Richmond, R.] Borders Gen Hosp, Melrose TD6 9BS, Roxburghshire, Scotland; [Ormerod, A. D.] Univ Aberdeen, Dept Appl Med, Aberdeen AB9 1FX, Scotland; [Ormerod, A. D.] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland	University of Glasgow; University of Aberdeen; University of Aberdeen	Boon, MH (corresponding author), Scottish Intercollegiate Guidelines Network, Glasgow, Lanark, Scotland.	michele.hiltonboon@nhs.net	Ozakinci, Gozde/B-7897-2012; Boon, Michele Hilton/AAB-8745-2021	Ozakinci, Gozde/0000-0001-5869-3274; Boon, Michele Hilton/0000-0002-2240-7923	Janssen-Cilag; Merck; Serono; Schering-Plough; Abbott; Pfizer; Wyeth	Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Serono; Schering-Plough(Merck & CompanySchering Plough Corporation); Abbott(Abbott Laboratories); Pfizer(Pfizer); Wyeth(Wyeth)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no funding from any organisation for the submitted work; ADB has been paid for consultancy and delivering lectures for Abbott, Pfizer, MSD, Janssen-Cilag, Leo, and Basilea and does consultancy for Merck and Novartis; MHB is employed by SIGN; JL was paid to attend one Abbott Advisory Board meeting and to deliver postgraduate education by Leo, has received meeting expenses from Pfizer, and has undertaken trials funded by Janssen-Cilag, Merck, Serono, Schering-Plough, Abbott, and Pfizer; HW has been paid to provide expert testimony to the Psoriatic Arthritis Advisory Panel and to develop and deliver a Wyeth educational presentation, and has received expenses from Abbott to attend one conference; HW's institution will receive payment for participating in a study of the validity of the PEST questionnaire; RR received travel costs and a conference registration fee from Wyeth; ADO was paid to attend one Abbott advisory board meeting, one Schering-Plough advisory board meeting, and to deliver lectures for Wyeth and Abbott, and received expenses to attend one conference from Wyeth and one conference from Janssen-Cilag; ADO's institution has received grants to conduct clinical trials of biologics for Abbott, Wyeth, Schering-Plough, and Janssen-Cilag; no other relationships or activities that could appear to have influenced the submitted work.	Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Ibrahim GH, 2009, CLIN EXP RHEUMATOL, V27, P469; Kaye JA, 2008, BRIT J DERMATOL, V159, P895, DOI 10.1111/j.1365-2133.2008.08707.x; Kimball AB, 2005, AM J CLIN DERMATOL, V6, P383, DOI 10.2165/00128071-200506060-00005; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Reich K, 2009, BRIT J DERMATOL, V160, P1040, DOI 10.1111/j.1365-2133.2008.09023.x; SIGN, 2010, 121 SIGN	8	32	34	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2010	341								c5623	10.1136/bmj.c5623	http://dx.doi.org/10.1136/bmj.c5623			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674ZN	21036815	Green Submitted			2022-12-24	WOS:000283792500001
J	Baker, M				Baker, M.			Genomics Seeing more SNPs	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1138	1138		10.1038/4671138a	http://dx.doi.org/10.1038/4671138a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981105	Bronze			2022-12-24	WOS:000283548600059
J	Quinn, TC; Serwadda, D				Quinn, Thomas C.; Serwadda, David			The future of HIV/AIDS in Africa: a shared responsibility	LANCET			English	Editorial Material									[Quinn, Thomas C.] NIAID, Bethesda, MD 20892 USA; [Quinn, Thomas C.] Johns Hopkins Univ, Ctr Global Hlth, Baltimore, MD 21205 USA; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Makerere University	Quinn, TC (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	tquinn@jhmi.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Institute of Medicine (US) Committee on Envisioning a Strategy for the Long-Term Burden of HIV/AIDS: African Needs and U.S. Interests, 2011, PREP FUT HIV AIDS AF; *UNAIDS, 2009, AIDS EP UPD	2	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1133	1134		10.1016/S0140-6736(10)62183-6	http://dx.doi.org/10.1016/S0140-6736(10)62183-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	21126758				2022-12-24	WOS:000289539300008
J	Tagami, S; Sekine, S; Kumarevel, T; Hino, N; Murayama, Y; Kamegamori, S; Yamamoto, M; Sakamoto, K; Yokoyama, S				Tagami, Shunsuke; Sekine, Shun-ichi; Kumarevel, Thirumananseri; Hino, Nobumasa; Murayama, Yuko; Kamegamori, Syunsuke; Yamamoto, Masaki; Sakamoto, Kensaku; Yokoyama, Shigeyuki			Crystal structure of bacterial RNA polymerase bound with a transcription inhibitor protein	NATURE			English	Article							3.3 ANGSTROM RESOLUTION; II ELONGATION COMPLEX; THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; CRYSTALLOGRAPHIC ANALYSIS; ACTIVE-CENTER; COILED-COIL; GRE FACTORS; AMINO-ACID; NMR SYSTEM	The multi-subunit DNA-dependent RNA polymerase (RNAP) is the principal enzyme of transcription for gene expression. Transcription is regulated by various transcription factors. Gre factor homologue 1 (Gfh1), found in the Thermus genus, is a close homologue of the well-conserved bacterial transcription factor GreA, and inhibits transcription initiation and elongation by binding directly to RNAP(1-8). The structural basis of transcription inhibition by Gfh1 has remained elusive, although the crystal structures of RNAP and Gfh1 have been determined separately(6-9). Here we report the crystal structure of Thermus thermophilus RNAP complexed with Gfh1. The amino-terminal coiled-coil domain of Gfh1 fully occludes the channel formed between the two central modules of RNAP; this channel would normally be used for nucleotide triphosphate (NTP) entry into the catalytic site. Furthermore, the tip of the coiled-coil domain occupies the NTP beta-gamma phosphate-binding site. The NTP-entry channel is expanded, because the central modules are 'ratcheted' relative to each other by similar to 7 degrees, as compared with the previously reported elongation complexes. This 'ratcheted state' is an alternative structural state, defined by a newly acquired contact between the central modules. Therefore, the shape of Gfh1 is appropriate to maintain RNAP in the ratcheted state. Simultaneously, the ratcheting expands the nucleic-acid-binding channel, and kinks the bridge helix, which connects the central modules. Taken together, the present results reveal that Gfh1 inhibits transcription by preventing NTP binding and freezing RNAP in the alternative structural state. The ratcheted state might also be associated with other aspects of transcription, such as RNAP translocation and transcription termination.	[Tagami, Shunsuke; Sekine, Shun-ichi; Murayama, Yuko; Kamegamori, Syunsuke; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Tagami, Shunsuke; Sekine, Shun-ichi; Hino, Nobumasa; Murayama, Yuko; Kamegamori, Syunsuke; Sakamoto, Kensaku; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Kumarevel, Thirumananseri] RIKEN SPring 8 Ctr, Harima Inst, Struct & Mol Biol Lab, Sayo, Hyogo 6795148, Japan; [Yamamoto, Masaki] RIKEN SPring 8 Ctr, Harima Inst, SR Life Sci Instrumentat Unit, Sayo, Hyogo 6795148, Japan	University of Tokyo; RIKEN; University of Tokyo; RIKEN; RIKEN	Sekine, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sekine@biochem.s.u-tokyo.ac.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Sekine, Shun-ichi/N-5450-2015; Kumarevel, Thirumananseri/C-6275-2012; Yamamoto, Masaki/B-7844-2015; Sakamoto, Kensaku/N-7496-2015; Tagami, Shunsuke/N-5057-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Sekine, Shun-ichi/0000-0001-8174-8704; Kumarevel, Thirumananseri/0000-0001-9326-6585; Yamamoto, Masaki/0000-0002-1311-1768; Sakamoto, Kensaku/0000-0003-2866-5031; Tagami, Shunsuke/0000-0002-1720-3627; Hino, Nobumasa/0000-0002-7072-1183	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JSPS Global Centers of Excellence; Grants-in-Aid for Scientific Research [22570175] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Global Centers of Excellence; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is based on experiments performed at SPring-8 (with the approval of the Japan Synchrotron Radiation Research Institute) and at the Swiss Light Source (SLS). We thank N. Shimizu for supporting our data collection at SPring-8 beamline BL41XU; T. Tomizaki and C. Schulze-Briese for supporting our data collection at SLS beamline X06SA; and Y. Fujii for assisting with our data collection and for comments. We thank T. Tanaka and K. Sakamoto for assistance in protein preparation. This work was supported in part by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (to S.-i.S.), a JSPS Grant-in-Aid for Scientific Research (to S.i.-S. and S. Y.), and the Targeted Proteins Research Program (TPRP), the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. S. T. was supported by the JSPS Global Centers of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms).	Abyzov A, 2010, PROTEINS, V78, P309, DOI 10.1002/prot.22544; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chumpolkulwong Namthip, 2006, Journal of Structural and Functional Genomics, V7, P31, DOI 10.1007/s10969-006-9007-y; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Lamour V, 2006, J MOL BIOL, V356, P179, DOI 10.1016/j.jmb.2005.10.083; Laptenko O, 2003, METHOD ENZYMOL, V371, P219; Laptenko O, 2006, EMBO J, V25, P2131, DOI 10.1038/sj.emboj.7601094; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Sakamoto K, 2009, STRUCTURE, V17, P335, DOI 10.1016/j.str.2009.01.008; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Symersky J, 2006, J BIOL CHEM, V281, P1309, DOI 10.1074/jbc.C500405200; Tagami S, 2010, ACTA CRYSTALLOGR F, V66, P64, DOI 10.1107/S1744309109049215; Tan Lin, 2008, J Biol, V7, P40, DOI 10.1186/jbiol98; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vassylyeva MN, 2007, EMBO REP, V8, P1038, DOI 10.1038/sj.embor.7401079; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	41	119	123	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					978	U282		10.1038/nature09573	http://dx.doi.org/10.1038/nature09573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21124318				2022-12-24	WOS:000285344600050
J	Smith, MD; Asche, F; Guttormsen, AG; Wiener, JB				Smith, Martin D.; Asche, Frank; Guttormsen, Atle G.; Wiener, Jonathan B.			Genetically Modified Salmon and Full Impact Assessment	SCIENCE			English	Editorial Material									[Smith, Martin D.; Wiener, Jonathan B.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Smith, Martin D.] Duke Univ, Dept Econ, Durham, NC 27708 USA; [Asche, Frank] Univ Stavanger, Dept Ind Econ, N-4036 Stavanger, Norway; [Guttormsen, Atle G.] Norwegian Univ Life Sci, Dept Econ & Resource Management, N-1432 As, Norway; [Wiener, Jonathan B.] Duke Univ, Sch Law, Durham, NC 27708 USA; [Wiener, Jonathan B.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Wiener, Jonathan B.] Resources Future Inc, Washington, DC 20036 USA	Duke University; Duke University; Universitetet i Stavanger; Norwegian University of Life Sciences; Duke University; Duke University; Resources for the Future	Smith, MD (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	marsmith@duke.edu	Asche, Frank/AAG-9920-2020; Smith, Martin D/D-9168-2016; Guttormsen, Atle/GZG-2356-2022	Asche, Frank/0000-0002-1540-9728; Smith, Martin D/0000-0002-4714-463X; 				*AQUABOUNTY TECHN, 2010, ENV ASS AQUADVANTAG; Asche F, 2008, MAR RESOUR ECON, V23, P527, DOI 10.1086/mre.23.4.42629678; CHALFANT JA, 1988, J POLIT ECON, V96, P391, DOI 10.1086/261543; *CVM, 2009, 187 CVM FDA; Food and Nutrition Board, 2007, SEAF CHOIC BAL BEN R; Guttormsen A. G., 2002, Marine Resource Economics, V17, P91; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Muir WM, 2004, EMBO REP, V5, P654, DOI 10.1038/sj.embor.7400197; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P18040, DOI 10.1073/pnas.0910577106; Pollack A, 2010, NY TIMES        0627, pA1; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Smith MD, 2010, SCIENCE, V327, P784, DOI 10.1126/science.1185345; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tveteras S., 2002, Marine Resource Economics, V17, P121; *VMAC, 2010, VMAC BRIEF PACK AQUA; Wilen JE, 2006, B MAR SCI, V78, P529	19	53	54	4	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1052	1053		10.1126/science.1197769	http://dx.doi.org/10.1126/science.1197769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097923				2022-12-24	WOS:000284374700025
J	Payne, D				Payne, David			Nutrition Sticky labels	BRITISH MEDICAL JOURNAL			English	Editorial Material							OSTEOARTHRITIS; GLUCOSAMINE		[Payne, David] BMJ, London WC1H 9JR, England		Payne, D (corresponding author), BMJ, London WC1H 9JR, England.	dpayne@bmj.com						*ALL NAT HLTH, 2009, NEUT OUR FREED SPEEC; BOWLER N, 2010, BBC NEWS        0707; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Wilkens P, 2010, JAMA-J AM MED ASSOC, V304, P45, DOI 10.1001/jama.2010.893; 1999, MIRROR          1004; 2010, C BRUSS 26 27 MAY; 2010, R LEHMANS J BLO 0712; NUTR HLTH CLAIMS EUR	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 26	2010	341								c5861	10.1136/bmj.c5861	http://dx.doi.org/10.1136/bmj.c5861			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YE	20978067				2022-12-24	WOS:000283786800026
J	Schultz, PH; Hermalyn, B; Colaprete, A; Ennico, K; Shirley, M; Marshall, WS				Schultz, Peter H.; Hermalyn, Brendan; Colaprete, Anthony; Ennico, Kimberly; Shirley, Mark; Marshall, William S.			The LCROSS Cratering Experiment	SCIENCE			English	Article							WATER; IMPACTS; SURFACE	As its detached upper-stage launch vehicle collided with the surface, instruments on the trailing Lunar Crater Observation and Sensing Satellite (LCROSS) Shepherding Spacecraft monitored the impact and ejecta. The faint impact flash in visible wavelengths and thermal signature imaged in the mid-infrared together indicate a low-density surface layer. The evolving spectra reveal not only OH within sunlit ejecta but also other volatile species. As the Shepherding Spacecraft approached the surface, it imaged a 25- to-30-meter-diameter crater and evidence of a high-angle ballistic ejecta plume still in the process of returning to the surface-an evolution attributed to the nature of the impactor.	[Schultz, Peter H.; Hermalyn, Brendan] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Colaprete, Anthony; Ennico, Kimberly; Shirley, Mark; Marshall, William S.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Marshall, William S.] Univ Space Res Assoc, Mountain View, CA 94043 USA	Brown University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universities Space Research Association (USRA)	Schultz, PH (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	peter_schultz@brown.edu	Ennico, Kimberly/L-9606-2014		LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD); NASA	LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD)(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA))	We thank the LCROSS Project and NASA's Exploration Systems Mission Directorate (ESMD) and NASA Science Mission Directorate (SMD; Planetary Geology and Geophysics) for support. We are also very grateful to the NASA Ames Vertical Gun Range technical team and the Thermophysics Facilities Branch at NASA Ames for their continued support in experiments. B. H. was supported through a NASA Rhode Island Space Grant fellowship for part of this study.	Anderson JLB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002075; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Ernst CA, 2007, ICARUS, V190, P334, DOI 10.1016/j.icarus.2007.03.030; ERNST CM, 2005, LUN PLAN SCI C, V36, P1475; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; HARRIS RS, 2007, 1360 LPI; Hermalyn B., 2010, LUNAR PLANET SCI, P41; Hermalyn B, 2010, ICARUS, V209, P866, DOI 10.1016/j.icarus.2010.05.025; HODGES RR, 1973, J GEOPHYS RES, V78, P8055, DOI 10.1029/JA078i034p08055; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Korycansky DG, 2009, METEORIT PLANET SCI, V44, P603, DOI 10.1111/j.1945-5100.2009.tb00755.x; Ong L, 2010, ICARUS, V207, P578, DOI 10.1016/j.icarus.2009.12.012; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; POTTER AE, 1988, SCIENCE, V241, P675, DOI 10.1126/science.241.4866.675; Schultz PH, 2007, ICARUS, V190, P295, DOI 10.1016/j.icarus.2007.06.006; Schultz PH, 2006, NATURE, V444, P184, DOI 10.1038/nature05303; SCHULTZ PH, 2006, WORKSH LUN CRAT OBS; SCHULTZ PH, 2009, EOS T AGU, V90; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788	22	112	114	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					468	472		10.1126/science.1187454	http://dx.doi.org/10.1126/science.1187454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966243				2022-12-24	WOS:000283329100029
J	Sharma, M; Yi, MG; Dong, H; Qin, HJ; Peterson, E; Busath, DD; Zhou, HX; Cross, TA				Sharma, Mukesh; Yi, Myunggi; Dong, Hao; Qin, Huajun; Peterson, Emily; Busath, David D.; Zhou, Huan-Xiang; Cross, Timothy A.			Insight into the Mechanism of the Influenza A Proton Channel from a Structure in a Lipid Bilayer	SCIENCE			English	Article							M2 ION-CHANNEL; VIRUS; TRANSMEMBRANE; SELECTIVITY; AMANTADINE; STATE; HISTIDINE; PROTEIN; MODEL; CONDUCTANCE	The M2 protein from the influenza A virus, an acid-activated proton-selective channel, has been the subject of numerous conductance, structural, and computational studies. However, little is known at the atomic level about the heart of the functional mechanism for this tetrameric protein, a His(37)-Trp(41) cluster. We report the structure of the M2 conductance domain (residues 22 to 62) in a lipid bilayer, which displays the defining features of the native protein that have not been attainable from structures solubilized by detergents. We propose that the tetrameric His(37)-Trp(41) cluster guides protons through the channel by forming and breaking hydrogen bonds between adjacent pairs of histidines and through specific interactions of the histidines with the tryptophan gate. This mechanism explains the main observations on M2 proton conductance.	[Yi, Myunggi; Dong, Hao; Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Sharma, Mukesh; Qin, Huajun; Cross, Timothy A.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Sharma, Mukesh; Cross, Timothy A.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Yi, Myunggi; Dong, Hao; Zhou, Huan-Xiang; Cross, Timothy A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Peterson, Emily; Busath, David D.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Brigham Young University	Zhou, HX (corresponding author), Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA.	hzhou4@fsu.edu; cross@magnet.fsu.edu	Zhou, Huan-Xiang/M-5170-2016; Sharma, Mukesh/F-8328-2010; Dong, Hao/H-2054-2011; zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/AAH-9836-2020	Zhou, Huan-Xiang/0000-0001-9020-0302; Sharma, Mukesh/0000-0003-3036-1846; Zhou, Huan-Xiang/0000-0001-9020-0302; Cross, Timothy/0000-0002-9413-0505	National Institute of Allergy and Infectious Diseases [AI023007]; NSF Division of Materials Research [0654118]; State of Florida [0654118]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023007] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF Division of Materials Research(National Science Foundation (NSF)); State of Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institute of Allergy and Infectious Diseases grant AI023007. The spectroscopy was conducted at the National High Magnetic Field Laboratory supported by Cooperative Agreement 0654118 between the NSF Division of Materials Research and the State of Florida. T.A.C., H.-X.Z., D.D.B., M.S., and M.Y. have applied for a patent on the mechanism reported here. The structure (an ensemble of eight models) has been deposited in the Protein Data Bank with accession code 2L0J.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Cady SD, 2008, P NATL ACAD SCI USA, V105, P1483, DOI 10.1073/pnas.0711500105; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chizhmakov IV, 2003, J PHYSIOL-LONDON, V546, P427, DOI 10.1113/jphysiol.2002.028910; Chizhmakov IV, 1996, J PHYSIOL-LONDON, V494, P329, DOI 10.1113/jphysiol.1996.sp021495; Cross TA, 2011, TRENDS BIOCHEM SCI, V36, P117, DOI 10.1016/j.tibs.2010.07.005; GUBAREVA L, 2009, MMWR-MORBID MORTAL W, V58, P1; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu J, 2007, BIOPHYS J, V92, P4335, DOI 10.1529/biophysj.106.090183; KRAUSE JA, 1991, ACTA CRYSTALLOGR B, V47, P506, DOI 10.1107/S0108768191000915; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Li C, 2007, BBA-BIOMEMBRANES, V1768, P3162, DOI 10.1016/j.bbamem.2007.08.025; Lin TI, 2001, J VIROL, V75, P3647, DOI 10.1128/JVI.75.8.3647-3656.2001; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Okada A, 2001, BIOCHEMISTRY-US, V40, P6053, DOI 10.1021/bi0028441; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; QUICK A, 1976, CAN J CHEM, V54, P2465, DOI 10.1139/v76-350; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Song XJ, 2001, MAGN RESON CHEM, V39, pS37, DOI 10.1002/mrc.957; Song XJ, 2001, MAGN RESON CHEM, V39, pS30, DOI 10.1002/mrc.956; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Tatara W, 2003, J PHYS CHEM A, V107, P7827, DOI 10.1021/jp030065z; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m; Yi MG, 2009, P NATL ACAD SCI USA, V106, P13311, DOI 10.1073/pnas.0906553106	31	365	366	6	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					509	512		10.1126/science.1191750	http://dx.doi.org/10.1126/science.1191750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966252	Green Accepted			2022-12-24	WOS:000283329100041
J	Lahtela, J; Nousiainen, HO; Stefanovic, V; Tallila, J; Viskari, H; Karikoski, R; Gentile, M; Saloranta, C; Varilo, T; Salonen, R; Kestila, M				Lahtela, Jenni; Nousiainen, Heidi O.; Stefanovic, Vedran; Tallila, Jonna; Viskari, Heli; Karikoski, Riitta; Gentile, Massimiliano; Saloranta, Carola; Varilo, Teppo; Salonen, Riitta; Kestila, Marjo			Brief Report: Mutant CHUK and Severe Fetal Encasement Malformation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BARTSOCAS-PAPAS-SYNDROME; KAPPA-B-KINASE; IKK-ALPHA; EPIDERMAL DIFFERENTIATION; MICE LACKING; SKIN; MORPHOGENESIS; CANCER	We report an autosomal recessive lethal syndrome characterized by multiple fetal malformations, the most obvious anomalies being the defective face and seemingly absent limbs, which are bound to the trunk and encased under the skin. We identified the molecular defect that causes this syndrome, using a combined strategy of gene-expression arrays, candidate-gene analysis, clinical studies, and genealogic investigations. A point mutation in two affected fetuses led to the loss of the conserved helix-loop-helix ubiquitous kinase (CHUK), also known as I(kappa)B kinase (alpha). CHUK has an essential role in the development of skin epidermis and its derivatives, along with various other morphogenetic events. (Funded by the Academy of Finland and others.).	[Kestila, Marjo] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Biomedicum Helsinki, Helsinki 00251, Finland; [Stefanovic, Vedran] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Karikoski, Riitta] Helsinki Univ Hosp, Dept Pathol, Helsinki, Finland; [Saloranta, Carola] Helsinki Univ Hosp, Dept Clin Genet, Helsinki, Finland; [Gentile, Massimiliano] Univ Helsinki, Biomedicum Genom, Helsinki, Finland; [Varilo, Teppo] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Salonen, Riitta] Vaestoliitto, Dept Med Genet, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Kestila, M (corresponding author), Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Biomedicum Helsinki, POB 104, Helsinki 00251, Finland.	marjo.kestila@thl.fi	Gentile, Massimo/R-3270-2016; Stefanovic, Vedran/L-8905-2013	Gentile, Massimo/0000-0002-5256-0726; Stefanovic, Vedran/0000-0001-5230-1698; Varilo, Teppo/0000-0002-5839-8854; Lahtela, Jenni Salla Pauliina/0000-0001-5664-0021	Academy of Finland [211124, 118468]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Supported by grants (211124 and 118468) from the Academy of Finland and by grants from the Sigrid Juselius Foundation (all to Dr. Kestil).	BARTSOCAS CS, 1972, J MED GENET, V9, P222, DOI 10.1136/jmg.9.2.222; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Descargues P, 2008, EMBO J, V27, P2639, DOI 10.1038/emboj.2008.196; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; HENNEKAM RCM, 1994, AM J MED GENET, V53, P102, DOI 10.1002/ajmg.1320530203; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Lanford, 1987, P GREENWOOD GENET CT, V6, P10; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; VARILO T, 1999, THESIS U HELINSKI HE; Veenstra-Knol HE, 2003, AM J MED GENET A, V123A, P243, DOI 10.1002/ajmg.a.20308; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	18	44	46	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1631	1637		10.1056/NEJMoa0911698	http://dx.doi.org/10.1056/NEJMoa0911698			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961246				2022-12-24	WOS:000283242700007
J	Wieseler, B; McGauran, N; Kaiser, T				Wieseler, Beate; McGauran, Natalie; Kaiser, Thomas			Finding studies on reboxetine: a tale of hide and seek	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS; REGISTRATION; PUBLICATION; DEPRESSION; GABAPENTIN; DOCUMENTS		[Wieseler, Beate; McGauran, Natalie; Kaiser, Thomas] Inst Qual & Efficiency Hlth Care, D-51105 Cologne, Germany		Wieseler, B (corresponding author), Inst Qual & Efficiency Hlth Care, Dillenburger Strasse 27, D-51105 Cologne, Germany.	beate.wieseler@iqwig.de		Wieseler, Beate/0000-0002-3519-754X; Kaiser, Thomas/0000-0003-0795-538X				Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; *FDA, 2010, IMPR SAF IMP FOOD ME; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; *I QUAL EFF HLTH C, 2009, A0520C I QUAL EFF HL; *I QUAL EFF HLTH C, 2008, GEN METH VERS 3 0; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Page ME, 2003, CNS DRUG REV, V9, P327; Preskorn Sheldon H, 2004, J Psychiatr Pract, V10, P57, DOI 10.1097/00131746-200401000-00006; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Stafford N, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2521; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Turner EH, 2008, SCIENCE, V322, P44, DOI 10.1126/science.322.5898.44c; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582	17	21	21	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2010	341								c4942	10.1136/bmj.c4942	http://dx.doi.org/10.1136/bmj.c4942			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KN	20940211				2022-12-24	WOS:000282886900011
J	Chen, JH; Stoltz, DA; Karp, PH; Ernst, SE; Pezzulo, AA; Moninger, TO; Rector, MV; Reznikov, LR; Launspach, JL; Chaloner, K; Zabner, J; Welsh, MJ				Chen, Jeng-Haur; Stoltz, David A.; Karp, Philip H.; Ernst, Sarah E.; Pezzulo, Alejandro A.; Moninger, Thomas O.; Rector, Michael V.; Reznikov, Leah R.; Launspach, Janice L.; Chaloner, Kathryn; Zabner, Joseph; Welsh, Michael J.			Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NASAL POTENTIAL DIFFERENCE; PSEUDOMONAS-AERUGINOSA; RESPIRATORY EPITHELIA; HYPERTONIC SALINE; SURFACE LIQUID; NA+ TRANSPORT; CHANNEL; DISEASE; ENAC	Defective transepithelial electrolyte transport is thought to initiate cystic fibrosis (CF) lung disease. Yet, how loss of CFTR affects electrolyte transport remains uncertain. CFTR-/- pigs spontaneously develop lung disease resembling human CF. At birth, their airways exhibit a bacterial host defense defect, but are not inflamed. Therefore, we studied ion transport in newborn nasal and tracheal/bronchial epithelia in tissues, cultures, and in vivo. CFTR-/- epithelia showed markedly reduced Cl- and HCO3- transport. However, in contrast to a widely held view, lack of CFTR did not increase transepithelial Na+ or liquid absorption or reduce periciliary liquid depth. Like human CF, CFTR-/- pigs showed increased amiloride-sensitive voltage and current, but lack of apical Cl- conductance caused the change, not increased Na+ transport. These results indicate that CFTR provides the predominant transcellular pathway for Cl- and HCO3- in porcine airway epithelia, and reduced anion permeability may initiate CF airway disease.	[Chen, Jeng-Haur; Stoltz, David A.; Karp, Philip H.; Ernst, Sarah E.; Pezzulo, Alejandro A.; Moninger, Thomas O.; Rector, Michael V.; Reznikov, Leah R.; Launspach, Janice L.; Zabner, Joseph; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Chaloner, Kathryn] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biostat, Iowa City, IA 52242 USA; [Chen, Jeng-Haur; Karp, Philip H.; Reznikov, Leah R.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Reznikov, Leah R./J-4314-2019; Chaloner, Kathryn/B-5090-2013; Chen, Jeng-Haur/E-1483-2011	Reznikov, Leah R./0000-0002-4074-9070; Chen, Jeng-Haur/0000-0001-6756-6939; Pezzulo, Alejandro/0000-0001-7544-5109; Zabner, Joseph/0000-0002-9606-1339; Stoltz, David/0000-0003-0893-9015; Welsh, Michael/0000-0002-1646-6206	National Heart Lung and Blood Institute [HL51670, HL091842, HL097622]; National Institute of Diabetes and Digestive and Kidney Diseases [DK54759]; Cystic Fibrosis Foundation; National Institute of Allergy and Infectious Diseases [AI076671]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670, T15HL097622, P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Lisaurie Lopez Rivera, Paula Ludwig, Theresa Mayhew, Peter Taft, Jingyang Zhang, and Yuping Zhang for excellent assistance. We thank Drs. John B Stokes and Peter M Snyder for helpful discussions. GlyH-101 was a generous gift from the Cystic Fibrosis Foundation Therapeutics and R. Bridges. This work was supported by the National Heart Lung and Blood Institute (grants HL51670, HL091842, and HL097622), the National Institute of Diabetes and Digestive and Kidney Diseases (grant DK54759), and the Cystic Fibrosis Foundation. D.A.S. is a Parker B. Francis Fellow and was supported by the National Institute of Allergy and Infectious Diseases (grant AI076671). M.J.W. is an Investigator of the HHMI. M.J.W. was a cofounder of Exemplar Genetics, a company that is licensing materials and technology related to this work.	[Anonymous], 2009, LANG ENV STAT COMP; Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Baker E, 1998, J CLIN INVEST, V102, P10, DOI 10.1172/JCI1795; Bates D., 2009, IME4 LINEAR MIXED EF; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; CULLEN JJ, 1987, J CLIN INVEST, V79, P73, DOI 10.1172/JCI112811; Davies JC, 2005, AM J RESP CRIT CARE, V171, P1015, DOI 10.1164/rccm.200408-1116OC; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; DUSZYK M, 1991, J THEOR BIOL, V151, P231, DOI 10.1016/S0022-5193(05)80362-5; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Flynn AN, 2009, P NATL ACAD SCI USA, V106, P3591, DOI 10.1073/pnas.0813393106; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Gray T., 2004, AM J PHYSIOL-LUNG C, V286, pL320; Griesenbach U., 2010, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2009-0265OC, DOI 10.1165/RCMB.2009-02650C]; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; HELMAN SI, 1973, AM J PHYSIOL, V225, P972, DOI 10.1152/ajplegacy.1973.225.4.972; Horisberger JD, 2003, PFLUG ARCH EUR J PHY, V445, P522, DOI 10.1007/s00424-002-0956-0; Huber R, 2010, CELL PHYSIOL BIOCHEM, V25, P145, DOI 10.1159/000272059; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; Kunzelmann K, 2006, FASEB J, V20, P545, DOI 10.1096/fj.05-4454fje; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Meyerholz D.K., 2010, AM J RESP C IN PRESS; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Robinson M, 1997, THORAX, V52, P900, DOI 10.1136/thx.52.10.900; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SATIR P, 1963, J CELL BIOL, V18, P345, DOI 10.1083/jcb.18.2.345; Schaedel C, 1999, J PEDIATR-US, V135, P739, DOI 10.1016/S0022-3476(99)70094-6; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Sheridan MB, 2005, HUM MOL GENET, V14, P3493, DOI 10.1093/hmg/ddi374; Sims DE, 1997, AM J PHYSIOL-LUNG C, V273, pL1036; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; WIDDICOMBE JH, 1985, P NATL ACAD SCI USA, V82, P6167, DOI 10.1073/pnas.82.18.6167; WILLUMSEN NJ, 1991, AM J PHYSIOL, V261, pC319, DOI 10.1152/ajpcell.1991.261.2.C319; WILLUMSEN NJ, 1991, AM J PHYSIOL, V261, pC332, DOI 10.1152/ajpcell.1991.261.2.C332; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1	60	185	188	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					911	923		10.1016/j.cell.2010.11.029	http://dx.doi.org/10.1016/j.cell.2010.11.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145458	Green Accepted, Bronze			2022-12-24	WOS:000285182600009
J	Bitton, S; Roth, J				Bitton, Samuel; Roth, Jesse			Addressing Food Insecurity Freedom From Want, Freedom From Fear	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bitton, Samuel] N Shore Long Isl Jewish Hlth Syst, Cohen Childrens Med Ctr New York, New Hyde Pk, NY USA; [Roth, Jesse] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Roth, Jesse] Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health; Yeshiva University; Albert Einstein College of Medicine	Roth, J (corresponding author), 149-37 Powells Cove Blvd, Whitestone, NY 11357 USA.	jesserothmd@hotmail.com						Alaimo K, 2001, PEDIATRICS, V108, P44; [Anonymous], 2010, J AM DIET ASSOC, V110, P1368, DOI 10.1016/j.jada.2010.07.015; Casey PH, 2006, PEDIATRICS, V118, pE1406, DOI 10.1542/peds.2006-0097; Food Research and Action Center, 2010, FOOD HARDSH CLOS LOO; Laraia BA, 2010, J AM DIET ASSOC, V110, P692, DOI 10.1016/j.jada.2010.02.014; Lee JS, 2001, J NUTR, V131, P1503, DOI 10.1093/jn/131.5.1503; Nord M, 2009, EC RES SERVICE PUBLI; Seligman HK, 2010, NEW ENGL J MED, V363, P6, DOI 10.1056/NEJMp1000072; Young J, 2009, PUBLIC HEALTH NUTR, V12, P2129, DOI 10.1017/S1368980009005795; SNAP FOOD STAMP MONT	10	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2405	2406		10.1001/jama.2010.1747	http://dx.doi.org/10.1001/jama.2010.1747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119087				2022-12-24	WOS:000284763900022
J	Resnic, FS; Gross, TP; Marinac-Dabic, D; Loyo-Berrios, N; Donnelly, S; Normand, SLT; Matheny, ME				Resnic, Frederic S.; Gross, Thomas P.; Marinac-Dabic, Danica; Loyo-Berrios, Nilsa; Donnelly, Sharon; Normand, Sharon-Lise T.; Matheny, Michael E.			Automated Surveillance to Detect Postprocedure Safety Signals of Approved Cardiovascular Devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERVENTIONAL CARDIOLOGY; RANDOMIZED-TRIAL; MEDICAL DEVICE; STENTS; CATHETERIZATION; COMPLICATIONS; METAANALYSIS; REGISTRY; HOLES; RISK	Context Ensuring the safety of medical devices challenges current surveillance approaches, which rely heavily on voluntary reporting of adverse events. Automated surveillance of clinical registries may provide early warnings in the postmarket evaluation of medical device safety. Objective To determine whether automated safety surveillance of clinical registries using a computerized tool can provide early warnings regarding the safety of new cardiovascular devices. Design, Setting, and Patients Prospective propensity-matched cohort analysis of 7 newly introduced cardiovascular devices, using clinical data captured in the Massachusetts implementation of the National Cardiovascular Data Repository CathPCI Registry for all adult patients undergoing percutaneous coronary intervention from April 2003 through September 2007 in Massachusetts. Main Outcome Measure Presence of any safety alert, triggered if the cumulative observed risk for a given device exceeded the upper 95% confidence interval (CI) of comparator control device. Predefined sensitivity analyses assessed robustness of alerts when triggered. Results We evaluated 74 427 consecutive interventional coronary procedures. Three of 21 safety analyses triggered sustained alerts in 2 implantable devices. Patients receiving Taxus Express2 drug-eluting stents experienced a 1.28-fold increased risk of post-procedural myocardial infarction (2.87% vs 2.25%; absolute risk increase, 0.62% [95% CI, 0.25%-0.99%]) and a 1.21-fold increased risk of major adverse cardiac events (4.24% vs 3.50%; absolute increase, 0.74% [95% CI, 0.29%-1.19%]) compared with those receiving alternative drug-eluting stents. Patients receiving Angio-Seal STS vascular closure devices experienced a 1.51-fold increased risk of major vascular complications (1.09% vs 0.72%; absolute increased risk, 0.37% [95% CI, 0.03%-0.71%]) compared with those receiving alternative vascular closure devices. Sensitivity analyses confirmed increased risk following use of the Taxus Express2 stent but not the Angio-Seal STS device. Conclusion Automated prospective surveillance of clinical registries is feasible and can identify low-frequency safety signals for new cardiovascular devices. JAMA. 2010;304(18):2019-2027 www.jama.com	[Resnic, Frederic S.; Donnelly, Sharon] Brigham & Womens Hosp, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Gross, Thomas P.; Marinac-Dabic, Danica; Loyo-Berrios, Nilsa] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Matheny, Michael E.] Tennessee Valley Healthcare Syst, Vet Adm Med Ctr, Nashville, TN USA; [Matheny, Michael E.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Food & Drug Administration (FDA); Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Resnic, FS (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	fresnic@partners.org	Matheny, Michael E/B-3541-2008	Matheny, Michael E/0000-0003-3217-4147; Normand, Sharon-Lise/0000-0001-7027-4769; Marinac-Dabic, Danica/0000-0002-1824-0104	Boston Scientific Inc; Abbott Vascular Inc; Cordis Corp; St Jude Medical; Medicines Company; National Library of Medicine [NIH R01-LM008142]; US Food and Drug Administration [HHSF 223200830058C]; Veterans Administration Health Services Research and Development Service [CDP 09-387]; Division of Healthcare Quality and Statistics, Massachusetts Department of Public Health; NATIONAL LIBRARY OF MEDICINE [R01LM008142] Funding Source: NIH RePORTER	Boston Scientific Inc(Boston Scientific); Abbott Vascular Inc(Abbott Laboratories); Cordis Corp; St Jude Medical(St. Jude Medical); Medicines Company; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); US Food and Drug Administration; Veterans Administration Health Services Research and Development Service; Division of Healthcare Quality and Statistics, Massachusetts Department of Public Health; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr Resnic and Dr Matheny reported filing a patent application, currently under review at the US Patent Office, for several key analytic components of the DELTA surveillance system; the intellectual property rights of Drs Resnic and Matheny (current and former employees of Brigham and Women's Hospital) related to the development of DELTA are assigned to the institution, and Partners Healthcare, the parent organization of Brigham and Women's Hospital, retains partial rights for DELTA use and licensing. Neither Dr Resnic nor Dr Matheny have previously received or anticipate any financial compensation, stock options, income, or ownership in DELTA, Coping Systems, or any other related commercial entity. Dr Resnic reported receiving modest consulting income from Boston Scientific Inc, Abbott Vascular Inc, Cordis Corp, and St Jude Medical and receiving research grants from The Medicines Company. No other authors reported dislosures.; This study was funded, in part, by grants from the National Library of Medicine (NIH R01-LM008142) and the US Food and Drug Administration (HHSF 223200830058C) as well as from the Veterans Administration Health Services Research and Development Service (CDP 09-387).; The National Institutes of Health, the Veterans Administration Health Services Research and Development Service, and the US Food and Drug Administration had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. However, the preliminary proposed study protocol was provided to the Veterans Administration Health Services Research and Development Service and the US Food and Drug Administration as part of the original grant and contract application process.; We acknowledge the significant system development and technical contributions of Richard Cope, BS, and Susan Robbins, BS, of Coping Systems Inc, Andover, Massachusetts. Coping Systems was a subcontractor to Brigham and Women's Hospital, and neither Mr Cope nor Ms Robbins received extra compensation for their contributions; Mr Cope is part owner of Coping Systems and is also named on the patent application filed by Dr Resnic and Dr Matheny. We also acknowledge the support of the Division of Healthcare Quality and Statistics, Massachusetts Department of Public Health.	Aggarwal A, 2009, HEART RHYTHM, V6, P1565, DOI 10.1016/j.hrthm.2009.08.006; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Garber AM, 2010, NEW ENGL J MED, V362, P1161, DOI 10.1056/NEJMp1000447; Gross T P, 1996, Stud Health Technol Inform, V28, P17; Hammill S, 2006, HEART RHYTHM, V3, P470, DOI 10.1016/j.hrthm.2006.01.019; Holman WL, 2009, J AM COLL SURGEONS, V208, P755, DOI 10.1016/j.jamcollsurg.2008.11.016; Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; *MA DAT AN CTR, 2009, PERC COR INT COMM MA; Maisel WH, 2007, NEW ENGL J MED, V356, P981, DOI 10.1056/NEJMp068305; Matheny ME, 2006, J AM MED INFORM ASSN, V13, P180, DOI 10.1197/jamia.M1908; Matheny ME, 2008, AM HEART J, V155, P114, DOI 10.1016/j.ahj.2007.08.022; Matheny Michael E, 2007, AMIA Annu Symp Proc, P518; Matheny ME, 2009, MED DECIS MAKING, V29, P247, DOI 10.1177/0272989X08327110; Mauri L, 2008, CIRCULATION, V118, P1817, DOI 10.1161/CIRCULATIONAHA.108.781377; Mauri L, 2008, NEW ENGL J MED, V359, P1330, DOI 10.1056/NEJMoa0801485; *NAT CARD DAT REG, 2010, DESCR NCDR CATHPCI R; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P1200, DOI 10.1016/j.jacc.2004.06.048; O'Shea JC, 2004, AM HEART J, V147, P977, DOI 10.1016/j.ahj.2004.03.001; Peterson ED, 2004, AM HEART J, V147, P985, DOI 10.1016/j.ahj.2004.03.002; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; Popma JJ, 2009, CIRC-CARDIOVASC INTE, V2, P133, DOI 10.1161/CIRCINTERVENTIONS.108.832048; Rao SV, 2008, AM HEART J, V156, P201, DOI 10.1016/j.ahj.2008.01.036; Resnic FS, 2004, MED DECIS MAKING, V24, P399, DOI 10.1177/0272989X04267012; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167; Samore MH, 2004, JAMA-J AM MED ASSOC, V291, P325, DOI 10.1001/jama.291.3.325; Shah JS, 2006, JAMA-J AM MED ASSOC, V296, P655, DOI 10.1001/jama.296.6.655; Stone GW, 2007, JAMA-J AM MED ASSOC, V298, P2497, DOI 10.1001/jama.298.21.2497; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Tavris Dale R, 2005, J Invasive Cardiol, V17, P644; Warren BS, 1999, CATHETER CARDIO INTE, V48, P162, DOI 10.1002/(SICI)1522-726X(199910)48:2<162::AID-CCD8>3.0.CO;2-2	33	50	50	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2019	2027		10.1001/jama.2010.1633	http://dx.doi.org/10.1001/jama.2010.1633			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063011	Bronze, Green Accepted			2022-12-24	WOS:000284000600020
J	Bredenoord, AL; Braude, P				Bredenoord, Annelien L.; Braude, Peter			Ethics of mitochondrial gene replacement: from bench to bedside	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DNA DISORDERS; DIAGNOSIS; RISKS		[Bredenoord, Annelien L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Braude, Peter] Kings Coll London, Dept Womens Hlth, London WC2R 2LS, England; [Braude, Peter] Guys Hosp, Ctr Preimplantat Genet Diag, London SE1 9RT, England	Utrecht University; Utrecht University Medical Center; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Bredenoord, AL (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Stratenum 6-131,PO Box 85500, NL-3508 GA Utrecht, Netherlands.	A.L.Bredenoord@umcutrecht.nl			MRC [G0701172, G0801061] Funding Source: UKRI; Medical Research Council [G0701172, G0801061] Funding Source: Medline; Wellcome Trust [086034] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		[Anonymous], 2008, NATURE, V452, P913, DOI 10.1038/452913a; BARRITT JA, 2001, REPROD BIOMED ONLINE, V3, P47; Bredenoord AL, 2008, HUM REPROD UPDATE, V14, P669, DOI 10.1093/humupd/dmn035; Bredenoord AL, 2008, HUM REPROD, V23, P2392, DOI 10.1093/humrep/den290; Bredenoord A, 2009, EUR J HUM GENET, V17, P1550, DOI 10.1038/ejhg.2009.88; Bredenoord AL, 2010, HUM REPROD, V25, P1354, DOI 10.1093/humrep/deq077; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Dresser Rebecca, 2004, IRB, V26, P1, DOI 10.2307/3563945; Dresser R, 2009, J LAW MED ETHICS, V37, P38, DOI 10.1111/j.1748-720X.2009.00349.x; Hawes SM, 2002, HUM REPROD, V17, P850, DOI 10.1093/humrep/17.4.850; Kimmelman J, 2008, NAT REV GENET, V9, P239, DOI 10.1038/nrg2317; Kimmelman Jonathan., 2010, GENE TRANSFER ETHICS; Malek J, 2007, J MED PHILOS, V32, P339, DOI 10.1080/03605310701515369; *MRC, 2004, ASS REPR SAF SOUND F; Parens E, 2001, SCIENCE, V292, P397, DOI 10.1126/science.292.5516.397; Pennings G, 2007, HUM REPROD, V22, P2585, DOI 10.1093/humrep/dem237; Pennings G, 2003, HUM REPROD UPDATE, V9, P397, DOI 10.1093/humupd/dmg031; Poulton J, 2010, NEUROMUSCULAR DISORD, V20, P559, DOI 10.1016/j.nmd.2010.05.008; Poulton J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b94; Sugarman J, 1999, SCIENCE, V285, P2071, DOI 10.1126/science.285.5436.2071; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; THE PRESIDENT'S COUNCIL ON BIOETHICS, 2004, REPR RESP REG NEW BI; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245	24	25	25	0	51	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2010	341								c6021	10.1136/bmj.c6021	http://dx.doi.org/10.1136/bmj.c6021			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	681KD	21059727				2022-12-24	WOS:000284310100003
J	Alwan, A; MacLean, DR; Riley, LM; d'Espaignet, ET; Mathers, CD; Stevens, GA; Bettcher, D				Alwan, Ala; MacLean, David R.; Riley, Leanne M.; d'Espaignet, Edouard Tursan; Mathers, Colin Douglas; Stevens, Gretchen Anna; Bettcher, Douglas			Chronic Diseases: Chronic Diseases and Development 5 Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries	LANCET			English	Article							PREVENTION	The burden of chronic, non-communicable diseases in low-income and middle-income countries is increasing. We outline a framework for monitoring of such diseases and review the mortality burden and the capacity of countries to respond to them. We show data from WHO data sources and published work for prevalence of tobacco use, overweight, and cause-specific mortality in 23 low-income and middle-income countries with a high burden of non-communicable disease. Data for national capacity for chronic disease prevention and control were generated from a global assessment that was done in WHO member states in 2009-10. Although reliable data for cause-specific mortality are scarce, non-communicable diseases were estimated to be responsible for 23.4 million (or 64% of the total) deaths in the 23 countries that we analysed, with 47% occurring in people who were younger than 70 years. Tobacco use and overweight are common in most of the countries and populations we examined, but coverage of cost-effective interventions to reduce these risk factors is low. Capacity for prevention and control of non-communicable diseases, including monitoring and surveillance operations nationally, is inadequate. A surveillance framework, including a minimum set of indicators covering exposures and outcomes, is essential for policy development and assessment and for monitoring of trends in disease. Technical, human, and fiscal resource constraints are major impediments to the establishment of effective prevention and control programmes. Despite increasing awareness and commitment to address chronic disease, concrete actions by global partners to plan and implement cost-effective interventions are inadequate.	[Alwan, Ala; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [d'Espaignet, Edouard Tursan; Bettcher, Douglas] WHO, Tobacco Free Initiat, CH-1211 Geneva, Switzerland; [Mathers, Colin Douglas; Stevens, Gretchen Anna] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization; World Health Organization	Alwan, A (corresponding author), WHO, Dept Chron Dis & Hlth Promot, 20 Ave Appia, CH-1211 Geneva, Switzerland.	alwana@who.int	Harding, Richard/G-9729-2012; d'Espaignet, Edouard Tursan/V-3857-2019	Mathers, Colin/0000-0002-0617-6731				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alleyne G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-15; [Anonymous], GLOB EC PROSP 2010; [Anonymous], CAUS DEATH IND 2001; [Anonymous], 2004, WHA5717 WHO; [Anonymous], WHO SURV MON; [Anonymous], 3 MIN HLTH; [Anonymous], WHO MORT DAT 2008; [Anonymous], 2010, WORLD HLTH STAT 2010; [Anonymous], INT STAT CLASS DIS; [Anonymous], WHO GLOB INFOBASE; [Anonymous], DISC PAP NONC DIS PO; [Anonymous], GLOB RISKS 2010 GLOB; [Anonymous], WHA561 WHO; [Anonymous], INT FUT EXPL ALT GLO; [Anonymous], WHOMNC012; [Anonymous], B WHO; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], WHAA5314 WHO; [Anonymous], 2 WHO GLOB INFOBASE; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; Ngo Anh D, 2010, BMC Res Notes, V3, P78, DOI 10.1186/1756-0500-3-78; Porapakkham Y, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-14; Strong K, 2008, EUR J CANCER PREV, V17, P162, DOI 10.1097/CEJ.0b013e3282b6fcc9; World Bank, 2009, GLOBAL ECONOMIC PROSPECTS: COMMODITIES AT THE CROSSROADS, P1, DOI 10.1596/978-0-8213-7799-4; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2008, ACT PLAN GLOB STRAT; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization, 2007, VERB AUT STAND ASC A; World Health Organization (WHO), WHO STEPS SURV MAN W	39	374	395	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1861	1868		10.1016/S0140-6736(10)61853-3	http://dx.doi.org/10.1016/S0140-6736(10)61853-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21074258				2022-12-24	WOS:000285439700035
J	Paynter, S; Ware, RS; Weinstein, P; Williams, G; Sly, PD				Paynter, Stuart; Ware, Robert S.; Weinstein, Philip; Williams, Gail; Sly, Peter D.			Childhood pneumonia: a neglected, climate-sensitive disease?	LANCET			English	Editorial Material									[Ware, Robert S.; Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia; [Paynter, Stuart; Ware, Robert S.; Williams, Gail] Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4029, Australia; [Weinstein, Philip] Univ S Australia, Grad Res Ctr, Adelaide, SA 5001, Australia	University of Queensland; University of Queensland; University of South Australia	Sly, PD (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia.	p.sly@uq.edu.au	Weinstein, Phil/C-9805-2011; Sly, Peter D/F-1486-2010; Ware, Robert S./B-2024-2014; Williams, Gail/S-8833-2019	Sly, Peter D/0000-0001-6305-2201; Ware, Robert S./0000-0002-6129-6736; Williams, Gail/0000-0002-4822-5263; Weinstein, Philip/0000-0001-9860-7166				[Anonymous], 2009, PROT HLTH CLIM CHANG; Chan PWK, 2002, PEDIATR PULM, V34, P47, DOI 10.1002/ppul.10095; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Confalonieri U, 2007, CLIMATE CHANGE 2007; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Moura FEA, 2006, AM J TROP MED HYG, V74, P165, DOI 10.4269/ajtmh.2006.74.165; Naylor RL, 2007, P NATL ACAD SCI USA, V104, P7752, DOI 10.1073/pnas.0701825104; Omer SB, 2008, EPIDEMIOL INFECT, V136, P1319, DOI 10.1017/S0950268807000015; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2008, GLOB BURD DIS 2004 U; Ye Y, 2009, AM J TROP MED HYG, V81, P770, DOI 10.4269/ajtmh.2009.09-0070; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	14	34	35	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1804	1805		10.1016/S0140-6736(10)62141-1	http://dx.doi.org/10.1016/S0140-6736(10)62141-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21111894				2022-12-24	WOS:000285439700006
J	Baker, M				Baker, M.			Genomics The tough new variants	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1136	1136		10.1038/4671136a	http://dx.doi.org/10.1038/4671136a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981104	Bronze			2022-12-24	WOS:000283548600058
J	Frankel, A; Vecchio, P				Frankel, Adam; Vecchio, Phillip			Personal View Commonly used, easily confused: let's eliminate hyper and hypo	BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCTOR-PATIENT COMMUNICATION		[Frankel, Adam; Vecchio, Phillip] Princess Alexandra Hosp, Medicat Safety Team, Woolloongabba, Qld 4102, Australia		Frankel, A (corresponding author), Princess Alexandra Hosp, Medicat Safety Team, Woolloongabba, Qld 4102, Australia.	a.frankel@uq.edu.au; phillip_vecchio@health.qld.gov.au	Frankel, Adam J/A-5001-2013	Frankel, Adam J/0000-0002-5198-7664				Kountz DS, 2009, POSTGRAD MED, V121, P171, DOI 10.3810/pgm.2009.09.2065; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Roughead Elizabeth E, 2009, Aust New Zealand Health Policy, V6, P18, DOI 10.1186/1743-8462-6-18; Schroeder R E, 1999, J Health Adm Educ, V17, P175; SIMPSON M, 1991, BRIT MED J, V303, P1385, DOI 10.1136/bmj.303.6814.1385; Valentin A, 2006, INTENS CARE MED, V32, P1591, DOI 10.1007/s00134-006-0290-7	7	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2010	341								c5867	10.1136/bmj.c5867	http://dx.doi.org/10.1136/bmj.c5867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZL	20961983				2022-12-24	WOS:000283552700002
J	Golomb, BA; Erickson, LC; Koperski, S; Sack, D; Enkin, M; Howick, J				Golomb, Beatrice A.; Erickson, Laura C.; Koperski, Sabrina; Sack, Deanna; Enkin, Murray; Howick, Jeremy			What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials	ANNALS OF INTERNAL MEDICINE			English	Article							LACTOSE-INTOLERANCE; HEART-DISEASE; OLIVE OIL; COUGH	Background: No regulations govern placebo composition. The composition of placebos can influence trial outcomes and merits reporting. Purpose: To assess how often investigators specify the composition of placebos in randomized, placebo-controlled trials. Data Sources: 4 English-language general and internal medicine journals with high impact factors. Study Selection: 3 reviewers screened titles and abstracts of the journals to identify randomized, placebo-controlled trials published from January 2008 to December 2009. Data Extraction: Reviewers independently abstracted data from the introduction and methods sections of identified articles, recording treatment type (pill, injection, or other) and whether placebo composition was stated. Discrepancies were resolved by consensus. Data Synthesis: Most studies did not disclose the composition of the study placebo. Disclosure was less common for pills than for injections and other treatments (8.2% vs. 26.7%; P = 0.002). Limitation: Journals with high impact factors may not be representative. Conclusion: Placebos were seldom described in randomized, controlled trials of pills or capsules. Because the nature of the placebo can influence trial outcomes, placebo formulation should be disclosed in reports of placebo-controlled trials.	Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; McMaster Univ, Hamilton, ON, Canada; Univ Oxford, Ctr Evidence Based Med, Oxford, England	University of California System; University of California San Diego; McMaster University; University of Oxford	Golomb, BA (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr 0995, La Jolla, CA 92093 USA.	bgolomb@ucsd.edu	Koperski, Sabrina/E-8112-2011; Howick, Jeremy/ADP-7644-2022	Koperski, Sabrina/0000-0003-0001-6478; Howick, Jeremy/0000-0003-0280-7206	University of California Foundation [3929]; Medical Research Council/Economic and Social Research Council [G0800055]; Medical Research Council [G0800055] Funding Source: researchfish; MRC [G0800055] Funding Source: UKRI	University of California Foundation; Medical Research Council/Economic and Social Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	By University of California Foundation Fund 3929-Medical Reasoning. The manuscript was revised while Dr. Howick was a recipient of a Medical Research Council/Economic and Social Research Council Interdisciplinary Postdoctoral Fellowship (G0800055).	ACHESON J, 1972, ATHEROSCLEROSIS, V15, P177, DOI 10.1016/0021-9150(72)90067-6; Covas M. -I., 2008, Inflammopharmacology, V16, P216, DOI 10.1007/s10787-008-8019-6; Cullinen Kathleen, 2006, Med Health R I, V89, P113; DEAN AG, 2009, OPENEPI OPEN SOURCE, V2010; Eccles R, 2006, RESP PHYSIOL NEUROBI, V152, P340, DOI 10.1016/j.resp.2005.10.004; Fito M, 2005, ATHEROSCLEROSIS, V181, P149, DOI 10.1016/j.atherosclerosis.2004.12.036; Golomb B, 2002, JAMA-J AM MED ASSOC, V287, P2502; GOLOMB BA, 1995, NATURE, V375, P530, DOI 10.1038/375530a0; Golomb BA, 2009, AM J BIOETHICS, V9, P34, DOI 10.1080/15265160903244242; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; LOPRINZI CL, 1990, JNCI-J NATL CANCER I, V82, P1127, DOI 10.1093/jnci/82.13.1127; MCCANN IL, 1984, J PERS SOC PSYCHOL, V46, P1142, DOI 10.1037/0022-3514.46.5.1142; Moher David, 2010, J Clin Epidemiol, V63, pe1, DOI [10.1136/bmj.c869, 10.1016/j.jclinepi.2010.03.004]; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Osterlund P, 2004, CLIN GASTROENTEROL H, V2, P696, DOI 10.1016/S1542-3565(04)00293-9; Paul IM, 2007, ARCH PEDIAT ADOL MED, V161, P1140, DOI 10.1001/archpedi.161.12.1140; Research Committee of the Scottish Society of Physicians, 1971, BMJ-BRIT MED J, V4, P775; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Wedlake L, 2008, EUR J CANCER, V44, P2212, DOI 10.1016/j.ejca.2008.07.018	21	43	44	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					532	535		10.7326/0003-4819-153-8-201010190-00010	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956710				2022-12-24	WOS:000283054600006
J	Vila-Perello, M; Muir, TW				Vila-Perello, Miquel; Muir, Tom W.			Biological Applications of Protein Splicing	CELL			English	Article							SITE-SPECIFIC INCORPORATION; SIGNALING PROTEIN; CYCLIC-PEPTIDES; REAL-TIME; SEMISYNTHESIS; LIGATION; RECOGNITION; SELECTIVITY; CHEMISTRY; REVEALS	Protein splicing is a naturally occurring process in which a protein editor, called an intein, performs a molecular disappearing act by cutting itself out of a host protein in a traceless manner. In the two decades since its discovery, protein splicing has been harnessed for the development of several protein-engineering methods. Collectively, these technologies help bridge the fields of chemistry and biology, allowing hitherto impossible manipulations of protein covalent structure. These tools and their application are the subject of this Primer.	[Vila-Perello, Miquel; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA	Rockefeller University	Muir, TW (corresponding author), Rockefeller Univ, Lab Synthet Prot Chem, 1230 York Ave, New York, NY 10021 USA.	muirt@rockefeller.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344	NCI NIH HHS [RC2 CA148354] Funding Source: Medline; NIGMS NIH HHS [R01 GM086868, R01 GM055843] Funding Source: Medline; NATIONAL CANCER INSTITUTE [RC2CA148354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055843, R01GM086868] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold U, 2002, J AM CHEM SOC, V124, P8522, DOI 10.1021/ja026114n; Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; Brunsveld L, 2006, ANGEW CHEM INT EDIT, V45, P6622, DOI 10.1002/anie.200600855; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; Ceccarini G, 2009, CELL METAB, V10, P148, DOI 10.1016/j.cmet.2009.07.001; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chatterjee C, 2010, J BIOL CHEM, V285, P11045, DOI 10.1074/jbc.R109.080291; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Cheriyan M, 2009, ADV DRUG DELIVER REV, V61, P899, DOI 10.1016/j.addr.2009.04.021; Erlanson DA, 1996, CHEM BIOL, V3, P981, DOI 10.1016/S1074-5521(96)90165-9; Evans TC, 1998, PROTEIN SCI, V7, P2256, DOI 10.1002/pro.5560071103; Frutos S, 2010, NAT CHEM BIOL, V6, P527, DOI [10.1038/NCHEMBIO.371, 10.1038/nchembio.371]; Giriat I, 2003, J AM CHEM SOC, V125, P7180, DOI 10.1021/ja034736i; Hackenberger CPR, 2008, ANGEW CHEM INT EDIT, V47, P10030, DOI 10.1002/anie.200801313; Hahn ME, 2004, ANGEW CHEM INT EDIT, V43, P5800, DOI 10.1002/anie.200461141; Hahn ME, 2007, CHEMBIOCHEM, V8, P2100, DOI 10.1002/cbic.200700404; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hofmann RM, 2001, BIOORG MED CHEM LETT, V11, P3091, DOI 10.1016/S0960-894X(01)00650-3; Kanno A, 2007, ANGEW CHEM INT EDIT, V46, P7595, DOI 10.1002/anie.200700538; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; Kumar KSA, 2009, ANGEW CHEM INT EDIT, V48, P8090, DOI 10.1002/anie.200902936; Lepenies B, 2010, CURR OPIN CHEM BIOL, V14, P404, DOI 10.1016/j.cbpa.2010.02.016; Li J, 2008, HUM GENE THER, V19, P958, DOI 10.1089/hum.2008.009; Li X, 2009, ANGEW CHEM INT EDIT, V48, P9184, DOI 10.1002/anie.200904472; Lin MZ, 2008, PHYSIOLOGY, V23, P131, DOI 10.1152/physiol.00007.2008; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Lu XQ, 2010, J AM CHEM SOC, V132, P1748, DOI 10.1021/ja9088549; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Pickin KA, 2008, J AM CHEM SOC, V130, P5667, DOI 10.1021/ja711244h; Piontek C, 2009, ANGEW CHEM INT EDIT, V48, P1941, DOI 10.1002/anie.200804735; Schwarzer D, 2005, CURR OPIN CHEM BIOL, V9, P561, DOI 10.1016/j.cbpa.2005.09.018; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Valiyaveetil FI, 2006, SCIENCE, V314, P1004, DOI 10.1126/science.1133415; Valiyaveetil FI, 2006, J AM CHEM SOC, V128, P11591, DOI 10.1021/ja0631955; Vila-Perello M, 2007, J AM CHEM SOC, V129, P8068, DOI 10.1021/ja072013j; Vitali F, 2006, EMBO J, V25, P150, DOI 10.1038/sj.emboj.7600911; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Xie N, 2009, BIOCONJUGATE CHEM, V20, P360, DOI 10.1021/bc800467a; Yuen CM, 2006, J AM CHEM SOC, V128, P8939, DOI 10.1021/ja062980e; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	56	126	141	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					191	200		10.1016/j.cell.2010.09.031	http://dx.doi.org/10.1016/j.cell.2010.09.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946979	Green Accepted, Bronze			2022-12-24	WOS:000283052200009
J	Yamada, K; Hirotsu, T; Matsuki, M; Butcher, RA; Tomioka, M; Ishihara, T; Clardy, J; Kunitomo, H; Iino, Y				Yamada, Koji; Hirotsu, Takaaki; Matsuki, Masahiro; Butcher, Rebecca A.; Tomioka, Masahiro; Ishihara, Takeshi; Clardy, Jon; Kunitomo, Hirofumi; Iino, Yuichi			Olfactory Plasticity Is Regulated by Pheromonal Signaling in Caenorhabditis elegans	SCIENCE			English	Article							DAUER PHEROMONE; C-ELEGANS; ADAPTATION; NEURONS; MEDIATE; EVOLUTION; ACTS	Population density-dependent dispersal is a well-characterized strategy of animal behavior in which dispersal rate increases when population density is higher. Caenorhabditis elegans shows positive chemotaxis to a set of odorants, but the chemotaxis switches from attraction to dispersal after prolonged exposure to the odorants. We show here that this plasticity of olfactory behavior is dependent on population density and that this regulation is mediated by pheromonal signaling. We show that a peptide, suppressor of NEP-2 (SNET-1), negatively regulates olfactory plasticity and that its expression is down-regulated by the pheromone. NEP-2, a homolog of the extracellular peptidase neprilysin, antagonizes SNET-1, and this function is essential for olfactory plasticity. These results suggest that population density information is transmitted through the external pheromone and endogenous peptide signaling to modulate chemotactic behavior.	[Yamada, Koji; Hirotsu, Takaaki; Matsuki, Masahiro; Tomioka, Masahiro; Kunitomo, Hirofumi; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Hirotsu, Takaaki; Ishihara, Takeshi] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan; [Butcher, Rebecca A.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Tokyo; Kyushu University; Harvard University; Harvard Medical School	Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	iino@biochem.s.u-tokyo.ac.jp	Hirotsu, Takaaki/G-9358-2013; IINO, YUICHI/G-4962-2014; KUNITOMO, HIROFUMI/G-4963-2014; TOMIOKA, MASAHIRO/G-4890-2014	Hirotsu, Takaaki/0000-0003-3936-8382; KUNITOMO, HIROFUMI/0000-0001-7312-7051; TOMIOKA, MASAHIRO/0000-0002-7537-714X	NIH [CA24487, GM087533]; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM087533, R00GM087533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge J. Ragains for synthesis of the dauer pheromone ascarosides. Y.I. and T. I. were supported by a Grant-in-aid for Scientific Research, J. C. by NIH grant CA24487, and R. A. B. by an NIH K99 Pathway to Independence Award (GM087533). We thank S. Mitani and P. Sengupta for srbc-64 and srbc-66 strains.	BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; DEVAULT A, 1988, FEBS LETT, V231, P54, DOI 10.1016/0014-5793(88)80701-4; Hirotsu T, 2005, GENES CELLS, V10, P517, DOI 10.1111/j.1365-2443.2005.00856.x; Hu Patrick J, 2007, WormBook, P1; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; TAUSSIG R, 1984, P NATL ACAD SCI-BIOL, V81, P4988, DOI 10.1073/pnas.81.15.4988; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P1837, DOI 10.1098/rspb.1999.0854; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Yamada K, 2009, GENETICS, V181, P1347, DOI 10.1534/genetics.108.099002; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	23	64	69	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1647	1650		10.1126/science.1192020	http://dx.doi.org/10.1126/science.1192020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929849	Green Accepted			2022-12-24	WOS:000282098100042
J	Franks, TM; Singh, G; Lykke-Andersen, J				Franks, Tobias M.; Singh, Guramrit; Lykke-Andersen, Jens			Upf1 ATPase-Dependent mRNP Disassembly Is Required for Completion of Nonsense-Mediated mRNA Decay	CELL			English	Article							EXON-JUNCTION COMPLEX; ENDONUCLEOLYTIC CLEAVAGE; SACCHAROMYCES-CEREVISIAE; SURVEILLANCE COMPLEX; BINDING-PROTEIN; QUALITY-CONTROL; CAENORHABDITIS-ELEGANS; PROCESSING BODIES; BOX PROTEIN; P-BODIES	Cellular mRNAs exist in messenger ribonucleoprotein (mRNP) complexes, which undergo transitions during the lifetime of the mRNAs and direct posttranscriptional gene regulation. A final posttranscriptional step in gene expression is the turnover of the mRNP, which involves degradation of the mRNA and recycling of associated proteins. How tightly associated protein components are released from degrading mRNPs is unknown. Here, we demonstrate that the ATPase activity of the RNA helicase Upf1 allows disassembly of mRNPs undergoing nonsense-mediated mRNA decay (NMD). In the absence of Upf1 ATPase activity, partially degraded NMD mRNA intermediates accumulate in complex with NMD factors and concentrate in processing bodies. Thus, disassembly and completion of turnover of mRNPs undergoing NMD requires ATP hydrolysis by Upf1. This uncovers a previously unappreciated and potentially regulated step in mRNA decay and raises the question of how other mRNA decay pathways release protein components of substrate mRNPs.	[Franks, Tobias M.; Singh, Guramrit; Lykke-Andersen, Jens] Univ Colorado, Boulder, CO 80309 USA; [Franks, Tobias M.; Lykke-Andersen, Jens] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego	Lykke-Andersen, J (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	jlykkeandersen@ucsd.edu		Lykke-Andersen, Jens/0000-0003-1821-0754	National Institutes of Health [R01 GM077243]; National Institute of General Medical Sciences [GM-07135]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007135, R01GM077243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Tom Blumenthal (University of Colorado), Melissa Moore (University of Massachusetts Medical Center), and Sebastien Durand (UCSD) for comments on the manuscript. Alex Choe and Claire Egan are thanked for technical support and Joachim Weischenfeldt for production of the antigen for anti-Smg1 antibodies. Drs. Marv Fritzler, Ed Chan, and Donald Bloch are thanked for human IC-6 serum. Dr. Oliver Muhlemann is thanked for the HA-Smg6 construct. Work on P bodies in our laboratory is supported by funding from grant R01 GM077243 from the National Institutes of Health to J.L.-A. T.M.F. has been supported by National Institutes of Health NRSA Institutional Training grant number GM-07135 from the National Institute of General Medical Sciences.	Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; CEREGHINO GP, 1995, MOL BIOL CELL, V6, P1125, DOI 10.1091/mbc.6.9.1125; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; CZAPLINSKI K, 1995, RNA, V1, P610; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Liu YM, 2003, RNA, V9, P677, DOI 10.1261/rna.2128903; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Muhlemann O, 2010, RNA BIOL, V7, P28; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Page MF, 1999, MOL CELL BIOL, V19, P5943; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Stalder L, 2009, RNA, V15, P1265, DOI 10.1261/rna.1672509; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; VREKEN P, 1992, MOL CELL BIOL, V12, P2986, DOI 10.1128/MCB.12.7.2986; Weng YM, 1998, RNA, V4, P205; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wilusz J, 2009, NAT STRUCT MOL BIOL, V16, P9, DOI 10.1038/nsmb0109-9; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	71	165	168	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					938	950		10.1016/j.cell.2010.11.043	http://dx.doi.org/10.1016/j.cell.2010.11.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145460	Green Accepted, Bronze			2022-12-24	WOS:000285182600011
J	McLachlan, JC				McLachlan, John C.			Christmas 2010: Reading between the Lines Integrative medicine and the point of credulity	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McLachlan, John C.] Univ Durham, Sch Med & Hlth, Stockton On Tees TS17 6BH, England	Durham University	McLachlan, JC (corresponding author), Univ Durham, Sch Med & Hlth, Stockton On Tees TS17 6BH, England.	j.c.mclachlan@durham.ac.uk	McLachlan, John/AAF-4203-2021	McLachlan, John/0000-0001-5493-2645				DIXON M, 2009, SCI BASED MED; *HOUS COMM SCI TEC, 4 HOUS COMM SCI TECH; Sokal A., 1998, INTELLECTUAL IMPOSTU; Sokal A., 1996, SOCIAL TEXT, V46/47, P217, DOI [10.2307/466856, DOI 10.2307/466856]; Strauss S, 2005, EVIDENCE BASED MED P, V3rd; 2009, DCS IMPROBABLE SCI	6	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 8	2010	341								c6979	10.1136/bmj.c6979	http://dx.doi.org/10.1136/bmj.c6979			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZL	21147748				2022-12-24	WOS:000285340300006
J	Saar, BG; Freudiger, CW; Reichman, J; Stanley, CM; Holtom, GR; Xie, XS				Saar, Brian G.; Freudiger, Christian W.; Reichman, Jay; Stanley, C. Michael; Holtom, Gary R.; Xie, X. Sunney			Video-Rate Molecular Imaging in Vivo with Stimulated Raman Scattering	SCIENCE			English	Article							HIGH-SENSITIVITY; LABEL-FREE; MICROSCOPY; STORAGE	Optical imaging in vivo with molecular specificity is important in biomedicine because of its high spatial resolution and sensitivity compared with magnetic resonance imaging. Stimulated Raman scattering (SRS) microscopy allows highly sensitive optical imaging based on vibrational spectroscopy without adding toxic or perturbative labels. However, SRS imaging in living animals and humans has not been feasible because light cannot be collected through thick tissues, and motion-blur arises from slow imaging based on backscattered light. In this work, we enable in vivo SRS imaging by substantially enhancing the collection of the backscattered signal and increasing the imaging speed by three orders of magnitude to video rate. This approach allows label-free in vivo imaging of water, lipid, and protein in skin and mapping of penetration pathways of topically applied drugs in mice and humans.	[Saar, Brian G.; Freudiger, Christian W.; Holtom, Gary R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Freudiger, Christian W.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Reichman, Jay; Stanley, C. Michael] Chroma Technol, Bellows Falls, VT 05101 USA	Harvard University; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu			Boehringer Ingelheim Fonds; Bill and Melinda Gates Foundation; NIH [1R01EB010244-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010244] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank J. MacArthur for advice on electronics and K. Sherwood, W. Faustino, and X. Zhang for helpful discussions. C. W. F. was supported by a Boehringer Ingelheim Fonds Ph.D. fellowship. This work was supported by the Bill and Melinda Gates Foundation and an NIH T-R01 award (1R01EB010244-01) to X. S. X. Patent applications based on this work have been filed by Harvard Univ. Imaging was performed in accordance with Harvard Univ. Faculty of Arts and Sciences Institutional Animal Care and Use Committee protocol number 29-01.	[Anonymous], 2010, ZEM US GUID; Cheng JX, 2002, J OPT SOC AM B, V19, P1363, DOI 10.1364/JOSAB.19.001363; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Combs CA, 2007, J MICROSC-OXFORD, V228, P330, DOI 10.1111/j.1365-2818.2007.01851.x; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fu D, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2780173; Ganikhanov F, 2006, OPT LETT, V31, P1872, DOI 10.1364/OL.31.001872; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Jacques S. L., 1987, Lasers in the Life Sciences, V1, P309; Konig K, 2007, MICROSC RES TECHNIQ, V70, P398, DOI 10.1002/jemt.20445; Lademann J, 2008, SKIN PHARMACOL PHYS, V21, P150, DOI 10.1159/000131079; Levenson M. D., 1988, INTRO NONLINEAR LASE; Li L, 2005, BIOPHYS J, V89, P3480, DOI 10.1529/biophysj.105.065607; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; Nandakumar P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033026; Ozeki Y, 2009, OPT EXPRESS, V17, P3651, DOI 10.1364/OE.17.003651; Ploetz E, 2007, APPL PHYS B-LASERS O, V87, P389, DOI 10.1007/s00340-007-2630-x; Prausnitz MR, 2004, NAT REV DRUG DISCOV, V3, P115, DOI 10.1038/nrd1304; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Rinia HA, 2006, J PHYS CHEM B, V110, P4472, DOI 10.1021/jp0564849; Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Slipchenko MN, 2010, ANALYST, V135, P2613, DOI 10.1039/c0an00252f; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	28	587	614	13	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1368	1370		10.1126/science.1197236	http://dx.doi.org/10.1126/science.1197236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127249	Green Submitted, Green Accepted			2022-12-24	WOS:000284902100039
J	Ellwood, MJ; Wille, M; Maher, W				Ellwood, Michael J.; Wille, Martin; Maher, William			Glacial Silicic Acid Concentrations in the Southern Ocean	SCIENCE			English	Article							CIRCUMPOLAR DEEP-WATER; DIATOMS; CIRCULATION; FRACTIONATION; NUTRIENTS	Reconstruction of nutrient concentrations in the deep Southern Ocean has produced conflicting results. The cadmium/calcium (Cd/Ca) data set suggests little change in nutrient concentrations during the last glacial period, whereas the carbon isotope data set suggests that nutrient concentrations were higher. We determined the silicon isotope composition of sponge spicules from the Atlantic and Pacific sectors of the Southern Ocean and found higher silicic acid concentrations in the Pacific sector during the last glacial period. We propose that this increase results from changes in the stoichiometric uptake of silicic acid relative to nitrate and phosphate by diatoms, thus facilitating a redistribution of nutrients across the Pacific and Southern Oceans. Our results are consistent with the global Cd/Ca data set and support the silicic acid leakage hypothesis.	[Ellwood, Michael J.; Wille, Martin] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Maher, William] Univ Canberra, Fac Sci Appl, Inst Appl Ecol, Canberra, ACT 2601, Australia	Australian National University; University of Canberra	Ellwood, MJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia.	michael.ellwood@anu.edu.au	Wille, Martin/AAU-7512-2020; Wille, Martin/A-1973-2009; Ellwood, Michael/G-7390-2011	Maher, William A./0000-0001-7564-3383; Ellwood, Michael/0000-0003-4288-8530; Wille, Martin/0000-0003-1083-4730	Australian Research Council [DP0770820, DP0771519]	Australian Research Council(Australian Research Council)	We acknowledge the Antarctic Research Facility at Florida State University for E33-22 core samples and the Ocean Drilling Program for ODP177 site 1089 core samples. This research was supported with funds from the Australian Research Council (grants DP0770820 and DP0771519). This manuscript benefited from the thoughtful comments of two anonymous reviewers.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; BOYLE EA, 1992, ANNU REV EARTH PL SC, V20, P245, DOI 10.1146/annurev.ea.20.050192.001333; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Chase Z, 2003, DEEP-SEA RES PT II, V50, P799, DOI 10.1016/S0967-0645(02)00595-7; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; De La Rocha CL, 1997, GEOCHIM COSMOCHIM AC, V61, P5051, DOI 10.1016/S0016-7037(97)00300-1; Ellwood MJ, 2006, EARTH PLANET SC LETT, V243, P749, DOI 10.1016/j.epsl.2006.01.016; Froelich PN, 1992, PALEOCEANOGRAPHY, V7, P739, DOI 10.1029/92PA02090; Georg RB, 2009, EARTH PLANET SC LETT, V283, P67, DOI 10.1016/j.epsl.2009.03.041; Hendry KR, 2010, EARTH PLANET SC LETT, V292, P290, DOI 10.1016/j.epsl.2010.02.005; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; HODELL DA, 2002, P OC DRILL PROGR SCI, V177; LEA DW, 1995, PALEOCEANOGRAPHY, V10, P733, DOI 10.1029/95PA01546; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; McCave IN, 2008, QUATERNARY SCI REV, V27, P1886, DOI 10.1016/j.quascirev.2008.07.010; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; Moy AD, 2006, J QUATERNARY SCI, V21, P763, DOI 10.1002/jqs.1067; Ninnemann US, 2002, EARTH PLANET SC LETT, V201, P383, DOI 10.1016/S0012-821X(02)00708-2; Ninnemann US, 1997, PALEOCEANOGRAPHY, V12, P560, DOI 10.1029/97PA01032; Pichevin LE, 2009, NATURE, V459, P1114, DOI 10.1038/nature08101; Piotrowski AM, 2004, EARTH PLANET SC LETT, V225, P205, DOI 10.1016/j.epsl.2004.06.002; Rosenthal Y, 1997, PALEOCEANOGRAPHY, V12, P787, DOI 10.1029/97PA02508; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; SARMIENTO JL, 2007, GLOBAL BIOGEOCHEM CY, V21; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Wille M, 2010, EARTH PLANET SC LETT, V292, P281, DOI 10.1016/j.epsl.2010.01.036	29	32	33	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1088	1091		10.1126/science.1194614	http://dx.doi.org/10.1126/science.1194614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20966217				2022-12-24	WOS:000284374700039
J	Nowack, B				Nowack, Bernd			Nanosilver Revisited Downstream	SCIENCE			English	Editorial Material							SILVER NANOPARTICLES; NANO-SILVER; EXPOSURE; SULFIDE; SLUDGE; RISK		Empa, Swiss Fed Labs Mat Sci & Technol, CH-9014 St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Nowack, B (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, CH-9014 St Gallen, Switzerland.	nowack@empa.ch	Nowack, Bernd/B-6425-2008	Nowack, Bernd/0000-0002-5676-112X				Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; Blaser SA, 2008, SCI TOTAL ENVIRON, V390, P396, DOI 10.1016/j.scitotenv.2007.10.010; Choi O, 2009, WATER RES, V43, P1879, DOI 10.1016/j.watres.2009.01.029; Faunce T, 2010, NANOMEDICINE-UK, V5, P617, DOI [10.2217/nnm.10.33, 10.2217/NNM.10.33]; Geranio L, 2009, ENVIRON SCI TECHNOL, V43, P8113, DOI 10.1021/es9018332; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Impellitteri CA, 2009, J ENVIRON QUAL, V38, P1528, DOI 10.2134/jeq2008.0390; Kim B, 2010, ENVIRON SCI TECHNOL, V44, P7509, DOI 10.1021/es101565j; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Tiede K, 2010, J ANAL ATOM SPECTROM, V25, P1149, DOI 10.1039/b926029c; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914	11	110	113	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2010	330	6007					1054	1055		10.1126/science.1198074	http://dx.doi.org/10.1126/science.1198074			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097924				2022-12-24	WOS:000284374700026
J	Zhang, YT; Baicker, K; Newhouse, JP				Zhang, Yuting; Baicker, Katherine; Newhouse, Joseph P.			Geographic Variation in the Quality of Prescribing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zhang, Yuting] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA; [Baicker, Katherine; Newhouse, Joseph P.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Newhouse, Joseph P.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Newhouse, Joseph P.] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University	Zhang, YT (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA.		Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022	Zhang, Yuting/0000-0002-6460-6779	NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088510] Funding Source: NIH RePORTER; NIMH NIH HHS [RC1 MH088510, RC1 MH088510-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*NAT COMM QUAL ASS, 2009, STAT HLTH CAR QUAL; National Committee for Quality Assurance, 2010, HEALTHC EFF DAT INF; Song YJ, 2010, NEW ENGL J MED, V363, P198; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Zhang YT, 2010, NEW ENGL J MED, V363, P405, DOI 10.1056/NEJMp1004872	5	93	93	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2010	363	21					1985	1988		10.1056/NEJMp1010220	http://dx.doi.org/10.1056/NEJMp1010220			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	681KC	21047217	Green Accepted			2022-12-24	WOS:000284310000002
J	Baerlocher, MO; Detsky, AS				Baerlocher, Mark Otto; Detsky, Allan S.			Discussing Radiation Risks Associated With CT Scans With Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPUTED-TOMOGRAPHY; EXPOSURE		[Baerlocher, Mark Otto; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Baerlocher, Mark Otto] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Baerlocher, MO (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	mark.baerlocher@utoronto.ca						Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Couchman GR, 2004, ACAD RADIOL, V11, P735, DOI 10.1016/j.acra.2004.03.050; EVAN KG, 2006, CONSENT GUIDE CANADI; Larson DB, 2007, AM J ROENTGENOL, V189, P271, DOI 10.2214/AJR.07.2248; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; National Research Council (US) Committee on the Biological Effects of Ionizing Radiation, 2006, HLTH RISKS EXP LOW L; Prokop M, 2005, EUR RADIOL, V15, pE35, DOI 10.1007/s10406-005-0164-z; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Terry PB, 2007, CHEST, V131, P563, DOI 10.1378/chest.06-1955	9	48	48	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2170	2171		10.1001/jama.2010.1591	http://dx.doi.org/10.1001/jama.2010.1591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21081730				2022-12-24	WOS:000284269800028
J	Nallamothu, BK; Krumholz, HM				Nallamothu, Brahmajee K.; Krumholz, Harlan M.			Putting Ad Hoc PCI on Pause	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTIONS; CARDIAC-CATHETERIZATION; AMERICAN-COLLEGE; MEDICAL THERAPY; ARTERY-DISEASE; CARDIOLOGISTS		[Nallamothu, Brahmajee K.] Vet Affairs Ann Arbor Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Div Cardiovasc Med, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, CHOP, Ann Arbor, MI USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Yale University	Nallamothu, BK (corresponding author), 1500 E Med Ctr Dr,SPC 5869, Ann Arbor, MI 48109 USA.	bnallamo@umich.edu	, Harlan/AAI-2875-2020					Blankenship JC, 2004, CATHETER CARDIO INTE, V63, P444, DOI 10.1002/ccd.20229; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Hannan EL, 2010, CIRCULATION, V121, P267, DOI 10.1161/CIRCULATIONAHA.109.887539; Hannan EL, 2009, JACC-CARDIOVASC INTE, V2, P350, DOI 10.1016/j.jcin.2009.01.006; Krone RJ, 2006, CATHETER CARDIO INTE, V68, P696, DOI 10.1002/ccd.20910; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; MYLER RK, 1986, CATHETER CARDIO DIAG, V12, P213, DOI 10.1002/ccd.1810120402; Peterson ED, 2008, NEW ENGL J MED, V359, P751, DOI 10.1056/NEJMe0804662; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626	10	32	34	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2059	2060		10.1001/jama.2010.1509	http://dx.doi.org/10.1001/jama.2010.1509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063016				2022-12-24	WOS:000284000600026
J	Gregg, C				Gregg, Christopher			Parental Control over the Brain	SCIENCE			English	Editorial Material									Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Gregg, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	cgregg@MCB.harvard.edu						Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Alter MD, 2009, BIOL PSYCHIAT, V66, P1061, DOI 10.1016/j.biopsych.2009.05.026; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Curley JP, 2010, DEV PSYCHOBIOL, V52, P312, DOI 10.1002/dev.20430; GREGG C, 2010, SCIENCE, V329, P5992; Hoppenbrouwers IA, 2008, ARCH NEUROL-CHICAGO, V65, P345, DOI 10.1001/archneurol.2007.63; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Keverne E B, 2001, Prog Brain Res, V133, P279; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Van Buggenhout G, 2009, EUR J HUM GENET, V17, P1367, DOI 10.1038/ejhg.2009.67	10	6	6	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					770	771		10.1126/science.1199054	http://dx.doi.org/10.1126/science.1199054			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051625				2022-12-24	WOS:000283855700029
J	Shahinian, VB; Kuo, YF; Gilbert, SM				Shahinian, Vahakn B.; Kuo, Yong-Fang; Gilbert, Scott M.			Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADIATION-THERAPY; HORMONAL-THERAPY; SUPPRESSION; MANAGEMENT; CARCINOMA; RADIOTHERAPY; ORCHIECTOMY; TRIAL	Background: The Medicare Modernization Act led to moderate reductions in reimbursement for androgen-deprivation therapy (ADT) for prostate cancer, starting in 2004 and followed by substantial changes in 2005. We hypothesized that these reductions would lead to decreases in the use of ADT for indications that were not evidence based. Methods: Using the Surveillance, Epidemiology, and End Results (SEER) Medicare database, we identified 54,925 men who received a diagnosis of incident prostate cancer from 2003 through 2005. We divided these men into groups according to the strength of the indication for ADT use. The use of ADT was deemed to be inappropriate as primary therapy for men with localized cancers of a low-to-moderate grade (for whom a survival benefit of such therapy was improbable), appropriate as adjuvant therapy with radiation therapy for men with locally advanced cancers (for whom a survival benefit was established), and discretionary for men receiving either primary or adjuvant therapy for localized but high-grade tumors. The proportion of men receiving ADT was calculated according to the year of diagnosis for each group. We used modified Poisson regression models to calculate the effect of the year of diagnosis on the use of ADT. Results: The rate of inappropriate use of ADT declined substantially during the study period, from 38.7% in 2003 to 30.6% in 2004 to 25.7% in 2005 (odds ratio for ADT use in 2005 vs. 2003, 0.72; 95% confidence interval [CI], 0.65 to 0.79). There was no decrease in the appropriate use of adjuvant ADT (odds ratio, 1.01; 95% CI, 0.86 to 1.19). In cases involving discretionary use, there was a significant decline in use in 2005 but not in 2004. Conclusions: Changes in the Medicare reimbursement policy in 2004 and 2005 were associated with reductions in ADT use, particularly among men for whom the benefits of such therapy were unclear. (Funded by the American Cancer Society.) N Engl J Med 2010;363:1822-32.	[Shahinian, Vahakn B.] Univ Michigan, Simpson Mem Inst 208, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kuo, Yong-Fang] Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA; [Kuo, Yong-Fang] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX USA; [Kuo, Yong-Fang] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX USA; [Gilbert, Scott M.] Univ Florida, Coll Med, Dept Urol, Gainesville, FL USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Florida	Shahinian, VB (corresponding author), Univ Michigan, Simpson Mem Inst 208, Dept Internal Med, 102 Observ Rd, Ann Arbor, MI 48109 USA.	vahakn@umich.edu			American Cancer Society [118244-RSGI-10-076-01-CPHPS]	American Cancer Society(American Cancer Society)	Supported by a Research Scholar Grant (118244-RSGI-10-076-01-CPHPS, to Dr. Shahinian) from the American Cancer Society.	[Anonymous], 2001, GAO011118; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Chang SL, 2009, J UROLOGY, V182, P255, DOI 10.1016/j.juro.2009.02.141; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Chodak GW, 2002, UROLOGY, V60, P201, DOI 10.1016/S0090-4295(02)01677-1; Christianson JB, 2006, J GEN INTERN MED, V21, pS9, DOI 10.1111/j.1525-1497.2006.00356.x; Conrad DA, 2004, MED CARE RES REV, V61, p37S, DOI 10.1177/1077558704266770; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P1420; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Granfors T, 1998, J UROLOGY, V159, P2030, DOI 10.1016/S0022-5347(01)63235-X; Hillman AL, 1998, AM J PUBLIC HEALTH, V88, P1699, DOI 10.2105/AJPH.88.11.1699; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Loblaw DA, 2004, J CLIN ONCOL, V22, P2927, DOI 10.1200/jco.2004.04.579; LOBLAW DA, 2004, J CLIN ONCOL, V22, P4435; Lu-Yao G, 2006, J UROLOGY, V176, P526, DOI 10.1016/j.juro.2006.03.098; *MED PAYM ADV COMM, 2007, REP C EFF MED PAYM C; National Comprehensive Cancer Network, 2004, J Natl Compr Canc Netw, V2, P224; Painter M Ray, 2005, Rev Urol, V7 Suppl 5, pS44; Pilepich MV, 1997, J CLIN ONCOL, V15, P1013, DOI 10.1200/JCO.1997.15.3.1013; Scardino Peter, 2005, J Natl Compr Canc Netw, V3 Suppl 1, pS29; Scherr D, 2003, UROLOGY, V61, P14, DOI 10.1016/S0090-4295(02)02395-6; Shahinian VB, 2007, J CLIN ONCOL, V25, P5359, DOI 10.1200/JCO.2006.09.9580; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002/cncr.20955; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Shen J, 2004, MED CARE, V42, P297, DOI 10.1097/01.mlr.0000114918.50088.1c; Weight CJ, 2008, CANCER-AM CANCER SOC, V112, P2195, DOI 10.1002/cncr.23421; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	140	144	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1822	1832		10.1056/NEJMsa0910784	http://dx.doi.org/10.1056/NEJMsa0910784			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674YK	21047226				2022-12-24	WOS:000283787800007
J	Wright, CF; Brice, P; Stewart, A; Burton, H				Wright, Caroline F.; Brice, Philippa; Stewart, Alison; Burton, Hilary			Realising the benefits of genetics for health	LANCET			English	Editorial Material							CONGENITAL-ANOMALIES; GENOME; CHALLENGES; BLOOD		[Wright, Caroline F.; Brice, Philippa; Stewart, Alison; Burton, Hilary] PHG Fdn, Strangeways Res Lab, Cambridge CB1 8RN, England		Wright, CF (corresponding author), PHG Fdn, Strangeways Res Lab, Cambridge CB1 8RN, England.	caroline.wright@phgfoundation.org	Wright, Caroline/N-5355-2015	Wright, Caroline/0000-0003-2958-5076				ALBERG C, 2010, BR J MIDWIFERY, V18, P220; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Burton H, 2010, HEART, V96, P474, DOI 10.1136/hrt.2009.189159; Burton H, 2010, J PUBLIC HEALTH-UK, V32, P259, DOI 10.1093/pubmed/fdp110; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Hadfield SG, 2007, BMJ-BRIT MED J, V335, P683, DOI 10.1136/bmj.39353.483160.BE; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Pollitt RJ, 2009, J INHERIT METAB DIS, V32, P395, DOI 10.1007/s10545-009-9962-0; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Srinivasan BS, 2010, REPROD BIOMED ONLINE, V21, P537, DOI 10.1016/j.rbmo.2010.05.012; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; *UK DEP HLTH, 2010, STAT PUBL HLTH ANN R; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 23	2010	376	9750					1370	1371		10.1016/S0140-6736(10)61310-4	http://dx.doi.org/10.1016/S0140-6736(10)61310-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971348				2022-12-24	WOS:000283627500008
J	Mitrofanov, IG; Sanin, AB; Boynton, WV; Chin, G; Garvin, JB; Golovin, D; Evans, LG; Harshman, K; Kozyrev, AS; Litvak, ML; Malakhov, A; Mazarico, E; McClanahan, T; Milikh, G; Mokrousov, M; Nandikotkur, G; Neumann, GA; Nuzhdin, I; Sagdeev, R; Shevchenko, V; Shvetsov, V; Smith, DE; Starr, R; Tretyakov, VI; Trombka, J; Usikov, D; Varenikov, A; Vostrukhin, A; Zuber, MT				Mitrofanov, I. G.; Sanin, A. B.; Boynton, W. V.; Chin, G.; Garvin, J. B.; Golovin, D.; Evans, L. G.; Harshman, K.; Kozyrev, A. S.; Litvak, M. L.; Malakhov, A.; Mazarico, E.; McClanahan, T.; Milikh, G.; Mokrousov, M.; Nandikotkur, G.; Neumann, G. A.; Nuzhdin, I.; Sagdeev, R.; Shevchenko, V.; Shvetsov, V.; Smith, D. E.; Starr, R.; Tretyakov, V. I.; Trombka, J.; Usikov, D.; Varenikov, A.; Vostrukhin, A.; Zuber, M. T.			Hydrogen Mapping of the Lunar South Pole Using the LRO Neutron Detector Experiment LEND	SCIENCE			English	Article							NEAR-SURFACE; ICE; PROSPECTOR; MERCURY; WATER; MOON; MARS	Hydrogen has been inferred to occur in enhanced concentrations within permanently shadowed regions and, hence, the coldest areas of the lunar poles. The Lunar Crater Observation and Sensing Satellite (LCROSS) mission was designed to detect hydrogen-bearing volatiles directly. Neutron flux measurements of the Moon's south polar region from the Lunar Exploration Neutron Detector (LEND) on the Lunar Reconnaissance Orbiter (LRO) spacecraft were used to select the optimal impact site for LCROSS. LEND data show several regions where the epithermal neutron flux from the surface is suppressed, which is indicative of enhanced hydrogen content. These regions are not spatially coincident with permanently shadowed regions of the Moon. The LCROSS impact site inside the Cabeus crater demonstrates the highest hydrogen concentration in the lunar south polar region, corresponding to an estimated content of 0.5 to 4.0% water ice by weight, depending on the thickness of any overlying dry regolith layer. The distribution of hydrogen across the region is consistent with buried water ice from cometary impacts, hydrogen implantation from the solar wind, and/or other as yet unknown sources.	[Mitrofanov, I. G.; Sanin, A. B.; Golovin, D.; Kozyrev, A. S.; Litvak, M. L.; Malakhov, A.; Mokrousov, M.; Nuzhdin, I.; Tretyakov, V. I.; Varenikov, A.; Vostrukhin, A.] Russian Acad Sci, Inst Space Res, Moscow 117997, Russia; [Boynton, W. V.; Harshman, K.] Univ Arizona, Tucson, AZ USA; [Chin, G.; Garvin, J. B.; Mazarico, E.; McClanahan, T.; Neumann, G. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Evans, L. G.] Comp Sci Corp, Greenbelt, MD USA; [Milikh, G.; Nandikotkur, G.; Sagdeev, R.; Usikov, D.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Starr, R.] Catholic Univ, Washington, DC USA; [Shevchenko, V.] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow, Russia; [Shvetsov, V.] Joint Inst Nucl Res, Dubna, Russia; [Smith, D. E.; Zuber, M. T.] MIT, Cambridge, MA 02139 USA; [Trombka, J.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Arizona; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Catholic University of America; Lomonosov Moscow State University; Joint Institute for Nuclear Research - Russia; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park	Mitrofanov, IG (corresponding author), Russian Acad Sci, Inst Space Res, Moscow 117997, Russia.	imitrofa@space.ru	Evans, Larry/F-7462-2012; Chin, Gordon/E-1520-2012; Neumann, Gregory A/I-5591-2013; Golovin, Dmitry/F-8588-2017; Malakhov, Alexey Vladimirovich/F-7953-2017; Litvak, Maxim/C-6453-2017; Mazarico, Erwan/N-6034-2014; Sanin, Anton/T-9393-2017; McClanahan, Timothy/C-8164-2012	Neumann, Gregory A/0000-0003-0644-9944; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Mazarico, Erwan/0000-0003-3456-427X; Garvin, James/0000-0003-1606-5645; Mitrofanov, Igor/0000-0001-7204-2101	NASA Exploration System Mission Directorate; Russian Federal Space Agency	NASA Exploration System Mission Directorate; Russian Federal Space Agency	The LRO Mission is supported by the NASA Exploration System Mission Directorate, and the LEND investigation is supported by the Russian Federal Space Agency. We acknowledge the LRO Project team at NASA's Goddard Space Flight Center for their outstanding support of the LEND investigation.	Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider DH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002030; Crider DH, 2003, ADV SPACE RES, V31, P2293, DOI 10.1016/S0273-1177(03)00530-1; Elphic RC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029954; Feldman WC, 1999, NUCL INSTRUM METH A, V422, P562, DOI 10.1016/S0168-9002(98)00934-6; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; Lawrence DJ, 2010, ASTROBIOLOGY, V10, P183, DOI 10.1089/ast.2009.0401; McKay D. S., 1991, LUNAR SOURCEBOOK, P285, DOI DOI 10.1006/ICAR.1999.6165; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mitrofanov IG, 2008, ASTROBIOLOGY, V8, P793, DOI 10.1089/ast.2007.0158; Mitrofanov IG, 2010, SPACE SCI REV, V150, P183, DOI 10.1007/s11214-009-9608-4; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; SALVAIL JR, 1994, ICARUS, V111, P441, DOI 10.1006/icar.1994.1155; Spudis P. D., 1998, Solar System Research, V32, P17; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; Vondrak R, 2010, SPACE SCI REV, V150, P7, DOI 10.1007/s11214-010-9631-5; Zuber MT, 2010, SPACE SCI REV, V150, P63, DOI 10.1007/s11214-009-9511-z	20	197	209	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					483	486		10.1126/science.1185696	http://dx.doi.org/10.1126/science.1185696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966247				2022-12-24	WOS:000283329100033
J	Tingen, C; Rodriguez, S; Campo-Engelstein, L; Woodruff, TK				Tingen, C.; Rodriguez, S.; Campo-Engelstein, L.; Woodruff, T. K.			Politics and Parthenotes	SCIENCE			English	Editorial Material							PARTHENOGENETIC ACTIVATION; STEM-CELLS; FERTILITY; CHILDREN; OOCYTES; CANCER		[Tingen, C.; Rodriguez, S.; Campo-Engelstein, L.; Woodruff, T. K.] Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Rodriguez, S.; Campo-Engelstein, L.] Northwestern Univ, Ctr Bioeth Sci & Soc, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Woodruff, TK (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	tkw@northwestern.edu		Tingen, Candace/0000-0003-3503-019X; Woodruff, Teresa/0000-0002-1197-3399				Aziz D, 2004, J PEDIATR SURG, V39, P750, DOI 10.1016/j.jpedsurg.2004.01.034; Barksdale EM, 2009, CURR OPIN PEDIATR, V21, P344, DOI 10.1097/MOP.0b013e32832b41ee; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Lampert KP, 2008, SEX DEV, V2, P290, DOI 10.1159/000195678; Lehrman S, 2010, SCI AM, V303, P18, DOI 10.1038/scientificamerican0910-18; Marshall VS, 1998, BIOL REPROD, V59, P1491, DOI 10.1095/biolreprod59.6.1491; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; *NIH, 1994, REP; NOONAN J, 1996, INTERVENTION REFLECT; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Talmor-Cohen A, 2002, MOL CELL ENDOCRINOL, V187, P145, DOI 10.1016/S0303-7207(01)00691-8; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81	15	11	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					453	453		10.1126/science.1196881	http://dx.doi.org/10.1126/science.1196881			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966235				2022-12-24	WOS:000283329100020
J	Ashton-Beaucage, D; Udell, CM; Lavoie, H; Baril, C; Lefrancois, M; Chagnon, P; Gendron, P; Caron-Lizotte, O; Bonneil, E; Thibault, P; Therrien, M				Ashton-Beaucage, Dariel; Udell, Christian M.; Lavoie, Hugo; Baril, Caroline; Lefrancois, Martin; Chagnon, Pierre; Gendron, Patrick; Caron-Lizotte, Olivier; Bonneil, Eric; Thibault, Pierre; Therrien, Marc			The Exon Junction Complex Controls the Splicing of mapk and Other Long Intron-Containing Transcripts in Drosophila	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; OSKAR MESSENGER-RNA; HUMAN RNPS1; MAMMALIAN-CELLS; MAGO NASHI; RAS; KINASE; GENE; COACTIVATOR; MUTATIONS	Signaling pathways are controlled by a vast array of posttranslational mechanisms. By contrast, little is known regarding the mechanisms that regulate the expression of their core components. We conducted an RNAi screen in Drosophila for factors modulating RAS/MAPK signaling and identified the Exon Junction Complex (EJC) as a key element of this pathway. The EJC binds the exon-exon junctions of mRNAs and thus far, has been linked exclusively to post-splicing events. Here, we report that the EJC is required for proper splicing of mapk transcripts by a mechanism that apparently controls exon definition. Moreover, whole transcriptome and RT-PCR analyses of EJC-depleted cells revealed that the splicing of long intron-containing genes, which includes mapk, is sensitive to EJC activity. These results identify a role for the EJC in the splicing of a subset of transcripts and suggest that RAS/MAPK signaling depends on the regulation of MAPK levels by the EJC.	[Ashton-Beaucage, Dariel; Udell, Christian M.; Lavoie, Hugo; Baril, Caroline; Lefrancois, Martin; Chagnon, Pierre; Gendron, Patrick; Caron-Lizotte, Olivier; Bonneil, Eric; Thibault, Pierre; Therrien, Marc] Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signaling, Montreal, PQ H3C 3J7, Canada; [Therrien, Marc] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Therrien, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signaling, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	marc.therrien@umontreal.ca		Thibault, Pierre/0000-0001-5993-0331; Gendron, Patrick/0000-0001-9829-2600; Ashton-Beaucage, Dariel/0000-0001-6987-5487; Lavoie, Hugo/0000-0003-0560-2409	Canadian Cancer Society; Canadian Institutes for Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to R. Boswell, E. Perkins, N. Perrimon, and D. St-Johnston, as well as the Bloomington and VDRC stock centers for fly stocks and cell lines. We thank Christian Charbonneau and Monica Nelea for assistance with microscopy; and Philippe Roux, Pierre Zindy, and Katherine Borden for their help with the polysome fractionation experiments. We also extend our gratitude to the IRIC HTS platform for use of the automated fluorescence microscope; to Michael Kubal (ABI) for help with analysis of the RNA-Seq data; and to Raphaelle Lambert for assistance with RT-qPCR and sequencing. D. A. B. is a recipient of Frederick Banting and Charles Best Canada Doctoral Scholarship. HL is a recipient of a Cancer Research Society postdoctoral fellowship. P. T. is recipient of a Tier I Canada Research Chair in Proteomics and Bioanalytical Spectrometry. M. T. is recipient of a Tier II Canada Research Chair in Intracellular Signaling. This work was supported by the Canadian Cancer Society and by the Canadian Institutes for Health Research.	BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Berghella L, 1996, GENETICS, V144, P117; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Budagyan B, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P515; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Douziech M, 2003, EMBO J, V22, P5068, DOI 10.1093/emboj/cdg506; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Eldridge AG, 1999, P NATL ACAD SCI USA, V96, P6125, DOI 10.1073/pnas.96.11.6125; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Herold N, 2009, MOL CELL BIOL, V29, P281, DOI 10.1128/MCB.01415-08; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karim FD, 1996, GENETICS, V143, P315; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Macchi P, 2003, J NEUROSCI, V23, P5778; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McCracken S, 2003, J BIOL CHEM, V278, P44153, DOI 10.1074/jbc.M306856200; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; MELNICK MB, 1993, DEVELOPMENT, V118, P127; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Mohr SE, 2001, GENE DEV, V15, P2886; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nykamp K, 2008, RNA, V14, P1378, DOI 10.1261/rna.1066008; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; ROY M, 2008, GENOMES RNA, V14, P1; Sakashita E, 2004, MOL CELL BIOL, V24, P1174, DOI 10.1128/MCB.24.3.1174-1187.2004; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Therrien M, 2000, GENETICS, V156, P1231; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; WEN J, 2010, EMBO J; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; XU T, 1993, DEVELOPMENT, V117, P1223; Yu Y, 2008, CELL, V135, P1224, DOI 10.1016/j.cell.2008.10.046; Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670	72	92	96	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					251	262		10.1016/j.cell.2010.09.014	http://dx.doi.org/10.1016/j.cell.2010.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946983	Bronze			2022-12-24	WOS:000283052200014
J	Webb, DJ				Webb, David J.			Value-based medicine pricing: NICE work?	LANCET			English	Editorial Material									Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Webb, DJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland.	cpu@ed.ac.uk						*2020HEALTH ORG, 2009, IMPR PAT OUTC CAN VA; BOSELEY S, 2010, NICE LOSE POWERS DEC; Collier J, 2007, BRIT MED J, V334, P435, DOI 10.1136/bmj.39136.464421.BE; *DEP BUS INN SKILL, 2009, PHARM PRIC REG SCHEM; Hutton J, 2007, INT J TECHNOL ASSESS, V23, P425, DOI 10.1017/S0266462307070651; Martin S., 2007, LINK HEALTHCARE SPEN; Taylor D, 2009, HEALTH ECON POLICY L, V4, P515, DOI 10.1017/S1744133109990247; Webb DJ, 2007, LANCET, V369, P1415, DOI 10.1016/S0140-6736(07)60648-5; 2007, PHARM PRICE REGULATI	9	13	14	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1552	1553		10.1016/S0140-6736(10)62137-X	http://dx.doi.org/10.1016/S0140-6736(10)62137-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21093902				2022-12-24	WOS:000290549700008
J	Junttila, MR; Karnezis, AN; Garcia, D; Madriles, F; Kortlever, RM; Rostker, F; Swigart, LB; Pham, DM; Seo, Y; Evan, GI; Martins, CP				Junttila, Melissa R.; Karnezis, Anthony N.; Garcia, Daniel; Madriles, Francesc; Kortlever, Roderik M.; Rostker, Fanya; Swigart, Lamorna Brown; Pham, David M.; Seo, Youngho; Evan, Gerard I.; Martins, Carla P.			Selective activation of p53-mediated tumour suppression in high-grade tumours	NATURE			English	Article							P53 RESTORATION; MOUSE MODELS; LUNG-CANCER; IN-VIVO; K-RAS; SENESCENCE; EXPRESSION; ONCOGENE; KRAS2	Non-small cell lung carcinoma (NSCLC) is the leading cause of cancer-related death worldwide, with an overall 5-year survival rate of only 10-15%(1). Deregulation of the Ras pathway is a frequent hallmark of NSCLC, often through mutations that directly activate Kras(2). p53 is also frequently inactivated in NSCLC and, because oncogenic Ras can be a potent trigger of p53 (ref. 3), it seems likely that oncogenic Ras signalling has a major and persistent role in driving the selection against p53. Hence, pharmacological restoration of p53 is an appealing therapeutic strategy for treating this disease(4). Here we model the probable therapeutic impact of p53 restoration in a spontaneously evolving mouse model of NSCLC initiated by sporadic oncogenic activation of endogenous Kras(5). Surprisingly, p53 restoration failed to induce significant regression of established tumours, although it did result in a significant decrease in the relative proportion of high-grade tumours. This is due to selective activation of p53 only in the more aggressive tumour cells within each tumour. Such selective activation of p53 correlates with marked upregulation in Ras signal intensity and induction of the oncogenic signalling sensor p19(ARF) (ref. 6). Our data indicate that p53-mediated tumour suppression is triggered only when oncogenic Ras signal flux exceeds a critical threshold. Importantly, the failure of low-level oncogenic Kras to engage p53 reveals inherent limits in the capacity of p53 to restrain early tumour evolution and in the efficacy of therapeutic p53 restoration to eradicate cancers.	[Junttila, Melissa R.; Karnezis, Anthony N.; Garcia, Daniel; Kortlever, Roderik M.; Rostker, Fanya; Swigart, Lamorna Brown; Evan, Gerard I.; Martins, Carla P.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Junttila, Melissa R.; Karnezis, Anthony N.; Garcia, Daniel; Kortlever, Roderik M.; Rostker, Fanya; Swigart, Lamorna Brown; Pham, David M.; Seo, Youngho; Evan, Gerard I.; Martins, Carla P.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Madriles, Francesc] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Pham, David M.; Seo, Youngho] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Research UK; CRUK Cambridge Institute; University of California System; University of California San Francisco	Evan, GI (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	gie20@cam.ac.uk	Seo, Youngho/D-5705-2013; Kortlever, Roderik/AAY-9220-2020	Seo, Youngho/0000-0001-5908-6636; Kortlever, Roderik/0000-0001-5558-2851	NCI [CA98018, CA100193]; AICR [09-0649]; Ellison Medical Foundation; Samuel R. Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA098018, R01CA100193] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AICR; Ellison Medical Foundation(Lawrence Ellison Foundation); Samuel R. Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to T. Jacks for the KR mice, C. Sherr and M. Roussel for the p19<SUP>ARF</SUP> antibody, M. Dail and A.-T. Maia for advice on Kras copy number analysis and V. Weinberg for guidance on statistical analysis. We also thank D. Tuveson and all the members of the Evan laboratory for their comments. This work was supported by grants NCI CA98018, NCI CA100193, AICR 09-0649, the Ellison Medical Foundation and from the Samuel R. Waxman Cancer Research Foundation (all to G.I.E.). M.R.J. is the Enrique Cepero, PhD Fellow of the Damon Runyon Cancer Research Foundation.	Bertwistle D, 2004, HYBRIDOMA HYBRIDOM, V23, P293, DOI 10.1089/hyb.2004.23.293; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1994, CANCER RES, V54, P1169; FELDSER D, 1953, NATURE IN PRESS, DOI DOI 10.1038/NATURE09535; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Wagner PL, 2009, AM J CLIN PATHOL, V132, P500, DOI 10.1309/AJCPF10ZUNSOLIFG; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	30	192	194	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					567	U244		10.1038/nature09526	http://dx.doi.org/10.1038/nature09526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107427	Green Submitted, Green Accepted			2022-12-24	WOS:000284584200043
J	Heymann, DL; Fine, PE; Griffiths, UK; Hall, AJ; Mounier-Jack, S				Heymann, David L.; Fine, Paul E.; Griffiths, Ulla K.; Hall, Andrew J.; Mounier-Jack, Sandra			Measles eradication: past is prologue	LANCET			English	Editorial Material							POLIO; HEALTH		[Heymann, David L.; Fine, Paul E.; Griffiths, Ulla K.; Hall, Andrew J.; Mounier-Jack, Sandra] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Heymann, David L.] Chatham House Ctr Global Hlth Secur, London, England	University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	david.heymann@hpa.org.uk						Closser S, 2010, CHASING POLIO PAKIST; de Quadros CA, 2008, EXPERT REV VACCINES, V7, P355, DOI 10.1586/14760584.7.3.355; *FORT WORLD HLTH A, 1988, GLOB ER POL YEAR 200; Heymann DL, 2006, BIOLOGICALS, V34, P75, DOI 10.1016/j.biologicals.2006.03.005; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; Meissner HC, 2004, PEDIATRICS, V114, P1065, DOI 10.1542/peds.2004-0440; MORLEY D, 1969, BMJ-BRIT MED J, V1, P363, DOI 10.1136/bmj.1.5640.363; MORLEY D, 1969, BRIT MED J, V1, P291; Moss WJ, 2009, CURR TOP MICROBIOL, V330, P173; Renne E, 2006, SOC SCI MED, V63, P1857, DOI 10.1016/j.socscimed.2006.04.025; Unger Jean-Pierre, 2006, Int J Integr Care, V6, pe14; Unger JP, 2003, INT J HEALTH PLAN M, V18, pS27, DOI 10.1002/hpm.723; *WHO, 2010, EXP ASS MEASL ER FEA; *WHO, 2010, WHO EP BRIEF, V8; World Health Organization, 2010, WHO UNICEF EST NAT I	15	22	22	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1719	1720		10.1016/S0140-6736(10)61934-4	http://dx.doi.org/10.1016/S0140-6736(10)61934-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690EI	21093636				2022-12-24	WOS:000284984900008
J	Sachedina, N; Donaldson, LJ				Sachedina, Nabihah; Donaldson, Liam J.			Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study	LANCET			English	Article							VIRUS-INFECTION; UNITED-STATES; CHILDREN; DEATHS	Background Young people (aged 0-18 years) have been disproportionately affected by pandemic influenza A H1N1 infection. We aimed to analyse paediatric mortality to inform clinical and public health policies for future influenza seasons and pandemics. Methods All paediatric deaths related to pandemic influenza A H1N1 infection from June 26,2009, to March 22,2010 in England were identified through daily reporting systems and cross-checking of records and were validated by confirmation of influenza infection by laboratory results or death certificates. Clinicians responsible for each individual child provided detailed information about past medical history, presentation, and clinical course of the acute illness. Case estimates of influenza A H1N1 were obtained from the Health Protection Agency. The primary outcome measures were population mortality rates and case-fatality rates. Findings 70 paediatric deaths related to pandemic influenza A H1N1 were reported. Childhood mortality rate was 6 per million population. The rate was highest for children aged less than 1 year. Mortality rates were higher for Bangladeshi children (47 deaths per million population [95% CI 17-103]) and Pakistani children (36 deaths per million population [18-64]) than for white British children (4 deaths per million [3-6]). 15 (21%) children who died were previously healthy; 45 (64%) had severe pre-existing disorders. The highest age-standardised mortality rate for a preexisting disorder was for chronic neurological disease (1536 per million population). 19 (27%) deaths occurred before inpatient admission. Children in this subgroup were significantly more likely to have been healthy or had only mild pre-existing disorders than those who died after admission (p=0-0109). Overall, 45 (64%) children had received oseltamivir: seven within 48 h of symptom onset. Interpretation Vaccination priority should be for children at increased risk of severe illness or death from influenza. This group might include those with specified pre-existing disorders and those in some ethnic minority groups. Early pre-hospital supportive and therapeutic care is also important.	[Donaldson, Liam J.] Natl Patient Safety Agcy, London W1T 5HD, England; [Sachedina, Nabihah; Donaldson, Liam J.] Dept Hlth, London SE1 6TE, England		Donaldson, LJ (corresponding author), Natl Patient Safety Agcy, 4-8 Maple St, London W1T 5HD, England.	liam.donaldson@npsa.nhs.uk			Department of Health	Department of Health	We thank the many clinicians in England who supplied the clinical information about their patients; Matthew Mak, Emma Stanton, Paul Rutter, and Tara Fajeyisan for their work in the validation of all deaths; Oliver Mytton for assistance with data analysis; and lain Yardley for assistance in editing the manuscript. This work was done as part of the public health response to pandemic influenza in England. The costs of the study were small and met from the Chief Medical Officer's budget within the Department of Health without the need for additional funding.	Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Butland BK, 2006, THORAX, V61, P383, DOI 10.1136/thx.2005.043646; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Castrodale L., 2009, Morbidity and Mortality Weekly Report, V58, P1341; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Cunha BA, 2009, CLIN INFECT DIS, V49, P1454, DOI 10.1086/644496; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Johnson BF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007671; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Lister P, 2009, LANCET, V374, P605, DOI [10.1016/S0140-6736(09)61512-9, 10.1016/S0140-6736(09)61513-0]; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Office for National Statistics, MID2007 POP EST ETHN; Office for National Statistics, 20029 ONS; Office for National Statistics, MID2008 POP EST ENGL; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Saklad M, 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Turner SJ, 2008, J BIOL, V8, P69; van 't Klooster TM, 2010, EUROSURV, V15; WHO, WHO GUID PHARM MAN P; Wright Peter F, 2009, N Engl J Med, V361, pe112, DOI 10.1056/NEJMopv0910749	24	105	107	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1846	1852		10.1016/S0140-6736(10)61195-6	http://dx.doi.org/10.1016/S0140-6736(10)61195-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21030071	Green Accepted			2022-12-24	WOS:000285439700033
J	Jeste, DV; Harris, JC				Jeste, Dilip V.; Harris, James C.			Wisdom-A Neuroscience Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SELF		[Jeste, Dilip V.] Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, La Jolla, CA 92093 USA; [Jeste, Dilip V.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Jeste, Dilip V.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Harris, James C.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Harris, James C.] Johns Hopkins Univ, Sch Med, Dept Behav Sci & Pediat, Baltimore, MD 21205 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins University	Jeste, DV (corresponding author), Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, 9500 Gilman Dr,Mail Code 0664, La Jolla, CA 92093 USA.	djeste@ucsd.edu			NIMH NIH HHS [MH080002] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH080002] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARDELT M, 1997, J GERONTOL B-PSYCHOL, V52, P15, DOI DOI 10.1093/GERONB/52B.1.P15; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Grossmann I, 2010, P NATL ACAD SCI USA, V107, P7246, DOI 10.1073/pnas.1001715107; Jeste DV, 2008, PSYCHIATRY, V71, P197, DOI 10.1521/psyc.2008.71.3.197; Lou HC, 2010, HUM BRAIN MAPP, V31, P185, DOI 10.1002/hbm.20855; Meeks TW, 2009, ARCH GEN PSYCHIAT, V66, P355, DOI 10.1001/archgenpsychiatry.2009.8; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Parisi JM, 2009, EDUC GERONTOL, V35, P867, DOI 10.1080/03601270902782453; Sternberg R. J., 2005, HDB WISDOM PSYCHOL P	10	22	25	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1602	1603		10.1001/jama.2010.1458	http://dx.doi.org/10.1001/jama.2010.1458			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940386				2022-12-24	WOS:000282816500025
J	Mohammadi, D				Mohammadi, Dara			Public health insecticide development: a status of hiatus	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Mohammadi, D (corresponding author), The Lancet, London NW1 7BY, England.							Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004	1	0	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2010	376	9748					1207	1207		10.1016/S0140-6736(10)61859-4	http://dx.doi.org/10.1016/S0140-6736(10)61859-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZT	20934581				2022-12-24	WOS:000283003500010
J	Mills, EJ; Rammohan, A; Awofeso, N				Mills, Edward J.; Rammohan, Anu; Awofeso, Niyi			Ageing faster with AIDS in Africa	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; COLLABORATIVE ANALYSIS; INFECTION		[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada; [Rammohan, Anu] Univ Western Australia, Sch Econ, Perth, WA 6009, Australia; [Awofeso, Niyi] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Awofeso, Niyi] Natl Open Univ Nigeria, Sch Publ Hlth, Lagos, Nigeria	University of Ottawa; University of Western Australia; University of Western Australia	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada.	edward.mills@uottawa.ca	Awofeso, Niyi/J-4705-2019	Rammohan, Anu/0000-0002-9062-4508				Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization ( WHO), 2009, 2009 AIDS EP UPD; Justice AC, 2010, INT J EPIDEMIOL, V39, P146, DOI 10.1093/ije/dyp342; Kautz T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2841; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Negin JC, 2010, B WORLD HEALTH ORGAN, V88, P1847; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; *NIH, 2010, NIH STAT NAT HIV AID; WHO, 2010, DEF OLD ELD PERS	9	29	31	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1131	1133		10.1016/S0140-6736(10)62180-0	http://dx.doi.org/10.1016/S0140-6736(10)62180-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	21126759				2022-12-24	WOS:000289539300007
J	Waldor, MK; Hotez, PJ; Clemens, JD				Waldor, Matthew K.; Hotez, Peter J.; Clemens, John D.			A National Cholera Vaccine Stockpile - A New Humanitarian and Diplomatic Resource	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Waldor, Matthew K.] Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; [Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Hotez, Peter J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Hotez, Peter J.] Sabin Vaccine Inst, Washington, DC USA; [Clemens, John D.] Int Vaccine Inst, Seoul, South Korea	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; George Washington University; International Vaccine Institute	Waldor, MK (corresponding author), Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA.			Waldor, Matthew/0000-0003-1843-7000; Hotez, Peter/0000-0001-8770-1042	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R37 AI042347, R01 AI042347] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042347, R37AI042347] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000346; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6	5	25	25	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					2279	2282		10.1056/NEJMp1012300	http://dx.doi.org/10.1056/NEJMp1012300			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PA	21105832	Green Accepted			2022-12-24	WOS:000285092100002
J	Harbour, JW; Onken, MD; Roberson, EDO; Duan, SH; Cao, L; Worley, LA; Council, ML; Matatall, KA; Helms, C; Bowcock, AM				Harbour, J. William; Onken, Michael D.; Roberson, Elisha D. O.; Duan, Shenghui; Cao, Li; Worley, Lori A.; Council, M. Laurin; Matatall, Katie A.; Helms, Cynthia; Bowcock, Anne M.			Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas	SCIENCE			English	Article							UBIQUITIN HYDROLASE; BRCA1-ASSOCIATED PROTEIN-1; GNAQ; ASSOCIATION	Metastasis is a defining feature of malignant tumors and is the most common cause of cancer-related death, yet the genetics of metastasis are poorly understood. We used exome capture coupled with massively parallel sequencing to search for metastasis-related mutations in highly metastatic uveal melanomas of the eye. Inactivating somatic mutations were identified in the gene encoding BRCA1-associated protein 1 (BAP1) on chromosome 3p21.1 in 26 of 31 (84%) metastasizing tumors, including 15 mutations causing premature protein termination and 5 affecting its ubiquitin carboxyl terminal hydrolase domain. One tumor harbored a frameshift mutation that was germline in origin, thus representing a susceptibility allele. These findings implicate loss of BAP1 in uveal melanoma metastasis and suggest that the BAP1 pathway may be a valuable therapeutic target.	[Harbour, J. William; Onken, Michael D.; Worley, Lori A.; Matatall, Katie A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Roberson, Elisha D. O.; Duan, Shenghui; Cao, Li; Council, M. Laurin; Helms, Cynthia; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Harbour, J. William; Bowcock, Anne M.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Harbour, JW (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	harbour@vision.wustl.edu; bowcock@genetics.wustl.edu	Harbour, J. William/B-1448-2015; Roberson, Elisha/ABC-1810-2020; Onken, Michael D/H-5620-2013; Roberson, Elisha D.O./J-1747-2012; Ferris, Laura/I-7689-2012	Harbour, J. William/0000-0002-1104-9809; Roberson, Elisha/0000-0001-5921-2399; Onken, Michael D/0000-0003-4082-1105; Roberson, Elisha D.O./0000-0001-5921-2399; Bowcock, Anne/0000-0001-8691-9090	National Cancer Institute [R01 CA125970]; Barnes-Jewish Hospital Foundation; Kling Family Foundation; Tumori Foundation; Horncrest Foundation; Research to Prevent Blindness, Inc.; NIH [P30 EY02687c]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR007279-31A1]; Washington University; NATIONAL CANCER INSTITUTE [R01CA125970] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barnes-Jewish Hospital Foundation; Kling Family Foundation; Tumori Foundation; Horncrest Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants to J.W.H. from the National Cancer Institute (R01 CA125970), Barnes-Jewish Hospital Foundation, Kling Family Foundation, Tumori Foundation, Horncrest Foundation, and a Research to Prevent Blindness David F. Weeks Professorship, and by awards to the Department of Ophthalmology and Visual Sciences at Washington University from a Research to Prevent Blindness, Inc., unrestricted grant, and the NIH Vision Core Grant P30 EY02687c. E.D.O.R. was supported by NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases training grant AR007279-31A1. We thank J. Hoisington-Lopez from the Center for Genome Sciences (Washington University School of Medicine) for running Solexa paired end sequences and M. Lovett for comments on the manuscript. J.W.H. and Washington University may receive income based on a license of related technology by the university to Castle Biosciences, Inc.	Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Bauer J, 2009, BRIT J CANCER, V101, P813, DOI 10.1038/sj.bjc.6605226; Alonso AGD, 2007, GENETICS, V176, P2099, DOI 10.1534/genetics.107.075739; Finger PT, 2009, ARCH PATHOL LAB MED, V133, P1197, DOI 10.1043/1543-2165-133.8.1197; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Landreville S, 2008, FUTURE ONCOL, V4, P629, DOI 10.2217/14796694.4.5.629; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2006, CANCER RES, V66, P4602, DOI 10.1158/0008-5472.CAN-05-4196; Onken MD, 2010, J MOL DIAGN, V12, P461, DOI 10.2353/jmoldx.2010.090220; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Worley LA, 2007, CLIN CANCER RES, V13, P1466, DOI 10.1158/1078-0432.CCR-06-2401	21	935	964	5	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1410	1413		10.1126/science.1194472	http://dx.doi.org/10.1126/science.1194472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21051595	Green Accepted			2022-12-24	WOS:000284902100051
J	Sankaran, VG; Nathan, DG				Sankaran, Vijay G.; Nathan, David G.			Reversing the Hemoglobin Switch.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FETAL-HEMOGLOBIN; BCL11A; EXPRESSION		[Sankaran, Vijay G.] Childrens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sankaran, VG (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA.							Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	5	33	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2258	2260		10.1056/NEJMcibr1010767	http://dx.doi.org/10.1056/NEJMcibr1010767			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121839				2022-12-24	WOS:000284832900016
J	Gorry, GA				Gorry, G. Anthony			Decisions, Decisions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tony@rice.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2339	2340		10.1001/jama.2010.1748	http://dx.doi.org/10.1001/jama.2010.1748			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119077				2022-12-24	WOS:000284763900001
J	Lind, PA; Berg, OG; Andersson, DI				Lind, Peter A.; Berg, Otto G.; Andersson, Dan I.			Mutational Robustness of Ribosomal Protein Genes	SCIENCE			English	Article							SINGLE-NUCLEOTIDE SUBSTITUTIONS; DNA-SEQUENCE DATA; DELETERIOUS MUTATIONS; BENEFICIAL MUTATIONS; MOLECULAR EVOLUTION; FITNESS; VIRUS; POPULATIONS; LANDSCAPE; SELECTION	The distribution of fitness effects (DFE) of mutations is of fundamental importance for understanding evolutionary dynamics and complex diseases and for conserving threatened species. DFEs estimated from DNA sequences have rarely been subject to direct experimental tests. We used a bacterial system in which the fitness effects of a large number of defined single mutations in two ribosomal proteins were measured with high sensitivity. The obtained DFE appears to be unimodal, where most mutations (120 out of 126) are weakly deleterious and the remaining ones are potentially neutral. The DFEs for synonymous and nonsynonymous substitutions are similar, suggesting that in some genes, strong fitness constraints are present at the level of the messenger RNA.	[Lind, Peter A.; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Berg, Otto G.] Uppsala Univ, Dept Mol Evolut, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden	Uppsala University; Uppsala University	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.	Dan.Andersson@imbim.uu.se		Andersson, Dan/0000-0001-6640-2174; Lind, Peter/0000-0003-1510-8324	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council to D. I. A. and O.G.B. We thank D. Hughes and P. B. Rainey for comments on the manuscript.	BUTCHER D, 1995, GENETICS, V141, P431; CABALLERO A, 1994, GENETICS, V138, P883; Carrasco P, 2007, J VIROL, V81, P12979, DOI 10.1128/JVI.00524-07; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Domingo-Calap P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000742; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; Keightley PD, 2010, PHILOS T R SOC B, V365, P1187, DOI 10.1098/rstb.2009.0266; KIMURA M, 1962, GENETICS, V47, P713; Lind PA, 2010, MOL MICROBIOL, V75, P1078, DOI 10.1111/j.1365-2958.2009.07030.x; MUKAI T, 1964, GENETICS, V50, P1; Nielsen R, 2003, MOL BIOL EVOL, V20, P1231, DOI 10.1093/molbev/msg147; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Orr HA, 2003, GENETICS, V163, P1519; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Piganeau G, 2003, P NATL ACAD SCI USA, V100, P10335, DOI 10.1073/pnas.1833064100; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Trindade S, 2010, PHILOS T R SOC B, V365, P1177, DOI 10.1098/rstb.2009.0287; Wloch DM, 2001, GENETICS, V159, P441	24	76	76	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					825	827		10.1126/science.1194617	http://dx.doi.org/10.1126/science.1194617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051637				2022-12-24	WOS:000283855700044
J	Krishnan, M; Mojarad, N; Kukura, P; Sandoghdar, V				Krishnan, Madhavi; Mojarad, Nassiredin; Kukura, Philipp; Sandoghdar, Vahid			Geometry-induced electrostatic trapping of nanometric objects in a fluid	NATURE			English	Article							OPTICAL MANIPULATION; BROWNIAN-MOTION; NANOPARTICLES; NANOSLIT; DNA; BIOMOLECULES; PRESSURE; DYNAMICS; FORCE	The ability to trap an object-whether a single atom or a macroscopic entity-affects fields as diverse as quantum optics(1), soft condensed-matter physics, biophysics and clinical medicine(2). Many sophisticated methodologies have been developed to counter the randomizing effect of Brownian motion in solution(3-10), but stable trapping of nanometre-sized objects remains challenging(8-10). Optical tweezers are widely used traps, but require sufficiently polarizable objects and thus are unable to manipulate small macromolecules. Confinement of single molecules has been achieved using electrokinetic feedback guided by tracking of a fluorescent label, but photophysical constraints limit the trap stiffness and lifetime(8). Here we show that a fluidic slit with appropriately tailored topography has a spatially modulated electrostatic potential that can trap and levitate charged objects in solution for up to several hours. We illustrate this principle with gold particles, polymer beads and lipid vesicles with diameters of tens of nanometres, which are all trapped without external intervention and independently of their mass and dielectric function. The stiffness and stability of our electrostatic trap is easily tuned by adjusting the system geometry and the ionic strength of the solution, and it lends itself to integration with other manipulation mechanisms. We anticipate that these features will allow its use for contact-free confinement of single proteins and macromolecules, and the sorting and fractionation of nanometre-sized objects or their assembly into high-density arrays.	[Krishnan, Madhavi; Mojarad, Nassiredin; Kukura, Philipp; Sandoghdar, Vahid] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Krishnan, M (corresponding author), ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland.	mkrishnan@ethz.ch	Sandoghdar, Vahid/AAT-8856-2020; Krishnan, Madhavi/J-4217-2015	Sandoghdar, Vahid/0000-0003-2594-4801; Krishnan, Madhavi/0000-0003-1274-7155; Kukura, Philipp/0000-0003-0136-7704	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. Alt for expert assistance in electron-beam lithography and the staff of the Center for Micro-and Nanoscience (FIRST), ETH Zurich, for clean-room support; H. Ewers for assistance in producing lipid vesicles; M. Celebrano and A. Renn for experimental input; M. Agio for discussions; and E. Petrov and R. Klemm for reading the manuscript. M.K. acknowledges a Marie Curie Intra-European Fellowship for Career Development of the European Commission, and greatly appreciates the support of B. Eichler, I. Monch and P. Schwille in the early stages of the project.	Adamczyk Z, 1996, ADV COLLOID INTERFAC, V63, P41, DOI 10.1016/0001-8686(95)00281-2; [Anonymous], 1992, INTERMOLECULAR SURFA; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988; Chiou PY, 2005, NATURE, V436, P370, DOI 10.1038/nature0383l; Chu S, 2002, NATURE, V416, P206, DOI 10.1038/416206a; Cohen AE, 2006, P NATL ACAD SCI USA, V103, P4362, DOI 10.1073/pnas.0509976103; Cordovez B, 2009, OPT EXPRESS, V17, P21134, DOI 10.1364/OE.17.021134; DUBOIS M, 1992, J CHEM PHYS, V96, P2278, DOI 10.1063/1.462078; Eichmann SL, 2008, LANGMUIR, V24, P714, DOI 10.1021/la702571z; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Hansen PM, 2005, NANO LETT, V5, P1937, DOI 10.1021/nl051289r; Jacobsen V., 2007, NANOBIOPHOTONICS, V3, P143, DOI DOI 10.1016/S1574-0641(07)80014-3; Jamshidi A, 2008, NAT PHOTONICS, V2, P85, DOI 10.1038/nphoton.2007.277; Jo K, 2007, P NATL ACAD SCI USA, V104, P2673, DOI 10.1073/pnas.0611151104; Juan ML, 2009, NAT PHYS, V5, P915, DOI 10.1038/NPHYS1422; KAPLAN PD, 1994, PHYS REV LETT, V73, P2793, DOI 10.1103/PhysRevLett.73.2793; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Krishnan M, 2007, NANO LETT, V7, P1270, DOI 10.1021/nl0701861; Krishnan M, 2008, SMALL, V4, P1900, DOI 10.1002/smll.200800227; Kukura P, 2009, NAT METHODS, V6, P923, DOI 10.1038/nmeth.1395; Loeb A. L., 1961, ELECT DOUBLE LAYER S; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; MAXWELL JC, 1954, TREATISE ELECT MAGNE, V1, P116; Polin M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041406; Reisner W, 2009, P NATL ACAD SCI USA, V106, P79, DOI 10.1073/pnas.0811468106; Soyka F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.208301; Stebe KJ, 2009, SCIENCE, V325, P159, DOI 10.1126/science.1174401; Tessier F, 2006, ELECTROPHORESIS, V27, P686, DOI 10.1002/elps.200500457; Yang AHJ, 2009, NATURE, V457, P71, DOI 10.1038/nature07593	32	179	184	1	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					692	U75		10.1038/nature09404	http://dx.doi.org/10.1038/nature09404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930840				2022-12-24	WOS:000282572500034
J	Kazatchkine, MD				Kazatchkine, Michel D.			Increased resources for the Global Fund, but pledges fall short of expected demand	LANCET			English	Editorial Material									Global Fund Fight AIDS TB & Malaria, CH-1214 Vernier, Switzerland		Kazatchkine, MD (corresponding author), Global Fund Fight AIDS TB & Malaria, CH-1214 Vernier, Switzerland.	michel.kazatchkine@theglobalfund.org						*GLOB FUND FIGHT A, RES SCEN 2011 2013; *GLOB FUND FIGHT A, 2010, GLOB FUND 3 VOL REPL; International Monetary Fund, 2010, WORLD EC OUTL DAT; MCNEIL DG, 2010, GLOBAL FIGHT AIDS FA	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2010	376	9751					1439	1440		10.1016/S0140-6736(10)61970-8	http://dx.doi.org/10.1016/S0140-6736(10)61970-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680QC	21036260				2022-12-24	WOS:000284248500004
J	Hino, T; Matsumoto, Y; Nagano, S; Sugimoto, H; Fukumori, Y; Murata, T; Iwata, S; Shiro, Y				Hino, Tomoya; Matsumoto, Yushi; Nagano, Shingo; Sugimoto, Hiroshi; Fukumori, Yoshihiro; Murata, Takeshi; Iwata, So; Shiro, Yoshitsugu			Structural Basis of Biological N2O Generation by Bacterial Nitric Oxide Reductase	SCIENCE			English	Article							CYTOCHROME-C-OXIDASE; PARACOCCUS-DENITRIFICANS; SPECTROSCOPIC CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; NO REDUCTASE; BC COMPLEX; HEME; PATHWAY; GLUTAMATES; STUTZERI	Nitric oxide reductase (NOR) is an iron-containing enzyme that catalyzes the reduction of nitric oxide (NO) to generate a major greenhouse gas, nitrous oxide (N2O). Here, we report the crystal structure of NOR from Pseudomonas aeruginosa at 2.7 angstrom resolution. The structure reveals details of the catalytic binuclear center. The non-heme iron (Fe-B) is coordinated by three His and one Glu ligands, but a His-Tyr covalent linkage common in cytochrome oxidases (COX) is absent. This structural characteristic is crucial for NOR reaction. Although the overall structure of NOR is closely related to COX, neither the D-nor K-proton pathway, which connect the COX active center to the intracellular space, was observed. Protons required for the NOR reaction are probably provided from the extracellular side.	[Hino, Tomoya; Matsumoto, Yushi; Nagano, Shingo; Sugimoto, Hiroshi; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Hino, Tomoya; Murata, Takeshi; Iwata, So] Japan Sci & Technol Agcy, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Hino, Tomoya; Murata, Takeshi; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Matsumoto, Yushi] Kyushu Univ, Med Inst Bioregulat, Postgenome Sci Ctr, Div Prot Chem, Fukuoka 8128552, Japan; [Nagano, Shingo] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Fukumori, Yoshihiro] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Iwata, So] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Membrane Prot Crystallog Grp, London SW7 2AZ, England	RIKEN; Japan Science & Technology Agency (JST); Kyoto University; Kyushu University; Tottori University; Kanazawa University; Imperial College London	Hino, T (corresponding author), RIKEN SPring 8 Ctr, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.		Shiro, Yoshitsugu Y/J-3757-2014; Murata, Takeshi/J-6181-2017; Murata, Takeshi/F-6114-2011; Sugimoto, Hiroshi/AAR-5442-2021; Sugimoto, Hiroshi/K-4041-2017; Fukumori, Yoshihiro/J-2483-2014	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Murata, Takeshi/0000-0002-5748-4670; Sugimoto, Hiroshi/0000-0002-3140-8362; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT); RIKEN; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Atomic coordinates and structure factors have been deposited to the Protein Data Bank (PDB) with code 3O0R. We thank T. Tosha for measurements of the enzymatic activity of cNOR under various conditions and the staff of the SPring-8 beamlines for their help with diffraction measurements. S.N., H. S., and Y.S. are supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Y.S. also acknowledges financial support from the Structural Biology and Molecular Ensemble projects of RIKEN. A part of this work was also supported by a grant from the ERATO IWATA Human Receptor Crystallography Project from the Japan Science and Technology Agency.	BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Blomberg LM, 2006, BBA-BIOENERGETICS, V1757, P240, DOI 10.1016/j.bbabio.2006.04.008; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Butler CS, 1997, BIOCHEMISTRY-US, V36, P16259, DOI 10.1021/bi971481a; Collman JP, 2008, P NATL ACAD SCI USA, V105, P15660, DOI 10.1073/pnas.0808606105; DeBoer APN, 1996, EUR J BIOCHEM, V242, P592, DOI 10.1111/j.1432-1033.1996.0592r.x; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Flock U, 2009, J INORG BIOCHEM, V103, P845, DOI 10.1016/j.jinorgbio.2009.02.008; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Gronberg KLC, 1999, BIOCHEMISTRY-US, V38, P13780, DOI 10.1021/bi9916426; HEISS B, 1989, J BACTERIOL, V171, P3288, DOI 10.1128/jb.171.6.3288-3297.1989; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kakishima K, 2007, BIOCHEM BIOPH RES CO, V355, P587, DOI 10.1016/j.bbrc.2007.02.017; Kumita H, 2004, J BIOL CHEM, V279, P55247, DOI 10.1074/jbc.M409996200; Lin YW, 2010, P NATL ACAD SCI USA, V107, P8581, DOI 10.1073/pnas.1000526107; Moenne-Loccoz P, 2000, J AM CHEM SOC, V122, P9344, DOI 10.1021/ja0016295; Moenne-Loccoz P, 1998, J AM CHEM SOC, V120, P5147, DOI 10.1021/ja973671e; Moenne-Loccoz P, 2007, NAT PROD REP, V24, P610, DOI 10.1039/B604194A; Regan JJ, 1998, J BIOENERG BIOMEMBR, V30, P35, DOI 10.1023/A:1020551326307; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; SHAPLEIGH JP, 1985, J BACTERIOL, V163, P837, DOI 10.1128/JB.163.3.837-840.1985; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Wuebbles DJ, 2009, SCIENCE, V326, P56, DOI 10.1126/science.1179571; YE RW, 1994, APPL ENVIRON MICROB, V60, P1053, DOI 10.1128/AEM.60.4.1053-1058.1994; Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620; ZUMFT WG, 1994, EUR J BIOCHEM, V219, P481, DOI 10.1111/j.1432-1033.1994.tb19962.x	31	245	249	1	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1666	1670		10.1126/science.1195591	http://dx.doi.org/10.1126/science.1195591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21109633				2022-12-24	WOS:000285390500064
J	Xia, LX; Jia, SJ; Huang, SJ; Wang, HL; Zhu, YX; Mu, YJ; Kan, LJ; Zheng, WJ; Wu, D; Li, XM; Sun, QM; Meng, AM; Chen, DH				Xia, Laixin; Jia, Shunji; Huang, Shoujun; Wang, Hailong; Zhu, Yuanxiang; Mu, Yanjun; Kan, Lijuan; Zheng, Wenjing; Wu, Di; Li, Xiaoming; Sun, Qinmiao; Meng, Anming; Chen, Dahua			The Fused/Smurf Complex Controls the Fate of Drosophila Germline Stem Cells by Generating a Gradient BMP Response	CELL			English	Article							BAG-OF-MARBLES; GENE; PROTEIN; NICHE; EXPRESSION; DIVISION; PIWI; DIFFERENTIATION; TRANSCRIPTION; DETERMINES	In the Drosophila ovary, germline stem cells (GSCs) are maintained primarily by bone morphogenetic protein (BMP) ligands produced by the stromal cells of the niche. This signaling represses GSC differentiation by blocking the transcription of the differentiation factor Bam. Remarkably, bam transcription begins only one cell diameter away from the GSC in the daughter cystoblasts (CBs). How this steep gradient of response to BMP signaling is formed has been unclear. Here, we show that Fused (Fu), a serine/threonine kinase that regulates Hedgehog, functions in concert with the E3 ligase Smurf to regulate ubiquitination and proteolysis of the BMP receptor Thickveins in CBs. This regulation generates a steep gradient of BMP activity between GSCs and CBs, allowing for bam expression on CBs and concomitant differentiation. We observed similar roles for Fu during embryonic development in zebrafish and in human cell culture, implying broad conservation of this mechanism.	[Xia, Laixin; Huang, Shoujun; Wang, Hailong; Zhu, Yuanxiang; Mu, Yanjun; Kan, Lijuan; Zheng, Wenjing; Chen, Dahua] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Xia, Laixin; Li, Xiaoming; Sun, Qinmiao; Meng, Anming] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Jia, Shunji; Wu, Di; Meng, Anming] Tsinghua Univ, Coll Life Sci, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Tsinghua University	Chen, DH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	chendh@ioz.ac.cn	Meng, Anming/A-4785-2012; Wenjing, Zheng/H-9766-2013; Zheng, Wenjing/M-7580-2015	Meng, Anming/0000-0001-7228-3431; Xia, Laixin/0000-0003-2735-9518	National Basic Research Program of China [2007CB947502, 2007CB507400]; NSFC [30630042, 30825026, 30830068]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	We thank Drs. Dennis McKearin, Duojia Pan, Peng Jin, and Zongping Xia for critical readings of the manuscript. This work was supported by grants from the National Basic Research Program of China (2007CB947502 and 2007CB507400 to D.C.) and from the NSFC (#30630042 and 30825026 to D.C. and #30830068 to A.M.).	Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Chen DS, 2009, DEVELOPMENT, V136, P4133, DOI 10.1242/dev.039032; Claret S, 2007, CURR BIOL, V17, P1326, DOI 10.1016/j.cub.2007.06.059; Cox DN, 2000, DEVELOPMENT, V127, P503; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Haley B, 2008, DEV BIOL, V321, P482, DOI 10.1016/j.ydbio.2008.06.015; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiang XY, 2008, DEV CELL, V14, P494, DOI 10.1016/j.devcel.2008.02.018; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Kitisin Krit, 2007, Sci STKE, V2007, pcm1, DOI 10.1126/stke.3992007cm1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Liu YJ, 2007, GENE DEV, V21, P1949, DOI 10.1101/gad.1557407; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Narbonne-Reveau K, 2006, MECH DEVELOP, V123, P197, DOI 10.1016/j.mod.2006.01.001; Nishikawa SI, 2008, COLD SH Q B, V73, P67, DOI 10.1101/sqb.2008.73.024; Nybakken KE, 2002, J BIOL CHEM, V277, P24638, DOI 10.1074/jbc.M110730200; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Ruel L, 2007, DEVELOPMENT, V134, P3677, DOI 10.1242/dev.011577; SanchezHerrero E, 1996, MECH DEVELOP, V55, P159, DOI 10.1016/0925-4773(96)00498-4; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Van Doren M, 1998, CURR BIOL, V8, P243; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	43	95	100	2	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					978	990		10.1016/j.cell.2010.11.022	http://dx.doi.org/10.1016/j.cell.2010.11.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145463	Bronze			2022-12-24	WOS:000285182600014
J	Szabo, E; Rampalli, S; Risueno, RM; Schnerch, A; Mitchell, R; Fiebig-Comyn, A; Levadoux-Martin, M; Bhatia, M				Szabo, Eva; Rampalli, Shravanti; Risueno, Ruth M.; Schnerch, Angelique; Mitchell, Ryan; Fiebig-Comyn, Aline; Levadoux-Martin, Marilyne; Bhatia, Mickie			Direct conversion of human fibroblasts to multilineage blood progenitors	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; MICE LACKING; IPS CELLS; EXPRESSION; TRANSCRIPTION; HEMATOPOIESIS; INDUCTION; TRANSPLANTATION; CIRCUITRY	As is the case for embryo-derived stem cells, application of reprogrammed human induced pluripotent stem cells is limited by our understanding of lineage specification. Here we demonstrate the ability to generate progenitors and mature cells of the haematopoietic fate directly from human dermal fibroblasts without establishing pluripotency. Ectopic expression of OCT4 (also called POU5F1)-activated haematopoietic transcription factors, together with specific cytokine treatment, allowed generation of cells expressing the pan-leukocyte marker CD45. These unique fibroblast-derived cells gave rise to granulocytic, monocytic, megakaryocytic and erythroid lineages, and demonstrated in vivo engraftment capacity. We note that adult haematopoietic programs are activated, consistent with bypassing the pluripotent state to generate blood fate: this is distinct from haematopoiesis involving pluripotent stem cells, where embryonic programs are activated. These findings demonstrate restoration of multipotency from human fibroblasts, and suggest an alternative approach to cellular reprogramming for autologous cell-replacement therapies that avoids complications associated with the use of human pluripotent stem cells.	[Szabo, Eva; Rampalli, Shravanti; Risueno, Ruth M.; Schnerch, Angelique; Mitchell, Ryan; Fiebig-Comyn, Aline; Levadoux-Martin, Marilyne; Bhatia, Mickie] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Schnerch, Angelique; Mitchell, Ryan; Bhatia, Mickie] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Bhatia, M (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca	Risueño, Ruth Muñoz/G-9969-2015	Risueño, Ruth Muñoz/0000-0003-4048-9536; Rampalli, Shravanti/0000-0002-6391-6409	Canadian Institute of Health Research (CIHR); Canadian Cancer Society Research Institute (CCS-RI); StemCell Network; Ontario Ministry of Research Innovation (MRI); Canadian Chair; Ministry of Research and Innovation (MRI); MITACS; Ontario Graduate Scholarship (OGS)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCS-RI); StemCell Network; Ontario Ministry of Research Innovation (MRI)(Ministry of Research and Innovation, Ontario); Canadian Chair; Ministry of Research and Innovation (MRI)(Ministry of Research and Innovation, Ontario); MITACS; Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship)	This work was supported by grants to M.B. from the Canadian Institute of Health Research (CIHR), the Canadian Cancer Society Research Institute (CCS-RI), the StemCell Network and the Ontario Ministry of Research Innovation (MRI). M.B. is supported by the Canadian Chair Program and holds the Canada Research Chair in human stem cell biology. E.S. is supported by Ministry of Research and Innovation (MRI) and MITACS fellowships, R.M.R is supported by a CCS-RI fellowship and R.M. is supported by an Ontario Graduate Scholarship (OGS). We thank T. Werbowetski-Ogilvie for her help.	Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brunner C, 2003, J EXP MED, V197, P1205, DOI 10.1084/jem.20022014; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Emslie D, 2008, J EXP MED, V205, P409, DOI 10.1084/jem.20072049; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Feugier P, 2003, TRANSFUSION, V43, P878, DOI 10.1046/j.1537-2995.2003.00446.x; Fried W, 2009, EXP HEMATOL, V37, P1007, DOI 10.1016/j.exphem.2009.05.010; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Ghozi MC, 1996, P NATL ACAD SCI USA, V93, P1935, DOI 10.1073/pnas.93.5.1935; Hassan HT, 1996, ACTA HAEMATOL-BASEL, V95, P257; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ichikawa M, 2004, CELL CYCLE, V3, P722; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanawaty A, 2009, BIOESSAYS, V31, P134, DOI 10.1002/bies.200800204; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; KISTLER B, 1995, ONCOGENE, V11, P1095; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; Kwon UK, 2006, BIOCHEM BIOPH RES CO, V344, P146, DOI 10.1016/j.bbrc.2006.03.119; Lebofsky R, 2007, CANCER CELL, V12, P102, DOI 10.1016/j.ccr.2007.07.013; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; Perlingeiro RCR, 2001, DEVELOPMENT, V128, P4597; Pfisterer P, 1996, MOL CELL BIOL, V16, P6160; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Strodtbeck D, 2005, BONE MARROW TRANSPL, V36, P1083, DOI 10.1038/sj.bmt.1705176; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vijayaragavan K, 2009, CELL STEM CELL, V4, P248, DOI 10.1016/j.stem.2008.12.011; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	47	529	615	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					521	U191		10.1038/nature09591	http://dx.doi.org/10.1038/nature09591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21057492				2022-12-24	WOS:000284584200033
J	Ali, S				Ali, Sabreen			Fast food feud at Golden Gate	LANCET			English	Editorial Material									Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Ali, S (corresponding author), Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England.	sabreenmaryam@gmail.com						[Anonymous], 2010, BBC NEWS        1110; NEWSOM G, 2010, SAN FRANCISCO C 1113; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; *RUDD FOOD CTR FOO, 2010, FAST FOOD FACTS EV F	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1723	1723		10.1016/S0140-6736(10)62114-9	http://dx.doi.org/10.1016/S0140-6736(10)62114-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690EI	21093638				2022-12-24	WOS:000284984900011
J	Nicholl, DJ; Hilton-Jones, D; Palace, J; Richmond, S; Finlayson, S; Winer, J; Weir, A; Maddison, P; Fletcher, N; Sussman, J; Silver, N; Nixon, J; Kullmann, D; Embleton, N; Beeson, D; Farrugia, ME; Hill, M; McDermott, C; Llewelyn, G; Leonard, J; Morris, M				Nicholl, David J.; Hilton-Jones, David; Palace, Jacqueline; Richmond, Sam; Finlayson, Sarah; Winer, John; Weir, Andrew; Maddison, Paul; Fletcher, Nick; Sussman, Jon; Silver, Nick; Nixon, John; Kullmann, Dimitri; Embleton, Nick; Beeson, David; Farrugia, Maria Elena; Hill, Marguerite; McDermott, Chris; Llewelyn, Gareth; Leonard, James; Morris, Michael			Orphan Drugs Open letter to prime minister David Cameron and health secretary Andrew Lansley	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nicholl, David J.] City Hosp, Birmingham, W Midlands, England; [Hilton-Jones, David; Palace, Jacqueline; Finlayson, Sarah] John Radcliffe Infirm, Oxford, England; [Richmond, Sam] Sunderland Royal Hosp, Sunderland, England; [Winer, John] Univ Hosp Birmingham, Birmingham, W Midlands, England; [Weir, Andrew] Royal Berkshire NHS Trust, Reading, Berks, England; [Maddison, Paul] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Fletcher, Nick; Silver, Nick] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England; [Sussman, Jon] Hope Hosp, Greater Manchester Neurosci Ctr, Salford M6 8HD, Lancs, England; [Nixon, John] Royal Preston Hosp, Preston, Lancs, England; [Kullmann, Dimitri] Inst Neurol, London, England; [Embleton, Nick] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Beeson, David] Weatherall Inst Mol Med, Oxford, England; [Farrugia, Maria Elena] So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland; [Hill, Marguerite] Abertawe Bro Morgannwg Univ, Local Hlth Board, Swansea, W Glam, Wales; [McDermott, Chris] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Llewelyn, Gareth] Royal Gwent Hosp, Newport, Gwent, Wales; [Leonard, James] UCL, Inst Child Hlth, London WC1E 6BT, England; [Morris, Michael] Myasthenia Gravis Assoc, Derby, England	University of Birmingham; Sunderland Royal Hospital; University of Birmingham; Royal Berkshire Hospital; Nottingham University Hospital NHS Trust; Walton Centre; Royal Preston Hospital; University of London; University College London; Newcastle University - UK; University of Oxford; University of Glasgow; University of Sheffield; Royal Gwent Hospital; University of London; University College London	Nicholl, DJ (corresponding author), City Hosp, Birmingham, W Midlands, England.	david.nicholl@nhs.net	Embleton, Nicholas/D-4905-2011; McDermott, Christopher/AAU-4988-2020; McDermott, Chris/GQZ-3919-2022; Kullmann, Dimitri M/A-3162-2009	Embleton, Nicholas/0000-0003-3750-5566; McDermott, Christopher/0000-0002-1269-9053; Kullmann, Dimitri M/0000-0001-6696-3545; Shaw, Pamela/0000-0002-8925-2567	MRC [G0701521] Funding Source: UKRI; Medical Research Council [G0701521] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BOSELEY S, 2002, GUARDIAN        0624; Leonard JV, 2009, LANCET, V373, P462, DOI 10.1016/S0140-6736(09)60169-0; MARTIN D, 2010, DAILY MAIL      0927	3	13	13	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 16	2010	341								c6466	10.1136/bmj.c6466	http://dx.doi.org/10.1136/bmj.c6466			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684WJ	21081599				2022-12-24	WOS:000284585600025
J	Rohani, P; Zhong, X; King, AA				Rohani, Pejman; Zhong, Xue; King, Aaron A.			Contact Network Structure Explains the Changing Epidemiology of Pertussis	SCIENCE			English	Article							BORDETELLA-PERTUSSIS; VACCINATION; ADULTS; IMMUNIZATION; RESURGENCE; ADOLESCENTS; INFANTS; MEASLES; SWEDEN; IMPACT	The epidemiology of whooping cough (pertussis) remains enigmatic. A leading cause of infant mortality globally, its resurgence in several developed nations-despite the availability and use of vaccines for many decades-has caused alarm. We combined data from a singular natural experiment and a detailed contact network study to show that age-specific contact patterns alone can explain shifts in prevalence and age-stratified incidence in the vaccine era. The practical implications of our results are notable: Ignoring age-structured contacts is likely to result in misinterpretation of epidemiological data and potentially costly policy missteps.	[Rohani, Pejman; Zhong, Xue; King, Aaron A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Rohani, Pejman; Zhong, Xue] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; [King, Aaron A.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Rohani, Pejman; King, Aaron A.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Rohani, P (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	rohani@umich.edu	King, Aaron A/B-8092-2012	King, Aaron A/0000-0001-6159-3207; rohani, pejman/0000-0002-7221-3801	Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Vaccine Modeling Initiative of the Bill & Melinda Gates Foundation	Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Vaccine Modeling Initiative of the Bill & Melinda Gates Foundation	We thank three anonymous reviewers for comments. P.R. and A.A.K. are supported by the Research and Policy in Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. P.R. was also supported by the Vaccine Modeling Initiative of the Bill & Melinda Gates Foundation.	ANDERSON R M, 1991; ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X; Broutin H, 2004, VACCINE, V22, P594, DOI 10.1016/j.vaccine.2003.07.018; Broutin H, 2010, P ROY SOC B-BIOL SCI, V277, P3239, DOI 10.1098/rspb.2010.0994; Carlsson Rose-Marie, 2009, Vaccine, V27, P5709, DOI 10.1016/j.vaccine.2009.07.092; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry JD, 2003, PEDIATRICS, V112, P405, DOI 10.1542/peds.112.2.405; CHERRY JD, 1989, WESTERN J MED, V150, P319; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; DEVILLE JG, 1995, CLIN INFECT DIS, V21, P639, DOI 10.1093/clinids/21.3.639; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Eidlitz-Markus T, 2007, CLIN PEDIATR, V46, P718, DOI 10.1177/0009922807302093; FINE PEM, 1982, LANCET, V1, P666; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Hallander HO, 2005, J CLIN MICROBIOL, V43, P2856, DOI 10.1128/JCM.43.6.2856-2865.2005; Keeling, 2008, MODELLING INFECT DIS; Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; Ntezayabo B, 2003, PEDIATR INFECT DIS J, V22, P22, DOI 10.1097/00006454-200301000-00009; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; ROMANUS V, 1987, PEDIATR INFECT DIS J, V6, P364, DOI 10.1097/00006454-198704000-00005; Schellekens Joop, 2005, Pediatr Infect Dis J, V24, pS19, DOI 10.1097/01.inf.0000160909.24879.e6; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS83, DOI 10.1097/01.inf.0000160919.94330.1a; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Walllinga J, 2005, PLOS MED, V2, P1152, DOI 10.1371/journal.pmed.0020316; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647	32	154	157	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					982	985		10.1126/science.1194134	http://dx.doi.org/10.1126/science.1194134			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071671				2022-12-24	WOS:000284118000048
J	Vincent, JL; Singer, M				Vincent, Jean-Louis; Singer, Mervyn			Critical Care 3 Critical care: advances and future perspectives	LANCET			English	Article							ACTIVATED PROTEIN-C; INTENSIVE INSULIN THERAPY; SURVIVING SEPSIS CAMPAIGN; QUALITY-OF-LIFE; ILL PATIENTS; INTRAVENOUS IMMUNOGLOBULIN; HEMODYNAMIC OPTIMIZATION; ECONOMIC OUTCOMES; DIGESTIVE-TRACT; SEPTIC SHOCK	Intensive care offers a standard of monitoring, intervention, and organ support that cannot be readily delivered in a general ward. Its expansion in the past few decades, including the creation of emergency and outreach teams, emphasises that intensive care has an increasingly prominent role within the hospital. Although outcomes are clearly improving, intensive care remains a nascent specialty in which we are still learning how to harness a powerful ability to manipulate physiology, biochemistry, and immunology to achieve best outcomes for the patient. The results of many multicentre studies have not lent support to, or have even confounded, expectations, drawing attention to several issues related to patient heterogeneity, trial design, and elucidation of underlying pathophysiological processes. However, these results have generated constructive introspection and reappraisal of treatments and management strategies that have benefited the patient. In addition to the medical, financial, and logistical challenges in the future, exciting opportunities will arise as new developments in diagnostic tests, therapeutic interventions, and technology are used to exploit an increasing awareness of how critical illness should be managed.	[Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium; [Singer, Mervyn] UCL, Dept Med, Bloomsbury Inst Intens Care Med, London, England	Universite Libre de Bruxelles; University of London; University College London	Vincent, JL (corresponding author), Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	jlvincen@ulb.ac.be	Singer, Mervyn/Q-6142-2019; Singer, Mervyn/J-4425-2012	Singer, Mervyn/0000-0002-1042-6350; Singer, Mervyn/0000-0002-1042-6350; Vincent, Jean-Louis/0000-0001-6011-6951	Eisai; Eli Lilly; Artisan; Astellas; UK Department of Health's National Institute for Health Research Comprehensive Biomedical Research Centre	Eisai(Eisai Co Ltd); Eli Lilly(Eli Lilly); Artisan; Astellas(Astellas Pharmaceuticals); UK Department of Health's National Institute for Health Research Comprehensive Biomedical Research Centre	J-LV has served as a paid consultant for Eli Lilly, Eisai, and GlaxoSmithKline; participated in clinical trials sponsored by Eisai, Eli Lilly, Artisan, and Astellas; and been an invited speaker at conferences supported by Eli Lilly, Esai, and GlaxoSmithKline. MS has served as a consultant to, and has been an invited speaker at conferences supported by, Eli Lilly and Deltas Medical. Additionally, Deltex Medical provides a yearly unrestricted donation to MS's research fund at University College London.; University College London Hospital/University College London receives support from the UK Department of Health's National Institute for Health Research Comprehensive Biomedical Research Centre funding scheme.	Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Angus DC, 2004, CRIT CARE MED, V32, P2199, DOI 10.1097/01.CCM.0000145228.62451.F6; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Armstrong L, 1999, AM J RESP CRIT CARE, V160, P1910, DOI 10.1164/ajrccm.160.6.9811084; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Breslow MJ, 2004, CRIT CARE MED, V32, P31, DOI 10.1097/01.CCM.0000104204.61296.41; Brienza N, 2009, CRIT CARE MED, V37, P2079, DOI 10.1097/CCM.0b013e3181a00a43; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; de Backer D, 2006, CRIT CARE MED, V34, P1918, DOI 10.1097/01.CCM.0000220498.48773.3C; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Eichacker PQ, 2007, INTENS CARE MED, V33, P396, DOI 10.1007/s00134-007-0556-8; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Flabouris Arthas, 2008, Crit Care Resusc, V10, P97; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Gomersall CD, 2000, CRIT CARE MED, V28, P607, DOI 10.1097/00003246-200003000-00001; Griffiths RD, 2007, CURR OPIN CRIT CARE, V13, P508, DOI 10.1097/MCC.0b013e3282efae05; Gupta A, 2009, J AM SOC NEPHROL, V20, P267, DOI 10.1681/ASN.2008030294; GUTIERREZ G, 1992, LANCET, V339, P195, DOI 10.1016/0140-6736(92)90002-K; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Hillman Ken, 2002, Curr Opin Crit Care, V8, P594, DOI 10.1097/00075198-200212000-00019; Jackson JC, 2009, CRIT CARE CLIN, V25, P615, DOI 10.1016/j.ccc.2009.04.005; Joyce DE, 2004, CRIT CARE MED, V32, pS280, DOI 10.1097/01.CCM.0000128037.72072.22; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kreyrnann KG, 2007, CRIT CARE MED, V35, P2677, DOI 10.1097/01.CCM.0000295263.12774.97; Laupland KB, 2007, CRIT CARE MED, V35, P2686, DOI 10.1097/01.CCM.0000295312.13466.1C; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Mackenzie AF, 2005, INTENS CARE MED, V31, P1624, DOI 10.1007/s00134-005-2829-4; MacLaren R, 2008, CRIT CARE MED, V36, P3184, DOI 10.1097/CCM.0b013e31818f2269; Marshall JC, 2008, J LEUKOCYTE BIOL, V83, P471, DOI 10.1189/jlb.0607380; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Martin G, 2009, CRIT CARE, V13, DOI 10.1186/cc7936; Matzo M, 2009, BIOSECUR BIOTERROR, V7, P199, DOI 10.1089/bsp.2009.0017; Moran JL, 2008, CRIT CARE MED, V36, P46, DOI 10.1097/01.CCM.0000295313.08084.58; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; Ospina-Tascon GA, 2008, CRIT CARE MED, V36, P1311, DOI 10.1097/CCM.0b013e318168ea3e; Papadimos Thomas J, 2008, Patient Saf Surg, V2, P3, DOI 10.1186/1754-9493-2-3; Poeze M, 2005, CRIT CARE, V9, pR771, DOI 10.1186/cc3902; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Pontes-Arruda A, 2008, JPEN-PARENTER ENTER, V32, P596, DOI 10.1177/0148607108324203; Pronovost P, 2006, CRIT CARE MED, V34, P1988, DOI 10.1097/01.CCM.0000226412.12612.B6; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Protti A, 2006, CRIT CARE, V10, DOI 10.1186/cc5014; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rubinson L, 2008, CHEST, V133, p18S, DOI 10.1378/chest.07-2690; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Shulman R, 2005, CRIT CARE, V9, pR516, DOI 10.1186/cc3793; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Singer M, 2007, LANCET, V370, P636, DOI 10.1016/S0140-6736(07)61317-8; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tan T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b822; Turgeon AF, 2007, ANN INTERN MED, V146, P193, DOI 10.7326/0003-4819-146-3-200702060-00009; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; *VET AFF TOT PAR N, 1991, NEW ENGL J MED, V325, P525, DOI DOI 10.1056/NEJM199108223250801; Vincent JL, 2006, PLOS MED, V3, P1488, DOI 10.1371/journal.pmed.0030346; Vincent JL, 2010, CRIT CARE MED, V38, P283, DOI 10.1097/CCM.0b013e3181b785a2; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Vincent JL, 2005, CRIT CARE MED, V33, P1225, DOI 10.1097/01.CCM.0000165962.16682.46; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134	79	50	54	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1354	1361		10.1016/S0140-6736(10)60575-2	http://dx.doi.org/10.1016/S0140-6736(10)60575-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20934211				2022-12-24	WOS:000283528600039
J	James, MT; Hemmelgarn, BR; Wiebe, N; Pannu, N; Manns, BJ; Klarenbach, SW; Tonelli, M				James, Matthew T.; Hemmelgarn, Brenda R.; Wiebe, Natasha; Pannu, Neesh; Manns, Braden J.; Klarenbach, Scott W.; Tonelli, Marcello		Alberta Kidney Dis Network	Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study	LANCET			English	Article							ACUTE-RENAL-FAILURE; PERCUTANEOUS CORONARY INTERVENTION; SERUM CREATININE; DISEASE; RISK; MORTALITY; OUTCOMES; NEPHROPATHY; PREDICTION; INCREASES	Background Low values of estimated glomerular filtration rate (eGFR) predispose to acute kidney injury, and proteinuria is a marker of kidney disease. We aimed to investigate how eGFR and proteinuria jointly modified the risks of acute kidney injury and subsequent adverse clinical outcomes. Methods We did a cohort study of 920 985 adults residing in Alberta, Canada, between 2002 and 2007. Participants not needing chronic dialysis at baseline and with at least one outpatient measurement of both serum creatinine concentration and proteinuria (urine dipstick or albumin-creatinine ratio) were included. We assessed hospital admission with acute kidney injury with validated administrative codes; other outcomes were all-cause mortality and a composite renal outcome of end-stage renal disease or doubling of serum creatinine concentration. Findings During median follow-up of 35 months (range 0-59 months), 6520 (0.7%) participants were admitted with acute kidney injury. In those with eGFR 60 mL/min per 1.73 m(2) or greater, the adjusted risk of admission with this disorder was about 4 times higher in those with heavy proteinuria measured by dipstick (rate ratio 4.4 vs no proteinuria, 95% CI 3.7-5.2). The adjusted rates of admission with acute kidney injury and kidney injury needing dialysis remained high in participants with heavy dipstick proteinuria for all values of eGFR. The adjusted rates of death and the composite renal outcome were also high in participants admitted with acute kidney injury, although the rise associated with this injury was attenuated in those with low baseline eGFR and heavy proteinuria. Interpretation These findings suggest that information on proteinuria and eGFR should be used together when identifying people at risk of acute kidney injury, and that an episode of acute kidney injury provides further long-term prognostic information in addition to eGFR and proteinuria.	[James, Matthew T.; Hemmelgarn, Brenda R.; Manns, Braden J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [James, Matthew T.; Hemmelgarn, Brenda R.; Manns, Braden J.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Wiebe, Natasha; Pannu, Neesh; Klarenbach, Scott W.; Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Klarenbach, Scott W.; Tonelli, Marcello] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Alberta; University of Alberta	Tonelli, M (corresponding author), 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2G3, Canada.	mtonelli-admin@med.ualberta.ca	Klarenbach, Scott/E-7731-2013; Wiebe, Natasha/V-7803-2019; Hug, Balthasar L./G-1568-2010; Hemmelgarn, Brenda R./I-6894-2012; Manns, Braden J/I-8942-2012; Tonelli, Marcello/B-3028-2009	Klarenbach, Scott/0000-0002-8611-1056; Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187	Alberta Heritage Foundation for Medical Research (AHFMR); Kidney Foundation of Canada/the Canadian Institutes for Health Research (CIHR); CIHR	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Kidney Foundation of Canada/the Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This study was funded by an interdisciplinary team grant from Alberta Heritage Foundation for Medical Research (AHFMR). MTJ is supported by a KRESCENT award from the Kidney Foundation of Canada/the Canadian Institutes for Health Research (CIHR) and an AHFMR fellowship award. MT is supported by a Health Scholar and SWK and BRH by Population Health Investigator Awards from the AHFMR. MT, BJM, and BRH are supported by New Investigator Awards from the CIHR.	Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2007, AM J KIDNEY DIS, V50, P712, DOI 10.1053/j.ajkd.2007.07.018; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Ishani A, 2009, J AM SOC NEPHROL, V20, P8; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V50, P1, DOI 10.1053/j.ajkd.2007.05.008; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Sin DD, 2003, CHEST, V124, P51, DOI 10.1378/chest.124.1.51; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	221	236	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2096	2103		10.1016/S0140-6736(10)61271-8	http://dx.doi.org/10.1016/S0140-6736(10)61271-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702LA	21094997				2022-12-24	WOS:000285895000027
J	deFilippi, CR; de Lemos, JA; Christenson, RH; Gottdiener, JS; Kop, WJ; Zhan, M; Seliger, SL				deFilippi, Christopher R.; de Lemos, James A.; Christenson, Robert H.; Gottdiener, John S.; Kop, Willem J.; Zhan, Min; Seliger, Stephen L.			Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREDICTION; DISEASE; RISK; VALIDATION; BIOMARKERS; COMMUNITY; EVENTS; UPDATE; MARKER; HEALTH	Context Older adults comprise the majority of new-onset heart failure (HF) diagnoses, but traditional risk-factor prediction models have limited accuracy in this population to identify those at highest risk for hospitalization or death. Objectives To determine if cardiac troponin T (cTnT) measured by a highly sensitive assay would be detectable in the majority of community-dwelling older adults, and if serial measures were associated with risk of HF hospitalization and cardiovascular death. Design, Setting, and Participants A longitudinal nationwide cohort study (Cardiovascular Health Study) of 4221 community-dwelling adults aged 65 years or older without prior HF who had cTnT measured using a highly sensitive assay at baseline (1989-1990) and repeated after 2 to 3 years (n=2918). Main Outcome Measures New-onset HF and cardiovascular death were examined through June 2008 with respect to cTnT concentrations, accounting for clinical risk predictors. Results Cardiac troponin T was detectable (>= 3.00 pg/mL) in 2794 participants (66.2%). During a median follow-up of 11.8 years, 1279 participants experienced new-onset HF and 1103 cardiovascular deaths occurred, with a greater risk of both end points associated with higher cTnT concentrations. Among those participants with the highest cTnT concentrations (>12.94 pg/mL), there was an incidence rate per 100 person-years of 6.4 (95% confidence interval [CI], 5.8-7.2; adjusted hazard ratio [aHR], 2.48; 95% CI, 2.04-3.00) for HF and an incidence rate of 4.8 (95% CI, 4.3-5.4; aHR, 2.91; 95% CI, 2.37-3.58) for cardiovascular death compared with participants with undetectable cTnT levels (incidence rate, 1.6; 95% CI, 1.4-1.8 and 1.1; 95% CI, 0.9-1.2 for HF and cardiovascular death, respectively). Among individuals with initially detectable cTnT, a subsequent increase of more than 50% (n=393, 22%) was associated with a greater risk for HF (aHR, 1.61; 95% CI, 1.32-1.97) and cardiovascular death (aHR, 1.65; 95% CI, 1.35-2.03) and a decrease of more than 50% (n=247, 14%) was associated with a lower risk for HF (aHR, 0.73; 95% CI, 0.54-0.97) and cardiovascular death (aHR, 0.71; 95% CI, 0.52-0.97) compared with participants with 50% or less change. Addition of baseline cTnT measurements to clinical risk factors was associated with only modest improvement in discrimination, with change in C statistic of 0.015 for HF and 0.013 for cardiovascular death. Conclusion In this cohort of older adults without known HF, baseline cTnT levels and changes in cTnT levels measured with a highly sensitive assay were significantly associated with incident HF and cardiovascular death. JAMA. 2010;304(22):2494-2502 www.jama.com	[deFilippi, Christopher R.; Gottdiener, John S.; Kop, Willem J.; Seliger, Stephen L.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21212 USA; [Christenson, Robert H.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21212 USA; [Zhan, Min] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21212 USA; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Southwestern Medical Center Dallas	deFilippi, CR (corresponding author), Univ Maryland, Sch Med, Dept Med, G3K63,22 S Greene St, Baltimore, MD 21212 USA.	cdefilip@medicine.umaryland.edu	de Lemos, James/ABD-6669-2021	Seliger, Stephen/0000-0002-1693-0734	Roche Diagnostics; Siemens Healthcare Diagnostics; Critical Diagnostics; BG Medicine; Biosite; Biosite/Inverness; Siemens; Siemens Medical Diagnostics and Response Biomedical; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085084, N01HC085085, N01HC085083, N01HC055222, N01HC015103, N01HC045133, N01HC075150, N01HC085086, N01HC085079, N01HC085080, N01HC085082, N01HC035129, N01HC085081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075366, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015928, R01AG020098, P30AG024827, R01AG027058] Funding Source: NIH RePORTER	Roche Diagnostics; Siemens Healthcare Diagnostics; Critical Diagnostics; BG Medicine; Biosite; Biosite/Inverness; Siemens(Siemens AG); Siemens Medical Diagnostics and Response Biomedical; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr deFilippi reported receiving honorarium, consulting, and grant support from Roche Diagnostics and Siemens Healthcare Diagnostics, and consulting and grant support from Critical Diagnostics and BG Medicine. Dr de Lemos reported receiving research support from Biosite and Roche Diagnostics, and consulting fees, lecture honoraria, or both from Roche Diagnostics, Biosite/Inverness, and Siemens. Dr Christenson reported receiving research funding from Siemens Medical Diagnostics and Response Biomedical. Dr Seliger reported receiving grant and consulting support from Roche Diagnostics. Drs Gottdiener, Kop, and Zahn reported no financial disclosures.; This study was supported by grants N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and U01 HL080295 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided through R01 AG-15928, R01 AG-20098, and AG-027058 from the National Institute on Aging; R01 HL-075366 from the NHLBI; and the University of Pittsburgh Claude D. Pepper Older Americans Independence Center P30-AG-024827. Additional funding was provided by Roche Diagnostics. Roche Diagnostics provided funding and laboratory reagents for the highly sensitive cardiac troponin T assay.	CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; deFilippi CR, 2010, J AM COLL CARDIOL, V55, P441, DOI 10.1016/j.jacc.2009.07.069; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hills, 1993, STAT MODELS EPIDEMIO; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kalogeropoulos A, 2010, CIRC-HEART FAIL, V3, P495, DOI 10.1161/CIRCHEARTFAILURE.109.904300; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Rautaharju PM, 1996, HYPERTENSION, V28, P8, DOI 10.1161/01.HYP.28.1.8; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sabatine MS, 2009, EUR HEART J, V30, P162, DOI 10.1093/eurheartj/ehn504; Schellenbaum GD, 2004, AM J EPIDEMIOL, V160, P628, DOI 10.1093/aje/kwh268; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Sundstrom J, 2009, EUR HEART J, V30, P773, DOI 10.1093/eurheartj/ehp047; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Vasile VC, 2010, CLIN CHEM, V56, P1086, DOI 10.1373/clinchem.2009.140616; Wu AHB, 2009, CLIN CHEM, V55, P52, DOI 10.1373/clinchem.2008.107391; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	34	538	555	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2494	2502		10.1001/jama.2010.1708	http://dx.doi.org/10.1001/jama.2010.1708			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21078811	Bronze, Green Accepted			2022-12-24	WOS:000285053300023
J	Geneau, R; Stuckler, D; Stachenko, S; Mckee, M; Ebrahim, S; Basu, S; Chockalingham, A; Mwatsama, M; Jamal, R; Alwan, A; Beaglehole, R				Geneau, Robert; Stuckler, David; Stachenko, Sylie; McKee, Martin; Ebrahim, Shah; Basu, Sanjay; Chockalingham, Arun; Mwatsama, Modi; Jamal, Rozmin; Alwan, Ala; Beaglehole, Robert			Chronic Diseases: Chronic Diseases and Development 1 Raising the priority of preventing chronic diseases: a political process	LANCET			English	Article							LOW-INCOME; DEVELOPING-COUNTRIES; HEALTH; TOBACCO; POLICY; TUBERCULOSIS; DETERMINANTS; GENERATION; STRATEGIES; MORTALITY	Chronic diseases especially cardiovascular diseases, diabetes cancer and chronic obstructive respiratory diseases, are neglected globally despite growing awareness of the serious burden that they cause Global and national policies have failed to stop, and in many cases have contributed to, the chronic disease pandemic Low cost and highly effective solutions for the prevention of chronic diseases are readily available the failure to respond is now a political rather than a technical issue We seek to understand this failure and to position chronic disease centrally on the global health and development agendas To identify strategies for generation of increased political priority for chronic diseases and to further the involvement of development agencies we use an adapted political process model This model has previously been used to assess the success and failure of social movements On the basis of this analysis we recommend three strategies reframe the debate to emphasise the societal determinants of disease and the inter relation between chronic disease, poverty, and development, mobilise resources through a cooperative and inclusive approach to development and by equitably distributing resources on the basis of avoidable mortality and build on emerging strategic and political opportunities such as the World Health Assembly 2008-13 Action Plan and the high level meeting of the UN General Assembly in 2011 on chronic disease Until the full set of threats which-include chronic disease-that trap poor households in cycles of debt and illness are addressed, progress towards equitable human development will remain inadequate	[Geneau, Robert] Univ Ottawa, Elizabeth Bruyere Res Inst, Ottawa, ON, Canada; [Stuckler, David] Univ Oxford, Dept Sociol, Oxford OX1 2JD, England; [Stachenko, Sylie] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2M7, Canada; [McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Ebrahim, Shah] S Asia Network Chron Dis, New Delhi, India; [Ebrahim, Shah] Publ Hlth Fdn India, New Delhi, India; [Basu, Sanjay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Basu, Sanjay] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA USA; [Chockalingham, Arun] NHLBI, Off Global Hlth, Bethesda, MD 20892 USA; [Jamal, Rozmin] Aga Khan Univ, Clin Res Unit, Karachi, Pakistan; [Alwan, Ala] WHO, CH-1211 Geneva, Switzerland; [Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand	University of Ottawa; University of Oxford; University of Alberta; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Aga Khan University; World Health Organization; University of Auckland	Geneau, R (corresponding author), Univ Ottawa, Elizabeth Bruyere Res Inst, 43 Bruyere, Ottawa, ON, Canada.		Stuckler, David/H-2261-2012; McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Geneau, Robert/0000-0001-6180-2515; McKee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abegunde DO, 2008, SOC SCI MED, V66, P2296, DOI 10.1016/j.socscimed.2008.01.041; Abubakari AR, 2009, PUBLIC HEALTH, V123, P602, DOI 10.1016/j.puhe.2009.07.009; *AG KHAN DEV NETW, 2009, SUMM MED BRIEF INT C; Alleyne G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-15; ALWAN A, 2010, LANCET, DOI DOI 10.1016/S0140.6736(10)61853.3; Alwan A, 2009, INT HEALTH, V1, P3, DOI 10.1016/j.inhe.2009.02.003; Anderson GF, 2009, HEALTH AFFAIR, V28, P202, DOI 10.1377/hlthaff.28.1.202; [Anonymous], 2003, BRIDGING RES POLICY; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2010, HLTH NUTR POPUL SER; [Anonymous], 2008, WORLD HLTH STAT 2008; [Anonymous], 2005, PREV CHRON DIS VIT I; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black N, 2001, BRIT MED J, V323, P275, DOI 10.1136/bmj.323.7307.275; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Costain AnneN., 1992, INVITING WOMENS REBE; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Diethelm PA, 2005, LANCET, V366, P86, DOI 10.1016/S0140-6736(05)66474-4; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Ebrahim Shahul, 2007, Prev Chronic Dis, V4, pA32; ELIADAROUS HE, 2010, EXP CLIN ENDOCRINOL, V118, P220; Emmelin A, 2007, CHEST, V132, P1615, DOI 10.1378/chest.07-1398; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Fuster V, 2005, LANCET, V366, P1512, DOI 10.1016/S0140-6736(05)67610-6; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gajalakshmi V, 2009, INT J EPIDEMIOL, V38, P1018, DOI 10.1093/ije/dyp225; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Hastings G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5650; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Institute of Medicine, 2010, PROM CARD HLTH DEV W; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jones H., 2009, EQUITY DEV WHY IT IS; KINGDON JW, 1995, AGENDAS ALTERNATIVE; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lomas Jonathan, 2005, Healthc Policy, V1, P55; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Marx Karl, 1971, GRUNDRISSE FDN CRITI; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mbatia J, 2009, INT J ENV RES PUB HE, V6, P1991, DOI 10.3390/ijerph6071991; McAdam D., 2010, READINGS SOCIAL MOVE; McAdam Doug., 1982, POLITICAL PROCESS DE; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; Mccoy D, 2009, LANCET, V373, P1645, DOI 10.1016/S0140-6736(09)60571-7; McDaniel PA, 2009, WOMEN HEALTH, V49, P441, DOI 10.1080/03630240903238800; McKee M, 2006, BRIT MED J, V333, P871, DOI 10.1136/bmj.39003.629606.BE; McMillen IC, 2008, BASIC CLIN PHARMACOL, V102, P82, DOI 10.1111/j.1742-7843.2007.00188.x; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; *NAT HEART LUNG BL, 2009, UN NHLBI CTR EXC; *NCD ALL, NCD ALL PUTT NONC DI; NUGENT R, 2009, CHRONIC DIS POSING G; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Ong EK, 2001, AM J PUBLIC HEALTH, V91, P1749, DOI 10.2105/AJPH.91.11.1749; *OXF ALL, 2006, CHRON DIS EC PERSP; Pisani E, 2008, WISDOM WHORES; Rabinoff M, 2007, AM J PUBLIC HEALTH, V97, P1981, DOI 10.2105/AJPH.2005.078014; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Ronsmans C, 2009, FOOD NUTR BULL, V30, pS547, DOI 10.1177/15648265090304S409; Sabatier PA, 2007, THEORIES POLICY PROC; SAMB B, 2010, LANCET, DOI DOI 10.1016/S0140.6736(10)61353.0; Schmidt H, 2008, LANCET, V372, P627, DOI 10.1016/S0140-6736(08)61269-6; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shiffman J, 2009, B WORLD HEALTH ORGAN, V87, P608, DOI 10.2471/BLT.08.060749; Stanciole A., 2006, ESTIMATION EC IMPACT; Stiglitz E., 2009, REPORT COMMISSION ME; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; *TRUST W, 2010, STAT PLAN 2010 2020; *UN, UN AG LAUDS ASS RES; Walt G, 2008, HEALTH POLICY PLANN, V23, P308, DOI 10.1093/heapol/czn024; Whitehead M, 2001, LANCET, V358, P165, DOI 10.1016/S0140-6736(01)05398-3; *WHO, NCDNET; *WHO, 2009, NONC DIS POV DEV AG; World Economic Forum-Global Risks Report, 2009, GLOB RISKS 2009 GLOB; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2004, TOB POV VIC CIRCL; World Health Organization (WHO), STEPWISE APPR SURV S	87	184	185	2	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2010	376	9753					1689	1698		10.1016/S0140-6736(10)61414-6	http://dx.doi.org/10.1016/S0140-6736(10)61414-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	683DD	21074260				2022-12-24	WOS:000284451000034
J	Kuhnert, F; Mancuso, MR; Shamloo, A; Wang, HT; Choksi, V; Florek, M; Su, H; Fruttiger, M; Young, WL; Heilshorn, SC; Kuo, CJ				Kuhnert, Frank; Mancuso, Michael R.; Shamloo, Amir; Wang, Hsiao-Ting; Choksi, Vir; Florek, Mareike; Su, Hua; Fruttiger, Marcus; Young, William L.; Heilshorn, Sarah C.; Kuo, Calvin J.			Essential Regulation of CNS Angiogenesis by the Orphan G Protein-Coupled Receptor GPR124	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; ALPHA-V INTEGRINS; INACTIVATION; ENDOTHELIUM; LETHALITY; GENE; MICE; NEUROGENESIS; HEMORRHAGE	The orphan G protein-coupled receptor (GPCR) GPR124/tumor endothelial marker 5 is highly expressed in central nervous system (CNS) endothelium. Here, we show that complete null or endothelial-specific GPR124 deletion resulted in embryonic lethality from CNS-specific angiogenesis arrest in forebrain and neural tube. Conversely, GPR124 overexpression throughout all adult vascular beds produced CNS-specific hyperproliferative vascular malformations. In vivo, GPR124 functioned cell-autonomously in endothelium to regulate sprouting, migration, and developmental expression of the blood-brain barrier marker Glut1, whereas in vitro, GPR124 mediated Cdc42-dependent directional migration to forebrain-derived, vascular endothelial growth factor-independent cues. Our results demonstrate CNS-specific angiogenesis regulation by an endothelial receptor and illuminate functions of the poorly understood adhesion GPCR subfamily. Further, the functional tropism of GPR124 marks this receptor as a therapeutic target for CNS-related vascular pathologies.	[Kuhnert, Frank; Mancuso, Michael R.; Wang, Hsiao-Ting; Kuo, Calvin J.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Shamloo, Amir] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Choksi, Vir] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Florek, Mareike] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Fruttiger, Marcus] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Young, William L.] Univ Calif San Francisco, Dept Neurol Surg, Ctr Cerebrovasc Res, Dept Anesthesia & Perioperat Care,Dept Neurol, San Francisco, CA 94110 USA; [Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of London; University College London; University of California System; University of California San Francisco; Stanford University	Kuo, CJ (corresponding author), Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA.	cjkuo@stanford.edu		, amir/0000-0002-0131-0567; Heilshorn, Sarah/0000-0002-9801-6304; Fruttiger, Marcus/0000-0002-6962-5485; Kuo, Calvin/0000-0002-7427-5985	American Heart Association (AHA) [AHA09PRE2110036, 10GRNT3130004]; National Institute of General Medical Science, NIH [GM07365]; NIH [R21 NS070153, R01NS27713, P01NS44155, 1DP2 OD006477, 1R21 NS058600, 1R01NS052830, 1R01NS064517, 1R01HL074267]; U.K. Medical Research Council [G0501711]; National Academies Keck Futures Initiative; Brain Tumor Society; Goldhirsh Foundation; Stanford Center for Children's Brain Tumors; NATIONAL CANCER INSTITUTE [R01CA095654, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064517, P01NS044155, R01NS027713, R21NS058600, R01NS052830, R21NS070153] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006477] Funding Source: NIH RePORTER; Medical Research Council [G0501711] Funding Source: researchfish; MRC [G0501711] Funding Source: UKRI	American Heart Association (AHA)(American Heart Association); National Institute of General Medical Science, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Academies Keck Futures Initiative; Brain Tumor Society; Goldhirsh Foundation; Stanford Center for Children's Brain Tumors; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are indebted to R. Daneman, B. Barres, C. Chartier, and the Kuo laboratory for comments; J. Yuan and J. Hampton for animal husbandry and genotyping; and A. Connolly and H. Vogel for neuropathology. F.K. was supported by an American Heart Association (AHA) Postdoctoral Fellowship and M.R.M. by AHA Predoctoral Fellowship AHA09PRE2110036 and the Stanford Medical Scientist Training Program Program (National Institute of General Medical Science, NIH, GM07365). This work was also supported by NIH R21 NS070153 and AHA 10GRNT3130004 (H.S.); NIH R01NS27713 (W.L.Y.); P01NS44155 (W.L.Y. and H.S.); U.K. Medical Research Council G0501711 (M.F.); NIH 1DP2 OD006477, 1R21 NS058600, and National Academies Keck Futures Initiative CS10 grants (S.C.H.); and NIH 1R01NS052830, 1R01NS064517, 1R01HL074267, Brain Tumor Society, Goldhirsh Foundation, and the Stanford Center for Children's Brain Tumors grants (C.J.K.). F.K., H.W., and C.J.K. have a patent pending regarding vascular applications of GPR124.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Ara T, 2005, BLOOD, V105, P3155, DOI 10.1182/blood-2004-07-2563; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fredriksson R, 2003, BIOCHEM BIOPH RES CO, V301, P725, DOI 10.1016/S0006-291X(03)00026-3; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; HERKEN R, 1989, J ANAT, V164, P85; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Mancuso Michael R., 2008, Lymphatic Research and Biology, V6, P173, DOI 10.1089/lrb.2008.1014; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; Pardridge William M, 2003, Methods Mol Med, V89, P385; Raab S, 2004, THROMB HAEMOSTASIS, V91, P595, DOI 10.1160/TH03-09-0582; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; St Croix B, 2000, SCIENCE, V289, P1197; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Vallon M, 2006, J BIOL CHEM, V281, P34179, DOI 10.1074/jbc.M605291200; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Zhu JW, 2002, DEVELOPMENT, V129, P2891	30	204	211	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					985	989		10.1126/science.1196554	http://dx.doi.org/10.1126/science.1196554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071672	Green Accepted			2022-12-24	WOS:000284118000049
J	Hughes, R				Hughes, Richard			Rational Testing Investigation of peripheral neuropathy	BRITISH MEDICAL JOURNAL			English	Editorial Material							SYMMETRIC POLYNEUROPATHY ROLE; PRACTICE PARAMETER EVALUATION; ELECTRODIAGNOSTIC MEDICINE; AMERICAN ASSOCIATION; PHYSICAL MEDICINE; NERVE BIOPSY; REHABILITATION; NEUROLOGY; ACADEMY				Hughes, R (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	rhughes11@btinternet.com						England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; Gabriel CM, 2000, J NEUROL NEUROSUR PS, V69, P442, DOI 10.1136/jnnp.69.4.442; Hughes RAC, 2004, BRAIN, V127, P1723, DOI 10.1093/brain/awh192; Hughes RAC, 2002, BRIT MED J, V324, P466, DOI 10.1136/bmj.324.7335.466; KELLY JJ, 1981, NEUROLOGY, V31, P1480, DOI 10.1212/WNL.31.11.1480; Rosenberg NR, 2001, J NEUROL NEUROSUR PS, V71, P205, DOI 10.1136/jnnp.71.2.205; Saperstein DS, 2003, ARCH NEUROL-CHICAGO, V60, P1296, DOI 10.1001/archneur.60.9.1296	8	11	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 5	2010	341								c6100	10.1136/bmj.c6100	http://dx.doi.org/10.1136/bmj.c6100			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	678DN	21056962				2022-12-24	WOS:000284052400006
J	Lamont, T; Cousins, D; Rosario, C				Lamont, Tara; Cousins, David; Rosario, Catherine			Safety Alerts Safer treatment doses for low molecular weight heparins: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK		[Lamont, Tara; Cousins, David; Rosario, Catherine] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						Baglin T, 2006, BRIT J HAEMATOL, V133, P19, DOI 10.1111/j.1365-2141.2005.05953.x; *BMJ GROUP, 2010, BRIT NAT FORM; *DEP HLTH EST FAC, 2010, EFA 2010 001 MED PAT; EDITH AN, 2009, ANN PHARMACOTHER, V43, P1064; Hendershot KM, 2006, J AM COLL SURGEONS, V203, P887, DOI 10.1016/j.jamcollsurg.2006.08.018; Hilmer SN, 2007, INTERN MED J, V37, P647, DOI 10.1111/j.1445-5994.2007.01457.x; LaPointe NMA, 2007, ARCH INTERN MED, V167, P1539, DOI 10.1001/archinte.167.14.1539; Lin BW, 2009, AM J EMERG MED, V27, P1060, DOI 10.1016/j.ajem.2008.08.018; MARCIL A, 2004, CAN J HOSP PHARM, P220; MCARTNEY R, 2009, IJPP S17, V17, pB38; National Institute for Health and Clinical Excellence, 2010, VEN THROMB RED RISK; *NHS PRESCR SERV, PRESCR DAT ENGL 2008	12	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 2	2010	341								c5884	10.1136/bmj.c5884	http://dx.doi.org/10.1136/bmj.c5884			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	678CU	21045026				2022-12-24	WOS:000284048200022
J	Sauka-Spengler, T; Bronner, M				Sauka-Spengler, Tatjana; Bronner, Marianne			SnapShot: Neural Crest	CELL			English	Editorial Material									[Sauka-Spengler, Tatjana; Bronner, Marianne] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Sauka-Spengler, T (corresponding author), CALTECH, Pasadena, CA 91125 USA.			Sauka-Spengler, Tatjana/0000-0001-9289-0263; Bronner, Marianne/0000-0003-4274-1862					0	20	20	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 29	2010	143	3					486	486	486.e1	10.1016/j.cell.2010.10.025	http://dx.doi.org/10.1016/j.cell.2010.10.025			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029868	Bronze			2022-12-24	WOS:000283603900021
J	Phillips, JS; Mason, MJ; Dixon, H				Phillips, John S.; Mason, Matthew J.; Dixon, Heather			Christmas 2010: Surgery Middle ear instrument nomenclature: a taxonomic approach	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Phillips, John S.] Univ British Columbia, Rotary Hearing Clin, Vancouver, BC V6Z 1Y6, Canada; [Mason, Matthew J.; Dixon, Heather] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of British Columbia; University of Cambridge	Phillips, JS (corresponding author), Univ British Columbia, Rotary Hearing Clin, Vancouver, BC V6Z 1Y6, Canada.	john.phillips@mac.com	Mason, Matthew James/AAX-9783-2021	Mason, Matthew James/0000-0001-7845-0720				Bill J.H., 1882, INT ENCY SURG SYSTEM, V2, P101; Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; Bryson Bill, 1990, MOTHER TONGUE ENGLIS; GOULEY JWS, 1877, MED REC, V12, P529; HELMUTH WT, 1875, DOCUMENTS ASSEMBLY S, V8, P195; JONES HM, 1881, TREATISE AURAL SURG; JONES HM, 1889, LANCET, V134, P159; JONES HM, 1889, LANCET, V134, P209; KEYES EL, 1875, MED REC, V10, P163; KINLOCH RA, 1877, AM J MED SCI, V74, P125; Knight Edward Henry, 1884, KNIGHTS NEW MECH DIC; PEMBERTON O, 1884, LANCET, V123, P927; RYERSON T, 1876, T MED SOC NEW JERSEY, P302; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; STEARN WT, 1959, SYST ZOOL, V8, P4, DOI 10.2307/2411603; Wilkinson DM, 2001, NATURE, V412, P485, DOI 10.1038/35087676	16	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2010	341								c5137	10.1136/bmj.c5137	http://dx.doi.org/10.1136/bmj.c5137			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XA	21149463				2022-12-24	WOS:000285551900009
J	Hatch, AJ; York, JD				Hatch, Ace J.; York, John D.			SnapShot: Inositol Phosphates	CELL			English	Editorial Material									[Hatch, Ace J.; York, John D.] Duke Univ, HHMI, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Hatch, AJ (corresponding author), Duke Univ, HHMI, Durham, NC 27710 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL055672] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Michell RH, 2009, CELL CALCIUM, V45, P521, DOI 10.1016/j.ceca.2009.03.007; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Sauer K, 2010, NAT REV IMMUNOL, V10, P257, DOI 10.1038/nri2745; Shears SB, 2009, ADV ENZYME REGUL, V49, P87, DOI 10.1016/j.advenzreg.2008.12.008	10	61	67	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					1030	U183	1030.e1	10.1016/j.cell.2010.11.045	http://dx.doi.org/10.1016/j.cell.2010.11.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145466	Bronze, Green Accepted			2022-12-24	WOS:000285182600018
J	Teschke, R; Schulze, J				Teschke, Rolf; Schulze, Johannes			Risk of Kava Hepatotoxicity and the FDA Consumer Advisory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Teschke, Rolf] Goethe Univ Frankfurt, Teaching Hosp, Dept Internal Med 2, Div Gastroenterol & Hepatol,Klinikum Hanau, D-63450 Hanau, Germany; [Schulze, Johannes] Goethe Univ Frankfurt, Fac Med, Off Dean, D-63450 Hanau, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Teschke, R (corresponding author), Goethe Univ Frankfurt, Teaching Hosp, Dept Internal Med 2, Div Gastroenterol & Hepatol,Klinikum Hanau, Leimenstr 20, D-63450 Hanau, Germany.	rolf.teschke@gmx.de						*AUSTR GOV DEP HLT, 2005, KAV FACT SHEET; Lasme P, 2008, J AGR FOOD CHEM, V56, P4976, DOI 10.1021/jf800439g; Sarris J, 2009, PSYCHOPHARMACOLOGY, V205, P399, DOI 10.1007/s00213-009-1549-9; Schmidt M., 2007, HERBALGRAM, V73, P45; Teschke R, 2010, LIVER INT, V30, P1270, DOI 10.1111/j.1478-3231.2010.02308.x; Teschke R, 2010, ANN HEPATOL, V9, P251, DOI 10.1016/S1665-2681(19)31634-5; U.S. Food and Drug Administration, CONS ADV KAV CONT DI; *WHO, 2007, ASS RISK HEP KAV PRO; Zhou P, 2010, FASEB J, V24, P4722, DOI 10.1096/fj.10-163311	9	32	33	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2174	2175		10.1001/jama.2010.1689	http://dx.doi.org/10.1001/jama.2010.1689			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21081732				2022-12-24	WOS:000284269800030
J	Karl, T; Harley, P; Emmons, L; Thornton, B; Guenther, A; Basu, C; Turnipseed, A; Jardine, K				Karl, T.; Harley, P.; Emmons, L.; Thornton, B.; Guenther, A.; Basu, C.; Turnipseed, A.; Jardine, K.			Efficient Atmospheric Cleansing of Oxidized Organic Trace Gases by Vegetation	SCIENCE			English	Article							DRY DEPOSITION; AEROSOLS; MODEL	The biosphere is the major source and sink of nonmethane volatile organic compounds (VOCs) in the atmosphere. Gas-phase chemical reactions initiate the removal of these compounds from the atmosphere, which ultimately proceeds via deposition at the surface or direct oxidation to carbon monoxide or carbon dioxide. We performed ecosystem-scale flux measurements that show that the removal of oxygenated VOC via dry deposition is substantially larger than is currently assumed for deciduous ecosystems. Laboratory experiments indicate efficient enzymatic conversion and potential up-regulation of various stress-related genes, leading to enhanced uptake rates as a response to ozone and methyl vinyl ketone exposure or mechanical wounding. A revised scheme for the uptake of oxygenated VOCs, incorporated into a global chemistry-transport model, predicts appreciable regional changes in annual dry deposition fluxes.	[Karl, T.; Harley, P.; Emmons, L.; Guenther, A.; Turnipseed, A.] Natl Ctr Atmospher Res, Boulder, CO 80301 USA; [Thornton, B.; Basu, C.] Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Jardine, K.] Univ Arizona, Tucson, AZ 85738 USA	National Center Atmospheric Research (NCAR) - USA; University of Northern Colorado; University of Arizona	Karl, T (corresponding author), Natl Ctr Atmospher Res, Boulder, CO 80301 USA.	tomkarl@ucar.edu	Jardine, Kolby J./N-2802-2013; Karl, Thomas/D-1891-2009; Emmons, Louisa K/R-8922-2016; Guenther, Alex B/B-1617-2008; Harley, Peter/E-1856-2014	Jardine, Kolby J./0000-0001-8491-9310; Karl, Thomas/0000-0003-2869-9426; Emmons, Louisa K/0000-0003-2325-6212; Guenther, Alex B/0000-0001-6283-8288; Harley, Peter/0000-0002-2647-1973; Basu, Chhandak/0000-0003-0520-0100	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	The National Center for Atmospheric Research is operated by the University Corporation for Atmospheric Research under sponsorship from the National Science Foundation.	Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; COLLINS W, 2004, CLIMATIC CHANGE, V52, P453; Emmons LK, 2010, GEOSCI MODEL DEV, V3, P43, DOI 10.5194/gmd-3-43-2010; Fall R, 2003, CHEM REV, V103, P4941, DOI 10.1021/cr0206521; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Paulot F, 2009, SCIENCE, V325, P730, DOI 10.1126/science.1172910; Paulson C.A., 1970, J APPL METEOROL, V9, P857, DOI [10.1175/1520-0450(1970)0092.0.co;2, DOI 10.1175/1520-0450(1970)009<0857:TMROWS>2.0.CO;2, 10.1175/1520-0450(1970)009, DOI 10.1175/1520-0450(1970)009]; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; WESELY ML, 1989, ATMOS ENVIRON, V23, P1293, DOI 10.1016/0004-6981(89)90153-4; Zhang LM, 2002, ATMOS ENVIRON, V36, P537, DOI 10.1016/S1352-2310(01)00447-2	15	157	159	4	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					816	819		10.1126/science.1192534	http://dx.doi.org/10.1126/science.1192534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20966216	Green Submitted			2022-12-24	WOS:000283855700041
J	Ouslander, JG				Ouslander, Joseph G.			A Murmur of Music	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												joseph.ouslander@fau.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2010	304	17					1875	1875		10.1001/jama.2010.1141	http://dx.doi.org/10.1001/jama.2010.1141			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674GT	21045087				2022-12-24	WOS:000283725900001
J	Lenzer, J; Brownlee, S				Lenzer, Jeanne; Brownlee, Shannon			Post-marketing Surveillance Why the FDA can't protect the public	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EPILEPSY; SUDDEN		[Brownlee, Shannon] Dartmouth Inst Hlth Policy & Clin Practice, Washington, DC USA			jeanne.lenzer@gmail.com						Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x; BUNKER M, 2010, COMMUNICATION   0503; DASHEIFF RM, 1991, J CLIN NEUROPHYSIOL, V8, P216, DOI 10.1097/00004691-199104000-00010; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; DRAZEN JM, 2007, FORUM DRUG DISCOVERY; *FDA, 2010, MAN US FAC DEV EXP; *FDA CTR DEV RAD H, 1997, 10 M FDAS CTR DEV RA; Levinson Daniel, 2009, ADVERSE EVENT REPORT; MAISEL WH, 2008, COMMUNICATION   0514; MALISOW C, 2005, EXPOSED NERVE; Nikolas H, 2007, EPILEPSY BEHAV, V10, P363, DOI 10.1016/j.yebeh.2007.01.005; STINE N, 2005, COMMUNICATION   0511; *US FDA, 1997, PREM APPR VAG NERV S; US Food Drug Adm, 1999, MAN RISKS MED PROD U	14	19	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2010	341								c4753	10.1136/bmj.c4753	http://dx.doi.org/10.1136/bmj.c4753			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	678CU	21045048				2022-12-24	WOS:000284048200030
J	Minassian, C; D'Aiuto, F; Hingorani, AD; Smeeth, L				Minassian, Caroline; D'Aiuto, Francesco; Hingorani, Aroon D.; Smeeth, Liam			Invasive Dental Treatment and Risk for Vascular Events A Self-Controlled Case Series	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; PERIODONTAL THERAPY; ACUTE INFECTION; ATHEROSCLEROSIS; INFLAMMATION; ASSOCIATIONS; MARKERS; UPDATE	Background: Treatment of periodontal disease may reduce cardiovascular risk in the longer term, but studies have suggested a link among dental procedures, acute inflammation, and endothelial dysfunction. However, whether such acute inflammatory effects translate into a short-lived increased risk for vascular events is not known. Objective: To investigate whether invasive dental treatment transiently increases the risk for vascular events. Design: Self-controlled case series. Setting: Data came from the U.S. Medicaid claims database. Patients: All persons exposed to invasive dental treatment with a primary hospital discharge diagnosis of ischemic stroke (n = 650) or myocardial infarction (n = 525) from 2002 to 2006. Measurements: The incidence of ischemic stroke and myocardial infarction in periods immediately after invasive dental treatment was compared with the incidence in all other observed time periods. Incidence ratios and 95% CIs were calculated. Results: The rate of vascular events significantly increased in the first 4 weeks after invasive dental treatment (incidence ratio, 1.50 [95% CI, 1.09 to 2.06]) and gradually returned to the baseline rate within 6 months. The positive association remained after exclusion of persons with diabetes, hypertension, or coronary artery disease or persons with prescriptions for antiplatelet or salicylate drugs before treatment. Limitations: Power to examine the effects of invasive dental treatment on stroke and myocardial infarction separately was limited because of the low frequency of invasive dental procedures. Lack of information about use of over-the-counter drugs limited the ability to assess confounding by possible withholding of antiplatelet or salicylate drugs before invasive dental treatment or by the use of nonsteroidal anti-inflammatory drugs after treatment. Conclusion: Invasive dental treatment may be associated with a transient increase in the risk for vascular events. However, the absolute risks are minimal, and the long-term benefits on vascular health will probably outweigh the short-lived adverse effects.	[Smeeth, Liam] UCL, London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Eastman Dent Inst, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University College London	Smeeth, L (corresponding author), UCL, London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Eastman Dent Inst, Keppel St, London WC1E 7HT, England.	liam.smeeth@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Hingorani, Aroon/0000-0001-8365-0081; Minassian, Caroline/0000-0001-9406-1928; Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Primary Funding Source: Wellcome Trust.	*AM DENT ASS, 2007, CURR DENT TERM 2007; D'Aiuto F, 2005, INFLAMM RES, V54, P412, DOI 10.1007/s00011-005-1375-4; D'Aiuto F, 2007, J CLIN PERIODONTOL, V34, P124, DOI 10.1111/j.1600-051X.2006.01037.x; D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Douglas IJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000154; El-Sharrawy Eman A, 2006, Anesth Prog, V53, P78, DOI 10.2344/0003-3006(2006)53[78:AOCPIA]2.0.CO;2; Farrington CP, 2010, J R STAT SOC C-APPL, V59, P457; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FARRINGTON CP, 2006, J ROYAL STAT SOC C, V55, P1; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Gibson JE, 2009, AM J EPIDEMIOL, V169, P761, DOI 10.1093/aje/kwn364; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Higashi Y, 2009, ATHEROSCLEROSIS, V206, P604, DOI 10.1016/j.atherosclerosis.2009.03.037; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Hocine M, 2005, STAT MED, V24, P4035, DOI 10.1002/sim.2413; Hubbard R, 2003, AM J EPIDEMIOL, V158, P77, DOI 10.1093/aje/kwg114; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; MAMODE N, 1995, BMJ-BRIT MED J, V310, P1215, DOI 10.1136/bmj.310.6989.1215; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Olsen I, 2008, TRANSFUS APHER SCI, V39, P173, DOI 10.1016/j.transci.2008.06.008; Persson GR, 2008, J CLIN PERIODONTOL, V35, P362, DOI 10.1111/j.1600-051X.2008.01281.x; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Slade GD, 2003, ARCH INTERN MED, V163, P1172, DOI 10.1001/archinte.163.10.1172; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P1; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342	36	63	67	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					499	506		10.7326/0003-4819-153-8-201010190-00006	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956706				2022-12-24	WOS:000283054600002
J	Lamont, T; Cousins, D; Hillson, R; Bischler, A; Terblanche, M				Lamont, Tara; Cousins, David; Hillson, Rowan; Bischler, Anna; Terblanche, Martinette			Safety Alerts Safer administration of insulin: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Cousins, David; Bischler, Anna; Terblanche, Martinette] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Hillson, Rowan] Hillingdon Hosp, London UB8 3NN, England	Brunel University; Imperial College London	Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						Belknap S., 2001, INT J QUAL HEALTH C, V13, P339; Cox AR., 2009, BR J DIABETES VASC D, V9, P84, DOI 10.1177/1474651409103902; Derr RL, 2007, DIABETES SPECTR, V20, P177, DOI DOI 10.2337/diaspect.20.3.177; Fowler D., 2010, SAFE EFFECTIVE USE I; *NHS DIAB, 2010, FIND 2009 NAT DIAB I; PAGE MD, 1992, DIABETIC MED, V9, P938, DOI 10.1111/j.1464-5491.1992.tb01735.x; Rushmer R, 2008, DIABETIC MED, V25, P960, DOI 10.1111/j.1464-5491.2008.02470.x; United States Pharmacopeia, 2010, MEDMARX 5 ANN DAT RE	8	27	27	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 13	2010	341								c5269	10.1136/bmj.c5269	http://dx.doi.org/10.1136/bmj.c5269			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	668FB	20943723				2022-12-24	WOS:000283252900017
J	Wang, YJ; Deng, XX; Mancarella, S; Hendron, E; Eguchi, S; Soboloff, J; Tang, XAD; Gill, DL				Wang, Youjun; Deng, Xiaoxiang; Mancarella, Salvatore; Hendron, Eunan; Eguchi, Satoru; Soboloff, Jonathan; Tang, Xiang D.; Gill, Donald L.			The Calcium Store Sensor, STIM1, Reciprocally Controls Orai and Ca(V)1.2 Channels	SCIENCE			English	Article							TRPC CHANNELS; CA2+ ENTRY; I-CRAC; ACTIVATION; DOMAINS; CELLS	Calcium signals, pivotal in controlling cell function, can be generated by calcium entry channels activated by plasma membrane depolarization or depletion of internal calcium stores. We reveal a regulatory link between these two channel subtypes mediated by the ubiquitous calcium-sensing STIM proteins. STIM1 activation by store depletion or mutational modification strongly suppresses voltage-operated calcium (Ca(V)1.2) channels while activating store-operated Orai channels. Both actions are mediated by the short STIM-Orai activating region (SOAR) of STIM1. STIM1 interacts with Ca(V)1.2 channels and localizes within discrete endoplasmic reticulum/plasma membrane junctions containing both Ca(V)1.2 and Orai1 channels. Hence, STIM1 interacts with and reciprocally controls two major calcium channels hitherto thought to operate independently. Such coordinated control of the widely expressed Ca(V)1.2 and Orai channels has major implications for Ca2+ signal generation in excitable and nonexcitable cells.	[Wang, Youjun; Deng, Xiaoxiang; Mancarella, Salvatore; Hendron, Eunan; Soboloff, Jonathan; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Wang, Youjun; Deng, Xiaoxiang; Mancarella, Salvatore; Hendron, Eunan; Soboloff, Jonathan; Gill, Donald L.] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Eguchi, Satoru] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Tang, Xiang D.] Nankai Univ, Sch Med, Dept Pharmacol, Tianjin 300071, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Nankai University	Gill, DL (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3400 N Broad St, Philadelphia, PA 19140 USA.	dgill@temple.edu	Soboloff, Jonathan/I-6995-2012; Wang, Youjun/H-4016-2013	Soboloff, Jonathan/0000-0001-5192-1297; Wang, Youjun/0000-0003-0961-1716; Deng, Xiaoxiang/0000-0002-7051-9057	NIH [HL55426, AI058173]; Novartis Institutes for Biomedical Research; American Heart Association; NSFC [30871011]; Tianjin S&T Support Project [08ZCKFSH04500]; "973" program [2010CB945001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for Biomedical Research; American Heart Association(American Heart Association); NSFC(National Natural Science Foundation of China (NSFC)); Tianjin S&T Support Project; "973" program(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Rabbit smooth muscle alpha<INF>1C</INF>, beta<INF>2a</INF>, and alpha<INF>2</INF>-delta<INF>1</INF> DNA were gifts from M. Davis, University of Missouri School of Medicine. This work was supported by NIH grants HL55426 and AI058173 (D. L. G.), a Novartis Institutes for Biomedical Research fellowship (Y.W.), the American Heart Association (J.S.), NSFC 30871011, Tianjin S&T Support Project 08ZCKFSH04500, and "973" program 2010CB945001 (X.P.T.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Matza D, 2009, IMMUNOL REV, V231, P257, DOI 10.1111/j.1600-065X.2009.00805.x; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Suzuki Y, 2010, MOL IMMUNOL, V47, P640, DOI 10.1016/j.molimm.2009.10.013; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	27	263	264	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					105	109		10.1126/science.1191086	http://dx.doi.org/10.1126/science.1191086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929813	Green Accepted			2022-12-24	WOS:000282334500046
J	Volpp, KG; Friedman, W; Romano, PS; Rosen, A; Silber, JH				Volpp, Kevin G.; Friedman, William; Romano, Patrick S.; Rosen, Amy; Silber, Jeffrey H.			Residency Training at a Crossroads: Duty-Hour Standards 2010	ANNALS OF INTERNAL MEDICINE			English	Article							MORTALITY; RISK; SLEEP; TIME	In 2003, the Accreditation Council for Graduate Medical Education (ACGME) implemented a single duty-hour standard nationwide. The evidence to date suggests that this neither improved nor worsened patient outcomes. In June 2010, the ACGME proposed a new set of duty-hour standards for implementation in July 2011. The main disadvantage of this approach is that there is no ability to determine whether different standards would have worked better to reduce resident fatigue while improving patient safety. Many unanswered questions remain about how to design duty-hour standards, but relatively little evidence exists. In addition, the same approach may not work in all specialties and all hospitals. A more flexible, dynamic policy that emphasizes ongoing testing and evaluation would be more likely to achieve improvements in clinical and educational outcomes.	[Silber, Jeffrey H.] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Hlth Incent, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; Univ Florida, Gainesville, FL 32610 USA; Univ Calif Davis, Sch Med, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA; Vet Affairs Boston Healthcare Syst, Ctr Org Leadership & Management Res, Boston, MA USA; Boston Univ, Sch Publ Hlth, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; State University System of Florida; University of Florida; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	Silber, JH (corresponding author), Childrens Hosp Philadelphia, Ctr Outcomes Res, 3535 Market St,Suite 1029, Philadelphia, PA 19104 USA.	silber@email.chop.edu	Romano, Patrick S/N-4225-2014; Friedman, William/GLR-1220-2022	Romano, Patrick S/0000-0001-6749-3979; Volpp, Kevin/0000-0003-1423-4599	National Heart, Lung, and Blood Institute [R01 HL082637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082637] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By grant R01 HL082637 from the National Heart, Lung, and Blood Institute.	Antiel RM, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1008305; Arora VM, 2008, QUAL SAF HEALTH CARE, V17, P11, DOI 10.1136/qshc.2006.018952; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Arora VM, 2009, J HOSP MED, V4, P433, DOI 10.1002/jhm.573; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x; Kirch DG, 2010, COMMUNICATION   0809; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Nasca P., 2010, BASICS ZYNADDSUBFX; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Pollack R, 2010, COMMUNICATION   0806; Richardson GS, 1996, SLEEP, V19, P718; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Silber JH, 2009, MED CARE, V47, P1191, DOI 10.1097/MLR.0b013e3181adcbff; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P1197, DOI 10.1001/jama.300.10.1197; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z	22	15	15	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					826	+		10.7326/0003-4819-153-12-201012210-00287	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00287			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	20956679	Green Accepted			2022-12-24	WOS:000285453700006
J	Katz, KA				Katz, Kenneth A.			Health Hazards of "Don't Ask, Don't Tell"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Katz, Kenneth A.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Katz, Kenneth A.] Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego	Katz, KA (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.							Gates GJ., 2010, LESBIAN GAY BISEXUAL; Nagel Frederick, 2010, Virtual Mentor, V12, P663, DOI 10.1001/virtualmentor.2010.12.8.pfor1-1008; *OFF SECR DEF, SUMM CHANG REV DONT; OREILLY KB, 2009, AM MED NEWS     1123; Smith DM, 2008, J HOMOSEXUAL, V54, P277, DOI 10.1080/00918360801982173	5	15	15	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2380	2381		10.1056/NEJMp1012496	http://dx.doi.org/10.1056/NEJMp1012496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZK	21121826				2022-12-24	WOS:000285340200002
J	Wenk, MR				Wenk, Markus R.			Lipidomics: New Tools and Applications	CELL			English	Article							RAMAN SCATTERING MICROSCOPY; MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; CRYSTAL-STRUCTURE; LIPIDS; PHOSPHOLIPIDS; IDENTIFICATION; MEDIATORS; CHEMISTRY; CELLS	Once viewed simply as a reservoir for carbon storage, lipids are no longer cast as bystanders in the drama of biological systems. The emerging field of lipidomics is driven by technology, most notably mass spectrometry, but also by complementary approaches for the detection and characterization of lipids and their biosynthetic enzymes in living cells. The development of these integrated tools promises to greatly advance our understanding of the diverse biological roles of lipids.	[Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117456, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Ctr Life Sci CeLS, Singapore 117456, Singapore; [Wenk, Markus R.] Univ Basel, CH-4003 Basel, Switzerland	National University of Singapore; National University of Singapore; University of Basel	Wenk, MR (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, 28 Med Dr, Singapore 117456, Singapore.	markus_wenk@nuhs.edu.sg	Wenk, Markus Rene/D-1441-2014					Alving CR, 2006, J LIPOSOME RES, V16, P157, DOI 10.1080/08982100600848553; Andreyev AY, 2010, MOL CELL PROTEOMICS, V9, P388, DOI 10.1074/mcp.M900432-MCP200; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Baker CJO, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S5; Becker JS, 2009, CHEM SOC REV, V38, P1969, DOI 10.1039/b618635c; Berry KAZ, 2010, EUR J MASS SPECTROM, V16, P463, DOI 10.1255/ejms.1083; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Deigner HP, 2008, CURR OPIN LIPIDOL, V19, P289, DOI 10.1097/MOL.0b013e3282fe1d0e; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ernst AM, 2010, FEBS LETT, V584, P1713, DOI 10.1016/j.febslet.2009.12.060; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2007, METHOD ENZYMOL, V432, P247, DOI 10.1016/S0076-6879(07)32011-9; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Gubbens J, 2010, MOL BIOSYST, V6, P1751, DOI 10.1039/c003064n; Hakomori S, 1997, CHEM BIOL, V4, P97, DOI 10.1016/S1074-5521(97)90253-2; Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; KIM HY, 1994, ANAL CHEM, V66, P3977, DOI 10.1021/ac00094a020; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Marshall AG, 2008, P NATL ACAD SCI USA, V105, P18090, DOI 10.1073/pnas.0805069105; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Martin DDO, 2008, FASEB J, V22, P797, DOI 10.1096/fj.07-9198com; Milne SB, 2010, NAT CHEM BIOL, V6, P205, DOI 10.1038/NCHEMBIO.311; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Miskovic L, 2010, TRENDS BIOTECHNOL, V28, P391, DOI 10.1016/j.tibtech.2010.05.003; Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Postle AD, 2009, J CHROMATOGR B, V877, P2716, DOI 10.1016/j.jchromb.2009.03.046; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ridenour WB, 2010, ANAL CHEM, V82, P1881, DOI 10.1021/ac9026115; Rinaldi S, 2010, PROG LIPID RES, V49, P87, DOI 10.1016/j.plipres.2009.09.001; Serhan CN, 2009, J THROMB HAEMOST, V7, P44, DOI 10.1111/j.1538-7836.2009.03396.x; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; SWARTZ GM, 1988, P NATL ACAD SCI USA, V85, P1902, DOI 10.1073/pnas.85.6.1902; SYED SA, 1992, LANCET, V339, P496, DOI 10.1016/0140-6736(92)91106-I; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Thomas MC, 2009, METHODS MOL BIOL, V579, P413, DOI 10.1007/978-1-60761-322-0_21; Tully SE, 2010, J AM CHEM SOC, V132, P3264, DOI 10.1021/ja1000505; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Volkmer A, 2005, J PHYS D APPL PHYS, V38, pR59, DOI 10.1088/0022-3727/38/5/R01; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wheelock CE, 2009, METHODS MOL BIOL, V580, P339, DOI 10.1007/978-1-60761-325-1_19; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yang K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001368; Yang PY, 2010, J AM CHEM SOC, V132, P656, DOI 10.1021/ja907716f; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]	65	412	419	3	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					888	895		10.1016/j.cell.2010.11.033	http://dx.doi.org/10.1016/j.cell.2010.11.033			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145456	Green Accepted, Bronze			2022-12-24	WOS:000285182600007
J	Tozan, Y; Klein, EY; Darley, S; Panicker, R; Laxminarayan, R; Breman, JG				Tozan, Yesim; Klein, Eili Y.; Darley, Sarah; Panicker, Rajashree; Laxminarayan, Ramanan; Breman, Joel G.			Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis	LANCET			English	Article							FALCIPARUM-MALARIA; CHILDREN; PRIORITIES; TANZANIA; HEALTH	Background Severely ill patients with malaria with vomiting, prostration, and altered consciousness cannot be treated orally and need injections. In rural areas, access to health facilities that provide parenteral antimalarial treatment is poor. Safe and effective treatment of most severe malaria cases is delayed or not achieved. Rectal artesunate interrupts disease progression by rapidly reducing parasite density, but should be followed by further antimalarial treatment. We estimated the cost-effectiveness of community-based prereferral artesunate treatment of children suspected to have severe malaria in areas with poor access to formal health care. Methods We assessed the cost-effectiveness (in international dollars) of the intervention from the provider perspective. We studied a cohort of 1000 newborn babies until 5 years of age. The analysis assessed how the cost-effectiveness results changed with low (25%), moderate (50%), high (75%), and full (100%) referral compliance and intervention uptake. Findings At low intervention uptake and referral compliance (25%), the intervention was estimated to avert 19 disability-adjusted life-years (DALYs; 95% CI 16-21) and to cost I$1173 (95% CI 1050-1297) per DALY averted. Under the full uptake and compliance scenario (100%), the intervention could avert 967 DALYs (884-1050) at a cost of I$77 (73-81) per DALY averted. Interpretation Prereferral artesunate treatment is a cost-effective, life-saving intervention, which can substantially improve the management of severe childhood malaria in rural African settings in which programmes for community health workers are in place.	[Tozan, Yesim] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA 02118 USA; [Klein, Eili Y.; Darley, Sarah; Panicker, Rajashree; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Klein, Eili Y.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Tozan, Yesim; Breman, Joel G.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Boston University; Princeton University; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Tozan, Y (corresponding author), Boston Univ, Sch Publ Hlth, Dept Int Hlth, 801 Massachusetts Ave, Boston, MA 02118 USA.	tozan@bu.edu	Klein, Eili/C-3745-2012; Laxminarayan, Ramanan/ABD-5050-2021	Klein, Eili/0000-0002-1304-5289	Disease Control Priorities Project; Fogarty International Center; US National Institutes of Health; Boston University	Disease Control Priorities Project; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University	Funding The Disease Control Priorities Project; Fogarty International Center; US National Institutes of Health; and the Peter Paul Career Development Professorship, Boston University.	[Anonymous], 11 NIH FOG INT CTR; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], 2010, GUID TREATM MAL; [Anonymous], COST EFF RESOUR ALLO, DOI DOI 10.1186/1478-7547-7-3; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Font Fidel, 2002, BMC Int Health Hum Rights, V2, P4, DOI 10.1186/1472-698X-2-4; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Goodman C, 2000, EC ANAL MALARIA CONT; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Idro R, 2006, ANN TROP MED PARASIT, V100, P95, DOI 10.1179/136485906X91459; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Montanari RM, 2001, B WORLD HEALTH ORGAN, V79, P648; Najera JA, 1996, WHOCTDMAL9610; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Onwujekwe O, 2007, ACTA TROP, V101, P95, DOI 10.1016/j.actatropica.2006.07.013; Roca-Feltrer A, 2008, TROP MED INT HEALTH, V13, P771, DOI 10.1111/j.1365-3156.2008.02076.x; Roll Back Malaria, 2007, ROLL BACK MAL; Simba DO, 2009, TROP MED INT HEALTH, V14, P775, DOI 10.1111/j.1365-3156.2009.02299.x; TEKLEHAIMANOT A, 2005, COMING GRIPS MALARIA; U.S. Department of State Bureau of Democracy, 2010, 2009 HUM RIGHTS REP; Warsame M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000149; *WHO, 2009, WORLD MAL REP; World Bank, 1993, WORLD DEV REP INV HL; World Health Organization (WHO), 2005, METH ASS US EST COST	30	25	26	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2010	376	9756					1910	1915		10.1016/S0140-6736(10)61460-2	http://dx.doi.org/10.1016/S0140-6736(10)61460-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KH	21122910				2022-12-24	WOS:000285439800032
J	Giorgi, C; Ito, K; Lin, HK; Santangelo, C; Wieckowski, MR; Lebiedzinska, M; Bononi, A; Bonora, M; Duszynski, J; Bernardi, R; Rizzuto, R; Tacchetti, C; Pinton, P; Pandolfi, PP				Giorgi, Carlotta; Ito, Keisuke; Lin, Hui-Kuan; Santangelo, Clara; Wieckowski, Mariusz R.; Lebiedzinska, Magdalena; Bononi, Angela; Bonora, Massimo; Duszynski, Jerzy; Bernardi, Rosa; Rizzuto, Rosario; Tacchetti, Carlo; Pinton, Paolo; Pandolfi, Pier Paolo			PML Regulates Apoptosis at Endoplasmic Reticulum by Modulating Calcium Release	SCIENCE			English	Article							CA2+ RELEASE; MITOCHONDRIA; BCL-2; CELLS	The promyelocytic leukemia (PML) tumor suppressor is a pleiotropic modulator of apoptosis. However, the molecular basis for such a diverse proapoptotic role is currently unknown. We show that extranuclear Pml was specifically enriched at the endoplasmic reticulum (ER) and at the mitochondria-associated membranes, signaling domains involved in ER-to-mitochondria calcium ion (Ca2+) transport and in induction of apoptosis. We found Pml in complexes of large molecular size with the inositol 1,4,5-trisphosphate receptor (IP3R), protein kinase Akt, and protein phosphatase 2a (PP2a). Pml was essential for Akt- and PP2a-dependent modulation of IP3R phosphorylation and in turn for IP3R-mediated Ca2+ release from ER. Our findings provide a mechanistic explanation for the pleiotropic role of Pml in apoptosis and identify a pharmacological target for the modulation of Ca2+ signals.	[Giorgi, Carlotta; Bononi, Angela; Bonora, Massimo; Pinton, Paolo] Univ Ferrara, Emilia Romagna Lab BioPharmaNet, Dept Expt & Diagnost Med, Sect Gen Pathol,ICSI, I-44100 Ferrara, Italy; [Giorgi, Carlotta; Bononi, Angela; Bonora, Massimo; Pinton, Paolo] Univ Ferrara, Lab Technol Adv Therapies, I-44100 Ferrara, Italy; [Giorgi, Carlotta] Univ Vita Salute San Raffaele, Ctr Excellence Cell Dev, Milan, Italy; [Giorgi, Carlotta] IIT Network, Res Unit Mol Neurosci, Milan, Italy; [Giorgi, Carlotta; Ito, Keisuke; Bernardi, Rosa; Pinton, Paolo; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Giorgi, Carlotta; Ito, Keisuke; Bernardi, Rosa; Pinton, Paolo; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Pathol, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Giorgi, Carlotta; Ito, Keisuke; Lin, Hui-Kuan; Bernardi, Rosa; Pinton, Paolo; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Dept Pathol, Canc Biol & Genet Program, New York, NY 10065 USA; [Santangelo, Clara; Tacchetti, Carlo] Univ Genoa, Ctr Cell Oncol, IFOM FIRC Inst Mol Oncol Fdn, Genoa, Italy; [Santangelo, Clara; Tacchetti, Carlo] Univ Genoa, Dept Expt Med, Ultrastruct MicroSCoBiO Res Ctr, Genoa, Italy; [Wieckowski, Mariusz R.; Lebiedzinska, Magdalena; Duszynski, Jerzy] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Bernardi, Rosa] San Raffaele Res Inst, Dept Mol Oncol, Milan, Italy; [Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, Padua, Italy; [Tacchetti, Carlo] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy	University of Ferrara; University of Ferrara; Vita-Salute San Raffaele University; Istituto Italiano di Tecnologia - IIT; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; IFOM - FIRC Institute of Molecular Oncology; University of Genoa; University of Genoa; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Padua; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pinton, P (corresponding author), Univ Ferrara, Emilia Romagna Lab BioPharmaNet, Dept Expt & Diagnost Med, Sect Gen Pathol,ICSI, I-44100 Ferrara, Italy.	pnp@unife.it; ppandolf@bidmc.harvard.edu	Lebiedzińska-Arciszewska, Magdalena/AAC-5956-2021; Lebiedzińska-Arciszewska, Magdalena/AAA-3279-2022; Pinton, Paolo/J-8025-2012; Giorgi, Carlotta/K-4649-2016; bernardi, rosa/B-1650-2013; Bonora, Massimo/AAC-3609-2022	Lebiedzińska-Arciszewska, Magdalena/0000-0002-2725-5551; Pinton, Paolo/0000-0001-7108-6508; bernardi, rosa/0000-0002-3607-6336; Bonora, Massimo/0000-0002-5752-3318; TACCHETTI, CARLO/0000-0003-4602-000X; Rizzuto, Rosario/0000-0001-7044-5097; Wieckowski, Mariusz/0000-0003-0789-4521; Giorgi, Carlotta/0000-0002-2494-7405; Duszynski, Jerzy/0000-0003-2937-6725; Pandolfi, Pier Paolo/0000-0002-5352-5295	National Cancer Institute; NIH; AIRC; FISM; Telethon; Ministry of Health; PRIN; FP7 "MyoAGE"; Cariparo Foundation; Ministry of Science and Higher Education in Poland; Polish Mitochondrial Network; NATIONAL CANCER INSTITUTE [R01CA102142, K99CA139009, R01CA071692, R01CA142874] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC(Fondazione AIRC per la ricerca sul cancro); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Telethon(Fondazione Telethon); Ministry of Health; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FP7 "MyoAGE"; Cariparo Foundation(Fondazione Cariparo); Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland); Polish Mitochondrial Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute (to P. P. P.); by K99 NIH (to I. K.); by AIRC, FISM, Telethon, Ministry of Health, and PRIN (to P. P.); by FP7 "MyoAGE", NIH, Cariparo Foundation, and AIRC (to R. R.); and by grants from the Ministry of Science and Higher Education in Poland and the Polish Mitochondrial Network (to M. L., J.D., and M. R. W.). We thank S. Missiroli, F. Poletti, and C. Agnoletto for carrying out some experiments, and J. Meldolesi and members of the Pandolfi and Pinton lab for stimulating discussions.	Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Giorgi C, 2008, CURR MOL MED, V8, P119; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Marchi S, 2008, BIOCHEM BIOPH RES CO, V375, P501, DOI 10.1016/j.bbrc.2008.07.153; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	21	305	316	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1247	1251		10.1126/science.1189157	http://dx.doi.org/10.1126/science.1189157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21030605	Green Accepted			2022-12-24	WOS:000284613700043
J	Lock, K; Smith, RD; Dangour, AD; Brown, MK; Pigatto, G; Hawkes, C; Fisberg, RM; Chalabi, Z				Lock, Karen; Smith, Richard D.; Dangour, Alan D.; Brown, Marcus Keogh; Pigatto, Gessuir; Hawkes, Corinna; Fisberg, Regina Mara; Chalabi, Zaid			Chronic Diseases: Chronic Diseases and Development 2 Health, agricultural, and economic effects of adoption of healthy diet recommendations	LANCET			English	Article							CORONARY-HEART-DISEASE; GLOBAL BURDEN; CONSUMPTION; RISK; TIME; FAT	Transition to diets that are high in saturated fat and sugar has caused a global public health concern as the pattern of food consumption is a mayor modifiable risk factor for chronic non-communicable diseases Although agri food systems are intimately associated with this transition, agriculture and health sectors are largely disconnected in their priorities policy, and analysis with neither side considering the complex inter relation between agri trade patterns of food consumption health, and development We show the importance of connection of these perspectives through estimation of the effect of adopting a healthy diet on population health, agricultural production trade the economy and livelihoods, with a computable general equilibrium approach On the basis of case studies from the UK and Brazil we suggest that benefits of a healthy diet policy will vary substantially between different populations, not only because of population dietary intake but also because of agricultural production trade and other economic factors	[Smith, Richard D.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England; [Lock, Karen; Smith, Richard D.; Dangour, Alan D.; Brown, Marcus Keogh; Chalabi, Zaid] Leverhulme Ctr Integrat Res Agr & Hlth, London, England; [Pigatto, Gessuir] Univ Estadual Paulista, Tupa, Brazil; [Hawkes, Corinna; Fisberg, Regina Mara] Univ Sao Paulo, Fac Publ Hlth, Sao Paulo, Brazil	University of London; London School of Hygiene & Tropical Medicine; Universidade Estadual Paulista; Universidade de Sao Paulo	Smith, RD (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, 15-17 Tavistock Pl, London WC1H 9SH, England.		Fisberg, Regina Mara/Q-6494-2019; Fisberg, Regina M/C-4069-2012; Pigatto, Gessuir GP/F-9053-2012	Fisberg, Regina Mara/0000-0002-4490-9035; Fisberg, Regina M/0000-0002-4490-9035; Pigatto, Gessuir GP/0000-0002-5240-2381; Smith, Richard/0000-0003-3837-6559; Dangour, Alan/0000-0001-6908-1273; Keogh-Brown, Marcus/0000-0002-7556-0016				*ABEF, 2008, REL AN 2008 2009; *ABIPECS, 2008, REL AB 2008; Allender S., 2008, CORONARY HEART DIS S; [Anonymous], 2008, WORLD HLTH STAT 2008; Bates B, 2010, NATL DIET NUTR SURVE; Beutels P, 2008, HEALTH ECON, V17, P1317, DOI 10.1002/hec.1339; Castro Michelle Alessandra de, 2009, Rev. Saúde Pública, V43, P991, DOI 10.1590/S0034-89102009005000084; *CENTR INT AG, 2009, WORLD FACTB GDP COMP; Curioni C, 2009, REV PANAM SALUD PUBL, V25, P9, DOI 10.1590/S1020-49892009000100002; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; DEJESUS C, 2007, CADEIA CARNE FRANGO, P191; DENKE MA, 1991, AM J CLIN NUTR, V54, P1036, DOI 10.1093/ajcn/54.6.1036; Ezzati M, 2004, COMP QUANTIFICATION; *FAO, 2008, LIV LONG SHAD ENV IS; FAO, 2008, STAT FOOD INS WORLD; *FAO STAT DIV, 2009, SUMM WORLD FOOD AGR; Fisberg RM, 2006, J AM DIET ASSOC, V106, P2067, DOI 10.1016/j.jada.2006.09.010; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; GENEAU R, 2010, LANCET, DOI DOI 10.1016/S0140.6736(10)61414-6; Hawkes C, 2010, TRADE FOOD DIET HLTH; Hawkes C, 2007, FOOD NUTR BULL, V28, pS312, DOI 10.1177/15648265070282S210; Hawkes C, 2006, B WORLD HEALTH ORGAN, V84, P984, DOI 10.2471/BLT.05.025650; *HLTH SAF EX, EST DAYS FULL DAY EQ; *HLTH SAF EX, EST INC RAT SELF REP; *HM GOV, 2008, FOOD MATT STRAT 21 C; Horridge M, 2008, EXERCISES CONTRIBUTI; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; *IBGE, 2001, EST PESQ INF DEM SOC; *ILO, 2010, EC ACT POP 1950 2010; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Lock K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2403; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Moura EC, 2009, REV PANAM SALUD PUBL, V26, P17, DOI 10.1590/S1020-49892009000700003; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; *NAT, BRAZ LAB STATS; *OFF NAT STAT, 2010, LAB MARK STAT STAT B; *OFF NAT STAT, LAB FORC SURV 2005; Pattanayak SK, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.2096; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; SCARF H, 1967, SIAM J APPL MATH, V15, P1328, DOI 10.1137/0115116; SCARF HE, 1967, 10 EC STUDIES TRADIT; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Smith RD, 2006, APPL HEALTH ECON HEA, V5, P55, DOI 10.2165/00148365-200605010-00007; Smith RD, 2010, J PUBLIC HEALTH-UK, V32, P2, DOI 10.1093/pubmed/fdp122; Smith RD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4571; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; Srinivasan CS, 2006, FOOD POLICY, V31, P53, DOI 10.1016/j.foodpol.2005.08.002; Stamler J, 2010, AM J CLIN NUTR, V91, P497, DOI 10.3945/ajcn.2010.29216; TARINO PWS, 2010, AM J CLIN NUTR, V91, P502; *UN FAO, FAOSTAT FOOD CONS DA; *WCRF, 2007, FOOD NUTR PHYS ACT P, pCH10; *WHO FAO, 2003, TECHN REP SER WHO FA, V916; *WHO FAO, 2008, COD AL AN FOOD PROD; World Health Organization, 2009, GLOB HLTH RISKS MORT; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; YACH D, 2004, GLOB STRAT DIET PHYS; Ye CY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-62	61	78	79	2	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2010	376	9753					1699	1709		10.1016/S0140-6736(10)61352-9	http://dx.doi.org/10.1016/S0140-6736(10)61352-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	683DD	21074259				2022-12-24	WOS:000284451000035
J	Han, DW; Tapia, N; Joo, JY; Greber, B; Arauzo-Bravo, MJ; Bernemann, C; Ko, K; Wu, GM; Stehling, M; Do, JT; Scholer, HR				Han, Dong Wook; Tapia, Natalia; Joo, Jin Young; Greber, Boris; Arauzo-Bravo, Marcos J.; Bernemann, Christof; Ko, Kinarm; Wu, Guangming; Stehling, Martin; Do, Jeong Tae; Schoeler, Hans R.			Epiblast Stem Cell Subpopulations Represent Mouse Embryos of Distinct Pregastrulation Stages	CELL			English	Article							CLONAL ANALYSIS; GROUND-STATE; PLURIPOTENCY; EXPRESSION; NANOG; LINES; CYCLE; MICE	Embryonic stem cells (ESCs) comprise at least two populations of cells with divergent states of pluripotency. Here, we show that epiblast stem cells (EpiSCs) also comprise two distinct cell populations that can be distinguished by the expression of a specific Oct4-GFP marker. These two subpopulations, Oct4-GFP positive and negative EpiSCs, are capable of converting into each other in vitro. Oct4-GFP positive and negative EpiSCs are distinct from ESCs with respect to global gene expression pattern, epigenetic profile, and Oct4 enhancer utilization. Oct4-GFP negative cells share features with cells of the late mouse epiblast and cannot form chimeras. However, Oct4-GFP positive EpiSCs, which only represent a minor EpiSC fraction, resemble cells of the early epiblast and can readily contribute to chimeras. Our findings suggest that the rare ability of EpiSCs to contribute to chimeras is due to the presence of the minor EpiSC fraction representing the early epiblast.	[Han, Dong Wook; Tapia, Natalia; Joo, Jin Young; Greber, Boris; Arauzo-Bravo, Marcos J.; Bernemann, Christof; Wu, Guangming; Stehling, Martin; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Ko, Kinarm] Konkuk Univ, Inst Biomed Sci & Technol, Ctr Stem Cell Res, Seoul 143701, South Korea; [Ko, Kinarm] Konkuk Univ, Sch Med, Dept Neurosci, Seoul 143701, South Korea; [Do, Jeong Tae] CHA Univ, CHA Stem Cell Inst, Lab Stem Cell & Dev Biol, Seoul 135081, South Korea; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Konkuk University; Konkuk University; Konkuk University Medical Center; Pochon Cha University; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	Marcos, Arauzo-Bravo/A-1706-2011; , HS/AAB-4434-2019; Han, Dong Wook/D-6041-2011; Tapia, Natalia/H-5500-2012	Marcos, Arauzo-Bravo/0000-0002-3264-464X; , HS/0000-0003-2643-5136; Do, Jeong Tae/0000-0001-6721-1441; Greber, Boris/0000-0002-9404-7293; Tapia, Natalia/0000-0003-0226-1952; Wu, Guangming/0000-0003-1923-7609	Federal Ministry of Education and Research (BMBF) initiative [01GN0539]	Federal Ministry of Education and Research (BMBF) initiative(Federal Ministry of Education & Research (BMBF))	We are indebted to all members of the Scholer laboratory for fruitful discussions on the results. We are especially grateful to Dr. Paul Tesar for providing the T9 EpiSC line. We are also grateful to Goran Key, Inge Sobek-Klocke, Martina Sinn, and David Obridge for technical assistance and Areti Malapetsas for editing the manuscript. This work was supported by the Federal Ministry of Education and Research (BMBF) initiative "Cell-Based Regenerative Medicine" (Grant 01GN0539).	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P349; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lovell-Badge R, 2007, NAT BIOTECHNOL, V25, P1114, DOI 10.1038/nbt1007-1114; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	25	166	172	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					617	627		10.1016/j.cell.2010.10.015	http://dx.doi.org/10.1016/j.cell.2010.10.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21056461	Bronze			2022-12-24	WOS:000284149100018
J	Waldo, GL; Ricks, TK; Hicks, SN; Cheever, ML; Kawano, T; Tsuboi, K; Wang, XY; Montell, C; Kozasa, T; Sondek, J; Harden, TK				Waldo, Gary L.; Ricks, Tiffany K.; Hicks, Stephanie N.; Cheever, Matthew L.; Kawano, Takeharu; Tsuboi, Kazuhito; Wang, Xiaoyue; Montell, Craig; Kozasa, Tohru; Sondek, John; Harden, T. Kendall			Kinetic Scaffolding Mediated by a Phospholipase C-beta and G(q) Signaling Complex	SCIENCE			English	Article							G-PROTEIN; RGS PROTEINS; ACTIVATION; RECEPTOR; DETERMINANTS; RECOGNITION; HYDROLYSIS; REGULATORS; SUBUNIT; BINDING	Transmembrane signals initiated by a broad range of extracellular stimuli converge on nodes that regulate phospholipase C (PLC)-dependent inositol lipid hydrolysis for signal propagation. We describe how heterotrimeric guanine nucleotide-binding proteins (G proteins) activate PLC-beta s and in turn are deactivated by these downstream effectors. The 2.7-angstrom structure of PLC-beta 3 bound to activated G alpha(q) reveals a conserved module found within PLC-beta s and other effectors optimized for rapid engagement of activated G proteins. The active site of PLC-beta 3 in the complex is occluded by an intramolecular plug that is likely removed upon G protein-dependent anchoring and orientation of the lipase at membrane surfaces. A second domain of PLC-beta 3 subsequently accelerates guanosine triphosphate hydrolysis by G alpha(q), causing the complex to dissociate and terminate signal propagation. Mutations within this domain dramatically delay signal termination in vitro and in vivo. Consequently, this work suggests a dynamic catch-and-release mechanism used to sharpen spatiotemporal signals mediated by diverse sensory inputs.	[Waldo, Gary L.; Ricks, Tiffany K.; Hicks, Stephanie N.; Cheever, Matthew L.; Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kawano, Takeharu; Tsuboi, Kazuhito; Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; [Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA; [Kozasa, Tohru] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Sondek, John] Univ N Carolina, Sch Med, Dept Biochem, Chapel Hill, NC 27599 USA; [Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins University; University of Tokyo; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Harden, TK (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	tkh@med.unc.edu	Wang, Xiaoyue/D-1046-2010; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Sondek, John/0000-0002-1127-8310	NIH [GM38213, GM57391, GM61454, GM074001, EY010852]; Ruth L. Kirschstein National Service [F31]; United Negro College; Japan Society for the Promotion of Science; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038213, R01GM061454, R01GM074001, R01GM057391, R01GM062299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Negro College; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants GM38213 and GM57391 (J.S. and T.K.H.), GM61454 and GM074001 (T.K.), and EY010852 (C.M.). T.K.R. was supported by a Ruth L. Kirschstein National Service Award F31 Predoctoral Fellowship and a United Negro College Fund Merck Graduate Science Research Dissertation Fellowship. K.T. was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science. We acknowledge the outstanding help with structural analyses by B. Temple, L. Betts, J. Vanhooke, T. Charpentier, V. Arshavsky, and M. Kosloff; with analysis of linker-deleted PLC-beta 3 by N. Vincent Jordan; with SPR analyses by A. Kimple; with [gamma<SUP>32</SUP>P]GTP purification by E. Lazarowski and the insightful comments on the manuscript by H. Dohlman, R. Nicholas, E. Ross, and K. Slep. Coordinates and structure factors for Ga<INF>q</INF>center dot PLC-b3 have been deposited under the PDB accession code 3OHM.	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Turcotte M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000148; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; WALDO GL, 1991, J BIOL CHEM, V266, P14217; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	39	140	143	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					974	980		10.1126/science.1193438	http://dx.doi.org/10.1126/science.1193438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20966218	Green Accepted			2022-12-24	WOS:000284118000046
J	Levi, M; Levy, JH; Andersen, HF; Truloff, D				Levi, Marcel; Levy, Jerrold H.; Andersen, Henning Friis; Truloff, David			Safety of Recombinant Activated Factor VII in Randomized Clinical Trials.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COAGULATION-FACTOR-VII; DOUBLE-BLIND; INTRACEREBRAL HEMORRHAGE; RISK-FACTORS; EFFICACY; CIRRHOSIS; THERAPY; SURGERY; PHARMACOKINETICS; TRANSFUSION	Background: The use of recombinant activated factor VII (rFVIIa) on an off-label basis to treat life-threatening bleeding has been associated with a perceived increased risk of thromboembolic complications. However, data from placebo-controlled trials are needed to properly assess the thromboembolic risk. To address this issue, we evaluated the rate of thromboembolic events in all published randomized, placebo-controlled trials of rFVIIa used on an off-label basis. Methods: We analyzed data from 35 randomized clinical trials (26 studies involving patients and 9 studies involving healthy volunteers) to determine the frequency of thromboembolic events. The data were pooled with the use of random-effects models to calculate the odds ratios and 95% confidence intervals. Results: Among 4468 subjects (4119 patients and 349 healthy volunteers), 498 had thromboembolic events (11.1%). Rates of arterial thromboembolic events among all 4468 subjects were higher among those who received rFVIIa than among those who received placebo (5.5% vs. 3.2%, P=0.003). Rates of venous thromboembolic events were similar among subjects who received rFVIIa and those who received placebo (5.3% vs. 5.7%). Among subjects who received rFVIIa, 2.9% had coronary arterial thromboembolic events, as compared with 1.1% of those who received placebo (P=0.002). Rates of arterial thromboembolic events were highest among subjects older than 65 years of age, as compared with those who were 65 years of age or younger (9.0% vs. 3.8%, P=0.003); the rates were especially high among subjects 75 years of age or older, as compared with those who were younger than 75 years of age (10.8% vs. 4.1%, P=0.02). Conclusions: In a large and comprehensive cohort of persons in placebo-controlled trials of rFVIIa, treatment with high doses of rFVIIa on an off-label basis significantly increased the risk of arterial but not venous thromboembolic events, especially among the elderly. (Funded by Novo Nordisk.) N Engl J Med 2010;363:1791-800.	[Levi, Marcel] Univ Amsterdam, Acad Med Ctr, Dept Med F4, NL-1105 AZ Amsterdam, Netherlands; [Levy, Jerrold H.] Emory Univ, Sch Med, Atlanta, GA USA; [Andersen, Henning Friis; Truloff, David] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark	University of Amsterdam; Academic Medical Center Amsterdam; Emory University; Novo Nordisk	Levi, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med F4, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.m.levi@amc.uva.nl	Levi, Marcel/AAZ-8559-2020		Novo Nordisk	Novo Nordisk(Novo Nordisk)	Supported by Novo Nordisk.	Abbott RD, 2003, J CLIN EPIDEMIOL, V56, P479, DOI 10.1016/S0895-4356(02)00611-X; Abshire T, 2008, SEMIN HEMATOL, V45, pS3, DOI 10.1053/j.seminhematol.2008.03.006; Aledort LM, 2004, J THROMB HAEMOST, V2, P1700, DOI 10.1111/j.1538-7836.2004.00944.x; Bijsterveld NR, 2004, BRIT J HAEMATOL, V124, P653, DOI 10.1111/j.1365-2141.2003.04811.x; Bijsterveld NR, 2002, CIRCULATION, V106, P2550, DOI 10.1161/01.CIR.0000038501.87442.02; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Bosch J, 2004, GASTROENTEROLOGY, V127, P1123, DOI 10.1053/j.gastro.2004.07.015; Bosch J, 2008, HEPATOLOGY, V47, P1604, DOI 10.1002/hep.22216; CARRENO V, 2001, 18 C INT SOC THROMB, pP2612; Chuansumrit A, 2005, BLOOD COAGUL FIBRIN, V16, P549, DOI 10.1097/01.mbc.0000186837.78432.2f; Diprose P, 2005, BRIT J ANAESTH, V95, P596, DOI 10.1093/bja/aei244; Ekert H, 2006, BLOOD COAGUL FIBRIN, V17, P389, DOI 10.1097/01.mbc.0000233369.03358.c1; Erhardtsen E, 1998, BLOOD COAGUL FIBRIN, V9, P741, DOI 10.1097/00001721-199811000-00003; Fridberg MJ, 2005, BLOOD COAGUL FIBRIN, V16, P259, DOI 10.1097/01.mbc.0000169218.15926.34; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; Friederich PW, 2003, LANCET, V361, P1138; Friederich PW, 2001, CIRCULATION, V103, P2555; Gill R, 2009, CIRCULATION, V120, P21, DOI 10.1161/CIRCULATIONAHA.108.834275; Hedner U, 2008, THROMB HAEMOSTASIS, V100, P557, DOI 10.1160/TH08-07-0434; Hedner U, 2006, SEMIN THROMB HEMOST, V32, P77, DOI 10.1055/s-2006-939557; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Levi M, 2005, CRIT CARE MED, V33, P883, DOI 10.1097/01.CCM.0000159087.85970.38; Levy JH, 2006, TRANSFUSION, V46, P919, DOI 10.1111/j.1537-2995.2006.00824.x; Lodge JPA, 2005, LIVER TRANSPLANT, V11, P973, DOI 10.1002/lt.20470; Lodge JPA, 2005, ANESTHESIOLOGY, V102, P269, DOI 10.1097/00000542-200502000-00006; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mayer SA, 2006, NEUROCRIT CARE, V4, P206, DOI 10.1385/NCC:4:3:206; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; Pihusch M, 2005, J THROMB HAEMOST, V3, P1935, DOI 10.1111/j.1538-7836.2005.01523.x; Planinsic RM, 2005, LIVER TRANSPLANT, V11, P895, DOI 10.1002/lt.20458; Raobaikady R, 2005, BRIT J ANAESTH, V94, P586, DOI 10.1093/bja/aei102; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; Sachs B, 2007, SPINE, V32, P2285, DOI 10.1097/BRS.0b013e3181557d45; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Shao YF, 2006, AM J SURG, V191, P245, DOI 10.1016/j.amjsurg.2005.10.019; Villar A, 2004, HAEMOPHILIA, V10, P352, DOI 10.1111/j.1365-2516.2004.00925.x; Wolzt M, 2004, THROMB HAEMOSTASIS, V91, P1090, DOI 10.1160/TH03-09-0605	41	445	466	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1791	1800		10.1056/NEJMoa1006221	http://dx.doi.org/10.1056/NEJMoa1006221			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674YK	21047223				2022-12-24	WOS:000283787800004
J	Leslie, WD; Morin, S; Lix, LM				Leslie, William D.; Morin, Suzanne; Lix, Lisa M.			A Before-and-After Study of Fracture Risk Reporting and Osteoporosis Treatment Initiation	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-DENSITY PROGRAM; QUALITY-OF-LIFE; CLINICAL-PRACTICE; POSTMENOPAUSAL WOMEN; ASSESSMENT-TOOL; PHARMACOLOGICAL-TREATMENT; PRACTICE GUIDELINES; OLDER WOMEN; VALIDATION; DENSITOMETRY	Background: Several national organizations recommend that fracture risk assessment and osteoporotic treatment be based on estimated absolute 10-year fracture risk rather than bone mineral density (BMD) alone. Objective: To assess the changes in physician prescribing behavior after introduction of absolute 10-year fracture risk reporting. Design: Before-and-after study. Setting: Manitoba, Canada, which has an integrated BMD program in which tests are linkable to a population-based administrative health database repository. Patients: Women 50 years or older who were not receiving osteoporosis medication (2042 before and 3889 after intervention). Intervention: Introduction of a system reporting absolute 10-year fracture risk along with dual-energy x-ray absorptiometry results. Measurements: The proportion of untreated women who were prescribed osteoporosis medications in the year after baseline BMD measurement. Results: Absolute fracture risk reporting reclassified more women (32.7%) into lower-risk categories than into higher-risk categories (10%). This effect was more prominent in women younger than 65 years. Fewer women per physician were prescribed osteoporosis drugs after introduction of absolute fracture risk reporting. The absolute fracture risk reporting system was associated with an overall reduction in osteoporosis medications dispensed (adjusted absolute reduction, 9.0 percentage points [95% CI, 3.9 to 14.2 percentage points]; relative reduction, 21.3% [CI, 9.2% to 33.5%]; P < 0.001). The reduction was attributed to fewer drugs dispensed to women at low and moderate risk for fracture. No differences in fracture rates were observed. Limitations: This was a nonrandomized study. The risk assessment system studied differs slightly from other 10-year fracture risk assessment models. Conclusion: Change from a T-score-based fracture risk reporting system to a system based on absolute 10-year fracture risk was associated with appropriate, guideline-based changes in prescription of osteoporosis medications.	Univ Saskatchewan, Saskatoon, SK, Canada; McGill Univ, Montreal, PQ, Canada	University of Saskatchewan; McGill University	Leslie, WD (corresponding author), Univ Manitoba, Dept Med C5121, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	bleslie@sbgh.mb.ca		Morin, Suzanne/0000-0002-4317-492X; Leslie, William/0000-0002-1056-1691				Adachi JD, 2001, OSTEOPOROSIS INT, V12, P903, DOI 10.1007/s001980170017; Balding DJ, 2004, APPL LONGITUDINAL AN; Baltzan MA, 1999, LANCET, V353, P1327, DOI 10.1016/S0140-6736(98)04835-1; Binkley N, 2005, J BONE MINER RES, V20, P195, DOI 10.1359/JBMR.041115; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; Cranney A, 2009, OSTEOPOROSIS INT, V20, P1621, DOI 10.1007/s00198-008-0823-8; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5; Donaldson MG, 2009, J BONE MINER RES, V24, P675, DOI [10.1359/jbmr.081203, 10.1359/JBMR.081203]; Fujiwara S, 2008, OSTEOPOROSIS INT, V19, P429, DOI 10.1007/s00198-007-0544-4; Hallberg I, 2004, OSTEOPOROSIS INT, V15, P834, DOI 10.1007/s00198-004-1622-5; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; Hansen KE, 2005, J BONE MINER RES, V20, P501, DOI 10.1359/JBMR.041134; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Ioannidis G, 2007, CAN FAM PHYSICIAN, V53, P1694; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Kozyrskyj AL, 1998, ANN PHARMACOTHER, V32, P1152, DOI 10.1345/aph.18117; Leslie WD, 2008, OSTEOPOROSIS INT, V19, P459, DOI 10.1007/s00198-008-0565-7; Leslie WD, 2006, BONE, V39, P361, DOI 10.1016/j.bone.2006.02.002; Leslie WD, 2005, J CLIN DENSITOM, V8, P25, DOI 10.1385/JCD:8:1:025; Leslie WD, 2003, OSTEOPOROSIS INT, V14, P334, DOI 10.1007/s00198-003-1375-6; Leslie WD, 2003, J CLIN DENSITOM, V6, P275, DOI 10.1385/JCD:6:3:275; Leslie WD, 2008, BONE, V43, P667, DOI 10.1016/j.bone.2008.06.001; Leslie WD, 2007, ARCH INTERN MED, V167, P1641, DOI 10.1001/archinte.167.15.1641; Leslie WD, 2009, J BONE MINER RES, V24, P353, DOI [10.1359/jbmr.081012, 10.1359/JBMR.081012]; Melton LJ, 2003, ENDOCRIN METAB CLIN, V32, P1, DOI 10.1016/S0889-8529(02)00061-0; Neuner JM, 2006, J AM GERIATR SOC, V54, P485, DOI 10.1111/j.1532-5415.2005.00622.x; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Richards JB, 2007, J BONE MINER RES, V22, P228, DOI 10.1359/JBMR.061109; Roos NP, 1999, MED CARE, V37, pJS10, DOI 10.1097/00005650-199906001-00005; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; Siminoski K, 2005, CAN ASSOC RADIOL J, V56, P178; Stock JL, 1998, ANN INTERN MED, V128, P996, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00006; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; Watts NB, 2008, J CLIN DENSITOM, V11, P473, DOI 10.1016/j.jocd.2008.04.003; *WHO COLL CTR DRUG, 2005, GUID ATC CLASS DDD A	41	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 2	2010	153	9					580	586		10.7326/0003-4819-153-9-201011020-00007	http://dx.doi.org/10.7326/0003-4819-153-9-201011020-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	673MH	21041577				2022-12-24	WOS:000283667000004
J	Derdowski, A; Sindi, SS; Klaips, CL; DiSalvo, S; Serio, TR				Derdowski, Aaron; Sindi, Suzanne S.; Klaips, Courtney L.; DiSalvo, Susanne; Serio, Tricia R.			A Size Threshold Limits Prion Transmission and Establishes Phenotypic Diversity	SCIENCE			English	Article							PSI+ PRION; NEURODEGENERATIVE DISEASES; SACCHAROMYCES-CEREVISIAE; YEAST; PROTEIN; PROPAGATION; GENERATION; PARTICLES; PROPAGONS; AMYLOIDS	According to the prion hypothesis, atypical phenotypes arise when a prion protein adopts an alternative conformation and persist when that form assembles into self-replicating aggregates. Amyloid formation in vitro provides a model for this protein-misfolding pathway, but the mechanism by which this process interacts with the cellular environment to produce transmissible phenotypes is poorly understood. Using the yeast prion Sup35/[PSI+], we found that protein conformation determined the size distribution of aggregates through its interactions with a molecular chaperone. Shifts in this range created variations in aggregate abundance among cells because of a size threshold for transmission, and this heterogeneity, along with aggregate growth and fragmentation, induced age-dependent fluctuations in phenotype. Thus, prion conformations may specify phenotypes as population averages in a dynamic system.	[Derdowski, Aaron; Sindi, Suzanne S.; Klaips, Courtney L.; DiSalvo, Susanne; Serio, Tricia R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Sindi, Suzanne S.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA	Brown University; Brown University	Sindi, SS (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, 185 Meeting St,POB G-L2, Providence, RI 02912 USA.	suzanne_sindi@brown.edu; tricia_serio@brown.edu	Serio, Tricia/GPP-7129-2022; DiSalvo, Susanne/AAR-9746-2020	Klaips, Courtney/0000-0002-4929-1641; Serio, Tricia/0000-0003-2687-7372	NIH [GM069802, GM085976, GM089049, AG034754, AG032818]; NSF [0548311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601, F32GM089049, F32GM085976, R01GM069802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG034754, F31AG032818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Rhind, M. Duennwald, J. Sherley, and members of their groups for assistance with centrifugal elutriation, and the Center for Computation and Visualization, the Leduc Bioimaging Facility, and the Flow Cytometry and Sorting Facility at Brown University for instrumentation and the assistance of the respective support staffs. We thank J. Bender, J. Laney, M. Tuite, and members of the Serio and Laney labs for helpful discussions and comments on the manuscript. This research was supported by grants from NIH (GM069802 to T.R.S., GM085976 to A.D., GM089049 to S.S.S., AG034754 to C.K., and AG032818 to S.D.) and NSF/ADVANCE (0548311 to T.R.S.).	Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Benkemoun L, 2006, FUNGAL GENET BIOL, V43, P789, DOI 10.1016/j.fgb.2006.06.006; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Byrne LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004670; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cox B, 2003, GENETICS, V165, P23; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Crapeau M, 2009, MOL BIOL CELL, V20, P2286, DOI 10.1091/mbc.E08-11-1097; Derkatch IL, 1996, GENETICS, V144, P1375; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2007, PRION, V1, P179, DOI 10.4161/pri.1.3.4840; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Pezza JA, 2009, MOL BIOL CELL, V20, P1068, DOI 10.1091/mbc.E08-04-0436; Pezza JA, 2007, PRION, V1, P36, DOI 10.4161/pri.1.1.3992; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rikhvanov EG, 2007, PRION, V1, P217, DOI 10.4161/pri.1.4.5058; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sindi SS, 2009, CURR OPIN MICROBIOL, V12, P623, DOI 10.1016/j.mib.2009.09.003; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	30	83	85	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2010	330	6004					680	683		10.1126/science.1197785	http://dx.doi.org/10.1126/science.1197785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030659	Green Accepted			2022-12-24	WOS:000283580600051
J	Hayne, PO; Greenhagen, BT; Foote, MC; Siegler, MA; Vasavada, AR; Paige, DA				Hayne, Paul O.; Greenhagen, Benjamin T.; Foote, Marc C.; Siegler, Matthew A.; Vasavada, Ashwin R.; Paige, David A.			Diviner Lunar Radiometer Observations of the LCROSS Impact	SCIENCE			English	Article							SURFACE	The Lunar Reconnaissance Orbiter (LRO) Diviner instrument detected a thermal emission signature 90 seconds after the Lunar Crater Observation and Sensing Satellite (LCROSS) Centaur impact and on two subsequent orbits. The impact heated a region of 30 to 200 square meters to at least 950 kelvin, providing a sustained heat source for the sublimation of up to similar to 300 kilograms of water ice during the 4 minutes of LCROSS post-impact observations. Diviner visible observations constrain the mass of the sunlit ejecta column to be similar to 10(-6) to 10(-5) kilograms per square meter, which is consistent with LCROSS estimates used to derive the relative abundance of the ice within the regolith.	[Hayne, Paul O.; Siegler, Matthew A.; Paige, David A.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Greenhagen, Benjamin T.; Foote, Marc C.; Vasavada, Ashwin R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Hayne, PO (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	phayne@ucla.edu	Greenhagen, Benjamin T/C-3760-2016	Greenhagen, Benjamin T/0000-0002-8252-9922; Hayne, Paul/0000-0003-4399-0449				BELYAKOV GV, 1977, COMBUST EXPLO SHOCK+, V13, P524; BRASLAU D, 1970, J GEOPHYS RES, V75, P3987, DOI 10.1029/JB075i020p03987; Carrier W. D.  III, 1973, Moon, V6, P250, DOI 10.1007/BF00562206; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; FANALE FP, 1984, ICARUS, V60, P476, DOI 10.1016/0019-1035(84)90157-X; FOOTE EJ, 2009, 40 LUN PLAN SCI C; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; Paige DA, 2010, SPACE SCI REV, V150, P125, DOI 10.1007/s11214-009-9529-2; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Rehfuss D. E., 1974, Moon, V11, P19, DOI 10.1007/BF01877790; Schultz PH, 2010, SCIENCE, V330, P468, DOI 10.1126/science.1187454; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Zhang JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038614	14	50	54	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					477	479		10.1126/science.1197135	http://dx.doi.org/10.1126/science.1197135			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966245				2022-12-24	WOS:000283329100031
J	Ghoreschi, K; Laurence, A; Yang, XP; Tato, CM; McGeachy, MJ; Konkel, JE; Ramos, HL; Wei, L; Davidson, TS; Bouladoux, N; Grainger, JR; Chen, QA; Kanno, Y; Watford, WT; Sun, HW; Eberl, G; Shevach, E; Belkaid, Y; Cua, DJ; Chen, WJ; O'Shea, JJ				Ghoreschi, Kamran; Laurence, Arian; Yang, Xiang-Ping; Tato, Cristina M.; McGeachy, Mandy J.; Konkel, Joanne E.; Ramos, Haydee L.; Wei, Lai; Davidson, Todd S.; Bouladoux, Nicolas; Grainger, John R.; Chen, Qian; Kanno, Yuka; Watford, Wendy T.; Sun, Hong-Wei; Eberl, GerRard; Shevach, EthanM.; Belkaid, Yasmine; Cua, Daniel J.; Chen, WanJun; O'Shea, John J.			Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling	NATURE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; HELPER-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; PROINFLAMMATORY IL-17(+); TH17 CELLS; IN-VIVO; DIFFERENTIATION; LINEAGE; INFLAMMATION	CD4(+) T-helper cells that selectively produce interleukin (IL)-17 (T(H)17), are critical for host defence and autoimmunity(1-4). Although crucial for T(H)17 cells in vivo(5,6), IL-23 has been thought to be incapable of driving initial differentiation. Rather, IL-6 and transforming growth factor (TGF)-beta 1 have been proposed to be the factors responsible for initiating specification(7-10). Here we show that T(H)17 differentiation can occur in the absence of TGF-beta signalling. Neither IL-6 nor IL-23 alone efficiently generated T(H)17 cells; however, these cytokines in combination with IL-1 beta effectively induced IL-17 production in naive precursors, independently of TGF-beta. Epigenetic modification of the Il17a, Il17f and Rorc promoters proceeded without TGF-beta 1, allowing the generation of cells that co-expressed ROR gamma t (encoded by Rorc) and T-bet. T-bet(+)ROR gamma t(+) T(H)17 cells are generated in vivo during experimental allergic encephalomyelitis, and adoptively transferred T(H)17 cells generated with IL-23 without TGF-beta 1 were pathogenic in this disease model. These data indicate an alternative mode for T(H)17 differentiation. Consistent with genetic data linking IL23R with autoimmunity, our findings re-emphasize the importance of IL-23 and therefore may have therapeutic implications.	[Ghoreschi, Kamran; Laurence, Arian; Yang, Xiang-Ping; Ramos, Haydee L.; Wei, Lai; Kanno, Yuka; Watford, Wendy T.; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Tato, Cristina M.; McGeachy, Mandy J.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA 94304 USA; [Konkel, Joanne E.; Chen, WanJun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Davidson, Todd S.; Chen, Qian; Shevach, EthanM.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Bouladoux, Nicolas; Grainger, John R.; Belkaid, Yasmine] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Eberl, GerRard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ghoreschi, K (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	ghoreschik@mail.nih.gov; osheajo@mail.nih.gov	Wei, Lai/D-1088-2014; Laurence, Arian/A-8770-2009; Eberl, Gerard/A-1160-2013; Yang, Xiangping/B-4833-2011; Kanno, Yuka/B-5802-2013	Laurence, Arian/0000-0003-0942-8292; Kanno, Yuka/0000-0001-5668-9319; Bouladoux, Nicolas/0000-0003-1593-671X; Eberl, Gerard/0000-0002-1119-5638; Grainger, John/0000-0002-4052-5923; Watford, Wendy/0000-0003-4261-5399; Ghoreschi, Kamran/0000-0002-5526-7517; Tato, Cristina M./0000-0002-0614-756X; Belkaid, Yasmine/0000-0001-9962-3571; Yang, Xiang-Ping/0000-0001-9003-1772	NIAMS; NIDCR; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000224, ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIHAR041173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Simone, J. Lay (Flow Cytometry Section, NIAMS) and the NIAMS LACU staff for technical support. This work has been supported by the Intramural Research Programs of NIAMS, NIDCR and NIAID.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	34	1013	1055	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					967	U144		10.1038/nature09447	http://dx.doi.org/10.1038/nature09447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962846	Green Accepted			2022-12-24	WOS:000283254700039
J	Keshavjee, S; Girard, F; Harrington, M; Farmer, PE				Keshavjee, Salmaan; Girard, Francoise; Harrington, Mark; Farmer, Paul E.			Time for a bold new vision at the Stop TB Partnership	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS		[Keshavjee, Salmaan; Farmer, Paul E.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA; [Keshavjee, Salmaan; Farmer, Paul E.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Keshavjee, Salmaan; Farmer, Paul E.] Partners Hlth, Boston, MA USA; [Girard, Francoise] Open Soc Fdn, New York, NY USA; [Harrington, Mark] Treatment Act Grp, New York, NY USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA.	salmaan_keshavjee@hms.harvard.edu		Keshavjee, Salmaan/0000-0002-6967-3305				[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Broekmans J., 2005, INVESTING STRATEGIES, P4; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Keshavjee S, 2010, INT J TUBERC LUNG D, V14, P1222; Keshavjee S, 2008, STEMMING TIDE MULTID; Lindert K., 2007, NUTS BOLTS BRAZILS B; *STOP TB PARTN, 2010, BAS FRAM PARTN STOP; Szreter S, 2002, AM J PUBLIC HEALTH, V92, P722, DOI 10.2105/AJPH.92.5.722; United Nations, 2010, MILL DEV GOALS REP 2; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665	10	2	4	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 16	2010	376	9749					1283	1284		10.1016/S0140-6736(10)61887-9	http://dx.doi.org/10.1016/S0140-6736(10)61887-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671RX	20951876				2022-12-24	WOS:000283528600008
J	Vikanes, A; Skjaerven, R; Grjibovski, AM; Gunnes, N; Vangen, S; Magnus, P				Vikanes, Ase; Skjaerven, Rolv; Grjibovski, Andrej M.; Gunnes, Nina; Vangen, Siri; Magnus, Per			Recurrence of hyperemesis gravidarum across generations: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HELICOBACTER-PYLORI INFECTION; NAUSEA; PREGNANCY; RISK; COMPLICATIONS; TERMINATION; PREVALENCE; NORWAY; BIRTH; WOMEN	Objective To estimate the risk of hyperemesis gravidarum ( hyperemesis) according to whether the daughters and sons under study were born after pregnancies complicated by hyperemesis. Design Population based cohort study. Setting Registry data from Norway. Participants Linked generational data from the medical birth registry of Norway (1967-2006): 544 087 units of mother and childbearing daughter and 399 777 units of mother and child producing son. Main outcome measure Hyperemesis in daughters in mother and childbearing daughter units and hyperemesis in female partners of sons in mother and child producing son units. Results Daughters who were born after a pregnancy complicated by hyperemesis had a 3% risk of having hyperemesis in their own pregnancy, while women who were born after an unaffected pregnancy had a risk of 1.1% (unadjusted odds ratio 2.9, 95% confidence interval 2.4 to 3.6). Female partners of sons who were born after pregnancies complicated by hyperemesis had a risk of 1.2% (1.0, 0.7 to 1.6). Daughters born after a pregnancy not complicated by hyperemesis had an increased risk of the condition if the mother had hyperemesis in a previous or subsequent pregnancy (3.2 (1.6 to 6.4) if hyperemesis had occurred in one of the mother's previous pregnancies and 3.7 (1.5 to 9.1) if it had occurred in a later pregnancy). Adjustment for maternal age at childbirth, period of birth, and parity did not change the estimates. Restrictions to firstborns did not influence the results. Conclusions Hyperemesis gravidarum is more strongly influenced by the maternal genotype than the fetal genotype, though environmental influences along the maternal line cannot be excluded as contributing factors.	[Vikanes, Ase; Skjaerven, Rolv; Gunnes, Nina; Vangen, Siri; Magnus, Per] Norwegian Inst Publ Hlth, Div Epidemiol, N-0403 Oslo, Norway; [Skjaerven, Rolv] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway; [Grjibovski, Andrej M.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, N-0403 Oslo, Norway; [Grjibovski, Andrej M.] Univ Tromso, Inst Community Med, N-9001 Tromso, Norway; [Grjibovski, Andrej M.] No State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia; [Vangen, Siri] Oslo Univ Hosp, Dept Obstet & Gynaecol, Natl Resource Ctr Womens Hlth, Oslo, Norway; [Magnus, Per] Univ Oslo, Inst Gen Practice & Community Med, N-0316 Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Bergen; Norwegian Institute of Public Health (NIPH); UiT The Arctic University of Tromso; Northern State Medical University; University of Oslo; University of Oslo	Vikanes, A (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, POB 4404, N-0403 Oslo, Norway.	ase.vigdis.vikanes@fhi.no	Grjibovski, Andrej/B-9815-2016	Grjibovski, Andrej/0000-0002-5464-0498	Norwegian Research Council [166145/V50]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was funded by the Norwegian Research Council (grant No 166145/V50).	ADAMS MM, 1994, OBSTET GYNECOL, V84, P35; Bailit JL, 2005, AM J OBSTET GYNECOL, V193, P811, DOI 10.1016/j.ajog.2005.02.132; Cedergren M, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.029; CHIN RKH, 1989, EUR J OBSTET GYN R B, V33, P215, DOI 10.1016/0028-2243(89)90132-9; COREY LA, 1992, OBSTET GYNECOL, V80, P989; DEPUE RH, 1987, AM J OBSTET GYNECOL, V156, P1137, DOI 10.1016/0002-9378(87)90126-8; Dodds L, 2006, OBSTET GYNECOL, V107, P285, DOI 10.1097/01.AOG.0000195060.22832.cd; Eliakim R, 2000, AM J PERINAT, V17, P207, DOI 10.1055/s-2000-9424; FAIRWEATHER DV, 1968, AM J OBSTET GYNECOL, V102, P135, DOI 10.1016/0002-9378(68)90445-6; Fejzo MS, 2008, EUR J OBSTET GYN R B, V141, P13, DOI 10.1016/j.ejogrb.2008.07.003; Fell DB, 2006, OBSTET GYNECOL, V107, P277, DOI 10.1097/01.AOG.0000195059.82029.74; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Gazmararian JA, 2002, OBSTET GYNECOL, V100, P94, DOI 10.1016/S0029-7844(02)02024-0; Golberg D, 2007, OBSTET GYNECOL, V110, P695, DOI 10.1097/01.AOG.0000278571.93861.26; Grjibovski AM, 2008, ACTA OBSTET GYN SCAN, V87, P20, DOI 10.1080/00016340701709273; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kallen B, 2003, ACTA OBSTET GYN SCAN, V82, P916, DOI 10.1034/j.1600-0412.2003.00307.x; Kim DR, 2009, ARCH WOMEN MENT HLTH, V12, P61, DOI 10.1007/s00737-009-0064-7; Mazzotta P, 2001, J PSYCHOSOM OBST GYN, V22, P7, DOI 10.3109/01674820109049946; Nordtveit TI, 2008, BRIT MED J, V336, P872, DOI 10.1136/bmj.39505.436539.BE; OBRIEN B, 1992, BIRTH-ISS PERINAT C, V19, P138, DOI 10.1111/j.1523-536X.1992.tb00671.x; Poursharif B, 2008, J PERINATOL, V28, P176, DOI 10.1038/sj.jp.7211906; Poursharif B, 2007, CONTRACEPTION, V76, P451, DOI 10.1016/j.contraception.2007.08.009; Sandven I, 2009, ACTA OBSTET GYN SCAN, V88, P1190, DOI 10.3109/00016340903284927; Signorello LB, 1998, EPIDEMIOLOGY, V9, P636, DOI 10.1097/00001648-199811000-00013; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Trogstad LIS, 2005, BJOG-INT J OBSTET GY, V112, P1641, DOI 10.1111/j.1471-0528.2005.00765.x; VELLACOTT ID, 1988, INT J GYNECOL OBSTET, V27, P57, DOI 10.1016/0020-7292(88)90088-4; Verberg MFG, 2005, HUM REPROD UPDATE, V11, P527, DOI 10.1093/humupd/dmi021; Vikanes A, 2008, SCAND J PUBLIC HEALT, V36, P135, DOI 10.1177/1403494807085189; World Health Organization (WHO), 2009, INT CLASS DIS	31	36	36	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2010	340								c2050	10.1136/bmj.c2050	http://dx.doi.org/10.1136/bmj.c2050			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591PO	21030362				2022-12-24	WOS:000277314300003
J	Allotey, P; Reidpath, DD; Yasin, S; Chan, CK; Aikins, AD				Allotey, Pascale; Reidpath, Daniel D.; Yasin, Shajahan; Chan, Carina K.; Aikins, Ama de-Graft			Rethinking health-care systems: a focus on chronicity	LANCET			English	Editorial Material							AFRICA		[Allotey, Pascale; Reidpath, Daniel D.; Yasin, Shajahan; Chan, Carina K.] Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Selangor 46150, De, Malaysia; [Aikins, Ama de-Graft] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana; [Aikins, Ama de-Graft] London Sch Econ & Polit Sci, LSE Hlth, London, England	Monash University; Monash University Sunway; University of Ghana; University of London; London School Economics & Political Science	Allotey, P (corresponding author), Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Sunway Campus, Selangor 46150, De, Malaysia.	pascale.allotey@monash.edu	Chan, Carina/AAO-6804-2021; Chan, Carina/O-6258-2014	Chan, Carina/0000-0002-1799-7877				Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; MBANYA JC, 2006, DIS MORTALITY SUBSAH, DOI DOI 10.1596/978-0-8213-6397-3; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mbeh George N, 2010, Glob Health Promot, V17, P17, DOI 10.1177/1757975910363925; Nattrass N, 2008, J PUBLIC HEALTH-UK, V30, P398, DOI 10.1093/pubmed/fdn075; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; RIFKIN SB, 1986, SOC SCI MED, V23, P559, DOI 10.1016/0277-9536(86)90149-8; SAMB B, 2010, LANCET          1111; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340	10	74	74	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					450	451		10.1016/S0140-6736(10)61856-9	http://dx.doi.org/10.1016/S0140-6736(10)61856-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721TX	21074257				2022-12-24	WOS:000287381800009
J	Becerra, MC; Appleton, SC; Franke, MF; Chalco, K; Arteaga, F; Bayona, J; Murray, M; Atwood, SS; Mitnick, CD				Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Chalco, Katiuska; Arteaga, Fernando; Bayona, Jaime; Murray, Megan; Atwood, Sidney S.; Mitnick, Carole D.			Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study	LANCET			English	Article							CLOSE CONTACTS	Background Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis have emerged as major global health threats. WHO recommends contact investigation in close contacts of patients with MDR and XDR tuberculosis. We aimed to assess the burden of tuberculosis disease in household contacts of such patients. Methods We undertook a retrospective cohort study of household contacts of patients treated for MDR or XDR tuberculosis in Lima, Peru, in 1996-2003. The primary outcome was active tuberculosis in household contacts at the time the index patient began MDR tuberculosis treatment and during the 4-year follow-up. We examined whether the occurrence of active tuberculosis in the household contacts differed by resistance pattern of the index patient: either MDR or XDR tuberculosis. Findings 693 households of index patients with MDR tuberculosis were enrolled in the study. In 48 households, the Mycobacterium tuberculosis isolate from the index patient was XDR. Of the 4503 household contacts, 117 (2.60%) had active tuberculosis at the time the index patient began MDR tuberculosis treatment there was no difference in prevalence between XDR and MDR tuberculosis households. During the 4-year follow-up, 242 contacts developed active tuberculosis the frequency of active tuberculosis was nearly two times higher in contacts of patients with XDR tuberculosis than it was in contacts of patients with MDR tuberculosis (hazard ratio 1.88, 95% CI 1.10-3.21). In the 359 contacts with active tuberculosis, 142 (40%) had had isolates tested for resistance against first-line drugs, of whom 129 (90.9%, 95% CI 85.0-94.6) had MDR tuberculosis. Interpretation In view of the high risk of disease recorded in household contacts of patients with MDR or XDR tuberculosis, tuberculosis programmes should implement systematic household contact investigations for all patients identified as having MDR or XDR tuberculosis. If shown to have active tuberculosis, these household contacts should be suspected as having MDR tuberculosis until proven otherwise.	[Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Bayona, Jaime; Mitnick, Carole D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Chalco, Katiuska; Arteaga, Fernando; Bayona, Jaime; Murray, Megan; Mitnick, Carole D.] Socios Salud Sucursal Peru, Lima, Peru; [Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Chalco, Katiuska; Arteaga, Fernando; Bayona, Jaime; Murray, Megan; Mitnick, Carole D.] Partners Hlth, Boston, MA USA; [Becerra, Mercedes C.; Murray, Megan; Atwood, Sidney S.; Mitnick, Carole D.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital	Becerra, MC (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	mbecerra@post.harvard.edu	Mitnick, Carole/GRO-1991-2022; Franke, Molly/AAK-7559-2020	Mitnick, Carole/0000-0002-3455-658X; Franke, Molly/0000-0002-4890-5728; Atwood, Sidney/0000-0001-8865-6300	Charles H Hood Foundation; David Rockefeller Center for Latin American Studies at Harvard University; Bill & Melinda Gates Foundation; National Heart, Lung, and Blood Institute [K01 HL080939]; National Institute of Allergy and Infectious Diseases [K01 A1065836]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL080939] Funding Source: NIH RePORTER	Charles H Hood Foundation; David Rockefeller Center for Latin American Studies at Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Charles H Hood Foundation, the David Rockefeller Center for Latin American Studies at Harvard University, and the Bill & Melinda Gates Foundation funded this study. The authors also acknowledge the support of career development awards from the National Heart, Lung, and Blood Institute (K01 HL080939, to MCB) and the National Institute of Allergy and Infectious Diseases (K01 A1065836, to CDM).	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Attamna A, 2009, THORAX, V64, P271, DOI 10.1136/thx.2008.100974; Bayona J, 2003, INT J TUBERC LUNG D, V7, pS501; Cobelens FGJ, 2008, PLOS MED, V5, P1037, DOI 10.1371/journal.pmed.0050150; Fraser A, 2006, Cochrane Database Syst Rev, pCD005435; Furin JJ, 2000, EUR J CLIN MICROBIOL, V19, P132, DOI 10.1007/s100960050445; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Kritski AL, 1996, AM J RESP CRIT CARE, V153, P331, DOI 10.1164/ajrccm.153.1.8542139; Medical Research Council, 1974, B WORLD HEALTH ORGAN, V51, P473; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mohammadi A., 2008, Eastern Mediterranean Health Journal, V14, P1238; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Teixeira L, 2001, INT J TUBERC LUNG D, V5, P321; Tuberculosis Coalition for Technical Assistance, INT STAND TUB CAR IS; *UNAIDS WHO, UNAIDS WHO EP FACT S; [World Health Organization International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance], 1997, WHOCDSTB1997229 INT; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization (WHO), GUID PROGR MAN DRUG	21	97	98	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					147	152		10.1016/S0140-6736(10)61972-1	http://dx.doi.org/10.1016/S0140-6736(10)61972-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21145581				2022-12-24	WOS:000286292800027
J	Park, H; Pontius, W; Guet, CC; Marko, JF; Emonet, T; Cluzel, P				Park, Heungwon; Pontius, William; Guet, Calin C.; Marko, John F.; Emonet, Thierry; Cluzel, Philippe			Interdependence of behavioural variability and response to small stimuli in bacteria	NATURE			English	Article							SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; CHEMOTAXIS; NOISE; SENSITIVITY; ROBUSTNESS; NETWORKS; SYSTEMS; GENE	The chemotaxis signalling network in Escherichia coli that controls the locomotion of bacteria is a classic model system for signal transduction(1,2). This pathway modulates the behaviour of flagellar motors to propel bacteria towards sources of chemical attractants. Although this system relaxes to a steady state in response to environmental changes, the signalling events within the chemotaxis network are noisy and cause large temporal variations of the motor behaviour even in the absence of stimulus(3). That the same signalling network governs both behavioural variability and cellular response raises the question of whether these two traits are independent. Here, we experimentally establish a fluctuation-response relationship in the chemotaxis system of living bacteria. Using this relationship, we demonstrate the possibility of inferring the cellular response from the behavioural variability measured before stimulus. In monitoring the pre- and post-stimulus switching behaviour of individual bacterial motors, we found that variability scales linearly with the response time for different functioning states of the cell. This study highlights that the fundamental relationship between fluctuation and response is not constrained to physical systems at thermodynamic equilibrium(4) but is extensible to living cells(5). Such a relationship not only implies that behavioural variability and cellular response can be coupled traits, but it also provides a general framework within which we can examine how the selection of a network design shapes this interdependence.	[Guet, Calin C.; Cluzel, Philippe] Harvard Univ, FAS Ctr Syst Biol, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Guet, Calin C.; Cluzel, Philippe] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Park, Heungwon] Univ Chicago, James Franck Inst, Inst Biophys Dynam, Chicago, IL 60637 USA; [Park, Heungwon] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Pontius, William; Emonet, Thierry] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pontius, William; Emonet, Thierry] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Marko, John F.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Marko, John F.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	Harvard University; Harvard University; University of Chicago; University of Chicago; Yale University; Yale University; Northwestern University; Northwestern University	Cluzel, P (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	cluzel@mcb.harvard.edu	Emonet, Thierry/AAI-3740-2020; Marko, John F./AAY-7111-2021	Marko, John F./0000-0003-4151-9530	NSF DMR [0213745]; NIH [R01AI059195-03, 1U54CA143869-01]; NSF [CCF0829836, PHY-0852130, DMR-0715099]; Alfred P. Sloan Research Fellowship; National Academies Keck Futures Initiative; Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	NSF DMR(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); National Academies Keck Futures Initiative; Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by an NSF DMR award 0213745 to the Materials Research Science and Engineering Center at the University of Chicago, and NIH award R01AI059195-03 (to P.C.). W.P. and T.E. were supported by NSF CCF0829836, an Alfred P. Sloan Research Fellowship, and a National Academies Keck Futures Initiative award (to T.E.). J.F.M. was supported by NSF awards PHY-0852130 and DMR-0715099 and NIH grant 1U54CA143869-01. This work was also supported by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. D. Trentham supplied caged L-aspartate. We thank J. S. Parkinson for ADCheB mutant strains RP4972 and RP4992. We thank T. Shimizu for discussions and sharing unpublished work. We thank H. Lee for help with the HPLC measurements. We thank J. Moffitt and K. Wood for comments on the manuscript and all members of the Cluzel laboratory for many discussions. W. Grus provided editorial assistance.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Anderson RL, 1942, ANN MATH STAT, V13, P1, DOI 10.1214/aoms/1177731638; Andrews BW, 2006, PLOS COMPUT BIOL, V2, P1407, DOI 10.1371/journal.pcbi.0020154; Bainer R, 2003, J MICROBIOL METH, V55, P315, DOI 10.1016/S0167-7012(03)00112-X; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Berg HC, 2000, PHYS TODAY, V53, P24, DOI 10.1063/1.882934; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; CALLEN HB, 1951, PHYS REV, V83, P34, DOI 10.1103/PhysRev.83.34; Chetrite R, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/08/P08005; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Cugliandolo LF, 1997, PHYS REV LETT, V79, P2168, DOI 10.1103/PhysRevLett.79.2168; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Dorignac J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.186105; Emonet T, 2008, P NATL ACAD SCI USA, V105, P3304, DOI 10.1073/pnas.0705463105; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Jasuja R, 1999, P NATL ACAD SCI USA, V96, P11346, DOI 10.1073/pnas.96.20.11346; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Prost J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.090601; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Ratnam R, 2000, J NEUROSCI, V20, P6672, DOI 10.1523/JNEUROSCI.20-17-06672.2000; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998	35	52	52	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					819	U114		10.1038/nature09551	http://dx.doi.org/10.1038/nature09551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21076396	Green Accepted			2022-12-24	WOS:000285093700045
J	Moller, BL				Moller, Birger Lindberg			Dynamic Metabolons	SCIENCE			English	Editorial Material							CYANOGENIC GLUCOSIDE DHURRIN; SORGHUM-BICOLOR; BIOSYNTHESIS; CONVERSION; EXPRESSION; CATALYZES; CLONING; COMPLEX		Univ Copenhagen, Dept Plant Biol & Biotechnol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark	University of Copenhagen	Moller, BL (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark.	blm@life.ku.dk	Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022	Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119				An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; Bartosova L, 2006, NEUROTOX RES, V9, P291, DOI 10.1007/BF03033319; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006; DRUMM JE, 1995, ACS SYM SER, V584, P396; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Moller BL, 2010, CURR OPIN PLANT BIOL, V13, P338, DOI 10.1016/j.pbi.2010.01.009; MOLLER BL, 1980, J BIOL CHEM, V255, P3049; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Rusch GM, 2009, DRUG CHEM TOXICOL, V32, P381, DOI 10.1080/01480540903154187; Sakurada K, 2009, TOXICOL LETT, V189, P110, DOI 10.1016/j.toxlet.2009.05.007; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; Thellier M, 2006, FEBS J, V273, P4287, DOI 10.1111/j.1742-4658.2006.05425.x; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659	18	97	98	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1328	1329		10.1126/science.1194971	http://dx.doi.org/10.1126/science.1194971			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127236				2022-12-24	WOS:000284902100026
J	Xiong, P; Nocek, JM; Vura-Weis, J; Lockard, JV; Wasielewski, MR; Hoffman, BM				Xiong, Peng; Nocek, Judith M.; Vura-Weis, Josh; Lockard, Jenny V.; Wasielewski, Michael R.; Hoffman, Brian M.			Faster Interprotein Electron Transfer in a [Myoglobin, b(5)] Complex with a Redesigned Interface	SCIENCE			English	Article							CYTOCHROME-OXIDASE; PROTEINS; STATE	Direct measurements of electron transfer (ET) within a protein-protein complex with a redesigned interface formed by physiological partner proteins myoglobin (Mb) and cytochrome b(5) (b(5)) reveal interprotein ET rates comparable to those observed within the photosynthetic reaction center. Brownian dynamics simulations show that Mb in which three surface acid residues are mutated to lysine binds b(5) in an ensemble of configurations distributed around a reactive most-probable structure. Correspondingly, charge-separation ET from a photoexcited singlet zinc porphyrin incorporated within Mb to the heme of b(5) and the follow-up charge-recombination exhibit distributed kinetics, with median rate constants, k(f)(s) = 2.1 x 10(9) second(-1) and k(b)(s) = 4.3 x 10(10) second(-1), respectively. The latter approaches that for the initial step in photosynthetic charge separation, k = 3.3 x 10(11) second(-1).	[Xiong, Peng; Nocek, Judith M.; Vura-Weis, Josh; Lockard, Jenny V.; Wasielewski, Michael R.; Hoffman, Brian M.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Xiong, Peng] Huaiyin Inst Technol, Sch Life Sci & Chem Engn, Huaian 223003, Jiangsu Prov, Peoples R China; [Vura-Weis, Josh; Lockard, Jenny V.; Wasielewski, Michael R.] Northwestern Univ, Argonne NW Solar Energy Res Ctr, Evanston, IL 60208 USA	Northwestern University; Huaiyin Institute of Technology; Northwestern University	Wasielewski, MR (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	bmh@northwestern.edu	Nocek, Judith/D-1254-2010; xiong, peng/AAF-1569-2021; xiong, peng/AAT-6376-2020		National Institute of Health [HL063203]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001059]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063203] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided as follows: P. X., J.M.N., and B. M. H., the National Institute of Health (grant HL063203); J.V.-W., J.V.L., and M. R. W., as part of the ANSER Center, an Energy Frontier Research Center funded by U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (DE-SC0001059).	[Anonymous], 2002, PHOTOSYNTHETICA; Beratan DN, 2009, ACCOUNTS CHEM RES, V42, P1669, DOI 10.1021/ar900123t; Berberan-Santos MN, 2005, CHEM PHYS, V315, P171, DOI 10.1016/j.chemphys.2005.04.006; Davidson VL, 2008, ACCOUNTS CHEM RES, V41, P730, DOI 10.1021/ar700252c; Geren L, 2009, METHOD ENZYMOL, V456, P507, DOI 10.1016/S0076-6879(08)04428-5; Gong XM, 2003, BIOCHEMISTRY-US, V42, P14492, DOI 10.1021/bi035603c; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Ivkovic-Jensen MM, 1999, BIOCHEMISTRY-US, V38, P1589, DOI 10.1021/bi9817156; Lukoyanov D, 2007, P NATL ACAD SCI USA, V104, P1451, DOI 10.1073/pnas.0610975104; NOCEK JM, 1991, J AM CHEM SOC, V113, P6822, DOI 10.1021/ja00018a017; Nocek JM, 1997, J AM CHEM SOC, V119, P2146, DOI 10.1021/ja9630811; Nocek JM, 2010, J AM CHEM SOC, V132, P6165, DOI 10.1021/ja100499j; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; PAPP S, 1990, BIOPHYS J, V58, P177, DOI 10.1016/S0006-3495(90)82363-8; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; WINKLER JR, 1995, BIOPHYS CHEM, V54, P199, DOI 10.1016/0301-4622(94)00156-E	16	50	50	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2010	330	6007					1075	1078		10.1126/science.1197054	http://dx.doi.org/10.1126/science.1197054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097931	Green Accepted			2022-12-24	WOS:000284374700035
J	Pen, I; Uller, T; Feldmeyer, B; Harts, A; While, GM; Wapstra, E				Pen, Ido; Uller, Tobias; Feldmeyer, Barbara; Harts, Anna; While, Geoffrey M.; Wapstra, Erik			Climate-driven population divergence in sex-determining systems	NATURE			English	Article							ADAPTIVE SIGNIFICANCE; OFFSPRING SEX; EVOLUTION; RATIO; SIZE	Sex determination is a fundamental biological process, yet its mechanisms are remarkably diverse(1,2). In vertebrates, sex can be determined by inherited genetic factors or by the temperature experienced during embryonic development(2,3). However, the evolutionary causes of this diversity remain unknown. Here we show that live-bearing lizards at different climatic extremes of the species' distribution differ in their sex-determining mechanisms, with temperature-dependent sex determination in lowlands and genotypic sex determination in highlands. A theoretical model parameterized with field data accurately predicts this divergence in sex-determining systems and the consequence thereof for variation in cohort sex ratios among years. Furthermore, we show that divergent natural selection on sex determination across altitudes is caused by climatic effects on lizard life history and variation in the magnitude of between-year temperature fluctuations. Our results establish an adaptive explanation for intra-specific divergence in sex-determining systems driven by phenotypic plasticity and ecological selection, thereby providing a unifying framework for integrating the developmental, ecological and evolutionary basis for variation in vertebrate sex determination.	[Pen, Ido; Feldmeyer, Barbara; Harts, Anna] Univ Groningen, Theoret Biol Grp, NL-9750 AA Haren, Netherlands; [Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [While, Geoffrey M.; Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia	University of Groningen; University of Oxford; University of Tasmania	Pen, I (corresponding author), Univ Groningen, Theoret Biol Grp, POB 14, NL-9750 AA Haren, Netherlands.	i.r.pen@rug.nl	Feldmeyer, Barbara/E-5067-2015; Wapstra, Erik/J-7482-2014; Feldmeyer, Barbara/F-9652-2013; While, Geoffrey M/O-6306-2017	Feldmeyer, Barbara/0000-0002-0413-7245; Wapstra, Erik/0000-0002-2050-8026; While, Geoffrey M/0000-0001-8122-9322	Australian Research Council [DP0877948]; Hermon Slade Foundation; Wenner-Gren Foundations	Australian Research Council(Australian Research Council); Hermon Slade Foundation; Wenner-Gren Foundations	Funding was provided by the Australian Research Council to E.W., T.U. and I.P. (DP0877948), by the Hermon Slade Foundation to E.W., T.U. and I.P., and by the Wenner-Gren Foundations to T.U.	Adolph SC, 1996, OIKOS, V77, P267, DOI 10.2307/3546065; Atkins N., 2007, THESIS U TASMANIA; Bull J. J., 1983, EVOLUTION SEX DETERM; BULMER MG, 1982, EVOLUTION, V36, P13, DOI 10.1111/j.1558-5646.1982.tb05005.x; Cadby CD, 2010, INTEGR ZOOL, V5, P164, DOI 10.1111/j.1749-4877.2010.00201.x; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; CONOVER DO, 1987, NATURE, V326, P496, DOI 10.1038/326496a0; CONOVER DO, 1984, AM NAT, V123, P297, DOI 10.1086/284205; Crews D, 2009, SEMIN CELL DEV BIOL, V20, P251, DOI 10.1016/j.semcdb.2009.02.004; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Leimar O, 2006, AM NAT, V167, P367, DOI 10.1086/499566; Melville J, 2000, BIOL J LINN SOC, V70, P667; Neaves L, 2006, J EXP ZOOL PART A, V305A, P74, DOI 10.1002/jez.a.249; Olsson M, 2002, EVOLUTION, V56, P1538; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Quinn AE, 2007, SCIENCE, V316, P411, DOI 10.1126/science.1135925; Radder R., 2009, CURR BIOL, V19, P1; Uller T, 2007, TRENDS ECOL EVOL, V22, P292, DOI 10.1016/j.tree.2007.03.008; Uller T, 2009, SEMIN CELL DEV BIOL, V20, P304, DOI 10.1016/j.semcdb.2008.11.013; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Van Dooren TJM, 2003, EVOLUTION, V57, P2667, DOI 10.1554/03-280; Wapstra E, 2004, P ROY SOC B-BIOL SCI, V271, pS230, DOI 10.1098/rsbl.2003.0152; Wapstra E, 2001, COPEIA, P646, DOI 10.1643/0045-8511(2001)001[0646:GVIAAS]2.0.CO;2; Wapstra E, 2001, J HERPETOL, V35, P194, DOI 10.2307/1566108; Wapstra E, 2009, J ANIM ECOL, V78, P84, DOI 10.1111/j.1365-2656.2008.01470.x; Warner DA, 2008, NATURE, V451, P566, DOI 10.1038/nature06519; Warner DA, 2009, EVOL ECOL, V23, P281, DOI 10.1007/s10682-007-9222-4; West-Eberhard Mary Jane, 2003, pi	28	120	122	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					436	U262		10.1038/nature09512	http://dx.doi.org/10.1038/nature09512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20981009				2022-12-24	WOS:000284313100042
J	Shrank, WH; Choudhry, NK; Fischer, MA; Avorn, J; Powell, M; Schneeweiss, S; Liberman, JN; Dollear, T; Brennan, TA; Brookhart, MA				Shrank, William H.; Choudhry, Niteesh K.; Fischer, Michael A.; Avorn, Jerry; Powell, Mark; Schneeweiss, Sebastian; Liberman, Joshua N.; Dollear, Timothy; Brennan, Troyen A.; Brookhart, M. Alan			The Epidemiology of Prescriptions Abandoned at the Pharmacy	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICATION ADHERENCE; NONADHERENCE; PERSISTENCE; MORTALITY; VALIDITY; DRUGS; PROXY	Background: Picking up prescriptions is an essential but previously unstudied component of adherence for patients who use retail pharmacies. Understanding the epidemiology and correlates of prescription abandonment may have an important effect on health care quality. Objective: To evaluate the rates and correlates of prescription abandonment. Design: Cross-sectional cohort study. Setting: One large retail pharmacy chain and one large pharmacy benefits manager (PBM) in the United States. Measurements: Prescriptions bottled at the retail pharmacy chain between 1 July 2008 and 30 September 2008 by patients insured by the PBM were identified. Pharmacy data were used to identify medications that were bottled and either dispensed or returned to stock (RTS) or abandoned. Data from the PBM were used to identify previous or subsequent dispensing at any pharmacy. The first (index) prescription in a class for each patient was assigned to 1 of 3 mutually exclusive outcomes: filled, RTS, or RTS with fill (in the 30 days after abandonment, the patient purchased a prescription for a medication in the same medication class at any pharmacy). Outcome rates were assessed by drug class, and generalized estimating equations were used to assess patient, neighborhood, insurance, and prescription characteristics associated with abandonment. Results: 10 349 139 index prescriptions were filled by 5 249 380 patients. Overall, 3.27% of index prescriptions were abandoned; 1.77% were RTS and 1.50% were RTS with fill. Patients were least likely to abandon opiate prescriptions. Prescriptions with copayments of $40 to $50 and prescriptions costing more than $50 were 3.40 times and 4.68 times more likely, respectively, to be abandoned than prescriptions with no copayment (P < 0.001 for both comparisons). New users of medications had a 2.74 times greater probability of abandonment than prevalent users (P < 0.001), and prescriptions delivered electronically were 1.64 times more likely to be abandoned than those that were not electronic (P < 0.001). Limitation: The study included mainly insured patients and analyzed data collected during the summer months only. Conclusion: Although prescription abandonment represents a small component of medication nonadherence, the correlates to abandonment highlight important opportunities to intervene and thereby improve medication taking.	[Shrank, William H.] Brigham & Womens Hosp, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Ctr Amer Polit Studies, Cambridge, MA 02138 USA; CVS Caremark, Woonsocket, RI USA; CVS Caremark, Hunt Valley, MD USA; Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; University of North Carolina; University of North Carolina Chapel Hill	Shrank, WH (corresponding author), Brigham & Womens Hosp, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	wshrank@partners.org			CVS Caremark; National Heart, Lung, and Blood Institute [HL-090505]; National Institutes of Health [AG-027400]; Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL090505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG027400] Funding Source: NIH RePORTER	CVS Caremark; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By a research grant from CVS Caremark. Dr. Shrank is supported by a career development award from the National Heart, Lung, and Blood Institute (HL-090505), and Dr. Brookhart is supported by a career development grant from the National Institutes of Health (AG-027400).; Dr. Shrank: Grants (money to institution): National Institutes of Health (National Heart, Lung, and Blood career development award), CVS Caremark. Drs. Choudhry, Fischer, Avorn, and Brookhart: Grants (money to institution): CVS Caremark. Dr. Schneeweiss: Grants (money to institution): CVS Caremark. Board membership: HealthCore. Consultancy: WHISCON, RTI Health Solutions, The Lewin Group. Grants/grants pending: Pfizer. Drs. Liberman, Dollear, and Brennan: Employment: CVS Caremark. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOf InterestForms.do?msNum = M10-1125.	Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Choudhry NK, 2007, HEALTH AFFAIR, V26, P186, DOI 10.1377/hlthaff.26.1.186; CHOUDHRY NK, 2010, ARCH INTERN IN PRESS, P27953; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Gellad WF, 2009, HEALTH SERV RES, V44, P606, DOI 10.1111/j.1475-6773.2008.00917.x; Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; *GRANT THORNT, 2007, COST DISP STUD IND C, P27953; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; *KAIS FAM FDN, US PRESCR DRUGS, P27953; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Lee JY, 1996, AM J HYPERTENS, V9, P719, DOI 10.1016/0895-7061(96)00056-8; Lee TJ, 2004, ALIMENT PHARM THER, V20, P1241, DOI 10.1111/j.1365-2036.2004.02289.x; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Shah NR, 2009, J GEN INTERN MED, V24, P233, DOI 10.1007/s11606-008-0870-z; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shrank WH, 2005, AM J MANAG CARE, V11, P16; Shrank WH, 2006, ANN PHARMACOTHER, V40, P1534, DOI 10.1345/aph.1H158; Shrank WH, 2009, MED CARE, V47, P319, DOI 10.1097/MLR.0b013e31818af850; Soobader MJ, 2001, AM J PUBLIC HEALTH, V91, P632, DOI 10.2105/AJPH.91.4.632; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; U. S. Bureau of the Census, 2002, CENS 2000 URB RUR CL; World Health Organization, 2003, ADHERENCE LONG TERM	28	79	79	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 16	2010	153	10					633	640		10.7326/0003-4819-153-10-201011160-00005	http://dx.doi.org/10.7326/0003-4819-153-10-201011160-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680ES	21079218				2022-12-24	WOS:000284215800015
J	De Roock, W; Jonker, DJ; Di Nicolantonio, F; Sartore-Bianchi, A; Tu, DS; Siena, S; Lamba, S; Arena, S; Frattini, M; Piessevaux, H; Van Cutsem, E; O'Callaghan, CJ; Khambata-Ford, S; Zalcberg, JR; Simes, J; Karapetis, CS; Bardelli, A; Tejpar, S				De Roock, Wendy; Jonker, Derek J.; Di Nicolantonio, Federica; Sartore-Bianchi, Andrea; Tu, Dongsheng; Siena, Salvatore; Lamba, Simona; Arena, Sabrina; Frattini, Milo; Piessevaux, Hubert; Van Cutsem, Eric; O'Callaghan, Chris J.; Khambata-Ford, Shirin; Zalcberg, John R.; Simes, John; Karapetis, Christos S.; Bardelli, Alberto; Tejpar, Sabine			Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH; OXALIPLATIN; IRINOTECAN; CARCINOMA; EFFICACY	Context Patients with metastatic colorectal cancer who have KRAS codon 12- or KRAS codon 13-mutated tumors are presently excluded from treatment with the anti-epidermal growth factor receptor monoclonal antibody cetuximab. Objective To test the hypothesis that KRAS codon 13 mutations are associated with a better outcome after treatment with cetuximab than observed with other KRAS mutations. Design, Setting, and Patients We studied the association between KRAS mutation status (p.G13D vs other KRAS mutations) and response and survival in a pooled data set of 579 patients with chemotherapy-refractory colorectal cancer treated with cetuximab between 2001 and 2008. Patients were included in the CO. 17, BOND, MABEL, EMR202600, EVEREST, BABEL, or SALVAGE clinical trials or received off-study treatment. Univariate and multivariate analyses, adjusting for possible prognostic factors and data set, were performed. The effect of the different mutations was studied in vitro by constructing isogenic cell lines with wild-type KRAS, p.G12V, or p.G13D mutant alleles and treating them with cetuximab. Main Outcome Measures The main efficacy end point was overall survival. Secondary efficacy end points were response rate and progression-free survival. Results In comparison with patients with other KRAS-mutated tumors, patients with p.G13D-mutated tumors (n=32) treated with cetuximab had longer overall survival (median, 7.6 [95% confidence interval {CI}, 5.7-20.5] months vs 5.7 [95% CI, 4.9-6.8] months; adjusted hazard ratio [HR], 0.50; 95% CI, 0.31-0.81; P=.005) and longer progression-free survival (median, 4.0 [95% CI, 1.9-6.2] months vs 1.9 [95% CI, 1.8-2.8] months; adjusted HR, 0.51; 95% CI, 0.32-0.81; P=.004). There was a significant interaction between KRAS mutation status (p.G13D vs other KRAS mutations) and overall survival benefit with cetuximab treatment (adjusted HR, 0.30; 95% CI, 0.14-0.67; P=.003). In vitro and mouse model analysis showed that although p.G12V-mutated colorectal cells were insensitive to cetuximab, p.G13D-mutated cells were sensitive, as were KRAS wild-type cells. Conclusions In this analysis, use of cetuximab was associated with longer overall and progression-free survival among patients with chemotherapy-refractory colorectal cancer with p.G13D-mutated tumors than with other KRAS-mutated tumors. Evaluation of cetuximab therapy in these tumors in prospective randomized trials may be warranted. JAMA. 2010; 304(16): 1812-1820	[Van Cutsem, Eric; Tejpar, Sabine] Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium; [Di Nicolantonio, Federica; Lamba, Simona; Arena, Sabrina; Bardelli, Alberto] Univ Turin, Sch Med, Inst Canc Res & Treatment, Mol Genet Lab, I-10060 Turin, Italy; [De Roock, Wendy; Tejpar, Sabine] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Jonker, Derek J.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Di Nicolantonio, Federica; Bardelli, Alberto] Italian Fdn Canc Res, Inst Mol Oncol, Milan, Italy; [Sartore-Bianchi, Andrea; Siena, Salvatore] Osped Niguarda Ca Granda, Falck Div Med Oncol, Milan, Italy; [Tu, Dongsheng; O'Callaghan, Chris J.] Natl Canc Inst Canada, Clin Trials Grp, Kingston, ON, Canada; [Frattini, Milo] Inst Pathol, Lab Mol Diagnost, Locarno, Switzerland; [Piessevaux, Hubert] Clin Univ St Luc, B-1200 Brussels, Belgium; [Khambata-Ford, Shirin] Bristol Myers Squibb Res & Dev, Princeton, NJ USA; [Zalcberg, John R.] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Zalcberg, John R.] Australasian Gastrointestinal Trials Grp, Melbourne, Vic, Australia; [Simes, John] Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, Australia; [Karapetis, Christos S.] Flinders Med Ctr, Adelaide, SA, Australia; [Karapetis, Christos S.] Flinders Univ S Australia, Adelaide, SA, Australia	KU Leuven; University Hospital Leuven; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Turin; KU Leuven; University of Ottawa; Ottawa Hospital Research Institute; IFOM - FIRC Institute of Molecular Oncology; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Queens University - Canada; Canadian Cancer Trials Group; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Bristol-Myers Squibb; Peter Maccallum Cancer Center; University of Melbourne; University of Sydney; Flinders Medical Centre; Flinders University South Australia	Tejpar, S (corresponding author), Univ Hosp Gasthuisberg, Digest Oncol Unit, Herestr 49, B-3000 Louvain, Belgium.	a.bardelli@unito.it; sabine.tejpar@uzleuven.be	Di Nicolantonio, Federica/A-2503-2011; SIENA, SALVATORE/AAC-5806-2019; Vickers, Michael M/E-4095-2010; Arena, Sabrina/H-4985-2012; Piessevaux, Hubert/N-9558-2019; Sartore-Bianchi, Andrea/AAB-9848-2019; Van+Cutsem, Eric/ABE-1762-2021; Simes, Robert John/P-1497-2014; BARDELLI, Alberto/J-9721-2018	Di Nicolantonio, Federica/0000-0001-9618-2010; SIENA, SALVATORE/0000-0002-2681-2846; Arena, Sabrina/0000-0002-1318-2494; Piessevaux, Hubert/0000-0003-1193-0601; Sartore-Bianchi, Andrea/0000-0003-0780-0409; Zalcberg, John/0000-0002-6624-0782; Karapetis, Christos/0000-0003-1741-996X; BARDELLI, Alberto/0000-0003-1647-5070; Lamba, Simona Elena/0000-0003-3207-1594	Merck Serono; Amgen; Bristol-Myers Squibb; Horizon Discovery; Institute for the Promotion of Innovation Through Science and Technology in Flanders (IWT-Vlaanderen); Siena are supported by Associazione Italiana Ricerca Cancro and Oncologia Ca'Granda Onlus Fondazione; Belgian Federation Against Cancer; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Merck Serono(Merck & Company); Amgen(Amgen); Bristol-Myers Squibb(Bristol-Myers Squibb); Horizon Discovery; Institute for the Promotion of Innovation Through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Siena are supported by Associazione Italiana Ricerca Cancro and Oncologia Ca'Granda Onlus Fondazione(Fondazione AIRC per la ricerca sul cancro); Belgian Federation Against Cancer; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Dr Siena reports serving as a member of advisory boards for Merck Serono, Amgen, AstraZeneca, and Celgene. Dr Van Cutsem reports receiving research funding from Merck Serono and Amgen. Dr Khambata-Ford reports owning equity in and is an employee of Bristol-Myers Squibb. Dr Zalcberg reports receiving travel and research support from Merck Serono and research support from Bristol-Myers Squibb. Dr Simes reports that his institution has received research grants from Bristol-Myers Squibb. Dr Karapetis reports serving as a member of an advisory board for Merck Serono. Dr Bardelli reports that he owns stock in and has received consultancy fees from Horizon Discovery. Dr Tejpar reports receiving research grants from Merck Serono. No other disclosures were reported.; Dr De Roock is supported by a PhD grant from the Institute for the Promotion of Innovation Through Science and Technology in Flanders (IWT-Vlaanderen). Drs Sartore-Bianchi and Siena are supported by Associazione Italiana Ricerca Cancro and Oncologia Ca'Granda Onlus Fondazione. Drs Van Cutsem and Tejpar are senior clinical investigators for the Fund for Scientific Research, Flanders and received research grants from the Belgian Federation Against Cancer.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; [Anonymous], 2008, CHMPEWP185042006 EMA; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; European Medicines Agency, 2007, QUEST ANSW MARK AUTH; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Guerrero S, 2000, CANCER RES, V60, P6750; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lee CN, 2010, J CLIN ONCOL, V28, pE111, DOI 10.1200/JCO.2009.24.0747; Lenz HJ, 2006, J CLIN ONCOL, V24, P4914, DOI 10.1200/JCO.2006.06.7595; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Pessino A, 2008, ANN ONCOL, V19, P711, DOI 10.1093/annonc/mdm516; Tejpar S, 2007, J CLIN ONCOL, V25; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; US Food and Drug Administration, CET ERB PAN VECT; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wellcome Trust Sanger Institute, CAT SOM MUT CANC; Wilke H, 2006, J CLIN ONCOL, V24, p158S	23	570	590	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1812	1820		10.1001/jama.2010.1535	http://dx.doi.org/10.1001/jama.2010.1535			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20978259	Bronze			2022-12-24	WOS:000283501300022
J	Karunatilaka, KS; Solem, A; Pyle, AM; Rueda, D				Karunatilaka, Krishanthi S.; Solem, Amanda; Pyle, Anna Marie; Rueda, David			Single-molecule analysis of Mss116-mediated group II intron folding	NATURE			English	Article							DEAD-BOX PROTEIN; CHAPERONE ACTIVITY; ATP HYDROLYSIS; SPECTROSCOPY; REQUIRES; RIBOZYME; FRET	DEAD-box helicases are conserved enzymes involved in nearly all aspects of RNA metabolism, but their mechanisms of action remain unclear. Here, we investigated the mechanism of the DEAD-box protein Mss116 on its natural substrate, the group II intron ai5 gamma. Group II introns are structurally complex catalytic RNAs considered evolutionarily related to the eukaryotic spliceosome, and an interesting paradigm for large RNA folding. We used single-molecule fluorescence to monitor the effect of Mss116 on folding dynamics of a minimal active construct, ai5 gamma-D135. The data show that Mss116 stimulates dynamic sampling between states along the folding pathway, an effect previously observed only with high Mg2+ concentrations. Furthermore, the data indicate that Mss116 promotes folding through discrete ATP-independent and ATP-dependent steps. We propose that Mss116 stimulates group II intron folding through a multi-step process that involves electrostatic stabilization of early intermediates and ATP hydrolysis during the final stages of native state assembly.	[Karunatilaka, Krishanthi S.; Solem, Amanda; Rueda, David] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Wayne State University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Rueda, D (corresponding author), Wayne State Univ, Dept Chem, 5101 Cass Ave, Detroit, MI 48202 USA.	anna.pyle@yale.edu; david.rueda@wayne.edu	Rueda, David S./F-9065-2014; Solem, Amanda/M-5959-2013; Solem, Amanda/A-3553-2010	Rueda, David S./0000-0003-4657-6323; Solem, Amanda/0000-0002-2056-9419; 	National Institutes of Health [R01GM085116, R01GM050313]; National Science Foundation [MCB-0747285]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085116, R01GM050313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. K. Sigel and O. Fedorova for many helpful and stimulating discussions and for commenting on the manuscript, and A. Feig, K. Musier-Forsyth and R. Lamichhane for protein gifts. This work was supported by the National Institutes of Health (R01GM085116 to D.R., R01GM050313 to A.M.P.) and the National Science Foundation (MCB-0747285 to D.R.). A.M.P. is an HHMI investigator.	Bifano AL, 2010, J MOL BIOL, V398, P429, DOI 10.1016/j.jmb.2010.03.025; Christian TD, 2009, P NATL ACAD SCI USA, V106, P21109, DOI 10.1073/pnas.0908640106; Clodi E, 1999, EMBO J, V18, P3776, DOI 10.1093/emboj/18.13.3776; Del Campo M, 2007, MOL CELL, V28, P159, DOI 10.1016/j.molcel.2007.07.028; Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503; Fedorova O, 2007, J MOL BIOL, V366, P1099, DOI 10.1016/j.jmb.2006.12.003; Fedorova O, 2010, J MOL BIOL, V397, P799, DOI 10.1016/j.jmb.2010.02.001; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; Hopkins JF, 2009, NUCLEIC ACIDS RES, V37, P6205, DOI 10.1093/nar/gkp646; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; KOCH JL, 1992, MOL CELL BIOL, V12, P1950, DOI 10.1128/MCB.12.5.1950; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Linder P, 2000, CURR BIOL, V10, pR887, DOI 10.1016/S0960-9822(00)00857-5; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; Noah JW, 2003, BIOCHEMISTRY-US, V42, P12466, DOI 10.1021/bi035339n; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Qin PZF, 1997, BIOCHEMISTRY-US, V36, P4718, DOI 10.1021/bi962665c; SHUMAN S, 1980, J BIOL CHEM, V255, P5396; Solem A, 2006, MOL CELL, V24, P611, DOI 10.1016/j.molcel.2006.10.032; Steiner M, 2008, P NATL ACAD SCI USA, V105, P13853, DOI 10.1073/pnas.0804034105; Steiner M, 2009, ANGEW CHEM INT EDIT, V48, P9739, DOI 10.1002/anie.200903809; Su LJ, 2005, NUCLEIC ACIDS RES, V33, P6674, DOI 10.1093/nar/gki973; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Waldsich C, 2007, NAT STRUCT MOL BIOL, V14, P37, DOI 10.1038/nsmb1181; ZHANG A, 1995, RNA, V1, P783; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017; ZINGLER N, 2010, NUCL ACIDS IN PRESS	35	62	63	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					935	U75		10.1038/nature09422	http://dx.doi.org/10.1038/nature09422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20944626	Green Accepted			2022-12-24	WOS:000283254700031
J	Noppe, IC				Noppe, Illene C.			Sounds of My Father	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												noppei@uwgb.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1535	1536		10.1001/jama.2010.1404	http://dx.doi.org/10.1001/jama.2010.1404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940374				2022-12-24	WOS:000282816500001
J	Knox, SM; Lombaert, IMA; Reed, X; Vitale-Cross, L; Gutkind, JS; Hoffman, MP				Knox, S. M.; Lombaert, I. M. A.; Reed, X.; Vitale-Cross, L.; Gutkind, J. S.; Hoffman, M. P.			Parasympathetic Innervation Maintains Epithelial Progenitor Cells During Salivary Organogenesis	SCIENCE			English	Article							GLAND BRANCHING MORPHOGENESIS; SUBMANDIBULAR-GLAND; STEM-CELLS; CONDITIONAL EXPRESSION; K-RAS; DIFFERENTIATION; MECHANISMS; NERVES; LIVER; SKIN	The maintenance of a progenitor cell population as a reservoir of undifferentiated cells is required for organ development and regeneration. However, the mechanisms by which epithelial progenitor cells are maintained during organogenesis are poorly understood. We report that removal of the parasympathetic ganglion in mouse explant organ culture decreased the number and morphogenesis of keratin 5-positive epithelial progenitor cells. These effects were rescued with an acetylcholine analog. We demonstrate that acetylcholine signaling, via the muscarinic M1 receptor and epidermal growth factor receptor, increased epithelial morphogenesis and proliferation of the keratin 5-positive progenitor cells. Parasympathetic innervation maintained the epithelial progenitor cell population in an undifferentiated state, which was required for organogenesis. This mechanism for epithelial progenitor cell maintenance may be targeted for organ repair or regeneration.	[Knox, S. M.; Lombaert, I. M. A.; Reed, X.; Hoffman, M. P.] Natl Inst Dent & Craniofacial Res, Matrix & Morphogenesis Unit, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Vitale-Cross, L.; Gutkind, J. S.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Hoffman, MP (corresponding author), Natl Inst Dent & Craniofacial Res, Matrix & Morphogenesis Unit, Lab Cell & Dev Biol, NIH, 30 Convent Dr, Bethesda, MD 20892 USA.	mhoffman@mail.nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016; Kim, Ji-Youn/A-5779-2017; Knox, Sarah Monica/GNW-5445-2022	Gutkind, J. Silvio/0000-0002-5150-4482; VItale-Cross, Lynn/0000-0001-7850-547X	National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551, ZIADE000722] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to thank V. N. Patel, I. T. Rebustini, L. M. Angerer, K. G. Ten-Hagen, K. M. Yamada, and S. Powers for discussions and critical reading of this manuscript. The study was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, NIH.	Avril-Delplanque A, 2005, STEM CELLS, V23, P992, DOI 10.1634/stemcells.2004-0197; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; COUGHLIN MD, 1975, DEV BIOL, V43, P123, DOI 10.1016/0012-1606(75)90136-0; Hai B, 2010, STEM CELLS DEV, V19, P1793, DOI 10.1089/scd.2009.0499; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Macias E, 2008, CANCER RES, V68, P162, DOI 10.1158/0008-5472.CAN-07-2461; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pavlov I. P., 1906, SCIENCE, V24, P613, DOI DOI 10.1126/SCIENCE.24.620.613; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Raimondi AR, 2006, AM J PATHOL, V168, P1654, DOI 10.2353/ajpath.2006.050847; Rebustini IT, 2009, DEV CELL, V17, P482, DOI 10.1016/j.devcel.2009.07.016; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Schafer MKH, 1998, NEUROSCIENCE, V84, P361, DOI 10.1016/S0306-4522(97)80196-0; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623	24	226	229	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1645	1647		10.1126/science.1192046	http://dx.doi.org/10.1126/science.1192046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929848	Green Accepted			2022-12-24	WOS:000282098100041
J	Thanukos, A; Scotchmoor, JG; Caldwell, R; Lindberg, DR				Thanukos, Anastasia; Scotchmoor, Judith G.; Caldwell, Roy; Lindberg, David R.			Science 101: Building the Foundations for Real Understanding	SCIENCE			English	Editorial Material									[Thanukos, Anastasia; Scotchmoor, Judith G.; Caldwell, Roy; Lindberg, David R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Caldwell, Roy; Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Caldwell, R (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.	rlcaldwell@berkeley.edu	Lindberg, David R/D-8138-2011		Howard Hughes Medical Institute [51003439] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bybee R, 2009, J RES SCI TEACH, V46, P865, DOI 10.1002/tea.20333; Lederman N.G., 2007, HDB RES SCI ED, P831, DOI [10.4324/9780203824696, DOI 10.4324/9780203824696]; Mooney C., 2009, UNSCIENTIFIC AM; National Science Board, 2010, SCI ENG IND 2010; ROCKMAN, UNDERSTANDING EVOLUT; STUHLSATZ MAM, 2010, 201008 ER BIOL SCI C	6	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1764	1765		10.1126/science.1186994	http://dx.doi.org/10.1126/science.1186994			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21127217				2022-12-24	WOS:000285603700028
J	Cannuscio, CC				Cannuscio, Carolyn C.			A Perfect Place to Die, Revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												carolyncannu@gmail.com	Cannuscio, Carolyn/A-1123-2007						0	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2452	2453		10.1001/jama.2010.1766	http://dx.doi.org/10.1001/jama.2010.1766			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139101				2022-12-24	WOS:000285053300002
J	Van Raamsdonk, CD; Griewank, KG; Crosby, MB; Garrido, MC; Vemula, S; Wiesner, T; Obenauf, AC; Wackernagel, W; Green, G; Bouvier, N; Sozen, MM; Baimukanova, G; Roy, R; Heguy, A; Dolgalev, I; Khanin, R; Busam, K; Speicher, MR; O'Brien, J; Bastian, BC				Van Raamsdonk, Catherine D.; Griewank, Klaus G.; Crosby, Michelle B.; Garrido, Maria C.; Vemula, Swapna; Wiesner, Thomas; Obenauf, Anna C.; Wackernagel, Werner; Green, Gary; Bouvier, Nancy; Sozen, M. Mert; Baimukanova, Gail; Roy, Ritu; Heguy, Adriana; Dolgalev, Igor; Khanin, Raya; Busam, Klaus; Speicher, Michael R.; O'Brien, Joan; Bastian, Boris C.			Mutations in GNA11 in Uveal Melanoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOMATIC MUTATIONS; ALPHA-SUBUNIT; HUMAN CANCER; BRAF; SKIN; MELANOCYTES; ACTIVATION; FREQUENCY; EXPOSURE; TUMORS	Background: Uveal melanoma is the most common intraocular cancer. There are no effective therapies for metastatic disease. Mutations in GNAQ, the gene encoding an alpha subunit of heterotrimeric G proteins, are found in 40% of uveal melanomas. Methods: We sequenced exon 5 of GNAQ and GNA11, a paralogue of GNAQ, in 713 melanocytic neoplasms of different types (186 uveal melanomas, 139 blue nevi, 106 other nevi, and 282 other melanomas). We sequenced exon 4 of GNAQ and GNA11 in 453 of these samples and in all coding exons of GNAQ and GNA11 in 97 uveal melanomas and 45 blue nevi. Results: We found somatic mutations in exon 5 (affecting Q209) and in exon 4 (affecting R183) in both GNA11 and GNAQ, in a mutually exclusive pattern. Mutations affecting Q209 in GNA11 were present in 7% of blue nevi, 32% of primary uveal melanomas, and 57% of uveal melanoma metastases. In contrast, we observed Q209 mutations in GNAQ in 55% of blue nevi, 45% of uveal melanomas, and 22% of uveal melanoma metastases. Mutations affecting R183 in either GNAQ or GNA11 were less prevalent (2% of blue nevi and 6% of uveal melanomas) than the Q209 mutations. Mutations in GNA11 induced spontaneously metastasizing tumors in a mouse model and activated the mitogen-activated protein kinase pathway. Conclusions: Of the uveal melanomas we analyzed, 83% had somatic mutations in GNAQ or GNA11. Constitutive activation of the pathway involving these two genes appears to be a major contributor to the development of uveal melanoma. (Funded by the National Institutes of Health and others.) N Engl J Med 2010;363:2191-9.	[Van Raamsdonk, Catherine D.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Griewank, Klaus G.; Crosby, Michelle B.; Garrido, Maria C.; Vemula, Swapna; Green, Gary; Bouvier, Nancy; Baimukanova, Gail; Bastian, Boris C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [O'Brien, Joan] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Bastian, Boris C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Roy, Ritu; O'Brien, Joan; Bastian, Boris C.] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Wiesner, Thomas] Med Univ Graz, Dept Dermatol, Graz, Austria; [Obenauf, Anna C.; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, Graz, Austria; [Wackernagel, Werner] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Bouvier, Nancy; Sozen, M. Mert; Heguy, Adriana; Dolgalev, Igor; Bastian, Boris C.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Bastian, Boris C.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	University of British Columbia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Medical University of Graz; Medical University of Graz; Medical University of Graz; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Van Raamsdonk, CD (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada.	bastianb@mskcc.org	Dolgalev, Igor/AAY-6406-2020; Griewank, Klaus G/A-9097-2017; Sozen, Mert M./E-7278-2011; Speicher, Michael R/B-5362-2013; Wackernagel, Werner/I-8581-2012; Van Raamsdonk, Catherine D./B-6207-2017; Heguy, Adriana/GPP-3907-2022	Dolgalev, Igor/0000-0003-4451-126X; Griewank, Klaus G/0000-0003-3899-9449; Sozen, Mert M./0000-0002-1672-2206; Speicher, Michael R/0000-0003-0105-955X; Wackernagel, Werner/0000-0002-4524-4012; Van Raamsdonk, Catherine D./0000-0002-4309-3513; Wiesner, Thomas/0000-0001-5877-2992; Bastian, Boris/0000-0003-1836-6062; Obenauf, Anna/0000-0002-9556-5914	National Institutes of Health [R01 CA131524]; Melanoma Research Alliance; Canadian Institutes of Health Research [MOP-79511]; Canadian Cancer Society [019055]; European Commission [HEALTH-F2-2008-202230]; Jubilaumsfonds of the Oesterreichische Nationalbank [12480, 13837]; Medical University Graz; Deutsche Forschungsgemeinschaft [GR 3671/1-1]; NATIONAL CANCER INSTITUTE [R01CA142873, R01CA131524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); European Commission(European CommissionEuropean Commission Joint Research Centre); Jubilaumsfonds of the Oesterreichische Nationalbank; Medical University Graz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Institutes of Health (R01 CA131524) and the Melanoma Research Alliance (both to Dr. Bastian), the Canadian Institutes of Health Research (MOP-79511) and the Canadian Cancer Society (019055) (both to Dr. Van Raamsdonk), the European Commission (GENINCA, contract no. HEALTH-F2-2008-202230), the Jubilaumsfonds of the Oesterreichische Nationalbank (12480 and 13837), and the Molecular Medicine program of Medical University Graz (to Dr. Obenauf), and Deutsche Forschungsgemeinschaft (research stipend GR 3671/1-1, to Dr. Griewank).	ABRAMSON DH, 2003, CANC MED 6, V2, P1242; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Bauer J, 2009, BRIT J CANCER, V101, P813, DOI 10.1038/sj.bjc.6605226; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; HORSMAN DE, 1993, CANCER, V71, P811, DOI 10.1002/1097-0142(19930201)71:3<811::AID-CNCR2820710325>3.0.CO;2-F; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; KUSTERSVANDEVEL.HV, 2009, ACTA NEUROPATHO 1122; Lamba S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006833; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Li WJ, 2000, CANCER RES, V60, P3757; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Mainster MA, 2010, AM J OPHTHALMOL, V149, P543, DOI 10.1016/j.ajo.2009.11.028; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; Mudhar HS, 2004, HISTOPATHOLOGY, V45, P1, DOI 10.1111/j.1365-2559.2004.01874.x; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Saldanha G, 2004, INT J CANCER, V111, P705, DOI 10.1002/ijc.20325; Singh AD, 2004, SURV OPHTHALMOL, V49, P419, DOI 10.1016/j.survophthal.2004.04.009; Singh AD, 1998, OPHTHALMOLOGY, V105, P195, DOI 10.1016/S0161-6420(98)92205-9; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Vajdic CM, 2002, INT J CANCER, V101, P175, DOI 10.1002/ijc.10579; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; White VA, 1998, CANCER, V83, P354, DOI 10.1002/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.3.CO;2-C; Zembowicz A, 2004, HISTOPATHOLOGY, V45, P433, DOI 10.1111/j.1365-2559.2004.01975.x; Zuidervaart W, 2005, BRIT J CANCER, V92, P2032, DOI 10.1038/sj.bjc.6602598	36	964	981	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2191	2199		10.1056/NEJMoa1000584	http://dx.doi.org/10.1056/NEJMoa1000584			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21083380	Green Accepted, Bronze			2022-12-24	WOS:000284832900006
J	Rothwell, PM; Wilson, M; Elwin, CE; Norrving, B; Algra, A; Warlow, CP; Meade, TW				Rothwell, Peter M.; Wilson, Michelle; Elwin, Carl-Eric; Norrving, Bo; Algra, Ale; Warlow, Charles P.; Meade, Tom W.			Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TRANSIENT ISCHEMIC ATTACK; ADENOMA RECURRENCE; PRIMARY PREVENTION; GENE-EXPRESSION; RISK; CYCLOOXYGENASE-2; SURVIVAL; COLON; CHEMOPREVENTION	Background High-dose aspirin (>= 500 mg daily) reduces long-term incidence of colorectal cancer, but adverse effects might limit its potential for long-term prevention. The long-term effectiveness of lower doses (75-300 mg daily) is unknown. We assessed the effects of aspirin on incidence and mortality due to colorectal cancer in relation to dose, duration of treatment, and site of tumour. Methods We followed up four randomised trials of aspirin versus control in primary (Thrombosis Prevention Trial, British Doctors Aspirin Trial) and secondary (Swedish Aspirin Low Dose Trial, UK-TA Aspirin Trial) prevention of vascular events and one trial of different doses of aspirin (Dutch TIA Aspirin Trial) and established the effect of aspirin on risk of colorectal cancer over 20 years during and after the trials by analysis of pooled individual patient data. Results In the four trials of aspirin versus control (mean duration of scheduled treatment 6.0 years), 391 (2.8%) of 14 033 patients had colorectal cancer during a median follow-up of 18.3 years. Allocation to aspirin reduced the 20-year risk of colon cancer (incidence hazard ratio [HR] 0.76, 0.60-0.96, p=0.02; mortality HR 0.65, 0.48-0.88, p=0.005), but not rectal cancer (0.90, 0.63-1.30, p=0.58; 0.80, 0.50-1.28, p=0.35). Where subsite data were available, aspirin reduced risk of cancer of the proximal colon (0.45, 0.28-0.74, p=0.001; 0.34, 0.18-0.66, p=0.001), but not the distal colon (1.10, 0.73-1.64, p=0.66; 1.21, 0.66-2.24, p=0.54; for incidence difference p=0.04, for mortality difference p=0.01). However, benefit increased with scheduled duration of treatment, such that allocation to aspirin of 5 years or longer reduced risk of proximal colon cancer by about 70% (0.35, 0.20-0.63; 0.24, 0.11-0.52; both p<0.0001) and also reduced risk of rectal cancer (0.58, 0.36-0.92, p=0.02; 0.47, 0.26-0.87, p=0.01). There was no increase in benefit at doses of aspirin greater than 75 mg daily, with an absolute reduction of 1.76% (0.61-2.91; p=0.001) in 20-year risk of any fatal colorectal cancer after 5-years scheduled treatment with 75-300 mg daily. However, risk of fatal colorectal cancer was higher on 30 mg versus 283 mg daily on long-term follow-up of the Dutch TIA trial (odds ratio 2.02, 0.70-6.05, p=0.15). Interpretation Aspirin taken for several years at doses of at least 75 mg daily reduced long-term incidence and mortality due to colorectal cancer. Benefit was greatest for cancers of the proximal colon, which are not otherwise prevented effectively by screening with sigmoidoscopy or colonoscopy.	[Rothwell, Peter M.; Wilson, Michelle] Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford, England; [Elwin, Carl-Eric] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Norrving, Bo] Lund Univ, Neurol Sect, Dept Clin Sci, S-22100 Lund, Sweden; [Algra, Ale] Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3508 TA Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Warlow, Charles P.] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Meade, Tom W.] Univ London, London Sch Hyg & Trop Med, London, England	University of Oxford; Karolinska Institutet; Lund University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Rothwell, PM (corresponding author), John Radcliffe Hosp, Univ Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Hug, Balthasar L./G-1568-2010; Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211; Norrving, Bo/0000-0002-8024-5096	Boehringer Ingelheim; Stroke Prevention Research Unit, Oxford, UK; NIHR; MRC [G0701113] Funding Source: UKRI; Medical Research Council [G0701113] Funding Source: researchfish	Boehringer Ingelheim(Boehringer Ingelheim); Stroke Prevention Research Unit, Oxford, UK; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PMR and BN have received honoraria for talks, advisory boards and clinical trial committees from several pharmaceutical companies with an interest in antiplatelet agents, including AstraZeneca, Bayer, Boehringer Ingelheim, Sanofi-BMS, and Servier. AA has received honoraria for advisory boards and research funding from Boehringer Ingelheim. The other authors declare no conflicts of interest.; We thank Richard Peto and Jill Boreham for access to data from the British Doctors Aspirin Trial; Christine Knottenbelt and Marilyn Goulding for their help in accessing long-term follow-up data from the TPT cohort; Birgit Peterson for help in collating data on causes of deaths in the SALT trial cohort; and Ziyah Mehta for help with analysis and production of graphs. The cost of cancer registry and death certificate follow-up of the UK-TIA Aspirin Trial was met by unrestricted research funds from the Stroke Prevention Research Unit, Oxford, UK. PMR is in receipt of an NIHR Senior Investigator Award.	Abela JE, 2009, BIOSCI TRENDS, V3, P158; [Anonymous], 1991, Lancet, V338, P1345; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Barry EL, 2009, CANCER EPIDEM BIOMAR, V18, P2726, DOI 10.1158/1055-9965.EPI-09-0363; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; BREWSTER D, 1995, PUBLIC HEALTH, V109, P285, DOI 10.1016/S0033-3506(95)80206-1; Brewster DH, 2002, EUR J CANCER, V38, P414, DOI 10.1016/S0959-8049(01)00385-9; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chapple KS, 2000, AM J PATHOL, V156, P545, DOI 10.1016/S0002-9440(10)64759-1; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; Elsaleh H, 2000, LANCET, V355, P1745, DOI 10.1016/S0140-6736(00)02261-3; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fasey N, 2002, BRIT J GEN PRACT, V52, P208; Flossmann E, 2007, INT J EPIDEMIOL, V36, P962, DOI 10.1093/ije/dym200; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Friedman GD, 1998, PHARMACOEPIDEM DR S, V7, P99, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; HAWKINS MM, 1992, BRIT J CANCER, V66, P408, DOI 10.1038/bjc.1992.279; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; Kelloff GJ, 2004, CLIN CANCER RES, V10, P3908, DOI 10.1158/1078-0432.CCR-03-0789; KOZUKA S, 1975, DIS COLON RECTUM, V18, P494, DOI 10.1007/BF02587218; Leopoldo S, 2008, ANN SURG ONCOL, V15, P1429, DOI 10.1245/s10434-007-9757-1; Levine JS, 2006, NEW ENGL J MED, V355, P2551, DOI 10.1056/NEJMcp063038; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Mahipal A, 2006, CANCER EPIDEM BIOMAR, V15, P1785, DOI 10.1158/1055-9965.EPI-05-0674; Meade TW, 1998, LANCET, V351, P233; Nasir Aejaz, 2004, Clin Colorectal Cancer, V3, P243, DOI 10.3816/CCC.2004.n.005; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pollock A M, 1995, Qual Health Care, V4, P184, DOI 10.1136/qshc.4.3.184; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; Wallace K, 2009, CANCER EPIDEM BIOMAR, V18, P2310, DOI 10.1158/1055-9965.EPI-09-0211; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X	52	932	967	3	109	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2010	376	9754					1741	1750		10.1016/S0140-6736(10)61543-7	http://dx.doi.org/10.1016/S0140-6736(10)61543-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690EI	20970847				2022-12-24	WOS:000284984900030
J	Han, L; Monne, M; Okumura, H; Schwend, T; Cherry, AL; Flot, D; Matsuda, T; Jovine, L				Han, Ling; Monne, Magnus; Okumura, Hiroki; Schwend, Thomas; Cherry, Amy L.; Flot, David; Matsuda, Tsukasa; Jovine, Luca			Insights into Egg Coat Assembly and Egg-Sperm Interaction from the X-Ray Structure of Full-Length ZP3	CELL			English	Article							ZONA-PELLUCIDA DOMAIN; SITE-DIRECTED MUTAGENESIS; MASS-SPECTROMETRY; VITELLINE ENVELOPE; RECEPTOR ACTIVITY; COMBINING SITE; FEMALE MICE; PROTEINS; MOUSE; GLYCOPROTEIN	ZP3, a major component of the zona pellucida (ZP) matrix coating mammalian eggs, is essential for fertilization by acting as sperm receptor. By retaining a propeptide that contains a polymerization-blocking external hydrophobic patch (EHP), we determined the crystal structure of an avian homolog of ZP3 at 2.0 angstrom resolution. The structure unveils the fold of a complete ZP domain module in a homodimeric arrangement required for secretion and reveals how EHP prevents premature incorporation of ZP3 into the ZP. This suggests mechanisms underlying polymerization and how local structural differences, reflected by alternative disulfide patterns, control the specificity of ZP subunit interaction. Close relative positioning of a conserved O-glycan important for sperm binding and the hypervariable, positively selected C-terminal region of ZP3 suggests a concerted role in the regulation of species-restricted gamete recognition. Alternative conformations of the area around the O-glycan indicate how sperm binding could trigger downstream events via intramolecular signaling.	[Han, Ling; Monne, Magnus; Okumura, Hiroki; Schwend, Thomas; Cherry, Amy L.; Jovine, Luca] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden; [Han, Ling; Monne, Magnus; Okumura, Hiroki; Schwend, Thomas; Cherry, Amy L.; Jovine, Luca] Karolinska Inst, Ctr Biosci, SE-14183 Huddinge, Sweden; [Okumura, Hiroki] Meijo Univ, Fac Agr, Dept Appl Biol Chem, Tempaku Ku, Nagoya, Aichi 4688502, Japan; [Flot, David] EMBL Grenoble, F-38042 Grenoble 9, France; [Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Karolinska Institutet; Karolinska Institutet; Meijo University; European Molecular Biology Laboratory (EMBL); Nagoya University	Jovine, L (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7, SE-14183 Huddinge, Sweden.	luca.jovine@ki.se	Monné, Magnus/D-5642-2012; Jovine, Luca/E-8170-2010; Jovine, Luca/J-3563-2019	Monné, Magnus/0000-0003-2344-3878; Jovine, Luca/0000-0002-2679-6946; Jovine, Luca/0000-0002-2679-6946; Cherry, Amy/0000-0002-8222-1071	Center for Biosciences; Swedish Research Council [2005-5102, 2007-6068]; European Community [ERG 31055]; Scandinavia-Japan Sasakawa Foundation; Japan Society for the Promotion of Science; MEXT; EMBO	Center for Biosciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission); Scandinavia-Japan Sasakawa Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EMBO(European Molecular Biology Organization (EMBO))	We thank CMC Biologics for expression plasmids pDEF38 and pNEF38; the ESRF for provision of synchrotron radiation facilities and Joanne McCarthy for assistance; Pavel Afonine, Ralf Grosse-Kunstleve, and Tom Terwilliger for help with PHENIX; Elmar Krieger and Alessandra Villa for help with molecular dynamics simulations; Hans Hebert for electron microscopy; Hisako Watanabe for help with sperm preparation; Franco Cotelli, Eveline Litscher, Rune Toftgard, and Paul Wassarman for discussions and comments. This work was supported by the Center for Biosciences; the Swedish Research Council (grants 2005-5102 and 2007-6068); the European Community (Marie Curie ERG 31055); the Scandinavia-Japan Sasakawa Foundation; Grant-in-aids from the Japan Society for the Promotion of Science and MEXT; and an EMBO Young Investigator award to L.J. Author Contributions: L.H. expressed proteins and analyzed mutants; M.M. generated constructs, purified and crystallized proteins, carried out model building, and refined the structures; H.O. generated and characterized constructs, expressed proteins, and performed and analyzed sperm binding assays; T.S. performed mass spectrometric analysis; A.L.C. analyzed crystallographic data; D.F. assisted data collection at ESRF; T.M. performed and analyzed sperm binding assays; L.J. directed the research, solved the structure, took part in structure refinement, ran molecular dynamics simulations, and wrote the manuscript with contributions from all other authors. L.J. dedicates this work to Marta, Smilla, and Sofia.	BARRATT CLR, 1993, HUM REPROD S; Bausek N, 2004, BIOL REPROD, V71, P684, DOI 10.1095/biolreprod.104.028605; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Boja ES, 2005, BIOCHEMISTRY-US, V44, P16445, DOI 10.1021/bi051883f; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Callebaut I, 2007, BIOINFORMATICS, V23, P1871, DOI 10.1093/bioinformatics/btm265; Chalabi S, 2006, BIOCHEMISTRY-US, V45, P637, DOI 10.1021/bi0512804; Chen J, 1998, P NATL ACAD SCI USA, V95, P6193, DOI 10.1073/pnas.95.11.6193; Darie CC, 2004, BIOCHEMISTRY-US, V43, P7459, DOI 10.1021/bi0495937; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Hasegawa A, 2006, REPRODUCTION, V132, P455, DOI 10.1530/rep.1.01016; Jansa SA, 2003, J MOL EVOL, V56, P294, DOI 10.1007/s00239-002-2401-6; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; Kanai S, 2008, MOL REPROD DEV, V75, P847, DOI 10.1002/mrd.20836; Kaul Renuka, 2001, Reprod Biomed Online, V2, P33; KINLOCH RA, 1995, P NATL ACAD SCI USA, V92, P263, DOI 10.1073/pnas.92.1.263; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; McLaughlin EA, 2010, MOL CELL ENDOCRINOL, DOI DOI 10.10.1016/J.MCE.2010.04.004; MILLAR SE, 1989, SCIENCE, V246, P935, DOI 10.1126/science.2479101; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Monne M, 2006, SEMIN REPROD MED, V24, P204, DOI 10.1055/s-2006-948550; Okumura H, 2007, BIOL REPROD, V76, P9, DOI 10.1095/biolreprod.106.056267; Pan JZ, 2000, MOL REPROD DEV, V55, P175, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;175::AID-MRD6&gt;3.0.CO;2-6; Quesada C, 2004, J BIOL CHEM, V279, P26627, DOI 10.1074/jbc.M401588200; Rankin T, 1996, DEVELOPMENT, V122, P2903; Sanejouand YH, 2004, PROTEINS, V57, P205, DOI 10.1002/prot.20197; Sasanami T, 2003, BIOL REPROD, V68, P1613, DOI 10.1095/biolreprod.102.011841; Sasanami T, 2006, CELLS TISSUES ORGANS, V183, P41, DOI 10.1159/000094905; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Shur BD, 2008, INT J DEV BIOL, V52, P703, DOI 10.1387/ijdb.082571bs; Sugiyama H, 1999, J BIOCHEM-TOKYO, V125, P469, DOI 10.1093/oxfordjournals.jbchem.a022310; Swann CA, 2007, REPRODUCTION, V133, P697, DOI 10.1530/REP-06-0043; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Takeuchi Y, 1999, EUR J BIOCHEM, V260, P736, DOI 10.1046/j.1432-1327.1999.00203.x; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Vo LH, 2000, BIOL REPROD, V62, P766, DOI 10.1095/biolreprod62.3.766; Waclawek M, 1998, BIOL REPROD, V59, P1230, DOI 10.1095/biolreprod59.5.1230; Wassarman PM, 2008, INT J DEV BIOL, V52, P665, DOI 10.1387/ijdb.072524pw; Yasumasu S, 2010, J BIOCHEM, V148, P439, DOI 10.1093/jb/mvq086; Zhao M, 2004, BIOCHEMISTRY-US, V43, P12090, DOI 10.1021/bi048958k	47	108	115	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					404	415		10.1016/j.cell.2010.09.041	http://dx.doi.org/10.1016/j.cell.2010.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	20970175	Green Submitted, Bronze			2022-12-24	WOS:000283603900014
J	Shoval, O; Alon, U				Shoval, Oren; Alon, Uri			SnapShot: Network Motifs	CELL			English	Editorial Material							FEEDFORWARD LOOP; GENE-REGULATION; CELL		[Shoval, Oren; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shoval, O (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.							Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6	10	85	86	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 15	2010	143	2					326	U158		10.1016/j.cell.2010.09.050	http://dx.doi.org/10.1016/j.cell.2010.09.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946989	Bronze			2022-12-24	WOS:000283052200020
J	Guly, CM; Forrester, JV				Guly, Catherine M.; Forrester, John V.			Investigation and management of uveitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							REFRACTORY UVEITIS; THERAPY; CYCLOSPORINE; POSTERIOR; INFLIXIMAB; BLINDNESS; ALPHA		[Guly, Catherine M.] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland; [Forrester, John V.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Guly, CM (corresponding author), Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland.	catherine.guly@doctors.org.uk						[Anonymous], 1999, Am J Ophthalmol, V127, P537; Daniel E, 2010, AM J OPHTHALMOL, V149, P423, DOI 10.1016/j.ajo.2009.09.026; Deuter CME, 2006, RETINA-J RET VIT DIS, V26, P786, DOI 10.1097/01.iae.0000244265.75771.71; Diaz-Llopis M, 2008, J OCUL PHARMACOL TH, V24, P351, DOI 10.1089/jop.2007.0104; Dick A. D., 2008, PRACTICAL MANUAL INT; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Gangaputra S, 2009, OPHTHALMOLOGY, V116, P2188, DOI 10.1016/j.ophtha.2009.04.020; Gilbert RE, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002218, DOI 10.1002/14651858.CD002218]; ISLAM N, 2007, BMJ CLIN EVID, V12, P705; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kempen John H, 2009, BMJ, V339, pb2480, DOI 10.1136/bmj.b2480; Kotter I, 2003, BRIT J OPHTHALMOL, V87, P423, DOI 10.1136/bjo.87.4.423; Lee RWJ, 2010, BRIT J OPHTHALMOL, V94, P269, DOI 10.1136/bjo.2009.176750; Maini R, 2004, BRIT J OPHTHALMOL, V88, P512, DOI 10.1136/bjo.2002.013334; Mansour AM, 2009, AM J OPHTHALMOL, V148, P310, DOI 10.1016/j.ajo.2009.03.023; Murphy CC, 2005, ARCH OPHTHALMOL-CHIC, V123, P634, DOI 10.1001/archopht.123.5.634; NUSSENBLATT RB, 1991, AM J OPHTHALMOL, V112, P138, DOI 10.1016/S0002-9394(14)76692-9; Pavesio C, 2010, OPHTHALMOLOGY, V117, P567, DOI 10.1016/j.ophtha.2009.11.027; Plskova J, 2007, AM J OPHTHALMOL, V144, P55, DOI 10.1016/j.ajo.2007.03.050; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; ROTHOVA A, 1992, BRIT J OPHTHALMOL, V76, P137, DOI 10.1136/bjo.76.3.137; Royal College of Ophthalmologists, 2006, GUID SCREEN UV JUV I; Suhler EB, 2009, ARCH OPHTHALMOL-CHIC, V127, P819, DOI 10.1001/archophthalmol.2009.141; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; van Kooij B, 2006, OCUL IMMUNOL INFLAMM, V14, P73, DOI 10.1080/09273940500545684; Yamada Y, 2010, BRIT J OPHTHALMOL, V94, P284, DOI 10.1136/bjo.2009.158840; YAZICI H, 1990, NEW ENGL J MED, V322, P281, DOI 10.1056/NEJM199002013220501	28	36	39	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2010	341								c4976	10.1136/bmj.c4976	http://dx.doi.org/10.1136/bmj.c4976			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668FB	20943722				2022-12-24	WOS:000283252900012
J	Riess, H				Riess, Helen			Empathy in Medicine-A Neurobiological Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PSYCHOTHERAPY		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wang Ambulatory Care Ctr,Dept Psychiat, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Riess, H (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wang Ambulatory Care Ctr,Dept Psychiat, 15 Parkman St,Ste 812, Boston, MA 02114 USA.	hriess@partners.org						Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Decety J, 2010, NEUROIMAGE, V50, P1676, DOI 10.1016/j.neuroimage.2010.01.025; GLUCKSMAN ML, 1981, PSYCHOTHER PSYCHOSOM, V36, P185, DOI 10.1159/000287543; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Marci Carl, 2005, Am J Psychother, V59, P213; Marci CD, 2007, J NERV MENT DIS, V195, P103, DOI 10.1097/01.nmd.0000253731.71025.fc; Shanafelt TD, 2009, JAMA-J AM MED ASSOC, V302, P1338, DOI 10.1001/jama.2009.1385; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x	10	69	69	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1604	1605		10.1001/jama.2010.1455	http://dx.doi.org/10.1001/jama.2010.1455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940387				2022-12-24	WOS:000282816500026
J	Cisse, M; Halabisky, B; Harris, J; Devidze, N; Dubal, DB; Sun, BG; Orr, A; Lotz, G; Kim, DH; Hamto, P; Ho, K; Yu, GQ; Mucke, L				Cisse, Moustapha; Halabisky, Brian; Harris, Julie; Devidze, Nino; Dubal, Dena B.; Sun, Binggui; Orr, Anna; Lotz, Gregor; Kim, Daniel H.; Hamto, Patricia; Ho, Kaitlyn; Yu, Gui-Qiu; Mucke, Lennart			Reversing EphB2 depletion rescues cognitive functions in Alzheimer model	NATURE			English	Article							AMYLOID-BETA-PROTEIN; DEPENDENT SYNAPTIC PLASTICITY; TRANSGENIC MOUSE MODEL; LONG-TERM POTENTIATION; PRECURSOR PROTEIN; CALCIUM INFLUX; BEHAVIORAL IMPAIRMENTS; CELLULAR PRION; IN-VITRO; DISEASE	Amyloid-beta oligomers may cause cognitive deficits in Alzheimer's disease by impairing neuronal NMDA-type glutamate receptors, whose function is regulated by the receptor tyrosine kinase EphB2. Here we show that amyloid-beta oligomers bind to the fibronectin repeats domain of EphB2 and trigger EphB2 degradation in the proteasome. To determine the pathogenic importance of EphB2 depletions in Alzheimer's disease and related models, we used lentiviral constructs to reduce or increase neuronal expression of EphB2 in memory centres of the mouse brain. In nontransgenic mice, knockdown of EphB2 mediated by short hairpin RNA reduced NMDA receptor currents and impaired long-term potentiation in the dentate gyrus, which are important for memory formation. Increasing EphB2 expression in the dentate gyrus of human amyloid precursor protein transgenic mice reversed deficits in NMDA receptor-dependent long-term potentiation and memory impairments. Thus, depletion of EphB2 is critical in amyloid-beta-induced neuronal dysfunction. Increasing EphB2 levels or function could be beneficial in Alzheimer's disease.	[Cisse, Moustapha; Halabisky, Brian; Harris, Julie; Devidze, Nino; Dubal, Dena B.; Sun, Binggui; Orr, Anna; Lotz, Gregor; Kim, Daniel H.; Hamto, Patricia; Ho, Kaitlyn; Yu, Gui-Qiu; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Cisse, Moustapha; Halabisky, Brian; Harris, Julie; Dubal, Dena B.; Sun, Binggui; Orr, Anna; Lotz, Gregor; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lmucke@gladstone.ucsf.edu	Sun, Binggui/J-9028-2016; CISSE, Moustapha/AAM-1022-2021; Dubal, Dena/AAL-2091-2021	Sun, Binggui/0000-0002-0386-6569; CISSE, Moustapha/0000-0003-3890-9183; Lotz, Gregor/0000-0002-0231-5503; Orr, Anna/0000-0002-4036-4277	NIH [AG011385, AG022074, NS041787]; McBean Family Foundation; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011385, R37AG011385, P01AG022074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McBean Family Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank I. Ethell for the plasmid encoding the Flag-tagged EphB2 receptor; D. J. Selkoe and D. Walsh for CHO-7PA2 cells; S. Finkbeiner for the plasmid encoding the NMDA receptor subunit NR1; J. Palop for comments; H. Solanoy, M. Thwin and X. Wang for technical support; G. Howard and S. Ordway for editorial review; J. Carroll for preparation of graphics; and M. Dela Cruz for administrative assistance. The study was supported by NIH grants AG011385, AG022074 and NS041787 to L.M., a fellowship from the McBean Family Foundation to M. C., and the National Center for Research Resources Grant RR18928-01 to the Gladstone Institutes.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Chen Y, 2008, NEURON GLIA BIOL, V4, P211, DOI 10.1017/S1740925X09990287; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dere E, 2005, BRAIN RES PROTOC, V16, P10, DOI 10.1016/j.brainresprot.2005.08.001; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Ikonemevic MD, 1999, EXP NEUROL, V160, P194, DOI 10.1006/exnr.1999.7196; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Meilandt WJ, 2008, J NEUROSCI, V28, P5007, DOI 10.1523/JNEUROSCI.0590-08.2008; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nakajima R, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-7; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Raber J, 2000, J NEUROSCI, V20, P2064; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Scheff SW, 2006, J ALZHEIMERS DIS, V9, P101; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Sze CI, 2001, J NEUROL SCI, V182, P151, DOI 10.1016/S0022-510X(00)00467-6; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; WAKABAYASHI K, 1994, BRAIN RES, V667, P24, DOI 10.1016/0006-8993(94)91709-4; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wu JQ, 2001, J PHYSIOL-LONDON, V533, P745, DOI 10.1111/j.1469-7793.2001.t01-1-00745.x; Xia ZG, 1996, J NEUROSCI, V16, P5425	50	304	322	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					47	52		10.1038/nature09635	http://dx.doi.org/10.1038/nature09635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21113149	Green Accepted			2022-12-24	WOS:000285921600028
J	de Lemos, JA; Drazner, MH; Omland, T; Ayers, CR; Khera, A; Rohatgi, A; Hashim, I; Berry, JD; Das, SR; Morrow, DA; McGuire, DK				de Lemos, James A.; Drazner, Mark H.; Omland, Torbjorn; Ayers, Colby R.; Khera, Amit; Rohatgi, Anand; Hashim, Ibrahim; Berry, Jarett D.; Das, Sandeep R.; Morrow, David A.; McGuire, Darren K.			Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDES; STABILIZED PATIENTS; PROGNOSTIC VALUE; EARLY-DIAGNOSIS; HEART-DISEASE; I ELEVATION; MECHANISMS; SAMPLE	Context Detectable levels of cardiac troponin T (cTnT) are strongly associated with structural heart disease and increased risk of death and adverse cardiovascular events; however, cTnT is rarely detectable in the general population using standard assays. Objectives To determine the prevalence and determinants of detectable cTnT in the population using a new highly sensitive assay and to assess whether cTnT levels measured with the new assay associate with pathological cardiac phenotypes and subsequent mortality. Design, Setting, and Participants Cardiac troponin T levels were measured using both the standard and the highly sensitive assays in 3546 individuals aged 30 to 65 years enrolled between 2000 and 2002 in the Dallas Heart Study, a multiethnic, population-based cohort study. Mortality follow-up was complete through 2007. Participants were placed into 5 categories based on cTnT levels. Main Outcome Measures Magnetic resonance imaging measurements of cardiac structure and function and mortality through a median of 6.4 (interquartile range, 6.0-6.8) years of follow-up. Results In Dallas County, the prevalence of detectable cTnT (>= 0.003 ng/mL) was 25.0% (95% confidence interval [CI], 22.7%-27.4%) with the highly sensitive assay vs 0.7% (95% CI, 0.3%-1.1%) with the standard assay. Prevalence was 37.1% (95% CI, 33.3%-41.0%) in men vs 12.9% (95% CI, 10.6%-15.2%) in women and 14.0% (95% CI, 11.2%-16.9%) in participants younger than 40 years vs 57.6% (95% CI, 47.0%-68.2%) in those 60 years and older. Prevalence of left ventricular hypertrophy increased from 7.5% (95% CI, 6.4%-8.8%) in the lowest cTnT category (>= 0.003 ng/mL) to 48.1% (95% CI, 36.7%-59.6%) in the highest (>= 0.014 ng/mL) (P<.001); prevalence of left ventricular systolic dysfunction and chronic kidney disease also increased across categories (P<.001 for each). During a median follow-up of 6.4 years, there were 151 total deaths, including 62 cardiovascular disease deaths. All-cause mortality increased from 1.9% (95% CI, 1.5%-2.6%) to 28.4% (95% CI, 21.0%-37.8%) across higher cTnT categories (P<.001). After adjustment for traditional risk factors, C-reactive protein level, chronic kidney disease, and N-terminal pro-brain-type natriuretic peptide level, cTnT category remained independently associated with all-cause mortality (adjusted hazard ratio, 2.8 [95% CI, 1.4-5.2] in the highest category). Adding cTnT categories to the fully adjusted mortality model modestly improved model fit (P=.02) and the integrated discrimination index (0.010 [95% CI, 0.002-0.018]; P=.01). Conclusion In this population-based cohort, cTnT detected with a highly sensitive assay was associated with structural heart disease and subsequent risk for all-cause mortality. JAMA. 2010;304(22):2503-2512 www.jama.com	[de Lemos, James A.; Drazner, Mark H.; Ayers, Colby R.; Khera, Amit; Rohatgi, Anand; Berry, Jarett D.; Das, Sandeep R.; McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [de Lemos, James A.; Drazner, Mark H.; Ayers, Colby R.; Khera, Amit; Rohatgi, Anand; Berry, Jarett D.; Das, Sandeep R.; McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Hashim, Ibrahim] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Omland, Torbjorn] Aker Univ Hosp, Div Med, Oslo, Norway; [Omland, Torbjorn] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Morrow, David A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Oslo; University of Oslo; Harvard University; Brigham & Women's Hospital	de Lemos, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, 5909 Harry Hines Blvd,HA 9-133, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021; McGuire, Darren K./AAL-4172-2021		Roche Diagnostics; Biosite/Inverness; Tethys Biomedical; Johnson Johnson; Siemens; AstraZeneca; Pfizer; BMS/sanofi-aventis; Merck/Schering; Abbott Laboratories; Beckman-Coulter; Boerhinger Ingelheim; Instrumentation Laboratories; Menarini; Merck; Sanofi-aventis; Servier; Accumetrics; Amgen; Beckman Coulter; Bristol-Myers Squibb; CV Therapeutics; Daiichi Sankyo Co Ltd; Eli Lilly and Co; GlaxoSmithKline; Integrated Therapeutics; Merck and Co; Merck-Schering Plough Joint Venture; Nanosphere; Novartis Pharmaceuticals; Nuvelo; Ortho-Clinical Diagnostics; Singulex; Tethys Bioscience; Biosite; F. Hoffmann LaRoche/Genentech; Cardiovascular Therapeutics; Novo Nordisk; Daiichi-Sankyo; Mitsubishi Tanabe Pharma; Donald W. Reynolds Foundation; National Institutes of Health (NIH)/NCRR-CR [M01-RR00633]; North and Central Texas Clinical and Translational Science Initiative (NIH) [UL1 RR024982]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633, UL1RR024982] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092229] Funding Source: NIH RePORTER	Roche Diagnostics; Biosite/Inverness; Tethys Biomedical; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Siemens(Siemens AG); AstraZeneca(AstraZeneca); Pfizer(Pfizer); BMS/sanofi-aventis(Sanofi-Aventis); Merck/Schering(Merck & Company); Abbott Laboratories(Abbott Laboratories); Beckman-Coulter; Boerhinger Ingelheim; Instrumentation Laboratories; Menarini(Menarini Group); Merck(Merck & Company); Sanofi-aventis(Sanofi-Aventis); Servier(Servier); Accumetrics; Amgen(Amgen); Beckman Coulter; Bristol-Myers Squibb(Bristol-Myers Squibb); CV Therapeutics; Daiichi Sankyo Co Ltd(Daiichi Sankyo Company Limited); Eli Lilly and Co(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Integrated Therapeutics; Merck and Co(Merck & Company); Merck-Schering Plough Joint Venture; Nanosphere; Novartis Pharmaceuticals(Novartis); Nuvelo; Ortho-Clinical Diagnostics; Singulex; Tethys Bioscience; Biosite; F. Hoffmann LaRoche/Genentech(Hoffmann-La RocheRoche HoldingGenentech); Cardiovascular Therapeutics; Novo Nordisk(Novo Nordisk); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Donald W. Reynolds Foundation; National Institutes of Health (NIH)/NCRR-CR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); North and Central Texas Clinical and Translational Science Initiative (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr de Lemos reported receiving research grants from Roche Diagnostics and Biosite/Inverness and receiving consulting fees and/or lecture honoraria from Tethys Biomedical, Johnson & Johnson, Roche Diagnostics, Biosite/Inverness, Siemens, AstraZeneca, Pfizer, BMS/sanofi-aventis, and Merck/Schering. Dr Drazner reported receiving consulting fees from Biosite/Inverness and lecture honoraria from GlaxoSmithKline. Dr Omland reported receiving research support and lecture honoraria from Roche Diagnostics and Abbott Laboratories. Dr Morrow reported receiving honoraria for educational presentations from Beckman-Coulter, CV Therapeutics, and Eli Lilly and receiving consulting fees from Beckman-Coulter, Boerhinger Ingelheim, Instrumentation Laboratories, Menarini, Merck, sanofi-aventis, Servier, Roche Diagnostics, Siemens, and AstraZeneca. The TIMI Study Group, which supports Dr Morrow's salary, has received significant research grant support from Accumetrics, Amgen, AstraZeneca, Beckman Coulter, Bristol-Myers Squibb, CV Therapeutics, Daiichi Sankyo Co Ltd, Eli Lilly and Co, GlaxoSmithKline, Integrated Therapeutics, Merck and Co, Merck-Schering Plough Joint Venture, Nanosphere, Novartis Pharmaceuticals, Nuvelo, Ortho-Clinical Diagnostics, Pfizer, Roche Diagnostics, sanofi-aventis, Siemens, and Singulex. Dr McGuire reported receiving grant support from GlaxoSmithKline; receiving consulting fees from Tethys Bioscience, Biosite, F. Hoffmann LaRoche/Genentech, Cardiovascular Therapeutics, AstraZeneca, Novo Nordisk, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, Johnson & Johnson, and sanofi-aventis; and receiving lecture honoraria from Pfizer and Takeda. No other authors reported disclosures.; Grant support for the Dallas Heart Study was provided by the Donald W. Reynolds Foundation and by US Public Health Service General Clinical Research Center grant M01-RR00633 from National Institutes of Health (NIH)/NCRR-CR. This study was supported in part by the North and Central Texas Clinical and Translational Science Initiative (NIH grant UL1 RR024982). Financial and materials support for measurements of cardiac troponin T (cTnT) levels in the present study were provided by Roche Diagnostics (Indianapolis, Indiana). Roche Diagnostics also previously provided materials and support for measurement of levels of cTnT, N-terminal pro-brain-type natriuretic peptide, and C-reactive protein in the Dallas Heart Study. Role of the Sponsor: Roche Diagnostics and the NIH had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Abdullah SM, 2005, AM J CARDIOL, V96, P1284, DOI 10.1016/j.amjcard.2005.06.073; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Antolini L, 2005, STAT MED, V24, P3927, DOI 10.1002/sim.2427; Apple FS, 2003, CLIN CHEM, V49, pA61; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Colosimo EA, 2002, J STAT COMPUT SIM, V72, P299, DOI 10.1080/00949650212847; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1161/CIRCULATIONAHA.105.555573; de Lemos JA, 2009, AM HEART J, V157, P746, DOI 10.1016/j.ahj.2008.12.017; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327; Eggers KM, 2008, AM HEART J, V156, P588, DOI 10.1016/j.ahj.2008.04.022; Eggers KM, 2007, CIRCULATION, V116, P1907, DOI 10.1161/CIRCULATIONAHA.107.708529; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; JONCKHEERE AR, 1967, BRIT J MATH STAT PSY, V20, P163, DOI 10.1111/j.2044-8317.1967.tb00385.x; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Konstantinides S, 2002, CIRCULATION, V106, P1263, DOI 10.1161/01.CIR.0000028422.51668.A2; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Lindahl B, 2001, J AM COLL CARDIOL, V38, P979, DOI 10.1016/S0735-1097(01)01501-7; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Morrow DA, 2009, CLIN CHEM, V55, P5, DOI 10.1373/clinchem.2008.117218; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; See R, 2008, ARCH INTERN MED, V168, P1055, DOI 10.1001/archinte.168.10.1055; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wong GC, 2002, CIRCULATION, V106, P202, DOI 10.1161/01.CIR.0000021921.14653.28; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762	37	816	831	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2503	2512		10.1001/jama.2010.1768	http://dx.doi.org/10.1001/jama.2010.1768			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139111	Green Accepted, Bronze			2022-12-24	WOS:000285053300024
J	Thumbs, A; Borgstein, E				Thumbs, Alexander; Borgstein, Eric			Commentary: managing oesophageal cancer in a resource poor setting-a Malawian example	BMJ-BRITISH MEDICAL JOURNAL			English	Review									[Thumbs, Alexander; Borgstein, Eric] Queen Elizabeth Cent Hosp, Dept Surg, Blantyre, Malawi; [Thumbs, Alexander; Borgstein, Eric] Univ Malawi, Coll Med, Blantyre, Malawi	University of Malawi; University of Malawi		alex_thumbs@hotmail.com						Lagergren J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6280; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; Sammon A, 2009, SQUAMOUS CANC ESOPHA	3	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2010	341								c6723	10.1136/bmj.c6723	http://dx.doi.org/10.1136/bmj.c6723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EH	21112910				2022-12-24	WOS:000284832100002
J	Tung, CC; Lobo, PA; Kimlicka, L; Van Petegem, F				Tung, Ching-Chieh; Lobo, Paolo A.; Kimlicka, Lynn; Van Petegem, Filip			The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule	NATURE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CALCIUM-RELEASE CHANNEL; MUTATION HOT-SPOT; S-NITROSYLATION; CA2+ RELEASE; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; ATOMIC MODELS; MUSCLE; DOMAIN	Many physiological events require transient increases in cytosolic Ca2+ concentrations. Ryanodine receptors (RyRs) are ion channels that govern the release of Ca2+ from the endoplasmic and sarcoplasmic reticulum(1). Mutations in RyRs can lead to severe genetic conditions that affect both cardiac and skeletal muscle, but locating the mutated residues in the full-length channel structure has been difficult(2,3). Here we show the 2.5 angstrom resolution crystal structure of a region spanning three domains of RyR type 1 (RyR1), encompassing amino acid residues 1-559. The domains interact with each other through a predominantly hydrophilic interface. Docking in RyR1 electron microscopy maps(4,5) unambiguously places the domains in the cytoplasmic portion of the channel, forming a 240-kDa cytoplasmic vestibule around the four-fold symmetry axis. We pinpoint the exact locations of more than 50 disease-associated mutations in full-length RyR1 and RyR2. The mutations can be classified into three groups: those that destabilize the interfaces between the three amino-terminal domains, disturb the folding of individual domains or affect one of six interfaces with other parts of the receptor. We propose a model whereby the opening of a RyR coincides with allosterically coupled motions within the N-terminal domains. This process can be affected by mutations that target various interfaces within and across subunits. The crystal structure provides a framework to understand the many disease-associated mutations in RyRs that have been studied using functional methods, and will be useful for developing new strategies to modulate RyR function in disease states.	[Tung, Ching-Chieh; Lobo, Paolo A.; Kimlicka, Lynn; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Van Petegem, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	filip.vanpetegem@gmail.com	Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	We thank the staff at beamline 08ID-1 of the Canadian Light source, the Stanford Synchrotron Radiation Lightsource, K. Beam for the rabbit RyR1 clone, K. Lau for assistance with preparing the figures and the movie file, and C. Ahern, E. Moore and R. Pancaroglu for comments on the manuscript. F.V.P. is funded by the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada, and is a CIHR new investigator and a Michael Smith Foundation for Health Research Scholar.	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Baker ML, 2002, P NATL ACAD SCI USA, V99, P12155, DOI 10.1073/pnas.182058899; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Bhuiyan ZA, 2007, CIRCULATION, V116, P1569, DOI 10.1161/CIRCULATIONAHA.107.711606; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; Marjamaa A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-12; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Serysheva I, 2005, J MOL BIOL, V345, P427, DOI 10.1016/j.jmb.2004.10.073; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Volkmann N, 2003, METHOD ENZYMOL, V374, P204, DOI 10.1016/S0076-6879(03)74010-5; Volkmann N, 2009, ACTA CRYSTALLOGR D, V65, P679, DOI 10.1107/S0907444909012876; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234	37	155	157	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					585	U267		10.1038/nature09471	http://dx.doi.org/10.1038/nature09471			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21048710				2022-12-24	WOS:000284584200047
J	Gilbert, LA; Hemann, MT				Gilbert, Luke A.; Hemann, Michael T.			DNA Damage-Mediated Induction of a Chemoresistant Niche	CELL			English	Article							BONE-MARROW; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; BREAST-CANCER; IN-VIVO; CELLS; SENESCENCE; INTERLEUKIN-6; SURVIVAL; CHEMOTHERAPY	While numerous cell-intrinsic processes are known to play decisive roles in chemotherapeutic response, relatively little is known about the impact of the tumor microenvironment on therapeutic outcome. Here, we use a well-established mouse model of Burkitt's lymphoma to show that paracrine factors in the tumor microenvironment modulate lymphoma cell survival following the administration of genotoxic chemotherapy. Specifically, IL-6 and Timp-1 are released in the thymus in response to DNA damage, creating a "chemo-resistant niche'' that promotes the survival of a minimal residual tumor burden and serves as a reservoir for eventual tumor relapse. Notably, IL-6 is released acutely from thymic endothelial cells in a p38-dependent manner following genotoxic stress, and this acute secretory response precedes the gradual induction of senescence in tumor-associated stromal cells. Thus, conventional chemotherapies can induce tumor regression while simultaneously eliciting stress responses that protect subsets of tumor cells in select anatomical locations from drug action.	[Gilbert, Luke A.; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hemann, MT (corresponding author), MIT, Koch Inst Integrat Canc Res MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hemann@mit.edu	Gilbert, Luke/AAC-5300-2019	Gilbert, Luke/0000-0001-5854-0825	NIH [RO1 CA128803]; Ludwig Center for Molecular Oncology at MIT; MIT; NATIONAL CANCER INSTITUTE [R01CA128803] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center for Molecular Oncology at MIT; MIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Holly Criscione and Tyler Miller for their experimental assistance. We thank Corbin Meacham for assistance with the cell migration assay. We would also like to acknowledge Eliza Vasile in the Koch Institute Microscopy Core Facility and Glen Paradis in the Koch Institute Flow Cytometry Core Facility for advice and services. Roderick Bronson provided expert pathology analysis, and Justin Pritchard performed bioinformatic analysis of cytokine arrays. We are grateful to Corbin Meacham, David Feldser, and Ross Dickins for critically reading the manuscript and the entire Hemann lab for helpful discussions. M.T.H. is a Rita Allen Fellow and the Latham Family Career Development Assistant Professor of Biology and is supported by NIH RO1 CA128803 and Ludwig Center for Molecular Oncology at MIT. L.A.G. is supported by the MIT Herman Eisen fellowship.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Corradini P, 1999, LEUKEMIA, V13, P1691, DOI 10.1038/sj.leu.2401559; DELREZ M, 1978, EXPERIENTIA, V34, P1221, DOI 10.1007/BF01922970; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gu L, 2005, BIOORGAN MED CHEM, V13, P4269, DOI 10.1016/j.bmc.2005.04.022; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Holen KD, 2001, LANCET ONCOL, V2, P290, DOI 10.1016/S1470-2045(00)00324-7; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Igntiadis M, 2008, EUR J CANCER, V44, P2726, DOI 10.1016/j.ejca.2008.09.033; Jourdan M, 2000, CELL DEATH DIFFER, V7, P1244, DOI 10.1038/sj.cdd.4400758; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Morrison AJ, 2005, CELL CYCLE, V4, P568; MULLERHERMELINK HK, 1987, AM J PATHOL, V129, P242; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; SEYMOUR JF, 1995, J CLIN ONCOL, V13, P575, DOI 10.1200/JCO.1995.13.3.575; Sfikakis PP, 2005, EUR J CLIN INVEST, V35, P380, DOI 10.1111/j.1365-2362.2005.01499.x; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Xenidis N, 2009, J CLIN ONCOL, V27, P2177, DOI 10.1200/JCO.2008.18.0497; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	39	318	331	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					355	366		10.1016/j.cell.2010.09.043	http://dx.doi.org/10.1016/j.cell.2010.09.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029859	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000283603900010
J	Hemberger, M; Pedersen, R				Hemberger, Myriam; Pedersen, Roger			Epigenome Disruptors	SCIENCE			English	Editorial Material							PLURIPOTENT STEM-CELLS; DNA METHYLATION; PROMOTER; GENOME; LINES		[Hemberger, Myriam] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Pedersen, Roger] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Hemberger, M (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Babraham Res Campus, Cambridge CB22 3AT, England.	myriam.hemberger@bbsrc.ac.uk		Hemberger, Myriam/0000-0003-3332-6958	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C230] Funding Source: Medline; Medical Research Council [G0600275] Funding Source: Medline; BBSRC [BBS/E/B/0000C230] Funding Source: UKRI; MRC [G0600275] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Dean W, 1998, DEVELOPMENT, V125, P2273; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hesson LB, 2010, CURR OPIN GENET DEV, V20, P290, DOI 10.1016/j.gde.2010.02.005; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Yamanaka S, 2010, CELL STEM CELL, V7, P1, DOI 10.1016/j.stem.2010.06.009; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	16	9	10	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					598	599		10.1126/science.1199006	http://dx.doi.org/10.1126/science.1199006			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030637				2022-12-24	WOS:000283580600025
J	Baker, M				Baker, Monya			The search for association	NATURE			English	Editorial Material							GENOME-WIDE ASSOCIATION; COMMON; VARIANTS											Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661	10	22	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1135	U150		10.1038/4671135a	http://dx.doi.org/10.1038/4671135a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981103	Bronze			2022-12-24	WOS:000283548600053
J	McDonald, B; Pittman, K; Menezes, GB; Hirota, SA; Slaba, I; Waterhouse, CCM; Beck, PL; Muruve, DA; Kubes, P				McDonald, Braedon; Pittman, Keir; Menezes, Gustavo B.; Hirota, Simon A.; Slaba, Ingrid; Waterhouse, Christopher C. M.; Beck, Paul L.; Muruve, Daniel A.; Kubes, Paul			Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; DYING CELLS; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; IMMUNE-SYSTEM; INJURY; IDENTIFICATION; HEPATOTOXICITY; RELEASE; HMGB1	Neutrophils are recruited from the blood to sites of sterile inflammation, where they contribute to wound healing but may also cause tissue damage. By using spinning disk confocal intravital microscopy, we examined the kinetics and molecular mechanisms of neutrophil recruitment to sites of focal hepatic necrosis in vivo. Adenosine triphosphate released from necrotic cells activated the Nlrp3 inflammasome to generate an inflammatory microenvironment that alerted circulating neutrophils to adhere within liver sinusoids. Subsequently, generation of an intravascular chemokine gradient directed neutrophil migration through healthy tissue toward foci of damage. Lastly, formyl-peptide signals released from necrotic cells guided neutrophils through nonperfused sinusoids into the injury. Thus, dynamic in vivo imaging revealed a multistep hierarchy of directional cues that guide neutrophil localization to sites of sterile inflammation.	[McDonald, Braedon; Pittman, Keir; Menezes, Gustavo B.; Slaba, Ingrid; Waterhouse, Christopher C. M.; Muruve, Daniel A.; Kubes, Paul] Univ Calgary, Immunol Res Grp, Calgary, AB T2N 4N1, Canada; [Hirota, Simon A.; Beck, Paul L.] Univ Calgary, Snyder Inst Infect Immun & Inflammat, Gastrointestinal Res Grp, Calgary, AB T2N 4N1, Canada; [Waterhouse, Christopher C. M.] Univ Calgary, Dept Pediat, Div Pediat Gastroenterol, Calgary, AB T2N 4N1, Canada; [Beck, Paul L.; Muruve, Daniel A.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Immunol Res Grp, Calgary, AB T2N 4N1, Canada.	pkubes@ucalgary.ca	Menezes, Gustavo B/B-3350-2013		Canadian Institutes of Health Research; Alberta Innovates (Health Solutions)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates (Health Solutions)	We thank C. Badick for excellent technical support. This study was supported by grants from the Canadian Institutes of Health Research and Alberta Innovates (Health Solutions).	Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	23	835	855	4	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					362	366		10.1126/science.1195491	http://dx.doi.org/10.1126/science.1195491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947763				2022-12-24	WOS:000282986700039
J	Stefl, R; Oberstrass, FC; Hood, JL; Jourdan, M; Zimmermann, M; Skrisovska, L; Maris, C; Peng, L; Hofr, C; Emeson, RB; Allain, FHT				Stefl, Richard; Oberstrass, Florian C.; Hood, Jennifer L.; Jourdan, Muriel; Zimmermann, Michal; Skrisovska, Lenka; Maris, Christophe; Peng, Li; Hofr, Ctirad; Emeson, Ronald B.; Allain, Frederic H-T			The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor Groove	CELL			English	Article							DOUBLE-STRANDED-RNA; TORSION ANGLE DYNAMICS; DSRNA-BINDING DOMAIN; ADENOSINE DEAMINASES; RIBONUCLEASE-III; EDITING ENZYME; PROTEIN-KINASE; GLUR-B; NMR; RECOGNITION	Sequence-dependent recognition of dsDNA-binding proteins is well understood, yet sequence-specific recognition of dsRNA by proteins remains largely unknown, despite their importance in RNA maturation pathways. Adenosine deaminases that act on RNA (ADARs) recode genomic information by the site-selective deamination of adenosine. Here, we report the solution structure of the ADAR2 double-stranded RNA-binding motifs (dsRBMs) bound to a stem-loop pre-mRNA encoding the R/G editing site of GluR-2. The structure provides a molecular basis for how dsRBMs recognize the shape, and also more surprisingly, the sequence of the dsRNA. The unexpected direct readout of the RNA primary sequence by dsRBMs is achieved via the minor groove of the dsRNA and this recognition is critical for both editing and binding affinity at the R/G site of GluR-2. More generally, our findings suggest a solution to the sequence-specific paradox faced by many dsRBM-containing proteins that are involved in post-transcriptional regulation of gene expression.	[Stefl, Richard; Oberstrass, Florian C.; Jourdan, Muriel; Skrisovska, Lenka; Maris, Christophe; Allain, Frederic H-T] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Peng, Li; Emeson, Ronald B.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Hood, Jennifer L.] Vanderbilt Univ, Grad Program Neurosci, Nashville, TN 37232 USA; [Stefl, Richard] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CZ-62500 Brno, Czech Republic; [Zimmermann, Michal; Hofr, Ctirad] Masaryk Univ, Fac Sci, Inst Expt Biol, Dept Funct Genom & Prote, CZ-62500 Brno, Czech Republic	Swiss Federal Institutes of Technology Domain; ETH Zurich; Vanderbilt University; Vanderbilt University; Masaryk University Brno; Masaryk University Brno	Allain, FHT (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	allain@mol.biol.ethz.ch	Stefl, Richard/D-7010-2012; Hofr, Ctirad/E-3322-2012	Stefl, Richard/0000-0003-0558-5952; Emeson, Ronald/0000-0002-4585-1648	Swiss National Science Foundation [3100A0-118118]; SNF-NCCR; National Institutes of Health [R01 NS33323]; Ministry of Education of the Czech Republic [MSM0021622413, Ingo LA08008]; GACR [204/08/1212, 305/10/1490]; GAAV [IAA401630903]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033323] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNF-NCCR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); GACR(Grant Agency of the Czech Republic); GAAV(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Swiss National Science Foundation (Nr. 3100A0-118118) and the SNF-NCCR structural biology to F. H. T. A and the National Institutes of Health (R01 NS33323) to R. B. E. R. S. is supported by the Ministry of Education of the Czech Republic (MSM0021622413, Ingo LA08008), GACR (204/08/1212, 305/10/1490), GAAV (IAA401630903), HHMI/EMBO start-up grant, and HFSP Career Development Award. M.Z. and C. H. are supported by GACR (204/08/H054) and by the Ministry of Education of the Czech Republic (MSM0021622415). M.Z. is in receipt of a Brno City Scholarship for Talented Ph.D.Students. The coordinates of the structures of GluR-2 LSL RNA, ADAR2 dsRBM1 bound to GluR-2 USL RNA, ADAR2 dsRBM2 bound to GluR-2 LSL RNA and ADAR2 dsRBM12 bound to GluR-2 have been deposited in the Protein Data Bank with accession codes 2l2j, 2I3c, 2l2k, and 2I3j, respectively.	Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Case D. A., 2002, AMBER 7; Chilibeck KA, 2006, J BIOL CHEM, V281, P16530, DOI 10.1074/jbc.M511831200; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Gan J, 2008, MOL MICROBIOL, V67, P143, DOI 10.1111/j.1365-2958.2007.06032.x; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HEALE BS, 2009, EMBO J; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuzmic P, 2006, MOL CELL ENDOCRINOL, V248, P172, DOI 10.1016/j.mce.2005.10.012; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEGAULT P, 1994, J AM CHEM SOC, V116, P8390, DOI 10.1021/ja00097a066; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Liu Y, 2000, P NATL ACAD SCI USA, V97, P12541, DOI 10.1073/pnas.97.23.12541; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Macbeth MR, 2004, RNA, V10, P1563, DOI 10.1261/rna.7920904; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Ohman M, 2000, RNA, V6, P687, DOI 10.1017/S1355838200000200; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Parks Malcolm R, 2004, J Transl Med, V2, P28, DOI 10.1186/1479-5876-2-28; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sansam CL, 2003, P NATL ACAD SCI USA, V100, P14018, DOI 10.1073/pnas.2336131100; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Steffensen M, 2002, INSUR MATH ECON, V31, P71, DOI 10.1016/S0167-6687(02)00127-0; Stefl R, 2006, STRUCTURE, V14, P345, DOI 10.1016/j.str.2005.11.013; Stefl R, 2005, RNA, V11, P592, DOI 10.1261/rna.7276805; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsui V, 2000, J BIOMOL NMR, V16, P9, DOI 10.1023/A:1008302430561; Valente L, 2005, PROG NUCLEIC ACID RE, V79, P299, DOI 10.1016/S0079-6603(04)79006-6; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Xu M, 2006, MOL BIOL CELL, V17, P3211, DOI 10.1091/mbc.E06-02-0162; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	63	167	173	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					225	237		10.1016/j.cell.2010.09.026	http://dx.doi.org/10.1016/j.cell.2010.09.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946981	Green Accepted, Bronze			2022-12-24	WOS:000283052200012
J	Morewedge, CK; Huh, YE; Vosgerau, J				Morewedge, Carey K.; Huh, Young Eun; Vosgerau, Joachim			Thought for Food: Imagined Consumption Reduces Actual Consumption	SCIENCE			English	Article							SENSORY-SPECIFIC SATIETY; ELABORATED INTRUSION THEORY; MENTAL PRACTICE; IMAGERY; HABITUATION; BEHAVIOR; CHILDREN; LIKING; HUMANS; MEMORY	The consumption of a food typically leads to a decrease in its subsequent intake through habituation-a decrease in one's responsiveness to the food and motivation to obtain it. We demonstrated that habituation to a food item can occur even when its consumption is merely imagined. Five experiments showed that people who repeatedly imagined eating a food (such as cheese) many times subsequently consumed less of the imagined food than did people who repeatedly imagined eating that food fewer times, imagined eating a different food (such as candy), or did not imagine eating a food. They did so because they desired to eat it less, not because they considered it less palatable. These results suggest that mental representation alone can engender habituation to a stimulus.	[Morewedge, Carey K.] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Huh, Young Eun; Vosgerau, Joachim] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Morewedge, CK (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Porter Hall 208, Pittsburgh, PA 15213 USA.	morewedge@cmu.edu	Huh, Young Eun/O-9359-2017	Huh, Young Eun/0000-0002-3069-319X	Carnegie Mellon University	Carnegie Mellon University	This work benefited from financial support from a grant to C. K. M. from the Berkman Faculty Development Fund at Carnegie Mellon University. We thank A. Kim, K. Khanna, M. Fei, L. Mosca, M. Christian, and Center for Behavioral Decision Research summer interns in 2008 and 2009 for help with the data collection. We thank C. Janiszewski, D. Kahneman, G. Loewenstein, B. Rolls, and L. Williams for helpful comments.	Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BRICKMAN P, 1978, J PERS SOC PSYCHOL, V36, P917, DOI 10.1037/0022-3514.36.8.917; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dadds MR, 1997, PSYCHOL BULL, V122, P89, DOI 10.1037/0033-2909.122.1.89; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; DEGRANDPRE RJ, 1993, J EXP ANAL BEHAV, V60, P641, DOI 10.1901/jeab.1993.60-641; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Epstein LH, 2009, PSYCHOL REV, V116, P384, DOI 10.1037/a0015074; Epstein LH, 2003, APPETITE, V41, P283, DOI 10.1016/S0195-6663(03)00106-5; Ernst MM, 2002, APPETITE, V38, P224, DOI 10.1006/appe.2001.0484; Frederick S., 1999, WELL BEING FDN HEDON, P302; Havermans RC, 2009, APPETITE, V52, P222, DOI 10.1016/j.appet.2008.09.020; Higgs S, 2008, PSYCHOL SCI, V19, P623, DOI 10.1111/j.1467-9280.2008.02132.x; Huber DE, 2008, J EXP PSYCHOL LEARN, V34, P1305, DOI 10.1037/a0013370; Kavanagh DJ, 2005, PSYCHOL REV, V112, P446, DOI 10.1037/0033-295X.112.2.446; Kemps E, 2007, J EXP PSYCHOL-APPL, V13, P95, DOI 10.1037/1076-898X.13.2.95; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; LANG PJ, 1977, BEHAV THER, V8, P862, DOI 10.1016/S0005-7894(77)80157-3; McSweeney FK, 2000, J EXP ANAL BEHAV, V74, P347, DOI 10.1901/jeab.2000.74-347; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; ROLLS BJ, 1982, PHYSIOL BEHAV, V29, P409, DOI 10.1016/0031-9384(82)90259-1; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rozin P, 1998, PSYCHOL SCI, V9, P392, DOI 10.1111/1467-9280.00073; Soetens B, 2006, J HEALTH PSYCHOL, V11, P655, DOI 10.1177/1359105306066615; TIFFANY ST, 1990, ADDICT BEHAV, V15, P531, DOI 10.1016/0306-4603(90)90053-Z; Williams LE, 2008, PSYCHOL SCI, V19, P302, DOI 10.1111/j.1467-9280.2008.02084.x; Wohldmann EL, 2007, J EXP PSYCHOL LEARN, V33, P254, DOI 10.1037/0278-7393.33.1.254; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	28	193	196	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1530	1533		10.1126/science.1195701	http://dx.doi.org/10.1126/science.1195701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692LE	21148388				2022-12-24	WOS:000285153500062
J	Takano, K; Watanabe-Takano, H; Suetsugu, S; Kurita, S; Tsujita, K; Kimura, S; Karatsu, T; Takenawa, T; Endo, T				Takano, Kazunori; Watanabe-Takano, Haruko; Suetsugu, Shiro; Kurita, Souichi; Tsujita, Kazuya; Kimura, Sumiko; Karatsu, Takashi; Takenawa, Tadaomi; Endo, Takeshi			Nebulin and N-WASP Cooperate to Cause IGF-1-Induced Sarcomeric Actin Filament Formation	SCIENCE			English	Article							SKELETAL-MUSCLE; ELONGATION-FACTORS; NUCLEATION	Insulin-like growth factor 1 (IGF-1) induces skeletal muscle maturation and enlargement (hypertrophy). These responses require protein synthesis and myofibril formation (myofibrillogenesis). However, the signaling mechanisms of myofibrillogenesis remain obscure. We found that IGF-1-induced phosphatidylinositol 3-kinase-Akt signaling formed a complex of nebulin and N-WASP at the Z bands of myofibrils by interfering with glycogen synthase kinase-3 beta in mice. Although N-WASP is known to be an activator of the Arp2/3 complex to form branched actin filaments, the nebulin-N-WASP complex caused actin nucleation for unbranched actin filament formation from the Z bands without the Arp2/3 complex. Furthermore, N-WASP was required for IGF-1-induced muscle hypertrophy. These findings present the mechanisms of IGF-1-induced actin filament formation in myofibrillogenesis required for muscle maturation and hypertrophy and a mechanism of actin nucleation.	[Takano, Kazunori; Watanabe-Takano, Haruko; Kurita, Souichi; Kimura, Sumiko; Endo, Takeshi] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba 2638522, Japan; [Takano, Kazunori; Watanabe-Takano, Haruko; Suetsugu, Shiro; Takenawa, Tadaomi; Endo, Takeshi] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Suetsugu, Shiro] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Suetsugu, Shiro] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan; [Tsujita, Kazuya; Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Karatsu, Takashi] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan	Chiba University; Japan Science & Technology Agency (JST); University of Tokyo; Japan Science & Technology Agency (JST); Kobe University; Chiba University	Endo, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, 1-33 Yayoicho, Chiba 2638522, Japan.	t.endo@faculty.chiba-u.jp	Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/AAF-4427-2019; Suetsugu, Shiro/ABB-6033-2020; Karatsu, Takashi/M-6937-2017	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; Karatsu, Takashi/0000-0002-8515-9584	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan [17A-10, 20B-13]; Grants-in-Aid for Scientific Research [22570153, 22770185] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Watanabe and T. Itoh for comments. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Research Grants (17A-10 and 20B-13) for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare of Japan.	Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McElhinny AS, 2003, TRENDS CARDIOVAS MED, V13, P195, DOI 10.1016/S1050-1738(03)00076-8; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Ojima K, 2000, J CELL BIOL, V150, P553, DOI 10.1083/jcb.150.3.553; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Pfuhl M, 1996, J MOL BIOL, V257, P367, DOI 10.1006/jmbi.1996.0169; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242	17	64	68	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1536	1540		10.1126/science.1197767	http://dx.doi.org/10.1126/science.1197767			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148390				2022-12-24	WOS:000285153500064
J	Cunningham, AL; Jones, CP; Ansell, J; Barry, JD				Cunningham, Andrew L.; Jones, Christopher P.; Ansell, James; Barry, Jonathan D.			Christmas 2010: Surgery Red for danger: the effects of red hair in surgical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BRITTLE CORNEA SYNDROME; RECEPTOR GENE; VARIANTS; REDHEADS; HUMANS; COLOR; PAIN		[Cunningham, Andrew L.; Jones, Christopher P.; Barry, Jonathan D.] Abertawe Bro Morgannwg NHS Trust, Morriston Hosp, Dept Gen Surg, Welsh Inst Metab & Obes Surg,Fdn Programme, Swansea SA6 6NL, W Glam, Wales	Morriston Hospital	Barry, JD (corresponding author), Abertawe Bro Morgannwg NHS Trust, Morriston Hosp, Dept Gen Surg, Welsh Inst Metab & Obes Surg,Fdn Programme, Swansea SA6 6NL, W Glam, Wales.	jbarry@doctors.org.uk						Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; Abu A, 2006, INVEST OPHTH VIS SCI, V47, P5283, DOI 10.1167/iovs.06-0206; [Anonymous], 2007, NATL GEOGRAPHIC  SEP; EIBERG H, 1987, CLIN GENET, V32, P125; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Klinge U, 2006, Hernia, V10, P472, DOI 10.1007/s10029-006-0145-8; Kumar VV, 2004, LARYNGOSCOPE, V114, P2031, DOI 10.1097/01.mlg.0000147942.82626.1c; Liem EB, 2006, ANESTH ANALG, V102, P313, DOI 10.1213/01.ANE.0000180769.51576.CD; Liem EB, 2005, ANESTHESIOLOGY, V102, P509, DOI 10.1097/00000542-200503000-00006; Liem EB, 2004, ANESTHESIOLOGY, V101, P279, DOI 10.1097/00000542-200408000-00006; Missmer SA, 2006, FERTIL STERIL, V85, P866, DOI 10.1016/j.fertnstert.2005.12.008; Mogil JS, 2005, J MED GENET, V42, P583, DOI 10.1136/jmg.2004.027698; ROYCE PM, 1990, EUR J PEDIATR, V149, P465, DOI 10.1007/BF01959396; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; *WIK, 2010, KISS JUD; 2010, HARMAN SAYS SORRY GI	16	6	6	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2010	341								c6931	10.1136/bmj.c6931	http://dx.doi.org/10.1136/bmj.c6931			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZU	21148222				2022-12-24	WOS:000285341200011
J	Casillas, CE; Kammen, DM				Casillas, Christian E.; Kammen, Daniel M.			The Energy-Poverty-Climate Nexus	SCIENCE			English	Editorial Material									[Casillas, Christian E.; Kammen, Daniel M.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Kammen, Daniel M.] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA; [Casillas, Christian E.; Kammen, Daniel M.] Univ Calif Berkeley, Renewable & Appropriate Energy Lab, Berkeley, CA 94720 USA; [Kammen, Daniel M.] World Bank, Washington, DC 20443 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; The World Bank	Kammen, DM (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	dkammen@worldbank.org						Alteri MA, 2002, AGR ECOSYST ENVIRON, V93, P1, DOI 10.1016/S0167-8809(02)00085-3; [Anonymous], EN SUST FUT SECR GEN; [Anonymous], 2005, ENERGY SERVICES MILL; Bierbaum R.M., 2010, WORLD DEV REPORT 201; Cabraal RA, 2005, ANNU REV ENV RESOUR, V30, P117, DOI 10.1146/annurev.energy.30.050504.144228; Cecelski E., 2000, ENABBING EQUITABLE A; Energy Sector Management Assistance Programme, 2007, TECHN EC ASS OFF GRI; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Flavin C., 2005, ENERGY DEV POTENTIAL; Independent Evaluation Group, 2008, WELF IMP RUR EL REAS; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; Jacobson A, 2005, ENERG POLICY, V33, P1825, DOI 10.1016/j.enpol.2004.02.017; JAFFE AB, 1994, ENERG POLICY, V22, P804, DOI 10.1016/0301-4215(94)90138-4; Johnson T., 2009, LOW CARBON DEV MEXIC; Kirubi C, 2009, WORLD DEV, V37, P1208, DOI 10.1016/j.worlddev.2008.11.005; McKinsey & Company, 2009, PATHW LOW CARB EC; Mills E, 2005, SCIENCE, V308, P1263, DOI 10.1126/science.1113090; Mostert W., 2007, UNLOCKING POTENTIAL; Romijn H, 2010, ENVIRON SCI POLICY, V13, P326, DOI 10.1016/j.envsci.2010.03.006; Smith KR, 2010, J EXPO SCI ENV EPID, V20, P406, DOI 10.1038/jes.2009.30; Stern PC, 2010, ENVIRON SCI TECHNOL, V44, P4847, DOI 10.1021/es100896p; [No title captured]	22	132	135	9	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1181	1182		10.1126/science.1197412	http://dx.doi.org/10.1126/science.1197412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	685FE	21109654				2022-12-24	WOS:000284613700021
J	Gerrett, D; Lamont, T; Paton, C; Barnes, TRE; Shah, A				Gerrett, David; Lamont, Tara; Paton, Carol; Barnes, Thomas R. E.; Shah, Amar			Safety Alerts Prescribing and monitoring lithium therapy: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHARMACOKINETICS		[Gerrett, David; Lamont, Tara] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Paton, Carol; Barnes, Thomas R. E.] Royal Coll Psychiatrists, Prescribing Observ Mental Hlth, London E1 8AA, England; [Paton, Carol] Oxleas NHS Fdn Trust, Dartford DA2 7WG, England; [Barnes, Thomas R. E.] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8RP, England; [Shah, Amar] Barnet Enfield & Haringey Mental Hlth Trust, N London Forensic Serv, London, England	Imperial College London	Gerrett, D (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	david.gerrett@npsa.nhs.uk						*HLTH SOC CAR INF, 2009, PRESCR COST AN DAT; Johnston AM, 1999, BRIT J PSYCHIAT, V175, P336, DOI 10.1192/bjp.175.4.336; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I HLTH, V38; National Patient Safety Agency, 2009, SAF LITH THER PAT SA; *PRESCR OBS MENT H, 2009, CRTUO69 PRESCR OBS M; Sproule BA, 2000, DRUG AGING, V16, P165, DOI 10.2165/00002512-200016030-00002; THAU K, 1993, LITHIUM, V4, P149; WARD ME, 1994, J CLIN PHARMACOL, V34, P280, DOI 10.1002/j.1552-4604.1994.tb01994.x	8	13	13	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 19	2010	341								c6258	10.1136/bmj.c6258	http://dx.doi.org/10.1136/bmj.c6258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684WU	21097572				2022-12-24	WOS:000284586800006
J	Levene, LS; Baker, R; Bankart, MJG; Khunti, K				Levene, Louis S.; Baker, Richard; Bankart, M. John G.; Khunti, Kamlesh			Association of Features of Primary Health Care With Coronary Heart Disease Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OUTCOMES FRAMEWORK; SOCIAL INEQUALITIES; CANCER-MORTALITY; RISK-FACTORS; US COUNTIES; ALL-CAUSE; QUALITY; DEPRIVATION; ENGLAND; INDICATORS	Context The goal of US health care reform is to extend access. In England, with a universal access health system, coronary heart disease (CHD) mortality rates have decreased by more than two-fifths in the last decade, but variations in rates between local populations persist. Objective To identify which features of populations and primary health care explain variations in CHD mortality rates between the 152 primary care trust populations in England. Design, Setting, and Participants A cross-sectional study in England of all 152 primary care trusts (total registered population, 54.3 million in 2008) using a hierarchical regression model with age-standardized CHD mortality rate as the dependent variable, and population characteristics (index of multiple deprivation, smoking, ethnicity, and registers of individuals with diabetes) and service characteristics (level of provision of primary care services, levels of detected hypertension, pay for performance data) as candidate explanatory variables. Main Outcome Measures Age-standardized CHD mortality rates in 2006, 2007, and 2008. Results The mean age-standardized CHD mortality rates per 100 000 European Standard Population were 97.9 (95% confidence interval [CI], 94.9-100.9) in 2006, 93.5 (95% CI, 90.4-96.5) in 2007, and 88.4 (95% CI, 85.7-91.1) in 2008. In all 3 years, 4 population characteristics were significantly positively associated with CHD mortality (index of multiple deprivation, smoking, white ethnicity, and registers of individuals with diabetes), and 1 service characteristic (levels of detected hypertension) was significantly negatively associated with CHD mortality (adjusted r(2) = 0.66 in 2006, adjusted r(2) = 0.68 in 2007, and adjusted r(2) = 0.67 in 2008). Other service characteristics did not contribute significantly to the model. Conclusion In England, variations in CHD mortality are predominantly explained by population characteristics; however, greater detection of hypertension is associated with lower CHD mortality. JAMA. 2010;304(18):2028-2034 www.jama.com	[Levene, Louis S.; Baker, Richard; Bankart, M. John G.; Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Levene, Louis S.; Baker, Richard; Bankart, M. John G.; Khunti, Kamlesh] Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Rutland, England	University of Leicester	Levene, LS (corresponding author), Univ Leicester, Dept Hlth Sci, 22-28 Princess Rd W, Leicester LE1 6TP, Leics, England.	lsl7@le.ac.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099	NIHR	NIHR(National Institute for Health Research (NIHR))	The study formed part of the program of the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Research and Care (CLARHC) in Leicestershire, Northamptonshire, and Rutland. The CLARHC is funded by the NIHR.	[Anonymous], QUAL OUTC FRAM; Ashworth M, 2007, BRIT J GEN PRACT, V57, P441; Ashworth Mark, 2006, BMC Fam Pract, V7, P68, DOI 10.1186/1471-2296-7-68; Ashworth M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2030; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Cohen J., 1983, APPL MULTIPLE REGRES; *COMM LOC GOV, ENGL IND DEPR 2007 S; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Gostin LO, 2010, JAMA-J AM MED ASSOC, V303, P1188, DOI 10.1001/jama/2010.375; Gulliford MC, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-12; Huxley R, 2006, INT J EPIDEMIOL, V35, P1025, DOI 10.1093/ije/dyl058; Lomax, 2007, STAT CONCEPTS 2 COUR; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; *NHS EMPL QUAL OUT, QUAL OUTC FRAM GUID; NHS Employers, QUAL OUTC FRAM GUID; *NHS INC CTR, NEIGH STAT MOD BAS E; *NHS INF CTR, NHS STAFF NUMB; *NHS NAT STAT, HLTH SURV ENGL 2006; *NHS NAT STAT, HLTH SURV ENGL 2008; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; *OFF NAT STAT, NAT STAT ONL POP EST; *OFF NAT STAT E RE, PCO POP 2008 RES INT; Saxena S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-96; *SECR STAT, 2000, NAT SERV FRAM COR HE; Shi L, 2005, PUBLIC HEALTH, V119, P699, DOI 10.1016/j.puhe.2004.12.007; Shi LY, 2005, AM J PUBLIC HEALTH, V95, P674, DOI 10.2105/AJPH.2003.031716; Strong M, 2006, J PUBLIC HEALTH, V28, P39, DOI 10.1093/pubmed/fdi065; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; World Health Organization, INT STAT CLASS DIS R; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2028	2034		10.1001/jama.2010.1636	http://dx.doi.org/10.1001/jama.2010.1636			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	677OB	21063012	Bronze			2022-12-24	WOS:000284000600021
J	Keshavjee, S; Farmer, PE				Keshavjee, Salmaan; Farmer, Paul E.			GLOBAL HEALTH Picking Up the Pace - Scale-Up of MDR Tuberculosis Treatment Programs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Keshavjee, Salmaan] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; Partners Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA.			Keshavjee, Salmaan/0000-0002-6967-3305				FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Keshavjee S., 2009, ADDRESSING THREAT DR, P141; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, PAND H1N1 2009 UPD 1; World Health Organization, 2010, WHOHTMTB20103	5	45	47	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1781	1784		10.1056/NEJMp1010023	http://dx.doi.org/10.1056/NEJMp1010023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YK	21047219				2022-12-24	WOS:000283787800001
J	Jacobson, SG; Cideciyan, AV				Jacobson, Samuel G.; Cideciyan, Artur V.			Treatment Possibilities for Retinitis Pigmentosa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jacobson, Samuel G.; Cideciyan, Artur V.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Jacobson, SG (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.		Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X				Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Flannery JG, 2006, NEURON, V50, P1, DOI 10.1016/j.neuron.2006.03.027; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297	5	55	60	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1669	1671		10.1056/NEJMcibr1007685	http://dx.doi.org/10.1056/NEJMcibr1007685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961252				2022-12-24	WOS:000283242700014
J	Chandra, A; Acosta, JD				Chandra, Anita; Acosta, Joie D.			Disaster Recovery Also Involves Human Recovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chandra, Anita; Acosta, Joie D.] RAND Corp, Arlington, VA 22202 USA	RAND Corporation	Chandra, A (corresponding author), RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA.	Anita_Chandra@rand.org						ACOSTA J, 2010, NAVIGATING LONG ROAD; Chandra A., 2009, ROLE NONGOVERNMENTAL; CHANDRA A, 2010, COMMUNITY RESILIENCE; *EM MED FDN, 2009, DEV NAT STAND ALL HA; Kates R.W., 1977, RECONSTRUCTION FOLLO, P1; NAVARRO M, 2010, NY TIMES        0617, pA19; PFEFFERBAUM BJ, 2009, HELPING FAMILIES COM, P265; U.S. Department of Health & Human Services, 2009, NAT HLTH SEC STRAT; *US DEP HOM SEC, 2010, NAT DIS REC IN PRESS; *US GOV ACC OFF, 2009, GAO09561	10	22	22	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1608	1609		10.1001/jama.2010.1456	http://dx.doi.org/10.1001/jama.2010.1456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940389				2022-12-24	WOS:000282816500028
J	Ben-Shem, A; Jenner, L; Yusupova, G; Yusupov, M				Ben-Shem, Adam; Jenner, Lasse; Yusupova, Gulnara; Yusupov, Marat			Crystal Structure of the Eukaryotic Ribosome	SCIENCE			English	Article							TRANSFER-RNA; TRANSLATION INITIATION; MESSENGER-RNA; ANGSTROM RESOLUTION; 70S RIBOSOME; 80S RIBOSOME; E-SITE; SUBUNIT; TRANSLOCATION; MOVEMENT	Crystal structures of prokaryotic ribosomes have described in detail the universally conserved core of the translation mechanism. However, many facets of the translation process in eukaryotes are not shared with prokaryotes. The crystal structure of the yeast 80S ribosome determined at 4.15 angstrom resolution reveals the higher complexity of eukaryotic ribosomes, which are 40% larger than their bacterial counterparts. Our model shows how eukaryote-specific elements considerably expand the network of interactions within the ribosome and provides insights into eukaryote-specific features of protein synthesis. Our crystals capture the ribosome in the ratcheted state, which is essential for translocation of mRNA and transfer RNA (tRNA), and in which the small ribosomal subunit has rotated with respect to the large subunit. We describe the conformational changes in both ribosomal subunits that are involved in ratcheting and their implications in coordination between the two associated subunits and in mRNA and tRNA translocation.	[Ben-Shem, Adam] IGBMC, F-67400 Illkirch Graffenstaden, France; INSERM, U964, F-67400 Illkirch Graffenstaden, France; CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ben-Shem, A (corresponding author), IGBMC, 1 Rue Laurent Fries,BP10142, F-67400 Illkirch Graffenstaden, France.	adam@igbmc.fr; marat@igbmc.fr	Yusupov, Marat/I-6126-2013; Yusupova, Gulnara/E-1877-2014; Jenner, Lasse/H-1584-2017	Yusupov, Marat/0000-0001-5544-0597; Ben-Shem, Adam/0000-0003-0297-8662; Jenner, Lasse/0000-0003-3917-8853	European Molecular Biology Organization; Human Frontier Science Program; French National Research Agency [ANR BLAN07-3_190451, ANR-07-PCVI-0015-01]; European Commission	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); French National Research Agency(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. Meskauskas and J. Dinman for providing the strain of S. cerevisiae and for support at the early stages of efforts in development of yeast ribosome purification protocol; A. Urzhumtzev for numerous invaluable crystallographic discussions; and R. Jackson for pointing out to us the possible benefits of glucose depletion in yeast. We gratefully acknowledge help with crystallographic programs from P. Afonine, K. Cowtan, G. Kleywegt, A. Lebedev, S. Panjikar, N. Pannu, R. Read, T. Terwilliger, L. Tong, A. Vagin, C. Vonrhein, and T. Yeates. We thank S. Melnikov and N. Garreau de Loubresse for help during the final stages of this work; M. Iskakova and N. Demeshkina for their participation and encouragement in early stages of this work; the staff of the Structural Biology Department core facility at IGBMC, Strasbourg; and S. Uge for assistance with computer infrastructure; C. Schulze-Briese and the staff at the Swiss Light Source, Switzerland; and A. Thompson and P. Legrand from the Soleil Synchrotron, France, for help with data collection. This work was supported by a European Molecular Biology Organization Long-Term Fellowship (A.B.-S.), Human Frontier Science Program, French National Research Agency grants ANR BLAN07-3_190451 and ANR-07-PCVI-0015-01, and the European Commission SPINE2. Coordinates and structure factors have been deposited with the Protein Data Bank with accession codes 3O2Z, 3O30, 3O58, and 3O5H.	Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Halic M, 2005, NAT STRUCT MOL BIOL, V12, P467, DOI 10.1038/nsmb933; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Korostelev A, 2007, P NATL ACAD SCI USA, V104, P16840, DOI 10.1073/pnas.0707850104; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SPIRIN AS, 1969, COLD SPRING HARB SYM, V34, P197, DOI 10.1101/SQB.1969.034.01.026; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	40	304	371	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1203	1209		10.1126/science.1194294	http://dx.doi.org/10.1126/science.1194294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109664				2022-12-24	WOS:000284613700031
J	Eisele, YS; Obermuller, U; Heilbronner, G; Baumann, F; Kaeser, SA; Wolburg, H; Walker, LC; Staufenbiel, M; Heikenwalder, M; Jucker, M				Eisele, Yvonne S.; Obermueller, Ulrike; Heilbronner, Goetz; Baumann, Frank; Kaeser, Stephan A.; Wolburg, Hartwig; Walker, Lary C.; Staufenbiel, Matthias; Heikenwalder, Mathias; Jucker, Mathias			Peripherally Applied A beta-Containing Inoculates Induce Cerebral beta-Amyloidosis	SCIENCE			English	Article							ALZHEIMER-DISEASE; PATHOGENESIS; DEPOSITION; PRIONS	The intracerebral injection of beta-amyloid-containing brain extracts can induce cerebral beta-amyloidosis and associated pathologies in susceptible hosts. We found that intraperitoneal inoculation with beta-amyloid-rich extracts induced beta-amyloidosis in the brains of beta-amyloid precursor protein transgenic mice after prolonged incubation times.	[Eisele, Yvonne S.; Obermueller, Ulrike; Heilbronner, Goetz; Baumann, Frank; Kaeser, Stephan A.; Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Eisele, Yvonne S.; Obermueller, Ulrike; Heilbronner, Goetz; Baumann, Frank; Kaeser, Stephan A.; Jucker, Mathias] DZNE German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Heilbronner, Goetz] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany; [Wolburg, Hartwig] Univ Tubingen, Dept Pathol, D-72076 Tubingen, Germany; [Walker, Lary C.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Walker, Lary C.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Staufenbiel, Matthias] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; [Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Emory University; Emory University; Novartis; University of Zurich; University Zurich Hospital	Jucker, M (corresponding author), Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de	Walker, L C/J-6541-2015; Baumann, Frank/F-7737-2016; Heikenwalder, Mathias/AAA-2269-2020; Eisele, Yvonne/E-7897-2015	Walker, L C/0000-0001-9166-3261; Eisele, Yvonne/0000-0002-3868-4327; Jucker, Mathias/0000-0001-9045-1072	Competence Network on Degenerative Dementias [BMBF-01GI0705]; Bundesministerium fur Bildung und Forschung as part of ERA-Net NEURON (MIPROTRAN); Center for Integrative Neuroscience (Deutsche Forschungsgemeinschaft); NIH [RR-00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER	Competence Network on Degenerative Dementias; Bundesministerium fur Bildung und Forschung as part of ERA-Net NEURON (MIPROTRAN); Center for Integrative Neuroscience (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank M.-J. Runser, L. Jacobson (Basel), F. Langer, J. Coomaraswamy, S. Grathwohl, N. Varvel, T. Hamaguchi, C. Schafer, A. Bosch, G. Frommer-Kastle, U. Scheurlen (Tubingen) for experimental help and A. Aguzzi (Zurich) for insightful comments. This work was supported by the Competence Network on Degenerative Dementias (BMBF-01GI0705), the Bundesministerium fur Bildung und Forschung as part of ERA-Net NEURON (MIPROTRAN), the Center for Integrative Neuroscience (Deutsche Forschungsgemeinschaft), and NIH RR-00165.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Bremer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007160; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Prusiner SB, 2004, PRION BIOL DIS; Storandt M, 2009, ARCH NEUROL-CHICAGO, V66, P1476, DOI 10.1001/archneurol.2009.272; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	15	434	443	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					980	982		10.1126/science.1194516	http://dx.doi.org/10.1126/science.1194516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20966215	Green Accepted			2022-12-24	WOS:000284118000047
J	Choudhry, NK; Shrank, WH				Choudhry, Niteesh K.; Shrank, William H.			Four-Dollar Generics -- Increased Accessibility, Impaired Quality Assurance.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Choudhry, Niteesh K.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.							[Anonymous], 2008, US TODAY; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; *KAIS FAM FDN HLTH, EMPL HLTH BEN 2009 A; Kohl H, 2007, J AM GERIATR SOC, V55, P1106, DOI 10.1111/j.1532-5415.2007.01286.x; *NAT ASS CHAIN DRU, 2008, RX SAL	5	69	69	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2010	363	20					1885	1887		10.1056/NEJMp1006189	http://dx.doi.org/10.1056/NEJMp1006189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	678CR	21067379				2022-12-24	WOS:000284047600003
J	McCartney, M				McCartney, Margaret			Medicine and the Media Men and midlife crises	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaretmccartney@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2010	341								c5661	10.1136/bmj.c5661	http://dx.doi.org/10.1136/bmj.c5661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	681KO	21068110				2022-12-24	WOS:000284312700010
J	Nutt, DJ; King, LA; Phillips, LD				Nutt, David J.; King, Leslie A.; Phillips, Lawrence D.		Independent Sci Comm Drugs	Drug harms in the UK: a multicriteria decision analysis	LANCET			English	Article							ILLICIT DRUGS; TOXICITY; MISUSE	Background Proper assessment of the harms caused by the misuse of drugs can inform policy makers in health, policing, and social care. We aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug harms in the UK. Method Members of the Independent Scientific Committee on Drugs, including two invited specialists, met in a 1-day interactive workshop to score 20 drugs on 16 criteria: nine related to the harms that a drug produces in the individual and seven to the harms to others. Drugs were scored out of 100 points, and the criteria were weighted to indicate their relative importance. Findings MCDA modelling showed that heroin, crack cocaine, and metamfetamine were the most harmful drugs to individuals (part scores 34, 37, and 32, respectively), whereas alcohol, heroin, and crack cocaine were the most harmful to others (46, 21, and 17, respectively). Overall, alcohol was the most harmful drug (overall harm score 72), with heroin (55) and crack cocaine (54) in second and third places. Interpretation These findings lend support to previous work assessing drug harms, and show how the improved scoring and weighting approach of MCDA increases the differentiation between the most and least harmful drugs. However, the findings correlate poorly with present UK drug classification, which is not based simply on considerations of harm.	[Nutt, David J.] Univ London Imperial Coll Sci Technol & Med, Neuropsychopharmacol Unit, London W12 0NN, England; [King, Leslie A.] EMCDDA, Lisbon, Portugal; [Phillips, Lawrence D.] Univ London London Sch Econ & Polit Sci, Dept Management, London WC2A 2AE, England	Imperial College London; University of London; London School Economics & Political Science	Nutt, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Neuropsychopharmacol Unit, Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	d.nutt@imperial.ac.uk			Centre for Crime and Justice Studies (UK); Facilitations Limited	Centre for Crime and Justice Studies (UK); Facilitations Limited	This study is funded by the Centre for Crime and Justice Studies (UK). Yuji Wu assisted with some of the data analyses.; DJN and LAK received travel expenses to attend the decision conference meeting. LAK is a consultant to the Department of Health and the EMCDDA. LDP is a director of Facilitations Limited, which paid him a consulting fee because it was the company engaged by the Centre for Crime and Justice Studies to run the study and analyse the data.	Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; *ADV COUNC MIS DRU, 2010, CONS US MULT DEC AN; [Anonymous], 2010, DRUGS RES OVERVIEW E; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; *BRIT MED ASS, 1987, LIV RISK; Coomber R, 1999, ADDICT RES, V7, P85, DOI 10.3109/16066359909004376; DODGSON J, 2000, MULTICRITERIA ANAL M; Gable RS, 2004, ADDICTION, V99, P686, DOI 10.1111/j.1360-0443.2004.00744.x; *HC HLTH COMM, 2010, 1511 HC HLTH COMM; Horn G., 2008, BRAIN SCI ADDICTION; King LA, 2010, HUM PSYCHOPHARM CLIN, V25, P162, DOI 10.1002/hup.1090; Morton A, 2009, RISK ANAL, V29, P764, DOI 10.1111/j.1539-6924.2008.01192.x; Murphy PI, 2007, LANCET, V369, P1856, DOI 10.1016/S0140-6736(07)60841-1; NICE (National Institute of Clinical Excellence), 2010, ALCOHOL USE DISORDER; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Phillips LD, 2007, ADVANCES IN DECISION ANALYSIS: FROM FOUNDATIONS TO APPLICATIONS, P375, DOI 10.1017/CBO9780511611308.020; REGANCIRINCIONE P, 1994, ORG BEHAV HUMAN DECI, V58, P246; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REP 2010; van Amsterdam J, 2010, EUR ADDICT RES, V16, P202, DOI 10.1159/000317249; Werb D., 2010, EFFECT DRUG LAW ENFO	20	869	890	5	246	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 6	2010	376	9752					1558	1565		10.1016/S0140-6736(10)61462-6	http://dx.doi.org/10.1016/S0140-6736(10)61462-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680QE	21036393				2022-12-24	WOS:000284248700033
J	Marciniak, SJ; Lomas, DA				Marciniak, Stefan J.; Lomas, David A.			Alpha(sub 1)-Antitrypsin Deficiency and Autophagy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marciniak, Stefan J.; Lomas, David A.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England	University of Cambridge	Marciniak, SJ (corresponding author), Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England.		Marciniak, Stefan J/F-1855-2010	Marciniak, Stefan/0000-0001-8472-7183	Medical Research Council [G0601840, G0500306] Funding Source: Medline; MRC [G0500306, G0601840] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	4	38	38	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1863	1864		10.1056/NEJMcibr1008007	http://dx.doi.org/10.1056/NEJMcibr1008007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674YK	21047232				2022-12-24	WOS:000283787800014
J	Brennan, KA; Genever, RW				Brennan, K. A.; Genever, R. W.			Practice Pointer Managing Parkinson's disease during surgery	BRITISH MEDICAL JOURNAL			English	Editorial Material							PERIOPERATIVE MANAGEMENT; TRANSDERMAL ROTIGOTINE; INDUCED DYSKINESIAS; PROPOFOL; ANESTHESIA		[Genever, R. W.] Chesterfield Royal Hosp NHS Fdn Trust, Calow S44 5BL, Chesterfield, England; [Brennan, K. A.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England	University of Sheffield	Genever, RW (corresponding author), Chesterfield Royal Hosp NHS Fdn Trust, Calow S44 5BL, Chesterfield, England.	Richard.Genever@chesterfieldroyal.nhs.uk			Boehringer Ingelheim; Glaxo Smith Kline; Teva; Lundbeck; Orion	Boehringer Ingelheim(Boehringer Ingelheim); Glaxo Smith Kline(GlaxoSmithKline); Teva(Teva Pharmaceutical Industries); Lundbeck(Lundbeck Corporation); Orion	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that RG has received sponsorship to attend medical conferences from Boehringer Ingelheim, Glaxo Smith Kline, Teva and Lundbeck, and Orion. RG has received honoraria for speaking at meetings from Glaxo Smith Kline and Orion. RG has received honoraria for sitting on advisory boards from Glaxo Smith Kline and Boehringer Ingelheim. KB has no relationships with any companies that might have an interest in the submitted work in the previous 3 years; and RG and KB have no non-financial interests that may be relevant to the submitted work.	ANDERSON BJ, 1994, BRIT J NEUROSURG, V8, P387, DOI 10.3109/02688699409029633; Brady M, 2009, COCHRANE DB SYST REV, V7; Davies RG, 2005, BRIT J ANAESTH, V95, P424, DOI 10.1093/bja/aei579; Furuya R, 1998, ANESTHESIOLOGY, V89, P261, DOI 10.1097/00000542-199807000-00035; Iyer SS, 2005, NEUROLOGY, V65, P1507, DOI 10.1212/01.wnl.0000183286.92632.71; Krauss JK, 1996, ANESTH ANALG, V83, P420, DOI 10.1097/00000539-199608000-00037; LeWitt PA, 2007, CLIN NEUROPHARMACOL, V30, P256, DOI 10.1097/wnf.0b013e318154c7c4; MADOPAR CR, 2009, SUMMARY PRODUCT CHAR; Mehta Samir, 2008, Am J Orthop (Belle Mead NJ), V37, P513; Nicholson G, 2002, BRIT J ANAESTH, V89, P904, DOI 10.4103/0019-5049.82658; *PARK UK, GET IT TIM; Pepper PV, 1999, J AM GERIATR SOC, V47, P967, DOI 10.1111/j.1532-5415.1999.tb01292.x; REED AP, 1992, ANESTH ANALG, V75, P850; Schrag A, 2000, BRIT MED J, V321, P21, DOI 10.1136/bmj.321.7252.21; SINEMET CR, 2009, SUMMARY PRODUCT CHAR; STOLTZ M, 2004, BRIT J ANAESTH, V96, P868; Ueda M, 1999, NEUROLOGY, V52, P777, DOI 10.1212/WNL.52.4.777; Wenzelburger R, 2002, BRAIN, V125, P871, DOI 10.1093/brain/awf084; Wullner U, 2010, J NEURAL TRANSM, V117, P855, DOI 10.1007/s00702-010-0425-4	19	29	31	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2010	341								c5718	10.1136/bmj.c5718	http://dx.doi.org/10.1136/bmj.c5718			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	678CD	21041319				2022-12-24	WOS:000284045500010
J	Chandler, VL				Chandler, Vicki L.			Paramutation's Properties and Puzzles	SCIENCE			English	Editorial Material							MAIZE; TRANS; INHERITANCE; EXPRESSION; LOCUS	Paramutation refers to the process by which homologous DNA sequences communicate in trans to establish meiotically heritable expression states. Although mechanisms are unknown, current data are consistent with the hypothesis that the establishment and heritable transmission of specific chromatin states underlies paramutation. Transcribed, noncoding tandem repeats and proteins implicated in RNA-directed transcriptional silencing in plants and yeast are required for paramutation, yet the specific molecules mediating heritable silencing remain to be determined.	Univ Arizona, Dept Plant Sci, Inst BIO5, Tucson, AZ 85719 USA	University of Arizona	Chandler, VL (corresponding author), Univ Arizona, Dept Plant Sci, Inst BIO5, Tucson, AZ 85719 USA.	chandler@ag.arizona.edu						Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Brzeska K, 2010, P NATL ACAD SCI USA, V107, P5516, DOI 10.1073/pnas.1001576107; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; COE EH, 1966, GENETICS, V53, P1035; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Haring M, 2010, PLANT J, V63, P366, DOI 10.1111/j.1365-313X.2010.04245.x; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Stam M, 2009, MOL PLANT, V2, P578, DOI 10.1093/mp/ssp020; Suter CM, 2010, TRENDS GENET, V26, P9, DOI 10.1016/j.tig.2009.11.003	12	55	55	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					628	629		10.1126/science.1191044	http://dx.doi.org/10.1126/science.1191044			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030647				2022-12-24	WOS:000283580600035
J	Rosenzweig, C; Solecki, W; Hammer, SA; Mehrotra, S				Rosenzweig, Cynthia; Solecki, William; Hammer, Stephen A.; Mehrotra, Shagun			Cities lead the way in climate-change action	NATURE			English	Editorial Material									[Rosenzweig, Cynthia] Goddard Inst Space Studies, Climate Impacts Grp, New York, NY 10025 USA; [Solecki, William] CUNY, Inst Sustainable Cities, New York, NY 10065 USA; [Hammer, Stephen A.] Joint US China Collaborat Clean Energy, Energy Smart Cities Initiat, Shanghai 200041, Peoples R China; [Mehrotra, Shagun] Columbia Univ, Earth Inst, Climate & Cities Facil, New York, NY 10027 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; City University of New York (CUNY) System; Columbia University	Rosenzweig, C (corresponding author), Goddard Inst Space Studies, Climate Impacts Grp, New York, NY 10025 USA.	crosenzweig@giss.nasa.gov						Bloomberg MR, 2010, ANN NY ACAD SCI, V1196, P1, DOI [10.1111/j.1749-6632.2009.05415.x, 10.1111/j.1749-6632.2009.05415_1.x]; de Sherbinin A., 2011, CHOICE REV ONLINE; Mehrotra S, 2009, FRAMEWORK CITY CLIMA; Parry M. L., 2007, CLIMATE CHANGE 2007; United Nations, 2009, WORLD POP PROSP 2009; World Bank, 2010, WORLD DEV REP 2010 P	6	439	444	12	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					909	911		10.1038/467909a	http://dx.doi.org/10.1038/467909a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668FT	20962822				2022-12-24	WOS:000283254700014
J	Arii, J; Goto, H; Suenaga, T; Oyama, M; Kozuka-Hata, H; Imai, T; Minowa, A; Akashi, H; Arase, H; Kawaoka, Y; Kawaguchi, Y				Arii, Jun; Goto, Hideo; Suenaga, Tadahiro; Oyama, Masaaki; Kozuka-Hata, Hiroko; Imai, Takahiko; Minowa, Atsuko; Akashi, Hiroomi; Arase, Hisashi; Kawaoka, Yoshihiro; Kawaguchi, Yasushi			Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1	NATURE			English	Article							LIGHT-CHAIN KINASE; CATALYTIC-ACTIVITY; CELL-FUSION; GLYCOPROTEINS GB; MEMBRANE-FUSION; IN-VITRO; PROTEIN; ACTIVATION; ALPHA; US3	Herpes simplex virus-1 (HSV-1), the prototype of the a-herpesvirus family, causes life-long infections in humans. Although generally associated with various mucocutaneous diseases, HSV-1 is also involved in lethal encephalitis(1). HSV-1 entry into host cells requires cellular receptors for both envelope glycoproteins B (gB) and D (gD)(2-4). However, the gB receptors responsible for its broad host range in vitro and infection of critical targets in vivo1 remain unknown. Here we show that non-muscle myosin heavy chain IIA (NMHC-IIA), a subunit of non-muscle myosin IIA (NM-IIA), functions as an HSV-1 entry receptor by interacting with gB. A cell line that is relatively resistant to HSV-1 infection(5) became highly susceptible to infection by this virus when NMHC-IIA was overexpressed. Antibody to NMHC-IIA blocked HSV-1 infection in naturally permissive target cells. Furthermore, knockdown of NMHC-IIA in the permissive cells inhibited HSV-1 infection as well as cell-cell fusion when gB, gD, gH and gL were coexpressed. Cell-surface expression of NMHC-IIA was markedly and rapidly induced during the initiation of HSV-1 entry. A specific inhibitor of myosin light chain kinase, which regulates NM-IIA by phosphorylation(6), reduced the redistribution of NMHC-IIA as well as HSV-1 infection in cell culture and in a murine model for herpes stromal keratitis. NMHC-IIA is ubiquitously expressed in various human tissues and cell types(7) and, therefore, is implicated as a functional gB receptor that mediates broad HSV-1 infectivity both in vitro and in vivo. The identification of NMHC-IIA as an HSV-1 entry receptor and the involvement of NM-IIA regulation in HSV-1 infection provide an insight into HSV-1 entry and identify new targets for antiviral drug development.	[Arii, Jun; Imai, Takahiko; Minowa, Atsuko; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis,Div Viral Infect, Dept Infect Dis Control,Minato Ku, Tokyo 1088639, Japan; [Arii, Jun; Akashi, Hiroomi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan; [Goto, Hideo; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; [Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, Microbial Dis Res Inst, Dept Immunochem, Suita, Osaka 5650871, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Arase, Hisashi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA; [Kawaoka, Yoshihiro] ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Japan Science & Technology Agency (JST)	Kawaguchi, Y (corresponding author), Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis,Div Viral Infect, Dept Infect Dis Control,Minato Ku, Tokyo 1088639, Japan.	ykawagu@ims.u-tokyo.ac.jp	Arase, Hisashi/C-8442-2009	Arase, Hisashi/0000-0002-1153-3166; Kawaguchi, Yasushi/0000-0001-8232-6925; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735	Japan Initiative for Global Research Network on Infectious Diseases; Founding Research Center for Emerging; Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health of Japan; Takeda Science Foundation; ERATO (Japan Science and Technology Agency); Japan Society for the Promotion of Science	Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Founding Research Center for Emerging; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health of Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank P. G. Spear, L. W. Enquist, Y. Matsuura, N. Mizushima, S. Sugano, R. Adelstein, T. Ichimura, K. Araki-Sasaki, Y. Mori and M. Takahashi for providing reagents, S. Koyama for technical assistance and K. Wells and S. Watson for critical reading of this manuscript. This study was supported by Grants-in-aid for Scientific Research, Grants-in-aid for Scientific Research in Priority Areas, Grants-in-aid for Specially Promoted Research, and contract research funds for the Program of Japan Initiative for Global Research Network on Infectious Diseases and the Program of Founding Research Center for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Science, Sports and Culture of Japan, by Grants-in-aid from the Ministry of Health of Japan, by grants from the Takeda Science Foundation, and by ERATO (Japan Science and Technology Agency). J. A. was supported by research fellowships from the Japan Society for the Promotion of Science by Young Scientists.	[Anonymous], 2007, FIELDS VIROLOGY; Arii J, 2009, J VIROL, V83, P4520, DOI 10.1128/JVI.02601-08; Balliet JW, 2006, J VIROL, V80, P440, DOI 10.1128/JVI.80.1.440-450.2006; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; CHAMSAI PT, 1989, VIROLOGY, V170, P468, DOI 10.1016/0042-6822(89)90438-8; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Demmin GL, 2001, J VIROL, V75, P10856, DOI 10.1128/JVI.75.22.10856-10869.2001; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Haraguchi T, 2007, FEBS LETT, V581, P4949, DOI 10.1016/j.febslet.2007.09.028; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; OLDEN K, 1976, CELL, V8, P383, DOI 10.1016/0092-8674(76)90150-1; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Polcicova K, 2005, P NATL ACAD SCI USA, V102, P11462, DOI 10.1073/pnas.0503230102; Sagou K, 2009, J VIROL, V83, P5773, DOI 10.1128/JVI.00103-09; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SARMIENTO M, 1979, J VIROL, V29, P1149, DOI 10.1128/JVI.29.3.1149-1158.1979; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Shimizu S, 2006, J PHYSIOL-LONDON, V570, P219, DOI 10.1113/jphysiol.2005.097998; Spear PG, 2006, VIROLOGY, V344, P17, DOI 10.1016/j.virol.2005.09.016; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590	34	158	173	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					859	U129		10.1038/nature09420	http://dx.doi.org/10.1038/nature09420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944748				2022-12-24	WOS:000282898700070
J	Shopsowitz, KE; Qi, H; Hamad, WY; MacLachlan, MJ				Shopsowitz, Kevin E.; Qi, Hao; Hamad, Wadood Y.; MacLachlan, Mark J.			Free-standing mesoporous silica films with tunable chiral nematic structures	NATURE			English	Article							CHOLESTERIC LIQUID-CRYSTALS; CELLULOSE; ORDER; SUSPENSIONS; GERMANIUM; BAND	Chirality at the molecular level is found in diverse biological structures, such as polysaccharides, proteins and DNA, and is responsible for many of their unique properties(1). Introducing chirality into porous inorganic solids may produce new types of materials that could be useful for chiral separation, stereospecific catalysis, chiral recognition (sensing) and photonic materials(2-5). Template synthesis of inorganic solids using the self-assembly of lyotropic liquid crystals offers access to materials with well-defined porous structures(6-12), but only recently has chirality been introduced into hexagonal mesostructures through the use of a chiral surfactant(13,14). Efforts to impart chirality at a larger length scale using self-assembly are almost unknown. Here we describe the development of a photonic mesoporous inorganic solid that is a cast of a chiral nematic liquid crystal formed from nanocrystalline cellulose. These materials may be obtained as free-standing films with high surface area. The peak reflected wavelength of the films can be varied across the entire visible spectrum and into the near-infrared through simple changes in the synthetic conditions. To the best of our knowledge these are the first materials to combine mesoporosity with long-range chiral ordering that produces photonic properties. Our findings could lead to the development of new materials for applications in, for example, tuneable reflective filters and sensors. In addition, this type of material could be used as a hard template to generate other new materials with chiral nematic structures.	[Shopsowitz, Kevin E.; Qi, Hao; MacLachlan, Mark J.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Hamad, Wadood Y.] FPInnovations, Vancouver, BC V6S 2L9, Canada	University of British Columbia	MacLachlan, MJ (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	mmaclach@chem.ubc.ca	Hatzikiriakos, Savvas/AAD-2672-2019; Shopsowitz, Kevin/A-2915-2013; MacLachlan, Mark J/I-2961-2013; MacLachlan, Mark/Z-2069-2019	Hatzikiriakos, Savvas/0000-0002-1456-7927; MacLachlan, Mark J/0000-0002-3546-7132; MacLachlan, Mark/0000-0002-3546-7132	Natural Sciences and Engineering Research Council (NSERC) of Canada; FPInnovations; UBC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); FPInnovations(German Research Foundation (DFG)); UBC	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada and FPInnovations. K.E.S. is grateful to UBC for a graduate fellowship.	Akagi K, 1998, SCIENCE, V282, P1683, DOI 10.1126/science.282.5394.1683; Armatas GS, 2006, SCIENCE, V313, P817, DOI 10.1126/science.1130101; ATTARD GS, 1995, NATURE, V378, P366, DOI 10.1038/378366a0; BROER DJ, 1995, NATURE, V378, P467, DOI 10.1038/378467a0; Che S, 2004, NATURE, V429, P281, DOI 10.1038/nature02529; DEVRIES H, 1951, ACTA CRYSTALLOGR, V4, P219, DOI 10.1107/S0365110X51000751; Dong XM, 1996, LANGMUIR, V12, P2076, DOI 10.1021/la950133b; Dujardin E, 2003, J MATER CHEM, V13, P696, DOI 10.1039/b212689c; Edgar CD, 2001, CELLULOSE, V8, P5, DOI 10.1023/A:1016624330458; Fireman-Shoresh S, 2005, J AM CHEM SOC, V127, P2650, DOI 10.1021/ja0454384; Gabashvili A, 2007, J PHYS CHEM B, V111, P11105, DOI 10.1021/jp072480n; Hodgkinson I, 2001, ADV MATER, V13, P889, DOI 10.1002/1521-4095(200107)13:12/13<889::AID-ADMA889>3.0.CO;2-K; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Johnson BFG, 1999, CHEM COMMUN, P1167, DOI 10.1039/a902441g; JOHNSON LN, 2005, EUR REV, V13, P77; Kopp VI, 1998, OPT LETT, V23, P1707, DOI 10.1364/OL.23.001707; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; MUKHERJEE SM, 1953, BIOCHIM BIOPHYS ACTA, V10, P499, DOI 10.1016/0006-3002(53)90295-9; Qiu HB, 2009, ANGEW CHEM INT EDIT, V48, P3069, DOI 10.1002/anie.200900303; Revol JF, 1998, J PULP PAP SCI, V24, P146; REVOL JF, 1992, INT J BIOL MACROMOL, V14, P170, DOI 10.1016/S0141-8130(05)80008-X; Robbie K, 1999, NATURE, V399, P764, DOI 10.1038/21612; Sharma V, 2009, SCIENCE, V325, P449, DOI 10.1126/science.1172051; Sun D, 2006, NATURE, V441, P1126, DOI 10.1038/nature04891; Thomas A, 2003, ADV FUNCT MATER, V13, P763, DOI 10.1002/adfm.200304383; YANG DK, 1994, J APPL PHYS, V76, P1331, DOI 10.1063/1.358518; Yang H, 1996, NATURE, V381, P589, DOI 10.1038/381589a0; Yang PD, 1998, NATURE, V396, P152	28	695	718	45	1090	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2010	468	7322					422	U246		10.1038/nature09540	http://dx.doi.org/10.1038/nature09540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085176				2022-12-24	WOS:000284313100039
J	Karlawish, J				Karlawish, Jason			Desktop Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Karlawish, Jason] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Karlawish, Jason] Univ Penn, Dept Med Eth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Karlawish, J (corresponding author), Univ Penn, Dept Med, 3615 Chestnut St, Philadelphia, PA 19104 USA.	Jason.Karlawish@uphs.upenn.edu						Aronowitz RA, 2009, MILBANK Q, V87, P417, DOI 10.1111/j.1468-0009.2009.00563.x; Greene JWC, 2007, PROCEEDINGS IEEE SOUTHEASTCON 2007, VOLS 1 AND 2, P221; Linnenbringer E, 2010, GENET MED, V12, P219, DOI 10.1097/GIM.0b013e3181cef9e1; National Heart Lung and Blood Institute, RISK ASS TOOL EST 10; Phillips LS, 2008, ANN INTERN MED, V148, P783, DOI 10.7326/0003-4819-148-10-200805200-00011; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; Vijan S, 2008, ANN INTERN MED, V149, P839, DOI 10.7326/0003-4819-149-11-200812020-00019; Volpp KG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-272; World Health Organization Collaborating Centre for Metabolic Bone Diseases, WHO FRACT RISK ASS T	9	9	10	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2061	2062		10.1001/jama.2010.1624	http://dx.doi.org/10.1001/jama.2010.1624			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063017				2022-12-24	WOS:000284000600027
J	Mudur, G				Mudur, Ganapati			Save the Children BMJ Christmas Appeal Mobile clinics in Delhi	BRITISH MEDICAL JOURNAL			English	Editorial Material												gsmudur@hotmail.com						Agarwal S, 2005, Indian J Public Health, V49, P141	1	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2010	341								c6800	10.1136/bmj.c6800	http://dx.doi.org/10.1136/bmj.c6800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691OG	21118876				2022-12-24	WOS:000285090100015
J	McCartney, M				McCartney, Margaret			Obesity Slimmed down surgery	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; NICE, 2006, OB GUID PREV ID ASS; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; 2009, DRUGS THER B, V47, P125	4	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2010	341								c5499	10.1136/bmj.c5499	http://dx.doi.org/10.1136/bmj.c5499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YE	20978064				2022-12-24	WOS:000283786800024
J	Newman, M				Newman, Melanie			Research Ethics The rules of retraction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												melanienewman@tbij.com						Corbyn Z., 2009, TIMES HIGHER ED 0820; *INT COMM MED J ED, CORR RETR EXPR CONC; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; LIU SV, 2005, LOGICAL BIOL, V5, P235; Martin A, 2008, J AM ACAD CHILD PSY, V47, P119, DOI 10.1097/chi.0b013e31815d6dba; *MHRA, 2008, MHRA INV GLAX SER; Nissen SE, 2010, JAMA-J AM MED ASSOC, V303, P1194, DOI 10.1001/jama.2010.333; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Sox HC, 2006, ANN INTERN MED, V144, P609, DOI 10.7326/0003-4819-144-8-200604180-00123; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008	10	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2010	341								c6985	10.1136/bmj.c6985	http://dx.doi.org/10.1136/bmj.c6985			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694YK	21138994				2022-12-24	WOS:000285337600023
J	Li, XY; Ko, HG; Chen, T; Descalzi, G; Koga, K; Wang, HS; Kim, SS; Shang, YZ; Kwak, C; Park, SW; Shim, J; Lee, K; Collingridge, GL; Kaang, BK; Zhuo, M				Li, Xiang-Yao; Ko, Hyoung-Gon; Chen, Tao; Descalzi, Giannina; Koga, Kohei; Wang, Hansen; Kim, Susan S.; Shang, Yuze; Kwak, Chuljung; Park, Soo-Won; Shim, Jaehoon; Lee, Kyungmin; Collingridge, Graham L.; Kaang, Bong-Kiun; Zhuo, Min			Alleviating Neuropathic Pain Hypersensitivity by Inhibiting PKM zeta in the Anterior Cingulate Cortex	SCIENCE			English	Article							KINASE M-ZETA; STIMULATED ADENYLYL CYCLASES; LONG-TERM POTENTIATION; IN-VIVO EXPERIENCE; SYNAPTIC-TRANSMISSION; MOLECULAR-BIOLOGY; MEMORY STORAGE; PROTEIN; MAINTENANCE; SENSITIZATION	Synaptic plasticity is a key mechanism for chronic pain. It occurs at different levels of the central nervous system, including spinal cord and cortex. Studies have mainly focused on signaling proteins that trigger these plastic changes, whereas few have addressed the maintenance of plastic changes related to chronic pain. We found that protein kinase M zeta (PKM zeta) maintains pain-induced persistent changes in the mouse anterior cingulate cortex (ACC). Peripheral nerve injury caused activation of PKM zeta in the ACC, and inhibiting PKM zeta by a selective inhibitor, zeta-pseudosubstrate inhibitory peptide (ZIP), erased synaptic potentiation. Microinjection of ZIP into the ACC blocked behavioral sensitization. These results suggest that PKM zeta in the ACC acts to maintain neuropathic pain. PKM zeta could thus be a new therapeutic target for treating chronic pain.	[Li, Xiang-Yao; Chen, Tao; Shim, Jaehoon; Collingridge, Graham L.; Kaang, Bong-Kiun; Zhuo, Min] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151747, South Korea; [Li, Xiang-Yao; Chen, Tao; Descalzi, Giannina; Koga, Kohei; Wang, Hansen; Kim, Susan S.; Shang, Yuze; Zhuo, Min] Univ Toronto, Ctr Study Pain, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Ko, Hyoung-Gon; Kwak, Chuljung; Park, Soo-Won; Shim, Jaehoon; Lee, Kyungmin; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Natl Creat Res Initiat,Ctr Nat Sci, Seoul 151747, South Korea; [Lee, Kyungmin] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu 700422, South Korea; [Collingridge, Graham L.] Univ Bristol, Sch Physiol & Pharmacol, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	Seoul National University (SNU); University of Toronto; Seoul National University (SNU); Kyungpook National University; University of Bristol	Kaang, BK (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151747, South Korea.	kaang@snu.ac.kr; min.zhuo@utoronto.ca	Lee, Kyungmin/AAH-9165-2020; Collingridge, Graham L/C-4605-2015; wang, hansen/I-2510-2019; Zhuo, Min/A-2072-2008; Li, xiang-Yao/B-7622-2011; collingridge, graham/AAI-8362-2020; Lee, Kyungmin/ABC-5624-2020	Collingridge, Graham L/0000-0002-9572-5359; wang, hansen/0000-0003-4414-3372; Zhuo, Min/0000-0001-9062-3241; Li, xiang-Yao/0000-0002-4793-0550; Lee, Kyungmin/0000-0002-5425-4212; Descalzi, Giannina/0000-0003-3734-394X; Park, Soowon/0000-0002-3348-940X; Ko, Hyoung-Gon/0000-0002-7730-6986	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health; Canada Research Chair; NeuroCanada; Canadian Institute for Health Research [CIHR66975, CIHR84256]; Ministry of Education, Science and Technology in Korea through National Research Foundation [R32-10142]; Fragile X Research Foundation of Canada; Korean Ministry of Science and Technology, Korea; BK21 fellowship, Korea; MRC (UK); MRC [G0601813] Funding Source: UKRI; Medical Research Council [G0601813] Funding Source: researchfish	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NeuroCanada; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Education, Science and Technology in Korea through National Research Foundation; Fragile X Research Foundation of Canada; Korean Ministry of Science and Technology, Korea; BK21 fellowship, Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, Canada Research Chair, NeuroCanada, and Canadian Institute for Health Research operating grants (CIHR66975 and CIHR84256) (M.Z.). M.Z., B.-K.K., and G. L. C. are also supported by the World-Class University (WCU) program of the Ministry of Education, Science and Technology in Korea through National Research Foundation (R32-10142). X.-Y.L., T. C., and H. W. are supported by postdoctoral fellowships from Fragile X Research Foundation of Canada. B.-K.K. is supported by the National Creative Research Initiative Program of the Korean Ministry of Science and Technology, Korea. H.-G. K. and C. K. are supported by a BK21 fellowship, Korea. G. L. C. receives support from the MRC (UK).	Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bliss TVP, 2006, SCIENCE, V313, P1058, DOI 10.1126/science.1132538; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelly MT, 2007, J NEUROSCI, V27, P3439, DOI 10.1523/JNEUROSCI.5612-06.2007; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Liauw J, 2005, J NEUROPHYSIOL, V94, P878, DOI 10.1152/jn.01205.2004; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Shema R, 2009, LEARN MEMORY, V16, P122, DOI 10.1101/lm.1183309; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Vadakkan KI, 2005, J PAIN, V6, P747, DOI 10.1016/j.jpain.2005.07.005; Wei F, 1999, J NEUROSCI, V19, P9346; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Wu LJ, 2005, J NEUROPHYSIOL, V94, P1805, DOI 10.1152/jn.00091.2005; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003	28	297	314	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1400	1404		10.1126/science.1191792	http://dx.doi.org/10.1126/science.1191792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127255				2022-12-24	WOS:000284902100048
J	Gaster, B; Edwards, K; Trinidad, SB; Gallagher, TH; Braddock, CH				Gaster, Barak; Edwards, Kelly; Trinidad, Susan Brown; Gallagher, Thomas H.; Braddock, Clarence H., III			Patient-Centered Discussions About Prostate Cancer Screening: A Real-World Approach	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFORMED DECISION-MAKING; AFRICAN-AMERICAN; PRIMARY-CARE; HEALTH-CARE; MEDICAL-DECISIONS; BREAST-CANCER; TIME; MEN; INTERVENTION; PREFERENCES	National guidelines recommend that primary care providers discuss the risks and benefits of prostate cancer screening with their patients but give little guidance on how to fit such a complex discussion into a busy clinic encounter. The authors propose a process-oriented approach (Ask-Tell-Ask) that promotes tailored conversations and value-based recommendations. The Ask-Tell-Ask approach includes diagnosing a patient's informational needs, providing targeted education based on those needs, and making a shared decision about testing. This time-efficient model emphasizes the provider's role as an interactive guide rather than a one-way supplier of information. Although there is no way to make these discussions simple, this streamlined strategy can help patients and providers efficiently negotiate the complex and important decision of screening for prostate cancer.	[Gaster, Barak] Univ Washington, Sch Med, Seattle, WA 98105 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	Gaster, B (corresponding author), Univ Washington, Sch Med, 4245 Roosevelt Way NE, Seattle, WA 98105 USA.	barakg@uw.edu		Trinidad, Susan Brown/0000-0002-5956-6557	CDC; National Cancer Institute through the Cancer Prevention and Control Research Network [1-U48-DP-000050]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000050] Funding Source: NIH RePORTER	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute through the Cancer Prevention and Control Research Network; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	In part by the CDC and the National Cancer Institute through the Cancer Prevention and Control Research Network, a network within the CDC's Prevention Research Centers Program (grant 1-U48-DP-000050).	Allen JD, 2009, AM J MENS HEALTH, V3, P340, DOI 10.1177/1557988308325460; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Back AL, 2005, CA-CANCER J CLIN, V55, P164, DOI 10.3322/canjclin.55.3.164; Bao YH, 2007, HEALTH SERV RES, V42, P950, DOI 10.1111/j.1475-6773.2006.00638.x; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Braddock C, 2008, J BONE JOINT SURG AM, V90A, P1830, DOI 10.2106/JBJS.G.00840; Briss P, 2004, AM J PREV MED, V26, P67, DOI 10.1016/j.amepre.2003.09.012; BRODY H, 1989, HASTINGS CENT REP, V19, P5, DOI 10.2307/3562634; Chan ECY, 2003, J COMMUN HEALTH, V28, P393, DOI 10.1023/A:1026072022853; Chan ECY, 2003, J GEN INTERN MED, V18, P350, DOI 10.1046/j.1525-1497.2003.20626.x; Cole SA, 1997, AM J MANAG C, V3, P649; Davison BJ, 2004, BJU INT, V93, P47, DOI 10.1111/j.1464-410X.2004.04553.x; Drake BF, 2010, J NATL MED ASSOC, V102, P164, DOI 10.1016/S0027-9684(15)30521-6; Dunn AS, 2001, AM J PREV MED, V20, P130, DOI 10.1016/S0749-3797(00)00288-9; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Frosch DL, 2008, ARCH INTERN MED, V168, P363, DOI 10.1001/archinternmed.2007.111; Greene GW, 1999, J AM DIET ASSOC, V99, P673, DOI 10.1016/S0002-8223(99)00164-9; Guerra CE, 2007, J GEN INTERN MED, V22, P901, DOI 10.1007/s11606-007-0142-3; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Hoffman RM, 2007, J GEN INTERN MED, V22, P1056, DOI 10.1007/s11606-007-0167-7; Hoffman RM, 2009, ARCH INTERN MED, V169, P1611, DOI 10.1001/archinternmed.2009.262; JAEN CR, 1994, J FAM PRACTICE, V38, P166; Kemp EC, 2008, J AM BOARD FAM MED, V21, P24, DOI 10.3122/jabfm.2008.01.070093; Kilbridge KL, 2009, J CLIN ONCOL, V27, P2015, DOI 10.1200/JCO.2008.17.3468; Kripalani S, 2007, AM J PREV MED, V33, P83, DOI 10.1016/j.amepre.2007.03.018; Krist AH, 2007, ANN FAM MED, V5, P112, DOI 10.1370/afm.623; Lim LS, 2008, AM J PREV MED, V34, P164, DOI 10.1016/j.amepre.2007.10.003; Linder SK, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-19; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; LUQUE JS, 2010, AM J MENS HLTH, P27953; Lyman GH, 2010, CANCER INVEST, V28, P1, DOI 10.3109/07357900903517001; McFall SL, 2009, HEALTH EDUC RES, V24, P280, DOI 10.1093/her/cyn018; Murphy AM, 2010, JAMA-J AM MED ASSOC, V303, P166, DOI 10.1001/jama.2009.1991; Myers R E, 2000, Semin Urol Oncol, V18, P172; Myers RE, 2005, J NATL MED ASSOC, V97, P1143; NEASE RF, 1995, J GEN INTERN MED, V10, P593, DOI 10.1007/BF02602742; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Ross L, 2010, J NATL MED ASSOC, V102, P228, DOI 10.1016/S0027-9684(15)30529-0; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sheridan SL, 2004, AM J PREV MED, V26, P56, DOI 10.1016/j.amepre.2003.09.011; Steginga SK, 2005, BJU INT, V96, P1209, DOI 10.1111/j.1464-410X.2005.05782.x; Talcott JA, 2003, UROLOGY, V61, P7, DOI 10.1016/S0090-4295(02)02148-9; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Vig EK, 2007, J GEN INTERN MED, V22, P1274, DOI 10.1007/s11606-007-0252-y; Volk RJ, 2007, AM J PREV MED, V33, P428, DOI 10.1016/j.amepre.2007.07.030; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Woolf SH, 2005, ANN INTERN MED, V143, P293, DOI 10.7326/0003-4819-143-4-200508160-00010; Woolf SH, 2005, AM FAM PHYSICIAN, V71, P1871; Woolf SH, 2005, PATIENT EDUC COUNS, V56, P116, DOI 10.1016/j.pec.2003.12.002; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	52	13	13	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 16	2010	153	10					661	665		10.7326/0003-4819-153-10-201011160-00010	http://dx.doi.org/10.7326/0003-4819-153-10-201011160-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680ES	21079223	Green Accepted			2022-12-24	WOS:000284215800020
J	Chia, NY; Chan, YS; Feng, B; Lu, XY; Orlov, YL; Moreau, D; Kumar, P; Yang, L; Jiang, JM; Lau, MS; Huss, M; Soh, BS; Kraus, P; Li, P; Lufkin, T; Lim, B; Clarke, ND; Bard, F; Ng, HH				Chia, Na-Yu; Chan, Yun-Shen; Feng, Bo; Lu, Xinyi; Orlov, Yuriy L.; Moreau, Dimitri; Kumar, Pankaj; Yang, Lin; Jiang, Jianming; Lau, Mei-Sheng; Huss, Mikael; Soh, Boon-Seng; Kraus, Petra; Li, Pin; Lufkin, Thomas; Lim, Bing; Clarke, Neil D.; Bard, Frederic; Ng, Huck-Hui			A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity	NATURE			English	Article							DEFINED FACTORS; MOUSE EMBRYOS; SELF-RENEWAL; LINES; ESTABLISHMENT; TRANSCRIPTION; EXPRESSION; REGULATOR; PROTEINS; COMPLEX	The derivation of human ES cells (hESCs) from human blastocysts represents one of the milestones in stem cell biology(1). The full potential of hESCs in research and clinical applications requires a detailed understanding of the genetic network that governs the unique properties of hESCs. Here, we report a genome-wide RNA interference screen to identify genes which regulate self-renewal and pluripotency properties in hESCs. Interestingly, functionally distinct complexes involved in transcriptional regulation and chromatin remodelling are among the factors identified in the screen. To understand the roles of these potential regulators of hESCs, we studied transcription factor PRDM14 to gain new insights into its functional roles in the regulation of pluripotency. We showed that PRDM14 regulates directly the expression of key pluripotency gene POU5F1 through its proximal enhancer. Genome-wide location profiling experiments revealed that PRDM14 colocalized extensively with other key transcription factors such as OCT4, NANOG and SOX2, indicating that PRDM14 is integrated into the core transcriptional regulatory network. More importantly, in a gain-of-function assay, we showed that PRDM14 is able to enhance the efficiency of reprogramming of human fibroblasts in conjunction with OCT4, SOX2 and KLF4. Altogether, our study uncovers a wealth of novel hESC regulators wherein PRDM14 exemplifies a key transcription factor required for the maintenance of hESC identity and the reacquisition of pluripotency in human somatic cells.	[Chia, Na-Yu; Chan, Yun-Shen; Feng, Bo; Lu, Xinyi; Yang, Lin; Jiang, Jianming; Lau, Mei-Sheng; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Chia, Na-Yu; Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Chan, Yun-Shen; Ng, Huck-Hui] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Lu, Xinyi; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Orlov, Yuriy L.; Huss, Mikael; Clarke, Neil D.] Genome Inst Singapore, Computat & Syst Biol Grp, Singapore 138672, Singapore; [Moreau, Dimitri; Kumar, Pankaj; Bard, Frederic] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Ctr Life Sci, Boston, MA 02115 USA; [Clarke, Neil D.; Bard, Frederic; Ng, Huck-Hui] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Harvard University; Harvard Medical School; National University of Singapore	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, 60 Biopolis St, Singapore 138672, Singapore.	fbard@imcb.a-star.edu.sg; nghh@gis.a-star.edu.sg	Chan, Yun-Shen/GWC-4616-2022; jiang, jianming/B-3421-2012; Clarke, Neil/D-9613-2014; Lufkin, Thomas/B-5352-2011; Kraus, Petra/I-5849-2014; Lufkin, Thomas/AAG-7476-2019; Orlov, Yuriy L/F-1520-2013; BARD, Frederic/G-9914-2011; Feng, Bo/D-7831-2014; Ng, Huck Hui/A-1135-2009; Moreau, Dimitri/E-5092-2012	jiang, jianming/0000-0003-3251-2716; Lufkin, Thomas/0000-0002-7902-4771; Kraus, Petra/0000-0002-6716-5550; Lufkin, Thomas/0000-0002-7902-4771; Orlov, Yuriy L/0000-0003-0587-1609; BARD, Frederic/0000-0002-3783-4805; Feng, Bo/0000-0002-4018-3257; Moreau, Dimitri/0000-0002-9282-3324; Huss, Mikael/0000-0003-0839-2451; CHIA, NA YU/0000-0003-1092-4699; LU, Xinyi/0000-0002-3885-3960	Biomedical Research Council (BMRC); Agency for Science, Technology and Research (A*STAR); Singapore Stem Cell Consortium	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium	We are grateful to the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR) and Singapore Stem Cell Consortium for funding. We are grateful to K. Kuay, L.-P. Yaw, C.-K. Tong and C.-W. Chang for technical assistance. We acknowledge V. Cacheux-Rataboul for karyotype analysis and the GTB group for sequencing. We are grateful to A. Surani, P. Tesar and R. Mckay for gift of EpiSCs and Q. Yu for plasmids. We thank A. Colman, A. Hutchins and T. Huber for comments on the manuscript.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chamovitz DA, 2009, EMBO REP, V10, P352, DOI 10.1038/embor.2009.33; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	30	346	374	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					316	U207		10.1038/nature09531	http://dx.doi.org/10.1038/nature09531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	20953172				2022-12-24	WOS:000284051000053
J	Wilkinson, RG; Pickett, KE; De Vogli, R				Wilkinson, Richard G.; Pickett, Kate E.; De Vogli, Roberto			Essay Equality, sustainability, and quality of life	BRITISH MEDICAL JOURNAL			English	Editorial Material							ORIENTATION; VALIDATION; MORTALITY		[Wilkinson, Richard G.] Univ Nottingham, Nottingham NG7 2RD, England; [Pickett, Kate E.] Univ York, York YO10 5DD, N Yorkshire, England; [De Vogli, Roberto] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of Nottingham; University of York - UK; University of London; University College London	Wilkinson, RG (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.	Richard@RichardWilkinson.net			ESRC [ES/H033084/1] Funding Source: UKRI; Department of Health [CSA/03/07/014] Funding Source: Medline; Economic and Social Research Council [ES/H033084/1] Funding Source: researchfish; National Institute for Health Research [CSA/03/07/014] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Blanden J., 2009, CTR EC ED CEE DISCUS, V139, P673; DORLING D, 2010, COMMUNICATION   0517; Hare B., 2006, AVOIDING DANGEROUS C, P191; *INT PAN CLIM CHAN, 2007, 4 IPPC INT PAN CLIM; JOWIT J, 2008, GUARDIAN        0628; Layard R., 2005, PROSPECT, V108; LOMBORG B, 2010, SMARTSOLUTIONS CLIMA; Moore PJ, 1996, ADDICT BEHAV, V21, P645, DOI 10.1016/0306-4603(95)00100-X; Nichols A, 2009, ENVIRON HEALTH INSIG, V3, P63; Pickett R. Wilkinson, 2010, SPIRIT LEVEL WHY EQU; Preston SH, 2007, INT J EPIDEMIOL, V36, P484, DOI 10.1093/ije/dym075; RICHINS ML, 1992, J CONSUM RES, V19, P303, DOI 10.1086/209304; Roberts J.Timmons., 2006, CLIMATE INJUSTICE GL; Ross NA, 2005, J URBAN HEALTH, V82, P101, DOI 10.1093/jurban/jti012; Saunders S, 2000, SOC BEHAV PERSONAL, V28, P219, DOI 10.2224/sbp.2000.28.3.219; Sheldon KM, 2000, J PERS, V68, P383, DOI 10.1111/1467-6494.00101; Wilkinson R., 2010, IMPACT INCOME INEQUA; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041; World Economic Forum, 2002, GLOB COMP REP 2001 2	19	25	25	1	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 2	2010	341								c5816	10.1136/bmj.c5816	http://dx.doi.org/10.1136/bmj.c5816			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	678CU	21045025				2022-12-24	WOS:000284048200003
J	Woodcock, J; Sharfstein, JM; Hamburg, M				Woodcock, Janet; Sharfstein, Joshua M.; Hamburg, Margaret			Regulatory Action on Rosiglitazone by the US Food and Drug Administration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet] Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Sharfstein, Joshua M.; Hamburg, Margaret] US FDA, Dept Hlth & Human Serv, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], GUID IND DIAB MELL E; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; United States Food and Drug Administration (FDA), FDA DRUG SAF COMM ON	6	114	116	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1489	1491		10.1056/NEJMp1010788	http://dx.doi.org/10.1056/NEJMp1010788			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KP	20942663				2022-12-24	WOS:000282887100001
J	Bennett-Guerrero, E; Zhao, Y; O'Brien, SM; Ferguson, TB; Peterson, ED; Gammie, JS; Song, HK				Bennett-Guerrero, Elliott; Zhao, Yue; O'Brien, Sean M.; Ferguson, T. B., Jr.; Peterson, Eric D.; Gammie, James S.; Song, Howard K.			Variation in Use of Blood Transfusion in Coronary Artery Bypass Graft Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-THORACIC-SURGEONS; LONG-TERM SURVIVAL; CARDIAC-SURGERY; CELL TRANSFUSION; CABG SURGERY; CONSERVATION; VARIABILITY; MORTALITY; SOCIETY; OPERATIONS	Context Perioperative blood transfusions are costly and have safety concerns. As a result, there have been multiple initiatives to reduce transfusion use. However, the degree to which perioperative transfusion rates vary among hospitals is unknown. Objective To assess hospital-level variation in use of allogeneic red blood cell (RBC), fresh-frozen plasma, and platelet transfusions in patients undergoing coronary artery bypass graft (CABG) surgery. Design, Setting, and Patients An observational cohort of 102 470 patients undergoing primary isolated CABG surgery with cardiopulmonary bypass during calendar year 2008 at 798 sites in the United States, contributing data to the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Main Outcome Measures Perioperative (intraoperative and postoperative) transfusion of RBCs, fresh-frozen plasma, and platelets. Results At hospitals performing at least 100 on-pump CABG operations (82 446 cases at 408 sites), the rates of blood transfusion ranged from 7.8% to 92.8% for RBCs, 0% to 97.5% for fresh-frozen plasma, and 0.4% to 90.4% for platelets. Multivariable analysis including data from all 798 sites (102 470 cases) revealed that after adjustment for patient-level risk factors, hospital transfusion rates varied by geographic location (P=.007), academic status (P=.03), and hospital volume (P<.001). However, these 3 hospital characteristics combined only explained 11.1% of the variation in hospital risk-adjusted RBC usage. Case mix explained 20.1% of the variation between hospitals in RBC usage. Conclusion Wide variability occurred in the rates of transfusion of RBCs and other blood products, independent of case mix, among patients undergoing CABG surgery with cardiopulmonary bypass in US hospitals in an adult cardiac surgical database. JAMA. 2010;304(14):1568-1575 www.jama.com	[Bennett-Guerrero, Elliott] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Perioperat Clin Res, Durham, NC 27710 USA; [Zhao, Yue; O'Brien, Sean M.] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Biostat, Durham, NC 27710 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Cardiol, Durham, NC 27710 USA; [Ferguson, T. B., Jr.] E Carolina Heart Inst, Dept Cardiovasc Sci, Greenville, NC USA; [Gammie, James S.] Univ Maryland, Med Ctr, Div Cardiac Surg, Baltimore, MD 21201 USA; [Song, Howard K.] Oregon Hlth & Sci Univ, Div Cardiothorac Surg, Portland, OR 97201 USA	Duke University; Duke University; Duke University; University of North Carolina; East Carolina University; University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University	Bennett-Guerrero, E (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Div Perioperat Clin Res, POB 3094, Durham, NC 27710 USA.	elliott.bennettguerrero@duke.edu	O'Brien, Sean/H-6268-2013; Peterson, Eric David/ABF-5033-2021		National Institutes of Health [R01 HL101382-01]; Society of Thoracic Surgeons (STS) through the National Adult Cardiac Surgery Database and the Duke Clinical Research Institute (DCRI)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Thoracic Surgeons (STS) through the National Adult Cardiac Surgery Database and the Duke Clinical Research Institute (DCRI)	Dr Bennett-Guerrero is principal investigator (grant R01 HL101382-01 from the National Institutes of Health) for a multicenter study assessing the impact of blood transfusion on peripheral and cerebral oxygenation and the microcirculation. He is also a named inventor on a patent application related to methods of washing red blood cells. No other authors have any disclosures.; This study was supported by the Society of Thoracic Surgeons (STS) through the National Adult Cardiac Surgery Database and the Duke Clinical Research Institute (DCRI).; This study was sponsored by the STS. Specifically, the DCRI has a contract with the STS to be their National Cardiac Data Warehouse and Analysis Center. In this role, the DCRI independently harvests data from each participating STS center, creates a national analysis database, and performs statistical analyses. The proposal for this study was submitted to and approved of by the STS National Database Publications Committee. After approval, the manuscript was reviewed by the coauthors and a final version was approved by the publications committee. The STS was involved in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; and in the review and approval of the manuscript.	Covin R, 2003, ARCH PATHOL LAB MED, V127, P415; DeAnda A, 2006, AM J MED QUAL, V21, P230, DOI 10.1177/1062860606289784; Edwards FH, 1998, J INVASIVE CARDIOL, V10, P485; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; Ferguson TB, 2000, ANN THORAC SURG, V69, P680, DOI 10.1016/S0003-4975(99)01538-6; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; GOODNOUGH LT, 1991, JAMA-J AM MED ASSOC, V265, P86, DOI 10.1001/jama.265.1.86; Helm RE, 1998, ANN THORAC SURG, V65, P125, DOI 10.1016/S0003-4975(97)01004-7; JACOBS JP, 2008, 46 ANN M SOC THOR SU; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030; Maddux FW, 2009, AM J MED QUAL, V24, P403, DOI 10.1177/1062860609339384; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195; Rosengart TK, 1997, J AM COLL SURGEONS, V184, P618; Scott BH, 2008, ANN CARD ANAESTH, V11, P15, DOI 10.4103/0971-9784.38444; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Shander A, 2007, BEST PRAC RES-CL ANA, V21, P271, DOI 10.1016/j.bpa.2007.01.002; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Shibata K, 2002, ANN THORAC SURG, V73, P739, DOI 10.1016/S0003-4975(01)03392-6; Snyder-Ramos SA, 2008, TRANSFUSION, V48, P1284, DOI 10.1111/j.1537-2995.2008.01666.x; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009; Surgenor SD, 2006, CIRCULATION, V114, pI43, DOI 10.1161/CIRCULATIONAHA.105.001271; US Department of Health and Human Services, 2007, 2007 NATIONWIDE BLOO; Van der Linden P, 2001, CAN J ANAESTH, V48, P894, DOI 10.1007/BF03017357; Welke KF, 2004, ANN THORAC SURG, V77, P1137, DOI 10.1016/j.athoracsur.2003.07.030	31	338	348	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1568	1575		10.1001/jama.2010.1406	http://dx.doi.org/10.1001/jama.2010.1406			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940382	Bronze			2022-12-24	WOS:000282816500021
J	Gray, CM; Loubser, S; Kriel, C; Mercer, M; Brookes, H				Gray, Clive M.; Loubser, Shayne; Kriel, Carina; Mercer, Monica; Brookes, Heather			Immunology for Clinicians: A "Trojan Horse" Approach	SCIENCE			English	Editorial Material									[Gray, Clive M.; Loubser, Shayne; Kriel, Carina; Mercer, Monica] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Brookes, Heather] Univ Johannesburg, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Johannesburg	Gray, CM (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.	cgray@nicd.ac.za		Gray, Clive/0000-0002-9293-901X				Abdool Karim S. S., 2010, HIV AIDS S AFRICA; Davis C., TEACHING MAT USING C; Debard N, 2005, NAT REV IMMUNOL, V5, P736, DOI 10.1038/nri1687; Kreber C., 2001, TEACH HIGH EDUC, V6, P217, DOI DOI 10.1080/13562510120045203; Maguire L., 2009, J SCHOLARSHIP LEARN, V9, P93; UNAIDS, 2009, 2009 AIDS EP UPD	6	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1613	1614		10.1126/science.1186963	http://dx.doi.org/10.1126/science.1186963			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653NK	20929838				2022-12-24	WOS:000282098100030
J	Summers, ZM; Fogarty, HE; Leang, C; Franks, AE; Malvankar, NS; Lovley, DR				Summers, Zarath M.; Fogarty, Heather E.; Leang, Ching; Franks, Ashley E.; Malvankar, Nikhil S.; Lovley, Derek R.			Direct Exchange of Electrons Within Aggregates of an Evolved Syntrophic Coculture of Anaerobic Bacteria	SCIENCE			English	Article							GEOBACTER-SULFURREDUCENS; SP-NOV; REDUCTION; OXIDATION; METHANE; HYDROGEN; ARCHAEA; FE(III); MICROORGANISM; CONSTRAINTS	Microbial consortia that cooperatively exchange electrons play a key role in the anaerobic processing of organic matter. Interspecies hydrogen transfer is a well-documented strategy for electron exchange in dispersed laboratory cultures, but cooperative partners in natural environments often form multispecies aggregates. We found that laboratory evolution of a coculture of Geobacter metallireducens and Geobacter sulfurreducens metabolizing ethanol favored the formation of aggregates that were electrically conductive. Sequencing aggregate DNA revealed selection for a mutation that enhances the production of a c-type cytochrome involved in extracellular electron transfer and accelerates the formation of aggregates. Aggregate formation was also much faster in mutants that were deficient in interspecies hydrogen transfer, further suggesting direct interspecies electron transfer.	[Summers, Zarath M.; Fogarty, Heather E.; Leang, Ching; Franks, Ashley E.; Malvankar, Nikhil S.; Lovley, Derek R.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Malvankar, Nikhil S.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	dlovley@microbio.umass.edu		Franks, Ashley/0000-0003-1664-6060	Office of Science (Office of Biological and Environmental Research), U.S. Department of Energy [DE-FC02-02ER63446, DE-FC-0004485]	Office of Science (Office of Biological and Environmental Research), U.S. Department of Energy(United States Department of Energy (DOE))	We thank P. Brown, C. Barrett, K. Zengler, and Y. Qiu for sequence analysis; L. Raboin for SEM assistance; and K. Rubin for photography assistance. Supported by the Office of Science (Office of Biological and Environmental Research), U.S. Department of Energy, Cooperative Agreement DE-FC02-02ER63446 and Award DE-FC-0004485.	Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; BRYANT MP, 1967, ARCH MIKROBIOL, V59, P20, DOI 10.1007/BF00406313; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Butler JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-103; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Coppi MV, 2004, J BACTERIOL, V186, P3022, DOI 10.1128/JB.186.10.3022-3028.2004; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Holmes DE, 2006, ENVIRON MICROBIOL, V8, P1805, DOI 10.1111/j.1462-2920.2006.01065.x; Juarez K, 2009, J MOL MICROB BIOTECH, V16, P146, DOI 10.1159/000115849; Kartal B, 2010, SCIENCE, V328, P702, DOI 10.1126/science.1185941; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Leang C, 2010, APPL ENVIRON MICROB, V76, P4080, DOI 10.1128/AEM.00023-10; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Marx CJ, 2009, SCIENCE, V324, P1150, DOI 10.1126/science.1173088; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Mehta T, 2005, APPL ENVIRON MICROB, V71, P8634, DOI 10.1128/AEM.71.12.8634-8641.2005; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; OZTURK SS, 1989, BIOTECHNOL BIOENG, V33, P745, DOI 10.1002/bit.260330612; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; Schink B, 2006, PROKARYOTES, V3, P5, DOI DOI 10.1007/0-387-30747-8_1; Schmidt JE, 1996, BIOTECHNOL BIOENG, V49, P229, DOI [10.1002/(SICI)1097-0290(19960205)49:3<229::AID-BIT1>3.0.CO;2-M, 10.1002/(SICI)1097-0290(19960205)49:3&lt;229::AID-BIT1&gt;3.0.CO;2-M]; Sorensen KB, 2001, MICROBIAL ECOL, V42, P1; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166	27	608	664	67	800	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1413	1415		10.1126/science.1196526	http://dx.doi.org/10.1126/science.1196526			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127257				2022-12-24	WOS:000284902100052
J	de Boer, Y				de Boer, Yvo			Copenhagen shows we need caution in Cancun	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					477	477		10.1038/468477a	http://dx.doi.org/10.1038/468477a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684WA	21107383	Bronze			2022-12-24	WOS:000284584200006
J	Puthenveedu, MA; Lauffer, B; Temkin, P; Vistein, R; Carlton, P; Thorn, K; Taunton, J; Weiner, OD; Parton, RG; von Zastrow, M				Puthenveedu, Manojkumar A.; Lauffer, Benjamin; Temkin, Paul; Vistein, Rachel; Carlton, Peter; Thorn, Kurt; Taunton, Jack; Weiner, Orion D.; Parton, Robert G.; von Zastrow, Mark			Sequence-Dependent Sorting of Recycling Proteins by Actin-Stabilized Endosomal Microdomains	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; COUPLED-RECEPTORS; ARP2/3 COMPLEX; DYNAMIC ACTIN; MULTIVESICULAR BODIES; PLASMA-MEMBRANE; CORTACTIN; RESENSITIZATION; CYTOSKELETON; PATHWAY	The functional consequences of signaling receptor endocytosis are determined by the endosomal sorting of receptors between degradation and recycling pathways. How receptors recycle efficiently, in a sequence-dependent manner that is distinct from bulk membrane recycling, is not known. Here, in live cells, we visualize the sorting of a prototypical sequence-dependent recycling receptor, the beta-2 adrenergic receptor, from bulk recycling proteins and the degrading delta-opioid receptor. Our results reveal a remarkable diversity in recycling routes at the level of individual endosomes, and indicate that sequence-dependent recycling is an active process mediated by distinct endosomal subdomains distinct from those mediating bulk recycling. We identify a specialized subset of tubular microdomains on endosomes, stabilized by a highly localized but dynamic actin machinery, that mediate this sorting, and provide evidence that these actin-stabilized domains provide the physical basis for a two-step kinetic and affinity-based model for protein sorting into the sequence-dependent recycling pathway.	[Puthenveedu, Manojkumar A.; Vistein, Rachel] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Lauffer, Benjamin; Temkin, Paul; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Carlton, Peter] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Thorn, Kurt; Weiner, Orion D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Taunton, Jack; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld 4072, Australia	Carnegie Mellon University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Queensland; University of Queensland	Puthenveedu, MA (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	map3@andrew.cmu.edu	Temkin, Paul A/F-9262-2011; Carlton, Peter/AAD-2403-2021; Weiner, Orion D/F-2576-2011; Parton, Robert G/C-5673-2009; Puthenveedu, Manojkumar/A-3795-2016	Carlton, Peter/0000-0002-5320-6024; Weiner, Orion D/0000-0002-1778-6543; Parton, Robert G/0000-0002-7494-5248; Thorn, Kurt/0000-0001-9310-288X; Vistein, Rachel/0000-0002-2172-9947; Puthenveedu, Manojkumar/0000-0002-3177-4231	NIH [DA024698, DA010711, GM084040]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010711, R00DA024698, K99DA024698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The majority of the imaging was performed at the Nikon Imaging Center at UCSF. We thank David Drubin, Matt Welch, John Sedat, Aylin Hanyaloglu, Aaron Marley, and James Hislop for essential reagents and valuable help. M.A.P. was supported by a K99/R00 grant DA024698, M.v.Z. by an R37 grant DA010711, and O.D.W. by an RO1 grant GM084040, all from the NIH. J.T. is an investigator of the Howard Hughes Medical Institute.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; FARQUHAR MG, 1983, METHOD ENZYMOL, V98, P1; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Ikonen E, 1996, MOL BIOL CELL, V7, P961, DOI 10.1091/mbc.7.6.961; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kaksonen M, 2000, J CELL SCI, V113, P4421; Lauffer BEL, 2009, J BIOL CHEM, V284, P2448, DOI 10.1074/jbc.M806370200; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; PARTON RG, 1991, J CELL BIOL, V113, P261, DOI 10.1083/jcb.113.2.261; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SCITA G, 2010, TRAFFIC, V7, P1539; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	56	233	235	1	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					761	773		10.1016/j.cell.2010.10.003	http://dx.doi.org/10.1016/j.cell.2010.10.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111236	Green Accepted, Bronze			2022-12-24	WOS:000284583500018
J	The, NS; Suchindran, C; North, KE; Popkin, BM; Gordon-Larsen, P				The, Natalie S.; Suchindran, Chirayath; North, Kari E.; Popkin, Barry M.; Gordon-Larsen, Penny			Association of Adolescent Obesity With Risk of Severe Obesity in Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOR-DISEASE-CONTROL; BODY-MASS INDEX; UNITED-STATES; US ADULTS; MORBID-OBESITY; PREVALENCE; INCREASES; CHILDREN; TRENDS; OVERWEIGHT	Context Although the prevalence of obesity has increased in recent years, individuals who are obese early in life have not been studied over time to determine whether they develop severe obesity in adulthood, thus limiting effective interventions to reduce severe obesity incidence and its potentially life-threatening associated conditions. Objective To determine incidence and risk of severe obesity in adulthood by adolescent weight status. Design, Setting, and Participants A cohort of 8834 individuals aged 12 to 21 years enrolled in 1996 in wave II of the US National Longitudinal Study of Adolescent Health, followed up into adulthood (ages 18-27 years during wave III [2001-2002] and ages 24-33 years during wave IV [2007-2009]). Height and weight were obtained via anthropometry and surveys administered in study participants' homes using standardized procedures. Main Outcome Measures New cases of adult-onset severe obesity were calculated by sex, race/ethnicity, and adolescent weight status. Sex-stratified, discrete time hazard models estimated the net effect of adolescent obesity (aged <20 years; body mass index [BMI] >= 95th percentile of the sex-specific BMI-for-age growth chart or BMI >= 30.0) on risk of severe obesity incidence in adulthood (aged <20 years; BMI >= 40.0), adjusting for race/ethnicity and age and weighted for national representation. Results In 1996, 79 (1.0%; 95% confidence interval [CI], 0.7%-1.4%) adolescents were severely obese; 60 (70.5%; 95% CI, 57.2%-83.9%) remained severely obese in adulthood. By 2009, 703 (7.9%; 95% CI, 7.4%-8.5%) non-severely obese adolescents had become severely obese in adulthood, with the highest rates for non-Hispanic black women. Obese adolescents were significantly more likely to develop severe obesity in young adulthood than normal-weight or overweight adolescents (hazard ratio, 16.0; 95% CI, 12.4-20.5). Conclusion In this cohort, obesity in adolescence was significantly associated with increased risk of incident severe obesity in adulthood, with variations by sex and race/ethnicity. JAMA. 2010;304(18):2042-2047 www.jama.com	[The, Natalie S.; Suchindran, Chirayath; Popkin, Barry M.; Gordon-Larsen, Penny] Univ N Carolina, Gillings Sch Global Publ Hlth, Carolina Populat Ctr, Chapel Hill, NC 27516 USA; [The, Natalie S.; Popkin, Barry M.; Gordon-Larsen, Penny] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27516 USA; [Suchindran, Chirayath] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27516 USA; [North, Kari E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27516 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gordon-Larsen, P (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Carolina Populat Ctr, 123 W Franklin St, Chapel Hill, NC 27516 USA.	pglarsen@unc.edu	Popkin, Barry/T-6633-2019	popkin, barry/0000-0001-9495-9324	National Institutes of Health [R01-HD057194]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057194, P01HD031921, R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grant R01-HD057194.; This research uses data from Add Health, a program project directed by Kathleen Mullan Harris, PhD, and designed by J. Richard Udry, PhD, Peter S. Bearman, PhD, and Kathleen Mullan Harris, PhD at the University of North Carolina, Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss, PhD, and Barbara Entwisle, PhD, both from the University of North Carolina, Chapel Hill, for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health Web site (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis. None of the acknowledged individuals received compensation for their assistance.	Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Bray G A, 2001, Rev Endocr Metab Disord, V2, P403, DOI 10.1023/A:1011808701117; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Chantala K, NONRESPONSE WAVE 3 A; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758; Freedman DS, 2007, J PEDIAT, V150, pe2; Gordon-Larsen P, 2007, OBESITY, V15, P2790, DOI 10.1038/oby.2007.331; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; McTigue KM, 2002, ANN INTERN MED, V136, P857, DOI 10.7326/0003-4819-136-12-200206180-00006; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; National Institutes of Health, 2000, PRACT GUID ID EV TRE; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Popkin BM, 1998, J NUTR, V128, P701, DOI 10.1093/jn/128.4.701; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Richardson DB, 2010, OCCUP ENVIRON MED, V67, P67, DOI 10.1136/oem.2008.044834; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Stevens J, 2003, INT J OBESITY, V27, P287, DOI 10.1038/sj.ijo.0802255; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Tanner BD, 2009, AM SURGEON, V75, P103; The NS, 2009, OBESITY, V17, P1441, DOI 10.1038/oby.2009.97; Tourangeau R, 1999, NATL LONGITUDINAL ST; Wang YC, 2011, INT J PEDIATR OBES, V6, P12, DOI 10.3109/17477161003587774; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65	33	288	291	2	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2042	2047		10.1001/jama.2010.1635	http://dx.doi.org/10.1001/jama.2010.1635			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063014	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000284000600023
J	Lewis, SL				Lewis, Simon L.			How to beat the media in the climate street fight	NATURE			English	Editorial Material									[Lewis, Simon L.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of Leeds		s.l.lewis@leeds.ac.uk		Lewis, Simon/0000-0002-8066-6851					0	1	1	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					7	7		10.1038/468007a	http://dx.doi.org/10.1038/468007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	674YF	21048720	Bronze			2022-12-24	WOS:000283786900006
J	Chen, YH; Hu, L; Punta, M; Bruni, R; Hillerich, B; Kloss, B; Rost, B; Love, J; Siegelbaum, SA; Hendrickson, WA				Chen, Yu-hang; Hu, Lei; Punta, Marco; Bruni, Renato; Hillerich, Brandan; Kloss, Brian; Rost, Burkhard; Love, James; Siegelbaum, Steven A.; Hendrickson, Wayne A.			Homologue structure of the SLAC1 anion channel for closing stomata in leaves	NATURE			English	Article							ABSCISIC-ACID; CHLORIDE CHANNEL; GUARD-CELL; PLASMA-MEMBRANE; SULFITE EFFLUX; PROTEIN; SELECTIVITY; MODEL; GENE; CONSERVATION	The plant SLAC1 anion channel controls turgor pressure in the aperture-defining guard cells of plant stomata, thereby regulating the exchange of water vapour and photosynthetic gases in response to environmental signals such as drought or high levels of carbon dioxide. Here we determine the crystal structure of a bacterial homologue (Haemophilus influenzae) of SLAC1 at 1.20 angstrom resolution, and use structure-inspired mutagenesis to analyse the conductance properties of SLAC1 channels. SLAC1 is a symmetrical trimer composed from quasi-symmetrical subunits, each having ten transmembrane helices arranged from helical hairpin pairs to form a central five-helix transmembrane pore that is gated by an extremely conserved phenylalanine residue. Conformational features indicate a mechanism for control of gating by kinase activation, and electrostatic features of the pore coupled with electrophysiological characteristics indicate that selectivity among different anions is largely a function of the energetic cost of ion dehydration.	[Chen, Yu-hang; Rost, Burkhard; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Chen, Yu-hang; Punta, Marco; Bruni, Renato; Hillerich, Brandan; Kloss, Brian; Rost, Burkhard; Love, James; Hendrickson, Wayne A.] New York Struct Biol Ctr, NYCOMPS, New York, NY 10027 USA; [Hu, Lei; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, D-85748 Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, D-85748 Munich, Germany; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Siegelbaum, Steven A.; Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Technical University of Munich; Technical University of Munich; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu	Hu, Lei/B-1455-2009; Rost, Burkhard/A-1908-2016; Punta, Marco/ABH-4698-2020	Rost, Burkhard/0000-0003-0179-8424; Punta, Marco/0000-0002-0050-0676; Bruni, Renato/0000-0002-2312-0254; Kloss, Brian/0000-0003-0130-8739	New York Consortium on Membrane Protein Structure (NYCOMPS) from the NIGMS Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, U54GM075026, R01GM034102] Funding Source: NIH RePORTER	New York Consortium on Membrane Protein Structure (NYCOMPS) from the NIGMS Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Mancia, L. Shapiro and M. Zhou for discussions; P. Rodriguez and A. Morrison for help with cloning and expression; J. Cheung, M. Collins, C. Min, S. Ye and Z. Zhang for advice in protein chemistry and crystallography; J. Schwanof and R. Abramowitz for help with synchrotron experiments; J. Riley for help with Xenopus oocyte injections; and M. Su for advice on the PSI-BLAST analysis of SLAC relatives. This project was supported in part by an award to the New York Consortium on Membrane Protein Structure (NYCOMPS) from the NIGMS Protein Structure Initiative. Beamline X4A at the National Synchrotron Light Source (NSLS), a DOE facility at Brookhaven National Laboratory, is supported by the New York Structural Biology Center.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FATT P, 1958, J PHYSIOL-LONDON, V142, P516, DOI 10.1113/jphysiol.1958.sp006034; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Grobler J, 1995, YEAST, V11, P1485, DOI 10.1002/yea.320111503; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lechenne B, 2007, MICROBIOL-SGM, V153, P905, DOI 10.1099/mic.0.2006/003335-0; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park H, 2000, YEAST, V16, P881, DOI 10.1002/1097-0061(200007)16:10<881::AID-YEA576>3.0.CO;2-3; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Saji S, 2008, PLANT CELL PHYSIOL, V49, P2, DOI 10.1093/pcp/pcm174; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; SCHMIDT C, 1994, PLANT PHYSIOL, V106, P383, DOI 10.1104/pp.106.1.383; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SCHROEDER JI, 1992, P NATL ACAD SCI USA, V89, P5025, DOI 10.1073/pnas.89.11.5025; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; TAYLOR DE, 1994, J BACTERIOL, V176, P2740, DOI 10.1128/JB.176.9.2740-2742.1994; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; WALTER EG, 1991, GENE, V101, P1, DOI 10.1016/0378-1119(91)90217-Y; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730	57	94	100	7	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1074	U157		10.1038/nature09487	http://dx.doi.org/10.1038/nature09487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981093	Green Accepted			2022-12-24	WOS:000283548600040
J	Brooks, N				Brooks, Nicholas			Is coronary artery bypass grafting the treatment of choice for diabetic patients with multivessel disease? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTION; RESTENOSIS; MELLITUS; OUTCOMES		[Brooks, Nicholas] Wythenshawe Hosp, Manchester M23 9LT, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Brooks, N (corresponding author), Wythenshawe Hosp, Manchester M23 9LT, England.	Nicholas.Brooks@uhsm.nhs.uk						Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057; Barsness GW, 1997, CIRCULATION, V96, P2551, DOI 10.1161/01.CIR.96.8.2551; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hong SJ, 2006, HEART, V92, P1119, DOI 10.1136/hrt.2005.075960; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Lee MS, 2010, AM J CARDIOL, V105, P1540, DOI 10.1016/j.amjcard.2010.01.009; Mathew V, 2004, CIRCULATION, V109, P476, DOI 10.1161/01.CIR.0000109693.64957.20; TIKALINOS TA, 2009, LANCET, V373, P911	11	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2010	341								c6961	10.1136/bmj.c6961	http://dx.doi.org/10.1136/bmj.c6961			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XA	21149466				2022-12-24	WOS:000285551900007
J	Pasternak, B; Hviid, A				Pasternak, Bjorn; Hviid, Anders			Use of Proton-Pump Inhibitors in Early Pregnancy and the Risk of Birth Defects.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; SAFETY; REGISTRATION; OMEPRAZOLE; MALFORMATIONS; REGISTER; COHORT	Background: Symptoms of gastroesophageal reflux are common in pregnancy, but there are limited data on the risk of birth defects associated with exposure to proton-pump inhibitors (PPIs) in early pregnancy. Methods: We conducted a cohort study to assess the association between exposure to PPIs during pregnancy and the risk of major birth defects among all infants born alive in Denmark between January 1996 and September 2008. We linked data from nationwide registries, including individual-level information on exposure to PPIs (prescriptions), birth defects, and potential confounders. Major birth defects, diagnosed within the first year of life, were categorized according to the standardized classification scheme of the European surveillance of congenital anomalies (EUROCAT). Our primary analyses assessed the use of PPIs from 4 weeks before conception through 12 weeks of gestation and from 0 through 12 weeks of gestation (first trimester). Results: Among 840,968 live births, 5082 involved exposure to PPIs between 4 weeks before conception and the end of the first trimester of pregnancy. There were 174 major birth defects in infants whose mothers had been exposed to PPIs during this period (3.4%), as compared with 21,811 in the group whose mothers had not been exposed (2.6%) (adjusted prevalence odds ratio, 1.23; 95% confidence interval [CI], 1.05 to 1.44). In analyses limited to exposure during the first trimester, there were 118 major birth defects among 3651 infants exposed to PPIs (3.2%), and the adjusted prevalence odds ratio was 1.10 (95% CI, 0.91 to 1.34). The risk of birth defects was not significantly increased in secondary analyses of exposure to individual PPIs during the first trimester or in analyses limited to the offspring of women who had filled PPI prescriptions and received enough doses to have a theoretical chance of first-trimester exposure. Conclusions: In this large cohort, exposure to PPIs during the first trimester of pregnancy was not associated with a significantly increased risk of major birth defects. (Funded by the Danish Medical Research Council and the Lundbeck Foundation.) N Engl J Med 2010;363:2114-23.	[Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Hug, Balthasar L./G-1568-2010; Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	Supported by the Danish Medical Research Council and the Lundbeck Foundation.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2008, PRIL; [Anonymous], 2002, DAT DANM STAT; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Dehlink E, 2009, CLIN EXP ALLERGY, V39, P246, DOI 10.1111/j.1365-2222.2008.03125.x; Diav-Citrin O, 2005, ALIMENT PHARM THER, V21, P269, DOI 10.1111/j.1365-2036.2005.02306.x; EKMAN L, 1985, SCAND J GASTROENTERO, V20, P53, DOI 10.3109/00365528509095819; Gill SK, 2009, AM J GASTROENTEROL, V104, P1541, DOI 10.1038/ajg.2009.122; Jepsen P, 2006, INT J RISK SAF MED, V18, P77; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Kallen B, 1998, BRIT J OBSTET GYNAEC, V105, P877, DOI 10.1111/j.1471-0528.1998.tb10233.x; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Lalkin A, 1998, AM J OBSTET GYNECOL, V179, P727, DOI 10.1016/S0002-9378(98)70072-9; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Matok I, 2009, ARCH DIS CHILD, V94, pe1; Matok I, 2009, NEW ENGL J MED, V360, P2528, DOI 10.1056/NEJMoa0807154; Mitchell AA, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P501; Nava-Ocampo AA, 2006, CAN FAM PHYSICIAN, V52, P853; Nielsen GL, 1999, ALIMENT PHARM THERAP, V13, P1085; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rey E, 2007, AM J GASTROENTEROL, V102, P2395, DOI 10.1111/j.1572-0241.2007.01452.x; Richter JE, 2005, ALIMENT PHARM THER, V22, P749, DOI 10.1111/j.1365-2036.2005.02654.x; Ruigomez A, 1999, AM J EPIDEMIOL, V150, P476	28	86	101	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2114	2123		10.1056/NEJMoa1002689	http://dx.doi.org/10.1056/NEJMoa1002689			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684XE	21105793				2022-12-24	WOS:000284587800006
J	Demontis, F; Perrimon, N				Demontis, Fabio; Perrimon, Norbert			FOXO/4E-BP Signaling in Drosophila Muscles Regulates Organism-wide Proteostasis during Aging	CELL			English	Article							FOXO TRANSCRIPTION FACTORS; EXTENDS LIFE-SPAN; PROTEIN-DEGRADATION; AUTOPHAGY; ELEGANS; DISEASE; CELLS; BODY; ACTIVATION; PATHWAYS	The progressive loss of muscle strength during aging is a common degenerative event of unclear pathogenesis. Although muscle functional decline precedes age-related changes in other tissues, its contribution to systemic aging is unknown. Here, we show that muscle aging is characterized in Drosophila by the progressive accumulation of protein aggregates that associate with impaired muscle function. The transcription factor FOXO and its target 4E-BP remove damaged proteins at least in part via the autophagy/lysosome system, whereas foxo mutants have dysfunctional proteostasis. Both FOXO and 4E-BP delay muscle functional decay and extend life span. Moreover, FOXO/4E-BP signaling in muscles decreases feeding behavior and the release of insulin from producing cells, which in turn delays the age-related accumulation of protein aggregates in other tissues. These findings reveal an organism-wide regulation of proteostasis in response to muscle aging and a key role of FOXO/4E-BP signaling in the coordination of organismal and tissue aging.	[Demontis, Fabio; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Demontis, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	fdemontis@genetics.med.harvard.edu; perrimon@receptor.med.harvard.edu		Demontis, Fabio/0000-0002-8698-9555; Perrimon, Norbert/0000-0001-7542-472X	NIH [1P01CA120964-01A1]; Paul F. Glenn Labs for the Molecular Biology of Aging; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Labs for the Molecular Biology of Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Andreas Brech, Didier Contamine, Ernst Hafen, Pierre Leopold, Susan Lindquist, Ioannis Nezis, Amita Sehgal, Marc Tatar, Robert Tjian, John Tower, the DRSC/TRiP, and members of the Perrimon lab for fly stocks, reagents, and advice. We thank Maria Ericsson for assistance with electron microscopy, Christians Villalta for embryo injection, and Chris Bakal, Rami Rahal, and Jonathan Zirin for critically reading the manuscript. This work was supported by the NIH (1P01CA120964-01A1) and a Pilot Project Grant from the Paul F. Glenn Labs for the Molecular Biology of Aging. F.D. is an Ellison Medical Foundation/AFAR postdoctoral fellow. N.P. is an investigator of the Howard Hughes Medical Institute.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Garigan D, 2002, GENETICS, V161, P1101; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Needham M, 2008, NEUROMUSCULAR DISORD, V18, P6, DOI 10.1016/j.nmd.2007.11.001; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Plata-Salaman CR, 1998, NEWS PHYSIOL SCI, V13, P298; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tower J, 2009, TRENDS ENDOCRIN MET, V20, P216, DOI 10.1016/j.tem.2008.12.005; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	49	430	441	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					813	825		10.1016/j.cell.2010.10.007	http://dx.doi.org/10.1016/j.cell.2010.10.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111239	Green Accepted, Bronze			2022-12-24	WOS:000284583500022
J	Ikeda, F; Crosetto, N; Dikic, I				Ikeda, Fumiyo; Crosetto, Nicola; Dikic, Ivan			What Determines the Specificity and Outcomes of Ubiquitin Signaling?	CELL			English	Article							POLYUBIQUITIN CHAINS; STRUCTURAL BASIS; BINDING DOMAINS; RECOGNITION; PROTEASOME; DEGRADATION; ACTIVATION; PROTEINS; COMPLEX; LIGASE	Ubiquitin signals and ubiquitin-binding domains are implicated in almost every cellular process, but how is their functionality achieved in cells? We assess recent advances in monitoring the dynamics and specificity of ubiquitin networks in vivo and discuss challenges ahead.	[Ikeda, Fumiyo; Crosetto, Nicola; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Ikeda, Fumiyo; Crosetto, Nicola; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Main, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Ikeda, Fumiyo/AAD-3770-2020; Dikic, Ivan/O-4650-2015	Ikeda, Fumiyo/0000-0003-0407-2768; Dikic, Ivan/0000-0001-8156-9511				Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, PROTEOMICS, V5, P2104, DOI 10.1002/pmic.200401089; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zhao SK, 2010, P NATL ACAD SCI USA, V107, P7704, DOI 10.1073/pnas.0908764107	42	125	131	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					677	681		10.1016/j.cell.2010.10.026	http://dx.doi.org/10.1016/j.cell.2010.10.026			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111228	Bronze			2022-12-24	WOS:000284583500009
J	Lubitz, SA; Yin, XY; Fontes, JD; Magnani, JW; Rienstra, M; Pai, M; Villalon, ML; Vasan, RS; Pencina, MJ; Levy, D; Larson, MG; Ellinor, PT; Benjamin, EJ				Lubitz, Steven A.; Yin, Xiaoyan; Fontes, Joao D.; Magnani, Jared W.; Rienstra, Michiel; Pai, Manju; Villalon, Mark L.; Vasan, Ramachandran S.; Pencina, Michael J.; Levy, Daniel; Larson, Martin G.; Ellinor, Patrick T.; Benjamin, Emelia J.			Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; COMMON VARIANTS; AGGREGATION; HISTORY; REGRESSION; INTERVAL; ZFHX3; SCORE	Context Although the heritability of atrial fibrillation (AF) is established, the contribution of familial AF to predicting new-onset AF remains unknown. Objective To determine whether familial occurrence of AF is associated with new-onset AF beyond established risk factors. Design, Setting, and Participants The Framingham Heart Study, a prospective community-based cohort study started in 1948. Original and Offspring Cohort participants were aged at least 30 years, were free of AF at the baseline examination, and had at least 1 parent or sibling enrolled in the study. The 4421 participants in this analysis (mean age, 54 [SD, 13] years; 54% women) were followed up through December 31, 2007. Main Outcome Measures Incremental predictive value of incorporating different features of familial AF (any familial AF, premature familial AF [onset <65 years old], number of affected relatives, and youngest age of onset in a relative) into a risk model for new-onset AF. Results Across 11 971 examinations during the period 1968-2007, 440 participants developed AF. Familial AF occurred among 1185 participants (26.8%) and premature familial AF occurred among 351 participants (7.9%). Atrial fibrillation occurred more frequently among participants with familial AF than without familial AF (unadjusted absolute event rates of 5.8% and 3.1%, respectively). The association was not attenuated by adjustment for AF risk factors (multivariable-adjusted hazard ratio, 1.40; 95% confidence interval [CI], 1.13-1.74) or reported AF-related genetic variants. Among the different features of familial AF examined, premature familial AF was associated with improved discrimination beyond traditional risk factors to the greatest extent (traditional risk factors, C statistic, 0.842 [95% CI, 0.826-0.858]; premature familial AF, C statistic, 0.846 [95% CI, 0.831-0.862]; P=.004). Modest changes in integrated discrimination improvement were observed with premature familial AF (2.1%). Net reclassification improvement (assessed using 8-year risk thresholds of <5%, 5%-10%, and >10%) did not change significantly with premature familial AF (index statistic, 0.011; 95% CI, -0.021 to 0.042; P=.51), although categoryless net reclassification was improved (index statistic, 0.127; 95% CI, 0.064-0.189; P=.009). Conclusions In this cohort, familial AF was associated with an increased risk of AF that was not attenuated by adjustment for AF risk factors including genetic variants. Assessment of premature familial AF was associated with a very slight increase in predictive accuracy compared with traditional risk factors. JAMA. 2010;304(20):2263-2269 www.jama.com	[Yin, Xiaoyan; Fontes, Joao D.; Magnani, Jared W.; Vasan, Ramachandran S.; Pencina, Michael J.; Levy, Daniel; Larson, Martin G.; Benjamin, Emelia J.] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Lubitz, Steven A.; Rienstra, Michiel; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Lubitz, Steven A.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Fontes, Joao D.; Magnani, Jared W.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA; [Pai, Manju; Villalon, Mark L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Pencina, Michael J.; Larson, Martin G.] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Benjamin, Emelia J.] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Rienstra, Michiel] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA	Framingham Heart Study; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Benjamin, EJ (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,Ste 2, Framingham, MA 01702 USA.	emelia@bu.edu	Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Ramachandran, Vasan/Y-2527-2019; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254; Rienstra, Michiel/0000-0002-2581-070X; Fontes, Joao Daniel/0000-0001-5011-0855; Ellinor, Patrick/0000-0002-2067-0533; Pencina, Michael/0000-0001-5798-8855; Benjamin, Emelia/0000-0003-4076-2336	National Institutes of Health (NIH) [T32HL007575, 6R01-NS17950, HL092577, R01AG028321, RC1-HL01056, 1R01HL102214, DA027021, HL104156]; American Heart Association [09FTF2190028]; Netherlands Organization for Scientific Research [825.09.020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Lubitz was supported by a National Institutes of Health (NIH) training grant in the Epidemiology of Cardiovascular Disease (grant T32HL007575). Dr Magnani is supported by American Heart Association grant 09FTF2190028. Dr Rienstra is supported by a Rubicon grant from the Netherlands Organization for Scientific Research (grant 825.09.020). Dr Benjamin is supported by NIH grant 6R01-NS17950. This work was supported by grants from the NIH to Drs Benjamin and Ellinor (grant HL092577), Dr Benjamin (grants R01AG028321, RC1-HL01056, and 1R01HL102214), and Dr Ellinor (grants DA027021 and HL104156).	[Anonymous], 2008, SAS 9 2 US GUID, P4517; Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Christophersen IE, 2009, CIRC-ARRHYTHMIA ELEC, V2, P378, DOI 10.1161/CIRCEP.108.786665; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dublin S, 2010, J GEN INTERN MED, V25, P853, DOI 10.1007/s11606-010-1340-y; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Ellinor PT, 2005, HUM GENET, V118, P179, DOI 10.1007/s00439-005-0034-8; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Marcus GM, 2008, HEART RHYTHM, V5, P826, DOI 10.1016/j.hrthm.2008.02.016; Murabito JM, 2005, JAMA-J AM MED ASSOC, V294, P3117, DOI 10.1001/jama.294.24.3117; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; GAINING MORE FLEXIBI	33	206	209	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2010	304	20					2263	2269		10.1001/jama.2010.1690	http://dx.doi.org/10.1001/jama.2010.1690			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KI	21076174	Bronze, Green Accepted			2022-12-24	WOS:000284548400025
J	Pan, BC; Xiong, Y; Steitz, TA				Pan, Baocheng; Xiong, Yong; Steitz, Thomas A.			How the CCA-Adding Enzyme Selects Adenine over Cytosine at Position 76 of tRNA	SCIENCE			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; POLYMERIZATION; TRANSLOCATION; POLYMERASE; MECHANISM; SUBSTRATE; TEMPLATE; NUCLEOTIDYLTRANSFERASE; MATURATION	CCA-adding enzymes [ATP(CTP):tRNA nucleotidyltransferases] add CCA onto the 3' end of transfer RNA (tRNA) precursors without using a nucleic acid template. Although the mechanism by which cytosine (C) is selected at position 75 of tRNA has been established, the mechanism by which adenine (A) is selected at position 76 remains elusive. Here, we report five cocrystal structures of the enzyme complexed with both a tRNA mimic and nucleoside triphosphates under catalytically active conditions. These structures suggest that adenosine 5'-monophosphate is incorporated onto the A76 position of the tRNA via a carboxylate-assisted, one-metal-ion mechanism with aspartate 110 functioning as a general base. The discrimination against incorporation of cytidine 5'-triphosphate (CTP) at position 76 arises from improper placement of the alpha phosphate of the incoming CTP, which results from the interaction of C with arginine 224 and prevents the nucleophilic attack by the 3' hydroxyl group of cytidine75.	[Pan, Baocheng; Xiong, Yong; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Steitz, Thomas A./C-6559-2009		NIH [GM57510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source beamline ID19 and at the National Synchrotron Light Source beamline X25. We also thank the staff of the Center for Structural Biology core facility at Yale University. This work was supported by NIH grant GM57510 (to T.A.S.). The coordinates and structure factors for the five structures have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank with accession numbers 3OVA, 3OV7, 3OVB, 3OUY, and 3OVS for preinsertion, initial, intermediate, product, and CTP complexes, respectively.	Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4; Balbo PB, 2007, STRUCTURE, V15, P1117, DOI 10.1016/j.str.2007.07.010; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; Cho HD, 2005, J BIOL CHEM, V280, P9555, DOI 10.1074/jbc.M412594200; Cho HDD, 2006, J BIOL CHEM, V281, P9801, DOI 10.1074/jbc.M512603200; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Steitz TA, 2007, STRUCTURE, V15, P1523, DOI 10.1016/j.str.2007.11.005; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Toh Y, 2008, EMBO J, V27, P1944, DOI 10.1038/emboj.2008.124; Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712; Tomita K, 2006, NATURE, V443, P956, DOI 10.1038/nature05204; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yue DX, 1996, RNA, V2, P895	24	24	25	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					937	940		10.1126/science.1194985	http://dx.doi.org/10.1126/science.1194985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071662	Green Accepted			2022-12-24	WOS:000284118000034
J	Roberts, I; Stott, R				Roberts, Ian; Stott, Robin			Doctors and climate change	LANCET			English	Editorial Material							HEALTH		[Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk						Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; GOLDSMITH B, 2010, TORONTO SUN; Haines A, 2009, LANCET, V374, P2035, DOI 10.1016/S0140-6736(09)61667-6; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Roberts I, 2010, ENERGY GLUT POLITICS; Roberts I, 2008, BMJ-BRIT MED J, V336, P165, DOI 10.1136/bmj.39468.596262.80; Ruiz- Arregui L, 2007, SALUD PUBLICA MEX; TFWG, 2010, UN CLIM CHANG C CANC; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	9	6	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2010	376	9755					1801	1802		10.1016/S0140-6736(10)62106-X	http://dx.doi.org/10.1016/S0140-6736(10)62106-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KG	21093038	Green Accepted			2022-12-24	WOS:000285439700004
J	Cheong, C; Matos, I; Choi, JH; Dandamudi, DB; Shrestha, E; Longhi, MP; Jeffrey, KL; Anthony, RM; Kluger, C; Nchinda, G; Koh, H; Rodriguez, A; Idoyaga, J; Pack, M; Velinzon, K; Park, CG; Steinman, RM				Cheong, Cheolho; Matos, Ines; Choi, Jae-Hoon; Dandamudi, Durga Bhavani; Shrestha, Elina; Longhi, M. Paula; Jeffrey, Kate L.; Anthony, Robert M.; Kluger, Courtney; Nchinda, Godwin; Koh, Hyein; Rodriguez, Anthony; Idoyaga, Juliana; Pack, Maggi; Velinzon, Klara; Park, Chae Gyu; Steinman, Ralph M.			Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209(+) Dendritic Cells for Immune T Cell Areas	CELL			English	Article							DC-SIGN; LYMPH-NODES; CROSS-PRESENTATION; MELANOMA PATIENTS; IN-VIVO; RECEPTOR; ANTIGEN; IDENTIFICATION; TOLERANCE; RESPONSES	Dendritic cells (DCs), critical antigen-presenting cells for immune control, normally derive from bone marrow precursors distinct from monocytes. It is not yet established if the large reservoir of monocytes can develop into cells with critical features of DCs in vivo. We now show that fully differentiated monocyte-derived DCs (Mo-DCs) develop in mice and DC-SIGN/CD209a marks the cells. Mo-DCs are recruited from blood monocytes into lymph nodes by lipopolysaccharide and live or dead gram-negative bacteria. Mobilization requires TLR4 and its CD14 coreceptor and Trif. When tested for antigen-presenting function, Mo-DCs are as active as classical DCs, including cross-presentation of proteins and live gram-negative bacteria on MHC I in vivo. Fully differentiated Mo-DCs acquire DC morphology and localize to T cell areas via L-selectin and CCR7. Thus the blood monocyte reservoir becomes the dominant presenting cell in response to select microbes, yielding DC-SIGN(+) cells with critical functions of DCs.	[Cheong, Cheolho; Matos, Ines; Choi, Jae-Hoon; Dandamudi, Durga Bhavani; Shrestha, Elina; Longhi, M. Paula; Kluger, Courtney; Nchinda, Godwin; Koh, Hyein; Rodriguez, Anthony; Idoyaga, Juliana; Pack, Maggi; Park, Chae Gyu; Steinman, Ralph M.] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10065 USA; [Cheong, Cheolho; Matos, Ines; Choi, Jae-Hoon; Dandamudi, Durga Bhavani; Shrestha, Elina; Longhi, M. Paula; Kluger, Courtney; Nchinda, Godwin; Koh, Hyein; Rodriguez, Anthony; Idoyaga, Juliana; Pack, Maggi; Park, Chae Gyu; Steinman, Ralph M.] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10065 USA; [Jeffrey, Kate L.] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA; [Anthony, Robert M.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Velinzon, Klara] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Cheong, C (corresponding author), Rockefeller Univ, Cellular Physiol & Immunol Lab, 1230 York Ave, New York, NY 10065 USA.	ccheong@rockefeller.edu; parkc@rockefeller.edu; steinma@rockefeller.edu	Markofski, Melissa M/Q-6372-2016; Steinman, Ralph/F-7729-2012	Markofski, Melissa M/0000-0003-0214-4246; Longhi, Paula/0000-0003-1854-4594; Park, Chae Gyu/0000-0003-1906-1308; Jeffrey, Kate/0000-0001-5746-0153	NIGMS [GM62116]; NIH [AI40045, AI40874]; Bill and Melinda Gates Foundation; New York Community Trust; Fundacao para a Ciencia e Tecnologia [SFRH/BD/41073/2007]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040045, R56AI040045, R01AI040874, R37AI040045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); New York Community Trust; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Steinman lab for valuable discussion, J. Adams for graphics, A.J. North and S.A. Galdeen for DIC imaging at the bioimaging resource center, S. Mazel and C. Bare for flow cytometry at the resource center of Rockefeller University, Y. Oh and I. Jang for CSP preparation, J.D. Schauer for mAb purification, J. Gonzalez for ELISA assays (Rockefeller University Center for Clinical and Translational Science, UL1RR024143 from National Center for Research Resource). We thank the Consortium for Functional Glycomics supported by NIGMS (GM62116) for DC-SIGN/CD209a<SUP>-/-</SUP> mice. We were supported by grants from the NIH (AI40045 and AI40874), the Bill and Melinda Gates Foundation (R.M.S.), New York Community Trust's Francis Florio funds for blood diseases (C.C.), and a Fundacao para a Ciencia e Tecnologia PhD scholarship (I.M. SFRH/BD/41073/2007).	Agger R, 2000, SCAND J IMMUNOL, V52, P138; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; de Vries IJM, 2003, CANCER RES, V63, P12; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DEVILLIERS WJS, 1994, J EXP MED, V180, P705, DOI 10.1084/jem.180.2.705; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; HEARD JM, 1987, CELL, V51, P663, DOI 10.1016/0092-8674(87)90135-8; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; JOHNSON WD, 1977, J EXP MED, V146, P1613, DOI 10.1084/jem.146.6.1613; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; ONAI N, 2007, J EXP MED, V193, P233; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schreurs MWJ, 1999, EUR J IMMUNOL, V29, P2835, DOI 10.1002/(SICI)1521-4141(199909)29:09<2835::AID-IMMU2835>3.0.CO;2-Q; Schuler-Thurner B, 2000, J IMMUNOL, V165, P3492, DOI 10.4049/jimmunol.165.6.3492; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacken PJ, 2005, BLOOD, V106, P1278, DOI 10.1182/blood-2005-01-0318; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Vremec D, 1997, J IMMUNOL, V159, P565; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	63	436	441	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					416	429		10.1016/j.cell.2010.09.039	http://dx.doi.org/10.1016/j.cell.2010.09.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029863	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000283603900015
J	Mizuno, H; Higashida, C; Yuan, YF; Ishizaki, T; Narumiya, S; Watanabe, N				Mizuno, Hiroaki; Higashida, Chiharu; Yuan, Yunfeng; Ishizaki, Toshimasa; Narumiya, Shuh; Watanabe, Naoki			Rotational Movement of the Formin mDia1 Along the Double Helical Strand of an Actin Filament	SCIENCE			English	Article							ADP-ACTIN; ATP-ACTIN; MECHANISM; DYNAMICS; POLYMERIZATION; NUCLEATION; PROFILIN; TWIST	Formin homology proteins (formins) elongate actin filaments (F-actin) by continuously associating with filament tips, potentially harnessing actin-generated pushing forces. During this processive elongation, formins are predicted to rotate along the axis of the double helical F-actin structure (referred to here as helical rotation), although this has not yet been definitively shown. We demonstrated helical rotation of the formin mDia1 by single-molecule fluorescence polarization (FLP). FLP of labeled F-actin, both elongating and depolymerizing from immobilized mDia1, oscillated with a periodicity corresponding to that of the F-actin long-pitch helix, and this was not altered by actin-bound nucleotides or the actin-binding protein profilin. Thus, helical rotation is an intrinsic property of formins. To harness pushing forces from growing F-actin, formins must be anchored flexibly to cell structures.	[Mizuno, Hiroaki; Watanabe, Naoki] Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Higashida, Chiharu; Yuan, Yunfeng; Ishizaki, Toshimasa; Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan	Tohoku University; Kyoto University	Watanabe, N (corresponding author), Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	nwatanabe@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Uehara Memorial Foundation; Human Frontier Science Program	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Human Frontier Science Program(Human Frontier Science Program)	We thank H. Honda for rabbit muscle acetone powder and T. M. Watanabe for customizing the G-track software. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and grants from the Uehara Memorial Foundation (N.W.) and the Human Frontier Science Program (N.W.).	Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higashida C, 2008, J CELL SCI, V121, P3403, DOI 10.1242/jcs.030940; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2009, NATURE, V457, P389, DOI 10.1038/457389a; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe N, 2010, P JPN ACAD B-PHYS, V86, P62, DOI 10.2183/pjab.86.62	27	80	81	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					80	83		10.1126/science.1197692	http://dx.doi.org/10.1126/science.1197692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21148346				2022-12-24	WOS:000285974000040
J	Teolis, BD; Jones, GH; Miles, PF; Tokar, RL; Magee, BA; Waite, JH; Roussos, E; Young, DT; Crary, FJ; Coates, AJ; Johnson, RE; Tseng, WL; Baragiola, RA				Teolis, B. D.; Jones, G. H.; Miles, P. F.; Tokar, R. L.; Magee, B. A.; Waite, J. H.; Roussos, E.; Young, D. T.; Crary, F. J.; Coates, A. J.; Johnson, R. E.; Tseng, W-L; Baragiola, R. A.			Cassini Finds an Oxygen-Carbon Dioxide Atmosphere at Saturn's Icy Moon Rhea	SCIENCE			English	Article							CONDENSED O-2; SATELLITES; OZONE; EUROPA	The flyby measurements of the Cassini spacecraft at Saturn's moon Rhea reveal a tenuous oxygen (O-2)-carbon dioxide (CO2) atmosphere. The atmosphere appears to be sustained by chemical decomposition of the surface water ice under irradiation from Saturn's magnetospheric plasma. This in situ detection of an oxidizing atmosphere is consistent with remote observations of other icy bodies, such as Jupiter's moons Europa and Ganymede, and suggestive of a reservoir of radiolytic O-2 locked within Rhea's ice. The presence of CO2 suggests radiolysis reactions between surface oxidants and organics or sputtering and/or outgassing of CO2 endogenic to Rhea's ice. Observations of outflowing positive and negative ions give evidence for pickup ionization as a major atmospheric loss mechanism.	[Teolis, B. D.; Miles, P. F.; Magee, B. A.; Waite, J. H.; Young, D. T.; Crary, F. J.] SW Res Inst, Space Sci & Engn Div, San Antonio, TX 78238 USA; [Jones, G. H.; Coates, A. J.] Univ Coll London, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; [Jones, G. H.; Coates, A. J.] UCL Birkbeck, Ctr Planetary Sci, London WC1E 6BT, England; [Tokar, R. L.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Roussos, E.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Johnson, R. E.; Tseng, W-L; Baragiola, R. A.] Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA 22903 USA	Southwest Research Institute; University of London; University College London; University of London; Birkbeck University London; University College London; United States Department of Energy (DOE); Los Alamos National Laboratory; Max Planck Society; University of Virginia	Teolis, BD (corresponding author), SW Res Inst, Space Sci & Engn Div, 6220 Culebra Rd, San Antonio, TX 78238 USA.	ben.teolis@swri.org	Roussos, Elias/H-2249-2011; Coates, Andrew/C-2396-2008; Jones, Geraint H./C-1682-2008	Coates, Andrew/0000-0002-6185-3125; Jones, Geraint H./0000-0002-5859-1136; Roussos, Elias/0000-0002-5699-0678	NASA under SwRI [1283095]; Jet Propulsion Laboratory under SwRI [1356497]; UK Science and Technology Facilities Council; NSF [AST0807830]; Science and Technology Facilities Council [PP/E001173/1, ST/H00260X/1, PP/D005213/1] Funding Source: researchfish; UK Space Agency [PP/D00084X/1, ST/I002642/1] Funding Source: researchfish; STFC [PP/E001173/1, PP/D005213/1, ST/H00260X/1] Funding Source: UKRI	NASA under SwRI; Jet Propulsion Laboratory under SwRI; UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NSF(National Science Foundation (NSF)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank E. Roussos, D. Mitchell, and the Cassini MIMI team for providing the MIMI data used in figs. S1 and S4 and N. G. Petrik, A. G. Kavetsky, and G. A. Kimmel at Pacific Northwest National Laboratory, Richland, Washington, USA, for contributing the O<INF>2</INF> electron-stimulated desorption measurements in fig. S9. The INMS and CAPS teams acknowledge support from NASA and the Jet Propulsion Laboratory under SwRI subcontracts 1283095 and 1356497, respectively. G.H.J. and A.J.C. acknowledge support for CAPS-ELS operations and analysis by the United Kingdom Space Agency, and G.H.J. was supported by a UK Science and Technology Facilities Council Advanced Fellowship. B.D.T. and R.A.B. acknowledge support by the NSF Astronomy and Astrophysics Program through grant AST0807830.	Carlson RW, 1999, SCIENCE, V283, P820, DOI 10.1126/science.283.5403.820; Clark RN, 2008, ICARUS, V193, P372, DOI 10.1016/j.icarus.2007.08.035; Coates AJ, 2010, ICARUS, V206, P618, DOI 10.1016/j.icarus.2009.07.013; Cruikshank DP, 2010, ICARUS, V206, P561, DOI 10.1016/j.icarus.2009.07.012; Cruikshank DP, 2005, ICARUS, V175, P268, DOI 10.1016/j.icarus.2004.09.003; Glein CR, 2008, ICARUS, V197, P157, DOI 10.1016/j.icarus.2008.03.021; Hall DT, 1998, ASTROPHYS J, V499, P475, DOI 10.1086/305604; Jones GH, 2008, SCIENCE, V319, P1380, DOI 10.1126/science.1151524; Khurana KK, 2008, ICARUS, V193, P465, DOI 10.1016/j.icarus.2007.08.005; Noll KS, 1997, NATURE, V388, P45, DOI 10.1038/40348; Noll KS, 1996, SCIENCE, V273, P341, DOI 10.1126/science.273.5273.341; Saur J, 2005, ASTROPHYS J, V620, pL115, DOI 10.1086/428665; Spencer J, 1998, ICARUS, V136, P349, DOI 10.1006/icar.1998.6024; Spencer JR, 2002, ASTRON J, V124, P3400, DOI 10.1086/344307; SPENCER JR, 1995, J GEOPHYS RES-PLANET, V100, P19049, DOI 10.1029/95JE01503; Stephan K., 2009, 40 LUN PLAN SCI C LU; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; Teolis BD, 2006, ASTROPHYS J, V644, pL141, DOI 10.1086/505743; Teolis BD, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3091998; Tseng WL, 2010, ICARUS, V206, P382, DOI 10.1016/j.icarus.2009.05.019; Waite JH, 2004, SPACE SCI REV, V114, P113, DOI 10.1007/s11214-004-1408-2; Wilson RJ, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014679; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	23	110	110	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1813	1815		10.1126/science.1198366	http://dx.doi.org/10.1126/science.1198366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21109635				2022-12-24	WOS:000285603700038
J	Prinz, WA				Prinz, William A.			Lipid Trafficking sans Vesicles: Where, Why, How?	CELL			English	Article							OXYSTEROL-BINDING PROTEIN; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; GLYCOSPHINGOLIPID SYNTHESIS; NONVESICULAR TRAFFICKING; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR-TRANSPORT; GOLGI-APPARATUS; STEROL TRANSFER; CHOLESTEROL	Eukaryotic cells possess a remarkable diversity of lipids, which distribute among cellular membranes by well-characterized vesicle trafficking pathways. However, transport of lipids by alternate, or "nonvesicular," routes is also critical for lipid synthesis, metabolism, and proper membrane partitioning. In the past few years, considerable progress has been made in characterizing the mechanisms of nonvesicular lipid transport and how it may go awry in particular diseases, but many fundamental questions remain for this rising field.	NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Prinz, WA (corresponding author), NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA.	williamp@intra.niddk.nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060004] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I thank Ted Steck, Jim Hurley, and Tim Schulz for reading the manuscript. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.	Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Choi JY, 2006, BIOCHEM SOC T, V34, P404, DOI 10.1042/BST0340404; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; HECHTBERGER P, 1995, FEBS LETT, V367, P201, DOI 10.1016/0014-5793(95)00567-S; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; Kok JW, 1998, BIOCHEM J, V333, P779, DOI 10.1042/bj3330779; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Raychaudhuri S, 2008, P NATL ACAD SCI USA, V105, P15785, DOI 10.1073/pnas.0808321105; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; SLEIGHT RG, 1983, J BIOL CHEM, V258, P9050; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; WARNOCK DE, 1994, P NATL ACAD SCI USA, V91, P2708, DOI 10.1073/pnas.91.7.2708; WATTENBERG BW, 1990, J CELL BIOL, V111, P421, DOI 10.1083/jcb.111.2.421; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83	39	84	84	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					870	874		10.1016/j.cell.2010.11.031	http://dx.doi.org/10.1016/j.cell.2010.11.031			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145454	Green Accepted, Bronze			2022-12-24	WOS:000285182600005
J	Kind, AJH; Bartels, C; Mell, MW; Mullahy, J; Smith, M				Kind, Amy J. H.; Bartels, Christie; Mell, Matthew W.; Mullahy, John; Smith, Maureen			For-Profit Hospital Status and Rehospitalizations at Different Hospitals: An Analysis of Medicare Data	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE PHYSICIANS; CONFIDENCE-INTERVALS; INSURANCE STATUS; PATIENT SAFETY; VOLUME; MORTALITY; QUALITY; MARKET; RISK; OPPORTUNITIES	Background: About one quarter of rehospitalized Medicare patients are admitted to hospitals different from their original hospital. The extent to which this practice is related to for-profit hospital status and affects payments and mortality is unknown. Objective: To describe and examine predictors of and payments for rehospitalization at a different hospital among Medicare patients rehospitalized within 30 days at for-profit and nonprofit or public hospitals. Design: Cohort study of patients discharged and rehospitalized from January 2005 to November 2006. Setting: Medicare fee-for-service hospitals throughout the United States. Participants: A 5% random national sample of Medicare patients with acute care rehospitalizations within 30 days of discharge (n = 74 564). Measurements: 30-day rehospitalizations at different hospitals and total payments or mortality over the subsequent 30 days. Multivariate logistic and quantile regression models included index hospital for-profit status, discharge counts, geographic region, rural-urban commuting area, and teaching status; patient socio-demographic characteristics, disability status, and comorbid conditions; and a measure of risk adjustment. Results: 16 622 patients (22%) in the sample were rehospitalized at a different hospital. Factors associated with increased risk for rehospitalization at a different hospital included index hospitalization at a for-profit, major medical school-affiliated, or low-volume hospital and having a Medicare-defined disability. Compared with patients rehospitalized at the same hospital, patients rehospitalized at different hospitals had higher adjusted 30-day total payments (median additional cost, $1308 per patient; P < 0.001) but no statistically significant differences in 30-day mortality, regardless of index hospital for-profit status. Limitation: The database lacked detailed clinical information about patients and did not include information about specific provider practice motivations or the role of patient choice in hospitalization venues. Conclusion: Rehospitalizations at different hospitals are common among Medicare patients, are more likely among those initially hospitalized at a for-profit hospital, and are related to increased overall payments without improved mortality.	[Kind, Amy J. H.] William S Middleton Vet Affairs Hosp, Geriatr Res Educ & Clin Ctr, Madison, WI 53705 USA; [Bartels, Christie; Smith, Maureen] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Mell, Matthew W.] Stanford Univ, Stanford, CA 94305 USA; [Mullahy, John] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53726 USA	Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Kind, AJH (corresponding author), William S Middleton Vet Affairs Hosp, Geriatr Res Educ & Clin Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA.	ajk@medicine.wisc.edu	Bartels, Christie Michels/ABG-4072-2020	Bartels, Christie Michels/0000-0001-6523-0374; Kind, Amy/0000-0002-7183-610X	University of Wisconsin (UW) Hartford Center of Excellence in Geriatrics; UW Health Innovation Program; National Center for Research Resources, National Institutes of Health through UW-Madison [1KL2RR025012-01, 1UL1RR025011]; UW Institute for Clinical and Translational Research; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025012, UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034551] Funding Source: NIH RePORTER	University of Wisconsin (UW) Hartford Center of Excellence in Geriatrics; UW Health Innovation Program; National Center for Research Resources, National Institutes of Health through UW-Madison(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UW Institute for Clinical and Translational Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the University of Wisconsin (UW) Hartford Center of Excellence in Geriatrics; the UW Health Innovation Program; a KL-2 grant from the National Center for Research Resources, National Institutes of Health (1KL2RR025012-01) through the Institutional Clinical and Translational Science Award (UW-Madison) program (1UL1RR025011 to Dr. Kind); and the Community-Academic Partnerships core of the UW Institute for Clinical and Translational Research.; University of Wisconsin Hartford Center of Excellence in Geriatrics, National Institutes of Health.	[Anonymous], 2009, CLIN CLASS SOFTW CCS; Archdeacon MT, 2007, J BONE JOINT SURG AM, V89A, P2625, DOI 10.2106/JBJS.F.01499; Berman L, 2010, J PEDIATR SURG, V45, P38, DOI 10.1016/j.jpedsurg.2009.10.006; Bhalla R, 2010, ANN INTERN MED, V152, P114, DOI 10.7326/0003-4819-152-2-201001190-00185; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Casalino LP, 2003, HEALTH AFFAIR, V22, P56, DOI 10.1377/hlthaff.22.6.56; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Cram P, 2008, MED CARE, V46, P467, DOI 10.1097/MLR.0b013e31816c43d9; Duggan M, 2002, RAND J ECON, V33, P433, DOI 10.2307/3087466; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elixhauser A, 2003, HEALTH AFFAIR, V22, P167, DOI 10.1377/hlthaff.22.2.167; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Goldsmith J, 2003, HEALTH AFFAIR, V22, P44, DOI 10.1377/hlthaff.22.4.44; Greene W. H., 1997, ECONOMETRIC ANAL; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kessler DP, 2002, RAND J ECON, V33, P488, DOI 10.2307/3087469; Kind AJH, 2007, J AM GERIATR SOC, V55, P365, DOI 10.1111/j.1532-5415.2007.01091.x; Kind AJH, 2010, ARCH PHYS MED REHAB, V91, P189, DOI 10.1016/j.apmr.2009.10.015; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Kolstad JT, 2009, MED CARE RES REV, V66, p28S, DOI 10.1177/1077558708325887; Koval KJ, 2006, J BONE JOINT SURG AM, V88A, P2124, DOI 10.2106/JBJS.F.00245; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; LUFT HS, 1990, JAMA-J AM MED ASSOC, V263, P2899, DOI 10.1001/jama.263.21.2899; *MED PAYM ADV COMM, 2009, C IMPR  INC MED PROG; Medicare Payment Advisory Commission, 2008, C REF DEL SYST WASH; Medicare Payment Advisory Commission, 2007, C PROM GREAT EFF MED; Mukamel DB, 2007, MED CARE, V45, P1227, DOI 10.1097/MLR.0b013e31812f56bb; Nathens AB, 2001, J TRAUMA, V50, P776, DOI 10.1097/00005373-200105000-00002; PETERSON ED, 1994, ANN INTERN MED, V121, P919, DOI 10.7326/0003-4819-121-12-199412150-00003; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (full printed version), 2003, UN TREATM CONFR RAC; United States Department of Agriculture (USDA) Economic Research Service, 2005, MEAS RUR RUR URB COM; *WA STAT DEP HLTH, 2010, 4 TIER CONS RUCA SYS; Weiss SJ, 2004, ACAD EMERG MED, V11, P38, DOI 10.1197/S1069-6563(03)00583-9; Yuan Z, 2000, MED CARE, V38, P231, DOI 10.1097/00005650-200002000-00012	44	55	55	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2010	153	11					718	727		10.7326/0003-4819-153-11-201012070-00005	http://dx.doi.org/10.7326/0003-4819-153-11-201012070-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690KN	21135295	Green Accepted			2022-12-24	WOS:000285003800004
J	Connaughton, M; Rivett, JG				Connaughton, Mark; Rivett, John G.			Easily Missed? Infective endocarditis	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL PRESENTATION; DIAGNOSIS		[Connaughton, Mark] St Marys Hosp, Cardiol Dept, Newport PO30 5TG, Wight, England; [Rivett, John G.] Martins Oak Surg, Battle TN33 0EA, England		Connaughton, M (corresponding author), St Marys Hosp, Cardiol Dept, Newport PO30 5TG, Wight, England.	mark.connaughton@iow.nhs.uk						Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Dodds GA, 1996, AM J CARDIOL, V77, P403, DOI 10.1016/S0002-9149(97)89372-1; Gouriet F, 2006, CLIN VACCINE IMMUNOL, V13, P301, DOI 10.1128/CVI.13.2.301.2006; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hill EE, 2006, CLIN MICROBIOL INFEC, V12, P5, DOI 10.1111/j.1469-0691.2005.01289.x; Hill EE, 2007, MAYO CLIN PROC, V82, P1165, DOI 10.4065/82.10.1165; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Netzer ROM, 2002, HEART, V88, P61, DOI 10.1136/heart.88.1.61; Rozich JD, 2003, J AM SOC ECHOCARDIOG, V16, P97, DOI 10.1067/mje.2003.36; San Martin J, 2010, J HEART VALVE DIS, V19, P131; Verhagen DWM, 2006, J ANTIMICROB CHEMOTH, V57, P819, DOI 10.1093/jac/dkl087	11	5	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 1	2010	341								c6596	10.1136/bmj.c6596	http://dx.doi.org/10.1136/bmj.c6596			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691OU	21123344				2022-12-24	WOS:000285091500014
J	Reis, PM; Jung, SH; Aristoff, JM; Stocker, R				Reis, Pedro M.; Jung, Sunghwan; Aristoff, Jeffrey M.; Stocker, Roman			How Cats Lap: Water Uptake by Felis catus	SCIENCE			English	Article							MECHANICAL DETERMINANTS; LICKING BEHAVIOR; DRINKING; TONGUE; MORPHOLOGY; SIZE; ENERGETICS; FREQUENCY; TRANSPORT; SURFACE	Animals have developed a range of drinking strategies depending on physiological and environmental constraints. Vertebrates with incomplete cheeks use their tongue to drink; the most common example is the lapping of cats and dogs. We show that the domestic cat (Felis catus) laps by a subtle mechanism based on water adhesion to the dorsal side of the tongue. A combined experimental and theoretical analysis reveals that Felis catus exploits fluid inertia to defeat gravity and pull liquid into the mouth. This competition between inertia and gravity sets the lapping frequency and yields a prediction for the dependence of frequency on animal mass. Measurements of lapping frequency across the family Felidae support this prediction, which suggests that the lapping mechanism is conserved among felines.	[Reis, Pedro M.; Stocker, Roman] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Reis, Pedro M.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Jung, Sunghwan] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA; [Aristoff, Jeffrey M.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Virginia Polytechnic Institute & State University; Princeton University	Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Stocker, Roman/N-8987-2019; Jung, Sunghwan/E-8752-2010; Reis, Pedro/F-1176-2010; Stocker, Roman/T-9456-2017	Reis, Pedro/0000-0003-3984-828X; Stocker, Roman/0000-0002-3199-0508				AHL AS, 1986, VET RES COMMUN, V10, P245, DOI 10.1007/BF02213989; [Anonymous], 1940, QUICK N WINK; Attenborough David, 2011, LECT ROYAL SOC ENCOU; BENTLEY PJ, 1979, J EXP BIOL, V79, P41; CHIEL HJ, 1992, BIOL CYBERN, V67, P403, DOI 10.1007/BF00200984; Christiansen P, 2005, J ZOOL, V266, P133, DOI 10.1017/S0952836905006643; Cundall D, 2000, J EXP BIOL, V203, P2171; DANIEL TL, 1989, OECOLOGIA, V79, P66, DOI 10.1007/BF00378241; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; Dilger W. C., 1962, ROOTS BEHAVIOR, P35; Doube M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004742; Glasheen JW, 1996, J EXP BIOL, V199, P2611; Gussekloo SWS, 2005, J EXP BIOL, V208, P3395, DOI 10.1242/jeb.01769; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; HEIDWEILLER J, 1990, CONDOR, V92, P1, DOI 10.2307/1368379; HEIDWEILLER J, 1992, ZOOMORPHOLOGY, V111, P141, DOI 10.1007/BF01632904; Hiiemae K.M., 1985, P262; KINGSOLVER JG, 1983, OECOLOGIA, V60, P214, DOI 10.1007/BF00379523; KOOLOOS JGM, 1989, J MORPHOL, V199, P327, DOI 10.1002/jmor.1051990308; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; Ojima K, 2000, ANN ANAT, V182, P47, DOI 10.1016/S0940-9602(00)80120-X; Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023; PRANGE HD, 1970, J EXP BIOL, V53, P763; RUSSELL AP, 1995, J ZOOL, V236, P161, DOI 10.1111/j.1469-7998.1995.tb01791.x; Smith K.K., 1989, American Scientist, V77, P28; THEXTON AJ, 1988, ARCH ORAL BIOL, V33, P331, DOI 10.1016/0003-9969(88)90066-0; Thexton AJ, 1998, J EXP ZOOL, V280, P327, DOI 10.1002/(SICI)1097-010X(19980401)280:5&lt;327::AID-JEZ2&gt;3.0.CO;2-Q; Trivedi Deepak, 2008, Applied Bionics and Biomechanics, V5, P99, DOI 10.1080/11762320802557865; Weijnen JAWM, 1998, NEUROSCI BIOBEHAV R, V22, P751, DOI 10.1016/S0149-7634(98)00003-7	29	87	89	10	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1231	1234		10.1126/science.1195421	http://dx.doi.org/10.1126/science.1195421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21071630				2022-12-24	WOS:000284613700038
J	Aaron, SD; Vandemheen, KL; Ramotar, K; Giesbrecht-Lewis, T; Tullis, E; Freitag, A; Paterson, N; Jackson, M; Lougheed, MD; Dowson, C; Kumar, V; Ferris, W; Chan, F; Doucette, S; Fergusson, D				Aaron, Shawn D.; Vandemheen, Katherine L.; Ramotar, Karam; Giesbrecht-Lewis, Tracy; Tullis, Elizabeth; Freitag, Andreas; Paterson, Nigel; Jackson, Mary; Lougheed, M. Diane; Dowson, Christopher; Kumar, Vijay; Ferris, Wendy; Chan, Francis; Doucette, Steve; Fergusson, Dean			Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLONIZATION; EPIDEMIOLOGY; CEPACIA; SPREAD; CF; IDENTIFICATION; MORBIDITY; MORTALITY; PATIENT; CANADA	Context Studies from Australia and the United Kingdom have shown that some patients with cystic fibrosis are infected with common transmissible strains of Pseudomonas aeruginosa. Objectives To determine the prevalence and incidence of infection with transmissible strains of P aeruginosa and whether presence of the organism was associated with adverse clinical outcomes in Canada. Design, Setting, and Participants Prospective observational cohort study of adult patients cared for at cystic fibrosis clinics in Ontario, Canada, with enrollment from September 2005 to September 2008. Sputum was collected at baseline, 3 months, and yearly thereafter for 3 years; and retrieved P aeruginosa isolates were genotyped. Vital status (death or lung transplant) was assessed for all enrolled patients until December 31, 2009. Main Outcome Measures Incidence and prevalence of P aeruginosa isolation, rates of decline in lung function, and time to death or lung transplantation. Results Of the 446 patients with cystic fibrosis studied, 102 were discovered to be infected with 1 of 2 common transmissible strains of P aeruginosa at study entry. Sixty-seven patients were infected with strain A (15%), 32 were infected with strain B (7%), and 3 were simultaneously infected with both strains (0.6%). Strain A was found to be genetically identical to the Liverpool epidemic strain but strain B has not been previously described as an epidemic strain. The incidence rate of new infections with these 2 transmissible strains was relatively low (7.0 per 1000 person-years; 95% confidence interval [CI], 1.8-12.2 per 1000 person-years). Compared with patients infected with unique strains of P aeruginosa, patients infected with the Liverpool epidemic strain (strain A) and strain B had similar declines in lung function (difference in decline in percent predicted forced expiratory volume in the first second of expiration of 0.64% per year [95% CI, -1.52% to 2.80% per year] and 1.66% per year [95% CI, -1.00% to 4.30%], respectively). However, the 3-year rate of death or lung transplantation was greater in those infected with the Liverpool epidemic strain (18.6%) compared with those infected with unique strains (8.7%) (adjusted hazard ratio, 3.26 [95% CI, 1.41 to 7.54]; P = .01). Conclusions A common strain of P aeruginosa (Liverpool epidemic strain/strain A) infects patients with cystic fibrosis in Canada and the United Kingdom. Infection with this strain in adult Canadian patients with cystic fibrosis was associated with a greater risk of death or lung transplantation. JAMA, 2010;304(19):2145-2153 www.jama.com	[Aaron, Shawn D.; Vandemheen, Katherine L.; Ramotar, Karam; Giesbrecht-Lewis, Tracy; Doucette, Steve; Fergusson, Dean] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Tullis, Elizabeth] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Freitag, Andreas] McMaster Univ, Hamilton, ON, Canada; [Paterson, Nigel] Univ Western Ontario, London, ON, Canada; [Jackson, Mary] Grand River Hosp, Kitchener, ON, Canada; [Lougheed, M. Diane] Queens Univ, Kingston, ON, Canada; [Dowson, Christopher] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Kumar, Vijay] Sudbury Reg Hosp, Sudbury, ON, Canada; [Ferris, Wendy; Chan, Francis] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; Western University (University of Western Ontario); Queens University - Canada; University of Warwick; Health Sciences North; University of Ottawa; Children's Hospital of Eastern Ontario	Aaron, SD (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Gen Campus,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	saaron@ohri.ca	Dowson, Christopher/ABG-5083-2021; Dowson, Chris/N-6195-2014	Dowson, Christopher/0000-0002-8294-8836; Dowson, Chris/0000-0002-8294-8836; Aaron, Shawn/0000-0002-4762-3542; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research; Canadian Cystic Fibrosis Foundation; Ontario Thoracic Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; Ontario Thoracic Society	Funded by the Canadian Institutes of Health Research, the Canadian Cystic Fibrosis Foundation, and the Ontario Thoracic Society.	Aaron SD, 2004, AM J RESP CRIT CARE, V169, P811, DOI 10.1164/rccm.200309-1306OC; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; GROTHUES D, 1988, J CLIN MICROBIOL, V26, P1973, DOI 10.1128/JCM.26.10.1973-1977.1988; JOHN M, 1994, PEDIATR PULM, V18, P108, DOI 10.1002/ppul.1950180210; Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Jones AM, 2010, CHEST, V137, P1405, DOI 10.1378/chest.09-2406; LAING FPY, 1995, J CLIN MICROBIOL, V33, P513, DOI 10.1128/JCM.33.3.513-518.1995; LIPUMA JJ, 1990, LANCET, V336, P1094, DOI 10.1016/0140-6736(90)92571-X; McCallum SJ, 2002, THORAX, V57, P559, DOI 10.1136/thorax.57.6.559; Mohan K, 2008, THORAX, V63, P839, DOI 10.1136/thx.2007.092486; Ramsey BW, 2002, AM J RESP CRIT CARE, V166, P906, DOI 10.1164/rccm.2207005; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Speert DP, 2002, AM J RESP CRIT CARE, V166, P988, DOI 10.1164/rccm.2203011; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Waine DJ, 2009, J CLIN MICROBIOL, V47, P3444, DOI 10.1128/JCM.00459-09; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108	28	132	133	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2145	2153		10.1001/jama.2010.1665	http://dx.doi.org/10.1001/jama.2010.1665			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21081727	Bronze			2022-12-24	WOS:000284269800025
J	Frieden, TR; Collins, FS				Frieden, Thomas R.; Collins, Francis S.			Intentional Infection of Vulnerable Populations in 1946-1948 Another Tragic History Lesson	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Collins, Francis S.] NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.	txf2@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				[Anonymous], 1979, BELMONT REPORT ETHIC; Lederer Susan, 1995, SUBJECTED SCI HUMAN; MAGNUSON HJ, 1956, MEDICINE, V35, P33, DOI 10.1097/00005792-195602000-00002; MAHONEY J F, 1946, Am J Syph Gonorrhea Vener Dis, V30, P1; Office of Human Subjects Research National Institutes of Health, REG ETH GUID; Reverby Susan M., 2009, EXAMINING TUSKEGEE I; SUSAN M, REVERBY FACULTY PAGE; *US DEP HHS, INF 1946 1948 US PUB	8	24	24	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2063	2064		10.1001/jama.2010.1554	http://dx.doi.org/10.1001/jama.2010.1554			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	20937719	Green Published			2022-12-24	WOS:000284000600028
J	Bodin, K; Ellmerich, S; Kahan, MC; Tennent, GA; Loesch, A; Gilbertson, JA; Hutchinson, WL; Mangione, PP; Gallimore, JR; Millar, DJ; Minogue, S; Dhillon, AP; Taylor, GW; Bradwell, AR; Petrie, A; Gillmore, JD; Bellotti, V; Botto, M; Hawkins, PN; Pepys, MB				Bodin, Karl; Ellmerich, Stephan; Kahan, Melvyn C.; Tennent, Glenys A.; Loesch, Andrzej; Gilbertson, Janet A.; Hutchinson, Winston L.; Mangione, Palma P.; Gallimore, J. Ruth; Millar, David J.; Minogue, Shane; Dhillon, Amar P.; Taylor, Graham W.; Bradwell, Arthur R.; Petrie, Aviva; Gillmore, Julian D.; Bellotti, Vittorio; Botto, Marina; Hawkins, Philip N.; Pepys, Mark B.			Antibodies to human serum amyloid P component eliminate visceral amyloid deposits	NATURE			English	Article							PHARMACOLOGICAL DEPLETION; AL AMYLOIDOSIS; COMPLEMENT; FIBRILS; MICE	Accumulation of amyloid fibrils in the viscera and connective tissues causes systemic amyloidosis, which is responsible for about one in a thousand deaths in developed countries(1). Localized amyloid can also have serious consequences; for example, cerebral amyloid angiopathy is an important cause of haemorrhagic stroke. The clinical presentations of amyloidosis are extremely diverse and the diagnosis is rarely made before significant organ damage is present(1). There is therefore a major unmet need for therapy that safely promotes the clearance of established amyloid deposits. Over 20 different amyloid fibril proteins are responsible for different forms of clinically significant amyloidosis and treatments that substantially reduce the abundance of the respective amyloid fibril precursor proteins can arrest amyloid accumulation(1). Unfortunately, control of fibril-protein production is not possible in some forms of amyloidosis and in others it is often slow and hazardous(1). There is no therapy that directly targets amyloid deposits for enhanced clearance. However, all amyloid deposits contain the normal, non-fibrillar plasma glycoprotein, serum amyloid P component (SAP)(2,3). Here we show that administration of anti-human-SAP antibodies to mice with amyloid deposits containing human SAP triggers a potent, complement-dependent, macrophage-derived giant cell reaction that swiftly removes massive visceral amyloid deposits without adverse effects. Anti-SAP-antibody treatment is clinically feasible because circulating human SAP can be depleted in patients by the bis-D-proline compound CPHPC4, thereby enabling injected anti-SAP antibodies to reach residual SAP in the amyloid deposits. The unprecedented capacity of this novel combined therapy to eliminate amyloid deposits should be applicable to all forms of systemic and local amyloidosis.	[Bodin, Karl; Ellmerich, Stephan; Kahan, Melvyn C.; Tennent, Glenys A.; Loesch, Andrzej; Gilbertson, Janet A.; Hutchinson, Winston L.; Mangione, Palma P.; Gallimore, J. Ruth; Millar, David J.; Taylor, Graham W.; Gillmore, Julian D.; Bellotti, Vittorio; Hawkins, Philip N.; Pepys, Mark B.] UCL, Ctr Amyloidosis & Acute Phase Prot, Div Med, London NW3 2PF, England; [Mangione, Palma P.; Bellotti, Vittorio] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy; [Minogue, Shane] UCL, Ctr Mol Cell Biol, Div Med, London NW3 2PF, England; [Dhillon, Amar P.] UCL, Dept Histopathol, London NW3 2PF, England; [Bradwell, Arthur R.] Univ Birmingham, Sch Med, Dept Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Bradwell, Arthur R.] Binding Site Ltd, Birmingham B14 4ZB, W Midlands, England; [Petrie, Aviva] UCL Eastman Dent Inst, Biostat Unit, London WC1X 8LD, England; [Botto, Marina] Univ London Imperial Coll Sci Technol & Med, Fac Med, Rheumatol Sect, London W12 0NN, England	University of London; University College London; University of Pavia; University of London; University College London; University of London; University College London; University of Birmingham; University of London; University College London; Imperial College London	Pepys, MB (corresponding author), UCL, Ctr Amyloidosis & Acute Phase Prot, Div Med, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	m.pepys@ucl.ac.uk	Bellotti, Vittorio/A-6201-2014	Bellotti, Vittorio/0000-0001-8678-662X; Mangione, Palma/0000-0003-0260-1400; Taylor, Graham/0000-0002-9672-8463; Bradwell, Arthur/0000-0002-1562-1606	Medical Research Council [G97900510]; University College London; Erik and Edith Fernstroms Foundation for Medical Research; Swedish Research Council; Medical Research Council [G7900510, G0901596] Funding Source: researchfish; National Centre for the Replacement [G0800737/1] Funding Source: researchfish; MRC [G0901596, G7900510] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London(General Electric); Erik and Edith Fernstroms Foundation for Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by Medical Research Council Programme Grant G97900510 to M.B.P. and P.N.H. and by the University College London Amyloidosis Research Fund. K.B. was supported by the Erik and Edith Fernstroms Foundation for Medical Research and a Postdoctoral Fellowship from the Swedish Research Council. K.B. dedicates his work to his late father, Gunnar Bodin. We thank S. Gordon, S. Wood, S. Kolstoe, J. Raynes, P. Simons and R. Al-Shawi for information, advice, reagents and support, and B. Jones for processing the manuscript.	Argiles A, 2002, NEPHROL DIAL TRANSPL, V17, P1136, DOI 10.1093/ndt/17.6.1136; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; BREATHNACH SM, 1981, NATURE, V293, P652, DOI 10.1038/293652a0; DEBEER FC, 1982, J IMMUNOL METHODS, V50, P17, DOI 10.1016/0022-1759(82)90300-3; DYCK RF, 1980, J EXP MED, V152, P1162, DOI 10.1084/jem.152.5.1162; Gillmore JD, 2010, BRIT J HAEMATOL, V148, P760, DOI 10.1111/j.1365-2141.2009.08036.x; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; HAWKINS PN, 1988, J EXP MED, V167, P903, DOI 10.1084/jem.167.3.903; KLAUS GGB, 1979, IMMUNOLOGY, V38, P687; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Lachmann HJ, 2003, BRIT J HAEMATOL, V122, P78, DOI 10.1046/j.1365-2141.2003.04433.x; Nakamura Y, 1999, PATHOL INT, V49, P898, DOI 10.1046/j.1440-1827.1999.00962.x; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Solomon A, 2003, CANCER BIOTHER RADIO, V18, P853, DOI 10.1089/108497803322702824; Solomon A, 2003, CLIN CANCER RES, V9, p3831S; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Verine J, 2007, HUM PATHOL, V38, P1798, DOI 10.1016/j.humpath.2007.04.013; WALL JS, 2010, BLOOD           0603, DOI DOI 10.1182/BLOOD-2010-03-273797; WEISS SW, 1973, AM J PATHOL, V72, P447; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; ZUCKERFRANKLIN D, 1970, J ULTRA MOL STRUCT R, V32, P247, DOI 10.1016/S0022-5320(70)80005-3	26	239	247	0	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					93	97		10.1038/nature09494	http://dx.doi.org/10.1038/nature09494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20962779	Green Accepted			2022-12-24	WOS:000283786900042
J	Kitzman, DW; Rich, MW				Kitzman, Dalane W.; Rich, Michael W.			Age Disparities in Heart Failure Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRESERVED EJECTION FRACTION; RANDOMIZED CONTROLLED-TRIAL; ASSOCIATION; UPDATE		[Kitzman, Dalane W.] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Rich, Michael W.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Wake Forest University; Washington University (WUSTL)	Kitzman, DW (corresponding author), Wake Forest Univ, Sch Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	dkitzman@wfubmc.edu	Rich, Michael/AAD-6167-2022	Rich, Michael/0000-0002-4243-9391	NATIONAL INSTITUTE ON AGING [R01AG018915, R37AG018915, P30AG021332] Funding Source: NIH RePORTER; NIA NIH HHS [R37AG18915, P30 AG021332, P30AG21332, R37 AG018915, R01 AG018915] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282	10	52	51	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2010	304	17					1950	1951		10.1001/jama.2010.1592	http://dx.doi.org/10.1001/jama.2010.1592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674GT	21045104	Green Accepted			2022-12-24	WOS:000283725900028
J	Goldberg, EE; Kohn, JR; Lande, R; Robertson, KA; Smith, SA; Igic, B				Goldberg, Emma E.; Kohn, Joshua R.; Lande, Russell; Robertson, Kelly A.; Smith, Stephen A.; Igic, Boris			Species Selection Maintains Self-Incompatibility	SCIENCE			English	Article							MATING SYSTEMS; POLYMORPHISM; EVOLUTION; DIVERSIFICATION; FERTILIZATION; SPECIATION; DIVERSITY; PLANTS; RATES	Identifying traits that affect rates of speciation and extinction and, hence, explain differences in species diversity among clades is a major goal of evolutionary biology. Detecting such traits is especially difficult when they undergo frequent transitions between states. Self-incompatibility, the ability of hermaphrodites to enforce outcrossing, is frequently lost in flowering plants, enabling self-fertilization. We show, however, that in the nightshade plant family (Solanaceae), species with functional self-incompatibility diversify at a significantly higher rate than those without it. The apparent short-term advantages of potentially self-fertilizing individuals are therefore offset by strong species selection, which favors obligate outcrossing.	[Goldberg, Emma E.; Robertson, Kelly A.; Igic, Boris] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Kohn, Joshua R.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Lande, Russell] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Smith, Stephen A.] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Diego; Imperial College London; The National Evolutionary Synthesis Center	Igic, B (corresponding author), Univ Illinois, Dept Biol Sci, 840 W Taylor St,M-C 067, Chicago, IL 60607 USA.	boris@uic.edu	Smith, Stephen/AAE-8623-2019	Smith, Stephen/0000-0003-2035-9531; Goldberg, Emma/0000-0002-7311-9606	NSF [DEB-0919089]; Division Of Environmental Biology [0919089] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. FitzJohn, A. Mooers, R. Olmstead, T. Paape, L. Popovic, D. L. Shade, and R. Ree for help and discussions. Data are deposited in the Dryad database with accession no. 1888. Funded by NSF grant DEB-0919089 to B.I.	Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; Busch JW, 2008, TRENDS PLANT SCI, V13, P128, DOI 10.1016/j.tplants.2008.01.002; Darwin C, 1903, MORE LETT C DARWIN R; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; GOULD SJ, 1982, SCIENCE, V216, P380, DOI 10.1126/science.7041256; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Igic B, 2006, P NATL ACAD SCI USA, V103, P1359, DOI 10.1073/pnas.0506283103; Igic B, 2004, NEW PHYTOL, V161, P97, DOI 10.1046/j.1469-8137.2003.00952.x; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Igic B, 2006, EVOLUTION, V60, P1098, DOI 10.1111/j.0014-3820.2006.tb01186.x; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; KAROLY K, 1994, AM NAT, V144, P677, DOI 10.1086/285700; Lewontin R. C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Maddison WP, 2006, EVOLUTION, V60, P1743, DOI 10.1554/05-666.1; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Olmstead RG, 2007, ACTA HORTIC, P255, DOI 10.17660/ActaHortic.2007.745.11; Porcher E, 2005, EVOLUTION, V59, P46, DOI 10.1111/j.0014-3820.2005.tb00893.x; Rabosky DL, 2010, TRENDS ECOL EVOL, V25, P68, DOI 10.1016/j.tree.2009.07.002; Schoen DJ, 2008, INT J PLANT SCI, V169, P119, DOI 10.1086/523356; SCHOEN DJ, 1991, P NATL ACAD SCI USA, V88, P4494, DOI 10.1073/pnas.88.10.4494; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; STEBBINS GL, 1974, FLOWERING PLANTS; Steinbachs JE, 2002, MOL BIOL EVOL, V19, P825, DOI 10.1093/oxfordjournals.molbev.a004139; Williams G. C, 1992, NATURAL SELECTION DO; ZAVADA MS, 1986, AM NAT, V128, P538, DOI 10.1086/284586	32	324	329	2	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					493	495		10.1126/science.1194513	http://dx.doi.org/10.1126/science.1194513			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966249				2022-12-24	WOS:000283329100036
J	Radu, A; Pichon, C; Camparo, P; Antoine, M; Allory, Y; Couvelard, A; Fromont, G; Hai, MTV; Ghinea, N				Radu, Aurelian; Pichon, Christophe; Camparo, Philippe; Antoine, Martine; Allory, Yves; Couvelard, Anne; Fromont, Gaelle; Hai, Mai Thu Vu; Ghinea, Nicolae			Expression of Follicle-Stimulating Hormone Receptor in Tumor Blood Vessels.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL-PROLIFERATION; PROSTATE-CANCER; BREAST-CANCER; FSH; LOCALIZATION; CARCINOMAS; PROTEINS	Background: In adult humans, the follicle-stimulating hormone (FSH) receptor is expressed only in the granulosa cells of the ovary and the Sertoli cells of the testis. It is minimally expressed by the endothelial cells of gonadal blood vessels. Methods: We used immunohistochemical and immunoblotting techniques involving four separate FSH-receptor-specific monoclonal antibodies that recognize different FSH receptor epitopes and in situ hybridization to detect FSH receptor in tissue samples from patients with a wide range of tumors. Immunoelectron microscopy was used to detect FSH receptor in mouse tumors. Results: In all 1336 patients examined, FSH receptor was expressed by endothelial cells in tumors of all grades, including early T1 tumors. The tumors were located in the prostate, breast, colon, pancreas, urinary bladder, kidney, lung, liver, stomach, testis, and ovary. In specimens obtained during surgery performed to remove tumors, the FSH receptor was not expressed in the normal tissues located more than 10 mm from the tumors. The tumor lymphatic vessels did not express FSH receptor. The endothelial cells that expressed FSH receptor were located at the periphery of the tumors in a layer that was approximately 10 mm thick; this layer extended both into and outside of the tumor. Immunoelectron microscopy in mice with xenograft tumors, after perfusion with anti-FSH-receptor antibodies coupled to colloidal gold, showed that the FSH receptor is exposed on the luminal endothelial surface and can bind and internalize circulating ligands. Conclusions: FSH receptor is selectively expressed on the surface of the blood vessels of a wide range of tumors. (Funded by INSERM.) N Engl J Med 2010;363:1621-30.	[Allory, Yves; Hai, Mai Thu Vu; Ghinea, Nicolae] Univ Paris Est, INSERM, U955, Eq 07, Creteil, France; [Radu, Aurelian] Mt Sinai Sch Med, New York, NY USA; [Pichon, Christophe] INSERM, U753, Villejuif, France; [Camparo, Philippe] Val de Grace Hosp, Paris, France; [Antoine, Martine] Tenon Hosp, Paris, France; [Couvelard, Anne] Beaujon Hosp, Clichy, France; [Fromont, Gaelle] Ctr Hosp Univ Poitiers, Poitiers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Val-de-Grace Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers	Ghinea, N (corresponding author), Univ Paris Est, INSERM, U955, Eq 07, 8 Rue Gen Sarrail, Creteil, France.	nicolae.ghinea@inserm.fr	fromont, gaelle/N-8708-2016; Ghinea, Nicolae/G-3188-2013	Anne, Couvelard/0000-0002-6316-1210	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Supported by INSERM.	Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Begum R, 2003, HISTOPATHOLOGY, V43, P244, DOI 10.1046/j.1365-2559.2003.01714.x; Belien JAM, 1999, J PATHOL, V189, P309; Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; BOCKERS TM, 1994, CELL TISSUE RES, V278, P595; Castro-Fernandez C, 2004, ENDOCRINE, V25, P49, DOI 10.1385/ENDO:25:1:49; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Eble J, 2004, WHO CLASSIFICATION T; Fernebro J, 2007, APMIS, V115, P707, DOI 10.1111/j.1600-0463.2007.apm_650.x; FOX SB, 1993, CANCER RES, V53, P4161; Green FL, 2006, AM JOINT COMMITTEE C; Hai MTV, 2004, BIOL CELL, V96, P133, DOI 10.1016/j.biolcel.2003.11.008; Macklon NS, 1998, MATURITAS, V30, P181, DOI 10.1016/S0378-5122(98)00072-3; Mariani S, 2006, J UROLOGY, V175, P2072, DOI 10.1016/S0022-5347(06)00273-4; Ohashi K, 1997, VIRCHOWS ARCH, V430, P107, DOI 10.1007/BF01008031; Plant TM, 2001, ENDOCR REV, V22, P764, DOI 10.1210/er.22.6.764; Rodins K, 2002, CLIN CANCER RES, V8, P1075; Shoji M, 1999, AM J PATHOL, V154, P909, DOI 10.1016/S0002-9440(10)65338-2; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Vannier B, 1996, BIOCHEMISTRY-US, V35, P1358, DOI 10.1021/bi952290f; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200	22	219	239	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1621	1630		10.1056/NEJMoa1001283	http://dx.doi.org/10.1056/NEJMoa1001283			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961245				2022-12-24	WOS:000283242700006
J	Barreda, VD; Palazzesi, L; Telleria, MC; Katinas, L; Crisci, JV; Bremer, K; Passalia, MG; Corsolini, R; Brizuela, RR; Bechis, F				Barreda, V. D.; Palazzesi, L.; Telleria, M. C.; Katinas, L.; Crisci, J. V.; Bremer, K.; Passalia, M. G.; Corsolini, R.; Rodriguez Brizuela, R.; Bechis, F.			Eocene Patagonia Fossils of the Daisy Family	SCIENCE			English	Article							ASTERACEAE; DIVERSITY; POLLEN		[Barreda, V. D.; Palazzesi, L.; Rodriguez Brizuela, R.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, Secc Paleopalinol, Buenos Aires, DF, Argentina; [Barreda, V. D.; Palazzesi, L.; Telleria, M. C.; Katinas, L.; Crisci, J. V.; Passalia, M. G.; Bechis, F.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Telleria, M. C.; Crisci, J. V.] Museo La Plata, Lab Sistemat & Biol Evolut, La Plata, Argentina; [Telleria, M. C.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Actuopalinol, Buenos Aires, DF, Argentina; [Katinas, L.; Crisci, J. V.] Museo La Plata, Div Plantas Vasc, La Plata, Argentina; [Bremer, K.] Stockholm Univ, SE-10691 Stockholm, Sweden; [Passalia, M. G.] Inst Invest Biodiversidad & Medioambiente, Lab Palinol & Paleobot, San Carlos De Bariloche, Rio Negro, Argentina; [Corsolini, R.] Museo Lago Gutierrez Dr Rosendo Pascual Geol & Pa, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Bechis, F.] Univ Nacl Rio Negro, Inst Invest Diversidad Cultural & Proc Cambio, San Carlos De Bariloche, Rio Negro, Argentina	Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); National University of La Plata; Museo La Plata; Stockholm University	Barreda, VD (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, Secc Paleopalinol, Ave Angel Gallardo 470,C1405DJR, Buenos Aires, DF, Argentina.	vbarreda@macn.gov.ar		Palazzesi, Luis/0000-0001-8026-4679; Barreda, Viviana Dora/0000-0002-1560-1277	CONICET; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); NSF; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. C. Hoch for the critical reading of the manuscript. Financial support was provided by grants of CONICET, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), and NSF.	Barreda V, 2007, BOT REV, V73, P31, DOI 10.1663/0006-8101(2007)73[31:PVTDTP]2.0.CO;2; Barreda V, 2010, REV PALAEOBOT PALYNO, V160, P102, DOI 10.1016/j.revpalbo.2010.02.004; Barreda V, 2009, REV PALAEOBOT PALYNO, V154, P22, DOI 10.1016/j.revpalbo.2008.11.005; Blackmore S, 2010, PLANT SYST EVOL, V284, P17, DOI 10.1007/s00606-009-0232-2; Telleria MC, 2010, PLANT SYST EVOL, V285, P75, DOI 10.1007/s00606-009-0257-6; Funk VA., 2005, BIOL SKRIFTER, V55, P343; Graham A., 1996, COMPOSITAE SYSTEMATI, V1, P123; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Macphail M. K., 1994, Papers and Proceedings of the Royal Society of Tasmania, V128, P1; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; Scott L, 2006, REV PALAEOBOT PALYNO, V142, P47, DOI 10.1016/j.revpalbo.2006.07.010; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Zavada MS, 2000, GRANA, V39, P39, DOI 10.1080/00173130150503795; Zhao Zaiming, 2006, Lundellia, V9, P51	14	67	72	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1621	1621		10.1126/science.1193108	http://dx.doi.org/10.1126/science.1193108			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929840				2022-12-24	WOS:000282098100032
J	Ghosh, S; Bachilo, SM; Simonette, RA; Beckingham, KM; Weisman, RB				Ghosh, Saunab; Bachilo, Sergei M.; Simonette, Rebecca A.; Beckingham, Kathleen M.; Weisman, R. Bruce			Oxygen Doping Modifies Near-Infrared Band Gaps in Fluorescent Single-Walled Carbon Nanotubes	SCIENCE			English	Article							STONE-WALES DEFECTS; OZONE ADSORPTION; OXIDATION; FUNCTIONALIZATION; PURIFICATION; OZONOLYSIS; MOBILITY; OZONIDES; C60O	Controlled chemical modifications of single-walled carbon nanotubes (SWCNTs) that tune their useful properties have been sought for multiple applications. We found that beneficial optical changes in SWCNTs resulted from introducing low concentrations of oxygen atoms. Stable covalently oxygen-doped nanotubes were prepared by exposure to ozone and then light. Treated samples showed distinct, structure-specific near-infrared fluorescence at wavelengths 10 to 15% longer than displayed by pristine semiconducting SWCNTs. Dopant sites harvest light energy absorbed in undoped nanotube regions by trapping mobile excitons. The oxygen-doped SWCNTs are much easier to detect and image than pristine SWCNTs because they give stronger near-infrared emission and do not absorb at the shifted emission wavelength.	[Ghosh, Saunab; Bachilo, Sergei M.; Weisman, R. Bruce] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Ghosh, Saunab; Bachilo, Sergei M.; Simonette, Rebecca A.; Beckingham, Kathleen M.; Weisman, R. Bruce] Rice Univ, RE Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA; [Simonette, Rebecca A.; Beckingham, Kathleen M.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University; Rice University; Rice University	Weisman, RB (corresponding author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA.	weisman@rice.edu	Ghosh, Saunab/DYO-7073-2022; Bachilo, Sergei/ABC-4606-2020	Bachilo, Sergei/0000-0001-5236-1383; Weisman, R. Bruce/0000-0001-8546-9980	NSF [CHE-0809020]; Welch Foundation [C-0807, C-1119]; NASA [NNX09AH43G]	NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NASA(National Aeronautics & Space Administration (NASA))	Supported by NSF grant CHE-0809020, Welch Foundation grants C-0807 and C-1119, and NASA grant NNX09AH43G. We thank J. K. Johnson for unpublished computational results, and C. Farach-Carson and D. Carson for providing the cultured cell line.	Akdim B, 2007, CHEM PHYS LETT, V445, P281, DOI 10.1016/j.cplett.2007.08.001; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; Banerjee S, 2002, J PHYS CHEM B, V106, P12144, DOI 10.1021/jp026304k; Cai LT, 2002, CHEM MATER, V14, P4235, DOI 10.1021/cm020273o; Chen ZY, 2006, J PHYS CHEM B, V110, P11624, DOI 10.1021/jp057494c; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; Ghosh S, 2010, NAT NANOTECHNOL, V5, P443, DOI [10.1038/NNANO.2010.68, 10.1038/nnano.2010.68]; Harutyunyan H, 2009, NANO LETT, V9, P2010, DOI 10.1021/nl9002798; Heymann D, 2002, J AM CHEM SOC, V124, P6317, DOI 10.1021/ja012488p; Heymann D, 2000, J AM CHEM SOC, V122, P11473, DOI 10.1021/ja0025651; Heymann D, 2006, CR CHIM, V9, P1107, DOI 10.1016/j.crci.2006.02.003; Hirsch A, 2005, TOP CURR CHEM, V245, P193; Kiowski O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.237402; Li MH, 2008, CARBON, V46, P466, DOI 10.1016/j.carbon.2007.12.012; Lu X, 2002, J PHYS CHEM B, V106, P2136, DOI 10.1021/jp015537t; Luer L, 2009, NAT PHYS, V5, P54, DOI [10.1038/nphys1149, 10.1038/NPHYS1149]; Mawhinney DB, 2000, J AM CHEM SOC, V122, P2383, DOI 10.1021/ja994094s; Murakami Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195407; Ogrin D, 2006, J AM CHEM SOC, V128, P11322, DOI 10.1021/ja061680u; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Picozzi S, 2004, J CHEM PHYS, V120, P7147, DOI 10.1063/1.1669381; Qin SH, 2004, MACROMOLECULES, V37, P3965, DOI 10.1021/ma049681z; Reich S., 2004, CARBON NANOTUBES BAS; Siitonen AJ, 2010, J PHYS CHEM LETT, V1, P2189, DOI 10.1021/jz100749c; Siitonen AJ, 2010, NANO LETT, V10, P1595, DOI 10.1021/nl9039845; Simmons JM, 2006, J PHYS CHEM B, V110, P7113, DOI 10.1021/jp0548422; Torrens ON, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.157401; Tsvaygboym K., 2007, THESIS RICE U; Weisman RB, 2001, J AM CHEM SOC, V123, P9720, DOI 10.1021/ja016267v; Yim WL, 2009, J PHYS CHEM C, V113, P17636, DOI 10.1021/jp908089c	31	272	277	4	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1656	1659		10.1126/science.1196382	http://dx.doi.org/10.1126/science.1196382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21109631				2022-12-24	WOS:000285390500061
J	Einstein, AJ; Weiner, SD; Bernheim, A; Kulon, M; Bokhari, S; Johnson, LL; Moses, JW; Balter, S				Einstein, Andrew J.; Weiner, Shepard D.; Bernheim, Adam; Kulon, Michal; Bokhari, Sabahat; Johnson, Lynne L.; Moses, Jeffrey W.; Balter, Stephen			Multiple Testing, Cumulative Radiation Dose, and Clinical Indications in Patients Undergoing Myocardial Perfusion Imaging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; NUCLEAR-MEDICINE; COMPUTED-TOMOGRAPHY; IONIZING-RADIATION; EXPOSURE; CANCER; RADIOLOGY; RISK; REVASCULARIZATION; ECHOCARDIOGRAPHY	Context Myocardial perfusion imaging (MPI) is the single medical test with the highest radiation burden to the US population. Although many patients undergoing MPI receive repeat MPI testing, or additional procedures involving ionizing radiation, no data are available characterizing their total longitudinal radiation burden and relating radiation burden with reasons for testing. Objectives To characterize procedure counts, cumulative estimated effective doses of radiation, and clinical indications for patients undergoing MPI. Design, Setting, and Patients A retrospective cohort study of 1097 consecutive patients undergoing index MPI during the first 100 days of 2006 (January 1-April 10) at Columbia University Medical Center, New York, New York, that evaluated all preceding medical imaging procedures involving ionizing radiation undergone beginning October 1988, and all subsequent procedures through June 2008, at the center. Main Outcome Measures Cumulative estimated effective dose of radiation, number of procedures involving radiation, and indications for testing. Results Patients underwent a median of 15 (interquartile range [IQR], 6-32; mean, 23.9) procedures involving radiation exposure; of which 4 (IQR, 2-8; mean, 6.5) were high-dose procedures (>= 3 mSv; ie, 1 year's background radiation), including 1 (IQR, 1-2; mean, 1.8) MPI study per patient. A total of 344 patients (31.4%) received cumulative estimated effective dose from all medical sources of more than 100 mSv. Multiple MPIs were performed in 424 patients (38.6%), for whom cumulative estimated effective dose was 121 mSv (IQR, 81-189; mean, 149 mSv). Men and white patients had higher cumulative estimated effective doses. More than 80% of initial and 90% of repeat MPI examinations were performed in patients with known cardiac disease or symptoms consistent with it. Conclusion In this institution, multiple testing with MPI was common and in many patients associated with high cumulative estimated doses of radiation. JAMA. 2010;304(19):2137-2144 www.jama.com	[Einstein, Andrew J.; Weiner, Shepard D.; Bernheim, Adam; Bokhari, Sabahat; Johnson, Lynne L.; Moses, Jeffrey W.; Balter, Stephen] Columbia Univ, Med Ctr, Div Cardiol, Dept Med, New York, NY 10032 USA; [Einstein, Andrew J.; Kulon, Michal; Balter, Stephen] Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10032 USA; [Bernheim, Adam] New York Presbyterian Hosp, New York, NY USA; [Bernheim, Adam] Staten Isl Univ Hosp, Dept Radiol, New York, NY USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital; Northwell Health	Einstein, AJ (corresponding author), Columbia Univ, Med Ctr, Div Cardiol, Dept Med, 622 W 168th St,PH 10-203A, New York, NY 10032 USA.	andrew.einstein@columbia.edu	Balter, S/P-6211-2019; Bokhari, Sabahat/GZM-2572-2022; Bokhari, Sabahat/GSI-6376-2022		Covidien; GE Healthcare; INVIA; Philips Medical Systems; Toshiba America Medical Systems; National Institutes of Health [KL2 RR024157]; Louis V. Gerstner, Jr. Scholars Program; Lewis Katz Cardiovascular Research Prize; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157] Funding Source: NIH RePORTER	Covidien; GE Healthcare(General ElectricGE Healthcare); INVIA; Philips Medical Systems; Toshiba America Medical Systems; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louis V. Gerstner, Jr. Scholars Program; Lewis Katz Cardiovascular Research Prize; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr Einstein reported having served as a consultant for the International Atomic Energy Agency and for GE Healthcare, having received support for other research from Spectrum Dynamics and a Nuclear Cardiology Foundation grant funded by Covidien, and having received travel funding from GE Healthcare, INVIA, Philips Medical Systems, and Toshiba America Medical Systems. Dr Moses reported having served as a consultant for GE Healthcare. Dr Balter reported having served as a consultant for the International Atomic Energy Agency and Siemens. All other authors reported no disclosures.; Dr Einstein was supported by a National Institutes of Health K12 institutional career development award (KL2 RR024157), by the Louis V. Gerstner, Jr. Scholars Program, and by the Lewis Katz Cardiovascular Research Prize for a Young Investigator.	[Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 1998, Ann ICRP, V28, P1; [Anonymous], 2008, ANN ICRP, V38, P1; Bedetti G, 2008, BRIT J RADIOL, V81, P699, DOI 10.1259/bjr/29507259; Berman DS, 2009, JACC-CARDIOVASC IMAG, V2, P273, DOI 10.1016/j.jcmg.2008.12.012; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chang SM, 2010, J AM COLL CARDIOL, V55, P221, DOI 10.1016/j.jacc.2009.09.022; Charles MW, 2006, J RADIOL PROT, V26, P325, DOI 10.1088/0952-4746/26/3/N02; Chen J, 2010, J AM COLL CARDIOL, V56, P702, DOI 10.1016/j.jacc.2010.05.014; DePuey G, 2009, CIRCULATION, V120, pS334; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Einstein AJ, 2009, JACC-CARDIOVASC IMAG, V2, P369, DOI 10.1016/j.jcmg.2008.10.008; *EUR COMM, 2008, RAD PROT 154 EUR GUI; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Fiscella K, 2001, MED CARE, V39, P8, DOI 10.1097/00005650-200101000-00003; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Griffey RT, 2009, AM J ROENTGENOL, V192, P887, DOI 10.2214/AJR.08.1351; Hachamovitch R, 2003, J AM COLL CARDIOL, V41, P1329, DOI 10.1016/S0735-1097(03)00125-6; Hendel RC, 2009, J AM COLL CARDIOL, V53, P2201, DOI 10.1016/j.jacc.2009.02.013; Hunter C, 2010, J NUCL MED, V51; Iglehart JK, 2006, NEW ENGL J MED, V354, P2822, DOI 10.1056/NEJMhpr061219; *IMV MED INF DIV, 2003, 2003 NUCL MED CENS M; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Lucas FL, 2007, AM HEART J, V154, P502, DOI 10.1016/j.ahj.2007.04.044; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Metz LD, 2007, J AM COLL CARDIOL, V49, P227, DOI 10.1016/j.jacc.2006.08.048; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; National Council on Radiation Protection and Measurements, 2009, 160 NCRP; National Research Council of the National Academies NRC, 2006, HLTH RISKS EXP LOW L; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Schinkel AFL, 2006, AM J CARDIOL, V97, P1, DOI 10.1016/j.amjcard.2005.07.102; Senthamizhchelvan S, 2010, J NUCL MED, V51, P1592, DOI 10.2967/jnumed.110.077669; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Stabin MG, 2001, J NUCL MED, V42, p243P; Stabin M, 2008, J NUCL MED, V49, p20N	40	129	129	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2137	2144		10.1001/jama.2010.1664	http://dx.doi.org/10.1001/jama.2010.1664			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21078807	Bronze, Green Accepted			2022-12-24	WOS:000284269800024
J	Spence, D				Spence, Des			From the Frontline Bad medicine: paediatric ear, nose, and throat surgery	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	4	4	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 17	2010	341								c6560	10.1136/bmj.c6560	http://dx.doi.org/10.1136/bmj.c6560			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684WO	21084364				2022-12-24	WOS:000284586200003
J	Ding, BS; Nolan, DJ; Butler, JM; James, D; Babazadeh, AO; Rosenwaks, Z; Mittal, V; Kobayashi, H; Shido, K; Lyden, D; Sato, TN; Rabbany, SY; Rafii, S				Ding, Bi-Sen; Nolan, Daniel J.; Butler, Jason M.; James, Daylon; Babazadeh, Alexander O.; Rosenwaks, Zev; Mittal, Vivek; Kobayashi, Hideki; Shido, Koji; Lyden, David; Sato, Thomas N.; Rabbany, Sina Y.; Rafii, Shahin			Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration	NATURE			English	Article							CELLS; ANGIOGENESIS; GROWTH; VEGF; DIFFERENTIATION; EXPRESSION; ID1	During embryogenesis, endothelial cells induce organogenesis before the development of circulation(1-4). These findings suggest that endothelial cells not only form passive conduits to deliver nutrients and oxygen, but also establish an instructive vascular niche, which through elaboration of paracrine trophogens stimulates organ regeneration, in a manner similar to endothelial-cell-derived angiocrine factors that support haematopoiesis(5-7). However, the precise mechanism by which tissue-specific subsets of endothelial cells promote organogenesis in adults is unknown. Here we demonstrate that liver sinusoidal endothelial cells (LSECs) constitute a unique population of phenotypically and functionally defined VEGFR3(+)CD34(-)VEGFR2(+)VE-cadherin(+)FactorVIII(+)CD452(-) endothelial cells, which through the release of angiocrine trophogens initiate and sustain liver regeneration induced by 70% partial hepatectomy. After partial hepatectomy, residual liver vasculature remains intact without experiencing hypoxia or structural damage, which allows study of physiological liver regeneration. Using this model, we show that inducible genetic ablation of vascular endothelial growth factor (VEGF)-A receptor-2 (VEGFR2) in the LSECs impairs the initial burst of hepatocyte proliferation (days 1-3 after partial hepatectomy) and subsequent reconstitution of the hepatovascular mass (days 4-8 after partial hepatectomy) by inhibiting upregulation of the endothelial-cell-specific transcription factor Id1. Accordingly, Id1-deficient mice also manifest defects throughout liver regeneration, owing to diminished expression of LSEC-derived angiocrine factors, including hepatocyte growth factor (HGF) and Wnt2. Notably, in in vitro co-cultures, VEGFR2-Id1 activation in LSECs stimulates hepatocyte proliferation. Indeed, intrasplenic transplantation of Id1(+/+) or Id1(-/-) LSECs transduced with Wnt2 and HGF (Id1(-/-)Wnt2(+)HGF(+) LSECs) re-establishes an inductive vascular niche in the liver sinusoids of the Id1(-/-) mice, initiating and restoring hepatovascular regeneration. Therefore, in the early phases of physiological liver regeneration, VEGFR2-Id1-mediated inductive angiogenesis in LSECs through release of angiocrine factors Wnt2 and HGF provokes hepatic proliferation. Subsequently, VEGFR2-Id1-dependent proliferative angiogenesis reconstitutes liver mass. Therapeutic co-transplantation of inductive VEGFR2(+)Id1(+)Wnt2(+)HGF(+) LSECs with hepatocytes provides an effective strategy to achieve durable liver regeneration.	[Ding, Bi-Sen; Nolan, Daniel J.; Butler, Jason M.; James, Daylon; Babazadeh, Alexander O.; Kobayashi, Hideki; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY 10065 USA; [Ding, Bi-Sen; Nolan, Daniel J.; Butler, Jason M.; James, Daylon; Babazadeh, Alexander O.; Kobayashi, Hideki; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Rosenwaks, Zev] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Mittal, Vivek] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Lyden, David] Weill Cornell Med Coll, Dept Pediat, New York, NY 10065 USA; [Sato, Thomas N.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11549 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; Nara Institute of Science & Technology; Hofstra University	Rafii, S (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY 10065 USA.	srafii@med.cornell.edu			Howard Hughes Medical Institute; Ansary Stem Cell Institute; National Institutes of Health [HL097797, U01 HL-66592-03, RC1 AI080309]; Qatar National Priorities Research Program; Anbinder and Newmans Own Foundations; Empire State Stem Cell Board; New York State Department of Health [NYS C024180]; MEXT; Takeda Science Foundation; Uehara Memorial Life Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097797, P01HL059312, P50HL084936, P01HL067839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Priorities Research Program(Qatar National Research Fund (QNRF)); Anbinder and Newmans Own Foundations; Empire State Stem Cell Board; New York State Department of Health; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Life Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S.R. is supported by the Howard Hughes Medical Institute, the Ansary Stem Cell Institute, National Institutes of Health grants HL097797, U01 HL-66592-03 and RC1 AI080309, the Qatar National Priorities Research Program, the Anbinder and Newmans Own Foundations, the Empire State Stem Cell Board and a New York State Department of Health grant, NYS C024180. T.N.S is supported by MEXT (Kiban-S), the Takeda Science Foundation and the Uehara Memorial Life Science Foundation. We are grateful to N. K. Hong for advice on mouse surgical procedure and F. Roth for editing the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Greene AK, 2003, ANN SURG, V237, P530, DOI 10.1097/00000658-200304000-00015; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Rafii S, 2008, SCIENCE, V319, P163, DOI 10.1126/science.1153615; Sakaguchi TF, 2008, CURR BIOL, V18, P1565, DOI 10.1016/j.cub.2008.08.065; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; van Buren G, 2008, J CLIN ONCOL, V26, P1836, DOI 10.1200/JCO.2007.11.6566; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	36	531	557	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					310	U240		10.1038/nature09493	http://dx.doi.org/10.1038/nature09493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068842	Green Accepted			2022-12-24	WOS:000284051000052
J	Bassani, DG; Kumar, R; Awasthi, S; Morris, SK; Paul, VK; Shet, A; Ram, U; Gaffey, MF; Black, RE; Jha, P; Mishra, B; Ramji, S; Subramaniyam, M				Bassani, Diego G.; Kumar, Rajesh; Awasthi, Shally; Morris, Shaun K.; Paul, Vinod K.; Shet, Anita; Ram, Usha; Gaffey, Michelle F.; Black, Robert E.; Jha, Prabhat; Mishra, Bhaskar; Ramji, Siddarth; Subramaniyam, Mani		Million Death Study Collaborators	Causes of neonatal and child mortality in India: a nationally representative mortality survey	LANCET			English	Article							DEATHS; MANAGEMENT; BANGLADESH; RATES	Background More than 2.3 million children died in India in 2005; however, the major causes of death have not been measured in the country. We investigated the causes of neonatal and child mortality in India and their differences by sex and region. Methods The Registrar General of India surveyed all deaths occurring in 2001-03 in 1.1 million nationally representative homes. Field staff interviewed household members and completed standard questions about events that preceded the death. Two of 130 physicians then independently assigned a cause to each death. Cause-specific mortality rates for 2005 were calculated nationally and for the six regions by combining the recorded proportions for each cause in the neonatal deaths and deaths at ages 1-59 months in the study with population and death totals from the United Nations. Findings There were 10 892 deaths in neonates and 12 260 in children aged 1-59 months in the study. When these details were projected nationally, three causes accounted for 78% (0.79 million of 1.01 million) of all neonatal deaths: prematurity and low birthweight (0.33 million, 99% CI 0.31 million to 0.35 million), neonatal infections (0.27 million, 0.25 million to 0.29 million), and birth asphyxia and birth trauma (0.19 million, 0.18 million to 0.21 million). Two causes accounted for 50% (0.67 million of 1.34 million) of all deaths at 1-59 months: pneumonia (0.37 million, 0.35 million to 0.39 million) and diarrhoeal diseases (0.30 million, 0.28 million to 0.32 million). In children aged 1-59 months, girls in central India had a five-times higher mortality rate (per 1000 livebirths) from pneumonia (20.9, 19.4-22.6) than did boys in south India (4.1, 3.0-5.6) and four-times higher mortality rate from diarrhoeal disease (17.7, 16.2-19.3) than did boys in west India (4.1, 3.0-5.5). Interpretation Five avoidable causes accounted for nearly 1.5 million child deaths in India in 2005, with substantial differences between regions and sexes. Expanded neonatal and intrapartum care, case management of diarrhoea and pneumonia, and addition of new vaccines to immunisation programmes could substantially reduce child deaths in India.	[Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	prabhat.jha@utoronto.ca	Ram, Usha/AAS-4140-2020; Bassani, Diego/G-2827-2015	Ram, Usha/0000-0001-6722-7347; Bassani, Diego/0000-0001-6704-3820; Shet, Anita/0000-0002-7204-8164; Jha, Prabhat/0000-0001-7067-8341	Fogarty International Centre of the US National Institutes of Health [R01 TW05991-01]; Canadian Institute of Health Research (CIHR) [IEG-53506]; International Development Research Centre [102172]; Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto; US Fund for UNICEF via Bill & Melinda Gates Foundation for CHERG [50140]; Canada Research Chair programme; FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER	Fogarty International Centre of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Development Research Centre; Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto; US Fund for UNICEF via Bill & Melinda Gates Foundation for CHERG; Canada Research Chair programme(Canada Research Chairs); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Registrar General of India established the SRS in 1971, has continued it ever since, and is collaborating with several of the authors on the ongoing Million Death Study. External funding is from the Fogarty International Centre of the US National Institutes of Health (grant R01 TW05991-01), Canadian Institute of Health Research (CIHR; IEG-53506), International Development Research Centre (Grant 102172), Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto, and the US Fund for UNICEF (via a grant from the Bill & Melinda Gates Foundation for CHERG; subgrant 50140). PJ is supported by the Canada Research Chair programme. SKM is a Fellow of the Pediatric Scientist Development Program. The opinions expressed in this paper are those of the authors and do not necessarily represent those of the Government of India. We thank Joy Lawn, Colin Mathers, Mikkel Oestergaard, Prem Mony, and Alvin Zipursky for comments; and Maya Kesler, Brendon Pezzack, Chinthanie Ramasundarahettige, Peter Rodriguez, and Wilson Suraweera for data support.	Ali M, 2005, B WORLD HEALTH ORGAN, V83, P27; ANKER M, 1999, STANDARD VERBAL AUTO; [Anonymous], WORLD POP PROSP 2008; [Anonymous], 2005, SPEC FERT MORT SURV; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Baqui AH, 2006, B WORLD HEALTH ORGAN, V84, P706, DOI 10.2471/BLT.05.026443; Bassani DG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-491; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Corsi DJ, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S3; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; *IIPS MACR, 2008, NAT FAM HLTH SURV NF; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Jha P, 2002, NATL MED J INDIA, V15, P32; Jha P, 2009, CHOOS HLTH ENT ALL I; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Maude GH, 1997, INT J EPIDEMIOL, V26, P1097, DOI 10.1093/ije/26.5.1097; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; *REG GEN IND, 2005, MED CERT CAUS DEATH; *REG GEN IND, 2001, CENS IND 2001; [Registrar General of India Centre for Global Health Research Ministry of Home Affairs], 2009, CAUS DEATH IND 2001; Ronsmans C, 2008, PAEDIATR PERINAT EP, V22, P269, DOI 10.1111/j.1365-3016.2008.00939.x; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8; World Health Organization, 1994, INT STAT CLASS DIS R; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; [No title captured]; [No title captured]	35	304	308	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1853	1860		10.1016/S0140-6736(10)61461-4	http://dx.doi.org/10.1016/S0140-6736(10)61461-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21075444	Green Accepted			2022-12-24	WOS:000285439700034
J	Guichard, A; McGillivray, SM; Cruz-Moreno, B; van Sorge, NM; Nizet, V; Bier, E				Guichard, Annabel; McGillivray, Shauna M.; Cruz-Moreno, Beatriz; van Sorge, Nina M.; Nizet, Victor; Bier, Ethan			Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst	NATURE			English	Article							LETHAL FACTOR; EDEMA FACTOR; WING VEIN; SEC15; RAB11; MORPHOGENESIS; PATHOGENESIS; COMPONENTS; ENDOSOMES; EFFECTOR	Bacillus anthracis is the causative agent of anthrax in humans and other mammals(1,2). In lethal systemic anthrax, proliferating bacilli secrete large quantities of the toxins lethal factor (LF) and oedema factor (EF), leading to widespread vascular leakage and shock. Whereas host targets of LF (mitogen-activated protein-kinase kinases) and EF (cAMP-dependent processes)(3) have been implicated in the initial phase of anthrax(1,2), less is understood about toxin action during the final stage of infection. Here we use Drosophila melanogaster to identify the Rab11/Sec15 exocyst, which acts at the last step of endocytic recycling, as a novel target of both EF and LF. EF reduces levels of apically localized Rab11 and indirectly blocks vesicle formation by its binding partner and effector Sec15 (Sec15-GFP), whereas LF acts more directly to reduce Sec15-GFP vesicles. Convergent effects of EF and LF on Rab11/Sec15 inhibit expression of and signalling by the Notch ligand Delta and reduce DE-cadherin levels at adherens junctions. In human endothelial cells, the two toxins act in a conserved fashion to block formation of Sec15 vesicles, inhibit Notch signalling, and reduce cadherin expression at adherens junctions. This coordinated disruption of the Rab11/Sec15 exocyst by anthrax toxins may contribute to toxin-dependent barrier disruption and vascular dysfunction during B. anthracis infection.	[Guichard, Annabel; Cruz-Moreno, Beatriz; Bier, Ethan] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [McGillivray, Shauna M.; van Sorge, Nina M.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [McGillivray, Shauna M.] Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Texas Christian University; University of California System; University of California San Diego	Bier, E (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ebier@ucsd.edu	McGillivray, Shauna/AAN-3074-2021; van Sorge, Nina/E-3290-2017; Nizet, Victor/AAF-3190-2019	McGillivray, Shauna/0000-0002-8863-1522; van Sorge, Nina/0000-0002-2695-5863; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health (NIH) [AI070654, NS29870, AI077780]; IRACDA NIH [GM068524]; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780, R56AI070654, R01AI070654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS029870, R01NS029870] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IRACDA NIH; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kurciyan for help in analysing the effects of expressing wild-type and dominant-negative forms of Rab in Drosophila, A. Cooper and members of the E.B. and V.N. laboratories and H. Bellen for comments on the manuscript and suggestions. We thank S. Leppla for providing purified preparations of LF, EF and PA, S. Stibitz for B. anthracis mutants, and the following investigators for providing antibodies: R. Cohen (anti-Rab11), A. Parks (anti-Dl), K. Irvine (anti-Serrate) and J. Collier (anti-LF). Support for these studies was provided by National Institutes of Health (NIH) R01 grants AI070654 and NS29870 (E. B.), AI077780 (V. N.), an IRACDA NIH postdoctoral fellowship GM068524 (S.M.M.) and a Biomedical Research Fellowship from The Hartwell Foundation (S.M.M.).	Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Gozes Y, 2006, INFECT IMMUN, V74, P1266, DOI 10.1128/IAI.74.2.1266-1272.2006; Guichard A, 2006, P NATL ACAD SCI USA, V103, P3244, DOI 10.1073/pnas.0510748103; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Lacy DB, 2002, CURR TOP MICROBIOL, V271, P61; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lunde K, 2003, DEVELOPMENT, V130, P235, DOI 10.1242/dev.00207; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Mourez M, 2005, REV PHYSIOL BIOCH P, V152, P135, DOI 10.1007/s10254-004-0028-2; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Tessier J, 2007, INFECT IMMUN, V75, P1895, DOI 10.1128/IAI.01632-06; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	33	77	78	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					854	U123		10.1038/nature09446	http://dx.doi.org/10.1038/nature09446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944747	Green Accepted			2022-12-24	WOS:000282898700069
J	Virtanen, A; Joutsensaari, J; Koop, T; Kannosto, J; Yli-Pirila, P; Leskinen, J; Makela, JM; Holopainen, JK; Poschl, U; Kulmala, M; Worsnop, DR; Laaksonen, A				Virtanen, Annele; Joutsensaari, Jorma; Koop, Thomas; Kannosto, Jonna; Yli-Pirila, Pasi; Leskinen, Jani; Makela, Jyrki M.; Holopainen, Jarmo K.; Poeschl, Ulrich; Kulmala, Markku; Worsnop, Douglas R.; Laaksonen, Ari			An amorphous solid state of biogenic secondary organic aerosol particles	NATURE			English	Article							ATMOSPHERIC PARTICLES; OLEIC-ACID; MODEL; OXIDATION; CLIMATE; CHEMISTRY; DIFFUSION; EMISSIONS; PRODUCTS; FORESTS	Secondary organic aerosol (SOA) particles are formed in the atmosphere from condensable oxidation products of anthropogenic and biogenic volatile organic compounds (VOCs)(1-7). On a global scale, biogenic VOCs account for about 90% of VOC emissions(1,8) and of SOA formation (90 billion kilograms of carbon per year)(1-4). SOA particles can scatter radiation and act as cloud condensation or ice nuclei, and thereby influence the Earth's radiation balance and climate(1,2,5,9,10). They consist of a myriad of different compounds with varying physicochemical properties, and little information is available on the phase state of SOA particles. Gas-particle partitioning models usually assume that SOA particles are liquid(1,5,11), but here we present experimental evidence that they can be solid under ambient conditions. We investigated biogenic SOA particles formed from oxidation products of VOCs in plant chamber experiments and in boreal forests within a few hours after atmospheric nucleation events. On the basis of observed particle bouncing in an aerosol impactor and of electron microscopy we conclude that biogenic SOA particles can adopt an amorphous solid-most probably glassy-state. This amorphous solid state should provoke a rethinking of SOA processes because it may influence the partitioning of semi-volatile compounds, reduce the rate of heterogeneous chemical reactions, affect the particles' ability to accommodate water and act as cloud condensation or ice nuclei, and change the atmospheric lifetime of the particles(12-15). Thus, the results of this study challenge traditional views of the kinetics and thermodynamics of SOA formation and transformation in the atmosphere and their implications for air quality and climate.	[Virtanen, Annele; Kannosto, Jonna; Makela, Jyrki M.] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Joutsensaari, Jorma; Worsnop, Douglas R.; Laaksonen, Ari] Univ Eastern Finland, Dept Math & Phys, Kuopio 70211, Finland; [Koop, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Yli-Pirila, Pasi; Leskinen, Jani; Holopainen, Jarmo K.] Univ Eastern Finland, Dept Environm Sci, Kuopio 70211, Finland; [Poeschl, Ulrich] Max Planck Inst Chem, Biogeochem Dept, D-55128 Mainz, Germany; [Kulmala, Markku; Worsnop, Douglas R.] Univ Helsinki, Dept Phys, Helsinki 00014, Finland; [Kulmala, Markku] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Worsnop, Douglas R.; Laaksonen, Ari] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland	Tampere University; University of Eastern Finland; University of Bielefeld; University of Eastern Finland; Max Planck Society; University of Helsinki; Stockholm University; Aerodyne Research; Finnish Meteorological Institute	Virtanen, A (corresponding author), Tampere Univ Technol, Dept Phys, POB 692, FIN-33101 Tampere, Finland.	annele.virtanen@tut.fi; thomas.koop@uni-bielefeld.de	Laaksonen, Ari/B-5094-2011; Virtanen, Annele/E-7699-2010; Pöschl, Ulrich/A-6263-2010; Mäkelä, Jyrki/G-4223-2014; Holopainen, Jarmo K./B-1656-2008; Worsnop, Douglas R/D-2817-2009; Koop, Thomas/B-7861-2008; Kulmala, Markku T/I-7671-2016	Laaksonen, Ari/0000-0002-1657-2383; Virtanen, Annele/0000-0002-2917-5344; Pöschl, Ulrich/0000-0003-1412-3557; Holopainen, Jarmo K./0000-0001-5026-3245; Worsnop, Douglas R/0000-0002-8928-8017; Koop, Thomas/0000-0002-7571-3684; Kulmala, Markku T/0000-0003-3464-7825; Makela, Jyrki Mikael/0000-0002-6757-3589	Academy of Finland [110763, 111543, 131019, 218115]; Maj and Tor Nessling foundation	Academy of Finland(Academy of Finland); Maj and Tor Nessling foundation	We acknowledge support by the Academy of Finland (decision numbers 110763, 111543, 131019, 218115 and Centre of Excellence Programme) and the Maj and Tor Nessling foundation. We also acknowledge J. Keskinen and A. Arffman for fruitful discussions concerning impactor performance, H. Kuuluvainen for his help in bounce factor measurements, K. Rissa for SEM imaging, L. Hao, P. Tiitta, A. Kortelainen and P. Miettinen for aerosol mass spectrometer analyses and their help during experiments, J. Jokiniemi, U. Tapper and J. Lyyranen (VTT Technical Research Centre of Finland) for the development of SEM sample collection and image analysis methods, A. Diekmann for the differential scanning calorimeter measurements and T. Wagner for providing polystyrene samples.	Bahreini R, 2005, ENVIRON SCI TECHNOL, V39, P5674, DOI 10.1021/es048061a; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; DAHNEKE B, 1971, J COLLOID INTERF SCI, V37, P342, DOI 10.1016/0021-9797(71)90302-X; Ehn M, 2007, ATMOS CHEM PHYS, V7, P211, DOI 10.5194/acp-7-211-2007; Fuzzi S, 2006, ATMOS CHEM PHYS, V6, P2017, DOI 10.5194/acp-6-2017-2006; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; HAMERI K, 2000, REP SER AEROSOL SCI, V47, P47; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; *IPCC, 2007, CLIM CHANG 2007 PHYS, P161; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Joutsensaari J, 2005, ATMOS CHEM PHYS, V5, P1489, DOI 10.5194/acp-5-1489-2005; Kalberer M, 2004, SCIENCE, V303, P1659, DOI 10.1126/science.1092185; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; Kavouras IG, 1998, NATURE, V395, P683, DOI 10.1038/27179; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P2657, DOI 10.5194/acp-8-2657-2008; Marcolli C, 2004, J PHYS CHEM A, V108, P2216, DOI [10.1021/jp036080l, 10.1021/jp0360801]; Maria SF, 2004, SCIENCE, V306, P1921, DOI 10.1126/science.1103491; Mentel TF, 2009, ATMOS CHEM PHYS, V9, P4387, DOI 10.5194/acp-9-4387-2009; Mikhailov E, 2009, ATMOS CHEM PHYS, V9, P9491, DOI 10.5194/acp-9-9491-2009; Murray BJ, 2008, ATMOS CHEM PHYS, V8, P5423, DOI 10.5194/acp-8-5423-2008; PANKOW JF, 1994, ATMOS ENVIRON, V28, P189, DOI 10.1016/1352-2310(94)90094-9; PANKOW JF, 1987, ATMOS ENVIRON, V21, P2275, DOI 10.1016/0004-6981(87)90363-5; PARKER R, 1995, CARBOHYD RES, V273, P147, DOI 10.1016/0008-6215(95)00120-I; Shiraiwa M, 2010, ATMOS CHEM PHYS, V10, P3673, DOI 10.5194/acp-10-3673-2010; STEIN SW, 1994, ATMOS ENVIRON, V28, P1739, DOI 10.1016/1352-2310(94)90136-8; Tunved P, 2006, SCIENCE, V312, P261, DOI 10.1126/science.1123052; Zahardis J, 2007, ATMOS CHEM PHYS, V7, P1237, DOI 10.5194/acp-7-1237-2007; Zobrist B, 2008, ATMOS CHEM PHYS, V8, P5221, DOI 10.5194/acp-8-5221-2008	29	553	557	13	559	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					824	827		10.1038/nature09455	http://dx.doi.org/10.1038/nature09455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944744				2022-12-24	WOS:000282898700063
J	Krug, U; Rollig, C; Koschmieder, A; Heinecke, A; Sauerland, MC; Schaich, M; Thiede, C; Kramer, M; Braess, J; Spiekermann, K; Haferlach, T; Haferlach, C; Koschmieder, S; Rohde, C; Serve, H; Wormann, B; Hiddemann, W; Ehninger, G; Berdel, WE; Buchner, T; Muller-Tidow, C				Krug, Utz; Roellig, Christoph; Koschmieder, Anja; Heinecke, Achim; Sauerland, Maria Cristina; Schaich, Markus; Thiede, Christian; Kramer, Michael; Braess, Jan; Spiekermann, Karsten; Haferlach, Torsten; Haferlach, Claudia; Koschmieder, Steffen; Rohde, Christian; Serve, Hubert; Woermann, Bernhard; Hiddemann, Wolfgang; Ehninger, Gerhard; Berdel, Wolfgang E.; Buechner, Thomas; Mueller-Tidow, Carsten		German Acute Myeloid Leukaemia Coo	Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes	LANCET			English	Article							MICRORNA-EXPRESSION SIGNATURES; RISK MYELODYSPLASTIC SYNDROME; STEM-CELL TRANSPLANTATION; ELDERLY-PATIENTS; INDUCTION CHEMOTHERAPY; FAVORABLE PROGNOSIS; DOSE CYTARABINE; NPM1 MUTATIONS; SURVIVAL; CANCER	Background About 50% of patients (age >= 60 years) who have acute myeloid leukaemia and are otherwise medically healthy (ie, able to undergo intensive chemotherapy) achieve a complete remission (CR) after intensive chemotherapy, but with a substantially increased risk of early death (ED) compared with younger patients. We verified the association of standard clinical and laboratory variables with CR and ED and developed a web-based application for risk assessment of intensive chemotherapy in these patients. Methods Multivariate regression analysis was used to develop risk scores with or without knowledge of the cytogenetic and molecular risk profiles for a cohort of 1406 patients (aged >= 60 years) with acute myeloid leukaemia, but otherwise medically healthy, who were treated with two courses of intensive induction chemotherapy (tioguanine, standard-dose cytarabine, and daunorubicin followed by high-dose cytarabine and mitoxantrone; or with high-dose cytarabine and mitoxantrone in the first and second induction courses) in the German Acute Myeloid Leukaemia Cooperative Group 1999 study. Risk prediction was validated in an independent cohort of 801 patients (aged >60 years) with acute myeloid leukaemia who were given two courses of cytarabine and daunorubicin in the Acute Myeloid Leukaemia 1996 study. Findings Body temperature, age, de-novo leukaemia versus leukaemia secondary to cytotoxic treatment or an antecedent haematological disease, haemoglobin, platelet count, fibrinogen, and serum concentration of lactate dehydrogenase were significantly associated with CR or ED. The probability of CR with knowledge of cytogenetic and molecular risk (score 1) was from 12% to 91%, and without knowledge (score 2) from 21% to 80%. The predicted risk of ED was from 6% to 69% for score 1 and from 7% to 63% for score 2. The predictive power of the risk scores was confirmed in the independent patient cohort (CR score 1, from 10% to 91%; CR score 2, from 16% to 80%; ED score 1, from 6% to 69%; and ED score 2, from 7% to 61%). Interpretation The scores for acute myeloid leukaemia can be used to predict the probability of CR and the risk of ED in older patients with acute myeloid leukaemia, but otherwise medically healthy, for whom intensive induction chemotherapy is planned. This information can help physicians with difficult decisions for treatment of these patients.	[Koschmieder, Anja; Koschmieder, Steffen; Rohde, Christian; Berdel, Wolfgang E.; Buechner, Thomas; Mueller-Tidow, Carsten] Univ Munster, Dept Med Haematol & Oncol A, Munster, Germany; [Roellig, Christoph; Schaich, Markus; Thiede, Christian; Kramer, Michael; Ehninger, Gerhard] Tech Univ Dresden, Dept Med 1, Dresden, Germany; [Heinecke, Achim; Sauerland, Maria Cristina] Univ Munster, Inst Biostat & Clin Res, Munster, Germany; [Braess, Jan; Spiekermann, Karsten; Hiddemann, Wolfgang] Univ Munich, Dept Internal Med 3, Munich, Germany; [Haferlach, Torsten; Haferlach, Claudia] Munich Leukaemia Lab, Munich, Germany; [Serve, Hubert] Goethe Univ Frankfurt, Dept Med, Frankfurt, Germany; [Woermann, Bernhard] Municipal Hosp, Dept Haematol & Oncol, Braunschweig, Germany	University of Munster; Technische Universitat Dresden; University of Munster; University of Munich; MLL Munich Leukemia Laboratory; Goethe University Frankfurt	Krug, U (corresponding author), Univ Hosp Munster, Dept Med A, Albert Schweitzer Str 33, D-48149 Munster, Germany.	utz.krug@ukmuenster.de	Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014; Sauerland, Maria Cristina/A-4154-2014; Gramatzki, Martin/A-9533-2010	Müller-Tidow, Carsten/0000-0002-7166-5232; Serve, Hubert/0000-0001-8472-5516; Koschmieder, Steffen/0000-0002-1011-8171; Kramer, Michael/0000-0002-0251-2726; Thiede, Christian/0000-0003-1241-2048	Amgen; Celgene; Bundesministerium fur Bildung und Forschung; Novartis; Bayer; Ambit; Bristol-Myers Sqibb; Mundipharma; Deutsche Forschungsgemeinschaft [Mu-1328/8-1]; Deutsche Krebshilfe; Sander-Foundation; Aicuris; Leverkusen; Deutsche Krebshilfe [70-2839-Bu4]	Amgen(Amgen); Celgene(Bristol-Myers SquibbCelgene Corporation); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Novartis(Novartis); Bayer(Bayer AG); Ambit; Bristol-Myers Sqibb; Mundipharma; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Sander-Foundation; Aicuris; Leverkusen; Deutsche Krebshilfe(Deutsche Krebshilfe)	UK has received expenses for travel, accommodation, and meetings from Amgen and Celgene. CT has received grants from Bundesministerium fur Bildung und Forschung; payment for lectures, including service on speakers' bureaus, from Novartis; payment for diagnostic services from Novartis and Ambit; and expenses for travel, accommodations, and meetings from Novartis, Bayer, and Ambit. TH has received payment for lectures including service on speakers' bureaus from Novartis, Bristol-Myers Sqibb, and Celgene; and has part ownership in Munich Leukemia Laboratory. CH has part ownership in Munich Leukemia Laboratory. SK has received grants from Novartis; and expenses for travel, accommodations, and meetings from Mundipharma, Novartis, and Bristol-Myers Sqibb. WEB has received grants from Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, and Sander-Foundation; payment for lectures, including service on speakers' bureaus, and development of educational presentations from Molecular and Targeted Therapy of Cancer; and expenses for travel, accommodations, and meetings from Amgen. CMT has received grants from Bundesministerium fur Bildung und Forschung; payment for lectures, including service on speakers' bureaus, from Novartis and Celgene; payment for manuscript preparation from Celgene; and expenses for travel, accommodations, and meetings from Celgene, Amgen, Novartis, and Bayer. GE has received payment for board membership from Rhon Klinikum; payment for consultancy from Aicuris, Leverkusen; and grants from Deutsche Forschungsgemeinschaft; payments for lectures, including service on speakers' bureaus, from Update Conference; has stock or stock options in Rhon Klinikum; and has received expenses for travel, accommodations, and meetings from Novartis. The other authors declare that they have no conflicts of interest.; This work was supported by a grant from the Deutsche Krebshilfe (70-2839-Bu4 to TB) and by a grant from the Deutsche Forschungsgemeinschaft (Mu-1328/8-1 to CMT and TB).	Anderson JE, 2002, BLOOD, V100, P3869, DOI 10.1182/blood-2001-12-0354; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; Bertz H, 2003, J CLIN ONCOL, V21, P1480, DOI 10.1200/JCO.2003.09.110; Breccia M, 2009, HEMATOL ONCOL, V27, P148, DOI 10.1002/hon.889; Buchner T, 2006, J CLIN ONCOL, V24, P2480, DOI 10.1200/JCO.2005.04.5013; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; COMINGS DE, 1973, EXP CELL RES, V77, P469, DOI 10.1016/0014-4827(73)90601-0; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Etienne A, 2007, CANCER, V109, P1376, DOI 10.1002/cncr.22537; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Giles FJ, 2007, BRIT J HAEMATOL, V136, P624, DOI 10.1111/j.1365-2141.2006.06476.x; Goldstone AH, 2002, BLOOD, V100, p88A; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Itzykson R, 2011, BLOOD, V117, P403, DOI 10.1182/blood-2010-06-289280; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1090, DOI 10.1002/cncr.21723; Kantarjian H, 2010, BLOOD, V116, P4422, DOI 10.1182/blood-2010-03-276485; Kern W, 2003, BLOOD, V101, P64, DOI 10.1182/blood-2002-02-0532; LOWENBERG B, 1989, J CLIN ONCOL, V7, P1268; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; Ohtake S, 2011, BLOOD, V117, P2358, DOI 10.1182/blood-2010-03-273243; Rollig C, 2010, BLOOD, V116, P971, DOI 10.1182/blood-2010-01-267302; Rollig C, 2009, BLOOD, V114, P139, DOI 10.1182/blood.V114.22.329.329; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Schnittger S, 2005, BLOOD, V106, p68A, DOI 10.1182/blood.V106.11.223.223; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Sekeres MA, 2009, BLOOD, V113, P28, DOI 10.1182/blood-2008-05-157065; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Walter RB, 2010, J CLIN ONCOL, V28, P1766, DOI 10.1200/JCO.2009.25.1066; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648	34	216	226	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					2000	2008		10.1016/S0140-6736(10)62105-8	http://dx.doi.org/10.1016/S0140-6736(10)62105-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131036				2022-12-24	WOS:000285807700029
J	McTighe, SM; Cowell, RA; Winters, BD; Bussey, TJ; Saksida, LM				McTighe, Stephanie M.; Cowell, Rosemary A.; Winters, Boyer D.; Bussey, Timothy J.; Saksida, Lisa M.			Paradoxical False Memory for Objects After Brain Damage	SCIENCE			English	Article							SHORT-TERM-MEMORY; RECOGNITION MEMORY; AMNESIC PATIENTS; PERIRHINAL CORTEX; ANIMAL-MODEL; RETROACTIVE INTERFERENCE; CONSOLIDATION; RETRIEVAL; LESIONS; IMPAIRMENT	Poor memory after brain damage is usually considered to be a result of information being lost or rendered inaccessible. It is assumed that such memory impairment must be due to the incorrect interpretation of previously encountered information as being novel. In object recognition memory experiments with rats, we found that memory impairment can take the opposite form: a tendency to treat novel experiences as familiar. This impairment could be rescued with the use of a visual-restriction procedure that reduces interference. Such a pattern of data can be explained in terms of a recent representational-hierarchical view of cognition.	[McTighe, Stephanie M.; Bussey, Timothy J.; Saksida, Lisa M.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [McTighe, Stephanie M.; Bussey, Timothy J.; Saksida, Lisa M.] Univ Cambridge, MRC, Cambridge CB2 3EB, England; [McTighe, Stephanie M.; Bussey, Timothy J.; Saksida, Lisa M.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Cowell, Rosemary A.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Winters, Boyer D.] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada	University of Cambridge; University of Cambridge; University of Cambridge; University of California System; University of California San Diego; University of Guelph	Saksida, LM (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	lms42@cam.ac.uk	Cowell, Rosemary/K-2366-2012; Bussey, Timothy J/M-2758-2016; Saksida, Lisa M/M-2753-2016	Bussey, Timothy J/0000-0001-7518-4041; Saksida, Lisa M/0000-0002-8416-8171	BBSRC; MRC at the University of Cambridge; Clinical Neuroscience Institute	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC at the University of Cambridge; Clinical Neuroscience Institute	Supported by a grant from the BBSRC (L. M. S., T.J.B., B. D. W.), and a 3-year MRC-funded Ph.D. studentship at the University of Cambridge, MRC/Wellcome Trust Behavioral and Clinical Neuroscience Institute (S.M.M.).	ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P5637, DOI 10.1073/pnas.91.12.5637; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Bartko SJ, 2010, NEUROPSYCHOLOGIA, V48, P2987, DOI 10.1016/j.neuropsychologia.2010.06.007; Bussey TJ, 2007, HIPPOCAMPUS, V17, P898, DOI 10.1002/hipo.20320; Bussey TJ, 1999, J NEUROSCI, V19, P495, DOI 10.1523/JNEUROSCI.19-01-00495.1999; Clark RE, 2010, NEUROPSYCHOLOGIA, V48, P2234, DOI 10.1016/j.neuropsychologia.2010.02.004; Cowan N, 2004, BRAIN, V127, P825, DOI 10.1093/brain/awh107; Cowell RA, 2006, J NEUROSCI, V26, P12186, DOI 10.1523/JNEUROSCI.2818-06.2006; Della Sala S, 2005, MEMORY, V13, P435, DOI 10.1080/09658210344000387; Dewar M, 2009, NEUROPSYCHOLOGY, V23, P627, DOI 10.1037/a0015568; Dewar MT, 2007, CORTEX, V43, P616, DOI 10.1016/S0010-9452(08)70492-1; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; MUMBY DG, 1994, BEHAV NEUROSCI, V108, P11, DOI 10.1037/0735-7044.108.1.11; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Saksida LM, 2010, NEUROPSYCHOLOGIA, V48, P2370, DOI 10.1016/j.neuropsychologia.2010.02.026; Saksida LM, 2009, SCIENCE, V325, P40, DOI 10.1126/science.1177156; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WARRINGT.EK, 1970, NATURE, V228, P628, DOI 10.1038/228628a0; WARRINGTON EK, 1974, NEUROPSYCHOLOGIA, V12, P419, DOI 10.1016/0028-3932(74)90072-4; WARRINGTON EK, 1978, NEUROPSYCHOLOGIA, V16, P169, DOI 10.1016/0028-3932(78)90104-5; Winters BD, 2005, J NEUROSCI, V25, P52, DOI 10.1523/JNEUROSCI.3827-04.2005; Winters BD, 2010, NEUROPSYCHOLOGIA, V48, P2251, DOI 10.1016/j.neuropsychologia.2010.01.023; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	25	100	100	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1408	1410		10.1126/science.1194780	http://dx.doi.org/10.1126/science.1194780			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127256				2022-12-24	WOS:000284902100050
J	Westerlund, H; Vahtera, J; Ferrie, JE; Singh-Manoux, A; Pentti, J; Melchior, M; Leineweber, C; Jokela, M; Siegrist, J; Goldberg, M; Zins, M; Kivimaki, M				Westerlund, Hugo; Vahtera, Jussi; Ferrie, Jane E.; Singh-Manoux, Archana; Pentti, Jaana; Melchior, Maria; Leineweber, Constanze; Jokela, Markus; Siegrist, Johannes; Goldberg, Marcel; Zins, Marie; Kivimaeki, Mika			Effect of retirement on major chronic conditions and fatigue: French GAZEL occupational cohort study	BRITISH MEDICAL JOURNAL			English	Article							PSYCHOSOCIAL WORK CHARACTERISTICS; MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; SLEEP DISTURBANCES; PHYSICAL HEALTH; NATIONAL-SURVEY; MORTALITY; RISK; POPULATION; TIREDNESS	Objectives To determine, using longitudinal analyses, if retirement is followed by a change in the risk of incident chronic diseases, depressive symptoms, and fatigue. Design Prospective study with repeat measures from 7 years before to 7 years after retirement. Setting Large French occupational cohort (the GAZEL study), 1989-2007. Participants 11 246 men and 2858 women. Main outcome measures Respiratory disease, diabetes, coronary heart disease and stroke, mental fatigue, and physical fatigue, measured annually by self report over the 15 year observation period; depressive symptoms measured at four time points. Results The average number of repeat measurements per participant was 12.1. Repeated measures logistic regression with generalised estimating equations showed that the cumulative prevalence of self reported respiratory disease, diabetes, and coronary heart disease and stroke increased with age, with no break in the trend around retirement. In contrast, retirement was associated with a substantial decrease in the prevalence of both mental fatigue (odds ratio for fatigue one year after versus one year before retirement 0.19, 95% confidence interval 0.18 to 0.21) and physical fatigue (0.27, 0.26 to 0.30). A major decrease was also observed in depressive symptoms (0.60, 0.53 to 0.67). The decrease in fatigue around retirement was more pronounced among people with a chronic disease before retirement. Conclusions Longitudinal modelling of repeat data showed that retirement did not change the risk of major chronic diseases but was associated with a substantial reduction in mental and physical fatigue and depressive symptoms, particularly among people with chronic diseases.	[Westerlund, Hugo; Leineweber, Constanze] Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden; [Westerlund, Hugo; Ferrie, Jane E.; Singh-Manoux, Archana; Jokela, Markus; Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Vahtera, Jussi; Pentti, Jaana; Kivimaeki, Mika] Finnish Inst Occupat Hlth, FI-00250 Helsinki, Finland; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, FI-20520 Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FI-20520 Turku, Finland; [Singh-Manoux, Archana; Melchior, Maria; Goldberg, Marcel; Zins, Marie] INSERM, U1018, F-94807 Villejuif, France; [Singh-Manoux, Archana; Melchior, Maria; Goldberg, Marcel; Zins, Marie] Univ Versailles, St Quentin En Yvelines, France; [Siegrist, Johannes] Univ Dusseldorf, Inst Med Soziol, D-40001 Dusseldorf, Germany	Stockholm University; University of London; University College London; Finnish Institute of Occupational Health; University of Turku; University of Turku; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Heinrich Heine University Dusseldorf	Westerlund, H (corresponding author), Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden.	hugo.westerlund@stress.su.se	Singh-Manoux, Archana/F-6804-2013; Ferrie, Jane/AAZ-2009-2020; Goldberg, Marcel/I-7834-2012; Vahtera, Jussi/J-3271-2013; Zins, Marie/AAX-6551-2021; Leineweber, Constanze/G-7052-2012; Siegrist, Johannes/AAL-6814-2021; Melchior, Maria/E-3992-2017; Jokela, Markus/A-4669-2009; Kivimaki, Mika/B-3607-2012; Westerlund, Hugo/A-3049-2012; Leineweber, Constanze/Z-1330-2019	Singh-Manoux, Archana/0000-0002-1244-5037; Goldberg, Marcel/0000-0002-6161-5880; Leineweber, Constanze/0000-0001-8433-2405; Siegrist, Johannes/0000-0002-7530-4178; Jokela, Markus/0000-0003-0117-0012; Kivimaki, Mika/0000-0002-4699-5627; Westerlund, Hugo/0000-0002-8806-5698; 	Swedish Council for Working Life and Social Research [2004-2021, 2007-1143, 2009-1758]; Academy of Finland [124271, 124322, 129262, 132944]; BUPA Foundation UK; National Institutes of Health/National Heart, Lung, and Blood Institute (NIH) [R01HL036310-20A2]; National Institute on Aging, NIH [R01AG013196, R01AG034454]; European Science Foundation; ESRC [RES-451-26-0491]; Agence nationale de la recherche (ANR); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); Academy of Finland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R01AG034454] Funding Source: NIH RePORTER; Economic and Social Research Council [RES-451-26-0491] Funding Source: researchfish	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Academy of Finland(Academy of Finland); BUPA Foundation UK; National Institutes of Health/National Heart, Lung, and Blood Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Science Foundation(European Science Foundation (ESF)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); Academy of Finland(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	HW and CL are supported by the Swedish Council for Working Life and Social Research (FAS, grants #2004-2021, #2007-1143, and #2009-1758), JV and MK are supported by the Academy of Finland (grants #124271, #124322, #129262, and #132944), MK is additionally supported by a BUPA Foundation UK specialist research grant and the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH) (R01HL036310-20A2). MK and AS-M are supported by the National Institute on Aging, NIH (R01AG013196; R01AG034454); AS-M is also supported by a EUYRI award from the European Science Foundation. This work was additionally supported by a grant from the ESRC Research Seminar Series Competition 2007/8 (RES-451-26-0491). The GAZEL Cohort Study was funded by EDF-GDF and INSERM and received grants from the "Cohortes Sante TGIR Program," Agence nationale de la recherche (ANR), and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET). The study sponsors did not contribute to the study design and had no role in the conduct of the study, data collection, data management, data analysis, or interpretation of the data, nor in the preparation, review, or approval of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) regarding the submitted work HW and CL have support from the Swedish Council for Working Life and Social Research (FAS); JV and MK have support from the Academy of Finland; MK has additional support from the BU PA Foundation, UK; MK and AS-M also have support from the National Institutes of Health (NIH), USA; AS-M has additional support from the European Science Foundation (ESF); JF and all other authors except JS have additional support from ESRC, UK; MG and MZ have additional support from the Institut de recherche en sante publique (INSERM) and Caisse centrale d'action sociale, France; and JS had support from Agence nationale de la recherche (ANR), France; (2) none of the authors have any relationships with any company or organisation that might have an interest in the submitted work in the previous 3 years; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) the authors have no non-financial interests that may be relevant to the submitted work."	Alavinia SM, 2008, INT ARCH OCC ENV HEA, V82, P39, DOI 10.1007/s00420-008-0304-6; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Avlund K, 1998, J CLIN EPIDEMIOL, V51, P323, DOI 10.1016/S0895-4356(97)00296-5; BOSSE R, 1987, PSYCHOL AGING, V2, P383, DOI 10.1037/0882-7974.2.4.383; Bultmann U, 2002, INT ARCH OCC ENV HEA, V75, P259, DOI 10.1007/s00420-001-0294-0; Butterworth P, 2006, SOC SCI MED, V62, P1179, DOI 10.1016/j.socscimed.2005.07.013; Buxton JW, 2005, SOC PSYCH PSYCH EPID, V40, P99, DOI 10.1007/s00127-005-0866-5; De Lange AH, 2009, J SLEEP RES, V18, P374, DOI 10.1111/j.1365-2869.2009.00735.x; De Raeve L, 2007, J OCCUP ENVIRON MED, V49, P890, DOI 10.1097/JOM.0b013e31811eadd3; Doyle Y, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3926; Drentea P, 2002, J AGING HEALTH, V14, P167, DOI 10.1177/089826430201400201; EKERDT DJ, 1983, AM J PUBLIC HEALTH, V73, P779, DOI 10.2105/AJPH.73.7.779; Evenson KR, 2002, AM J EPIDEMIOL, V155, P692, DOI 10.1093/aje/155.8.692; Fahlen G, 2006, INT ARCH OCC ENV HEA, V79, P371, DOI 10.1007/s00420-005-0063-6; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gall TL, 1997, J GERONTOL B-PSYCHOL, V52, pP110, DOI 10.1093/geronb/52B.3.P110; Goldberg M, 2001, AM J EPIDEMIOL, V154, P373, DOI 10.1093/aje/154.4.373; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Goldberg M, 2006, J CLIN EPIDEMIOL, V59, P1213, DOI 10.1016/j.jclinepi.2006.02.020; Goldberg P, 2001, J EPIDEMIOL COMMUN H, V55, P233, DOI 10.1136/jech.55.4.233; Gump BB, 2005, STROKE, V36, P98, DOI 10.1161/01.STR.0000149626.50127.d0; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hardy SE, 2008, J AM GERIATR SOC, V56, P1910, DOI 10.1111/j.1532-5415.2008.01957.x; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Jokela M, 2010, EPIDEMIOLOGY, V21, P284, DOI 10.1097/EDE.0b013e3181d61f53; Mein G, 2003, J EPIDEMIOL COMMUN H, V57, P46, DOI 10.1136/jech.57.1.46; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; Melchior M, 2009, AM J PUBLIC HEALTH, V99, P1417, DOI 10.2105/AJPH.2008.142273; Metzger MH, 2002, J CLIN EPIDEMIOL, V55, P48, DOI 10.1016/S0895-4356(01)00409-7; Mojon-Azzi S, 2007, SWISS MED WKLY, V137, P581; Moncrieff G, 2007, BRIT MED J, V334, P1221, DOI 10.1136/bmj.39182.615405.94; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Vahtera J, 2009, SLEEP, V32, P1459, DOI 10.1093/sleep/32.11.1459; van Solinge H, 2007, RES AGING, V29, P225, DOI 10.1177/0164027506298223; Villamil E, 2006, PSYCHOL MED, V36, P999, DOI 10.1017/S0033291706007719; VOGEL J, 2006, HEALTHIER SOC ANAL A, P267; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1	38	149	150	0	31	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 23	2010	341								c6149	10.1136/bmj.c6149	http://dx.doi.org/10.1136/bmj.c6149			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688DV	21098617	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000284830900010
J	Bertero, MG; Verschueren, E; Paetzold, B; Serrrano, L				Bertero, Michela G.; Verschueren, Erik; Paetzold, Bernhard; Serrrano, Luis			ENHANCED SnapShot: Macromolecular Machines	CELL			English	Editorial Material									[Bertero, Michela G.; Verschueren, Erik; Paetzold, Bernhard; Serrrano, Luis] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Bertero, MG (corresponding author), Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain.		verschueren, erik/D-4436-2015	verschueren, erik/0000-0001-5842-6344; Bertero, Michela/0000-0002-2012-6706; Paetzold, Bernhard/0000-0003-3882-9036				Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750	3	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 12	2010	143	4							652.e1	10.1016/j.cell.2010.10.035	http://dx.doi.org/10.1016/j.cell.2010.10.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074054	Bronze			2022-12-24	WOS:000284149100022
J	Capewell, S; Lloyd-Jones, DM				Capewell, Simon; Lloyd-Jones, Donald M.			Optimal Cardiovascular Prevention Strategies for the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEART-DISEASE MORTALITY		[Lloyd-Jones, Donald M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Lloyd-Jones, Donald M.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA; [Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Liverpool	Lloyd-Jones, DM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	dlj@northwestern.edu	Lloyd-Jones, Donald M/C-5899-2009	Lloyd-Jones, Donald/0000-0003-0847-6110	Medical Research Council [G0500920] Funding Source: Medline; MRC [G0500920] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; National Institute for Health and Clinical Excellence, 2010, NICE PUBL HLTH GUID; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; Rose G., 1992, STRATEGY PREVENTIVE; Zatonski W, 2008, EUR J EPIDEMIOL, V23, P3, DOI 10.1007/s10654-007-9195-1	10	30	32	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2057	2058		10.1001/jama.2010.1641	http://dx.doi.org/10.1001/jama.2010.1641			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063015				2022-12-24	WOS:000284000600025
J	Evers, ACC; Brouwers, HAA; Hukkelhoven, CWPM; Nikkels, PGJ; Boon, J; van Egmond-Linden, A; Hillegersberg, J; Snuif, YS; Sterken-Hooisma, S; Bruinse, HW; Kwee, A				Evers, Annemieke C. C.; Brouwers, Hens A. A.; Hukkelhoven, Chantal W. P. M.; Nikkels, Peter G. J.; Boon, Janine; van Egmond-Linden, Anneke; Hillegersberg, Jacqueline; Snuif, Yvette S.; Sterken-Hooisma, Sietske; Bruinse, Hein W.; Kwee, Anneke			Perinatal mortality and severe morbidity in low and high risk term pregnancies in the Netherlands: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CARE; HEALTH; EUROPE; INDICATORS; BIRTHS; FETAL	Objective To compare incidences of perinatal mortality and severe perinatal morbidity between low risk term pregnancies supervised in primary care by a midwife and high risk pregnancies supervised in secondary care by an obstetrician. Design Prospective cohort study using aggregated data from a national perinatal register. Setting Catchment area of the neonatal intensive care unit (NICU) of the University Medical Center in Utrecht, a region in the centre of the Netherlands covering 13% of the Dutch population. Participants Pregnant women at 37 weeks' gestation or later with a singleton or twin pregnancy without congenital malformations. Main outcome measures Perinatal death (antepartum, intrapartum, and neonatal) or admission to a level 3 NICU. Results During the study period 37 735 normally formed infants were delivered at 37 weeks' gestation or later. Sixty antepartum stillbirths (1.59 (95% confidence interval 1.19 to 1.99) per 1000 babies delivered), 22 intrapartum stillbirths (0.58 (0.34 to 0.83) per 1000 babies delivered), and 210 NICU admissions (5.58 (4.83 to 6.33) per 1000 live births) occurred, of which 17 neonates died (0.45 (0.24 to 0.67) per 1000 live births). The overall perinatal death rate was 2.62 (2.11 to 3.14) per 1000 babies delivered and was significantly higher for nulliparous women compared with multiparous women (relative risk 1.65, 95% confidence interval 1.11 to 2.45). Infants of pregnant women at low risk whose labour started in primary care under the supervision of a midwife had a significant higher risk of delivery related perinatal death than did infants of pregnant women at high risk whose labour started in secondary care under the supervision of an obstetrician (relative risk 2.33, 1.12 to 4.83). NICU admission rates did not differ between pregnancies supervised by a midwife and those supervised by an obstetrician. Infants of women who were referred by a midwife to an obstetrician during labour had a 3.66 times higher risk of delivery related perinatal death than did infants of women who started labour supervised by an obstetrician (relative risk 3.66, 1.58 to 8.46) and a 2.5-fold higher risk of NICU admission (2.51, 1.87 to 3.37). Conclusions Infants of pregnant women at low risk whose labour started in primary care under the supervision of a midwife in the Netherlands had a higher risk of delivery related perinatal death and the same risk of admission to the NICU compared with infants of pregnant women at high risk whose labour started in secondary care under the supervision of an obstetrician. An important limitation of the study is that aggregated data of a large birth registry database were used and adjustment for confounders and clustering was not possible. However, the findings are unexpected and the obstetric care system of the Netherlands needs further evaluation.	[Evers, Annemieke C. C.; Bruinse, Hein W.; Kwee, Anneke] Univ Med Ctr Utrecht, Dept Obstet, NL-3584 EA Utrecht, Netherlands; [Brouwers, Hens A. A.] Univ Med Ctr Utrecht, Dept Neonatol, NL-3584 EA Utrecht, Netherlands; [Hukkelhoven, Chantal W. P. M.] Netherlands Perinatal Registry, Utrecht, Netherlands; [Nikkels, Peter G. J.] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 EA Utrecht, Netherlands; [Boon, Janine] Diakonessenhosp, Dept Obstet & Gynaecol, Utrecht, Netherlands; [van Egmond-Linden, Anneke] Zuwe Hofpoort Hosp, Dept Obstet & Gynaecol, Woerden, Netherlands; [Hillegersberg, Jacqueline] St Antonius Hosp, Dept Pediat, Nieuwegein, Netherlands; [Snuif, Yvette S.] Admiraal de Ruyter Hosp, Dept Obstet & Gynaecol, Goes, Netherlands; [Sterken-Hooisma, Sietske] Meander Med Ctr, Dept Obstet & Gynaecol, Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Diakonessenhuis; St. Antonius Hospital Utrecht; Meander Medisch Centrum	Evers, ACC (corresponding author), Univ Med Ctr Utrecht, Dept Obstet, NL-3584 EA Utrecht, Netherlands.	a.evers@umcutrecht.nl		Hukkelhoven, Chantal/0000-0002-0015-1883				Achterberg P. W., 2005, MEASURING BEST INT D; Amelink-Verburg MP, 2008, BJOG-INT J OBSTET GY, V115, P570, DOI 10.1111/j.1471-0528.2007.01580.x; Anthony S, 2009, PAEDIATR PERINAT EP, V23, P292, DOI 10.1111/j.1365-3016.2009.01044.x; Buitendijk S, 2003, EUR J OBSTET GYN R B, V111, pS66, DOI 10.1016/j.ejogrb.2003.09.007; Buitendijk S E, 2004, Ned Tijdschr Geneeskd, V148, P1855; College voor Zorgverzekeringen, 2003, VERL VAD 2003; de Jonge A, 2009, BJOG-INT J OBSTET GY, V116, P1177, DOI 10.1111/j.1471-0528.2009.02175.x; Merkus J M W M, 2008, Ned Tijdschr Geneeskd, V152, P2707; Mohangoo A D, 2008, Ned Tijdschr Geneeskd, V152, P2718; Ravelli A C J, 2008, Ned Tijdschr Geneeskd, V152, P2728; Richardus JH, 2003, BJOG-INT J OBSTET GY, V110, P97; Wildman K, 2003, EUR J OBSTET GYN R B, V111, pS53, DOI 10.1016/j.ejogrb.2003.09.006; Zeitlin J, 2009, J EPIDEMIOL COMMUN H, V63, P681, DOI 10.1136/jech.2009.087296	13	100	101	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 2	2010	341								c5639	10.1136/bmj.c5639	http://dx.doi.org/10.1136/bmj.c5639			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	678CU	21045050	hybrid			2022-12-24	WOS:000284048200001
J	Annas, GJ				Annas, George J.			Resurrection of a Stem-Cell Funding Barrier - Dickey-Wicker in Court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							POLITICS		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 1996, NEW ENGL J MED, V334, P1329, DOI 10.1056/NEJM199605163342012; Annas GJ, 2004, NATURE, V431, P19, DOI 10.1038/431019a; FLANNERY EJ, 2000, COMMISSIONED PAPERS, V2, pD1; *NAT BIOETH ADV CO, 1999, ETH ISS HUM STEM CEL, V1	4	10	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1687	1689		10.1056/NEJMp1010466	http://dx.doi.org/10.1056/NEJMp1010466			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979467				2022-12-24	WOS:000283546400002
J	Paige, DA; Siegler, MA; Zhang, JA; Hayne, PO; Foote, EJ; Bennett, KA; Vasavada, AR; Greenhagen, BT; Schofield, JT; McCleese, DJ; Foote, MC; DeJong, E; Bills, BG; Hartford, W; Murray, BC; Allen, CC; Snook, K; Soderblom, LA; Calcutt, S; Taylor, FW; Bowles, NE; Bandfield, JL; Elphic, R; Ghent, R; Glotch, TD; Wyatt, MB; Lucey, PG				Paige, David A.; Siegler, Matthew A.; Zhang, Jo Ann; Hayne, Paul O.; Foote, Emily J.; Bennett, Kristen A.; Vasavada, Ashwin R.; Greenhagen, Benjamin T.; Schofield, John T.; McCleese, Daniel J.; Foote, Marc C.; DeJong, Eric; Bills, Bruce G.; Hartford, Wayne; Murray, Bruce C.; Allen, Carlton C.; Snook, Kelly; Soderblom, Laurence A.; Calcutt, Simon; Taylor, Fredric W.; Bowles, Neil E.; Bandfield, Joshua L.; Elphic, Richard; Ghent, Rebecca; Glotch, Timothy D.; Wyatt, Michael B.; Lucey, Paul G.			Diviner Lunar Radiometer Observations of Cold Traps in the Moon's South Polar Region	SCIENCE			English	Article							WATER ICE; MERCURY; STABILITY; SURFACE; POLES	Diviner Lunar Radiometer Experiment surface-temperature maps reveal the existence of widespread surface and near-surface cryogenic regions that extend beyond the boundaries of persistent shadow. The Lunar Crater Observation and Sensing Satellite (LCROSS) struck one of the coldest of these regions, where subsurface temperatures are estimated to be 38 kelvin. Large areas of the lunar polar regions are currently cold enough to cold-trap water ice as well as a range of both more volatile and less volatile species. The diverse mixture of water and high-volatility compounds detected in the LCROSS ejecta plume is strong evidence for the impact delivery and cold-trapping of volatiles derived from primitive outer solar system bodies.	[Paige, David A.; Siegler, Matthew A.; Zhang, Jo Ann; Hayne, Paul O.; Foote, Emily J.; Bennett, Kristen A.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Vasavada, Ashwin R.; Greenhagen, Benjamin T.; Schofield, John T.; McCleese, Daniel J.; Foote, Marc C.; DeJong, Eric; Bills, Bruce G.; Hartford, Wayne] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Murray, Bruce C.] CALTECH, Pasadena, CA 90025 USA; [Allen, Carlton C.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Snook, Kelly] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Soderblom, Laurence A.] US Geol Survey, Flagstaff, AZ 86001 USA; [Calcutt, Simon; Taylor, Fredric W.; Bowles, Neil E.] Univ Oxford, Oxford OX1 3PU, England; [Bandfield, Joshua L.] Univ Washington, Seattle, WA 98195 USA; [Elphic, Richard] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Ghent, Rebecca] Univ Toronto, Toronto, ON M5S 3B1, Canada; [Glotch, Timothy D.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Wyatt, Michael B.] Brown Univ, Providence, RI 02912 USA; [Lucey, Paul G.] Univ Hawaii, Honolulu, HI 96822 USA	University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of the Interior; United States Geological Survey; University of Oxford; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Brown University; University of Hawaii System	Paige, DA (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, 595 Charles E Young Dr E, Los Angeles, CA 90095 USA.	dap@moon.ucla.edu	Greenhagen, Benjamin T/C-3760-2016	Greenhagen, Benjamin T/0000-0002-8252-9922; Bandfield, Joshua/0000-0003-3571-3716; Calcutt, Simon/0000-0002-0102-3170; Hayne, Paul/0000-0003-4399-0449; Taylor, Fred/0000-0002-0675-9769	National Aeronautics and Space Administration; Science and Technology Facilities Council [ST/H00243X/1] Funding Source: researchfish	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the many people at the Jet Propulsion Laboratory and the Goddard Space Flight Center who contributed to the success of the Diviner instrument and the LRO project. We also thank the National Aeronautics and Space Administration for funding this investigation.	Araki H, 2009, SCIENCE, V323, P897, DOI 10.1126/science.1164146; Bills BG, 1999, GEOPHYS RES LETT, V26, P3045, DOI 10.1029/1999GL008348; Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider DH, 2003, ADV SPACE RES, V31, P2293, DOI 10.1016/S0273-1177(03)00530-1; Elphic RC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029954; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; Hansen CJ, 1996, ICARUS, V120, P247, DOI 10.1006/icar.1996.0049; Harmon JK, 2007, SPACE SCI REV, V132, P307, DOI 10.1007/s11214-007-9234-y; Hayne PO, 2010, SCIENCE, V330, P477, DOI 10.1126/science.1197135; HODGES RR, 1980, LUN PLAN SCI C, V11, P2463; INGERSOLL AP, 1992, ICARUS, V100, P40, DOI 10.1016/0019-1035(92)90016-Z; LANGSETH MG, 1976, P LUNAR PLANET SCI C, V7, P3143; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; MITROFANOV I, 2010, LUN PLAN SCI C, V41, P2250; MORGAN TH, 1991, J GEOPHYS RES-SPACE, V96, P1351, DOI 10.1029/90JA02127; Paige DA, 2010, SPACE SCI REV, V150, P125, DOI 10.1007/s11214-009-9529-2; PAIGE DA, 1992, SCIENCE, V258, P643, DOI 10.1126/science.258.5082.643; Schorghofer N, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002779; Schultz PH, 2010, SCIENCE, V330, P468, DOI 10.1126/science.1187454; TAYLOR GJ, 2004, P SPAC RES ROUNDT 6; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; WARD WR, 1975, SCIENCE, V189, P377, DOI 10.1126/science.189.4200.377; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Zhang JA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041806; Zhang JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038614	27	268	272	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					479	482		10.1126/science.1187726	http://dx.doi.org/10.1126/science.1187726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966246				2022-12-24	WOS:000283329100032
J	Shokrollahi, K; Whitaker, IS; Manning, SR; Mannasiev, D; Hiew, LY; Cooper, MACS				Shokrollahi, K.; Whitaker, I. S.; Manning, S. R.; Mannasiev, D.; Hiew, L. Y.; Cooper, M. A. C. S.			10-Minute Consultation Macromastia (large breasts): request for breast reduction	BRITISH MEDICAL JOURNAL			English	Editorial Material							MAMMAPLASTY; SURGERY		[Manning, S. R.] Sandwell Dist Gen Hosp, Lyndon B71 4NU, West Bromwich, England; [Shokrollahi, K.; Whitaker, I. S.; Hiew, L. Y.; Cooper, M. A. C. S.] Morriston Hosp, Welsh Ctr Burns & Plast Surg, Swansea SA6 6NL, W Glam, Wales; [Mannasiev, D.] Yardley Wood, Goodrest Croft Surg, Birmingham B14 4DU, England	Morriston Hospital	Manning, SR (corresponding author), Sandwell Dist Gen Hosp, Lyndon B71 4NU, West Bromwich, England.	stephen.manning@doctors.org.uk	Shokrollahi, Kayvan/V-4993-2019; Whitaker, Iain/O-5896-2019	Shokrollahi, Kayvan/0000-0003-1044-7781; Whitaker, Iain/0000-0002-3922-2079				Dafydd H, 2009, ANN PLAS SURG, V62, P244, DOI 10.1097/SAP.0b013e31817fe502; Greenbaum AR, 2003, BRIT J PLAST SURG, V56, P230, DOI 10.1016/S0007-1226(03)00122-X; Klassen A, 2000, ANN PLAS SURG, V45, P676; Klassen A, 1996, BMJ-BRIT MED J, V313, P454; Klassen A, 1996, BRIT J PLAST SURG, V49, P433, DOI 10.1016/S0007-1226(96)90025-9	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 13	2010	341								c5408	10.1136/bmj.c5408	http://dx.doi.org/10.1136/bmj.c5408			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668FB	20943725	Green Accepted			2022-12-24	WOS:000283252900014
J	Bate, R; Attaran, A				Bate, Roger; Attaran, Amir			A counterfeit drug treaty: great idea, wrong implementation	LANCET			English	Editorial Material									[Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [Attaran, Amir] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [Bate, Roger] Amer Enterprise Inst Publ Policy Res, Washington, DC USA	University of Ottawa; University of Ottawa; American Enterprise Institute for Public Policy Research	Attaran, A (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca						ATTARAN A, WHY MAKE INT CRIME M; Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100; *COUNC EUR, 2010, MEDICRIME DRAFT COUN; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; *ECCP COUNC EUR, 2008, 3 M APR 15; *EUR COMM CRIM PRO, 2009, DRAFT COUNC EUR CONV; Ludwig SP, 2005, DRUG DEV IND PHARM, V31, P215, DOI 10.1081/DDC-200047811; LYNN J, 2010, REUTERS         0512; Mullard A, 2010, LANCET, V375, P1335, DOI 10.1016/S0140-6736(10)60560-0; *US FDA, 2008, UPD QUEST ANSW HEP S; 1929, INT CONV SUPPR COUNT	11	13	13	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2010	376	9751					1446	1448		10.1016/S0140-6736(10)61416-X	http://dx.doi.org/10.1016/S0140-6736(10)61416-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680QC	21036261				2022-12-24	WOS:000284248500008
J	Wolfe-Simon, F; Blum, JS; Kulp, TR; Gordon, GW; Hoeft, SE; Pett-Ridge, J; Stolz, JF; Webb, SM; Weber, PK; Davies, PCW; Anbar, AD; Oremland, RS				Wolfe-Simon, Felisa; Blum, Jodi Switzer; Kulp, Thomas R.; Gordon, Gwyneth W.; Hoeft, Shelley E.; Pett-Ridge, Jennifer; Stolz, John F.; Webb, Samuel M.; Weber, Peter K.; Davies, Paul C. W.; Anbar, Ariel D.; Oremland, Ronald S.			A Bacterium That Can Grow by Using Arsenic Instead of Phosphorus	SCIENCE			English	Article							MARINE	Life is mostly composed of the elements carbon, hydrogen, nitrogen, oxygen, sulfur, and phosphorus. Although these six elements make up nucleic acids, proteins, and lipids and thus the bulk of living matter, it is theoretically possible that some other elements in the periodic table could serve the same functions. Here, we describe a bacterium, strain GFAJ-1 of the Halomonadaceae, isolated from Mono Lake, California, that is able to substitute arsenic for phosphorus to sustain its growth. Our data show evidence for arsenate in macromolecules that normally contain phosphate, most notably nucleic acids and proteins. Exchange of one of the major bio-elements may have profound evolutionary and geochemical importance.	[Wolfe-Simon, Felisa; Davies, Paul C. W.; Anbar, Ariel D.] NASA, Astrobiol Inst, Washington, DC 20546 USA; [Wolfe-Simon, Felisa; Blum, Jodi Switzer; Kulp, Thomas R.; Hoeft, Shelley E.; Oremland, Ronald S.] US Geol Survey, Menlo Pk, CA 94025 USA; [Gordon, Gwyneth W.; Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Pett-Ridge, Jennifer; Weber, Peter K.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Stolz, John F.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Webb, Samuel M.] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Davies, Paul C. W.] Arizona State Univ, BEYOND Ctr Fundamental Concepts Sci, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	National Aeronautics & Space Administration (NASA); United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Duquesne University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wolfe-Simon, F (corresponding author), NASA, Astrobiol Inst, Washington, DC 20546 USA.	felisawolfesimon@gmail.com	, Jennifer Pett RIdge/AFF-7780-2022; Weber, Peter Kilian/AAP-9517-2020; , Jennifer Pett RIdge/AAE-9934-2022; Webb, Samuel M/D-4778-2009	Weber, Peter Kilian/0000-0001-6022-6050; Webb, Samuel M/0000-0003-1188-0464; Webb, Eric/0000-0003-4085-7730; Pett-Ridge, Jennifer/0000-0002-4439-2398	DOE Office of Basic Energy Sciences, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; DOE at Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; DOE OBER [SCW1039]; NASA Exobiology; NASA; NASA Astrobiology Institute at the U.S. Geological Survey, Menlo Park, CA	DOE Office of Basic Energy Sciences, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE at Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); DOE OBER(United States Department of Energy (DOE)); NASA Exobiology(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute at the U.S. Geological Survey, Menlo Park, CA	The authors thank S. Benner, W. Hastings, I. L. ten Kate, A. Pohorille, B. Rosen, D. Schulze-Makuch, and R. Shapiro for stimulating discussions. We thank G. King, A. Oren, and L. Young for constructive criticisms of earlier drafts of this manuscript and S. Baesman, M. Dudash, and L. Miller for technical assistance. Cultures of GFAJ-1 were submitted to the American Type Culture Collection and Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) culture collections on 21 March 2011 and will be available from these sources within several months. Until then, samples of GFAJ-1 are available to the community from the Oremland lab upon completion of a materials transfer agreement, which is required by the U.S. Geological Survey for the transfer of bacterial cultures. Sequence data are deposited with GenBank (accession HQ449183). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a division of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Basic Energy Sciences, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. NanoSIMS analyses were performed under the auspices of the DOE at Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. J.P.R. and P.K.W. were supported in part by the DOE OBER Genomic Sciences program SCW1039. R.S.O. and J.F.S. were supported by NASA Exobiology. F.W.S. acknowledges support from the NASA Postdoctoral Program, NASA Astrobiology/Exobiology, and the NASA Astrobiology Institute while in residence at the U.S. Geological Survey, Menlo Park, CA. The authors declare no conflicts of interest.	BAER CD, 1981, INORG CHEM, V20, P905, DOI 10.1021/ic50217a052; BERG JM, 2007, BIOCHEMISTRY; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HOLBROOK SR, 1985, ACTA CRYSTALLOGR B, V41, P255, DOI 10.1107/S0108768185002087; Jameson G. B., 2007, BIOL INORGANIC CHEM, P354; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Lide D. R., 2009, J AM CHEM SOC, V90th, DOI [DOI 10.1021/JA906434C, DOI 10.1021/acs.est.8b00586]; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; MANDELSTAM J, 1960, BACTERIOL REV, V24, P289, DOI 10.1128/MMBR.24.3.289-308.1960; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Oremland RS, 2004, FEMS MICROBIOL ECOL, V48, P15, DOI 10.1016/j.femsec.2003.12.016; Pickering IJ, 2000, PLANT PHYSIOL, V122, P1171, DOI 10.1104/pp.122.4.1171; Quillaguaman J, 2006, ENZYME MICROB TECH, V38, P148, DOI 10.1016/j.enzmictec.2005.05.013; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Smith PG, 2005, ENVIRON SCI TECHNOL, V39, P248, DOI 10.1021/es049358b; Takeuchi M, 2007, J BIOTECHNOL, V127, P434, DOI 10.1016/j.jbiotec.2006.07.018; Wolfe-Simon F, 2009, INT J ASTROBIOL, V8, P69, DOI 10.1017/S1473550408004394	18	303	312	8	418	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1163	1166		10.1126/science.1197258	http://dx.doi.org/10.1126/science.1197258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21127214	Green Submitted			2022-12-24	WOS:000291205200038
J	Akavia, UD; Litvin, O; Kim, J; Sanchez-Garcia, F; Kotliar, D; Causton, HC; Pochanard, P; Mozes, E; Garraway, LA; Pe'er, D				Akavia, Uri David; Litvin, Oren; Kim, Jessica; Sanchez-Garcia, Felix; Kotliar, Dylan; Causton, Helen C.; Pochanard, Panisa; Mozes, Eyal; Garraway, Levi A.; Pe'er, Dana			An Integrated Approach to Uncover Drivers of Cancer	CELL			English	Article							GENE-EXPRESSION; MELANOMA; MITF; IDENTIFICATION; TRANSFORMATION; INTERFERENCE; REGULATORS; NETWORKS; MODULES; PROTEIN	Systematic characterization of cancer genomes has revealed a staggering number of diverse aberrations that differ among individuals, such that the functional importance and physiological impact of most tumor genetic alterations remain poorly defined. We developed a computational framework that integrates chromosomal copy number and gene expression data for detecting aberrations that promote cancer progression. We demonstrate the utility of this framework using a melanoma data set. Our analysis correctly identified known drivers of melanoma and predicted multiple tumor dependencies. Two dependencies, TBC1D16 and RAB27A, confirmed empirically, suggest that abnormal regulation of protein trafficking contributes to proliferation in melanoma. Together, these results demonstrate the ability of integrative Bayesian approaches to identify candidate drivers with biological, and possibly therapeutic, importance in cancer.	[Akavia, Uri David; Litvin, Oren; Sanchez-Garcia, Felix; Kotliar, Dylan; Causton, Helen C.; Mozes, Eyal; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Akavia, Uri David; Litvin, Oren; Pe'er, Dana] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Kim, Jessica; Pochanard, Panisa; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, Jessica; Pochanard, Panisa; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Columbia University; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	dpeer@biology.columbia.edu	Lin, Jessica J/U-3020-2019; Akavia, Uri David/P-8437-2019	Pe'er, Dana/0000-0002-9259-8817; Causton, Helen/0000-0003-4630-6569	National Institutes of Health Roadmap Initiative; NIH [1-DP2-OD002414-01]; National Centers for Biomedical Computing [1U54CA121852-01A1]; Burroughs Wellcome Fund; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414] Funding Source: NIH RePORTER	National Institutes of Health Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Biomedical Computing; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors will like to thank Nir Hacohen, Antonio Iavarone, Daphne Koller, Liz Miller, Itsik Pe'er, Suzanne Pfeffer, Neal Rosen, and Olga Troyanskaya for valuable comments. This research was supported by the National Institutes of Health Roadmap Initiative, NIH Director's New Innovator Award Program through grant number 1-DP2-OD002414-01, and National Centers for Biomedical Computing Grant 1U54CA121852-01A1. D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Jordens I., 2006, CELL RES, V19, P412; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Sanchez-Garcia F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-189; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang L., 2009, CANCER SCI, V100, P1801; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Ying HQ, 2010, P NATL ACAD SCI USA, V107, P6912, DOI 10.1073/pnas.0914930107; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	42	350	357	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					1005	1017		10.1016/j.cell.2010.11.013	http://dx.doi.org/10.1016/j.cell.2010.11.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21129771	Green Accepted, Bronze			2022-12-24	WOS:000285182600016
J	Seitzinger, S				Seitzinger, Sybil			A sustainable planet needs scientists to think ahead	NATURE			English	Editorial Material									Int Geosphere Biosphere Programme, Stockholm, Sweden		Seitzinger, S (corresponding author), Int Geosphere Biosphere Programme, Stockholm, Sweden.	Sybil.seitzinger@igbp.kva.se							0	4	4	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2010	468	7324					601	601		10.1038/468601a	http://dx.doi.org/10.1038/468601a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	688GB	21124410	Bronze			2022-12-24	WOS:000284836700004
J	Pitman, RK				Pitman, Roger K.			A Recent VA Rules Change and the Traumatic Event Requirement in PTSD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pitman, Roger K.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Pitman, Roger K.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pitman, RK (corresponding author), MGH E, Massachusetts Gen Hosp, 120 2nd Ave, Charlestown, MA 02129 USA.	roger_pitman@hms.harvard.edu						American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; DAO J, 2010, NEW YORK TIMES  1220, pA1; First M.B., 2004, DSM 4 TR GUIDEBOOK; SATEL S, 2010, WALL STREET J   0717, pW3; SHINSEKI E, 2010, US TODAY        0712, pA9; US Department of Veterans Affairs, 2010, FED REGISTER, P39843; WEATHERS FA, 2009, PRACTICE GUIDELINES, P23	8	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2409	2410		10.1001/jama.2010.1739	http://dx.doi.org/10.1001/jama.2010.1739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119089				2022-12-24	WOS:000284763900024
J	Culler, SJ; Hoff, KG; Smolke, CD				Culler, Stephanie J.; Hoff, Kevin G.; Smolke, Christina D.			Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins	SCIENCE			English	Article							KAPPA-B; EXPRESSION; SELECTION; ACTIVATION; EVOLUTION; MICRORNA; APTAMER	Synthetic genetic devices that interface with native cellular pathways can be used to change natural networks to implement new forms of control and behavior. The engineering of gene networks has been limited by an inability to interface with native components. We describe a class of RNA control devices that overcome these limitations by coupling increased abundance of particular proteins to targeted gene expression events through the regulation of alternative RNA splicing. We engineered RNA devices that detect signaling through the nuclear factor kappa B and Wnt signaling pathways in human cells and rewire these pathways to produce new behaviors, thereby linking disease markers to noninvasive sensing and reprogrammed cellular fates. Our work provides a genetic platform that can build programmable sensing-actuation devices enabling autonomous control over cellular behavior.	[Culler, Stephanie J.; Hoff, Kevin G.; Smolke, Christina D.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Smolke, Christina D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California Institute of Technology; Stanford University	Smolke, CD (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 210-41, Pasadena, CA 91125 USA.	csmolke@stanford.edu	Taylor, Graham/A-4027-2012		Caltech Joseph Jacobs Institute for Molecular Engineering for Medicine; NIH; U.S. Department of Defense; Alfred P. Sloan Foundation; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091298] Funding Source: NIH RePORTER	Caltech Joseph Jacobs Institute for Molecular Engineering for Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hertel for providing the pHis-BIVT-MS2-RSp55 construct, M. Jensen for providing pCD19t-Tk-T2A-IL15op_epHIV7, L. J. Maher for providing pGAD24, and B. Stewart for laboratory assistance. This work was supported by the Caltech Joseph Jacobs Institute for Molecular Engineering for Medicine (grant to C. D. S.), the NIH (fellowship to K. G. H., grant to C. D. S.), the U.S. Department of Defense (grant to C. D. S.), the Alfred P. Sloan Foundation (fellowship to C. D. S.), and the Bill and Melinda Gates Foundation (grant to C. D. S.). The authors have filed for a patent related to this work.	Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Beltinger C, 1999, P NATL ACAD SCI USA, V96, P8699, DOI 10.1073/pnas.96.15.8699; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; CAREY J, 1983, BIOCHEMISTRY-US, V22, P4723, DOI 10.1021/bi00289a017; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chan R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj028; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Culler SJ, 2010, NUCLEIC ACIDS RES, V38, P5152, DOI 10.1093/nar/gkq248; Davidson EA, 2007, NAT CHEM BIOL, V3, P23, DOI 10.1038/nchembio846; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Hellweg CE, 2006, ANN NY ACAD SCI, V1091, P191, DOI 10.1196/annals.1378.066; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kim DS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-23; Lee HK, 2007, CANCER RES, V67, P9315, DOI 10.1158/0008-5472.CAN-07-1128; Lifang Yang, 2008, J Exp Clin Cancer Res, V27, P42, DOI 10.1186/1756-9966-27-42; Link KH, 2009, GENE THER, V16, P1189, DOI 10.1038/gt.2009.81; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mi J, 2006, NUCLEIC ACIDS RES, V34, P3577, DOI 10.1093/nar/gkl482; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Song Y, 2006, INT J GYNECOL CANCER, V16, P156, DOI 10.1111/j.1525-1438.2006.00470.x; Suess B, 2008, RNA BIOL, V5, P24, DOI 10.4161/rna.5.1.5955; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Villemaire J, 2003, J BIOL CHEM, V278, P50031, DOI 10.1074/jbc.M308897200; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011; Wurster SE, 2008, RNA, V14, P1037, DOI 10.1261/rna.878908	30	206	218	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1251	1255		10.1126/science.1192128	http://dx.doi.org/10.1126/science.1192128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109673	Green Accepted			2022-12-24	WOS:000284613700044
J	Ganten, D; Haines, A; Souhami, R				Ganten, Detlev; Haines, Andy; Souhami, Robert			Health co-benefits of policies to tackle climate change	LANCET			English	Editorial Material							STRATEGIES		[Ganten, Detlev] German Natl Acad Sci Leopoldina, D-06108 Halle, Germany; [Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Souhami, Robert] Acad Med Sci, London, England	University of London; London School of Hygiene & Tropical Medicine	Ganten, D (corresponding author), German Natl Acad Sci Leopoldina, D-06108 Halle, Germany.	detlev.ganten@charite.de		Haines, Andy/0000-0002-8053-4605				*AC MED SCI, 2009, MIT CLIM CHANG IMPR; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Gill M, 2009, LANCET, V374, P1953, DOI 10.1016/S0140-6736(09)61830-4; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; *INT MED PAN, 2010, STAT HLTH COB POL TA; Markandya A, 2009, LANCET, V374, P2006, DOI 10.1016/S0140-6736(09)61715-3; NHS Sustainable Development Unit, 2008, NHS ENGL CARB EM CAR; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Stern N., 2007, EC CLIMATE CHANGE; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	11	28	28	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2010	376	9755					1802	1804		10.1016/S0140-6736(10)62139-3	http://dx.doi.org/10.1016/S0140-6736(10)62139-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KG	21111893				2022-12-24	WOS:000285439700005
J	Devos, DP; Reynaud, EG				Devos, Damien P.; Reynaud, Emmanuel G.			Intermediate Steps	SCIENCE			English	Editorial Material							COMPARATIVE GENOMICS; BUDDING BACTERIA; RIBOSOMAL-RNA; CELL-WALL; EUKARYOTES; MEMBRANE; ARCHAEA; ORIGIN; VERRUCOMICROBIA; PLANCTOMYCES		[Devos, Damien P.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Reynaud, Emmanuel G.] UCD Sci Ctr, Sch Biol & Environm Sci, Dublin 4, Ireland	European Molecular Biology Laboratory (EMBL)	Devos, DP (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	devos@embl.de; emmanuel.reynaud@ucd.ie	Reynaud, Emamnuel/H-2928-2019; devos, damien/ABH-5348-2020	Reynaud, Emamnuel/0000-0003-1502-661X; Devos, Damien/0000-0002-9453-4753				Aravind L, 2006, CURR OPIN STRUC BIOL, V16, P409, DOI 10.1016/j.sbi.2006.04.006; Bauer M, 2004, J MOL EVOL, V59, P571, DOI 10.1007/s00239-004-2643-6; Chistoserdova L, 2004, MOL BIOL EVOL, V21, P1234, DOI 10.1093/molbev/msh113; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; FERST JA, 1991, P NATL ACAD SCI USA, V88, P8184; Forterre P, 2011, RES MICROBIOL, V162, P77, DOI 10.1016/j.resmic.2010.10.005; Fuerst JA, 1998, FEMS MICROBIOL LETT, V166, P29, DOI 10.1111/j.1574-6968.1998.tb13179.x; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; HACKSTADT T, 1991, P NATL ACAD SCI USA, V88, P3937, DOI 10.1073/pnas.88.9.3937; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; KERGER BD, 1988, ARCH MICROBIOL, V149, P255, DOI 10.1007/BF00422014; KONIG E, 1984, ARCH MICROBIOL, V138, P200, DOI 10.1007/BF00402120; Lee KC, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-4; Lee KC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-5; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Pearson A, 2003, P NATL ACAD SCI USA, V100, P15352, DOI 10.1073/pnas.2536559100; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Pilhofer M, 2008, J BACTERIOL, V190, P3192, DOI 10.1128/JB.01797-07; Pilhofer M, 2007, MOL BIOL EVOL, V24, P1439, DOI 10.1093/molbev/msm069; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; SANCHEZAMAT A, 1990, APPL ENVIRON MICROB, V56, P2717; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Wachtershauser G, 2003, MOL MICROBIOL, V47, P13, DOI 10.1046/j.1365-2958.2003.03267.x; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yee B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-37	30	60	60	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1187	1188		10.1126/science.1196720	http://dx.doi.org/10.1126/science.1196720			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109658				2022-12-24	WOS:000284613700025
J	Shah, ND; Montori, VM; Krumholz, HM; Tu, K; Alexander, GC; Jackevicius, CA				Shah, Nilay D.; Montori, Victor M.; Krumholz, Harlan M.; Tu, Karen; Alexander, G. Caleb; Jackevicius, Cynthia A.			Responding to an FDA Warning - Geographic Variation in the Use of Rosiglitazone.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shah, Nilay D.; Montori, Victor M.] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Tu, Karen; Jackevicius, Cynthia A.] Univ Toronto, Toronto, ON, Canada; [Tu, Karen] Toronto Western Hosp, Family Hlth Team, Toronto, ON M5T 2S8, Canada; [Tu, Karen; Jackevicius, Cynthia A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Alexander, G. Caleb] Univ Chicago, Chicago, IL 60637 USA; [Alexander, G. Caleb] Univ Illinois, Chicago Sch Pharm, Chicago, IL USA; [Jackevicius, Cynthia A.] Western Univ Hlth Sci, Los Angeles, CA USA; [Jackevicius, Cynthia A.] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA	Mayo Clinic; Yale University; Yale University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Western University of Health Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Shah, ND (corresponding author), Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA.		, Harlan/AAI-2875-2020					Congress of The United States Congressional Budget Office, 2008, GEOGR VAR HLTH CAR S; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Wagner AK, 2006, PHARMACOEPIDEM DR S, V15, P369, DOI 10.1002/pds.1193; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344	6	53	53	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2081	2084		10.1056/NEJMp1011042	http://dx.doi.org/10.1056/NEJMp1011042			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684XE	21083379	Bronze			2022-12-24	WOS:000284587800001
J	Adeyi, O; Atun, R				Adeyi, Olusoji; Atun, Rifat			Universal access to malaria medicines: innovation in financing and delivery	LANCET			English	Editorial Material									[Adeyi, Olusoji; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Adeyi, O (corresponding author), Global Fund Fight AIDS TB & Malaria, Chemin Blandonnet 8, CH-1214 Geneva, Switzerland.	Olusoji.Adeyi@Theglobalfund.org	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				ACTwatch Group, 2009, 5 PAN AFR MAL C NAIR; AMFm Task Force of the Roll Back Malaria Partnership, 2007, AFF MED FAC MAL AMFM; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2010, ECONOMIST       0107; Arrow Kenneth J., 2004, SAV LIV BUYING TIM E; Frost L, 2009, PROCESS EVALUATION P; *GLOB FUND, 2009, 5 YEAR EV GLOB FUND; Gwatkin D. R., 2005, REACHING POOR HLTH N; Laxminarayan R, 2006, HEALTH AFFAIR, V25, P325, DOI 10.1377/hlthaff.25.2.325; Laxminarayan R, 2009, HEALTH AFFAIR, V28, P949, DOI 10.1377/hlthaff.28.4.949; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; President's Malaria Initiative, PRES MAL IN; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; The Global Fund, 2009, GLOB FUND 5 YEAR EV; The Global Fund, 2010, AFF MED FAC MAL FREQ; The World Bank, 2010, COUNT MAL OUT JUN 4; WHO, 2006, GUID TREATM MAL; WHO, 2010, GUID TREATM MAL, V2nd	20	33	33	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1869	1871		10.1016/S0140-6736(10)61189-0	http://dx.doi.org/10.1016/S0140-6736(10)61189-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KG	20940074				2022-12-24	WOS:000285439700036
J	Hu, FH; Luo, WB; Hong, M				Hu, Fanghao; Luo, Wenbin; Hong, Mei			Mechanisms of Proton Conduction and Gating in Influenza M2 Proton Channels from Solid-State NMR	SCIENCE			English	Article							A VIRUS; ION-CHANNEL; TAUTOMERIC EQUILIBRIA; TRANSMEMBRANE PEPTIDE; BINDING-SITE; ACID-BASE; H-BOND; HISTIDINE; MODEL; SPECTROSCOPY	The M2 protein of influenza viruses forms an acid-activated tetrameric proton channel. We used solid-state nuclear magnetic resonance spectroscopy to determine the structure and functional dynamics of the pH-sensing and proton-selective histidine-37 in M2 bound to a cholesterol-containing virus-envelope-mimetic membrane so as to better understand the proton conduction mechanism. In the high-pH closed state, the four histidines form an edge-face p-stacked structure, preventing the formation of a hydrogen-bonded water chain to conduct protons. In the low-pH conducting state, the imidazoliums hydrogen-bond extensively with water and undergo microsecond ring reorientations with an energy barrier greater than 59 kilojoules per mole. This barrier is consistent with the temperature dependence of proton conductivity, suggesting that histidine-37 dynamically shuttles protons into the virion. We propose a proton conduction mechanism in which ring-flip-assisted imidazole deprotonation is the rate-limiting step.	[Hu, Fanghao; Luo, Wenbin; Hong, Mei] Iowa State Univ, Dept Chem, Ames, IA 50011 USA	Iowa State University	Hong, M (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	mhong@iastate.edu		Hong, Mei/0000-0001-5255-5858	NSF [MCB-543473]; NIH [GM088204]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088204] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Li for discussions. This work was supported by NSF grant MCB-543473 and NIH grant GM088204.	Ash EL, 2000, P NATL ACAD SCI USA, V97, P10371, DOI 10.1073/pnas.97.19.10371; BACHOVCHIN WW, 1978, J AM CHEM SOC, V100, P8041, DOI 10.1021/ja00494a001; Brinen LS, 1996, BIOCHEMISTRY-US, V35, P5999, DOI 10.1021/bi9530200; Bureekaew S, 2009, NAT MATER, V8, P831, DOI [10.1038/NMAT2526, 10.1038/nmat2526]; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Cady SD, 2009, BIOCHEMISTRY-US, V48, P7356, DOI 10.1021/bi9008837; Chen HN, 2007, BIOPHYS J, V93, P3470, DOI 10.1529/biophysj.107.105742; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Fischbach I, 2004, J PHYS CHEM B, V108, P18500, DOI 10.1021/jp046848h; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; Henry B, 2002, J AM CHEM SOC, V124, P2025, DOI 10.1021/ja011638t; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Khurana E, 2009, P NATL ACAD SCI USA, V106, P1069, DOI 10.1073/pnas.0811720106; Lin TI, 2001, J VIROL, V75, P3647, DOI 10.1128/JVI.75.8.3647-3656.2001; Luo WB, 2007, J PHYS CHEM B, V111, P10825, DOI 10.1021/jp073823k; Luo WB, 2010, J AM CHEM SOC, V132, P2378, DOI 10.1021/ja9096219; Luo WB, 2009, BIOCHEMISTRY-US, V48, P6361, DOI 10.1021/bi900716s; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; MUNOWITZ M, 1982, J AM CHEM SOC, V104, P1192, DOI 10.1021/ja00369a007; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Okada A, 2001, BIOCHEMISTRY-US, V40, P6053, DOI 10.1021/bi0028441; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Scheiner S, 2002, J AM CHEM SOC, V124, P13257, DOI 10.1021/ja027200q; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Song XJ, 2001, MAGN RESON CHEM, V39, pS30, DOI 10.1002/mrc.956; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m; Yi MG, 2009, P NATL ACAD SCI USA, V106, P13311, DOI 10.1073/pnas.0906553106	34	254	258	8	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					505	508		10.1126/science.1191714	http://dx.doi.org/10.1126/science.1191714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966251	Green Accepted			2022-12-24	WOS:000283329100040
J	Rimer, JD; An, ZH; Zhu, ZN; Lee, MH; Goldfarb, DS; Wesson, JA; Ward, MD				Rimer, Jeffrey D.; An, Zhihua; Zhu, Zina; Lee, Michael H.; Goldfarb, David S.; Wesson, Jeffrey A.; Ward, Michael D.			Crystal Growth Inhibitors for the Prevention of L-Cystine Kidney Stones Through Molecular Design	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; CALCIUM-OXALATE MONOHYDRATE; HEXAGONAL L-CYSTINE; MALARIA PIGMENT; CRYSTALLIZATION; NUCLEATION; ADDITIVES; BINDING; MODEL; DIMETHYLESTER	Crystallization of L-cystine is a critical step in the pathogenesis of cystine kidney stones. Treatments for this disease are somewhat effective but often lead to adverse side effects. Real-time in situ atomic force microscopy (AFM) reveals that L-cystine dimethylester (L-CDME) and L-cystine methylester (L-CME) dramatically reduce the growth velocity of the six symmetry-equivalent {100} steps because of specific binding at the crystal surface, which frustrates the attachment of L-cystine molecules. L-CDME and L-CME produce L-cystine crystals with different habits that reveal distinct binding modes at the crystal surfaces. The AFM observations are mirrored by reduced crystal yield and crystal size in the presence of L-CDME and L-CME, collectively suggesting a new pathway to the prevention of L-cystine stones by rational design of crystal growth inhibitors.	[Rimer, Jeffrey D.; An, Zhihua; Zhu, Zina; Lee, Michael H.; Ward, Michael D.] NYU, Dept Chem, New York, NY 10003 USA; [Rimer, Jeffrey D.; An, Zhihua; Zhu, Zina; Lee, Michael H.; Ward, Michael D.] NYU, Inst Mol Design, New York, NY 10003 USA; [Goldfarb, David S.] New York Harbor Vet Affairs Med Ctr, Nephrol Sect, New York, NY 10010 USA; [Goldfarb, David S.] NYU, Sch Med, New York, NY 10010 USA; [Wesson, Jeffrey A.] Dept Vet Affairs Med Ctr, Div Nephrol, Milwaukee, WI 53295 USA; [Wesson, Jeffrey A.] Med Coll Wisconsin, Milwaukee, WI 53295 USA	New York University; New York University; New York University; Medical College of Wisconsin	Ward, MD (corresponding author), NYU, Dept Chem, 100 Washington Sq E, New York, NY 10003 USA.	mdw3@nyu.edu	Wesson, Jeffrey/ABA-8942-2021; An, Zhihua/A-6662-2009	Lee, Michael/0000-0002-5739-8369; Goldfarb, David/0000-0002-9215-1273	NIH [NIDDK R01-DK068551]; NYU Molecular Design Institute; Office of Rare Disease Research [1U54DK083908-01]; NSF/U.S. Department of Energy (DOE) (NSF/DOE) [CHE-0535644]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK083908, R01DK068551] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0822838] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU Molecular Design Institute; Office of Rare Disease Research; NSF/U.S. Department of Energy (DOE) (NSF/DOE)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported primarily by NIH (NIDDK R01-DK068551) and the NYU Molecular Design Institute. The authors also acknowledge support from the Office of Rare Disease Research (1U54DK083908-01) and the Advanced Photon Source, ChemMatCARS Sector 15, which is principally supported by NSF/U.S. Department of Energy (DOE) (NSF/DOE; CHE-0535644). The authors thank C. Hu, M. Li, Y.-S. Chen, and G. Kowach for technical assistance and B. Kahr for helpful discussions.	Ahmed K, 2006, POSTGRAD MED J, V82, P799, DOI 10.1136/pgmj.2005.044156; Becker G, 2007, NEPHROLOGY, V12, pS4, DOI 10.1111/j.1440-1797.2006.00722.x; Buller R, 2002, CRYST GROWTH DES, V2, P553, DOI 10.1021/cg025550i; Carta R, 1996, J CHEM ENG DATA, V41, P414, DOI 10.1021/je9501853; CHANEY MO, 1974, ACTA CRYSTALLOGR B, V30, P711, DOI 10.1107/S0567740874003566; Clydesdale G, 2003, J PHYS CHEM B, V107, P4826, DOI 10.1021/jp022423o; Dahaoui S, 1999, J PHYS CHEM A, V103, P6240, DOI 10.1021/jp990641k; DAVEY RJ, 1992, J CHEM SOC FARADAY T, V88, P3461, DOI 10.1039/ft9928803461; Dolin DJ, 2005, J ENDOUROL, V19, P429, DOI 10.1089/end.2005.19.429; FOREMAN JW, 1987, METABOLISM, V36, P1185, DOI 10.1016/0026-0495(87)90246-0; Fujiki Y, 2006, ANGEW CHEM INT EDIT, V45, P4764, DOI 10.1002/anie.200601470; GIRIJA EK, 1995, J MATER SCI-MATER M, V6, P617, DOI 10.1007/BF00123439; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+; HILLIER AC, 1994, SCIENCE, V263, P1261, DOI 10.1126/science.263.5151.1261; Jung T, 2004, LANGMUIR, V20, P8587, DOI 10.1021/la0488755; Kessler A, 2008, NEUROCHEM RES, V33, P737, DOI 10.1007/s11064-007-9486-7; LEVITT LS, 1975, INDIAN J PHYS, V49, P696; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Mattoo A, 2008, SEMIN NEPHROL, V28, P181, DOI 10.1016/j.semnephrol.2008.01.011; MICHAELS AS, 1961, J PHYS CHEM-US, V65, P1730, DOI 10.1021/j100827a014; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Nakagawa Y, 2000, J UROLOGY, V164, P1481, DOI 10.1016/S0022-5347(05)67011-5; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; OUGHTON BM, 1959, ACTA CRYSTALLOGR, V12, P396, DOI 10.1107/S0365110X59001177; Sheng XX, 2005, P NATL ACAD SCI USA, V102, P267, DOI 10.1073/pnas.0406835101; Sizemore JP, 2009, CRYST GROWTH DES, V9, P2637, DOI 10.1021/cg8011124; Solomonov I, 2007, J AM CHEM SOC, V129, P2615, DOI 10.1021/ja0674183; Stephenson AE, 2008, SCIENCE, V322, P724, DOI 10.1126/science.1159417; Tiller W. A., 1991, SCI CRYSTALLIZATION; Ward MD, 2001, CHEM REV, V101, P1697, DOI 10.1021/cr000020j; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Weissbuch I, 2003, CRYST GROWTH DES, V3, P125, DOI 10.1021/cg0200560; Wilmer MJ, 2007, PEDIATR RES, V62, P151, DOI 10.1203/PDR.0b013e31809fd9a7	34	155	159	4	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					337	341		10.1126/science.1191968	http://dx.doi.org/10.1126/science.1191968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947757	Green Accepted			2022-12-24	WOS:000282986700032
J	Ruschak, AM; Religa, TL; Breuer, S; Witt, S; Kay, LE				Ruschak, Amy M.; Religa, Tomasz L.; Breuer, Sarah; Witt, Susanne; Kay, Lewis E.			The proteasome antechamber maintains substrates in an unfolded state	NATURE			English	Article							SIDE-CHAIN DYNAMICS; 20S PROTEASOME; NMR-SPECTROSCOPY; FOLDING PATHWAY; METHYL-GROUPS; BETA-SHEET; WW DOMAIN; RELAXATION; PROTEIN; MECHANISM	Eukaryotes and archaea use a protease called the proteasome that has an integral role in maintaining cellular function through the selective degradation of proteins(1-4). Proteolysis occurs in a barrelshaped 20S core particle, which in Thermoplasma acidophilum is built from four stacked homoheptameric rings of subunits, alpha and beta, arranged alpha(7)beta(7)beta(7)alpha(7) (ref. 5). These rings form three interconnected cavities, including a pair of antechambers (formed by alpha(7)beta(7)) through which substrates are passed before degradation and a catalytic chamber (beta(7)beta(7)) where the peptide-bond hydrolysis reaction occurs(4,5). Although it is clear that substrates must be unfolded to enter through narrow, gated passageways (13 angstrom in diameter) located on the alpha-rings(1,6,7), the structural and dynamical properties of substrates inside the proteasome antechamber remain unclear. Confinement in the antechamber might be expected to promote folding and thus impede proteolysis. Here we investigate the folding, stability and dynamics of three small protein substrates in the antechamber by methyl transverse-relaxation-optimized NMR spectroscopy(8). We show that these substrates interact actively with the antechamber walls and have drastically altered kinetic and equilibrium properties that maintain them in unstructured states so as to be accessible for hydrolysis.	[Ruschak, Amy M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ruschak, Amy M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Biochem & Chem, Toronto, ON M5S 1A8, Canada; [Breuer, Sarah; Witt, Susanne] Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	University of Toronto; University of Toronto; Max Planck Society	Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca			European Molecular Biology Organization [ALTF 827-2006]; Canadian Institutes of Health Research (CIHR); Canada Research Chair in Biochemistry; Natural Sciences and Engineering Research Council of Canada	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemistry(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors would like to thank J. Forman-Kay for providing laboratory space and for discussions, R. Muhandiram for NMR support, H. Lin for help designing protein purification protocols, X. Li and A. Shimmer for assistance with the plate reader, and W. Baumeister for discussions. T. L. R. acknowledges The European Molecular Biology Organization (ALTF 827-2006) and The Canadian Institutes of Health Research (CIHR) for postdoctoral fellowships. L. E. K. holds a Canada Research Chair in Biochemistry. This work was supported by grants from the CIHR and the Natural Sciences and Engineering Research Council of Canada.	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Cheng AG, 2009, OLIGONUCLEOTIDES, V19, P203, DOI 10.1089/oli.2008.0176; Choy WY, 2003, J AM CHEM SOC, V125, P1748, DOI 10.1021/ja021179b; Clore GM, 2007, CURR OPIN STRUC BIOL, V17, P603, DOI 10.1016/j.sbi.2007.08.013; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ellis RJ, 2003, CURR BIOL, V13, pR881, DOI 10.1016/j.cub.2003.10.051; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Forster A, 2003, TRENDS CELL BIOL, V13, P550, DOI 10.1016/j.tcb.2003.09.001; Hutschenreiter S, 2004, EMBO J, V23, P2488, DOI 10.1038/sj.emboj.7600262; Jager M, 2006, P NATL ACAD SCI USA, V103, P10648, DOI 10.1073/pnas.0600511103; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; Jager M, 2008, BIOPOLYMERS, V90, P751, DOI 10.1002/bip.21101; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; MATSUNAGA N, 1977, J PHYS CHEM-US, V6, P1133; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; Sharon M, 2006, J BIOL CHEM, V281, P9569, DOI 10.1074/jbc.M511951200; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stollar EJ, 2003, J BIOL CHEM, V278, P43699, DOI 10.1074/jbc.M308029200; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Tugarinov V, 2007, J AM CHEM SOC, V129, P1743, DOI 10.1021/ja067827z; Tugarinov V, 2006, J AM CHEM SOC, V128, P7299, DOI 10.1021/ja060817d; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	34	93	93	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					868	U142		10.1038/nature09444	http://dx.doi.org/10.1038/nature09444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944750				2022-12-24	WOS:000282898700072
J	Sacco, A; Mourkioti, F; Tran, R; Choi, J; Llewellyn, M; Kraft, P; Shkreli, M; Delp, S; Pomerantz, JH; Artandi, SE; Blau, HM				Sacco, Alessandra; Mourkioti, Foteini; Tran, Rose; Choi, Jinkuk; Llewellyn, Michael; Kraft, Peggy; Shkreli, Marina; Delp, Scott; Pomerantz, Jason H.; Artandi, Steven E.; Blau, Helen M.			Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice	CELL			English	Article							MEDIATED GENE-THERAPY; SKELETAL-MUSCLE REGENERATION; REPLICATIVE LIFE-SPAN; SELF-RENEWAL; HUMAN LIVER; SPINAL DEFORMITY; SATELLITE CELLS; MITOTIC CLOCK; MOUSE; MDX	In Duchenne muscular dystrophy (DMD), dystrophin mutation leads to progressive lethal skeletal muscle degeneration. For unknown reasons, dystrophin deficiency does not recapitulate DMD in mice (mdx), which have mild skeletal muscle defects and potent regenerative capacity. We postulated that human DMD progression is a consequence of loss of functional muscle stem cells (MuSC), and the mild mouse mdx phenotype results from greater MuSC reserve fueled by longer telomeres. We report that mdx mice lacking the RNA component of telomerase (mdx/mTR) have shortened telomeres in muscle cells and severe muscular dystrophy that progressively worsens with age. Muscle wasting severity parallels a decline in MuSC regenerative capacity and is ameliorated histologically by transplantation of wild-type MuSC. These data show that DMD progression results, in part, from a cell-autonomous failure of MuSC to maintain the damage-repair cycle initiated by dystrophin deficiency. The essential role of MuSC function has therapeutic implications for DMD.	[Sacco, Alessandra; Mourkioti, Foteini; Tran, Rose; Kraft, Peggy; Pomerantz, Jason H.; Blau, Helen M.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med,Sch Med, Stanford, CA 94305 USA; [Choi, Jinkuk; Shkreli, Marina; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Canc Biol Program, Stanford, CA 94305 USA; [Llewellyn, Michael; Delp, Scott] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, BioX Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pomerantz, JH (corresponding author), Univ Calif San Francisco, Div Plast & Reconstruct Surg, Craniofacial & Mesenchymal Biol Program, Eli & Edythe Broad Ctr Regenerat Med,Dept Surg, San Francisco, CA 94143 USA.	jason.pomerantz@ucsfmedctr.org; hblau2@stanford.edu		Choi, Jinkuk/0000-0002-2449-8291; Mourkioti, Foteini/0000-0002-7119-6640; Delp, Scott/0000-0002-9643-7551	American Heart Association [10SDG3510024]; NIH [AG009521, AG020961]; Muscular Dystrophy Association [4320]; Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG009521, R01AG020961] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Kassie Koleckar for excellent technical support; Fabio Rossi for providing the alpha 7-integrin-PE-conjugated antibody; Jackie Kustan for help with the scheme; and Frezghi Habte at the Stanford Small Imaging Facility for help with the CT-Scan. This work was supported by American Heart Association Scientist Development Grant 10SDG3510024 to F. M.; NIH grants AG009521 and AG020961; Muscular Dystrophy Association grant 4320; and the Baxter Foundation to H.M.B.	Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HARRIS JB, 1981, TOXICON, V19, P419, DOI 10.1016/0041-0101(81)90046-5; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; ODA T, 1993, J PEDIATR ORTHOPED, V13, P478, DOI 10.1097/01241398-199307000-00012; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Renault V, 2002, EXP GERONTOL, V37, P1513, DOI 10.1016/S0531-5565(02)00095-5; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533; VAZIRI H, 1993, AM J HUM GENET, V52, P661; WEBSTER C, 1986, HUM GENET, V74, P74; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Westerman KA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-96; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; WILKINS KE, 1976, J BONE JOINT SURG AM, V58, P24, DOI 10.2106/00004623-197658010-00004; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; ZATZ M, 1991, J NEUROL SCI, V102, P190, DOI 10.1016/0022-510X(91)90068-I	57	338	348	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1059	1071		10.1016/j.cell.2010.11.039	http://dx.doi.org/10.1016/j.cell.2010.11.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21145579	Green Accepted, Bronze			2022-12-24	WOS:000285625400005
J	Canfield, DE; Stewart, FJ; Thamdrup, B; De Brabandere, L; Dalsgaard, T; Delong, EF; Revsbech, NP; Ulloa, O				Canfield, Don E.; Stewart, Frank J.; Thamdrup, Bo; De Brabandere, Loreto; Dalsgaard, Tage; Delong, Edward F.; Revsbech, Niels Peter; Ulloa, Osvaldo			A Cryptic Sulfur Cycle in Oxygen-Minimum-Zone Waters off the Chilean Coast	SCIENCE			English	Article							NITRATE REDUCTION; SULFATE-REDUCTION; MOLECULAR ANALYSIS; HYDROGEN-SULFIDE; PROKARYOTES; PHYLOGENY; DIVERSITY; OXIDATION; SEDIMENTS; SYMBIONT	Nitrogen cycling is normally thought to dominate the biogeochemistry and microbial ecology of oxygen-minimum zones in marine environments. Through a combination of molecular techniques and process rate measurements, we showed that both sulfate reduction and sulfide oxidation contribute to energy flux and elemental cycling in oxygen-free waters off the coast of northern Chile. These processes may have been overlooked because in nature, the sulfide produced by sulfate reduction immediately oxidizes back to sulfate. This cryptic sulfur cycle is linked to anammox and other nitrogen cycling processes, suggesting that it may influence biogeochemical cycling in the global ocean.	[Canfield, Don E.; Thamdrup, Bo; De Brabandere, Loreto] Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; [Canfield, Don E.; Thamdrup, Bo; De Brabandere, Loreto] Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark; [Stewart, Frank J.; Delong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02138 USA; [Stewart, Frank J.; Delong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02138 USA; [Dalsgaard, Tage] Aarhus Univ, Natl Environm Res Inst, DK-8600 Silkeborg, Denmark; [Revsbech, Niels Peter] Aarhus Univ, Dept Biol Sci, Microbiol Sect, DK-8000 Aarhus C, Denmark; [Ulloa, Osvaldo] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Ulloa, Osvaldo] Univ Concepcion, Ctr Invest Oceanog Pacifico Sur Oriental, Concepcion, Chile	University of Southern Denmark; University of Southern Denmark; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Aarhus University; Aarhus University; Universidad de Concepcion; Universidad de Concepcion	Canfield, DE (corresponding author), Univ So Denmark, Inst Biol, Campusvej 55, DK-5230 Odense M, Denmark.	dec@biology.sdu.dk	Canfield, Don/C-1735-2012; Ulloa, Osvaldo/E-1821-2011; Revsbech, Niels P/I-8040-2013; Thamdrup, Bo/F-3889-2016; De Brabandere, Loreto C/A-8134-2014; Dalsgaard, Tage/J-6258-2014	Canfield, Don/0000-0001-7602-8366; Ulloa, Osvaldo/0000-0002-9501-5576; Thamdrup, Bo/0000-0002-1221-7077; Dalsgaard, Tage/0000-0003-2604-6499; Revsbech, Niels Peter/0000-0002-2193-262X	Agouron Institute; Danish National Research Foundation; Gordon and Betty Moore Foundation; Chilean Fondap Program	Agouron Institute(Pfizer); Danish National Research Foundation(Danmarks Grundforskningsfond); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Chilean Fondap Program(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	We thank the captain and crew of the Agor Vidal Gormaz from the Chilean Navy for their kind support, and the Agouron Institute, the Danish National Research Foundation, the Gordon and Betty Moore Foundation, and the Chilean Fondap Program for financial support. Additional thanks to G. Alarcon, G. Friederich, and J. Jennings for operational and experimental support. The genome sequence data are accessible on NCBI's Sequence Read Archive via accession number SRA025088.	ALBERT DB, 1995, DEEP-SEA RES PT I, V42, P1239, DOI 10.1016/0967-0637(95)00042-5; Bruchert V, 2003, GEOCHIM COSMOCHIM AC, V67, P4505, DOI 10.1016/S0016-7037(03)00275-8; Bulow SE, 2010, DEEP-SEA RES PT I, V57, P384, DOI 10.1016/j.dsr.2009.10.014; CALVERT SE, 1971, DEEP-SEA RES, V18, P505, DOI 10.1016/0011-7471(71)90074-X; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; DALSGAARD T, 1994, APPL ENVIRON MICROB, V60, P291, DOI 10.1128/AEM.60.1.291-297.1994; DUGDALE RC, 1977, DEEP-SEA RES, V24, P601, DOI 10.1016/0146-6291(77)90530-6; Escribano R, 2004, DEEP-SEA RES PT II, V51, P2389, DOI 10.1016/j.dsr2.2004.08.011; Finster KW, 2010, ANTON LEEUW INT J G, V97, P221, DOI 10.1007/s10482-009-9403-y; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grimm F, 2008, MICROBIAL SULFUR METABOLISM, P101, DOI 10.1007/978-3-540-72682-1_9; Jensen MM, 2009, MAR CHEM, V113, P102, DOI 10.1016/j.marchem.2009.01.002; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Lavin P, 2010, ENV MICROBIOL REP, V2, P728, DOI 10.1111/j.1758-2229.2010.00167.x; MCCREADY RGL, 1983, ARCH MICROBIOL, V135, P182, DOI 10.1007/BF00414476; Meyer B, 2007, APPL ENVIRON MICROB, V73, P7664, DOI 10.1128/AEM.01272-07; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Meyer B, 2007, MICROBIOL-SGM, V153, P2026, DOI 10.1099/mic.0.2006/003152-0; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; OLSON DB, 1993, DEEP-SEA RES PT II, V40, P673, DOI 10.1016/0967-0645(93)90051-N; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Stevens H, 2008, ENVIRON MICROBIOL, V10, P1244, DOI 10.1111/j.1462-2920.2007.01539.x; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; WYRTKI K, 1962, DEEP-SEA RES, V9, P11, DOI 10.1016/0011-7471(62)90243-7	30	411	423	14	366	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1375	1378		10.1126/science.1196889	http://dx.doi.org/10.1126/science.1196889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21071631	Green Published			2022-12-24	WOS:000284902100041
J	Dehaene, S; Pegado, F; Braga, LW; Ventura, P; Nunes, G; Jobert, A; Dehaene-Lambertz, G; Kolinsky, R; Morais, J; Cohen, L				Dehaene, Stanislas; Pegado, Felipe; Braga, Lucia W.; Ventura, Paulo; Nunes Filho, Gilberto; Jobert, Antoinette; Dehaene-Lambertz, Ghislaine; Kolinsky, Regine; Morais, Jose; Cohen, Laurent			How Learning to Read Changes the Cortical Networks for Vision and Language	SCIENCE			English	Article							CHILDREN LEARN; VISUAL-CORTEX; SPEECH SOUNDS; BRAIN; RECOGNITION; LITERACY; REORGANIZATION; ACTIVATION; REGIONS; WRITE	Does literacy improve brain function? Does it also entail losses? Using functional magnetic resonance imaging, we measured brain responses to spoken and written language, visual faces, houses, tools, and checkers in adults of variable literacy (10 were illiterate, 22 became literate as adults, and 31 were literate in childhood). As literacy enhanced the left fusiform activation evoked by writing, it induced a small competition with faces at this location, but also broadly enhanced visual responses in fusiform and occipital cortex, extending to area V1. Literacy also enhanced phonological activation to speech in the planum temporale and afforded a top-down activation of orthography from spoken inputs. Most changes occurred even when literacy was acquired in adulthood, emphasizing that both childhood and adult education can profoundly refine cortical organization.	[Dehaene, Stanislas; Pegado, Felipe; Jobert, Antoinette; Dehaene-Lambertz, Ghislaine] INSERM, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas; Pegado, Felipe; Jobert, Antoinette; Dehaene-Lambertz, Ghislaine] CEA, Direct Sci Vivant, I2BM, Neurospin Ctr, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas; Pegado, Felipe; Jobert, Antoinette; Dehaene-Lambertz, Ghislaine] Univ Paris 11, F-91405 Orsay, France; [Dehaene, Stanislas] Coll France, F-75005 Paris, France; [Braga, Lucia W.; Nunes Filho, Gilberto] Int Ctr Neurosci & Rehabil, SARAH Network, BR-71535005 Brasilia, DF, Brazil; [Ventura, Paulo] Univ Lisbon, Fac Psychol, P-1600214 Lisbon, Portugal; [Kolinsky, Regine; Morais, Jose] Univ Libre Bruxelles, Fac Psychol, B-1050 Brussels, Belgium; [Kolinsky, Regine] Fonds Rech Sci FNRS, B-1000 Brussels, Belgium; [Cohen, Laurent] Univ Paris 06, Fac Med Pitie Salpetriere, F-75013 Paris, France; [Cohen, Laurent] Grp Hosp Pitie Salpetriere, AP HP, Dept ofNeurol, F-75651 Paris, France; [Cohen, Laurent] INSERM, Inst Cerveau & Moelle Epiniere, Ctr Rech, UMRS 975, Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; Universidade de Lisboa; Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Dehaene, S (corresponding author), INSERM, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France.	stanislas.dehaene@gmail.com	Braga, Lucia/AAQ-1030-2020; Dehaene, Ghislaine/O-3633-2017; Nunes Filho, Gilberto/J-1535-2012; Ventura, Paulo/D-8585-2013	Dehaene, Ghislaine/0000-0003-2221-9081; cohen, laurent/0000-0002-5010-9085; Pegado, Felipe/0000-0001-9203-8687; Ventura, Paulo/0000-0002-4059-4419; Ventura, Paulo/0000-0003-0150-6268	Institut National de la Sante et de la Recherche Medicale (INSERM); Commissariat a l'Energie Atomique (CEA); College de France; Agence Nationale de la Recherche; Fundacao para a Ciencia e a Tecnologia; European Community [PTDC/PSI/66077/2006]; SARAH Network of Rehabilitation Hospitals; Belgian French community [2.4586.07, 06/11-342]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission); College de France; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission); SARAH Network of Rehabilitation Hospitals; Belgian French community	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Commissariat a l'Energie Atomique (CEA), College de France, Agence Nationale de la Recherche (project CORELEX), Fundacao para a Ciencia e a Tecnologia, the European Community FEDER funding (Project PTDC/PSI/66077/2006, "Cognitive consequences of literacy"), SARAH Network of Rehabilitation Hospitals, and by two grants from the Belgian French community (Fonds de la Recherche Fondamentale Collective 2.4586.07 and Action de Recherche Concertee 06/11-342). We gratefully acknowledge A. Amadon, M.-H. Baju, L. Labruna, D. Le Bihan, L. Hertz-Pannier, P. Pinel, and the NeuroSpin infrastructure groups at NeuroSpin; C. Carvalho, L. Querido, S. Fernandes, and T. Fernandes at the Faculty of Psychology, University of Lisbon; and D. Y. Suguieda, R. S. Vera, A. G. Tauil, E. Amemiya, L. G. N. Nunes, S. B. de Oliveira, and C. L. M. Gillis at SARAH Brasilia.	Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Blau V, 2010, BRAIN, V133, P868, DOI 10.1093/brain/awp308; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Booth JR, 2003, HUM BRAIN MAPP, V19, P155, DOI 10.1002/hbm.10111; Brem S, 2010, P NATL ACAD SCI USA, V107, P7939, DOI 10.1073/pnas.0904402107; Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461; Castro-Caldas A, 1999, EUR J NEUROL, V6, P23, DOI 10.1046/j.1468-1331.1999.610023.x; Castro-Caldas A, 1998, BRAIN, V121, P1053, DOI 10.1093/brain/121.6.1053; Cheung H, 2004, LANG COGNITIVE PROC, V19, P1, DOI 10.1080/01690960344000071; Cohen L, 2004, NEUROIMAGE, V23, P1256, DOI 10.1016/j.neuroimage.2004.07.052; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2008, NEUROIMAGE, V40, P353, DOI 10.1016/j.neuroimage.2007.11.036; Dehaene S, 2009, READING BRAIN; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Desroches AS, 2010, BRAIN RES, V1356, P73, DOI 10.1016/j.brainres.2010.07.097; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Eger E, 2005, NEUROIMAGE, V26, P1128, DOI 10.1016/j.neuroimage.2005.03.010; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; Harel A, 2010, CEREB CORTEX, V20, P2304, DOI 10.1093/cercor/bhp316; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Jacquemot C, 2003, J NEUROSCI, V23, P9541; Kherif F, 2011, CEREB CORTEX, V21, P103, DOI 10.1093/cercor/bhq063; Li G, 2006, HUM BRAIN MAPP, V27, P144, DOI 10.1002/hbm.20173; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; Maurer U, 2006, NEUROIMAGE, V33, P749, DOI 10.1016/j.neuroimage.2006.06.025; MORAIS J, 1986, COGNITION, V24, P45, DOI 10.1016/0010-0277(86)90004-1; Nazir TA, 2004, BRAIN LANG, V88, P294, DOI 10.1016/S0093-934X(03)00168-8; Perre L, 2009, BRAIN RES, V1275, P73, DOI 10.1016/j.brainres.2009.04.018; Petersson KM, 2007, EUR J NEUROSCI, V26, P791, DOI 10.1111/j.1460-9568.2007.05701.x; Petersson KM, 1999, NEUROIMAGE, V10, P45, DOI 10.1006/nimg.1999.0446; Petersson KM, 2000, J COGNITIVE NEUROSCI, V12, P364, DOI 10.1162/089892900562147; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rossion B, 2004, P NATL ACAD SCI USA, V101, P14521, DOI 10.1073/pnas.0405613101; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; Ventura P, 2007, COGNITION, V105, P547, DOI 10.1016/j.cognition.2006.12.005; Yoncheva YN, 2010, CEREB CORTEX, V20, P622, DOI 10.1093/cercor/bhp129; Ziegler JC, 2008, J EXP PSYCHOL LEARN, V34, P643, DOI 10.1037/0278-7393.34.3.643	44	748	773	11	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1359	1364		10.1126/science.1194140	http://dx.doi.org/10.1126/science.1194140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	689BK	21071632	Green Published			2022-12-24	WOS:000284902100037
J	Ripatti, S; Tikkanen, E; Orho-Melander, M; Havulinna, AS; Silander, K; Sharma, A; Guiducci, C; Perola, M; Jula, A; Sinisalo, J; Lokki, ML; Nieminen, MS; Melander, O; Salomaa, V; Peltonen, L; Kathiresan, S				Ripatti, Samuli; Tikkanen, Emmi; Orho-Melander, Marju; Havulinna, Aki S.; Silander, Kaisa; Sharma, Amitabh; Guiducci, Candace; Perola, Markus; Jula, Antti; Sinisalo, Juha; Lokki, Marja-Liisa; Nieminen, Markku S.; Melander, Olle; Salomaa, Veikko; Peltonen, Leena; Kathiresan, Sekar			A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses	LANCET			English	Article							HOSPITAL DISCHARGE REGISTER; CARDIOVASCULAR EVENTS; PREDICTIVE ABILITY; ROC CURVE; RECLASSIFICATION; STATISTICS; MARKER; AREA	Background Comparison of patients with coronary heart disease and controls in genome-wide association studies has revealed several single nucleotide polymorphisms (SNPs) associated with coronary heart disease. We aimed to establish the external validity of these findings and to obtain more precise risk estimates using a prospective cohort design. Methods We tested 13 recently discovered SNPs for association with coronary heart disease in a case-control design including participants differing from those in the discovery samples (3829 participants with prevalent coronary heart disease and 48 897 controls free of the disease) and a prospective cohort design including 30 725 participants free of cardiovascular disease from Finland and Sweden. We modelled the 13 SNPs as a multilocus genetic risk score and used Cox proportional hazards models to estimate the association of genetic risk score with incident coronary heart disease. For case-control analyses we analysed associations between individual SNPs and quintiles of genetic risk score using logistic regression. Findings In prospective cohort analyses, 1264 participants had a first coronary heart disease event during a median 10.7 years' follow-up (IQR 6.7-13.6). Genetic risk score was associated with a first coronary heart disease event. When compared with the bottom quintile of genetic risk score, participants in the top quintile were at 1.66-times increased risk of coronary heart disease in a model adjusting for traditional risk factors (95% CI 1.35-2.04, p value for linear trend=7.3x10(-10)). Adjustment for family history did not change these estimates. Genetic risk score did not improve C index over traditional risk factors and family history (p=0.19), nor did it have a significant effect on net reclassification improvement (2.2%, p=0.18); however, it did have a small effect on integrated discrimination index (0.004, p=0.0006). Results of the case-control analyses were similar to those of the prospective cohort analyses. Interpretation Using a genetic risk score based on 13 SNPs associated with coronary heart disease, we can identify the 20% of individuals of European ancestry who are at roughly 70% increased risk of a first coronary heart disease event. The potential clinical use of this panel of SNPs remains to be defined.	[Ripatti, Samuli; Tikkanen, Emmi; Silander, Kaisa; Peltonen, Leena] Univ Helsinki, FIMM, FIM-00014 Helsinki, Finland; [Ripatti, Samuli; Tikkanen, Emmi; Havulinna, Aki S.; Silander, Kaisa; Perola, Markus; Jula, Antti; Salomaa, Veikko; Peltonen, Leena] Natl Inst Hlth & Welf, Helsinki, Finland; [Orho-Melander, Marju; Sharma, Amitabh; Melander, Olle] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Guiducci, Candace; Peltonen, Leena; Kathiresan, Sekar] Broad Inst, Cambridge, MA USA; [Sinisalo, Juha; Nieminen, Markku S.] Helsinki Univ Cent Hosp, Dept Med, Div Cardiol, Helsinki, Finland; [Lokki, Marja-Liisa] Univ Helsinki, Haartman Inst, Transplantat Lab, FIM-00014 Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton, England; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	University of Helsinki; Finland National Institute for Health & Welfare; Lund University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ripatti, S (corresponding author), Univ Helsinki, FIMM, POB 20, FIM-00014 Helsinki, Finland.	samuli.ripatti@fimm.fi	Ripatti, Samuli/H-9446-2014; Havulinna, Aki/AAM-4769-2021	Ripatti, Samuli/0000-0002-0504-1202; Sinisalo, Juha/0000-0002-0169-5137; Melander, Olle/0000-0002-2581-484X; Perola, Markus/0000-0003-4842-1667	Merck; Daiichi Sankyo; Alnylam; Pfizer; Wellcome Trust [WT089062/Z/097Z, WT089061/Z/09/Z]; US National Institutes of Health [R01 HL087676]; Donovan Family Foundation; Center of Excellence for Complex Disease Genetics of the Academy of Finland [213506, 129680]; Biocentrum Helsinki Foundation; Nordic Center of Excellence in Disease Genetics; Academy of Finland [129494]; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Finnish Academy [129322]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER	Merck(Merck & Company); Daiichi Sankyo(Daiichi Sankyo Company Limited); Alnylam; Pfizer(Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donovan Family Foundation; Center of Excellence for Complex Disease Genetics of the Academy of Finland(Academy of Finland); Biocentrum Helsinki Foundation; Nordic Center of Excellence in Disease Genetics; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Academy(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SK has received consultancy fees from Merck and Daiichi Sankyo and grants from Alnylam and Pfizer. All other authors declare that they have no conflicts of interest.; We wish to dedicate this paper to the memory of Leena Peltonen, who passed away on March 11, 2010. This work was supported by the Wellcome Trust (WT089062/Z/097Z, WT089061/Z/09/Z), US National Institutes of Health (R01 HL087676), and the Donovan Family Foundation. We thank David Altshuler for guidance and helpful suggestions regarding study design and analyses. LP was supported by the Center of Excellence for Complex Disease Genetics of the Academy of Finland (grants 213506, 129680), the Biocentrum Helsinki Foundation, and The Nordic Center of Excellence in Disease Genetics. VS is supported by the Academy of Finland (grant number 129494), the Finnish Foundation for Cardiovascular Research, and the Sigrid Juselius Foundation. JS was funded by Finnish Foundation for Cardiovascular Research, Special governmental subsidy for health sciences research (EVO). MP was supported by Finnish Foundation for Cardiovascular Research and Finnish Academy Salve Program, grant number 129322	Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Healy DG, 2006, LANCET NEUROL, V5, P701, DOI 10.1016/S1474-4422(06)70524-5; Hedges L.V., 1985, STAT METHODS META AN; Heistaro S., 2008, METHODOLOGY REPORT H; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Langholz B, 1996, STAT SCI, V11, P35; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Musunuru K, 2010, ANNU REV GENOM HUM G, V11, P91, DOI 10.1146/annurev-genom-082509-141637; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; SAMANI NJ, 2007, NEW ENGL J MED, V357, P1; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; VARTIAINEN E, 2009, INT J EPIDEMIOL, V12, P1; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249	29	398	418	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 23	2010	376	9750					1393	1400		10.1016/S0140-6736(10)61267-6	http://dx.doi.org/10.1016/S0140-6736(10)61267-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971364	Green Published			2022-12-24	WOS:000283627500034
J	Wiegand, KC; Shah, SP; Al-Agha, OM; Zhao, YJ; Tse, K; Zeng, T; Senz, J; McConechy, MK; Anglesio, MS; Kalloger, SE; Yang, W; Heravi-Moussavi, A; Giuliany, R; Chow, C; Fee, J; Zayed, A; Prentice, L; Melnyk, N; Turashvili, G; Delaney, AD; Madore, J; Yip, S; McPherson, AW; Ha, G; Bell, L; Fereday, S; Tam, A; Galletta, L; Tonin, PN; Provencher, D; Miller, D; Jones, SJM; Moore, RA; Morin, GB; Oloumi, A; Boyd, N; Aparicio, SA; Shih, IM; Mes-Masson, AM; Bowtell, DD; Hirst, M; Gilks, B; Marra, MA; Huntsman, DG				Wiegand, Kimberly C.; Shah, Sohrab P.; Al-Agha, Osama M.; Zhao, Yongjun; Tse, Kane; Zeng, Thomas; Senz, Janine; McConechy, Melissa K.; Anglesio, Michael S.; Kalloger, Steve E.; Yang, Winnie; Heravi-Moussavi, Alireza; Giuliany, Ryan; Chow, Christine; Fee, John; Zayed, Abdalnasser; Prentice, Leah; Melnyk, Nataliya; Turashvili, Gulisa; Delaney, Allen D.; Madore, Jason; Yip, Stephen; McPherson, Andrew W.; Ha, Gavin; Bell, Lynda; Fereday, Sian; Tam, Angela; Galletta, Laura; Tonin, Patricia N.; Provencher, Diane; Miller, Dianne; Jones, Steven J. M.; Moore, Richard A.; Morin, Gregg B.; Oloumi, Arusha; Boyd, Niki; Aparicio, Samuel A.; Shih, Ie-Ming; Mes-Masson, Anne-Marie; Bowtell, David D.; Hirst, Martin; Gilks, Blake; Marra, Marco A.; Huntsman, David G.			ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLEAR-CELL CARCINOMA; DISTINCT-HISTOLOGIC-TYPE; GRADE SEROUS CARCINOMA; POOR-PROGNOSIS; MECHANISMS; EXPRESSION; RESISTANCE; CANCER; COMPONENT; STAGE	BACKGROUND Ovarian clear-cell and endometrioid carcinomas may arise from endometriosis, but the molecular events involved in this transformation have not been described. METHODS We sequenced the whole transcriptomes of 18 ovarian clear-cell carcinomas and 1 ovarian clear-cell carcinoma cell line and found somatic mutations in ARID1A (the AT-rich interactive domain 1A [SWI-like] gene) in 6 of the samples. ARID1A encodes BAF250a, a key component of the SWI-SNF chromatin remodeling complex. We sequenced ARID1A in an additional 210 ovarian carcinomas and a second ovarian clear-cell carcinoma cell line and measured BAF250a expression by means of immunohistochemical analysis in an additional 455 ovarian carcinomas. RESULTS ARID1A mutations were seen in 55 of 119 ovarian clear-cell carcinomas (46%), 10 of 33 endometrioid carcinomas (30%), and none of the 76 high-grade serous ovarian carcinomas. Seventeen carcinomas had two somatic mutations each. Loss of the BAF250a protein correlated strongly with the ovarian clear-cell carcinoma and endometrioid carcinoma subtypes and the presence of ARID1A mutations. In two patients, ARID1A mutations and loss of BAF250a expression were evident in the tumor and contiguous atypical endometriosis but not in distant endometriotic lesions. CONCLUSIONS These data implicate ARID1A as a tumor-suppressor gene frequently disrupted in ovarian clear-cell and endometrioid carcinomas. Since ARID1A mutation and loss of BAF250a can be seen in the preneoplastic lesions, we speculate that this is an early event in the transformation of endometriosis into cancer.	[Huntsman, David G.] BC Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC, Canada; [Zhao, Yongjun; Tse, Kane; Zeng, Thomas; Delaney, Allen D.; Tam, Angela; Jones, Steven J. M.; Moore, Richard A.; Morin, Gregg B.; Hirst, Martin; Marra, Marco A.] Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Fee, John; Turashvili, Gulisa; Oloumi, Arusha; Aparicio, Samuel A.] BC Canc Res Ctr, Vancouver, BC, Canada; [Chow, Christine; Gilks, Blake; Huntsman, David G.] Genet Pathol Evaluat Ctr, Vancouver, BC, Canada; [Wiegand, Kimberly C.; Miller, Dianne; Morin, Gregg B.; Aparicio, Samuel A.; Gilks, Blake; Marra, Marco A.; Huntsman, David G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Morin, Gregg B.; Marra, Marco A.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Madore, Jason; Provencher, Diane; Mes-Masson, Anne-Marie] CHU Montreal, Hop Notre Dame, Inst Canc Montreal, Ctr Rech, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Provencher, Diane; Mes-Masson, Anne-Marie] Univ Montreal, Montreal, PQ, Canada; [Fereday, Sian; Galletta, Laura; Bowtell, David D.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Bowtell, David D.] Univ Melbourne, Melbourne, Vic, Australia; [Shih, Ie-Ming] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; Simon Fraser University; Universite de Montreal; McGill University; Universite de Montreal; Peter Maccallum Cancer Center; University of Melbourne; Johns Hopkins University	Huntsman, DG (corresponding author), BC Canc Agcy, Ctr Translat & Appl Genom, Rm 3427,600 W 10th Ave, Vancouver, BC, Canada.	dhuntsma@bccancer.bc.ca	Yip, Stephen/E-9994-2012; Huntsman, David/ABE-6082-2020; Morin, Gregg B/E-9123-2012; sdsd, shihieih/ABE-6190-2020; Hirst, Martin/B-7684-2016; Ha, Gavin/N-1984-2019; Marra, Marco A/B-5987-2008; Bowtell, David/H-1007-2016; Jones, Steven J/C-3621-2009	Yip, Stephen/0000-0002-8514-9861; Morin, Gregg B/0000-0001-8949-4374; Ha, Gavin/0000-0001-7578-7272; Marra, Marco A/0000-0001-7146-7175; Bowtell, David/0000-0001-9089-7525; Jones, Steven J/0000-0003-3394-2208; Anglesio, Michael/0000-0003-1639-5003; Madore, Jason/0000-0002-3499-474X; Aparicio, Samuel/0000-0002-0487-9599; Fereday, Sian/0000-0002-8559-8579; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Turashvili, Gulisa/0000-0001-6125-5865	British Columbia (BC) Cancer Foundation; Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research (CIHR); Genome Canada; OvCaRe; Michael Smith Foundation for Health Research (MSFHR); CIHR [STP-53912]; Canadian Breast Cancer Foundation; Canada Research Chair in Molecular Oncology; Sanofi-Aventis, Canada; Ovarian Cancer Canada; U.S. Army Medical Research and Materiel Command [DAMD17-O1-1-0729]; Cancer Council Tasmania; Cancer Foundation of Western Australia; National Health and Medical Research Council of Australia; National Cancer Institute, National Institutes of Health [RO1CA103937, RO1CA129080]; NATIONAL CANCER INSTITUTE [R01CA129080, R01CA103937] Funding Source: NIH RePORTER	British Columbia (BC) Cancer Foundation; Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); OvCaRe; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canada Research Chair in Molecular Oncology(Canada Research Chairs); Sanofi-Aventis, Canada(Sanofi-Aventis); Ovarian Cancer Canada; U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the British Columbia (BC) Cancer Foundation and the Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation (to the OvCaRe ovarian cancer research team in Vancouver) and the Canadian Institutes of Health Research (CIHR). The Michael Smith Genome Sciences Centre (MSGSC), with which many of the authors are affiliated, is funded by Genome Canada, and OvCaRe and the MSGSC are also funded by the Michael Smith Foundation for Health Research (MSFHR). Salary support is provided by MSFHR to Drs. Shah, Marra, Jones, and Huntsman; by the CIHR Training Program for Clinician Scientists in Molecular Oncologic Pathology to Drs. Al-Agha and Turashvili (STP-53912); by the CIHR Bioinformatics Training Program for Health Research to Mr. McPherson and Mr. Ha; by the Canadian Breast Cancer Foundation to Dr. Shah; and a Canada Research Chair in Molecular Oncology to Dr. Aparicio. The Genetic Pathology Evaluation Centre, which constructed the tissue microarrays, has received nondirected research grants from Sanofi-Aventis, Canada. The contributing tumor banks were supported by OvCaRe and Ovarian Cancer Canada (VGH, Banque de Tissus et de Donnees of the Reseau de Recherche sur le Cancer of the Fonds de la Recherche en Sante du Quebec, affiliated with the Canadian Tumor Repository Network), and by a grant (DAMD17-O1-1-0729) from the U.S. Army Medical Research and Materiel Command; grants from the Cancer Council Tasmania, the Cancer Foundation of Western Australia, and the National Health and Medical Research Council of Australia to AOCS; and grants from the National Cancer Institute, National Institutes of Health (RO1CA103937 and RO1CA129080).	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Dent J, 2003, BRIT J CANCER, V88, P1578, DOI 10.1038/sj.bjc.6600896; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; GILKS CB, 2009, J ONCOL         1230; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; JEMAL A, 2010, CA CANC J CLIN  0707; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; Kozmik Z, 2001, GENOMICS, V73, P140, DOI 10.1006/geno.2001.6477; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; LAU DHM, 1991, CANCER RES, V51, P5181; Mitelman F, 1997, CANCER GENET CYTOGEN, V95, P1, DOI 10.1016/S0165-4608(96)00252-X; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Ness RB, 2003, AM J OBSTET GYNECOL, V189, P280, DOI 10.1067/mob.2003.408; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Sato N, 2000, CANCER RES, V60, P7052; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Suehiro Y, 2000, ONCOLOGY-BASEL, V59, P50, DOI 10.1159/000012137; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO;2-X; Tavassoli F.A., 2003, PATHOLOGY GENETICS T, V4; Vigano P, 2006, HUM REPROD UPDATE, V12, P77, DOI 10.1093/humupd/dmi037; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450	35	1113	1167	5	137	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1532	1543		10.1056/NEJMoa1008433	http://dx.doi.org/10.1056/NEJMoa1008433			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942669	Bronze, Green Accepted			2022-12-24	WOS:000282887100007
J	Field, GD; Gauthier, JL; Sher, A; Greschner, M; Machado, TA; Jepson, LH; Shlens, J; Gunning, DE; Mathieson, K; Dabrowski, W; Paninski, L; Litke, AM; Chichilnisky, EJ				Field, Greg D.; Gauthier, Jeffrey L.; Sher, Alexander; Greschner, Martin; Machado, Timothy A.; Jepson, Lauren H.; Shlens, Jonathon; Gunning, Deborah E.; Mathieson, Keith; Dabrowski, Wladyslaw; Paninski, Liam; Litke, Alan M.; Chichilnisky, E. J.			Functional connectivity in the retina at the resolution of photoreceptors	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; CELL RECEPTIVE-FIELDS; MACAQUE MONKEY RETINA; MIDGET GANGLION-CELLS; PRIMATE RETINA; COLOR-VISION; CONE INPUTS; BIPOLAR CELLS; S-CONE; PHYSIOLOGICAL-BASIS	To understand a neural circuit requires knowledge of its connectivity. Here we report measurements of functional connectivity between the input and ouput layers of the macaque retina at single-cell resolution and the implications of these for colour vision. Multi-electrode technology was used to record simultaneously from complete populations of the retinal ganglion cell types (midget, parasol and small bistratified) that transmit high-resolution visual signals to the brain. Fine-grained visual stimulation was used to identify the location, type and strength of the functional input of each cone photoreceptor to each ganglion cell. The populations of ON and OFF midget and parasol cells each sampled the complete population of long- and middle-wavelength-sensitive cones. However, only OFF midget cells frequently received strong input from short-wavelength-sensitive cones. ON and OFF midget cells showed a small non-randomtendency to selectively sample from either long- or middle-wavelength-sensitive cones to a degree not explained by clumping in the cone mosaic. These measurements reveal computations in a neural circuit at the elementary resolution of individual neurons.	[Field, Greg D.; Gauthier, Jeffrey L.; Greschner, Martin; Machado, Timothy A.; Jepson, Lauren H.; Shlens, Jonathon; Chichilnisky, E. J.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; [Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Gunning, Deborah E.; Mathieson, Keith] Univ Glasgow, Dept Phys & Astron, Glasgow G12 8QQ, Lanark, Scotland; [Dabrowski, Wladyslaw] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, PL-2330059 Krakow, Poland; [Paninski, Liam] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Paninski, Liam] Columbia Univ, Ctr Theoret Neurosci, New York, NY 10027 USA	Salk Institute; University of California System; University of California Santa Cruz; University of Glasgow; AGH University of Science & Technology; Columbia University; Columbia University	Chichilnisky, EJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ej@salk.edu	Gunning, Deborah/P-5825-2015; Dabrowski, Wladyslaw/AAS-6369-2020; Mathieson, Keith/G-6308-2011; Field, Greg/AAI-1428-2021	Dabrowski, Wladyslaw/0000-0001-9061-9568; Mathieson, Keith/0000-0002-9517-8076; Field, Greg/0000-0001-5942-2679; Chichilnisky, E.J./0000-0002-5613-0248; Gauthier, Jeffrey/0000-0002-0509-8532; Machado, Tim/0000-0003-3762-1460; Sher, Alexander/0000-0001-6655-6456	Helen Hay Whitney Foundation; German Research Foundation; National Institutes of Health (NIH) National Research Service [NS054519-01]; Chapman Foundation; Miller Institute for Basic Research in Science; Polish Ministry of Science and Higher Education; Burroughs Wellcome Fund Career Award at Scientific Interface; Engineering and Physical Sciences Research Council; Royal Society of Edinburgh; McKnight Foundation; NSF [PHY-0750525]; Sloan Research Fellowship; NIH [EY13150]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054519] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/G042446/1, EP/E039731/1] Funding Source: researchfish; EPSRC [EP/G042446/1, EP/E039731/1] Funding Source: UKRI	Helen Hay Whitney Foundation; German Research Foundation(German Research Foundation (DFG)); National Institutes of Health (NIH) National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chapman Foundation; Miller Institute for Basic Research in Science; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Burroughs Wellcome Fund Career Award at Scientific Interface(Burroughs Wellcome Fund); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society of Edinburgh; McKnight Foundation; NSF(National Science Foundation (NSF)); Sloan Research Fellowship(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Helen Hay Whitney Foundation (G.D.F.), German Research Foundation (M.G.), National Institutes of Health (NIH) National Research Service Award (NS054519-01) and Chapman Foundation (J.L.G.), Miller Institute for Basic Research in Science (J.S.), Polish Ministry of Science and Higher Education (W.D.), Burroughs Wellcome Fund Career Award at Scientific Interface (A.S.), Engineering and Physical Sciences Research Council (D.E.G.), Royal Society of Edinburgh (K.M.), McKnight Foundation (A.M.L. and E.J.C.), NSF Grant PHY-0750525 (A.M.L.), a Sloan Research Fellowship and NIH Grant EY13150 (E.J.C). We thank C. K. Hulse for technical assistance; M. I. Grivich, D. Petrusca, A. Grillo, P. Grybos, P. Hottowy and S. Kachiguine for technical development; H. Fox, M. Taffe, E. Callaway and K. Osborn for providing access to retinas; S. Barry for machining; F. Rieke and T. Sejnowski for providing comments on the manuscript. We thank the San Diego Supercomputer Center and the National Science Foundation (Cooperative Agreements 05253071 and 0438741) for large-scale data storage.	[Anonymous], 1991, COMPUTATIONAL MODELS, DOI [10.7551/mitpress/2002.003.0010, DOI 10.7551/MITPRESS/2002.003.0010]; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; Buzas P, 2006, J NEUROSCI, V26, P11148, DOI 10.1523/JNEUROSCI.3237-06.2006; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; Chatterjee S, 2002, NEURON, V35, P1135, DOI 10.1016/S0896-6273(02)00874-7; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P197, DOI 10.1113/jphysiol.1975.sp011087; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DEVALOIS RL, 1966, J OPT SOC AM, V56, P966, DOI 10.1364/JOSA.56.000966; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Diller L, 2004, J NEUROSCI, V24, P1079, DOI 10.1523/JNEUROSCI.3828-03.2004; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; JACOBS GH, 1965, NATURE, V206, P487, DOI 10.1038/206487a0; Jusuf PR, 2006, J NEUROSCI, V26, P3908, DOI 10.1523/JNEUROSCI.4891-05.2006; KAISER PK, 1990, J PHYSIOL-LONDON, V422, P153, DOI 10.1113/jphysiol.1990.sp017978; Klug K, 2003, J NEUROSCI, V23, P9881; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; LEE BB, 1994, VISION RES, V34, P3081, DOI 10.1016/0042-6989(94)90074-4; Lee BB, 1996, VISION RES, V36, P631, DOI 10.1016/0042-6989(95)00167-0; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; Lee SCS, 2007, J COMP NEUROL, V502, P126, DOI 10.1002/cne.21284; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Packer OS, 1996, J NEUROSCI, V16, P2251; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; Reid RC, 2002, J NEUROSCI, V22, P6158; Rodieck R.W., 1998, 1 STEPS SEEING; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Sincich LC, 2009, NAT NEUROSCI, V12, P967, DOI 10.1038/nn.2352; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Solomon SG, 2005, J NEUROSCI, V25, P4527, DOI 10.1523/JNEUROSCI.3921-04.2005; Sun H, 2006, J NEUROPHYSIOL, V95, P837, DOI 10.1152/jn.00714.2005; Tailby C, 2008, J PHYSIOL-LONDON, V586, P5947, DOI 10.1113/jphysiol.2008.161893; Wachtler T, 2007, J VISION, V7, DOI 10.1167/7.8.6; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1994, VISION RES, V34, P561, DOI 10.1016/0042-6989(94)90013-2; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115	51	200	206	6	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					673	U54		10.1038/nature09424	http://dx.doi.org/10.1038/nature09424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930838	Green Accepted			2022-12-24	WOS:000282572500030
J	Moravcevic, K; Mendrola, JM; Schmitz, KR; Wang, YH; Slochower, D; Janmey, PA; Lemmon, MA				Moravcevic, Katarina; Mendrola, Jeannine M.; Schmitz, Karl R.; Wang, Yu-Hsiu; Slochower, David; Janmey, Paul A.; Lemmon, Mark A.			Kinase Associated-1 Domains Drive MARK/PAR1 Kinases to Membrane Targets by Binding Acidic Phospholipids	CELL			English	Article							PROTEIN-KINASE; MOLECULAR DISSECTION; PLASMA-MEMBRANE; SEPTIN; CHECKPOINT; ORGANIZATION; MORPHOGENESIS; LOCALIZATION; RECOGNITION; ACTIVATION	Phospholipid-binding modules such as PH, C1, and C2 domains play crucial roles in location-dependent regulation of many protein kinases. Here, we identify the KA1 domain (kinase associated-1 domain), found at the C terminus of yeast septin-associated kinases (Kcc4p, Gin4p, and Hsl1p) and human MARK/PAR1 kinases, as a membrane association domain that binds acidic phospholipids. Membrane localization of isolated KA1 domains depends on phosphatidylserine. Using X-ray crystallography, we identified a structurally conserved binding site for anionic phospholipids in KA1 domains from Kcc4p and MARK1. Mutating this site impairs membrane association of both KA1 domains and intact proteins and reveals the importance of phosphatidylserine for bud neck localization of yeast Kcc4p. Our data suggest that KA1 domains contribute to "coincidence detection," allowing kinases to bind other regulators (such as septins) only at the membrane surface. These findings have important implications for understanding MARK/PAR1 kinases, which are implicated in Alzheimer's disease, cancer, and autism.	[Moravcevic, Katarina; Mendrola, Jeannine M.; Lemmon, Mark A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Moravcevic, Katarina; Schmitz, Karl R.; Slochower, David; Janmey, Paul A.; Lemmon, Mark A.] Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA; [Janmey, Paul A.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Wang, Yu-Hsiu] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Wang, Yu-Hsiu; Slochower, David; Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Wang, Yu-Hsiu/N-8094-2013	Wang, Yu-Hsiu/0000-0001-9753-5535; Lemmon, Mark/0000-0002-3379-5319; Schmitz, Karl/0000-0003-1411-7624	NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy [DE-AC02-06CH11357]; NIGMS; NSF [DMR-0936384]; NIH [RR-01646, R01-GM056846]; American Heart Association Great Rivers Affiliate; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275, R01GM056846] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Great Rivers Affiliate(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Lemmon, Ferguson, and Bi laboratories and Ben Black, Jim Shorter, and Greg Van Duyne for constructive comments. Erfei Bi, Scott Emr, and Daryll DeWald provided yeast strains used in this study. Crystallographic data were collected in part at the GM/CA Collaborative Access Team at the Advanced Photon Source (APS), funded by NCI (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of APS was supported by the U.S. Department of Energy, under contract No. DE-AC02-06CH11357. Additional crystallographic data were collected at beamline F2 at the Cornell High Energy Synchrotron Source (CHESS), supported by NIGMS and the NSF (under award DMR-0936384), using the Macromolecular Diffraction at CHESS (MacCHESS) facility, supported by the NIH (award RR-01646). This work was funded in part by NIH grant R01-GM056846 (to M. A. L.) and a predoctoral fellowship from the American Heart Association Great Rivers Affiliate (K.M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Crutchley J, 2009, MOL BIOL CELL, V20, P1926, DOI 10.1091/mbc.E08-08-0848; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demel R A, 1994, Subcell Biochem, V23, P83; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Elbert M, 2005, MOL BIOL CELL, V16, P532, DOI 10.1091/mbc.E04-07-0549; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Halstead JR, 2005, TRENDS PHARMACOL SCI, V26, P654, DOI 10.1016/j.tips.2005.10.004; Hanrahan J, 2003, MOL CELL, V12, P663, DOI 10.1016/j.molcel.2003.08.006; HIKIJI T, 1988, J BIOCHEM-TOKYO, V104, P894, DOI 10.1093/oxfordjournals.jbchem.a122579; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Okuzaki D, 2001, FEBS LETT, V489, P197, DOI 10.1016/S0014-5793(01)02104-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; Sanchez-Barrena MJ, 2007, MOL CELL, V26, P427, DOI 10.1016/j.molcel.2007.04.013; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shulewitz MJ, 1999, MOL CELL BIOL, V19, P7123; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Szkotnicki L, 2008, MOL BIOL CELL, V19, P4675, DOI 10.1091/mbc.E08-06-0663; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	61	120	125	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					966	977		10.1016/j.cell.2010.11.028	http://dx.doi.org/10.1016/j.cell.2010.11.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145462	Green Accepted, Bronze			2022-12-24	WOS:000285182600013
J	Coll, NS; Vercammen, D; Smidler, A; Clover, C; Van Breusegem, F; Dangl, JL; Epple, P				Coll, Nuria S.; Vercammen, Dominique; Smidler, Andrea; Clover, Charles; Van Breusegem, Frank; Dangl, Jeffery L.; Epple, Petra			Arabidopsis Type I Metacaspases Control Cell Death	SCIENCE			English	Article							DISEASE RESISTANCE; SIGNALING COMPONENTS; THALIANA; PROTEASE; LESION-SIMULATING-DISEASE1; ACCLIMATION; SPECIFICITY; BACTERIAL; PATHOGEN; FAMILIES	Metacaspases are distant relatives of animal caspases found in protozoa, fungi, and plants. Limited experimental data exist defining their function(s), despite their discovery by homology modeling a decade ago. We demonstrated that two type I metacaspases, AtMC1 and AtMC2, antagonistically control programmed cell death in Arabidopsis. AtMC1 is a positive regulator of cell death and requires conserved caspase-like putative catalytic residues for its function. AtMC2 negatively regulates cell death. This function is independent of the putative catalytic residues. Manipulation of the Arabidopsis type I metacaspase regulatory module can nearly eliminate the hypersensitive cell death response (HR) activated by plant intracellular immune receptors. This does not lead to enhanced pathogen proliferation, decoupling HR from restriction of pathogen growth.	[Coll, Nuria S.; Smidler, Andrea; Clover, Charles; Dangl, Jeffery L.; Epple, Petra] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Vercammen, Dominique; Van Breusegem, Frank] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Vercammen, Dominique; Van Breusegem, Frank] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, 108 Coker Hall,CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu; pepple@email.unc.edu	Van Breusegem, Frank/AAJ-2647-2020; Coll, Nuria S./Y-6326-2019; Van Breusegem, Frank/Y-2999-2019; Coll, Núria Sánchez/L-4961-2015	Van Breusegem, Frank/0000-0002-3147-0860; Coll, Nuria S./0000-0002-8889-0399; Coll, Núria Sánchez/0000-0002-8889-0399; Smidler, Andrea/0000-0002-3281-1161	NIH [RO1 GM057171]; Swiss National Science Foundation [PBEZA-115173]; Ghent University [12051403]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Direct For Biological Sciences [0639964] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ghent University(Ghent University); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. McDowell (Virginia Tech, Blacksburg, VA) and M. Nishimura (UNC) for critical reading of the manuscript. This work was funded by NIH RO1 GM057171 to J. L. D.; a Swiss National Science Foundation Fellowship (PBEZA-115173) to N.S.C.; and the Research Fund, Ghent University (grant 12051403), and Fonds voor Wetenschappelijk Onderzoek-Vlaanderen to F. V. B. and D. V., respectively. We thank D. Baltrus for statistical analysis, T. Perdue of the UNC Biology Microscope Facility for patient and expert assistance, E. Washington and T. Eitas for pMDC7 vectors, B. van de Cotte for technical assistance, and K. Overmyer for early contributions to this work.	Aravind L, 2002, PROTEINS, V46, P355, DOI 10.1002/prot.10060; Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chichkova NV, 2010, EMBO J, V29, P1149, DOI 10.1038/emboj.2010.1; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hatsugai N, 2009, GENE DEV, V23, P2496, DOI 10.1101/gad.1825209; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Lam E, 2000, PLANT MOL BIOL, V44, pVII; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; Muhlenbock P, 2008, PLANT CELL, V20, P2339, DOI 10.1105/tpc.108.059618; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200	31	290	318	5	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1393	1397		10.1126/science.1194980	http://dx.doi.org/10.1126/science.1194980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21097903				2022-12-24	WOS:000284902100046
J	Fang, M; Shen, ZR; Huang, S; Zhao, LP; Chen, S; Mak, TW; Wang, XD				Fang, Min; Shen, Zhirong; Huang, Song; Zhao, Liping; Chen, She; Mak, Tak W.; Wang, Xiaodong			The ER UDPase ENTPD5 Promotes Protein N-Glycosylation, the Warburg Effect, and Proliferation in the PTEN Pathway	CELL			English	Article							SECRETORY PATHWAY; ENDOPLASMIC-RETICULUM; TUMOR-SUPPRESSOR; QUALITY-CONTROL; CELL-SURVIVAL; AKT; KINASE; CANCER; METABOLISM; GROWTH	PI3K and PTEN lipid phosphatase control the level of cellular phosphatidylinositol (3,4,5)-trisphosphate, an activator of AKT kinases that promotes cell growth and survival. Mutations activating AKT are commonly observed in human cancers. We report here that ENTPD5, an endoplasmic reticulum (ER) enzyme, is upregulated in cell lines and primary human tumor samples with active AKT. ENTPD5 hydrolyzes UDP to UMP to promote protein N-glycosylation and folding in ER. Knockdown of ENTPD5 in PTEN null cells causes ER stress and loss of growth factor receptors. ENTPD5, together with cytidine monophosphate kinase-1 and adenylate kinase-1, constitute an ATP hydrolysis cycle that converts ATP to AMP, resulting in a compensatory increase in aerobic glycolysis known as the Warburg effect. The growth of PTEN null cells is inhibited both in vitro and in mouse xenograft tumor models. ENTPD5 is therefore an integral part of the PI3K/PTEN regulatory loop and a potential target for anti-cancer therapy.	[Fang, Min; Shen, Zhirong; Huang, Song; Zhao, Liping; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Fang, Min; Shen, Zhirong; Huang, Song; Zhao, Liping; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, She; Wang, Xiaodong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Mak, Tak W.] Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institute of Biological Sciences, Beijing; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Wang, XD (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	xiaodong.wang@utsouthwestern.edu		Wang, Xiaodong/0000-0001-9885-356X; Shen, Zhirong/0000-0003-4552-1670	National Cancer Institute (NCI) [PO1 CA 95471]; Chinese Ministry of Science and Technology; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to express our gratitude to Drs. Fenghe Du and Liping Liu for excellent technical assistance. We are grateful for Dr. Aijun Liu from the 301 Hospital in Beijing for providing the human prostate tumor samples and Dr. Benjamin Tu from University of Texas Southwestern for help with the phosphofructose sugar measurement. We thank Mr. Gregory Kunkel and Dr. Lai Wang for critical reading of the manuscript. This work is also supported by a grant from the National Cancer Institute (NCI) (PO1 CA 95471) and the National High Technology Projects 863 from Chinese Ministry of Science and Technology.	Bermudo R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-315; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GEVERS W, 1966, BIOCHEM J, V98, P720, DOI 10.1042/bj0980720; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Read R, 2009, VET PATHOL, V46, P491, DOI 10.1354/vp.08-VP-0201-R-AM; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; Warburg O, 1925, KLIN WOCHENSCHR, V4, P534, DOI DOI 10.1007/BF01726151; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	27	148	157	3	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					711	724		10.1016/j.cell.2010.10.010	http://dx.doi.org/10.1016/j.cell.2010.10.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21074248	Bronze			2022-12-24	WOS:000284583500014
J	Ng, SF; Lin, RCY; Laybutt, DR; Barres, R; Owens, JA; Morris, MJ				Ng, Sheau-Fang; Lin, Ruby C. Y.; Laybutt, D. Ross; Barres, Romain; Owens, Julie A.; Morris, Margaret J.			Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring	NATURE			English	Article							LOW-BIRTH-WEIGHT; BODY-MASS INDEX; CHILDHOOD; OBESITY; UNDERNUTRITION; TRANSMISSION; ASSOCIATION; PROTEIN; PLASMA; ISLETS	The global prevalence of obesity is increasing across most ages in both sexes. This is contributing to the early emergence of type 2 diabetes and its related epidemic(1,2). Having either parent obese is an independent risk factor for childhood obesity(3). Although the detrimental impacts of diet-induced maternal obesity on adiposity and metabolism in offspring are well established(4), the extent of any contribution of obese fathers is unclear, particularly the role of non-genetic factors in the causal pathway. Here we show that paternal high-fat-diet (HFD) exposure programs beta-cell 'dysfunction' in rat F-1 female offspring. Chronic HFD consumption in Sprague-Dawley fathers induced increased body weight, adiposity, impaired glucose tolerance and insulin sensitivity. Relative to controls, their female offspring had an early onset of impaired insulin secretion and glucose tolerance that worsened with time, and normal adiposity. Paternal HFD altered the expression of 642 pancreatic islet genes in adult female offspring (P < 0.01); genes belonged to 13 functional clusters, including cation and ATP binding, cytoskeleton and intracellular transport. Broader pathway analysis of 2,492 genes differentially expressed (P < 0.05) demonstrated involvement of calcium-, MAPK- and Wnt-signalling pathways, apoptosis and the cell cycle. Hypomethylation of the Il13ra2 gene, which showed the highest fold difference in expression (1.76-fold increase), was demonstrated. This is the first report in mammals of non-genetic, intergenerational transmission of metabolic sequelae of a HFD from father to offspring.	[Ng, Sheau-Fang; Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Laybutt, D. Ross] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Barres, Romain] Univ New S Wales, Sch Med Sci, Dept Anat, Sydney, NSW 2052, Australia; [Owens, Julie A.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Adelaide	Morris, MJ (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia.	m.morris@unsw.edu.au	Lin, Ruby CY/A-1636-2009; Owens, Julie A/C-9744-2009; BARRES, Romain/N-2501-2016; Morris, Margaret J/J-4285-2013	Lin, Ruby CY/0000-0003-4163-511X; Owens, Julie A/0000-0002-7498-1353; BARRES, Romain/0000-0002-0158-519X; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council (NHMRC) of Australia; Ministry of Higher Education; National University of Malaysia; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); National University of Malaysia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by the National Health and Medical Research Council (NHMRC) of Australia (M.J.M.). S.F.N. is supported by Ministry of Higher Education and National University of Malaysia, R.C.Y.L. is supported by the NHMRC Peter Doherty Fellowship.	Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Bouchard C, 2009, AM J CLIN NUTR, V89, pS1494, DOI 10.3945/ajcn.2009.27113C; Chamson-Reig A, 2006, J ENDOCRINOL, V191, P83, DOI 10.1677/joe.1.06754; David M, 2002, ANN NY ACAD SCI, V973, P207, DOI 10.1111/j.1749-6632.2002.tb04633.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Grunau C, 2000, NUCLEIC ACIDS RES, V28, P1053, DOI 10.1093/nar/28.5.1053; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hypponen E, 2003, BMJ-BRIT MED J, V326, P19, DOI 10.1136/bmj.326.7379.19; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasturi SS, 2008, J ANDROL, V29, P251, DOI 10.2164/jandrol.107.003731; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Le Stunff C, 2001, NAT GENET, V29, P96, DOI 10.1038/ng707; Leibel NI, 2006, J CLIN ENDOCR METAB, V91, P1275, DOI 10.1210/jc.2005-1707; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Morris Margaret J, 2009, Expert Rev Endocrinol Metab, V4, P625, DOI 10.1586/eem.09.45; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Power C, 2003, J EPIDEMIOL COMMUN H, V57, P969, DOI 10.1136/jech.57.12.969; Prior LJ, 2008, INT J OBESITY, V32, P1585, DOI 10.1038/ijo.2008.141; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sharpe RM, 2010, PHILOS T R SOC B, V365, P1697, DOI 10.1098/rstb.2009.0206; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Tarquini B, 1999, PEDIATRICS, V103, P998, DOI 10.1542/peds.103.5.998; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; ZHANG XY, 1993, MOL CELL BIOL, V13, P6810, DOI 10.1128/MCB.13.11.6810	42	931	980	3	191	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					963	U103		10.1038/nature09491	http://dx.doi.org/10.1038/nature09491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962845				2022-12-24	WOS:000283254700038
J	Sima, CS; Panageas, KS; Schrag, D				Sima, Camelia S.; Panageas, Katherine S.; Schrag, Deborah			Cancer Screening Among Patients With Advanced Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; BREAST-CANCER; INCIDENCE TRENDS; PROSTATE-CANCER; MAMMOGRAPHY; OVERDIAGNOSIS; CARE; PHYSICIANS; WOMEN	Context Cancer screening has been integrated into routine primary care but does not benefit patients with limited life expectancy. Objective To evaluate the extent to which patients with advanced cancer continue to be screened for new cancers. Design, Setting, and Participants Utilization of cancer screening procedures (mammography, Papanicolaou test, prostate-specific antigen [PSA], and lower gastrointestinal [GI] endoscopy) was assessed in 87 736 fee-for-service Medicare enrollees aged 65 years or older diagnosed with advanced lung, colorectal, pancreatic, gastroesophageal, or breast cancer between 1998 and 2005, and reported to one of the Surveillance, Epidemiology, and End Results (SEER) tumor registries. Participants were followed up until death or December 31, 2007, whichever came first. A group of 87 307 Medicare enrollees without cancer were individually matched by age, sex, race, and SEER registry to patients with cancer and observed over the same period to evaluate screening rates in context. Demographic and clinical characteristics associated with screening were also investigated. Main Outcome Measure For each cancer screening test, utilization rates were defined as the percentage of patients who were screened following the diagnosis of an incurable cancer. Results Among women following advanced cancer diagnosis compared with controls, at least 1 screening mammogram was received by 8.9% (95% confidence interval [CI], 8.6%-9.1%) vs 22.0% (95% CI, 21.7%-22.5%); Papanicolaou test screening was received by 5.8% (95% CI, 5.6%-6.1%) vs 12.5% (95% CI, 12.2%-12.8%). Among men following advanced cancer diagnosis compared with controls, PSA test was received by 15.0% (95% CI, 14.7%-15.3%) vs 27.2% (95% CI, 26.8%-27.6%). For all patients following advanced diagnosis compared with controls, lower GI endoscopy was received by 1.7% (95% CI, 1.6%-1.8%) vs 4.7% (95% CI, 4.6%-4.9%). Screening was more frequent among patients with a recent history of screening (16.2% [95% CI, 15.4%-16.9%] of these patients had mammography, 14.7% [95% CI, 13.7%-15.6%] had a Papanicolaou test, 23.3% [95% CI, 22.6%-24.0%] had a PSA test, and 6.1% [95% CI, 5.2%-7.0%] had lower GI endoscopy). Conclusion A sizeable proportion of patients with advanced cancer continue to undergo cancer screening tests that do not have a meaningful likelihood of providing benefit. JAMA. 2010;304(14):1584-1591 www.jama.com	[Sima, Camelia S.; Panageas, Katherine S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Schrag, Deborah] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Sima, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St,2nd Floor, New York, NY 10065 USA.	simac@mskcc.org	Hug, Balthasar L./G-1568-2010		National Cancer Institute [R01 1147503]; Schrag; NATIONAL CANCER INSTITUTE [R01CA131847] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Schrag; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Obtained funding: Schrag.; This research was supported by grant R01 1147503 from the National Cancer Institute (Dr Schrag).	Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; American Cancer Society, AM CANC SOC GUID EAR; [Anonymous], 2002, AJCC CANC STAGING MA; [Anonymous], INT CLASSIFICATION D, V3rd; [Anonymous], US PREV SERV TASK FO; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Back AL, 2005, JAMA-J AM MED ASSOC, V293, P1374, DOI 10.1001/jama.293.11.1374; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; CREWDSON J, 2009, ATLANTIC        1119; Cronin KA, 2005, CANCER CAUSE CONTROL, V16, P701, DOI 10.1007/s10552-005-0693-8; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Etzioni R, 2002, J NATL CANCER I, V94, P981; GRADY D, NY TIMES        1103; Iglehart JK, 2009, NEW ENGL J MED, V361, P229, DOI 10.1056/NEJMp0904854; Jerant AF, 2008, ARCH INTERN MED, V168, P1317, DOI 10.1001/archinte.168.12.1317; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Partridge AH, 2009, NEW ENGL J MED, V361, P2499, DOI 10.1056/NEJMp0911288; Rousseau P, 2000, J CLIN ONCOL, V18, P2000, DOI 10.1200/JCO.2000.18.9.2000; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; *SEER PROGR, LOC REG DIST STAG AD; Sirovich BE, 2004, JAMA-J AM MED ASSOC, V291, P2990, DOI 10.1001/jama.291.24.2990; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; The National Cancer Institute, SEER MED MED ENR CLA; Truog RD, 2009, NEW ENGL J MED, V361, P2501, DOI 10.1056/NEJMp0911447; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Warren JL, 2002, MED CARE, V40, P3; WELCH GH, 2004, SHOULD I BE TESTED C; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Woloshin S, 2010, JAMA-J AM MED ASSOC, V303, P164, DOI 10.1001/jama.2009.2007; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; 2007, CPT STANDARD EDITION	35	56	57	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1584	1591		10.1001/jama.2010.1449	http://dx.doi.org/10.1001/jama.2010.1449			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940384	Green Accepted, Bronze			2022-12-24	WOS:000282816500023
J	Zhou, RB; Yazdi, AS; Menu, P; Tschopp, J				Zhou, Rongbin; Yazdi, Amir S.; Menu, Philippe; Tschopp, Juerg			A role for mitochondria in NLRP3 inflammasome activation	NATURE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; OXYGEN SPECIES PRODUCTION; NALP3 INFLAMMASOME; DISEASE; CELLS; PATHOGENESIS; DYSFUNCTION; APOPTOSIS; AUTOPHAGY; CHANNEL	An inflammatory response initiated by the NLRP3 inflammasome is triggered by a variety of situations of host 'danger', including infection and metabolic dysregulation(1,2). Previous studies suggested that NLRP3 inflammasome activity is negatively regulated by autophagy and positively regulated by reactive oxygen species (ROS) derived from an uncharacterized organelle. Here we show that mitophagy/autophagy blockade leads to the accumulation of damaged, ROS-generating mitochondria, and this in turn activates the NLRP3 inflammasome. Resting NLRP3 localizes to endoplasmic reticulum structures, whereas on inflammasome activation both NLRP3 and its adaptor ASC redistribute to the perinuclear space where they co-localize with endoplasmic reticulum and mitochondria organelle clusters. Notably, both ROS generation and inflammasome activation are suppressed when mitochondrial activity is dysregulated by inhibition of the voltage-dependent anion channel. This indicates that NLRP3 inflammasome senses mitochondrial dysfunction and may explain the frequent association of mitochondrial damage with inflammatory diseases.	[Zhou, Rongbin; Yazdi, Amir S.; Menu, Philippe; Tschopp, Juerg] Univ Lausanne, Ctr Immun & Infect, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Ctr Immun & Infect, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Zhou, Rongbin/B-1430-2013		Swiss National Science Foundation; Institute for Arthritis Research; DFG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute for Arthritis Research; DFG(German Research Foundation (DFG))	This study was supported by grants of the Swiss National Science Foundation and by the Institute for Arthritis Research. A.S.Y. is a recipient of a stipend of the DFG. We would like to thank K. Schroder, C. Thomas and J. Vince for critical reading of the manuscript and G. W. Knott, EPFL, Lausanne, for help in collecting electron micrographs.	Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Latz E, 2010, BLOOD, V116, P1393, DOI 10.1182/blood-2010-06-287342; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Restivo NL, 2004, J PEDIATR GASTR NUTR, V38, P534, DOI 10.1097/00005176-200405000-00014; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yamagata H, 2009, ONCOGENE, V28, P3563, DOI 10.1038/onc.2009.213; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	28	3300	3440	22	686	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					221	225		10.1038/nature09663	http://dx.doi.org/10.1038/nature09663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21124315				2022-12-24	WOS:000286143400040
J	Xiang, Y; Yuan, QA; Vogt, N; Looger, LL; Jan, LY; Jan, YN				Xiang, Yang; Yuan, Quan; Vogt, Nina; Looger, Loren L.; Jan, Lily Yeh; Jan, Yuh Nung			Light-avoidance-mediating photoreceptors tile the Drosophila larval body wall	NATURE			English	Article							DEG/ENAC PROTEIN PICKPOCKET1; PROGRAMMED CELL-DEATH; SENSORY NEURONS; C-ELEGANS; GENE; EXPRESSION; CHANNELS; TRANSDUCTION; NOCICEPTION; VERTEBRATES	Photoreceptors for visual perception, phototaxis or light avoidance are typically clustered in eyes or related structures such as the Bolwig organ of Drosophila larvae. Unexpectedly, we found that the class IV dendritic arborization neurons of Drosophila melanogaster larvae respond to ultraviolet, violet and blue light, and are major mediators of light avoidance, particularly at high intensities. These class IV dendritic arborization neurons, which are present in every body segment, have dendrites tiling the larval body wall nearly completely without redundancy. Dendritic illumination activates class IV dendritic arborization neurons. These novel photoreceptors use phototransduction machinery distinct from other photoreceptors in Drosophila and enable larvae to sense light exposure over their entire bodies and move out of danger.	[Xiang, Yang; Yuan, Quan; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA; [Xiang, Yang; Yuan, Quan; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94158 USA; [Xiang, Yang; Yuan, Quan; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94158 USA; [Vogt, Nina] NYU, Ctr Dev Genet, New York, NY 10003 USA; [Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; New York University; Howard Hughes Medical Institute	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA.	yuhnung.jan@ucsf.edu	Yuan, Quan/E-7688-2013	Jan, Lily/0000-0003-3938-8498; Vogt, Nina/0000-0002-2658-9138; Jan, Yuh Nung/0000-0003-1367-6299	Human Frontier Science Program; Deutsche Forschungsgemeinschaft; NIH [2R37NS040929]; Howard Hughes Medical Institute, Janelia Farm Campus; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute, Janelia Farm Campus(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Garrity, C. Desplan, J. Blau, C. Montell, J. Hall, H. Amrein, L. Tian, S. Younger and S. Zhu for fly stocks and reagents; T. Jin for technical support; C. Han for generating whole larval images; H. H. Lee for collaboration to identify the 19-12-GAL4 and 21-7-GAL4 lines; R. Yang, H. H. Lee, B. Ye, J. Parrish, P. Soba, B. Schroeder and J. Bagley for discussions and advice; B. Ye, R. Yang, W. Ge and J. Berg for critical reading of the manuscript; and Jan laboratory members for discussions. Y.X. was a recipient of a Long-term Fellowship from the Human Frontier Science Program, N.V. is supported by Deutsche Forschungsgemeinschaft. This work is supported by a NIH grant (2R37NS040929) to Y.N.J. Y.X. and Q.Y. are associates, L.Y.J. and Y.N.J. are investigators of the Howard Hughes Medical Institute. L. L. L. is supported by the Howard Hughes Medical Institute, Janelia Farm Campus.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bai JW, 2009, NAT PROTOC, V4, P1502, DOI 10.1038/nprot.2009.147; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Fu YB, 2005, CURR OPIN NEUROBIOL, V15, P415, DOI 10.1016/j.conb.2005.06.011; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Millott N., 1968, Symposia of the Zoological Society of London, VNo. 23, P1; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Phillips JB, 2001, J EXP BIOL, V204, P2543; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SAITO M, 1991, J NEUROSCI, V11, P2135; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; STEVEN DM, 1963, BIOL REV, V38, P204, DOI 10.1111/j.1469-185X.1963.tb00783.x; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Ueda A, 2008, J NEUROGENET, V22, P103, DOI 10.1080/01677060701807954; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WILLSON RC, 1981, SCIENCE, V211, P700, DOI 10.1126/science.211.4483.700; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057; [No title captured]	49	295	299	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					921	U312		10.1038/nature09576	http://dx.doi.org/10.1038/nature09576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21068723	Green Accepted			2022-12-24	WOS:000285344600038
J	Suzuki, J; Umeda, M; Sims, PJ; Nagata, S				Suzuki, Jun; Umeda, Masato; Sims, Peter J.; Nagata, Shigekazu			Calcium-dependent phospholipid scrambling by TMEM16F	NATURE			English	Article							SCOTT-SYNDROME; BLOOD-COAGULATION; APOPTOTIC CELLS; EXPRESSION CLONING; PHOSPHATIDYLSERINE; FAMILY; PHOSPHATIDYLETHANOLAMINE; LYMPHOCYTES; DISORDER; EXPOSURE	In all animal cells, phospholipids are asymmetrically distributed between the outer and inner leaflets of the plasma membrane(1). This asymmetrical phospholipid distribution is disrupted in various biological systems. For example, when blood platelets are activated, they expose phosphatidylserine (PtdSer) to trigger the clotting system(2,3). The PtdSer exposure is believed to be mediated by Ca2+-dependent phospholipid scramblases that transport phospholipids bidirectionally(1,4), but its molecular mechanism is still unknown. Here we show that TMEM16F (transmembrane protein 16F) is an essential component for the Ca2+-dependent exposure of PtdSer on the cell surface. When a mouse B-cell line, Ba/F3, was treated with a Ca2+ ionophore under low-Ca2+ conditions, it reversibly exposed PtdSer. Using this property, we established a Ba/F3 subline that strongly exposed PtdSer by repetitive fluorescence-activated cell sorting. A complementary DNA library was constructed from the subline, and a cDNA that caused Ba/F3 to expose PtdSer spontaneously was identified by expression cloning. The cDNA encoded a constitutively active mutant of TMEM16F, a protein with eight transmembrane segments(5). Wild-type TMEM16F was localized on the plasma membrane and conferred Ca2+-dependent scrambling of phospholipids. A patient with Scott syndrome(6,7), which results from a defect in phospholipid scrambling activity(8,9), was found to carry a mutation at a splice-acceptor site of the gene encoding TMEM16F, causing the premature termination of the protein.	[Suzuki, Jun; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Suzuki, Jun; Nagata, Shigekazu] Japan Sci & Technology Corp, Core Res Evolut Sci & Technol, Kyoto 6068501, Japan; [Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Sims, Peter J.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; University of Rochester	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science; National Institutes of Health, USA	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Wiedmer for critical reading of our manuscript, and M. Fujii and M. Harayama for secretarial assistance. This work was supported in part by Grants-in-Aid for Specially Promoted Research (to S.N.) and for Young Scientists Start-up (to J.S.) from the Japan Society for the Promotion of Science. J.S. is supported by a research fellowship from the Japan Society for the Promotion of Science. P.J.S. was supported by grants from the National Institutes of Health, USA.	AOKI Y, 1994, J BIOCHEM-TOKYO, V116, P291, DOI 10.1093/oxfordjournals.jbchem.a124522; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; FUKUNAGA R, 1990, J BIOL CHEM, V265, P14008; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; KAVATHAS P, 1983, NATURE, V306, P385, DOI 10.1038/306385a0; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KOJIMA H, 1994, J CLIN INVEST, V94, P2237, DOI 10.1172/JCI117586; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Weiss HJ, 1997, BLOOD, V90, P475, DOI 10.1182/blood.V90.1.475; Wielders SJH, 2009, THROMB HAEMOSTASIS, V102, P76, DOI 10.1160/TH08-11-0719; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	36	591	611	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					834	U135		10.1038/nature09583	http://dx.doi.org/10.1038/nature09583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21107324	Green Submitted			2022-12-24	WOS:000285093700048
J	Neely, GG; Hess, A; Costigan, M; Keene, AC; Goulas, S; Langeslag, M; Griffin, RS; Belfer, I; Dai, F; Smith, SB; Diatchenko, L; Gupta, V; Xia, CP; Amann, S; Kreitz, S; Heindl-Erdmann, C; Wolz, S; Ly, CV; Arora, S; Sarangi, R; Dan, D; Novatchkova, M; Rosenzweig, M; Gibson, DG; Truong, D; Schramek, D; Zoranovic, T; Cronin, SJF; Angjeli, B; Brune, K; Dietzl, G; Maixner, W; Meixner, A; Thomas, W; Pospisilik, JA; Alenius, M; Kress, M; Subramaniam, S; Garrity, PA; Bellen, HJ; Woolf, CJ; Penninger, JM				Neely, G. Gregory; Hess, Andreas; Costigan, Michael; Keene, Alex C.; Goulas, Spyros; Langeslag, Michiel; Griffin, Robert S.; Belfer, Inna; Dai, Feng; Smith, Shad B.; Diatchenko, Luda; Gupta, Vaijayanti; Xia, Cui-Ping; Amann, Sabina; Kreitz, Silke; Heindl-Erdmann, Cornelia; Wolz, Susanne; Ly, Cindy V.; Arora, Suchir; Sarangi, Rinku; Dan, Debasis; Novatchkova, Maria; Rosenzweig, Mark; Gibson, Dustin G.; Truong, Darwin; Schramek, Daniel; Zoranovic, Tamara; Cronin, Shane J. F.; Angjeli, Belinda; Brune, Kay; Dietzl, Georg; Maixner, William; Meixner, Arabella; Thomas, Winston; Pospisilik, J. Andrew; Alenius, Mattias; Kress, Michaela; Subramaniam, Sai; Garrity, Paul A.; Bellen, Hugo J.; Woolf, Clifford J.; Penninger, Josef M.			A Genome-wide Drosophila Screen for Heat Nociception Identifies alpha 2 delta 3 as an Evolutionarily Conserved Pain Gene	CELL			English	Article							BLOOD OXYGENATION; NEUROPATHIC PAIN; BARREL CORTEX; MECHANISMS; SYNESTHESIA; MORPHOGENESIS; TRANSDUCTION; STIMULATION; PERCEPTION; MANAGEMENT	Worldwide, acute, and chronic pain affects 20% of the adult population and represents an enormous financial and emotional burden. Using genome-wide neuronal-specific RNAi knockdown in Drosophila, we report a global screen for an innate behavior and identify hundreds of genes implicated in heat nociception, including the alpha 2 delta family calcium channel subunit straightjacket (stj). Mice mutant for the stj ortholog CACNA2D3 (alpha 2 delta 3) also exhibit impaired behavioral heat pain sensitivity. In addition, in humans, alpha 2 delta 3 SNP variants associate with reduced sensitivity to acute noxious heat and chronic back pain. Functional imaging in alpha 2 delta 3 mutant mice revealed impaired transmission of thermal pain-evoked signals from the thalamus to higher-order pain centers. Intriguingly, in alpha 2 delta 3 mutant mice, thermal pain and tactile stimulation triggered strong cross-activation, or synesthesia, of brain regions involved in vision, olfaction, and hearing.	[Costigan, Michael; Woolf, Clifford J.] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Neurobiol, Boston, MA 02115 USA; [Costigan, Michael; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Neely, G. Gregory; Goulas, Spyros; Xia, Cui-Ping; Amann, Sabina; Novatchkova, Maria; Truong, Darwin; Schramek, Daniel; Zoranovic, Tamara; Cronin, Shane J. F.; Angjeli, Belinda; Meixner, Arabella; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Neely, G. Gregory] Garvan Inst Med Res, Neurosci Program, Sydney, NSW 2010, Australia; [Hess, Andreas; Kreitz, Silke; Heindl-Erdmann, Cornelia; Wolz, Susanne; Brune, Kay] Univ Erlangen Nurnberg, Dept Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Keene, Alex C.] NYU, Dept Biol, New York, NY 10003 USA; [Langeslag, Michiel; Kress, Michaela] Innsbruck Med Univ, Dept Physiol, Div Physiol & Med Phys, A-6020 Innsbruck, Austria; [Griffin, Robert S.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02129 USA; [Belfer, Inna; Dai, Feng] Univ Pittsburgh, Dept Anesthesiol, Mol Epidemiol Pain Program, Pittsburgh, PA USA; [Smith, Shad B.; Diatchenko, Luda; Gibson, Dustin G.; Maixner, William] Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC 27599 USA; [Gupta, Vaijayanti; Arora, Suchir; Sarangi, Rinku; Dan, Debasis; Subramaniam, Sai] Strand Life Sci Pvt Ltd, Bangalore, Karnataka, India; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Dept Mol & Human Genet, HHMI, Houston, TX 77030 USA; [Rosenzweig, Mark; Garrity, Paul A.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02458 USA; [Dietzl, Georg] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Thomas, Winston] Deltagen Inc, San Mateo, CA 94403 USA; [Pospisilik, J. Andrew] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Alenius, Mattias] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Garvan Institute of Medical Research; University of Erlangen Nuremberg; New York University; Medical University of Innsbruck; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Howard Hughes Medical Institute; Brandeis University; Howard Hughes Medical Institute; Stanford University; Max Planck Society; Linkoping University	Woolf, CJ (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Program Neurobiol, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu; josef.penninger@imba.oeaw.ac.at	Schramek, Daniel/J-5792-2014; Penninger, Josef M/I-6860-2013; Heindl-Erdmann, Cornelia/F-4809-2018; Pryjda, Tamara/O-5714-2019; neely, graham/A-6511-2011; Schramek, Daniel/AAL-1470-2020; Woolf, Clifford/A-9784-2010; Smith, Shad/AAO-8760-2020; Neely, Greg/AAB-4642-2020	Penninger, Josef M/0000-0002-8194-3777; Schramek, Daniel/0000-0001-9977-2104; Neely, Greg/0000-0002-1957-9732; zoranovic, tamara/0000-0002-5369-6385; Bellen, Hugo/0000-0001-5992-5989; Goulas, Spyros/0000-0002-7445-8917; Kress, Michaela/0000-0002-8921-7470; Gibson, Dustin/0000-0002-9073-3376; Garrity, Paul/0000-0002-8274-6564; Langeslag, Michiel/0000-0003-4883-7339	National Institute of Health NRSA [1 F32GM086207-01]; NIH [NS039518, NS038253, NS044232]; Mary Curie IIF; EuroThymaide; DFG [661/TP4]; BMBF [01EM0514, 01GQ0731, 0314102]; Doerenkamp Foundation for Innovations in Animal and Consumer Protection; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232, R01NS039518, R01NS058870, R37NS039518, P01NS072040, R01NS038253] Funding Source: NIH RePORTER	National Institute of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Curie IIF; EuroThymaide(European Commission); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Doerenkamp Foundation for Innovations in Animal and Consumer Protection; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of our laboratories and the VDRC for helpful discussions and excellent technical support. We thank Ricardo de Matos Simoes for support with statistical analysis. We thank B.J. Dickson for elav/UAS Dicer 2 stocks. alpha 2 delta 3 mutant mice were generated by Deltagen (San Mateo, CA). J.M.P. is supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU (AustroMouse), ApoSys, and an EU ERC Advanced Grant. A.C.K. is supported by National Institute of Health NRSA 1 F32GM086207-01. C.J.W. is supported by NIH NS039518 and NS038253. G.G.N. was supported by a Mary Curie IIF Fellowship and EuroThymaide. A.H. is supported by DFG 661/TP4 and BMBF (01EM0514, 01GQ0731, 0314102) and K.B. by the Doerenkamp Foundation for Innovations in Animal and Consumer Protection. P.A.G. is supported by NIH NS044232.	Aleman A, 2001, NEUROREPORT, V12, P2827, DOI 10.1097/00001756-200109170-00015; Arthurs OJ, 2002, TRENDS NEUROSCI, V25, P27, DOI 10.1016/S0166-2236(00)01995-0; Atlas SJ, 2001, SPINE, V26, P1179, DOI 10.1097/00007632-200105150-00017; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beauchamp MS, 2008, J NEUROSCI, V28, P13696, DOI 10.1523/JNEUROSCI.3872-08.2008; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dudycha GJ, 1935, J ABNORM SOC PSYCH, V30, P57, DOI 10.1037/h0060678; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Hess A, 2000, J NEUROSCI, V20, P3328, DOI 10.1523/JNEUROSCI.20-09-03328.2000; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Koester SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-212; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Ly CV, 2008, J CELL BIOL, V181, P157, DOI 10.1083/jcb.200712152; Manev H, 2004, EUR J PHARMACOL, V491, P207, DOI 10.1016/j.ejphar.2004.03.030; MELZACK R., 1999, PAIN S, V6, pS121, DOI [10.1016/s0304-3959(99)00145-1, DOI 10.1016/S0304-3959(99)00145-1]; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; PITCHER GM, 1995, NEUROSCIENCE, V65, P273, DOI 10.1016/0306-4522(94)00477-M; Premkumar LS, 2010, AAPS J, V12, P361, DOI 10.1208/s12248-010-9196-y; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Stuurman N, 1999, EXP CELL RES, V248, P350, DOI 10.1006/excr.1999.4396; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x	44	194	200	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					628	638		10.1016/j.cell.2010.09.047	http://dx.doi.org/10.1016/j.cell.2010.09.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074052	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000284149100019
J	Margolis, SS; Salogiannis, J; Lipton, DM; Mandel-Brehm, C; Wills, ZP; Mardinly, AR; Hu, LD; Greer, PL; Bikoff, JB; Ho, HYH; Soskis, MJ; Sahin, M; Greenberg, ME				Margolis, Seth S.; Salogiannis, John; Lipton, David M.; Mandel-Brehm, Caleigh; Wills, Zachary P.; Mardinly, Alan R.; Hu, Linda; Greer, Paul L.; Bikoff, Jay B.; Ho, Hsin-Yi Henry; Soskis, Michael J.; Sahin, Mustafa; Greenberg, Michael E.			EphB-Mediated Degradation of the RhoA GEF Ephexin5 Relieves a Developmental Brake on Excitatory Synapse Formation	CELL			English	Article							DENDRITIC SPINE MORPHOGENESIS; GROWTH CONE; TYROSINE PHOSPHORYLATION; ANGELMAN SYNDROME; EXCHANGE FACTORS; STRUCTURAL BASIS; IN-VIVO; RECEPTORS; SYNAPTOGENESIS; ACTIVATION	The mechanisms that promote excitatory synapse formation and maturation have been extensively studied. However, the molecular events that limit excitatory synapse development so that synapses form at the right time and place and in the correct numbers are less well understood. We have identified a RhoA guanine nucleotide exchange factor, Ephexin5, which negatively regulates excitatory synapse development until EphrinB binding to the EphB receptor tyrosine kinase triggers Ephexin5 phosphorylation, ubiquitination, and degradation. The degradation of Ephexin5 promotes EphB-dependent excitatory synapse development and is mediated by Ube3A, a ubiquitin ligase that is mutated in the human cognitive disorder Angelman syndrome and duplicated in some forms of Autism Spectrum Disorders (ASDs). These findings suggest that aberrant EphB/Ephexin5 signaling during the development of synapses may contribute to the abnormal cognitive function that occurs in Angelman syndrome and, possibly, ASDs.	[Margolis, Seth S.; Salogiannis, John; Lipton, David M.; Mandel-Brehm, Caleigh; Wills, Zachary P.; Mardinly, Alan R.; Hu, Linda; Greer, Paul L.; Bikoff, Jay B.; Ho, Hsin-Yi Henry; Soskis, Michael J.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Sahin, Mustafa] Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu	SAHIN, MUSTAFA/I-8653-2019; Bikoff, Jay/N-8107-2018; Salogiannis, John/AAX-3128-2021	SAHIN, MUSTAFA/0000-0001-7044-2953; Salogiannis, John/0000-0002-1988-7284; mandel-brehm, caleigh/0000-0001-7764-6529; Wills, Zachary/0000-0001-9822-6742; Mardinly, Alan/0000-0001-9891-6719	National Institute of Neurological Disorders and Stroke [RO1 5R01NS045500]; NRSA [5T32AG00222-15]; Edward R. and Anne G. Lefler postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward R. and Anne G. Lefler postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Thompson, Y. Zhou, and H. Ye for assistance in generating mice; E. Griffith, J. Zieg, S. Cohen, I. Spiegel, M. Andzelm, and the Greenberg lab for critical discussions. This work was supported by National Institute of Neurological Disorders and Stroke grant RO1 5R01NS045500 (M.E.G); NRSA Training grant 5T32AG00222-15 (S.S.M.); and Edward R. and Anne G. Lefler postdoctoral fellowship (S.S.M.).	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Fasen K, 2008, TRAFFIC, V9, P251, DOI 10.1111/j.1600-0854.2007.00679.x; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sharfe N, 2003, J IMMUNOL, V170, P6024, DOI 10.4049/jimmunol.170.12.6024; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	33	172	181	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					442	455		10.1016/j.cell.2010.09.038	http://dx.doi.org/10.1016/j.cell.2010.09.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029865	Green Accepted, Bronze			2022-12-24	WOS:000283603900017
J	Heo, JB; Sung, S				Heo, Jae Bok; Sung, Sibum			Vernalization-Mediated Epigenetic Silencing by a Long Intronic Noncoding RNA	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; X-CHROMOSOME; POLYCOMB; REQUIRES; FLC; TRANSCRIPTION; COMPLEX; GENES	Vernalization is an environmentally-induced epigenetic switch in which winter cold triggers epigenetic silencing of floral repressors and thus provides competence to flower in spring. In Arabidopsis, winter cold triggers enrichment of tri-methylated histone H3 Lys(27) at chromatin of the floral repressor, FLOWERING LOCUS C (FLC), and results in epigenetically stable repression of FLC. This epigenetic change is mediated by an evolutionarily conserved repressive complex, polycomb repressive complex 2 (PRC2). Here, we show that a long intronic noncoding RNA [termed COLD ASSISTED INTRONIC NONCODING RNA (COLDAIR)] is required for the vernalization-mediated epigenetic repression of FLC. COLDAIR physically associates with a component of PRC2 and targets PRC2 to FLC. Our results show that COLDAIR is required for establishing stable repressive chromatin at FLC through its interaction with PRC2.	[Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Sung, S (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	sbsung@mail.utexas.edu	Sung, Sibum/AAM-6500-2020		University of Texas at Austin; NSF	University of Texas at Austin; NSF(National Science Foundation (NSF))	We thank the members of Sung lab and E. Huq for helpful discussions, C. Pikaard for RNAPIV and RNAPV mutant seeds, and J. Goodrich for GFP::CLF seeds. S.S. thanks R. Amasino for encouragement and mentoring on the vernalization study. This work was supported by the start-up funds from the University of Texas at Austin and in part by the NSF to S.S.	De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Doyle MR, 2009, PLANT PHYSIOL, V151, P1688, DOI 10.1104/pp.109.145581; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Hsieh TF, 2003, TRENDS PLANT SCI, V8, P439, DOI 10.1016/S1360-1385(03)00189-4; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Khaitovich P, 2006, PLOS GENET, V2, P1590, DOI 10.1371/journal.pgen.0020171; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Lang A., 1965, PHYSL FLOWE INITIATI, P1371; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Sheldon CC, 2009, PLANT J, V59, P488, DOI 10.1111/j.1365-313X.2009.03883.x; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	27	740	798	17	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					76	79		10.1126/science.1197349	http://dx.doi.org/10.1126/science.1197349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21127216				2022-12-24	WOS:000285974000039
J	Jan, CH; Friedman, RC; Ruby, JG; Bartel, DP				Jan, Calvin H.; Friedman, Robin C.; Ruby, J. Graham; Bartel, David P.			Formation, regulation and evolution of Caenorhabditis elegans 3 ' UTRs	NATURE			English	Article							3' UNTRANSLATED REGIONS; GENE-EXPRESSION; MESSENGER-RNAS; POLYADENYLATION; COMPLEX; SEQUENCES; TARGETS; SWITCH	Post-transcriptional gene regulation frequently occurs through elements in mRNA 3' untranslated regions (UTRs)(1,2). Although crucial roles for 3'UTR-mediated gene regulation have been found in Caenorhabditis elegans(3-5), most C. elegans genes have lacked annotated 3'UTRs(6,7). Here we describe a high-throughput method for reliable identification of polyadenylated RNA termini, and we apply this method, called poly(A)-position profiling by sequencing (3P-Seq), to determine C. elegans 3'UTRs. Compared to standard methods also recently applied to C. elegans UTRs(8), 3P-Seq identified 8,580 additional UTRs while excluding thousands of shorter UTR isoforms that do not seem to be authentic. Analysis of this expanded and corrected data set suggested that the high A/U content of C. elegans 3'UTRs facilitated genome compaction, because the elements specifying cleavage and polyadenylation, which are A/U rich, can more readily emerge in A/U-rich regions. Indeed, 30% of the protein-coding genes have mRNAs with alternative, partially overlapping end regions that generate another 10,480 cleavage and polyadenylation sites that had gone largely unnoticed and represent potential evolutionary intermediates of progressive UTR shortening. Moreover, a third of the convergently transcribed genes use palindromic arrangements of bidirectional elements to specify UTRs with convergent overlap, which also contributes to genome compaction by eliminating regions between genes. Although nematode 3'UTRs have median length only one-sixth that of mammalian 3'UTRs, they have twice the density of conserved microRNA sites, in part because additional types of seed-complementary sites are preferentially conserved. These findings reveal the influence of cleavage and polyadenylation on the evolution of genome architecture and provide resources for studying post-transcriptional gene regulation.	[Jan, Calvin H.; Friedman, Robin C.; Ruby, J. Graham; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jan, Calvin H.; Friedman, Robin C.; Ruby, J. Graham; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Jan, Calvin H.; Friedman, Robin C.; Ruby, J. Graham; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Friedman, Robin C.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Friedman, Robin/0000-0003-2097-8332	NIH [GM067031]; National Science Foundation; Krell Institute/Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Krell Institute/Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Burge and members of the Bartel lab for discussions and the WIBR Genome Technology Core for sequencing. This work was supported by NIH grant GM067031 (D.P.B.), a National Science Foundation predoctoral fellowship (C.H.J.) and a Krell Institute/Department of Energy Computational Sciences Graduate Fellowship (R.C.F.).	Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Blumenthal Thomas, 2005, WormBook, P1, DOI 10.1895/wormbook.1.5.1; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Clark AM, 2010, NUCLEIC ACIDS RES, V38, P3780, DOI 10.1093/nar/gkq083; Evans D, 2001, GENE DEV, V15, P2562, DOI 10.1101/gad.920501; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Mangone M, 2008, NUCLEIC ACIDS RES, V36, pD57, DOI 10.1093/nar/gkm946; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Nunes NM, 2010, EMBO J, V29, P1523, DOI 10.1038/emboj.2010.42; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	36	314	330	1	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					97	U114		10.1038/nature09616	http://dx.doi.org/10.1038/nature09616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21085120	Green Accepted, Green Submitted			2022-12-24	WOS:000285921600039
J	Cafaro, J; Rieke, F				Cafaro, Jon; Rieke, Fred			Noise correlations improve response fidelity and stimulus encoding	NATURE			English	Article							RETINAL GANGLION-CELLS; FEEDFORWARD INHIBITION; FIRING RATE; CORTEX; VARIABILITY; SELECTIVITY; EXCITATION; NEURONS; INFORMATION; INTEGRATION	Computation in the nervous system often relies on the integration of signals from parallel circuits with different functional properties. Correlated noise in these inputs can, in principle, have diverse and dramatic effects on the reliability of the resulting computations(1-8). Such theoretical predictions have rarely been tested experimentally because of a scarcity of preparations that permit measurement of both the covariation of a neuron's input signals and the effect on a cell's output of manipulating such covariation. Here we introduce a method to measure covariation of the excitatory and inhibitory inputs a cell receives. This method revealed strong correlated noise in the inputs to two types of retinal ganglion cell. Eliminating correlated noise without changing other input properties substantially decreased the accuracy with which a cell's spike outputs encoded light inputs. Thus, covariation of excitatory and inhibitory inputs can be a critical determinant of the reliability of neural coding and computation.	[Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Cafaro, Jon; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	rieke@u.washington.edu			HHMI; NIH [EY-11850]; NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Dacey, O. Packer, J. Crook, B. Peterson and T. Haun for providing primate tissue; P. Newman and E. Martinson for technical assistance; T. Azevedo, E. J. Chichilnisky, F. Dunn, G. Murphy, S. Kuo, E. Shea-Brown, M. Shadlen and W. Spain for comments on the manuscript and discussions. Support was provided by HHMI and NIH (EY-11850).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Calkins DJ, 1996, NATURE, V381, P613, DOI 10.1038/381613a0; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Leary CJ, 2008, J NEUROSCI, V28, P5481, DOI 10.1523/JNEUROSCI.5041-07.2008; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; POLYAK S., 1949, DOCUMENTA OPHTHALMOL, V3, P24, DOI 10.1007/BF00162597; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Taylor WR, 2002, J NEUROSCI, V22, P7712; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545	32	96	97	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					964	U363		10.1038/nature09570	http://dx.doi.org/10.1038/nature09570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21131948	Green Accepted			2022-12-24	WOS:000285344600047
J	Ai, M; Min, S; Grosjean, Y; Leblanc, C; Bell, R; Benton, R; Suh, GSB				Ai, Minrong; Min, Soohong; Grosjean, Yael; Leblanc, Charlotte; Bell, Rati; Benton, Richard; Suh, Greg S. B.			Acid sensing by the Drosophila olfactory system	NATURE			English	Article							CARBON-DIOXIDE; CHEMOSENSORY RECEPTORS; TARGETED EXPRESSION; AVOIDANCE; NEURONS; TRANSMISSION; BEHAVIOR; REVEALS; MINOS; MAP	The odour of acids has a distinct quality that is perceived as sharp, pungent and often irritating(1). How acidity is sensed and translated into an appropriate behavioural response is poorly understood. Here we describe a functionally segregated population of olfactory sensory neurons in the fruitfly, Drosophila melanogaster, that are highly selective for acidity. These olfactory sensory neurons express IR64a, a member of the recently identified ionotropic receptor (IR) family of putative olfactory receptors(2). In vivo calcium imaging showed that IR64a+ neurons projecting to the DC4 glomerulus in the antennal lobe are specifically activated by acids. Flies in which the function of IR64a+ neurons or the IR64a gene is disrupted had defects in acid-evoked physiological and behavioural responses, but their responses to non-acidic odorants remained unaffected. Furthermore, artificial stimulation of IR64a+ neurons elicited avoidance responses. Taken together, these results identify cellular and molecular substrates for acid detection in the Drosophila olfactory system and support a labelled-line mode of acidity coding at the periphery.	[Ai, Minrong; Min, Soohong; Leblanc, Charlotte; Suh, Greg S. B.] NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA; [Grosjean, Yael; Bell, Rati; Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	New York University; University of Lausanne	Suh, GSB (corresponding author), NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA.	greg.suh@med.nyu.edu	Suh, Seong Bae/K-2434-2016; Grosjean, Yael/E-2634-2017; Min, Soohong/AEK-2200-2022; Min, Soohong/I-1607-2018	Grosjean, Yael/0000-0003-0689-8344; Suh, Greg/0000-0003-4381-658X; Min, Soohong/0000-0003-0683-2935	National Research Service Award; Boehringer Ingelheim Foundation; Centre National de la Recherche Scientifique; European Research Council; Swiss National Science Foundation; Alfred P. Sloan Foundation; Whitehall Foundation; Whitehead President Award; NIH [1RO1GM089746]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC010936] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Whitehall Foundation; Whitehead President Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Dus for helpful discussions and technical support for making anti-IR64a antibody; M. Kim for technical assistance; J. Treisman, N. Ringstad, C. Desplan, M. Warman, G. Fishell, M. Chesler, A. Wong, L. Vosshall and D. Anderson for discussions and comments on the manuscript; and R. Lehmann for sharing her two-photon microscope. This work was initiated in D. Anderson's laboratory at California Institute of Technology. G.S.B.S. thanks H.-R. Song for support. Financial support was provided by a National Research Service Award fellowship (M.A.), the Boehringer Ingelheim Foundation (R. Bell), the Centre National de la Recherche Scientifique (Y.G.), a European Research Council Starting Independent Researcher Grant (R. Benton), the Swiss National Science Foundation (R. Benton), the Alfred P. Sloan Foundation (G.S.), the Whitehall Foundation (G.S.), a Whitehead President Award (G.S.) and NIH grant 1RO1GM089746 (G.S).	Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; DRAVNIEKS A, 1982, SCIENCE, V218, P799, DOI 10.1126/science.7134974; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; FRANZ G, 1994, P NATL ACAD SCI USA, V91, P4746, DOI 10.1073/pnas.91.11.4746; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Sambongi Y, 2000, NEUROREPORT, V11, P2229, DOI 10.1097/00001756-200007140-00033; SHANBHAG SR, 1995, CELL TISSUE RES, V282, P237, DOI 10.1007/BF00319115; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	25	223	234	13	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					691	U112		10.1038/nature09537	http://dx.doi.org/10.1038/nature09537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21085119	Green Submitted, Green Accepted			2022-12-24	WOS:000284836700040
J	Gill, TM; Allore, HG; Gahbauer, EA; Murphy, TE				Gill, Thomas M.; Allore, Heather G.; Gahbauer, Evelyne A.; Murphy, Terrence E.			Change in Disability After Hospitalization or Restricted Activity in Older Persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL PERFORMANCE; CONTROLLED-TRIAL; LIFE EXPECTANCY; ELDERLY-PEOPLE; GAIT SPEED; ADULTS; RISK; CARE; REHABILITATION; FORECASTS	Context Disability among older persons is a complex and highly dynamic process, with high rates of recovery and frequent transitions between states of disability. The role of intervening illnesses and injuries (ie, events) on these transitions is uncertain. Objectives To evaluate the relationship between intervening events and transitions among states of no disability, mild disability, severe disability, and death and to determine the association of physical frailty with these transitions. Design, Setting, and Participants Prospective cohort study conducted in greater New Haven, Connecticut, from March 1998 to December 2008 of 754 community-living persons aged 70 years or older who were nondisabled at baseline in 4 essential activities of daily living: bathing, dressing, walking, and transferring. Telephone interviews were completed monthly for more than 10 years to assess disability and ascertain exposure to intervening events, which included illnesses and injuries leading to either hospitalization or restricted activity. Physical frailty (defined as gait speed > 10 seconds on the rapid gait test) was assessed every 18 months through 108 months. Main Outcome Measure Transitions between no disability, mild disability, and severe disability and 3 transitions from each of these states to death, evaluated each month. Results Hospitalization was strongly associated with 8 of the 9 possible transitions, with increased multivariable hazard ratios (HRs) as high as 168 (95% confidence interval [CI], 118-239) for the transition from no disability to severe disability and decreased HRs as low as 0.41 (95% CI, 0.30-0.54) for the transition from mild disability to no disability. Restricted activity also increased the likelihood of transitioning from no disability to both mild and severe disability (HR, 2.59; 95% CI, 2.23-3.02; and HR, 8.03; 95% CI, 5.28-12.21), respectively, and from mild disability to severe disability (HR, 1.45; 95% CI, 1.14-1.84), but was not associated with recovery from mild or severe disability. For all 9 transitions, the presence of physical frailty accentuated the associations of the intervening events. For example, the absolute risk of transitioning from no disability to mild disability within 1 month after hospitalization for frail individuals was 34.9% (95% CI, 34.5%-35.3%) vs 4.9% (95% CI, 4.7%-5.1%) for non-frail individuals. Among the possible reasons for hospitalization, fall-related injury conferred the highest likelihood of developing new or worsening disability. Conclusions Among older persons, particularly those who were physically frail, intervening illnesses and injuries greatly increased the likelihood of developing new or worsening disability. Only the most potent events, ie, those leading to hospitalization, reduced the likelihood of recovery from disability. JAMA. 2010; 304(17): 1919-1928	[Gill, Thomas M.] Yale Univ, Sch Med, Dept Internal Med, Adler Geriatr Ctr, New Haven, CT 06504 USA	Yale University	Gill, TM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Adler Geriatr Ctr, 20 York St, New Haven, CT 06504 USA.	thomas.gill@yale.edu	Gill, Thomas M./H-7043-2019; Murphy, Terrence E/A-9394-2009	Gill, Thomas M./0000-0002-6450-0368; Allore, Heather/0000-0001-7685-8175	National Institute on Aging [R37AG17560, R01AG022993, K24AG021507]; NATIONAL INSTITUTE ON AGING [R37AG017560, R01AG022993, K24AG021507, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work for this report was funded by grants from the National Institute on Aging (R37AG17560, R01AG022993). The study was conducted at the Yale Claude D. Pepper Older Americans Independence Center (P30AG21342). Dr Gill is the recipient of a Midcareer Investigator Award in Patient-Oriented Research (K24AG021507) from the National Institute on Aging.	Allison P. D., 1995, SURVIVAL ANAL USING; Baker CJ, 2010, ANN INTERN MED, V152, P36, DOI 10.7326/0003-4819-152-1-201001050-00008; Barry LC, 2008, ARCH GEN PSYCHIAT, V65, P172, DOI 10.1001/archgenpsychiatry.2007.17; BENICHOU J, 1990, BIOMETRICS, V46, P813, DOI 10.2307/2532098; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Ferrucci Luigi, 1997, JAMA (Journal of the American Medical Association), V277, P728, DOI 10.1001/jama.277.9.728; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Gill TM, 2008, J AM GERIATR SOC, V56, P436, DOI 10.1111/j.1532-5415.2007.01603.x; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Gill TM, 2001, J AM GERIATR SOC, V49, P1039, DOI 10.1046/j.1532-5415.2001.49206.x; Goodwin James S, 2002, Lancet, V359, P1358, DOI 10.1016/S0140-6736(02)08318-6; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Hardy SE, 2005, AM J EPIDEMIOL, V161, P575, DOI 10.1093/aje/kwi083; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Hoenig H, 1997, J AM GERIATR SOC, V45, P1371, DOI 10.1111/j.1532-5415.1997.tb02939.x; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lin HQ, 2008, BIOMETRICS, V64, P1032, DOI 10.1111/j.1541-0420.2008.01011.x; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; MANTON KG, 1993, J GERONTOL, V48, P11, DOI 10.1093/geronj/48.Special_Issue.11; Olshansky SJ, 2009, MILBANK Q, V87, P842, DOI 10.1111/j.1468-0009.2009.00581.x; Rich MW, 2001, J GERONTOL A-BIOL, V56, pM88, DOI 10.1093/gerona/56.2.M88; ROCKWOOD K, 1994, CAN MED ASSOC J, V150, P489; Straus SE, 2002, JAMA-J AM MED ASSOC, V288, P1396, DOI 10.1001/jama.288.11.1396; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Tinetti ME, 2002, JAMA-J AM MED ASSOC, V287, P2098, DOI 10.1001/jama.287.16.2098; US Census Bureau, AM FACTFINDER; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881	40	336	341	1	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2010	304	17					1919	1928		10.1001/jama.2010.1568	http://dx.doi.org/10.1001/jama.2010.1568			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674GT	21045098	Green Accepted, Bronze			2022-12-24	WOS:000283725900022
J	Srikanth, CV; Wall, DM; Maldonado-Contreras, A; Shi, HN; Zhou, DG; Demma, Z; Mumy, KL; McCormick, BA				Srikanth, C. V.; Wall, Daniel M.; Maldonado-Contreras, Ana; Shi, Hai Ning; Zhou, Daoguo; Demma, Zachary; Mumy, Karen L.; McCormick, Beth A.			Salmonella Pathogenesis and Processing of Secreted Effectors by Caspase-3	SCIENCE			English	Article							EPITHELIAL-CELLS; TYPHIMURIUM; PROTEIN; INVASION; ACTIN; IDENTIFICATION; FILAMENTS; ABILITY; GROWTH; DOMAIN	The enteric pathogen Salmonella enterica serovar Typhimurium causes food poisoning resulting in gastroenteritis. The S. Typhimurium effector Salmonella invasion protein A (SipA) promotes gastroenteritis by functional motifs that trigger either mechanisms of inflammation or bacterial entry. During infection of intestinal epithelial cells, SipA was found to be responsible for the early activation of caspase-3, an enzyme that is required for SipA cleavage at a specific recognition motif that divided the protein into its two functional domains and activated SipA in a manner necessary for pathogenicity. Other caspase-3 cleavage sites identified in S. Typhimurium appeared to be restricted to secreted effector proteins, which indicates that this may be a general strategy used by this pathogen for processing of its secreted effectors.	[Srikanth, C. V.; Wall, Daniel M.; Shi, Hai Ning; Mumy, Karen L.; McCormick, Beth A.] Harvard Univ, Sch Med, Dept Pediat Gastroenterol & Nutr, Boston, MA 02129 USA; [Srikanth, C. V.; Wall, Daniel M.; Shi, Hai Ning; Mumy, Karen L.; McCormick, Beth A.] Massachusetts Gen Hosp, Boston, MA 02129 USA; [Srikanth, C. V.; Maldonado-Contreras, Ana; Demma, Zachary; Mumy, Karen L.; McCormick, Beth A.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Wall, Daniel M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Zhou, Daoguo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Glasgow; Purdue University System; Purdue University; Purdue University West Lafayette Campus	McCormick, BA (corresponding author), Harvard Univ, Sch Med, Dept Pediat Gastroenterol & Nutr, Boston, MA 02129 USA.	Beth.McCormick@umassmed.edu	Maldonado-Contreras, Ana/ABA-2738-2020	Maldonado-Contreras, Ana/0000-0002-5967-9623	NIH [DK56754, DK33506]; Crohn's and Colitis Foundation of America; Tenovus Scotland; Society for General Microbiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, P30DK040561, R01DK056754] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Tenovus Scotland; Society for General Microbiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by grants from the NIH (DK56754 and DK33506) and the Crohn's and Colitis Foundation of America to B. A. M. Additional grant support was provided by Tenovus Scotland and a Society for General Microbiology travel award to D. M. W. The use of human volunteers in this study was in accordance with appropriate guidelines and was approved by the University of Massachusetts Medical School Review Board for the Protection of Human Subjects (approval no. 13006).	Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Cherayil BJ, 2000, INFECT IMMUN, V68, P5567, DOI 10.1128/IAI.68.10.5567-5574.2000; Chiu HJ, 2005, MICROBIOL-SGM, V151, P3277, DOI 10.1099/mic.0.28115-0; Deane JE, 2008, J MOL BIOL, V377, P985, DOI 10.1016/j.jmb.2008.01.072; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Lee CA, 2000, P NATL ACAD SCI USA, V97, P12283, DOI 10.1073/pnas.97.22.12283; LEE CA, 1992, P NATL ACAD SCI USA, V89, P1847, DOI 10.1073/pnas.89.5.1847; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; MCCORMICK BA, 1988, INFECT IMMUN, V56, P2209, DOI 10.1128/IAI.56.9.2209-2217.1988; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Nhan TQ, 2006, AM J PATHOL, V169, P729, DOI 10.2353/ajpath.2006.060105; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ramarao N, 2007, FEBS LETT, V581, P853, DOI 10.1016/j.febslet.2007.01.057; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Wall DM, 2007, CELL MICROBIOL, V9, P2299, DOI 10.1111/j.1462-5822.2007.00960.x; Wood MW, 2000, CELL MICROBIOL, V2, P293, DOI 10.1046/j.1462-5822.2000.00054.x; Zakeri Z, 2008, ADV EXP MED BIOL, V615, P1, DOI 10.1007/978-1-4020-6554-5_1; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	22	76	82	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					390	393		10.1126/science.1194598	http://dx.doi.org/10.1126/science.1194598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947770	Green Accepted			2022-12-24	WOS:000282986700046
J	Ajikumar, PK; Xiao, WH; Tyo, KEJ; Wang, Y; Simeon, F; Leonard, E; Mucha, O; Phon, TH; Pfeifer, B; Stephanopoulos, G				Ajikumar, Parayil Kumaran; Xiao, Wen-Hai; Tyo, Keith E. J.; Wang, Yong; Simeon, Fritz; Leonard, Effendi; Mucha, Oliver; Phon, Too Heng; Pfeifer, Blaine; Stephanopoulos, Gregory			Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli	SCIENCE			English	Article							LYCOPENE PRODUCTION; BIOSYNTHETIC GENES; CYTOCHROME-P450; TERPENOIDS; TAXADIENE; CONSTRUCTION; OXYGENASES; CELLS; YEAST; STEP	Taxol (paclitaxel) is a potent anticancer drug first isolated from the Taxus brevifolia Pacific yew tree. Currently, cost-efficient production of Taxol and its analogs remains limited. Here, we report a multivariate-modular approach to metabolic-pathway engineering that succeeded in increasing titers of taxadiene-the first committed Taxol intermediate-approximately 1 gram per liter (similar to 15,000-fold) in an engineered Escherichia coli strain. Our approach partitioned the taxadiene metabolic pathway into two modules: a native upstream methylerythritol-phosphate (MEP) pathway forming isopentenyl pyrophosphate and a heterologous downstream terpenoid-forming pathway. Systematic multivariate search identified conditions that optimally balance the two pathway modules so as to maximize the taxadiene production with minimal accumulation of indole, which is an inhibitory compound found here. We also engineered the next step in Taxol biosynthesis, a P450-mediated 5 alpha-oxidation of taxadiene to taxadien-5 alpha-ol. More broadly, the modular pathway engineering approach helped to unlock the potential of the MEP pathway for the engineered production of terpenoid natural products.	[Wang, Yong; Pfeifer, Blaine] Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA; [Ajikumar, Parayil Kumaran; Xiao, Wen-Hai; Tyo, Keith E. J.; Simeon, Fritz; Leonard, Effendi; Mucha, Oliver; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Ajikumar, Parayil Kumaran; Phon, Too Heng; Stephanopoulos, Gregory] Singapore MIT Alliance, Chem & Pharmaceut Engn Program, Singapore 117546, Singapore	Tufts University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Pfeifer, B (corresponding author), Tufts Univ, Dept Biol & Chem Engn, 4 Colby St, Medford, MA 02155 USA.	blaine.pfeifer@tufts.edu; gregstep@mit.edu	Tyo, Keith/H-6227-2012; Tyo, Keith/D-1817-2009; Tyo, Keith/AAM-4543-2020	Tyo, Keith/0000-0002-2342-0687	Singapore-MIT Alliance [SMA-2]; NIH [1-R01-GM085323-01A1]; Milheim Foundation [2006-17]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085323] Funding Source: NIH RePORTER	Singapore-MIT Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milheim Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Renu for extraction, purification, and characterization of metabolite Indole; C. Santos for providing the pACYCmelA plasmid, constructive suggestions during the experiments, and preparation of the manuscript; D. Dugar, H. Zhou, and X. Huang for helping with experiments and suggestions; and K. Hiller for data analysis and comments on the manuscript. We gratefully acknowledge support by the Singapore-MIT Alliance (SMA-2) and NIH, grant 1-R01-GM085323-01A1. B.P. acknowledges the Milheim Foundation Grant for Cancer Research 2006-17. A patent application that is based on the results presented here has been filed by MIT. P. K. A. designed the experiments and performed the engineering and screening of the strains; W-H. X. performed screening of the strains, bioreactor experiments, and GC-MS analysis; F. S. carried out the quantitative PCR measurements; O.M. performed the extraction and characterization of taxadiene standard; E. L., Y.W., and B. P. supported with cloning experiments; P. K. A., K.E.J.T., T. H. P., B. P. and G. S. analyzed the data; P. K. A., K.E.J.T., and G. S. wrote the manuscript; G. S. supervised the research; and all of the authors contributed to discussion of the research and edited and commented on the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Chang MCY, 2006, NAT CHEM BIOL, V2, P674, DOI 10.1038/nchembio836; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; Engels B, 2008, METAB ENG, V10, P201, DOI 10.1016/j.ymben.2008.03.001; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Farmer WR, 2001, BIOTECHNOL PROGR, V17, P57, DOI 10.1021/bp000137t; Frense D, 2007, APPL MICROBIOL BIOT, V73, P1233, DOI 10.1007/s00253-006-0711-0; Goodman J., 2001, STORY TAXOL NATURE P; HOLTON RA, 1994, J AM CHEM SOC, V116, P1597, DOI 10.1021/ja00083a066; Holton RA., 1995, TAXOL SCI APPL, P97, DOI DOI 10.1002/CHIN.199552275; Huang QL, 2001, BIOORGAN MED CHEM, V9, P2237, DOI 10.1016/S0968-0896(01)00072-4; Jennewein S, 2005, BIOTECHNOL BIOENG, V89, P588, DOI 10.1002/bit.20390; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Kaspera Rudiger, 2006, Phytochemistry Reviews, V5, P433, DOI 10.1007/s11101-006-9006-4; Kingston DGI, 2007, PHYTOCHEMISTRY, V68, P1844, DOI 10.1016/j.phytochem.2006.11.009; Klein-Marcuschamer D, 2007, TRENDS BIOTECHNOL, V25, P417, DOI 10.1016/j.tibtech.2007.07.006; Leonard E, 2007, APPL ENVIRON MICROB, V73, P7246, DOI 10.1128/AEM.01411-07; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Morrone D, 2010, APPL MICROBIOL BIOT, V85, P1893, DOI 10.1007/s00253-009-2219-x; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Rontein D, 2008, J BIOL CHEM, V283, P6067, DOI 10.1074/jbc.M708950200; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Suffness M, 1995, TAXOL SCI APPL, P3; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003; Walji AM, 2007, SYNLETT, P1477, DOI 10.1055/s-2007-980382; Walker K, 2001, PHYTOCHEMISTRY, V58, P1, DOI 10.1016/S0031-9422(01)00160-1; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005	36	1106	1271	46	1000	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					70	74		10.1126/science.1191652	http://dx.doi.org/10.1126/science.1191652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929806	Green Submitted, Green Accepted			2022-12-24	WOS:000282334500035
J	Tursun, B; Patel, T; Kratsios, P; Hobert, O				Tursun, Baris; Patel, Tulsi; Kratsios, Paschalis; Hobert, Oliver			Direct Conversion of C. elegans Germ Cells into Specific Neuron Types	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HISTONE CHAPERONES; STEM-CELLS; GENE; EXPRESSION; DIFFERENTIATION; TOTIPOTENCY; INDUCTION; ENCODES; PATHWAY	The ability of transcription factors to directly reprogram the identity of cell types is usually restricted and is defined by cellular context. Through the ectopic expression of single Caenorhabditis elegans transcription factors, we found that the identity of mitotic germ cells can be directly converted into that of specific neuron types: glutamatergic, cholinergic, or GABAergic. This reprogramming event requires the removal of the histone chaperone LIN-53 (RbAp46/48 in humans), a component of several histone remodeling and modifying complexes, and this removal can be mimicked by chemical inhibition of histone deacetylases. Our findings illustrate the ability of germ cells to be directly converted into individual, terminally differentiated neuron types and demonstrate that a specific chromatin factor provides a barrier for cellular reprogramming.	[Tursun, Baris; Patel, Tulsi; Kratsios, Paschalis; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Tursun, B (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.	bt2189@columbia.edu; or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854; Tursun, Baris/0000-0001-7293-8629; Kratsios, Paschalis/0000-0002-1363-9271	NIH [R01NS039996-05, R01NS050266-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266, R01NS039996] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants R01NS039996-05 and R01NS050266-03. O.H. is an Investigator of the HHMI and B.T. is a Francis Goelet Research Scientist. We thank T. Schedl, M. Krause, J. McGhee, P. Sengupta, Y. B. Qi, Y. Jin, M. Nonet, S. Strome, and members of the Hobert lab for reagents; I. Greenwald and members of the Hobert lab for comments on the manuscript; and Q. Chen for expert assistance in strain generation.	AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BARTON MK, 1987, GENETICS, V115, P107; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Cinar H, 2005, CURR BIOL, V15, P340, DOI 10.1016/j.cub.2005.02.025; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; CUI M, 2007, WORMBOOK, DOI DOI 10.1895/W0RMB00K.1.139.1; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Prasad B, 2008, DEV BIOL, V323, P207, DOI 10.1016/j.ydbio.2008.08.029; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	28	153	153	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2011	331	6015					304	308		10.1126/science.1199082	http://dx.doi.org/10.1126/science.1199082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21148348	Green Accepted			2022-12-24	WOS:000286636300029
J	Wei, W; Hamby, AM; Zhou, KL; Feller, MB				Wei, Wei; Hamby, Aaron M.; Zhou, Kaili; Feller, Marla B.			Development of asymmetric inhibition underlying direction selectivity in the retina	NATURE			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; VISUAL EXPERIENCE; IDENTIFICATION; ORGANIZATION; CONNECTIONS; MECHANISMS; DENDRITES	Establishing precise synaptic connections is crucial to the development of functional neural circuits. The direction-selective circuit in the retina relies upon highly selective wiring of inhibitory inputs from starburst amacrine cells(1) (SACs) onto four subtypes of ON-OFF direction-selective ganglion cells (DSGCs), each preferring motion in one of four cardinal directions(2). It has been reported in rabbit that the SACs on the 'null' sides of DSGCs form functional GABA (c-aminobutyric acid)-mediated synapses, whereas those on the preferred sides do not(3). However, it is not known how the asymmetric wiring between SACs and DSGCs is established during development. Here we report that in transgenic mice with cell-type-specific labelling, the synaptic connections from SACs to DSGCs were of equal strength during the first postnatal week, regardless of whether the SAC was located on the preferred or null side of the DSGC. However, by the end of the second postnatal week, the strength of the synapses made from SACs on the null side of a DSGC significantly increased whereas those made from SACs located on the preferred side remained constant. Blocking retinal activity by intraocular injections of muscimol or gabazine during this period did not alter the development of direction selectivity. Hence, the asymmetric inhibition between the SACs and DSGCs is achieved by a developmental program that specifically strengthens the GABA-mediated inputs from SACs located on the null side, in a manner not dependent on neural activity.	[Wei, Wei; Hamby, Aaron M.; Zhou, Kaili; Feller, Marla B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Feller, Marla B.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Feller, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mfeller@berkeley.edu			National Institutes of Health [RO1EY013528, ARRA EY019498]; NATIONAL EYE INSTITUTE [R01EY013528, R01EY019498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Nakanishi for mGluR2-GFP mice, A. Huberman for Drd4-GFP mice, J. Elstrott for help with MATLAB software, X. Han for mouse genotyping, J. Ledue for imaging assistance and A. Blankenship for reading the manuscript. This work was supported by grants RO1EY013528 and ARRA EY019498 from the National Institutes of Health.	Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Elstrott J, 2010, J NEUROSCI, V30, P11197, DOI 10.1523/JNEUROSCI.2302-10.2010; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Famiglietti EV, 2002, VISUAL NEUROSCI, V19, P145, DOI 10.1017/S0952523802191139; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; VANEY DI, 1989, NEUROBIOLOGY INNER R, P157; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Wei W, 2010, NAT PROTOC, V5, P1347, DOI 10.1038/nprot.2010.106; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	30	131	133	4	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					402	+		10.1038/nature09600	http://dx.doi.org/10.1038/nature09600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21131947	Green Accepted			2022-12-24	WOS:000286385600053
J	Denoeud, F; Henriet, S; Mungpakdee, S; Aury, JM; Da Silva, C; Brinkmann, H; Mikhaleva, J; Olsen, LC; Jubin, C; Canestro, C; Bouquet, JM; Danks, G; Poulain, J; Campsteijn, C; Adamski, M; Cross, I; Yadetie, F; Muffato, M; Louis, A; Butcher, S; Tsagkogeorga, G; Konrad, A; Singh, S; Jensen, MF; Cong, EH; Eikeseth-Otteraa, H; Noel, B; Anthouard, V; Porcel, BM; Kachouri-Lafond, R; Nishino, A; Ugolini, M; Chourrout, P; Nishida, H; Aasland, R; Huzurbazar, S; Westhof, E; Delsuc, F; Lehrach, H; Reinhardt, R; Weissenbach, J; Roy, SW; Artiguenave, F; Postlethwait, JH; Manak, JR; Thompson, EM; Jaillon, O; Du Pasquier, L; Boudinot, P; Liberles, DA; Volff, JN; Philippe, H; Lenhard, B; Roest Crollius, H; Wincker, P; Chourrout, D				Denoeud, France; Henriet, Simon; Mungpakdee, Sutada; Aury, Jean-Marc; Da Silva, Corinne; Brinkmann, Henner; Mikhaleva, Jana; Olsen, Lisbeth Charlotte; Jubin, Claire; Canestro, Cristian; Bouquet, Jean-Marie; Danks, Gemma; Poulain, Julie; Campsteijn, Coen; Adamski, Marcin; Cross, Ismael; Yadetie, Fekadu; Muffato, Matthieu; Louis, Alexandra; Butcher, Stephen; Tsagkogeorga, Georgia; Konrad, Anke; Singh, Sarabdeep; Jensen, Marit Flo; Cong, Evelyne Huynh; Eikeseth-Otteraa, Helen; Noel, Benjamin; Anthouard, Veronique; Porcel, Betina M.; Kachouri-Lafond, Rym; Nishino, Atsuo; Ugolini, Matteo; Chourrout, Pascal; Nishida, Hiroki; Aasland, Rein; Huzurbazar, Snehalata; Westhof, Eric; Delsuc, Frederic; Lehrach, Hans; Reinhardt, Richard; Weissenbach, Jean; Roy, Scott W.; Artiguenave, Francois; Postlethwait, John H.; Manak, J. Robert; Thompson, Eric M.; Jaillon, Olivier; Du Pasquier, Louis; Boudinot, Pierre; Liberles, David A.; Volff, Jean-Nicolas; Philippe, Herve; Lenhard, Boris; Roest Crollius, Hugues; Wincker, Patrick; Chourrout, Daniel			Plasticity of Animal Genome Architecture Unmasked by Rapid Evolution of a Pelagic Tunicate	SCIENCE			English	Article							ORIGINS; INTRON; GENES	Genomes of animals as different as sponges and humans show conservation of global architecture. Here we show that multiple genomic features including transposon diversity, developmental gene repertoire, physical gene order, and intron-exon organization are shattered in the tunicate Oikopleura, belonging to the sister group of vertebrates and retaining chordate morphology. Ancestral architecture of animal genomes can be deeply modified and may therefore be largely nonadaptive. This rapidly evolving animal lineage thus offers unique perspectives on the level of genome plasticity. It also illuminates issues as fundamental as the mechanisms of intron gain.	[Denoeud, France; Aury, Jean-Marc; Da Silva, Corinne; Jubin, Claire; Poulain, Julie; Noel, Benjamin; Anthouard, Veronique; Porcel, Betina M.; Weissenbach, Jean; Artiguenave, Francois; Jaillon, Olivier; Wincker, Patrick] CEA, Inst Genom, Evry, France; [Denoeud, France; Aury, Jean-Marc; Da Silva, Corinne; Jubin, Claire; Poulain, Julie; Noel, Benjamin; Anthouard, Veronique; Porcel, Betina M.; Weissenbach, Jean; Artiguenave, Francois; Jaillon, Olivier; Wincker, Patrick] CNRS, UMR 8030, Evry, France; [Denoeud, France; Aury, Jean-Marc; Da Silva, Corinne; Jubin, Claire; Poulain, Julie; Noel, Benjamin; Anthouard, Veronique; Porcel, Betina M.; Weissenbach, Jean; Artiguenave, Francois; Jaillon, Olivier; Wincker, Patrick] Univ Evry, Evry, France; [Henriet, Simon; Mungpakdee, Sutada; Mikhaleva, Jana; Olsen, Lisbeth Charlotte; Bouquet, Jean-Marie; Danks, Gemma; Campsteijn, Coen; Adamski, Marcin; Yadetie, Fekadu; Jensen, Marit Flo; Cong, Evelyne Huynh; Eikeseth-Otteraa, Helen; Ugolini, Matteo; Thompson, Eric M.; Lenhard, Boris; Chourrout, Daniel] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Brinkmann, Henner; Philippe, Herve] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Canestro, Cristian; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Danks, Gemma; Lenhard, Boris] Univ Bergen, Bergen Ctr Computat Sci, Bergen, Norway; [Cross, Ismael] Univ Cadiz, Genet Lab, Cadiz, Spain; [Muffato, Matthieu; Louis, Alexandra; Roest Crollius, Hugues] Ecole Normale Super, CNRS, IBENS, Dyogen Lab,UMR8197, Paris, France; [Butcher, Stephen; Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Tsagkogeorga, Georgia; Delsuc, Frederic] Univ Montpellier 2, CNRS, Inst Sci Evolut, Lab Paleontol Phylogenie & Paleobiol,UMR 5554, Montpellier, France; [Singh, Sarabdeep; Huzurbazar, Snehalata] Univ Wyoming, Dept Stat, Laramie, WY 82071 USA; [Kachouri-Lafond, Rym; Westhof, Eric] Univ Strasbourg, CNRS, Inst Biol Cellulaire & Mol, Strasbourg, France; [Nishino, Atsuo; Nishida, Hiroki] Osaka Univ, Dept Biol Sci, Osaka, Japan; [Chourrout, Pascal] Ctr Hosp Albi, Albi, France; [Aasland, Rein] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Lehrach, Hans; Reinhardt, Richard] Max Planck Inst Mol Genet, Berlin, Germany; [Roy, Scott W.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Thompson, Eric M.; Lenhard, Boris] Univ Bergen, Dept Biol, Bergen, Norway; [Du Pasquier, Louis] Univ Basel, Inst Zool & Evolutionary Biol, Basel, Switzerland; [Boudinot, Pierre] INRA Virol & Immunol Mol, Jouy En Josas, France; [Konrad, Anke; Liberles, David A.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Volff, Jean-Nicolas] Univ Lyon 1, Ecole Normale Super Lyon, Ecole Normale Super, Inst Genom Fonct Lyon,UMR 5242,CNRS,INRA, F-69365 Lyon, France; [Canestro, Cristian] Univ Barcelona, Dept Genet, E-08007 Barcelona, Spain	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Bergen; Universite de Montreal; University of Oregon; University of Bergen; Universidad de Cadiz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Iowa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Wyoming; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Osaka University; University of Bergen; Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Bergen; University of Basel; INRAE; University of Wyoming; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); University of Barcelona	Wincker, P (corresponding author), CEA, Inst Genom, Evry, France.	pwincker@genoscope.cns.fr; Daniel.Chourrout@sars.uib.no	Nishino, Atsuo/F-5393-2013; boudinot, pierre/L-4246-2016; Nishino, Atsuo/AAH-1387-2019; Cross, Ismael/K-1674-2014; Singh, Sarabdeep/D-7881-2017; Delsuc, Frederic/B-4381-2009; Cañestro, Cristian/L-9661-2014; Yadetie, Fekadu/HDL-8798-2022; Konrad, Anke/AAP-4688-2020; Nishida, Hiroki/B-1851-2008; Jaillon, Olivier/GRY-6287-2022; Konrad, Anke/X-9107-2019; Aury, Jean-Marc/N-1621-2019	Nishino, Atsuo/0000-0003-2818-4377; Nishino, Atsuo/0000-0003-2818-4377; Cross, Ismael/0000-0002-2291-5629; Delsuc, Frederic/0000-0002-6501-6287; Cañestro, Cristian/0000-0003-4623-8105; Nishida, Hiroki/0000-0002-7249-1668; Konrad, Anke/0000-0003-3994-460X; Aury, Jean-Marc/0000-0003-1718-3010; DA SILVA, Corinne/0000-0002-7618-7831; Henriet, Simon/0000-0001-8792-6639; Manak, John/0000-0002-6562-7694; Porcel, Betina/0000-0003-0169-5302; Lenhard, Boris/0000-0002-1114-1509; Yadetie, Fekadu/0000-0002-2484-9047; Noel, Benjamin/0000-0002-5830-3253; Jaillon, Olivier/0000-0002-7237-9596; ROEST CROLLIUS, Hugues/0000-0002-8209-173X; Huzurbazar, Snehalata/0000-0001-9637-5445; Louis, Alexandra/0000-0001-7032-5650; Poulain, Julie/0000-0002-8744-3116; Olsen, Lisbeth Charlotte/0000-0002-7469-0169; Denoeud, France/0000-0001-8819-7634; Muffato, Matthieu/0000-0002-7860-3560; Reinhardt, Richard/0000-0001-9376-2132; Danks, Gemma/0000-0001-7004-0065; Mikhaleva, Yana/0000-0002-5872-0495; boudinot, pierre/0000-0002-7490-9677	Sars Centre; Norwegian Research Council; Genoscope; NSF [IOS-0719577, DBI-0743374]; NATIONAL LIBRARY OF MEDICINE [Z01LM000073, ZIALM000073] Funding Source: NIH RePORTER	Sars Centre; Norwegian Research Council(Research Council of NorwayEuropean Commission); Genoscope; NSF(National Science Foundation (NSF)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The Sars Centre budget, the Functional Genomics (FUGE) Programme of the Norwegian Research Council, Genoscope, and NSF grants IOS-0719577 and DBI-0743374 supported the research. This is publication ISEM-2010-123 of the Institut des Sciences de l'Evolution de Montpellier. GENBANK/European Molecular Biology Laboratory sequence accession numbers are CABV01000001-CABV01005917, CABW01000001-CABW01006678, FN653015-FN654274, FN654275-FN658470, FP700189-FP710243, FP710258-FP791398, and FP791400-FP884219. The sequence data for Capitella teleta, Daphnia pulex, Helobdella robusta and Lottia gigantea were produced by the U.S. Department of Energy Joint Genome Institute (www.jgi.doe.gov/) in collaboration with the community of users. We thank I. Ahel, B. Haubold, and one anonymous reviewer for generous advice. This article is dedicated to Hans Prydz and Kare Rommetveit for their pioneer roles in the Sars Centre establishment.	Bouquet JM, 2009, J PLANKTON RES, V31, P359, DOI 10.1093/plankt/fbn132; Cousineau B, 1998, CELL, V94, P451, DOI 10.1016/S0092-8674(00)81586-X; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Edvardsen RB, 2005, CURR BIOL, V15, pR12, DOI 10.1016/j.cub.2004.12.010; Eickbush TH, 2002, CURR OPIN GENET DEV, V12, P669, DOI 10.1016/S0959-437X(02)00359-3; Hughes T, 2007, J MOL EVOL, V65, P574, DOI 10.1007/s00239-007-9041-9; Katju V, 2003, GENETICS, V165, P1793; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Marz M, 2008, J MOL EVOL, V67, P594, DOI 10.1007/s00239-008-9149-6; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Nguyen HD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-69; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Roy SW, 2009, TRENDS GENET, V25, P67, DOI 10.1016/j.tig.2008.11.004; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Satou Y, 2003, DEV GENES EVOL, V213, P211, DOI 10.1007/s00427-003-0330-z; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Thompson EM, 2001, DEV BIOL, V238, P260, DOI 10.1006/dbio.2001.0414; Volff JN, 2004, MOL BIOL EVOL, V21, P2022, DOI 10.1093/molbev/msh207; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	25	198	202	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1381	1385		10.1126/science.1194167	http://dx.doi.org/10.1126/science.1194167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21097902	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000284902100043
J	Feldser, DM; Kostova, KK; Winslow, MM; Taylor, SE; Cashman, C; Whittaker, CA; Sanchez-Rivera, FJ; Resnick, R; Bronson, R; Hemann, MT; Jacks, T				Feldser, David M.; Kostova, Kamena K.; Winslow, Monte M.; Taylor, Sarah E.; Cashman, Chris; Whittaker, Charles A.; Sanchez-Rivera, Francisco J.; Resnick, Rebecca; Bronson, Roderick; Hemann, Michael T.; Jacks, Tyler			Stage-specific sensitivity to p53 restoration during lung cancer progression	NATURE			English	Article							ONCOGENIC K-RAS; TUMOR PROGRESSION; IN-VIVO; SENESCENCE; PROLIFERATION; AMPLIFICATION; EXPRESSION; MICE	Tumorigenesis is a multistep process that results from the sequential accumulation of mutations in key oncogene and tumour suppressor pathways. Personalized cancer therapy that is based on targeting these underlying genetic abnormalities presupposes that sustained inactivation of tumour suppressors and activation of oncogenes is essential in advanced cancers. Mutations in the p53 tumour-suppressor pathway are common in human cancer and significant efforts towards pharmaceutical reactivation of defective p53 pathways are underway(1-3). Here we show that restoration of p53 in established murine lung tumours leads to significant but incomplete tumour cell loss specifically in malignant adenocarcinomas, but not in adenomas. We define amplification of MAPK signalling as a critical determinant of malignant progression and also a stimulator of Arf tumour-suppressor expression. The response to p53 restoration in this context is critically dependent on the expression of Arf. We propose that p53 not only limits malignant progression by suppressing the acquisition of alterations that lead to tumour progression, but also, in the context of p53 restoration, responds to increased oncogenic signalling to mediate tumour regression. Our observations also underscore that the p53 pathway is not engaged by low levels of oncogene activity that are sufficient for early stages of lung tumour development. These data suggest that restoration of pathways important in tumour progression, as opposed to initiation, may lead to incomplete tumour regression due to the stage-heterogeneity of tumour cell populations.	[Feldser, David M.; Kostova, Kamena K.; Winslow, Monte M.; Taylor, Sarah E.; Cashman, Chris; Whittaker, Charles A.; Sanchez-Rivera, Francisco J.; Resnick, Rebecca; Hemann, Michael T.; Jacks, Tyler] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Feldser, David M.; Kostova, Kamena K.; Winslow, Monte M.; Taylor, Sarah E.; Cashman, Chris; Whittaker, Charles A.; Sanchez-Rivera, Francisco J.; Resnick, Rebecca; Hemann, Michael T.; Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Bronson, Roderick] Tufts Univ, Boston, MA 02115 USA; [Bronson, Roderick] Harvard Univ, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Tufts University; Harvard University; Harvard Medical School	Jacks, T (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Kostova, Kamena/AAK-9431-2020; Sánchez-Rivera, Francisco J./AAV-6985-2020	Kostova, Kamena/0000-0001-9973-401X; Sánchez-Rivera, Francisco J./0000-0002-8466-8563; Resnick, Rebecca/0000-0001-5804-4418; Whittaker, Charles/0000-0002-2400-0094; Feldser, David/0000-0001-5975-864X	National Cancer Institute [P30-CA14051]; American Cancer Society; MIT; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); MIT; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank M. DuPage and C. Kim for critical reading of the manuscript. We are indebted to D. Crowley, E. Vasile and M. Griffin at the Koch Institute Core facilities (supported by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute). We are grateful to M. Luo for microarray support. We thank M. Leversha at MSKCC for FISH. D. M. F. has been supported by the American Cancer Society (New England Area Fellow), and is a current Fellow of the Leukemia and Lymphoma Society. K. K. K. is supported by the John Reed Fund of the MIT undergraduate research program. M.M.W. was a Merck Fellow of the Damon Runyon Cancer Research Foundation and a Genentech postdoctoral fellow. T.J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar. The Howard Hughes Medical Institute supported this work.	Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Bolstad BM, 2005, STAT BIOL HEALTH, P13; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu ML, 1998, ONCOGENE, V17, P2403, DOI 10.1038/sj.onc.1202456; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107	25	208	214	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					572	U249		10.1038/nature09535	http://dx.doi.org/10.1038/nature09535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107428	Green Accepted, Green Submitted			2022-12-24	WOS:000284584200044
J	Gooley, TA; Chien, JW; Pergam, SA; Hingorani, S; Sorror, ML; Boeckh, M; Martin, PJ; Sandmaier, BM; Marr, KA; Appelbaum, FR; Storb, R; McDonald, GB				Gooley, Ted A.; Chien, Jason W.; Pergam, Steven A.; Hingorani, Sangeeta; Sorror, Mohamed L.; Boeckh, Michael; Martin, Paul J.; Sandmaier, Brenda M.; Marr, Kieren A.; Appelbaum, Frederick R.; Storb, Rainer; McDonald, George B.			Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; INVASIVE FUNGAL-INFECTIONS; RISK-FACTORS; IMMUNE RECONSTITUTION; CONDITIONING REGIMEN; URSODEOXYCHOLIC ACID; RECIPIENTS; CYTOMEGALOVIRUS; COMPLICATIONS	Background: Over the past decade, advances have been made in the care of patients undergoing transplantation. We conducted a study to determine whether these advances have improved the outcomes of transplantation. Methods: We analyzed overall mortality, mortality not preceded by relapse, recurrent malignant conditions, and the frequency and severity of major complications of transplantation, including graft-versus-host disease (GVHD) and hepatic, renal, pulmonary, and infectious complications, among 1418 patients who received their first allogeneic transplants at our center in Seattle in the period from 1993 through 1997 and among 1148 patients who received their first allogeneic transplants in the period from 2003 through 2007. Components of the Pretransplant Assessment of Mortality (PAM) score were used in regression models to adjust for the severity of illness at the time of transplantation. Results: In the 2003-2007 period, as compared with the 1993-1997 period, we observed significant decreases in mortality not preceded by relapse, both at day 200 (by 60%) and overall (by 52%), the rate of relapse or progression of a malignant condition (by 21%), and overall mortality (by 41%), after adjustment for components of the PAM score. The results were similar when the analyses were limited to patients who received myeloablative conditioning therapy. We also found significant decreases in the risk of severe GVHD; disease caused by viral, bacterial, and fungal infections; and damage to the liver, kidneys, and lungs. Conclusions: We found a substantial reduction in the hazard of death related to allogeneic hematopoietic-cell transplantation, as well as increased long-term survival, over the past decade. Improved outcomes appear to be related to reductions in organ damage, infection, and severe acute GVHD. (Funded by the National Institutes of Health.) N Engl J Med 2010;363:2091-101.	[McDonald, George B.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Gastroenterol Hepatol Sect D2 190, Seattle, WA 98109 USA; [Pergam, Steven A.; Boeckh, Michael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [Chien, Jason W.; Pergam, Steven A.; Sorror, Mohamed L.; Boeckh, Michael; Martin, Paul J.; Sandmaier, Brenda M.; Marr, Kieren A.; Appelbaum, Frederick R.; Storb, Rainer; McDonald, George B.] Univ Washington, Dept Med, Seattle, WA USA; [Hingorani, Sangeeta] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Gooley, Ted A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McDonald, GB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, Gastroenterol Hepatol Sect D2 190, 1100 Fairview Ave N, Seattle, WA 98109 USA.		Boeckh, Michael/AAA-1607-2022; Pergam, Steven A/C-2286-2008	Pergam, Steven A/0000-0002-6333-5196	National Institutes of Health [CA 18029, CA 15704, CA78902, HL36444, HL088201, HL088021, HL096831, DK063038]; American Society for Blood and Marrow Transplantation; ViroPharma; Roche/Genentech; Astellas; Pfizer; Merck; Vical; Chimerix; AiCuris; Boehringer Ingelheim; Theraclone Sciences; Soligenix; Basilea; Evolva; Gentium; NATIONAL CANCER INSTITUTE [P30CA015704, P01CA018029, P01CA078902] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036444, K23HL096831, K99HL088021, R00HL088021, R01HL088201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK063038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Blood and Marrow Transplantation; ViroPharma; Roche/Genentech(Roche HoldingGenentech); Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer); Merck(Merck & Company); Vical; Chimerix; AiCuris; Boehringer Ingelheim(Boehringer Ingelheim); Theraclone Sciences; Soligenix; Basilea; Evolva; Gentium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (CA 18029, CA 15704, CA78902, HL36444, HL088201, HL088021, HL096831, and DK063038) from the National Institutes of Health.; Dr. Gooley reports serving as a statistical consultant to DOR BioPharma; Dr. Pergam, receiving research funding from Chimerix and ViroPharma (through a sponsored American Society for Blood and Marrow Transplantation New Investigator Award), and consulting fees from ViroPharma; Dr. Boeckh, receiving grant support, consulting fees, or both from Roche/Genentech, ViroPharma, Astellas, Pfizer, Merck, Vical, Chimerix, AiCuris, Boehringer Ingelheim, and Theraclone Sciences; Dr. Martin, receiving grant support from Roche and Soligenix and payments for serving on data and safety monitoring boards for Pfizer; Dr. Marr, receiving grant support from Astellas and Merck and consulting fees from Astellas, Basilea, Evolva, Merck, and Pfizer; and Dr. McDonald, being a consultant to and holding an equity position with Soligenix and receiving consulting fees from Gentium. No other potential conflict of interest relevant to this article was reported.	al-Jurf M, 2005, J CLIN ONCOL, V23, P5074, DOI 10.1200/JCO.2005.09.020; Appelbaum F, 2009, THOMAS HEMATOPOIETIC; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Boeckh M, 1999, BLOOD, V93, P1781, DOI 10.1182/blood.V93.5.1781; Chien JW, 2010, BONE MARROW TRANSPL, V45, P317, DOI 10.1038/bmt.2009.129; Chien JW, 2008, BLOOD, V111, P2462, DOI 10.1182/blood-2007-09-101709; Clark JG, 1999, CRIT CARE MED, V27, P1800, DOI 10.1097/00003246-199909000-00016; de Lima M, 2004, BLOOD, V104, P857, DOI 10.1182/blood-2004-02-0414; Freudenberger TD, 2003, BLOOD, V102, P3822, DOI 10.1182/blood-2002-06-1813; FRIED RH, 1992, ANN INTERN MED, V116, P624, DOI 10.7326/0003-4819-116-8-624; Fukuda T, 2003, BLOOD, V102, P827, DOI 10.1182/blood-2003-02-0456; Gooley TA, 2005, HEPATOLOGY, V41, P345, DOI 10.1002/hep.20529; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Hakki M, 2003, BLOOD, V102, P3060, DOI 10.1182/blood-2002-11-3472; Hingorani SR, 2008, BIOL BLOOD MARROW TR, V14, P1365, DOI 10.1016/j.bbmt.2008.09.015; Hingorani SR, 2005, KIDNEY INT, V67, P272, DOI 10.1111/j.1523-1755.2005.00078.x; Hockenbery DM, 2007, BLOOD, V109, P4557, DOI 10.1182/blood-2006-05-021139; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Martin PJ, 2004, BIOL BLOOD MARROW TR, V10, P320, DOI 10.1016/j.bbmt.2003.12.304; McCune JS, 2009, CLIN PHARMACOL THER, V85, P615, DOI 10.1038/clpt.2009.27; McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860; McDonald GB, 2010, HEPATOLOGY, V51, P1450, DOI 10.1002/hep.23533; Mielcarek M, 2009, BLOOD, V113, P2888, DOI 10.1182/blood-2008-07-168401; Nakamae H, 2009, BIOL BLOOD MARROW TR, V15, P694, DOI 10.1016/j.bbmt.2009.02.009; Narimatsu H, 2005, BIOL BLOOD MARROW TR, V11, P429, DOI 10.1016/j.bbmt.2005.01.010; Parimon T, 2006, ANN INTERN MED, V144, P407, DOI 10.7326/0003-4819-144-6-200603210-00007; Parimon T, 2005, AM J RESP CRIT CARE, V172, P384, DOI 10.1164/rccm.200502-212OC; Patriarca F, 2004, BONE MARROW TRANSPL, V33, P751, DOI 10.1038/sj.bmt.1704426; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Ruutu T, 2002, BLOOD, V100, P1977, DOI 10.1182/blood-2001-12-0159; Sandmaier BM, 2009, THOMAS HEMATOPOIETIC, P1043; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Storek J, 2001, BLOOD, V97, P3380, DOI 10.1182/blood.V97.11.3380; Strasser SI, 2009, THOMAS HEMATOPOIETIC; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Yokoe D, 2009, BONE MARROW TRANSPL, V44, P495, DOI 10.1038/bmt.2009.261	40	1038	1059	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2091	2101		10.1056/NEJMoa1004383	http://dx.doi.org/10.1056/NEJMoa1004383			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684XE	21105791	Green Accepted			2022-12-24	WOS:000284587800004
J	Chien, EYT; Liu, W; Zhao, QA; Katritch, V; Han, GW; Hanson, MA; Shi, L; Newman, AH; Javitch, JA; Cherezov, V; Stevens, RC				Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Han, Gye Won; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.			Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; DRUG-SEEKING BEHAVIOR; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; BINDING-SITE; INDUCED REINSTATEMENT; COCAINE-SEEKING; IONIC LOCK; D-3; IDENTIFICATION	Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain. The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small molecule D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops. On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are observed. Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R. This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.	[Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katritch, Vsevolod] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Hanson, Michael A.] Receptos, San Diego, CA 92121 USA; [Shi, Lei] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Newman, Amy Hauck] Natl Inst Drug Abuse, Med Chem Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Columbia University; Columbia University; Columbia University	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Han, Gye Won/GLQ-8724-2022; Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; soler, martha maricel m gomez/L-6025-2014; Katritch, Vsevolod/Q-8357-2016; Shi, Lei/AAV-1321-2020; Han, Gye Won/GLT-1531-2022; Liu, Wei/F-1820-2011; Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLQ-8673-2022	Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; soler, martha maricel m gomez/0000-0002-4412-8108; Katritch, Vsevolod/0000-0003-3883-4505; Shi, Lei/0000-0002-4137-096X; Javitch, Jonathan/0000-0001-7395-2967	Protein Structure Initiative (PSI) [U54 GM074961, U54 GM094618]; NIH Roadmap [P50 GM073197]; NIH [R21 RR025336, GM075915]; Pfizer; National Institute on Drug Abuse [DA022413, MH54137, DA023694]; National Science Foundation [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089857, R01GM075915, P50GM073197, U54GM074961, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023694, ZIADA000424, K05DA022413] Funding Source: NIH RePORTER	Protein Structure Initiative (PSI); NIH Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Science Foundation(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by Protein Structure Initiative (PSI) grant U54 GM074961 and PSI: Biology grant U54 GM094618 for structure production, NIH Roadmap grant P50 GM073197 for technology development, NIH grant R21 RR025336 (V. C.), and Pfizer. Additional support was provided by the National Institute on Drug Abuse Intramural Research Program (A.H.N.), grants DA022413 and MH54137 (J.A.J.), and grant DA023694 (L. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Science or the NIH. We thank J. Velasquez for help with molecular biology, T. Trinh and K. Allin for help with baculovirus expression, D. Gray for assistance with eticlopride synthesis, M. Griffor for large-scale production of the receptor, X. Qiu for suggestions, and A. Walker for assistance with manuscript preparation. We acknowledge Y. Zheng, The Ohio State University and M. Caffrey, Trinity College (Dublin, Ireland), for the generous loan of the in meso robot (built with support from NIH grant GM075915), the National Science Foundation (grant IIS0308078), and Science Foundation Ireland (grant 02-IN1-B266); and J. Smith, R. Fischetti, and N. Sanishvili at the GM/CA-CAT beamline at the Advanced Photon Source, for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (grant Y1-CO-1020) and the National Institute of General Medical Sciences (grant Y1-GM-1104). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3PBL. A. H. N. is an inventor on a patent application from the National Institutes of Health that covers the use of R-22 and analogs as D3 receptor selective agents. R. C. S. is on the Board of Directors of Receptos, which does structure-directed drug discovery on GPCRs.	Alberts GL, 1998, MOL PHARMACOL, V54, P379, DOI 10.1124/mol.54.2.379; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Boeckler F, 2006, PHARMACOL THERAPEUT, V112, P281, DOI 10.1016/j.pharmthera.2006.04.007; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Civelli Olivier, 1995, P155; DEPAULIS T, 1985, EUR J MED CHEM, V20, P273; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Duman Ronald S., 1995, P303; Gilbert JG, 2005, SYNAPSE, V57, P17, DOI 10.1002/syn.20152; Griffon N, 1996, J NEURAL TRANSM, V103, P1163, DOI 10.1007/BF01271201; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Holmes A, 2004, NEUROPHARMACOLOGY, V47, P1117, DOI 10.1016/j.neuropharm.2004.07.034; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kuzhikandathil EV, 2004, MOL CELL NEUROSCI, V26, P144, DOI 10.1016/j.mcn.2004.01.014; Levant B, 1997, PHARMACOL REV, V49, P231; Newman AH, 2009, J MED CHEM, V52, P2559, DOI 10.1021/jm900095y; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pilla M, 1999, NATURE, V400, P371, DOI 10.1038/43944; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Shi L, 2001, BIOCHEMISTRY-US, V40, P12339, DOI 10.1021/bi011204a; Silvano E, 2010, MOL PHARMACOL, V78, P925, DOI 10.1124/mol.110.065755; Simpson MM, 1999, MOL PHARMACOL, V56, P1116, DOI 10.1124/mol.56.6.1116; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; Spiller K, 2008, PSYCHOPHARMACOLOGY, V196, P533, DOI 10.1007/s00213-007-0986-6; STRADER CD, 1991, J BIOL CHEM, V266, P5; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vorel SR, 2002, J NEUROSCI, V22, P9595; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xi ZX, 2006, NEUROPSYCHOPHARMACOL, V31, P1393, DOI 10.1038/sj.npp.1300912	39	919	934	2	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1091	1095		10.1126/science.1197410	http://dx.doi.org/10.1126/science.1197410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097933	Green Accepted			2022-12-24	WOS:000284374700040
J	Daffis, S; Szretter, KJ; Schriewer, J; Li, JQ; Youn, S; Errett, J; Lin, TY; Schneller, S; Zust, R; Dong, HP; Thiel, V; Sen, GC; Fensterl, V; Klimstra, WB; Pierson, TC; Buller, RM; Gale, M; Shi, PY; Diamond, MS				Daffis, Stephane; Szretter, Kristy J.; Schriewer, Jill; Li, Jianqing; Youn, Soonjeon; Errett, John; Lin, Tsai-Yu; Schneller, Stewart; Zust, Roland; Dong, Hongping; Thiel, Volker; Sen, Ganes C.; Fensterl, Volker; Klimstra, William B.; Pierson, Theodore C.; Buller, R. Mark; Gale, Michael, Jr.; Shi, Pei-Yong; Diamond, Michael S.			2 '-O methylation of the viral mRNA cap evades host restriction by IFIT family members	NATURE			English	Article							NILE-VIRUS-INFECTION; PROTEINS; GENES; METHYLTRANSFERASE; TRANSLATION; IDENTIFICATION; INITIATION; INDUCTION; PROTECTS; ALPHA	Cellular messenger RNA (mRNA) of higher eukaryotes and many viral RNAs are methylated at the N-7 and 2'-O positions of the 5' guanosine cap by specific nuclear and cytoplasmic methyltransferases (MTases), respectively. Whereas N-7 methylation is essential for RNA translation and stability(1), the function of 2'-O methylation has remained uncertain since its discovery 35 years ago(2-4). Here we show that a West Nile virus (WNV) mutant (E218A) that lacks 2'-O MTase activity was attenuated in wild-type primary cells and mice but was pathogenic in the absence of type I interferon (IFN) signalling. 2'-O methylation of viral RNA did not affect IFN induction in WNV-infected fibroblasts but instead modulated the antiviral effects of IFN-induced proteins with tetratricopeptide repeats (IFIT), which are interferon-stimulated genes (ISGs) implicated in regulation of protein translation. Poxvirus and coronavirus mutants that lacked 2'-O MTase activity similarly showed enhanced sensitivity to the antiviral actions of IFN and, specifically, IFIT proteins. Our results demonstrate that the 2'-O methylation of the 5' cap of viral RNA functions to subvert innate host antiviral responses through escape of IFIT-mediated suppression, and suggest an evolutionary explanation for 2'-O methylation of cellular mRNA: to distinguish self from non-self RNA. Differential methylation of cytoplasmic RNA probably serves as an example for pattern recognition and restriction of propagation of foreign viral RNA in host cells.	[Daffis, Stephane; Szretter, Kristy J.; Youn, Soonjeon; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Li, Jianqing; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Buller, R. Mark; Gale, Michael, Jr.; Shi, Pei-Yong; Diamond, Michael S.] Midw Reg Ctr Biodef & Emerging Infect Dis Res, St Louis, MO 63104 USA; [Schriewer, Jill; Buller, R. Mark] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Errett, John; Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Lin, Tsai-Yu; Pierson, Theodore C.] NIH, Viral Pathogenesis Sect, Viral Dis Lab, Bethesda, MD 20892 USA; [Schneller, Stewart] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA; [Zust, Roland; Thiel, Volker] Kantonal Hosp St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Thiel, Volker] Univ Zurich, Vetsuisse Fac, CH-8006 Zurich, Switzerland; [Dong, Hongping; Shi, Pei-Yong] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA; [Sen, Ganes C.; Fensterl, Volker] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Klimstra, William B.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Buller, R. Mark; Gale, Michael, Jr.; Shi, Pei-Yong; Diamond, Michael S.] Pacific NW Reg Ctr Biodef & Emerging Infect Dis R, St Louis, MO 63104 USA; [Buller, R. Mark; Gale, Michael, Jr.; Shi, Pei-Yong; Diamond, Michael S.] NE Reg Ctr Biodef & Emerging Infect Dis Res, St Louis, MO 63104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Saint Louis University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; Auburn University System; Auburn University; Kantonsspital St. Gallen; University of Zurich; State University of New York (SUNY) System; Wadsworth Center; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	diamond@borcim.wustl.edu	Thiel, Volker/AAI-2391-2019; Lin, Tsai-Yu/B-8873-2016; Diamond, Michael/AAH-1733-2019	Lin, Tsai-Yu/0000-0002-8076-1584; Diamond, Michael/0000-0002-8791-3165; Gale, Michael/0000-0002-6332-7436; Szretter, Kristy/0000-0003-0391-2307; Thiel, Volker/0000-0002-5783-0887	National Institutes of Health [U54 AI081680, U19 AI083019, R01 AI074973, R01 AI56540, U54 AI057160, U54 AI057158, R01 CA068782]; Swiss National Science Foundation [3100A0-118425/1]; Novartis Foundation; NATIONAL CANCER INSTITUTE [R01CA068782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, U54AI057160, U54AI081680, U19AI056540, U19AI083019, ZIAAI000957, R01AI074973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants U54 AI081680, U19 AI083019 and R01 AI074973 (to M.G. and M.S.D.), R01 AI56540 (to S.S.), U54 AI057160 (to R.M.B.) and U54 AI057158 (to P.Y.S.), R01 CA068782 (to G.C.S.) the Swiss National Science Foundation, 3100A0-118425/1, and the Novartis Foundation (to V.T. and R.Z.). We thank H. Virgin and B. Moss for reading the manuscript.	Coley SE, 2005, J VIROL, V79, P3097, DOI 10.1128/JVI.79.5.3097-3106.2005; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; LANGBERG SR, 1981, J BIOL CHEM, V256, P54; Latner DR, 2002, VIROLOGY, V301, P64, DOI 10.1006/viro.2002.1538; MUTHUKRISHNAN S, 1978, J BIOL CHEM, V253, P1710; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	25	560	585	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					452	456		10.1038/nature09489	http://dx.doi.org/10.1038/nature09489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085181	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000284313100046
J	Sabo, JL; Finlay, JC; Kennedy, T; Post, DM				Sabo, John L.; Finlay, Jacques C.; Kennedy, Theodore; Post, David M.			The Role of Discharge Variation in Scaling of Drainage Area and Food Chain Length in Rivers	SCIENCE			English	Article							ECOSYSTEM SIZE; ENERGY AVAILABILITY; WEB STRUCTURE; FRESH-WATERS; DISTURBANCE; FISH; STREAMS; HETEROGENEITY; LAKES	Food chain length (FCL) is a fundamental component of food web structure. Studies in a variety of ecosystems suggest that FCL is determined by energy supply, environmental stability, and/or ecosystem size, but the nature of the relationship between environmental stability and FCL, and the mechanism linking ecosystem size to FCL, remain unclear. Here we show that FCL increases with drainage area and decreases with hydrologic variability and intermittency across 36 North American rivers. Our analysis further suggests that hydrologic variability is the mechanism underlying the correlation between ecosystem size and FCL in rivers. Ecosystem size lengthens river food chains by integrating and attenuating discharge variation through stream networks, thereby enhancing environmental stability in larger river systems.	[Sabo, John L.] Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA; [Finlay, Jacques C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Kennedy, Theodore] US Geol Survey, SW Biol Sci Ctr, Flagstaff, AZ 86001 USA; [Post, David M.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Arizona State University; Arizona State University-Tempe; University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Geological Survey; Yale University	Sabo, JL (corresponding author), Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, POB 874501, Tempe, AZ 85287 USA.	John.L.Sabo@asu.edu	Post, David M/A-6987-2009; Finlay, Jacques/B-6081-2011; Sabo, John L/B-1872-2013	Post, David M/0000-0003-1434-7729; Finlay, Jacques/0000-0002-7968-7030; Kennedy, Theodore/0000-0003-3477-3629	NSF [DEB-0315990, DEB-0316679, DEB-0317137, DEB-0635088, EF-0553768]; University of California, Santa Barbara; State of California	NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	The authors thank S. Beck, M. Bernot, M. Booth, M. Caron, O. Champoux, C. Crenshaw, D. Cunjak, D. Caissie, R. Doucett, S. J. Fisher, N. B. Grimm, R. O. Hall, T. K. Harms, B. Hungate, K. Luttermoser, W. McDowell, G. Morin, P. Mulholland, R. J. Naiman, J. Regetz, E. Rosi-Marshall, R. Sponseller, C. U. Soykan, and L. Thompson; the Minnesota Department of Natural Resources for fish samples; the STROUD New York Watersheds Project for access to study sites and metabolism data; the Los Angeles Department of Water and Power, the Coweeta Long-Term Ecological Research (LTER) project, the H. J. Andrews LTER project, Oak Ridge National Laboratory, Environment Canada, and the U.S. Forest Service for flow data. This work was supported by grants from NSF, including DEB-0315990 to J.C.F., DEB-0316679 to D.M.P., and DEB-0317137 and DEB-0635088 to J.L.S.. The work was also supported by a Sabbatical Fellowship to J.L.S. at the National Center for Ecological Analysis and Synthesis, a center funded by NSF (grant EF-0553768); the University of California, Santa Barbara; and the State of California. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. government.	Barnett TP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006704; CLOSS GP, 1994, ECOL MONOGR, V64, P1, DOI 10.2307/2937053; Elton C. S., 1927, ANIMAL ECOLOGY; FISHER SG, 1982, ECOL MONOGR, V52, P93, DOI 10.2307/2937346; GROSSMAN GD, 1982, AM NAT, V120, P423, DOI 10.1086/284004; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; KIDD KA, 1995, SCIENCE, V269, P240, DOI 10.1126/science.269.5221.240; Knighton D., 1998, FLUVIAL FORMS PROCES; Leopold L.B., 1953, HYDRAULIC GEOMETRY S, V252, P22; Liang S, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007971; McHugh PA, 2010, ECOL LETT, V13, P881, DOI 10.1111/j.1461-0248.2010.01484.x; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; PIMM SL, 1982, FOOD WEBS; Post DM, 2007, GEOMORPHOLOGY, V89, P111, DOI 10.1016/j.geomorph.2006.07.014; Post DM, 2007, OIKOS, V116, P775, DOI 10.1111/j.2007.0030-1299.15552.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Power ME, 2008, ECOL MONOGR, V78, P263, DOI 10.1890/06-0902.1; Sabo JL, 2008, ECOL MONOGR, V78, P19, DOI 10.1890/06-1340.1; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; Townsend CR, 1998, ECOL LETT, V1, P200; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Walters AW, 2008, ECOLOGY, V89, P3261, DOI 10.1890/08-0273.1; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558	33	163	169	5	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					965	967		10.1126/science.1196005	http://dx.doi.org/10.1126/science.1196005			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20947729				2022-12-24	WOS:000284118000043
J	van Os, J; Kenis, G; Rutten, BPF				van Os, Jim; Kenis, Gunter; Rutten, Bart P. F.			The environment and schizophrenia	NATURE			English	Article							DAILY-LIFE STRESS; PSYCHOTIC SYMPTOMS; CHILDHOOD TRAUMA; CANNABIS USE; NONPSYCHOTIC DISORDERS; FAMILIAL LIABILITY; BIRTH-COHORT; BRAIN-INJURY; RISK-FACTORS; URBANICITY	Psychotic syndromes can be understood as disorders of adaptation to social context. Although heritability is often emphasized, onset is associated with environmental factors such as early life adversity, growing up in an urban environment, minority group position and cannabis use, suggesting that exposure may have an impact on the developing 'social' brain during sensitive periods. Therefore heritability, as an index of genetic influence, may be of limited explanatory power unless viewed in the context of interaction with social effects. Longitudinal research is needed to uncover gene-environment interplay that determines how expression of vulnerability in the general population may give rise to more severe psychopathology.	[van Os, Jim; Kenis, Gunter; Rutten, Bart P. F.] Maastricht Univ, Med Ctr, SEARCH, European Grad Sch Neurosci, NL-6200 MD Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London SE5 8AF, England	Maastricht University; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ, Med Ctr, SEARCH, European Grad Sch Neurosci, NL-6200 MD Maastricht, Netherlands.	j.vanos@sp.unimaas.nl	van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; van Os, Jim/I-9496-2012	van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Rutten, Bart/0000-0002-9834-6346	Dutch Health Research Council [10-000-1002]; European Community [HEALTH-F2-2009-241909]	Dutch Health Research Council; European Community(European Commission)	The authors thank P. R. Hof, C. Morgan and M. Wichers for comments on earlier versions of this paper. Supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002), and the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI).	Argyropoulos SV, 2008, ACTA PSYCHIAT SCAND, V118, P214, DOI 10.1111/j.1600-0447.2008.01205.x; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; ARSENEAULT L, AM J PSYCHI IN PRESS; Barkus E, 2010, ANNU REV CLIN PSYCHO, V6, P365, DOI 10.1146/annurev.clinpsy.121208.131220; Bendall S, 2008, SCHIZOPHRENIA BULL, V34, P568, DOI 10.1093/schbul/sbm121; Bourque F, 2011, PSYCHOL MED, V41, P897, DOI 10.1017/S0033291710001406; Boydell J, 2001, BMJ-BRIT MED J, V323, P1336, DOI 10.1136/bmj.323.7325.1336; Bresnahan M, 2007, INT J EPIDEMIOL, V36, P751, DOI 10.1093/ije/dym041; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Carboni E, 2010, NEUROSCIENCE, V168, P156, DOI 10.1016/j.neuroscience.2010.03.046; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chen LS, 2009, SCHIZOPHR RES, V111, P159, DOI 10.1016/j.schres.2009.03.030; Colvert E, 2008, J ABNORM CHILD PSYCH, V36, P1057, DOI 10.1007/s10802-008-9232-x; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; Darroch J, 1997, AM J EPIDEMIOL, V145, P661; DAVID A, 1995, SCHIZOPHR RES, V14, P247, DOI 10.1016/0920-9964(94)00068-J; Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Dominguez MDG, 2010, AM J PSYCHIAT, V167, P1075, DOI 10.1176/appi.ajp.2010.09060883; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Elklit A, 2011, SCHIZOPHRENIA BULL, V37, P1305, DOI 10.1093/schbul/sbq048; Ferdinand RF, 2005, ADDICTION, V100, P612, DOI 10.1111/j.1360-0443.2005.01070.x; Fergusson DM, 2003, PSYCHOL MED, V33, P15, DOI 10.1017/S0033291702006402; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Fisher HL, 2011, SCHIZOPHRENIA BULL, V37, P546, DOI 10.1093/schbul/sbp103; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Galdos M, 2011, SCHIZOPHRENIA BULL, V37, P1179, DOI 10.1093/schbul/sbq029; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; Goodwin RD, 2003, PSYCHOL MED, V33, P1089, DOI 10.1017/S0033291703007888; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Guo SW, 2000, HUM HERED, V50, P286, DOI 10.1159/000022931; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hanssen M, 2003, SOC PSYCH PSYCH EPID, V38, P149, DOI 10.1007/s00127-003-0622-7; Homer BD, 2008, PSYCHOL BULL, V134, P301, DOI 10.1037/0033-2909.134.2.301; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hutchinson G, 1996, BRIT J PSYCHIAT, V169, P776, DOI 10.1192/bjp.169.6.776; Jager G, 2010, J AM ACAD CHILD PSY, V49, P561, DOI 10.1016/j.jaac.2010.02.001; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132; Kaschube M, 2002, J NEUROSCI, V22, P7206; Keen DV, 2010, BRIT J PSYCHIAT, V196, P274, DOI 10.1192/bjp.bp.109.065490; Keller MC, 2010, BEHAV GENET, V40, P377, DOI 10.1007/s10519-009-9320-x; Kelly BD, 2010, SCHIZOPHR RES, V116, P75, DOI 10.1016/j.schres.2009.10.015; KENDLER KS, 1994, AM J PSYCHIAT, V151, P1605; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Lieberman JA, 1997, NEUROPSYCHOPHARMACOL, V17, P205, DOI 10.1016/S0893-133X(97)00045-6; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; March D, 2008, EPIDEMIOL REV, V30, P84, DOI 10.1093/epirev/mxn006; Maric N, 2004, SOC PSYCH PSYCH EPID, V39, P600, DOI 10.1007/s00127-004-0803-z; Mason OJ, 2009, J NERV MENT DIS, V197, P783, DOI 10.1097/NMD.0b013e3181b9760b; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; McMillan KA, 2009, CAN J PSYCHIAT, V54, P477, DOI 10.1177/070674370905400709; Minozzi S, 2010, DRUG ALCOHOL REV, V29, P304, DOI 10.1111/j.1465-3362.2009.00132.x; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Morgan C, 2010, SCHIZOPHRENIA BULL, V36, P655, DOI 10.1093/schbul/sbq051; Morrison PD, 2009, PSYCHOL MED, V39, P1607, DOI 10.1017/S0033291709005522; Mortensen PB, 2010, PSYCHOL MED, V40, P201, DOI 10.1017/S0033291709990419; Mueller SC, 2010, NEUROPSYCHOLOGIA, V48, P3037, DOI 10.1016/j.neuropsychologia.2010.06.013; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Nestor L, 2008, NEUROIMAGE, V40, P1328, DOI 10.1016/j.neuroimage.2007.12.059; Nestor L, 2010, NEUROIMAGE, V49, P1133, DOI 10.1016/j.neuroimage.2009.07.022; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; PETERSON CC, 1995, J CHILD PSYCHOL PSYC, V36, P459, DOI 10.1111/j.1469-7610.1995.tb01303.x; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; RODGERS B, 1990, J CHILD PSYCHOL PSYC, V31, P393, DOI 10.1111/j.1469-7610.1990.tb01577.x; Rutten BPF, 2009, SCHIZOPHRENIA BULL, V35, P1045, DOI 10.1093/schbul/sbp104; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Selten JP, 2005, BRIT J PSYCHIAT, V187, P101, DOI 10.1192/bjp.187.2.101; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Sheu YS, 2010, NEUROIMAGE, V53, P412, DOI 10.1016/j.neuroimage.2010.06.043; Stefanis N, 2006, SCHIZOPHR RES, V85, P266, DOI 10.1016/j.schres.2006.03.036; Taylor SE, 2006, BIOL PSYCHIAT, V60, P296, DOI 10.1016/j.biopsych.2005.09.027; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Toulopoulou T, 2007, ARCH GEN PSYCHIAT, V64, P1348, DOI 10.1001/archpsyc.64.12.1348; van Os J, 2003, AM J PSYCHIAT, V160, P477, DOI 10.1176/appi.ajp.160.3.477; Van Os J, 2000, BRIT J PSYCHIAT, V176, P243, DOI 10.1192/bjp.176.3.243; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; VANWINKEL R, ARCH GEN PS IN PRESS; Veling W, 2008, PSYCHOL MED, V38, P1251, DOI 10.1017/S0033291708003474; Veling W, 2008, AM J PSYCHIAT, V165, P66, DOI 10.1176/appi.ajp.2007.07030423; Weiser M, 2004, ACTA PSYCHIAT SCAND, V110, P471, DOI 10.1111/j.1600-0447.2004.00385.x; Weiser M, 2008, BIOL PSYCHIAT, V63, P602, DOI 10.1016/j.biopsych.2007.05.029; Weiser M, 2007, BRIT J PSYCHIAT, V191, P320, DOI 10.1192/bjp.bp.106.031328; Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388; Wichers M, 2008, NEUROPSYCHOPHARMACOL, V33, P3030, DOI 10.1038/sj.npp.1301520; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101; [No title captured], DOI DOI 10.1093/SCHBUL/SBQ011	99	991	1000	8	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					203	212		10.1038/nature09563	http://dx.doi.org/10.1038/nature09563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068828				2022-12-24	WOS:000284051000036
J	van Wageningen, S; Kemmeren, P; Lijnzaad, P; Margaritis, T; Benschop, JJ; de Castro, IJ; van Leenen, D; Koerkamp, MJAG; Ko, CW; Miles, AJ; Brabers, N; Brok, MO; Lenstra, TL; Fiedler, D; Fokkens, L; Aldecoa, R; Apweiler, E; Taliadouros, V; Sameith, K; van de Pasch, LAL; van Hooff, SR; Bakker, LV; Krogan, NJ; Snel, B; Holstege, FCP				van Wageningen, Sake; Kemmeren, Patrick; Lijnzaad, Philip; Margaritis, Thanasis; Benschop, Joris J.; de Castro, Ines J.; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Ko, Cheuk W.; Miles, Antony J.; Brabers, Nathalie; Brok, Mariel O.; Lenstra, Tineke L.; Fiedler, Dorothea; Fokkens, Like; Aldecoa, Rodrigo; Apweiler, Eva; Taliadouros, Virginia; Sameith, Katrin; van de Pasch, Loes A. L.; van Hooff, Sander R.; Bakker, Linda V.; Krogan, Nevan J.; Snel, Berend; Holstege, Frank C. P.			Functional Overlap and Regulatory Links Shape Genetic Interactions between Signaling Pathways	CELL			English	Article							ACTIVATED PROTEIN-KINASE; 2C SER/THR PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHATASES; ACTIN CYTOSKELETON; DUPLICATED GENES; BACKUP CIRCUITS; YEAST; NETWORK; CELL	To understand relationships between phosphorylation-based signaling pathways, we analyzed 150 deletion mutants of protein kinases and phosphatases in S. cerevisiae using DNA microarrays. Downstream changes in gene expression were treated as a phenotypic readout. Double mutants with synthetic genetic interactions were included to investigate genetic buffering relationships such as redundancy. Three types of genetic buffering relationships are identified: mixed epistasis, complete redundancy, and quantitative redundancy. In mixed epistasis, the most common buffering relationship, different gene sets respond in different epistatic ways. Mixed epistasis arises from pairs of regulators that have only partial overlap in function and that are coupled by additional regulatory links such as repression of one by the other. Such regulatory modules confer the ability to control different combinations of processes depending on condition or context. These properties likely contribute to the evolutionary maintenance of paralogs and indicate a way in which signaling pathways connect for multiprocess control.	[van Wageningen, Sake; Kemmeren, Patrick; Lijnzaad, Philip; Margaritis, Thanasis; Benschop, Joris J.; de Castro, Ines J.; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Ko, Cheuk W.; Miles, Antony J.; Brabers, Nathalie; Brok, Mariel O.; Lenstra, Tineke L.; Aldecoa, Rodrigo; Apweiler, Eva; Taliadouros, Virginia; Sameith, Katrin; van de Pasch, Loes A. L.; van Hooff, Sander R.; Bakker, Linda V.; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Fiedler, Dorothea; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Fokkens, Like; Snel, Berend] Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Lijnzaad, Philip; Bakker, Linda V.] Netherlands Bioinformat Ctr, NL-6525 GA Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; Utrecht University	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Univ Weg 100, Utrecht, Netherlands.	f.c.p.holstege@umcutrecht.nl	Lenstra, Tineke/E-9429-2013; Snel, Berend/B-8886-2011; Lenstra, Tineke/L-3958-2016; Lijnzaad, Philip/ABE-4205-2021; Holstege, Frank/AAM-9944-2021; Aldecoa, Rodrigo/I-3569-2012; Benschop, Joris j/C-7809-2012	Snel, Berend/0000-0002-5804-8547; Lenstra, Tineke/0000-0002-4440-9962; Lijnzaad, Philip/0000-0002-7535-583X; Fokkens, Like/0000-0001-6696-4409; Kemmeren, Patrick/0000-0003-2237-7354; Sameith, Katrin/0000-0003-4306-930X; Aldecoa, Rodrigo/0000-0002-8041-3416; Groot Koerkamp, Marian JA/0000-0002-0867-0821; de Castro, Ines/0000-0001-8710-3667	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO) [016.108.607, 817.02.015, 050.71.057, 911.06.009, 021.002.035, 863.07.007, 700.57.407]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Netherlands Bioinformatics Centre (NBIC) and the Netherlands Organization of Scientific Research (NWO), grants 016.108.607, 817.02.015, 050.71.057, 911.06.009, 021.002.035 (T. L. L.), 863.07.007 (P. K.), 700.57.407 (J.J.B.).	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; Erdman S, 2001, GENETICS, V159, P919; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; INNAN H, 1997, J BIOL CHEM, V1, P17749; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kiel C, 2010, CELL, V140, P33, DOI 10.1016/j.cell.2009.12.028; MA D, 1995, MOL BIOL CELL, V6, P889, DOI 10.1091/mbc.6.7.889; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rodriguez-Pena JM, 2005, MICROBIOL-SGM, V151, P2241, DOI 10.1099/mic.0.27989-0; ROTH FP, 2009, EMBO REP, V4, P246; van Bakel H, 2004, EMBO REP, V5, P964, DOI 10.1038/sj.embor.7400253; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Young C, 2002, EUKARYOT CELL, V1, P1032, DOI 10.1128/EC.1.6.1032-1040.2002; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759	44	98	101	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					991	1004		10.1016/j.cell.2010.11.021	http://dx.doi.org/10.1016/j.cell.2010.11.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145464	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000285182600015
J	Pavelka, N; Rancati, G; Zhu, J; Bradford, WD; Saraf, A; Florens, L; Sanderson, BW; Hattem, GL; Li, R				Pavelka, Norman; Rancati, Giulia; Zhu, Jin; Bradford, William D.; Saraf, Anita; Florens, Laurence; Sanderson, Brian W.; Hattem, Gaye L.; Li, Rong			Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast	NATURE			English	Article							IDENTIFICATION TECHNOLOGY; SACCHAROMYCES-CEREVISIAE; CELLS; EVOLUTION; PEPTIDES	Aneuploidy, referring here to genome contents characterized by abnormal numbers of chromosomes, has been associated with developmental defects, cancer and adaptive evolution in experimental organisms(1-9). However, it remains unresolved how aneuploidy impacts gene expression and whether aneuploidy could directly bring about phenotypic variation and improved fitness over that of euploid counterparts. Here we show, using quantitative mass spectrometry-based proteomics and phenotypic profiling, that levels of protein expression in aneuploid yeast strains largely scale with chromosome copy numbers, following the same trend as that observed for the transcriptome, and that aneuploidy confers diverse phenotypes. We designed a novel scheme to generate, through random meiotic segregation, 38 stable and fully isogenic aneuploid yeast strains with distinct karyotypes and genome contents between 1N and 3N without involving any genetic selection. Through quantitative growth assays under various conditions or in the presence of a panel of chemotherapeutic or antifungal drugs, we found that some aneuploid strains grew significantly better than euploid control strains under conditions suboptimal for the latter. These results provide strong evidence that aneuploidy directly affects gene expression at both the transcriptome and proteome levels and can generate significant phenotypic variation that could bring about fitness gains under diverse conditions. Our findings suggest that the fitness ranking between euploid and aneuploid cells is dependent on context and karyotype, providing the basis for the notion that aneuploidy can directly underlie phenotypic evolution and cellular adaptation.	[Pavelka, Norman; Rancati, Giulia; Zhu, Jin; Bradford, William D.; Saraf, Anita; Florens, Laurence; Sanderson, Brian W.; Hattem, Gaye L.; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org	Pavelka, Norman/G-4577-2018	Pavelka, Norman/0000-0003-4542-9970; Florens, Laurence/0000-0002-9310-6650; Hattem, Gaye/0000-0002-2411-3056; Rancati, Giulia/0000-0003-0835-0139	NIH [RO1GM059964]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. W. Seidel for assistance with microarray data analysis, B. Fleharty and A. Peak for technical assistance with microarray hybridization, A. Perera and K. Walton for assistance in genome resequencing, W. McDowell for technical assistance with qPCR, J. Haug for technical support with flow cytometry experiments, G. Chen for technical suggestions, and A. Paulson for assistance with the submission of microarray and sequencing data to public repositories. This work was performed to fulfil, in part, requirements for J. Zhu's PhD thesis research as a student registered with the Open University. This work was supported by NIH grant RO1GM059964 to R.L.	de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens Laurence, 2006, V328, P159; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; MACK M, 1988, MOL GEN GENET, V211, P260, DOI 10.1007/BF00330602; PARRY EM, 1970, GENET RES, V16, P333, DOI 10.1017/S0016672300002597; Pavelka N, 2010, CURR OPIN CELL BIOL, V22, P809, DOI 10.1016/j.ceb.2010.06.003; Polakova S, 2009, P NATL ACAD SCI USA, V106, P2688, DOI 10.1073/pnas.0809793106; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; STCHARLES J, 2010, GENETICS        0810, DOI DOI 10.1534/GENETICS.110.121533; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	25	386	389	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					321	325		10.1038/nature09529	http://dx.doi.org/10.1038/nature09529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	20962780	Green Accepted			2022-12-24	WOS:000284051000054
J	Halfmann, R; Lindquist, S				Halfmann, Randal; Lindquist, Susan			Epigenetics in the Extreme: Prions and the Inheritance of Environmentally Acquired Traits	SCIENCE			English	Editorial Material							YEAST; EVOLUTION; FORM	Prions are an unusual form of epigenetics: Their stable inheritance and complex phenotypes come about through protein folding rather than nucleic acid-associated changes. With intimate ties to protein homeostasis and a remarkable sensitivity to stress, prions are a robust mechanism that links environmental extremes with the acquisition and inheritance of new traits.	[Halfmann, Randal; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Halfmann, Randal; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu		Halfmann, Randal/0000-0002-6592-1471	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fleming AB, 2001, EMBO J, V20, P5219, DOI 10.1093/emboj/20.18.5219; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Namy O, 2008, NAT CELL BIOL, V10, P1069, DOI 10.1038/ncb1766; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shkundina IS, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1519, DOI 10.1134/S0006297907130081; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006; West-Eberhard Mary Jane, 2003, pi	31	163	166	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2010	330	6004					629	632		10.1126/science.1191081	http://dx.doi.org/10.1126/science.1191081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030648				2022-12-24	WOS:000283580600036
J	Law, MJ; Lower, KM; Voon, HPJ; Hughes, JR; Garrick, D; Viprakasit, V; Mitson, M; De Gobbi, M; Marra, M; Morris, A; Abbott, A; Wilder, SP; Taylor, S; Santos, GM; Cross, J; Ayyub, H; Jones, S; Ragoussis, J; Rhodes, D; Dunham, I; Higgs, DR; Gibbons, RJ				Law, Martin J.; Lower, Karen M.; Voon, Hsiao P. J.; Hughes, Jim R.; Garrick, David; Viprakasit, Vip; Mitson, Matthew; De Gobbi, Marco; Marra, Marco; Morris, Andrew; Abbott, Aaron; Wilder, Steven P.; Taylor, Stephen; Santos, Guilherme M.; Cross, Joe; Ayyub, Helena; Jones, Steven; Ragoussis, Jiannis; Rhodes, Daniela; Dunham, Ian; Higgs, Douglas R.; Gibbons, Richard J.			ATR-X Syndrome Protein Targets Tandem Repeats and Influences Allele-Specific Expression in a Size-Dependent Manner	CELL			English	Article							LINKED MENTAL-RETARDATION; CHROMATIN IMMUNOPRECIPITATION; HISTONE CHAPERONE; MUTATIONS; LOCALIZATION; DAXX; HETEROCHROMATIN; QUADRUPLEXES; BINDING; GENES	ATRX is an X-linked gene of the SWI/SNF family, mutations in which cause syndromal mental retardation and downregulation of a-globin expression. Here we show that ATRX binds to tandem repeat (TR) sequences in both telomeres and euchromatin. Genes associated with these TRs can be dysregulated when ATRX is mutated, and the change in expression is determined by the size of the TR, producing skewed allelic expression. This reveals the characteristics of the affected genes, explains the variable phenotypes seen with identical ATRX mutations, and illustrates a new mechanism underlying variable penetrance. Many of the TRs are G rich and predicted to form non-B DNA structures (including G-quadruplex) in vivo. We show that ATRX binds G-quadruplex structures in vitro, suggesting a mechanism by which ATRX may play a role in various nuclear processes and how this is perturbed when ATRX is mutated.	[Law, Martin J.; Lower, Karen M.; Voon, Hsiao P. J.; Hughes, Jim R.; Garrick, David; Mitson, Matthew; De Gobbi, Marco; Cross, Joe; Ayyub, Helena; Higgs, Douglas R.; Gibbons, Richard J.] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; [Taylor, Stephen] John Radcliffe Hosp, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DS, England; [Viprakasit, Vip] Mahidol Univ, Siriaj Hosp, Fac Med, Dept Paediat, Bangkok 10700, Thailand; [Morris, Andrew; Abbott, Aaron; Ragoussis, Jiannis] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Wilder, Steven P.; Dunham, Ian] European Bioinformat Inst, Cambridge CB10 1SD, England; [Santos, Guilherme M.; Rhodes, Daniela] MRC, Struct Studies Div, Mol Biol Lab, Cambridge CB2 0QH, England; [Marra, Marco; Jones, Steven] Univ British Columbia, BCCA Genome Sci Ctr, Vancouver, BC V6T 1Z4, Canada	University of Oxford; University of Oxford; Mahidol University; University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); MRC Laboratory Molecular Biology; University of British Columbia	Gibbons, RJ (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	richard.gibbons@imm.ox.ac.uk	Ragoussis, Ioannis/AAD-9790-2022; Marra, Marco A/B-5987-2008; GARRICK, David/O-5734-2019; De Gobbi, Marco/E-8136-2013; Jones, Steven J/C-3621-2009; Garrick, David/F-1728-2017; Voon, Hsiao/G-9264-2014; Gibbons, Richard/E-6937-2011	Marra, Marco A/0000-0001-7146-7175; GARRICK, David/0000-0001-7422-7986; Jones, Steven J/0000-0003-3394-2208; Garrick, David/0000-0001-7422-7986; Voon, Hsiao/0000-0002-7179-6611; Dunham, Ian/0000-0003-2525-5598; De Gobbi, Marco/0000-0003-4261-7642; Cross, Joe Wilson/0000-0003-4814-7098; Wilder, Steven/0000-0001-8049-2559; Santos, Guilherme/0000-0003-1489-2161; Higgs, Douglas/0000-0003-3579-8705; Ragoussis, Ioannis/0000-0002-8515-0934; Gibbons, Richard/0000-0002-7680-9311; Lower, Karen/0000-0003-2196-5234	Medical Research Council; National Institute of Health Biomedical Research Centre; Thailand Research Fund (TRF); BIOTEC, Thailand; Oxford University; Medical Research Council [MC_U137961147, G1000801j, MC_U105184333, G1000801b] Funding Source: researchfish; MRC [MC_U137961147, MC_U105184333] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Biomedical Research Centre; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); BIOTEC, Thailand; Oxford University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the members of the families studied for their participation; S. Butler and J. Sloane-Stanley for tissue culture; C. Wippo, J. Huddleston, and L. Marcelline for genotyping; P. Vathesatogkit and R. Totong for SNP validation; A. Goriely for assistance with pyrosequencing; C. Bachrati for gel-shift probes; and W. Wood for critical reading of the manuscript. In addition to others, the work was supported by the Medical Research Council and the National Institute of Health Biomedical Research Centre Programme. V.V. is supported by Thailand Research Fund (TRF) and BIOTEC, Thailand. K.M.L. was supported by an Oxford Nuffield Medical Fellowship, Oxford University.	Argentaro A, 2007, P NATL ACAD SCI USA, V104, P11939, DOI 10.1073/pnas.0704057104; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; De Gobbi M, 2007, BLOOD, V110, P4503, DOI 10.1182/blood-2007-06-097964; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; FIBACH E, 1991, INT J CELL CLONING, V9, P57, DOI 10.1002/stem.5530090108; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; GIBBONS RJ, 1991, J MED GENET, V28, P729, DOI 10.1136/jmg.28.11.729; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; GIRALDO R, 1994, P NATL ACAD SCI USA, V91, P7658, DOI 10.1073/pnas.91.16.7658; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Higgs DR, 1998, SEMIN HEMATOL, V35, P93; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kernohan KD, 2010, DEV CELL, V18, P191, DOI 10.1016/j.devcel.2009.12.017; Kourmouli N, 2005, BIOCHEM BIOPH RES CO, V337, P901, DOI 10.1016/j.bbrc.2005.09.132; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schneiderman JI, 2009, P NATL ACAD SCI USA, V106, P14472, DOI 10.1073/pnas.0905816106; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILKIE AOM, 1990, AM J HUM GENET, V46, P1127; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100	37	287	298	4	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					367	378		10.1016/j.cell.2010.09.023	http://dx.doi.org/10.1016/j.cell.2010.09.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029860	Bronze			2022-12-24	WOS:000283603900011
J	Tian, D; Sun, S; Lee, JT				Tian, Di; Sun, Sha; Lee, Jeannie T.			The Long Noncoding RNA, Jpx, Is a Molecular Switch for X Chromosome Inactivation	CELL			English	Article							IMPRINTED XIST EXPRESSION; EMBRYONIC STEM-CELLS; EARLY MOUSE EMBRYOS; DOSAGE COMPENSATION; TSIX TRANSCRIPTION; ANTISENSE TRANSCRIPTION; CHROMATIN-STRUCTURE; GENE; METHYLATION; REPEAT	Once protein-coding, the X-inactivation center (Xic) is now dominated by large noncoding RNAs (ncRNA). X chromosome inactivation (XCI) equalizes gene expression between mammalian males and females by inactivating one X in female cells. XCI requires Xist, an ncRNA that coats the X and recruits Polycomb proteins. How Xist is controlled remains unclear but likely involves negative and positive regulators. For the active X, the antisense Tsix RNA is an established Xist repressor. For the inactive X, here, we identify Xic-encoded Jpx as an Xist activator. Jpx is developmentally regulated and accumulates during XCI. Deleting Jpx blocks XCI and is female lethal. Posttranscriptional Jpx knockdown recapitulates the knockout, and supplying Jpx in trans rescues lethality. Thus, Jpx is trans-acting and functions as ncRNA. Furthermore, Delta Jpx is rescued by truncating Tsix, indicating an antagonistic relationship between the ncRNAs. We conclude that Xist is controlled by two RNA-based switches: Tsix for Xa and Jpx for Xi.	[Tian, Di; Sun, Sha; Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Tian, Di; Sun, Sha; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA; [Tian, Di; Sun, Sha; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tian, Di; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Lee, JT (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	lee@molbio.mgh.harvard.edu			NIH [K08-HD053824, RO1-GM58839];  [T32-CA009216]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD053824] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Jeon for providing Xist riboprobes, and A. Chess, D. Lessing, B. Payer, and S. Pinter for critical reading of the manuscript and all members of the laboratory for their helpful input throughout this project. This work was funded by NIH grants K08-HD053824 to D.T., RO1-GM58839 to J.T.L., and a Pathology training grant T32-CA009216. J.T.L. is also an Investigator of the Howard Hughes Medical Institute.	Ahn Janice Y, 2010, BMC Dev Biol, V10, P90, DOI 10.1186/1471-213X-10-90; ARIEL M, 1995, NAT GENET, V9, P312, DOI 10.1038/ng0395-312; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CATTANACH BM, 1967, GENETICS, V57, P331; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Davidow LS, 2007, CHROMOSOME RES, V15, P137, DOI 10.1007/s10577-007-1121-6; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Johnston CM, 2002, GENOMICS, V80, P236, DOI 10.1006/geno.2002.6819; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Ohhata T, 2006, CYTOGENET GENOME RES, V113, P345, DOI 10.1159/000090851; Ohhata T, 2008, DEVELOPMENT, V135, P227, DOI 10.1242/dev.008490; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sado T, 2001, DEVELOPMENT, V128, P1275; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Shevchenko AI, 2007, CHROMOSOME RES, V15, P127, DOI 10.1007/s10577-006-1115-9; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Simmler MC, 1996, HUM MOL GENET, V5, P1713, DOI 10.1093/hmg/5.11.1713; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; ZUCCOTTI M, 1995, NAT GENET, V9, P316, DOI 10.1038/ng0395-316	63	364	400	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					390	403		10.1016/j.cell.2010.09.049	http://dx.doi.org/10.1016/j.cell.2010.09.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029862	Bronze, Green Accepted			2022-12-24	WOS:000283603900013
J	Rappaport, SM; Smith, MT				Rappaport, Stephen M.; Smith, Martyn T.			Environment and Disease Risks	SCIENCE			English	Editorial Material							GENOME; DAMAGE		[Rappaport, Stephen M.; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rappaport, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	srappaport@berkeley.edu			NIEHS NIH HHS [P42ES04705, P42 ES004705, U54 ES016115, U54ES016115] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES016115, P42ES004705] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Haltdorsson TL, 2009, ENVIRON RES, V109, P22, DOI 10.1016/j.envres.2008.08.011; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; McHale CM, 2010, MUTAT RES-REV MUTAT, V705, P172, DOI 10.1016/j.mrrev.2010.04.001; Mounicou S, 2009, CHEM SOC REV, V38, P1119, DOI 10.1039/b713633c; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Rubino FM, 2009, MASS SPECTROM REV, V28, P725, DOI 10.1002/mas.20207; Vineis P, 2004, INT J EPIDEMIOL, V33, P945, DOI 10.1093/ije/dyh277; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	15	481	510	10	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					460	461		10.1126/science.1192603	http://dx.doi.org/10.1126/science.1192603			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966241	Green Accepted			2022-12-24	WOS:000283329100026
J	Ren, DC; Tu, HC; Kim, H; Wang, GX; Bean, GR; Takeuchi, O; Jeffers, JR; Zambetti, GP; Hsieh, JJD; Cheng, EHY				Ren, Decheng; Tu, Ho-Chou; Kim, Hyungjin; Wang, Gary X.; Bean, Gregory R.; Takeuchi, Osamu; Jeffers, John R.; Zambetti, Gerard P.; Hsieh, James J. -D.; Cheng, Emily H. -Y.			BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program	SCIENCE			English	Article							BCL-2 FAMILY-MEMBERS; MITOCHONDRIAL APOPTOSIS; MEMBRANE PERMEABILIZATION; NEURONAL APOPTOSIS; CYTOCHROME-C; JNK PATHWAY; BH3 DOMAINS; PROTEINS; MECHANISM; RELEASE	Although the proteins BAX and BAK are required for initiation of apoptosis at the mitochondria, how BAX and BAK are activated remains unsettled. We provide in vivo evidence demonstrating an essential role of the proteins BID, BIM, and PUMA in activating BAX and BAK. Bid, Bim, and Puma triple-knockout mice showed the same developmental defects that are associated with deficiency of Bax and Bak, including persistent interdigital webs and imperforate vaginas. Genetic deletion of Bid, Bim, and Puma prevented the homo-oligomerization of BAX and BAK, and thereby cytochrome c-mediated activation of caspases in response to diverse death signals in neurons and T lymphocytes, despite the presence of other BH3-only molecules. Thus, many forms of apoptosis require direct activation of BAX and BAK at the mitochondria by a member of the BID, BIM, or PUMA family of proteins.	[Ren, Decheng; Tu, Ho-Chou; Kim, Hyungjin; Wang, Gary X.; Bean, Gregory R.; Hsieh, James J. -D.; Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Takeuchi, Osamu] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Jeffers, John R.; Zambetti, Gerard P.] St Jude Childrens Hosp, Memphis, TN 38105 USA; [Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Osaka University; St Jude Children's Research Hospital; Washington University (WUSTL)	Cheng, EHY (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	chenge1@mskcc.org	Zambetti, Gerard/N-8093-2018; Takeuchi, Osamu/D-6007-2011; Ren, decheng/B-8310-2011; Takeuchi, Osamu/AAG-9359-2019	Zambetti, Gerard/0000-0002-0929-5007; Takeuchi, Osamu/0000-0002-1260-6232; Wang, Gary/0000-0002-8013-0766	NIH [R01CA125562, R01GM083159, P30CA21765]; Searle Scholars Program; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA125562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to all the investigators whose research could not be appropriately cited owing to space limitation. We thank T. D. Westergard and H.-F. Chen for technical assistance. This work was supported by grants to E.H.-Y.C. from NIH (R01CA125562) and the Searle Scholars Program, and to G.P.Z. from NIH (R01GM083159 and P30CA21765)	Besirli CG, 2005, J CELL BIOL, V170, P401, DOI 10.1083/jcb.200501138; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gross A., 1999, Genes Dev, V13, P1899; Harris CA, 2001, J BIOL CHEM, V276, P37754; Kim HA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1972; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	30	344	372	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1390	1393		10.1126/science.1190217	http://dx.doi.org/10.1126/science.1190217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127253	Green Accepted			2022-12-24	WOS:000284902100045
J	Giulivi, C; Zhang, YF; Omanska-Klusek, A; Ross-Inta, C; Wong, S; Hertz-Picciotto, I; Tassone, F; Pessah, IN				Giulivi, Cecilia; Zhang, Yi-Fan; Omanska-Klusek, Alicja; Ross-Inta, Catherine; Wong, Sarah; Hertz-Picciotto, Irva; Tassone, Flora; Pessah, Isaac N.			Mitochondrial Dysfunction in Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-CHAIN DISORDERS; COPY NUMBER; SPECTRUM; DNA; DEFICIENCY; METABOLISM; CHILDREN; MUSCLE; CELLS	Context Impaired mitochondrial function may influence processes highly dependent on energy, such as neurodevelopment, and contribute to autism. No studies have evaluated mitochondrial dysfunction and mitochondrial DNA (mtDNA) abnormalities in a well-defined population of children with autism. Objective To evaluate mitochondrial defects in children with autism. Design, Setting, and Patients Observational study using data collected from patients aged 2 to 5 years who were a subset of children participating in the Childhood Autism Risk From Genes and Environment study in California, which is a population-based, case-control investigation with confirmed autism cases and age-matched, genetically unrelated, typically developing controls, that was launched in 2003 and is still ongoing. Mitochondrial dysfunction and mtDNA abnormalities were evaluated in lymphocytes from 10 children with autism and 10 controls. Main Outcome Measures Oxidative phosphorylation capacity, mtDNA copy number and deletions, mitochondrial rate of hydrogen peroxide production, and plasma lactate and pyruvate. Results The reduced nicotinamide adenine dinucleotide (NADH) oxidase activity (normalized to citrate synthase activity) in lymphocytic mitochondria from children with autism was significantly lower compared with controls (mean, 4.4 [95% confidence interval {CI}, 2.8-6.0] vs 12 [95% CI, 8-16], respectively; P=.001). The majority of children with autism (6 of 10) had complex I activity below control range values. Higher plasma pyruvate levels were found in children with autism compared with controls (0.23 mM [95% CI, 0.15-0.31 mM] vs 0.08 mM [95% CI, 0.04-0.12 mM], respectively; P=.02). Eight of 10 cases had higher pyruvate levels but only 2 cases had higher lactate levels compared with controls. These results were consistent with the lower pyruvate dehydrogenase activity observed in children with autism compared with controls (1.0 [95% CI, 0.6-1.4] nmol x [min x mg protein](-1) vs 2.3 [95% CI, 1.7-2.9] nmol x [min x mg protein](-1), respectively; P=.01). Children with autism had higher mitochondrial rates of hydrogen peroxide production compared with controls (0.34 [95% CI, 0.26-0.42] nmol x [min x mg of protein](-1) vs 0.16 [95% CI, 0.12-0.20] nmol x [min x mg protein](-1) by complex III; P=.02). Mitochondrial DNA overreplication was found in 5 cases (mean ratio of mtDNA to nuclear DNA: 239 [95% CI, 217239] vs 179 [95% CI, 165-193] in controls; P=10(-4)). Deletions at the segment of cytochrome b were observed in 2 cases (ratio of cytochrome b to ND1: 0.80 [95% CI, 0.68-0.92] vs 0.99 [95% CI, 0.93-1.05] for controls; P=.01). Conclusion In this exploratory study, children with autism were more likely to have mitochondrial dysfunction, mtDNA overreplication, and mtDNA deletions than typically developing children. JAMA. 2010;304(21):2389-2396 www.jama.com	[Giulivi, Cecilia; Zhang, Yi-Fan; Omanska-Klusek, Alicja; Ross-Inta, Catherine; Wong, Sarah; Pessah, Isaac N.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Hertz-Picciotto, Irva] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Hertz-Picciotto, Irva; Tassone, Flora] Univ Calif Davis, Sch Med, Davis, CA 95616 USA; [Hertz-Picciotto, Irva; Pessah, Isaac N.] Univ Calif Davis, Ctr Childrens Environm Hlth & Dis Prevent, Davis, CA 95616 USA; [Hertz-Picciotto, Irva; Tassone, Flora; Pessah, Isaac N.] Univ Calif Davis, Med Invest Neurodev Disorders Inst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Giulivi, C (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, 1 Shields Ave,1120 Haring Hall, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Pessah, Isaac N/K-7985-2017; Giulivi, Cecilia/ABB-7809-2020; Giulivi, Cecilia/AAV-6774-2021	Pessah, Isaac N/0000-0002-8149-588X; Giulivi, Cecilia/0000-0003-1033-7435; Hertz-Picciotto, Irva/0000-0001-6952-2390	University of California, Davis; MIND Institute [FT19900]; National Institute of Environmental Health Sciences [P01 ES11269, R01 ES015359]; Autism Speaks; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015359, R01ES012691, P01ES011269] Funding Source: NIH RePORTER	University of California, Davis(University of California System); MIND Institute; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Autism Speaks; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study received funding from the 2008 Medical Investigations of Neurodevelopmental Disorders Institute Pilot Research Grant, University of California, Davis, and support from Autism Speaks awarded to Dr Giulivi. Additional funding was provided by the MIND Institute Gift Funds FT19900 to Dr Tassone. Additional support was provided by grants P01 ES11269 and R01 ES015359 from the National Institute of Environmental Health Sciences. Additional funding was received by Dr Pessah through an Environmental Innovator Award from Autism Speaks.	Aldred S, 2003, J AUTISM DEV DISORD, V33, P93, DOI 10.1023/A:1022238706604; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; DEMEIRLEIR L, 1993, PEDIATR NEUROL, V9, P216, DOI 10.1016/0887-8994(93)90088-T; Erecinska M, 1996, BBA-BIOENERGETICS, V1277, P13, DOI 10.1016/S0005-2728(96)00103-X; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Filipek PA, 2004, J AUTISM DEV DISORD, V34, P615, DOI 10.1007/s10803-004-5283-1; Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596; FISCHER JC, 1985, CLIN CHIM ACTA, V145, P89, DOI 10.1016/0009-8981(85)90022-1; GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122; GIULIVI C, 2003, SIGNAL TRANSDUCTION, P311; Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117; Haynes V, 2010, AM J PHYSIOL-ENDOC M, V298, pE978, DOI 10.1152/ajpendo.00739.2009; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Hertz-Picciotto I, 2006, ENVIRON HEALTH PERSP, V114, P1119, DOI 10.1289/ehp.8483; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Krebs H A, 1973, Symp Soc Exp Biol, V27, P299; Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Meng XM, 2005, NEUROLOGY, V64, P1644, DOI 10.1212/01.WNL.0000160391.58004.D4; Ming X, 2010, BRAIN DEV-JPN, V32, P105, DOI 10.1016/j.braindev.2008.12.017; Mullen E. M, 1995, MULLEN SCALES EARLY; National Institute of Neurological Disorders and Stroke, AUT FACT SHEET; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P1; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; SHAY JW, 1990, J BIOL CHEM, V265, P14802; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; SPARROW SS, 1985, J PEDIATR PSYCHOL, V10, P215, DOI 10.1093/jpepsy/10.2.215; STJERNHOLM RL, 1967, J BACTERIOL, V93, P1657, DOI 10.1128/JB.93.5.1657-1661.1967; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; World Medical Association, DECL HELS ETH PRINC; Zecavati N, 2009, CURR NEUROL NEUROSCI, V9, P129, DOI 10.1007/s11910-009-0021-x; Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2	43	280	286	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2389	2396		10.1001/jama.2010.1706	http://dx.doi.org/10.1001/jama.2010.1706			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119085	Green Accepted, Bronze			2022-12-24	WOS:000284763900020
J	Mitton-Fry, RM; DeGregorio, SJ; Wang, JM; Steitz, TA; Steitz, JA				Mitton-Fry, Rachel M.; DeGregorio, Suzanne J.; Wang, Jimin; Steitz, Thomas A.; Steitz, Joan A.			Poly(A) Tail Recognition by a Viral RNA Element Through Assembly of a Triple Helix	SCIENCE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; HUMAN TELOMERASE RNA; TERTIARY INTERACTIONS; KAPOSIS-SARCOMA; NUCLEAR-RNA; PSEUDOKNOT; BINDING; DECAY	Kaposi's sarcoma-associated herpesvirus produces a highly abundant, nuclear noncoding RNA, polyadenylated nuclear (PAN) RNA, which contains an element that prevents its decay. The 79-nucleotide expression and nuclear retention element (ENE) was proposed to adopt a secondary structure like that of a box H/ACA small nucleolar RNA (snoRNA), with a U-rich internal loop that hybridizes to and protects the PAN RNA poly(A) tail. The crystal structure of a complex between the 40-nucleotide ENE core and oligo(A)(9) RNA at 2.5 angstrom resolution reveals that unlike snoRNAs, the U-rich loop of the ENE engages its target through formation of a major-groove triple helix. A-minor interactions extend the binding interface. Deadenylation assays confirm the functional importance of the triple helix. Thus, the ENE acts as an intramolecular RNA clamp, sequestering the PAN poly(A) tail and preventing the initiation of RNA decay.	[Mitton-Fry, Rachel M.; DeGregorio, Suzanne J.; Steitz, Joan A.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, New Haven, CT 06536 USA; [Wang, Jimin; Steitz, Thomas A.] Yale Univ, Bass Ctr Mol & Struct Biol, Dept MB&B, New Haven, CT 06536 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Bass Ctr Mol & Struct Biol, HHMI, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu	Steitz, Thomas A./C-6559-2009		NIH [CA16038, GM022778]; Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026154, P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Borah, K. Tycowski, K. Herbert, and K. Riley for critical reading of the manuscript and the entire Steitz laboratories for helpful discussion. We thank S. Strobel and G. Conn for the generous gifts of iridium(III) hexamine and 3'-hepatitis delta virus (HDV) plasmid, respectively. Special thanks to Y. Zuo and G. Blaha for crystallography assistance, P. Moore and E. Paulson for NMR assistance, and M.-D. Shu, D. Mishler, and K. Durniak for technical assistance. X-ray data were collected at the National Synchrotron Light Source (X29A) at Brookhaven National Laboratory (13). Financial support for this research was provided by NIH grant CA16038 to J.A.S. and NIH grant GM022778 to T. A. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. R.M.M.-F. is supported by a Jane Coffin Childs Memorial Fund Postdoctoral fellowship. J.A.S. and T. A. S. are investigators of the Howard Hughes Medical Institute. Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 3P22.	Conrad NK, 2007, P NATL ACAD SCI USA, V104, P10412, DOI 10.1073/pnas.0704187104; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Conrad NK, 2005, EMBO J, V24, P1831, DOI 10.1038/sj.emboj.7600662; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; DSOUZA DJ, 1992, J BIOMOL STRUCT DYN, V10, P141, DOI 10.1080/07391102.1992.10508634; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; FELSENFELD G, 1957, J AM CHEM SOC, V79, P2023, DOI 10.1021/ja01565a074; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Jin H, 2007, MOL CELL, V26, P205, DOI 10.1016/j.molcel.2007.03.014; Kim NK, 2008, J MOL BIOL, V384, P1249, DOI 10.1016/j.jmb.2008.10.005; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; Sun R, 1996, P NATL ACAD SCI USA, V93, P11883, DOI 10.1073/pnas.93.21.11883; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Viejo-Borbolla Abel, 2004, Curr HIV/AIDS Rep, V1, P5, DOI 10.1007/s11904-004-0001-3; Wu HH, 2007, P NATL ACAD SCI USA, V104, P6655, DOI 10.1073/pnas.0701534104; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641	25	123	127	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1244	1247		10.1126/science.1195858	http://dx.doi.org/10.1126/science.1195858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109672	Green Accepted			2022-12-24	WOS:000284613700042
J	Dhingra, N; Jha, P; Sharma, VP; Cohen, AA; Jotkar, RM; Rodriguez, PS; Bassani, DG; Suraweera, W; Laxminarayan, R; Peto, R				Dhingra, Neeraj; Jha, Prabhat; Sharma, Vinod P.; Cohen, Alan A.; Jotkar, Raju M.; Rodriguez, Peter S.; Bassani, Diego G.; Suraweera, Wilson; Laxminarayan, Ramanan; Peto, Richard		Million Death Study Collaborators	Adult and child malaria mortality in India: a nationally representative mortality survey	LANCET			English	Article							VERBAL AUTOPSIES; DEATHS; BURDEN; VALIDATION; FRACTIONS; DISEASES; SMOKING; AFRICA; HEALTH; RATES	Background National malaria death rates are difficult to assess because reliably diagnosed malaria is likely to be cured, and deaths in the community from undiagnosed malaria could be misattributed in retrospective enquiries to other febrile causes of death, or vice-versa. We aimed to estimate plausible ranges of malaria mortality in India, the most populous country where the disease remains common. Methods Full-time non-medical field workers interviewed families or other respondents about each of 122 000 deaths during 2001-03 in 6671 randomly selected areas of India, obtaining a half-page narrative plus answers to specific questions about the severity and course of any fevers. Each field report was sent to two of 130 trained physicians, who independently coded underlying causes, with discrepancies resolved either via anonymous reconciliation or adjudication. Findings Of all coded deaths at ages 1 month to 70 years, 2681 (3.6%) of 75 342 were attributed to malaria. Of these, 2419 (90%) were in rural areas and 2311 (86%) were not in any health-care facility. Death rates attributed to malaria correlated geographically with local malaria transmission rates derived independently from the Indian malaria control programme. The adjudicated results show 205 000 malaria deaths per year in India before age 70 years (55 000 in early childhood, 30 000 at ages 5-14 years, 120 000 at ages 15-69 years); 1.8% cumulative probability of death from malaria before age 70 years. Plausible lower and upper bounds (on the basis of only the initial coding) were 125 000-277 000. Malaria accounted for a substantial minority of about 1.3 million unattended rural fever deaths attributed to infectious diseases in people younger than 70 years. Interpretation Despite uncertainty as to which unattended febrile deaths are from malaria, even the lower bound greatly exceeds the WHO estimate of only 15 000 malaria deaths per year in India (5000 early childhood, 10 000 thereafter). This low estimate should be reconsidered, as should the low WHO estimate of adult malaria deaths worldwide.	[Dhingra, Neeraj; Jha, Prabhat; Cohen, Alan A.; Jotkar, Raju M.; Rodriguez, Peter S.; Bassani, Diego G.; Suraweera, Wilson] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada; [Dhingra, Neeraj; Jha, Prabhat; Cohen, Alan A.; Jotkar, Raju M.; Rodriguez, Peter S.; Bassani, Diego G.; Suraweera, Wilson] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 2C5, Canada; [Dhingra, Neeraj] Natl AIDS Control Org, New Delhi, India; [Sharma, Vinod P.] Indian Inst Technol, Ctr Rural Dev & Technol, New Delhi, India; [Jotkar, Raju M.] St Johns Res Inst, Bangalore, Karnataka, India; [Laxminarayan, Ramanan] Resources Future Inc, Washington, DC 20036 USA; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Peto, Richard] Univ Oxford, Epidemiol Studies Unit, Oxford, England	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; St. John's National Academy of Health Sciences; St. John's Research Institute; Resources for the Future; University of Oxford; University of Oxford	Jha, P (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada.	prabhatjha@utoronto.ca	Suraweera, Wilson MG/O-8962-2014; Laxminarayan, Ramanan/ABD-5050-2021; Bassani, Diego/G-2827-2015	Bassani, Diego/0000-0001-6704-3820; Cohen, Alan/0000-0003-4113-3988; Rodriguez, Peter/0000-0003-2272-9962; Suraweera, Wilson/0000-0001-9673-5746; Jha, Prabhat/0000-0001-7067-8341	Fogarty International Center of the US National Institutes of Health [R01 TW05991-01]; Canadian Institute of Health Research (CIHR) [IEG-53506]; Li Ka Shing Knowledge Institute; UK Medical Research Council; Keenan Research Centre at St Michael's Hospital, University of Toronto; FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER; Medical Research Council [MC_U137686857] Funding Source: researchfish; MRC [MC_U137686857] Funding Source: UKRI	Fogarty International Center of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute(University of Toronto); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Keenan Research Centre at St Michael's Hospital, University of Toronto; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Registrar General of India established the SRS in 1971, has continued it ever since, and is collaborating with several of the authors on the ongoing Million Death Study. External funding is from the Fogarty International Center of the US National Institutes of Health (grant R01 TW05991-01), Canadian Institute of Health Research (CIHR; IEG-53506), Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto (CGHR support), and UK Medical Research Council (CTSU support). Additional support was provided by the Disease Control Priorities Network, University of Washington. PI le supported by the Canada Research Chair programme. The opinions expressed in this paper are those of the authors and do not necessarily represent those of the Government of India. We thank David Fisman, Hellen Gelband, Adrianna Murphy, and Torn Peto for comments, and Brendon Pezzack for graphics.	Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; [Anonymous], 2008, WORLD MAL REP 2008; Bawah AA, 2007, AM J TROP MED HYG, V77, P145, DOI 10.4269/ajtmh.2007.77.145; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; *CENTR BUR HLTH IN, 2007, NAT HLTH PROF 2007; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Chaturvedi HK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-301; Cohen AA, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-1; Diamond-Smith Nadia, 2009, Malar J, V8, P24, DOI 10.1186/1475-2875-8-24; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Gogoi S. C., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P526; Gupta E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-92; Hamer DH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-210; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; *INT I POP SCI, 2002, NAT FAM HLTH SURV 2; *INT I POP SCI, 2006, DLHS2 INT I POP SCI; Jain V, 2008, AM J TROP MED HYG, V79, P636; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2001, NATL MED J INDIA, V14, P129; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Kumar R, 2006, Indian J Public Health, V50, P90; Maude GH, 1997, INT J EPIDEMIOL, V26, P1097, DOI 10.1093/ije/26.5.1097; *NIMR NVBDCP, 2007, IN DEPTH REV MAL NAT; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; *REG GEN IND, 2005, MED CERT CAUS DEATH; *REG GEN IND, 2005, SAMPL REG SYST STAT; Registrar General of India and Center for Global Health Research, 2009, CAUS DEATH IND 2001; Reuben Rachel, 1997, Indian Journal of Pediatrics, V64, P243, DOI 10.1007/BF02752458; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Runsewe-Abiodun Iyabo T, 2006, BMC Pediatr, V6, P19, DOI 10.1186/1471-2431-6-19; Sarkar J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-133; Sharma SK, 2004, ANN TROP MED PARASIT, V98, P459, DOI 10.1179/000349804225003569; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; Smith D. L., 2009, SHRINKING MALARIA MA, P108; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; United Nations Department of Economic and Social Affairs Population Division, 2008, WORLD POP PROSP; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 1994, INT STAT CLASS DIS R; [No title captured]	48	191	195	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1768	1774		10.1016/S0140-6736(10)60831-8	http://dx.doi.org/10.1016/S0140-6736(10)60831-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690EI	20970179	Green Accepted			2022-12-24	WOS:000284984900032
J	Rittle, J; Green, MT				Rittle, Jonathan; Green, Michael T.			Cytochrome P450 Compound I: Capture, Characterization, and C-H Bond Activation Kinetics	SCIENCE			English	Article							BIOINORGANIC CHEMISTRY; LAURIC ACID; CHLOROPEROXIDASE; P450CAM; HYDROXYLATION; INTERMEDIATE; SPECTROSCOPY; RESONANCE; FUNCTIONALIZATION; OXIDATIONS	Cytochrome P450 enzymes are responsible for the phase I metabolism of approximately 75% of known pharmaceuticals. P450s perform this and other important biological functions through the controlled activation of C-H bonds. Here, we report the spectroscopic and kinetic characterization of the long-sought principal intermediate involved in this process, P450 compound I (P450-I), which we prepared in approximately 75% yield by reacting ferric CYP119 with m-chloroperbenzoic acid. The Mossbauer spectrum of CYP119-I is similar to that of chloroperoxidase compound I, although its electron paramagnetic resonance spectrum reflects an increase in vertical bar J vertical bar/D, the ratio of the exchange coupling to the zero-field splitting. CYP119-I hydroxylates the unactivated C-H bonds of lauric acid [D(C-H) similar to 100 kilocalories per mole], with an apparent second-order rate constant of k(app) = 1.1 x 10(7) per molar per second at 4 degrees C. Direct measurements put a lower limit of k >= 210 per second on the rate constant for bound substrate oxidation, whereas analyses involving kinetic isotope effects predict a value in excess of 1400 per second.	[Rittle, Jonathan; Green, Michael T.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Green, MT (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	mtg10@psu.edu			NSF	NSF(National Science Foundation (NSF))	This work was supported by NSF. We thank T. Grove and J. C. Calixto Moreno for assistance with GC-MS and C. Krest for help with preliminary EPR experiments. The CYP119 plasmid was graciously provided by P. R. Ortiz de Montellano.	Behan RK, 2007, J AM CHEM SOC, V129, P5855, DOI 10.1021/ja064590y; Chandrasena REP, 2004, J AM CHEM SOC, V126, P115, DOI 10.1021/ja038237t; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Davydov R, 2005, J AM CHEM SOC, V127, P1403, DOI 10.1021/ja045351i; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Denisov IG, 2001, J BIOL CHEM, V276, P11648, DOI 10.1074/jbc.M010219200; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Denisov IG, 2001, J INORG BIOCHEM, V87, P215, DOI 10.1016/S0162-0134(01)00328-2; EGAWA T, 1992, FEBS LETT, V305, P206, DOI 10.1016/0014-5793(92)80668-7; EGAWA T, 1994, BIOCHEM BIOPH RES CO, V201, P1464, DOI 10.1006/bbrc.1994.1868; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Green MT, 2001, J AM CHEM SOC, V123, P9218, DOI 10.1021/ja010105h; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Hoffman BM, 2003, P NATL ACAD SCI USA, V100, P3575, DOI 10.1073/pnas.0636464100; Karlin KD, 2010, NATURE, V463, P168, DOI 10.1038/463168a; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; Kim SH, 2005, DALTON T, P3464, DOI 10.1039/b506764m; Kim SH, 2006, J AM CHEM SOC, V128, P5598, DOI 10.1021/ja060776l; Klinman Judith P., 2009, P132, DOI 10.1039/9781847559975-00132; Koo LS, 2002, J AM CHEM SOC, V124, P5684, DOI 10.1021/ja017174g; Lim YR, 2010, J MICROBIOL BIOTECHN, V20, P574, DOI 10.4014/jmb.0909.09007; Makris TM, 2006, J INORG BIOCHEM, V100, P507, DOI 10.1016/j.jinorgbio.2006.01.025; McLean MA, 1998, BIOCHEM BIOPH RES CO, V252, P166, DOI 10.1006/bbrc.1998.9584; Newcomb M, 2003, J AM CHEM SOC, V125, P6064, DOI 10.1021/ja0343858; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Que L, 2001, SCIENCE, V292, P651; Rabe KS, 2008, CHEMBIOCHEM, V9, P420, DOI 10.1002/cbic.200700450; Rittle J, 2010, INORG CHEM, V49, P3610, DOI 10.1021/ic902062d; RUTTER R, 1984, BIOCHEMISTRY-US, V23, P6809, DOI 10.1021/bi00321a082; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schunemann V, 2002, J INORG BIOCHEM, V91, P586, DOI 10.1016/S0162-0134(02)00476-2; Sligar SG, 2005, BIOCHEM BIOPH RES CO, V338, P346, DOI 10.1016/j.bbrc.2005.08.094; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Stone KL, 2006, P NATL ACAD SCI USA, V103, P12307, DOI 10.1073/pnas.0603159103; Stone KL, 2005, P NATL ACAD SCI USA, V102, P16563, DOI 10.1073/pnas.0507069102; van Rantwijk F, 2000, CURR OPIN BIOTECH, V11, P554, DOI 10.1016/S0958-1669(00)00143-9; Wang Q, 2009, J AM CHEM SOC, V131, P10629, DOI 10.1021/ja9031105; Wright RL, 1996, FEBS LETT, V384, P235, DOI 10.1016/0014-5793(96)00322-5; ZAKS A, 1995, J AM CHEM SOC, V117, P10419, DOI 10.1021/ja00147a001; Zhang R, 2006, ORG LETT, V8, P2731, DOI 10.1021/ol060762k	43	922	922	13	490	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					933	937		10.1126/science.1193478	http://dx.doi.org/10.1126/science.1193478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071661				2022-12-24	WOS:000284118000033
J	Roignant, JY; Treisman, JE				Roignant, Jean-Yves; Treisman, Jessica E.			Exon Junction Complex Subunits Are Required to Splice Drosophila MAP Kinase, a Large Heterochromatic Gene	CELL			English	Article							OSKAR MESSENGER-RNA; RECEPTOR TYROSINE KINASE; MAGO-NASHI; SIGNALING PATHWAY; BINDING PROTEIN; CORE COMPLEX; CELL-DEATH; NONSENSE; EXPRESSION; TRANSLATION	The exon junction complex (EJC) is assembled on spliced mRNAs upstream of exon-exon junctions and can regulate their subsequent translation, localization, or degradation. We isolated mutations in Drosophila mago nashi (mago), which encodes a core EJC subunit, based on their unexpectedly specific effects on photoreceptor differentiation. Loss of Mago prevents epidermal growth factor receptor signaling, due to a large reduction in MAPK mRNA levels. MAPK expression also requires the EJC subunits Y14 and eIF4AIII and EJC-associated splicing factors. Mago depletion does not affect the transcription or stability of MAPK mRNA but alters its splicing pattern. MAPK expression from an exogenous promoter requires Mago only when the template includes introns. MAPK is the primary functional target of mago in eye development; in cultured cells, Mago knockdown disproportionately affects other large genes located in heterochromatin. These data support a nuclear role for EJC components in splicing a specific subset of introns.	[Roignant, Jean-Yves; Treisman, Jessica E.] NYU Sch Med, Kimmel Ctr Biol & Med, Dept Cell Biol, Skirball Inst, New York, NY 10016 USA	New York University	Treisman, JE (corresponding author), NYU Sch Med, Kimmel Ctr Biol & Med, Dept Cell Biol, Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	jessica.treisman@med.nyu.edu		Roignant, Jean-Yves/0000-0003-1395-2150; Treisman, Jessica/0000-0002-7453-107X	National Institutes of Health [EY13777]; NATIONAL EYE INSTITUTE [R01EY013777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Robert Boswell, Barry Dickson, Anne Ephrussi, Ruth Lehmann, James Skeath, Daniel St Johnston, Marc Therrien, the Developmental Studies Hybridoma Bank, the Drosophila Genomics Resource Center, and the Bloomington Drosophila stock center for reagents. We also thank Antonio-Javier Lopez for searching for recursive splice sites in MAPK pre-mRNA and Madeline Crosby for providing a list of heterochromatic genes. We are grateful to the NYU Cancer Institute Genomics Facility and Laura Hogan for assistance with qRT-PCR and deep sequencing and to Stuart Brown and Zuojian Tang for bio-informatics analysis. The manuscript was improved by the critical comments of Sergio Astigarraga, Ines Carrrera, Kerstin Hofmeyer, Kevin Legent, Sylvie Ozon Rickman, Hyung Don Ryoo, Josie Steinhauer, Andrea Zamparini, and Jiri Zavadil. This work was supported by the National Institutes of Health (grant EY13777 to J.E.T.).	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Carrera I, 2008, MOL CELL BIOL, V28, P5238, DOI 10.1128/MCB.00747-08; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dimitri P, 2003, MOL BIOL EVOL, V20, P503, DOI 10.1093/molbev/msg048; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; EBERL DF, 1993, GENETICS, V134, P277; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Golembo M, 1996, DEVELOPMENT, V122, P223; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Halfar K, 2001, DEVELOPMENT, V128, P1687; HAY BA, 1994, DEVELOPMENT, V120, P2121; Herold N, 2009, MOL CELL BIOL, V29, P281, DOI 10.1128/MCB.01415-08; HOU XS, 1995, CELL, V81, P63, DOI 10.1016/0092-8674(95)90371-2; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Janody F, 2004, GENETICS, V166, P187, DOI 10.1534/genetics.166.1.187; Karim FD, 1998, DEVELOPMENT, V125, P1; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; Li C, 2003, MOL CELL BIOL, V23, P7363, DOI 10.1128/MCB.23.20.7363-7376.2003; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martin-Blanco E, 1999, DEVELOPMENT, V126, P5739; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Mohr SE, 2001, GENE DEV, V15, P2886; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Newmark PA, 1997, DEVELOPMENT, V124, P3197; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nykamp K, 2008, RNA, V14, P1378, DOI 10.1261/rna.1066008; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Parma DH, 2007, DEV BIOL, V308, P507, DOI 10.1016/j.ydbio.2007.06.007; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Roignant JY, 2006, GENE DEV, V20, P795, DOI 10.1101/gad.1390506; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shepard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007853; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	70	90	94	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					238	250		10.1016/j.cell.2010.09.036	http://dx.doi.org/10.1016/j.cell.2010.09.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946982	Green Accepted, Bronze			2022-12-24	WOS:000283052200013
J	Acar, M; Pando, BF; Arnold, FH; Elowitz, MB; van Oudenaarden, A				Acar, Murat; Pando, Bernardo F.; Arnold, Frances H.; Elowitz, Michael B.; van Oudenaarden, Alexander			A General Mechanism for Network-Dosage Compensation in Gene Circuits	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING; YEAST; ROBUSTNESS; PROTEIN; REPRESSION; SYSTEMS; GAL80P; MEMORY; SIGNAL	Coping with variations in network dosage is crucial for maintaining optimal function in gene networks. We explored how network structure facilitates network-level dosage compensation. By using the yeast galactose network as a model, we combinatorially deleted one of the two copies of its four regulatory genes and found that network activity was robust to the change in network dosage. A mathematical analysis revealed that a two-component genetic circuit with elements of opposite regulatory activity (activator and inhibitor) constitutes a minimal requirement for network-dosage invariance. Specific interaction topologies and a one-to-one interaction stoichiometry between the activating and inhibiting agents were additional essential elements facilitating dosage invariance. This mechanism of network-dosage invariance could represent a general design for gene network structure in cells.	[Acar, Murat; Elowitz, Michael B.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Pando, Bernardo F.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Arnold, Frances H.] CALTECH, Div Biochem & Mol Biophys, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	California Institute of Technology; Massachusetts Institute of Technology (MIT); California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Massachusetts Institute of Technology (MIT)	Acar, M (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	acar@caltech.edu	van Oudenaarden, Alexander/AAA-1705-2019; Acar, Murat/AIB-8244-2022	Arnold, Frances H./0000-0002-4027-364X	Center for Biological Circuit Design at Caltech; NIH; NSF; Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, R01GM068664, R01GM068957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028299] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	Center for Biological Circuit Design at Caltech; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank J. J. Collins, M. Thattai, and H. Youk for helpful discussions and/or comments on the manuscript. M. A. was supported by a fellowship grant from the Center for Biological Circuit Design at Caltech. B. F. P. and A.v.O were supported by grants from NIH and NSF. Work in the Elowitz laboratory was supported by the Packard Foundation, NSF, and NIH. Work in the Arnold laboratory was supported by NIH.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 2007, INTRO SYSTEMS BIOL D; Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Fell D., 1997, UNDERSTANDING CONTRO; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; LIU YJ, 1995, MOL GEN GENET, V248, P182, DOI 10.1007/BF02190799; Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841; Mizutani A, 2003, EMBO J, V22, P2178, DOI 10.1093/emboj/cdg220; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Peng G, 2000, MOL CELL BIOL, V20, P5140, DOI 10.1128/MCB.20.14.5140-5148.2000; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; SuzukiFujimoto T, 1996, MOL CELL BIOL, V16, P2504; Timson DJ, 2002, BIOCHEM J, V363, P515, DOI 10.1042/0264-6021:3630515; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	28	74	75	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1656	1660		10.1126/science.1190544	http://dx.doi.org/10.1126/science.1190544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929850	Green Accepted			2022-12-24	WOS:000282098100045
J	Morishita, H; Miwa, JM; Heintz, N; Hensch, TK				Morishita, Hirofumi; Miwa, Julie M.; Heintz, Nathaniel; Hensch, Takao K.			Lynx1, a Cholinergic Brake, Limits Plasticity in Adult Visual Cortex	SCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; OCULAR-DOMINANCE PLASTICITY; LATERAL GENICULATE-NUCLEUS; MUSCARINIC RECEPTORS; PROTOTOXIN LYNX1; GABA RELEASE; MODULATION; INHIBITION; NEUROMODULATORS; INTERNEURONS	Experience-dependent brain plasticity typically declines after an early critical period during which circuits are established. Loss of plasticity with closure of the critical period limits improvement of function in adulthood, but the mechanisms that change the brain's plasticity remain poorly understood. Here, we identified an increase in expression of Lynx1 protein in mice that prevented plasticity in the primary visual cortex late in life. Removal of this molecular brake enhanced nicotinic acetylcholine receptor signaling. Lynx1 expression thus maintains stability of mature cortical networks in the presence of cholinergic innervation. The results suggest that modulating the balance between excitatory and inhibitory circuits reactivates visual plasticity and may present a therapeutic target.	[Morishita, Hirofumi; Hensch, Takao K.] Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Miwa, Julie M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Miwa, Julie M.; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Hensch, Takao K.] Harvard Univ, Dept Mol Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; California Institute of Technology; Howard Hughes Medical Institute; Rockefeller University; Harvard University	Hensch, TK (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	takao.hensch@childrens.harvard.edu	Morishita, Hirofumi/J-9619-2015; Hensch, Takao/L-4182-2019	Morishita, Hirofumi/0000-0002-1045-1337; Miwa, Julie/0000-0002-4418-3756	James S. McDonnell Foundation "Recovery from Amblyopia" network; NIH [1 DP1 OD 003699-01]; Ellison Medical Foundation; Howard Hughes Medical Institute; California Tobacco-Related Disease Research Program; Japanese Society for Promotion of Science;  [DA-17279]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003699] Funding Source: NIH RePORTER	James S. McDonnell Foundation "Recovery from Amblyopia" network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Tobacco-Related Disease Research Program(University of California System); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Fagiolini, H. A. Lester, and A. Takesian for their helpful comments on the manuscript and M. Marcotrigiano for animal maintenance. This study was supported by the James S. McDonnell Foundation "Recovery from Amblyopia" network (T. K. H.), NIH Director's Pioneer Award (1 DP1 OD 003699-01 to T. K. H.), the Ellison Medical Foundation (T. K. H.), Howard Hughes Medical Institute (N.H.), DA-17279 and California Tobacco-Related Disease Research Program (J.M.M.), and the Japanese Society for Promotion of Science (H.M.)	Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Aracri P, 2010, CEREB CORTEX, V20, P1539, DOI 10.1093/cercor/bhp214; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Davis JA, 2006, PSYCHOPHARMACOLOGY, V184, P345, DOI 10.1007/s00213-005-0047-y; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; GU Q, 1993, EUR J NEUROSCI, V5, P475, DOI 10.1111/j.1460-9568.1993.tb00514.x; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hess RF, 2009, EUR J NEUROSCI, V29, P1064, DOI 10.1111/j.1460-9568.2009.06650.x; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Kang JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005995; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Kuo MC, 2009, NEUROSCIENCE, V163, P430, DOI 10.1016/j.neuroscience.2009.06.026; Lempert P, 2005, OPHTHAL PHYSL OPT, V25, P592, DOI 10.1111/j.1475-1313.2005.00329.x; Levi DM, 2009, PHILOS T R SOC B, V364, P399, DOI 10.1098/rstb.2008.0203; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; Mann EO, 2008, CURR OPIN NEUROL, V21, P155, DOI 10.1097/WCO.0b013e3282f52f5f; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; PARKINSON D, 1988, EXP BRAIN RES, V73, P553, DOI 10.1007/BF00406614; Pfeffer CK, 2009, J NEUROSCI, V29, P3419, DOI 10.1523/JNEUROSCI.1377-08.2009; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Plessy C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003012; PRUSKY GT, 1987, BRAIN RES, V412, P131, DOI 10.1016/0006-8993(87)91447-8; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Satta R, 2008, P NATL ACAD SCI USA, V105, P16356, DOI 10.1073/pnas.0808699105; Silver MA, 2008, NEURON, V60, P904, DOI 10.1016/j.neuron.2008.09.038; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Wandell BA, 2009, NAT REV NEUROSCI, V10, P873, DOI 10.1038/nrn2741	36	275	285	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1238	1240		10.1126/science.1195320	http://dx.doi.org/10.1126/science.1195320			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21071629	Green Accepted			2022-12-24	WOS:000284613700040
J	Cohen, P; Tcherpakov, M				Cohen, Philip; Tcherpakov, Marianna			Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?	CELL			English	Article							SMALL-MOLECULE INHIBITOR; UNANCHORED POLYUBIQUITIN CHAINS; KAPPA-B ACTIVATION; DEUBIQUITINATING ENZYME; DNA-DAMAGE; LIGASE; PROTEASOME; MDM2; P53; IDENTIFICATION	Protein phosphorylation and protein ubiquitination regulate most aspects of cell life, and defects in these control mechanisms cause cancer and many other diseases. In the past decade, protein kinases have become one of the most important classes of drug targets for the pharmaceutical industry. In contrast, drug discovery programs that target components of the ubiquitin system have lagged behind. In this Perspective, we discuss the reasons for the delay in this pipeline, the drugs targeting the ubiquitin system that have been developed, and new approaches that may popularize this area of drug discovery in the future.	[Cohen, Philip] MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Cohen, Philip] Scottish Inst Cell Signalling, Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Tcherpakov, Marianna] BCC Res, Wellesley, MA 02481 USA	University of Dundee; University of Dundee	Cohen, P (corresponding author), MRC Prot Phosphorylat Unit, Dow St, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk	高, 雨莉/HGU-8187-2022		Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett EJ, 2008, NAT STRUCT MOL BIOL, V15, P20, DOI 10.1038/nsmb0108-20; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Everly MJ, 2008, TRANSPLANTATION, V86, P1754, DOI 10.1097/TP.0b013e318190af83; FISCHER EH, 1955, J BIOL CHEM, V216, P121; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; LAWLER B, 2009, BIO53B GLOB MARK BCC; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Lierman E, 2006, BLOOD, V108, P1374, DOI 10.1182/blood-2006-02-004457; Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Maguire M, 2008, CANCER RES, V68, P3232, DOI 10.1158/0008-5472.CAN-07-5271; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nakajima H, 2008, BIOCHEM BIOPH RES CO, V368, P1007, DOI 10.1016/j.bbrc.2008.01.166; Oliveira AM, 2006, J CLIN ONCOL, V24, pe2; Oliveira Andre M, 2006, J Clin Oncol, V24, pe2, DOI 10.1200/JCO.2005.04.4818; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; TCHERPAKOV M, 2010, PHM066A BCC; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	55	220	227	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					686	693		10.1016/j.cell.2010.11.016	http://dx.doi.org/10.1016/j.cell.2010.11.016			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111230	Bronze			2022-12-24	WOS:000284583500011
J	Campbell, PJ; Yachida, S; Mudie, LJ; Stephens, PJ; Pleasance, ED; Stebbings, LA; Morsberger, LA; Latimer, C; McLaren, S; Lin, ML; McBride, DJ; Varela, I; Nik-Zainal, SA; Leroy, C; Jia, MM; Menzies, A; Butler, AP; Teague, JW; Griffin, CA; Burton, J; Swerdlow, H; Quail, MA; Stratton, MR; Iacobuzio-Donahue, C; Futreal, PA				Campbell, Peter J.; Yachida, Shinichi; Mudie, Laura J.; Stephens, Philip J.; Pleasance, Erin D.; Stebbings, Lucy A.; Morsberger, Laura A.; Latimer, Calli; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena A.; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Griffin, Constance A.; Burton, John; Swerdlow, Harold; Quail, Michael A.; Stratton, Michael R.; Iacobuzio-Donahue, Christine; Futreal, P. Andrew			The patterns and dynamics of genomic instability in metastatic pancreatic cancer	NATURE			English	Article							COPY NUMBER ANALYSIS; HUMAN BREAST-CANCER; GENETIC-HETEROGENEITY; EVOLUTION; TUMORS; REARRANGEMENTS; RESOLUTION; MUTATIONS; LEUKEMIA; CELLS	Pancreatic cancer is an aggressive malignancy with a five-year mortality of 97-98%, usually due to widespread metastatic disease. Previous studies indicate that this disease has a complex genomic landscape, with frequent copy number changes and point mutations(1-5), but genomic rearrangements have not been characterized in detail. Despite the clinical importance of metastasis, there remain fundamental questions about the clonal structures of metastatic tumours(6,7), including phylogenetic relationships among metastases, the scale of ongoing parallel evolution in metastatic and primary sites(7), and how the tumour disseminates. Here we harness advances in DNA sequencing(8-12) to annotate genomic rearrangements in 13 patients with pancreatic cancer and explore clonal relationships among metastases. We find that pancreatic cancer acquires rearrangements indicative of telomere dysfunction and abnormal cell-cycle control, namely dysregulated G1-to-S-phase transition with intact G2-M checkpoint. These initiate amplification of cancer genes and occur predominantly in early cancer development rather than the later stages of the disease. Genomic instability frequently persists after cancer dissemination, resulting in ongoing, parallel and even convergent evolution among different metastases. We find evidence that there is genetic heterogeneity among metastasis-initiating cells, that seeding metastasis may require driver mutations beyond those required for primary tumours, and that phylogenetic trees across metastases show organ-specific branches. These data attest to the richness of genetic variation in cancer, brought about by the tandem forces of genomic instability and evolutionary selection.	[Campbell, Peter J.; Mudie, Laura J.; Stephens, Philip J.; Pleasance, Erin D.; Stebbings, Lucy A.; Latimer, Calli; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena A.; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Burton, John; Swerdlow, Harold; Quail, Michael A.; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; [Yachida, Shinichi; Morsberger, Laura A.; Griffin, Constance A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; [Yachida, Shinichi; Morsberger, Laura A.; Griffin, Constance A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; University of Cambridge; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of London; Institute of Cancer Research - UK	Futreal, PA (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	ciacobu@jhmi.edu; paf@sanger.ac.uk	Iacobuzio-Donahue, Christine/ABF-1295-2020; Varela, Ignacio/AAA-7680-2021; Quail, michael/ABE-6131-2020; Nik-Zainal, Serena/ABD-4437-2020; Varela, Ignacio/G-1699-2016	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Nik-Zainal, Serena/0000-0001-5054-1727; Swerdlow, Harold/0000-0002-9510-160X	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Uehara memorial foundation; Skip Viragh Foundation; Michael Rolphe Foundation; National Institutes of Health [CA106610, CA140599]; The International Human Frontier Science Program Organization; NATIONAL CANCER INSTITUTE [K08CA106610, R01CA140599] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Uehara memorial foundation(Uehara Memorial Foundation); Skip Viragh Foundation; Michael Rolphe Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z). P.J.C. is funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). S.Y. has support from the Uehara memorial foundation. We would also like to acknowledge the financial support of the Skip Viragh Foundation and the Michael Rolphe Foundation for the autopsy programme, and funding from the National Institutes of Health (grants CA106610 and CA140599). I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. We would like to thank U. McDermott for discussions and a critical reading of the manuscript.	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Embuscado EE, 2005, CANCER BIOL THER, V4, P548, DOI 10.4161/cbt.4.5.1663; Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Hashimoto Y, 2008, J GASTROINTEST SURG, V12, P17, DOI 10.1007/s11605-007-0383-9; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; MCLINTOCK B, 1941, GENETICS, V26, P234; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645	30	971	1004	3	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1109	1113		10.1038/nature09460	http://dx.doi.org/10.1038/nature09460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981101	Green Accepted			2022-12-24	WOS:000283548600048
J	Doak, DF; Morris, WF				Doak, Daniel F.; Morris, William F.			Demographic compensation and tipping points in climate-induced range shifts	NATURE			English	Article							EXTINCTION; RESPONSES; IMPACTS; PLANTS	To persist, species are expected to shift their geographical ranges polewards or to higher elevations as the Earth's climate warms(1-4). However, although many species' ranges have shifted in historical times, many others have not, or have shifted only at the high-latitude or high-elevation limits, leading to range expansions rather than contractions(5-11). Given these idiosyncratic responses to climate warming, and their varied implications for species' vulnerability to climate change, a critical task is to understand why some species have not shifted their ranges, particularly at the equatorial or low-elevation limits, and whether such resilience will last as warming continues. Here we show that compensatory changes in demographic rates are buffering southern populations of two North American tundra plants against the negative effects of a warming climate, slowing their northward range shifts, but that this buffering is unlikely to continue indefinitely. Southern populations of both species showed lower survival and recruitment but higher growth of individual plants, possibly owing to longer, warmer growing seasons. Because of these and other compensatory changes, the population growth rates of southern populations are not at present lower than those of northern ones. However, continued warming may yet prove detrimental, as most demographic rates that improved in moderately warmer years declined in the warmest years, with the potential to drive future population declines. Our results emphasize the need for long-term, range-wide measurement of all population processes to detect demographic compensation and to identify nonlinear responses that may lead to sudden range shifts as climatic tipping points are exceeded.	[Doak, Daniel F.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Morris, William F.] Duke Univ, Dept Biol, Durham, NC 27708 USA	University of Wyoming; Duke University	Doak, DF (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	ddoak@uwyo.edu			NSF [DEB-9806818, DEB-0087096, DEB-0716433]	NSF(National Science Foundation (NSF))	This work was supported by NSF grants DEB-9806818, DEB-0087096 and DEB-0716433. We thank the many field and laboratory assistants who have helped over the years, and J. Estes, N. Haddad, A. Rose and W. Thuiller.	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Chapin FS, 1996, ECOLOGY, V77, P822, DOI 10.2307/2265504; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; TULJAPURKAR S, 1990, POPULATION DYNAMICS, P91; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000	23	310	312	2	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					959	962		10.1038/nature09439	http://dx.doi.org/10.1038/nature09439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962844				2022-12-24	WOS:000283254700037
J	Rauzi, M; Lenne, PF; Lecuit, T				Rauzi, Matteo; Lenne, Pierre-Francois; Lecuit, Thomas			Planar polarized actomyosin contractile flows control epithelial junction remodelling	NATURE			English	Article							ADHERENS JUNCTIONS; APICAL CONSTRICTION; CELL-SHAPE; TISSUE MORPHOGENESIS; ALPHA-CATENIN; E-CADHERIN; DROSOPHILA; NETWORK; FORCES; INTERCALATION	Force generation by Myosin-II motors on actin filaments drives cell and tissue morphogenesis(1-15). In epithelia, contractile forces are resisted at apical junctions by adhesive forces dependent on E-cadherin(16), which also transmits tension(6,17-19). During Drosophila embryonic germband extension, tissue elongation is driven by cell intercalation(20), which requires an irreversible and planar polarized remodelling of epithelial cell junctions(4,5). We investigate how cell deformations emerge from the interplay between force generation and cortical force transmission during this remodelling in Drosophila melanogaster. The shrinkage of dorsal-ventral-oriented ('vertical') junctions during this process is known to require planar polarized junctional contractility by Myosin II (refs 4,5,7,12). Here we show that this shrinkage is not produced by junctional Myosin II itself, but by the polarized flow of medial actomyosin pulses towards 'vertical' junctions. This anisotropic flow is oriented by the planar polarized distribution of E-cadherin complexes, in that medial Myosin II flows towards 'vertical' junctions, which have relatively less E-cadherin than transverse junctions. Our evidence suggests that the medial flow pattern reflects equilibrium properties of force transmission and coupling to E-cadherin by a-Catenin. Thus, epithelial morphogenesis is not properly reflected by Myosin II steady state distribution but by polarized contractile actomyosin flows that emerge from interactions between E-cadherin and actomyosin networks.	[Rauzi, Matteo; Lenne, Pierre-Francois; Lecuit, Thomas] Univ Aix Marseille 2, CNRS, IBDML, UMR6216, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Aix Marseille 2, CNRS, IBDML, UMR6216, Campus Luminy,Case 907, F-13288 Marseille 09, France.	lenne@ibdml.univ-mrs.fr; lecuit@ibdml.univ-mrs.fr		Rauzi, Matteo/0000-0002-6313-0668; Lenne, Pierre-Francois/0000-0003-1066-7506	HFSP; CNRS; Fondation pour la Recherche Medicale; ANR-Blanc; Region PACA; ANR-PCV; Amplitude Systems	HFSP(Human Frontier Science Program); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR-Blanc(French National Research Agency (ANR)); Region PACA(Region Provence-Alpes-Cote d'Azur); ANR-PCV(French National Research Agency (ANR)); Amplitude Systems	We thank R. Levayer, M. Mavrakis and J.-M. Philippe for making and sharing respectively the utrophin-GFP, GAP43-Venus and GAP43-Cherry transgenic lines. We are grateful to our colleagues for their gifts of reagents: B. Bement, R. Karess, H. Oda, A. Martin and E. Wieschaus. We thank E. Munro and all members of the Lecuit and Lenne groups for discussions, and comments on the manuscript. This work was supported by a Programme Grant from HFSP to T. L, P.-F.L and E. Munro, by the CNRS, the Fondation pour la Recherche Medicale (to T. L), the ANR-Blanc 2005 (to T. L. and P.-F.L), Region PACA and ANR-PCV 2008 (to P.-F.L and T. L.). M. R. was supported by a PhD fellowship by the Region PACA and Amplitude Systems.	Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bertet C, 2009, DEVELOPMENT, V136, P4199, DOI 10.1242/dev.040402; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cavey Matthieu, 2008, V420, P219, DOI 10.1007/978-1-59745-583-1_13; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Oda H, 2001, J CELL SCI, V114, P493; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	36	422	429	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1110	U515		10.1038/nature09566	http://dx.doi.org/10.1038/nature09566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21068726				2022-12-24	WOS:000285553800060
J	Pin, PA; Benlloch, R; Bonnet, D; Wremerth-Weich, E; Kraft, T; Gielen, JJL; Nilsson, O				Pin, Pierre A.; Benlloch, Reyes; Bonnet, Dominique; Wremerth-Weich, Elisabeth; Kraft, Thomas; Gielen, Jan J. L.; Nilsson, Ove			An Antagonistic Pair of FT Homologs Mediates the Control of Flowering Time in Sugar Beet	SCIENCE			English	Article							ANNUAL HABIT; LOCUS-T; VERNALIZATION; REPRESSOR; GENE; ARABIDOPSIS	Cultivated beets (Beta vulgaris ssp. vulgaris) are unable to form reproductive shoots during the first year of their life cycle. Flowering only occurs if plants get vernalized, that is, pass through the winter, and are subsequently exposed to an increasing day length (photoperiod) in spring. Here, we show that the regulation of flowering time in beets is controlled by the interplay of two paralogs of the FLOWERING LOCUS T (FT) gene in Arabidopsis that have evolved antagonistic functions. BvFT2 is functionally conserved with FT and essential for flowering. In contrast, BvFT1 represses flowering and its down-regulation is crucial for the vernalization response in beets. These data suggest that the beet has evolved a different strategy relative to Arabidopsis and cereals to regulate vernalization.	[Pin, Pierre A.; Benlloch, Reyes; Nilsson, Ove] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Pin, Pierre A.; Wremerth-Weich, Elisabeth; Kraft, Thomas] Syngenta Seeds AB, S-26123 Landskrona, Sweden; [Bonnet, Dominique; Gielen, Jan J. L.] Syngenta Seeds SAS, F-31790 St Sauveur, France	Swedish University of Agricultural Sciences; Umea University; Syngenta; Syngenta	Nilsson, O (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden.	Ove.Nilsson@genfys.slu.se	Benlloch, Reyes/K-1110-2019; Benlloch, Reyes/L-7526-2014	Benlloch, Reyes/0000-0002-0364-1589; PIN, Pierre A./0000-0001-8933-1452; Nilsson, Ove/0000-0002-1033-1909	Swedish Research Council; Swedish Governmental Agency for Innovation Systems; Sudzucker	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Agency for Innovation Systems(Vinnova); Sudzucker	We thank F. Domene, J. Bensefelt, A. Karlsson, R. Sant, P. van Roggen, and A.-M. Nilsson for technical assistance, and Y. Fischer for help in preparing the manuscript. We also thank C. Bellini for critical reading of the manuscript. This work was supported by the Swedish Research Council and the Swedish Governmental Agency for Innovation Systems to O.N. and T. K., as well as by Sudzucker. Phylogenetic data have been deposited with Dryad Digital Repository (DOI: 10.5061/dryad.4930). Nucleotide sequences have been deposited with GenBank under accession numbers HM448909 to HM448918 and HQ148107 to HQ148132. The use of BvFT1 and BvFT2 in control of sugar beet flowering is the subject of the patent application WO2010/025888.	Abegg F. A., 1936, J AGR RES, V53, P493; Abegg FA, 1936, J AGRIC RES, V53, P0493; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; [Anonymous], 2010, The use of BvFT1 and BvFT2 in control of sugar beet flowering is the subject of the patent application, Patent No. [WO2010/025888, 2010025888]; Bell GDH, 1942, J AGR SCI, V32, P112, DOI 10.1017/S0021859600047584; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; BOUDRY P, 1994, THEOR APPL GENET, V88, P852, DOI 10.1007/BF01253996; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Gyllenstrand N, 2007, PLANT PHYSIOL, V144, P248, DOI 10.1104/pp.107.095802; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; JUNG C, 1993, THEOR APPL GENET, V86, P449, DOI 10.1007/BF00838560; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Letschert JPW, 1993, WAGENINGEN AGR U PAP, V93-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Ohno S., 1970, EVOLUTION GENE DUPLI; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Tadege M, 2001, PLANT J, V28, P545, DOI 10.1046/j.1365-313X.2001.01182.x; Van Dijk H, 2009, J EXP BOT, V60, P3143, DOI 10.1093/jxb/erp142; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	24	302	324	7	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1397	1400		10.1126/science.1197004	http://dx.doi.org/10.1126/science.1197004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127254				2022-12-24	WOS:000284902100047
J	Musunuru, K; Pirruccello, JP; Do, R; Peloso, GM; Guiducci, C; Sougnez, C; Garimella, KV; Fisher, S; Abreu, J; Barry, AJ; Fennell, T; Banks, E; Ambrogio, L; Cibulskis, K; Kernytsky, A; Gonzalez, E; Rudzicz, N; Engert, JC; DePristo, MA; Daly, MJ; Cohen, JC; Hobbs, HH; Altshuler, D; Schonfeld, G; Gabriel, SB; Yue, P; Kathiresan, S				Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Peloso, Gina M.; Guiducci, Candace; Sougnez, Carrie; Garimella, Kiran V.; Fisher, Sheila; Abreu, Justin; Barry, Andrew J.; Fennell, Tim; Banks, Eric; Ambrogio, Lauren; Cibulskis, Kristian; Kernytsky, Andrew; Gonzalez, Elena; Rudzicz, Nicholas; Engert, James C.; DePristo, Mark A.; Daly, Mark J.; Cohen, Jonathan C.; Hobbs, Helen H.; Altshuler, David; Schonfeld, Gustav; Gabriel, Stacey B.; Yue, Pin; Kathiresan, Sekar			Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DENSITY-LIPOPROTEIN; APO-B GENE; APOLIPOPROTEIN-B; FATTY LIVER; CAUCASIAN FAMILIES; HYPOBETALIPOPROTEINEMIA; METABOLISM; LIPASE; INHIBITION; CAPTURE	We sequenced all protein-coding regions of the genome (the "exome") in two family members with combined hypolipidemia, marked by extremely low plasma levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. These two participants were compound heterozygotes for two distinct nonsense mutations in ANGPTL3 (encoding the angiopoietin-like 3 protein). ANGPTL3 has been reported to inhibit lipoprotein lipase and endothelial lipase, thereby increasing plasma triglyceride and HDL cholesterol levels in rodents. Our finding of ANGPTL3 mutations highlights a role for the gene in LDL cholesterol metabolism in humans and shows the usefulness of exome sequencing for identification of novel genetic causes of inherited disorders.	[Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Daly, Mark J.; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Musunuru, Kiran; Daly, Mark J.; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Peloso, Gina M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Guiducci, Candace; Sougnez, Carrie; Garimella, Kiran V.; Fisher, Sheila; Abreu, Justin; Barry, Andrew J.; Fennell, Tim; Banks, Eric; Ambrogio, Lauren; Cibulskis, Kristian; Kernytsky, Andrew; Gonzalez, Elena; DePristo, Mark A.; Daly, Mark J.; Altshuler, David; Gabriel, Stacey B.; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Musunuru, Kiran; Pirruccello, James P.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Do, Ron; Rudzicz, Nicholas; Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Peloso, Gina M.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Schonfeld, Gustav; Yue, Pin] Washington Univ, Sch Med, St Louis, MO USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; McGill University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan@partners.org	Altshuler, David M/A-4476-2009; Cibulskis, Kristian/AAC-7380-2019; Daly, Mark J/B-2453-2017	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Pirruccello, James/0000-0001-6088-4037; Gonzalez, Elena/0000-0003-4380-663X; Cibulskis, Kristian/0000-0003-1343-1582; Engert, James/0000-0001-8411-4790; Garimella, Kiran/0000-0002-6212-5736	National Human Genome Research Institute of the National Institutes of Health (NIH) [U54 HG003067]; National Heart, Lung, and Blood Institute (NHLBI) of the NIH [RC1 HL099793, RC1 HL099634, RC2 HL101864, K99 HL098364, R01 HL082896]; Donovan Family Foundation; Sarnoff Cardiovascular Research Foundation; Canadian Institutes of Health Research; National Human Genome Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082896, K99HL098364, RL1HL092550, RC1HL099793, RC1HL099634, RC2HL101864] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donovan Family Foundation; Sarnoff Cardiovascular Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Human Genome Research Institute of the National Institutes of Health (NIH) (Medical Sequencing Program grant U54 HG003067, to the Broad Institute for exome sequencing), the National Heart, Lung, and Blood Institute (NHLBI) of the NIH (RC1 HL099793, RC1 HL099634, and RC2 HL101864, to Dr. Kathiresan; K99 HL098364, to Dr. Musunuru; and R01 HL082896, to Drs. Cohen and Hobbs for analysis of ANGPTL3 in the Dallas Heart Study), the Donovan Family Foundation (to Dr. Kathiresan), the Sarnoff Cardiovascular Research Foundation (a research fellowship, to Mr. Pirruccello), and the Canadian Institutes of Health Research (a Canada Graduate Doctoral Scholarship, to Mr. Do).; Funded by the National Human Genome Research Institute and others	Ando Y, 2003, J LIPID RES, V44, P1216, DOI 10.1194/jlr.M300031-JLR200; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Elias N, 2000, ARTERIOSCL THROM VAS, V20, P1309, DOI 10.1161/01.ATV.20.5.1309; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hooper AJ, 2005, CRIT REV CL LAB SCI, V42, P515, DOI 10.1080/10408360500295113; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pulai JI, 1998, AM J MED GENET, V76, P79, DOI 10.1002/(SICI)1096-8628(19980226)76:1<79::AID-AJMG15>3.3.CO;2-E; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schonfeld G, 2005, CELL MOL LIFE SCI, V62, P1372, DOI 10.1007/s00018-005-4473-0; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; Sherva R, 2007, J LIPID RES, V48, P2632, DOI 10.1194/jlr.M700078-JLR200; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Tarugi P, 1996, GASTROENTEROLOGY, V111, P1125, DOI 10.1016/S0016-5085(96)70082-3; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Yuan B, 2000, AM J HUM GENET, V66, P1699, DOI 10.1086/302904; Yue P, 2005, METABOLISM, V54, P682, DOI 10.1016/j.metabol.2004.12.013	22	461	497	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2220	2227		10.1056/NEJMoa1002926	http://dx.doi.org/10.1056/NEJMoa1002926			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	20942659	Green Accepted			2022-12-24	WOS:000284832900009
J	Armulik, A; Genove, G; Mae, M; Nisancioglu, MH; Wallgard, E; Niaudet, C; He, LQ; Norlin, J; Lindblom, P; Strittmatter, K; Johansson, BR; Betsholtz, C				Armulik, Annika; Genove, Guillem; Mae, Maarja; Nisancioglu, Maya H.; Wallgard, Elisabet; Niaudet, Colin; He, Liqun; Norlin, Jenny; Lindblom, Per; Strittmatter, Karin; Johansson, Bengt R.; Betsholtz, Christer			Pericytes regulate the blood-brain barrier	NATURE			English	Article							ENDOTHELIAL-CELLS; UP-REGULATION; MUTANT MICE; EXPRESSION; INDUCTION; LEADS; ABNORMALITIES; TRANSCRIPTS; ASTROCYTES; ACTIVATION	The blood-brain barrier (BBB) consists of specific physical barriers, enzymes and transporters, which together maintain the necessary extracellular environment of the central nervous system (CNS)(1). The main physical barrier is found in the CNS endothelial cell, and depends on continuous complexes of tight junctions combined with reduced vesicular transport(2). Other possible constituents of the BBB include extracellular matrix, astrocytes and pericytes(3), but the relative contribution of these different components to the BBB remains largely unknown(1,3). Here we demonstrate a direct role of pericytes at the BBB in vivo. Using a set of adult viable pericyte-deficient mouse mutants we show that pericyte deficiency increases the permeability of the BBB to water and a range of low-molecular-mass and high-molecular-mass tracers. The increased permeability occurs by endothelial transcytosis, a process that is rapidly arrested by the drug imatinib. Furthermore, we show that pericytes function at the BBB in at least two ways: by regulating BBB-specific gene expression patterns in endothelial cells, and by inducing polarization of astrocyte end-feet surrounding CNS blood vessels. Our results indicate a novel and critical role for pericytes in the integration of endothelial and astrocyte functions at the neurovascular unit, and in the regulation of the BBB.	[Armulik, Annika; Genove, Guillem; Mae, Maarja; Nisancioglu, Maya H.; Wallgard, Elisabet; Niaudet, Colin; He, Liqun; Norlin, Jenny; Strittmatter, Karin; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, SE-17177 Stockholm, Sweden; [Lindblom, Per] AstraZeneca AB, Clin Dev, SE-43183 Molndal, Sweden; [Johansson, Bengt R.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Electron Microscopy Unit, SE-40530 Gothenburg, Sweden	Karolinska Institutet; AstraZeneca; University of Gothenburg	Betsholtz, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Scheelesvag 2, SE-17177 Stockholm, Sweden.	annika.armulik@ki.se; christer.betsholtz@ki.se	Genove, Guillem/F-1158-2011; Andaloussi Mäe, Maarja/AAA-9215-2022	He, Liqun/0000-0003-2127-7597; Genove, Guillem/0000-0002-8558-3107; Keller, Annika/0000-0003-1466-3633	Leducq Foundation; Swedish Governmental Agency for Innovation Systems (Vinnova); EU; Swedish Cancer Society and Research Council; Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, and Torsten and Ragnar Soderberg Foundations	Leducq Foundation(Leducq Foundation); Swedish Governmental Agency for Innovation Systems (Vinnova)(Vinnova); EU(European Commission); Swedish Cancer Society and Research Council; Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, and Torsten and Ragnar Soderberg Foundations(Knut & Alice Wallenberg Foundation)	We thank U. Eriksson and members of the Betsholtz laboratory for discussion, P. Soriano, L. Sorokin and R. Hallman for reagents, and S. Kamph and the Scheele animal house for technical assistance. This work was supported by the Leducq Foundation, the Swedish Governmental Agency for Innovation Systems (Vinnova), the EU Fp6 Program Lymphangiogenomics, the Swedish Cancer Society and Research Council, the Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, and Torsten and Ragnar Soderberg Foundations.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernacki J, 2008, PHARMACOL REP, V60, P600; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; He L, 2008, J AM SOC NEPHROL, V19, P260, DOI 10.1681/ASN.2007050588; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; KARNOVASKY MORRIS J., 1967, J CELL BIOL, V35, P213, DOI 10.1083/jcb.35.1.213; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; MOOS T, 1993, NEUROPATH APPL NEURO, V19, P120, DOI 10.1111/j.1365-2990.1993.tb00416.x; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tidhar A, 2001, DEV DYNAM, V220, P60, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1089>3.0.CO;2-X; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	33	1629	1679	5	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					557	U231		10.1038/nature09522	http://dx.doi.org/10.1038/nature09522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	20944627				2022-12-24	WOS:000284584200041
J	Chen, LQ; Hou, BH; Lalonde, S; Takanaga, H; Hartung, ML; Qu, XQ; Guo, WJ; Kim, JG; Underwood, W; Chaudhuri, B; Chermak, D; Antony, G; White, FF; Somerville, SC; Mudgett, MB; Frommer, WB				Chen, Li-Qing; Hou, Bi-Huei; Lalonde, Sylvie; Takanaga, Hitomi; Hartung, Mara L.; Qu, Xiao-Qing; Guo, Woei-Jiun; Kim, Jung-Gun; Underwood, William; Chaudhuri, Bhavna; Chermak, Diane; Antony, Ginny; White, Frank F.; Somerville, Shauna C.; Mudgett, Mary Beth; Frommer, Wolf B.			Sugar transporters for intercellular exchange and nutrition of pathogens	NATURE			English	Article							FANCONI-BICKEL-SYNDROME; POWDERY MILDEW; ENDOPLASMIC-RETICULUM; GLUCOSE-TRANSPORTER; BACTERIAL-BLIGHT; PETUNIA-HYBRIDA; GENE; ARABIDOPSIS; SUCROSE; RESISTANCE	Sugar efflux transporters are essential for the maintenance of animal blood glucose levels, plant nectar production, and plant seed and pollen development. Despite broad biological importance, the identity of sugar efflux transporters has remained elusive. Using optical glucose sensors, we identified a new class of sugar transporters, named SWEETs, and show that at least six out of seventeen Arabidopsis, two out of over twenty rice and two out of seven homologues in Caenorhabditis elegans, and the single copy human protein, mediate glucose transport. Arabidopsis SWEET8 is essential for pollen viability, and the rice homologues SWEET11 and SWEET14 are specifically exploited by bacterial pathogens for virulence by means of direct binding of a bacterial effector to the SWEET promoter. Bacterial symbionts and fungal and bacterial pathogens induce the expression of different SWEET genes, indicating that the sugar efflux function of SWEET transporters is probably targeted by pathogens and symbionts for nutritional gain. The metazoan homologues may be involved in sugar efflux from intestinal, liver, epididymis and mammary cells.	[Chen, Li-Qing; Hou, Bi-Huei; Lalonde, Sylvie; Takanaga, Hitomi; Hartung, Mara L.; Qu, Xiao-Qing; Guo, Woei-Jiun; Chaudhuri, Bhavna; Chermak, Diane; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Kim, Jung-Gun; Mudgett, Mary Beth] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Antony, Ginny; White, Frank F.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Underwood, William; Somerville, Shauna C.] Energy Biosci Inst, Berkeley, CA 94720 USA	Carnegie Institution for Science; Stanford University; Kansas State University	Frommer, WB (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	wfrommer@carnegiescience.edu	Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017; GUO, WOEI-JIUN/F-8487-2012; Antony, Ginny/ABC-9539-2021	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Antony, Ginny/0000-0003-0619-3176; Underwood, William/0000-0002-9920-8228	Department of Energy [DE-FG02-04ER15542]; NIH (NIDDK) [1RO1DK079109]; Carnegie Institution; National Natural Science Foundation of China (NSFC) [30771288]; NSF [IOS-0821801]; NIH [ZRO1GM06886-06A1, F32GM083439-02]; NSF; USDA NIFA [2007-35319-18103]; NSF Plant Genome [DBI-0820831]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068886, F32GM083439] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Carnegie Institution; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); USDA NIFA(United States Department of Agriculture (USDA)); NSF Plant Genome(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was made possible by grants from the Department of Energy (DE-FG02-04ER15542) and NIH (NIDDK; 1RO1DK079109) to W.B.F., X.-Q.Q. was supported by The Carnegie Institution and the National Natural Science Foundation of China (NSFC; 30771288). NSF (IOS-0821801) and NIH (ZRO1GM06886-06A1) to M.B.M. and J.-G.K. was supported 50% by NIH and 50% by NSF. W.U. was supported in part by an NIH postdoctoral fellowship (F32GM083439-02). G.A. and F.F.W. were supported by grants from USDA NIFA (2007-35319-18103) and NSF Plant Genome (DBI-0820831).	AKED J, 1993, NEW PHYTOL, V123, P271, DOI 10.1111/j.1469-8137.1993.tb03735.x; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; ANTONY G, 2003, PLANT CELL IN PRESS; *AR, 2010, PLANT MEMBR PROT DAT; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ballatori N, 1996, AM J PHYSIOL-REG I, V270, pR1156, DOI 10.1152/ajpregu.1996.270.5.R1156; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bermejo C, 2010, BIOCHEM J, V432, P399, DOI 10.1042/BJ20100946; *BIOP, 2010, SLC TABL; Bisseling T, 2009, SCIENCE, V324, P691, DOI 10.1126/science.1174404; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Detaille D, 1999, EUR J PHARMACOL, V377, P127, DOI 10.1016/S0014-2999(99)00413-6; Engel ML, 2005, PLANT PHYSIOL, V138, P2124, DOI 10.1104/pp.104.054213; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Ge YX, 2001, MOL GENET GENOMICS, V265, P414, DOI 10.1007/s004380100449; Ge YX, 2000, PLANT J, V24, P725, DOI 10.1046/j.1365-313x.2000.00926.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guan YF, 2008, PLANT PHYSIOL, V147, P852, DOI 10.1104/pp.108.118026; Hamada M, 2005, DIFFERENTIATION, V73, P364, DOI 10.1111/j.1432-0436.2005.00037.x; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HESSE M, 2004, TAPETUM CYTOLOGY FUN, P1; Hosokawa M, 2002, AM J PHYSIOL-ENDOC M, V282, pE794, DOI 10.1152/ajpendo.00374.2001; Hou BH, 2009, CELL CALCIUM, V46, P130, DOI 10.1016/j.ceca.2009.06.003; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; *HUM PROT ATL, 2010, RAG1AP1 HUM PROT ATL; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Lalonde S, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; MANZ F, 1987, PEDIATR NEPHROL, V1, P509, DOI 10.1007/BF00849262; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; PATRICK JW, 1989, AUST J PLANT PHYSIOL, V16, P53, DOI 10.1071/PP9890053; Quirino BF, 1999, PLANT MOL BIOL, V40, P267, DOI 10.1023/A:1006199932265; Quirino BF, 2001, PLANT MOL BIOL, V46, P447, DOI 10.1023/A:1010639015959; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Song LF, 2009, PLANT SIGNAL BEHAV, V4, P1193, DOI 10.4161/psb.4.12.10063; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; Sutton PN, 2007, PHYSIOL PLANTARUM, V129, P787, DOI 10.1111/j.1399-3054.2007.00863.x; Sutton PN, 1999, PLANTA, V208, P426, DOI 10.1007/s004250050578; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Takanaga H, 2010, FASEB J, V24, P2849, DOI 10.1096/fj.09-146472; Tang DJ, 2005, J BACTERIOL, V187, P6231, DOI 10.1128/JB.187.17.6231-6237.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; UDVARDI MK, 1990, MOL PLANT MICROBE IN, V3, P334, DOI 10.1094/MPMI-3-334; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yuan M, 2009, PLANT CELL PHYSIOL, V50, P947, DOI 10.1093/pcp/pcp046; Zhou YC, 2007, PLANT J, V49, P750, DOI 10.1111/j.1365-313X.2006.03000.x	61	858	979	30	469	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					527	U199		10.1038/nature09606	http://dx.doi.org/10.1038/nature09606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107422	Green Accepted			2022-12-24	WOS:000284584200034
J	Rustagi, D; Engel, S; Kosfeld, M				Rustagi, Devesh; Engel, Stefanie; Kosfeld, Michael			Conditional Cooperation and Costly Monitoring Explain Success in Forest Commons Management	SCIENCE			English	Article							PUBLIC-GOODS EXPERIMENTS; CONFORMIST TRANSMISSION; ALTRUISTIC PUNISHMENT; LOCAL ENFORCEMENT; COLLECTIVE ACTION; EVOLUTION; GOVERNANCE; PEOPLE; INSTITUTIONS; SANCTIONS	Recent evidence suggests that prosocial behaviors like conditional cooperation and costly norm enforcement can stabilize large-scale cooperation for commons management. However, field evidence on the extent to which variation in these behaviors among actual commons users accounts for natural commons outcomes is altogether missing. Here, we combine experimental measures of conditional cooperation and survey measures on costly monitoring among 49 forest user groups in Ethiopia with measures of natural forest commons outcomes to show that (i) groups vary in conditional cooperator share, (ii) groups with larger conditional cooperator share are more successful in forest commons management, and (iii) costly monitoring is a key instrument with which conditional cooperators enforce cooperation. Our findings are consistent with models of gene-culture coevolution on human cooperation and provide external validity to laboratory experiments on social dilemmas.	[Rustagi, Devesh; Engel, Stefanie] ETH, Inst Environm Decis, CH-8092 Zurich, Switzerland; [Kosfeld, Michael] Goethe Univ Frankfurt, Fac Econ & Business Adm, D-60323 Frankfurt, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Goethe University Frankfurt	Rustagi, D (corresponding author), ETH, Inst Environm Decis, Univ Str 22, CH-8092 Zurich, Switzerland.	devesh.rustagi@env.ethz.ch; kosfeld@econ.uni-frankfurt.de	Engel, Stefanie/A-7397-2009; Engel, Stefanie/B-6533-2009		North-South Centre at ETH Zurich; German Federal Ministry of Education and Research (BMBF) [BioTEAM 01LM0201]; German Federal Ministry of Economic Cooperation and Development (BMZ) via the Centre for Development Research, Bonn; German Organization for Technical Cooperation (GTZ); Oromia State Forest Enterprises Supervising Agency	North-South Centre at ETH Zurich; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Economic Cooperation and Development (BMZ) via the Centre for Development Research, Bonn; German Organization for Technical Cooperation (GTZ); Oromia State Forest Enterprises Supervising Agency	We especially thank the communities that participated in our research and our research assistants. This study was financially supported by the North-South Centre at ETH Zurich, the German Federal Ministry of Education and Research (BMBF) (BioTEAM 01LM0201), and the German Federal Ministry of Economic Cooperation and Development (BMZ) via the Centre for Development Research, Bonn. We also acknowledge in-kind support from the German Organization for Technical Cooperation (GTZ) and the Oromia State Forest Enterprises Supervising Agency.	Agrawal A, 2006, WORLD DEV, V34, P149, DOI 10.1016/j.worlddev.2005.07.013; Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; AMENTE G, 2005, THESIS A LUDWIGS U F; [Anonymous], 1996, HALTING DEGRADATION; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Cardenas J.C., 2000, ENVIRON DEV SUSTAIN, V2, P305, DOI DOI 10.1023/A:1011422313042; Cardenas JC, 2003, J DEV ECON, V70, P263, DOI 10.1016/S0304-3878(02)00098-6; Chhatre A, 2008, P NATL ACAD SCI USA, V105, P13286, DOI 10.1073/pnas.0803399105; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Falk A, 2002, DRAMA COMMONS, P157; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gibson CC, 2005, WORLD DEV, V33, P273, DOI 10.1016/j.worlddev.2004.07.013; Gunnthorsdottir A, 2007, J ECON BEHAV ORGAN, V62, P304, DOI 10.1016/j.jebo.2005.03.008; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Gurven M, 2008, AM ANTHROPOL, V110, P179, DOI 10.1111/j.1548-1433.2008.00024.x; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2009, EXP ECON, V12, P87, DOI 10.1007/s10683-008-9197-1; Keser C, 2000, SCAND J ECON, V102, P23, DOI 10.1111/1467-9442.00182; Kocher MG, 2008, ECON LETT, V101, P175, DOI 10.1016/j.econlet.2008.07.015; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; Levitt SD, 2008, SCIENCE, V319, P909, DOI 10.1126/science.1153640; Olson M., 1965, LOGIC COLLECTIVE ACT; Ones U, 2007, J ECON BEHAV ORGAN, V62, P495, DOI 10.1016/j.jebo.2005.04.018; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Price ME, 2002, EVOL HUM BEHAV, V23, P203, DOI 10.1016/S1090-5138(01)00093-9; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Trainer J., 1996, FOREST INVENTORY IND; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	44	290	297	6	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					961	965		10.1126/science.1193649	http://dx.doi.org/10.1126/science.1193649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	678XY	21071668				2022-12-24	WOS:000284118000042
J	Chao, HT; Chen, HM; Samaco, RC; Xue, MS; Chahrour, M; Yoo, J; Neul, JL; Gong, SC; Lu, HC; Heintz, N; Ekker, M; Rubenstein, JLR; Noebels, JL; Rosenmund, C; Zoghbi, HY				Chao, Hsiao-Tuan; Chen, Hongmei; Samaco, Rodney C.; Xue, Mingshan; Chahrour, Maria; Yoo, Jong; Neul, Jeffrey L.; Gong, Shiaoching; Lu, Hui-Chen; Heintz, Nathaniel; Ekker, Marc; Rubenstein, John L. R.; Noebels, Jeffrey L.; Rosenmund, Christian; Zoghbi, Huda Y.			Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes	NATURE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CPG-BINDING PROTEIN-2; MOUSE MODEL; NEURONAL MECP2; YOUNG GIRLS; 67 KDA; MICE; GENE; SCHIZOPHRENIA; MUTATION	Mutations in the X-linked MECP2 gene, which encodes the transcriptional regulator methyl-CpG-binding protein 2 (MeCP2), cause Rett syndrome and several neurodevelopmental disorders including cognitive disorders, autism, juvenile-onset schizophrenia and encephalopathy with early lethality. Rett syndrome is characterized by apparently normal early development followed by regression, motor abnormalities, seizures and features of autism, especially stereotyped behaviours. The mechanisms mediating these features are poorly understood. Here we show that mice lacking Mecp2 from GABA (c-aminobutyric acid)-releasing neurons recapitulate numerous Rett syndrome and autistic features, including repetitive behaviours. Loss of MeCP2 from a subset of forebrain GABAergic neurons also recapitulates many features of Rett syndrome. MeCP2-deficient GABAergic neurons show reduced inhibitory quantal size, consistent with a presynaptic reduction in glutamic acid decarboxylase 1 (Gad1) and glutamic acid decarboxylase 2 (Gad2) levels, and GABA immunoreactivity. These data demonstrate that MeCP2 is critical for normal function of GABA-releasing neurons and that subtle dysfunction of GABAergic neurons contributes to numerous neuropsychiatric phenotypes.	[Chao, Hsiao-Tuan; Xue, Mingshan; Noebels, Jeffrey L.; Rosenmund, Christian; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Chao, Hsiao-Tuan; Chen, Hongmei; Samaco, Rodney C.; Chahrour, Maria; Noebels, Jeffrey L.; Rosenmund, Christian; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yoo, Jong; Noebels, Jeffrey L.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Neul, Jeffrey L.; Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Neul, Jeffrey L.; Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, New York, NY 10021 USA; [Gong, Shiaoching; Heintz, Nathaniel] Howard Hughes Med Inst, New York, NY 10021 USA; [Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada; [Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; University of Ottawa; University of California System; University of California San Francisco	Rosenmund, C (corresponding author), Charite, Neurosci Res Ctr, D-10117 Berlin, Germany.	christian.rosenmund@charite.de; hzoghbi@bcm.edu	Rosenmund, Christian/AAC-3596-2020; Neul, Jeffrey/AAF-5324-2020	Rosenmund, Christian/0000-0002-3905-2444; Chahrour, Maria/0000-0002-3174-1480; Zoghbi, Huda/0000-0002-0700-3349; Xue, Mingshan/0000-0003-1463-8884; Neul, Jeffrey/0000-0002-5628-5872; Noebels, Jeffrey/0000-0002-2887-0839; Samaco, Rodney/0000-0001-5636-5314	Howard Hughes Medical Institute; National Institute of Neurological Disorders and Stroke (NINDS) [HD053862, 29709]; Simons Foundation; Rett Syndrome Research Trust; Intellectual and Developmental Disability Research Centers [HD024064]; International Rett Syndrome Foundation; Autism Speaks; National Institute of Mental Health [F31MH078678]; Baylor Research Advocates for Student Scientists; McNair Fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, R01HD062553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH078678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS052240, R01NS048884, T32NS043124, R01NS057819] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; Rett Syndrome Research Trust; Intellectual and Developmental Disability Research Centers; International Rett Syndrome Foundation; Autism Speaks; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Baylor Research Advocates for Student Scientists; McNair Fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Schuster for pronuclear injections; C. Spencer and R. Paylor for advice on behavioural assays; M. Albright for advice on slice electrophysiology; R. Atkinson, Y. Sun, J. Tang and S. Vaishnav for technical advice; V. Brandt for editorial advice. This work was supported by the Howard Hughes Medical Institute, the National Institute of Neurological Disorders and Stroke (NINDS) HD053862, the Simons Foundation, the Rett Syndrome Research Trust (H.Y.Z.); the Intellectual and Developmental Disability Research Centers HD024064 (H.Y.Z., C.R. and J. L. Noebels); NINDS 29709 (J. L. Noebels); the International Rett Syndrome Foundation (C.R.); Autism Speaks (R.C.S.); the National Institute of Mental Health F31MH078678, Baylor Research Advocates for Student Scientists and McNair Fellowships (H.-T.C.).	Adachi M, 2009, J NEUROSCI, V29, P4218, DOI 10.1523/JNEUROSCI.4225-08.2009; Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen D, 2002, AM J PSYCHIAT, V159, P148, DOI 10.1176/appi.ajp.159.1.148-a; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Deidrick Kathleen M, 2005, J Child Neurol, V20, P708, DOI 10.1177/08830738050200090201; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hagberg B, 2002, MENT RETARD DEV D R, V8, P61, DOI 10.1002/mrdd.10020; Jedele Kerry Baldwin, 2007, Semin Pediatr Neurol, V14, P108, DOI 10.1016/j.spen.2007.07.002; Klauck SM, 2002, AM J HUM GENET, V70, P1034, DOI 10.1086/339553; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; Lundorf MD, 2005, AM J MED GENET B, V135B, P94, DOI 10.1002/ajmg.b.30137; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Weese-Mayer DE, 2008, PEDIATR PULM, V43, P1045, DOI 10.1002/ppul.20866; Weese-Mayer DE, 2006, PEDIATR RES, V60, P443, DOI 10.1203/01.pdr.0000238302.84552.d0; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389	50	806	823	2	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					263	269		10.1038/nature09582	http://dx.doi.org/10.1038/nature09582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068835	Green Submitted, Green Accepted			2022-12-24	WOS:000284051000043
J	Bartke, T; Vermeulen, M; Xhemalce, B; Robson, SC; Mann, M; Kouzarides, T				Bartke, Till; Vermeulen, Michiel; Xhemalce, Blerta; Robson, Samuel C.; Mann, Matthias; Kouzarides, Tony			Nucleosome-Interacting Proteins Regulated by DNA and Histone Methylation	CELL			English	Article							CHROMATIN MODIFICATIONS; HETEROCHROMATIN; TRANSCRIPTION; BINDING; H3; ACETYLATION; RECOGNITION; COMPLEX; KDM2A; HP1	Modifications on histones or on DNA recruit proteins that regulate chromatin function. Here, we use nucleosomes methylated on DNA and on histone H3 in an affinity assay, in conjunction with a SILAC-based proteomic analysis, to identify "crosstalk'' between these two distinct classes of modification. Our analysis reveals proteins whose binding to nucleosomes is regulated by methylation of CpGs, H3K4, H3K9, and H3K27 or a combination thereof. We identify the origin recognition complex (ORC), including LRWD1 as a subunit, to be a methylation-sensitive nucleosome interactor that is recruited cooperatively by DNA and histone methylation. Other interactors, such as the lysine demethylase Fbxl11/KDM2A, recognize nucleosomes methylated on histones, but their recruitment is disrupted by DNA methylation. These data establish SILAC nucleosome affinity purifications (SNAP) as a tool for studying the dynamics between different chromatin modifications and provide a modification binding "profile'' for proteins regulated by DNA and histone methylation.	[Bartke, Till; Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony] Gurdon Inst, Cambridge CB2 1QN, England; [Bartke, Till; Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony] Dept Pathol, Cambridge CB2 1QN, England; [Vermeulen, Michiel; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Max Planck Society	Kouzarides, T (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk	Mann, Matthias/A-3454-2013; Vermeulen, Michiel/C-8883-2013	Mann, Matthias/0000-0003-1292-4799; Vermeulen, Michiel/0000-0003-0836-6894; Xhemalce, Blerta/0000-0002-0517-9607; Kouzarides, Tony/0000-0002-8918-4162	EMBO; HFSP; Dutch Cancer Society; European Union; Cancer Research UK	EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); Dutch Cancer Society(KWF Kankerbestrijding); European Union(European Commission); Cancer Research UK(Cancer Research UK)	We would like to thank Kevin Ford, Timothy Richmond, Bruce Stillman, Jonathan Widom, and Yi Zhang for providing materials; Helder Ferreira and Tom Owen-Hughes for advice on native chemical ligations; and Peter Tessarz and Emmanuelle Vire for experimental help. This work was supported by postdoctoral fellowships to T.B. from EMBO and HFSP and by a fellowship to M.V. from the Dutch Cancer Society. The M.M. laboratory is supported by the Max-Planck Society for the Advancement of Science and HEROIC, a grant from the European Union under the 6<SUP>th</SUP> Research Framework Programme. The T.K. lab is funded by grants from Cancer Research UK and the European Union (Epitron, HEROIC, and SMARTER). T. K. is a director of Abcam Ltd.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nguyen DP, 2009, J AM CHEM SOC, V131, P14194, DOI 10.1021/ja906603s; Vicent GP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000567; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tolbert TJ, 2002, ANGEW CHEM INT EDIT, V41, P2171, DOI 10.1002/1521-3773(20020617)41:12<2171::AID-ANIE2171>3.0.CO;2-Q; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Zhao Q, 2007, J BIOL CHEM, V282, P647, DOI 10.1074/jbc.M604029200	34	422	436	0	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					470	484		10.1016/j.cell.2010.10.012	http://dx.doi.org/10.1016/j.cell.2010.10.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029866	Green Accepted, Bronze			2022-12-24	WOS:000283603900019
J	Yachida, S; Jones, S; Bozic, I; Antal, T; Leary, R; Fu, BJ; Kamiyama, M; Hruban, RH; Eshleman, JR; Nowak, MA; Velculescu, VE; Kinzler, KW; Vogelstein, B; Iacobuzio-Donahue, CA				Yachida, Shinichi; Jones, Sian; Bozic, Ivana; Antal, Tibor; Leary, Rebecca; Fu, Baojin; Kamiyama, Mihoko; Hruban, Ralph H.; Eshleman, James R.; Nowak, Martin A.; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert; Iacobuzio-Donahue, Christine A.			Distant metastasis occurs late during the genetic evolution of pancreatic cancer	NATURE			English	Article							CARCINOMA; GENOME; TUMORS; MODEL	Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated(1,2), is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy(3). Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.	[Yachida, Shinichi; Fu, Baojin; Kamiyama, Mihoko; Hruban, Ralph H.; Eshleman, James R.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [Jones, Sian; Leary, Rebecca; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Jones, Sian; Leary, Rebecca; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Bozic, Ivana; Antal, Tibor; Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Dept Math, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Antal, Tibor] Univ Edinburgh, Sch Math, Edinburgh EH9 3JZ, Midlothian, Scotland; [Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; University of Edinburgh; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Iacobuzio-Donahue, CA (corresponding author), Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA.	ciacobu@jhmi.edu	Jones, Sian/A-5050-2012; Bozic, Ivana/C-5003-2008; Velculescu, Victor/ABF-4846-2020; Gotoh, Osamu/B-4704-2012; Nowak, Martin A/A-6977-2008; Antal, Tibor/A-4512-2008; Iacobuzio-Donahue, Christine/ABF-1295-2020	Bozic, Ivana/0000-0003-2761-825X; Velculescu, Victor/0000-0003-1195-438X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023	National Institutes of Health [CA106610, CA62924, CA43460, CA57345, CA121113, GM078986]; Bill and Melinda Gates Foundation [37874]; Uehara Memorial Foundation; AACR-Barletta Foundation; John Templeton Foundation; Sol Goldman Pancreatic Cancer Research Center; Michael Rolfe Pancreatic Cancer Foundation; George Rubis Endowment for Pancreatic Cancer Research; Joseph C. Monastra Foundation for Pancreatic Cancer Research; Alfredo Scatena Memorial Fund; Virginia and the D. K. Ludwig Fund for Cancer Research; The Joint Programin Mathematical Biology and J. Epstein; NATIONAL CANCER INSTITUTE [K08CA106610, R37CA043460, P50CA062924, R01CA057345, R37CA057345, R01CA121113, R01CA043460, R01CA140599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); AACR-Barletta Foundation; John Templeton Foundation; Sol Goldman Pancreatic Cancer Research Center; Michael Rolfe Pancreatic Cancer Foundation; George Rubis Endowment for Pancreatic Cancer Research; Joseph C. Monastra Foundation for Pancreatic Cancer Research; Alfredo Scatena Memorial Fund; Virginia and the D. K. Ludwig Fund for Cancer Research; The Joint Programin Mathematical Biology and J. Epstein; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants CA106610 (C.A.I.-D.), CA62924 (C.A.I.-D., M.A.N.), CA43460 (B. V.), CA57345 (K. W. K. and V. E. V.), CA121113 (V. E. V. and K. W. K.), GM078986 (M.A.N.), the Bill and Melinda Gates Foundation Grand Challenges Grant 37874, the Uehara Memorial Foundation (S.Y.), the AACR-Barletta Foundation (C.A.I.-D.), the John Templeton Foundation, Pilot Funding from the Sol Goldman Pancreatic Cancer Research Center, the Michael Rolfe Pancreatic Cancer Foundation, the George Rubis Endowment for Pancreatic Cancer Research, the Joseph C. Monastra Foundation for Pancreatic Cancer Research, the Alfredo Scatena Memorial Fund, the Virginia and the D. K. Ludwig Fund for Cancer Research, The Joint Programin Mathematical Biology and J. Epstein. We would like to acknowledge T. C. Cornish, C. Henderson,	AMIKURA K, 1995, INT J PANCREATOL, V17, P139; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Embuscado EE, 2005, CANCER BIOL THER, V4, P548, DOI 10.4161/cbt.4.5.1663; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fu BJ, 2007, CANCER BIOL THER, V6, P1546, DOI 10.4161/cbt.6.10.4708; Hisa T, 2008, WORLD J GASTROENTERO, V14, P1958, DOI 10.3748/wjg.14.1958; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Rew DA, 2000, EUR J SURG ONCOL, V26, P405, DOI 10.1053/ejso.1999.0907; SASAKI K, 1988, CANCER, V62, P989, DOI 10.1002/1097-0142(19880901)62:5<989::AID-CNCR2820620525>3.0.CO;2-U; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Steel GG, 1977, GROWTH KINETICS TUMO; Terada T, 1998, ARCH PATHOL LAB MED, V122, P42; Yachida S, 2009, ARCH PATHOL LAB MED, V133, P413, DOI 10.1043/1543-2165-133.3.413	21	1764	1849	5	255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1114	U126		10.1038/nature09515	http://dx.doi.org/10.1038/nature09515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981102	Green Accepted			2022-12-24	WOS:000283548600049
J	Hassan, F; Kamruzzaman, M; Mekalanos, JJ; Faruque, SM				Hassan, Faizule; Kamruzzaman, M.; Mekalanos, John J.; Faruque, Shah M.			Satellite phage TLC phi enables toxigenic conversion by CTX phage through dif site alteration	NATURE			English	Article							VIBRIO-CHOLERAE O139; FILAMENTOUS PHAGE; INTEGRATION; GENOME; TOXIN; FORM; RECOMBINASES; REPLICATION; GENES; XERD	Bacterial chromosomes often carry integrated genetic elements (for example plasmids, transposons, prophages and islands) whose precise function and contribution to the evolutionary fitness of the host bacterium are unknown. The CTX phi prophage, which encodes cholera toxin in Vibrio cholerae(1), is known to be adjacent to a chromosomally integrated element of unknown function termed the toxin-linked cryptic (TLC)(2). Here we report the characterization of a TLC-related element that corresponds to the genome of a satellite filamentous phage (TLC-Kn phi 1), which uses the morphogenesis genes of another filamentous phage (fs2 phi) to form infectious TLC-Kn phi 1 phage particles. The TLC-Kn phi 1 phage genome carries a sequence similar to the dif recombination sequence, which functions in chromosome dimer resolution using XerC and XerD recombinases(3). The dif sequence is also exploited by lysogenic filamentous phages (for example CTX phi) for chromosomal integration of their genomes. Bacterial cells defective in the dimer resolution often show an aberrant filamentous cell morphology(3,4). We found that acquisition and chromosomal integration of the TLC-Kn phi 1 genome restored a perfect dif site and normal morphology to V. cholerae wild-type and mutant strains with dif(-) filamentation phenotypes. Furthermore, lysogeny of a dif(-) non-toxigenic V. cholerae with TLC-Kn phi 1 promoted its subsequent toxigenic conversion through integration of CTX phi into the restored dif site. These results reveal a remarkable level of cooperative interactions between multiple filamentous phages in the emergence of the bacterial pathogen that causes cholera.	[Hassan, Faizule; Kamruzzaman, M.; Faruque, Shah M.] Int Ctr Diarrhoeal Dis Res, Mol Genet Lab, Dhaka 1212, Bangladesh; [Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	International Centre for Diarrhoeal Disease Research (ICDDR); Harvard University; Harvard Medical School	Faruque, SM (corresponding author), Int Ctr Diarrhoeal Dis Res, Mol Genet Lab, Dhaka 1212, Bangladesh.	faruque@icddrb.org	Kamruzzaman, Muhammad/S-2756-2019	Faruque, Shah/0000-0002-7006-622X; Kamruzzaman, Muhammad/0000-0003-2005-9846	National Institutes of Health under Harvard Medical School and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) [RO1-GM068851, RO1-AI070963]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068851] Funding Source: NIH RePORTER	National Institutes of Health under Harvard Medical School and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. M. Zaved Waise and S. M. Nashir Udden for technical assistance. This research was funded in part by the National Institutes of Health (grants RO1-GM068851 and RO1-AI070963) under different sub-agreements between the Harvard Medical School and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). The ICDDR,B is supported by countries and agencies that share its concern for the health problems of developing countries.	BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Das B, 2010, P NATL ACAD SCI USA, V107, P4377, DOI 10.1073/pnas.0910212107; Davis BM, 2000, P NATL ACAD SCI USA, V97, P8572, DOI 10.1073/pnas.140109997; Davis BM, 2002, EMBO J, V21, P4240, DOI 10.1093/emboj/cdf427; Ehara M, 1997, FEMS MICROBIOL LETT, V154, P293, DOI 10.1016/S0378-1097(97)00345-5; Faruque SA, 2002, INFECT IMMUN, V70, P163, DOI 10.1128/IAI.70.1.163-170.2002; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1280, DOI 10.1073/pnas.0237385100; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Faruque SM, 2001, INFECT IMMUN, V69, P6084, DOI 10.1128/IAI.69.10.6084-6090.2001; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Huber KE, 2002, NATURE, V417, P656, DOI 10.1038/nature00782; Iida T, 2002, J BACTERIOL, V184, P4933, DOI 10.1128/JB.184.17.4933-4935.2002; Ikema M, 1998, MICROBIOL-SGM, V144, P1901, DOI 10.1099/00221287-144-7-1901; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kimsey HH, 2004, J BIOL CHEM, V279, P2640, DOI 10.1074/jbc.M311109200; McLeod SM, 2004, MOL MICROBIOL, V54, P935, DOI 10.1111/j.1365-2958.2004.04309.x; Rubin EJ, 1998, MOL MICROBIOL, V28, P1247, DOI 10.1046/j.1365-2958.1998.00889.x; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; Waldor MK, 1997, MOL MICROBIOL, V24, P917, DOI 10.1046/j.1365-2958.1997.3911758.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	21	71	76	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					982	985		10.1038/nature09469	http://dx.doi.org/10.1038/nature09469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20944629	Green Accepted, Bronze			2022-12-24	WOS:000283254700042
J	Mawuenyega, KG; Sigurdson, W; Ovod, V; Munsell, L; Kasten, T; Morris, JC; Yarasheski, KE; Bateman, RJ				Mawuenyega, Kwasi G.; Sigurdson, Wendy; Ovod, Vitaliy; Munsell, Ling; Kasten, Tom; Morris, John C.; Yarasheski, Kevin E.; Bateman, Randall J.			Decreased Clearance of CNS beta-Amyloid in Alzheimer's Disease	SCIENCE			English	Article							IN-VIVO		[Mawuenyega, Kwasi G.; Sigurdson, Wendy; Ovod, Vitaliy; Munsell, Ling; Kasten, Tom; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Sigurdson, Wendy; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Morris, John C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Yarasheski, Kevin E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Bateman, Randall J.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bateman, RJ (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	batemanr@wustl.edu	Yarasheski, Kevin E/A-3025-2008; Yarasheski, Kevin/AAC-7450-2021; Morris, John C/A-1686-2012	Yarasheski, Kevin/0000-0001-5436-2451; Bateman, Randall/0000-0002-7729-1702	NIH [K08 AG027091, K23 AG030946, R01 NS065667, P50 AG05681, P01 AG03991, UL1 RR024992, P41 RR000954, P60 DK020579, P30 DK056341]; Eli Lilly research; Knight Initiative for Alzheimer's Research; James and Elizabeth McDonnell Fund for Alzheimer's Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG027091, P50AG005681, P01AG003991, K23AG030946] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly research; Knight Initiative for Alzheimer's Research; James and Elizabeth McDonnell Fund for Alzheimer's Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to the participants for their time and effort. The authors thank J. X. Wang for gas chromatography-mass spectrometry (MS) analysis and R. Connors and R. Potter for immunoprecipitation-MS analysis. Special thanks to D. M. Holtzman for mentoring, support, and review of the manuscript. This work was supported by grants from NIH (nos. K08 AG027091, K23 AG030946, R01 NS065667, P50 AG05681, P01 AG03991, UL1 RR024992, P41 RR000954, P60 DK020579, and P30 DK056341), an anonymous foundation, Eli Lilly research, the Knight Initiative for Alzheimer's Research, and the James and Elizabeth McDonnell Fund for Alzheimer's Research. R.J.B. and D. M. Holtzman are cofounders of a company (C2N Diagnostics) that has licensed a pending Washington University patent on the technology described in this article.	Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864	7	1416	1496	6	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1774	1774		10.1126/science.1197623	http://dx.doi.org/10.1126/science.1197623			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21148344	Green Accepted			2022-12-24	WOS:000285603700030
J	Ratje, AH; Loerke, J; Mikolajka, A; Brunner, M; Hildebrand, PW; Starosta, AL; Donhofer, A; Connell, SR; Fucini, P; Mielke, T; Whitford, PC; Onuchic, JN; Yu, YN; Sanbonmatsu, KY; Hartmann, RK; Penczek, PA; Wilson, DN; Spahn, CMT				Ratje, Andreas H.; Loerke, Justus; Mikolajka, Aleksandra; Bruenner, Matthias; Hildebrand, Peter W.; Starosta, Agata L.; Doenhoefer, Alexandra; Connell, Sean R.; Fucini, Paola; Mielke, Thorsten; Whitford, Paul C.; Onuchic, Jose N.; Yu, Yanan; Sanbonmatsu, Karissa Y.; Hartmann, Roland K.; Penczek, Pawel A.; Wilson, Daniel N.; Spahn, Christian M. T.			Head swivel on the ribosome facilitates translocation by means of intra-subunit tRNA hybrid sites	NATURE			English	Article							ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGES; INTERMEDIATE STATES; MESSENGER-RNA; 70S RIBOSOME; TRANSLATION; MECHANISM; MOVEMENT; GTP	The elongation cycle of protein synthesis involves the delivery of aminoacyl-transfer RNAs to the aminoacyl-tRNA-binding site (A site) of the ribosome, followed by peptide-bond formation and translocation of the tRNAs through the ribosome to reopen the A site(1,2). The translocation reaction is catalysed by elongation factor G (EF-G) in a GTP-dependent manner(3). Despite the availability of structures of various EF-G-ribosome complexes, the precise mechanism by which tRNAs move through the ribosome still remains unclear. Here we use multiparticle cryoelectron microscopy analysis to resolve two previously unseen subpopulations within Thermus thermophilus EF-G-ribosome complexes at subnanometre resolution, one of them with a partly translocated tRNA. Comparison of these substates reveals that translocation of tRNA on the 30S subunit parallels the swivelling of the 30S head and is coupled to unratcheting of the 30S body. Because the tRNA maintains contact with the peptidyl-tRNA-binding site (P site) on the 30S head and simultaneously establishes interaction with the exit site (E site) on the 30S platform, a novel intra-subunit 'pe/E' hybrid state is formed. This state is stabilized by domain IV of EF-G, which interacts with the swivelled 30S-head conformation. These findings provide direct structural and mechanistic insight into the 'missing link' in terms of tRNA intermediates involved in the universally conserved translocation process.	[Ratje, Andreas H.; Loerke, Justus; Bruenner, Matthias; Hildebrand, Peter W.; Mielke, Thorsten; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Ratje, Andreas H.; Hartmann, Roland K.] Univ Marburg, Inst Pharmazeut Chem, D-35037 Marburg, Germany; [Mikolajka, Aleksandra; Starosta, Agata L.; Doenhoefer, Alexandra; Wilson, Daniel N.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Mikolajka, Aleksandra; Starosta, Agata L.; Doenhoefer, Alexandra; Wilson, Daniel N.] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Mikolajka, Aleksandra; Wilson, Daniel N.] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Connell, Sean R.; Fucini, Paola] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Whitford, Paul C.; Sanbonmatsu, Karissa Y.] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Onuchic, Jose N.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Onuchic, Jose N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Yu, Yanan] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA; [Penczek, Pawel A.] Univ Texas Houston, Sch Med, Houston, TX 77030 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; University of Munich; University of Munich; University of Munich; Goethe University Frankfurt; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California San Diego; University of California System; University of California San Diego; State University System of Florida; Florida State University; University of Texas System; University of Texas Health Science Center Houston	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, Ziegelstr 5-9, D-10117 Berlin, Germany.	wilson@lmb.uni-muenchen.de; christian.spahn@charite.de	Fucini, Paola/M-1118-2014; Starosta, Agata/D-9535-2017; Connell, Sean/ABF-6090-2021; Connell, Sean R/K-6725-2013; Wilson, Daniel/AAE-8504-2019; connell, sean/B-2305-2012; Yu, Yan/GYV-4514-2022	Fucini, Paola/0000-0003-1724-8507; Starosta, Agata/0000-0003-3915-5723; Connell, Sean/0000-0001-7807-7049; Connell, Sean R/0000-0001-7807-7049; Wilson, Daniel/0000-0003-3816-3828; connell, sean/0000-0001-7807-7049; Loerke, Justus/0000-0002-3424-8536	Deutsche Forschungsgemeinschaft (DFG) [SFB 740 TP A3, TP Z1, SP 1130/2-1, FU579 1-3, HA 1672/7-5, WI3285/1-1]; European Union 3D-EM Network of Excellence; European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); US National Institutes of Health (NIH) [GM 60635]; Goethe University Frankfurt (DFG) [EXC 115]; Human Frontiers of Science Program [HFSP67/07]; LANL; National Science Foundation (NSF) [PHY-0822283]; NIH [R01-GM072686]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072686, R01GM060635] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union 3D-EM Network of Excellence(European Commission); European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goethe University Frankfurt (DFG)(German Research Foundation (DFG)); Human Frontiers of Science Program(Human Frontier Science Program); LANL(United States Department of Energy (DOE)Los Alamos National Laboratory); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The present work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; SFB 740 TP A3 and TP Z1, SP 1130/2-1 to C.M.T.S., FU579 1-3 to P.F., HA 1672/7-5 to R.K.H. and WI3285/1-1 to D.N.W.), the European Union 3D-EM Network of Excellence (to C.M.T.S.), the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum) and US National Institutes of Health (NIH; grant GM 60635 to P.A.P.), the Cluster of Excellence 'Macromolecular complexes' at the Goethe University Frankfurt (DFG Project EXC 115 to P.F. and S.C.), and the Human Frontiers of Science Program Young Investigators Award HFSP67/07 (to P.F.). We thank the New Mexico Computing Application Center for generous time on the Encanto Supercomputer. P.C.W. is currently funded by a LANL Director's Fellowship. This work was also supported by the Center for Theoretical Biological Physics sponsored by the National Science Foundation (NSF; grant PHY-0822283) with additional support from NSF-MCB-0543906, the LANL LDRD program and NIH grant R01-GM072686.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, REP PROG PHYS, V69, P1383, DOI 10.1088/0034-4885/69/5/R03; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Matassova NB, 2001, RNA, V7, P1879; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Orzechowski M, 2008, BIOPHYS J, V95, P5692, DOI 10.1529/biophysj.108.139451; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Shoji S, 2009, ACS CHEM BIOL, V4, P93, DOI 10.1021/cb8002946; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spirin AS, 2009, J BIOL CHEM, V284, P21103, DOI 10.1074/jbc.X109.001552; Ticu C, 2009, EMBO J, V28, P2053, DOI 10.1038/emboj.2009.169; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Whitford PC, 2009, BIOPHYS J, V96, pL7, DOI 10.1016/j.bpj.2008.10.033; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	42	268	270	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					713	U143		10.1038/nature09547	http://dx.doi.org/10.1038/nature09547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124459	Green Accepted			2022-12-24	WOS:000284836700045
J	Zuccotti, G; Pogliani, L; Pariani, E; Amendola, A; Zanetti, A				Zuccotti, GianVincenzo; Pogliani, Laura; Pariani, Elena; Amendola, Antonella; Zanetti, Alessandro			Transplacental Antibody Transfer Following Maternal Immunization With a Pandemic 2009 Influenza A(H1N1) MF59-Adjuvanted Vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MOTHERS		[Zuccotti, GianVincenzo; Pogliani, Laura] Univ Milan, Dept Pediat, Milan, Italy; [Pariani, Elena; Amendola, Antonella; Zanetti, Alessandro] Univ Milan, Dept Publ Hlth Microbiol & Virol, Milan, Italy	University of Milan; University of Milan	Zuccotti, G (corresponding author), Univ Milan, Dept Pediat, Milan, Italy.	gianvincenzo.zuccotti@unimi.it	Amendola, Antonella/M-8980-2016; Pariani, Elena/M-3491-2016; Zuccotti, Gianvincenzo/H-8572-2017	Amendola, Antonella/0000-0002-0499-8977; Pariani, Elena/0000-0001-5681-3455; Zuccotti, Gianvincenzo/0000-0002-2795-9874				Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	6	53	54	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2360	2361		10.1001/jama.2010.1729	http://dx.doi.org/10.1001/jama.2010.1729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119083				2022-12-24	WOS:000284763900016
J	Doitsh, G; Cavrois, M; Lassen, KG; Zepeda, O; Yang, ZY; Santiago, ML; Hebbeler, AM; Greene, WC				Doitsh, Gilad; Cavrois, Marielle; Lassen, Kara G.; Zepeda, Orlando; Yang, Zhiyuan; Santiago, Mario L.; Hebbeler, Andrew M.; Greene, Warner C.			Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION; BYSTANDER APOPTOSIS; LYMPHOCYTES; FUSION; ACTIVATION; MECHANISM; THERAPY; ENTRY; DEATH	The mechanism by which CD4 T cells are depleted in HIV-infected hosts remains poorly understood. In ex vivo cultures of human tonsil tissue, CD4 T cells undergo a pronounced cytopathic response following HIV infection. Strikingly, >95% of these dying cells are not productively infected but instead correspond to bystander cells. We now show that the death of these "bystander'' cells involves abortive HIV infection. Inhibitors blocking HIV entry or early steps of reverse transcription prevent CD4 T cell death while inhibition of later events in the viral life cycle does not. We demonstrate that the nonpermissive state exhibited by the majority of resting CD4 tonsil T cells leads to accumulation of incomplete reverse transcripts. These cytoplasmic nucleic acids activate a host defense program that elicits a coordinated proapoptotic and proinflammatory response involving caspase-3 and caspase-1 activation. While this response likely evolved to protect the host, it centrally contributes to the immunopathogenic effects of HIV.	[Doitsh, Gilad; Cavrois, Marielle; Lassen, Kara G.; Zepeda, Orlando; Yang, Zhiyuan; Santiago, Mario L.; Hebbeler, Andrew M.; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu	Yang, Zhiyuan/C-9543-2012	Yang, Zhiyuan/0000-0002-1175-4188; Santiago, Mario L./0000-0001-7792-2706	Universitywide AIDS Research Program [F04-GIVI-210]; UCSF-GIVI Center for AIDS Research, NIH/NIAID [P30 AI027763]; Francis Goelet Fellowship; UCSF, NIH/NIGMS [T32 GM007618-32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA036502] Funding Source: NIH RePORTER	Universitywide AIDS Research Program; UCSF-GIVI Center for AIDS Research, NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Francis Goelet Fellowship; UCSF, NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank David N. Levy for the NLENG1 plasmid; David Fenard for the NL4-3 variant plasmids SIM, GIA, GIA-SKY, and SKY; George M. Shaw for the WEAU 16-8 env clone; and Suraj J. Patel, Kevin R. King, and Martin L. Yarmush for the H35 ISRE-GFP reporter cell line. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: AMD3100, T-20, Saquinavir, Amprenavir, Indinavir, Nevirapine, Efavirenz, and AZT-resistant HIV-1 clones #629 and #964. Special thanks to Dr. Eva Herker for assistance with fluorescence microscopy; to Dr. Stefanie Sowinski for help with assessing inflammatory responses in primary immune cells; and to Jason Neidleman for stimulating discussions and technical advice. We also thank Marty Bigos for assistance with the flow cytometry; Stephen Ordway and Gary Howard for editorial assistance; John C.W. Carroll and Alisha Wilson for graphics; and Robin Givens and Sue Cammack for administrative assistance. Funding for this project was provided by the Universitywide AIDS Research Program, F04-GIVI-210 (G.D.); the UCSF-GIVI Center for AIDS Research, NIH/NIAID P30 AI027763 (M.C.); the Francis Goelet Fellowship (K.G.L.); and the UCSF Medical Scientist Training Program, NIH/NIGMS T32 GM007618-32 (O.Z.).	ARTS EJ, 1994, ANTIMICROB AGENTS CH, V38, P1008, DOI 10.1128/AAC.38.5.1008; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Grivel JC, 2003, AIDS RES HUM RETROV, V19, P211, DOI 10.1089/088922203763315713; Hayden MS, 2003, AIDS, V17, P629, DOI 10.1097/00002030-200303070-00021; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Holm GH, 2005, J VIROL, V79, P6299, DOI 10.1128/JVI.79.10.6299-6311.2005; Holm GH, 2004, J VIROL, V78, P4541, DOI 10.1128/JVI.78.9.4541-4551.2004; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Labonte JA, 2000, J VIROL, V74, P10690, DOI 10.1128/JVI.74.22.10690-10698.2000; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; MARGOLIS LB, 1995, AIDS RES HUM RETROV, V11, P697, DOI 10.1089/aid.1995.11.697; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; SCHRODER K, 2010, NAT CELL BIOL, V9, P310; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Swiggard WJ, 2004, AIDS RES HUM RETROV, V20, P285, DOI 10.1089/088922204322996527; Thomas C, 2009, NAT MED, V15, P855, DOI 10.1038/nm0809-855; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Vlahakis SR, 2001, J CLIN INVEST, V107, P207, DOI 10.1172/JCI11109; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	41	310	318	2	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					789	801		10.1016/j.cell.2010.11.001	http://dx.doi.org/10.1016/j.cell.2010.11.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111238	Bronze, Green Accepted			2022-12-24	WOS:000284583500020
J	Shibata, Y; Shemesh, T; Prinz, WA; Palazzo, AF; Kozlov, MM; Rapoport, TA				Shibata, Yoko; Shemesh, Tom; Prinz, William A.; Palazzo, Alexander F.; Kozlov, Michael M.; Rapoport, Tom A.			Mechanisms Determining the Morphology of the Peripheral ER	CELL			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; RIBOSOME RECEPTOR; ROUGH; BINDING; IDENTIFICATION; BIOSYNTHESIS; MICROTUBULES; ORGANIZATION; GTPASES	The endoplasmic reticulum (ER) consists of the nuclear envelope and a peripheral network of tubules and membrane sheets. The tubules are shaped by the curvature-stabilizing proteins reticulons and DP1/Yop1p, but how the sheets are formed is unclear. Here, we identify several sheet-enriched membrane proteins in the mammalian ER, including proteins that translocate and modify newly synthesized polypeptides, as well as coiled-coil membrane proteins that are highly upregulated in cells with proliferated ER sheets, all of which are localized by membrane-bound polysomes. These results indicate that sheets and tubules correspond to rough and smooth ER, respectively. One of the coiled-coil proteins, Climp63, serves as a "luminal ER spacer'' and forms sheets when overexpressed. More universally, however, sheet formation appears to involve the reticulons and DP1/Yop1p, which localize to sheet edges and whose abundance determines the ratio of sheets to tubules. These proteins may generate sheets by stabilizing the high curvature of edges.	[Shemesh, Tom; Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Shibata, Yoko; Palazzo, Alexander F.; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Shibata, Yoko] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Prinz, William A.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Palazzo, Alexander F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Toronto	Kozlov, MM (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	michk@post.tau.ac.il; tom_rapoport@hms.harvard.edu	Shemesh, Tom/J-5060-2013; Palazzo, Alexander/B-1270-2013	Palazzo, Alexander/0000-0002-9700-1995	American Heart Association; National Institute of Diabetes and Digestive and Kidney Diseases; Israel Science Foundation (ISF); Marie Curie network "Virus Entry"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060105] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Israel Science Foundation (ISF)(Israel Science Foundation); Marie Curie network "Virus Entry"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Denison, J. Minsteris, and S. Gygi for mass spectrometry analysis; J. Baughman for microarray analysis; A. Condon and A. Boye-Doe for technical assistance; J. Iwasa for help with illustrations; G. Kreibich, K. Ogawa-Goto, L. Lu, and R. Yan for materials; the Nikon Imaging Center and the Electron Microscopy facility at HMS for microscopy assistance; and R. Klemm and A. Osborne for critical reading of the manuscript. Y.S. was supported by the American Heart Association and is a Howard Hughes Medical Institute postdoctoral fellow. W.A.P. is supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. T.A.R. is a Howard Hughes Medical Institute Investigator. M.M.K. is supported by the Israel Science Foundation (ISF) and the Marie Curie network "Virus Entry.''	AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Benyamini P, 2009, MOL BIOL CELL, V20, P732, DOI 10.1091/mbc.E08-07-0682; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Christensen AK, 1999, ANAT REC, V255, P116, DOI 10.1002/(SICI)1097-0185(19990601)255:2<116::AID-AR2>3.0.CO;2-O; Dawson TR, 2009, J CELL BIOL, V184, P659, DOI 10.1083/jcb.200806174; Fawcett D.W., 1981, CELL; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HINMAN ND, 1970, SCIENCE, V170, P1222, DOI 10.1126/science.170.3963.1222; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Nikonov AV, 2007, J CELL SCI, V120, P2248, DOI 10.1242/jcs.008979; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Senda T, 1998, ANAT REC, V251, P339; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sparkes I, 2010, PLANT CELL, V22, P1333, DOI 10.1105/tpc.110.074385; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Ueno T, 2010, J BIOL CHEM, V285, P29941, DOI 10.1074/jbc.M109.094607; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; VOGEL F, 1990, EUR J CELL BIOL, V53, P197; [No title captured]	38	324	331	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					774	788		10.1016/j.cell.2010.11.007	http://dx.doi.org/10.1016/j.cell.2010.11.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111237	Bronze, Green Accepted			2022-12-24	WOS:000284583500019
J	Rad, R; Rad, L; Wang, W; Cadinanos, J; Vassiliou, G; Rice, S; Campos, LS; Yusa, K; Banerjee, R; Li, MA; de la Rosa, J; Strong, A; Lu, D; Ellis, P; Conte, N; Yang, FT; Liu, PT; Bradley, A				Rad, Roland; Rad, Lena; Wang, Wei; Cadinanos, Juan; Vassiliou, George; Rice, Stephen; Campos, Lia S.; Yusa, Kosuke; Banerjee, Ruby; Li, Meng Amy; de la Rosa, Jorge; Strong, Alexander; Lu, Dong; Ellis, Peter; Conte, Nathalie; Yang, Fang Tang; Liu, Pentao; Bradley, Allan			PiggyBac Transposon Mutagenesis: A Tool for Cancer Gene Discovery in Mice	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; SLEEPING-BEAUTY; CHROMOSOMAL TRANSPOSITION; TRANSGENIC MICE; MOUSE; NETWORKS; SCREENS; SYSTEM	Transposons are mobile DNA segments that can disrupt gene function by inserting in or near genes. Here, we show that insertional mutagenesis by the PiggyBac transposon can be used for cancer gene discovery in mice. PiggyBac transposition in genetically engineered transposon-transposase mice induced cancers whose type (hematopoietic versus solid) and latency were dependent on the regulatory elements introduced into transposons. Analysis of 63 hematopoietic tumors revealed that PiggyBac is capable of genome-wide mutagenesis. The PiggyBac screen uncovered many cancer genes not identified in previous retroviral or Sleeping Beauty transposon screens, including Spic, which encodes a PU.1-related transcription factor, and Hdac7, a histone deacetylase gene. PiggyBac and Sleeping Beauty have different integration preferences. To maximize the utility of the tool, we engineered 21 mouse lines to be compatible with both transposon systems in constitutive, tissue-or temporal-specific mutagenesis. Mice with different transposon types, copy numbers, and chromosomal locations support wide applicability.	[Rad, Roland; Rad, Lena; Wang, Wei; Cadinanos, Juan; Vassiliou, George; Rice, Stephen; Campos, Lia S.; Yusa, Kosuke; Banerjee, Ruby; Li, Meng Amy; Strong, Alexander; Lu, Dong; Ellis, Peter; Conte, Nathalie; Yang, Fang Tang; Liu, Pentao; Bradley, Allan] Wellcome Trust Sanger Inst, Hinxton Cambridge CB10 1SA, England; [Cadinanos, Juan; de la Rosa, Jorge] IMOMA, Oviedo 33193, Spain	Wellcome Trust Sanger Institute	Bradley, A (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Hinxton Cambridge CB10 1SA, England.	abradley@sanger.ac.uk	Yang, Fan/GYU-4249-2022; Wilson, Matthew H/K-3193-2013	Yang, Fengtang/0000-0002-3573-2354; Vassiliou, George/0000-0003-4337-8022; Cadinanos, Juan/0000-0001-7561-7759; Conte, Nathalie/0000-0002-1010-3121; Bradley, Allan/0000-0002-2349-8839; de la Rosa, Jorge/0000-0002-0201-2078	Wellcome Trust; Deutsche Forschungsgemeinschaft; Fundacion Maria Cristina Masaveu Peterson	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacion Maria Cristina Masaveu Peterson	We thank the research support facility team, B. L. Ng, B. Fu, and Y. Hooks for technical assistance; N. Carter and C. Lopez-Otin for experimental resources; L. Wessels, J. ten Hoeve, and J. de Ridder for software used in data analysis; D. Saur for technical advice; and H. Prosser for reagents. The work was supported by the Wellcome Trust. R. R. and J. R. are recipients of a fellowship from the Deutsche Forschungsgemeinschaft and the Fundacion Maria Cristina Masaveu Peterson, respectively.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Hoemann CD, 2000, MOL CELL BIOL, V20, P3831, DOI 10.1128/MCB.20.11.3831-3842.2000; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Willis TG, 1998, BLOOD, V91, P1873, DOI 10.1182/blood.V91.6.1873.1873_1873_1881	23	163	183	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1104	1107		10.1126/science.1193004	http://dx.doi.org/10.1126/science.1193004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20947725	Green Accepted			2022-12-24	WOS:000284374700044
J	Li, AA; Gong, H; Zhang, B; Wang, QD; Yan, C; Wu, JP; Liu, QA; Zeng, SQ; Luo, QM				Li, Anan; Gong, Hui; Zhang, Bin; Wang, Qingdi; Yan, Cheng; Wu, Jingpeng; Liu, Qian; Zeng, Shaoqun; Luo, Qingming			Micro-Optical Sectioning Tomography to Obtain a High-Resolution Atlas of the Mouse Brain	SCIENCE			English	Article							VISUALIZATION	The neuroanatomical architecture is considered to be the basis for understanding brain function and dysfunction. However, existing imaging tools have limitations for brainwide mapping of neural circuits at a mesoscale level. We developed a micro-optical sectioning tomography (MOST) system that can provide micrometer-scale tomography of a centimeter-sized whole mouse brain. Using MOST, we obtained a three-dimensional structural data set of a Golgi-stained whole mouse brain at the neurite level. The morphology and spatial locations of neurons and traces of neurites could be clearly distinguished. We found that neighboring Purkinje cells stick to each other.	[Li, Anan; Gong, Hui; Zhang, Bin; Wang, Qingdi; Yan, Cheng; Wu, Jingpeng; Liu, Qian; Zeng, Shaoqun; Luo, Qingming] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Luo, QM (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China.	qluo@mail.hust.edu.cn	Wu, Jingpeng/H-3955-2019; Liu, Qian/D-8184-2011; Qian, Liu/GYU-5886-2022; Wu, Jingpeng/B-5489-2019; liu, qian/HDM-2936-2022	Liu, Qian/0000-0002-8398-1021; Wu, Jingpeng/0000-0003-1604-8802; LI, Anan/0000-0002-5877-4813; Luo, Qingming/0000-0002-6725-9311; Zeng, Shaoqun/0000-0002-1802-337X	National Natural Science Foundation of China [30727002, 60025514, 30700214, 30925013]; Program for Changjiang Scholars and Innovative Research Team in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	We thank P. Wu, J. B. Wu, and L. Wu for their early work in MOST; L. Fu, T. H. Xu, and W. Zhou for helpful discussions; Z. Dong and Z. Feng for assistance in experiments; J. Zhou for the nanowire sample; and Diatome AG, Switzerland, for the diamond knife. Supported by the National Natural Science Foundation of China (grants 30727002, 60025514, 30700214, and 30925013) and the Program for Changjiang Scholars and Innovative Research Team in University.	Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Chin MH, 2007, PHYSIOL GENOMICS, V30, P313, DOI 10.1152/physiolgenomics.00287.2006; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Franklin K., 2007, MOUSE BRAIN STEREOTA; Hayworth K. J., 2006, MICROSC MICROANAL, V12, P86; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kandel E R, 2000, PRINCIPLES NEURAL SC, P19; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mayerich D, 2008, J MICROSC-OXFORD, V231, P134, DOI 10.1111/j.1365-2818.2008.02024.x; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Standring S, 2004, GRAYS ANATOMY ANATOM, V39th; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Williams RW, 2000, RES PRO CEL, V30, P21; Wilt BA, 2009, ANNU REV NEUROSCI, V32, P435, DOI 10.1146/annurev.neuro.051508.135540	18	311	337	17	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1404	1408		10.1126/science.1191776	http://dx.doi.org/10.1126/science.1191776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21051596				2022-12-24	WOS:000284902100049
J	Voss, JE; Vaney, MC; Duquerroy, S; Vonrhein, C; Girard-Blanc, C; Crublet, E; Thompson, A; Bricogne, G; Rey, FA				Voss, James E.; Vaney, Marie-Christine; Duquerroy, Stephane; Vonrhein, Clemens; Girard-Blanc, Christine; Crublet, Elodie; Thompson, Andrew; Bricogne, Gerard; Rey, Felix A.			Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography	NATURE			English	Article							SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; CONFORMATIONAL-CHANGE; SPIKE PROTEIN; ENVELOPE; SURFACE; REPLACEMENT; E1; PH	Chikungunya virus (CHIKV) is an emerging mosquito-borne alphavirus that has caused widespread outbreaks of debilitating human disease in the past five years(1). CHIKV invasion of susceptible cells is mediated by two viral glycoproteins, E1 and E2, which carry the main antigenic determinants and form an icosahedral shell at the virion surface. Glycoprotein E2, derived from furin cleavage of the p62 precursor into E3 and E2, is responsible for receptor binding, and E1 for membrane fusion. In the context of a concerted multidisciplinary effort to understand the biology of CHIKV2, here we report the crystal structures of the precursor p62-E1 heterodimer and of the mature E3-E2-E1 glycoprotein complexes. The resulting atomic models allow the synthesis of a wealth of genetic, biochemical, immunological and electron microscopy data accumulated over the years on alphaviruses in general. This combination yields a detailed picture of the functional architecture of the 25 MDa alphavirus surface glycoprotein shell. Together with the accompanying report on the structure of the Sindbis virus E2-E1 heterodimer at acidic pH (ref. 3), this work also provides new insight into the acid-triggered conformational change on the virus particle and its inbuilt inhibition mechanism in the immature complex.	[Voss, James E.; Vaney, Marie-Christine; Duquerroy, Stephane; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France; [Voss, James E.; Vaney, Marie-Christine; Duquerroy, Stephane; Rey, Felix A.] CNRS, URA 3015, F-75724 Paris 15, France; [Duquerroy, Stephane] Univ Paris Sud, Fac Orsay, F-91405 Orsay, France; [Vonrhein, Clemens; Bricogne, Gerard] Global Phasing Ltd, Cambridge CB3 0AX, England; [Girard-Blanc, Christine; Crublet, Elodie] Inst Pasteur, Dept Biol Struct & Chim, F-75724 Paris 15, France; [Girard-Blanc, Christine; Crublet, Elodie] CNRS, URA 2185, F-75724 Paris 15, France; [Thompson, Andrew] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Global Phasing Limited; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); SOLEIL Synchrotron	Rey, FA (corresponding author), Inst Pasteur, Dept Virol, Unite Virol Struct, 25 Rue Dr Roux, F-75724 Paris 15, France.	rey@pasteur.fr	Rey, Felix/B-6497-2012	Rey, Felix/0000-0002-9953-7988; Duquerroy, Stephane/0000-0003-4386-8013	European Union Research Traning Network; French 'Agence Nationale de la Recherche'; Merck-Serono; Pediatric Dengue Vaccine Initiative; Institut Pasteur [PTR201 CHIKV]	European Union Research Traning Network; French 'Agence Nationale de la Recherche'(French National Research Agency (ANR)); Merck-Serono(Merck & Company); Pediatric Dengue Vaccine Initiative; Institut Pasteur(European Commission)	We thank the CHIKV task force at Institut Pasteur, in particular the group of F. Tangy and the staff of platform PF8 for the CHIKV complementary DNA; A. Haouz of PF6 for crystallogenesis; the staff of synchrotron beamlines PROXIMA 1 at Soleil, ID23-eh2 at the European Synchrotron Radiation Facility and PX-I at the Swiss Light Source; M. Rossmann and Y. Sun for providing the 16 angstrom cryo-EM map of CHIKV virion-like particles and for sharing the coordinates and manuscript of the low pH structure of the SINVE1-E2 heterodimer before publication; and members of the F.A.R. laboratory for help during data collection. J.E.V. was supported by a Marie Curie fellowship through the European Union Research Traning Network program "Intrapath''. This work was funded in part by the French 'Agence Nationale de la Recherche' grant DENtry in the program 'Microbiologie, Infections et Immunite', by Merck-Serono, by the Pediatric Dengue Vaccine Initiative and by the Institut Pasteur program PTR201 CHIKV to F.A.R..	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2010, BUSTER VERSION 2 9; CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FLYNN DC, 1990, J VIROL, V64, P3643, DOI 10.1128/JVI.64.8.3643-3653.1990; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; HALSTEAD SB, 2004, PEDIAT INFECT DIS, P2178; Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004; JOHNSON F, 1922, B SCH ORIENT STUDIES, V2, P417; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KIELIAN M, 1985, J CELL BIOL, V101, P2284, DOI 10.1083/jcb.101.6.2284; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LOBIGS M, 1990, J VIROL, V64, P4346, DOI 10.1128/JVI.64.9.4346-4355.1990; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993; MEYER WJ, 1992, J VIROL, V66, P3504, DOI 10.1128/JVI.66.6.3504-3513.1992; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Pierro DJ, 2008, J VIROL, V82, P2966, DOI 10.1128/JVI.02060-07; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; SALMINEN A, 1992, J CELL BIOL, V116, P349, DOI 10.1083/jcb.116.2.349; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; WAHLBERG JM, 1989, J VIROL, V63, P4991, DOI 10.1128/JVI.63.12.4991-4997.1989; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Wu SR, 2007, J BIOL CHEM, V282, P6752, DOI 10.1074/jbc.M609125200; ZIEMIECKI A, 1980, J GEN VIROL, V50, P111, DOI 10.1099/0022-1317-50-1-111	44	432	444	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					709	U137		10.1038/nature09555	http://dx.doi.org/10.1038/nature09555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124458				2022-12-24	WOS:000284836700044
J	Clem, RL; Huganir, RL				Clem, Roger L.; Huganir, Richard L.			Calcium-Permeable AMPA Receptor Dynamics Mediate Fear Memory Erasure	SCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; CONDITIONED FEAR; SPONTANEOUS-RECOVERY; IN-VIVO; EXTINCTION; AMYGDALA; PHOSPHORYLATION; RECONSOLIDATION; MECHANISMS	Traumatic fear memories can be inhibited by behavioral therapy for humans, or by extinction training in rodent models, but are prone to recur. Under some conditions, however, these treatments generate a permanent effect on behavior, which suggests that emotional memory erasure has occurred. The neural basis for such disparate outcomes is unknown. We found that a central component of extinction-induced erasure is the synaptic removal of calcium-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors (AMPARs) in the lateral amygdala. A transient up-regulation of this form of plasticity, which involves phosphorylation of the glutamate receptor 1 subunit of the AMPA receptor, defines a temporal window in which fear memory can be degraded by behavioral experience. These results reveal a molecular mechanism for fear erasure and the relative instability of recent memory.	[Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu			NIH [R01NS036715, F32 MH087037-01]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH087037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from NIH (R01NS036715) and the Howard Hughes Medical Institute. R. L. C. was supported by a postdoctoral fellowship from NIH (F32 MH087037-01). We thank G. Thomas, D. Linden, L. Volk, and A. Lade for helpful comments.	Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Huff NC, 2009, BEHAV NEUROSCI, V123, P834, DOI 10.1037/a0016511; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Mao SC, 2006, J NEUROSCI, V26, P8892, DOI 10.1523/JNEUROSCI.0365-06.2006; Maren S, 2006, P NATL ACAD SCI USA, V103, P18020, DOI 10.1073/pnas.0608398103; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; McNally RJ, 2007, CLIN PSYCHOL REV, V27, P750, DOI 10.1016/j.cpr.2007.01.003; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Urcelay GP, 2009, LEARN BEHAV, V37, P60, DOI 10.3758/LB.37.1.60; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002	30	360	365	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1108	1112		10.1126/science.1195298	http://dx.doi.org/10.1126/science.1195298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21030604	Green Accepted			2022-12-24	WOS:000284374700045
J	Scott, M; Gunderson, CW; Mateescu, EM; Zhang, ZG; Hwa, T				Scott, Matthew; Gunderson, Carl W.; Mateescu, Eduard M.; Zhang, Zhongge; Hwa, Terence			Interdependence of Cell Growth and Gene Expression: Origins and Consequences	SCIENCE			English	Article							ESCHERICHIA-COLI; PROTEIN; RIBOSOMES; BACTERIA	In bacteria, the rate of cell proliferation and the level of gene expression are intimately intertwined. Elucidating these relations is important both for understanding the physiological functions of endogenous genetic circuits and for designing robust synthetic systems. We describe a phenomenological study that reveals intrinsic constraints governing the allocation of resources toward protein synthesis and other aspects of cell growth. A theory incorporating these constraints can accurately predict how cell proliferation and gene expression affect one another, quantitatively accounting for the effect of translation-inhibiting antibiotics on gene expression and the effect of gratuitous protein expression on cell growth. The use of such empirical relations, analogous to phenomenological laws, may facilitate our understanding and manipulation of complex biological systems before underlying regulatory circuits are elucidated.	[Scott, Matthew; Mateescu, Eduard M.; Hwa, Terence] Univ Calif San Diego, Dept Phys, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Gunderson, Carl W.; Zhang, Zhongge; Hwa, Terence] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hwa, T (corresponding author), Univ Calif San Diego, Dept Phys, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA.	hwa@ucsd.edu	Hwa, Terence/J-4012-2013; Hwa, Terry/GOJ-9904-2022	Hwa, Terence/0000-0003-1837-6842; 	NIH [RO1GM77298]; NSF [MCB0746581, PHY0822283]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077298] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bremer, L. Csonka, P. Dennis, M. Ehrenberg, P. Geiduschek, M. Schaechter, A. Tadmor, and members of the Hwa lab for suggestions and discussions; D. Hughes for the Sm mutant strains; and P.-h. Lee and B. Willumsen for the use of unpublished data. Supported by NIH grant RO1GM77298, NSF grant MCB0746581, and the NSF-supported Center for Theoretical Biological Physics (grant PHY0822283). M. S. was supported by a Natural Sciences and Engineering Research Council of Canada fellowship.	Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257; Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; Bremer H, 1996, ESCHERICHIA COLI SAL; Chou CP, 2007, APPL MICROBIOL BIOT, V76, P521, DOI 10.1007/s00253-007-1039-0; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; FORCHHAMMER J, 1971, J MOL BIOL, V55, P563, DOI 10.1016/0022-2836(71)90337-8; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Maaloe O., 1979, BIOL REGUL DEV, V1, P487; MIKKOLA R, 1991, BIOCHIMIE, V73, P1551, DOI 10.1016/0300-9084(91)90190-C; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; VIND J, 1993, J MOL BIOL, V231, P678, DOI 10.1006/jmbi.1993.1319; Youk H, 2009, NATURE, V462, P875, DOI 10.1038/nature08653; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545	22	752	762	8	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2010	330	6007					1099	1102		10.1126/science.1192588	http://dx.doi.org/10.1126/science.1192588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097934				2022-12-24	WOS:000284374700042
J	Muotri, AR; Marchetto, MCN; Coufal, NG; Oefner, R; Yeo, G; Nakashima, K; Gage, FH				Muotri, Alysson R.; Marchetto, Maria C. N.; Coufal, Nicole G.; Oefner, Ruth; Yeo, Gene; Nakashima, Kinichi; Gage, Fred H.			L1 retrotransposition in neurons is modulated by MeCP2	NATURE			English	Article							CPG-BINDING PROTEIN-2; METHYL-CPG; STEM-CELLS; HISTONE DEACETYLASE; ADULT NEUROGENESIS; RETT-SYNDROME; TRANSCRIPTION; HIPPOCAMPUS; SEQUENCES; ELEMENTS	Long interspersed nuclear elements-1 (LINE-1 or L1s) are abundant retrotransposons that comprise approximately 20% of mammalian genomes(1-3). Active L1 retrotransposons can impact the genome in a variety of ways, creating insertions, deletions, new splice sites or gene expression fine-tuning(4-6). We have shown previously that L1 retrotransposons are capable of mobilization in neuronal progenitor cells from rodents and humans and evidence of massive L1 insertions was observed in adult brain tissues but not in other somatic tissues(7,8). In addition, L1 mobility in the adult hippocampus can be influenced by the environment(9). The neuronal specificity of somatic L1 retrotransposition in neural progenitors is partially due to the transition of a Sox2/HDAC1 repressor complex to a Wnt-mediated T-cell factor/lymphoid enhancer factor (TCF/LEF) transcriptional activator(7,10). The transcriptional switch accompanies chromatin remodelling during neuronal differentiation, allowing a transient stimulation of L1 transcription(7). The activity of L1 retrotransposons during brain development can have an impact on gene expression and neuronal function, thereby increasing brain-specific genetic mosaicism(11,12). Further understanding of the molecular mechanisms that regulate L1 expression should provide new insights into the role of L1 retrotransposition during brain development. Here we show that L1 neuronal transcription and retrotransposition in rodents are increased in the absence of methyl-CpG-binding protein 2 (MeCP2), a protein involved in global DNA methylation and human neurodevelopmental diseases. Using neuronal progenitor cells derived from human induced pluripotent stem cells and human tissues, we revealed that patients with Rett syndrome (RTT), carrying MeCP2 mutations, have increased susceptibility for L1 retrotransposition. Our data demonstrate that L1 retrotransposition can be controlled in a tissue-specific manner and that disease-related genetic mutations can influence the frequency of neuronal L1 retrotransposition. Our findings add a new level of complexity to the molecular events that can lead to neurological disorders.	[Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat,Dept Cellular & Mol Med, Rady Childrens Hosp San Diego,Stem Cell Program, La Jolla, CA 92093 USA; [Marchetto, Maria C. N.; Coufal, Nicole G.; Oefner, Ruth; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Yeo, Gene] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA; [Nakashima, Kinichi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol Neurosci, Ikoma 6300101, Japan	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Nara Institute of Science & Technology	Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat,Dept Cellular & Mol Med, Rady Childrens Hosp San Diego,Stem Cell Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.	muotri@ucsd.edu; gage@salk.edu	Yeo, Gene/AAE-7676-2019; Coufal, Nicole/ABA-9471-2021	Yeo, Gene/0000-0002-0799-6037; Coufal, Nicole/0000-0001-6547-1733	National Institutes of Health [1-DP2-OD006495-01]; Emerald Foundation; Mathers Foundation; Lookout Fund; NIH/NINDS [R01MH088485]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088485] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Mathers Foundation; Lookout Fund; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.R.M. is supported by the National Institutes of Health through the NIH Director's New Innovator Award Program, 1-DP2-OD006495-01 and by the Emerald Foundation. F.H.G. is supported by the Mathers Foundation, Lookout Fund, and NIH/NINDS R01MH088485. The authors would like to thank A. Huynh, B. Aimone, K. Stecker, B. Berg and D. Sepp for help during the 3D brain model assembly, J. Moran and J. Garcia-Perez for discussion and critical review of the manuscript, M. Gage for editorial comments, and B. Moddy and G. Peng for experimental assistance.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Yu F, 2001, NUCLEIC ACIDS RES, V29, P4493, DOI 10.1093/nar/29.21.4493; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	30	439	484	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2010	468	7322					443	446		10.1038/nature09544	http://dx.doi.org/10.1038/nature09544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085180	Green Accepted, Green Submitted			2022-12-24	WOS:000284313100044
J	Yooseph, S; Nealson, KH; Rusch, DB; McCrow, JP; Dupont, CL; Kim, M; Johnson, J; Montgomery, R; Ferriera, S; Beeson, K; Williamson, SJ; Tovchigrechko, A; Allen, AE; Zeigler, LA; Sutton, G; Eisenstadt, E; Rogers, YH; Friedman, R; Frazier, M; Venter, JC				Yooseph, Shibu; Nealson, Kenneth H.; Rusch, Douglas B.; McCrow, John P.; Dupont, Christopher L.; Kim, Maria; Johnson, Justin; Montgomery, Robert; Ferriera, Steve; Beeson, Karen; Williamson, Shannon J.; Tovchigrechko, Andrey; Allen, Andrew E.; Zeigler, Lisa A.; Sutton, Granger; Eisenstadt, Eric; Rogers, Yu-Hui; Friedman, Robert; Frazier, Marvin; Venter, J. Craig			Genomic and functional adaptation in surface ocean planktonic prokaryotes	NATURE			English	Article							PROTEIN; DIVERSITY; DATABASE; ALIGNMENT; FAMILIES; IRON	The understanding of marine microbial ecology and metabolism has been hampered by the paucity of sequenced reference genomes. To this end, we report the sequencing of 137 diverse marine isolates collected from around the world. We analysed these sequences, along with previously published marine prokaryotic genomes, in the context of marine metagenomic data, to gain insights into the ecology of the surface ocean prokaryotic picoplankton (0.1-3.0 mu m size range). The results suggest that the sequenced genomes define two microbial groups: one composed of only a few taxa that are nearly always abundant in picoplanktonic communities, and the other consisting of many microbial taxa that are rarely abundant. The genomic content of the second group suggests that these microbes are capable of slow growth and survival in energy-limited environments, and rapid growth in energy-rich environments. By contrast, the abundant and cosmopolitan picoplanktonic prokaryotes for which there is genomic representation have smaller genomes, are probably capable of only slow growth and seem to be relatively unable to sense or rapidly acclimate to energy-rich conditions. Their genomic features also lead us to propose that one method used to avoid predation by viruses and/or bacterivores is by means of slow growth and the maintenance of low biomass.	[Yooseph, Shibu; Nealson, Kenneth H.; Rusch, Douglas B.; McCrow, John P.; Dupont, Christopher L.; Kim, Maria; Johnson, Justin; Montgomery, Robert; Ferriera, Steve; Beeson, Karen; Williamson, Shannon J.; Tovchigrechko, Andrey; Allen, Andrew E.; Zeigler, Lisa A.; Sutton, Granger; Eisenstadt, Eric; Rogers, Yu-Hui; Friedman, Robert; Frazier, Marvin; Venter, J. Craig] J Craig Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute	Nealson, KH (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.	knealson@usc.edu	Allen, Andrew E/C-4896-2012	Allen, Andrew E/0000-0001-5911-6081; Yooseph, Shibu/0000-0001-5581-5002	Gordon and Betty Moore Foundation [521]; Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-FC02-02ER63453]; JCVI; US National Science Foundation [0850256]; Direct For Biological Sciences [0850256] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); JCVI; US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to acknowledge the Gordon and Betty Moore Foundation (grant award agreement #521); the Department of Energy, Office of Science, Office of Biological and Environmental Research (DE-FC02-02ER63453); and the JCVI for funding this research. A.T. and S.Y. also acknowledge support from US National Science Foundation grant 0850256. We also thank the JCVI Software Engineering team for their contribution to the analyses, L. Sheehan for help with manuscript editing, and M. Thiagarajan, L. Foster, I. Singh and M. Lewis for help with data management. Finally, we thank the many collaborators who provided strains for sequencing, including R. Amann, F. Azam, D. Bartlett, R. Belas, C. Bolch, E. Bonch-Osmolovskaya, J. Bowman, I. Brettar, T. Brinkhoff, A. Buchan, R. Case, R. Caviccholi, P. Chisholm, R. Edwards, D. Emerson, P. Falkowski, C. Francis, B. Fuchs, S. Giovannoni, J. Gonzalez, D. Green, A. Hagstrom, M. Hart, M. Haygood, R. Hill, M. Hofle, J.-C. Cho, K. Jurgens, S.-J. Kim, G. King, N. King, S. Kjelleberg, M. Klotz, M. Labrenz, E. Lilly, V. T. Marteinsson, M. A. Moran, A. Murray, J. C. Murrell, C. Pedros-Alio, J. Pinhassi, M. Polz, M. Rappe, A.-L. Reysenbach, F. Rodriguez-Valera, E. Rosenberg, N. Ruby, D. Scanlan, H. Schaefer, L. Shimkets, J. Siefert, M. Simon, T. Sokolova, E. Stabb, L. Stal, N. Tandeau de Marsac, B. Tebo, T. Thomas, C. Vetriani, I. Wagner-Dobler, B. Ward, J. Waterbury, B. Wawrik and A. Yayanos.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOND PL, 1995, APPL ENVIRON MICROB, V61, P1910, DOI 10.1128/AEM.61.5.1910-1916.1995; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Grimes DJ, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P209; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hagstrom A, 2002, APPL ENVIRON MICROB, V68, P3628, DOI 10.1128/AEM.68.7.3628-3633.2002; INGRAHAM JL, 1983, GROWTH BACTERIAL CEL, P435; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lis H, 2009, AQUAT MICROB ECOL, V56, P241, DOI 10.3354/ame01347; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McCaig AE, 1999, APPL ENVIRON MICROB, V65, P1721; Morel FMM, 2008, LIMNOL OCEANOGR, V53, P400, DOI 10.4319/lo.2008.53.1.0400; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nealson KH, 2007, ISME J, V1, P185, DOI 10.1038/ismej.2007.43; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Yooseph S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-182; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340	44	200	202	3	110	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					60	+		10.1038/nature09530	http://dx.doi.org/10.1038/nature09530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	21048761	hybrid			2022-12-24	WOS:000283786900035
J	Hogg, JR; Goff, SP				Hogg, J. Robert; Goff, Stephen P.			Upf1 Senses 3 ' UTR Length to Potentiate mRNA Decay	CELL			English	Article							EXON JUNCTION COMPLEX; MURINE LEUKEMIA-VIRUS; GAG-POL JUNCTION; TERMINATION CODONS; MEDIATED DECAY; SACCHAROMYCES-CEREVISIAE; TRANSLATION TERMINATION; SURVEILLANCE MACHINERY; MAMMALIAN-CELLS; READ-THROUGH	The selective degradation of mRNAs by the nonsense-mediated decay pathway is a quality control process with important consequences for human disease. From initial studies using RNA hairpin-tagged mRNAs for purification of messenger ribonucleoproteins assembled on transcripts with HIV-1 3' untranslated region (3'UTR) sequences, we uncover a two-step mechanism for Upf1-dependent degradation of mRNAs with long 3'UTRs. We demonstrate that Upf1 associates with mRNAs in a 3'UTR length-dependent manner and is highly enriched on transcripts containing 3'UTRs known to elicit NMD. Surprisingly, Upf1 recruitment and subsequent RNA decay can be antagonized by retroviral RNA elements that promote translational readthrough. By modulating the efficiency of translation termination, recognition of long 3'UTRs by Upf1 is uncoupled from the initiation of decay. We propose a model for 3'UTR length surveillance in which equilibrium binding of Upf1 to mRNAs precedes a kinetically distinct commitment to RNA decay.	[Hogg, J. Robert; Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Hogg, J. Robert; Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Hogg, JR (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	jh2721@columbia.edu; spg1@columbia.edu	Goff, Stephen P/K-6337-2014; Hogg, J. Robert/AAE-6539-2021; Hogg, J. Robert/O-2327-2018	Goff, Stephen P/0000-0003-0693-5547; Hogg, J. Robert/0000-0001-5729-5135	NRSA [1F32GM087737]; NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087737] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jens Lykke-Andersen and Brian Houck-Loomis for generously providing reagents and Kathleen Collins, Lisa Postow, and Jason Rodriguez for critical reading of the manuscript. Mass spectrometry was performed by Mary Ann Gawinowicz in the Columbia University Medical Center protein core facility. J.R.H. is supported by NRSA postdoctoral fellowship 1F32GM087737. S.P.G. is an investigator of the Howard Hughes Medical Institute.	Allamand V, 2008, J GENE MED, V10, P217, DOI 10.1002/jgm.1140; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; FELSENSTEIN KM, 1992, J VIROL, V66, P6601, DOI 10.1128/JVI.66.11.6601-6608.1992; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hogg JR, 2007, GENE DEV, V21, P3067, DOI 10.1101/gad.1603907; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Johansson MJO, 2007, P NATL ACAD SCI USA, V104, P20872, DOI 10.1073/pnas.0709257105; Johns L, 2007, MOL CELL BIOL, V27, P5630, DOI 10.1128/MCB.00410-07; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; LEHI, 2001, EMBO J, V20, P4987; LEHI, 2000, EMBO J, V19, P6860; Lim F, 2002, NUCLEIC ACIDS RES, V30, P4138, DOI 10.1093/nar/gkf552; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Maderazo AB, 2003, MOL CELL BIOL, V23, P842, DOI 10.1128/MCB.23.3.842-851.2003; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Salvatori F, 2009, AM J HEMATOL, V84, P720, DOI 10.1002/ajh.21539; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Valente ST, 2006, MOL CELL, V23, P597, DOI 10.1016/j.molcel.2006.07.021; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Weiss SL, 1998, RNA, V4, P816, DOI 10.1017/S1355838298971990; Weng YM, 1998, RNA, V4, P205; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; WILLS NM, 1994, EMBO J, V13, P4137, DOI 10.1002/j.1460-2075.1994.tb06731.x; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Zhang SA, 1997, RNA, V3, P234	59	233	236	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 29	2010	143	3					379	389		10.1016/j.cell.2010.10.005	http://dx.doi.org/10.1016/j.cell.2010.10.005			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029861	Green Accepted, Bronze			2022-12-24	WOS:000283603900012
J	Kim, J; Woo, AJ; Chu, JL; Snow, JW; Fujiwara, Y; Kim, CG; Cantor, AB; Orkin, SH				Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Kim, Chul Geun; Cantor, Alan B.; Orkin, Stuart H.			A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs	CELL			English	Article							RNAI SCREEN; C-MYC; DEVELOPMENTAL REGULATORS; ESSENTIAL COFACTOR; SELF-RENEWAL; PLURIPOTENCY; COMPLEX; PROTEIN; GENES; TRRAP	c-Myc (Myc) is an important transcriptional regulator in embryonic stem (ES) cells, somatic cell reprogramming, and cancer. Here, we identify a Myc-centered regulatory network in ES cells by combining protein-protein and protein-DNA interaction studies and show that Myc interacts with the NuA4 complex, a regulator of ES cell identity. In combination with regulatory network information, we define three ES cell modules (Core, Polycomb, and Myc) and show that the modules are functionally separable, illustrating that the overall ES cell transcription program is composed of distinct units. With these modules as an analytical tool, we have reassessed the hypothesis linking an ES cell signature with cancer or cancer stem cells. We find that the Myc module, independent of the Core module, is active in various cancers and predicts cancer outcome. The apparent similarity of cancer and ES cell signatures reflects, in large part, the pervasive nature of Myc regulatory networks.	[Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Cantor, Alan B.; Orkin, Stuart H.] Childrens Hosp, Dept Pediat Oncol, Boston, MA 02115 USA; [Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Cantor, Alan B.; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Jonghwan; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Cantor, Alan B.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Fujiwara, Yuko; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Kim, Chul Geun] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Hanyang University	Orkin, SH (corresponding author), Childrens Hosp, Dept Pediat Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Kim, Jonghwan/AAR-2815-2021	Woo, Andrew/0000-0003-1198-6373; Kim, Jonghwan/0000-0002-9919-9843; Kim, Chul Geun/0000-0002-5848-3338; Cantor, Alan/0000-0002-5136-028X	NIH/NIGMS [K99GM088384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM088384] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jennifer Trowbridge for critical reading of the manuscript, the Taplin Biological Mass Spectrometry Facility at Harvard Medical School for mass-spectrometry and peptide identification, and the Microarray Core Facility at the Dana Farber Cancer Institute for ChIP sample processing. The project described is partially supported by Award Number K99GM088384 to J.K. from the NIH/NIGMS. S.H.O. is an investigator of the Howard Hughes Medical Institute.	Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cole MD, 2006, SEMIN CANCER BIOL, V16, P241, DOI 10.1016/j.semcancer.2006.08.003; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wong DJ, 2008, CELL CYCLE, V7, P3622, DOI 10.4161/cc.7.23.7104; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	495	508	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					313	324		10.1016/j.cell.2010.09.010	http://dx.doi.org/10.1016/j.cell.2010.09.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946988	Green Accepted, Bronze			2022-12-24	WOS:000283052200019
J	Jaskelioff, M; Muller, FL; Paik, JH; Thomas, E; Jiang, S; Adams, AC; Sahin, E; Kost-Alimova, M; Protopopov, A; Cadinanos, J; Horner, JW; Maratos-Flier, E; DePinho, RA				Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Adams, Andrew C.; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; Maratos-Flier, Eleftheria; DePinho, Ronald A.			Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice	NATURE			English	Article							NEURAL STEM-CELLS; OLFACTORY-BULB; DNA-DAMAGE; CHROMOSOMAL INSTABILITY; LIFE-SPAN; CANCER; NEUROGENESIS; ADULT; MOUSE; RECOMBINATION	An ageing world population has fuelled interest in regenerative remedies that may stem declining organ function and maintain fitness. Unanswered is whether elimination of intrinsic instigators driving age-associated degeneration can reverse, as opposed to simply arrest, various afflictions of the aged. Such instigators include progressively damaged genomes. Telomerase-deficient mice have served as a model system to study the adverse cellular and organismal consequences of wide-spread endogenous DNA damage signalling activation in vivo(1). Telomere loss and uncapping provokes progressive tissue atrophy, stem cell depletion, organ system failure and impaired tissue injury responses(1). Here, we sought to determine whether entrenched multi-system degeneration in adult mice with severe telomere dysfunction can be halted or possibly reversed by reactivation of endogenous telomerase activity. To this end, we engineered a knock-in allele encoding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-oestrogen receptor (TERT-ER) under transcriptional control of the endogenous TERT promoter. Homozygous TERT-ER mice have short dysfunctional telomeres and sustain increased DNA damage signalling and classical degenerative phenotypes upon successive generational matings and advancing age. Telomerase reactivation in such late generation TERT-ER mice extends telomeres, reduces DNA damage signalling and associated cellular checkpoint responses, allows resumption of proliferation in quiescent cultures, and eliminates degenerative phenotypes across multiple organs including testes, spleens and intestines. Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2(+) neural progenitors, Dcx(+) newborn neurons, and Olig2(+) oligodendrocyte populations. Consistent with the integral role of subventricular zone neural progenitors in generation and maintenance of olfactory bulb interneurons(2), this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses. Accumulating evidence implicating telomere damage as a driver of age-associated organ decline and disease risk(1,3) and the marked reversal of systemic degenerative phenotypes in adult mice observed here support the development of regenerative strategies designed to restore telomere integrity.	[Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA; [Adams, Andrew C.; Maratos-Flier, Eleftheria] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu		Muller, Florian/0000-0001-7568-2948; Cadinanos, Juan/0000-0001-7561-7759; DePinho, Ronald/0000-0002-5625-577X	Susan G. Komen for the Cure fellowship [PDF060881]; NIH National Cancer Institute [R01CA84628, U01CA141508]; Belfer Foundation; American Cancer Society (ACS) [PF-08-261-01-TBE]; NATIONAL CANCER INSTITUTE [U01CA141508, R01CA084628] Funding Source: NIH RePORTER	Susan G. Komen for the Cure fellowship(Susan G. Komen Breast Cancer Foundation); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Belfer Foundation; American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank R. Segal for critical comments, R. Bronson, K. Ligon and C. Maire for histological advice, S. S. Chae for assistance with neurosphere measurement studies and L. Cameron for time-lapse microscopy studies. M.J. was supported in part by a Susan G. Komen for the Cure fellowship (PDF060881). F.L.M. was supported by ACS fellowship PF-08-261-01-TBE. This work and R.A.D. was supported by R01CA84628 and U01CA141508 grants from the NIH National Cancer Institute and the Belfer Foundation. R.A.D. was supported by an American Cancer Society Research Professorship.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Best BP, 2009, REJUV RES, V12, P199, DOI 10.1089/rej.2009.0847; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Caporaso GL, 2003, MOL CELL NEUROSCI, V23, P693, DOI 10.1016/S1044-7431(03)00103-9; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Gorczyca W, 2001, METHOD CELL BIOL, V64, P421; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Ju ZY, 2008, BIOCHIMIE, V90, P24, DOI 10.1016/j.biochi.2007.09.006; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lafreniere D, 2009, OTOLARYNG CLIN N AM, V42, P123, DOI 10.1016/j.otc.2008.09.001; Lee J, 2010, NEUROCHEM RES, V35, P211, DOI 10.1007/s11064-009-0044-3; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Mahoney JE, 2008, PROC SPIE, V6859, DOI 10.1117/12.763858; Maser RS, 2007, MOL CELL BIOL, V27, P2253, DOI 10.1128/MCB.01354-06; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Potzner MR, 2007, MOL CELL BIOL, V27, P5316, DOI 10.1128/MCB.00339-07; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052	35	508	537	3	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					102	U1700		10.1038/nature09603	http://dx.doi.org/10.1038/nature09603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21113150	Green Accepted			2022-12-24	WOS:000285921600040
J	Weerapana, E; Wang, C; Simon, GM; Richter, F; Khare, S; Dillon, MBD; Bachovchin, DA; Mowen, K; Baker, D; Cravatt, BF				Weerapana, Eranthie; Wang, Chu; Simon, Gabriel M.; Richter, Florian; Khare, Sagar; Dillon, Myles B. D.; Bachovchin, Daniel A.; Mowen, Kerri; Baker, David; Cravatt, Benjamin F.			Quantitative reactivity profiling predicts functional cysteines in proteomes	NATURE			English	Article							COMPLEX PROTEIN MIXTURES; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; IDENTIFICATION; THIOL; ELECTROPHILES; PEPTIDES; RESIDUES	Cysteine is the most intrinsically nucleophilic amino acid in proteins, where its reactivity is tuned to perform diverse biochemical functions. The absence of a consensus sequence that defines functional cysteines in proteins has hindered their discovery and characterization. Here we describe a proteomics method to profile quantitatively the intrinsic reactivity of cysteine residues en masse directly in native biological systems. Hyper-reactivity was a rare feature among cysteines and it was found to specify a wide range of activities, including nucleophilic and reductive catalysis and sites of oxidative modification. Hyper-reactive cysteines were identified in several proteins of uncharacterized function, including a residue conserved across eukaryotic phylogeny that we show is required for yeast viability and is involved in iron-sulphur protein biogenesis. We also demonstrate that quantitative reactivity profiling can form the basis for screening and functional assignment of cysteines in computationally designed proteins, where it discriminated catalytically active from inactive cysteine hydrolase designs.	[Weerapana, Eranthie; Wang, Chu; Simon, Gabriel M.; Bachovchin, Daniel A.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Weerapana, Eranthie; Wang, Chu; Simon, Gabriel M.; Dillon, Myles B. D.; Bachovchin, Daniel A.; Mowen, Kerri; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Richter, Florian; Khare, Sagar; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Richter, Florian; Baker, David] Univ Washington, Interdisciplinary Program Biomol Struct & Design, Seattle, WA 98195 USA; [Khare, Sagar; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Scripps Research Institute; Scripps Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	Wang, Chu/C-4442-2015; Wang, Chu/AAE-8759-2021; wang, chu/GYJ-2191-2022; Baker, David/K-8941-2012	Wang, Chu/0000-0002-6925-1268; Wang, Chu/0000-0002-6925-1268; Baker, David/0000-0001-7896-6217	National Institutes of Health [CA087660, MH084512]; Pfizer; Koshland Graduate Fellowship; National Science Foundation; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA087660, R37CA087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090294, R01GM085117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Koshland Graduate Fellowship; National Science Foundation(National Science Foundation (NSF)); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank T. Bartfai, I. Wilson and members of the B.F.C. laboratory for comments and critical reading of the manuscript, T. Ji for experimental assistance and J. Gallaher for expression of designed proteins. This work was supported by the National Institutes of Health (CA087660, MH084512), a Pfizer Postdoctoral Fellowship (E.W.), a Koshland Graduate Fellowship in Enzyme Biochemistry (G.M.S.), a National Science Foundation predoctoral fellowship (D.A.B.) and the Skaggs Institute for Chemical Biology.	Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Chen G, 2003, J AM CHEM SOC, V125, P8130, DOI 10.1021/ja034287m; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dennehy MK, 2006, CHEM RES TOXICOL, V19, P20, DOI 10.1021/tx050312l; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giles NM, 2003, BIOCHEM BIOPH RES CO, V300, P1, DOI 10.1016/S0006-291X(02)02770-5; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Isom DG, 2010, P NATL ACAD SCI USA, V107, P4908, DOI 10.1073/pnas.0910421107; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KNOWLES JR, 1976, CRC CR REV BIOCH MOL, V4, P165, DOI 10.3109/10409237609105457; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; LEWIS CT, 1989, J BIOL CHEM, V264, P27; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Ma S, 2007, J AM CHEM SOC, V129, P13633, DOI 10.1021/ja074222+; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Nazif T, 2001, P NATL ACAD SCI USA, V98, P2967, DOI 10.1073/pnas.061028898; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Okerberg ES, 2005, P NATL ACAD SCI USA, V102, P4996, DOI 10.1073/pnas.0501205102; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Shiio Y, 2006, NAT PROTOC, V1, P139, DOI 10.1038/nprot.2006.22; Shin NY, 2007, CHEM RES TOXICOL, V20, P859, DOI 10.1021/tx700031r; Silverman JA, 2002, J BIOL CHEM, V277, P30968, DOI 10.1074/jbc.M203172200; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; THOMPSON S, 1989, BIOCHEMISTRY-US, V28, P5735, DOI 10.1021/bi00440a006; VALLEE BL, 1955, P NATL ACAD SCI USA, V41, P327, DOI 10.1073/pnas.41.6.327; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; Weerapana E, 2008, NAT CHEM BIOL, V4, P405, DOI 10.1038/nchembio.91; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhao YM, 2009, PROTEOMICS, V9, P4632, DOI 10.1002/pmic.200900398	50	1033	1059	21	397	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					790	U79		10.1038/nature09472	http://dx.doi.org/10.1038/nature09472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21085121	Green Accepted			2022-12-24	WOS:000285093700038
J	Buhr, ED; Yoo, SH; Takahashi, JS				Buhr, Ethan D.; Yoo, Seung-Hee; Takahashi, Joseph S.			Temperature as a Universal Resetting Cue for Mammalian Circadian Oscillators	SCIENCE			English	Article							HEAT-SHOCK FACTOR-1; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; PERIPHERAL-TISSUES; BODY-TEMPERATURE; DNA-BINDING; CLOCK GENE; ENTRAINMENT	Environmental temperature cycles are a universal entraining cue for all circadian systems at the organismal level with the exception of homeothermic vertebrates. We report here that resistance to temperature entrainment is a property of the suprachiasmatic nucleus (SCN) network and is not a cell-autonomous property of mammalian clocks. This differential sensitivity to temperature allows the SCN to drive circadian rhythms in body temperature, which can then act as a universal cue for the entrainment of cell-autonomous oscillators throughout the body. Pharmacological experiments show that network interactions in the SCN are required for temperature resistance and that the heat shock pathway is integral to temperature resetting and temperature compensation in mammalian cells. These results suggest that the evolutionarily ancient temperature resetting response can be used in homeothermic animals to enhance internal circadian synchronization.	[Buhr, Ethan D.; Yoo, Seung-Hee; Takahashi, Joseph S.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Buhr, Ethan D.; Yoo, Seung-Hee; Takahashi, Joseph S.] Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Northwestern University; Northwestern University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Takahashi, JS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644	NIH [P50 MH074924, T32 AG 20418]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020418] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Takahashi laboratory for helpful discussions; S. Panda and J. B. Hogenesch for providing the U-2 OS cells; S. A. Kay for providing PG 99-465; and R. I. Morimoto for providing HSP70 antibody. We especially thank V. Kumar and K. Shimomura for suggestions and discussion on the manuscript. This work was supported by NIH P50 MH074924 to J. S. T. and T32 AG 20418 to E. D. B. J. S. T. is an Investigator and S.H.Y. was an Associate in the Howard Hughes Medical Institute. J. S. T. has a paid consulting relationship with, and owns stock in, ReSet Therapeutics, Inc., a biotechnology company that works on circadian rhythms and metabolism.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; CHOI HS, 1991, J BIOL CHEM, V266, P11858; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Diernfellner ACR, 2005, GENE DEV, V19, P1968, DOI 10.1101/gad.345905; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Herzog ED, 2003, J NEUROPHYSIOL, V90, P763, DOI 10.1152/jn.00129.2003; HOFFMANN K, 1969, OECOLOGIA, V3, P184, DOI 10.1007/BF00416981; HONMA S, 1988, PHYSIOL BEHAV, V44, P247, DOI 10.1016/0031-9384(88)90146-1; Honma S, 2008, J BIOL RHYTHM, V23, P91, DOI 10.1177/0748730407311124; Kabrita CS, 2008, BRAIN RES, V1195, P20, DOI 10.1016/j.brainres.2007.12.020; Kaushik R, 2007, PLOS BIOL, V5, P1257, DOI 10.1371/journal.pbio.0050146; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Tataroglu O, 2006, J BIOL RHYTHM, V21, P185, DOI 10.1177/0748730406287529; Wadekar SA, 2004, MOL ENDOCRINOL, V18, P500, DOI 10.1210/me.2003-0215; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yokota S, 2000, CANCER RES, V60, P2942; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida T, 2009, P NATL ACAD SCI USA, V106, P1648, DOI 10.1073/pnas.0806741106	48	544	555	14	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					379	385		10.1126/science.1195262	http://dx.doi.org/10.1126/science.1195262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947768	Green Accepted			2022-12-24	WOS:000282986700044
J	Luo, SJ; Kleemann, GA; Ashraf, JM; Shaw, WM; Murphy, CT				Luo, Shijing; Kleemann, Gunnar A.; Ashraf, Jasmine M.; Shaw, Wendy M.; Murphy, Coleen T.			TGF-beta and Insulin Signaling Regulate Reproductive Aging via Oocyte and Germline Quality Maintenance	CELL			English	Article							AGE-RELATED-CHANGES; CAENORHABDITIS-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; STEM-CELLS; SPERM; NONDISJUNCTION; ABNORMALITIES; TEMPERATURE; DROSOPHILA	Reproductive cessation is perhaps the earliest aging phenotype that humans experience. Similarly, reproduction of Caenorhabditis elegans ceases in midadulthood. Although somatic aging has been studied in both worms and humans, mechanisms regulating reproductive aging are not yet understood. Here, we show that TGF-beta Sma/Mab and Insulin/IGF-1 signaling regulate C. elegans reproductive aging by modulating multiple aspects of the reproductive process, including embryo integrity, oocyte fertilizability, chromosome segregation fidelity, DNA damage resistance, and oocyte and germline morphology. TGF-beta activity regulates reproductive span and germline/oocyte quality noncell-autonomously and is temporally and transcriptionally separable from its regulation of growth. Chromosome segregation, cell cycle, and DNA damage response genes are upregulated in TGF-beta mutant oocytes, decline in aged mammalian oocytes, and are critical for oocyte quality maintenance. Our data suggest that C. elegans and humans share many aspects of reproductive aging, including the correlation between reproductive aging and declining oocyte quality and mechanisms determining oocyte quality.	[Luo, Shijing; Kleemann, Gunnar A.; Ashraf, Jasmine M.; Shaw, Wendy M.; Murphy, Coleen T.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Luo, Shijing; Kleemann, Gunnar A.; Ashraf, Jasmine M.; Shaw, Wendy M.; Murphy, Coleen T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Murphy, CT (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ctmurphy@princeton.edu		Murphy, Coleen/0000-0002-8257-984X	NIH [1DP2OD004402-01, P50 GM071508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004402] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Cathy Savage-Dunn (CUNY) for CS122 and pCS227; David Sherwood (Duke University) for NK640; Barth Grant (Rutgers) for RT130 and alpha-RME-2 antibody; members of the Murphy Laboratory and Z. Gitai for comments on the manuscript; and March of Dimes Basil O'Connor Starting Scholar, NIH New Innovator (1DP2OD004402-01), and NIH (P50 GM071508) awards for funding.	Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Blondin P, 1997, J ANDROL, V18, P454; Cant MA, 2008, P NATL ACAD SCI USA, V105, P5332, DOI 10.1073/pnas.0711911105; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Garigan D, 2002, GENETICS, V161, P1101; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; Goud P, 1999, FERTIL STERIL, V72, P245, DOI 10.1016/S0015-0282(99)00231-9; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Greenstein David, 2005, WormBook, P1, DOI 10.1895/wormbook.1.53.1; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hagedorn EJ, 2009, DEV CELL, V17, P187, DOI 10.1016/j.devcel.2009.06.006; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; HARTGE P, 1979, GENETICS, V91, P67; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Jud M, 2007, DEV GENES EVOL, V217, P221, DOI 10.1007/s00427-006-0130-3; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; Liang J, 2007, DEV BIOL, V305, P714, DOI 10.1016/j.ydbio.2007.02.038; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Luo SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000789; Magli MC, 2007, FERTIL STERIL, V87, P534, DOI 10.1016/j.fertnstert.2006.07.1512; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Miller Michael A., 2006, V351, P193; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; ROSE AM, 1979, GENETICS, V92, P409; Rubio C, 2003, HUM REPROD, V18, P182, DOI 10.1093/humrep/deg015; Saito TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000735; Savage-Dunn C, 2000, DEV BIOL, V223, P70, DOI 10.1006/dbio.2000.9713; Savage-Dunn Cathy, 2005, WormBook, P1; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Steuerwald NM, 2007, REPROD BIOMED ONLINE, V14, P700, DOI 10.1016/S1472-6483(10)60671-2; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tang L, 2010, MOL BIOL CELL, V21, P885, DOI 10.1091/mbc.E09-09-0811; TOKUNAGA C, 1970, GENETICS, V65, P75; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Wang JJ, 2002, DEVELOPMENT, V129, P4989; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Zhao R, 2008, AGING CELL, V7, P344, DOI 10.1111/j.1474-9726.2008.00379.x	57	155	161	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					299	312		10.1016/j.cell.2010.09.013	http://dx.doi.org/10.1016/j.cell.2010.09.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946987	Bronze, Green Accepted			2022-12-24	WOS:000283052200018
J	Murakami, K; Yasunaga, T; Noguchi, TQP; Gomibuchi, Y; Ngo, KX; Uyeda, TQP; Wakabayashi, T				Murakami, Kenji; Yasunaga, Takuo; Noguchi, Taro Q. P.; Gomibuchi, Yuki; Ngo, Kien X.; Uyeda, Taro Q. P.; Wakabayashi, Takeyuki			Structural Basis for Actin Assembly, Activation of ATP Hydrolysis, and Delayed Phosphate Release	CELL			English	Article							ATOMIC MODEL; F-ACTIN; ELECTRON-MICROGRAPHS; INORGANIC-PHOSPHATE; CRYSTAL-STRUCTURE; POLYMERIZATION; FILAMENT; ADP; VISUALIZATION; TROPOMYOSIN	Assembled actin filaments support cellular signaling, intracellular trafficking, and cytokinesis. ATP hydrolysis triggered by actin assembly provides the structural cues for filament turnover in vivo. Here, we present the cryo-electron microscopic (cryo-EM) structure of filamentous actin (F-actin) in the presence of phosphate, with the visualization of some alpha-helical backbones and large side chains. A complete atomic model based on the EM map identified intermolecular interactions mediated by bound magnesium and phosphate ions. Comparison of the F-actin model with G-actin monomer crystal structures reveals a critical role for bending of the conserved proline-rich loop in triggering phosphate release following ATP hydrolysis. Crystal structures of G-actin show that mutations in this loop trap the catalytic site in two intermediate states of the ATPase cycle. The combined structural information allows us to propose a detailed molecular mechanism for the biochemical events, including actin polymerization and ATPase activation, critical for actin filament dynamics.	[Murakami, Kenji; Gomibuchi, Yuki; Wakabayashi, Takeyuki] Teikyo Univ, Sch Sci & Engn, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Wakabayashi, Takeyuki] Teikyo Univ, Fac Med Technol, Dept Judo Therapy, Utsunomiya, Tochigi 3208551, Japan; [Yasunaga, Takuo] Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Dept Biosci & Bioinformat, Fukuoka 820850, Japan; [Noguchi, Taro Q. P.; Ngo, Kien X.; Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Wakabayashi, Takeyuki] Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Teikyo University; Teikyo University; Kyushu Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Wakabayashi, T (corresponding author), Teikyo Univ, Sch Sci & Engn, Dept Biosci, Toyosatodai 1-1, Utsunomiya, Tochigi 3208551, Japan.	wakabayashi@nasu.bio.teikyo-u.ac.jp	NGO, Kien Xuan/GLU-7155-2022; Yasunaga, Takuo/C-8316-2009	Yasunaga, Takuo/0000-0002-2494-9603; NGO, Kien Xuan/0000-0002-9710-5452	Ministry of Education, Science, Technology, and Sports of Japan; SENTAN,	Ministry of Education, Science, Technology, and Sports of Japan; SENTAN,(Japan Science & Technology Agency (JST))	We thank Dr. Murray Stewart (MRC Lab. Mol. Biol., Cambridge) for discussions and advice on crystallography; Dr. Ralph Davis and Dr. Karl-Magnus Larsson (Stanford University) for critical reading of the manuscript; Dr. Akihiro Narita for his contribution to this work at the early stages; Dr. Soichi Wakatsuki and colleagues at Photon Factory, KEK for data collection at the synchrotron site; Dr. Koji Yonekura for the program to calculate a figure of merit; Dr. Hideo Higuchi for fluorometry; and Yuji Tuji, Akito Tominaga, Ryuta Mikawa, and Harumi Kiuchi for assistance with crystallography and/or biochemical experiments. This work was supported by grants from Human Frontier Science Program and Grant-in-Aid for Scientific Research on Priority Areas (Bio-supramolecule) from the Ministry of Education, Science, Technology, and Sports of Japan to T.W. and a grant from SENTAN, JST to T.Q.P.U.	Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; DANCKER P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P197, DOI 10.1016/0304-4165(90)90116-E; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heintz D, 1996, BIOCHEMISTRY-US, V35, P12686, DOI 10.1021/bi961159k; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAKI K, 1962, ARCH BIOCHEM BIOPHYS, V98, P323, DOI 10.1016/0003-9861(62)90190-X; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Noda K, 2006, J PLASMA PHYS, V72, P1037, DOI 10.1017/S0022377806005174; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; NONOMURA Y, 1975, J BIOCHEM, V78, P1101, DOI 10.1093/oxfordjournals.jbchem.a130988; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICKARD JE, 1986, J MOL BIOL, V191, P273, DOI 10.1016/0022-2836(86)90264-0; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025; Yasunaga T, 2008, J ELECTRON MICROSC, V57, P101, DOI 10.1093/jmicro/dfn006; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	43	108	109	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					275	287		10.1016/j.cell.2010.09.034	http://dx.doi.org/10.1016/j.cell.2010.09.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946985	Bronze			2022-12-24	WOS:000283052200016
J	Nakada, D; Saunders, TL; Morrison, SJ				Nakada, Daisuke; Saunders, Thomas L.; Morrison, Sean J.			Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells	NATURE			English	Article							PEUTZ-JEGHERS-SYNDROME; DROSOPHILA LKB1; GENE; KINASE; DEFICIENCY; PATHWAY; MAINTENANCE; MICE; EMBRYOGENESIS; PROGENITORS	Little is known about metabolic regulation in stem cells and how this modulates tissue regeneration or tumour suppression. We studied the Lkb1 tumour suppressor and its substrate AMP-activated protein kinase (AMPK), kinases that coordinate metabolism with cell growth. Deletion of the Lkb1 (also called Stk11) gene in mice caused increased haematopoietic stem cell (HSC) division, rapid HSC depletion and pancytopenia. HSCs depended more acutely on Lkb1 for cell-cycle regulation and survival than many other haematopoietic cells. HSC depletion did not depend on mTOR activation or oxidative stress. Lkb1-deficient HSCs, but not myeloid progenitors, had reduced mitochondrial membrane potential and ATP levels. HSCs deficient for two catalytic alpha-subunits of AMPK (AMPK-deficient HSCs) showed similar changes in mitochondrial function but remained able to reconstitute irradiated mice. Lkb1-deficient HSCs, but not AMPK-deficient HSCs, exhibited defects in centrosomes and mitotic spindles in culture, and became aneuploid. Lkb1 is therefore required for HSC maintenance through AMPK-dependent and AMPK-independent mechanisms, revealing differences in metabolic and cell-cycle regulation between HSCs and some other haematopoietic progenitors.	[Nakada, Daisuke; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Nakada, Daisuke; Saunders, Thomas L.; Morrison, Sean J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329; Nakada, Daisuke/0000-0001-6010-7094; Saunders, Thom/0000-0003-2015-101X	Howard Hughes Medical Institute; University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) [CA46592]; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH)(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Howard Hughes Medical Institute. Flow cytometry was partially supported by the University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) CA46592. D.N. was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science. We thank A. Prendergast and C. Sifuentes for technical assistance; E. Hughes and the UM Transgenic Animal Model Core for help generating Lkb1<SUP>fl</SUP> mice; D. Adams and M. White for flow cytometry; E. Smith for antibody production; C. Mountford, S. Grove and R. Coolon for mouse colony management; and L. Cantley and C. Thompson for discussions.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bonaccorsi S, 2007, DEVELOPMENT, V134, P2183, DOI 10.1242/dev.02848; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cao YH, 2010, CELL RES, V20, P99, DOI 10.1038/cr.2009.141; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Pearson HB, 2008, CANCER RES, V68, P2223, DOI 10.1158/0008-5472.CAN-07-5169; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shorning BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004264; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Watts JL, 2000, DEVELOPMENT, V127, P1467; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074	45	374	387	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					653	U69		10.1038/nature09571	http://dx.doi.org/10.1038/nature09571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124450	Green Accepted			2022-12-24	WOS:000284836700032
J	Navarro, P; Oldfield, A; Legoupi, J; Festuccia, N; Dubois, A; Attia, M; Schoorlemmer, J; Rougeulle, C; Chambers, I; Avner, P				Navarro, Pablo; Oldfield, Andrew; Legoupi, Julie; Festuccia, Nicola; Dubois, Agnes; Attia, Mikael; Schoorlemmer, Jon; Rougeulle, Claire; Chambers, Ian; Avner, Philip			Molecular coupling of Tsix regulation and pluripotency	NATURE			English	Article							X-CHROMOSOME; TRANSCRIPTIONAL NETWORK; XIST TRANSCRIPTION; INACTIVATION; EXPRESSION; CTCF	The reprogramming of X-chromosome inactivation during the acquisition of pluripotency in vivo and in vitro(1) is accompanied by the repression of Xist(2), the trigger of X-inactivation(3), and the upregulation of its antisense counterpart Tsix(4). We have shown that key factors supporting pluripotency-Nanog, Oct4 and Sox2-bind within Xist intron 1 in undifferentiated embryonic stem cells (ESC) to repress Xist transcription(5). However, the relationship between transcription factors of the pluripotency network and Tsix regulation has remained unclear(5,6). Here we show that Tsix upregulation in embryonic stem cells depends on the recruitment of the pluripotent marker Rex1, and of the reprogramming-associated factors Klf4 and c-Myc, by the DXPas34 minisatellite associated with the Tsix promoter. Upon deletion of DXPas34, binding of the three factors is abrogated and the transcriptional machinery is no longer efficiently recruited to the Tsix promoter. Additional analyses including knockdown experiments further demonstrate that Rex1 is critically important for efficient transcription elongation of Tsix. Hence, distinct embryonic-stem-cell-specific complexes couple X-inactivation reprogramming and pluripotency, with Nanog, Oct4 and Sox2 repressing Xist to facilitate the reactivation of the inactive X, and Klf4, c-Myc and Rex1 activating Tsix to remodel Xist chromatin(7-10) and ensure random X-inactivation upon differentiation(1). The holistic pattern of Xist/Tsix regulation by pluripotent factors that we have identified suggests a general direct governance of complex epigenetic processes by the machinery dedicated to pluripotency.	[Navarro, Pablo; Oldfield, Andrew; Legoupi, Julie; Dubois, Agnes; Attia, Mikael; Rougeulle, Claire; Avner, Philip] Inst Pasteur, URA 2578, Unite Genet Mol Murine, F-75724 Paris 15, France; [Navarro, Pablo; Festuccia, Nicola; Chambers, Ian] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, Ctr Dev Stem Cell Biol,MRC, Edinburgh EH9 3JQ, Midlothian, Scotland; [Oldfield, Andrew; Rougeulle, Claire] Univ Paris Diderot, CNRS, UMR Epigenet & Destin Cellulaire 7216, F-75205 Paris 13, France; [Schoorlemmer, Jon] ARAID Fdn, Zaragoza 50013, Spain; [Schoorlemmer, Jon] Fac Vet, Inst Aragones Ciencias Salud, Dept Anat & Embriol, Zaragoza 50013, Spain	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Avner, P (corresponding author), Inst Pasteur, URA 2578, Unite Genet Mol Murine, F-75724 Paris 15, France.	pablo.navarro@ed.ac.uk; pavner@pasteur.fr	Chambers, Ian/H-5416-2011; Oldfield, Andrew J./AAP-4354-2021; Oldfield, Andrew/ABF-1343-2021; Schoorlemmer, Jon/R-6814-2019	Chambers, Ian/0000-0003-2605-1597; Oldfield, Andrew/0000-0002-5401-9909; Schoorlemmer, Jon/0000-0001-6933-0567; Rougeulle, Claire/0000-0003-3861-4940	Institut Pasteur; Royal Society; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [05-JCJC-0166-01, 07-BLAN-0047-01]; EU Epigenome Network of Excellence; INSERM; European Research Council; Wellcome Trust; EU; Medical Research Council; Medical Research Council [G0700711B] Funding Source: researchfish	Institut Pasteur(European Commission); Royal Society(Royal Society of London); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); EU Epigenome Network of Excellence; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Clerc for discussions. P.N. was initially supported by recurrent funding from the Institut Pasteur and then by the Royal Society (a Newton International Fellowship). P.A. was supported by recurrent funding from the Centre National de la Recherche Scientifique and the Institut Pasteur, contracts 05-JCJC-0166-01 and 07-BLAN-0047-01 from the Agence Nationale de la Recherche and funding from the EU Epigenome Network of Excellence. C.R. was supported by the INSERM 'Avenir' programme and by the European Research Council 'starting grant' programme. Research in I.C.'s laboratory was supported by the Wellcome Trust, by the EU Framework 7 project "EuroSyStem'' and by a Medical Research Council studentship (to N.F.).	BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Do Kim J, 2007, NUCLEIC ACIDS RES, V35, P3442, DOI 10.1093/nar/gkm235; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; Navarro P, 2010, BIOESSAYS, V32, P581, DOI 10.1002/bies.201000019; Navarro P, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-8; Navarro P, 2009, FEBS LETT, V583, P1721, DOI 10.1016/j.febslet.2009.03.043; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103	30	144	147	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					457	U287		10.1038/nature09496	http://dx.doi.org/10.1038/nature09496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085182				2022-12-24	WOS:000284313100047
J	Kessler, SA; Shimosato-Asano, H; Keinath, NF; Wuest, SE; Ingram, G; Panstruga, R; Grossniklaus, U				Kessler, Sharon A.; Shimosato-Asano, Hiroko; Keinath, Nana F.; Wuest, Samuel E.; Ingram, Gwyneth; Panstruga, Ralph; Grossniklaus, Ueli			Conserved Molecular Components for Pollen Tube Reception and Fungal Invasion	SCIENCE			English	Article							MALE-GAMETE DELIVERY; POWDERY MILDEW; ARABIDOPSIS-THALIANA; DOUBLE FERTILIZATION; SYNERGID CELL; RESISTANCE; PROTEINS; GENE; DISRUPTS; FAMILY	During sexual reproduction in flowering plants such as Arabidopsis, a tip-growing pollen tube (PT) is guided to the synergid cells of the female gametophyte, where it bursts and releases the two sperm. Here we show that PT reception and powdery mildew (PM) infection, which involves communication between a tip-growing hypha and a plant epidermal cell, share molecular components. NORTIA (NTA), a member of the MLO family originally discovered in the context of PM resistance, and FERONIA (FER), a receptor-like kinase, both control PT reception in synergids. Homozygous fer mutants also display PM resistance, revealing a new function for FER and suggesting that conserved components, such as FER and distinct MLO proteins, are involved in both PT reception and PM infection.	[Kessler, Sharon A.; Shimosato-Asano, Hiroko; Wuest, Samuel E.; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Keinath, Nana F.; Panstruga, Ralph] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Ingram, Gwyneth] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland	University of Zurich; Max Planck Society; University of Edinburgh	Grossniklaus, U (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	grossnik@botinst.uzh.ch	Panstruga, Ralph/F-3340-2011; Grossniklaus, Ueli/A-2736-2012; Kessler, Sharon A/T-4784-2017; Grossniklaus, Ueli/E-9995-2016	Panstruga, Ralph/0000-0002-3756-8957; Kessler, Sharon A/0000-0002-7964-0451; Grossniklaus, Ueli/0000-0002-0522-8974; Ingram, Gwyneth/0000-0002-1425-9545; Wuest, Samuel/0000-0003-3982-0770	University of Zurich; Max Planck Society; Human Frontiers in Science Program; Forschungskredit of the University of Zurich; International Max Planck Research School; Royal Society of London; Deutsche Forschungsgemeinschaft [SFB670]; Swiss National Science Foundation	University of Zurich; Max Planck Society(Max Planck SocietyFoundation CELLEX); Human Frontiers in Science Program(Human Frontier Science Program); Forschungskredit of the University of Zurich; International Max Planck Research School; Royal Society of London(Royal Society of London); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank A. Boisson-Dernier for providing pLat52:DsRED and for critical reading of this manuscript; S. Schauer for providing plasmids; A. Reinstadler for technical assistance with pathogen assays; and J. M. Escobar-Restrepo, H. Lindner, M. Bayer, C. Jager-Baroux, S. Pien, V. Gagliardini, and members of the Grossniklaus lab for helpful discussions. This work was supported by the University of Zurich, the Max Planck Society, fellowships of the Human Frontiers in Science Program (to S.A.K.), the Forschungskredit of the University of Zurich (to H.S.-A.), the International Max Planck Research School (to N.F.K.), the Royal Society of London (to G.I.), and grants from the Deutsche Forschungsgemeinschaft (SFB670 to R.P.) and the Swiss National Science Foundation (to U.G.).	Amano K, 1986, HOST RANGE GEOGRAPHI; AMICI JB, 1847, ANN SCI NATURELLES, P193; Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Boisson-Dernier A, 2008, CURR BIOL, V18, P63, DOI 10.1016/j.cub.2007.11.067; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Capron A, 2008, PLANT CELL, V20, P3038, DOI 10.1105/tpc.108.061713; Chen ZY, 2009, PLANT CELL, V21, P1972, DOI 10.1105/tpc.108.062653; Chen ZY, 2006, PLANT MOL BIOL, V60, P583, DOI 10.1007/s11103-005-5082-x; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Dresselhaus T, 2006, CURR OPIN PLANT BIOL, V9, P41, DOI 10.1016/j.pbi.2005.11.002; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; Higashiyama T, 2002, J PLANT RES, V115, P149, DOI 10.1007/s102650200020; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; LIVIUS T, AB URBE CONDITA LIBE; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Piffanelli P, 2002, PLANT PHYSIOL, V129, P1076, DOI 10.1104/pp.010954; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Sandaklie-Nikolova L, 2007, PLANT PHYSIOL, V144, P1753, DOI 10.1104/pp.107.098236; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051	30	286	312	6	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					968	971		10.1126/science.1195211	http://dx.doi.org/10.1126/science.1195211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071669				2022-12-24	WOS:000284118000044
J	Voorhees, RM; Schmeing, TM; Kelley, AC; Ramakrishnan, V				Voorhees, Rebecca M.; Schmeing, T. Martin; Kelley, Ann C.; Ramakrishnan, V.			The Mechanism for Activation of GTP Hydrolysis on the Ribosome	SCIENCE			English	Article							ELONGATION-FACTOR TU; AMINOACYL-TRANSFER-RNA; TRANSITION-STATE ANALOG; CENTER-DOT-GDP; EF-TU; CRYSTAL-STRUCTURE; BINDING DOMAIN; COMPLEX; PROTEIN; CONFORMATION	Protein synthesis requires several guanosine triphosphatase (GTPase) factors, including elongation factor Tu (EF-Tu), which delivers aminoacyl-transfer RNAs (tRNAs) to the ribosome. To understand how the ribosome triggers GTP hydrolysis in translational GTPases, we have determined the crystal structure of EF-Tu and aminoacyl-tRNA bound to the ribosome with a GTP analog, to 3.2 angstrom resolution. EF-Tu is in its active conformation, the switch I loop is ordered, and the catalytic histidine is coordinating the nucleophilic water in position for inline attack on the gamma-phosphate of GTP. This activated conformation is due to a critical and conserved interaction of the histidine with A2662 of the sarcin-ricin loop of the 23S ribosomal RNA. The structure suggests a universal mechanism for GTPase activation and hydrolysis in translational GTPases on the ribosome.	[Voorhees, Rebecca M.; Schmeing, T. Martin; Kelley, Ann C.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	martin.schmeing@mcgill.ca; ramak@mrc-lmb.cam.ac.uk		Ramakrishnan, V/0000-0002-4699-2194; VOORHEES, REBECCA/0000-0003-1640-2293	Medical Research Council UK; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Gates-Cambridge scholarship; Medical Research Council [MC_U105184332] Funding Source: researchfish; MRC [MC_U105184332] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Gates-Cambridge scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Green for reagents and D. de Sanctis at the European Synchrotron Radiation Facility for facilitating data collection. This work was supported by the Medical Research Council UK, the Wellcome Trust, the Agouron Institute, and the Louis-Jeantet Foundation. R. M. V. is supported by a Gates-Cambridge scholarship, and T. M. S. by the Human Frontier Science Program and Emmanuel College. V. R. is on the Scientific Advisory Board and holds stock options in Rib-X pharmaceuticals. Transfer of Thermus thermophilis ribosome strain T. th. HB8-MRC-MSAW1 requires a Materials Transfer Agreement with the MRC. Coordinates and structure factors have been deposited at the Protein Data Bank with accession codes 2xqd and 2xqe.	BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BILGIN N, 1994, J MOL BIOL, V235, P813, DOI 10.1006/jmbi.1994.1041; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; ECCLESTON JF, 1982, J BIOL CHEM, V257, P5046; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; HOLMBERG L, 1994, BIOCHEMISTRY-US, V33, P15159, DOI 10.1021/bi00254a027; JACQUET E, 1988, EMBO J, V7, P2861, DOI 10.1002/j.1460-2075.1988.tb03142.x; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Knudsen C, 2001, J BIOL CHEM, V276, P22183, DOI 10.1074/jbc.M102186200; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; MESTERS JR, 1994, J MOL BIOL, V242, P644, DOI 10.1006/jmbi.1994.1614; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; RAMBELLI F, 1989, BIOCHEM J, V259, P307, DOI 10.1042/bj2590307; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengupta J, 2008, J MOL BIOL, V382, P179, DOI 10.1016/j.jmb.2008.07.004; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Wieden HJ, 2001, J MOL EVOL, V52, P129, DOI 10.1007/s002390010141	33	268	273	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					835	838		10.1126/science.1194460	http://dx.doi.org/10.1126/science.1194460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051640	Green Accepted			2022-12-24	WOS:000283855700047
J	Perrings, C; Naeem, S; Ahrestani, F; Bunker, DE; Burkill, P; Canziani, G; Elmqvist, T; Ferrati, R; Fuhrman, JA; Jaksic, F; Kawabata, Z; Kinzig, A; Mace, GM; Milano, F; Mooney, H; Prieur-Richard, AH; Tschirhart, J; Weisser, W				Perrings, C.; Naeem, S.; Ahrestani, F.; Bunker, D. E.; Burkill, P.; Canziani, G.; Elmqvist, T.; Ferrati, R.; Fuhrman, J. A.; Jaksic, F.; Kawabata, Z.; Kinzig, A.; Mace, G. M.; Milano, F.; Mooney, H.; Prieur-Richard, A. -H.; Tschirhart, J.; Weisser, W.			Ecosystem Services for 2020	SCIENCE			English	Editorial Material							AGRICULTURAL SUSTAINABILITY; BIODIVERSITY INDICATORS; CHALLENGES; POLICY; SCIENCE		[Perrings, C.; Kinzig, A.] Arizona State Univ, Tempe, AZ 85287 USA; [Naeem, S.; Ahrestani, F.] Columbia Univ, New York, NY 10027 USA; [Bunker, D. E.] New Jersey Inst Technol, Newark, NJ 07102 USA; [Burkill, P.] Sir Alister Hardy Fdn Ocean Sci, Plymouth PL1 2PB, Devon, England; [Canziani, G.; Ferrati, R.; Milano, F.] Univ Nacl Ctr, Buenos Aires, DF, Argentina; [Elmqvist, T.] Stockholm Univ, SE-10691 Stockholm, Sweden; [Fuhrman, J. A.] Univ So Calif, Los Angeles, CA 90089 USA; [Jaksic, F.] Pontificia Univ Catolica Chile, Santiago, Chile; [Kawabata, Z.] Res Inst Humanity & Nat, Kyoto 6038047, Japan; [Mace, G. M.] Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; [Mooney, H.] Stanford Univ, Stanford, CA 94305 USA; [Prieur-Richard, A. -H.] Museum Natl Hist Nat, F-75231 Paris 05, France; [Tschirhart, J.] Univ Wyoming, Laramie, WY 82071 USA; [Weisser, W.] Univ Jena, D-07743 Jena, Germany	Arizona State University; Arizona State University-Tempe; Columbia University; New Jersey Institute of Technology; Comision Nacional de Energia Atomica (CNEA); Stockholm University; University of Southern California; Pontificia Universidad Catolica de Chile; Research Institute for Humanity & Nature (RIHN); Imperial College London; Stanford University; Museum National d'Histoire Naturelle (MNHN); University of Wyoming; Friedrich Schiller University of Jena	Perrings, C (corresponding author), Arizona State Univ, Tempe, AZ 85287 USA.	Charles.Perrings@asu.edu	Mace, Georgina M/I-3072-2016; Weisser, Wolfgang W/B-9718-2014; Elmqvist, Thomas/AAY-6344-2021; Ahrestani, Farshid/B-4844-2012; Fuhrman, Jed A/C-6461-2013; Jaksic, Fabian M/G-1705-2014	Mace, Georgina M/0000-0001-8965-5211; Weisser, Wolfgang W/0000-0002-2757-8959; Elmqvist, Thomas/0000-0002-4617-6197; Ahrestani, Farshid/0000-0002-0979-4359; Fuhrman, Jed A/0000-0002-2361-1985; Jaksic, Fabian M/0000-0003-0098-0291	Natural Environment Research Council [SAH01001] Funding Source: researchfish; NERC [SAH01001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bulling MT, 2010, PHILOS T R SOC B, V365, P2107, DOI 10.1098/rstb.2010.0022; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CBD (Convention on Biological Diversity), 2010, REV UPD STRAT PLAN T; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Mace GM, 2010, CURR OPIN ENV SUST, V2, P3, DOI 10.1016/j.cosust.2010.03.003; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; *MILL EC ASS, 2005, EC HUM WELL BEING GE; Mooney H, 2009, SCIENCE, V325, P1474, DOI 10.1126/science.1180935; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Secretariat of the convention on biological diversity, 2020, GLOBAL BIODIVERSITY; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	21	129	149	5	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					323	324		10.1126/science.1196431	http://dx.doi.org/10.1126/science.1196431			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947748				2022-12-24	WOS:000282986700022
J	Gravel, D; Bell, T; Barbera, C; Bouvier, T; Pommier, T; Venail, P; Mouquet, N				Gravel, Dominique; Bell, Thomas; Barbera, Claire; Bouvier, Thierry; Pommier, Thomas; Venail, Patrick; Mouquet, Nicolas			Experimental niche evolution alters the strength of the diversity-productivity relationship	NATURE			English	Article							PSEUDOMONAS-FLUORESCENS; ECOSYSTEM PRODUCTIVITY; PLANT DIVERSITY; BIODIVERSITY; GENERALISTS; ASSEMBLAGES; SPECIALISTS; RESOURCE; SERVICES; MODEL	The relationship between biodiversity and ecosystem functioning (BEF) has become a cornerstone of community and ecosystem ecology(1-3) and an essential criterion for making decisions in conservation biology and policy planning(4,5). It has recently been proposed that evolutionary history should influence the BEF relationship because it determines species traits and, thus, species' ability to exploit resources(6,7). Here we test this hypothesis by combining experimental evolution with a BEF experiment. We isolated 20 bacterial strains from a marine environment and evolved each to be generalists or specialists(8). We then tested the effect of evolutionary history on the strength of the BEF relationship with assemblages of 1 to 20 species constructed from the specialists, generalists and ancestors(9). Assemblages of generalists were more productive on average because of their superior ability to exploit the environmental heterogeneity(10). The slope of the BEF relationship was, however, stronger for the specialist assemblages because of enhanced niche complementarity. These results show how the BEF relationship depends critically on the legacy of past evolutionary events.	[Gravel, Dominique] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Gravel, Dominique; Barbera, Claire; Venail, Patrick; Mouquet, Nicolas] Univ Montpellier 2, CNRS, Inst Sci Evolut UMR 5554, F-34095 Montpellier 05, France; [Bell, Thomas] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Bouvier, Thierry; Pommier, Thomas] Univ Montpellier 2, CNRS, Ecosyst Langunaires UMR 5119, F-34095 Montpellier 05, France; [Pommier, Thomas] Univ Lyon 1, CNRS, INRA, UMR 5557,USC 1193,Lab Ecol Microbienne, F-69622 Villeurbanne, France	University of Quebec; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Gravel, D (corresponding author), Univ Quebec, Dept Biol Chim & Geog, 300 Alee Ursulines, Rimouski, PQ G5L 3A1, Canada.	dominique_gravel@uqar.qc.ca; nmouquet@univ-montp2.fr	Bouvier, Thierry/A-1895-2013; MOUQUET, Nicolas/AAL-1440-2021; Pommier, Thomas/AAR-1115-2021; Venail, Patrick/D-2968-2018	Pommier, Thomas/0000-0003-2986-5326; Venail, Patrick/0000-0003-1126-280X; Mouquet, Nicolas/0000-0003-1840-6984; Bell, Thomas/0000-0002-2615-3932; bouvier, thierry/0000-0002-7151-5680	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Program;  [ANR-09-JCJC-0110-01]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); 	We thank T. Barraclough, G. Bell, M. Loreau, R. C. MacLean and A. Paquette for comments on earlier versions of the manuscript. This work was supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada and a research grant from the Canada Research Chair Program, to D.G., and research grant ANR-09-JCJC-0110-01, to N.M.	Abrams PA, 2006, EVOLUTION, V60, P427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barrett RDH, 2005, AM NAT, V166, P470, DOI 10.1086/444440; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bell T., 2009, BIODIVERSITY ECOSYST, P121, DOI DOI 10.1093/ACPROF:OSO/9780199547951.003.0009; Bell T, 2009, AM NAT, V174, P836, DOI 10.1086/647931; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kinzig A. P., 2002, FUNCTIONAL CONSEQUEN; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; LEVINS RICHARD, 1968; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, P ROY SOC B-BIOL SCI, V268, P303, DOI 10.1098/rspb.2000.1366; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; MacLean RC, 2005, J EVOLUTION BIOL, V18, P1376, DOI 10.1111/j.1420-9101.2005.00931.x; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; Naeem S., 2009, BIODIVERSITY ECOSYST; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	38	137	139	8	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					89	U1601		10.1038/nature09592	http://dx.doi.org/10.1038/nature09592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21131946				2022-12-24	WOS:000285921600037
J	Bloomfield, G; Skelton, J; Ivens, A; Tanaka, Y; Kay, RR				Bloomfield, Gareth; Skelton, Jason; Ivens, Alasdair; Tanaka, Yoshimasa; Kay, Robert R.			Sex Determination in the Social Amoeba Dictyostelium discoideum	SCIENCE			English	Article							CELLULAR SLIME-MOLD; UNIPARENTAL INHERITANCE; MACROCYST FORMATION; MITOCHONDRIAL-DNA; POLYMORPHISM	The genetics of sex determination remain mysterious in many organisms, including some that are otherwise well studied. Here we report the discovery and analysis of the mating-type locus of the model organism Dictyostelium discoideum. Three forms of a single genetic locus specify this species' three mating types: two versions of the locus are entirely different in sequence, and the third resembles a composite of the other two. Single, unrelated genes are sufficient to determine two of the mating types, whereas homologs of both these genes are required in the composite type. The key genes encode polypeptides that possess no recognizable similarity to established protein families. Sex determination in the social amoebae thus appears to use regulators that are unrelated to any others currently known.	[Bloomfield, Gareth; Tanaka, Yoshimasa; Kay, Robert R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Bloomfield, Gareth; Skelton, Jason; Ivens, Alasdair] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Tanaka, Yoshimasa] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; University of Tsukuba	Bloomfield, G (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	garethb@mrc-lmb.cam.ac.uk		Ivens, Al/0000-0002-0112-3876; Kay, Robert R/0000-0001-9836-7967; Bloomfield, Gareth/0000-0003-4269-8059	Wellcome Trust [06724]; Medical Research Council; MRC [MC_U105115237] Funding Source: UKRI; Medical Research Council [MC_U105115237] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust grant number 06724 and core funding from the Medical Research Council. We thank the Dicty Stock Center (www.dictybase.org/StockCenter/StockCenter.html), D. Francis, H. Hagiwara, and P. Schaap for providing strains; T. Feltwell, N. Nikolaidou-Katsaridou, and K. Jagels for technical assistance; and M. Fookes, C. Carret, K. Brooks, C. Pears, N. Barry, and the members and associate members of the Dictyostelium group at the Laboratory of Molecular Biology for valuable advice and discussions. A. I. is now at Fios Genomics, ETTC, King's Buildings, Edinburgh EH9 3JL, UK. We are grateful to the U.S. Department of Energy Joint Genome Institute (www.jgi.doe.gov/) and co-workers, and to the Actyostelium Genome Consortium for making the Dictyostelium purpureum and Acytostelium subglobosum genome data available before publication. Microarray data are available under accession no. E-TABM-394 and the array design under A-SGRP-3 at www.ebi.ac.uk/arrayexpress/, and DNA sequences have been deposited in EMBL-Bank under accessions nos. FN543120 to FN543124, FN994780, FR666792, and FR666793.	BLASKOVICS JC, 1957, BIOL BULL-US, V113, P58, DOI 10.2307/1538802; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ERDOS GW, 1973, P NATL ACAD SCI USA, V70, P1828, DOI 10.1073/pnas.70.6.1828; FILOSA MF, 1972, DEV BIOL, V29, P1, DOI 10.1016/0012-1606(72)90038-3; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Hurst LD, 1996, P ROY SOC B-BIOL SCI, V263, P415, DOI 10.1098/rspb.1996.0063; KAWANO S, 1987, J GEN MICROBIOL, V133, P3175; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; MIRFAKHRAI M, 1990, GENETICS, V124, P607; Muramoto T, 2003, MECH DEVELOP, V120, P965, DOI 10.1016/S0925-4773(03)00136-9; ODAY DH, 1979, CAN J MICROBIOL, V25, P1416, DOI 10.1139/m79-221; RAPER KB, 1984, DICTYOSTELIDS, pCH9; ROBSON GE, 1979, GENETICS, V93, P861; ROBSON GE, 1980, CURR GENET, V1, P229, DOI 10.1007/BF00390948; SAGA Y, 1983, J CELL SCI, V60, P157; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Urushihara H, 2006, EUR J CELL BIOL, V85, P961, DOI 10.1016/j.ejcb.2006.05.012; WALLACE MA, 1979, J GEN MICROBIOL, V113, P327, DOI 10.1099/00221287-113-2-327; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	23	65	66	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1533	1536		10.1126/science.1197423	http://dx.doi.org/10.1126/science.1197423			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148389	Green Accepted			2022-12-24	WOS:000285153500063
J	Hoffmann, M; Hilton-Taylor, C; Angulo, A; Bohm, M; Brooks, TM; Butchart, SHM; Carpenter, KE; Chanson, J; Collen, B; Cox, NA; Darwall, WRT; Dulvy, NK; Harrison, LR; Katariya, V; Pollock, CM; Quader, S; Richman, NI; Rodrigues, ASL; Tognelli, MF; Vie, JC; Aguiar, JM; Allen, DJ; Allen, GR; Amori, G; Ananjeva, NB; Andreone, F; Andrew, P; Ortiz, ALA; Baillie, JEM; Baldi, R; Bell, BD; Biju, SD; Bird, JP; Black-Decima, P; Blanc, JJ; Bolanos, F; Bolivar, W; Burfield, IJ; Burton, JA; Capper, DR; Castro, F; Catullo, G; Cavanagh, RD; Channing, A; Chao, NL; Chenery, AM; Chiozza, F; Clausnitzer, V; Collar, NJ; Collett, LC; Collette, BB; Fernandez, CFC; Craig, MT; Crosby, MJ; Cumberlidge, N; Cuttelod, A; Derocher, AE; Diesmos, AC; Donaldson, JS; Duckworth, JW; Dutson, G; Dutta, SK; Emslie, RH; Farjon, A; Fowler, S; Freyhof, J; Garshelis, DL; Gerlach, J; Gower, DJ; Grant, TD; Hammerson, GA; Harris, RB; Heaney, LR; Hedges, SB; Hero, JM; Hughes, B; Hussain, SA; Icochea, J; Inger, RF; Ishii, N; Iskandar, DT; Jenkins, RKB; Kaneko, Y; Kottelat, M; Kovacs, KM; Kuzmin, SL; La Marca, E; Lamoreux, JF; Lau, MWN; Lavilla, EO; Leus, K; Lewison, RL; Lichtenstein, G; Livingstone, SR; Lukoschek, V; Mallon, DP; McGowan, PJK; McIvor, A; Moehlman, PD; Molur, S; Alonso, AM; Musick, JA; Nowell, K; Nussbaum, RA; Olech, W; Orlov, NL; Papenfuss, TJ; Parra-Olea, G; Perrin, WF; Polidoro, BA; Pourkazemi, M; Racey, PA; Ragle, JS; Ram, M; Rathbun, G; Reynolds, RP; Rhodin, AGJ; Richards, SJ; Rodriguez, LO; Ron, SR; Rondinini, C; Rylands, AB; de Mitcheson, YS; Sanciangco, JC; Sanders, KL; Santos-Barrera, G; Schipper, J; Self-Sullivan, C; Shi, YC; Shoemaker, A; Short, FT; Sillero-Zubiri, C; Silvano, DL; Smith, KG; Smith, AT; Snoeks, J; Stattersfield, AJ; Symes, AJ; Taber, AB; Talukdar, BK; Temple, HJ; Timmins, R; Tobias, JA; Tsytsulina, K; Tweddle, D; Ubeda, C; Valenti, SV; van Dijk, PP; Veiga, LM; Veloso, A; Wege, DC; Wilkinson, M; Williamson, EA; Xie, F; Young, BE; Akcakaya, HR; Bennun, L; Blackburn, TM; Boitani, L; Dublin, HT; da Fonseca, GAB; Gascon, C; Lacher, TE; Mace, GM; Mainka, SA; McNeely, JA; Mittermeier, RA; Reid, GM; Rodriguez, JP; Rosenberg, AA; Samways, MJ; Smart, J; Stein, BA; Stuart, SN				Hoffmann, Michael; Hilton-Taylor, Craig; Angulo, Ariadne; Boehm, Monika; Brooks, Thomas M.; Butchart, Stuart H. M.; Carpenter, Kent E.; Chanson, Janice; Collen, Ben; Cox, Neil A.; Darwall, William R. T.; Dulvy, Nicholas K.; Harrison, Lucy R.; Katariya, Vineet; Pollock, Caroline M.; Quader, Suhel; Richman, Nadia I.; Rodrigues, Ana S. L.; Tognelli, Marcelo F.; Vie, Jean-Christophe; Aguiar, John M.; Allen, David J.; Allen, Gerald R.; Amori, Giovanni; Ananjeva, Natalia B.; Andreone, Franco; Andrew, Paul; Aquino Ortiz, Aida Luz; Baillie, Jonathan E. M.; Baldi, Ricardo; Bell, Ben D.; Biju, S. D.; Bird, Jeremy P.; Black-Decima, Patricia; Blanc, J. Julian; Bolanos, Federico; Bolivar-G, Wilmar; Burfield, Ian J.; Burton, James A.; Capper, David R.; Castro, Fernando; Catullo, Gianluca; Cavanagh, Rachel D.; Channing, Alan; Chao, Ning Labbish; Chenery, Anna M.; Chiozza, Federica; Clausnitzer, Viola; Collar, Nigel J.; Collett, Leah C.; Collette, Bruce B.; Fernandez, Claudia F. Cortez; Craig, Matthew T.; Crosby, Michael J.; Cumberlidge, Neil; Cuttelod, Annabelle; Derocher, Andrew E.; Diesmos, Arvin C.; Donaldson, John S.; Duckworth, J. W.; Dutson, Guy; Dutta, S. K.; Emslie, Richard H.; Farjon, Aljos; Fowler, Sarah; Freyhof, Joerg; Garshelis, David L.; Gerlach, Justin; Gower, David J.; Grant, Tandora D.; Hammerson, Geoffrey A.; Harris, Richard B.; Heaney, Lawrence R.; Hedges, S. Blair; Hero, Jean-Marc; Hughes, Baz; Hussain, Syed Ainul; Icochea M, Javier; Inger, Robert F.; Ishii, Nobuo; Iskandar, Djoko T.; Jenkins, Richard K. B.; Kaneko, Yoshio; Kottelat, Maurice; Kovacs, Kit M.; Kuzmin, Sergius L.; La Marca, Enrique; Lamoreux, John F.; Lau, Michael W. N.; Lavilla, Esteban O.; Leus, Kristin; Lewison, Rebecca L.; Lichtenstein, Gabriela; Livingstone, Suzanne R.; Lukoschek, Vimoksalehi; Mallon, David P.; McGowan, Philip J. K.; McIvor, Anna; Moehlman, Patricia D.; Molur, Sanjay; Munoz Alonso, Antonio; Musick, John A.; Nowell, Kristin; Nussbaum, Ronald A.; Olech, Wanda; Orlov, Nikolay L.; Papenfuss, Theodore J.; Parra-Olea, Gabriela; Perrin, William F.; Polidoro, Beth A.; Pourkazemi, Mohammad; Racey, Paul A.; Ragle, James S.; Ram, Mala; Rathbun, Galen; Reynolds, Robert P.; Rhodin, Anders G. J.; Richards, Stephen J.; Rodriguez, Lily O.; Ron, Santiago R.; Rondinini, Carlo; Rylands, Anthony B.; de Mitcheson, Yvonne Sadovy; Sanciangco, Jonnell C.; Sanders, Kate L.; Santos-Barrera, Georgina; Schipper, Jan; Self-Sullivan, Caryn; Shi, Yichuan; Shoemaker, Alan; Short, Frederick T.; Sillero-Zubiri, Claudio; Silvano, Debora L.; Smith, Kevin G.; Smith, Andrew T.; Snoeks, Jos; Stattersfield, Alison J.; Symes, Andrew J.; Taber, Andrew B.; Talukdar, Bibhab K.; Temple, Helen J.; Timmins, Rob; Tobias, Joseph A.; Tsytsulina, Katerina; Tweddle, Denis; Ubeda, Carmen; Valenti, Sarah V.; van Dijk, Peter Paul; Veiga, Liza M.; Veloso, Alberto; Wege, David C.; Wilkinson, Mark; Williamson, Elizabeth A.; Xie, Feng; Young, Bruce E.; Akcakaya, H. Resit; Bennun, Leon; Blackburn, Tim M.; Boitani, Luigi; Dublin, Holly T.; da Fonseca, Gustavo A. B.; Gascon, Claude; Lacher, Thomas E., Jr.; Mace, Georgina M.; Mainka, Susan A.; McNeely, Jeffery A.; Mittermeier, Russell A.; Reid, Gordon McGregor; Paul Rodriguez, Jon; Rosenberg, Andrew A.; Samways, Michael J.; Smart, Jane; Stein, Bruce A.; Stuart, Simon N.			The Impact of Conservation on the Status of the World's Vertebrates	SCIENCE			English	Article							GLOBAL BIODIVERSITY; CLIMATE-CHANGE; EXTINCTIONS; DECLINES; BENEFITS; FUTURE; INDEX	Using data for 25,780 species categorized on the International Union for Conservation of Nature Red List, we present an assessment of the status of the world's vertebrates. One-fifth of species are classified as Threatened, and we show that this figure is increasing: On average, 52 species of mammals, birds, and amphibians move one category closer to extinction each year. However, this overall pattern conceals the impact of conservation successes, and we show that the rate of deterioration would have been at least one-fifth again as much in the absence of these. Nonetheless, current conservation efforts remain insufficient to offset the main drivers of biodiversity loss in these groups: agricultural expansion, logging, overexploitation, and invasive alien species.	[Hoffmann, Michael; Stuart, Simon N.] United Nations Environm Programme World Conservat, IUCN SSC Species Survival Commiss, Cambridge CB3 0DL, England; [Cox, Neil A.; Tognelli, Marcelo F.] Conservat Int, IUCN CI Biodivers Assessment Unit, Arlington, VA 22202 USA; [Hilton-Taylor, Craig; Darwall, William R. T.; Katariya, Vineet; Pollock, Caroline M.; Allen, David J.; Collett, Leah C.; Cuttelod, Annabelle; Shi, Yichuan; Smith, Kevin G.] IUCN, Species Programme, Cambridge CB3 0DL, England; [Angulo, Ariadne] IUCN CI Biodivers Assessment Unit, Toronto, ON M5S 1X1, Canada; [Angulo, Ariadne; Carpenter, Kent E.; Chanson, Janice; Cox, Neil A.; Tognelli, Marcelo F.; Vie, Jean-Christophe; Lamoreux, John F.; Polidoro, Beth A.; Ragle, James S.; Sanciangco, Jonnell C.] IUCN, Species Programme, CH-1196 Gland, Switzerland; [Boehm, Monika; Collen, Ben; Richman, Nadia I.; Ram, Mala; Blackburn, Tim M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Brooks, Thomas M.; Young, Bruce E.] NatureServe, Arlington, VA 22209 USA; [Brooks, Thomas M.] Univ Philippines Los Banos, World Agroforestry Ctr ICRAF, Laguna 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Butchart, Stuart H. M.; Burfield, Ian J.; Collar, Nigel J.; Crosby, Michael J.; Stattersfield, Alison J.; Symes, Andrew J.; Wege, David C.; Bennun, Leon] BirdLife Int, Cambridge CB3 0NA, England; [Carpenter, Kent E.; Polidoro, Beth A.; Sanciangco, Jonnell C.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Chanson, Janice] IUCN CI Biodivers Assessment Unit, Cheltenham, Vic 3192, Australia; [Dulvy, Nicholas K.; Harrison, Lucy R.] Simon Fraser Univ, Dept Biol Sci, IUCN Shark Specialist Grp, Burnaby, BC V5A 1S6, Canada; [Quader, Suhel] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Rodrigues, Ana S. L.] CNRS, UMR5175, Ctr Ecol Fonct & Evolut, F-34293 Montpellier, France; [Tognelli, Marcelo F.] IADIZA CONICET, CCT Mendoza, RA-5500 Mendoza, Argentina; [Aguiar, John M.; Lacher, Thomas E., Jr.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Allen, Gerald R.] Western Australian Museum, Perth, WA 6986, Australia; [Amori, Giovanni] CNR, Inst Ecosyst Studies, I-00185 Rome, Italy; [Ananjeva, Natalia B.; Orlov, Nikolay L.] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Andreone, Franco] Museo Reg Sci Nat, I-10123 Turin, Italy; [Andrew, Paul] Taronga Conservat Soc Australia, Taronga Zoo, Sydney, NSW 2088, Australia; [Baillie, Jonathan E. M.] Zool Soc London, London NW1 4RY, England; [Baldi, Ricardo] Ctr Nacl Pagagon CONICET, Unidad Invest Ecol Terrestre, RA-9120 Puerto Madryn, Argentina; [Baldi, Ricardo] Wildlife Conservat Soc, Patagonian & Andean Steppe Program, RA-9120 Puerto Madryn, Argentina; [Bell, Ben D.] Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington 6140, New Zealand; [Biju, S. D.] Univ Delhi, Sch Environm Studies, Systemat Lab, Delhi 110007, India; [Bird, Jeremy P.] Pacific Inst Sustainable Dev, Ctr Biodivers & Biosecur Studies, Manado, North Sulawesi, Indonesia; [Black-Decima, Patricia] Univ Nacl Tucuman, Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Argentina; [Black-Decima, Patricia] Univ Nacl Tucuman, Inst Miguel Lillo, RA-4000 San Miguel De Tucuman, Argentina; [Bolanos, Federico] Univ Costa Rica, Escuela Biol, San Jose 115012060, Costa Rica; [Bolivar-G, Wilmar] Univ Valle, Fac Ciencias Nat & Exactas, Dept Biol, Secc Zool, Cali, Colombia; [Burton, James A.] Earthwatch Inst, Oxford OX2 7DE, England; [Burton, James A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Castro, Fernando] Univ Valle, Lab Herpetol, Cali, Colombia; [Catullo, Gianluca] WWF Italy Specis Off, I-00198 Rome, Italy; [Cavanagh, Rachel D.] British Antarctic Survey, Cambridge CB3 0ET, England; [Channing, Alan] Univ Western Cape, Biodivers & Conservat Biol Dept, ZA-7535 Bellville, South Africa; [Chao, Ning Labbish] Bioamazonia Conservat Int, Baltimore, MD 21230 USA; [Chao, Ning Labbish] Univ Fed Amazonas, Depto Ciencias Pesqueiras, BR-60700 Manaus, Amazonas, Brazil; [Chao, Ning Labbish] Natl Museum Marine Biol & Aquarium, Checheng 944, Pingtung, Taiwan; [Chiozza, Federica; Rondinini, Carlo; Boitani, Luigi] Univ Roma La Sapienza, Dept Anim & Human Biol, I-00185 Rome, Italy; [Clausnitzer, Viola] Senckenberg Museum Nat Hist Goerlitz, D-02806 Goerlitz, Germany; [Collette, Bruce B.] Smithsonian Inst, Natl Museum Nat Hist, Natl Marine Fisheries Serv Systemat Lab, Washington, DC 20013 USA; [Craig, Matthew T.] Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00681 USA; [Cumberlidge, Neil] Univ Michigan, Dept Biol, Marquette, MI 49855 USA; [Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Diesmos, Arvin C.] Natl Museum Philippines, Div Zool, Herpetol Sect, Manila 1000, Philippines; [Donaldson, John S.] S African Natl Biodivers Inst, KRC, ZA-7735 Claremont, South Africa; [Dutson, Guy] Birds Australia, Carlton, Vic 3053, Australia; [Dutta, S. K.] N Orissa Univ, Mayurbhanj 757003, Orissa, India; [Emslie, Richard H.] IUCN SSC African Rhino Specialist Grp, ZA-3245 Hilton, South Africa; [Farjon, Aljos] Royal Bot Gardens, Herbarium Lib Art & Arch, Richmond TW9 3AB, Surrey, England; [Fowler, Sarah; Valenti, Sarah V.] NatureBur, Newbury RG14 5SJ, Berks, England; [Freyhof, Joerg] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Garshelis, David L.] Minnesota Dept Nat Resources, Grand Rapids, MN 55744 USA; [Gerlach, Justin] Nat Protect Trust Seychelles, Cambridge CB1 7BX, England; [Gower, David J.; Wilkinson, Mark] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Grant, Tandora D.] San Diego Zoo Inst Conservat Res, Escondido, CA 92027 USA; [Hammerson, Geoffrey A.] NatureServe, Port Townsend, WA 98368 USA; [Harris, Richard B.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Heaney, Lawrence R.; Inger, Robert F.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Hedges, S. Blair] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hero, Jean-Marc] Griffith Univ, Sch Environm, Environm Futures Ctr, Griffith, Qld 4222, Australia; [Hughes, Baz] Wildfowl & Wetlands Trust, Slimbridge GL2 7BT, Glos, England; [Hussain, Syed Ainul] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Ishii, Nobuo] Tokyo Womans Christian Univ, Sch Arts & Sci, Suginami Ku, Tokyo 1678585, Japan; [Iskandar, Djoko T.] Inst Teknol Bandung, Sch Life Sci & Technol, Bandung 40132, Indonesia; [Jenkins, Richard K. B.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England; [Jenkins, Richard K. B.] Bangor Univ, Sch Environm & Nat Resources, Bangor LL57 2UW, Gwynedd, Wales; [Jenkins, Richard K. B.] Madagasikara Voakajy, Antananarivo 101, Madagascar; [Kaneko, Yoshio] Iwate Prefectural Univ, Takizawa, Iwate 0200193, Japan; [Kottelat, Maurice] Natl Univ Singapore, Dept Biol Sci, Raffles Museum Biodivers Res, Singapore 117546, Singapore; [Kovacs, Kit M.] Norwegian Polar Res Inst, N-9296 Tromso, Norway; [Kuzmin, Sergius L.] Russian Acad Sci, Inst Ecol & Evolut, Moscow 119071, Russia; [La Marca, Enrique] Univ Los Andes, Escuela Geog, Lab Biogeog, Merida 5101, Venezuela; [Lamoreux, John F.] IUCN Species Programme, Randolph, NH 03593 USA; [Lau, Michael W. N.] Kadoorie Farm & Bot Garden, Tai Po, Hong Kong, Peoples R China; [Lavilla, Esteban O.] Fdn Miguel Lillo CONICET, Inst Herpetol, RA-4000 San Miguel De Tucuman, Argentina; [Leus, Kristin] European Reg Off, Conservat Breeding Specialist Grp, B-2170 Merksem, Belgium; [Lewison, Rebecca L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Lichtenstein, Gabriela] Inst Nacl Antropol & Pensamiento Latinoamer, RA-1426 Buenos Aires, DF, Argentina; [Livingstone, Suzanne R.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Lukoschek, Vimoksalehi] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Lukoschek, Vimoksalehi] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Mallon, David P.] Manchester Metropolitan Univ, Dept Biol Chem & Hlth Sci, Manchester M1 5GD, Lancs, England; [McGowan, Philip J. K.] Newcastle Univ, Biol Field Stn, World Pheasant Assoc, Newcastle Upon Tyne NE15 0HT, Tyne & Wear, England; [Moehlman, Patricia D.] Wildlife Trust Alliance, Arusha, Tanzania; [Molur, Sanjay] Zoo Outreach Org, Coimbatore 641004, Tamil Nadu, India; [Munoz Alonso, Antonio] Colegio Frontera Sur, San Cristobal Las Casas 29290, Chiapas, Mexico; [Musick, John A.] Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Nowell, Kristin] CAT, Cape Neddick, ME 03902 USA; [Nussbaum, Ronald A.] Univ Michigan, Museum Zool, Div Reptiles & Amphibians, Ann Arbor, MI 48109 USA; [Olech, Wanda] Warsaw Univ Life Sci, PL-02786 Warsaw, Poland; [Papenfuss, Theodore J.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Parra-Olea, Gabriela] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Perrin, William F.] NOAA, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Pourkazemi, Mohammad] Int Sturgeon Res Inst, Rasht, Iran; [Racey, Paul A.] Univ Exeter Cornwall, Ctr Ecol & Conservat, Penryn TR10 9EZ, England; [Rathbun, Galen] Calif Acad Sci San Francisco, Dept Ornithol & Mammal, Cambria, CA 93428 USA; [Reynolds, Robert P.] Smithsonian Inst, Natl Museum Nat Hist, Patuxent Wildlife Res Ctr, USGS, Washington, DC 20013 USA; [Rhodin, Anders G. J.] Chelonian Res Fdn, Lunenburg, MA 01462 USA; [Richards, Stephen J.] S Australian Museum, Herpetol Dept, Adelaide, SA 5000, Australia; [Richards, Stephen J.] Conservat Int, Rapid Assessment Program, Atherton, Qld 4883, Australia; [Rodriguez, Lily O.] German Tech Cooperat GmbH, Lima 27, Peru; [Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador; [de Mitcheson, Yvonne Sadovy] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [de Mitcheson, Yvonne Sadovy] Soc Conservat Reef Fish Aggregat, San Diego, CA 92126 USA; [Sanders, Kate L.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Santos-Barrera, Georgina] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Evolut Biol, Mexico City 04510, DF, Mexico; [Schipper, Jan] Univ Hawaii, Pacific Cooperat Studies Unit, Big Isl Invas Species Comm, Hilo, HI 96720 USA; [Self-Sullivan, Caryn] Sirenian Int, Fredericksburg, VA 22401 USA; [Self-Sullivan, Caryn] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA; [Shoemaker, Alan] IUCN SSC Tapir Specialist Grp, Columbia, SC 29210 USA; [Short, Frederick T.] Univ New Hampshire, Jackson Estuarine Lab, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Sillero-Zubiri, Claudio] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney OX13 5QL, England; [Silvano, Debora L.] Univ Catolica Brasilia, Zool Lab, BR-71966700 Taguatinga, DF, Brazil; [Smith, Andrew T.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Snoeks, Jos] Royal Museum Cent Africa, B-3080 Tervuren, Belgium; [Snoeks, Jos] Katholieke Univ Leuven, Lab Anim Div & Systemat, B-3000 Louvain, Belgium; [Taber, Andrew B.] Jalan CIFOR, Ctr Int Forestry Res, Situ Gede 16115, Bogor Barat, Indonesia; [Talukdar, Bibhab K.] Aaranyak & Int Rhino Fdn, Gauhati 781028, Assam, India; [Temple, Helen J.] Biodivers Consultancy Ltd, Cambridge CB2 9LJ, England; [Tobias, Joseph A.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Tsytsulina, Katerina] Natl Inst Biol Resources, Vertebrate Res Div, Inchon 404708, South Korea; [Tweddle, Denis] S African Inst Aquat Biodivers, ZA-6140 Grahamstown, South Africa; [Ubeda, Carmen] Univ Nacl Comahue, Ctr Reg Univ Bariloche, Dept Zool, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Veiga, Liza M.] Museu Paraense Emilio Goeldi, BR-66017970 Belem, Para, Brazil; [Veiga, Liza M.] Fed Univ Para, BR-66075110 Belem, Para, Brazil; [Veloso, Alberto] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Williamson, Elizabeth A.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Xie, Feng] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Peoples R China; [Akcakaya, H. Resit] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Dublin, Holly T.] IUCN ESARO, African Elephant Specialist Grp, IUCN SSC, Nairobi 00200, Kenya; [Dublin, Holly T.] Wildlife Conservat Soc, Bronx, NY 10460 USA; [da Fonseca, Gustavo A. B.] Global Environm Facil, Washington, DC 20433 USA; [da Fonseca, Gustavo A. B.] Univ Fed Minas Gerais, Dept Zool, BR-31270901 Belo Horizonte, MG, Brazil; [Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Mainka, Susan A.; McNeely, Jeffery A.; Mittermeier, Russell A.; Smart, Jane] IUCN, CH-1196 Gland, Switzerland; [Reid, Gordon McGregor] N England Zool Soc, Chester Zoo, Chester CH2 1LH, Cheshire, England; [Paul Rodriguez, Jon] Inst Venezolano Invest Cient, Ctr Ecol, Caracas 1020A, Venezuela; [Samways, Michael J.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7602 Matieland, South Africa; [Stein, Bruce A.] Natl Wildlife Federat, Washington, DC 20004 USA; [Stuart, Simon N.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Stuart, Simon N.] Al Ain Wildlife Pk & Resort, Abu Dhabi, U Arab Emirates	Conservation International; Zoological Society of London; Nature Conservancy; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of Tasmania; BirdLife International; Old Dominion University; Simon Fraser University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Texas A&M University System; Texas A&M University College Station; Western Australian Museum; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR); Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Zoological Society of London; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Victoria University Wellington; University of Delhi; Universidad Nacional de Tucuman; Miguel Lillo Foundation; Universidad Nacional de Tucuman; Universidad Costa Rica; Universidad del Valle; University of Edinburgh; Universidad del Valle; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of the Western Cape; Universidade Federal de Amazonas; National Museum of Marine Biology & Aquarium; Sapienza University Rome; Senckenberg Gesellschaft fur Naturforschung (SGN); National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Michigan System; University of Michigan; University of Alberta; National Museum of the Philippines; South African National Biodiversity Institute; Royal Botanic Gardens, Kew; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Natural History Museum London; Zoological Society of San Diego; University of Montana System; University of Montana; Field Museum of Natural History (Chicago); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Griffith University; Wildlife Institute of India; Institute Technology of Bandung; University of Kent; Bangor University; Iwate Prefectural University; National University of Singapore; Norwegian Polar Institute; Russian Academy of Sciences; University of Los Andes Venezuela; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; California State University System; San Diego State University; University of Glasgow; University of California System; University of California Irvine; James Cook University; Manchester Metropolitan University; Newcastle University - UK; El Colegio de la Frontera Sur (ECOSUR); William & Mary; Virginia Institute of Marine Science; University of Michigan System; University of Michigan; Warsaw University of Life Sciences; University of California System; University of California Berkeley; Universidad Nacional Autonoma de Mexico; National Oceanic Atmospheric Admin (NOAA) - USA; University of Exeter; California Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey; Pontificia Universidad Catolica del Ecuador; University of Hong Kong; University of Adelaide; Universidad Nacional Autonoma de Mexico; University of Hawaii System; University Hawaii Hilo; University System of Georgia; Georgia Southern University; University System Of New Hampshire; University of New Hampshire; University of Oxford; Universidade Catolica de Brasilia; Arizona State University; Arizona State University-Tempe; Royal Museum for Central Africa; KU Leuven; CGIAR; Center for International Forestry Research (CIFOR); University of Oxford; National Institute of Biological Resources; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Universidad Nacional del Comahue; Museu Paraense Emilio Goeldi; Universidade Federal do Para; Universidad de Chile; University of Stirling; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Wildlife Conservation Society; Universidade Federal de Minas Gerais; Imperial College London; Venezuelan Institute Science Research; Stellenbosch University; University of Bath	Hoffmann, M (corresponding author), United Nations Environm Programme World Conservat, IUCN SSC Species Survival Commiss, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	mike.hoffmann@iucn.org	Orlov, Nikolai/AAF-4316-2021; Veiga, Liza/C-6667-2009; Collette, Bruce B./AAA-9532-2019; Alonso, Luis Antonio Muñoz/V-7652-2019; Blackburn, Tim M/A-7685-2011; Rinaldi2, Carlos/D-4479-2011; Tognelli, Marcelo/L-3958-2019; Silvano, Débora/H-4235-2012; Wilkinson, Mark/J-2026-2014; Ron, Santiago/J-4203-2019; ANDREONE, FRANCO/H-4942-2012; Donaldson, John/F-6833-2011; Hu, Lile/E-7961-2015; Rondinini, Carlo/E-9027-2011; Rodrigues, Ana/GYQ-6273-2022; Self-Sullivan, Caryn/H-2605-2012; Ananjeva, Natalia/AAF-4308-2021; Iskasndar, Djoko/AAD-2204-2021; Olech, Wanda/AAB-5072-2022; Rodriguez, Jon P/G-7224-2012; Derocher, Andrew/J-4469-2012; Sanders, Kate L/D-1507-2019; Lobo, Diele/I-9106-2012; Blackburn, Tim/AAC-3144-2019; Williamson, Elizabeth/N-8958-2019; Williamson, Elizabeth/B-9090-2011; Dulvy, Nicholas/I-2895-2012; Rodriguez, Jon P/A-1491-2009; Butchart, Stuart/AAJ-1852-2021; Collen, Ben/D-5055-2011; Diesmos, Arvin C./AGG-8542-2022; Mace, Georgina M/I-3072-2016; Böhm, Michael/C-3638-2011; Collen, Ben/F-2543-2016; Stein, Bruce/S-5283-2019; Rodrigues, Ana S.L./A-5914-2009; Pourkazemi, Mohammad/C-9510-2017; Lukoschek, vimoksalehi/C-6126-2013; Williamson, Elizabeth/E-4727-2016; Akcakaya, H. Resit/A-7830-2008; Harrison, Lucy/F-9494-2011; Cumberlidge, Neil/I-4044-2019; Butchart, Stuart HM/Y-2711-2018; Jenkins, Richard KB/A-4567-2012; Hoffmann, Michael/E-6419-2010; Böhm, Monika/E-1153-2018; Schipper, Jan/N-5266-2015	Alonso, Luis Antonio Muñoz/0000-0002-0225-0332; Tognelli, Marcelo/0000-0002-9761-4505; Silvano, Débora/0000-0001-7349-5962; Wilkinson, Mark/0000-0002-9459-8976; Ron, Santiago/0000-0001-6300-9350; ANDREONE, FRANCO/0000-0001-9809-5818; Donaldson, John/0000-0002-7930-1695; Self-Sullivan, Caryn/0000-0003-0785-3682; Iskasndar, Djoko/0000-0002-8923-6081; Olech, Wanda/0000-0002-6166-3954; Derocher, Andrew/0000-0002-1104-7774; Sanders, Kate L/0000-0002-9581-268X; Blackburn, Tim/0000-0003-0152-2663; Williamson, Elizabeth/0000-0001-6848-9154; Dulvy, Nicholas/0000-0002-4295-9725; Rodriguez, Jon P/0000-0001-5019-2870; Butchart, Stuart/0000-0002-1140-4049; Mace, Georgina M/0000-0001-8965-5211; Collen, Ben/0000-0003-2564-4243; Rodrigues, Ana S.L./0000-0003-4775-0127; Pourkazemi, Mohammad/0000-0002-0496-8049; Lukoschek, vimoksalehi/0000-0002-0268-3808; Williamson, Elizabeth/0000-0001-6848-9154; Akcakaya, H. Resit/0000-0002-8679-5929; Hoffmann, Michael/0000-0003-4785-2254; Böhm, Monika/0000-0003-0585-0832; Lichtenstein, Gabriela/0000-0002-1717-0941; Brooks, Thomas/0000-0001-8159-3116; Blanc, Julian/0000-0003-4331-5339; Lavilla, Esteban Orlando/0000-0001-7024-3049; Rondinini, Carlo/0000-0002-6617-018X; Ragle, James/0000-0002-5829-3745; Tobias, Joseph/0000-0003-2429-6179; Gerlach, Justin/0000-0002-0157-0449; Sanciangco, Jonnell Cueto/0000-0001-8268-3180; Richman, Nadia/0000-0003-4072-1622; Ubeda, Carmen/0000-0001-8962-4001; CASTRO HERRERA, FERNANDO/0000-0002-7626-0103; Samways, Michael J./0000-0003-4237-6025; Schipper, Jan/0000-0002-8338-7874; Molur, Sanjay/0000-0001-8230-518X	Division Of Environmental Biology [0818798] Funding Source: National Science Foundation; NERC [cpb010001, bas0100025] Funding Source: UKRI; Natural Environment Research Council [cpb010001, bas0100025] Funding Source: researchfish	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Brooke MD, 2008, CONSERV BIOL, V22, P417, DOI 10.1111/j.1523-1739.2008.00905.x; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; C?lix M., 2018, EUROPEAN RED LIST SA; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CDB, 2002, CONTRIBUTION 6 NATL; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Cooper John, 2006, Marine Ornithology, V34, P1; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Dulvy NK, 2006, CAN J FISH AQUAT SCI, V63, P1267, DOI 10.1139/F06-035; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; GASCON C, 2007, AMPHIBIAN CONSERVATI; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, SCIENCE, V313, P1051, DOI 10.1126/science.1131302; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; TEEB, 2008, EC ECOSYSTEMS BIODIV; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	41	930	988	22	1015	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1503	1509		10.1126/science.1194442	http://dx.doi.org/10.1126/science.1194442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	20978281	Green Submitted			2022-12-24	WOS:000285153500055
J	Nishiyama, T; Ladurner, R; Schmitz, J; Kreidl, E; Schleiffer, A; Bhaskara, V; Bando, M; Shirahige, K; Hyman, AA; Mechtler, K; Peters, JM				Nishiyama, Tomoko; Ladurner, Rene; Schmitz, Julia; Kreidl, Emanuel; Schleiffer, Alexander; Bhaskara, Venugopal; Bando, Masashige; Shirahige, Katsuhiko; Hyman, Anthony A.; Mechtler, Karl; Peters, Jan-Michael			Sororin Mediates Sister Chromatid Cohesion by Antagonizing Wapl	CELL			English	Article							DNA-REPLICATION; COMPLEX; ESTABLISHMENT; ACETYLATION; DROSOPHILA; ANAPHASE; PROTEIN; ROLES; PROPHASE; BINDING	Sister chromatid cohesion is essential for chromosome segregation and is mediated by cohesin bound to DNA. Cohesin-DNA interactions can be reversed by the cohesion-associated protein Wapl, whereas a stably DNA-bound form of cohesin is thought to mediate cohesion. In vertebrates, Sororin is essential for cohesion and stable cohesin-DNA interactions, but how Sororin performs these functions is unknown. We show that DNA replication and cohesin acetylation promote binding of Sororin to cohesin, and that Sororin displaces Wapl from its binding partner Pds5. In the absence of Wapl, Sororin becomes dispensable for cohesion. We propose that Sororin maintains cohesion by inhibiting Wapl's ability to dissociate cohesin from DNA. Sororin has only been identified in vertebrates, but we show that many invertebrate species contain Sororin-related proteins, and that one of these, Dalmatian, is essential for cohesion in Drosophila. The mechanism we describe here may therefore be widely conserved among different species.	[Nishiyama, Tomoko; Ladurner, Rene; Schmitz, Julia; Kreidl, Emanuel; Schleiffer, Alexander; Bhaskara, Venugopal; Mechtler, Karl; Peters, Jan-Michael] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Bando, Masashige; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Tokyo; Max Planck Society	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	peters@imp.univie.ac.at	Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Mechtler, Karl/AAF-2717-2019	Hyman, Anthony A/0000-0003-3664-154X; Mechtler, Karl/0000-0002-3392-9946; Kreidl, Emanuel/0000-0002-4037-5881; Ladurner, Rene/0000-0001-9261-7304; Schleiffer, Alexander/0000-0001-6251-2747; Shirahige, Katsuhiko/0000-0002-7862-1144; Bhaskara, Venugopal/0000-0002-8807-3292; /0000-0002-8002-9967	European Molecular Biology Organization (EMBO); Japanese Society for the Promotion of Science (JSPS); Boehringer Ingelheim; Austrian Science Fund [F34-B03]; EC	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund(Austrian Science Fund (FWF)); EC(European CommissionEuropean Commission Joint Research Centre)	We are grateful to O. Hudecz, P. Huis in't Veld, I. Poser, and M. Sykora for assistance and reagents; to G. Karpen, J. Knoblich, C. Lehner, and C. Sunkel for reagents and advice on Drosophila experiments; and to N. Kraut for BI 2536. T.N. is supported by the European Molecular Biology Organization (EMBO) and the Japanese Society for the Promotion of Science (JSPS). K.S. is supported by Grant-in-Aid for Scientific Research (S). Research in the groups of J.-M.P. and K.M. is supported by Boehringer Ingelheim and the Austrian Science Fund via the special research program "Chromosome Dynamics'' (F34-B03). Work in the groups of J.-M.P., K.M., and A.A.H. was also supported by the EC via the Integrated Project "MitoCheck.''	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Diaz-Martinez LA, 2007, CELL CYCLE, V6, P714, DOI 10.4161/cc.6.6.3935; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Prokopenko SN, 2000, GENETICS, V156, P1691; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Sakuno T, 2009, CHROMOSOME RES, V17, P239, DOI 10.1007/s10577-008-9013-y; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	29	246	259	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					737	749		10.1016/j.cell.2010.10.031	http://dx.doi.org/10.1016/j.cell.2010.10.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111234	Bronze			2022-12-24	WOS:000284583500016
J	Carvalho, P; Stanley, AM; Rapoport, TA				Carvalho, Pedro; Stanley, Ann Marie; Rapoport, Tom A.			Retrotranslocation of a Misfolded Luminal ER Protein by the Ubiquitin-Ligase Hrd1p	CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; AAA-ATPASE; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; RETRO-TRANSLOCATION; COMPLEX; GLYCOPROTEINS; DISLOCATION	Misfolded, luminal endoplasmic reticulum (ER) proteins are retrotranslocated into the cytosol and degraded by the ubiquitin/proteasome system. This ERAD-L pathway requires a protein complex consisting of the ubiquitin ligase Hrd1p, which spans the ER membrane multiple times, and the membrane proteins Hrd3p, Usa1p, and Der1p. Here, we show that Hrd1p is the central membrane component in ERAD-L; its overexpression bypasses the need for the other components of the Hrd1p complex. Hrd1p function requires its oligomerization, which in wildtype cells is facilitated by Usa1p. Site-specific photo-crosslinking indicates that, at early stages of retro-translocation, Hrd1p interacts with a substrate segment close to the degradation signal. This interaction follows the delivery of substrate through other ERAD components, requires the presence of transmembrane segments of Hrd1p, and depends on both the ubiquitin ligase activity of Hrd1p and the function of the Cdc48p ATPase complex. Our results suggest a model for how Hrd1p promotes polypeptide movement through the ER membrane.	[Carvalho, Pedro; Stanley, Ann Marie; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Carvalho, Pedro; Stanley, Ann Marie; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Carvalho, P (corresponding author), CRG, Dept Cell & Dev Biol, Dr Aiguader 88, Barcelona 08003, Spain.	pedro.carvalho@crg.es; tom_rapoport@hms.harvard.edu	Carvalho, Pedro/HHN-1424-2022	Carvalho, Pedro/0000-0002-9691-5277	Jane Coffin Child Memorial fund; Ruth L. Kirschstein National Research Service Award; NIH [GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	Jane Coffin Child Memorial fund; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Hampton, D. Ng, D. Pellman, P. Schultz, J. Weissman, and Y. Ye for reagents. We thank D. Pellman, Y. Ye, A. Stein, and D. Finley for critical reading of the manuscript. P.C. was supported by the Jane Coffin Child Memorial fund and is currently a special fellow of the Leukemia and Lymphoma Society, and A.M.S. is supported by a Ruth L. Kirschstein National Research Service Award postdoctoral fellowship. T.A.R. is supported by NIH grant GM052586 and is a Howard Hughes Medical Institute Investigator.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Plemper RK, 1999, J CELL SCI, V112, P4123; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	47	217	225	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 12	2010	143	4					579	591		10.1016/j.cell.2010.10.028	http://dx.doi.org/10.1016/j.cell.2010.10.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074049	Green Accepted, Bronze			2022-12-24	WOS:000284149100015
J	Tsukagoshi, H; Busch, W; Benfey, PN				Tsukagoshi, Hironaka; Busch, Wolfgang; Benfey, Philip N.			Transcriptional Regulation of ROS Controls Transition from Proliferation to Differentiation in the Root	CELL			English	Article							REACTIVE OXYGEN; ARABIDOPSIS ROOT; HYDROGEN-PEROXIDE; CELL-DIVISION; THIOREDOXIN; SUPEROXIDE; EXPRESSION; OXIDASE; INTERPLAY; PATHWAY	The balance between cellular proliferation and differentiation is a key aspect of development in multicellular organisms. Using high-resolution expression data from the Arabidopsis root, we identified a transcription factor, UPBEAT1 (UPB1), that regulates this balance. Genomewide expression profiling coupled with ChIP-chip analysis revealed that UPB1 directly regulates the expression of a set of peroxidases that modulate the balance of reactive oxygen species (ROS) between the zones of cell proliferation and the zone of cell elongation where differentiation begins. Disruption of UPB1 activity alters this ROS balance, leading to a delay in the onset of differentiation. Modulation of either ROS balance or peroxidase activity through chemical reagents affects the onset of differentiation in a manner consistent with the postulated UPB1 function. This pathway functions independently of auxin and cytokinin plant hormonal signaling. Comparison to ROS-regulated growth control in animals suggests that a similar mechanism is used in plants and animals.	[Tsukagoshi, Hironaka; Busch, Wolfgang; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Tsukagoshi, Hironaka; Busch, Wolfgang; Benfey, Philip N.] Duke Univ, Inst Genome Sci, Durham, NC 27708 USA; [Tsukagoshi, Hironaka; Busch, Wolfgang; Benfey, Philip N.] Duke Univ, Policy Ctr Syst Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Busch, Wolfgang/B-8593-2008; Tsukagoshi, Hironaka/D-5832-2018	Busch, Wolfgang/0000-0003-2042-7290; Tsukagoshi, Hironaka/0000-0003-0058-4926	NSF; JSPS	NSF(National Science Foundation (NSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the NSF Arabidopsis 2010 program. H.T. was supported by a JSPS Postdoctoral Fellowship for Research Abroad. We thank H. Cui for advice on ChIP-chip; R. Mittler for the apx1 mutant; M.A. Torres for AtrbohC, D, and F mutants; K.D. Birnbaum, Y. Helariutta, Y. Tada, X. Dong, and B. Scheres for comments on the manuscript; and members of the Benfey laboratory for discussions and advice. P.N.B. is a founder and CEO of GrassRoots Biotechnology.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Barcelo AR, 1997, INT REV CYTOL, V176, P87, DOI 10.1016/S0074-7696(08)61609-5; Bashandy T, 2010, PLANT CELL, V22, P376, DOI 10.1105/tpc.109.071225; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Bestwick CS, 1997, PLANT CELL, V9, P209, DOI 10.1105/tpc.9.2.209; BIELSKI BHJ, 1980, J PHYS CHEM-US, V84, P830, DOI 10.1021/j100445a006; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; BROUWER KS, 1986, PLANT PHYSIOL, V82, P236, DOI 10.1104/pp.82.1.236; Burch PM, 2005, ANTIOXID REDOX SIGN, V7, P741, DOI 10.1089/ars.2005.7.741; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Caliskan M, 1998, PLANT J, V15, P165, DOI 10.1046/j.1365-313X.1998.00191.x; CHEN GX, 1989, PLANT CELL PHYSIOL, V30, P987; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; FEDERICO R, 1986, PLANTA, V167, P300, DOI 10.1007/BF00391430; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Maeda H, 2008, ANN NY ACAD SCI, V1130, P149, DOI 10.1196/annals.1430.012; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Owusu-Ansah E., 2008, NATURE PROTOCOLS, DOI [10.1038/nprot.2008.23, DOI 10.1038/NPROT.2008.23]; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Passardi F, 2006, PLANTA, V223, P965, DOI 10.1007/s00425-005-0153-4; Pitzschke A, 2006, ANTIOXID REDOX SIGN, V8, P1757, DOI 10.1089/ars.2006.8.1757; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Tognolli M, 2002, GENE, V288, P129, DOI 10.1016/S0378-1119(02)00465-1; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Ubeda-Tomas S, 2009, CURR BIOL, V19, P1194, DOI 10.1016/j.cub.2009.06.023; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019	41	645	679	7	183	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					606	616		10.1016/j.cell.2010.10.020	http://dx.doi.org/10.1016/j.cell.2010.10.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074051	Bronze			2022-12-24	WOS:000284149100017
J	Joesch, M; Schnell, B; Raghu, SV; Reiff, DF; Borst, A				Joesch, Maximilian; Schnell, Bettina; Raghu, Shamprasad Varija; Reiff, Dierk F.; Borst, Alexander			ON and OFF pathways in Drosophila motion vision	NATURE			English	Article							OPTIC LOBE; VISUAL INTERNEURONS; RESPONSE PROPERTIES; WILD-TYPE; MELANOGASTER; EXPRESSION; MEDULLA; CHANNEL; NEURONS; SYSTEM	Motion vision is a major function of all visual systems, yet the underlying neural mechanisms and circuits are still elusive. In the lamina, the first optic neuropile of Drosophila melanogaster, photoreceptor signals split into five parallel pathways, L1-L5(1). Here we examine how these pathways contribute to visual motion detection by combining genetic block and reconstitution of neural activity in different lamina cell types with whole-cell recordings from downstream motion-sensitive neurons(2,3). We find reduced responses to moving gratings if L1 or L2 is blocked; however, reconstitution of photoreceptor input to only L1 or L2 results in wild-type responses. Thus, the first experiment indicates the necessity of both pathways, whereas the second indicates sufficiency of each single pathway. This contradiction can be explained by electrical coupling between L1 and L2, allowing for activation of both pathways even when only one of them receives photoreceptor input. A fundamental difference between the L1 pathway and the L2 pathway is uncovered when blocking L1 or L2 output while presenting moving edges of positive (ON) or negative (OFF) contrast polarity: blocking L1 eliminates the response to moving ON edges, whereas blocking L2 eliminates the response to moving OFF edges. Thus, similar to the segregation of photoreceptor signals in ON and OFF bipolar cell pathways in the vertebrate retina(4), photoreceptor signals segregate into ON-L1 and OFF-L2 channels in the lamina of Drosophila.	[Joesch, Maximilian; Schnell, Bettina; Raghu, Shamprasad Varija; Reiff, Dierk F.; Borst, Alexander] MPI Neurobiol, Dept Syst & Computat Neurobiol, D-82152 Martinsried, Germany		Borst, A (corresponding author), MPI Neurobiol, Dept Syst & Computat Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	borst@neuro.mpg.de	Raghu, Shamprasad Varija/AAV-3044-2020	Schnell, Bettina/0000-0001-7700-2600; Joesch, Maximilian/0000-0002-3937-1330				BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BRAND AH, 1993, DEVELOPMENT, V118, P401; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Haag J, 2005, J COMP PHYSIOL A, V191, P445, DOI 10.1007/s00359-005-0605-0; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Johns DC, 1999, J NEUROSCI, V19, P1691; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Reichardt W, 1961, SENS COMMUN, P303; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	30	215	216	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					300	U186		10.1038/nature09545	http://dx.doi.org/10.1038/nature09545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068841				2022-12-24	WOS:000284051000050
J	Yi, CQ; Jia, GF; Hou, GH; Dai, Q; Zhang, W; Zheng, GQ; Jian, X; Yang, CG; Cui, QA; He, CA				Yi, Chengqi; Jia, Guifang; Hou, Guanhua; Dai, Qing; Zhang, Wen; Zheng, Guanqun; Jian, Xing; Yang, Cai-Guang; Cui, Qiang; He, Chuan			Iron-catalysed oxidation intermediates captured in a DNA repair dioxygenase	NATURE			English	Article							BASE-EXCISION-REPAIR; CRYSTAL-STRUCTURES; ALKB PROTEIN; FTO GENE; DEMETHYLATION; 3-METHYLTHYMINE; RECOGNITION; BACTERIAL; LESIONS; DAMAGE	Mononuclear iron-containing oxygenases conduct a diverse variety of oxidationfunctions in biology(1,2), includingthe oxidative demethylation of methylated nucleic acids and histones(3,4). Escherichia coli AlkB is the first such enzyme that was discovered to repair methylated nucleic acids(5,6), which are otherwise cytotoxic and/or mutagenic. AlkB human homologues are known to play pivotal roles in various processes(7-11). Here we present structural characterization of oxidation intermediates for these demethylases. Using a chemical cross-linking strategy(12,13), complexes of AlkB-double stranded DNA (dsDNA) containing 1,N-6-etheno adenine (epsilon A), N-3-methyl thymine (3-meT) and N-3-methyl cytosine (3-meC) are stabilized and crystallized, respectively. Exposing these crystals, grown under anaerobic conditions containing iron(II) and alpha-ketoglutarate (alpha KG), to dioxygen initiates oxidation in crystallo. Glycol (from epsilon A) and hemiaminal (from 3-meT) intermediates are captured; a zwitterionic intermediate (from 3-meC) is also proposed, based on crystallographic observations and computational analysis. The observation of these unprecedented intermediates provides direct support for the oxidative demethylation mechanism for these demethylases. This study also depicts a general mechanistic view of how a methyl group is oxidatively removed from different biological substrates.	[Yi, Chengqi; Jia, Guifang; Zhang, Wen; Zheng, Guanqun; Jian, Xing; Yang, Cai-Guang; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yi, Chengqi; Jia, Guifang; Zhang, Wen; Zheng, Guanqun; Jian, Xing; Yang, Cai-Guang; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Hou, Guanhua; Cui, Qiang] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Hou, Guanhua; Cui, Qiang] Univ Wisconsin, Inst Theoret Chem, Madison, WI 53706 USA; [Dai, Qing] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Yang, Cai-Guang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Chicago; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	He, CA (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Jian, Xing/N-3753-2018; Dai, Qing/ABD-8444-2021	Jian, Xing/0000-0002-0043-8729; Yi, Chengqi/0000-0003-2540-9729	National Institutes of Health [GM071440, GM084028]; Advanced Photon Source at Argonne National Laboratory; United States Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084028, R01GM071440] Funding Source: NIH RePORTER; Division Of Chemistry [0840494] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced Photon Source at Argonne National Laboratory; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the National Institutes of Health (GM071440 to C.H.; GM084028 to Q.C.), beamlines 23ID-B (General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT)), 19BM-D (Structual Biology Center (SBC-CAT)), 14BM-C (BioCARS) and 21ID-D (Life Sciences Collaborative Access Team (LS-CAT)) at the Advanced Photon Source at Argonne National Laboratory, the National Institutes of Health and the United States Department of Energy. Computational resources from the National Center for Supercomputing Applications at the University of Illinois and the Center of High Throughput Computing at UW-Madison are appreciated. We also thank X. Yang, Z. Ren and E. Duguid for crystallographic discussions.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burzlaff NI, 1999, NATURE, V401, P721, DOI 10.1038/44400; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Mishina Y, 2003, J AM CHEM SOC, V125, P8730, DOI 10.1021/ja034636c; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Searls T, 1999, TETRAHEDRON, V55, P11985, DOI 10.1016/S0040-4020(99)00703-6; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; YI C, 2009, ACCOUNTS CHEM RES, V42, P530; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106	38	110	112	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					330	U223		10.1038/nature09497	http://dx.doi.org/10.1038/nature09497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068844	Green Accepted			2022-12-24	WOS:000284051000056
J	Rouget, C; Papin, C; Boureux, A; Meunier, AC; Franco, B; Robine, N; Lai, EC; Pelisson, A; Simonelig, M				Rouget, Christel; Papin, Catherine; Boureux, Anthony; Meunier, Anne-Cecile; Franco, Benedicte; Robine, Nicolas; Lai, Eric C.; Pelisson, Alain; Simonelig, Martine			Maternal mRNA deadenylation and decay by the piRNA pathway in the early Drosophila embryo	NATURE			English	Article							TRANSLATIONAL REGULATION; AXIS SPECIFICATION; BINDING-PROTEIN; GERMLINE; LOCALIZATION; NANOS; PIWI; MELANOGASTER; ACTIVATION; MUTATIONS	Piwi-associated RNAs (piRNAs), a specific class of 24- to 30-nucleotide-long RNAs produced by the Piwi-type of Argonaute proteins, have a specific germline function in repressing transposable elements. This repression is thought to involve heterochromatin formation and transcriptional and post-transcriptional silencing(1-6). The piRNA pathway has other essential functions in germline stem cell maintenance(7) and in maintaining germline DNA integrity(8-10). Here we uncover an unexpected function of the piRNA pathway in the decay of maternal messenger RNAs and in translational repression in the early embryo. A subset of maternal mRNAs is degraded in the embryo at the maternal-to-zygotic transition. In Drosophila, maternal mRNA degradation depends on the RNA-binding protein Smaug and the deadenylase CCR4(11-13), as well as the zygotic expression of a microRNA cluster(14). Using mRNA encoding the embryonic posterior morphogen Nanos (Nos) as a paradigm to study maternal mRNA decay, we found that CCR4-mediated deadenylation of nos depends on components of the piRNA pathway including piRNAs complementary to a specific region in the nos 3' untranslated region. Reduced deadenylation when piRNA-induced regulation is impaired correlates with nos mRNA stabilization and translational derepression in the embryo, resulting in head development defects. Aubergine, one of the Argonaute proteins in the piRNA pathway, is present in a complex with Smaug, CCR4, nos mRNA and piRNAs that target the nos 3' untranslated region, in the bulk of the embryo. We propose that piRNAs and their associated proteins act together with Smaug to recruit the CCR4 deadenylation complex to specific mRNAs, thus promoting their decay. Because the piRNAs involved in this regulation are produced from transposable elements, this identifies a direct developmental function for transposable elements in the regulation of gene expression.	[Rouget, Christel; Papin, Catherine; Meunier, Anne-Cecile; Franco, Benedicte; Simonelig, Martine] CNRS, UPR1142, Inst Human Genet, mRNA Regulat & Dev, F-34396 Montpellier 5, France; [Boureux, Anthony] Univ Montpellier 2, CNRS, UMR5237, CRBM, F-34293 Montpellier, France; [Robine, Nicolas; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, Rockefeller Res Labs 1017, New York, NY 10065 USA; [Pelisson, Alain] CNRS, UPR1142, Inst Human Genet, RNA Silencing & Control Transposit, F-34396 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Memorial Sloan Kettering Cancer Center; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Simonelig, M (corresponding author), CNRS, UPR1142, Inst Human Genet, mRNA Regulat & Dev, 141 Rue Cardonille, F-34396 Montpellier 5, France.	Martine.Simonelig@igh.cnrs.fr	Lai, Eric/AAO-1143-2021; Lai, Eric C/A-3412-2008	Lai, Eric/0000-0002-8432-5851; Robine, Nicolas/0000-0001-5698-8183; Simonelig, Martine/0000-0002-3731-6979	Centre National de la Recherche Scientifique [UPR1142]; Agence Nationale de la Recherche (ANR Blanche) [ANR-06-BLAN-0343]; Fondation pour la Recherche Medicale (FRM); Association pour la Recherche sur le Cancer (ARC); National Institutes of Health (NIH) [R01-GM083300]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR Blanche)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Nakamura, M. Siomi, H. Siomi, C. Smibert, H. Lin, P. Macdonald, T. Schupbach, W. Theurkauf, R. Wharton and P. Zamore, for their gifts of antibodies or Drosophila stocks. We thank M. Benkirane for the gift of 29-O-methyl anti-miR129. This work was supported by the Centre National de la Recherche Scientifique UPR1142, the Agence Nationale de la Recherche (ANR Blanche ANR-06-BLAN-0343), the Fondation pour la Recherche Medicale (FRM, Equipe FRM 2007) and the Association pour la Recherche sur le Cancer (ARC Libre 2009) to M.S. and by the National Institutes of Health (NIH R01-GM083300) to E.C.L. C.R., A.C.M. and B.F. held salaries from ANR Blanche.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Benoit B, 1999, NUCLEIC ACIDS RES, V27, P3771, DOI 10.1093/nar/27.19.3771; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Chou TB, 1996, GENETICS, V144, P1673; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Dahanukar A, 1996, GENE DEV, V10, P2610, DOI 10.1101/gad.10.20.2610; Dahanukar A, 1999, MOL CELL, V4, P209, DOI 10.1016/S1097-2765(00)80368-8; GAVIS ER, 1994, NATURE, V369, P315, DOI 10.1038/369315a0; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Juge F, 2002, EMBO J, V21, P6603, DOI 10.1093/emboj/cdf633; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; LEHMANN R, 1991, DEVELOPMENT, V112, P679; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lim AK, 2009, J CELL BIOL, V186, P333, DOI 10.1083/jcb.200904063; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; SCHUPBACH T, 1991, GENETICS, V129, P1119; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649	40	314	329	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1128	U144		10.1038/nature09465	http://dx.doi.org/10.1038/nature09465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20953170	Green Accepted			2022-12-24	WOS:000283548600052
J	Arrenberg, AB; Stainier, DYR; Baier, H; Huisken, J				Arrenberg, Aristides B.; Stainier, Didier Y. R.; Baier, Herwig; Huisken, Jan			Optogenetic Control of Cardiac Function	SCIENCE			English	Article							CONDUCTION SYSTEM; ZEBRAFISH; CHANNELRHODOPSIN-2; DISSECTION; BEHAVIOR	The cardiac pacemaker controls the rhythmicity of heart contractions and can be substituted by a battery-operated device as a last resort. We created a genetically encoded, optically controlled pacemaker by expressing halorhodopsin and channelrhodopsin in zebrafish cardiomyocytes. Using patterned illumination in a selective plane illumination microscope, we located the pacemaker and simulated tachycardia, bradycardia, atrioventricular blocks, and cardiac arrest. The pacemaker converges to the sinoatrial region during development and comprises fewer than a dozen cells by the time the heart loops. Perturbation of the activity of these cells was entirely reversible, demonstrating the resilience of the endogenous pacemaker. Our studies combine optogenetics and light-sheet microscopy to reveal the emergence of organ function during development.	[Stainier, Didier Y. R.; Huisken, Jan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Stainier, Didier Y. R.; Huisken, Jan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Arrenberg, Aristides B.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 95158 USA; [Arrenberg, Aristides B.] Univ Freiburg, Inst Biol 1, D-79104 Freiburg, Germany; [Huisken, Jan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Freiburg; Max Planck Society	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	didier.stainier@ucsf.edu	Huisken, Jan/B-2472-2009	Huisken, Jan/0000-0001-7250-3756; Stainier, Didier/0000-0002-0382-0026; Arrenberg, Aristides/0000-0001-8262-7381	NIH [HL54737, R01 NS053358]; Packard Foundation; Sandler Opportunity Award; Byers Award for Basic Science; NIH Nanomedicine Development Center; Human Frontier Science Program (HFSP); Boehringer Ingelheim Fonds (B.I.F.); Krevans fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); Sandler Opportunity Award; Byers Award for Basic Science; NIH Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Boehringer Ingelheim Fonds (B.I.F.)(Boehringer Ingelheim); Krevans fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Mikawa, R. Shaw, and A. Mussigbrodt for feedback and comments on the manuscript. Supported by NIH grant HL54737 (D.Y.R.S.), the Packard Foundation (D.Y.R.S.), NIH grant R01 NS053358 (H.B.), a Sandler Opportunity Award, the Byers Award for Basic Science (H.B.), and the NIH Nanomedicine Development Center "Optical Control of Biological Functions" (H.B.). J.H. was supported by a Human Frontier Science Program (HFSP) cross-disciplinary fellowship. A.B.A. was supported by a Boehringer Ingelheim Fonds (B.I.F.) and a Krevans fellowship. The optogenetic idea, transgenic lines, and original observation originated in H.B.'s lab; follow-up experiments were carried out in D.Y.R.S.'s lab as an equal collaboration between A.B.A. and J.H. All authors worked on the manuscript, which was drafted by A.B.A. and J.H.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Baier H, 2009, CURR OPIN NEUROBIOL, V19, P553, DOI 10.1016/j.conb.2009.08.001; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Jenkins MW, 2010, NAT PHOTONICS, V4, P623, DOI 10.1038/NPHOTON.2010.166; Jongbloed MRM, 2008, THESCIENTIFICWORLDJO, V8, P239, DOI 10.1100/tsw.2008.40; KAMINO K, 1981, NATURE, V290, P595, DOI 10.1038/290595a0; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mikawa T, 2007, SEMIN CELL DEV BIOL, V18, P90, DOI 10.1016/j.semcdb.2006.12.008; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nygren A, 1998, CIRC RES, V82, P63; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; SCHERF D., 1927, ZEIT SCHR GES EXP MED, V57, P188, DOI 10.1007/BF02610224; Scherz PJ, 2008, DEVELOPMENT, V135, P1179, DOI 10.1242/dev.010694; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Sedmera D, 2003, AM J PHYSIOL-HEART C, V284, pH1152, DOI 10.1152/ajpheart.00870.2002; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; WILDERS R, 2007, C P IEEE ENG MED BIO, P152; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	28	316	327	5	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					971	974		10.1126/science.1195929	http://dx.doi.org/10.1126/science.1195929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071670				2022-12-24	WOS:000284118000045
J	Clarkson, AN; Huang, BS; MacIsaac, SE; Mody, I; Carmichael, ST				Clarkson, Andrew N.; Huang, Ben S.; MacIsaac, Sarah E.; Mody, Istvan; Carmichael, S. Thomas			Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke	NATURE			English	Article							RECEPTOR SUBUNITS; ALPHA-5 SUBUNIT; PLASTICITY; BRAIN; MECHANISMS; RATS; MICE; REORGANIZATION; CONDUCTANCES; ACTIVATION	Stroke is a leading cause of disability, but no pharmacological therapy is currently available for promoting recovery. The brain region adjacent to stroke damage-the peri-infarct zone-is critical for rehabilitation, as it shows heightened neuroplasticity, allowing sensorimotor functions to re-map from damaged areas(1-3). Thus, understanding the neuronal properties constraining this plasticity is important for the development of new treatments. Here we show that after a stroke in mice, tonic neuronal inhibition is increased in the peri-infarct zone. This increased tonic inhibition is mediated by extrasynaptic GABA(A) receptors and is caused by an impairment in GABA (gamma-aminobutyric acid) transporter (GAT-3/GAT-4) function. To counteract the heightened inhibition, we administered in vivo a benzodiazepine inverse agonist specific for alpha 5-subunit-containing extrasynaptic GABA(A) receptors at a delay after stroke. This treatment produced an early and sustained recovery of motor function. Genetically lowering the number of alpha 5- or delta-subunit-containing GABA(A) receptors responsible for tonic inhibition also proved beneficial for recovery after stroke, consistent with the therapeutic potential of diminishing extrasynaptic GABA(A) receptor function. Together, our results identify new pharmacological targets and provide the rationale for a novel strategy to promote recovery after stroke and possibly other brain injuries.	[Clarkson, Andrew N.; Huang, Ben S.; MacIsaac, Sarah E.; Mody, Istvan; Carmichael, S. Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Huang, Ben S.; Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA; [Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Carmichael, ST (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 635 Charles Young Dr S, Los Angeles, CA 90095 USA.	scarmichael@mednet.ucla.edu	Huang, Ben S./AAH-8370-2019	Huang, Ben S./0000-0003-2838-6315; Carmichael, S Thomas/0000-0002-1169-9203; Clarkson, Andrew/0000-0003-3804-3834	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Larry L. Hillblom Foundation; Coelho Endowment; National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS30549]; American Heart Association; New Zealand Neurological Foundation; Health Research Council of New Zealand; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R01NS030549] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Larry L. Hillblom Foundation; Coelho Endowment; National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); New Zealand Neurological Foundation; Health Research Council of New Zealand(Health Research Council of New Zealand); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I.M., A.N.C. and S.T.C. were supported by The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. S.T.C. was supported by the Larry L. Hillblom Foundation, I. M. was supported by the Coelho Endowment and National Institutes of Health/National Institute of Neurological Disorders and Stroke grant NS30549. This manuscript was completed partially during tenure of an American Heart Association Postdoctoral Fellowship, a Repatriation Fellowship from the New Zealand Neurological Foundation and the Sir Charles Hercus Fellowship from the Health Research Council of New Zealand (A.N.C.). We thank E. O. Mann, J. Chu, J. J. Overman, J. Zhong and R. M. Lazaro for discussion and assistance.	Alonso-Alonso Miguel, 2007, Cerebrovasc Dis, V24 Suppl 1, P157, DOI 10.1159/000107392; Atack JR, 2006, NEUROPHARMACOLOGY, V51, P1023, DOI 10.1016/j.neuropharm.2006.04.018; BARLOW R, 1990, TRENDS PHARMACOL SCI, V11, P404, DOI 10.1016/0165-6147(90)90146-Y; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Collinson N, 2002, J NEUROSCI, V22, P5572; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Di Lazzaro V, 2010, CEREB CORTEX, V20, P1523, DOI 10.1093/cercor/bhp216; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Dobkin BH, 2008, NAT CLIN PRACT NEURO, V4, P76, DOI 10.1038/ncpneuro0709; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, pE288, DOI 10.1161/STROKEAHA.109.551820; Foeller E, 2005, J NEUROPHYSIOL, V94, P4387, DOI 10.1152/jn.00553.2005; Frahm C, 2004, J COMP NEUROL, V478, P176, DOI 10.1002/cne.20282; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Keros S, 2005, J NEUROPHYSIOL, V94, P2073, DOI 10.1152/jn.00520.2005; Kharlamov EA, 2008, BRAIN RES, V1210, P29, DOI 10.1016/j.brainres.2008.02.070; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Moore CS, 2008, J NEUROIMMUNOL, V203, P79, DOI 10.1016/j.jneuroim.2008.06.030; Neumann-Haefelin T, 1998, NEUROSCIENCE, V87, P871, DOI 10.1016/S0306-4522(98)00124-9; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Que M, 1999, NEUROSCIENCE, V93, P1233, DOI 10.1016/S0306-4522(99)00197-9; Redecker C, 2000, J NEUROSCI, V20, P5045; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Tanaka Y, 2008, J NEUROSCI METH, V171, P118, DOI 10.1016/j.jneumeth.2008.02.021; Verheugen JAH, 1999, J NEUROSCI, V19, P2546; Walker Matthew C., 2008, V44, P29, DOI 10.1007/400_2007_030; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029	38	574	592	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					305	U193		10.1038/nature09511	http://dx.doi.org/10.1038/nature09511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21048709	Green Accepted, Green Submitted			2022-12-24	WOS:000284051000051
J	Bai, JH; Hu, ZT; Dittman, JS; Pym, ECG; Kaplan, JM				Bai, Jihong; Hu, Zhitao; Dittman, Jeremy S.; Pym, Edward C. G.; Kaplan, Joshua M.			Endophilin Functions as a Membrane-Bending Molecule and Is Delivered to Endocytic Zones by Exocytosis	CELL			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; BAR; PROTEINS; CURVATURE; DOMAIN; TRANSMISSION; SYNAPTOJANIN; DOCKING; DYNAMIN; ACTIN	Two models have been proposed for endophilin function in synaptic vesicle (SV) endocytosis. The scaffolding model proposes that endophilin's SH3 domain recruits essential endocytic proteins, whereas the membrane-bending model proposes that the BAR domain induces positively curved membranes. We show that mutations disrupting the scaffolding function do not impair endocytosis, whereas those disrupting membrane bending cause significant defects. By anchoring endophilin to the plasma membrane, we show that endophilin acts prior to scission to promote endocytosis. Despite acting at the plasma membrane, the majority of endophilin is targeted to the SV pool. Photoactivation studies suggest that the soluble pool of endophilin at synapses is provided by unbinding from the adjacent SV pool and that the unbinding rate is regulated by exocytosis. Thus, endophilin participates in an association-dissociation cycle with SVs that parallels the cycle of exo- and endocytosis. This endophilin cycle may provide a mechanism for functionally coupling endocytosis and exocytosis.	[Bai, Jihong; Hu, Zhitao; Pym, Edward C. G.; Kaplan, Joshua M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Bai, Jihong; Hu, Zhitao; Pym, Edward C. G.; Kaplan, Joshua M.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Dittman, Jeremy S.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu	hu, zhitao/H-5626-2011	Hu, Zhitao/0000-0002-2948-3339; Dittman, Jeremy S./0000-0002-3850-9078	Jane Coffin Childs postdoctoral fellowship; NIH [GM54728, K99MH085039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH085039] Funding Source: NIH RePORTER	Jane Coffin Childs postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the following for strains and reagents: Roger Tsien, Jennifer Lippincott-Schwartz, and the C. elegans Genetics Stock Center. We thank members of the Kaplan lab and Susana Garcia for critical comments. This work was supported by a Jane Coffin Childs postdoctoral fellowship (J.B.) and by NIH grants GM54728 (J.M.K.) and K99MH085039 (J.B.).	Ch'ng Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000283; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shupliakov O, 2009, NEUROSCIENCE, V158, P204, DOI 10.1016/j.neuroscience.2008.03.035; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118	33	87	95	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					430	441		10.1016/j.cell.2010.09.024	http://dx.doi.org/10.1016/j.cell.2010.09.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029864	Green Accepted, Bronze			2022-12-24	WOS:000283603900016
J	Currie, TE; Greenhill, SJ; Gray, RD; Hasegawa, T; Mace, R				Currie, Thomas E.; Greenhill, Simon J.; Gray, Russell D.; Hasegawa, Toshikazu; Mace, Ruth			Rise and fall of political complexity in island South-East Asia and the Pacific	NATURE			English	Article							EVOLUTION	There is disagreement about whether human political evolution has proceeded through a sequence of incremental increases in complexity, or whether larger, non-sequential increases have occurred. The extent to which societies have decreased in complexity is also unclear. These debates have continued largely in the absence of rigorous, quantitative tests. We evaluated six competing models of political evolution in Austronesian-speaking societies using phylogenetic methods. Here we show that in the best-fitting model political complexity rises and falls in a sequence of small steps. This is closely followed by another model in which increases are sequential but decreases can be either sequential or in bigger drops. The results indicate that large, non-sequential jumps in political complexity have not occurred during the evolutionary history of these societies. This suggests that, despite the numerous contingent pathways of human history, there are regularities in cultural evolution that can be detected using computational phylogenetic methods.	[Currie, Thomas E.; Hasegawa, Toshikazu] Univ Tokyo, Grad Sch Arts & Sci, Evolutionary Cognit Sci Res Ctr, Tokyo 1538902, Japan; [Currie, Thomas E.; Mace, Ruth] UCL, Dept Anthropol, Human Evolutionary Ecol Grp, London WC1H 0BW, England; [Greenhill, Simon J.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland 1142, New Zealand; [Greenhill, Simon J.] Univ Auckland, Computat Evolut Grp, Auckland 1142, New Zealand	University of Tokyo; University of London; University College London; University of Auckland; University of Auckland	Currie, TE (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Evolutionary Cognit Sci Res Ctr, Tokyo 1538902, Japan.	t.currie@ucl.ac.uk	Greenhill, Simon/I-3554-2019; Greenhill, Simon J/B-3114-2011; Gray, Russell/H-2078-2015	Greenhill, Simon/0000-0001-7832-6156; Greenhill, Simon J/0000-0001-7832-6156; Gray, Russell/0000-0002-9858-0191; Mace, Ruth/0000-0002-6137-7739	ESRC/NERC; Japan Society for the Promotion of Science; Royal Society of New Zealand; European Research Council	ESRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Royal Society of New Zealand(Royal Society of New Zealand); European Research Council(European Research Council (ERC)European Commission)	We thank R. Green, who passed away recently, for his advice and support of phylogenetic studies of cultural evolution. We thank R. Foley and M. Dunn for their comments during an earlier stage of this research, and R. Blust and A. Pawley for comments on the manuscript. T.C. was supported by an ESRC/NERC Interdisciplinary Studentship and a Japan Society for the Promotion of Science Postdoctoral Fellowship. S.G. and R.G. were supported by the Royal Society of New Zealand Marsden Fund. R.M. was supported by a European Research Council grant.	[Anonymous], 1999, CHIEFDOMS PATHWAYS C, DOI DOI 10.1017/CBO9780511558238.002; [Anonymous], 1997, GUNS GERMS STEEL; BELLWOOD P, 1996, ORIGINS ANCESTRY ALL, P19; Bondarenko D. M., 2002, SOCIAL EVOLUTION HIS, V1, P54; Campbell RB, 2009, CURR ANTHROPOL, V50, P821, DOI 10.1086/648398; Carneiro Robert L., 2003, EVOLUTIONISM CULTURA; Currie TE, 2009, P NATL ACAD SCI USA, V106, P7339, DOI 10.1073/pnas.0804698106; Dennett DC., 1996, DARWINS DANGEROUS ID; Flannery KV, 1972, ANNU REV ECOL SYST, V3, P399, DOI DOI 10.1146/ANNUREV.ES.03.110172.002151; Glover I., 2004, SE ASIA PREHISTORY H; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Hage P., 1999, ASIAN PERSPECT, V38, P200; Hazen RM, 2010, ELEMENTS, V6, P43, DOI 10.2113/gselements.6.1.43; Johnson Allen, 2000, EVOLUTION HUMAN SOC; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; KIRCH PV, 2001, RC HAWAIKI ANCESTRAL; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Mace R, 2005, TRENDS ECOL EVOL, V20, P116, DOI 10.1016/j.tree.2004.12.002; Marcos S, 2008, EUR PHYS J A, V37, P251, DOI 10.1140/epja/i2008-10619-1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Richerson PJ, 2009, HUM BIOL, V81, P211, DOI 10.3378/027.081.0306; Richerson PJ., 2001, P BR ACAD, V110, P197; Service E.R., 1962, PRIMITIVE SOCIAL ORG; SPENCER CS, 1990, J ANTHROPOL ARCHAEOL, V9, P1, DOI 10.1016/0278-4165(90)90004-W; Tainter JA, 2006, ANNU REV ANTHROPOL, V35, P59, DOI 10.1146/annurev.anthro.35.081705.123136; Turchin P, 2009, SOC EVOL HIST, V8, P167; Wright HT, 2006, J ANTHROPOL RES, V62, P305, DOI 10.3998/jar.0521004.0062.301; Yoffee N., 1993, ARCHAEOLOGICAL THEOR, P60; Yoffee N, 2005, MYTHS ARCHAIC STATE	30	129	132	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					801	804		10.1038/nature09461	http://dx.doi.org/10.1038/nature09461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944739				2022-12-24	WOS:000282898700057
J	Dillon, ME; Wang, G; Huey, RB				Dillon, Michael E.; Wang, George; Huey, Raymond B.			Global metabolic impacts of recent climate warming	NATURE			English	Article							TEMPERATURE; ECTOTHERMS; ANIMALS; ECOLOGY; PLANTS; SHIFT; SIZE; MASS	Documented shifts in geographical ranges(1,2), seasonal phenology(3,4), community interactions(5), genetics(3,6) and extinctions(7) have been attributed to recent global warming(8-10). Many such biotic shifts have been detected at mid-to high latitudes in the Northern Hemisphere(4,9,10)-a latitudinal pattern that is expected(4,8,10,11) because warming is fastest in these regions(8). In contrast, shifts in tropical regions are expected to be less marked(4,8,10,11) because warming is less pronounced there(8). However, biotic impacts of warming are mediated through physiology, and metabolic rate, which is a fundamental measure of physiological activity and ecological impact, increases exponentially rather than linearly with temperature in ectotherms(12). Therefore, tropical ectotherms (with warm baseline temperatures) should experience larger absolute shifts in metabolic rate than the magnitude of tropical temperature change itself would suggest, but the impact of climate warming on metabolic rate has never been quantified on a global scale. Here we show that estimated changes in terrestrial metabolic rates in the tropics are large, are equivalent in magnitude to those in the north temperate-zone regions, and are in fact far greater than those in the Arctic, even though tropical temperature change has been relatively small. Because of temperature's nonlinear effects on metabolism, tropical organisms, which constitute much of Earth's biodiversity, should be profoundly affected by recent and projected climate warming(2,13,14).	[Dillon, Michael E.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Wang, George; Huey, Raymond B.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Wyoming; University of Washington; University of Washington Seattle	Dillon, ME (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	Michael.Dillon@uwyo.edu	Huey, Raymond/F-1597-2010; Dillon, Michael/A-2564-2012	Dillon, Michael/0000-0002-7263-5537; Huey, Raymond/0000-0002-4962-8670	NSF [IOB-041684]	NSF(National Science Foundation (NSF))	We thank T. L. Daniel, C. Martinez del Rio, W. R. Rice and J. Tewksbury for discussion, and S. L. Chown for sharing his data on latitudinal variation in E. Research was funded in part by NSF IOB-041684 to R.B.H. and by an NSF Minority Postdoctoral Fellowship to M.E.D.	Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; del Rio CM, 2008, TRENDS ECOL EVOL, V23, P256, DOI 10.1016/j.tree.2008.01.010; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Downs CJ, 2008, FUNCT ECOL, V22, P239, DOI 10.1111/j.1365-2435.2007.01371.x; DUNHAM AE, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P95; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hastings D. A., 1999, GLOBAL LAND ONE KILO; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; IPCC, 2007, CONTRIBUTION WORKING; Irlich UM, 2009, AM NAT, V174, P819, DOI 10.1086/647904; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Lott N., 2001, FCC INTEGRATED SURFA; O'Connor MP, 2007, OIKOS, V116, P1058, DOI 10.1111/j.2006.0030-1299.15534.x; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Portner HO, 2002, J EXP BIOL, V205, P2217; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; RICE WR, 1994, P NATL ACAD SCI USA, V91, P225, DOI 10.1073/pnas.91.1.225; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Savage VM, 2004, J THEOR BIOL, V227, P525, DOI 10.1016/j.jtbi.2003.11.030; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	32	584	600	12	568	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					704	U88		10.1038/nature09407	http://dx.doi.org/10.1038/nature09407			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930843				2022-12-24	WOS:000282572500037
J	Becks, L; Agrawal, AF				Becks, Lutz; Agrawal, Aneil F.			Higher rates of sex evolve in spatially heterogeneous environments	NATURE			English	Article							DELETERIOUS MUTATIONS; RECOMBINATION; SELECTION; EVOLUTION; ADVANTAGE; INCREASES	The evolution and maintenance of sexual reproduction has puzzled biologists for decades(1,2). Although this field is rich in hypotheses(3-5), experimental evidence is scarce. Some important experiments have demonstrated differences in evolutionary rates between sexual and asexual populations(6-8); other experiments have documented evolutionary changes in phenomena related to genetic mixing, such as recombination(9,10) and selfing(11). However, direct experiments of the evolution of sex within populations are extremely rare (but see ref. 12). Here we use the rotifer, Brachionus calyciflorus, which is capable of both sexual and asexual reproduction, to test recent theory(13-15) predicting that there is more opportunity for sex to evolve in spatially heterogeneous environments. Replicated experimental populations of rotifers were maintained in homogeneous environments, composed of either high-or low-quality food habitats, or in heterogeneous environments that consisted of a mix of the two habitats. For populations maintained in either type of homogeneous environment, the rate of sex evolves rapidly towards zero. In contrast, higher rates of sex evolve in populations experiencing spatially heterogeneous environments. The data indicate that the higher level of sex observed under heterogeneity is not due to sex being less costly or selection against sex being less efficient; rather sex is sufficiently advantageous in heterogeneous environments to overwhelm its inherent costs(2). Counter to some alternative theories(16,17) for the evolution of sex, there is no evidence that genetic drift plays any part in the evolution of sex in these populations.	[Becks, Lutz; Agrawal, Aneil F.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Becks, Lutz] Univ Cologne, Ctr Biol Sci, Inst Zool, Dept Gen Ecol, D-50931 Cologne, Germany	University of Toronto; University of Cologne	Becks, L (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada.	lutz.becks@utoronto.ca	Becks, Lutz/I-8256-2012		Volkswagen Foundation [I/83 517]; Natural Sciences and Engineering Research Council (Canada)	Volkswagen Foundation(Volkswagen); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank C. Kearns and N. G. Hairston Jr for providing the sediment with resting eggs from which the Brachionus cultures were established. This research was funded by the Volkswagen Foundation to L.B. (I/83 517) and the Natural Sciences and Engineering Research Council (Canada) to A.F.A.	Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Agrawal AF, 2009, AM NAT, V174, pS54, DOI 10.1086/599082; Agrawal AF, 2009, EVOLUTION, V63, P2131, DOI 10.1111/j.1558-5646.2009.00695.x; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bell G., 1982, MASTERPIECE NATURE E; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Feldman MW, 1996, ANNU REV GENET, V30, P261, DOI 10.1146/annurev.genet.30.1.261; FELSENSTEIN J, 1976, ANNU REV GENET, V10, P253, DOI 10.1146/annurev.ge.10.120176.001345; FELSENSTEIN J, 1976, GENETICS, V83, P845; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Gilbert JJ, 2003, LIMNOL OCEANOGR, V48, P1297, DOI 10.4319/lo.2003.48.3.1297; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Hadany L, 2007, GENETICS, V176, P1713, DOI 10.1534/genetics.107.074203; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; KOROL AB, 1994, HEREDITY, V72, P64, DOI 10.1038/hdy.1994.7; Lenormand T, 2000, GENETICS, V156, P423; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; Peters AD, 2007, J EVOLUTION BIOL, V20, P1206, DOI 10.1111/j.1420-9101.2006.01283.x; Poon A, 2004, GENETICS, V166, P19, DOI 10.1534/genetics.166.1.19; Pylkov KV, 1998, GENET RES, V71, P247, DOI 10.1017/S0016672398003243; Roze D, 2010, GENETICS, V184, P1095, DOI 10.1534/genetics.109.108258; SMITH JM, 1978, EVOLUTION SEX; Team R. D. C., 2009, R LANGUAGE ENV STAT; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; WOLF HG, 1987, GENETICA, V72, P151, DOI 10.1007/BF00123174	32	100	101	3	308	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					89	+		10.1038/nature09449	http://dx.doi.org/10.1038/nature09449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20944628				2022-12-24	WOS:000283786900041
J	Rubtsov, YP; Niec, RE; Josefowicz, S; Li, L; Darce, J; Mathis, D; Benoist, C; Rudensky, AY				Rubtsov, Yuri P.; Niec, Rachel E.; Josefowicz, Steven; Li, Li; Darce, Jaime; Mathis, Diane; Benoist, Christophe; Rudensky, Alexander Y.			Stability of the Regulatory T Cell Lineage in Vivo	SCIENCE			English	Article							TRANSCRIPTION FACTOR FOXP3; DIFFERENTIATION; SELF; AUTOIMMUNITY; HOMEOSTASIS; GENERATION; INDUCTION; ORIGIN	Tissue maintenance and homeostasis can be achieved through the replacement of dying cells by differentiating precursors or self-renewal of terminally differentiated cells or relies heavily on cellular longevity in poorly regenerating tissues. Regulatory T cells (T(reg) cells) represent an actively dividing cell population with critical function in suppression of lethal immune-mediated inflammation. The plasticity of T(reg) cells has been actively debated because it could factor importantly in protective immunity or autoimmunity. By using inducible labeling and tracking of T(reg) cell fate in vivo, or transfers of highly purified T(reg) cells, we have demonstrated notable stability of this cell population under physiologic and inflammatory conditions. Our results suggest that self-renewal of mature T(reg) cells serves as a major mechanism of maintenance of the T(reg) cell lineage in adult mice.	[Rubtsov, Yuri P.; Niec, Rachel E.; Josefowicz, Steven; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Rubtsov, Yuri P.; Niec, Rachel E.; Josefowicz, Steven; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Li, Li; Darce, Jaime; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Josefowicz, Steven Z/B-8716-2011; Li, Li/C-8478-2011; Rubtsov, Yury P/A-8227-2014	Rubtsov, Yury P/0000-0001-9175-3013; Niec, Rachel/0000-0002-8525-3693; josefowicz, steven/0000-0001-7453-779X	NIH [GM07739, AI51530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051530, R37AI034206, R01AI051530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Forbush, T. Chu, L. Karpik, A. Bravo, J. Herlihy, P. Zarin, G. Gerard, A. Ortiz-Lopes, and K. Hattori for assistance with mouse colony management; F. Costantini for R26Y mice; V. Kuchroo for Foxp3-IRES-GFP mice; P. Chambon for Cre-ERT2 plasmid; E. Pamer, C. Shi, and E. Leiner for L. monocytogenes and assistance with experiments; and P. Fink and K. Simmons for cells from Rag2pGFP mice and helpful discussion. R.E.N. was supported by NIH Medical Scientist Training Program grant GM07739. A.Y.R. is an investigator with the Howard Hughes Medical Institute, and this work was also supported by grant AI51530 from the NIH to C. B. and D.M.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Malek TR, 2008, J CLIN IMMUNOL, V28, P635, DOI 10.1007/s10875-008-9235-y; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	27	496	509	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1667	1671		10.1126/science.1191996	http://dx.doi.org/10.1126/science.1191996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929851	Green Accepted			2022-12-24	WOS:000282098100048
J	Johannessen, CM; Boehm, JS; Kim, SY; Thomas, SR; Wardwell, L; Johnson, LA; Emery, CM; Stransky, N; Cogdill, AP; Barretina, J; Caponigro, G; Hieronymus, H; Murray, RR; Salehi-Ashtiani, K; Hill, DE; Vidal, M; Zhao, JJ; Yang, XP; Alkan, O; Kim, S; Harris, JL; Wilson, CJ; Myer, VE; Finan, PM; Root, DE; Roberts, TM; Golub, T; Flaherty, KT; Dummer, R; Weber, BL; Sellers, WR; Schlegel, R; Wargo, JA; Hahn, WC; Garraway, LA				Johannessen, Cory M.; Boehm, Jesse S.; Kim, So Young; Thomas, Sapana R.; Wardwell, Leslie; Johnson, Laura A.; Emery, Caroline M.; Stransky, Nicolas; Cogdill, Alexandria P.; Barretina, Jordi; Caponigro, Giordano; Hieronymus, Haley; Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc; Zhao, Jean J.; Yang, Xiaoping; Alkan, Ozan; Kim, Sungjoon; Harris, Jennifer L.; Wilson, Christopher J.; Myer, Vic E.; Finan, Peter M.; Root, David E.; Roberts, Thomas M.; Golub, Todd; Flaherty, Keith T.; Dummer, Reinhard; Weber, Barbara L.; Sellers, William R.; Schlegel, Robert; Wargo, Jennifer A.; Hahn, William C.; Garraway, Levi A.			COT drives resistance to RAF inhibition through MAP kinase pathway reactivation	NATURE			English	Article							TUMOR PROGRESSION; SIGNALING PATHWAY; BRAF; MUTATIONS; CANCER; CELLS; GENE; TRANSFORMATION; SENSITIVITY; ACTIVATION	Oncogenic mutations in the serine/threonine kinase B-RAF (also known as BRAF) are found in 50-70% of malignant melanomas(1). Pre-clinical studies have demonstrated that the B-RAF(V600E) mutation predicts a dependency on the mitogen-activated protein kinase (MAPK) signalling cascade in melanoma(2-6)-an observation that has been validated by the success of RAF and MEK inhibitors in clinical trials(7-9). However, clinical responses to targeted anticancer therapeutics are frequently confounded by de novo or acquired resistance(10-12). Identification of resistance mechanisms in a manner that elucidates alternative 'druggable' targets may inform effective long-term treatment strategies(13). Here we expressed similar to 600 kinase and kinase-related open reading frames (ORFs) in parallel to interrogate resistance to a selective RAF kinase inhibitor. We identified MAP3K8 (the gene encoding COT/Tpl2) as a MAPK pathway agonist that drives resistance to RAF inhibition in B-RAF(V600E) cell lines. COT activates ERK primarily through MEK-dependent mechanisms that do not require RAF signalling. Moreover, COT expression is associated with de novo resistance in B-RAF(V600E) cultured cell lines and acquired resistance in melanoma cells and tissue obtained from relapsing patients following treatment with MEK or RAF inhibitors. We further identify combinatorial MAPK pathway inhibition or targeting of COT kinase activity as possible therapeutic strategies for reducing MAPK pathway activation in this setting. Together, these results provide new insights into resistance mechanisms involving the MAPK pathway and articulate an integrative approach through which high-throughput functional screens may inform the development of novel therapeutic strategies.	[Johannessen, Cory M.; Boehm, Jesse S.; Kim, So Young; Thomas, Sapana R.; Johnson, Laura A.; Stransky, Nicolas; Barretina, Jordi; Hieronymus, Haley; Yang, Xiaoping; Alkan, Ozan; Root, David E.; Golub, Todd; Hahn, William C.; Garraway, Levi A.] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Johannessen, Cory M.; Kim, So Young; Thomas, Sapana R.; Wardwell, Leslie; Johnson, Laura A.; Emery, Caroline M.; Barretina, Jordi; Hahn, William C.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, So Young; Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc; Hahn, William C.] Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; [Cogdill, Alexandria P.; Flaherty, Keith T.; Wargo, Jennifer A.] Massachusetts Gen Hosp, Div Surg Oncol Med Oncol & Dermatol, Boston, MA 02114 USA; [Barretina, Jordi; Golub, Todd; Hahn, William C.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Caponigro, Giordano; Wilson, Christopher J.; Myer, Vic E.; Finan, Peter M.; Weber, Barbara L.; Sellers, William R.; Schlegel, Robert] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Hieronymus, Haley; Golub, Todd] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc; Zhao, Jean J.; Roberts, Thomas M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhao, Jean J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kim, Sungjoon; Harris, Jennifer L.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Novartis; University of Zurich; University Zurich Hospital	Garraway, LA (corresponding author), Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA.	Levi_Garraway@dfci.harvard.edu	Hill, David E/B-6617-2011; Barretina, Jordi/A-7192-2013	Barretina, Jordi/0000-0002-3478-4080; Cogdill, Alexandria/0000-0001-8917-9462; Boehm, Jesse/0000-0002-6795-6336; Wilson, Christopher/0000-0002-9146-522X; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243	NIH [CA134502]; Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; US National Cancer Institute [R33 CA128625, RC2 CA148268]; Swiss National Foundation [310040-103671]; Gottfried and Julia Bangerter Rhyner Stiftung; Ellison Foundation; DFCI Strategic Initiative; NATIONAL CANCER INSTITUTE [P50CA093683, R33CA128625, R01CA134502, K08CA115927, RC2CA148268] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Gottfried and Julia Bangerter Rhyner Stiftung; Ellison Foundation(Lawrence Ellison Foundation); DFCI Strategic Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Broad Institute/Novartis Cancer Cell Line Encyclopedia (CCLE) for contributing cell line genomic data, expression data and pharmacological cell line sensitivity data; J. Thibault and A. Shipway for CCLE related tissue culture; R. Depinho, G. Dunn, S. Ethier, H. Greulich, A. Henderson, D. Kaplan, R. Levine, C. Miller, H. Piwnica-Worms, H. Suzuki, M. Vigny, D. Vollrath and the Harvard Institute of Proteomics for contributing templates for the kinase collection; J. Du and D. B. Wheeler for assistance with functional testing of kinases; D. A. Barbie for helpful discussions, S. E. Moody and H. W. Cheung for technical assistance, and J. K. Grenier and S. J. Silver for compiling and annotating the list of kinases. This work was supported by the NIH Director's New Innovator Award (L. A. G.), grants from the Novartis Institutes for Biomedical Research (L. A. G.), Melanoma Research Alliance (L. A. G.), Starr Cancer Consortium(L. A. G.) the US National Cancer Institute (R33 CA128625, RC2 CA148268) (W. C. H.), NIH (CA134502) (J.J.Z) the Swiss National Foundation (310040-103671) (R. D.), the Gottfried and Julia Bangerter Rhyner Stiftung (R. D.) the Ellison Foundation (M. V. and CCSB) and institute sponsored research funds from the DFCI Strategic Initiative (M. V. and CCSB).	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; George D, 2008, BIOORG MED CHEM LETT, V18, P4952, DOI 10.1016/j.bmcl.2008.08.037; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hirata K, 2010, BIOL PHARM BULL, V33, P133, DOI 10.1248/bpb.33.133; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Infante JR, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.2503; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Lee KM, 2009, CANCER RES, V69, P8043, DOI 10.1158/0008-5472.CAN-09-2316; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Schwartz GK, 2009, J CLIN ONCOL, V27; Seth R, 2009, GUT, V58, P1234, DOI 10.1136/gut.2008.159137; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433	29	1100	1143	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					968	U370		10.1038/nature09627	http://dx.doi.org/10.1038/nature09627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21107320	Green Accepted			2022-12-24	WOS:000285344600048
J	Ley, TJ; Ding, L; Walter, MJ; McLellan, MD; Lamprecht, T; Larson, DE; Kandoth, C; Payton, JE; Baty, J; Welch, J; Harris, CC; Lichti, CF; Townsend, RR; Fulton, RS; Dooling, DJ; Koboldt, DC; Schmidt, H; Zhang, QY; Osborne, JR; Lin, L; O'Laughlin, M; McMichael, JF; Delehaunty, KD; McGrath, SD; Fulton, LA; Magrini, VJ; Vickery, TL; Hundal, J; Cook, LL; Conyers, JJ; Swift, GW; Reed, JP; Alldredge, PA; Wylie, T; Walker, J; Kalicki, J; Watson, MA; Heath, S; Shannon, WD; Varghese, N; Nagarajan, R; Westervelt, P; Tomasson, MH; Link, DC; Graubert, TA; DiPersio, JF; Mardis, ER; Wilson, RK				Ley, Timothy J.; Ding, Li; Walter, Matthew J.; McLellan, Michael D.; Lamprecht, Tamara; Larson, David E.; Kandoth, Cyriac; Payton, Jacqueline E.; Baty, Jack; Welch, John; Harris, Christopher C.; Lichti, Cheryl F.; Townsend, R. Reid; Fulton, Robert S.; Dooling, David J.; Koboldt, Daniel C.; Schmidt, Heather; Zhang, Qunyuan; Osborne, John R.; Lin, Ling; O'Laughlin, Michelle; McMichael, Joshua F.; Delehaunty, Kim D.; McGrath, Sean D.; Fulton, Lucinda A.; Magrini, Vincent J.; Vickery, Tammi L.; Hundal, Jasreet; Cook, Lisa L.; Conyers, Joshua J.; Swift, Gary W.; Reed, Jerry P.; Alldredge, Patricia A.; Wylie, Todd; Walker, Jason; Kalicki, Joelle; Watson, Mark A.; Heath, Sharon; Shannon, William D.; Varghese, Nobish; Nagarajan, Rakesh; Westervelt, Peter; Tomasson, Michael H.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Mardis, Elaine R.; Wilson, Richard K.			DNMT3A Mutations in Acute Myeloid Leukemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DNA-METHYLTRANSFERASES; PROGNOSTIC IMPACT; CLINICAL-RESPONSE; ADULT PATIENTS; CANCER; TRANSCRIPTION; RECRUITMENT; SCHEDULE; ICF	Background: The genetic alterations responsible for an adverse outcome in most patients with acute myeloid leukemia (AML) are unknown. Methods: Using massively parallel DNA sequencing, we identified a somatic mutation in DNMT3A, encoding a DNA methyltransferase, in the genome of cells from a patient with AML with a normal karyotype. We sequenced the exons of DNMT3A in 280 additional patients with de novo AML to define recurring mutations. Results: A total of 62 of 281 patients (22.1%) had mutations in DNMT3A that were predicted to affect translation. We identified 18 different missense mutations, the most common of which was predicted to affect amino acid R882 (in 37 patients). We also identified six frameshift, six nonsense, and three splice-site mutations and a 1.5-Mbp deletion encompassing DNMT3A. These mutations were highly enriched in the group of patients with an intermediate-risk cytogenetic profile (56 of 166 patients, or 33.7%) but were absent in all 79 patients with a favorable-risk cytogenetic profile (P<0.001 for both comparisons). The median overall survival among patients with DNMT3A mutations was significantly shorter than that among patients without such mutations (12.3 months vs. 41.1 months, P<0.001). DNMT3A mutations were associated with adverse outcomes among patients with an intermediate-risk cytogenetic profile or FLT3 mutations, regardless of age, and were independently associated with a poor outcome in Cox proportional-hazards analysis. Conclusions: DNMT3A mutations are highly recurrent in patients with de novo AML with an intermediate-risk cytogenetic profile and are independently associated with a poor outcome. (Funded by the National Institutes of Health and others.) N Engl J Med 2010;363:2424-33.	[Ley, Timothy J.; Ding, Li; Zhang, Qunyuan; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Ley, Timothy J.; Ding, Li; McLellan, Michael D.; Larson, David E.; Kandoth, Cyriac; Harris, Christopher C.; Fulton, Robert S.; Dooling, David J.; Koboldt, Daniel C.; Schmidt, Heather; Zhang, Qunyuan; Osborne, John R.; Lin, Ling; O'Laughlin, Michelle; McMichael, Joshua F.; Delehaunty, Kim D.; McGrath, Sean D.; Fulton, Lucinda A.; Magrini, Vincent J.; Vickery, Tammi L.; Hundal, Jasreet; Cook, Lisa L.; Conyers, Joshua J.; Swift, Gary W.; Reed, Jerry P.; Alldredge, Patricia A.; Wylie, Todd; Walker, Jason; Kalicki, Joelle; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Ctr, St Louis, MO 63110 USA; [Ley, Timothy J.; Walter, Matthew J.; Lamprecht, Tamara; Welch, John; Lichti, Cheryl F.; Townsend, R. Reid; Heath, Sharon; Shannon, William D.; Westervelt, Peter; Tomasson, Michael H.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Ley, Timothy J.; Walter, Matthew J.; Townsend, R. Reid; Watson, Mark A.; Shannon, William D.; Varghese, Nobish; Nagarajan, Rakesh; Westervelt, Peter; Tomasson, Michael H.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Payton, Jacqueline E.; Watson, Mark A.; Varghese, Nobish; Nagarajan, Rakesh] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Baty, Jack] Washington Univ, Div Biostat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Dept Genet, 660 S Euclid Ave,Campus Box 8007, St Louis, MO 63110 USA.	timley@wustl.edu	Mardis, Elaine/W-2202-2019; Lichti, Cheryl/C-6359-2013; McGrath, Sean David/AAT-3540-2020; Walker, Jason/A-9702-2013; Magrini, Vincent/AAT-5830-2020; Wilson, Richard K./AAF-4139-2019; Walter, Matthew J/S-7758-2018	McGrath, Sean David/0000-0001-9064-8449; Walker, Jason/0000-0001-7547-5789; Magrini, Vincent/0000-0002-2019-4872; Wilson, Richard K./0000-0002-1992-1358; Lichti, Cheryl/0000-0003-4099-4954; Tomasson, Michael/0000-0003-4518-7123; Graubert, Timothy/0000-0002-7710-1171; MCLELLAN, MICHAEL/0000-0002-2703-8784; Westover, Tamara/0000-0002-1000-6698; Larson, David/0000-0001-7934-5906; Kandoth, Cyriac/0000-0002-1345-3573	National Center for Research Resources [UL1 RR024992]; National Institutes of Health [UL1 RR024992, P41RR000954, PO1 CA101937, U54 HG003079]; Barnes-Jewish Hospital Foundation [00335-0505-02]; Washington University Cancer Genome Initiative; NATIONAL CANCER INSTITUTE [P01CA101937] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; Washington University Cancer Genome Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Center for Research Resources (UL1 RR024992), the National Institutes of Health (P41RR000954 and UL1 RR024992, to Dr. Townsend; PO1 CA101937, to Dr. Ley; and U54 HG003079, to Dr. Wilson), and the Barnes-Jewish Hospital Foundation (00335-0505-02, to Dr. Ley).; We thank Nancy Reidelberger for administrative support; Todd Hepler, William Schroeder, Justin Lolofie, Scott Abbott, Shawn Leonard, Ken Swanson, Indraniel Das, and Michael Kiwala for their contributions to the Laboratory Information Management System; Gary Stiehr, Richard Wohlstadter, Matt Weil, and Kelly Fallon for information-technology support; Jin Shao for statistical support; Clara Bloomfield, Michael Caligiuri, and James Vardiman for providing the AML samples from the CALGB Leukemia Bank; the Washington University Cancer Genome Initiative for support; Alvin J. Siteman for supporting the sequencing of the original AML genome that is further described in this study; and our patients.	Blum W, 2010, P NATL ACAD SCI USA, V107, P7473, DOI 10.1073/pnas.1002650107; Boissel N, 2010, J CLIN ONCOL, V28, P3717, DOI 10.1200/JCO.2010.28.2285; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Chou WC, 2010, BLOOD, V115, P2749, DOI 10.1182/blood-2009-11-253070; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Ehrlich M, 2008, AUTOIMMUNITY, V41, P253, DOI 10.1080/08916930802024202; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2005, NEW ENGL J MED, V352, P740; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; Fazi F, 2007, BLOOD, V109, P4432, DOI 10.1182/blood-2006-09-045781; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Jiang YL, 2005, HUM MUTAT, V25, P56, DOI 10.1002/humu.20113; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Liu SJ, 2005, CANCER RES, V65, P1277, DOI 10.1158/0008-5472.CAN-04-4532; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Wang YA, 2005, CANCER BIOL THER, V4, P1138, DOI 10.4161/cbt.4.10.2073; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117	37	1390	1434	4	120	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2424	2433		10.1056/NEJMoa1005143	http://dx.doi.org/10.1056/NEJMoa1005143			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21067377	Green Published, Green Accepted			2022-12-24	WOS:000285340200008
J	Gurumurthy, S; Xie, SZ; Alagesan, B; Kim, J; Yusuf, RZ; Saez, B; Tzatsos, A; Ozsolak, F; Milos, P; Ferrari, F; Park, PJ; Shirihai, OS; Scadden, DT; Bardeesy, N				Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Ozsolak, Fatih; Milos, Patrice; Ferrari, Francesco; Park, Peter J.; Shirihai, Orian S.; Scadden, David T.; Bardeesy, Nabeel			The Lkb1 metabolic sensor maintains haematopoietic stem cell survival	NATURE			English	Article							PEUTZ-JEGHERS-SYNDROME; GLUCOSE-HOMEOSTASIS; TUMOR SUPPRESSION; IN-VIVO; PATHWAY; KINASE; MICE; APOPTOSIS; SYSTEM; ENERGY	Haematopoietic stem cells (HSCs) can convert between growth states that have marked differences in bioenergetic needs. Although often quiescent in adults, these cells become proliferative upon physiological demand. Balancing HSC energetics in response to nutrient availability and growth state is poorly understood, yet essential for the dynamism of the haematopoietic system. Here we show that the Lkb1 tumour suppressor is critical for the maintenance of energy homeostasis in haematopoietic cells. Lkb1 inactivation in adult mice causes loss of HSC quiescence followed by rapid depletion of all haematopoietic subpopulations. Lkb1-deficient bone marrow cells exhibit mitochondrial defects, alterations in lipid and nucleotide metabolism, and depletion of cellular ATP. The haematopoietic effects are largely independent of Lkb1 regulation of AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling. Instead, these data define a central role for Lkb1 in restricting HSC entry into cell cycle and in broadly maintaining energy homeostasis in haematopoietic cells through a novel metabolic checkpoint.	[Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Scadden, David T.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Scadden, David T.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Scadden, David T.; Bardeesy, Nabeel] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Xie, Stephanie Z.; Yusuf, Rushdia Z.; Saez, Borja; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Xie, Stephanie Z.; Yusuf, Rushdia Z.; Saez, Borja; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA; [Ozsolak, Fatih; Milos, Patrice] Hel BioSci Corp, Cambridge, MA 02139 USA; [Ferrari, Francesco; Park, Peter J.] Childrens Hosp, Ctr Biomed Informat, Boston, MA 02115 USA; [Ferrari, Francesco; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Ferrari, Francesco; Park, Peter J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shirihai, Orian S.] Boston Univ, Med Ctr, Mitochondria ARC, Evans Res Ctr,Dept Med, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Boston University	Bardeesy, N (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	Scadden.David@MGH.Harvard.edu; Bardeesy.Nabeel@MGH.Harvard.edu	Ferrari, Francesco/H-5007-2012; Saez, Borja/L-7411-2015	Ferrari, Francesco/0000-0002-9811-3753; Saez, Borja/0000-0001-7908-7089; Park, Peter/0000-0001-9378-960X; Shirihai, Orian/0000-0002-9502-2661; Xie, Stephanie/0000-0002-0284-494X	NIH [U01 CA141576-01, DK050234]; Ellison Medical Foundation; Massachusetts Biotechnology Research Council; NATIONAL CANCER INSTITUTE [U01CA141576] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Massachusetts Biotechnology Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank the Harvard Stem Cell Institute Flow Cytometry Core and D. Brown and the MGH Electron Microscope Imaging Core for expertise and advice. V. Levy and M. Leisa provided technical assistance in the SeaHorse measurements. D. Van Buren provided advice and assistance in pilot experiments. We thank A. Camacho for mouse colony assistance. We would also like to thank A. Kimmelman, R. Mostoslavsky, M. Vander Heiden, L. Ellisen, W. Kim and M. Ivan for discussions and critical review of the manuscript. We are grateful to S. Morrison and R. DePinho for sharing unpublished data. N.B. would like to acknowledge support from NIH U01 CA141576-01. D.T.S would like to acknowledge support from NIH DK050234 and Ellison Medical Foundation. S.G. was supported by a Massachusetts Biotechnology Research Council Tosteson Fellowship. S.Z.X. was supported by an NIH Ruth L. Kirschstein National Research Service Award.	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Torchia EC, 2007, MOL CELL BIOL, V27, P7918, DOI 10.1128/MCB.00099-07; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09	35	298	313	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					659	U75		10.1038/nature09572	http://dx.doi.org/10.1038/nature09572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124451	Green Accepted			2022-12-24	WOS:000284836700033
J	Luk, E; Ranjan, A; FitzGerald, PC; Mizuguchi, G; Huang, Y; Wei, D; Wu, C				Luk, Ed; Ranjan, Anand; FitzGerald, Peter C.; Mizuguchi, Gaku; Huang, Yingzi; Wei, Debbie; Wu, Carl			Stepwise Histone Replacement by SWR1 Requires Dual Activation with Histone H2A.Z and Canonical Nucleosome	CELL			English	Article							VARIANT H2A.Z; CHROMATIN; TRANSCRIPTION; REPLICATION; PROMOTERS; EXCHANGE; COMPLEX; ACETYLATION; STABILITY; DYNAMICS	Histone variant H2A.Z-containing nucleosomes are incorporated at most eukaryotic promoters. This incorporation is mediated by the conserved SWR1 complex, which replaces histone H2A in canonical nucleosomes with H2A.Z in an ATP-dependent manner. Here, we show that promoter-proximal nucleosomes are highly heterogeneous for H2A.Z in Saccharomyces cerevisiae, with substantial representation of nucleosomes containing one, two, or zero H2A.Z molecules. SWR1-catalyzed H2A.Z replacement in vitro occurs in a stepwise and unidirectional fashion, one H2A.Z-H2B dimer at a time, producing heterotypic nucleosomes as intermediates and homotypic H2A.Z nucleosomes as end products. The ATPase activity of SWR1 is specifically stimulated by H2A-containing nucleosomes without ensuing histone H2A eviction. Remarkably, further addition of free H2A.Z-H2B dimer leads to hyperstimulation of ATPase activity, eviction of nucleosomal H2A-H2B, and deposition of H2A.Z-H2B. These results suggest that the combination of H2A-containing nucleosome and free H2A.Z-H2B dimer acting as both effector and substrate for SWR1 governs the specificity and outcome of the replacement reaction.	[Luk, Ed; Ranjan, Anand; Mizuguchi, Gaku; Huang, Yingzi; Wei, Debbie; Wu, Carl] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [FitzGerald, Peter C.] NCI, Genome Anal Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Luk, E (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	luked@mail.nih.gov; carlwu@helix.nih.gov		Luk, Ed/0000-0002-6619-2258	National Cancer Institute; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [ZIABC005263] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W.H. Wu for the yeast strain SWR1-FL htz1 Delta and J. Landry for the yeast strain yJL036. We also thank H. Cam and C. Rubin for advice on microarray techniques, F. Pugh and members of the Wu lab for critical reading of the manuscript, and anonymous reviewers for helpful suggestions. This work was supported by the intramural research program of the National Cancer Institute (C.W.) and by the Leukemia and Lymphoma Society (E.L. and A.R.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Chakravarthy S, 2004, COLD SPRING HARB SYM, V69, P227, DOI 10.1101/sqb.2004.69.227; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Gutierrez JL, 2007, EMBO J, V26, P730, DOI 10.1038/sj.emboj.7601524; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Jackson JD, 2000, NUCLEIC ACIDS RES, V28, P3811, DOI 10.1093/nar/28.19.3811; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yoshida T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000910; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	50	154	158	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					725	736		10.1016/j.cell.2010.10.019	http://dx.doi.org/10.1016/j.cell.2010.10.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111233	Green Accepted			2022-12-24	WOS:000284583500015
J	Long, MA; Jin, DZZ; Fee, MS				Long, Michael A.; Jin, Dezhe Z.; Fee, Michale S.			Support for a synaptic chain model of neuronal sequence generation	NATURE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; IDENTIFIED HVC NEURONS; WHOLE-CELL RECORDINGS; ZEBRA FINCH; TERMINAL DENDRITES; NEURAL ACTIVITY; VOCAL CONTROL; NUCLEUS HVC; IN-VITRO; SONGBIRD	In songbirds, the remarkable temporal precision of song is generated by a sparse sequence of bursts in the premotor nucleus HVC. To distinguish between two possible classes of models of neural sequence generation, we carried out intracellular recordings of HVC neurons in singing zebra finches (Taeniopygia guttata). We found that the subthreshold membrane potential is characterized by a large, rapid depolarization 5-10 ms before burst onset, consistent with a synaptically connected chain of neurons in HVC. We found no evidence for the slow membrane potential modulation predicted by models in which burst timing is controlled by subthreshold dynamics. Furthermore, bursts ride on an underlying depolarization of similar to 10-ms duration, probably the result of a regenerative calcium spike within HVC neurons that could facilitate the propagation of activity through a chain network with high temporal precision. Our results provide insight into the fundamental mechanisms by which neural circuits can generate complex sequential behaviours.	[Long, Michael A.; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Jin, Dezhe Z.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Fee, MS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fee@mit.edu	Jin, Dezhe/AAE-6788-2020	Fee, Michale/0000-0001-7539-1745	National Institutes of Health [MH067105, DC009280]; Alfred P. Sloan Research Fellowship; National Science Foundation [IOS-0827731]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC009280, R00DC009280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Wilson, S. Seung, A. Andalman, J. Goldberg and A. Gray for comments on earlier versions of this manuscript. We would also like to thank A. Andalman, D. Aronov and T. Ramee for help with acquisition and analysis software. This work is supported by funding from the National Institutes of Health to M.S.F. (MH067105) and M.A.L. (DC009280), and from the Alfred P. Sloan Research Fellowship and the National Science Foundation to D.Z.J. (IOS-0827731).	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AMARI SI, 1972, IEEE T COMPUT, VC 21, P1197, DOI 10.1109/T-C.1972.223477; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Jun JK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000723; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kubota M, 1998, J NEUROPHYSIOL, V80, P914, DOI 10.1152/jn.1998.80.2.914; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lashley K.S., 1951, PROBLEM SERIAL ORDER, V21; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Lewicki MS, 1996, J NEUROSCI, V16, P5854; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; MOONEY R, 1992, J NEUROSCI, V12, P2464; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Solis MM, 2005, J NEUROSCI, V25, P2811, DOI 10.1523/JNEUROSCI.5285-04.2005; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; VU ET, 1994, J NEUROSCI, V14, P6924; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	46	238	242	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					394	399		10.1038/nature09514	http://dx.doi.org/10.1038/nature09514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20972420	Green Submitted, Green Accepted			2022-12-24	WOS:000284313100034
J	Freiwald, WA; Tsao, DY				Freiwald, Winrich A.; Tsao, Doris Y.			Functional Compartmentalization and Viewpoint Generalization Within the Macaque Face-Processing System	SCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; INFEROTEMPORAL CORTEX; OBJECT RECOGNITION; SINGLE NEURONS; VISUAL-CORTEX; MONKEY; AREA; REPRESENTATION; PERCEPTION; MEMORY	Primates can recognize faces across a range of viewing conditions. Representations of individual identity should thus exist that are invariant to accidental image transformations like view direction. We targeted the recently discovered face-processing network of the macaque monkey that consists of six interconnected face-selective regions and recorded from the two middle patches (ML, middle lateral, and MF, middle fundus) and two anterior patches (AL, anterior lateral, and AM, anterior medial). We found that the anatomical position of a face patch was associated with a unique functional identity: Face patches differed qualitatively in how they represented identity across head orientations. Neurons in ML and MF were view-specific; neurons in AL were tuned to identity mirror-symetrically across views, thus achieving partial view invariance; and neurons in AM, the most anterior face patch, achieved almost full view invariance.	[Freiwald, Winrich A.] Rockefeller Univ, New York, NY 10065 USA; [Tsao, Doris Y.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Rockefeller University; California Institute of Technology	Freiwald, WA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	wfreiwald@rockefeller.edu; dortsao@caltech.edu			Humboldt Foundation; German Science Foundation [FR 1437/3-1]; German Ministry of Science, Bremen Center for Advanced Imaging [01GO0506]; NIH [1R01EY019702]; Alfred Sloan Foundation; John Merck Foundation; Searle Foundation; Klingenstein Foundation; NSF [BCS-0847798]; Alexander von Humboldt Foundation; Irma T. Hirschl Trust; Monique Weill-Caulier Trust; Klingenstein Fellowship; Sinsheimer Scholar Award; Pew Scholar Award; NATIONAL EYE INSTITUTE [R01EY019702] Funding Source: NIH RePORTER	Humboldt Foundation(Alexander von Humboldt Foundation); German Science Foundation(German Research Foundation (DFG)); German Ministry of Science, Bremen Center for Advanced Imaging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred Sloan Foundation(Alfred P. Sloan Foundation); John Merck Foundation; Searle Foundation; Klingenstein Foundation(Klingenstein Philanthropies); NSF(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Irma T. Hirschl Trust; Monique Weill-Caulier Trust; Klingenstein Fellowship(Klingenstein Philanthropies); Sinsheimer Scholar Award; Pew Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to M. Livingstone, S. Moeller, C. Cadieu, and A. Tsao for discussions; N. Schweers for outstanding technical assistance; S. Chang and the late D. Freeman for stimulus programming; the Humboldt Foundation Sofia Kovalevskaya Award, German Science Foundation grant FR 1437/3-1, the German Ministry of Science (Grant 01GO0506, Bremen Center for Advanced Imaging), and NIH 1R01EY019702 for financial support; and the Otto Loewi Minerva Center for logistic support. D. Y. T. is supported by the Alfred Sloan Foundation, the John Merck Foundation, the Searle Foundation, the Klingenstein Foundation, and NSF CAREER Award BCS-0847798. W. A. F. is supported by a Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation, an Irma T. Hirschl and Monique Weill-Caulier Trusts Award, a Klingenstein Fellowship Award, a Sinsheimer Scholar Award, and a Pew Scholar Award.	Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Biederman I, 2000, SPATIAL VISION, V13, P241, DOI 10.1163/156856800741063; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Eifuku S, 2004, J NEUROPHYSIOL, V91, P358, DOI 10.1152/jn.00198.2003; HASSELMO ME, 1989, EXP BRAIN RES, V75, P417; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Li N, 2008, SCIENCE, V321, P1502, DOI 10.1126/science.1160028; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; McKone E, 2005, J EXP PSYCHOL HUMAN, V31, P1181, DOI 10.1037/0096-1523.31.6.1181; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rollenhagen JE, 2000, SCIENCE, V287, P1506, DOI 10.1126/science.287.5457.1506; Rolls ET, 2007, NEUROPSYCHOLOGIA, V45, P124, DOI 10.1016/j.neuropsychologia.2006.04.019; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; SALEEM KS, 1993, CEREB CORTEX, V3, P454, DOI 10.1093/cercor/3.5.454; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; VETTER T, 1994, CURR BIOL, V4, P18, DOI 10.1016/S0960-9822(00)00004-X; Wallis G, 2001, P NATL ACAD SCI USA, V98, P4800, DOI 10.1073/pnas.071028598; YAMANE S, 1988, EXP BRAIN RES, V73, P209, DOI 10.1007/BF00279674; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	34	408	412	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					845	851		10.1126/science.1194908	http://dx.doi.org/10.1126/science.1194908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051642	Green Accepted			2022-12-24	WOS:000283855700050
J	Pitt, JN; Ferre-D'Amare, AR				Pitt, Jason N.; Ferre-D'Amare, Adrian R.			Rapid Construction of Empirical RNA Fitness Landscapes	SCIENCE			English	Article							IN-VITRO; SELECTION; EVOLUTION; SEQUENCES; RIBOZYMES; MOLECULES; BINDING; LIGANDS	Evolution is an adaptive walk through a hypothetical fitness landscape, which depicts the relationship between genotypes and the fitness of each corresponding phenotype. We constructed an empirical fitness landscape for a catalytic RNA by combining next-generation sequencing, computational analysis, and "serial depletion," an in vitro selection protocol. By determining the reaction rate constant for every point mutant of a catalytic RNA, we demonstrated that abundance in serially depleted pools correlates with biochemical activity (correlation coefficient r = 0.67, standard score Z = 7.4). Therefore, enumeration of each genotype by deep sequencing yielded a fitness landscape containing similar to 10(7) unique sequences, without requiring measurement of the phenotypic fitness for each sequence. High-throughput mapping between genotype and phenotype may apply to artificial selections, host-pathogen interactions, and other biomedically relevant evolutionary phenomena.	[Ferre-D'Amare, Adrian R.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, 1100 Fairview Ave N, Seattle, WA 98109 USA.	aferre@fhcrc.org			W.M. Keck Foundation; Howard Hughes Medical Institute (HHMI)	W.M. Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	We thank R. Basom, A. Marty, and the staff of the Fred Hutchison Cancer Research Center Genomics Shared Resource for performing the Illumina sequencing and D. Bartel, B. Fritz, R. Knight, H. Malik, W. Noble, H. Robins, A. Roll-Mecak, and M. Tewari for discussions. This work was supported by the W.M. Keck Foundation and the Howard Hughes Medical Institute (HHMI). A.R.F.-D. is an investigator of the HHMI. Illumina sequence data have been deposited with the National Center for Biotechnology Information Sequence Read Archive with accession code SRA020870.	Carothers JM, 2004, J AM CHEM SOC, V126, P5130, DOI 10.1021/ja031504a; de la Pena M, 2009, RNA, V15, P1949, DOI 10.1261/rna.1889509; Domingo E, 2009, EMBO REP, V10, P444, DOI 10.1038/embor.2009.61; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fernandez G, 2007, J VIROL, V81, P2485, DOI 10.1128/JVI.01594-06; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; LEHMAN N, 1993, CURR BIOL, V3, P723, DOI 10.1016/0960-9822(93)90019-K; Pitt JN, 2010, NUCLEIC ACIDS RES, V38, P7908, DOI 10.1093/nar/gkq661; Pitt JN, 2009, J AM CHEM SOC, V131, P3532, DOI 10.1021/ja8067325; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Schuster P, 2001, BIOL CHEM, V382, P1301, DOI 10.1515/BC.2001.162; Schuster P, 2009, EUR REV, V17, P281, DOI 10.1017/S1062798709000787; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Stich M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-46; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Vlassov A, 2001, P NATL ACAD SCI USA, V98, P7706, DOI 10.1073/pnas.141041098; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	26	114	119	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					376	379		10.1126/science.1192001	http://dx.doi.org/10.1126/science.1192001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947767	Green Accepted			2022-12-24	WOS:000282986700043
J	Wang, K; Diskin, SJ; Zhang, HT; Attiyeh, EF; Winter, C; Hou, CP; Schnepp, RW; Diamond, M; Bosse, K; Mayes, PA; Glessner, J; Kim, C; Frackelton, E; Garris, M; Wang, Q; Glaberson, W; Chiavacci, R; Nguyen, L; Jagannathan, J; Saeki, N; Sasaki, H; Grant, SFA; Iolascon, A; Mosse, YP; Cole, KA; Li, HZ; Devoto, M; McGrady, PW; London, WB; Capasso, M; Rahman, N; Hakonarson, H; Maris, JM				Wang, Kai; Diskin, Sharon J.; Zhang, Haitao; Attiyeh, Edward F.; Winter, Cynthia; Hou, Cuiping; Schnepp, Robert W.; Diamond, Maura; Bosse, Kristopher; Mayes, Patrick A.; Glessner, Joseph; Kim, Cecilia; Frackelton, Edward; Garris, Maria; Wang, Qun; Glaberson, Wendy; Chiavacci, Rosetta; Nguyen, Le; Jagannathan, Jayanti; Saeki, Norihisa; Sasaki, Hiroki; Grant, Struan F. A.; Iolascon, Achille; Mosse, Yael P.; Cole, Kristina A.; Li, Hongzhe; Devoto, Marcella; McGrady, Patrick W.; London, Wendy B.; Capasso, Mario; Rahman, Nazneen; Hakonarson, Hakon; Maris, John M.			Integrative genomics identifies LMO1 as a neuroblastoma oncogene	NATURE			English	Article							COPY NUMBER; CHROMOSOMAL TRANSLOCATIONS; ACTIVATING MUTATIONS; ALK KINASE; GENE; TRANSCRIPTION; CANCER; INTERACTS; TARGET; CELLS	Neuroblastoma is a childhood cancer of the sympathetic nervous system that accounts for approximately 10% of all paediatric oncology deaths(1,2). To identify genetic risk factors for neuroblastoma, we performed a genome-wide association study (GWAS) on 2,251 patients and 6,097 control subjects of European ancestry from four case series. Here we report a significant association within LIM domain only 1 (LMO1) at 11p15.4 (rs110419, combined P = 5.2 x 10(-16), odds ratio of risk allele = 1.34 (95% confidence interval 1.25-1.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P < 0.0001) and survival (P = 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression.	[Wang, Kai; Zhang, Haitao; Hou, Cuiping; Glessner, Joseph; Kim, Cecilia; Frackelton, Edward; Glaberson, Wendy; Chiavacci, Rosetta; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Attiyeh, Edward F.; Winter, Cynthia; Schnepp, Robert W.; Diamond, Maura; Bosse, Kristopher; Mayes, Patrick A.; Garris, Maria; Wang, Qun; Nguyen, Le; Jagannathan, Jayanti; Mosse, Yael P.; Cole, Kristina A.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Attiyeh, Edward F.; Winter, Cynthia; Schnepp, Robert W.; Diamond, Maura; Bosse, Kristopher; Mayes, Patrick A.; Garris, Maria; Wang, Qun; Nguyen, Le; Jagannathan, Jayanti; Mosse, Yael P.; Cole, Kristina A.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Nguyen, Le; Li, Hongzhe; Devoto, Marcella] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Saeki, Norihisa; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Nguyen, Le; Grant, Struan F. A.; Mosse, Yael P.; Cole, Kristina A.; Devoto, Marcella; Hakonarson, Hakon; Maris, John M.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Devoto, Marcella; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Iolascon, Achille; Capasso, Mario] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [McGrady, Patrick W.] Univ Florida, Dept Stat, Gainesville, FL 32603 USA; [McGrady, Patrick W.] Childrens Oncol Grp, Gainesville, FL 32603 USA; [London, Wendy B.] Dana Farber Childrens Hosp, Ctr Canc, Boston, MA 02115 USA; [London, Wendy B.] Childrens Oncol Grp, Boston, MA 02115 USA; [Iolascon, Achille; Capasso, Mario] Univ Naples Federico 2, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy; [Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; National Cancer Center - Japan; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; CEINGE Biotecnologie Avanzate; Sapienza University Rome; State University System of Florida; University of Florida; Children's Oncology Group (COG); Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Children's Oncology Group (COG); University of Naples Federico II; University of London; Institute of Cancer Research - UK	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu; maris@chop.edu	Devoto, Marcella/AAP-7595-2021; Cole, Kristina/M-3922-2015; London, Wendy Beth/ABA-8948-2021; London, Wendy/ABD-4624-2021; Iolascon, Achille/A-4461-2014; Capasso, Mario/D-1617-2014; Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	London, Wendy Beth/0000-0003-3571-6538; Capasso, Mario/0000-0003-3306-1259; Glessner, Joseph/0000-0001-5131-2811; Mayes, Patrick/0000-0001-9104-4161; DEVOTO, MARCELLA/0000-0002-4431-5114; Grant, Struan/0000-0003-2025-5302; iolascon, achille/0000-0002-9558-0356; Rahman, Nazneen/0000-0003-4376-0440	National Institutes of Health [R01-CA124709]; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute; Associazione Oncologia Pediatrica e Neuroblastoma; Cotswold Foundation; Children's Hospital of Philadelphia;  [UL1-RR024134-03]; NATIONAL CANCER INSTITUTE [R01CA124709, U10CA098413, R00CA151869, U10CA098543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Associazione Oncologia Pediatrica e Neuroblastoma; Cotswold Foundation; Children's Hospital of Philadelphia; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We acknowledge the Children's Oncology Group for providing most blood and tumour specimens and clinical and outcome data (U10-CA98543 and U10-CA98413) from neuroblastoma patients. We thank G. P. Tonini for providing neuroblastoma DNA samples in the Italian replication cohort. This work was supported in part by National Institutes of Health grant R01-CA124709 (to J.M.M.), the Giulio D'Angio Endowed Chair (J.M.M.), the Alex's Lemonade Stand Foundation (J.M.M.), the Evan Dunbar Foundation (J.M.M.), the Rally Foundation (J.M.M.), Andrew's Army Foundation (J.M.M.), the Abramson Family Cancer Research Institute (J.M.M.), a Howard Hughes Medical Institute Research Training Fellowship (K. B.), a fellowship from Associazione Oncologia Pediatrica e Neuroblastoma (M. C.), a Research Development Award from the Cotswold Foundation (H. H.), UL1-RR024134-03 (H. H.) and an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia (H.H.).	Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; FISCH P, 1992, ONCOGENE, V7, P2389; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Neale Geoffrey A. M., 1997, Leukemia (Basingstoke), V11, P289; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Rabbitts TH, 1999, CANCER RES, V59, p1794S; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618	22	216	222	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					216	220		10.1038/nature09609	http://dx.doi.org/10.1038/nature09609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21124317	Green Accepted			2022-12-24	WOS:000286143400039
J	Ruta, V; Datta, SR; Vasconcelos, ML; Freeland, J; Looger, LL; Axel, R				Ruta, Vanessa; Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Freeland, Jessica; Looger, Loren L.; Axel, Richard			A dimorphic pheromone circuit in Drosophila from sensory input to descending output	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; MALE COURTSHIP BEHAVIOR; RECEPTOR NEURONS; NEURAL CIRCUITRY; FRUITLESS GENE; MELANOGASTER; REPRESENTATION; AGGRESSION; ORGANIZATION; BRAIN	Drosophila show innate olfactory-driven behaviours that are observed in naive animals without previous learning or experience, suggesting that the neural circuits that mediate these behaviours are genetically programmed. Despite the numerical simplicity of the fly nervous system, features of the anatomical organization of the fly brain often confound the delineation of these circuits. Here we identify a neural circuit responsive to cVA, a pheromone that elicits sexually dimorphic behaviours(1-4). We have combined neural tracing using an improved photoactivatable green fluorescent protein (PA-GFP) with electrophysiology, optical imaging and laser-mediated microlesioning to map this circuit from the activation of sensory neurons in the antennae to the excitation of descending neurons in the ventral nerve cord. This circuit is concise and minimally comprises four neurons, connected by three synapses. Three of these neurons are overtly dimorphic and identify a male-specific neuropil that integrates inputs from multiple sensory systems and sends outputs to the ventral nerve cord. This neural pathway suggests a means by which a single pheromone can elicit different behaviours in the two sexes.	[Ruta, Vanessa; Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Freeland, Jessica; Axel, Richard] Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Ruta, Vanessa; Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Freeland, Jessica; Axel, Richard] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu		Ruta, Vanessa/0000-0002-4963-2768; Axel, Richard/0000-0002-3141-4076; Vasconcelos, Maria Luisa/0000-0001-6248-3667; Datta, Sandeep/0000-0002-8068-3862	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Helen Hay Whitney Foundation; Burroughs Welcome Fund; Howard Hughes Medical Institute	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Helen Hay Whitney Foundation; Burroughs Welcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank T. Jessell, C. Zuker and members of the Axel laboratory for discussion and comments on this manuscript; J. Flores for technical assistance; B. Dickson for reagents; P. Kisloff for assistance in the preparation of this manuscript; and M. Gutierrez and A. Nemes for general laboratory support. This work was funded in part by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative. Further financial support was provided by the Helen Hay Whitney Foundation (V.R. and S.R.D.), the Burroughs Welcome Fund (S.R.D.) and the Howard Hughes Medical Institute (R.A. and L.L.L.).	BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Chan YB, 2007, P NATL ACAD SCI USA, V104, P19577, DOI 10.1073/pnas.0709803104; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dulac C, 2007, CURR OPIN NEUROBIOL, V17, P675, DOI 10.1016/j.conb.2008.01.009; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Ito K, 1998, LEARN MEMORY, V5, P52; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	33	232	235	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					686	U106		10.1038/nature09554	http://dx.doi.org/10.1038/nature09554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124455				2022-12-24	WOS:000284836700039
J	Ginhoux, F; Greter, M; Leboeuf, M; Nandi, S; See, P; Gokhan, S; Mehler, MF; Conway, SJ; Ng, LG; Stanley, ER; Samokhvalov, IM; Merad, M				Ginhoux, Florent; Greter, Melanie; Leboeuf, Marylene; Nandi, Sayan; See, Peter; Gokhan, Solen; Mehler, Mark F.; Conway, Simon J.; Ng, Lai Guan; Stanley, E. Richard; Samokhvalov, Igor M.; Merad, Miriam			Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages	SCIENCE			English	Article							MOUSE BRAIN; YOLK-SAC; CELLS; RECEPTOR; ORIGIN; MICE; HEMATOPOIESIS; FRACTALKINE; PHAGOCYTES; MONOCYTES	Microglia are the resident macrophages of the central nervous system and are associated with the pathogenesis of many neurodegenerative and brain inflammatory diseases; however, the origin of adult microglia remains controversial. We show that postnatal hematopoietic progenitors do not significantly contribute to microglia homeostasis in the adult brain. In contrast to many macrophage populations, we show that microglia develop in mice that lack colony stimulating factor-1 (CSF-1) but are absent in CSF-1 receptor-deficient mice. In vivo lineage tracing studies established that adult microglia derive from primitive myeloid progenitors that arise before embryonic day 8. These results identify microglia as an ontogenically distinct population in the mononuclear phagocyte system and have implications for the use of embryonically derived microglial progenitors for the treatment of various brain disorders.	[Ginhoux, Florent; Greter, Melanie; Leboeuf, Marylene; Merad, Miriam] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Ginhoux, Florent; Greter, Melanie; Leboeuf, Marylene; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Ginhoux, Florent; See, Peter; Ng, Lai Guan] BIOPOLIS, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Nandi, Sayan; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Rose F Kennedy Ctr Res Intellectual & Dev Disabil, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Psychiat, Bronx, NY 10461 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Behav Sci, Bronx, NY 10461 USA; [Conway, Simon J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Samokhvalov, Igor M.] RIKEN Kobe, CDB, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Indiana University System; Indiana University Bloomington; RIKEN	Ginhoux, F (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, 1425 Madison Ave, New York, NY 10029 USA.	Florent_ginhoux@immunol.a-star.edu.sg; Miriam.Merad@mssm.edu	Stanley, Evan R/J-9154-2013; Ng, Lai Guan/N-6980-2019; Ng, Lai Guan/E-5673-2011	Stanley, Evan R/0000-0002-2910-2065; Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; See, Peter/0000-0003-4428-7763; Greter, Melanie/0000-0002-7220-5369	NIH [CA112100, HL086899, AI080884, CA32551, CA26504, MH66290, NS38902]; RIKEN; National Science Foundation of Switzerland; NATIONAL CANCER INSTITUTE [R37CA026504, R01CA112100, R01CA032551, R01CA026504] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060714, R01HL086899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038902] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN; National Science Foundation of Switzerland(Swiss National Science Foundation (SNSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Nishikawa, H. Snoeck, and P. S. Frenette for intellectual input in the study; the RIKEN CDB Laboratory for Animal Resources and Genetic Engineering for providing the Runx1-MER-Cre-MER mice; G. Hoeffel, X. H. Zong, R. Basu and H. Ketchum for technical assistance; and L. Robinson for critical review and editing of the manuscript. This work was supported by NIH grants CA112100, HL086899, and AI080884 to M. M.; CA32551 and CA26504 to E. R. S.; and MH66290 and NS38902 to M. M. I. M. S. is supported by a grant from RIKEN Strategic Programs for Research and Development (President's Fund). M. G. is supported by the National Science Foundation of Switzerland. Runx1-MER-Cre-MER mice have CDB accession. no. CDB0524K (www.cdb.riken.jp/arg/mutant%20mice%20list.html).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; BLEVINS G, 1995, J NEUROSCI RES, V40, P535, DOI 10.1002/jnr.490400412; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; LEONG SK, 1992, GLIA, V6, P39, DOI 10.1002/glia.440060106; Lichanska AM, 2000, EXP HEMATOL, V28, P601, DOI 10.1016/S0301-472X(00)00157-0; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; LING EA, 1979, J ANAT, V128, P847; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; SOROKIN SP, 1992, ANAT REC, V232, P527, DOI 10.1002/ar.1092320410; Vallieres L, 2003, J NEUROSCI, V23, P5197; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822	31	2949	3021	16	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					841	845		10.1126/science.1194637	http://dx.doi.org/10.1126/science.1194637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20966214	Green Accepted			2022-12-24	WOS:000283855700049
J	Lobo, MK; Covington, HE; Chaudhury, D; Friedman, AK; Sun, HS; Damez-Werno, D; Dietz, DM; Zaman, S; Koo, JW; Kennedy, PJ; Mouzon, E; Mogri, M; Neve, RL; Deisseroth, K; Han, MH; Nestler, EJ				Lobo, Mary Kay; Covington, Herbert E., III; Chaudhury, Dipesh; Friedman, Allyson K.; Sun, HaoSheng; Damez-Werno, Diane; Dietz, David M.; Zaman, Samir; Koo, Ja Wook; Kennedy, Pamela J.; Mouzon, Ezekiell; Mogri, Murtaza; Neve, Rachael L.; Deisseroth, Karl; Han, Ming-Hu; Nestler, Eric J.			Cell Type-Specific Loss of BDNF Signaling Mimics Optogenetic Control of Cocaine Reward	SCIENCE			English	Article							CONDITIONED-PLACE PREFERENCE; MESOLIMBIC DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS; IN-VIVO; BASAL GANGLIA; NEUROTROPHIC FACTOR; DELTA-FOSB; KINASE-B; RECEPTOR; NEURONS	The nucleus accumbens is a key mediator of cocaine reward, but the distinct roles of the two subpopulations of nucleus accumbens projection neurons, those expressing dopamine D1 versus D2 receptors, are poorly understood. We show that deletion of TrkB, the brain-derived neurotrophic factor (BDNF) receptor, selectively from D1+ or D2+ neurons oppositely affects cocaine reward. Because loss of TrkB in D2+ neurons increases their neuronal excitability, we next used optogenetic tools to control selectively the firing rate of D1+ and D2+ nucleus accumbens neurons and studied consequent effects on cocaine reward. Activation of D2+ neurons, mimicking the loss of TrkB, suppresses cocaine reward, with opposite effects induced by activation of D1+ neurons. These results provide insight into the molecular control of D1+ and D2+ neuronal activity as well as the circuit-level contribution of these cell types to cocaine reward.	[Lobo, Mary Kay; Covington, Herbert E., III; Sun, HaoSheng; Damez-Werno, Diane; Dietz, David M.; Zaman, Samir; Koo, Ja Wook; Kennedy, Pamela J.; Mouzon, Ezekiell; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Mogri, Murtaza; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Stanford University; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Han, Ming-Hu/G-8836-2012; Lobo, Mary Kay/K-7734-2015; Dietz, David/AAW-4574-2021; Dietz, David/J-9458-2015	Lobo, Mary Kay/0000-0002-9419-2079; Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Sun, Haosheng/0000-0003-3919-559X	National Institute on Drug Abuse; MSSM [NIDA T32 DA007135-26A2]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007359, P01DA008227, T32DA007135, R01DA014133] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MSSM; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Heintz and P. Greengard (Rockefeller University) and C. R. Gerfen (NIH/NIMH) for providing us with D1-Cre, D2-Cre, D1-GFP, and D2-GFP mice. We thank M. S. Levine and X. W. Yang (UCLA) for providing us with D1-GFP and D2-GFP mice. We thank L. Parada (UTSouthwestern) for providing us with the flTrkB mice. We thank V. Lessman (Otto-von-Guericke-Universitat) for providing us with the TrkB (full length)-GFP construct. This work was supported by grants from the National Institute on Drug Abuse, and M. K. L. is supported by the Drug Abuse Research Training Program at MSSM (NIDA T32 DA007135-26A2).	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Bahi A, 2008, PSYCHOPHARMACOLOGY, V199, P169, DOI 10.1007/s00213-008-1164-1; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; CAO JL, 2010, P NATL ACAD IN PRESS; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Crooks KR, 2010, NEUROPHARMACOLOGY, V58, P1067, DOI 10.1016/j.neuropharm.2010.01.014; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Freeman AY, 2003, NEUROSCIENCE, V117, P147, DOI 10.1016/S0306-4522(02)00802-3; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Grimm JW, 2003, J NEUROSCI, V23, P742; Heusner CL, 2005, J NEUROSCI, V25, P6651, DOI 10.1523/JNEUROSCI.1474-05.2005; Horger BA, 1999, J NEUROSCI, V19, P4110; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Luikart BW, 2003, NEUROSCIENCE, V117, P847, DOI 10.1016/S0306-4522(02)00719-4; Mikkelsen JD, 2005, EUR J PHARMACOL, V519, P223, DOI 10.1016/j.ejphar.2005.06.049; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Peoples L L, 2007, ScientificWorldJournal, V7, P22; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Self DW, 2010, RECEPT SER, P479, DOI 10.1007/978-1-60327-333-6_17; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Vassoler FM, 2008, J NEUROSCI, V28, P8735, DOI 10.1523/JNEUROSCI.5277-07.2008; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006	40	572	584	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					385	390		10.1126/science.1188472	http://dx.doi.org/10.1126/science.1188472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947769	Green Accepted			2022-12-24	WOS:000282986700045
J	Zhang, MJ; Su, YQ; Sugiura, K; Xia, GL; Eppig, JJ				Zhang, Meijia; Su, You-Qiang; Sugiura, Koji; Xia, Guoliang; Eppig, John J.			Granulosa Cell Ligand NPPC and Its Receptor NPR2 Maintain Meiotic Arrest in Mouse Oocytes	SCIENCE			English	Article							NATRIURETIC-PEPTIDE; CUMULUS CELLS; CYCLIC-GMP; MATURATION; GPR3; FOLLICLES; VITRO; OVARY; BMP15	Granulosa cells of mammalian Graafian follicles maintain oocytes in meiotic arrest, which prevents their precocious maturation. We show that mouse mural granulosa cells, which line the follicle wall, express natriuretic peptide precursor type C (Nppc) messenger RNA (mRNA), whereas cumulus cells surrounding oocytes express mRNA of the NPPC receptor NPR2, a guanylyl cyclase. NPPC increased cGMP levels in cumulus cells and oocytes and inhibited meiotic resumption in vitro. Meiotic arrest was not sustained in most Graafian follicles of Nppc or Npr2 mutant mice, and meiosis resumed precociously. Oocyte-derived paracrine factors promoted cumulus cell expression of Npr2 mRNA. Therefore, the granulosa cell ligand NPPC and its receptor NPR2 in cumulus cells prevent precocious meiotic maturation, which is critical for maturation and ovulation synchrony and for normal female fertility.	[Zhang, Meijia; Xia, Guoliang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Zhang, Meijia; Su, You-Qiang; Sugiura, Koji; Eppig, John J.] Jackson Lab, 600 Main St, Bar Harbor 04609, ME USA	China Agricultural University; Jackson Laboratory	Eppig, JJ (corresponding author), Jackson Lab, 600 Main St, Bar Harbor 04609, ME USA.	glxia@cau.edu.cn; john.eppig@jax.org	Sugiura, Koji/AAE-2966-2019; Su, You-Qiang/C-6160-2019	Sugiura, Koji/0000-0001-8945-3353; Su, You-Qiang/0000-0003-3537-6246; Xia, Guoliang/0000-0003-3674-0142; Zhang, Meijia/0000-0001-7803-3054	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD23839, HD21970]; National Basic Research Program of China [2007CB947401, 2006CB504003]; State Key Laboratory for Agrobiotechnology of China [2009SKLAB07-5]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023839] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD021970, R37HD021970] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory for Agrobiotechnology of China; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank G. Cox, T. Gridley, and M. A. Handel for comments in preparation of the manuscript and L. Jaffe for helpful discussions. J.J.E., K. S., and Y.-Q.S. were supported by grants HD23839 and HD21970 from Eunice Kennedy Shriver National Institute of Child Health and Human Development. M.Z. and G. X. received support from National Basic Research Program of China (grants 2007CB947401 and 2006CB504003) and grant 2009SKLAB07-5 from State Key Laboratory for Agrobiotechnology of China. We also thank M. Mazuk, Baylor College of Medicine, for providing GDF9 and BMP15 and M. O'Brien and K. Wigglesworth for technical assistance.	Diaz FJ, 2007, J CELL SCI, V120, P1330, DOI 10.1242/jcs.000968; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Jankowski M, 1997, BIOL REPROD, V56, P59, DOI 10.1095/biolreprod56.1.59; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Richard FJ, 2001, BIOL REPROD, V65, P1444, DOI 10.1095/biolreprod65.5.1444; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; TORNELL J, 1990, ENDOCRINOLOGY, V126, P1504, DOI 10.1210/endo-126-3-1504; Tsuji T, 2008, BIOCHEM BIOPH RES CO, V376, P186, DOI 10.1016/j.bbrc.2008.08.139; Vaccari S, 2009, BIOL REPROD, V81, P595, DOI 10.1095/biolreprod.109.077768	15	354	396	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					366	369		10.1126/science.1193573	http://dx.doi.org/10.1126/science.1193573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947764	Green Accepted			2022-12-24	WOS:000282986700040
J	Wagner, CR; Kuervers, L; Baillie, DL; Yanowitz, JL				Wagner, Cynthia R.; Kuervers, Lynnette; Baillie, David L.; Yanowitz, Judith L.			xnd-1 regulates the global recombination landscape in Caenorhabditis elegans	NATURE			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC RECOMBINATION; C-ELEGANS; DNA; COMPLEX; PRDM9; CROSSOVERS; GERMLINE; HOTSPOTS; REVEALS	Meiotic crossover (CO) recombination establishes physical linkages between homologous chromosomes that are required for their proper segregation into developing gametes, and promotes genetic diversity by shuffling genetic material between parental chromosomes. COs require the formation of double strand breaks (DSBs) to create the substrate for strand exchange. DSBs occur in small intervals called hotspots(1-3) and significant variation in hotspot usage exists between and among individuals(4). This variation is thought to reflect differences in sequence identity and chromatin structure, DNA topology and/or chromosome domain organization(1,5-9). Chromosomes show different frequencies of nondisjunction (NDJ)(10), reflecting inherent differences in meiotic crossover control, yet the underlying basis of these differences remains elusive. Here we show that a novel chromatin factor, X non-disjunction factor 1 (xnd-1), is responsible for the global distribution of COs in C. elegans. xnd-1 is also required for formation of double-strand breaks (DSBs) on the X, but surprisingly XND-1 protein is autosomally enriched. We show that xnd-1 functions independently of genes required for X chromosome-specific gene silencing, revealing a novel pathway that distinguishes the X from autosomes in the germ line, and further show that xnd-1 exerts its effects on COs, at least in part, by modulating levels of H2A lysine 5 acetylation.	[Wagner, Cynthia R.; Yanowitz, Judith L.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Kuervers, Lynnette; Baillie, David L.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Yanowitz, Judith L.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Yanowitz, Judith L.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA	Carnegie Institution for Science; Simon Fraser University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yanowitz, JL (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	yanowitzjl@mwri.magee.edu	Yanowitz, Judith L/AGJ-8504-2022	Yanowitz, Judith L/0000-0001-6886-8787	Carnegie Institution of Washington, NIH [K01AG031296]; MWRI; NSERC; NATIONAL INSTITUTE ON AGING [K01AG031296] Funding Source: NIH RePORTER	Carnegie Institution of Washington, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MWRI; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Bembenek, A. Bortvin, G. Deshpande, M. Halpern, V. Jantsch, A. MacQueen and D. Mets for comments on the manuscript; the Koshland lab and Baltimore Area Worm Club for discussions; M. Siddiqi for microscopy support. We are indebted to the Caenorhabditis Genetics Center and the C. elegans Knockout Consortium for worm stocks and Y. Kohara for cDNAs. This work was supported by the Carnegie Institution of Washington, NIH K01AG031296, and MWRI start-up funds to J.L.Y.D.L.B. was supported by a Canada Research Chair and a grant from NSERC.	BARNES TM, 1995, GENETICS, V141, P159; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; BRENNER S, 1974, GENETICS, V77, P71; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; CHAN A, 2006, PROTOCOL 21 ANTIBODY; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HODGKIN J, 1979, GENETICS, V91, P67; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lim JGY, 2008, GENETICS, V180, P715, DOI 10.1534/genetics.108.090142; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petty EL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000699; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Smolikov S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000088; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; ZETKA MC, 1995, GENETICS, V141, P1339	36	56	57	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					839	U103		10.1038/nature09429	http://dx.doi.org/10.1038/nature09429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944745	Green Accepted, Green Submitted			2022-12-24	WOS:000282898700066
J	Nicodeme, E; Jeffrey, KL; Schaefer, U; Beinke, S; Dewell, S; Chung, CW; Chandwani, R; Marazzi, I; Wilson, P; Coste, H; White, J; Kirilovsky, J; Rice, CM; Lora, JM; Prinjha, RK; Lee, K; Tarakhovsky, A				Nicodeme, Edwige; Jeffrey, Kate L.; Schaefer, Uwe; Beinke, Soren; Dewell, Scott; Chung, Chun-wa; Chandwani, Rohit; Marazzi, Ivan; Wilson, Paul; Coste, Herve; White, Julia; Kirilovsky, Jorge; Rice, Charles M.; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin; Tarakhovsky, Alexander			Suppression of inflammation by a synthetic histone mimic	NATURE			English	Article							BROMODOMAIN PROTEIN BRD4; TRANSCRIPTIONAL ELONGATION; GENE-EXPRESSION; BINDING MODULES; P-TEFB; CHROMATIN; COMPLEXES; MACHINES	Interaction of pathogens with cells of the immune system results in activation of inflammatory gene expression. This response, although vital for immune defence, is frequently deleterious to the host due to the exaggerated production of inflammatory proteins. The scope of inflammatory responses reflects the activation state of signalling proteins upstream of inflammatory genes as well as signal-induced assembly of nuclear chromatin complexes that support mRNA expression(1-4). Recognition of post-translationally modified histones by nuclear proteins that initiate mRNA transcription and support mRNA elongation is a critical step in the regulation of gene expression(5-10). Here we present a novel pharmacological approach that targets inflammatory gene expression by interfering with the recognition of acetylated histones by the bromodomain and extra terminal domain (BET) family of proteins. We describe a synthetic compound (I-BET) that by 'mimicking' acetylated histones disrupts chromatin complexes responsible for the expression of key inflammatory genes in activated macrophages, and confers protection against lipopolysaccharide-induced endotoxic shock and bacteria-induced sepsis. Our findings suggest that synthetic compounds specifically targeting proteins that recognize post-translationally modified histones can serve as a new generation of immunomodulatory drugs.	[Jeffrey, Kate L.; Schaefer, Uwe; Chandwani, Rohit; Marazzi, Ivan; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA; [Nicodeme, Edwige; Coste, Herve; Kirilovsky, Jorge] Ctr Res GSK, F-91140 Villebon Sur Yvette, France; [Beinke, Soren; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin] GlaxoSmithKline, Med Res Ctr, Epinova DPU, Immunoinflammat Ctr Excellence Drug Discovery, Stevenage SG1 2NY, Herts, England; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA; [Chung, Chun-wa; Wilson, Paul; White, Julia] GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England; [Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA	Rockefeller University; GlaxoSmithKline; GlaxoSmithKline; Rockefeller University; GlaxoSmithKline; Rockefeller University	Tarakhovsky, A (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10065 USA.	Kevin.2.Lee@gsk.com; tarakho@rockefeller.edu		Chandwani, Rohit/0000-0003-4781-6069; Jeffrey, Kate/0000-0001-5746-0153; marazzi, ivan/0000-0003-3376-0922	NIHKL2 Career Development Award; American Italian Cancer Foundation; National Health and Medical Research Council of Australia	NIHKL2 Career Development Award; American Italian Cancer Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We would like to acknowledge R. Grimley and C. Patel for supplying FRET data and R. Woodward, C. Delves, E. Jones and P. Holmes for protein production. J. Witherington, N. Smithers, S. Baddeley, J. Seal and L. Cutler provided compound selectivity and pharmacokinetics data. G. Krysa, O. Mirguet and R. Gosmini contributed to the discovery, development and characterization of the compound. We thank R. Anthony and S. McCleary for assistance with animal models, R. Gejman for bioinformatics analysis of gene expression kinetics and A. Santana and T. Chapman for technical assistance. We would like to thank C. Nathan, R. Medzhitov, S. Rudensky and S. Smale for helpful discussions and S. Sampath for his contribution to the concept of 'histone mimicry'. R. C. is supported by an NIHKL2 Career Development Award and I. M. is supported by the American Italian Cancer Foundation. K. L. J. is supported by the National Health and Medical Research Council of Australia and is currently a Rockefeller University Women in Science Fellow.	Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Huang HD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-57; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; RITTIRSCH D, 2008, NAT PROTOC, V4, P31, DOI DOI 10.1038/NPROT.2008.214; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029	27	1128	1264	5	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1119	1123		10.1038/nature09589	http://dx.doi.org/10.1038/nature09589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21068722	Green Accepted			2022-12-24	WOS:000285553800062
J	Gan, BY; Hu, JA; Jiang, S; Liu, YC; Sahin, E; Zhuang, L; Fletcher-Sananikone, E; Colla, S; Wang, YA; Chin, L; DePinho, RA				Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.			Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells	NATURE			English	Article							MITOCHONDRIAL BIOGENESIS; ENERGY; RESISTANCE; PATHWAY; BIOLOGY; STRESS; KINASE; FOXOS	The capacity to fine-tune cellular bioenergetics with the demands of stem-cell maintenance and regeneration is central to normal development and ageing, and to organismal survival during periods of acute stress. How energy metabolism and stem-cell homeostatic processes are coordinated is not well understood. Lkb1 acts as an evolutionarily conserved regulator of cellular energy metabolism in eukaryotic cells and functions as the major upstream kinase to phosphorylate AMP-activated protein kinase (AMPK) and 12 other AMPK-related kinases(1-3). Whether Lkb1 regulates stem-cell maintenance remains unknown. Here we show that Lkb1 has an essential role in haematopoietic stem cell (HSC) homeostasis. We demonstrate that ablation of Lkb1 in adult mice results in severe pancytopenia and subsequent lethality. Loss of Lkb1 leads to impaired survival and escape from quiescence of HSCs, resulting in exhaustion of the HSC pool and a marked reduction of HSC repopulating potential in vivo. Lkb1 deletion has an impact on cell proliferation in HSCs, but not on more committed compartments, pointing to context-specific functions for Lkb1 in haematopoiesis. The adverse impact of Lkb1 deletion on haematopoiesis was predominantly cell-autonomous and mTOR complex 1 (mTORC1)-independent, and involves multiple mechanisms converging on mitochondrial apoptosis and possibly downregulation of PGC-1 coactivators and their transcriptional network, which have critical roles in mitochondrial biogenesis and function. Thus, Lkb1 serves as an essential regulator of HSCs and haematopoiesis, and more generally, points to the critical importance of coupling energy metabolism and stem-cell homeostasis.	[Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Gan, Boyi/HDM-4206-2022	DePinho, Ronald/0000-0002-5625-577X; Colla, Simona/0000-0001-6583-8910	DOD [TS093049]; Multiple Myeloma Research Foundation; Robert A. and Renee E. Belfer Foundation;  [U01CA141508];  [R21CA135057]; NATIONAL CANCER INSTITUTE [R21CA135057, U01CA141508] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Multiple Myeloma Research Foundation; Robert A. and Renee E. Belfer Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to A. Berns for providing the Rosa26-creERt2 mouse strain. We are also grateful to S. Zhou for assistance in the animal facility and C. Lim for assistance with genotyping. We thank S. Lazo-Kallanian, J. Daley and P. Schow for assistance with flow cytometry. We also thank N. Bardeesy and S. Morrison for communicating unpublished information; A. Stegh for comments on apoptosis; and D. Nakada for western blotting protocol from sorted HSCs. This research was supported by U01CA141508 (R.A.D. and L.C.), R21CA135057 (R.A.D. and B.G.) and DOD TSCRP Career Transition Award (TS093049) (B.G.). B.G. and J.H. are the Research Fellows of the Leukemia and Lymphoma Society. Y.A.W. is supported by Multiple Myeloma Research Foundation. R.A.D. was supported by an American Cancer Society Research Professorship and the Robert A. and Renee E. Belfer Foundation.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Gan B, 2009, CELL CYCLE, V8, P1003, DOI 10.4161/cc.8.7.8045; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Li C., 2003, ANAL GENE EXPRESSION; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	24	318	332	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2010	468	7324					701	U125		10.1038/nature09595	http://dx.doi.org/10.1038/nature09595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124456	Green Accepted			2022-12-24	WOS:000284836700042
J	Guzman, JN; Sanchez-Padilla, J; Wokosin, D; Kondapalli, J; Ilijic, E; Schumacker, PT; Surmeier, DJ				Guzman, Jaime N.; Sanchez-Padilla, Javier; Wokosin, David; Kondapalli, Jyothisri; Ilijic, Ema; Schumacker, Paul T.; Surmeier, D. James			Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1	NATURE			English	Article							CALCIUM-CHANNEL BLOCKERS; MITOCHONDRIA; DISEASE; CELLS; MUTATIONS	Parkinson's disease is a pervasive, ageing-related neurodegenerative disease the cardinal motor symptoms of which reflect the loss of a small group of neurons, the dopaminergic neurons in the substantia nigra pars compacta(1) (SNc). Mitochondrial oxidant stress is widely viewed as being responsible for this loss(2), but why these particular neurons should be stressed is a mystery. Here we show, using transgenic mice that expressed a redox-sensitive variant of green fluorescent protein targeted to the mitochondrial matrix, that the engagement of plasma membrane L-type calcium channels during normal autonomous pacemaking created an oxidant stress that was specific to vulnerable SNc dopaminergic neurons. The oxidant stress engaged defences that induced transient, mild mitochondrial depolarization or uncoupling. The mild uncoupling was not affected by deletion of cyclophilin D, which is a component of the permeability transition pore, but was attenuated by genipin and purine nucleotides, which are antagonists of cloned uncoupling proteins. Knocking out DJ-1 (also known as PARK7 in humans and Park7 in mice), which is a gene associated with an early-onset form of Parkinson's disease, downregulated the expression of two uncoupling proteins (UCP4 (SLC25A27) and UCP5 (SLC25A14)), compromised calcium-induced uncoupling and increased oxidation of matrix proteins specifically in SNc dopaminergic neurons. Because drugs approved for human use can antagonize calcium entry through L-type channels, these results point to a novel neuroprotective strategy for both idiopathic and familial forms of Parkinson's disease.	[Guzman, Jaime N.; Sanchez-Padilla, Javier; Wokosin, David; Ilijic, Ema; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Kondapalli, Jyothisri; Schumacker, Paul T.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Tuluc, Petronel/C-2527-2011	Schumacker, Paul T/0000-0001-9591-2034	Picower Foundation; Hartman Foundation; Falk Trust; Parkinson's Disease Foundation; NIH [NS047085, NS 054850, K12GM088020, HL35440, RR025355]; DOD [W81XWH-07-1-0170]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS047085, P30NS054850] Funding Source: NIH RePORTER	Picower Foundation; Hartman Foundation; Falk Trust(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Parkinson's Disease Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge the technical help of P. Hockberger, N. Schwarz, S. Ulrich, Y. Chen, C. S. Chan, D. Dryanovskiand K. Saporito. We acknowledge S. Chan for supplying quantitative PCR primer sets. We acknowledge the gifts of DJ-1 knockout mice from T. and V. Dawson, Ucp2 knockout mice from D. Kong and B. Lowell, and cyclophilin D knockout mice from S. J. Korsmeyer. This work was supported by the Picower Foundation, the Hartman Foundation, the Falk Trust, the Parkinson's Disease Foundation, NIH grants NS047085 (D.J.S.), NS 054850 (D.J.S.), K12GM088020 (J.S.-P.), HL35440 (P.T.S.) and RR025355 (P.T.S.), and DOD contract W81XWH-07-1-0170 (D.J.S.).	ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cookson MR, 2010, MOVEMENT DISORD, V25, pS44, DOI 10.1002/mds.22713; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Eisenberg MJ, 2004, AM J MED, V116, P35, DOI 10.1016/j.amjmed.2003.08.027; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Khaliq ZM, 2010, J NEUROSCI, V30, P7401, DOI 10.1523/JNEUROSCI.0143-10.2010; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Nicholls D., 2002, BIOENERGETICS, V3; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	33	573	586	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					696	U119		10.1038/nature09536	http://dx.doi.org/10.1038/nature09536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21068725	Green Accepted			2022-12-24	WOS:000284836700041
J	Graham, AL; Hayward, AD; Watt, KA; Pilkington, JG; Pemberton, JM; Nussey, DH				Graham, Andrea L.; Hayward, Adam D.; Watt, Kathryn A.; Pilkington, Jill G.; Pemberton, Josephine M.; Nussey, Daniel H.			Fitness Correlates of Heritable Variation in Antibody Responsiveness in a Wild Mammal	SCIENCE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; FEMALE SOAY SHEEP; AUTOIMMUNE-DISEASE; SUSCEPTIBILITY; AUTOANTIBODIES; POPULATION; TOLERANCE; PREVALENCE; MODEL; AGE	A functional immune system is important for survival in natural environments, where individuals are frequently exposed to parasites. Yet strong immune responses may have fitness costs if they deplete limited energetic resources or cause autoimmune disease. We have found associations between fitness and heritable self-reactive antibody responsiveness in a wild population of Soay sheep. The occurrence of self-reactive antibodies correlated with overall antibody responsiveness and was associated with reduced reproduction in adults of both sexes. However, in females, the presence of self-reactive antibodies was positively associated with adult survival during harsh winters. Our results highlight the complex effects of natural selection on immune responsiveness and suggest that fitness trade-offs may maintain immunoheterogeneity, including genetic variation in autoimmune susceptibility.	[Graham, Andrea L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Graham, Andrea L.; Hayward, Adam D.; Watt, Kathryn A.; Pilkington, Jill G.; Pemberton, Josephine M.; Nussey, Daniel H.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Graham, Andrea L.; Watt, Kathryn A.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Graham, Andrea L.; Nussey, Daniel H.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland	Princeton University; University of Edinburgh; University of Edinburgh; University of Edinburgh	Graham, AL (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	algraham@princeton.edu	Graham, Andrea L./P-7296-2019; Hayward, Adam/B-7659-2016; Pemberton, Josephine M/F-3100-2010; Nussey, Daniel H/F-4155-2010; Graham, Andrea L./A-8808-2010; Graham, Andrea/GON-8450-2022	Graham, Andrea L./0000-0002-6580-2755; Hayward, Adam/0000-0001-6953-7509; Graham, Andrea L./0000-0002-6580-2755; 	Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; Wellcome Trust; Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center; Biotechnology and Biological Sciences Research Council [BB/H021868/1] Funding Source: researchfish; Natural Environment Research Council [NE/E01237X/1, NE/G004854/1] Funding Source: researchfish; BBSRC [BB/H021868/1] Funding Source: UKRI; NERC [NE/E01237X/1, NE/G004854/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Science and Technology Directorate, U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Biotechnology and Biological Sciences and Natural Environment Research Councils; the Wellcome Trust; and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center. Thanks to the National Trust for Scotland and Scottish National Heritage for permission to work on St. Kilda; the Ministry of Defense, QinetiQ, Amey, and Eurest Support Services staff on St. Kilda and Benbecula for logistical support; T. Clutton-Brock, M. Crawley, B. Grenfell, and many field volunteers for the data set and samples; F. Howison, N. Sanderson, K. Fairlie-Clarke, J. Matthews, and A. Nisbet for laboratory assistance; and A. Read, B. Grenfell, T. Little, D. Gray, R. Mellanby, S. Caserta, B. Craig, T. Coulson, J. Slate, R. Maizels, W. Craigens, and members of the Wild Evolution Group for discussions.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Attanasio R, 2001, CLIN EXP IMMUNOL, V123, P361, DOI 10.1046/j.1365-2249.2001.01454.x; Clatworthy MR, 2007, P NATL ACAD SCI USA, V104, P7169, DOI 10.1073/pnas.0608889104; Clutton-Brock T.H., 2004, SOAY SHEEP DYNAMICS; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; CluttonBrock TH, 1996, J ANIM ECOL, V65, P675, DOI 10.2307/5667; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; COVELLI V, 1989, J IMMUNOL, V142, P1224; Devalapalli AP, 2006, SCAND J IMMUNOL, V64, P125, DOI 10.1111/j.1365-3083.2006.01785.x; Dighiero G, 1999, IMMUNOL TODAY, V20, P423, DOI 10.1016/S0167-5699(99)01509-1; Falconer D. S, 1996, INTRO QUANTITATIVE G; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lee YH, 2009, LUPUS, V18, P727, DOI 10.1177/0961203309104020; Liang KP, 2007, J RHEUMATOL, V34, P1203; Limaye N, 2008, GENES IMMUN, V9, P61, DOI 10.1038/sj.gene.6364446; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; Marrow P, 1996, PHILOS T R SOC B, V351, P17, DOI 10.1098/rstb.1996.0002; Nilsson BO, 2006, J AUTOIMMUN, V27, P281, DOI 10.1016/j.jaut.2006.10.002; Njemini R, 2002, CLIN EXP IMMUNOL, V127, P99, DOI 10.1046/j.1365-2249.2002.01713.x; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Smee NM, 2007, JAVMA-J AM VET MED A, V230, P1180, DOI 10.2460/javma.230.8.1180; Tavecchia G, 2005, J ANIM ECOL, V74, P201, DOI 10.1111/j.1365-2656.2005.00916.x; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Wood JD, 1998, DIGEST DIS SCI, V43, P1443, DOI 10.1023/A:1018842210330	33	153	154	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					662	665		10.1126/science.1194878	http://dx.doi.org/10.1126/science.1194878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030656				2022-12-24	WOS:000283580600046
J	Iwashyna, TJ; Ely, EW; Smith, DM; Langa, KM				Iwashyna, Theodore J.; Ely, E. Wesley; Smith, Dylan M.; Langa, Kenneth M.			Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISABLED OLDER WOMEN; INTENSIVE-CARE-UNIT; QUALITY-OF-LIFE; MORTALITY; DELIRIUM; DECLINE; STATES; DEMENTIA; HEALTH; HOSPITALIZATION	Context Cognitive impairment and functional disability are major determinants of caregiving needs and societal health care costs. Although the incidence of severe sepsis is high and increasing, the magnitude of patients' long-term cognitive and functional limitations after sepsis is unknown. Objective To determine the change in cognitive impairment and physical functioning among patients who survive severe sepsis, controlling for their presepsis functioning. Design, Setting, and Patients A prospective cohort involving 1194 patients with 1520 hospitalizations for severe sepsis drawn from the Health and Retirement Study, a nationally representative survey of US residents (1998-2006). A total of 9223 respondents had a baseline cognitive and functional assessment and had linked Medicare claims; 516 survived severe sepsis and 4517 survived a nonsepsis hospitalization to at least 1 follow-up survey and are included in the analysis. Main Outcome Measures Personal interviews were conducted with respondents or proxies using validated surveys to assess the presence of cognitive impairment and to determine the number of activities of daily living (ADLs) and instrumental ADLs (IADLs) for which patients needed assistance. Results Survivors' mean age at hospitalization was 76.9 years. The prevalence of moderate to severe cognitive impairment increased 10.6 percentage points among patients who survived severe sepsis, an odds ratio (OR) of 3.34 (95% confidence interval [CI], 1.53-7.25) in multivariable regression. Likewise, a high rate of new functional limitations was seen following sepsis: in those with no limits before sepsis, a mean 1.57 new limitations (95% CI, 0.99-2.15); and for those with mild to moderate limitations before sepsis, a mean of 1.50 new limitations (95% CI, 0.87-2.12). In contrast, nonsepsis general hospitalizations were associated with no change in moderate to severe cognitive impairment (OR, 1.15; 95% CI, 0.80-1.67; P for difference vs sepsis=.01) and with the development of fewer new limitations (mean among those with no limits before hospitalization, 0.48; 95% CI, 0.39-0.57; P for difference vs sepsis <.001 and mean among those with mild to moderate limits, 0.43; 95% CI, 0.23-0.63; P for difference=.001). The declines in cognitive and physical function persisted for at least 8 years. Conclusions Severe sepsis in this older population was independently associated with substantial and persistent new cognitive impairment and functional disability among survivors. The magnitude of these new deficits was large, likely resulting in a pivotal downturn in patients' ability to live independently. JAMA. 2010; 304(16): 1787-1794	[Iwashyna, Theodore J.; Langa, Kenneth M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Ely, E. Wesley] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Ely, E. Wesley] VA Tennessee Valley Geriatr Res & Educ Clin Ctr, Nashville, TN USA; [Smith, Dylan M.] SUNY Stony Brook, Med Ctr, Dept Prevent Med, Stony Brook, NY 11794 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Ann Arbor Vet Affairs Hlth Serv, Res & Dev Serv Ctr Excellence, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan	Iwashyna, TJ (corresponding author), 3A23 300 NIB,SPC 5419,300 N Ingalls, Ann Arbor, MI 48109 USA.	tiwashyn@umich.edu	Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172; Iwashyna, Theodore/0000-0002-4226-9310; Langa, Kenneth/0000-0002-2798-1836	National Institutes of Health [K08 HL091249, R01 AG027010, R01 AG030155, AG027472]; Society of Critical Care Medicine; Michigan Institute for Clinical and Health Research [UL1RR024986]; National Institute on Aging [U01 AG09740]; Veterans Affairs Merit Award; Tennessee Valley Geriatric Research, Education and Clinical Center; National Institute of Diabetes and Digestive and Kidney Disease [P60 DK-20572]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030155, R01AG027472, U01AG009740, R01AG027010, K23AG001023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Critical Care Medicine; Michigan Institute for Clinical and Health Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs Merit Award(US Department of Veterans Affairs); Tennessee Valley Geriatric Research, Education and Clinical Center; National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants K08 HL091249, R01 AG027010, and R01 AG030155 from the National Institutes of Health; the Society of Critical Care Medicine's 2010 Vision Grant; and by pilot support from grant UL1RR024986 from the Michigan Institute for Clinical and Health Research. Grant U01 AG09740 from the National Institute on Aging provided funding for the Health and Retirement Study, which is performed at the Institute for Social Research, University of Michigan. Dr Ely was supported by grant AG027472 from the National Institutes of Health, by the Veterans Affairs Merit Award, and by the Tennessee Valley Geriatric Research, Education and Clinical Center. Consultative support was provided by the Measurement Core of the Michigan Diabetes Center through grant P60 DK-20572 from the National Institute of Diabetes and Digestive and Kidney Disease.	Allison PD, 2009, FIXED EFFECTS REGRES; Alzheimer's Association, 2006, EARL ONS DEM NAT CHA; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Banaszak-Holl J, 2004, ALZ DIS ASSOC DIS, V18, P83, DOI 10.1097/01.wad.0000126619.80941.91; Boyd CM, 2005, J GERONTOL A-BIOL, V60, P888, DOI 10.1093/gerona/60.7.888; Boyd CM, 2009, J AM GERIATR SOC, V57, P1757, DOI 10.1111/j.1532-5415.2009.02455.x; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; CHELLURI L, 1993, JAMA-J AM MED ASSOC, V269, P3119, DOI 10.1001/jama.269.24.3119; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fonda S, 2004, DOCUMENTATION PHYS F; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Health and Retirement Study, 2008, SAMPL SIZ RESP RAT; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Herzog AR, 1997, J GERONTOL B-PSYCHOL, V52, P37, DOI 10.1093/geronb/52B.Special_Issue.37; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Iwashyna TJ, 2010, ANN INTERN MED, V153, P204, DOI 10.7326/0003-4819-153-3-201008030-00013; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kaarlola A, 2006, CRIT CARE MED, V34, P2120, DOI 10.1097/01.CCM.0000227656.31911.2E; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P1191, DOI 10.1093/gerona/59.11.1191; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; Langa KM, 2004, JAMA-J AM MED ASSOC, V292, P2901, DOI 10.1001/jama.292.23.2901; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McConnell S, 2008, EVALUATION REV, V32, P157, DOI 10.1177/0193841X07309115; Mehta KM, 2003, J GERONTOL A-BIOL, V58, P461; MIKKELSEN ME, 2008, AM THOR SOC MAY 21 T; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Ofstedal M, 2005, DOCUMENTATION COGNIT, DOI DOI 10.1371/journal.pone.0144722; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rozzini R, 2005, J GERONTOL A-BIOL, V60, P1180, DOI 10.1093/gerona/60.9.1180; Saint S, 2002, AM J RESP CRIT CARE, V165, P1475, DOI 10.1164/rccm.2110035; Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sharshar T, 2009, CRIT CARE MED, V37, P3047, DOI 10.1097/CCM.0b013e3181b027e9; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Yende Sachin, 2007, Curr Infect Dis Rep, V9, P382, DOI 10.1007/s11908-007-0059-3; Ziegler-Graham K, 2008, ALZHEIMERS DEMENT, V4, P316, DOI 10.1016/j.jalz.2008.05.2479; Zivin K, 2010, AM J GERIAT PSYCHIAT, V18, P1036, DOI 10.1097/JGP.0b013e3181dba6d2	51	1404	1481	4	97	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1787	1794		10.1001/jama.2010.1553	http://dx.doi.org/10.1001/jama.2010.1553			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20978258	Green Accepted, Bronze			2022-12-24	WOS:000283501300019
J	Bettencourt, L; West, G				Bettencourt, Luis; West, Geoffrey			A unified theory of urban living	NATURE			English	Editorial Material							GENERAL-MODEL; CITIES; GROWTH		[Bettencourt, Luis; West, Geoffrey] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Bettencourt, L (corresponding author), Los Alamos Natl Lab, Los Alamos, NM 87545 USA.		Bettencourt, Luis/R-9861-2019	Limb, Melanie Ruth/0000-0002-6258-3366				[Anonymous], 2010, GLOBAL SUSTAINABILIT; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; BETTENCOURT LMA, PLOS ONE IN PRESS; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brown M.A., 2009, POLICY SOC, V27, P285, DOI [10.1016/j.polsoc.2009.01.001, DOI 10.1016/J.POLSOC.2009.01.001]; Jacobs J., 1961, DEATH LIFE GREAT AM; UN-Habitat, 2010, STAT WORLDS CIT 2010; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	10	460	472	12	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					912	913		10.1038/467912a	http://dx.doi.org/10.1038/467912a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668FT	20962823				2022-12-24	WOS:000283254700015
J	Park, CY; Shcheglovitov, A; Dolmetsch, R				Park, Chan Young; Shcheglovitov, Aleksandr; Dolmetsch, Ricardo			The CRAC Channel Activator STIM1 Binds and Inhibits L-Type Voltage-Gated Calcium Channels	SCIENCE			English	Article							MEDIUM SPINY NEURONS; T-LYMPHOCYTES; SKELETAL-MUSCLE; PLASMA-MEMBRANE; CA2+ CHANNELS; STORE; ENTRY; ORAI1; INFLUX; SENSOR	Voltage-and store-operated calcium (Ca2+) channels are the major routes of Ca2+ entry in mammalian cells, but little is known about how cells coordinate the activity of these channels to generate coherent calcium signals. We found that STIM1 (stromal interaction molecule 1), the main activator of store-operated Ca2+ channels, directly suppresses depolarization-induced opening of the voltage-gated Ca2+ channel Ca(V)1.2. STIM1 binds to the C terminus of Ca(V)1.2 through its Ca2+ release-activated Ca2+ activation domain, acutely inhibits gating, and causes long-term internalization of the channel from the membrane. This establishes a previously unknown function for STIM1 and provides a molecular mechanism to explain the reciprocal regulation of these two channels in cells.	[Park, Chan Young; Shcheglovitov, Aleksandr; Dolmetsch, Ricardo] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Park, Chan Young] UNIST, Sch Nanobiotechnol & Chem Engn, Ulsan 689798, South Korea	Stanford University; Ulsan National Institute of Science & Technology (UNIST)	Dolmetsch, R (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu	Park, Chan Young/F-5696-2010; Tuluc, Petronel/C-2527-2011	Park, Chan Young/0000-0002-5183-3665; 	NIH [DP1OD003889, R21MH087898]; Simons Fund for Autism Research; California Institute for Regenerative Medicine [TG 01159]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Fund for Autism Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grants DP1OD003889 and R21MH087898, the Simons Fund for Autism Research, the California Institute for Regenerative Medicine grant TG 01159. We thank A. Budzillo for help with experiments, and R. Lewis and A. Nigh for feedback on the manuscript.	BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HESS P, 1988, CAN J PHYSIOL PHARM, V66, P1218, DOI 10.1139/y88-201; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tsien Richard W., 1995, Trends in Neurosciences, V18, P52, DOI 10.1016/0166-2236(95)93867-W; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	29	242	245	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					101	105		10.1126/science.1191027	http://dx.doi.org/10.1126/science.1191027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929812				2022-12-24	WOS:000282334500045
J	Ozsolak, F; Kapranov, P; Foissac, S; Kim, SW; Fishilevich, E; Monaghan, AP; John, B; Milos, PM				Ozsolak, Fatih; Kapranov, Philipp; Foissac, Sylvain; Kim, Sang Woo; Fishilevich, Elane; Monaghan, A. Paula; John, Bino; Milos, Patrice M.			Comprehensive Polyadenylation Site Maps in Yeast and Human Reveal Pervasive Alternative Polyadenylation	CELL			English	Article							MESSENGER-RNA POLYADENYLATION; NONCODING RNAS; BIDIRECTIONAL PROMOTERS; GENE-EXPRESSION; TRANSCRIPTION; POLY(A); DNA; POLYMERASE; SEQUENCE; CLEAVAGE	The emerging discoveries on the link between polyadenylation and disease states underline the need to fully characterize genome-wide polyadenylation states. Here, we report comprehensive maps of global polyadenylation events inhuman and yeast generated using refinements to the Direct RNA Sequencing technology. This direct approach provides a quantitative view of genome-wide polyadenylation states in a strand-specific manner and requires only attomole RNA quantities. The polyadenylation profiles revealed an abundance of unannotated polyadenylation sites, alternative polyadenylation patterns, and regulatory element-associated poly(A)(+) RNAs. We observed differences in sequence composition surrounding canonical and noncanonical human polyadenylation sites, suggesting novel noncoding RNA-specific polyadenylation mechanisms in humans. Furthermore, we observed the correlation level between sense and antisense transcripts to depend on gene expression levels, supporting the view that overlapping transcription from opposite strands may play a regulatory role. Our data provide a comprehensive view of the polyadenylation state and overlapping transcription.	[Ozsolak, Fatih; Kapranov, Philipp; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA; [Foissac, Sylvain] Integromics, Madrid 28760, Spain; [Kim, Sang Woo; Fishilevich, Elane; John, Bino] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Monaghan, A. Paula] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ozsolak, F (corresponding author), Helicos BioSci Corp, Cambridge, MA 02139 USA.	fatihozsolak@gmail.com; pmilos@helicosbio.com		Kim, Sang Woo/0000-0002-3144-4822; Kapranov, Philipp/0000-0003-2647-4856; Foissac, Sylvain/0000-0002-2631-5356	National Human Genome Research Institute [R01-HG005230]; National Institutes of Health [GM079756, MH60774]; American Cancer Society [RSG0905401]; Spanish Ministry of Science and Innovation-FEDER (CDTI) [IDI-20091293]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060774] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Spanish Ministry of Science and Innovation-FEDER (CDTI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank our Helicos and Integromics colleagues for technical assistance and discussions. This work was supported by the National Human Genome Research Institute (grant R01-HG005230 to F.O. and P.M.M.). B.J. is supported by the National Institutes of Health (grant GM079756) and the American Cancer Society (grant RSG0905401), A.P.M. is supported by the National Institutes of Health (grant MH60774), and S.F. is supported by the Spanish Ministry of Science and Innovation-FEDER (CDTI loan IDI-20091293). F.O., P.K., and P.M.M. are employees of Helicos BioSciences Corporation. S.F. is an employee of Integromics.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bennett CL, 2001, IMMUNOGENETICS, V53, P435, DOI 10.1007/s002510100358; BHAT BM, 1987, J VIROL, V61, P3938, DOI 10.1128/JVI.61.12.3938-3945.1987; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Costessi L, 2006, NUCLEIC ACIDS RES, V34, P243, DOI 10.1093/nar/gkj425; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Graber JH, 2002, NUCLEIC ACIDS RES, V30, P1851, DOI 10.1093/nar/30.8.1851; GUBLER U, 1987, METHOD ENZYMOL, V152, P330; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; HIGGS DR, 1983, NATURE, V306, P398, DOI 10.1038/306398a0; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Liu DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-77; Lopez F, 2006, RNA, V12, P1794, DOI 10.1261/rna.136206; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Mahadevan S, 1997, GENE, V190, P69, DOI 10.1016/S0378-1119(96)00708-1; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mondal N, 2001, NATURE, V413, P435, DOI 10.1038/35096590; MOREIRA A, 1995, EMBO J, V14, P3809, DOI 10.1002/j.1460-2075.1995.tb00050.x; Muro EM, 2008, P NATL ACAD SCI USA, V105, P20286, DOI 10.1073/pnas.0807813105; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; ORKIN SH, 1985, EMBO J, V4, P453, DOI 10.1002/j.1460-2075.1985.tb03650.x; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; Rigault C, 2006, BBA-MOL CELL BIOL L, V1761, P1469, DOI 10.1016/j.bbalip.2006.09.014; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Slomovic S, 2010, P NATL ACAD SCI USA, V107, P7407, DOI 10.1073/pnas.0910621107; Slomovic S, 2008, METHOD ENZYMOL, V447, P501, DOI 10.1016/S0076-6879(08)02224-6; SPIEGELMAN S, 1970, NATURE, V227, P1029, DOI 10.1038/2271029a0; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yoon OK, 2010, RNA, V16, P1256, DOI 10.1261/rna.2038810; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	69	288	301	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					1018	1029		10.1016/j.cell.2010.11.020	http://dx.doi.org/10.1016/j.cell.2010.11.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145465	Green Accepted, Bronze			2022-12-24	WOS:000285182600017
J	de Gonzalez, AB; Hartge, P; Cerhan, JR; Flint, AJ; Hannan, L; MacInnis, RJ; Moore, SC; Tobias, GS; Anton-Culver, H; Freeman, LB; Beeson, WL; Clipp, SL; English, DR; Folsom, AR; Freedman, DM; Giles, G; Hakansson, N; Henderson, KD; Hoffman-Bolton, J; Hoppin, JA; Koenig, KL; Lee, IM; Linet, MS; Park, Y; Pocobelli, G; Schatzkin, A; Sesso, HD; Weiderpass, E; Willcox, BJ; Wolk, A; Zeleniuch-Jacquotte, A; Willett, WC; Thun, MJ				de Gonzalez, Amy Berrington; Hartge, Patricia; Cerhan, James R.; Flint, Alan J.; Hannan, Lindsay; MacInnis, Robert J.; Moore, Steven C.; Tobias, Geoffrey S.; Anton-Culver, Hoda; Freeman, Laura Beane; Beeson, W. Lawrence; Clipp, Sandra L.; English, Dallas R.; Folsom, Aaron R.; Freedman, D. Michal; Giles, Graham; Hakansson, Niclas; Henderson, Katherine D.; Hoffman-Bolton, Judith; Hoppin, Jane A.; Koenig, Karen L.; Lee, I-Min; Linet, Martha S.; Park, Yikyung; Pocobelli, Gaia; Schatzkin, Arthur; Sesso, Howard D.; Weiderpass, Elisabete; Willcox, Bradley J.; Wolk, Alicja; Zeleniuch-Jacquotte, Anne; Willett, Walter C.; Thun, Michael J.			Body-Mass Index and Mortality among 1.46 Million White Adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; BREAST-CANCER; PREDICTING MORTALITY; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; WOMENS HEALTH; BETA-CAROTENE; EARLY MARKER	Background: A high body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) is associated with increased mortality from cardiovascular disease and certain cancers, but the precise relationship between BMI and all-cause mortality remains uncertain. Methods: We used Cox regression to estimate hazard ratios and 95% confidence intervals for an association between BMI and all-cause mortality, adjusting for age, study, physical activity, alcohol consumption, education, and marital status in pooled data from 19 prospective studies encompassing 1.46 million white adults, 19 to 84 years of age (median, 58). Results: The median baseline BMI was 26.2. During a median follow-up period of 10 years (range, 5 to 28), 160,087 deaths were identified. Among healthy participants who never smoked, there was a J-shaped relationship between BMI and all-cause mortality. With a BMI of 22.5 to 24.9 as the reference category, hazard ratios among women were 1.47 (95 percent confidence interval [CI], 1.33 to 1.62) for a BMI of 15.0 to 18.4; 1.14 (95% CI, 1.07 to 1.22) for a BMI of 18.5 to 19.9; 1.00 (95% CI, 0.96 to 1.04) for a BMI of 20.0 to 22.4; 1.13 (95% CI, 1.09 to 1.17) for a BMI of 25.0 to 29.9; 1.44 (95% CI, 1.38 to 1.50) for a BMI of 30.0 to 34.9; 1.88 (95% CI, 1.77 to 2.00) for a BMI of 35.0 to 39.9; and 2.51 (95% CI, 2.30 to 2.73) for a BMI of 40.0 to 49.9. In general, the hazard ratios for the men were similar. Hazard ratios for a BMI below 20.0 were attenuated with longer-term follow-up. Conclusions: In white adults, overweight and obesity (and possibly underweight) are associated with increased all-cause mortality. All-cause mortality is generally lowest with a BMI of 20.0 to 24.9. N Engl J Med 2010;363:2211-9.	[de Gonzalez, Amy Berrington] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Cerhan, James R.] Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN USA; [Flint, Alan J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sesso, Howard D.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Sesso, Howard D.] Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA; [Lee, I-Min] Harvard Univ, Sch Med, Boston, MA USA; [Hannan, Lindsay; Thun, Michael J.] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [MacInnis, Robert J.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Giles, Graham] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [MacInnis, Robert J.] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge, England; [Anton-Culver, Hoda] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Beeson, W. Lawrence] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA; [Henderson, Katherine D.] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA 91010 USA; [Clipp, Sandra L.; Hoffman-Bolton, Judith] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Hakansson, Niclas; Wolk, Alicja] Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, Stockholm, Sweden; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hoppin, Jane A.] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC USA; [Koenig, Karen L.; Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Pocobelli, Gaia] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Pocobelli, Gaia] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Weiderpass, Elisabete] Canc Registry Norway, Oslo, Norway; [Weiderpass, Elisabete] Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland; [Willcox, Bradley J.] Pacific Hlth Res Inst, Honolulu, HI USA; [Willcox, Bradley J.] Queens Med Ctr, Honolulu, HI USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; American Cancer Society; University of Melbourne; Cancer Council Victoria; Cancer Research UK; University of Cambridge; University of California System; University of California Irvine; Loma Linda University; City of Hope; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; Karolinska Institutet; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); New York University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Oslo; Samfundet Folkhalsan; Pacific Health Research & Education Institute; The Queen's Medical Center	de Gonzalez, AB (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Rm 7034,6120 Execut Blvd, Bethesda, MD 20892 USA.	berringtona@mail.nih.gov	de gonzalez, amy berrington/L-7017-2017; Lee, I-Min/ABD-5409-2021; Weiderpass, Elisabete/M-4029-2016; Weiderpass, Elisabete/AAP-2747-2021; Håkansson, Niclas/L-7913-2013; Tobias, Geoffrey S/M-4135-2016; Moore, Steven/D-8760-2016; Freeman, Laura E. Beane/C-4468-2015; English, Dallas/AAH-5005-2019	de gonzalez, amy berrington/0000-0002-7332-8387; Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128; Håkansson, Niclas/0000-0001-7673-5554; Tobias, Geoffrey S/0000-0002-2878-8253; Moore, Steven/0000-0002-8169-1661; Freeman, Laura E. Beane/0000-0003-1294-4124; English, Dallas/0000-0001-7828-8188; Hoppin, Jane/0000-0001-8456-0969; MacInnis, Robert/0000-0002-1627-5047; Giles, Graham/0000-0003-4946-9099; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Cerhan, James/0000-0002-7482-178X; Park, Yikyung/0000-0002-6281-489X	National Institutes of Health (NIH); Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), NIH; Iovate Health Sciences USA; NATIONAL CANCER INSTITUTE [R01CA077398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049030] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); Iovate Health Sciences USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Intramural Research Program of the National Institutes of Health (NIH) and the Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), NIH. Details regarding funding for the individual studies are listed in the Supplementary Appendix.; Dr. Sesso reports receiving consulting fees from Iovate Health Sciences USA. No other potential conflict of interest relevant to this article was reported.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BEESON WL, 1989, CANCER, V64, P570, DOI 10.1002/1097-0142(19890801)64:3<570::AID-CNCR2820640303>3.0.CO;2-4; Bernstein L, 2002, CANCER CAUSE CONTROL, V13, P625, DOI 10.1023/A:1019552126105; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Comstock GW, 1997, CANCER EPIDEM BIOMAR, V6, P907; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; *DEP HLTH HUM SERV, 2006, NAT HLTH NUTR EX SUR; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P1254; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P483, DOI 10.1001/jama.269.4.483; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; Giles G G, 2002, IARC Sci Publ, V156, P69; Hayes RB, 2005, MUTAT RES-FUND MOL M, V592, P147, DOI 10.1016/j.mrfmmm.2005.06.013; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; *INT OB TASK FORC, GLOB PREV AD OB; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Moore SC, 2008, INT J OBESITY, V32, P730, DOI 10.1038/sj.ijo.0803801; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Orsini N, 2008, J INTERN MED, V264, P442, DOI 10.1111/j.1365-2796.2008.01985.x; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pischon T, 2010, NEW ENGL J MED, V362, P2433; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; SAS, 2009, SAS VERS 9 0; SCHAIRER C, 1994, CANCER CAUSE CONTROL, V5, P491, DOI 10.1007/BF01831376; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; TONIOLO PG, 1995, JNCI-J NATL CANCER I, V87, P190, DOI 10.1093/jnci/87.3.190; Weiderpass E, 2004, CANCER EPIDEM BIOMAR, V13, P1121; White E, 2004, AM J EPIDEMIOL, V159, P83, DOI 10.1093/aje/kwh010; Whitlock G, 2009, LANCET, V374, P114, DOI 10.1016/S0140-6736(09)61280-0; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2004, LANCET, V363, P902; Wolk A, 2006, JAMA-J AM MED ASSOC, V296, P1371, DOI 10.1001/jama.296.11.1371	44	1524	1556	2	129	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2211	2219		10.1056/NEJMoa1000367	http://dx.doi.org/10.1056/NEJMoa1000367			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121834	Green Accepted, Bronze			2022-12-24	WOS:000284832900008
J	Sudmant, PH; Kitzman, JO; Antonacci, F; Alkan, C; Malig, M; Tsalenko, A; Sampas, N; Bruhn, L; Shendure, J; Eichler, EE				Sudmant, Peter H.; Kitzman, Jacob O.; Antonacci, Francesca; Alkan, Can; Malig, Maika; Tsalenko, Anya; Sampas, Nick; Bruhn, Laurakay; Shendure, Jay; Eichler, Evan E.		1000 Genomes Project	Diversity of Human Copy Number Variation and Multicopy Genes	SCIENCE			English	Article							HUMAN GENOME; SEGMENTAL DUPLICATIONS; HUMAN-DISEASE; EVOLUTION; SCHIZOPHRENIA; POLYMORPHISMS; CONVERSION; SELECTION; DELETION; 15Q13.3	Copy number variants affect both disease and normal phenotypic variation, but those lying within heavily duplicated, highly identical sequence have been difficult to assay. By analyzing short-read mapping depth for 159 human genomes, we demonstrated accurate estimation of absolute copy number for duplications as small as 1.9 kilobase pairs, ranging from 0 to 48 copies. We identified 4.1 million "singly unique nucleotide" positions informative in distinguishing specific copies and used them to genotype the copy and content of specific paralogs within highly duplicated gene families. These data identify human-specific expansions in genes associated with brain development, reveal extensive population genetic diversity, and detect signatures consistent with gene conversion in the human species. Our approach makes similar to 1000 genes accessible to genetic studies of disease association.	[Sudmant, Peter H.; Kitzman, Jacob O.; Antonacci, Francesca; Alkan, Can; Malig, Maika; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Tsalenko, Anya; Sampas, Nick; Bruhn, Laurakay] Agilent Technol, Santa Clara, CA 95051 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Agilent Technologies; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Ye, Kai/B-3640-2012; Antonacci, Francesca/F-5457-2013; Browning, Brian L/A-1178-2010; Shendure, Jay/AAU-3684-2021; Wilson, Richard K./AAF-4139-2019; Sahinalp, Suleyman Cenk/X-7843-2018; Rosenstiel, Philip/A-5137-2009; Khurana, Ekta/C-4933-2013; Altshuler, David M/A-4476-2009; Myers, Simon R/A-6792-2015; Dahl, Andreas/E-3783-2017; Wang, Jun/A-7261-2013; Cooper, David N/H-4384-2011; Alkan, Can/D-2982-2009; Chen, Ken/AAU-1432-2021; Mills, Ryan/F-4225-2010; Li, Yingrui/K-1064-2015; Tumian, Afidalina/J-4404-2014	Antonacci, Francesca/0000-0002-5833-6186; Browning, Brian L/0000-0001-6454-6633; Wilson, Richard K./0000-0002-1992-1358; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Rosenstiel, Philip/0000-0002-9692-8828; Altshuler, David M/0000-0002-7250-4107; Myers, Simon R/0000-0002-2585-9626; Dahl, Andreas/0000-0002-2668-8371; Cooper, David N/0000-0002-8943-8484; Alkan, Can/0000-0002-5443-0706; Chen, Ken/0000-0003-4013-5279; Mills, Ryan/0000-0003-3425-6998; Keane, Thomas/0000-0001-7532-6898; Hinrichs, Angie/0000-0002-1697-1130; Zalunin, Vadim/0000-0002-7722-1958; Chinwalla, Asif/0000-0001-7831-3996; Leinonen, Rasko/0000-0002-2639-7187; Sudmant, Peter/0000-0002-9573-8248; Shendure, Jay/0000-0002-1516-1865; Balasubramanian, Shankar/0000-0002-0281-5815; Swerdlow, Harold/0000-0002-9510-160X; Radhakrishnan, Rajesh/0000-0001-7170-699X; Kulesha, Eugene/0000-0002-4285-6232; Herrero, Javier/0000-0001-7313-717X; Sebat, Jonathan/0000-0002-9087-526X; Schaffner, Stephen/0000-0001-6699-3568; Eberle, Michael/0000-0001-8965-1253; Keinan, Alon/0000-0002-9760-1122; Aguinaga, Jesus Christ/0000-0003-0664-6219; Abyzov, Alexej/0000-0001-5405-6729; Sherry, Stephen/0000-0002-7982-076X; McLaren, William/0000-0001-6218-1116; Clark, Andrew/0000-0001-7159-8511; MCLELLAN, MICHAEL/0000-0002-2703-8784; Cibulskis, Kristian/0000-0003-1343-1582; Tumian, Afidalina/0000-0003-2763-6677; Haraksingh, Rajini/0000-0002-6644-8874; MacArthur, Daniel/0000-0002-5771-2290; Keenan, Stephen/0000-0002-9141-7690; Kitzman, Jacob/0000-0002-6145-882X; Clarke, Laura/0000-0002-5989-6898; Walter, Klaudia/0000-0003-4448-0301; Stone, Eric/0000-0002-2725-4209	Natural Sciences and Engineering Research Council of Canada; NSF; NIH [HG004120]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, P01HG004120, U54HG003273, ZIAHG000024] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank M. Ventura and M. Ross for sharing unpublished data; C. Lee for technical assistance; C. Campbell, J. Kidd, P. Green, and M. Hoopman for discussion; and T. Brown for manuscript preparation assistance. This work was supported by a Natural Sciences and Engineering Research Council of Canada Fellowship (P. H. S.), an NSF Graduate Research Fellowship (J.O.K.), and NIH grant HG004120 to E. E. E. E. E. E. is an Investigator of the Howard Hughes Medical Institute. E. E. E is on the scientific advisory board for Pacific Biosciences. A. T., N.S., and L. B. are employees of Agilent Technologies. J. S. is a member of the scientific advisory boards of Tandem Technologies, Stratos Genomics, Good Start Genetics, and Adaptive TCR. Sequence and array data are deposited at the NCBI under accessions SRP002878, SRP003500, SRP000031, SRP000032, and GSE24334.	*1000 GEN PROJ, 2010, NATURE          1028, DOI DOI 10.1038/NATURE09534; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Force A, 1999, GENETICS, V151, P1531; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Innan H, 2003, P NATL ACAD SCI USA, V100, P8793, DOI 10.1073/pnas.1031592100; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; PALLANCK L, 1995, NATURE, V376, P25, DOI 10.1038/376025a0; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Urban TJ, 2009, NAT MED, V15, P1110, DOI 10.1038/nm1009-1110; Xue YL, 2008, AM J HUM GENET, V83, P337, DOI 10.1016/j.ajhg.2008.08.004	30	458	480	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					641	646		10.1126/science.1197005	http://dx.doi.org/10.1126/science.1197005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030649	Green Submitted, Green Accepted			2022-12-24	WOS:000283580600039
J	Kong, A; Thorleifsson, G; Gudbjartsson, DF; Masson, G; Sigurdsson, A; Jonasdottir, A; Walters, GB; Jonasdottir, A; Gylfason, A; Kristinsson, KT; Gudjonsson, SA; Frigge, ML; Helgason, A; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Masson, Gisli; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Walters, G. Bragi; Jonasdottir, Adalbjorg; Gylfason, Arnaldur; Kristinsson, Kari Th.; Gudjonsson, Sigurjon A.; Frigge, Michael L.; Helgason, Agnar; Thorsteinsdottir, Unnur; Stefansson, Kari			Fine-scale recombination rate differences between sexes, populations and individuals	NATURE			English	Article							HUMAN GENOME; MEIOTIC RECOMBINATION; SEQUENCE VARIANTS; SELECTION; HOTSPOTS; HUMANS; PRDM9; MAP; GENE	Meiotic recombinations contribute to genetic diversity by yielding new combinations of alleles. Recently, high-resolution recombination maps were inferred from high-density single-nucleotide polymorphism (SNP) data using linkage disequilibrium (LD) patterns that capture historical recombination events(1,2). The use of these maps has been demonstrated by the identification of recombination hotspots(2) and associated motifs(3), and the discovery that the PRDM(9) gene affects the proportion of recombinations occurring at hotspots(4-6). However, these maps provide no information about individual or sex differences. Moreover, locus-specific demographic factors like natural selection(7) can bias LD-based estimates of recombination rate. Existing genetic maps based on family data avoid these shortcomings(8), but their resolution is limited by relatively few meioses and a low density of markers. Here we used genome-wide SNP data from(15),257 parent-offspring pairs to construct the first recombination maps based on directly observed recombinations with a resolution that is effective down to 10 kilobases (kb). Comparing male and female maps reveals that about 15% of hot-spots in one sex are specific to that sex. Although male recombinations result in more shuffling of exons within genes, female recombinations generate more new combinations of nearby genes. We discover novel associations between recombination characteristics of individuals and variants in the PRDM9 gene and we identify new recombination hotspots. Comparisons of our maps with two LD-based maps inferred from data of HapMap populations of Utah residents with ancestry from northern and western Europe (CEU) and Yoruba in Ibadan, Nigeria (YRI) reveal population differences previously masked by noise and map differences at regions previously described as targets of natural selection.	[Kong, Augustine; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Masson, Gisli; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Walters, G. Bragi; Jonasdottir, Adalbjorg; Gylfason, Arnaldur; Kristinsson, Kari Th.; Gudjonsson, Sigurjon A.; Frigge, Michael L.; Helgason, Agnar; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, IS-101 Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	University of Iceland; University of Iceland	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kari.stefansson@decode.is	Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019; Walters, G. Bragi/L-4215-2013	Walters, G. Bragi/0000-0002-5415-6487; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgason, Agnar/0000-0002-8545-3767; Kong, Augustine/0000-0001-8193-5438; Gudjonsson, Sigurjon A./0000-0001-9314-7412				Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lang MR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000744; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; O'Reilly PF, 2008, GENOME RES, V18, P1304, DOI 10.1101/gr.067181.107; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508	18	386	391	2	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1099	1103		10.1038/nature09525	http://dx.doi.org/10.1038/nature09525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981099				2022-12-24	WOS:000283548600046
J	Neafsey, DE; Lawniczak, MKN; Park, DJ; Redmond, SN; Coulibaly, MB; Traore, SF; Sagnon, N; Costantini, C; Johnson, C; Wiegand, RC; Collins, FH; Lander, ES; Wirth, DF; Kafatos, FC; Besansky, NJ; Christophides, GK; Muskavitch, MAT				Neafsey, D. E.; Lawniczak, M. K. N.; Park, D. J.; Redmond, S. N.; Coulibaly, M. B.; Traore, S. F.; Sagnon, N.; Costantini, C.; Johnson, C.; Wiegand, R. C.; Collins, F. H.; Lander, E. S.; Wirth, D. F.; Kafatos, F. C.; Besansky, N. J.; Christophides, G. K.; Muskavitch, M. A. T.			SNP Genotyping Defines Complex Gene-Flow Boundaries Among African Malaria Vector Mosquitoes	SCIENCE			English	Article							ANOPHELES-GAMBIAE S.S.; INCIPIENT SPECIATION; MOLECULAR-FORMS; DIFFERENTIATION; DIVERGENCE; ISLANDS	Mosquitoes in the Anopheles gambiae complex show rapid ecological and behavioral diversification, traits that promote malaria transmission and complicate vector control efforts. A high-density, genome-wide mosquito SNP-genotyping array allowed mapping of genomic differentiation between populations and species that exhibit varying levels of reproductive isolation. Regions near centromeres or within polymorphic inversions exhibited the greatest genetic divergence, but divergence was also observed elsewhere in the genomes. Signals of natural selection within populations were overrepresented among genomic regions that are differentiated between populations, implying that differentiation is often driven by population-specific selective events. Complex genomic differentiation among speciating vector mosquito populations implies that tools for genome-wide monitoring of population structure will prove useful for the advancement of malaria eradication.	[Neafsey, D. E.; Park, D. J.; Johnson, C.; Wiegand, R. C.; Lander, E. S.; Wirth, D. F.; Muskavitch, M. A. T.] Broad Inst, Cambridge, MA 02142 USA; [Lawniczak, M. K. N.; Redmond, S. N.; Kafatos, F. C.; Christophides, G. K.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Coulibaly, M. B.; Traore, S. F.] Malaria Res & Training Ctr, Bamako, Mali; [Sagnon, N.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Costantini, C.] Inst Rech Dev, Unite Rech R016, Montpellier, France; [Costantini, C.] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Collins, F. H.; Besansky, N. J.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Wirth, D. F.; Muskavitch, M. A. T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Muskavitch, M. A. T.] Boston Coll, Chestnut Hill, MA 02467 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Imperial College London; Institut de Recherche pour le Developpement (IRD); University of Notre Dame; Harvard University; Harvard T.H. Chan School of Public Health; Boston College	Muskavitch, MAT (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	marc.muskavitch@bc.edu	Costantini, Carlo/F-3470-2012; Coulibaly, Mamadou/AAE-7006-2019	Costantini, Carlo/0000-0003-1016-129X; redmond, seth/0000-0003-2653-760X; Lawniczak, Mara/0000-0002-3006-2080; Christophides, George/0000-0002-3323-1687	Burroughs Wellcome Fund [1008238]; Broad Institute; Wellcome Trust [077229/Z/05/Z]; National Human Genome Research Institute; Harvard School of Public Health Department of Immunology and Infectious Diseases; Biotechnology and Biological Sciences Research Council [BB/E002641/1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; BBSRC [BB/E002641/1] Funding Source: UKRI	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Broad Institute; Wellcome Trust(Wellcome TrustEuropean Commission); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Harvard School of Public Health Department of Immunology and Infectious Diseases; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Burroughs Wellcome Fund Request 1008238, the Broad Institute Director's Fund, the Wellcome Trust Programme grant 077229/Z/05/Z to F.C.K. and G.K.C., National Human Genome Research Institute support to E.S.L., the Harvard School of Public Health Department of Immunology and Infectious Diseases, and the DeLuca Professorship from Boston College to M.A.T.M. In addition, M.K.N.L. was supported by a Biotechnology and Biological Sciences Research Council research grant BB/E002641/1 to G.K.C. Sequencing data for array validation have been deposited in the National Center for Biotechnology Information Short Read Archive with accession numbers SRX005397 to SRX005403. SNPs have been submitted to dbSNP Build B133 (ss/rs numbers in progress) and, meanwhile, are listed in the supporting online material. ArrayExpress accession number: A-AFFY-167.	Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Butlin RK, 2005, MOL ECOL, V14, P2621, DOI 10.1111/j.1365-294X.2005.02617.x; Cassone BJ, 2008, MOL ECOL, V17, P2491, DOI 10.1111/j.1365-294X.2008.03774.x; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143; Curtis C.F., 1982, P290; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Koufopanou V, 2002, MOL BIOL EVOL, V19, P239, DOI 10.1093/oxfordjournals.molbev.a004077; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Slotman M, 2004, GENETICS, V167, P275, DOI 10.1534/genetics.167.1.275; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Slotman MA, 2006, AM J TROP MED HYG, V74, P641, DOI 10.4269/ajtmh.2006.74.641; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269	33	134	134	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					514	517		10.1126/science.1193036	http://dx.doi.org/10.1126/science.1193036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966254	Green Published, Green Accepted			2022-12-24	WOS:000283329100043
J	Ivers, LC; Farmer, P; Almazor, CP; Leandre, F				Ivers, Louise C.; Farmer, Paul; Almazor, Charles Patrick; Leandre, Fernet			Five complementary interventions to slow cholera: Haiti	LANCET			English	Editorial Material									[Ivers, Louise C.; Farmer, Paul] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Almazor, Charles Patrick; Leandre, Fernet] Partners Hlth Zanmi Lasante, Port Au Prince, Haiti	Harvard University; Harvard Medical School	Farmer, P (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	paul_farmer@hms.harvard.edu	Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230				[Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; CDC, 2010, AC WAT DIARRH CHOL H; d'Adestcy AC., 2004, MOVING MOUNTAINS RAC, P93; Dorell C., 2010, Morbidity and Mortality Weekly Report, V59, P1018; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Farmer P, 2003, LANCET, V361, P420, DOI 10.1016/S0140-6736(03)12380-X; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; Farmer Paul, 1992, AIDS ACCUSATION HAIT; Fraser B, 2010, LANCET, V376, P1813, DOI 10.1016/S0140-6736(10)62151-4; Frew SE, 2009, HEALTH AFFAIR, V28, P1760, DOI 10.1377/hlthaff.28.6.1760; Harris JB, 2010, LANCET, V376, P1961, DOI 10.1016/S0140-6736(10)62172-1; Ivers LC, 2010, CURBING CERVICAL CAN; Lasante Zanmi, 2008, WOCH NAN SOL DEN RIG; Lawrence P.R., 2002, WATER POVERTY INDEX; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; Soni A, 2009, HEALTH AFFAIR, V28, P1617, DOI 10.1377/hlthaff.28.6.1617; *UNAIDS WHO, 2005, AIDS EP UPD DEC 2005; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013	18	40	41	2	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2048	2051		10.1016/S0140-6736(10)62243-X	http://dx.doi.org/10.1016/S0140-6736(10)62243-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702LA	21146206				2022-12-24	WOS:000285895000007
J	Finkelstein, IJ; Visnapuu, ML; Greene, EC				Finkelstein, Ilya J.; Visnapuu, Mari-Liis; Greene, Eric C.			Single-molecule imaging reveals mechanisms of protein disruption by a DNA translocase	NATURE			English	Article							RNA-POLYMERASE; RECBCD ENZYME; REPLICATION FORK; LAC REPRESSOR; TRANSCRIPTION; BINDING; REPLISOME; HELICASE; OPERATOR; MOTOR	In physiological settings, nucleic-acid translocases must act on substrates occupied by other proteins, and an increasingly appreciated role of translocases is to catalyse protein displacement from RNA andDNA(1-4). However, little is known regarding the inevitable collisions that must occur, and the fate of protein obstacles and the mechanisms by which they are evicted from DNA remain unexplored. Here we sought to establish the mechanistic basis for protein displacement from DNA using RecBCD as a model system. Using nanofabricated curtains of DNA and multicolour single-molecule microscopy, we visualized collisions between a model translocase and different DNA-bound proteins in real time. We show that the DNA translocase RecBCD can disrupt core RNA polymerase, holoenzymes, stalled elongation complexes and transcribing RNA polymerases in either head-to-head or head-to-tail orientations, as well as EcoRI(E111Q), lac repressor and even nucleosomes. RecBCD did not pause during collisions and often pushed proteins thousands of base pairs before evicting them from DNA. We conclude that RecBCD overwhelms obstacles through direct transduction of chemomechanical force with no need for specific protein-protein interactions, and that proteins can be removed from DNA through active disruption mechanisms that act on a transition state intermediate as they are pushed from one nonspecific site to the next.	[Greene, Eric C.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Finkelstein, Ilya J.; Visnapuu, Mari-Liis; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Greene, EC (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.	ecg2108@columbia.edu			NIH [F32GM80864, GM074739, GM082848]; Columbia University; Nanoscale Science and Engineering Initiative of the National Science Foundation [CHE-0641523]; New York State Office of Science, Technology, and Academic Research; NATIONAL CANCER INSTITUTE [R01CA146940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082848, R01GM074739, F32GM080864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University; Nanoscale Science and Engineering Initiative of the National Science Foundation(National Science Foundation (NSF)); New York State Office of Science, Technology, and Academic Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Gottesman, R. Gonzalez and members of the Greene laboratory for discussion and assistance throughout this work. We thank P. Modrich for providing an expression construct encoding EcoRI<SUP>E111Q</SUP>, R. Landick and K. Adelmanfor providing RNAP constructs, and J. Gelles for providing plasmids encoding RecBCD. I.J.F. was supported by an NIH Fellowship (F32GM80864). Funding was provided by the National Institutes of Health (GM074739 and GM082848 to E.C.G.). This work was partially supported by the Initiatives in Science and Engineering program through Columbia University, the Nanoscale Science and Engineering Initiative of the National Science Foundation under NSF Award Number CHE-0641523, and by the New York State Office of Science, Technology, and Academic Research. E.C.G is an Early Career Scientist with the Howard Hughes Medical Institute. We apologize to colleagues whose work we were unable to cite owing to length restrictions.	Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BONNEANDREA C, 1990, NATURE, V343, P719, DOI 10.1038/343719a0; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; EGGLESTON AK, 1995, J BIOL CHEM, V270, P2024, DOI 10.1074/jbc.270.5.2024; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LIN SY, 1970, NATURE, V228, P1184, DOI 10.1038/2281184a0; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LIU B, 1994, P NATL ACAD SCI USA, V91, P10660, DOI 10.1073/pnas.91.22.10660; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; Marquis KA, 2008, GENE DEV, V22, P1786, DOI 10.1101/gad.1684008; Mollazadeh-Beidokhti L, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031922; Noom MC, 2007, NAT METHODS, V4, P1031, DOI 10.1038/nmeth1126; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; PAVCO PA, 1991, NUCLEIC ACIDS RES, V19, P4639, DOI 10.1093/nar/19.17.4639; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816	30	125	126	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					983	987		10.1038/nature09561	http://dx.doi.org/10.1038/nature09561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21107319	Green Accepted			2022-12-24	WOS:000285344600051
J	Pereyra, FP; Jia, XM; McLaren, PJ; Telenti, A; de Bakker, PIW; Walker, BD; Ripke, S; Brumme, CJ; Pulit, SL; Carrington, M; Kadie, CM; Carlson, JM; Heckerman, D; Graham, RR; Plenge, RM; Deeks, SG; Gianniny, L; Crawford, G; Sullivan, J; Gonzalez, E; Davies, L; Camargo, A; Moore, JM; Beattie, N; Gupta, S; Crenshaw, A; Burtt, NP; Guiducci, C; Gupta, N; Carrington, M; Gao, XJ; Qi, Y; Yuki, Y; Piechocka-Trocha, A; Cutrell, E; Rosenberg, R; Moss, KL; Lemay, P; O'Leary, J; Schaefer, T; Verma, P; Toth, I; Block, B; Baker, B; Rothchild, A; Lian, J; Proudfoot, J; Alvino, DML; Vine, S; Addo, MM; Allen, TM; Altfeld, M; Henn, MR; Le Gall, S; Streeck, H; Haas, DW; Kuritzkes, DR; Robbins, GK; Shafer, RW; Gulick, RM; Shikuma, CM; Haubrich, R; Riddler, S; Sax, PE; Daar, ES; Ribaudo, HJ; Agan, B; Agarwal, S; Ahern, RL; Allen, BL; Altidor, S; Altschuler, EL; Ambardar, S; Anastos, K; Anderson, B; Anderson, V; Andrady, U; Antoniskis, D; Bangsberg, D; Barbaro, D; Barrie, W; Bartczak, J; Barton, S; Basden, P; Basgoz, N; Bazner, S; Bellos, NC; Benson, AM; Berger, J; Bernard, NF; Bernard, AM; Birch, C; Bodner, SJ; Bolan, RK; Boudreaux, ET; Bradley, M; Braun, JF; Brndjar, JE; Brown, SJ; Brown, K; Brown, ST; Burack, J; Bush, LM; Cafaro, V; Campbell, O; Campbell, J; Carlson, RH; Carmichael, JK; Casey, KK; Cavacuiti, C; Celestin, G; Chambers, ST; Chez, N; Chirch, LM; Cimoch, PJ; Cohen, D; Cohn, LE; Conway, B; Cooper, DA; Cornelson, B; Cox, DT; Cristofano, MV; Cuchural, G; Czartoski, JL; Dahman, JM; Daly, JS; Davis, BT; Davis, K; Davod, SM; Deeks, SG; DeJesus, E; Dietz, CA; Dunham, E; Dunn, ME; Ellerin, TB; Eron, JJ; Fangman, JJW; Farel, CE; Ferlazzo, H; Fidler, S; Fleenor-Ford, A; Frankel, R; Freedberg, KA; French, NK; Fuchs, JD; Fuller, JD; Gaberman, J; Gallant, JE; Gandhi, RT; Garcia, E; Garmon, D; Gathe, JC; Gaultier, CR; Gebre, W; Gilman, FD; Gilson, I; Goepfert, PA; Gottlieb, MS; Goulston, C; Groger, RK; Gurley, TD; Haber, S; Hardwicke, R; Hardy, WD; Harrigan, PR; Hawkins, TN; Heath, S; Hecht, FM; Henry, WK; Hladek, M; Hoffman, RP; Horton, JM; Hsu, RK; Huhn, GD; Hunt, P; Hupert, MJ; Illeman, ML; Jaeger, H; Jellinger, RM; John, M; Johnson, JA; Johnson, KL; Johnson, H; Johnson, K; Joly, J; Jordan, WC; Kauffman, CA; Khanlou, H; Killian, RK; Kim, AY; Kim, DD; Kinder, CA; Kirchner, JT; Kogelman, L; Kojic, EM; Korthuis, T; Kurisu, W; Kwon, DS; LaMar, M; Lampiris, H; Lanzafame, M; Lederman, MM; Lee, DM; Lee, JML; Lee, MJ; Lee, ETY; Lemoine, J; Levy, JA; Llibre, JM; Liguori, MA; Little, SJ; Liu, AY; Lopez, AJ; Loutfy, MR; Loy, D; Mohammed, DY; Man, A; Mansour, MK; Marconi, VC; Markowitz, M; Marques, R; Martin, JN; Martin, HL; Mayer, KH; McElrath, MJ; McGhee, TA; McGovern, BH; McGowan, K; McIntyre, D; Mcleod, GX; Menezes, P; Mesa, G; Metroka, CE; Meyer-Olson, D; Miller, AO; Montgomery, K; Mounzer, KC; Nagami, EH; Nagin, I; Nahass, RG; Nelson, MO; Nielsen, C; Norene, DL; O'Connor, DH; Ojikutu, BO; Okulicz, J; Oladehin, OO; Oldfield, EC; Olender, SA; Ostrowski, M; Owen, WF; Pae, E; Parsonnet, J; Pavlatos, AM; Perlmutter, AM; Pierce, MN; Pincus, JM; Pisani, L; Price, LJ; Proia, L; Prokesch, RC; Pujet, HC; Ramgopal, M; Rathod, A; Rausch, M; Ravishankar, J; Rhame, FS; Richards, CS; Richman, DD; Robbins, GK; Rodes, B; Rodriguez, M; Rose, RC; Rosenberg, ES; Rosenthal, D; Ross, PE; Rubin, DS; Rumbaugh, E; Saenz, L; Salvaggio, MR; Sanchez, WC; Sanjana, VM; Santiago, S; Schmidt, W; Schuitemaker, H; Sestak, PM; Shalit, P; Shay, W; Shirvani, VN; Silebi, VI; Sizemore, JM; Skolnik, PR; Sokol-Anderson, M; Sosman, JM; Stabile, P; Stapleton, JT; Starrett, S; Stein, F; Stellbrink, HJ; Sterman, FL; Stone, VE; Stone, DR; Tambussi, G; Taplitz, RA; Tedaldi, EM; Telenti, A; Theisen, W; Torres, R; Tosiello, L; Tremblay, C; Tribble, MA; Trinh, PD; Tsao, A; Ueda, P; Vaccaro, A; Valadas, E; Vanig, TJ; Vecino, I; Vega, VM; Veikley, W; Wade, BH; Walworth, C; Wanidworanun, C; Ward, DJ; Warner, DA; Weber, RD; Webster, D; Weis, S; Wheeler, DA; White, DJ; Wilkins, E; Winston, A; Wlodaver, CG; van't Wout, A; Wright, DP; Yang, OO; Yurdin, DL; Zabukovic, BW; Zachary, KC; Zeeman, B; Zhao, M				Pereyra, Florencia; Jia, Xiaoming; McLaren, Paul J.; Telenti, Amalio; de Bakker, Paul I. W.; Walker, Bruce D.; Ripke, Stephan; Brumme, Chanson J.; Pulit, Sara L.; Carrington, Mary; Kadie, Carl M.; Carlson, Jonathan M.; Heckerman, David; Graham, Robert R.; Plenge, Robert M.; Deeks, Steven G.; Gianniny, Lauren; Crawford, Gabriel; Sullivan, Jordan; Gonzalez, Elena; Davies, Leela; Camargo, Amy; Moore, Jamie M.; Beattie, Nicole; Gupta, Supriya; Crenshaw, Andrew; Burtt, Noel P.; Guiducci, Candace; Gupta, Namrata; Carrington, Mary; Gao, Xiaojiang; Qi, Ying; Yuki, Yuko; Piechocka-Trocha, Alicja; Cutrell, Emily; Rosenberg, Rachel; Moss, Kristin L.; Lemay, Paul; O'Leary, Jessica; Schaefer, Todd; Verma, Pranshu; Toth, Ildiko; Block, Brian; Baker, Brett; Rothchild, Alissa; Lian, Jeffrey; Proudfoot, Jacqueline; Alvino, Donna Marie L.; Vine, Seanna; Addo, Marylyn M.; Allen, Todd M.; Altfeld, Marcus; Henn, Matthew R.; Le Gall, Sylvie; Streeck, Hendrik; Haas, David W.; Kuritzkes, Daniel R.; Robbins, Gregory K.; Shafer, Robert W.; Gulick, Roy M.; Shikuma, Cecilia M.; Haubrich, Richard; Riddler, Sharon; Sax, Paul E.; Daar, Eric S.; Ribaudo, Heather J.; Agan, Brian; Agarwal, Shanu; Ahern, Richard L.; Allen, Brady L.; Altidor, Sherly; Altschuler, Eric L.; Ambardar, Sujata; Anastos, Kathryn; Anderson, Ben; Anderson, Val; Andrady, Ushan; Antoniskis, Diana; Bangsberg, David; Barbaro, Daniel; Barrie, William; Bartczak, J.; Barton, Simon; Basden, Patricia; Basgoz, Nesli; Bazner, Suzane; Bellos, Nicholaos C.; Benson, Anne M.; Berger, Judith; Bernard, Nicole F.; Bernard, Annette M.; Birch, Christopher; Bodner, Stanley J.; Bolan, Robert K.; Boudreaux, Emilie T.; Bradley, Meg; Braun, James F.; Brndjar, Jon E.; Brown, Stephen J.; Brown, Katherine; Brown, Sheldon T.; Burack, Jedidiah; Bush, Larry M.; Cafaro, Virginia; Campbell, Omobolaji; Campbell, John; Carlson, Robert H.; Carmichael, J. Kevin; Casey, Kathleen K.; Cavacuiti, Chris; Celestin, Gregory; Chambers, Steven T.; Chez, Nancy; Chirch, Lisa M.; Cimoch, Paul J.; Cohen, Daniel; Cohn, Lillian E.; Conway, Brian; Cooper, David A.; Cornelson, Brian; Cox, David T.; Cristofano, Michael V.; Cuchural, George, Jr.; Czartoski, Julie L.; Dahman, Joseph M.; Daly, Jennifer S.; Davis, Benjamin T.; Davis, Kristine; Davod, Sheila M.; Deeks, Steven G.; DeJesus, Edwin; Dietz, Craig A.; Dunham, Eleanor; Dunn, Michael E.; Ellerin, Todd B.; Eron, Joseph J.; Fangman, John J. W.; Farel, Claire E.; Ferlazzo, Helen; Fidler, Sarah; Fleenor-Ford, Anita; Frankel, Renee; Freedberg, Kenneth A.; French, Neel K.; Fuchs, Jonathan D.; Fuller, Jon D.; Gaberman, Jonna; Gallant, Joel E.; Gandhi, Rajesh T.; Garcia, Efrain; Garmon, Donald; Gathe, Joseph C., Jr.; Gaultier, Cyril R.; Gebre, Wondwoosen; Gilman, Frank D.; Gilson, Ian; Goepfert, Paul A.; Gottlieb, Michael S.; Goulston, Claudia; Groger, Richard K.; Gurley, T. Douglas; Haber, Stuart; Hardwicke, Robin; Hardy, W. David; Harrigan, P. Richard; Hawkins, Trevor N.; Heath, Sonya; Hecht, Frederick M.; Henry, W. Keith; Hladek, Melissa; Hoffman, Robert P.; Horton, James M.; Hsu, Ricky K.; Huhn, Gregory D.; Hunt, Peter; Hupert, Mark J.; Illeman, Mark L.; Jaeger, Hans; Jellinger, Robert M.; John, Mina; Johnson, Jennifer A.; Johnson, Kristin L.; Johnson, Heather; Johnson, Kay; Joly, Jennifer; Jordan, Wilbert C.; Kauffman, Carol A.; Khanlou, Homayoon; Killian, Robert K.; Kim, Arthur Y.; Kim, David D.; Kinder, Clifford A.; Kirchner, Jeffrey T.; Kogelman, Laura; Kojic, Erna Milunka; Korthuis, Todd; Kurisu, Wayne; Kwon, Douglas S.; LaMar, Melissa; Lampiris, Harry; Lanzafame, Massimiliano; Lederman, Michael M.; Lee, David M.; Lee, Jean M. L.; Lee, Marah J.; Lee, Edward T. Y.; Lemoine, Janice; Levy, Jay A.; Llibre, Josep M.; Liguori, Michael A.; Little, Susan J.; Liu, Anne Y.; Lopez, Alvaro J.; Loutfy, Mono R.; Loy, Dawn; Mohammed, Debbie Y.; Man, Alan; Mansour, Michael K.; Marconi, Vincent C.; Markowitz, Martin; Marques, Rui; Martin, Jeffrey N.; Martin, Harold L., Jr.; Mayer, Kenneth Hugh; McElrath, M. Juliana; McGhee, Theresa A.; McGovern, Barbara H.; McGowan, Katherine; McIntyre, Dawn; Mcleod, Gavin X.; Menezes, Prema; Mesa, Greg; Metroka, Craig E.; Meyer-Olson, Dirk; Miller, Andy O.; Montgomery, Kate; Mounzer, Karam C.; Nagami, Ellen H.; Nagin, Iris; Nahass, Ronald G.; Nelson, Margret O.; Nielsen, Craig; Norene, David L.; O'Connor, David H.; Ojikutu, Bisola O.; Okulicz, Jason; Oladehin, Olakunle O.; Oldfield, Edward C., III; Olender, Susan A.; Ostrowski, Mario; Owen, William F., Jr.; Pae, Eunice; Parsonnet, Jeffrey; Pavlatos, Andrew M.; Perlmutter, Aaron M.; Pierce, Michael N.; Pincus, Jonathan M.; Pisani, Leandro; Price, Lawrence Jay; Proia, Laurie; Prokesch, Richard C.; Pujet, Heather Calderon; Ramgopal, Moti; Rathod, Almas; Rausch, Michael; Ravishankar, J.; Rhame, Frank S.; Richards, Constance Shamuyarira; Richman, Douglas D.; Robbins, Gregory K.; Rodes, Berta; Rodriguez, Milagros; Rose, Richard C., III; Rosenberg, Eric S.; Rosenthal, Daniel; Ross, Polly E.; Rubin, David S.; Rumbaugh, Elease; Saenz, Luis; Salvaggio, Michelle R.; Sanchez, William C.; Sanjana, Veeraf M.; Santiago, Steven; Schmidt, Wolfgang; Schuitemaker, Hanneke; Sestak, Philip M.; Shalit, Peter; Shay, William; Shirvani, Vivian N.; Silebi, Vanessa I.; Sizemore, James M., Jr.; Skolnik, Paul R.; Sokol-Anderson, Marcia; Sosman, James M.; Stabile, Paul; Stapleton, Jack T.; Starrett, Sheree; Stein, Francine; Stellbrink, Hans-Jurgen; Sterman, F. Lisa; Stone, Valerie E.; Stone, David R.; Tambussi, Giuseppe; Taplitz, Randy A.; Tedaldi, Ellen M.; Telenti, Amalio; Theisen, William; Torres, Richard; Tosiello, Lorraine; Tremblay, Cecile; Tribble, Marc A.; Trinh, Phuong D.; Tsao, Alice; Ueda, Peggy; Vaccaro, Anthony; Valadas, Emilia; Vanig, Thanes J.; Vecino, Isabel; Vega, Vilma M.; Veikley, Wenoah; Wade, Barbara H.; Walworth, Charles; Wanidworanun, Chingchai; Ward, Douglas J.; Warner, Daniel A.; Weber, Robert D.; Webster, Duncan; Weis, Steve; Wheeler, David A.; White, David J.; Wilkins, Ed; Winston, Alan; Wlodaver, Clifford G.; van't Wout, Angelique; Wright, David P.; Yang, Otto O.; Yurdin, David L.; Zabukovic, Brandon W.; Zachary, Kimon C.; Zeeman, Beth; Zhao, Meng		Int HIV Controllers Study	The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation	SCIENCE			English	Article							DISEASE PROGRESSION; SURFACE EXPRESSION; INFECTION; AIDS; ALLELES; MHC; RESTRICTION; ASSOCIATION; THERAPY; ABSENCE	Infectious and inflammatory diseases have repeatedly shown strong genetic associations within the major histocompatibility complex (MHC); however, the basis for these associations remains elusive. To define host genetic effects on the outcome of a chronic viral infection, we performed genome-wide association analysis in a multiethnic cohort of HIV-1 controllers and progressors, and we analyzed the effects of individual amino acids within the classical human leukocyte antigen (HLA) proteins. We identified >300 genome-wide significant single-nucleotide polymorphisms (SNPs) within the MHC and none elsewhere. Specific amino acids in the HLA-B peptide binding groove, as well as an independent HLA-C effect, explain the SNP associations and reconcile both protective and risk HLA alleles. These results implicate the nature of the HLA-viral peptide interaction as the major factor modulating durable control of HIV infection.	[Pereyra, Florencia; Walker, Bruce D.; Brumme, Chanson J.; Carrington, Mary; Piechocka-Trocha, Alicja; Cutrell, Emily; Rosenberg, Rachel; Moss, Kristin L.; Lemay, Paul; O'Leary, Jessica; Schaefer, Todd; Verma, Pranshu; Toth, Ildiko; Block, Brian; Baker, Brett; Rothchild, Alissa; Lian, Jeffrey; Proudfoot, Jacqueline; Alvino, Donna Marie L.; Vine, Seanna; Addo, Marylyn M.; Allen, Todd M.; Altfeld, Marcus; Le Gall, Sylvie; Streeck, Hendrik; Bazner, Suzane; Birch, Christopher; Bradley, Meg; Kwon, Douglas S.; Nagami, Ellen H.; Pae, Eunice; Rathod, Almas; Tsao, Alice; Ueda, Peggy; Zeeman, Beth] Massachusetts Inst Technol & Harvard, Massachusetts Gen Hosp, Regon Inst, Boston, MA USA; [Pereyra, Florencia; Kuritzkes, Daniel R.; Sax, Paul E.; Farel, Claire E.; Johnson, Jennifer A.; Liu, Anne Y.; McGowan, Katherine; Theisen, William] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Infect Dis, Boston, MA 02115 USA; [Jia, Xiaoming] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [McLaren, Paul J.; de Bakker, Paul I. W.; Ripke, Stephan; Pulit, Sara L.; Plenge, Robert M.; Gianniny, Lauren; Crawford, Gabriel; Sullivan, Jordan; Gonzalez, Elena; Davies, Leela; Camargo, Amy; Moore, Jamie M.; Beattie, Nicole; Gupta, Supriya; Crenshaw, Andrew; Burtt, Noel P.; Guiducci, Candace; Gupta, Namrata; Henn, Matthew R.] Harvard & MIT, Broad Inst, Cambridge, MA USA; [McLaren, Paul J.; de Bakker, Paul I. W.; Pulit, Sara L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA; [Telenti, Amalio] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Div Biomed Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ripke, Stephan] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Dept Med, Boston, MA USA; [Gao, Xiaojiang; Qi, Ying; Yuki, Yuko] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick, Frederick, MD 21701 USA; [Kadie, Carl M.] Microsoft Res, Redmond, WA USA; [Carlson, Jonathan M.; Heckerman, David] Microsoft Res, Los Angeles, CA USA; [Graham, Robert R.] Genentech Inc, San Francisco, CA 94080 USA; [Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Deeks, Steven G.; Hecht, Frederick M.; Hunt, Peter; Lampiris, Harry; Levy, Jay A.; Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Haas, David W.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Shafer, Robert W.] Stanford Univ, Palo Alto, CA 94304 USA; [Gulick, Roy M.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Shikuma, Cecilia M.] Univ Hawaii, John A Burns Sch Med, Hawaii Ctr AIDS, Honolulu, HI 96822 USA; [Haubrich, Richard; Little, Susan J.; Richman, Douglas D.; Taplitz, Randy A.] Univ Calif San Diego, San Diego, CA 92103 USA; [Riddler, Sharon] Univ Pittsburgh, Pittsburgh, PA USA; [Daar, Eric S.; Hardy, W. David; Yang, Otto O.] Univ Calif Los Angeles, Los Angeles, CA USA; [Ribaudo, Heather J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Agan, Brian] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Agarwal, Shanu] Summa Hlth Syst, Akron, OH USA; [Allen, Brady L.; Lee, David M.] Uptown Phys Grp, Dallas, TX USA; [Altidor, Sherly; Metroka, Craig E.] St Lukes Roosevelt Hosp, New York, NY 10025 USA; [Altschuler, Eric L.; Mohammed, Debbie Y.] Univ Med & Dent New Jersey, New Jersey Med Sch, Univ Hosp, Newark, NJ 07103 USA; [Anastos, Kathryn] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Anderson, Ben] St Leonards Med Ctr, St Leonards, NSW, Australia; [Anderson, Val; Andrady, Ushan] Ysbyty Gwynedd Hosp, Bangor, Gwynedd, Wales; [Antoniskis, Diana; Man, Alan; Rumbaugh, Elease] Kaiser Permanente, Portland, OR USA; [Barbaro, Daniel; Hupert, Mark J.; Johnson, Heather] Tarrant Cty Infect Dis Associates, Ft Worth, TX USA; [Bartczak, J.] Rowan Tree Med, Wilton Manors, FL USA; [Barton, Simon] Chelsea & Westminster Hosp, St Stephens Ctr, London, England; [Bellos, Nicholaos C.] SW Infect Dis Associates, Dallas, TX USA; [Berger, Judith] St Barnabas Hosp, Bronx, NY USA; [Bernard, Nicole F.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; [Bernard, Annette M.] Thacker Thompson & Bernard, Atlanta, GA USA; [Bodner, Stanley J.] Vanderbilt Univ, Sch ofMedicine, Hermitage, TN USA; [Bolan, Robert K.] LA Gay & Lesbian Ctr, Los Angeles, CA USA; [Boudreaux, Emilie T.] Louisiana State Univ, Hlth Sci Ctr, Univ Med Ctr E Clin, Lafayatte, LA USA; [Braun, James F.] Callen Lorde Community Hlth Ctr, Phys Res Network, New York, NY USA; [Brndjar, Jon E.] Brndjar Med Associates, Allentown, PA USA; [Brown, Stephen J.] AIDS Res Alliance, Los Angeles, CA USA; [Brown, Katherine] David Powell Community Hlth Ctr, Austin, TX USA; [Brown, Sheldon T.] James J Peters VA Med Ctr, Bronx, NY USA; [Burack, Jedidiah] Sunrise Med Grp, Brooklyn, NY USA; [Bush, Larry M.] Univ Miami, Miller Sch Med, Lake Worth, FL USA; [Cafaro, Virginia] WellSpring Med Grp, San Francisco, CA USA; [Campbell, John] Moses Cone Hlth Syst, Greensboro, NC USA; [Carlson, Robert H.] HealthPartners Infect Dis, St Paul, MN USA; [Carmichael, J. Kevin] El Rio Special Immunol Associates, Tucson, AZ USA; [Casey, Kathleen K.; McIntyre, Dawn] Jersey Shore Univ, Med Ctr, Neptune, NJ USA; [Cavacuiti, Chris; Cornelson, Brian] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Celestin, Gregory] PATH Ctr, Brooklyn Hosp Ctr, Brooklyn, NY USA; [Chambers, Steven T.] Univ Otago, Christchurch, New Zealand; [Chez, Nancy] HELP Project Samaritan, Bronx, NY USA; [Chirch, Lisa M.; Dunham, Eleanor; Joly, Jennifer] David E Rogers Ctr HIV AIDS Care, Southampton, NY USA; [Cimoch, Paul J.; Walworth, Charles] Ctr Special Immunol, Fountain Valley, CA USA; [Cohen, Daniel; Mayer, Kenneth Hugh] Fenway Community Hlth, Boston, MA USA; [Cohn, Lillian E.] 9th St Internal Med Associates, Philadelphia, PA USA; [Conway, Brian] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Cooper, David A.] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Cox, David T.] Metro Infect Dis Consultants, Indianapolis, IN USA; [Cristofano, Michael V.] John H Stroger Hosp Cook Cty, Chicago, IL USA; [Cuchural, George, Jr.] New England Qual Care Alliance, Braintree, MA USA; [Czartoski, Julie L.; Lee, Jean M. L.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Dahman, Joseph M.] Desert AIDS Project, Palm Springs, CA USA; [Daly, Jennifer S.] Univ Massachusetts, Mem Med Ctr, Worcester, MA 01605 USA; [Davis, Kristine] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Dietz, Craig A.] Kansas City Free Hlth Clin, Kansas City, MO USA; [Ellerin, Todd B.] S Shore Hosp, Weymouth, MA USA; [Eron, Joseph J.; Menezes, Prema] Univ N Carolina, Chapel Hill, NC USA; [Fangman, John J. W.] AIDS Resource Ctr Wisconsin, Milwaukee, WI USA; [Ferlazzo, Helen; Stein, Francine] Visiting Nurse Assoc Cent New Jersey, Ctr Community Hlth, Asbury Pk, NJ USA; [Fidler, Sarah; Winston, Alan] Univ London Imperial Coll Sci Technol & Med, London, England; [Fleenor-Ford, Anita] Heartland Clin, Paducah, KY USA; [Frankel, Renee] Morristown Mem Hosp, Morristown, NJ USA; [Fuchs, Jonathan D.] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Fuller, Jon D.; Skolnik, Paul R.] Boston Univ, Med Ctr, Boston, MA USA; [Gaberman, Jonna] Baystate Med Ctr, Springfield, MA USA; [Gallant, Joel E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Gaultier, Cyril R.] Tower Infect Dis, Los Angeles, CA USA; [Gebre, Wondwoosen] Nassau Univ Med Ctr, E Meadow, NY USA; [Gilman, Frank D.; Kurisu, Wayne] Sharp Rees Stealy Med Ctr, San Diego, CA USA; [Gilson, Ian] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Goepfert, Paul A.; Heath, Sonya] Univ Alabama, Birmingham, AL USA; [Gottlieb, Michael S.] Synergy Hematol & Oncol, Los Angeles, CA USA; [Goulston, Claudia] Univ Utah, Salt Lake City, UT USA; [Groger, Richard K.] S Dayton Acute Care Consultants, Dayton, OH USA; [Haber, Stuart; Shay, William] St Vincents Hosp, New York, NY USA; [Hardwicke, Robin] Univ Texas Hlth Sci Ctr, Houston, TX USA; [Harrigan, P. Richard] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Hawkins, Trevor N.; Veikley, Wenoah] SW CARE Ctr, Santa Fe, NM USA; [Henry, W. Keith] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Hladek, Melissa] Catholic Univ Amer, Sch Nursing, Washington, DC 20064 USA; [Hoffman, Robert P.] St Johns Mercy Med Ctr, Springfield, MA USA; [Horton, James M.] CMC Myers Pk Med Ctr, Charlotte, NC USA; [Hsu, Ricky K.; Liguori, Michael A.] NYU, Med Ctr, New York, NY 10016 USA; [Huhn, Gregory D.] Ruth M Rothshon Care Ctr, Chicago, IL USA; [Illeman, Mark L.] Feldman Med Grp, San Francisco, CA USA; [Jaeger, Hans] HIV Res & Clin Care Ctr, Munich, Germany; [Jellinger, Robert M.] Albany Med Coll, Albany, NY 12208 USA; [John, Mina] Murdoch Univ, Murdoch, WA 6150, Australia; [Johnson, Kay] Univ Cincinnati, Cincinnati, OH USA; [Jordan, Wilbert C.] OASIS Clin, Los Angeles, CA USA; [Kauffman, Carol A.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Khanlou, Homayoon] AIDS Healthcare Fdn, Los Angeles, CA USA; [Killian, Robert K.] Capitol Hill Med, Seattle, WA USA; [Kim, David D.] Astor Med Grp, New York, NY USA; [Kinder, Clifford A.] Kinder Med Grp, Miami, FL USA; [Kirchner, Jeffrey T.] Lancaster Gen Hosp, Lancaster, PA USA; [Kogelman, Laura; McGovern, Barbara H.] Tufts Med Ctr, Boston, MA USA; [Kojic, Erna Milunka] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Korthuis, Todd] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Lanzafame, Massimiliano] GB Rossi Hosp, Verona, Italy; [Lederman, Michael M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Lee, Marah J.] LifeWay, Ft Lauderdale, FL USA; [Lee, Edward T. Y.] St Claire Med Associate, Toronto, ON, Canada; [Lemoine, Janice] Greater Lawrence Family Hlth Ctr, Lawrence, MA USA; [Llibre, Josep M.] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; [Lopez, Alvaro J.] Infect Dis Consultants, Tucker, GA USA; [Loutfy, Mono R.; Ostrowski, Mario] Univ Toronto, Toronto, ON, Canada; [Loy, Dawn; Prokesch, Richard C.; Vega, Vilma M.] Infect Dis Associates, Sarasota, FL USA; [Marconi, Vincent C.] Emory Univ, Sch Med, Atlanta, GA USA; [Markowitz, Martin] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Martin, Harold L., Jr.] Pk Nicollet Clin, St Louis, MN USA; [McGhee, Theresa A.] Absolute Care, Atlanta, GA USA; [Mcleod, Gavin X.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Mesa, Greg] Highland Med Associates, Hendersonville, NC USA; [Meyer-Olson, Dirk] Hannover Med Sch, Abt Klin Immunol, D-30623 Hannover, Germany; [Miller, Andy O.] Hosp Special Surg, New York, NY 10021 USA; [Mounzer, Karam C.] Philadelphia FIGHT, Philadelphia, PA USA; [Nagin, Iris] Lower E Side Serv Ctr, New York, NY USA; [Nielsen, Craig] Univ Colorado, Aurora, CO USA; [Norene, David L.] Sutter Med Grp, Sacramento, CA USA; [O'Connor, David H.; Sosman, James M.] Univ Wisconsin, Madison, WI USA; [Okulicz, Jason] Brooke Army Med Ctr, San Antonio, TX USA; [Oldfield, Edward C., III] Eastern Virginia Med Sch, Norfolk, VA 23501 USA; [Olender, Susan A.] Columbia Univ, Med Ctr, New York, NY USA; [Owen, William F., Jr.] CA Pacific Med Ctr, San Francisco, CA USA; [Parsonnet, Jeffrey] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Pavlatos, Andrew M.] St Joseph Hosp, Chicago, IL USA; [Pincus, Jonathan M.] Codman Sq Hlth Ctr, Dorchester, MA USA; [Pisani, Leandro; Rodriguez, Milagros; Saenz, Luis; Santiago, Steven] CARE Resource, Miami, FL USA; [Price, Lawrence Jay] Castro Mission Hlth Ctr, San Francisco, CA USA; [Proia, Laurie] Rush Med Coll, Chicago, IL 60612 USA; [Pujet, Heather Calderon] Boulder Community Hosp, Boulder, CO USA; [Ramgopal, Moti] Midway Immunol & Res Ctr, Ft Pierce, FL USA; [Rausch, Michael] Aerztezentrum Nollendorfpl, Berlin, Germany; [Ravishankar, J.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Rhame, Frank S.] Clin 42, Minneapolis, MN USA; [Richards, Constance Shamuyarira] King Edward Mem Hosp, Paget, Bermuda; [Rodes, Berta] Hosp Carlos III, Fdn Invest Biomed, Madrid, Spain; [Rose, Richard C., III] Summit Med Grp, Knoxville, TN USA; [Rosenthal, Daniel] Med Consultants S Florida, Coral Springs, FL USA; [Ross, Polly E.] Western N Carolina Community Hlth Serv, Asheville, NC USA; [Rubin, David S.] New York Hosp, Queens Med Ctr, Flushing, NY USA; [Salvaggio, Michelle R.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Sanchez, William C.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Sanjana, Veeraf M.] Village Care Hlth Ctr, New York, NY USA; [Schuitemaker, Hanneke; van't Wout, Angelique] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Sestak, Philip M.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Shalit, Peter] Swedish Med Ctr, Seattle, WA USA; [Shirvani, Vivian N.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Silebi, Vanessa I.] Mercy Hosp, Miami, FL USA; [Sizemore, James M., Jr.] Univ Tennessee, Chattanooga, TN USA; [Sokol-Anderson, Marcia] St Louis Univ, St Louis, MO 63103 USA; [Stabile, Paul] William F Ryan Community Hlth Ctr, New York, NY USA; [Stapleton, Jack T.] Univ Iowa, Iowa City, IA USA; [Starrett, Sheree] Rivington House & Village Care, New York, NY USA; [Stellbrink, Hans-Jurgen] Infekt Med Ctr Hamburg, Hamburg, Germany; [Sterman, F. Lisa] Calif Pacific Med Ctr, San Francisco, CA USA; [Stone, David R.] Lemuel Shattuck Hosp, Boston, MA USA; [Tambussi, Giuseppe] Fdn San Raffaele Del Monte Tabor, Milan, Italy; [Tedaldi, Ellen M.] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Torres, Richard] Yale Univ, Sch Med, Bridgeport, CT USA; [Tosiello, Lorraine] Jersey City Med Ctr, Jersey City, NJ USA; [Tremblay, Cecile] Univ Montreal, Montreal, PQ, Canada; [Tribble, Marc A.] Baylor Univ, Med Ctr, Dallas, TX USA; [Trinh, Phuong D.] Montgomery Infect Dis Associates, Silver Spring, MD USA; [Vaccaro, Anthony] Northwestern Univ, Chicago, IL 60611 USA; [Valadas, Emilia] Hosp Santa Maria, Fac Med Lisboa, Lisbon, Portugal; [Vanig, Thanes J.] Spectrum Med Grp, Phoenix, AZ USA; [Vecino, Isabel; Weis, Steve] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA; [Wade, Barbara H.] Infect Dis Associates NW Florida, Pensacola, FL USA; [Ward, Douglas J.] Dupont Circle Phys Grp, Washington, DC USA; [Weber, Robert D.] Infect Dis Specialists, Colorado Springs, CO USA; [Webster, Duncan] St Johns Hosp, St John, NB, Canada; [Wheeler, David A.] Clin Alliance Res & Educ Infect Dis, Annandale, VA USA; [White, David J.] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England; [Wilkins, Ed] N Manchester Grp Hosp, Manchester, Lancs, England; [Wright, David P.] Cent Texas Clin Res, Austin, TX USA; [Yurdin, David L.] Primary Hlth Care, Des Moines, IA USA; [Zabukovic, Brandon W.] Mem Neighborhood Hlth Ctr Cent Clin, South Bend, IN USA; [Zhao, Meng] United Hlth Serv Hosp, Binghamton, NY USA; [Pierce, Michael N.] All Med & Rehabil New York, Bronx, NY USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Lausanne; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Microsoft; Microsoft; Roche Holding; Genentech; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco; Vanderbilt University; Stanford University; Cornell University; University of Hawaii System; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; Uniformed Services University of the Health Sciences - USA; Summa Health System; Mount Sinai St. Luke's; Mount Sinai West; Rutgers State University New Brunswick; Rutgers State University Medical Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Kaiser Permanente; Imperial College London; Saint Barnabas Hospital; McGill University; Vanderbilt University; Louisiana State University System; Louisiana State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Jersey Shore University Medical Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Brooklyn Hospital Center; University of Otago; University of British Columbia; University of New South Wales Sydney; Kirby Institute; John H Stroger Junior Hospital Cook County; Fred Hutchinson Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; University of Iowa; Orlando Immunology Center; University of North Carolina; University of North Carolina Chapel Hill; Imperial College London; Atlantic Health System; San Francisco Department of Public Health; Boston University; Baystate Medical Center; Johns Hopkins University; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Saint Vincents Hospital Manhattan; University of Texas System; University of Texas Health Science Center Houston; B.C. Centre for Excellence in HIV/AIDS; Hennepin County Medical Center; Catholic University of America; New York University; Albany Medical College; Murdoch University; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Tufts Medical Center; Brown University; Oregon Health & Science University; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Case Western Reserve University; Hospital Germans Trias i Pujol; University of Toronto; Emory University; Rockefeller University; Columbia University; Hannover Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Wisconsin System; University of Wisconsin Madison; San Antonio Military Medical Center; United States Department of Defense; United States Army; Eastern Virginia Medical School; Columbia University; California Pacific Medical Center; Dartmouth College; Rush University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Hospital Carlos III; NewYork-Presbyterian Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; Georgetown University; University of Amsterdam; Academic Medical Center Amsterdam; St. Paul's Hospital; University of Saskatchewan; Swedish Medical Center; Cedars Sinai Medical Center; University of Tennessee System; University of Tennessee at Chattanooga; Saint Louis University; University of Iowa; California Pacific Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Yale University; Universite de Montreal; Baylor University; Baylor University Medical Center; Northwestern University; Universidade de Lisboa; Hospital Santa Maria; University of North Texas System; University of North Texas Health Science Center; Heart of England NHS Foundation Trust; University of Birmingham	Walker, BD (corresponding author), Massachusetts Inst Technol & Harvard, Massachusetts Gen Hosp, Regon Inst, Boston, MA USA.	pdebakker@rics.bwh.harvard.edu; bwalker@partners.org	VALLET, Yannick/F-9979-2011; Telenti, Amalio/AAY-1674-2021; Rothchild, Alissa/AAM-2635-2020; Robbins, Gregory/F-7988-2011; Bolan, Robert/AAD-4716-2020; Hunt, Peter W./P-2976-2017; Lanzafame, Massimiliano/AAU-5736-2021; Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Allen, Todd/F-5473-2011; Ripke, Stephan/AAK-5486-2021; Miller, Andy/AAE-2500-2022; Addo, Marylyn M./GNP-2548-2022; Lewin, Jonathan S/A-4331-2009; Marconi, Vincent/GRJ-4553-2022; Altfeld, Marcus/AAE-7306-2019; de Bakker, Paul IW/B-8730-2009; Block, Brian/L-4001-2019; Little, Susan/AAA-6116-2019; Winston, Alan/AGZ-3015-2022; Hardy, W. David/AHD-8960-2022	Rothchild, Alissa/0000-0001-7484-1193; Hunt, Peter W./0000-0002-4571-4870; Marconi, Vincent/0000-0001-8409-4689; Allen, Todd/0000-0002-6609-1318; Miller, Andy/0000-0003-2762-0878; Marconi, Vincent/0000-0001-8409-4689; Altfeld, Marcus/0000-0001-5972-2997; de Bakker, Paul IW/0000-0001-7735-7858; Block, Brian/0000-0002-0779-1170; Winston, Alan/0000-0002-5847-8416; Birch, Christopher/0000-0001-5824-2676; Jia, Xiaoming/0000-0002-5104-5431; Brumme, Chanson/0000-0003-2722-5288; Fuller, Jon/0000-0001-9475-1902; Stapleton, Jack/0000-0002-2302-9055; Hladek, Melissa/0000-0002-0625-2474; Campbell, Mobola/0000-0002-5772-2368; Pulit, Sara/0000-0002-2502-3669; Tambussi, Giuseppe/0000-0002-0604-2960; ripke, stephan/0000-0003-3622-835X; Ojikutu, Bisola/0000-0001-7957-8881; Robbins, Gregory/0000-0001-7545-5817; Farel, Claire/0000-0002-4678-7713; McLaren, Paul/0000-0001-6019-7018; Addo, Marylyn/0000-0003-2836-9224; Lian, Jeffrey/0000-0001-9470-7864; Gonzalez, Elena/0000-0003-4380-663X; Le Gall, Sylvie/0000-0003-0385-926X; Fidler, Sarah/0000-0003-1676-7583; van 't Wout, Angelique/0000-0003-3705-2392; Valadas, Emilia/0000-0001-5213-1473; Korthuis, Philip/0000-0001-5556-3597	Mark and Lisa Schwartz Foundation; Bill and Melinda Gates Foundation; Harvard University Center for AIDS Research [P-30-AI060354]; University of California San Francisco (UCSF) Center for AIDS Research [P-30 AI27763]; UCSF Clinical and Translational Science Institute [UL1 RR024131]; Center for AIDS Research Network of Integrated Clinical Systems [R24 AI067039]; NIH [AI28568, AI030914, AI087145, K24AI069994, AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI069465, AI069511]; Swiss National Science Foundation (SNF) [33CSC0-108787, 310000-110012]; NIH/National Institute of Mental Health [MH085520]; National Cancer Institute/NIH [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131, UL1RR024975, TL1RR024978, KL2RR024977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069432, UM1AI069484, UM1AI068636, UM1AI069495, UM1AI069450, UM1AI069452, U01AI069419, UM1AI069419, T32AI007061, P30AI027763, P30AI050410, UM1AI069423, U01AI069452, U01AI069465, UM1AI069434, U01AI069424, U01AI069513, K24AI069994, U01AI069532, U01AI069450, P30AI060354, R01AI028568, UM1AI069477, R01AI077505, UM1AI069556, U01AI069472, UM1AI069501, UM1AI069471, U01AI069467, K24AI064086, UM1AI069415, U01AI069495, UM1AI069532, R24AI067039, UM1AI069465, U01AI069511, U01AI069423, R37AI028568, R24AI106039, U01AI069474, K24AI051966, U01AI068636, U01AI038844, U01AI069484, U01AI032782, U01AI069428, UM1AI069467, U01AI069434, UM1AI069432, U01AI069477, UM1AI068634, U01AI046370, U01AI025859, UM1AI069474, UM1AI069511, UM1AI069513, R01AI087145, U01AI069501, UM1AI069424, U01AI069471, U01AI068634, U01AI034853, U01AI034835, U01AI027661, U01AI069415, UM1AI069502, U01AI069556, U01AI069502, UM1AI069428, UM1AI069472, R01AI030914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907, U01MH085520, R01MH071205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA019809] Funding Source: NIH RePORTER	Mark and Lisa Schwartz Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Harvard University Center for AIDS Research; University of California San Francisco (UCSF) Center for AIDS Research; UCSF Clinical and Translational Science Institute; Center for AIDS Research Network of Integrated Clinical Systems; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NIH/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was made possible through a generous donation from the Mark and Lisa Schwartz Foundation and a subsequent award from the Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation. This work was also supported in part by the Harvard University Center for AIDS Research (grant P-30-AI060354); University of California San Francisco (UCSF) Center for AIDS Research (grant P-30 AI27763); UCSF Clinical and Translational Science Institute (grant UL1 RR024131); Center for AIDS Research Network of Integrated Clinical Systems (grant R24 AI067039); and NIH grants AI28568 and AI030914 (B. D. W.); AI087145 and K24AI069994 (S. G. D.); AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI68634, AI069502, AI069419, AI068636, and RR024975 (AIDS Clinical Trials Group); and AI077505 and MH071205 (D. W. H.). The Swiss HIV Cohort Study is supported by the Swiss National Science Foundation (SNF grants 33CSC0-108787 and 310000-110012). S. Ripke acknowledges support from NIH/National Institute of Mental Health (grant MH085520). This project has been funded in whole or in part with funds from National Cancer Institute/NIH (grant HHSN261200800001E to M. Carrington). The content of this publication does not necessarily reflect the views or policies of the U. S. Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U. S. government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Blanco-Gelaz MA, 2006, INT IMMUNOL, V18, P211, DOI 10.1093/intimm/dxh364; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Costello C, 1999, AIDS, V13, P1990, DOI 10.1097/00002030-199910010-00031; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; KLEIN MR, 1994, J INFECT DIS, V169, P1244, DOI 10.1093/infdis/169.6.1244; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Stewart-Jones GBE, 2005, J IMMUNOL, V175, P2459, DOI 10.4049/jimmunol.175.4.2459; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898	31	851	864	7	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1551	1557		10.1126/science.1195271	http://dx.doi.org/10.1126/science.1195271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21051598	Green Accepted, Green Published			2022-12-24	WOS:000285153500069
J	Bates, M				Bates, Mark			A New Approach to Fluorescence Microscopy	SCIENCE			English	Editorial Material							OPTICAL RECONSTRUCTION MICROSCOPY; LOCALIZATION; PROBES; RESOLUTION; CELLS		Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany	Max Planck Society	Bates, M (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany.	mbates@ggweg.de						Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bates M, 2008, CURR OPIN CHEM BIOL, V12, P505, DOI 10.1016/j.cbpa.2008.08.008; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	17	2	2	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1334	1335		10.1126/science.1200252	http://dx.doi.org/10.1126/science.1200252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127240	Green Published			2022-12-24	WOS:000284902100030
J	Daneman, R; Zhou, L; Kebede, AA; Barres, BA				Daneman, Richard; Zhou, Lu; Kebede, Amanuel A.; Barres, Ben A.			Pericytes are required for blood-brain barrier integrity during embryogenesis	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; IN-VITRO; UP-REGULATION; ASTROCYTES; OCCLUDIN; RATS; CNS; OLIGODENDROCYTES; MORPHOGENESIS	Vascular endothelial cells in the central nervous system (CNS) forma barrier that restricts the movement of molecules and ions between the blood and the brain. This blood-brain barrier (BBB) is crucial to ensure proper neuronal function and protect the CNS from injury and disease(1). Transplantation studies have demonstrated that the BBB is not intrinsic to the endothelial cells, but is induced by interactions with the neural cells(2). Owing to the close spatial relationship between astrocytes and endothelial cells, it has been hypothesized that astrocytes induce this critical barrier postnatally(3), but the timing of BBB formation has been controversial(4-9). Here we demonstrate that the barrier is formed during embryogenesis as endothelial cells invade the CNS and pericytes are recruited to the nascent vessels, over a week before astrocyte generation. Analysing mice with null and hypomorphic alleles of Pdgfrb, which have defects in pericyte generation, we demonstrate that pericytes are necessary for the formation of the BBB, and that absolute pericyte coverage determines relative vascular permeability. We demonstrate that pericytes regulate functional aspects of the BBB, including the formation of tight junctions and vesicle trafficking in CNS endothelial cells. Pericytes do not induce BBB-specific gene expression in CNS endothelial cells, but inhibit the expression of molecules that increase vascular permeability and CNS immune cell infiltration. These data indicate that pericyte-endothelial cell interactions are critical to regulate the BBB during development, and disruption of these interactions may lead to BBB dysfunction and neuroinflammation during CNS injury and disease.	[Daneman, Richard; Kebede, Amanuel A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Zhou, Lu; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Daneman, R (corresponding author), Univ Calif San Francisco, Dept Anat, 513 Parnassus Ave,HSW1301, San Francisco, CA 94143 USA.	Richard.daneman@ucsf.edu			NINDS [R01-NS045621]; Myelin Repair Foundation; NMSS [RG3936A7]; UCSF; AHA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045621] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Myelin Repair Foundation; NMSS(National Multiple Sclerosis Society); UCSF; AHA(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Perrino for electron microscopy preparations. Work was supported by grants from the NINDS (R01-NS045621; B.A.B), Myelin Repair Foundation (B.A.B., R.D.), NMSS (Grant-RG3936A7; B.A.B.), UCSF Fellow's Program (R.D.) and AHA (R.D.).	BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; Bolz S, 1996, CELL TISSUE RES, V284, P355, DOI 10.1007/s004410050596; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; He ZJ, 2009, CHINESE MED J-PEKING, V122, P2346, DOI 10.3760/cma.j.issn.0366-6999.2009.19.029; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirase T, 1997, J CELL SCI, V110, P1603; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kniesel U, 1996, DEV BRAIN RES, V96, P229, DOI 10.1016/S0165-3806(96)00117-4; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Lai CH, 2005, BRAIN RES REV, V50, P258, DOI 10.1016/j.brainresrev.2005.07.004; Lee SW, 2009, INT J MOL MED, V23, P279, DOI 10.3892/ijmm_00000128; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Nag S, 2005, LAB INVEST, V85, P1189, DOI 10.1038/labinvest.3700325; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	33	1233	1271	7	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					562	U238		10.1038/nature09513	http://dx.doi.org/10.1038/nature09513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	20944625	Green Accepted			2022-12-24	WOS:000284584200042
J	Kanchanawong, P; Shtengel, G; Pasapera, AM; Ramko, EB; Davidson, MW; Hess, HF; Waterman, CM				Kanchanawong, Pakorn; Shtengel, Gleb; Pasapera, Ana M.; Ramko, Ericka B.; Davidson, Michael W.; Hess, Harald F.; Waterman, Clare M.			Nanoscale architecture of integrin-based cell adhesions	NATURE			English	Article							FOCAL ADHESIONS; ACTIN-FILAMENTS; PROTEIN; FORCE; TALIN; MICROSCOPY; PROBES	Cell adhesions to the extracellular matrix (ECM) are necessary for morphogenesis, immunity and wound healing(1,2). Focal adhesions are multifunctional organelles that mediate cell-ECM adhesion, force transmission, cytoskeletal regulation and signalling(1-3). Focal adhesions consist of a complex network(4) of trans-plasma-membrane integrins and cytoplasmic proteins that form a <200-nm plaque(5,6) linking the ECM to the actin cytoskeleton. The complexity of focal adhesion composition and dynamics implicate an intricate molecular machine(7,8). However, focal adhesion molecular architecture remains unknown. Here we used three-dimensional super-resolution fluorescence microscopy (interferometric photo-activated localization microscopy)(9) to map nanoscale protein organization in focal adhesions. Our results reveal that integrins and actin are vertically separated by a similar to 40-nm focal adhesion core region consisting of multiple protein-specific strata: a membrane-apposed integrin signalling layer containing integrin cytoplasmic tails, focal adhesion kinase and paxillin; an intermediate force-transduction layer containing talin and vinculin; and an uppermost actin-regulatory layer containing zyxin, vasodilator-stimulated phosphoprotein and alpha-actinin. By localizing amino- and carboxyterminally tagged talins, we reveal talin's polarized orientation, indicative of a role in organizing the focal adhesion strata. The composite multilaminar protein architecture provides a molecular blueprint for understanding focal adhesion functions.	[Kanchanawong, Pakorn; Pasapera, Ana M.; Waterman, Clare M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Shtengel, Gleb; Hess, Harald F.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Ramko, Ericka B.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Waterman, CM (corresponding author), NHLBI, NIH, Bethesda, MD 20892 USA.	davidson@magnet.fsu.edu; hessh@janelia.hhmi.org; watermancm@nhlbi.nih.gov	Kanchanawong, Pakorn/M-1315-2017	Kanchanawong, Pakorn/0000-0001-8765-3861; Waterman, Clare/0000-0001-6142-6775	Division of Intramural Research, NHLBI; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005105] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Lippincott-Schwartz, G. Patterson and M. Parsons for sharing DNA; S. Xie for help with automation software; K. Jaqaman for MATLAB code; and HHMI Janelia Farm Scientific Computing and NIH Helix systems for computing resources. Funding: Division of Intramural Research, NHLBI (P.K., A.M.P. and C.M.W.); Howard Hughes Medical Institute (G.S. and H.F.H.).	AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHEN WT, 1982, J CELL BIOL, V95, P205, DOI 10.1083/jcb.95.1.205; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dulkeith E, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205424; Franz CM, 2005, J CELL SCI, V118, P5315, DOI 10.1242/jcs.02653; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hell SW, 2009, NAT PHOTONICS, V3, P381, DOI 10.1038/NPHOTON.2009.112; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; PALADE GE, 1954, J EXP MED, V100, P641, DOI 10.1084/jem.100.6.641; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pollard TD, 2009, J BIOL CHEM, V284, P5433, DOI 10.1074/jbc.R800043200; Press W., 1986, NUMERICAL RECIPES; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Wang Yu-li, 2007, Sci STKE, V2007, ppe10; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 1999, J CELL SCI, V112, P1655	35	984	1005	8	416	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					580	U262		10.1038/nature09621	http://dx.doi.org/10.1038/nature09621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107430	Green Accepted			2022-12-24	WOS:000284584200046
J	Scherber, C; Eisenhauer, N; Weisser, WW; Schmid, B; Voigt, W; Fischer, M; Schulze, ED; Roscher, C; Weigelt, A; Allan, E; Bessler, H; Bonkowski, M; Buchmann, N; Buscot, F; Clement, LW; Ebeling, A; Engels, C; Halle, S; Kertscher, I; Klein, AM; Koller, R; Konig, S; Kowalski, E; Kummer, V; Kuu, A; Lange, M; Lauterbach, D; Middelhoff, C; Migunova, VD; Milcu, A; Muller, R; Partsch, S; Petermann, JS; Renker, C; Rottstock, T; Sabais, A; Scheu, S; Schumacher, J; Temperton, VM; Tscharntke, T				Scherber, Christoph; Eisenhauer, Nico; Weisser, Wolfgang W.; Schmid, Bernhard; Voigt, Winfried; Fischer, Markus; Schulze, Ernst-Detlef; Roscher, Christiane; Weigelt, Alexandra; Allan, Eric; Bessler, Holger; Bonkowski, Michael; Buchmann, Nina; Buscot, Francois; Clement, Lars W.; Ebeling, Anne; Engels, Christof; Halle, Stefan; Kertscher, Ilona; Klein, Alexandra-Maria; Koller, Robert; Koenig, Stephan; Kowalski, Esther; Kummer, Volker; Kuu, Annely; Lange, Markus; Lauterbach, Dirk; Middelhoff, Cornelius; Migunova, Varvara D.; Milcu, Alexandru; Mueller, Ramona; Partsch, Stephan; Petermann, Jana S.; Renker, Carsten; Rottstock, Tanja; Sabais, Alexander; Scheu, Stefan; Schumacher, Jens; Temperton, Vicky M.; Tscharntke, Teja			Bottom-up effects of plant diversity on multitrophic interactions in a biodiversity experiment	NATURE			English	Article							TROPHIC GROUPS; TOP-DOWN; COMMUNITIES; ECOSYSTEMS; GRASSLANDS; SERVICES; WEB	Biodiversity is rapidly declining(1), and this may negatively affect ecosystem processes(2), including economically important ecosystem services(3). Previous studies have shown that biodiversity has positive effects on organisms and processes(4) across trophic levels(5). However, only a few studies have so far incorporated an explicit food-web perspective(6). In an eight-year biodiversity experiment, we studied an unprecedented range of above-and below-ground organisms and multitrophic interactions. A multitrophic data set originating from a single long-term experiment allows mechanistic insights that would not be gained from meta-analysis of different experiments. Here we show that plant diversity effects dampen with increasing trophic level and degree of omnivory. This was true both for abundance and species richness of organisms. Furthermore, we present comprehensive above-ground/below-ground biodiversity food webs. Both above ground and below ground, herbivores responded more strongly to changes in plant diversity than did carnivores or omnivores. Density and richness of carnivorous taxa was independent of vegetation structure. Below-ground responses to plant diversity were consistently weaker than above-ground responses. Responses to increasing plant diversity were generally positive, but were negative for biological invasion, pathogen infestation and hyperparasitism. Our results suggest that plant diversity has strong bottom-up effects on multitrophic interaction networks, with particularly strong effects on lower trophic levels. Effects on higher trophic levels are indirectly mediated through bottom-up trophic cascades.	[Scherber, Christoph; Ebeling, Anne; Tscharntke, Teja] Univ Gottingen, Dept Crop Sci, D-37077 Gottingen, Germany; [Scherber, Christoph; Weisser, Wolfgang W.; Voigt, Winfried; Roscher, Christiane; Weigelt, Alexandra; Allan, Eric; Clement, Lars W.; Ebeling, Anne; Halle, Stefan; Kertscher, Ilona; Klein, Alexandra-Maria; Kowalski, Esther; Lange, Markus; Lauterbach, Dirk; Mueller, Ramona] Univ Jena, Inst Ecol, D-07743 Jena, Germany; [Eisenhauer, Nico; Partsch, Stephan; Sabais, Alexander; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Eisenhauer, Nico] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Schmid, Bernhard; Petermann, Jana S.] Univ Zurich, Inst Environm Sci, CH-8057 Zurich, Switzerland; [Fischer, Markus] Univ Bern, CH-3013 Bern, Switzerland; [Fischer, Markus; Kummer, Volker; Rottstock, Tanja] Univ Potsdam, Inst Biochem & Biol, D-14469 Potsdam, Germany; [Schulze, Ernst-Detlef; Middelhoff, Cornelius; Schumacher, Jens; Temperton, Vicky M.] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, D-06120 Halle, Germany; [Weigelt, Alexandra] Univ Leipzig, Inst Biol 1, D-04103 Leipzig, Germany; [Bessler, Holger; Engels, Christof] Humboldt Univ, Dept Plant Nutr, D-14195 Berlin, Germany; [Bonkowski, Michael; Koller, Robert] Univ Cologne, Cologne Bioctr, Dept Terr Ecol, D-50674 Cologne, Germany; [Buchmann, Nina] Swiss Fed Inst Technol, Inst Plant Anim & Agroecosyst Sci, LFW C56, CH-8092 Zurich, Switzerland; [Buscot, Francois; Koenig, Stephan] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, D-06102 Halle, Germany; [Klein, Alexandra-Maria] Leuphana Univ Lueneburg, Inst Ecol & Environm Chem, D-21335 Luneburg, Germany; [Kuu, Annely] Tallinn Univ Technol, Tartu Coll, EE-51008 Tartu, Estonia; [Migunova, Varvara D.] KI Skryabin All Russian Inst Helminthol, Moscow 117218, Russia; [Milcu, Alexandru] Imperial Coll London, Div Biol, NERC Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Petermann, Jana S.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Renker, Carsten] Mainz Museum Nat Hist, D-55116 Mainz, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, D-07743 Jena, Germany; [Temperton, Vicky M.] Forschungszentrum Julich GmbH, Phytosphere Inst ICG 3, D-52425 Julich, Germany	University of Gottingen; Friedrich Schiller University of Jena; University of Gottingen; University of Minnesota System; University of Minnesota Twin Cities; University of Zurich; University of Bern; University of Potsdam; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Humboldt University of Berlin; University of Cologne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leuphana University Luneburg; Tallinn University of Technology; Federal Scientific Centre VIEV; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of British Columbia; Friedrich Schiller University of Jena; Helmholtz Association; Research Center Julich	Scherber, C (corresponding author), Univ Gottingen, Dept Crop Sci, Grisebachstr 6, D-37077 Gottingen, Germany.	christoph.scherber@agr.uni-goettingen.de	Migunova, Varvara/Q-3899-2018; Schulze, Ernst-Detlef/K-9627-2014; Schmid, Bernhard/C-8625-2009; Petermann, Jana/E-2130-2013; Eisenhauer, Nico/I-3191-2019; Scheu, Stefan/H-7049-2015; Tscharntke, Teja/N-5123-2014; Kuu, Annely/AAL-4740-2020; Klein, Alexandra-Maria/J-5871-2016; Buscot, Francois/A-4125-2016; Buchmann, Nina/E-6095-2011; Scherber, Christoph/B-6611-2009; Fischer, Markus/C-6411-2008; Petermann, Jana/AAK-9787-2020; Bonkowski, Michael/C-3700-2013; Koenig, Stephan/GRX-2480-2022; Weisser, Wolfgang W/B-9718-2014; Eisenhauer, Nico/I-5932-2012; Allan, Eric/AAR-9566-2020; Milcu, Alexandru/X-6267-2018	Schmid, Bernhard/0000-0002-8430-3214; Petermann, Jana/0000-0002-3898-5656; Eisenhauer, Nico/0000-0002-0371-6720; Klein, Alexandra-Maria/0000-0003-2139-8575; Buscot, Francois/0000-0002-2364-0006; Buchmann, Nina/0000-0003-0826-2980; Scherber, Christoph/0000-0001-7924-8911; Fischer, Markus/0000-0002-5589-5900; Petermann, Jana/0000-0002-3898-5656; Bonkowski, Michael/0000-0003-2656-1183; Weisser, Wolfgang W/0000-0002-2757-8959; Eisenhauer, Nico/0000-0002-0371-6720; Allan, Eric/0000-0001-9641-9436; Milcu, Alexandru/0000-0002-2889-1234; Kuu, Annely/0000-0002-0335-6243; Koller, Robert/0000-0001-7251-7242; Temperton, Vicky/0000-0003-0543-4521	Deutsche Forschungsgemeinschaft [FOR 456]; Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. M. Tylianakis, P. Batary, Y. Clough, M. J. Crawley, J. Fox, J. Frund, D. Gladbach and A. Hector for comments that improved this manuscript. The gardeners, technicians, student helpers and managers of the Jena Experiment are acknowledged for their assistance. This work was supported by the Deutsche Forschungsgemeinschaft (FOR 456).	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cardinale Bradley, 2009, P105; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grace JB., 2015, STRUCTURAL EQUATION; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; HUNTER MD, 1992, ECOLOGY, V73, P724; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Myers N, 1996, P NATL ACAD SCI USA, V93, P2764, DOI 10.1073/pnas.93.7.2764; OGUSHI T, 2007, ECOLOGICAL COMMUNITI; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; PRICE PW, 1992, BIOTROPICA, V24, P273, DOI 10.2307/2388522; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SCHMID B, 2010, BIODIVERSITY ECOSYST, P14; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Wardle DA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P155	29	601	626	29	797	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					553	556		10.1038/nature09492	http://dx.doi.org/10.1038/nature09492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	20981010				2022-12-24	WOS:000284584200040
J	Runguphan, W; Qu, XD; O'Connor, SE				Runguphan, Weerawat; Qu, Xudong; O'Connor, Sarah E.			Integrating carbon-halogen bond formation into medicinal plant metabolism	NATURE			English	Article							INDOLE ALKALOID BIOSYNTHESIS; FLAVIN-DEPENDENT HALOGENASES; CATHARANTHUS-ROSEUS; BENZYLISOQUINOLINE ALKALOIDS; IMMATURE SEEDS; PISUM SATIVUM; REBH; CHLORINATION; PERIWINKLE; STRATEGIES	Halogenation, which was once considered a rare occurrence in nature, has now been observed in many natural product biosynthetic pathways(1). However, only a small fraction of halogenated compounds have been isolated from terrestrial plants(2). Given the impact that halogenation can have on the biological activity of natural products(1), we reasoned that the introduction of halides into medicinal plant metabolism would provide the opportunity to rationally bioengineer a broad variety of novel plant products with altered, and perhaps improved, pharmacological properties. Here we report that chlorination biosynthetic machinery from soil bacteria can be successfully introduced into the medicinal plant Catharanthus roseus (Madagascar periwinkle). These prokaryotic halogenases function within the context of the plant cell to generate chlorinated tryptophan, which is then shuttled into monoterpene indole alkaloid metabolism to yield chlorinated alkaloids. A new functional group-a halide-is thereby introduced into the complex metabolism of C. roseus, and is incorporated in a predictable and regioselective manner onto the plant alkaloid products. Medicinal plants, despite their genetic and developmental complexity, therefore seem to be a viable platform for synthetic biology efforts.	[Runguphan, Weerawat; Qu, Xudong; O'Connor, Sarah E.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	O'Connor, SE (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	soc@mit.edu	O'Connor, Sarah Ellen/X-2893-2019; Runguphan, Weerawat/GSM-9179-2022; Qu, Xudong/E-1778-2016; O'Connor, Sarah/O-5850-2016	Qu, Xudong/0000-0002-3301-8536; Runguphan, Weerawat/0000-0001-5707-3516; O'Connor, Sarah/0000-0003-0356-6213	NIH [GM074820]; American Cancer Society [RSG-07-025-01-CDD]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074820] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the NIH (GM074820) and the American Cancer Society (RSG-07-025-01-CDD). We thank H.-Y. Lee and M. Tjandra for assistance with NMR characterizations and L. Li for high-resolution mass spectroscopy analysis.	AMAT M, 1990, J ORG CHEM, V55, P6299, DOI 10.1021/jo00313a017; Bernhardt P, 2007, CHEM BIOL, V14, P888, DOI 10.1016/j.chembiol.2007.07.008; Bitto E, 2008, PROTEINS, V70, P289, DOI 10.1002/prot.21627; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; DELUCA V, 1987, PLANT PHYSIOL, V85, P1099, DOI 10.1104/pp.85.4.1099; DELUCA V, 1989, P NATL ACAD SCI USA, V86, P2582; Frederich M, 2002, J NAT PROD, V65, P1381, DOI 10.1021/np020070e; GANDAR JC, 1967, CR ACAD SCI D NAT, V265, P1795; Gribble GW, 2003, CHEMOSPHERE, V52, P289, DOI 10.1016/S0045-6535(03)00207-8; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hughes EH, 2002, BIOTECHNOL PROGR, V18, P1183, DOI 10.1021/bp025603o; Li SW, 2004, CURR MED RES OPIN, V20, P409, DOI 10.1185/030079904125003080; Loris EA, 2007, CHEM BIOL, V14, P979, DOI 10.1016/j.chembiol.2007.08.009; MARUMO S, 1968, NATURE, V219, P959, DOI 10.1038/219959b0; Mccoy E, 2006, J AM CHEM SOC, V128, P14276, DOI 10.1021/ja066787w; Menzies JRW, 1998, EUR J PHARMACOL, V350, P101, DOI 10.1016/S0014-2999(98)00232-5; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Roy AD, 2010, J AM CHEM SOC, V132, P12243, DOI 10.1021/ja1060406; Runguphan W, 2009, P NATL ACAD SCI USA, V106, P13673, DOI 10.1073/pnas.0903393106; Runguphan W, 2009, NAT CHEM BIOL, V5, P151, DOI 10.1038/nchembio.141; Sanchez C, 2005, P NATL ACAD SCI USA, V102, P461, DOI 10.1073/pnas.0407809102; Schumacher RW, 1999, TETRAHEDRON, V55, P935, DOI 10.1016/S0040-4020(98)01100-4; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; van Pee KH, 2006, APPL MICROBIOL BIOT, V70, P631, DOI 10.1007/s00253-005-0232-2; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zehner S, 2005, CHEM BIOL, V12, P445, DOI 10.1016/j.chembiol.2005.02.005; Zhu WM, 2005, J INTEGR PLANT BIOL, V47, P892, DOI 10.1111/j.1744-7909.2005.00042.x; Zhu XF, 2009, J MOL BIOL, V391, P74, DOI 10.1016/j.jmb.2009.06.008	32	159	163	4	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2010	468	7322					461	U294		10.1038/nature09524	http://dx.doi.org/10.1038/nature09524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	681KP	21048708	Green Accepted, Green Submitted			2022-12-24	WOS:000284313100048
J	Garneau, JE; Dupuis, ME; Villion, M; Romero, DA; Barrangou, R; Boyaval, P; Fremaux, C; Horvath, P; Magadan, AH; Moineau, S				Garneau, Josiane E.; Dupuis, Marie-Eve; Villion, Manuela; Romero, Dennis A.; Barrangou, Rodolphe; Boyaval, Patrick; Fremaux, Christophe; Horvath, Philippe; Magadan, Alfonso H.; Moineau, Sylvain			The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA	NATURE			English	Article							ESCHERICHIA-COLI; REPEATS; IDENTIFICATION; RNAS; EXPRESSION; RESISTANCE; DEFENSE; GENE; DIVERSITY; SEQUENCES	Bacteria and Archaea have developed several defence strategies against foreign nucleic acids such as viral genomes and plasmids. Among them, clustered regularly interspaced short palindromic repeats (CRISPR) loci together with cas (CRISPR-associated) genes form the CRISPR/Cas immune system, which involves partially palindromic repeats separated by short stretches of DNA called spacers, acquired from extrachromosomal elements. It was recently demonstrated that these variable loci can incorporate spacers from infecting bacteriophages and then provide immunity against subsequent bacteriophage infections in a sequence-specific manner. Here we show that the Streptococcus thermophilus CRISPR1/Cas system can also naturally acquire spacers from a self-replicating plasmid containing an antibiotic-resistance gene, leading to plasmid loss. Acquired spacers that match antibiotic-resistance genes provide a novel means to naturally select bacteria that cannot uptake and disseminate such genes. We also provide in vivo evidence that the CRISPR1/Cas system specifically cleaves plasmid and bacteriophage double-stranded DNA within the proto-spacer, at specific sites. Our data show that the CRISPR/Cas immune system is remarkably adapted to cleave invading DNA rapidly and has the potential for exploitation to generate safer microbial strains.	[Garneau, Josiane E.; Dupuis, Marie-Eve; Villion, Manuela; Magadan, Alfonso H.; Moineau, Sylvain] Univ Laval, Felix dHerelle Reference Ctr Bacterial Viruses, Dept Biochim Microbiol & Bioinformat, Fac Med Dent,Grp Rech Ecol Buccale,Fac Sci & Geni, Quebec City, PQ G1V 0A6, Canada; [Romero, Dennis A.; Barrangou, Rodolphe] Danisco USA Inc, Madison, WI 53716 USA; [Boyaval, Patrick; Fremaux, Christophe; Horvath, Philippe] Danisco France SAS, F-86220 Dange St Romain, France	Laval University	Moineau, S (corresponding author), Univ Laval, Felix dHerelle Reference Ctr Bacterial Viruses, Dept Biochim Microbiol & Bioinformat, Fac Med Dent,Grp Rech Ecol Buccale,Fac Sci & Geni, Quebec City, PQ G1V 0A6, Canada.	Sylvain.Moineau@bcm.ulaval.ca	Magadan, Alfonso Hernandez/M-5994-2019; HORVATH, Philippe/K-5266-2015; Magadán, Alfonso Hernández/K-4455-2012; Barrangou, Rodolphe/I-2878-2014; Moineau, Sylvain/N-3578-2013; Moineau, Sylvain/I-7231-2019	Magadan, Alfonso Hernandez/0000-0003-2556-7890; HORVATH, Philippe/0000-0003-2015-8123; Magadán, Alfonso Hernández/0000-0003-2556-7890; Barrangou, Rodolphe/0000-0002-0648-3504; Moineau, Sylvain/0000-0002-2832-5101	Novalait/FQRNT; Clarin/FICYT; NSERC; CIHR	Novalait/FQRNT(FQRNT); Clarin/FICYT; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	We thank T.R. Klaenhammer for pTRK687, B. Conway for editorial assistance, D. Tremblay, A. Fleury and B. Stahl for technical assistance. M.-E.D. is the recipient of a Novalait/FQRNT graduate scholarship and A.H.M. of a Clarin/FICYT postdoctoral scholarship. S.M. acknowledges funding from NSERC (Discovery program) and CIHR (Team Grant-Emerging: Novel Alternatives to Antibiotics).	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buckley ND, 1999, APPL ENVIRON MICROB, V65, P3800; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Duplessis M, 2005, VIROLOGY, V340, P192, DOI 10.1016/j.virol.2005.05.033; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Girard SL, 2007, PLASMID, V58, P174, DOI 10.1016/j.plasmid.2007.03.003; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; KIEWIET R, 1993, APPL ENVIRON MICROB, V59, P358, DOI 10.1128/AEM.59.2.358-364.1993; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MOINEAU S, 1992, CAN J MICROBIOL, V38, P875, DOI 10.1139/m92-143; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Nieto C, 2000, PLASMID, V43, P205, DOI 10.1006/plas.2000.1465; OCHMAN H, 1988, GENETICS, V120, P621; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Sambrook J, 2001, MOL CLONING LAB MANU; SOMKUTI GA, 1986, J IND MICROBIOL, V1, P157, DOI 10.1007/BF01569267; Sturino JM, 2002, APPL ENVIRON MICROB, V68, P588, DOI 10.1128/AEM.68.2.588-596.2002; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Turgeon N, 2001, PLASMID, V45, P171, DOI 10.1006/plas.2001.1517; Vaillancourt K, 2008, APPL ENVIRON MICROB, V74, P1264, DOI 10.1128/AEM.01585-07	36	1369	1661	32	790	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					67	71		10.1038/nature09523	http://dx.doi.org/10.1038/nature09523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	21048762				2022-12-24	WOS:000283786900036
J	Sanchez, SE; Petrillo, E; Beckwith, EJ; Zhang, X; Rugnone, ML; Hernando, CE; Cuevas, JC; Herz, MAG; Depetris-Chauvin, A; Simpson, CG; Brown, JWS; Cerdan, PD; Borevitz, JO; Mas, P; Ceriani, MF; Kornblihtt, AR; Yanovsky, MJ				Sanchez, Sabrina E.; Petrillo, Ezequiel; Beckwith, Esteban J.; Zhang, Xu; Rugnone, Matias L.; Hernando, C. Esteban; Cuevas, Juan C.; Herz, Micaela A. Godoy; Depetris-Chauvin, Ana; Simpson, Craig G.; Brown, John W. S.; Cerdan, Pablo D.; Borevitz, Justin O.; Mas, Paloma; Fernanda Ceriani, M.; Kornblihtt, Alberto R.; Yanovsky, Marcelo J.			A methyl transferase links the circadian clock to the regulation of alternative splicing	NATURE			English	Article							ARABIDOPSIS-THALIANA; DROSOPHILA-MELANOGASTER; RECIPROCAL REGULATION; ARGININE METHYLATION; PHOSPHOLIPASE-C; GENE; METHYLTRANSFERASE; EXPRESSION; REQUIRES; BEHAVIOR	Circadian rhythms allow organisms to time biological processes to the most appropriate phases of the day-night cycle(1). Posttranscriptional regulation is emerging as an important component of circadian networks(2-6), but the molecular mechanisms linking the circadian clock to the control of RNA processing are largely unknown. Here we show that PROTEIN ARGININE METHYL TRANSFERASE 5 (PRMT5), which transfers methyl groups to arginine residues present in histones(7) and Sm spliceosomal proteins(8,9), links the circadian clock to the control of alternative splicing in plants. Mutations in PRMT5 impair several circadian rhythms in Arabidopsis thaliana and this phenotype is caused, at least in part, by a strong alteration in alternative splicing of the core-clock gene PSEUDO RESPONSE REGULATOR 9 (PRR9). Furthermore, genome-wide studies show that PRMT5 contributes to the regulation of many pre-messenger-RNA splicing events, probably by modulating 5'-splice-site recognition. PRMT5 expression shows daily and circadian oscillations, and this contributes to the mediation of the circadian regulation of expression and alternative splicing of a subset of genes. Circadian rhythms in locomotor activity are also disrupted in dart5-1, a mutant affected in the Drosophila melanogaster PRMT5 homologue, and this is associated with alterations in splicing of the core-clock gene period and several clock-associated genes. Our results demonstrate a key role for PRMT5 in the regulation of alternative splicing and indicate that the interplay between the circadian clock and the regulation of alternative splicing by PRMT5 constitutes a common mechanism that helps organisms to synchronize physiological processes with daily changes in environmental conditions.	[Sanchez, Sabrina E.; Rugnone, Matias L.; Hernando, C. Esteban; Yanovsky, Marcelo J.] UBA CONICET, Fac Agron, IFEVA, Buenos Aires, DF, Argentina; [Petrillo, Ezequiel; Herz, Micaela A. Godoy; Kornblihtt, Alberto R.] UBA CONICET, FCEyN, IFIBYNE, Buenos Aires, DF, Argentina; [Beckwith, Esteban J.; Depetris-Chauvin, Ana; Cerdan, Pablo D.; Fernanda Ceriani, M.; Yanovsky, Marcelo J.] IIBBA CONICET, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Zhang, Xu; Borevitz, Justin O.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Cuevas, Juan C.; Mas, Paloma] Consortium CSIC IRTA UAB, CRAG, Barcelona 08034, Spain; [Simpson, Craig G.; Brown, John W. S.] SCRI, Genet Programme, Dundee DD2 5DA, Scotland; [Brown, John W. S.] Univ Dundee, SCRI, Div Plant Sci, Dundee DD2 5DA, Scotland	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Chicago; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; James Hutton Institute; James Hutton Institute; University of Dundee	Yanovsky, MJ (corresponding author), UBA CONICET, Fac Agron, IFEVA, C1417DSE, Buenos Aires, DF, Argentina.	yanovsky@agro.uba.ar	Borevitz, Justin/B-5423-2012; Mas, Paloma/B-8215-2016	Borevitz, Justin/0000-0001-8408-3699; Mas, Paloma/0000-0002-3780-8041; Kornblihtt, Alberto/0000-0003-4322-0831; Ceriani, Maria/0000-0001-8945-3070; Hernando, Carlos Esteban/0000-0002-7459-2083; Cuevas, Juan C/0000-0003-0909-1247; Simpson, Craig/0000-0002-1723-1492; Petrillo, Ezequiel/0000-0002-0025-3708	Fundacion Antorchas; Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina; University of Buenos Aires; European Union Network of Excellence on Alternative Splicing (EURASNET); Ministerio de Educacion y Ciencia; European Young Investigator Awards; EMBO; Proyecto de Investigacion Cientifica y Tecnologica [2006-1249]	Fundacion Antorchas; Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); European Union Network of Excellence on Alternative Splicing (EURASNET); Ministerio de Educacion y Ciencia(Spanish Government); European Young Investigator Awards; EMBO(European Molecular Biology Organization (EMBO)); Proyecto de Investigacion Cientifica y Tecnologica	We thank E. M. Farre and S. L. Harmer for seeds; J. J. Casal and S. Mora-Garcia for critical reading of the manuscript; the laboratories of A. R. K. and M.J.Y. for discussions; J. Fuller and P. Tondi for technical assistance. This work was supported by grants from the Fundacion Antorchas, the Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina, the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina and the University of Buenos Aires to M.J.Y. and A.R.K., and from the European Union Network of Excellence on Alternative Splicing (EURASNET) to A.R.K. and J.W.S.B. M.J.Y. and A.R.K. are Howard Hughes Medical Institute international research scholars. P.M.'s laboratory is supported by a Ministerio de Educacion y Ciencia grant, the European Young Investigator Awards and the EMBO Young Investigator Awards; M.F.C.'s laboratory is supported by Proyecto de Investigacion Cientifica y Tecnologica 2006-1249.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Majercak J, 2004, MOL CELL BIOL, V24, P3359, DOI 10.1128/MCB.24.8.3359-3372.2004; Matsushika A, 2002, PLANT CELL PHYSIOL, V43, P833, DOI 10.1093/pcp/pcf118; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Raczynska KD, 2010, NUCLEIC ACIDS RES, V38, P265, DOI 10.1093/nar/gkp869; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Schoning JC, 2008, NUCLEIC ACIDS RES, V36, P6977, DOI 10.1093/nar/gkn847; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Simpson CG, 2008, PLANT J, V53, P1035, DOI 10.1111/j.1365-313X.2007.03392.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang D, 2001, MOL CELL, V7, P319, DOI 10.1016/S1097-2765(01)00180-0; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	45	215	222	1	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					112	+		10.1038/nature09470	http://dx.doi.org/10.1038/nature09470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20962777	Green Published, Green Submitted			2022-12-24	WOS:000283786900046
J	King, AC; Guralnik, JM				King, Abby C.; Guralnik, Jack M.			Maximizing the Potential of an Aging Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISABILITY		[King, Abby C.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA; [King, Abby C.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	King, AC (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, 159 Campus Dr,HRP Redwood Bldg,T221, Stanford, CA 94305 USA.	king@stanford.edu	King, Abby/AAD-5257-2021	King, Abby/0000-0002-7949-8811	NATIONAL INSTITUTE ON AGING [U01AG022376] Funding Source: NIH RePORTER; NIA NIH HHS [U01 AG022376, 2U01 AG022376-05A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Fried LP, 2004, J URBAN HEALTH, V81, P64, DOI 10.1093/jurban/jth094; Fuller-Thomson E, 2009, J GERONTOL A-BIOL, V64, P1333, DOI 10.1093/gerona/glp130; Kerse N, 2005, J AM GERIATR SOC, V53, P1951, DOI 10.1111/j.1532-5415.2005.00466.x; King AC, 2007, HEALTH PSYCHOL, V26, P718, DOI 10.1037/0278-6133.26.6.718; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Minkler M, 2006, NEW ENGL J MED, V355, P695, DOI 10.1056/NEJMsa044316; Nguyen Huong Q, 2008, Prev Chronic Dis, V5, pA14; Physical Activity Guidelines Advisory Committee, 2008, REP PHYS ACT GUID AD; *US DEP HHS, 2008, ODPHP PUBL U, V42	10	39	40	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2010	304	17					1944	1945		10.1001/jama.2010.1577	http://dx.doi.org/10.1001/jama.2010.1577			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674GT	21045101	Green Accepted			2022-12-24	WOS:000283725900025
J	Colaprete, A; Schultz, P; Heldmann, J; Wooden, D; Shirley, M; Ennico, K; Hermalyn, B; Marshall, W; Ricco, A; Elphic, RC; Goldstein, D; Summy, D; Bart, GD; Asphaug, E; Korycansky, D; Landis, D; Sollitt, L				Colaprete, Anthony; Schultz, Peter; Heldmann, Jennifer; Wooden, Diane; Shirley, Mark; Ennico, Kimberly; Hermalyn, Brendan; Marshall, William; Ricco, Antonio; Elphic, Richard C.; Goldstein, David; Summy, Dustin; Bart, Gwendolyn D.; Asphaug, Erik; Korycansky, Don; Landis, David; Sollitt, Luke			Detection of Water in the LCROSS Ejecta Plume	SCIENCE			English	Article							LUNAR RADIOMETER OBSERVATIONS; ICE	Several remote observations have indicated that water ice may be presented in permanently shadowed craters of the Moon. The Lunar Crater Observation and Sensing Satellite (LCROSS) mission was designed to provide direct evidence (1). On 9 October 2009, a spent Centaur rocket struck the persistently shadowed region within the lunar south pole crater Cabeus, ejecting debris, dust, and vapor. This material was observed by a second "shepherding" spacecraft, which carried nine instruments, including cameras, spectrometers, and a radiometer. Near-infrared absorbance attributed to water vapor and ice and ultraviolet emissions attributable to hydroxyl radicals support the presence of water in the debris. The maximum total water vapor and water ice within the instrument field of view was 155 +/- 12 kilograms. Given the estimated total excavated mass of regolith that reached sunlight, and hence was observable, the concentration of water ice in the regolith at the LCROSS impact site is estimated to be 5.6 +/- 2.9% by mass. In addition to water, spectral bands of a number of other volatile compounds were observed, including light hydrocarbons, sulfur-bearing species, and carbon dioxide.	[Colaprete, Anthony; Heldmann, Jennifer; Wooden, Diane; Shirley, Mark; Ennico, Kimberly; Marshall, William; Ricco, Antonio; Elphic, Richard C.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Schultz, Peter; Hermalyn, Brendan] Brown Univ, Providence, RI 02912 USA; [Goldstein, David; Summy, Dustin] Univ Texas Austin, Austin, TX 78712 USA; [Bart, Gwendolyn D.] Univ Idaho, Moscow, ID 83844 USA; [Asphaug, Erik; Korycansky, Don] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Landis, David] Aurora Design & Technol, Palm Harbor, FL 34685 USA; [Sollitt, Luke] The Citadel, Charleston, SC 29409 USA; [Marshall, William] Univ Space Res Assoc, Mountain View, CA 94043 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Brown University; University of Texas System; University of Texas Austin; Idaho; University of Idaho; University of California System; University of California Santa Cruz; Universities Space Research Association (USRA)	Colaprete, A (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	Anthony.Colaprete-1@nasa.gov	Ricco, Antonio J/A-5273-2010; Asphaug, Erik/AAC-9455-2020; Goldstein, David/AAY-8125-2020; Bart, Gwendolyn/B-1365-2009; Ennico, Kimberly/L-9606-2014	Bart, Gwendolyn/0000-0002-4768-2972; Ricco, Antonio/0000-0002-2355-4984	LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD); LRO	LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD)(National Aeronautics & Space Administration (NASA)); LRO	We thank the LCROSS Project and NASA's Exploration Systems Mission Directorate (ESMD) and NASA Science Mission Directorate (SMD) for support, and are very grateful to the LRO project and the LRO instrument leads for supporting the LCROSS targeting and impact observations, and for the three referees who provided reviews that greatly improved this paper. R.C.E. was supported by an LRO Participating Scientist grant.	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Bockelee-Morvan D, 2004, SPACE SCI S, P391; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; COLAPRETE A, 2009, 40 LUN PLAN SCI SC L; Crider DH, 2000, J GEOPHYS RES-PLANET, V105, P26773, DOI 10.1029/2000JE001277; ELPHIC RC, 2007, GEOPHYS RES LET, V13; ENNICO K, 2009, 40 LUN PLAN SCI C LU; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; HANSEN JE, 1970, J ATMOS SCI, V27, P265, DOI 10.1175/1520-0469(1970)027<0265:NILSBT>2.0.CO;2; Hayne PO, 2010, SCIENCE, V330, P477, DOI 10.1126/science.1197135; Hodges R.R., 1981, LUNAR PLANETARY I SC, P451; MCCLANAHAN TP, 2009, 40 LUN PLAN SCI LUN; Mitrofanov IG, 2010, SCIENCE, V330, P483, DOI 10.1126/science.1185696; Noda H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035692; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Press W. H., 2007, NUMERICAL RECIPES; ROUSSELOT P, 1991, ASTEORIDS COMETS MET; Schultz PH, 2007, ICARUS, V190, P295, DOI 10.1016/j.icarus.2007.06.006; Schultz PH, 2010, SCIENCE, V330, P468, DOI 10.1126/science.1187454; Spudis P. D., 1998, Solar System Research, V32, P17; SUMMY D, 2009, 40 LUN PLAN SCI C LU; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; TEODORO LFA, 2009, ANN M LUN EXPL AN GR; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Wooden DH, 2004, SPACE SCI S, P33	28	448	469	4	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					463	468		10.1126/science.1186986	http://dx.doi.org/10.1126/science.1186986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966242				2022-12-24	WOS:000283329100028
J	Liu, B; Tahk, S; Yee, KM; Fan, GP; Shuai, K				Liu, Bin; Tahk, Samuel; Yee, Kathleen M.; Fan, Guoping; Shuai, Ke			The Ligase PIAS1 Restricts Natural Regulatory T Cell Differentiation by Epigenetic Repression	SCIENCE			English	Article							TRANSCRIPTION FACTOR FOXP3; DNA METHYLATION; STAT5 ACTIVATION; EXPRESSION; GENE; MAINTENANCE; LINEAGE; SUMO-1; DNMT3A	CD4(+)Foxp3(+) regulatory T (T(reg)) cells are important for maintaining immune tolerance. Understanding the molecular mechanism that regulates T(reg) differentiation will facilitate the development of effective therapeutic strategies against autoimmune diseases. We report here that the SUMO E3 ligase PIAS1 restricts the differentiation of natural T(reg) cells by maintaining a repressive chromatin state of the Foxp3 promoter. PIAS1 acts by binding to the Foxp3 promoter to recruit DNA methyltransferases and heterochromatin protein 1 for epigenetic modifications. Pias1 deletion caused promoter demethylation, reduced histone H3 methylation at Lys(9), and enhanced promoter accessibility. Consistently, Pias1(-/-) mice displayed an increased natural T(reg) cell population and were resistant to the development of experimental autoimmune encephalomyelitis. Our studies have identified an epigenetic mechanism that negatively regulates the differentiation of natural T(reg) cells.	[Liu, Bin; Tahk, Samuel; Shuai, Ke] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Yee, Kathleen M.; Shuai, Ke] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liu, B (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, 11-934 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	bliu@ucla.edu; kshuai@mednet.ucla.edu		Fan, Guoping/0000-0001-5235-6410	NIH [R01AI063286, R01GM085797]; UCLA Jonsson Comprehensive Cancer Center; National Institutes of Health [K01 AR52717-01]; UCLA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085797] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Jonsson Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Chernishof and I. Garcia for technical assistance, C. Dong for helpful discussions, and the UCLA flow cytometry core facility. Supported by grants from the NIH (R01AI063286 and R01GM085797) and the UCLA Jonsson Comprehensive Cancer Center (K. S.). B. L. is supported by a Research Scientist Development Award from the National Institutes of Health (K01 AR52717-01). S.T. is supported by a UCLA Tumor Immunology Training Fellowship. K.S. and B.L. are inventors of a U.S. patent entitled "PIAS molecules that recognize and bind STAT proteins and uses thereof" (Patent No.: US 7,265,202 B1).	Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fragale A, 2008, J IMMUNOL, V181, P1673, DOI 10.4049/jimmunol.181.3.1673; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu QY, 2008, CHEM J CHINESE U, V29, P505; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Nagar M, 2008, INT IMMUNOL, V20, P1041, DOI 10.1093/intimm/dxn062; Park J, 2008, J MOL MED, V86, P1269, DOI 10.1007/s00109-008-0392-5; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	30	77	79	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					521	525		10.1126/science.1193787	http://dx.doi.org/10.1126/science.1193787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966256	Green Accepted			2022-12-24	WOS:000283329100045
J	Su, XH; Chakravarti, D; Cho, MS; Liu, LZ; Gi, YJ; Lin, YL; Leung, ML; El-Naggar, A; Creighton, CJ; Suraokar, MB; Wistuba, I; Flores, ER				Su, Xiaohua; Chakravarti, Deepavali; Cho, Min Soon; Liu, Lingzhi; Gi, Young Jin; Lin, Yu-Li; Leung, Marco L.; El-Naggar, Adel; Creighton, Chad J.; Suraokar, Milind B.; Wistuba, Ignacio; Flores, Elsa R.			TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs	NATURE			English	Article							LI-FRAUMENI-SYNDROME; P63 EXPRESSION; P53; CANCER; P73; MUTANT; MICE; PROGRESSION; CARCINOMA; FAMILY	Aberrant expression of microRNAs (miRNAs) and the enzymes that control their processing have been reported in multiple biological processes including primary and metastatic tumours(1-6), but the mechanisms governing this are not clearly understood. Here we show that TAp63, a p53 family member, suppresses tumorigenesis and metastasis, and coordinately regulates Dicer and miR-130b to suppress metastasis. Metastatic mouse and human tumours deficient in TAp63 express Dicer at very low levels, and we found that modulation of expression of Dicer and miR-130b markedly affected the metastatic potential of cells lacking TAp63. TAp63 binds to and transactivates the Dicer promoter, demonstrating direct transcriptional regulation of Dicer by TAp63. These data provide a novel understanding of the roles of TAp63 in tumour and metastasis suppression through the coordinate transcriptional regulation of Dicer and miR-130b and may have implications for the many processes regulated by miRNAs.	[Su, Xiaohua; Chakravarti, Deepavali; Cho, Min Soon; Liu, Lingzhi; Gi, Young Jin; Lin, Yu-Li; Leung, Marco L.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chakravarti, Deepavali; Cho, Min Soon; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [El-Naggar, Adel; Suraokar, Milind B.; Wistuba, Ignacio] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Flores, ER (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	elsaflores@mdanderson.org	Leung, Marco/AAH-3178-2021	Hartl, Carla/0000-0001-9769-7462; Liu, Ling-Zhi/0000-0001-9234-457X	NCI [CA16672]; American Cancer Society [RSG-07-082-01-MGO]; Susan G. Komen Foundation [BCTR600208]; Hildegardo E. and Olga M. Flores Foundation; NCI-Cancer Center [CA-16672]; Genitourinary Cancer SPORE [P50CA091846]; Lung Cancer SPORE [P50CA070907, U01DE019765]; Rita Allen Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA016672, P50CA091846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE019765] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Hildegardo E. and Olga M. Flores Foundation; NCI-Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genitourinary Cancer SPORE; Lung Cancer SPORE; Rita Allen Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank C.-g. Liu for technical assistance with miRNA analyses and A. Multani for metaphase analyses (funded by NCI CA16672); K. Y. Tsai for scientific discussions and comments on the manuscript; and D. Yu, J. Jackson and S. Rehman for reagents and advice. This work was supported by grants to E.R.F. from the American Cancer Society (RSG-07-082-01-MGO), the Susan G. Komen Foundation (BCTR600208) and the Hildegardo E. and Olga M. Flores Foundation. This work was supported in part by an NCI-Cancer Center Core Grant (CA-16672) (University of Texas M. D. Anderson Cancer Center), a Career Development Award from the Genitourinary Cancer SPORE (P50CA091846) to E.R.F., Lung Cancer SPORE (P50CA070907) to I. W. and U01DE019765 to A.E.-N. E.R.F. is a scholar of the Rita Allen Foundation and the V Foundation for Cancer Research.	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maruya SI, 2004, CLIN CANCER RES, V10, P3825, DOI 10.1158/1078-0432.CCR-03-0370; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Park BJ, 2000, CANCER RES, V60, P3370; Park HR, 2004, TUMORI, V90, P239, DOI 10.1177/030089160409000214; Pruneri G, 2005, J PATHOL, V206, P337, DOI 10.1002/path.1787; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	29	339	351	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					986	U168		10.1038/nature09459	http://dx.doi.org/10.1038/nature09459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962848	Green Accepted			2022-12-24	WOS:000283254700043
J	Rockman, MV; Skrovanek, SS; Kruglyak, L				Rockman, Matthew V.; Skrovanek, Sonja S.; Kruglyak, Leonid			Selection at Linked Sites Shapes Heritable Phenotypic Variation in C. elegans	SCIENCE			English	Article							GENE-EXPRESSION; NATURAL-SELECTION; DNA POLYMORPHISM; EVOLUTION; GENOME; RECOMBINATION; CONSEQUENCES; MUTATION; TRAITS	Mutation generates the heritable variation that genetic drift and natural selection shape. In classical quantitative genetic models, drift is a function of the effective population size and acts uniformly across traits, whereas mutation and selection act trait-specifically. We identified thousands of quantitative trait loci (QTLs) influencing transcript abundance traits in a cross of two Caenorhabditis elegans strains; although trait-specific mutation and selection explained some of the observed pattern of QTL distribution, the pattern was better explained by trait-independent variation in the intensity of selection on linked sites. Our results suggest that traits in C. elegans exhibit different levels of variation less because of their own attributes than because of differences in the effective population sizes of the genomic regions harboring their underlying loci.	[Rockman, Matthew V.] NYU, Dept Biol, New York, NY 10003 USA; [Rockman, Matthew V.] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Rockman, Matthew V.; Skrovanek, Sonja S.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rockman, Matthew V.; Skrovanek, Sonja S.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Carl Icahn Lab, Princeton, NJ 08544 USA; [Skrovanek, Sonja S.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	New York University; New York University; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Rockman, MV (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	mrockman@nyu.edu; leonid@genomics.princeton.edu			NIH National Center for Research Resources; NIH [R01 HG004321, R01 GM089972, P50 GM071508]; Jane Coffin Childs Fellowship; Ellison Foundation; James S. McDonnell Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089972, P50GM071508] Funding Source: NIH RePORTER	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Fellowship; Ellison Foundation(Lawrence Ellison Foundation); James S. McDonnell Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Andersen, A. Chang, J. Gerke, R. Ghosh, D. Gresham, M. Hahn, A. Paaby, D. Pollard, H. Seidel, and J. Shapiro for comments on the manuscript. We thank the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains. Our work was supported by the NIH (grants R01 HG004321 to L. K., R01 GM089972 to M. V. R., and P50 GM071508 to the Lewis-Sigler Institute), a Jane Coffin Childs Fellowship (M. V. R.), an Ellison Foundation New Scholar Award (M. V. R.), and a James S. McDonnell Foundation Centennial Fellowship (L. K.). L. K. is an investigator of the Howard Hughes Medical Institute. Microarray data have been deposited at the Gene Expression Omnibus with accession number GSE23857.	Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; BARNES TM, 1995, GENETICS, V141, P159; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Cutter AD, 2003, MOL BIOL EVOL, V20, P665, DOI 10.1093/molbev/msg072; Cutter AD, 2010, GENOME RES, V20, P1103, DOI 10.1101/gr.104331.109; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Genissel A, 2008, MOL BIOL EVOL, V25, P101, DOI 10.1093/molbev/msm247; Graustein A, 2002, GENETICS, V161, P99; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Houle D, 1998, GENETICA, V102-3, P241, DOI 10.1023/A:1017034925212; HUDSON RR, 1995, GENETICS, V141, P1605; Jovelin R, 2009, MOL BIOL EVOL, V26, P2373, DOI 10.1093/molbev/msp142; Kaiser VB, 2009, TRENDS GENET, V25, P9, DOI 10.1016/j.tig.2008.10.009; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lawniczak MKN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r125; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Noor MAF, 2001, GENETICS, V159, P581; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Ronald J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000678; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Tung J, 2009, MOL BIOL EVOL, V26, P2047, DOI 10.1093/molbev/msp113; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	31	154	155	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					372	376		10.1126/science.1194208	http://dx.doi.org/10.1126/science.1194208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947766	Green Accepted			2022-12-24	WOS:000282986700042
J	Schindel, D				Schindel, David			Biology without borders	NATURE			English	Editorial Material												schindeld@si.edu						*AUSTR NAT RES MAN, 2002, NAT CONS APPR ACC UT; Grajal A, 1999, CONSERV BIOL, V13, P6, DOI 10.1046/j.1523-1739.1999.013001006.x; *SECR CONV BIOL DI, 2008, TECHN SER SECR CONV, V38; *SECR CONV BIOL DI, 2002, APP 2 BONN GUID ACC	4	16	17	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					779	781		10.1038/467779a	http://dx.doi.org/10.1038/467779a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944713	Bronze			2022-12-24	WOS:000282898700033
J	Walton, DA; Ivers, LC				Walton, David A.; Ivers, Louise C.			Responding to Cholera in Post-Earthquake Haiti.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Walton, David A.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; Partners Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Walton, DA (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.		Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230				*MIN SANT PUBL POP, 2005, ENQ MORT MORB UT SER; Sullivan CA, 2003, NAT RESOUR FORUM, V27, P189, DOI 10.1111/1477-8947.00054; 2010, 101112 WASH CLUSTER	3	61	66	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					3	5		10.1056/NEJMp1012997	http://dx.doi.org/10.1056/NEJMp1012997			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702UY	21142690	Bronze			2022-12-24	WOS:000285922600002
J	Raffaele, S; Farrer, RA; Cano, LM; Studholme, DJ; MacLean, D; Thines, M; Jiang, RHY; Zody, MC; Kunjeti, SG; Donofrio, NM; Meyers, BC; Nusbaum, C; Kamoun, S				Raffaele, Sylvain; Farrer, Rhys A.; Cano, Liliana M.; Studholme, David J.; MacLean, Daniel; Thines, Marco; Jiang, Rays H. Y.; Zody, Michael C.; Kunjeti, Sridhara G.; Donofrio, Nicole M.; Meyers, Blake C.; Nusbaum, Chad; Kamoun, Sophien			Genome Evolution Following Host Jumps in the Irish Potato Famine Pathogen Lineage	SCIENCE			English	Article							PHYTOPHTHORA-INFESTANS; HISTONE METHYLATION; RXLR EFFECTORS; SEQUENCES; DISEASE	Many plant pathogens, including those in the lineage of the Irish potato famine organism Phytophthora infestans, evolve by host jumps followed by specialization. However, how host jumps affect genome evolution remains largely unknown. To determine the patterns of sequence variation in the P. infestans lineage, we resequenced six genomes of four sister species. This revealed uneven evolutionary rates across genomes with genes in repeat-rich regions showing higher rates of structural polymorphisms and positive selection. These loci are enriched in genes induced in planta, implicating host adaptation in genome evolution. Unexpectedly, genes involved in epigenetic processes formed another class of rapidly evolving residents of the gene-sparse regions. These results demonstrate that dynamic repeat-rich genome compartments underpin accelerated gene evolution following host jumps in this pathogen lineage.	[Raffaele, Sylvain; Farrer, Rhys A.; Cano, Liliana M.; Studholme, David J.; MacLean, Daniel; Thines, Marco; Kamoun, Sophien] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Thines, Marco] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Thines, Marco] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Dept Biol Sci, D-60323 Frankfurt, Germany; [Jiang, Rays H. Y.; Zody, Michael C.; Nusbaum, Chad] Massachusetts Inst Technol & Harvard, Broad Inst, Cambridge, MA 02141 USA; [Kunjeti, Sridhara G.; Donofrio, Nicole M.; Meyers, Blake C.] Univ Delaware, Newark, DE 19716 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Delaware	Kamoun, S (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	sophien.kamoun@tsl.ac.uk	Kamoun, Sophien/B-3529-2009; Raffaele, Sylvain/F-7187-2012; MacLean, Dan/C-7046-2013; Meyers, Blake/B-6535-2012; Kunjeti, Sridhara/AFU-0653-2022; Thines, Marco/H-1685-2011; Cano, Liliana M/O-7041-2016; Raffaele, Sylvain/K-6673-2019; Studholme, David/H-6790-2019	Kamoun, Sophien/0000-0002-0290-0315; Raffaele, Sylvain/0000-0002-2442-9632; MacLean, Dan/0000-0003-1032-0887; Meyers, Blake/0000-0003-3436-6097; Cano, Liliana M/0000-0002-7996-4181; Raffaele, Sylvain/0000-0002-2442-9632; Studholme, David/0000-0002-3010-6637; Kunjeti, Sridhara/0000-0002-6326-2644; Farrer, Rhys/0000-0001-8456-7458	Gatsby Charitable Foundation; Marie-Curie IEF [255104]; National Research Initiative of the U.S. Department of Agriculture [2006-35600-16623]; NSF [EF-0523670]; Ministry of Research, Science and the Arts of Hesse (Germany)	Gatsby Charitable Foundation; Marie-Curie IEF(European Commission); National Research Initiative of the U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Ministry of Research, Science and the Arts of Hesse (Germany)	We thank the Broad Institute Sequencing Platform and J. Pike for sequencing; G. Kessel and V. Vleeshouwers for biomaterial; and D. Weigel, J. Dangl, and J. Ecker for useful comments. This project was funded by the Gatsby Charitable Foundation, Marie-Curie IEF contract 255104, National Research Initiative of the U.S. Department of Agriculture grant 2006-35600-16623, NSF grant EF-0523670, and research funding program LOEWE of the Ministry of Research, Science and the Arts of Hesse (Germany). Sequences are deposited in GenBank under the submission accession numbers SRA02326-2329 and SRA024355 and in the Short Read Archive under study accession numbers ERP000341-344.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Elango N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000015; Elizondo LI, 2009, CURR GENOMICS, V10, P64, DOI 10.2174/138920209787581271; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Liu ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/molbev/msi049; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zeh DW, 2009, BIOESSAYS, V31, P715, DOI 10.1002/bies.200900026; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	20	283	289	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1540	1543		10.1126/science.1193070	http://dx.doi.org/10.1126/science.1193070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148391				2022-12-24	WOS:000285153500065
J	Qi, XX; Lan, SY; Wang, WJ; Schelde, LM; Dong, HH; Wallat, GD; Ly, H; Liang, YY; Dong, CJ				Qi, Xiaoxuan; Lan, Shuiyun; Wang, Wenjian; Schelde, Lisa McLay; Dong, Haohao; Wallat, Gregor D.; Ly, Hinh; Liang, Yuying; Dong, Changjiang			Cap binding and immune evasion revealed by Lassa nucleoprotein structure	NATURE			English	Article							CRYSTAL-STRUCTURE; VIRUS NUCLEOPROTEIN; L-PROTEIN; DENDRITIC CELLS; RNA; TREX1; TRANSCRIPTION; ENDONUCLEASE; REPLICATION; RECOGNITION	Lassa virus, the causative agent of Lassa fever, causes thousands of deaths annually and is a biological threat agent, for which there is no vaccine and limited therapy. The nucleoprotein (NP) of Lassa virus has essential roles in viral RNA synthesis and immune suppression, the molecular mechanisms of which are poorly understood. Here we report the crystal structure of Lassa virus NP at 1.80 angstrom resolution, which reveals amino (N)- and carboxy (C)-terminal domains with structures unlike any of the reported viral NPs. The N domain folds into a novel structure with a deep cavity for binding the m7GpppN cap structure that is required for viral RNA transcription, whereas the C domain contains 3'-5' exoribonuclease activity involved in suppressing interferon induction. To our knowledge this is the first X-ray crystal structure solved for an arenaviral NP, which reveals its unexpected functions and indicates unique mechanisms in cap binding and immune evasion. These findings provide great potential for vaccine and drug development.	[Qi, Xiaoxuan; Dong, Haohao; Wallat, Gregor D.; Dong, Changjiang] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Lan, Shuiyun; Schelde, Lisa McLay; Ly, Hinh; Liang, Yuying] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, Guangzhou 510080, Guangdong, Peoples R China	University of St Andrews; Emory University; Sun Yat Sen University	Dong, CJ (corresponding author), Univ St Andrews, Sch Chem, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	hly@emory.edu; yliang5@emory.edu; cd26@st-andrews.ac.uk		Qi, Xiaoxuan/0000-0001-5191-3713	Southeast Regional Center of Excellence for Emerging Infections and Biodefense [5-U54-AI-057157-06]; Emory University Research Committee (URC); Emory DDRDC [DK64399]; American Cancer Society [RSG-06-162-01-GMC]; NIH [R01AI083409, AI067704];  [5-U19-AI057266-07]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, U54AI057157, R01AI083409, R01AI093580, R01AI067704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399] Funding Source: NIH RePORTER	Southeast Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory University Research Committee (URC); Emory DDRDC; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	C.D. wishes to thank J. Naismith for his continuing support, encouragement and advice; R. M. Elliott for providing the human beta-globin containing plasmid phRL-CMV and his critical reading of the manuscript; H. Liu for discussions; and L. Major for the pLou3 plasmid. C.D. is a Wellcome trust career development fellow (083501/Z/07/Z). We thank the staff at IO2 and IO3 beam stations of Diamond light sources for their assistance with data collection. This work was supported in part by funds from the Southeast Regional Center of Excellence for Emerging Infections and Biodefense (5-U54-AI-057157-06), the pilot component of the U19 grant (5-U19-AI057266-07), and the Emory University Research Committee (URC) to Y.L. and H. L.; a seed grant from the Emory DDRDC (DK64399) and a research scholar grant from the American Cancer Society (RSG-06-162-01-GMC) to H.L.; NIH grant R01AI083409 to Y.L.; and NIH grant AI067704 to T. G. Parslow and Y.L. We thank K. Curtis and T. W. Geisbert for providing us with non-infectious genomic RNA samples of LASV, and J. Aronson for the PICV virus.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Baize S, 2004, J IMMUNOL, V172, P2861, DOI 10.4049/jimmunol.172.5.2861; Baize S, 2009, J VIROL, V83, P5890, DOI 10.1128/JVI.01948-08; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Cisneros GA, 2009, J AM CHEM SOC, V131, P1550, DOI 10.1021/ja8082818; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; EDINGTON GM, 1972, T ROY SOC TROP MED H, V66, P381, DOI 10.1016/0035-9203(72)90268-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; FISHERHOCH S, 1988, J MED VIROL, V26, P127, DOI 10.1002/jmv.1890260204; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; JIN H, 1993, J VIROL, V67, P1396, DOI 10.1128/JVI.67.3.1396-1404.1993; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Lan SY, 2008, ARCH VIROL, V153, P1241, DOI 10.1007/s00705-008-0101-2; Lan SY, 2009, J VIROL, V83, P6357, DOI 10.1128/JVI.00019-09; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Lelke M, 2010, J VIROL, V84, P1934, DOI 10.1128/JVI.01657-09; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MEYER BJ, 1993, J VIROL, V67, P2621, DOI 10.1128/JVI.67.5.2621-2627.1993; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Muller S, 2007, J GEN VIROL, V88, P1568, DOI 10.1099/vir.0.82529-0; Pinschewer DD, 2003, J VIROL, V77, P3882, DOI 10.1128/JVI.77.6.3882-3887.2003; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POLYAK SJ, 1995, J VIROL, V69, P3211, DOI 10.1128/JVI.69.5.3211-3215.1995; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	50	199	208	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					779	U65		10.1038/nature09605	http://dx.doi.org/10.1038/nature09605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21085117	Green Accepted			2022-12-24	WOS:000285093700036
J	Li, XY; Gianoulis, TA; Yip, KY; Gerstein, M; Snyder, M				Li, Xiyan; Gianoulis, Tara A.; Yip, Kevin Y.; Gerstein, Mark; Snyder, Michael			Extensive In Vivo Metabolite-Protein Interactions Revealed by Large-Scale Systematic Analyses	CELL			English	Article							GLOBAL ANALYSIS; SACCHAROMYCES-CEREVISIAE; YEAST; KINASE; RECONSTRUCTION; BIOSYNTHESIS; CYTOSCAPE; MUTANTS; PATHWAY	Natural small compounds comprise most cellular molecules and bind proteins as substrates, products, cofactors, and ligands. However, a large-scale investigation of in vivo protein-small metabolite interactions has not been performed. We developed a mass spectrometry assay for the large-scale identification of in vivo protein-hydrophobic small metabolite interactions in yeast and analyzed compounds that bind ergosterol biosynthetic proteins and protein kinases. Many of these proteins bind small metabolites; a few interactions were previously known, but the vast majority are new. Importantly, many key regulatory proteins such as protein kinases bind metabolites. Ergosterol was found to bind many proteins and may function as a general regulator. It is required for the activity of Ypk1, a mammalian AKT/SGK kinase homolog. Our study defines potential key regulatory steps in lipid biosynthetic pathways and suggests that small metabolites may play a more general role as regulators of protein activity and function than previously appreciated.	[Li, Xiyan; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Li, Xiyan; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Gianoulis, Tara A.; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Yip, Kevin Y.; Gerstein, Mark; Snyder, Michael] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	Stanford University; Yale University; Yale University; Yale University; Yale University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Li, Xiyan/B-5495-2011; Yip, Kevin/AAT-4771-2020	Li, Xiyan/0000-0002-1959-2160; Yip, Kevin/0000-0001-5516-9944; Snyder, Michael/0000-0003-0784-7987	NIH; NSF [DBI-1042344]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062480] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Davidov and X. Zhou for technical assistance and Drs. H. Im, M. Bruno, and L. Wu for comments on the manuscript. This work was supported by grants from the NIH (M.S. and M.G.) and in part from an NSF grant DBI-1042344 (X.L. and M.S.). The conceptual design for the project was developed by X.L. and M.S. Laboratory experiments were performed by X.L. Data analyses were performed by X.L., T.G., K.Y.Y., and M.G. The manuscript was prepared by X.L. and M.S.	Alberts B, 2002, MOL BIOL CELL; Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Babu P, 2004, J BIOL CHEM, V279, P27138, DOI 10.1074/jbc.M403071200; Beloqui A, 2009, SCIENCE, V326, P252, DOI 10.1126/science.1174094; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Carrier A, 2000, J CHROMATOGR A, V876, P97, DOI 10.1016/S0021-9673(00)00148-5; Cascante M, 2008, ESSAYS BIOCHEM, V45, P67, DOI 10.1042/BSE0450067; Caydasi AK, 2009, DEV CELL, V16, P146, DOI 10.1016/j.devcel.2008.10.013; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Horak Christine E, 2002, Funct Integr Genomics, V2, P171; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Jacquier N, 2010, J CELL SCI, V123, P2218, DOI 10.1242/jcs.063073; KARST F, 1977, MOL GEN GENET, V154, P269, DOI 10.1007/BF00571282; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maynard Jennifer A., 2009, Biotechnology Journal, V4, P1542, DOI 10.1002/biot.200900195; Morozov VN, 2003, RAPID COMMUN MASS SP, V17, P2430, DOI 10.1002/rcm.1213; Nicholson JK, 2008, J PROTEOME RES, V7, P3637, DOI 10.1021/pr8005099; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Snyder M, 2009, FEBS LETT, V583, P3895, DOI 10.1016/j.febslet.2009.11.011; Tagore R, 2008, J AM CHEM SOC, V130, P14111, DOI 10.1021/ja806463c; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Yano KI, 1997, P NATL ACAD SCI USA, V94, P1721, DOI 10.1073/pnas.94.5.1721; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	39	152	156	4	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					639	650		10.1016/j.cell.2010.09.048	http://dx.doi.org/10.1016/j.cell.2010.09.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21035178	Bronze, Green Accepted			2022-12-24	WOS:000284149100020
J	Richards, M; Brayne, C				Richards, Marcus; Brayne, Carol			Alzheimer's disease What do we mean by Alzheimer's disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEMENTIA; DIAGNOSIS; LIFE; SERVICES; HEALTH		[Richards, Marcus] MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 0SR, England	University of Cambridge	Richards, M (corresponding author), MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England.	m.richards@nshd.mrc.ac.uk	Brayne, Carol/AAA-4285-2020	Brayne, Carol/0000-0001-5307-663X; Richards, Marcus/0000-0001-9191-2192	MRC [MC_U123092722, G9901400] Funding Source: UKRI; Medical Research Council [G9901400, MC_U123092722] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banerjee S, 2009, INT J GERIATR PSYCH, V24, P748, DOI 10.1002/gps.2191; BERRIOS GE, 1990, INT J GERIATR PSYCH, V5, P355, DOI 10.1002/gps.930050603; BRAYNE C, 1988, LANCET, V1, P1265; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Esiri MM, 2001, LANCET, V357, P169; HACHINSKI V, 2008, JAMA-J AM MED ASSOC, V300, P2171; Hatch SL, 2007, J GERONTOL B-PSYCHOL, V62, pS404, DOI 10.1093/geronb/62.6.S404; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Luengo-Fernandez R., 2010, DEMENTIA 2010; Martyn C, 2010, BMJ-BRIT MED J, V340, P1219; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; National Audit Office, 2007, IMPR SERV SUPP PEOPL; Rothschild D, 1937, AM J PSYCHIAT, V93, P757, DOI 10.1176/ajp.93.4.757; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; *UK GOV DEP HLTH, 2009, LIV WELL DEM NAT DEM; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; DSM 5 FUTURE PSYCHIA	22	33	34	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 12	2010	341								c4670	10.1136/bmj.c4670	http://dx.doi.org/10.1136/bmj.c4670			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KN	20940218				2022-12-24	WOS:000282886900022
J	Kim, KP; Weiner, BM; Zhang, LR; Jordan, A; Dekker, J; Kleckner, N				Kim, Keun P.; Weiner, Beth M.; Zhang, Liangran; Jordan, Amy; Dekker, Job; Kleckner, Nancy			Sister Cohesion and Structural Axis Components Mediate Homolog Bias of Meiotic Recombination	CELL			English	Article							DOUBLE-STRAND BREAK; SYNAPTONEMAL COMPLEX-FORMATION; CHROMATID COHESION; CHIASMA FORMATION; CROSSING-OVER; MEK1 KINASE; MEIOSIS; ORGANIZATION; TRANSITION; CROSSOVER	Meiotic double-strand break (DSB)-initiated recombination must occur between homologous maternal and paternal chromosomes ("homolog bias"), even though sister chromatids are present. Through physical recombination analyses, we show that sister cohesion, normally mediated by meiotic cohesin Rec8, promotes "sister bias"; that meiosis-specific axis components Red1/Mek1kinase counteract this effect, thereby satisfying an essential precondition for homolog bias; and that other components, probably recombinosome-related, directly ensure homolog partner selection. Later, Rec8 acts positively to ensure maintenance of bias. These complexities mirror opposing dictates for global sister cohesion versus local separation and differentiation of sisters at recombination sites. Our findings support DSB formation within axis-tethered recombinosomes containing both sisters and ensuing programmed sequential release of "first" and "second" DSB ends. First-end release would create a homology-searching "tentacle." Rec8 and Red1/Mek1 also independently license recombinational progression and abundantly localize to different domains. These domains could comprise complementary environments that integrate inputs from DSB repair and mitotic chromosome morphogenesis into the complete meiotic program.	[Kim, Keun P.; Weiner, Beth M.; Zhang, Liangran; Jordan, Amy; Dekker, Job; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01655 USA; [Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	Harvard University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu		Kim, Keun/0000-0002-5973-8259; zhang, liangran/0000-0002-8550-6742	National Institutes of Health [GM-044794]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kleckner laboratory members and many other colleagues for helpful comments, A. Amon for Tet repressor/operator and pREC8-MCD1 strains, and N. Hollingsworth for mek1as. Research was supported by National Institutes of Health Grant GM-044794 to N.K.	Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Callender TL, 2010, GENETICS, V185, P771, DOI 10.1534/genetics.110.117523; Cha R.S., 2000, GENE DEV, V14, P493; Covo S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001006; Diaz-Martinez LA, 2008, J CELL SCI, V121, P2107, DOI 10.1242/jcs.029132; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Joshi N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000557; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lao JP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000519; Latypov V, 2010, MOL CELL BIOL, V30, P1570, DOI 10.1128/MCB.00919-09; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Malone RE, 2004, EUKARYOT CELL, V3, P598, DOI 10.1128/EC.3.3.598-609.2004; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Niu H., 2005, MOL BIOL CELL, V16, P5804; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sanchez-Moran E., 2007, GENE DEV, V21, P2220; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Sheridan S., 2006, GENE DEV, V20, P1685; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Terentyev Y, 2010, NUCLEIC ACIDS RES, V38, P4349, DOI 10.1093/nar/gkq137; Thompson DA, 1999, GENETICS, V153, P621; Wu HY, 2010, CURR BIOL, V20, P1707, DOI 10.1016/j.cub.2010.09.016; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	48	170	171	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					924	937		10.1016/j.cell.2010.11.015	http://dx.doi.org/10.1016/j.cell.2010.11.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145459	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000285182600010
J	Creton, S; Jentsch, S				Creton, Sandrine; Jentsch, Stefan			SnapShot: The SUMO System	CELL			English	Editorial Material							UBIQUITIN		[Creton, Sandrine; Jentsch, Stefan] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Creton, S (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.							Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591	6	34	37	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					848	U329		10.1016/j.cell.2010.11.026	http://dx.doi.org/10.1016/j.cell.2010.11.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111242	Bronze			2022-12-24	WOS:000284583500025
J	Tsuchida, T; Koga, R; Horikawa, M; Tsunoda, T; Maoka, T; Matsumoto, S; Simon, JC; Fukatsu, T				Tsuchida, Tsutomu; Koga, Ryuichi; Horikawa, Mitsuyo; Tsunoda, Tetsuto; Maoka, Takashi; Matsumoto, Shogo; Simon, Jean-Christophe; Fukatsu, Takema			Symbiotic Bacterium Modifies Aphid Body Color	SCIENCE			English	Article							ACYRTHOSIPHON-PISUM; ENDOSYMBIONT; RESISTANCE; PARASITISM; INSECTS	Color variation within populations of the pea aphid influences relative susceptibility to predators and parasites. We have discovered that infection with a facultative endosymbiont of the genus Rickettsiella changes the insects' body color from red to green in natural populations. Approximately 8% of pea aphids collected in Western Europe carried the Rickettsiella infection. The infection increased amounts of blue-green polycyclic quinones, whereas it had less of an effect on yellow-red carotenoid pigments. The effect of the endosymbiont on body color is expected to influence prey-predator interactions, as well as interactions with other endosymbionts.	[Tsuchida, Tsutomu; Matsumoto, Shogo] RIKEN, Adv Sci Inst, Mol Entomol Lab, Wako, Saitama 3510198, Japan; [Koga, Ryuichi; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; [Horikawa, Mitsuyo; Tsunoda, Tetsuto] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan; [Maoka, Takashi] Res Inst Prod Dev, Kyoto 6060805, Japan; [Simon, Jean-Christophe] Univ Rennes 1, INRA, UMR 1099, BiO3P, F-35653 Le Rheu, France	RIKEN; National Institute of Advanced Industrial Science & Technology (AIST); Tokushima Bunri University; INRAE; Universite de Rennes	Tsuchida, T (corresponding author), RIKEN, Adv Sci Inst, Mol Entomol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-tsuchida@riken.jp; t-fukatsu@aist.go.jp	Simon, Jean-Christophe/I-2700-2014		Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan [22128007]; INRA AIP Bioresources; RIKEN; Grants-in-Aid for Scientific Research [22590032] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); INRA AIP Bioresources; RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Peccoud, Y. Outreman, S. Stoeckel, L. Mieuzet, J. Jaquiery, and W. Weisser for aphid sampling; J. Bonhomme, L. Mieuzet, and J. Makino for aphid rearing and genotyping; and X.-Y. Meng and S. Hanada for help with electron microscopy. This work was supported by the Japan-France Integrated Action Program SAKURA of the Japan Society for the Promotion of Science (to T. F. and J.-C.S.); the Grant-in-Aid for Scientific Research on Innovative Areas (22128007) of the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. F.); and funds from INRA AIP Bioresources (to J.-C.S.). T. T. was supported by a RIKEN special postdoctoral research fellowship.	BOWIE JH, 1966, NATURE, V210, P395, DOI 10.1038/210395a0; BROWN KS, 1975, CHEM SOC REV, V4, P263, DOI 10.1039/cs9750400263; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Leonard J, 2010, EVOLUTION PRIMARY SE; Libbrecht R, 2007, J INSECT BEHAV, V20, P25, DOI 10.1007/s10905-006-9055-y; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; MULLER F. P., 1962, Z. PflKrarikh., V69, P129; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; RUXTON GD, 2005, AVOIDING ATTAK EVOLU; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611	18	287	316	5	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2010	330	6007					1102	1104		10.1126/science.1195463	http://dx.doi.org/10.1126/science.1195463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097935				2022-12-24	WOS:000284374700043
J	Harel-Sharvit, L; Eldad, N; Haimovich, G; Barkai, O; Duek, L; Choder, M				Harel-Sharvit, Liat; Eldad, Naama; Haimovich, Gal; Barkai, Oren; Duek, Lea; Choder, Mordechai			RNA Polymerase II Subunits Link Transcription and mRNA Decay to Translation	CELL			English	Article							P-BODIES; SACCHAROMYCES-CEREVISIAE; DEPENDENT TRANSLATION; INITIATION-FACTORS; YEAST; PROTEIN; RPB4; COMPLEX; MUTATIONS; BINDING	Little is known about crosstalk between the eukaryotic transcription and translation machineries that operate in different cell compartments. The yeast proteins Rpb4p and Rpb7p represent one such link as they form a heterodimer that shuttles between the nucleus, where it functions in transcription, and the cytoplasm, where it functions in the major mRNA decay pathways. Here we show that the Rpb4/7 heterodimer interacts physically and functionally with components of the translation initiation factor 3 (eIF3), and is required for efficient translation initiation. Efficient translation in the cytoplasm depends on association of Rpb4/7 with RNA polymerase II (Pol II) in the nucleus, leading to a model in which Pol II remotely controls translation. Hence, like in prokaryotes, the eukaryotic translation is coupled to transcription. We propose that Rpb4/7, through its interactions at each step in the mRNA life-cycle, represents a class of factors, "mRNA coordinators," which integrate the various stages of gene expression into a system.	[Harel-Sharvit, Liat; Eldad, Naama; Haimovich, Gal; Barkai, Oren; Duek, Lea; Choder, Mordechai] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Choder, M (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel.	choder@technion.ac.il	Haimovich, Gal/H-3316-2019	Haimovich, Gal/0000-0002-3360-5108	Israel Science Foundation; Rappaport Foundation; Paamei Tikva	Israel Science Foundation(Israel Science Foundation); Rappaport Foundation; Paamei Tikva	We thank Nancy Woychik for the rpb6<SUP>Q100R</SUP> strain, David Jansma for the rpb1<SUP>C67S;</SUP> <SUP>C70S</SUP> strain, Allan Hinnebusch for anti-Nip1p and for GST fusion constructs, Tien-Hsien Chang for the DHH1-GFP plasmid and Parag Sadhale for anti-Rpb7p Abs. The help of Almog Bregman is highly appreciated. We thank Elite Levin for statistical analyses. We thank Allan Hinnebusch and Leos Valasec for critically reading the manuscript and for their advice. This work was supported by the Israel Science Foundation, by Rappaport Foundation and by Paamei Tikva.	Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; CHODER M, 1993, J BACTERIOL, V175, P6358, DOI 10.1128/JB.175.19.6358-6363.1993; Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; CHODER M, 1993, MOL CELL BIOL, V13, P6984, DOI 10.1128/MCB.13.11.6984; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Daulny A, 2008, P NATL ACAD SCI USA, V105, P19649, DOI 10.1073/pnas.0809372105; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Donaldson IM, 2000, J BIOL CHEM, V275, P13780, DOI 10.1074/jbc.275.18.13780; Eldad N, 2008, NUCLEIC ACIDS RES, V36, P6728, DOI 10.1093/nar/gkn754; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Farago M, 2003, MOL BIOL CELL, V14, P2744, DOI 10.1091/mbc.E02-11-0740; FUGE EK, 1994, J BACTERIOL, V176, P5802, DOI 10.1128/JB.176.18.5802-5813.1994; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Paz I, 2001, J BACTERIOL, V183, P4477, DOI 10.1128/JB.183.15.4477-4483.2001; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pillai B, 2003, J BIOL CHEM, V278, P3339, DOI 10.1074/jbc.M112180200; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Rosenheck S, 1998, J BACTERIOL, V180, P6187; Ruiz-Echevarria MJ, 1998, P NATL ACAD SCI USA, V95, P8721, DOI 10.1073/pnas.95.15.8721; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Sheffer A, 1999, MOL CELL BIOL, V19, P2672; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Singh SR, 2007, BIOCHEM BIOPH RES CO, V356, P266, DOI 10.1016/j.bbrc.2007.02.120; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tan Q, 2003, MOL CELL BIOL, V23, P3329, DOI 10.1128/MCB.23.9.3329-3338.2003; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; Verma-Gaur J, 2008, EUKARYOT CELL, V7, P1009, DOI 10.1128/EC.00057-08; Wyers F, 2000, MOL CELL BIOL, V20, P3538, DOI 10.1128/MCB.20.10.3538-3549.2000	59	140	142	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					552	563		10.1016/j.cell.2010.10.033	http://dx.doi.org/10.1016/j.cell.2010.10.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074047	Bronze			2022-12-24	WOS:000284149100013
J	Marchetto, MCN; Carromeu, C; Acab, A; Yu, D; Yeo, GW; Mu, YL; Chen, G; Gage, FH; Muotri, AR				Marchetto, Maria C. N.; Carromeu, Cassiano; Acab, Allan; Yu, Diana; Yeo, Gene W.; Mu, Yangling; Chen, Gong; Gage, Fred H.; Muotri, Alysson R.			A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells	CELL			English	Article							AUTISM-SPECTRUM; MOUSE MODEL; MECP2; BRAIN; DISEASE; MUTATIONS; PHENOTYPE; SYMPTOMS; GENE; PHOSPHORYLATION	Autism spectrum disorders (ASD) are complex neurodevelopmental diseases in which different combinations of genetic mutations may contribute to the phenotype. Using Rett syndrome (RTT) as an ASD genetic model, we developed a culture system using induced pluripotent stem cells (iPSCs) from RTT patients' fibroblasts. RTT patients' iPSCs are able to undergo X-inactivation and generate functional neurons. Neurons derived from RTT-iPSCs had fewer synapses, reduced spine density, smaller soma size, altered calcium signaling and electrophysiological defects when compared to controls. Our data uncovered early alterations in developing human RTT neurons. Finally, we used RTT neurons to test the effects of drugs in rescuing synaptic defects. Our data provide evidence of an unexplored developmental window, before disease onset, in RTT syndrome where potential therapies could be successfully employed. Our model recapitulates early stages of a human neurodevelopmental disease and represents a promising cellular tool for drug screening, diagnosis and personalized treatment.	[Carromeu, Cassiano; Acab, Allan; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego,Stem Cell Program, Dept Pediat,Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Marchetto, Maria C. N.; Yu, Diana; Mu, Yangling; Gage, Fred H.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Yeo, Gene W.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA; [Chen, Gong] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego,Stem Cell Program, Dept Pediat,Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	muotri@ucsd.edu	Yeo, Gene/AAE-7676-2019; Carromeu, Cassiano/B-1487-2014	Yeo, Gene/0000-0002-0799-6037; Carromeu, Cassiano/0000-0002-7570-2213; Chen JNU, Gong/0000-0002-1857-3670	Emerald Foundation; National Institutes of Health [1-DP2-OD006495-01]; California Institute for Regenerative Medicine [RL1-00649-1, RC1-00115-1]; Lookout Fund; Mathers Foundation; Glenn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006495] Funding Source: NIH RePORTER	Emerald Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Lookout Fund; Mathers Foundation; Glenn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the Emerald Foundation and by the National Institutes of Health through the NIH Director's New Innovator Award Program, 1-DP2-OD006495-01. F.H.G. is supported by California Institute for Regenerative Medicine RL1-00649-1 and RC1-00115-1, The Lookout Fund and the Mathers Foundation. C.C. is a fellow from the International Rett Syndrome Foundation. M.C.N.M. is a Christopher and Danna Reeve Foundation fellow. G.C. was supported by the Glenn Foundation. We would like to thank Monica Coenraads for critical discussion; the Greenwood Genetic Center clinical diagnostic laboratory for X-inactivation analysis; Dr. Jeannie T. Lee for the Xist probe; and M.L. Gage for editorial comments.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Charman T, 2002, BRAIN DEV-JPN, V24, P281, DOI 10.1016/S0387-7604(02)00058-X; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hagberg G, 2001, BRAIN DEV-JPN, V23, pS227, DOI 10.1016/S0387-7604(01)00375-8; Hammer S, 2002, MENT RETARD DEV D R, V8, P94, DOI 10.1002/mrdd.10023; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Kellermayer R, 2006, EUR J MED GENET, V49, P445, DOI 10.1016/j.ejmg.2006.04.003; KERR AM, 1987, BRAIN DEV-JPN, V9, P487, DOI 10.1016/S0387-7604(87)80070-0; Kishi N, 2010, EXP NEUROL, V222, P51, DOI 10.1016/j.expneurol.2009.12.007; Laccone F, 2001, HUM MUTAT, V17, P183, DOI 10.1002/humu.3; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2010, HUM MOL GENET, V19, pR71, DOI 10.1093/hmg/ddq159; Mironov SL, 2009, J PHYSIOL-LONDON, V587, P2473, DOI 10.1113/jphysiol.2009.169805; Muotri AR, 2009, EPILEPSY BEHAV, V14, P81, DOI 10.1016/j.yebeh.2008.09.021; Niethammer M, 1996, J NEUROSCI, V16, P2157; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; Piven J, 1997, AM J PSYCHIAT, V154, P185; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P1; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Samaco RC, 2004, HUM MOL GENET, V13, P629, DOI 10.1093/hmg/ddh063; Santos M, 2007, GENES BRAIN BEHAV, V6, P277, DOI 10.1111/j.1601-183X.2006.00258.x; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zappella M, 2003, AM J MED GENET B, V119B, P102, DOI 10.1002/ajmg.b.10070; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	57	938	975	3	180	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					527	539		10.1016/j.cell.2010.10.016	http://dx.doi.org/10.1016/j.cell.2010.10.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074045	Green Accepted, Bronze			2022-12-24	WOS:000284149100011
J	Oberg, M; Jaakkola, MS; Woodward, A; Peruga, A; Pruss-Ustun, A				Oberg, Mattias; Jaakkola, Maritta S.; Woodward, Alistair; Peruga, Armando; Pruess-Ustuen, Annette			Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries	LANCET			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; PASSIVE SMOKING; LEGISLATION; CHILDREN; HEALTH; IMPACT	Background Exposure to second-hand smoke is common in many countries but the magnitude of the problem worldwide is poorly described. We aimed to estimate the worldwide exposure to second-hand smoke and its burden of disease in children and adult non-smokers in 2004. Methods The burden of disease from second-hand smoke was estimated as deaths and disability-adjusted life-years (DALYs) for children and adult non-smokers. The calculations were based on disease-specific relative risk estimates and area-specific estimates of the proportion of people exposed to second-hand smoke, by comparative risk assessment methods, with data from 192 countries during 2004. Findings Worldwide, 40% of children, 33% of male non-smokers, and 35% of female non-smokers were exposed to second-hand smoke in 2004. This exposure was estimated to have caused 379 000 deaths from ischaemic heart disease, 165 000 from lower respiratory infections, 36 900 from asthma, and 21 400 from lung cancer. 603 000 deaths were attributable to second-hand smoke in 2004, which was about 1.0% of worldwide mortality. 47% of deaths from second-hand smoke occurred in women, 28% in children, and 26% in men. DALYs lost because of exposure to second-hand smoke amounted to 10.9 million, which was about 0.7% of total worldwide burden of diseases in DALYs in 2004. 61% of DALYs were in children. The largest disease burdens were from lower respiratory infections in children younger than 5 years (5 939 000), ischaemic heart disease in adults (2 836 000), and asthma in adults (1 246 000) and children (651 000). Interpretation These estimates of worldwide burden of disease attributable to second-hand smoke suggest that substantial health gains could be made by extending effective public health and clinical interventions to reduce passive smoking worldwide.	[Pruess-Ustuen, Annette] WHO, Dept Publ Hlth & Environm, CH-1211 Geneva 27, Switzerland; [Oberg, Mattias] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Jaakkola, Maritta S.] Univ Oulu, Resp Med Unit, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Jaakkola, Maritta S.] Univ Oulu, Inst Clin Med, Oulu, Finland; [Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	World Health Organization; Karolinska Institutet; University of Oulu; University of Oulu; University of Auckland	Pruss-Ustun, A (corresponding author), WHO, Dept Publ Hlth & Environm, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	pruessa@who.int	Peruga, Armando/G-9739-2019	Oberg, Mattias/0000-0001-5377-530X; Jaakkola, Maritta S./0000-0003-1373-7784; Woodward, Alistair/0000-0001-5425-6018	Swedish National Board of Health and Welfare; Bloomberg Philanthropies	Swedish National Board of Health and Welfare; Bloomberg Philanthropies	We thank the Swedish National Board of Health and Welfare and the Bloomberg Philanthropies for their funding support. The authors alone are responsible for the views expressed in this publication, which do not necessarily reflect the decisions or the stated policy of WHO or of its Member States. (C) World Health Organization, 2010.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; California Environmental Protection Agency, 2005, PROP ID ENV TOB SMOK; Centers for Disease Control and Prevention, GLOB YOUTH TOB SURV; Eriksen MP, 2008, ANNU REV PUBL HEALTH, V29, P171, DOI 10.1146/annurev.publhealth.29.020907.090920; ETZEL RA, 1992, PEDIATRICS, V90, P228; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2004, COMP QUANTIFICATION; Fontana L, 2007, G Ital Med Lav Ergon, V29, P484; Gan Q, 2007, TOB CONTROL, V16, P417, DOI 10.1136/tc.2007.021477; Institute of Medicine, 2009, SECONDH SMOK EXP CAR; Intenational Labour Office, 2008, GLOB EMPL TRENDS WOM; International Agency for Research on Cancer, 2009, EV EFF SMOK FREE POL; International Agency for Research on Cancer, 2004, TOB SMOK INV SMOK; Jaakkola MS, 2006, EUR RESPIR J, V28, P397, DOI 10.1183/09031936.06.00001306; Jaakkola MS, 2003, AM J PUBLIC HEALTH, V93, P2055, DOI 10.2105/AJPH.93.12.2055; Jaakkola MS, 1999, ENVIRON HEALTH PERSP, V107, P829, DOI 10.2307/3434561; Li JS, 1999, PEDIATR PULM, V27, P5, DOI 10.1002/(SICI)1099-0496(199901)27:1<5::AID-PPUL3>3.0.CO;2-5; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Lopez MJ, 2007, TOB CONTROL, V16, P373, DOI 10.1136/tc.2006.019679; McNabola A, 2009, INT J ENV RES PUB HE, V6, P741, DOI 10.3390/ijerph6020741; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Musk AW, 2003, RESPIROLOGY, V8, P286, DOI 10.1046/j.1440-1843.2003.00483.x; Oberg M, GLOBAL ESTI IN PRESS; Pell Jill P, 2008, N Engl J Med, V359, P482, DOI 10.1056/NEJMsa0706740; Pr?ss-?st?n, 2010, 2 HAND SMOKE ASSESSI; SCHONHERR E., 1928, ZEITSCHR KREBSFORSCH, V27, P436, DOI 10.1007/BF02125480; The Gallup Organization, 2009, SURV TOB AN REP; United Nations, 2009, MILL DEV GOALS REP 2; US Department of Health Education and Welfare, 1972, DHEW PUBL; US Surgeon General, 2006, HLTH CONS INV EXP TO; WHO, 2002, RED RISKS PROM HLTH; Wipfli H, 2008, AM J PUBLIC HEALTH, V98, P672, DOI 10.2105/AJPH.2007.126631; Woodward A, 2001, TOB CONTROL, V10, P383, DOI 10.1136/tc.10.4.383; World Health Organization, 2009, WHO FRAM CONV TOB CO; World Health Organization, 1999, INT CONS ENV TOB SMO; World Health Organization, 2009, GLOB BURD DIS 2004 U; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization (WHO), 2009, GUID IMPL WHO FRAM C	38	1137	1181	4	199	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					139	146		10.1016/S0140-6736(10)61388-8	http://dx.doi.org/10.1016/S0140-6736(10)61388-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21112082				2022-12-24	WOS:000286292800026
J	Nelson, EJ; Nelson, DS; Salam, MA; Sack, DA				Nelson, Eric J.; Nelson, Danielle S.; Salam, Mohammed A.; Sack, David A.			Antibiotics for Both Moderate and Severe Cholera.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nelson, Eric J.] Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA; [Nelson, Danielle S.] Santa Clara Valley Med Ctr, Milpitas, CA USA; [Salam, Mohammed A.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Sack, David A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Lucile Packard Children's Hospital (LPCH); Stanford University; Santa Clara Valley Medical Center; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nelson, EJ (corresponding author), Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA.							KHAN MU, 1982, J TROP MED HYG, V85, P27; LINDENBA.J, 1967, B WORLD HEALTH ORGAN, V36, P871; RAHAMAN MM, 1976, ANTIMICROB AGENTS CH, V10, P610, DOI 10.1128/AAC.10.4.610; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; Weil AA, 2009, CLIN INFECT DIS, V49, P1473, DOI 10.1086/644779	5	64	64	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					5	7		10.1056/NEJMp1013771	http://dx.doi.org/10.1056/NEJMp1013771			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21142691				2022-12-24	WOS:000285922600003
J	Aoki, SK; Diner, EJ; de Roodenbeke, CT; Burgess, BR; Poole, SJ; Braaten, BA; Jones, AM; Webb, JS; Hayes, CS; Cotter, PA; Low, DA				Aoki, Stephanie K.; Diner, Elie J.; de Roodenbeke, Claire t'Kint; Burgess, Brandt R.; Poole, Stephen J.; Braaten, Bruce A.; Jones, Allison M.; Webb, Julia S.; Hayes, Christopher S.; Cotter, Peggy A.; Low, David A.			A widespread family of polymorphic contact-dependent toxin delivery systems in bacteria	NATURE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI; INHIBITION; GROWTH	Bacteria have developed mechanisms to communicate and compete with one another in diverse environments(1). A new form of intercellular communication, contact-dependent growth inhibition (CDI), was discovered recently in Escherichia coli(2). CDI is mediated by the CdiB/CdiA two-partner secretion (TPS) system. CdiB facilitates secretion of the CdiA 'exoprotein' onto the cell surface. An additional small immunity protein (CdiI) protects CDI+ cells from autoinhibition(2,3). The mechanisms by which CDI blocks cell growth and by which CdiI counteracts this growth arrest are unknown. Moreover, the existence of CDI activity in other bacteria has not been explored. Here we show that the CDI growth inhibitory activity resides within the carboxy-terminal region of CdiA (CdiA-CT), and that CdiI binds and inactivates cognate CdiA-CT, but not heterologous CdiA-CT. Bioinformatic and experimental analyses show that multiple bacterial species encode functional CDI systems with high sequence variability in the CdiA-CT and CdiI coding regions. CdiA-CT heterogeneity implies that a range of toxic activities are used during CDI. Indeed, CdiA-CTs from uropathogenic E. coli and the plant pathogen Dickeya dadantii have different nuclease activities, each providing a distinct mechanism of growth inhibition. Finally, we show that bacteria lacking the CdiA-CT and CdiI coding regions are unable to compete with isogenic wild-type CDI+ cells both in laboratory media and on a eukaryotic host. Taken together, these results suggest that CDI systems constitute an intricate immunity network with an important function in bacterial competition.	[Aoki, Stephanie K.; de Roodenbeke, Claire t'Kint; Burgess, Brandt R.; Poole, Stephen J.; Braaten, Bruce A.; Jones, Allison M.; Webb, Julia S.; Hayes, Christopher S.; Cotter, Peggy A.; Low, David A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Diner, Elie J.; Hayes, Christopher S.; Cotter, Peggy A.; Low, David A.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Low, DA (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	low@lifesci.ucsb.edu	Hayes, Christopher/A-5505-2009; Pacific-Southwest, RCE/B-6155-2009		National Science Foundation [0642052]; Tri-Counties Blood Bank; National Institutes of Health [GM078634, AI043986, U54AI065359]; United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2001-52100-11316]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, R01AI043986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Tri-Counties Blood Bank; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Charkowski, A. Collmer, J. Roth and H. Schweizer for plasmids, bacterial strains and helpful discussions; W. Lathem for Y. pestis CO92 DNA; and R. Christoffersen for helpful advice on plant experiments. This work was supported by National Science Foundation grant 0642052 (D.A.L.), a Tri-Counties Blood Bank Postdoctoral Fellowship (S.K.A.) and National Institutes of Health grants GM078634 (C.S.H.), AI043986 (P.A.C.) and U54AI065359 (D.A.L., P.A.C. and C.S.H.). The content is the sole responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. This project made use of preliminary sequences from the Dickeya dadantii 3937 genome project supported by the Initiative for Future Agriculture and Food Systems grant no. 2001-52100-11316 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service.	Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; BRAATEN BA, 1994, CELL, V76, P577, DOI 10.1016/0092-8674(94)90120-1; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; DUPORT C, 1995, J BIOL CHEM, V270, P8920, DOI 10.1074/jbc.270.15.8920; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ham JH, 2004, MOL PLANT MICROBE IN, V17, P184, DOI 10.1094/MPMI.2004.17.2.184; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Luo CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-552; Pagni M, 2001, Brief Bioinform, V2, P51, DOI 10.1093/bib/2.1.51; Rojas CM, 2004, MOL PLANT MICROBE IN, V17, P644, DOI 10.1094/MPMI.2004.17.6.644; Yap MN, 2006, J BACTERIOL, V188, P2280, DOI 10.1128/JB.188.6.2280-2284.2006	14	214	227	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					439	442		10.1038/nature09490	http://dx.doi.org/10.1038/nature09490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085179	Green Accepted			2022-12-24	WOS:000284313100043
J	Clark, WF; Sontrop, JM; Macnab, JJ; Salvadori, M; Moist, L; Suri, R; Garg, AX				Clark, William F.; Sontrop, Jessica M.; Macnab, Jennifer J.; Salvadori, Marina; Moist, Louise; Suri, Rita; Garg, Amit X.			Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEMOLYTIC-UREMIC SYNDROME; O157-H7 INFECTION; HEALTH SEQUELAE; KIDNEY-FUNCTION; OUTBREAK; CONSUMPTION; PREVALENCE; PREDICTION; CONTINUUM; ILLNESS	Objectives To evaluate the risk for hypertension, renal impairment, and cardiovascular disease within eight years of gastroenteritis from drinking water contaminated with Escherichia coli O157:H7 and Campylobacter. Design A prospective cohort study. Setting Walkerton, Ontario, Canada. Participants 1977 adult participants in the Walkerton Health Study recruited between 2002 and 2005 after an outbreak of gastroenteritis in May 2000, when a municipal water system was contaminated, with no pre-outbreak history of outcome measures. Outcome measures Information was collected annually via survey, physical examination, and laboratory assessment. Primary measures were acute gastroenteritis (diarrhoeal illness lasting >3 days, bloody diarrhoea, or >3 loose stools/day), hypertension (blood pressure >= 140/90 mm Hg), and renal impairment (microalbuminuria or estimated glomerular filtration rate <60 ml/min/1.73 m(2)). Self reported physician diagnosis of cardiovascular disease (myocardial infarction, stroke, or congestive heart failure) was a secondary outcome. Results Acute gastroenteritis at the time of the outbreak was reported by 1067 (54%) of participants. Incident hypertension was detected in 697 (35%) (294 (32%) of group not exposed to acute gastroenteritis v 403 (38%) of exposed group). While 572 (29%) had at least one indicator of renal impairment (266 (29%) of unexposed v 306 (29%) of exposed), only 30 (1.5%) had both (8 (0.9%) of unexposed v 22 (2.1%) of exposed). Cardiovascular disease was reported by 33/1749 (1.9%). The adjusted hazard ratios for hypertension and cardiovascular disease after acute gastroenteritis were 1.33 (95% confidence interval 1.14 to 1.54) and 2.13 (1.03 to 4.43) respectively. The adjusted hazard ratio for the presence of either indicator of renal impairment was 1.15 (0.97 to 1.35) and was 3.41 (1.51 to 7.71) for the presence of both. Conclusion Gastroenteritis from drinking water contaminated with E coli O157:H7 and Campylobacter was associated with an increased risk for hypertension, renal impairment, and self reported cardiovascular disease. Annual monitoring of blood pressure and periodic monitoring of renal function may be warranted for individuals who experience E coli O157:H7 gastroenteritis.	[Clark, William F.; Sontrop, Jessica M.; Moist, Louise; Suri, Rita; Garg, Amit X.] London Hlth Sci Ctr, Dept Med, Div Nephrol, London, ON, Canada; [Clark, William F.; Sontrop, Jessica M.; Moist, Louise; Suri, Rita; Garg, Amit X.] London Hlth Sci Ctr, London Kidney Clin Res Unit, London, ON, Canada; [Sontrop, Jessica M.; Macnab, Jennifer J.; Moist, Louise; Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Salvadori, Marina] Childrens Hosp, London Hlth Sci Ctr, Dept Pediat Infect Dis, London, ON, Canada	London Health Sciences Centre; London Health Sciences Centre; Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario)	Clark, WF (corresponding author), Victoria Hosp, A2-343 Westminster Tower,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	William.Clark@lhsc.on.ca	Garg, Amit X/G-3295-2011; Clark, Bill/G-3287-2011; Moist, Louise/G-3334-2011; Suri, Rita S/G-3348-2011	Suri, Rita S/0000-0002-0519-3927; Sontrop, Jessica M./0000-0001-7784-2028	Ontario Ministry of Health and Long term Care	Ontario Ministry of Health and Long term Care(Ministry of Health and Long-Term Care, Ontario)	This study was funded by the Ontario Ministry of Health and Long term Care, which had no role in design and conduct of the study; collection, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Blair A, 2007, AM J IND MED, V50, P199, DOI 10.1002/ajim.20281; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Breslow N E, 1980, IARC Sci Publ, P5; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P803; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Dzau VJ, 2004, CIRCULATION, V109, P1, DOI 10.1161/01.CIR.0000133445.78855.aa; Effler P, 2001, EMERG INFECT DIS, V7, P812; Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602; *EXP COMM DIAGN CL, 2003, DIABETES CARE, V261, P5; *FDA, 2009, BBB CAMP JEJ; Frenzen PD, 2005, J FOOD PROTECT, V68, P2623, DOI 10.4315/0362-028X-68.12.2623; Garg AX, 2006, KIDNEY INT, V70, P807, DOI 10.1038/sj.ki.5001645; Garg AX, 2006, J CLIN EPIDEMIOL, V59, P421, DOI 10.1016/j.jclinepi.2005.08.014; Garg AX, 2005, CAN MED ASSOC J, V173, P261, DOI 10.1503/cmaj.050581; Garg AX, 2005, CAN J PUBLIC HEALTH, V96, P125, DOI 10.1007/BF03403675; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; Germani Y, 1997, LANCET, V349, P1670, DOI 10.1016/S0140-6736(05)62636-0; Groenwold RHH, 2010, INT J EPIDEMIOL, V39, P107, DOI 10.1093/ije/dyp332; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hamner S, 2007, APPL ENVIRON MICROB, V73, P2369, DOI 10.1128/AEM.00141-07; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hirsch AT, 2004, CIRCULATION, V110, P2774, DOI 10.1161/01.CIR.0000147616.76919.99; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Karmali MA, 2009, KIDNEY INT, V75, pS4, DOI 10.1038/ki.2008.608; Kehl SC, 2002, J CLIN MICROBIOL, V40, P2711, DOI 10.1128/JCM.40.8.2711-2715.2002; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L, DOI [10.1007/0-387-29150-4, DOI 10.1007/0-387-29150-4]; Leotta GA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-46; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Liuzzo G, 2001, Rays, V26, P221; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Ohmi K, 1998, BIOCHEM BIOPH RES CO, V251, P137, DOI 10.1006/bbrc.1998.9417; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Olsen SJ, 2002, EMERG INFECT DIS, V8, P370, DOI 10.3201/eid0804.000218; Petruzziello TN, 2009, KIDNEY INT, V75, pS17, DOI 10.1038/ki.2008.612; Powell M, 2001, INT J FOOD MICROBIOL, V69, P209, DOI 10.1016/S0168-1605(01)00495-0; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Salvadori MI, 2009, KIDNEY INT, V75, pS33, DOI 10.1038/ki.2008.616; Sehgal R, 2008, T ROY SOC TROP MED H, V102, P380, DOI 10.1016/j.trstmh.2008.01.015; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; Tarr PI, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133817; TARR PI, 1990, J INFECT DIS, V162, P553, DOI 10.1093/infdis/162.2.553; *US FDA, 2009, BBB ESCH COL O157 H7; Vassalotti JA, 2007, AM J KIDNEY DIS, V50, P169, DOI 10.1053/j.ajkd.2007.06.013; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; Whittaker PJ, 2009, EPIDEMIOL INFECT, V137, P375, DOI 10.1017/S0950268808001702; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363	56	40	44	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2010	341								c6020	10.1136/bmj.c6020	http://dx.doi.org/10.1136/bmj.c6020			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684WO	21084368	Green Published, hybrid			2022-12-24	WOS:000284586200004
J	Kraman, M; Bambrough, PJ; Arnold, JN; Roberts, EW; Magiera, L; Jones, JO; Gopinathan, A; Tuveson, DA; Fearon, DT				Kraman, Matthew; Bambrough, Paul J.; Arnold, James N.; Roberts, Edward W.; Magiera, Lukasz; Jones, James O.; Gopinathan, Aarthi; Tuveson, David A.; Fearon, Douglas T.			Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-alpha	SCIENCE			English	Article							IFN-GAMMA; T-CELLS; TUMOR PROGRESSION; HUMAN-MELANOMA; BONE-MARROW; CANCER; INHIBITION; GROWTH; DIFFERENTIATION; IMMUNOGENICITY	The stromal microenvironment of tumors, which is a mixture of hematopoietic and mesenchymal cells, suppresses immune control of tumor growth. A stromal cell type that was first identified in human cancers expresses fibroblast activation protein-alpha (FAP). We created a transgenic mouse in which FAP-expressing cells can be ablated. Depletion of FAP-expressing cells, which made up only 2% of all tumor cells in established Lewis lung carcinomas, caused rapid hypoxic necrosis of both cancer and stromal cells in immunogenic tumors by a process involving interferon-gamma and tumor necrosis factor-alpha. Depleting FAP-expressing cells in a subcutaneous model of pancreatic ductal adenocarcinoma also permitted immunological control of growth. Therefore, FAP-expressing cells are a nonredundant, immune-suppressive component of the tumor microenvironment.	[Kraman, Matthew; Bambrough, Paul J.; Arnold, James N.; Roberts, Edward W.; Magiera, Lukasz; Jones, James O.; Fearon, Douglas T.] Univ Cambridge, MRC Ctr, Dept Med, Wellcome Trust Immunol Unit, Cambridge CB2 2QH, England; [Gopinathan, Aarthi; Tuveson, David A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Gopinathan, Aarthi] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	MRC Laboratory Molecular Biology; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine	Fearon, DT (corresponding author), Univ Cambridge, MRC Ctr, Dept Med, Wellcome Trust Immunol Unit, Hills Rd, Cambridge CB2 2QH, England.	dtf1000@cam.ac.uk	Arnold, James/ABE-3900-2021	Arnold, James/0000-0002-6949-0613; Roberts, Edward/0000-0002-8229-1715; Magiera, Lukasz/0000-0002-8234-5066; Kraman, Matthew/0000-0002-5040-0067	Wellcome Trust; National Institutes for Health Research Cambridge Biomedical Research Centre; Cancer Research UK; Hutchison Whampoa; University of Cambridge	Wellcome Trust(Wellcome Trust); National Institutes for Health Research Cambridge Biomedical Research Centre; Cancer Research UK(Cancer Research UK); Hutchison Whampoa; University of Cambridge(University of Cambridge)	We thank A. Betz, F. Randow, and C. Feig for their discussions. This research was supported by the Wellcome Trust and the National Institutes for Health Research Cambridge Biomedical Research Centre. D. A. T. was supported by Cancer Research UK, Hutchison Whampoa, and the University of Cambridge.	Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Bauer S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2080; BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69; Zhang B, 2008, J CLIN INVEST, V118, P1398, DOI 10.1172/JCI33522; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Dolznig Helmut, 2005, Cancer Immun, V5, P10; DOUKAS J, 1990, J IMMUNOL, V145, P1727; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; KLEIN G, 1960, CANCER RES, V20, P1561; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Nelson DJ, 2001, J IMMUNOL, V166, P5557, DOI 10.4049/jimmunol.166.9.5557; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Schuler T, 2003, J IMMUNOL, V170, P4427, DOI 10.4049/jimmunol.170.9.4427; Speiser DE, 2006, J IMMUNOL, V177, P1338, DOI 10.4049/jimmunol.177.2.1338; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684	30	769	805	6	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					827	830		10.1126/science.1195300	http://dx.doi.org/10.1126/science.1195300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051638				2022-12-24	WOS:000283855700045
J	Wallace, BD; Wang, HW; Lane, KT; Scott, JE; Orans, J; Koo, JS; Venkatesh, M; Jobin, C; Yeh, LA; Mani, S; Redinbo, MR				Wallace, Bret D.; Wang, Hongwei; Lane, Kimberly T.; Scott, John E.; Orans, Jillian; Koo, Ja Seol; Venkatesh, Madhukumar; Jobin, Christian; Yeh, Li-An; Mani, Sridhar; Redinbo, Matthew R.			Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme	SCIENCE			English	Article							BETA-GLUCURONIDASE; METABOLISM; PHARMACOGENETICS; DIARRHEA; COLITIS; COLON	The dose-limiting side effect of the common colon cancer chemotherapeutic CPT-11 is severe diarrhea caused by symbiotic bacterial beta-glucuronidases that reactivate the drug in the gut. We sought to target these enzymes without killing the commensal bacteria essential for human health. Potent bacterial beta-glucuronidase inhibitors were identified by high-throughput screening and shown to have no effect on the orthologous mammalian enzyme. Crystal structures established that selectivity was based on a loop unique to bacterial beta-glucuronidases. Inhibitors were highly effective against the enzyme target in living aerobic and anaerobic bacteria, but did not kill the bacteria or harm mammalian cells. Finally, oral administration of an inhibitor protected mice from CPT-11-induced toxicity. Thus, drugs may be designed to inhibit undesirable enzyme activities in essential microbial symbiotes to enhance chemotherapeutic efficacy.	[Wallace, Bret D.; Lane, Kimberly T.; Orans, Jillian; Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Wang, Hongwei; Venkatesh, Madhukumar; Mani, Sridhar] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Wang, Hongwei; Venkatesh, Madhukumar; Mani, Sridhar] Albert Einstein Coll Med, Dept Oncol, Bronx, NY 10461 USA; [Wang, Hongwei; Venkatesh, Madhukumar; Mani, Sridhar] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Scott, John E.; Yeh, Li-An] N Carolina Cent Univ, BRITE, Durham, NC 27707 USA; [Koo, Ja Seol; Jobin, Christian] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; North Carolina Central University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Redinbo, MR (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	redinbo@unc.edu		Wallace, Bret/0000-0002-9107-5045; Koo, Ja Seol/0000-0002-1202-075X	NIH [CA98468, CA127231]; UNC Chapel Hill; Damon Runyon Cancer Research Foundation [CI15-02]; Golden Leaf Foundation; State of North Carolina; NATIONAL CANCER INSTITUTE [R01CA127231, R01CA161879, R01CA098468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Chapel Hill; Damon Runyon Cancer Research Foundation; Golden Leaf Foundation; State of North Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Redinbo Laboratory at UNC Chapel Hill, the Mani lab and Einstein College of Medicine, and the BRITE Institute for experimental assistance and helpful discussions; B. Allard at UNC Chapel Hill for her expert help with the cytotoxicity assay; B. Sartor at UNC for providing bacterial cell lines; and E. Burgos in the Schramm lab at Einstein for use of the HPLC. Supported by NIH grant CA98468 ( M. R. R.), the SPIRE Postdoctoral Fellowship Program at UNC Chapel Hill (K. T. L.), Damon Runyon Cancer Research Foundation grant CI15-02 and NIH grant CA127231 ( S. M.), and a grant from the Golden Leaf Foundation and the State of North Carolina (L.-A.Y.). Atomic coordinates and structure factors have been deposited with the PDB ( accession codes: 3K4A, 3K46, 3K4D, 3LPF, and 3LPG). The authors remember Lisa Benkowski and Stacey Micoli, for whom CPT-11's efficacy was limited by its toxicity.	Basinska Agnieszka, 2003, Ann Univ Mariae Curie Sklodowska Med, V58, P386; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cummings JH, 1997, JPEN-PARENTER ENTER, V21, P357, DOI 10.1177/0148607197021006357; Farnleitner AH, 2002, WATER RES, V36, P975, DOI 10.1016/S0043-1354(01)00288-3; Fittkau M, 2004, J CANCER RES CLIN, V130, P388, DOI 10.1007/s00432-004-0557-8; Flieger D, 2007, ONCOLOGY-BASEL, V72, P10, DOI 10.1159/000111083; GRILL JP, 1995, CURR MICROBIOL, V31, P23, DOI 10.1007/BF00294629; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Hu ZP, 2006, TOXICOL APPL PHARM, V216, P225, DOI 10.1016/j.taap.2006.05.020; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Kurita A, 2011, CANCER CHEMOTH PHARM, V67, P201, DOI 10.1007/s00280-010-1310-4; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; Ma MK, 2003, CURR MED CHEM, V10, P41, DOI 10.2174/0929867033368619; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; Nagar S, 2006, DRUG METAB REV, V38, P393, DOI 10.1080/03602530600739835; NIWA T, 1972, J BIOCHEM-TOKYO, V72, P207, DOI 10.1093/oxfordjournals.jbchem.a129889; NORD CE, 1984, AM J MED, V76, P99, DOI 10.1016/0002-9343(84)90250-X; Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Ray J, 1999, J HERED, V90, P119, DOI 10.1093/jhered/90.1.119; Redinbo Matthew R., 1999, Current Opinion in Structural Biology, V9, P29, DOI 10.1016/S0959-440X(99)80005-0; Russell WM, 2001, APPL ENVIRON MICROB, V67, P1253, DOI 10.1128/AEM.67.3.1253-1261.2001; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Sears S, 1999, GASTROINTEST ENDOSC, V50, P841, DOI 10.1016/S0016-5107(99)70171-9; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Smith NF, 2006, TOXICOL IN VITRO, V20, P163, DOI 10.1016/j.tiv.2005.06.045; Stamp D, 2004, MED HYPOTHESES, V63, P555, DOI 10.1016/j.mehy.2004.05.005; Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164; Tobin PJ, 2003, ONCOL REP, V10, P1977; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	575	606	10	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					831	835		10.1126/science.1191175	http://dx.doi.org/10.1126/science.1191175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051639	Green Published, Green Accepted			2022-12-24	WOS:000283855700046
J	Logan, GD; Crump, MJC				Logan, Gordon D.; Crump, Matthew J. C.			Cognitive Illusions of Authorship Reveal Hierarchical Error Detection in Skilled Typists	SCIENCE			English	Article							NEURAL SYSTEM; HANDS	The ability to detect errors is an essential component of cognitive control. Studies of error detection in humans typically use simple tasks and propose single-process theories of detection. We examined error detection by skilled typists and found illusions of authorship that provide evidence for two error-detection processes. We corrected errors that typists made and inserted errors in correct responses. When asked to report errors, typists took credit for corrected errors and accepted blame for inserted errors, claiming authorship for the appearance of the screen. However, their typing rate showed no evidence of these illusions, slowing down after corrected errors but not after inserted errors. This dissociation suggests two error-detection processes: one sensitive to the appearance of the screen and the other sensitive to keystrokes.	[Logan, Gordon D.; Crump, Matthew J. C.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Logan, GD (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA.	gordon.logan@vanderbilt.edu	Crump, Matthew/A-9103-2011	Crump, Matthew/0000-0002-5612-0090; Logan, Gordon/0000-0002-8301-7726	NSF [BCS 0646588, BCS 0957074]	NSF(National Science Foundation (NSF))	We thank J. D. Schall for comments on the manuscript. This research was supported by grants BCS 0646588 and BCS 0957074 from the NSF.	Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gordon AM, 1995, EXP BRAIN RES, V107, P281; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Knoblich G, 2004, J EXP PSYCHOL HUMAN, V30, P657, DOI 10.1037/0096-1523.30.4.657; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Liu X, 2010, MEM COGNITION, V38, P474, DOI 10.3758/MC.38.4.474; Logan GD, 2009, PSYCHOL SCI, V20, P1296, DOI 10.1111/j.1467-9280.2009.02442.x; LONG J, 1976, ERGONOMICS, V19, P93, DOI 10.1080/00140137608931517; NIELSEN TI, 1963, SCAND J PSYCHOL, V4, P225, DOI 10.1111/j.1467-9450.1963.tb01326.x; NORMAN DA, 1981, PSYCHOL REV, V88, P1, DOI 10.1037/0033-295X.88.1.1; RABBITT P, 1978, ERGONOMICS, V21, P945, DOI 10.1080/00140137808931800; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; RUMELHART DE, 1982, COGNITIVE SCI, V6, P1; SALTHOUSE TA, 1986, PSYCHOL BULL, V99, P303, DOI 10.1037/0033-2909.99.3.303; SHAFFER LH, 1976, PSYCHOL REV, V83, P375, DOI 10.1037/0033-295X.83.5.375; Wegner DM, 2002, BRADFORD BOOKS, P1; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	22	95	95	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2010	330	6004					683	686		10.1126/science.1190483	http://dx.doi.org/10.1126/science.1190483			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	672KB	21030660				2022-12-24	WOS:000283580600052
J	Shin, J; Bossenz, M; Chung, Y; Ma, H; Byron, M; Taniguchi-Ishigaki, N; Zhu, XC; Jiao, BW; Hall, LL; Green, MR; Jones, SN; Hermans-Borgmeyer, I; Lawrence, JB; Bach, I				Shin, JongDae; Bossenz, Michael; Chung, Young; Ma, Hong; Byron, Meg; Taniguchi-Ishigaki, Naoko; Zhu, Xiaochun; Jiao, Baowei; Hall, Lisa L.; Green, Michael R.; Jones, Stephen N.; Hermans-Borgmeyer, Irm; Lawrence, Jeanne B.; Bach, Ingolf			Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice	NATURE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTORS; EMBRYONIC STEM-CELLS; DOSAGE COMPENSATION; LIM COFACTORS; EXPRESSION; GENE; LINES; RLIM; DIFFERENTIATION; DISRUPTION	Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X chromosome (Xm)(1,2). Both forms of XCI require the non-coding Xist RNA that coats the inactive X chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X chromosome (Delta m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in Delta m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.	[Shin, JongDae; Ma, Hong; Taniguchi-Ishigaki, Naoko; Zhu, Xiaochun; Jiao, Baowei; Green, Michael R.; Bach, Ingolf] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Green, Michael R.; Bach, Ingolf] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Zhu, Xiaochun; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Byron, Meg; Hall, Lisa L.; Jones, Stephen N.; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; [Bossenz, Michael; Hermans-Borgmeyer, Irm] Univ Hamburg, Ctr Mol Neurobiol, D-20246 Hamburg, Germany; [Chung, Young] Stem Cell & Regenerat Med Int Inc, Marlborough, MA 01752 USA; [Chung, Young] CHA Univ, Sch Med, Seoul 135081, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Hamburg; Pochon Cha University	Bach, I (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	ingolf.bach@umassmed.edu	Chung, Young Gie/AAC-8149-2020	Lawrence, Jeanne/0000-0001-6572-3128; JIAO, BAOWEI/0000-0001-8559-9160	National Institutes of Health (National Cancer Institute) [R01CA131158]; National Institute of Diabetes and Digestive and Kidney Diseases [5 P30 DK32520, GM053234]; NATIONAL CANCER INSTITUTE [R01CA131158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053234, R01GM033977] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Boyartchuk, T. Fazzio, E. Heard, P. Kaufman, O. Rando, D. Riethmacher and J. Sharp for advice and/or reagents, D. Kim for help in ES cell analysis, and J. Zhu for statistics. I.B. is a member of the University of Massachusetts DERC (DK32520). This work was supported by National Institutes of Health grants R01CA131158 (National Cancer Institute) and 5 P30 DK32520 (National Institute of Diabetes and Digestive and Kidney Diseases) to I.B., and GM053234 to J.B.L.	Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; BARLOW PW, 1972, J EMBRYOL EXP MORPH, V27, P447; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Chung Y, 2006, METHOD ENZYMOL, V418, P135, DOI 10.1016/S0076-6879(06)18009-X; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; FEINBERG RF, 1989, LAB INVEST, V61, P20; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Nagy A., 2003, MANIPULATING MOUSE E; Novik EI, 2006, TISSUE ENG, V12, P1515, DOI 10.1089/ten.2006.12.1515; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; OSHIMA RG, 1983, DEV BIOL, V99, P447, DOI 10.1016/0012-1606(83)90294-4; Ostendorff HP, 2000, GENOMICS, V69, P120, DOI 10.1006/geno.2000.6311; Ostendorff HP, 2006, DEV DYNAM, V235, P786, DOI 10.1002/dvdy.20669; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Panning B, 2004, METHOD ENZYMOL, V376, P419; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007	37	120	122	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					977	U157		10.1038/nature09457	http://dx.doi.org/10.1038/nature09457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962847	Green Accepted			2022-12-24	WOS:000283254700041
J	Watanabe, A; Choe, S; Chaptal, V; Rosenberg, JM; Wright, EM; Grabe, M; Abramson, J				Watanabe, Akira; Choe, Seungho; Chaptal, Vincent; Rosenberg, John M.; Wright, Ernest M.; Grabe, Michael; Abramson, Jeff			The mechanism of sodium and substrate release from the binding pocket of vSGLT	NATURE			English	Article							AMINO-ACID ANTIPORTER; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TRANSPORTER; COTRANSPORTER; MODEL; RESOLUTION; SOFTWARE; INSIGHTS; HOMOLOG	Membrane co-transport proteins that use a five-helix inverted repeat motif have recently emerged as one of the largest structural classes of secondary active transporters(1,2). However, despite many structural advances there is no clear evidence of how ion and substrate transport are coupled. Here we report a comprehensive study of the sodium/galactose transporter from Vibrio parahaemolyticus (vSGLT), consisting of molecular dynamics simulations, biochemical characterization and a new crystal structure of the inward-open conformation at a resolution of 2.7 angstrom. Our data show that sodium exit causes a reorientation of transmembrane helix 1 that opens an inner gate required for substrate exit, and also triggers minor rigid-body movements in two sets of transmembrane helical bundles. This cascade of events, initiated by sodium release, ensures proper timing of ion and substrate release. Once set in motion, these molecular changes weaken substrate binding to the transporter and allow galactose readily to enter the intracellular space. Additionally, we identify an allosteric pathway between the sodium-binding sites, the unwound portion of transmembrane helix 1 and the substrate-binding site that is essential in the coupling of co-transport.	[Watanabe, Akira; Chaptal, Vincent; Wright, Ernest M.; Abramson, Jeff] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Choe, Seungho; Rosenberg, John M.; Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Rosenberg, John M.; Grabe, Michael] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Abramson, J (corresponding author), Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA.	mdgrabe@pitt.edu; jabramson@mednet.ucla.edu	Choe, Seungho/B-1877-2008	Choe, Seungho/0000-0003-2291-747X; chaptal, vincent/0000-0003-2603-0294	NIH [GM078844, RGY0069, DK19567]; Human Frontier Science Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Vondriska and K. Philipson as well as members of the Abramson, Wright and Grabe labs for useful discussions and for reading the manuscript. We would also like to thank S. Faham for contributions at the early stages of this work, S. Iwata for advance release of the Mhp1 coordinates (Protein Data Bank ID, 2X79), and R. Roskies for assistance with the computations. Simulations were carried out through a TeraGrid grant at the Pittsburgh Supercomputing Center and the Texas Advanced Computing Center. This work was supported by NIH grants GM078844 (J.A.), RGY0069 (J.A.) and DK19567 (E.M.W.), and a grant from the Human Frontier Science Program (J.A.). M.G. is an Alfred P. Sloan Research Fellow.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; DeLano W.L., 2002, PYMOL MOL VIEWER; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Isaji M, 2007, CURR OPIN INVEST DR, V8, P285; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Joosten RP, 2009, ACTA CRYSTALLOGR D, V65, P176, DOI 10.1107/S0907444908037591; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Turk E, 2006, BIOCHEMISTRY-US, V45, P1470, DOI 10.1021/bi052160z; Veenstra M, 2004, BIOCHEMISTRY-US, V43, P3620, DOI 10.1021/bi0357210; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	39	147	148	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					988	U162		10.1038/nature09580	http://dx.doi.org/10.1038/nature09580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21131949	Green Accepted			2022-12-24	WOS:000285344600052
J	Bandyopadhyay, S; Mehta, M; Kuo, D; Sung, MK; Chuang, R; Jaehnig, EJ; Bodenmiller, B; Licon, K; Copeland, W; Shales, M; Fiedler, D; Dutkowski, J; Guenole, A; van Attikum, H; Shokat, KM; Kolodner, RD; Huh, WK; Aebersold, R; Keogh, MC; Krogan, NJ; Ideker, T				Bandyopadhyay, Sourav; Mehta, Monika; Kuo, Dwight; Sung, Min-Kyung; Chuang, Ryan; Jaehnig, Eric J.; Bodenmiller, Bernd; Licon, Katherine; Copeland, Wilbert; Shales, Michael; Fiedler, Dorothea; Dutkowski, Janusz; Guenole, Aude; van Attikum, Haico; Shokat, Kevan M.; Kolodner, Richard D.; Huh, Won-Ki; Aebersold, Ruedi; Keogh, Michael-Christopher; Krogan, Nevan J.; Ideker, Trey			Rewiring of Genetic Networks in Response to DNA Damage	SCIENCE			English	Article							H2A VARIANT HTZ1; SACCHAROMYCES-CEREVISIAE; YEAST; PATHWAYS; FAMILY; MAPS; CELL	Although cellular behaviors are dynamic, the networks that govern these behaviors have been mapped primarily as static snapshots. Using an approach called differential epistasis mapping, we have discovered widespread changes in genetic interaction among yeast kinases, phosphatases, and transcription factors as the cell responds to DNA damage. Differential interactions uncover many gene functions that go undetected in static conditions. They are very effective at identifying DNA repair pathways, highlighting new damage-dependent roles for the Slt2 kinase, Pph3 phosphatase, and histone variant Htz1. The data also reveal that protein complexes are generally stable in response to perturbation, but the functional relations between these complexes are substantially reorganized. Differential networks chart a new type of genetic landscape that is invaluable for mapping cellular responses to stimuli.	[Mehta, Monika; Keogh, Michael-Christopher] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Bandyopadhyay, Sourav; Licon, Katherine; Dutkowski, Janusz; Kolodner, Richard D.; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kuo, Dwight; Chuang, Ryan; Copeland, Wilbert; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Sung, Min-Kyung; Huh, Won-Ki] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Sung, Min-Kyung; Huh, Won-Ki] Seoul Natl Univ, Inst Microbiol, Res Ctr Funct Cellul, Seoul 151742, South Korea; [Jaehnig, Eric J.; Kolodner, Richard D.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Jaehnig, Eric J.; Kolodner, Richard D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Bodenmiller, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Shales, Michael; Fiedler, Dorothea; Shokat, Kevan M.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Fiedler, Dorothea; Shokat, Kevan M.] Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Guenole, Aude; van Attikum, Haico] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands; [Kolodner, Richard D.; Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; Seoul National University (SNU); Seoul National University (SNU); Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Diego	Keogh, MC (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	michael.keogh@einstein.yu.edu; krogan@cmp.ucsf.edu; tideker@ucsd.edu	van Attikum, Haico/A-4596-2010; jaehnig, eric/CCF-3596-2022; Califano, Andrea/F-7239-2012; Huh, Won-Ki/AAQ-6767-2021	Van Attikum, Haico/0000-0001-8590-0240; Ideker, Trey/0000-0002-1708-8454; Jaehnig, Eric/0000-0001-9618-6011; Mehta, Monika/0000-0003-3928-3733	NIH [R01-ES14811, R01-GM084279]; 21C Frontier Functional Proteomics Project [FPR08A1-060]; SystemsX.ch; Swiss National Science Foundation; NCI [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026017, R01GM026017, R01GM084448, R01GM084279, P50GM081879] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Collins, H. Hombauer, A. Desai, S. Gasser, X. Shen, and S. Choi for helpful discussions and strains. This work was funded by NIH grants R01-ES14811 and R01-GM084279. Additionally, W-K. H. and M-K. S. were funded by the 21C Frontier Functional Proteomics Project (FPR08A1-060), R. A. and B. B. were supported by SystemsX.ch and the Swiss National Science Foundation, and M-C. K. was supported by the NCI (P30CA013330). N.J.K. is a Keck Young Investigator Fellow and a Searle Fellow. T.I. is a David and Lucille Packard Fellow. R. D. K. is a paid consultant to On-Q-ity.	Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Begley TJ, 2002, MOL CANCER RES, V1, P103; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Heideker J, 2007, CELL CYCLE, V6, P3058, DOI 10.4161/cc.6.24.5100; Jaimovich A, 2010, BIOINFORMATICS, V26, pi228, DOI 10.1093/bioinformatics/btq197; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948	22	334	337	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1385	1389		10.1126/science.1195618	http://dx.doi.org/10.1126/science.1195618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127252	Green Accepted			2022-12-24	WOS:000284902100044
J	Smith, FA; Boyer, AG; Brown, JH; Costa, DP; Dayan, T; Ernest, SKM; Evans, AR; Fortelius, M; Gittleman, JL; Hamilton, MJ; Harding, LE; Lintulaakso, K; Lyons, SK; McCain, C; Okie, JG; Saarinen, JJ; Sibly, RM; Stephens, PR; Theodor, J; Uhen, MD				Smith, Felisa A.; Boyer, Alison G.; Brown, James H.; Costa, Daniel P.; Dayan, Tamar; Ernest, S. K. Morgan; Evans, Alistair R.; Fortelius, Mikael; Gittleman, John L.; Hamilton, Marcus J.; Harding, Larisa E.; Lintulaakso, Kari; Lyons, S. Kathleen; McCain, Christy; Okie, Jordan G.; Saarinen, Juha J.; Sibly, Richard M.; Stephens, Patrick R.; Theodor, Jessica; Uhen, Mark D.			The Evolution of Maximum Body Size of Terrestrial Mammals	SCIENCE			English	Article							DIVERSIFICATION; VEGETATION; DINOSAURS; DYNAMICS	The extinction of dinosaurs at the Cretaceous/Paleogene (K/Pg) boundary was the seminal event that opened the door for the subsequent diversification of terrestrial mammals. Our compilation of maximum body size at the ordinal level by sub-epoch shows a near-exponential increase after the K/Pg. On each continent, the maximum size of mammals leveled off after 40 million years ago and thereafter remained approximately constant. There was remarkable congruence in the rate, trajectory, and upper limit across continents, orders, and trophic guilds, despite differences in geological and climatic history, turnover of lineages, and ecological variation. Our analysis suggests that although the primary driver for the evolution of giant mammals was diversification to fill ecological niches, environmental temperature and land area may have ultimately constrained the maximum size achieved.	[Smith, Felisa A.; Brown, James H.; Hamilton, Marcus J.; Okie, Jordan G.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Boyer, Alison G.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Dayan, Tamar] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Ernest, S. K. Morgan] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Ernest, S. K. Morgan] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Evans, Alistair R.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Fortelius, Mikael; Lintulaakso, Kari; Saarinen, Juha J.] Univ Helsinki, Dept Geosci & Geog, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Gittleman, John L.; Stephens, Patrick R.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Harding, Larisa E.] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden; [Lyons, S. Kathleen] MRC 121, Smithsonian Inst, Washington, DC 20013 USA; [McCain, Christy] Univ Colorado, CU Nat Hist Museum, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Sibly, Richard M.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Theodor, Jessica] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Uhen, Mark D.] George Mason Univ, Dept Atmospher Ocean & Earth Sci, Fairfax, VA 22030 USA	University of New Mexico; Yale University; University of California System; University of California Santa Cruz; Tel Aviv University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Monash University; University of Helsinki; University System of Georgia; University of Georgia; Umea University; Smithsonian Institution; University of Colorado System; University of Colorado Boulder; University of Reading; University of Calgary; George Mason University	Smith, FA (corresponding author), Univ New Mexico, Dept Biol, MSC03 2020, Albuquerque, NM 87131 USA.	fasmith@unm.edu	Opazo, Luis-Felipe/G-9586-2011; Smith, Felisa/ABE-6160-2021; Uhen, Mark D/AAZ-3158-2020; Ernest, S.K. Morgan/O-2532-2015; Evans, Alistair R/D-4239-2011; Ernest, Morgan/A-4355-2008; Lintulaakso, Kari/N-7775-2013; Costa, Daniel/E-2616-2013	Smith, Felisa/0000-0001-6262-436X; Uhen, Mark D/0000-0002-2689-0801; Ernest, S.K. Morgan/0000-0002-6026-8530; Evans, Alistair R/0000-0002-4078-4693; Ernest, Morgan/0000-0002-6026-8530; Lyons, S. Kathleen/0000-0001-5112-2508; Sibly, Richard/0000-0001-6828-3543; Theodor, Jessica/0000-0002-5159-7041; Fortelius, Mikael/0000-0002-4851-783X; Lintulaakso, Kari/0000-0001-9627-8821; Costa, Daniel/0000-0002-0233-5782	Integrating Macroecological Pattern and Process across Scales (IMPPS) NSF Research Coordination Network (NSF) [DEB-0541625]	Integrating Macroecological Pattern and Process across Scales (IMPPS) NSF Research Coordination Network (NSF)(National Science Foundation (NSF))	This project was supported by the Integrating Macroecological Pattern and Process across Scales (IMPPS) NSF Research Coordination Network (NSF grant DEB-0541625 to F. A. S., S. K. M. E., and S. K. L.). This is IMPPS publication no. 11.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Crompton A. W., 1980, COMP PHYSL PRIMITIVE, P1; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; GUNNELL GF, 1995, PALAEOGEOGR PALAEOCL, V115, P265, DOI 10.1016/0031-0182(94)00115-O; GUNNELL GF, 1998, EVOLUTION TERTIARY M, V1, P91; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Marquet PA, 1998, EVOL ECOL, V12, P127, DOI 10.1023/A:1006567227154; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rensch B., 1959, EVOLUTION SPECIES LE; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Tappan H., 1974, TOPICS MOL OXYGEN RE, P81; Trammer J, 2005, EVOLUTION, V59, P941; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	29	188	190	3	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1216	1219		10.1126/science.1194830	http://dx.doi.org/10.1126/science.1194830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109666				2022-12-24	WOS:000284613700034
J	Jaramillo, C; Ochoa, D; Contreras, L; Pagani, M; Carvajal-Ortiz, H; Pratt, LM; Krishnan, S; Cardona, A; Romero, M; Quiroz, L; Rodriguez, G; Rueda, MJ; de la Parra, F; Moron, S; Green, W; Bayona, G; Montes, C; Quintero, O; Ramirez, R; Mora, G; Schouten, S; Bermudez, H; Navarrete, R; Parra, F; Alvaran, M; Osorno, J; Crowley, JL; Valencia, V; Vervoort, J				Jaramillo, Carlos; Ochoa, Diana; Contreras, Lineth; Pagani, Mark; Carvajal-Ortiz, Humberto; Pratt, Lisa M.; Krishnan, Srinath; Cardona, Agustin; Romero, Millerlandy; Quiroz, Luis; Rodriguez, Guillermo; Rueda, Milton J.; de la Parra, Felipe; Moron, Sara; Green, Walton; Bayona, German; Montes, Camilo; Quintero, Oscar; Ramirez, Rafael; Mora, German; Schouten, Stefan; Bermudez, Hermann; Navarrete, Rosa; Parra, Francisco; Alvaran, Mauricio; Osorno, Jose; Crowley, James L.; Valencia, Victor; Vervoort, Jeff			Effects of Rapid Global Warming at the Paleocene-Eocene Boundary on Neotropical Vegetation	SCIENCE			English	Article							THERMAL MAXIMUM; CERREJON FORMATION; CLIMATE; TEMPERATURE; DISCRIMINATION; COLOMBIA; CANOPY; FOREST; TREE; CO2	Temperatures in tropical regions are estimated to have increased by 3 degrees to 5 degrees C, compared with Late Paleocene values, during the Paleocene-Eocene Thermal Maximum (PETM, 56.3 million years ago) event. We investigated the tropical forest response to this rapid warming by evaluating the palynological record of three stratigraphic sections in eastern Colombia and western Venezuela. We observed a rapid and distinct increase in plant diversity and origination rates, with a set of new taxa, mostly angiosperms, added to the existing stock of low-diversity Paleocene flora. There is no evidence for enhanced aridity in the northern Neotropics. The tropical rainforest was able to persist under elevated temperatures and high levels of atmospheric carbon dioxide, in contrast to speculations that tropical ecosystems were severely compromised by heat stress.	[Jaramillo, Carlos; Ochoa, Diana; Contreras, Lineth; Carvajal-Ortiz, Humberto; Cardona, Agustin; Romero, Millerlandy; Quiroz, Luis; Moron, Sara; Green, Walton; Bayona, German; Montes, Camilo] Smithsonian Trop Res Inst, Balboa, Panama; [Ochoa, Diana] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA; [Contreras, Lineth; Rodriguez, Guillermo; Rueda, Milton J.; de la Parra, Felipe] Colombian Petr Inst, Bucaramanga, Colombia; [Contreras, Lineth] Goethe Univ Frankfurt, Inst Geosci, D-60438 Frankfurt, Germany; [Pagani, Mark; Krishnan, Srinath] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Carvajal-Ortiz, Humberto; Pratt, Lisa M.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Quiroz, Luis] Univ Saskatchewan, Dept Geol, Saskatoon, SK, Canada; [Rodriguez, Guillermo] Missouri Univ Sci & Technol, Dept Geol Sci & Engn, Rolla, MO 65409 USA; [Rueda, Milton J.] Paleoflora Ltd, Zapatoca, Colombia; [Moron, Sara] Univ Minnesota, Dept Geol, Minneapolis, MN 55455 USA; [Bayona, German; Montes, Camilo] Corp Geol Ares, Bogota, Colombia; [Quintero, Oscar] Petroleos Venezuela SA PDVSA Explorac, Nucleoteca Concepc, Maracaibo, Venezuela; [Mora, German] Goucher Coll, Baltimore, MD 21204 USA; [Schouten, Stefan] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Texel, Netherlands; [Bermudez, Hermann; Alvaran, Mauricio] Univ Caldas, Dept Geol Sci, Manizales, Colombia; [Parra, Francisco] Univ Toulouse 3, CU Ponsan Bellevue, F-31078 Tolulouse 04, France; [Osorno, Jose] Agencia Nacl Hidrocarburos, Bogota, Colombia; [Crowley, James L.] Boise State Univ, Dept Geosci, Boise, ID 83725 USA; [Valencia, Victor] Valencia Geoserv, Tucson, AZ 85712 USA; [Vervoort, Jeff] Washington State Univ, Sch Earth & Environm Sci, Pullman, WA 99164 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; East Tennessee State University; Goethe University Frankfurt; Yale University; Indiana University System; Indiana University Bloomington; University of Saskatchewan; University of Missouri System; Missouri University of Science & Technology; University of Minnesota System; University of Minnesota Twin Cities; PDVSA; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universidad de Caldas; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Idaho; Boise State University; Washington State University	Jaramillo, C (corresponding author), Smithsonian Trop Res Inst, Box 0843-03092, Balboa, Panama.	jaramilloc@si.edu	Vervoort, Jeff/AAJ-6234-2020; Ochoa, Diana/AAV-1916-2020; Morón, Sara/AAK-5199-2021; Pagani, Mark/B-3233-2008	Ochoa, Diana/0000-0001-6242-4202; Montes, Camilo/0000-0002-3553-0787; Bermudez, Hermann/0000-0003-0656-2007; Crowley, James/0000-0001-5069-0773; Polanco, Sara/0000-0002-1270-4377; Parra Navarrete, Francisco Javier/0000-0003-0801-9446; jaramillo, carlos/0000-0002-2616-5079; Vervoort, Jeff/0000-0002-1138-4527	Banco de la Republica; National Geographic; Smithsonian Women's Club; Instituto de Colombiano de Petroleo (ICP)-Ecopetrol SA; NSF [EAR-0628358, ATM-0902882]; Netherlands Organisation for Scientific Research; Smithsonian	Banco de la Republica; National Geographic(National Geographic Society); Smithsonian Women's Club; Instituto de Colombiano de Petroleo (ICP)-Ecopetrol SA; NSF(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Smithsonian(Smithsonian Institution)	Supported by Banco de la Republica, National Geographic, Smithsonian Women's Club, Instituto de Colombiano de Petroleo (ICP)-Ecopetrol SA, and Smithsonian, M.P. was supported by NSF EAR-0628358 and ATM-0902882. S.S. was supported by a VISI grant from Netherlands Organisation for Scientific Research. Thanks to PDVSA for access to Mar 2X and the Instituto de Patrimonio Cultural of Venezuela for allowing us to sample in Riecito Mache. Thanks to Agencia Nacional de Hidrocarburos, A. Pardo, J. Sanchez, C. Guerrero, M. Carvalho, and the Colombian Armed Forces for logistic support. Thanks to the biostratigraphic team at ICP. Patrice Brenac did preliminary palynological analysis of Gonzales. N. Atkins provided editing support. A. Mets (NIOZ) is thanked for analytical assistance. K. Winter, H. Muller-Landau, J. Wright, and S. Punyasena and three anonymous reviewers provided comments on the manuscript. Special thanks to M. I. Barreto for continuous support and sources of ideas.	BASSOW SL, 1994, ECOL APPL, V4, P593, DOI 10.2307/1941960; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Krause GH, 2010, FUNCT PLANT BIOL, V37, P890, DOI 10.1071/FP10034; Huber M, 2008, SCIENCE, V321, P353, DOI 10.1126/science.1161170; Huber M, 2009, NATURE, V457, P669, DOI 10.1038/457669a; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Jaramillo CA, 2007, PALYNOLOGY, V31, P153, DOI 10.2113/gspalynol.31.1.153; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Pagani M, 2006, SCIENCE, V314, P1556, DOI 10.1126/science.1136110; Punyasena SW, 2008, J BIOGEOGR, V35, P117, DOI 10.1111/j.1365-2699.2007.01773.x; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Royer DL, 2010, P NATL ACAD SCI USA, V107, P517, DOI 10.1073/pnas.0913188107; Schuettpelz E, 2009, P NATL ACAD SCI USA, V106, P11200, DOI 10.1073/pnas.0811136106; Scotese CR., 2001, ATLAS EARTH HIST PRO; STOSKOPF NC, 1981, UNDERSTANDING CROP P; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Westerhold T, 2009, EARTH PLANET SC LETT, V287, P412, DOI 10.1016/j.epsl.2009.08.027; Wing SL, 2009, P NATL ACAD SCI USA, V106, P18627, DOI 10.1073/pnas.0905130106; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zeebe RE, 2009, NAT GEOSCI, V2, P576, DOI 10.1038/NGEO578	27	198	203	3	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					957	961		10.1126/science.1193833	http://dx.doi.org/10.1126/science.1193833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071667				2022-12-24	WOS:000284118000041
J	Victora, GD; Schwickert, TA; Fooksman, DR; Kamphorst, AO; Meyer-Hermann, M; Dustin, ML; Nussenzweig, MC				Victora, Gabriel D.; Schwickert, Tanja A.; Fooksman, David R.; Kamphorst, Alice O.; Meyer-Hermann, Michael; Dustin, Michael L.; Nussenzweig, Michel C.			Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter	CELL			English	Article							ANTI-HAPTEN ANTIBODY; HELPER T-CELLS; CENTER B-CELLS; IN-VIVO; DENDRITIC CELLS; AFFINITY MATURATION; IMMUNE-RESPONSE; SELF-TOLERANCE; PLASMA-CELL; SELECTION	The germinal center (GC) reaction produces high-affinity antibodies by random mutation and selective clonal expansion of B cells with high-affinity receptors. The mechanism by which B cells are selected remains unclear, as does the role of the two anatomically defined areas of the GC, light zone (LZ) and dark zone (DZ). We combined a transgenic photoactivatable fluorescent protein tracer with multiphoton laser-scanning microscopy and flow cytometry to examine anatomically defined LZ and DZ B cells and GC selection. We find that B cell division is restricted to the DZ, with a net vector of B cell movement from the DZ to the LZ. The decision to return to the DZ and undergo clonal expansion is controlled by T helper cells in the GC LZ, which discern between LZ B cells based on the amount of antigen captured and presented. Thus, T cell help, and not direct competition for antigen, is the limiting factor in GC selection.	[Victora, Gabriel D.; Schwickert, Tanja A.; Kamphorst, Alice O.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Victora, Gabriel D.; Fooksman, David R.; Dustin, Michael L.] NYU, Sch Med, Skirball Inst Biomol Med, Martin & Helen Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, D-38124 Braunschweig, Germany	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; New York University; Helmholtz Association; Helmholtz-Center for Infection Research	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Dustin, Michael/AAM-4611-2020; Victora, Gabriel/C-5946-2011	Victora, Gabriel/0000-0001-8807-348X; Schwickert, Tanja/0000-0002-3371-2376; Dustin, Michael/0000-0003-4983-6389; Kamphorst, Alice/0000-0002-9230-9501	NIH [R01 AI072529, P01 AI071195, CA009161-34]; NYSDOH [C023046]; EU-NEST; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072529, P01AI071195] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSDOH; EU-NEST(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank J. Lippincott-Schwartz (NIH), R. Tsien (UCSD), and B. Schaefer (USU) for the PA-GFP, tdTomato, and UbC constructs, respectively; the MSKCC Genomics Facility for performing the microarray experiments; J. Zavadil (NYU) for guidance in microarray analysis; A. North and S. Bhuvanendran (Rockefeller University Bio-Imaging Resource Center) for help with multiphoton imaging; R. Scheuerman (University of Texas Southwestern Medical Center) for ACS gene lists for GSEA analysis; and T. Cameron for helpful discussion. This work was supported in part by NIH grants R01 AI072529 (M.C.N. and M.L.D.) and P01 AI071195 (M.L.D.). Support for the Rockefeller University multiphoton microscope and cell sorter was granted by the Empire State Stem Cell Fund through NYSDOH Contract #C023046. D.R.F. was supported by NIH training grant CA009161-34. M.M.-H. was supported by the EU-NEST project MAMOCELL in FP6. M.C.N. is an HHMI Investigator.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Brink R, 2008, IMMUNOL CELL BIOL, V86, P31, DOI 10.1038/sj.icb.7100143; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Figge MT, 2008, J EXP MED, V205, P3019, DOI 10.1084/jem.20081160; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; GOIDL EA, 1968, J IMMUNOL, V100, P371; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HAN SH, 1995, J IMMUNOL, V155, P556; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hogerkorp CM, 2006, J IMMUNOL, V177, P4341, DOI 10.4049/jimmunol.177.7.4341; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; KATZ DH, 1970, J EXP MED, V132, P261, DOI 10.1084/jem.132.2.261; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Meyer-Hermann M, 2001, J THEOR BIOL, V210, P265, DOI 10.1006/jtbi.2001.2297; Meyer-Hermann M, 2009, TRENDS IMMUNOL, V30, P157, DOI 10.1016/j.it.2009.01.005; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; NUSSENZWEIG V, 1967, J EXP MED, V126, P727, DOI 10.1084/jem.126.4.727; Oprea M, 1997, J IMMUNOL, V158, P5155; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RAJEWSKY K, 1969, J EXP MED, V129, P1131, DOI 10.1084/jem.129.6.1131; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schneider M, 2005, BIOPHYS J, V89, P1346, DOI 10.1529/biophysj.104.054502; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Tarlinton DM, 2000, IMMUNOL TODAY, V21, P436, DOI 10.1016/S0167-5699(00)01687-X; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	66	767	777	1	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 12	2010	143	4					592	605		10.1016/j.cell.2010.10.032	http://dx.doi.org/10.1016/j.cell.2010.10.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074050	Green Accepted, Bronze			2022-12-24	WOS:000284149100016
J	Kodera, N; Yamamoto, D; Ishikawa, R; Ando, T				Kodera, Noriyuki; Yamamoto, Daisuke; Ishikawa, Ryoki; Ando, Toshio			Video imaging of walking myosin V by high-speed atomic force microscopy	NATURE			English	Article							HAND-OVER-HAND; PROCESSIVE MYOSIN; MECHANISM; ADP; COORDINATION; MOVEMENT; DYNAMICS; KINETICS; BINDING; STROKE	The dynamic behaviour of myosin V molecules translocating along actin filaments has been mainly studied by optical microscopy. The processive hand-over-hand movement coupled with hydrolysis of adenosine triphosphate was thereby demonstrated. However, the protein molecules themselves are invisible in the observations and have therefore been visualized by electron microscopy in the stationary states. The concomitant assessment of structure and dynamics has been unfeasible, a situation prevailing throughout biological research. Here we directly visualize myosin V molecules walking along actin tracks, using high-speed atomic force microscopy. The high-resolution movies not only provide corroborative 'visual evidence' for previously speculated or demonstrated molecular behaviours, including lever-arm swing, but also reveal more detailed behaviours of the molecules, leading to a comprehensive understanding of the motor mechanism. Our direct and dynamic high-resolution visualization is a powerful new approach to studying the structure and dynamics of biomolecules in action.	[Kodera, Noriyuki; Yamamoto, Daisuke; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Kodera, Noriyuki; Yamamoto, Daisuke; Ando, Toshio] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ishikawa, Ryoki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol, Maebashi, Gunma 3718511, Japan	Kanazawa University; Japan Science & Technology Agency (JST); Gunma University	Ando, T (corresponding author), Kanazawa Univ, Dept Phys, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tando@kenroku.kanazawa-u.ac.jp	Kodera, Noriyuki/AAJ-1797-2020; ANDO, Toshio/E-7054-2015; Kodera, Noriyuki/E-6569-2015	ANDO, Toshio/0000-0001-8819-154X; Kodera, Noriyuki/0000-0003-4880-8423	JST; JSPS; MEXT-Japan	JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Uchihashi and H. Yamashita for technical assistance and discussion, and J. Sellers for critical reading of the draft and for comments. This work was supported by CREST/JST, Special Coordination Funds for Promoting Science and Technology (Effective Promotion of Joint Research with Industry, Academia, and Government) from JST, a Grant-in-Aid for Basic Research (S) from JSPS, and Knowledge Cluster/MEXT-Japan.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Hansma PK, 2006, SCIENCE, V314, P601, DOI 10.1126/science.1133497; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kitazawa M, 2003, JPN J APPL PHYS 1, V42, P4844, DOI 10.1143/JJAP.42.4844; Kodera N, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336113; Koide H, 2006, BIOCHEMISTRY-US, V45, P11598, DOI 10.1021/bi0613877; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Okada T, 2007, BIOCHEM BIOPH RES CO, V354, P379, DOI 10.1016/j.bbrc.2006.12.200; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Sellers J. R., 2008, MYOS SUP MOL MOT, P289; Sellers JR, 2010, NAT STRUCT MOL BIOL, V17, P590, DOI 10.1038/nsmb.1820; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; Syed S, 2006, EMBO J, V25, P1795, DOI 10.1038/sj.emboj.7601060; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Yamamoto D, 2010, METHOD ENZYMOL, V475, P541, DOI 10.1016/S0076-6879(10)75020-5; Yamamoto D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384009; Yamashita H, 2009, J STRUCT BIOL, V167, P153, DOI 10.1016/j.jsb.2009.04.011; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	35	560	571	10	252	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					72	+		10.1038/nature09450	http://dx.doi.org/10.1038/nature09450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20935627	Green Submitted			2022-12-24	WOS:000283786900037
J	Lane, N; Martin, W				Lane, Nick; Martin, William			The energetics of genome complexity	NATURE			English	Article							MITOCHONDRIAL GENE-EXPRESSION; EUKARYOTIC GENOMES; EVOLUTION; BACTERIA; ORIGIN; CELL; OXYGEN; DNA; COMPARTMENTALIZATION; CHROMOSOMES	All complex life is composed of eukaryotic (nucleated) cells. The eukaryotic cell arose from prokaryotes just once in four billion years, and otherwise prokaryotes show no tendency to evolve greater complexity. Why not? Prokaryotic genome size is constrained by bioenergetics. The endosymbiosis that gave rise to mitochondria restructured the distribution of DNA in relation to bioenergetic membranes, permitting a remarkable 200,000-fold expansion in the number of genes expressed. This vast leap in genomic capacity was strictly dependent on mitochondrial power, and prerequisite to eukaryote complexity: the key innovation en route to multicellular life.	[Lane, Nick] UCL, Dept Genet Evolut & Environm, London W1E 6BT, England; [Martin, William] Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany	University of London; University College London; Heinrich Heine University Dusseldorf	Lane, N (corresponding author), UCL, Dept Genet Evolut & Environm, Gower St, London W1E 6BT, England.	nick.lane@ucl.ac.uk	Martin, William/C-5680-2008; Martin, William F./O-5446-2015	Martin, William F./0000-0003-1478-6449; Lane, Nick/0000-0002-5433-3973	UCL; German Research Foundation; European Research Council (Networkorigins)	UCL; German Research Foundation(German Research Foundation (DFG)); European Research Council (Networkorigins)(European Research Council (ERC))	We are indebted to A. Hidalgo, D. Braben, F. Harold, J. Ellis, H. Schulz-Vogt, J. Allen, G. Shields and L. Sweetlove for many discussions and comments on the manuscript, M. Farmer, H. Schulz-Vogt and R. Allen for microscopic images. N.L. is very grateful to the UCL Provost's Venture Research Fellowship, W. M. to the German Research Foundation and the European Research Council (Networkorigins) for funding.	ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210; Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Cavalier-Smith T, 2009, INT J BIOCHEM CELL B, V41, P307, DOI 10.1016/j.biocel.2008.10.002; Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; DANIELS EW, 1968, Z ZELLFORSCH MIK ANA, V91, P159, DOI 10.1007/BF00364307; Davidov Y, 2009, BIOESSAYS, V31, P748, DOI 10.1002/bies.200900018; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; FENCHEL T, 1983, MICROBIAL ECOL, V9, P99, DOI 10.1007/BF02015125; Forterre P, 2010, P NATL ACAD SCI USA, V107, P12739, DOI 10.1073/pnas.1007720107; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Harold F. M., 1986, VITAL FORCE STUDY BI; Johnston DT, 2009, P NATL ACAD SCI USA, V106, P16925, DOI 10.1073/pnas.0909248106; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kunin V, 2003, GENOME RES, V13, P1589, DOI 10.1101/gr.1092603; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Lane N., 2005, POWER SEX SUICIDE MI; Lane N., 2009, LIFE ASCENDING 10 GR; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Makarieva AM, 2005, P ROY SOC B-BIOL SCI, V272, P2219, DOI 10.1098/rspb.2005.3225; MARGULIS L, 1976, NATURE, V264, P620, DOI 10.1038/264620a0; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Mendell JE, 2008, P NATL ACAD SCI USA, V105, P6730, DOI 10.1073/pnas.0707522105; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Nilsson M, 1997, BIOTECHNOL BIOENG, V54, P461, DOI 10.1002/(SICI)1097-0290(19970605)54:5<461::AID-BIT6>3.0.CO;2-C; Parfrey LW, 2008, MOL BIOL EVOL, V25, P787, DOI 10.1093/molbev/msn032; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Pinevich AV, 1997, ENDOCYTOBIOSIS CELL, V12, P9; Piruat JI, 2005, J BIOL CHEM, V280, P42676, DOI 10.1074/jbc.M507044200; Pisani D, 2007, MOL BIOL EVOL, V24, P1752, DOI 10.1093/molbev/msm095; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Robinson NP, 2007, P NATL ACAD SCI USA, V104, P5806, DOI 10.1073/pnas.0700206104; Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5; Rokas A, 2008, ANNU REV GENET, V42, P235, DOI 10.1146/annurev.genet.42.110807.091513; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schulz HN, 2002, APPL ENVIRON MICROB, V68, P5746, DOI 10.1128/AEM.68.11.5746-5749.2002; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; SHAY JW, 1990, J BIOL CHEM, V265, P14802; Shimizu M, 2010, P NATL ACAD SCI USA, V107, P10760, DOI 10.1073/pnas.0911692107; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Van Der Giezen M, 2009, J EUKARYOT MICROBIOL, V56, P221, DOI 10.1111/j.1550-7408.2009.00407.x; Vats P, 2009, CELL MOL LIFE SCI, V66, P3353, DOI 10.1007/s00018-009-0092-5; Vellai T, 1998, J MOL EVOL, V46, P499, DOI 10.1007/PL00006331; Vellai T, 1999, P ROY SOC B-BIOL SCI, V266, P1571, DOI 10.1098/rspb.1999.0817; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WUJEK DE, 1979, T AM MICROSC SOC, V98, P143, DOI 10.2307/3225953; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9; [No title captured]	74	693	710	16	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					929	934		10.1038/nature09486	http://dx.doi.org/10.1038/nature09486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962839				2022-12-24	WOS:000283254700030
J	Shaw, DE; Maragakis, P; Lindorff-Larsen, K; Piana, S; Dror, RO; Eastwood, MP; Bank, JA; Jumper, JM; Salmon, JK; Shan, YB; Wriggers, W				Shaw, David E.; Maragakis, Paul; Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Eastwood, Michael P.; Bank, Joseph A.; Jumper, John M.; Salmon, John K.; Shan, Yibing; Wriggers, Willy			Atomic-Level Characterization of the Structural Dynamics of Proteins	SCIENCE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; DISULFIDE BOND ISOMERIZATION; FOLDING TRANSITION-STATES; BETA-HAIRPIN FORMATION; PHI-VALUE ANALYSIS; WW DOMAIN; RELAXATION DISPERSION; FORCE-FIELD; SPEED LIMIT; SIMULATIONS	Molecular dynamics (MD) simulations are widely used to study protein motions at an atomic level of detail, but they have been limited to time scales shorter than those of many biologically critical conformational changes. We examined two fundamental processes in protein dynamics-protein folding and conformational change within the folded state-by means of extremely long all-atom MD simulations conducted on a special-purpose machine. Equilibrium simulations of a WW protein domain captured multiple folding and unfolding events that consistently follow a well-defined folding pathway; separate simulations of the protein's constituent substructures shed light on possible determinants of this pathway. A 1-millisecond simulation of the folded protein BPTI reveals a small number of structurally distinct conformational states whose reversible interconversion is slower than local relaxations within those states by a factor of more than 1000.	[Shaw, David E.; Maragakis, Paul; Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Eastwood, Michael P.; Bank, Joseph A.; Jumper, John M.; Salmon, John K.; Shan, Yibing; Wriggers, Willy] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Columbia University	Shaw, DE (corresponding author), DE Shaw Res, 120 W 45th St, New York, NY 10036 USA.	David.Shaw@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Dror, Ron/0000-0002-6418-2793; Wriggers, Willy/0000-0001-5326-3152				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Cota E, 2000, J MOL BIOL, V302, P713, DOI 10.1006/jmbi.2000.4053; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Ensign DL, 2009, BIOPHYS J, V96, pL53, DOI 10.1016/j.bpj.2009.01.024; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Geierhaas CD, 2008, PROTEIN ENG DES SEL, V21, P215, DOI 10.1093/protein/gzm092; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; Jager M, 2006, P NATL ACAD SCI USA, V103, P10648, DOI 10.1073/pnas.0600511103; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; Juraszek J, 2010, BIOPHYS J, V98, P646, DOI 10.1016/j.bpj.2009.10.039; KARPLUS M, 1994, PROTEIN SCI, V3, P650; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lei HX, 2007, CURR OPIN STRUC BIOL, V17, P187, DOI 10.1016/j.sbi.2007.03.003; LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu F, 2008, P NATL ACAD SCI USA, V105, P2369, DOI 10.1073/pnas.0711908105; Liu F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3262489; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Nymeyer H, 2000, P NATL ACAD SCI USA, V97, P634, DOI 10.1073/pnas.97.2.634; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; Persson E, 2008, J AM CHEM SOC, V130, P1774, DOI 10.1021/ja0775873; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; Settanni G, 2005, P NATL ACAD SCI USA, V102, P628, DOI 10.1073/pnas.0406754102; Shaw D. E, 2009, P ACM IEEE C SUP SC0; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; WAGNER G, 1987, J MOL BIOL, V196, P227, DOI 10.1016/0022-2836(87)90524-9; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; WUTHRICH K, 1975, FEBS LETT, V50, P265, DOI 10.1016/0014-5793(75)80504-7; Zhou YQ, 1999, J MOL BIOL, V285, P1371, DOI 10.1006/jmbi.1998.2374	48	1276	1285	12	506	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					341	346		10.1126/science.1187409	http://dx.doi.org/10.1126/science.1187409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947758				2022-12-24	WOS:000282986700033
J	Nazarian, R; Shi, HB; Wang, Q; Kong, XJ; Koya, RC; Lee, H; Chen, ZG; Lee, MK; Attar, N; Sazegar, H; Chodon, T; Nelson, SF; McArthur, G; Sosman, JA; Ribas, A; Lo, RS				Nazarian, Ramin; Shi, Hubing; Wang, Qi; Kong, Xiangju; Koya, Richard C.; Lee, Hane; Chen, Zugen; Lee, Mi-Kyung; Attar, Narsis; Sazegar, Hooman; Chodon, Thinle; Nelson, Stanley F.; McArthur, Grant; Sosman, Jeffrey A.; Ribas, Antoni; Lo, Roger S.			Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation	NATURE			English	Article							BRAF; MUTATIONS; KINASE; SENSITIVITY; PATHWAY; CRAF; MEK	Activating B-RAF(V600E) (also known as BRAF) kinase mutations occur in similar to 7% of human malignancies and similar to 60% of melanomas(1). Early clinical experience with a novel class I RAF-selective inhibitor, PLX4032, demonstrated an unprecedented 80% anti-tumour response rate among patients with B-RAF(V600E)-positive melanomas, but acquired drug resistance frequently develops after initial responses(2). Hypotheses for mechanisms of acquired resistance to B-RAF inhibition include secondary mutations in B-RAF(V600E), MAPK reactivation, and activation of alternative survival pathways(3-5). Here we show that acquired resistance to PLX4032 develops by mutually exclusive PDGFR beta (also known as PDGFRB) upregulation or N-RAS (also known as NRAS) mutations but not through secondary mutations in B-RAF(V600E). We used PLX4032-resistant sub-lines artificially derived from B-RAF(V600E)-positive melanoma cell lines and validated key findings in PLX4032-resistant tumours and tumour-matched, short-term cultures from clinical trial patients. Induction of PDGFR beta RNA, protein and tyrosine phosphorylation emerged as a dominant feature of acquired PLX4032 resistance in a subset of melanoma sub-lines, patient-derived biopsies and short-term cultures. PDGFR beta-upregulated tumour cells have low activated RAS levels and, when treated with PLX4032, do not reactivate the MAPK pathway significantly. In another subset, high levels of activated N-RAS resulting from mutations lead to significant MAPK pathway reactivation upon PLX4032 treatment. Knockdown of PDGFR beta or N-RAS reduced growth of the respective PLX4032-resistant subsets. Overexpression of PDGFR beta or N-RAS(Q61K) conferred PLX4032 resistance to PLX4032-sensitive parental cell lines. Importantly, MAPK reactivation predicts MEK inhibitor sensitivity. Thus, melanomas escape B-RAF(V600E) targeting not through secondary B-RAF(V600E) mutations but via receptor tyrosine kinase (RTK)-mediated activation of alternative survival pathway(s) or activated RAS-mediated reactivation of the MAPK pathway, suggesting additional therapeutic strategies.	[Nazarian, Ramin; Shi, Hubing; Wang, Qi; Kong, Xiangju; Lee, Mi-Kyung; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Nazarian, Ramin; Shi, Hubing; Wang, Qi; Kong, Xiangju; Koya, Richard C.; Lee, Hane; Chen, Zugen; Lee, Mi-Kyung; Attar, Narsis; Sazegar, Hooman; Chodon, Thinle; Nelson, Stanley F.; Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Koya, Richard C.; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA; [Lee, Hane; Chen, Zugen; Nelson, Stanley F.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Human Genet, Los Angeles, CA 90095 USA; [Attar, Narsis; Sazegar, Hooman; Chodon, Thinle; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Pediat, Los Angeles, CA 90095 USA; [McArthur, Grant] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Sosman, Jeffrey A.] Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Peter Maccallum Cancer Center; Vanderbilt University	Lo, RS (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, 52-121 CHS, Los Angeles, CA 90095 USA.	rlo@mednet.ucla.edu	Nelson, Stanley F/D-4771-2009; Shi, Hubing/B-8445-2014	Nelson, Stanley F/0000-0002-2082-3114; McArthur, Grant/0000-0001-8908-6071; Shi, Hubing/0000-0002-2926-3440; Wang, Qi/0000-0002-6420-1720	Dermatology Foundation; Burroughs Wellcome Fund; STOP CANCER Foundation; Margaret E. Early Medical Trust; Ian Copeland Memorial Melanoma Fund; V Foundation for Cancer Research; Melanoma Research Foundation; American Skin Association; Caltech-UCLA Joint Center for Translational Medicine; Wesley Coyle Memorial Fund; Melanoma Research Alliance; T32 Tumor Immunology Training Grant; California Institute for Regenerative Medicine (CIRM); Jonsson Cancer Center Foundation (JCCF); NATIONAL CANCER INSTITUTE [K24CA097588, K22CA151638] Funding Source: NIH RePORTER	Dermatology Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); STOP CANCER Foundation; Margaret E. Early Medical Trust; Ian Copeland Memorial Melanoma Fund; V Foundation for Cancer Research; Melanoma Research Foundation; American Skin Association; Caltech-UCLA Joint Center for Translational Medicine; Wesley Coyle Memorial Fund; Melanoma Research Alliance; T32 Tumor Immunology Training Grant; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Jonsson Cancer Center Foundation (JCCF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to G. Bollag and P. Lin (Plexxikon) for providing PLX4032, J.S. Economou for biopsies, B. Comin-Anduix for FACS assistance, S. Mok for assistance with virus production, C. Ng for tissue acquisition and culture establishment, R. Huang for patient tissue processing, N. Doan for immunohistochemistry, P. Mischel for discussion, B. Chmielowski for coordinated patient care, T. L. Toy for technical help with library generation for deep sequencing, and B. Harry for help with analysis of deep sequence data. R. S. L. acknowledges funding from the following: Dermatology Foundation, Burroughs Wellcome Fund, STOP CANCER Foundation, Margaret E. Early Medical Trust, Ian Copeland Memorial Melanoma Fund, V Foundation for Cancer Research, Melanoma Research Foundation, American Skin Association, Caltech-UCLA Joint Center for Translational Medicine, Wesley Coyle Memorial Fund, and Melanoma Research Alliance. R. N. is supported by a post-doctoral fellowship from the T32 Tumor Immunology Training Grant (S. Dubinett). A. R. is supported by the California Institute for Regenerative Medicine (CIRM), the Jonsson Cancer Center Foundation (JCCF), and Caltech-UCLA Joint Center for Translational Medicine. Array and sequence work were performed within the Jonsson Comprehensive Cancer Center Gene Expression Shared Resource. Patient-informed consent was obtained for the research performed in this study. We would like to thank all the patients that participated in this study.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794	18	1628	1692	3	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					973	U377		10.1038/nature09626	http://dx.doi.org/10.1038/nature09626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21107323	Green Accepted			2022-12-24	WOS:000285344600049
J	Ricci-Vitiani, L; Pallini, R; Biffoni, M; Todaro, M; Invernici, G; Cenci, T; Maira, G; Parati, EA; Stassi, G; Larocca, LM; De Maria, R				Ricci-Vitiani, Lucia; Pallini, Roberto; Biffoni, Mauro; Todaro, Matilde; Invernici, Gloria; Cenci, Tonia; Maira, Giulio; Parati, Eugenio Agostino; Stassi, Giorgio; Larocca, Luigi Maria; De Maria, Ruggero			Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells	NATURE			English	Article							VASCULOGENIC MIMICRY; IN-VIVO; CANCER; IDENTIFICATION; ANGIOGENESIS; RESISTANCE; MECHANISMS; MELANOMA; NICHE	Glioblastoma is a highly angiogenetic malignancy, the neoformed vessels of which are thought to arise by sprouting of pre-existing brain capillaries. The recent demonstration that a population of glioblastoma stem-like cells (GSCs) maintains glioblastomas(1,2) indicates that the progeny of these cells may not be confined to the neural lineage(3). Normal neural stem cells are able to differentiate into functional endothelial cells(4). The connection between neural stem cells and the endothelial compartment seems to be critical in glioblastoma, where cancer stem cells closely interact with the vascular niche and promote angiogenesis through the release of vascular endothelial growth factor (VEGF) and stromal-derived factor 1 (refs 5-9). Here we show that a variable number (range 20-90%, mean 60.7%) of endothelial cells in glioblastoma carry the same genomic alteration as tumour cells, indicating that a significant portion of the vascular endothelium has a neoplastic origin. The vascular endothelium contained a subset of tumorigenic cells that produced highly vascularized anaplastic tumours with areas of vasculogenic mimicry in immunocompromised mice. In vitro culture of GSCs in endothelial conditions generated progeny with phenotypic and functional features of endothelial cells. Likewise, orthotopic or subcutaneous injection of GSCs in immunocompromised mice produced tumour xenografts, the vessels of which were primarily composed of human endothelial cells. Selective targeting of endothelial cells generated by GSCs in mouse xenografts resulted in tumour reduction and degeneration, indicating the functional relevance of the GSC-derived endothelial vessels. These findings describe a new mechanism for tumour vasculogenesis and may explain the presence of cancer-derived endothelial-like cells in several malignancies.	[Ricci-Vitiani, Lucia; Biffoni, Mauro; De Maria, Ruggero] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Pallini, Roberto; Maira, Giulio] Univ Cattolica Sacro Cuore, Dept Neurosurg, I-00168 Rome, Italy; [Todaro, Matilde; Stassi, Giorgio] Univ Palermo, Dept Surg & Oncol Sci, I-90127 Palermo, Italy; [Invernici, Gloria; Parati, Eugenio Agostino] Neurol Inst Carlo Besta, Fdn IRCCS, UO Cerebrovasc Dis Cellular Neurobiol Lab, I-20133 Milan, Italy; [Cenci, Tonia; Larocca, Luigi Maria] Univ Cattolica Sacro Cuore, Inst Pathol, I-00168 Rome, Italy; [Stassi, Giorgio] Carattere Sci Fdn Salvatore Maugeri, Ist Ricovero & Cura, I-27100 Pavia, Italy; [De Maria, Ruggero] Mediterranean Inst Oncol, I-95029 Catania, Italy	Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Palermo; IRCCS Istituto Neurologico Besta; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Mediterranean Institute of Oncology	De Maria, R (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	pallini@rm.unicatt.it; demaria@iss.it	Ricci Vitiani, Lucia/J-8320-2016; PALLINI, Roberto/AAA-3747-2019; todaro, matilde/AAC-1003-2022; Cenci, Tonia/K-1010-2016; Pallini, Roberto/AAA-3760-2019; Parati, Eugenio Agostino/AAN-5893-2021; Stassi, Giorgio/AAC-1175-2022; Larocca, Luigi M/A-1577-2008; Cenci, Tonia/AAC-1372-2019; Biffoni, Mauro/J-8318-2016; Larocca, Luigi Maria/M-9590-2019; Parati, Eugenio A/G-8765-2011; De Maria, Ruggero/S-6385-2019	Ricci Vitiani, Lucia/0000-0001-7336-5615; PALLINI, Roberto/0000-0002-4611-8827; todaro, matilde/0000-0001-8686-8043; Cenci, Tonia/0000-0003-2838-8433; Parati, Eugenio Agostino/0000-0001-5020-6523; Larocca, Luigi M/0000-0003-1739-4758; Cenci, Tonia/0000-0002-6272-4587; Biffoni, Mauro/0000-0002-1304-9060; Larocca, Luigi Maria/0000-0003-1739-4758; De Maria, Ruggero/0000-0003-2255-0583	Associazione Italiana per la Ricerca sul Cancro	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank L. Naldini for providing the lentiviral vectors and S. Forte for gene array data elaboration. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Ricci-Vitiani L, 2008, CELL DEATH DIFFER, V15, P1491, DOI 10.1038/cdd.2008.72; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604	23	931	978	6	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					824	U121		10.1038/nature09557	http://dx.doi.org/10.1038/nature09557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21102434				2022-12-24	WOS:000285093700046
J	Gilchrist, DA; Dos Santos, G; Fargo, DC; Xie, B; Gao, YA; Li, LP; Adelman, K				Gilchrist, Daniel A.; Dos Santos, Gilberto; Fargo, David C.; Xie, Bin; Gao, Yuan; Li, Leping; Adelman, Karen			Pausing of RNA Polymerase II Disrupts DNA-Specified Nucleosome Organization to Enable Precise Gene Regulation	CELL			English	Article							DROSOPHILA-MELANOGASTER; PROMOTER ARCHITECTURE; GAGA FACTOR; POL-II; P-TEFB; TRANSCRIPTION; ELONGATION; CHROMATIN; BINDING; NELF	Metazoan transcription is controlled through either coordinated recruitment of transcription machinery to the gene promoter or regulated pausing of RNA polymerase II (Pol II) in early elongation. We report that a striking difference between genes that use these distinct regulatory strategies lies in the "default" chromatin architecture specified by their DNA sequences. Pol II pausing is prominent at highly regulated genes whose sequences inherently disfavor nucleosome formation within the gene but favor occlusion of the promoter by nucleosomes. In contrast, housekeeping genes that lack pronounced Pol II pausing show higher nucleosome occupancy downstream, but their promoters are deprived of nucleosomes regardless of polymerase binding. Our results indicate that a key role of paused Pol II is to compete with nucleosomes for occupancy of highly regulated promoters, thereby preventing the formation of repressive chromatin architecture	[Gilchrist, Daniel A.; Dos Santos, Gilberto; Adelman, Karen] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Fargo, David C.] NIEHS, Lib Informat Serv, NIH, Res Triangle Pk, NC 27709 USA; [Li, Leping] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Gao, Yuan] Johns Hopkins Univ, Inst Cell Engn, Neurogenerat & Stem Cell Biol Program, Baltimore, MD 21205 USA; [Xie, Bin; Gao, Yuan] Johns Hopkins Univ, Lieber Inst Brain Dev, Div Genom Epigenom & Bioinformat, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Johns Hopkins University; Johns Hopkins University	Adelman, K (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	adelmank@niehs.nih.gov	Gao, Yuan/E-1706-2011; Li, Leping/F-6497-2019	Li, Leping/0000-0003-4208-0259; Gilchrist, Daniel/0000-0003-1668-2790; Adelman, Karen/0000-0001-5364-334X	NIH, National Institute of Environmental Health Sciences [Z01 ES101987, ES101765]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101765, ZIAES101987, Z01ES101987, ZICES102445, Z01ES101765] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Nechaev, T. Kunkel, and G. Hu for critical reading of the manuscript. We acknowledge L. Pederson for production of the NELF-B protein, J. Tucker and the NIEHS microarray core for help with arrays, and S. Dai and J. Grovenstein for computational support. This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (grant Z01 ES101987 to K.A. and grant ES101765 to L.L.). D.A.G. and K.A. designed experiments, D.A.G., G.D.S., B.X., and Y.G. performed experiments, D.A.G., D.C.F., L.L., and K.A. performed data analysis, and D.A.G. and K.A. prepared the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dimarcq JL, 1997, INSECT BIOCHEM MOLEC, V27, P877, DOI 10.1016/S0965-1748(97)00072-6; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2009, METHODS, V48, P398, DOI 10.1016/j.ymeth.2009.02.024; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	42	290	292	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					540	551		10.1016/j.cell.2010.10.004	http://dx.doi.org/10.1016/j.cell.2010.10.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074046	Green Accepted, Bronze			2022-12-24	WOS:000284149100012
J	Levy, DL; Heald, R				Levy, Daniel L.; Heald, Rebecca			Nuclear Size Is Regulated by Importin alpha and Ntf2 in Xenopus	CELL			English	Article							SYSTEMS-ANALYSIS; PROTEIN IMPORT; EGG EXTRACTS; PORE COMPLEX; TRANSPORT; ENVELOPE; RAN; LAMINA; CELLS; ORGANIZATION	The size of the nucleus varies among different cell types, species, and disease states, but mechanisms of nuclear size regulation are poorly understood. We investigated nuclear scaling in the pseudotetraploid frog Xenopus laevis and its smaller diploid relative Xenopus tropicalis, which contains smaller cells and nuclei. Nuclear scaling was recapitulated in vitro using egg extracts, demonstrating that titratable cytoplasmic factors determine nuclear size to a greater extent than DNA content. Nuclear import rates correlated with nuclear size, and varying the concentrations of two transport factors, importin alpha and Ntf2, was sufficient to account for nuclear scaling between the two species. Both factors modulated lamin B3 import, with importin alpha increasing overall import rates and Ntf2 reducing import based on cargo size. Importin alpha also contributes to nuclear size changes during early X. laevis development. Thus, nuclear transport mechanisms are physiological regulators of both interspecies and developmental nuclear scaling.	[Levy, Daniel L.; Heald, Rebecca] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	bheald@berkeley.edu	Levy, Daniel/AAA-7205-2019	Levy, Daniel/0000-0002-7853-3275; Heald, Rebecca/0000-0001-6671-6528	NIH [DP1 OD000818]; American Cancer Society [PF-09-041-01-DDC]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Steve Bird, Mary Dasso, Dirk Gorlich, David Halpin, Richard Harland, Petr Kalab, Jan Liphardt, Alan Lowe, Andreas Merdes, Jon Soderholm, and Karsten Weis for reagents. We acknowledge Steve Bird and Saori Haigo for conducting the initial nuclear scaling experiments in egg extracts; Saori Haigo, Esther Kieserman, and Richard Harland's laboratory for help with Xenopus embryos; and Abby Dernburg for use of the Marianas SDC microscope. We thank members of the Heald lab for helpful advice; Rose Loughlin, Jeff Tang, Karsten Weis, and David Weisblat for constructive comments on the manuscript; and Favian Hernandez for artwork. R.H. is supported by the NIH Director's Pioneer Award (DP1 OD000818) and The Miller Institute for Basic Research in Science. D. L. L. acknowledges support from an American Cancer Society postdoctoral fellowship (PF-09-041-01-DDC).	AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Cavalier-Smith T, 2005, ANN BOT-LONDON, V95, P147, DOI 10.1093/aob/mci010; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Fankhauser G, 1939, J HERED, V30, P379, DOI 10.1093/oxfordjournals.jhered.a104767; Feldherr C, 1998, J CELL SCI, V111, P1889; Goldberg MW, 2008, J CELL SCI, V121, P215, DOI 10.1242/jcs.022020; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Grammer TC, 2005, MECH DEVELOP, V122, P263, DOI 10.1016/j.mod.2004.11.003; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; Hall MN, 2004, CELL GROWTH CONTROL; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485; HORNER HA, 1983, J CELL SCI, V63, P135; JENKINS H, 1993, J CELL SCI, V106, P275; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x; LOWE AR, 2010, NATURE IN PRESS, DOI DOI 10.10.1038/NATURE09285; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Maresca Thomas J., 2006, V322, P459; Marshall WF, 2008, SEMIN CELL DEV BIOL, V19, P520, DOI 10.1016/j.semcdb.2008.07.007; Marshall WF, 2002, TRENDS CELL BIOL, V12, P414, DOI 10.1016/S0962-8924(02)02341-3; MAUL GG, 1977, J CELL BIOL, V73, P748, DOI 10.1083/jcb.73.3.748; Montorzi M, 2000, MOL REPROD DEV, V55, P75, DOI 10.1002/(SICI)1098-2795(200001)55:1<75::AID-MRD10>3.0.CO;2-Z; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; NIEUWKOOP PD, 1967, NORMAL TABLE XENOPOU; Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Riddick G, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100160; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	43	158	161	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					288	298		10.1016/j.cell.2010.09.012	http://dx.doi.org/10.1016/j.cell.2010.09.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946986	Bronze, Green Accepted			2022-12-24	WOS:000283052200017
J	Shoemaker, CJ; Eyler, DE; Green, R				Shoemaker, Christopher J.; Eyler, Daniel E.; Green, Rachel			Dom34:Hbs1 Promotes Subunit Dissociation and Peptidyl-tRNA Drop-Off to Initiate No-Go Decay	SCIENCE			English	Article							YEAST TRANSLATION INITIATION; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNAS; TERMINATION; RIBOSOME; RELEASE; ELONGATION; ERF1; RECONSTITUTION; DEGRADATION	No-go decay (NGD) is one of several messenger RNA (mRNA) surveillance systems dedicated to the removal of defective mRNAs from the available pool. Two interacting factors, Dom34 and Hbs1, are genetically implicated in NGD in yeast. Using a reconstituted yeast translation system, we show that Dom34: Hbs1 interacts with the ribosome to promote subunit dissociation and peptidyl-tRNA drop-off. Our data further indicate that these recycling activities are shared by the homologous translation termination factor complex eRF1:eRF3, suggesting a common ancestral function. Because Dom34: Hbs1 activity exhibits no dependence on either peptide length or A-site codon identity, we propose that this quality-control system functions broadly to recycle ribosomes throughout the translation cycle whenever stalls occur.	[Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM059425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Frolova L, 1996, RNA, V2, P334; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gandhi R, 2008, J BIOL CHEM, V283, P32218, DOI 10.1074/jbc.M803785200; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Passos DO, 2009, MOL BIOL CELL, V20, P3025, DOI 10.1091/mbc.E09-01-0028; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Si K, 1999, MOL CELL BIOL, V19, P1416; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; VOGEL Z, 1971, EUR J BIOCHEM, V21, P582, DOI 10.1111/j.1432-1033.1971.tb01504.x; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016	28	221	229	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					369	372		10.1126/science.1192430	http://dx.doi.org/10.1126/science.1192430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947765	Green Accepted			2022-12-24	WOS:000282986700041
J	Robertson, JL; Kolmakova-Partensky, L; Miller, C				Robertson, Janice L.; Kolmakova-Partensky, Ludmila; Miller, Christopher			Design, function and structure of a monomeric ClC transporter	NATURE			English	Article							EXCHANGE TRANSPORTER; AMMONIA TRANSPORT; CHLORIDE CHANNEL; MECHANISM; ENERGETICS; REVEALS; AMTB	Channels and transporters of the ClC family cause the transmembrane movement of inorganic anions in service of a variety of biological tasks, from the unusual-the generation of the kilowatt pulses with which electric fish stun their prey-to the quotidian-the acidification of endosomes, vacuoles and lysosomes(1). The homodimeric architecture of ClC proteins, initially inferred from single-molecule studies of an elasmobranch Cl- channel(2) and later confirmed by crystal structures of bacterial Cl-/H+ antiporters(3,4), is apparently universal. Moreover, the basic machinery that enables ion movement through these proteins-the aqueous pores for anion diffusion in the channels and the ion-coupling chambers that coordinate Cl- and H+ antiport in the transporters-are contained wholly within each subunit of the homodimer. The near-normal function of a bacterial ClC transporter straitjacketed by covalent cross-links across the dimer interface and the behaviour of a concatemeric human homologue argue that the transport cycle resides within each subunit and does not require rigid-body rearrangements between subunits(5,6). However, this evidence is only inferential, and because examples are known in which quaternary rearrangements of extramembrane ClC domains that contribute to dimerization modulate transport activity(7), we cannot declare as definitive a 'parallel-pathways' picture in which the homodimer consists of two singlesubunit transporters operating independently. A strong prediction of such a view is that it should in principle be possible to obtain a monomeric ClC. Here we exploit the known structure of a ClC Cl-/H+ exchanger, ClC-ec1 from Escherichia coli, to design mutants that destabilize the dimer interface while preserving both the structure and the transport function of individual subunits. The results demonstrate that the ClC subunit alone is the basic functional unit for transport and that cross-subunit interaction is not required for Cl-/H+ exchange in ClC transporters.	[Robertson, Janice L.; Kolmakova-Partensky, Ludmila; Miller, Christopher] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Miller, C (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	cmiller@brandeis.edu		Robertson, Janice/0000-0002-5499-9943	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031768, R01GM031768] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM031768, R37 GM031768] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Chen LR, 2009, BIOPHYS J, V96, P4622, DOI 10.1016/j.bpj.2009.03.004; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Elvington SM, 2009, EMBO J, V28, P3090, DOI 10.1038/emboj.2009.259; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; MacKenzie KR, 2008, CURR OPIN STRUC BIOL, V18, P412, DOI 10.1016/j.sbi.2008.04.007; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; Metcalf DG, 2009, J MOL BIOL, V392, P1087, DOI 10.1016/j.jmb.2009.06.032; Middleton Richard E., 1994, Methods (Orlando), V6, P28, DOI 10.1006/meth.1994.1005; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Nguitragool W, 2007, P NATL ACAD SCI USA, V104, P20659, DOI 10.1073/pnas.0708639104; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Theobald DL, 2010, NAT STRUCT MOL BIOL, V17, P2, DOI 10.1038/nsmb0110-2; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	30	82	84	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					844	847		10.1038/nature09556	http://dx.doi.org/10.1038/nature09556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21048711	Green Accepted			2022-12-24	WOS:000285093700050
J	Wang, R; Chadalavada, K; Wilshire, J; Kowalik, U; Hovinga, KE; Geber, A; Fligelman, B; Leversha, M; Brennan, C; Tabar, V				Wang, Rong; Chadalavada, Kalyani; Wilshire, Jennifer; Kowalik, Urszula; Hovinga, Koos E.; Geber, Adam; Fligelman, Boris; Leversha, Margaret; Brennan, Cameron; Tabar, Viviane			Glioblastoma stem-like cells give rise to tumour endothelium	NATURE			English	Article							NERVOUS-SYSTEM; RECURRENT GLIOBLASTOMA; IN-VIVO; ANGIOGENESIS; EGFR; IDENTIFICATION; RECRUITMENT; INHIBITION; PATHWAYS; MARKER	Glioblastoma (GBM) is among the most aggressive of human cancers(1). A key feature of GBMs is the extensive network of abnormal vasculature characterized by glomeruloid structures and endothelial hyperplasia(2). Yet the mechanisms of angiogenesis and the origin of tumour endothelial cells remain poorly defined(3-5). Here we demonstrate that a subpopulation of endothelial cells within glioblastomas harbour the same somatic mutations identified within tumour cells, such as amplification of EGFR and chromosome 7. We additionally demonstrate that the stem-cell-like CD133(+) fraction includes a subset of vascular endothelial-cadherin (CD144)-expressing cells that show characteristics of endothelial progenitors capable of maturation into endothelial cells. Extensive in vitro and in vivo lineage analyses, including single cell clonal studies, further show that a subpopulation of the CD133(+) stem-like cell fraction is multipotent and capable of differentiation along tumour and endothelial lineages, possibly via an intermediate CD133(+)/CD144(+) progenitor cell. The findings are supported by genetic studies of specific exons selected from The Cancer Genome Atlas(6), quantitative FISH and comparative genomic hybridization data that demonstrate identical genomic profiles in the CD133(+) tumour cells, their endothelial progenitor derivatives and mature endothelium. Exposure to the clinical anti-angiogenesis agent bevacizumab(7) or to a gamma-secretase inhibitor(8) as well as knockdown shRNA studies demonstrate that blocking VEGF or silencing VEGFR2 inhibits the maturation of tumour endothelial progenitors into endothelium but not the differentiation of CD133(+) cells into endothelial progenitors, whereas c-secretase inhibition or NOTCH1 silencing blocks the transition into endothelial progenitors. These data may provide new perspectives on the mechanisms of failure of anti-angiogenesis inhibitors currently in use. The lineage plasticity and capacity to generate tumour vasculature of the putative cancer stem cells within glioblastoma are novel findings that provide new insight into the biology of gliomas and the definition of cancer stemness, as well as the mechanisms of tumour neo-angiogenesis.	[Wang, Rong; Kowalik, Urszula; Hovinga, Koos E.; Geber, Adam; Fligelman, Boris; Brennan, Cameron; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Wang, Rong; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA; [Wang, Rong; Brennan, Cameron; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA; [Hovinga, Koos E.] Univ Amsterdam, Acad Med Ctr, Neurosurg Ctr Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Amsterdam; Academic Medical Center Amsterdam; Memorial Sloan Kettering Cancer Center	Tabar, V (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA.	tabarv@mskcc.org	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891; Geber, Adam/0000-0003-3022-0525	New York State Stem Cell Science Fund (NYSTEM); NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	New York State Stem Cell Science Fund (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank J. Imai, H. Xu, G. Lee, M. Tomishima and L. Studer for critical reading of the manuscript, P. Gutin for assistance with tissue acquisition and discussions, B. Weksler for the brain endothelial cell line (hCMEC), S. Jhanwar for the clinical cytogenetics data and M. Sadelain and E. Papapetrou for the lentiviral vectors. Funding was provided in part through a grant from the New York State Stem Cell Science Fund (NYSTEM).	Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Beaty RM, 2007, J NEURO-ONCOL, V81, P241, DOI 10.1007/s11060-006-9227-9; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Franco-Hernandez C, 2007, INT J ONCOL, V30, P209; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hendrix MJC, 2002, CANCER RES, V62, P665; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Iwamoto FM, 2009, NEUROLOGY, V73, P1200, DOI 10.1212/WNL.0b013e3181bc0184; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VOYTA JC, 1984, J CELL BIOL, V99, pA81; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604	31	865	914	1	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					829	U128		10.1038/nature09624	http://dx.doi.org/10.1038/nature09624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21102433				2022-12-24	WOS:000285093700047
J	Vispute, TP; Zhang, HY; Sanna, A; Xiao, R; Huber, GW				Vispute, Tushar P.; Zhang, Huiyan; Sanna, Aimaro; Xiao, Rui; Huber, George W.			Renewable Chemical Commodity Feedstocks from Integrated Catalytic Processing of Pyrolysis Oils	SCIENCE			English	Article							BIO-OIL; LIQUID-FUEL; BIOMASS; HYDROCARBONS; CONVERSION; ZEOLITE; AROMATIZATION; ALKYLATION; AROMATICS; ETHYLENE	Fast pyrolysis of lignocellulosic biomass produces a renewable liquid fuel called pyrolysis oil that is the cheapest liquid fuel produced from biomass today. Here we show that pyrolysis oils can be converted into industrial commodity chemical feedstocks using an integrated catalytic approach that combines hydroprocessing with zeolite catalysis. The hydroprocessing increases the intrinsic hydrogen content of the pyrolysis oil, producing polyols and alcohols. The zeolite catalyst then converts these hydrogenated products into light olefins and aromatic hydrocarbons in a yield as much as three times higher than that produced with the pure pyrolysis oil. The yield of aromatic hydrocarbons and light olefins from the biomass conversion over zeolite is proportional to the intrinsic amount of hydrogen added to the biomass feedstock during hydroprocessing. The total product yield can be adjusted depending on market values of the chemical feedstocks and the relative prices of the hydrogen and biomass.	[Vispute, Tushar P.; Zhang, Huiyan; Sanna, Aimaro; Huber, George W.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA; [Zhang, Huiyan; Xiao, Rui] Southeast Univ, Sch Energy & Environm, Nanjing 210096, Peoples R China; [Sanna, Aimaro] Univ Nottingham, Dept Chem & Environm Engn, Energy & Sustainabil Res Div, Nottingham NG7 2RD, England	University of Massachusetts System; University of Massachusetts Amherst; Southeast University - China; University of Nottingham	Vispute, TP (corresponding author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.		Huber, George/D-2569-2018; Huber, George/Y-2473-2019; Zhang, Huiyan/A-8640-2011	Huber, George/0000-0002-7838-6893; Zhang, Huiyan/0000-0002-4818-7156	U.S. Department of Energy Office of Energy Efficiency and Renewable Energy [DE-FG36-08GO18212]; Defense Advanced Research Projects Agency (DARPA) through the Defense Science Office [HR0011-09-C-0075]; National Basic Research Program of China (973 Program) [2010CB732206]; National Natural Science Foundation of China [51076031]	U.S. Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Defense Advanced Research Projects Agency (DARPA) through the Defense Science Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy, under grant DE-FG36-08GO18212; and by the Defense Advanced Research Projects Agency (DARPA) through the Defense Science Office Agreement HR0011-09-C-0075) (Approved for Public Release, Distribution Unlimited); the National Basic Research Program of China (973 Program, grant no. 2010CB732206); and the National Natural Science Foundation of China (grant no. 51076031). The views, opinions, and/or findings contained in this article/presentation are those of the author/presenter and should not be interpreted as representing the official views or policies, either expressed or implied, of the DARPA or the Department of Defense. We thank A. Javaid for the microfiltration of bio-oil, Y. Cheng for help with zeolite upgrading experiments, and the National Renewable Energy Laboratory and P. H. Steele from the Forest Products Department at Mississippi State University for providing us with bio-oil samples. The University of Massachusetts has filed a patent based on the methods presented here. G. W. H. has a financial interest in Anellotech, a privately held company focused on producing renewable petrochemicals from biomass.	ADJAYE JD, 1995, FUEL PROCESS TECHNOL, V45, P161, DOI 10.1016/0378-3820(95)00034-5; ADJAYE JD, 1995, FUEL PROCESS TECHNOL, V45, P185, DOI 10.1016/0378-3820(95)00040-E; Agrawal R, 2007, P NATL ACAD SCI USA, V104, P4828, DOI 10.1073/pnas.0609921104; Anex R. P., 2009, DIV FUEL CHEM, V54, P704; [Anonymous], ICIS PRIC REP; Bartholomew CH, 2006, FUNDAMENTALS OF INDUSTRIAL CATALYTIC PROCESSES, 2ND EDITION, P1, DOI 10.1002/9780471730071; Bayerbach R, 2009, J ANAL APPL PYROL, V85, P98, DOI 10.1016/j.jaap.2008.10.021; Carlson TR, 2008, CHEMSUSCHEM, V1, P397, DOI 10.1002/cssc.200800018; Carlson TR, 2011, ENERG ENVIRON SCI, V4, P145, DOI 10.1039/c0ee00341g; CHEN NY, 1986, CHEMTECH, V16, P506; Chornet, 2001, [No title captured], Patent No. [6172272B1, 6172272, 6,172,272 ]; Choudhary VR, 2001, MICROPOR MESOPOR MAT, V47, P253, DOI 10.1016/S1387-1811(01)00385-7; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Crossley S, 2010, SCIENCE, V327, P68, DOI 10.1126/science.1180769; Czernik S, 2004, ENERG FUEL, V18, P590, DOI 10.1021/ef034067u; Degnan TF, 2001, APPL CATAL A-GEN, V221, P283, DOI 10.1016/S0926-860X(01)00807-9; Elliott DC, 2007, ENERG FUEL, V21, P1792, DOI 10.1021/ef070044u; Gayubo AG, 2004, IND ENG CHEM RES, V43, P2610, DOI 10.1021/ie030791o; GUISNET M, 1992, APPL CATAL A-GEN, V89, P1, DOI 10.1016/0926-860X(92)80075-N; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Huber GW, 2003, SCIENCE, V300, P2075, DOI 10.1126/science.1085597; Klass DL., 1998, BIOMASS RENEWABLE EN; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Lappin G., 1989, ALPHA OLEFINS APPL H; Li N, 2010, J CATAL, V270, P48, DOI 10.1016/j.jcat.2009.12.006; Marker T. L., 2005, DEFG3605GO15085 UOP; Miller JE, 1999, FUEL, V78, P1363, DOI 10.1016/S0016-2361(99)00072-1; Milne T, 1997, DEV THERMOCHEMICAL B, P409, DOI DOI 10.1007/978-94-009-1559-6_32; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; National Research Council and National Academy of Engineering, 2004, HYDR EC OPP COSTS BA; Oasmaa A, 1999, ENERG FUEL, V13, P914, DOI 10.1021/ef980272b; Olcay H, 2010, CHEMCATCHEM, V2, P1420, DOI 10.1002/cctc.201000134; Padro C, 1999, NRELTP57027079, DOI 10.2172/12212; Perego C, 2002, CATAL TODAY, V73, P3, DOI 10.1016/S0920-5861(01)00511-9; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Shabtai J. S., 1999, [No title captured], Patent No. [US 5959167 A, 5959167, US 5959167]; SZMANT H, 1989, ORGANIC BUILDING BLO; Vispute TP, 2009, GREEN CHEM, V11, P1433, DOI 10.1039/b912522c; Wright MM, 2010, FUEL, V89, pS11, DOI 10.1016/j.fuel.2010.07.029; Zhao C, 2010, CHEM COMMUN, V46, P412, DOI 10.1039/b916822b; Zhao C, 2009, ANGEW CHEM INT EDIT, V48, P3987, DOI 10.1002/anie.200900404	42	850	888	31	879	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1222	1227		10.1126/science.1194218	http://dx.doi.org/10.1126/science.1194218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109668				2022-12-24	WOS:000284613700036
J	Chen, ZC; Borek, D; Padrick, SB; Gomez, TS; Metlagel, Z; Ismail, AM; Umetani, J; Billadeau, DD; Otwinowski, Z; Rosen, MK				Chen, Zhucheng; Borek, Dominika; Padrick, Shae B.; Gomez, Timothy S.; Metlagel, Zoltan; Ismail, Ayman M.; Umetani, Junko; Billadeau, Daniel D.; Otwinowski, Zbyszek; Rosen, Michael K.			Structure and control of the actin regulatory WAVE complex	NATURE			English	Article							WASP/SCAR PROTEINS; TYROSINE KINASE; CELL-MIGRATION; WASP FAMILY; PHOSPHORYLATION; ACTIVATION; MEMBRANE; MODEL; RAC1; INTEGRATION	Members of the Wiskott-Aldrich syndrome protein (WASP) family control cytoskeletal dynamics by promoting actin filament nucleation with the Arp2/3 complex. The WASP relative WAVE regulates lamellipodia formation within a 400-kilodalton, hetero-pentameric WAVE regulatory complex (WRC). The WRC is inactive towards the Arp2/3 complex, but can be stimulated by the Rac GTPase, kinases and phosphatidylinositols. Here we report the 2.3-angstrom crystal structure of the WRC and complementary mechanistic analyses. The structure shows that the activity-bearing VCA motif of WAVE is sequestered by a combination of intramolecular and intermolecular contacts within the WRC. Rac and kinases appear to destabilize a WRC element that is necessary for VCA sequestration, suggesting the way in which these signals stimulate WRC activity towards the Arp2/3 complex. The spatial proximity of the Rac binding site and the large basic surface of the WRC suggests how the GTPase and phospholipids could cooperatively recruit the complex to membranes.	[Chen, Zhucheng; Borek, Dominika; Padrick, Shae B.; Metlagel, Zoltan; Ismail, Ayman M.; Umetani, Junko; Otwinowski, Zbyszek; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Zhucheng; Padrick, Shae B.; Metlagel, Zoltan; Ismail, Ayman M.; Umetani, Junko; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu	Otwinowski, Zbyszek/F-3665-2011; Borek, Dominika M/D-2943-2011	Borek, Dominika M/0000-0002-4321-6253; Otwinowski, Zbyszek/0000-0003-3640-8545; Padrick, Shae/0000-0002-6916-6194	Cancer Research Institute; NIH [1F32-GM06917902, R01-AI065474, R01-GM053163, R01-GM056322]; Allergic Diseases Training grant [AI07047]; Welch Foundation [I-1544]; Howard Hughes Medical Institute; US DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007047, R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163, R01GM056322] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergic Diseases Training grant; Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Chen for providing samples of full-length WRC and VCA polypeptide for electron microscopy and some biochemical analyses, C. Pak for helping with the total internal reflection fluorescence experiment, D. Tomchick and C. Brautigam for technical assistance and N. Grishin for assistance with sequence analysis and discussion. Research was supported by fellowships from the Cancer Research Institute and the NIH (1F32-GM06917902) to Z.C. and S.B.P., respectively, an Allergic Diseases Training grant (AI07047) to T.S.G., grants from the NIH to D.D.B. (R01-AI065474), Z.O. (R01-GM053163) and M.K.R. (R01-GM056322), a grant from the Welch Foundation to M.K.R. (I-1544) and the Howard Hughes Medical Institute. D.D.B. is a Leukemia and Lymphoma Society Scholar. Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the US DOE under contract DE-AC02-06CH11357.	Ardern H, 2006, CELL MOTIL CYTOSKEL, V63, P6, DOI 10.1002/cm.20101; Borek D, 2007, J SYNCHROTRON RADIAT, V14, P24, DOI 10.1107/S0909049506046589; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stovold CF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-11; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Vartiainen MK, 2004, CURR OPIN CELL BIOL, V16, P174, DOI 10.1016/j.ceb.2004.02.004; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	50	309	322	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					533	U207		10.1038/nature09623	http://dx.doi.org/10.1038/nature09623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107423	Green Accepted			2022-12-24	WOS:000284584200035
J	Kaschube, M; Schnabel, M; Lowel, S; Coppola, DM; White, LE; Wolf, F				Kaschube, Matthias; Schnabel, Michael; Loewel, Siegrid; Coppola, David M.; White, Leonard E.; Wolf, Fred			Universality in the Evolution of Orientation Columns in the Visual Cortex	SCIENCE			English	Article							SELECTIVITY; ARRANGEMENT; EXPERIENCE; SYMMETRY	The brain's visual cortex processes information concerning form, pattern, and motion within functional maps that reflect the layout of neuronal circuits. We analyzed functional maps of orientation preference in the ferret, tree shrew, and galago-three species separated since the basal radiation of placental mammals more than 65 million years ago-and found a common organizing principle. A symmetry-based class of models for the self-organization of cortical networks predicts all essential features of the layout of these neuronal circuits, but only if suppressive long-range interactions dominate development. We show mathematically that orientation-selective long-range connectivity can mediate the required interactions. Our results suggest that self-organization has canalized the evolution of the neuronal circuitry underlying orientation preference maps into a single common design.	[Kaschube, Matthias; Schnabel, Michael; Wolf, Fred] Univ Gottingen, Fac Phys, Bernstein Ctr Computat Neurosci, Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; [Kaschube, Matthias; Schnabel, Michael; Wolf, Fred] Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Kaschube, Matthias] Princeton Univ, Dept Phys, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Schnabel, Michael] Northwestern Univ, Phys Sci Oncol Ctr, NW Inst Complex Syst, Dept Appl Math, Evanston, IL 60208 USA; [Schnabel, Michael] Northwestern Univ, Phys Sci Oncol Ctr, NW Inst Complex Syst, Dept Phys, Evanston, IL 60208 USA; [Loewel, Siegrid] Univ Jena, Inst Gen Zool & Anim Physiol, D-07743 Jena, Germany; [Loewel, Siegrid] Univ Gottingen, Sch Biol, D-37073 Gottingen, Germany; [Coppola, David M.] Randolph Macon Coll, Dept Biol, Ashland, VA 23005 USA; [White, Leonard E.] Duke Univ, Duke Inst Brain Sci, Dept Community & Family Med, Durham, NC 27710 USA	Max Planck Society; University of Gottingen; Princeton University; Northwestern University; Northwestern University; Friedrich Schiller University of Jena; University of Gottingen; Duke University	Kaschube, M (corresponding author), Univ Gottingen, Fac Phys, Bernstein Ctr Computat Neurosci, Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany.	kaschube@princeton.edu; fred-wl@nld.ds.mpg.de	Wolf, Fred/D-5771-2011	Wolf, Fred/0000-0002-7068-3762	Human Frontier Science Program; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie [01GQ0430, 01GQ0922]; NSF [0641433]; NIH/National Institute of General Medical Sciences [P50 GM071508]; Whitehall Foundation; National Science Foundation (NSF) [PHY05-51164]; NATIONAL EYE INSTITUTE [R01EY006821, R01EY011488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF)); NSF(National Science Foundation (NSF)); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Whitehall Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Crowley, J. Fischer, T. Geisel, H. Greenside, A. Grinvald, M. Gutnick, J. Kaas, T. Kottos, T. Moser, and J. Schmitz for discussions; B. Bosking for acquiring and processing imaging data; W. Keil and L. Reichl for calculations; B. Goetze for graphics; D. Fitzpatrick for support of imaging experiments (NIH/National Eye Institute (NEI) EY06821 and EY11488); and the Kavli Institute for Theoretical Physics for its hospitality. This work was funded by grants from the Human Frontier Science Program and Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie to S. L. and F. W. (01GQ0430 and 01GQ0922); NSF to D. M. C. (0641433); NIH/National Institute of General Medical Sciences to M. K. (P50 GM071508); and the Whitehall Foundation to L. E. W. and was supported in part by the National Science Foundation (NSF PHY05-51164).	Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Kaas JH, 2008, BRAIN RES BULL, V75, P384, DOI 10.1016/j.brainresbull.2007.10.009; Kaschube M, 2002, J NEUROSCI, V22, P7206; Kaschube M, 2009, P NATL ACAD SCI USA, V106, P17205, DOI 10.1073/pnas.0901615106; Kaschube M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015009; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Lee HY, 2003, P NATL ACAD SCI USA, V100, P16036, DOI 10.1073/pnas.2531343100; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Mayer N, 2002, NEUROCOMPUTING, V44, P533, DOI 10.1016/S0925-2312(02)00417-4; MAYNARDSMITH J, 1985, Q REV BIOL, V60, P265, DOI DOI 10.1086/414425); Niven JE, 2004, PLOS BIOL, V2, P22, DOI 10.1371/journal.pbio.0020019; Obermayer K, 1997, NEURAL COMPUT, V9, P555, DOI 10.1162/neco.1997.9.3.555; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Reichl L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.208101; Van Hooser SD, 2007, NEUROSCIENTIST, V13, P639, DOI 10.1177/1073858407306597; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wolf F, 1998, NATURE, V395, P73, DOI 10.1038/25736; Wolf F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208701	28	114	115	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1113	1116		10.1126/science.1194869	http://dx.doi.org/10.1126/science.1194869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21051599	Green Accepted			2022-12-24	WOS:000284374700046
J	Fields, RD				Fields, R. Douglas			Change in the Brain's White Matter	SCIENCE			English	Editorial Material							MYELINATION; RELEASE; OLIGODENDROCYTES; ARCHITECTURE; MECHANISM; IMPULSES; NEURONS; CELLS		NICHHD, Nervous Syst Dev & Plast Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, RD (corresponding author), NICHHD, Nervous Syst Dev & Plast Sect, NIH, Bethesda, MD 20892 USA.	fieldsd@mail.nih.gov	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	Intramural NIH HHS [Z99 HD999999, ZIA HD000713-23] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Fields RD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001128; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Markham JA, 2009, BRAIN RES, V1288, P9, DOI 10.1016/j.brainres.2009.06.087; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 1998, J NEUROSCI, V18, P9303; Ullen F, 2009, NEURON GLIA BIOL, V5, P28, DOI 10.1017/S1740925X09990330	18	141	146	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					768	769		10.1126/science.1199139	http://dx.doi.org/10.1126/science.1199139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051624	Green Accepted			2022-12-24	WOS:000283855700028
J	Kubo, K; Entani, T; Takara, A; Wang, N; Fields, AM; Hua, ZH; Toyoda, M; Kawashima, S; Ando, T; Isogai, A; Kao, T; Takayama, S				Kubo, Ken-ichi; Entani, Tetsuyuki; Takara, Akie; Wang, Ning; Fields, Allison M.; Hua, Zhihua; Toyoda, Mamiko; Kawashima, Shin-ichi; Ando, Toshio; Isogai, Akira; Kao, Teh-hui; Takayama, Seiji			Collaborative Non-Self Recognition System in S-RNase-Based Self-Incompatibility	SCIENCE			English	Article							F-BOX GENE; POLLEN; LOCUS; IDENTIFICATION; DETERMINANT; REGION; SLF	Self-incompatibility in flowering plants prevents inbreeding and promotes outcrossing to generate genetic diversity. In Solanaceae, a multiallelic gene, S-locus F-box (SLF), was previously shown to encode the pollen determinant in self-incompatibility. It was postulated that an SLF allelic product specifically detoxifies its non-self S-ribonucleases (S-RNases), allelic products of the pistil determinant, inside pollen tubes via the ubiquitin-26S-proteasome system, thereby allowing compatible pollinations. However, it remained puzzling how SLF, with much lower allelic sequence diversity than S-RNase, might have the capacity to recognize a large repertoire of non-self S-RNases. We used in vivo functional assays and protein interaction assays to show that in Petunia, at least three types of divergent SLF proteins function as the pollen determinant, each recognizing a subset of non-self S-RNases. Our findings reveal a collaborative non-self recognition system in plants.	[Wang, Ning; Hua, Zhihua; Kao, Teh-hui] Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA; [Kubo, Ken-ichi; Entani, Tetsuyuki; Takara, Akie; Toyoda, Mamiko; Kawashima, Shin-ichi; Isogai, Akira; Takayama, Seiji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Fields, Allison M.; Kao, Teh-hui] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ando, Toshio] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nara Institute of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chiba University	Kao, T (corresponding author), Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA.	txk3@psu.edu; takayama@bs.naist.jp	ANDO, Toshio/E-7054-2015; Messier, Claude/A-2322-2008; Isogai, Akira/O-8897-2017; Hua, Zhihua/B-8835-2012; Hua, Zhihua/AAD-1146-2021	ANDO, Toshio/0000-0001-8819-154X; Messier, Claude/0000-0002-4791-1763; Isogai, Akira/0000-0001-8095-0441; 	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; NSF [IOB-0543201, IOS-0843195]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NSF(National Science Foundation (NSF))	We thank A. Miyawaki for Venus vectors; M. Iwano, H. Shiba, Y. Wada, P. Nakayama, M. Kakita, X. Meng, T. Tsuchimatsu, and K. K. Shimizu for discussion; and N. Katsui, M. Matsumura-Kawashima, M. Okamura, Y. Egusa, K. Kajihara, M. Bothe, and M. Goralczyk for technical assistance. Supported by Grant-in-Aid for Creative Scientific Research (A.I.) and Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (S.T.), Grant-in-Aid for the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan to the Nara Institute of Science and Technology, and NSF grants IOB-0543201 and IOS-0843195 (T.-h. K.). Sequence data have been deposited in GenBank under accession numbers AB568388 to AB568423.	Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; Entani T, 2003, GENES CELLS, V8, P203, DOI 10.1046/j.1365-2443.2003.00626.x; Entani T, 1999, BIOSCI BIOTECH BIOCH, V63, P1882, DOI 10.1271/bbb.63.1882; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; Hua ZH, 2008, MOL PLANT, V1, P575, DOI 10.1093/mp/ssn032; Hua ZH, 2007, PLANT CELL, V19, P3593, DOI 10.1105/tpc.107.055426; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; McClure B, 2009, J EXP BOT, V60, P1069, DOI 10.1093/jxb/erp024; Minamikawa M, 2010, PLANT MOL BIOL, V74, P143, DOI 10.1007/s11103-010-9662-z; Newbigin E, 2008, PLANT CELL, V20, P2286, DOI 10.1105/tpc.108.060327; Okada K, 2004, J JPN SOC HORTIC SCI, V73, P524, DOI 10.2503/jjshs.73.524; Okada K, 2008, PLANT MOL BIOL, V66, P389, DOI 10.1007/s11103-007-9277-1; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Sassa H, 2007, GENETICS, V175, P1869, DOI 10.1534/genetics.106.068858; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Tsukamoto T, 2005, PLANT MOL BIOL, V57, P141, DOI 10.1007/s11103-004-6852-6; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Wheeler MJ, 2009, NATURE, V459, P992, DOI 10.1038/nature08027; Zhou Z, 2003, APPL MATH LETT, V16, P165, DOI 10.1016/S0893-9659(03)80027-7	23	204	221	6	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					796	799		10.1126/science.1195243	http://dx.doi.org/10.1126/science.1195243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051632				2022-12-24	WOS:000283855700036
J	Del Bene, F; Wyart, C; Robles, E; Tran, A; Looger, L; Scott, EK; Isacoff, EY; Baier, H				Del Bene, Filippo; Wyart, Claire; Robles, Estuardo; Tran, Amanda; Looger, Loren; Scott, Ethan K.; Isacoff, Ehud Y.; Baier, Herwig			Filtering of Visual Information in the Tectum by an Identified Neural Circuit	SCIENCE			English	Article							ZEBRAFISH OPTIC TECTUM; SUPERIOR COLLICULUS; LARVAL ZEBRAFISH; IN-VIVO; ENHANCER; CELLS	The optic tectum of zebrafish is involved in behavioral responses that require the detection of small objects. The superficial layers of the tectal neuropil receive input from retinal axons, while its deeper layers convey the processed information to premotor areas. Imaging with a genetically encoded calcium indicator revealed that the deep layers, as well as the dendrites of single tectal neurons, are preferentially activated by small visual stimuli. This spatial filtering relies on GABAergic interneurons (using the neurotransmitter gamma-aminobutyric acid) that are located in the superficial input layer and respond only to large visual stimuli. Photo-ablation of these cells with KillerRed, or silencing of their synaptic transmission, eliminates the size tuning of deeper layers and impairs the capture of prey.	[Wyart, Claire; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wyart, Claire; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Del Bene, Filippo; Robles, Estuardo; Tran, Amanda; Scott, Ethan K.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Looger, Loren] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Isacoff, Ehud Y.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@calmail.berkeley.edu; herwig.baier@ucsf.edu	isacoff, ehud/AAP-1459-2020; Wyart, Claire/H-3783-2016; del bene, filippo/D-1245-2010; Wyart, Claire/AAB-4603-2020	Wyart, Claire/0000-0002-1668-4975; del bene, filippo/0000-0001-8551-2846; Wyart, Claire/0000-0002-1668-4975; Tran, Amanda/0000-0002-8393-6124; Isacoff, Ehud Y./0000-0003-4775-9359; Robles, Estuardo/0000-0002-1202-2050; Scott, Ethan/0000-0003-3150-9216	Human Frontier Science Program long-term postdoctoral fellowship; Marie Curie Outgoing International Fellowship [UMR5020]; CNRS [UMR5020]; NSF; NIH Nanomedicine Development Center for the Optical Control of Biological Function [PN2 EY018241]; NSF/FIBR [0623527]; Sandler Opportunity Award; Byers Basic Science Award; NIHR [R01 EY012406, R01 NS053358]; NATIONAL EYE INSTITUTE [R01EY012406, PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050833, R01NS053358] Funding Source: NIH RePORTER	Human Frontier Science Program long-term postdoctoral fellowship(Human Frontier Science Program); Marie Curie Outgoing International Fellowship(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); NSF(National Science Foundation (NSF)); NIH Nanomedicine Development Center for the Optical Control of Biological Function(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF/FIBR(National Science Foundation (NSF)); Sandler Opportunity Award; Byers Basic Science Award; NIHR(National Institute for Health Research (NIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Staub for care of animals, T. Muller for the gad67 probe, K. Kawakami for Tol2 and TeTxLC-CFP reagents, L. Garner for advice on the visual setup, and J. Nakai for the GCaMP1.6 vector. F. D. B. and C. W. were supported, respectively, by a Human Frontier Science Program long-term postdoctoral fellowship and a Marie Curie Outgoing International Fellowship (with CNRS UMR5020 "Neurosciences Sensorielles, Comportement Cognition," Lyon, France). E. R. was supported by an NSF postdoctoral fellowship. This work was funded by the NIH Nanomedicine Development Center for the Optical Control of Biological Function (PN2 EY018241, E.Y.I. and H. B.), NSF/FIBR 0623527 (E.Y.I.), a Sandler Opportunity Award (H. B.), the Byers Basic Science Award (H. B.), and NIH grants R01 EY012406 and R01 NS053358 (H.B.).	Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Baier H, 2009, CURR OPIN NEUROBIOL, V19, P553, DOI 10.1016/j.conb.2009.08.001; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; DRAGER UC, 1975, NATURE, V253, P203, DOI 10.1038/253203a0; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Isa T, 2002, CURR OPIN NEUROBIOL, V12, P668, DOI 10.1016/S0959-4388(02)00387-2; MEEK J, 1978, J COMP NEUROL, V182, P89, DOI 10.1002/cne.901820107; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Nevin LM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-36; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Portugues R, 2009, CURR OPIN NEUROBIOL, V19, P644, DOI 10.1016/j.conb.2009.10.007; Ramdya P, 2008, NAT NEUROSCI, V11, P1083, DOI 10.1038/nn.2166; Ramdya P, 2006, J NEUROSCI METH, V157, P230, DOI 10.1016/j.jneumeth.2006.04.021; Roeser T, 2003, J NEUROSCI, V23, P3726; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2407, DOI 10.1016/0306-4522(82)90204-4; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott Jared M., 2009, Journal of the Botanical Research Institute of Texas, V3, P13; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; Sumbre G, 2008, NATURE, V456, P102, DOI 10.1038/nature07351; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; VANEGAS H, 1974, J COMP NEUROL, V154, P43, DOI 10.1002/cne.901540104; Vanegas H, 1984, COMP NEUROLOGY OPTIC; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000	28	172	174	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					669	673		10.1126/science.1192949	http://dx.doi.org/10.1126/science.1192949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030657	Green Accepted			2022-12-24	WOS:000283580600048
J	Gladstone, GR; Hurley, DM; Retherford, KD; Feldman, PD; Pryor, WR; Chaufray, JY; Versteeg, M; Greathouse, TK; Steffl, AJ; Throop, H; Parker, JW; Kaufmann, DE; Egan, AF; Davis, MW; Slater, DC; Mukherjee, J; Miles, PF; Hendrix, AR; Colaprete, A; Stern, SA				Gladstone, G. Randall; Hurley, Dana M.; Retherford, Kurt D.; Feldman, Paul D.; Pryor, Wayne R.; Chaufray, Jean-Yves; Versteeg, Maarten; Greathouse, Thomas K.; Steffl, Andrew J.; Throop, Henry; Parker, Joel Wm.; Kaufmann, David E.; Egan, Anthony F.; Davis, Michael W.; Slater, David C.; Mukherjee, Joey; Miles, Paul F.; Hendrix, Amanda R.; Colaprete, Anthony; Stern, S. Alan			LRO-LAMP Observations of the LCROSS Impact Plume	SCIENCE			English	Article							MOLECULAR-HYDROGEN; BAND SYSTEM; LUNAR; MISSION; TABLE	On 9 October 2009, the Lunar Crater Observation and Sensing Satellite (LCROSS) sent a kinetic impactor to strike Cabeus crater, on a mission to search for water ice and other volatiles expected to be trapped in lunar polar soils. The Lyman Alpha Mapping Project (LAMP) ultraviolet spectrograph onboard the Lunar Reconnaissance Orbiter (LRO) observed the plume generated by the LCROSS impact as far-ultraviolet emissions from the fluorescence of sunlight by molecular hydrogen and carbon monoxide, plus resonantly scattered sunlight from atomic mercury, with contributions from calcium and magnesium. The observed light curve is well simulated by the expansion of a vapor cloud at a temperature of similar to 1000 kelvin, containing similar to 570 kilograms (kg) of carbon monoxide, similar to 140 kg of molecular hydrogen, similar to 160 kg of calcium, similar to 120 kg of mercury, and similar to 40 kg of magnesium.	[Gladstone, G. Randall; Retherford, Kurt D.; Chaufray, Jean-Yves; Versteeg, Maarten; Greathouse, Thomas K.; Davis, Michael W.; Slater, David C.; Mukherjee, Joey; Miles, Paul F.] SW Res Inst, San Antonio, TX 78238 USA; [Hurley, Dana M.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Feldman, Paul D.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Pryor, Wayne R.] Cent Arizona Coll, Coolidge, AZ 85228 USA; [Steffl, Andrew J.; Throop, Henry; Parker, Joel Wm.; Kaufmann, David E.; Egan, Anthony F.; Stern, S. Alan] SW Res Inst, Boulder, CO 80302 USA; [Hendrix, Amanda R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Colaprete, Anthony] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Southwest Research Institute; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Gladstone, GR (corresponding author), SW Res Inst, San Antonio, TX 78238 USA.	rgladstone@swri.edu	Hurley, Dana/F-4488-2015; Davis, Michael/AAK-3433-2021	Hurley, Dana/0000-0003-1052-1494; Davis, Michael/0000-0003-4338-1635; Parker, Joel/0000-0002-3672-0603	NASA; NASA Lunar Science Institute [NNA09DB31A]	NASA(National Aeronautics & Space Administration (NASA)); NASA Lunar Science Institute	We thank the LRO project and other LRO instrument leads for supporting the LCROSS support observations. In particular we thank C. Tooley, D. Everett, M. Houghton, A. Bartels, R. Saylor, R. Vondrak, G. Chin, J. Keller, T. Johnson, and C. Baker for making it happen. We also thank D. Goldstein and D. Summy for useful simulations and predictions, R. Killen and D. Boice for helpful discussions, and the referees for excellent comments. The LAMP is funded by NASA, whose financial support we gratefully acknowledge. One of us (D.M.H.) also acknowledges support from NASA Lunar Science Institute grant NNA09DB31A.	ABGRALL H, 1993, ASTRON ASTROPHYS SUP, V101, P323; ABGRALL H, 1993, ASTRON ASTROPHYS SUP, V101, P273; Abgrall H, 1997, ASTROPHYS J, V481, P557, DOI 10.1086/304017; ANDERS E, 1977, PHILOS T R SOC A, V285, P23, DOI 10.1098/rsta.1977.0040; ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Blanford G., 1985, LUNAR BASES SPACE AC, P603; Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider DH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002030; CRIDER DH, 2000, J GEOPHYS RES, V26, P773; Curdt W, 2001, ASTRON ASTROPHYS, V375, P591, DOI 10.1051/0004-6361:20010364; Gladstone GR, 2010, SPACE SCI REV, V150, P161, DOI 10.1007/s11214-009-9578-6; Goldstein DB, 2009, AIP CONF PROC, V1084, P1061; Hodges R.R., 1981, LUNAR PLANETARY I SC, P451; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Korycansky DG, 2009, METEORIT PLANET SCI, V44, P603, DOI 10.1111/j.1945-5100.2009.tb00755.x; McClintock WE, 2009, SCIENCE, V324, P610, DOI 10.1126/science.1172525; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; PILLINGER CT, 1979, REP PROG PHYS, V42, P897, DOI 10.1088/0034-4885/42/5/003; Reed GW, 1999, METEORIT PLANET SCI, V34, P809, DOI 10.1111/j.1945-5100.1999.tb01394.x; Tozzi GP, 1998, ASTRON ASTROPHYS, V330, P753; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033	22	103	105	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					472	476		10.1126/science.1186474	http://dx.doi.org/10.1126/science.1186474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966244				2022-12-24	WOS:000283329100030
J	Gong, ZF; Liu, JQ; Guo, C; Zhou, YQ; Teng, Y; Liu, L				Gong, Zhefeng; Liu, Jiangqu; Guo, Chao; Zhou, Yanqiong; Teng, Yan; Liu, Li			Two Pairs of Neurons in the Central Brain Control Drosophila Innate Light Preference	SCIENCE			English	Article							SENSORY NEURONS; MELANOGASTER; BEHAVIOR; ULTRASTRUCTURE; EXPRESSION; DISTINCT; CIRCUIT; MEDIATE; SWITCH; CLOCK	Appropriate preferences for light or dark conditions can be crucial for an animal's survival. Innate light preferences are not static in some animals, including the fruit fly Drosophila melanogaster, which prefers darkness in the feeding larval stage but prefers light in adulthood. To elucidate the neural circuit underlying light preference, we examined the neurons involved in larval phototactic behavior by regulating neuronal functions. Modulating activity of two pairs of isomorphic neurons in the central brain switched the larval light preference between photophobic and photophilic. These neurons were found to be immediately downstream of pdf-expressing lateral neurons, which are innervated by larval photoreceptors. Our results revealed a neural mechanism that could enable the adjustment of animals' response strategies to environmental stimuli according to biological needs.	[Gong, Zhefeng; Liu, Jiangqu; Guo, Chao; Zhou, Yanqiong; Liu, Li] Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China; [Liu, Jiangqu; Guo, Chao; Zhou, Yanqiong] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China; [Teng, Yan] Chinese Acad Sci, Inst Biophys, Prot Sci Core Facil Ctr, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Gong, ZF (corresponding author), Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China.	zfgong@moon.ibp.ac.cn; liuli@sun5.ibp.ac.cn			National Natural Sciences Foundation of China [30770682, 30621004, 30625022]; '973 Program' [2005CB522804, 2009CB918702]; Chinese Academy of Sciences [KSCX2-YW-R-247]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); '973 Program'(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank K. Rao for antibody to Pdf; J. Blau, K. Scott, M. Rosbach, T. Lee, C. Feng, Y. Zhong, W. Yi, Y. Jan, and R. Jiao for fly stocks and constructs; and C. Wang and X. Hao for facility setup. We thank the DGRC (Kyoto) and the Bloomington fly stock center for the fly stocks, and Developmental Studies Hybridoma Bank for antibodies. We also thank H. Gong for technical assistance, and J. Fleming and R. Wolf for valuable comments. This work was supported by the National Natural Sciences Foundation of China [grant 30770682 (Z.G.) and grants 30621004 and 30625022 (L.L.)], the '973 Program' [grants 2005CB522804 and 2009CB918702 (L.L.)], and the Knowledge Innovation Program of the Chinese Academy of Sciences [grant KSCX2-YW-R-247 (L.L.)].	Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; Busto M, 1999, J NEUROSCI, V19, P3337; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; DIRCKSEN H, 1987, CELL TISSUE RES, V250, P377; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; GROSSFIELD J, 1971, P NATL ACAD SCI USA, V68, P2669, DOI 10.1073/pnas.68.11.2669; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Li WZ, 2009, CELL TISSUE RES, V336, P509, DOI 10.1007/s00441-009-0781-2; Malpel S, 2002, DEVELOPMENT, V129, P1443; MANNING M, 1981, BEHAV GENET, V11, P557, DOI 10.1007/BF01065790; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; SAWIN FP, 1994, J INSECT BEHAV, V7, P553, DOI 10.1007/BF02025449; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021	25	62	67	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					499	502		10.1126/science.1195993	http://dx.doi.org/10.1126/science.1195993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966250				2022-12-24	WOS:000283329100038
J	Lawniczak, MKN; Emrich, SJ; Holloway, AK; Regier, AP; Olson, M; White, B; Redmond, S; Fulton, L; Appelbaum, E; Godfrey, J; Farmer, C; Chinwalla, A; Yang, SP; Minx, P; Nelson, J; Kyung, K; Walenz, BP; Garcia-Hernandez, E; Aguiar, M; Viswanathan, LD; Rogers, YH; Strausberg, RL; Saski, CA; Lawson, D; Collins, FH; Kafatos, FC; Christophides, GK; Clifton, SW; Kirkness, EF; Besansky, NJ				Lawniczak, M. K. N.; Emrich, S. J.; Holloway, A. K.; Regier, A. P.; Olson, M.; White, B.; Redmond, S.; Fulton, L.; Appelbaum, E.; Godfrey, J.; Farmer, C.; Chinwalla, A.; Yang, S. -P.; Minx, P.; Nelson, J.; Kyung, K.; Walenz, B. P.; Garcia-Hernandez, E.; Aguiar, M.; Viswanathan, L. D.; Rogers, Y. -H.; Strausberg, R. L.; Saski, C. A.; Lawson, D.; Collins, F. H.; Kafatos, F. C.; Christophides, G. K.; Clifton, S. W.; Kirkness, E. F.; Besansky, N. J.			Widespread Divergence Between Incipient Anopheles gambiae Species Revealed by Whole Genome Sequences	SCIENCE			English	Article							MOLECULAR-FORMS; ECOLOGICAL SPECIATION; GENE FLOW; ISLANDS; SEGREGATION; CULICIDAE; SELECTION; DIPTERA; S.S.	The Afrotropical mosquito Anopheles gambiae sensu stricto, a major vector of malaria, is currently undergoing speciation into the M and S molecular forms. These forms have diverged in larval ecology and reproductive behavior through unknown genetic mechanisms, despite considerable levels of hybridization. Previous genome-wide scans using gene-based microarrays uncovered divergence between M and S that was largely confined to gene-poor pericentromeric regions, prompting a speciation-with-ongoing-gene-flow model that implicated only about 3% of the genome near centromeres in the speciation process. Here, based on the complete M and S genome sequences, we report widespread and heterogeneous genomic divergence inconsistent with appreciable levels of interform gene flow, suggesting a more advanced speciation process and greater challenges to identify genes critical to initiating that process.	[White, B.; Collins, F. H.; Besansky, N. J.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA; [Lawniczak, M. K. N.; Redmond, S.; Kafatos, F. C.; Christophides, G. K.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Emrich, S. J.; Regier, A. P.; Olson, M.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Holloway, A. K.] J David Gladstone Inst, San Francisco, CA 94158 USA; [Fulton, L.; Appelbaum, E.; Godfrey, J.; Farmer, C.; Chinwalla, A.; Yang, S. -P.; Minx, P.; Nelson, J.; Kyung, K.; Clifton, S. W.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; [Walenz, B. P.; Garcia-Hernandez, E.; Aguiar, M.; Viswanathan, L. D.; Rogers, Y. -H.; Strausberg, R. L.; Kirkness, E. F.] J Craig Venter Inst, Rockville, MD 20850 USA; [Saski, C. A.] Clemson Univ, Clemson Univ Genom Inst, Clemson, SC 29634 USA; [Lawson, D.] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England	University of Notre Dame; Imperial College London; University of Notre Dame; University of California System; University of California San Francisco; The J David Gladstone Institutes; Washington University (WUSTL); J. Craig Venter Institute; Clemson University; European Molecular Biology Laboratory (EMBL)	Besansky, NJ (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA.	nbesansk@nd.edu	Holloway, Alisha/H-9574-2013	Holloway, Alisha/0000-0001-9810-389X; Lawniczak, Mara/0000-0002-3006-2080; redmond, seth/0000-0003-2653-760X; Lawson, Daniel/0000-0001-7765-983X; Chinwalla, Asif/0000-0001-7831-3996; Christophides, George/0000-0002-3323-1687	National Human Genome Research Institute [U54-HG00379, U54-HG03068]; NIH [RO1 AI63508, AI076584]; Biotechnology and Biological Sciences Research Council [BB/E002641/1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003068, R01HG000379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076584, R01AI063508] Funding Source: NIH RePORTER; BBSRC [BB/E002641/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C519670/1] Funding Source: researchfish	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank W. M. Gelbart, an early advocate of this project, and J. L. Feder, P. Nosil, and M. W. Hahn for critical review. P. Howell of MR4 provided mosquitoes. Funding for genome sequencing of M (U54-HG00379) and S (U54-HG03068) was provided by the National Human Genome Research Institute. N.J.B. was supported by NIH (RO1 AI63508 and AI076584). M.K.N.L. was supported by Biotechnology and Biological Sciences Research Council research grant BB/E002641/1 to G.K.C. Sequence data are deposited with GenBank (accessions ABKP00000000 and ABKQ00000000).	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Carneiro M, 2009, GENETICS, V181, P593, DOI 10.1534/genetics.108.096826; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Du W, 2005, INSECT MOL BIOL, V14, P179, DOI 10.1111/j.1365-2583.2005.00544.x; Feder JL, 2010, EVOLUTION, V64, P1729, DOI [10.1111/j.1558-5646.2009.00943.x, 10.1111/j.1558-5646.2010.00943.x]; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Li YF, 2008, EVOLUTION, V62, P2984, DOI 10.1111/j.1558-5646.2008.00486.x; Mehren JE, 2007, CURR BIOL, V17, pR240, DOI 10.1016/j.cub.2007.02.014; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x	24	206	208	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					512	514		10.1126/science.1195755	http://dx.doi.org/10.1126/science.1195755			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966253	Green Accepted			2022-12-24	WOS:000283329100042
J	Johnson, WE; Onorato, DP; Roelke, ME; Land, ED; Cunningham, M; Belden, RC; McBride, R; Jansen, D; Lotz, M; Shindle, D; Howard, J; Wildt, DE; Penfold, LM; Hostetler, JA; Oli, MK; O'Brien, SJ				Johnson, Warren E.; Onorato, David P.; Roelke, Melody E.; Land, E. Darrell; Cunningham, Mark; Belden, Robert C.; McBride, Roy; Jansen, Deborah; Lotz, Mark; Shindle, David; Howard, JoGayle; Wildt, David E.; Penfold, Linda M.; Hostetler, Jeffrey A.; Oli, Madan K.; O'Brien, Stephen J.			Genetic Restoration of the Florida Panther	SCIENCE			English	Article							CONSERVATION; PUMAS	The rediscovery of remnant Florida panthers (Puma concolor coryi) in southern Florida swamplands prompted a program to protect and stabilize the population. In 1995, conservation managers translocated eight female pumas (P. c. stanleyana) from Texas to increase depleted genetic diversity, improve population numbers, and reverse indications of inbreeding depression. We have assessed the demographic, population-genetic, and biomedical consequences of this restoration experiment and show that panther numbers increased threefold, genetic heterozygosity doubled, survival and fitness measures improved, and inbreeding correlates declined significantly. Although these results are encouraging, continued habitat loss, persistent inbreeding, infectious agents, and possible habitat saturation pose new dilemmas. This intensive management program illustrates the challenges of maintaining populations of large predators worldwide.	[Johnson, Warren E.; O'Brien, Stephen J.] NCI, Lab Genom Divers, Frederick, MD 21702 USA; [Onorato, David P.; Land, E. Darrell; Cunningham, Mark; Lotz, Mark; Shindle, David] Florida Fish & Wildlife Conservat Commiss, Naples, FL 34114 USA; [Roelke, Melody E.] NCI, SAIC Frederick, Lab Genom Divers, Frederick, MD 21702 USA; [Belden, Robert C.] US Fish & Wildlife Serv, Vero Beach, FL 32960 USA; [McBride, Roy] Livestock Protect Co, Alpine, TX 79832 USA; [Jansen, Deborah] Big Cypress Natl Preserve, Ochopee, FL 34141 USA; [Howard, JoGayle; Wildt, David E.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Penfold, Linda M.] White Oak Conservat Ctr, Yulee, FL 32046 USA; [Hostetler, Jeffrey A.; Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Florida Fish & Wildlife Conservation Commission; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; United States Department of the Interior; US Fish & Wildlife Service; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; State University System of Florida; University of Florida	Johnson, WE (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	warjohns@mail.nih.gov; Dave.Onorato@MyFWC.com; stephenobrien@nih.gov	Onorato, Dave/AAD-2563-2021; Hostetler, Jeffrey A./A-3345-2011; Johnson, Warren/D-4149-2016; OBRIEN, STEPHEN/ABD-1346-2020	Onorato, Dave/0000-0002-4716-6847; Hostetler, Jeffrey A./0000-0003-3669-1758; Johnson, Warren/0000-0002-5954-186X; OBRIEN, STEPHEN/0000-0001-7857-0757	Florida Fish and Wildlife Conservation Commission (FWC); Everglades National Park (EVER); BCNP; U.S. Fish and Wildlife Service; National Cancer Institute, National Institutes of Health (NIH) [N01-CO-12400]; NIH, National Cancer Institute, Center for Cancer Research; Florida Panther Research and Management Trust; NATIONAL CANCER INSTITUTE [ZIABC005367] Funding Source: NIH RePORTER	Florida Fish and Wildlife Conservation Commission (FWC); Everglades National Park (EVER); BCNP; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Panther Research and Management Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We dedicate this study to the memory of Ulysses Seal and Ernst Mayr, important heroes in the conservation struggle of the Florida panther. Funded by the Florida Fish and Wildlife Conservation Commission (FWC) via purchases of Florida panther license plates. Other major funding for the field work was provided by Everglades National Park (EVER), the BCNP, and federal funds from the U.S. Fish and Wildlife Service (especially in the early years) as well as from the National Cancer Institute, National Institutes of Health (NIH), under contract number N01-CO-12400. This research was supported in part by the Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research, and the Florida Panther Research and Management Trust Fund. All panther captures, sampling, and radio collaring were authorized by U. S. Fish and Wildlife Service Endangered Species Permits TE01553-3 (FWC) and TE146761-1 (BCNP). We thank many individuals for their help in this project, who are named in SOM reference S25.	BARONE MA, 1994, J MAMMAL, V75, P150, DOI 10.2307/1382247; Culver M, 2008, ANIM CONSERV, V11, P104, DOI 10.1111/j.1469-1795.2007.00154.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Cunningham MW, 2008, J WILDLIFE DIS, V44, P537, DOI 10.7589/0090-3558-44.3.537; Cunningham MW, 1999, J WILDLIFE DIS, V35, P519, DOI 10.7589/0090-3558-35.3.519; Currier M.J.P, 1983, MAMMALIAN SPECIES, V200, P1, DOI [10.2307/3503951, DOI 10.2307/3503951]; FOSTER ML, 1995, WILDLIFE SOC B, V23, P95; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Janis MW, 2002, J WILDLIFE MANAGE, V66, P839, DOI 10.2307/3803148; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; McBride RT, 2008, SOUTHEAST NAT, V7, P381, DOI 10.1656/1528-7092-7.3.381; O'Brien SJ., 2003, TEARS CHEETAH OTHER; OBRIEN SJ, 1990, NATL GEOGR RES, V6, P485; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Roelke ME, 2006, J WILDLIFE DIS, V42, P234, DOI 10.7589/0090-3558-42.2.234; ROELKE ME, 1993, J WILDLIFE DIS, V29, P36, DOI 10.7589/0090-3558-29.1.36; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Seal US., 1994, PLAN GENETIC RESTORA	22	336	342	4	477	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1641	1645		10.1126/science.1192891	http://dx.doi.org/10.1126/science.1192891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929847	Green Accepted			2022-12-24	WOS:000282098100040
J	Famulski, JK; Trivedi, N; Howell, D; Yang, YA; Tong, YA; Gilbertson, R; Solecki, DJ				Famulski, Jakub K.; Trivedi, Niraj; Howell, Danielle; Yang, Yuan; Tong, Yiai; Gilbertson, Richard; Solecki, David J.			Siah Regulation of Pard3A Controls Neuronal Cell Adhesion During Germinal Zone Exit	SCIENCE			English	Article							ASYMMETRIC DIVISION; GRANULE CELLS; MIGRATION; NEOCORTEX; BRAIN; CENTROSOME; POLARITY; MODE	The brain's circuitry is established by directed migration and synaptogenesis of neurons during development. Although neurons mature and migrate in specific patterns, little is known about how neurons exit their germinal zone niche. We found that cerebellar granule neuron germinal zone exit is regulated by proteasomal degradation of Pard3A by the Seven in Absentia homolog (Siah) E3 ubiquitin ligase. Pard3A gain of function and Siah loss of function induce precocious radial migration. Time-lapse imaging using a probe to measure neuronal cell contact reveals that Pard3A promotes adhesive interactions needed for germinal zone exit by recruiting the epithelial tight junction adhesion molecule C to the neuronal cell surface. Our findings define a Siah-Pard3A signaling pathway that controls adhesion-dependent exit of neuronal progenitors or immature neurons from a germinal zone niche.	[Famulski, Jakub K.; Trivedi, Niraj; Howell, Danielle; Yang, Yuan; Tong, Yiai; Gilbertson, Richard; Solecki, David J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Solecki, DJ (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	david.solecki@stjude.org	Gilbertson, Richard James/ABE-1346-2021; Solecki, David/N-8080-2018	Gilbertson, Richard James/0000-0001-7539-9472; 	American Lebanese Syrian Associated Charities (ALSAC); National Cancer Institute Cancer Center; March of Dimes Basil O'Connor Starter Scholar Research Award; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA129541, P01CA096832] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); March of Dimes Basil O'Connor Starter Scholar Research Award(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to J. Morgan, M. Dyer, M. Roussel, and N. Ayad for critically reading the manuscript; A. Sawa, S. Zakharenko, and B. Schulman for insightful discussions; S. Connell, R. Baird, and K. Kilborn (Intelligent Imaging Innovations) for timely data analysis advice and support; G. Chan for providing space for some of the revision experiments; and S. Naron for excellent editorial assistance. G. Miesenbock and Memorial Sloan-Kettering Cancer Center provided the pHluorin reporter, A. Miyawaki provided Venus, F. Polleux provided pCIG2, M. Aurrand-Lions provided anti-JAM-C antiserum, I. Dikic provided the hemagglutinin-ubiquitin (HA-Ubq) construct, and A. Sawa shared Siah reagents. Supported by American Lebanese Syrian Associated Charities (ALSAC, D.J.S.), a National Cancer Institute Cancer Center Support Grant (D.J.S.), and a March of Dimes Basil O'Connor Starter Scholar Research Award (D.J.S.).	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; FISHELL G, 1991, DEVELOPMENT, V113, P755; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2009, CANCER RES, V69, P8835, DOI 10.1158/0008-5472.CAN-09-1676; Karakuzu O, 2009, DEVELOPMENT, V136, P943, DOI 10.1242/dev.029363; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Metin C, 2008, J NEUROSCI, V28, P11746, DOI 10.1523/JNEUROSCI.3860-08.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Polleux F, 2002, DEVELOPMENT, V129, P3147; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic P, 1985, CELL CONTACT ADHESIO, P67; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	29	69	70	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1834	1838		10.1126/science.1198480	http://dx.doi.org/10.1126/science.1198480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21109632	Green Accepted			2022-12-24	WOS:000285603700044
J	Gallo, CM; Wang, JT; Motegi, F; Seydoux, G				Gallo, Christopher M.; Wang, Jennifer T.; Motegi, Fumio; Seydoux, Geraldine			Cytoplasmic Partitioning of P Granule Components Is Not Required to Specify the Germline in C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; ASYMMETRY; PROTEINS	Asymmetric segregation of P granules during the first four divisions of the Caenorhabditis elegans embryo is a classic example of cytoplasmic partitioning of germline determinants. It is thought that asymmetric partitioning of P granule components during mitosis is essential to distinguish germline from soma. We have identified a mutant (pptr-1) in which P granules become unstable during mitosis and P granule proteins and RNAs are distributed equally to somatic and germline blastomeres. Despite symmetric partitioning of P granule components, pptr-1 mutants segregate a germline that uniquely expresses P granules during postembryonic development. pptr-1 mutants are fertile, except at high temperatures. Hence, asymmetric partitioning of maternal P granules is not essential to specify germ cell fate. Instead, it may serve to protect the nascent germline from stress.	[Gallo, Christopher M.; Wang, Jennifer T.; Motegi, Fumio; Seydoux, Geraldine] Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Seydoux, G (corresponding author), Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Dept Mol Biol & Genet, 725 N Wolfe St,PCTB 706, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu	SEYDOUX, Geraldine/AAA-2005-2020	Wang, Jennifer/0000-0002-8506-5182; Seydoux, Geraldine/0000-0001-8257-0493	NIH [GM080042, HD007276, HD037047]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080042] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. H. Kim, S. Strome, E. Voronina, K. Kemphues, K. Bennett, and C. Eckmann for reagents and advice. We also obtained reagents from the National Bioresource Project for the Nematode (Japan), the Caenorhabditis Genetics Center, and the Developmental Studies Hybridoma Bank (USA). This work was supported by NIH grants GM080042 to C. M. G., HD007276 to J.T.W., and HD037047 to G. S. G. S. is a Howard Hughes Medical Institute investigator. Plasmids are supplied under a Materials Transfer Agreement from the Howard Hughes Medical Institute.	Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Daniels BR, 2009, J CELL BIOL, V184, P473, DOI 10.1083/jcb.200809077; Gonczy Pierre, 2005, WormBook, P1; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kawasaki L, 2004, GENETICS, V167, P645, DOI 10.1534/genetics.103.023093; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Munro E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003400; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Spike C, 2008, GENETICS, V178, P1973, DOI 10.1534/genetics.107.083469; Strome Susan, 2005, WormBook, P1, DOI 10.1895/wormbook.1.9.1; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Updike D, 2010, J ANDROL, V31, P53, DOI 10.2164/jandrol.109.008292; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	20	95	98	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1685	1689		10.1126/science.1193697	http://dx.doi.org/10.1126/science.1193697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21127218	Green Accepted			2022-12-24	WOS:000285390500069
J	Bottke, WF; Walker, RJ; Day, JMD; Nesvorny, D; Elkins-Tanton, L				Bottke, William F.; Walker, Richard J.; Day, James M. D.; Nesvorny, David; Elkins-Tanton, Linda			Stochastic Late Accretion to Earth, the Moon, and Mars	SCIENCE			English	Article							SIDEROPHILE ELEMENT SYSTEMATICS; CORE FORMATION; OSMIUM ISOTOPE; ASTEROID BELT; MANTLE; ORIGIN; DIFFERENTIATION; CONSTRAINTS; METEORITES; SILICATE	Core formation should have stripped the terrestrial, lunar, and martian mantles of highly siderophile elements (HSEs). Instead, each world has disparate, yet elevated HSE abundances. Late accretion may offer a solution, provided that >= 0.5% Earth masses of broadly chondritic planetesimals reach Earth's mantle and that similar to 10 and similar to 1200 times less mass goes to Mars and the Moon, respectively. We show that leftover planetesimal populations dominated by massive projectiles can explain these additions, with our inferred size distribution matching those derived from the inner asteroid belt, ancient martian impact basins, and planetary accretion models. The largest late terrestrial impactors, at 2500 to 3000 kilometers in diameter, potentially modified Earth's obliquity by similar to 10 degrees, whereas those for the Moon, at similar to 250 to 300 kilometers, may have delivered water to its mantle.	[Bottke, William F.; Nesvorny, David] SW Res Inst, Boulder, CO 80302 USA; [Bottke, William F.; Nesvorny, David] NASA, Lunar Sci Inst, Boulder, CO 80302 USA; [Walker, Richard J.; Day, James M. D.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Day, James M. D.] Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; [Elkins-Tanton, Linda] MIT, Cambridge, MA 02139 USA	National Aeronautics & Space Administration (NASA); University System of Maryland; University of Maryland College Park; University of California System; University of California San Diego; Scripps Institution of Oceanography; Massachusetts Institute of Technology (MIT)	Bottke, WF (corresponding author), SW Res Inst, 1050 Walnut St,Suite 400, Boulder, CO 80302 USA.	bottke@boulder.swri.edu	Day, James/A-5099-2010; Walker, Richard/K-6869-2016; Elkins-Tanton, Linda/C-5508-2008	Day, James/0000-0001-9520-3465; Walker, Richard/0000-0003-0348-2407; Elkins-Tanton, Linda/0000-0003-4008-1098	NASA's Lunar Science Institute [NNA09DB33A]; NASA [NNG04GJ49A]; Direct For Mathematical & Physical Scien [0747154] Funding Source: National Science Foundation	NASA's Lunar Science Institute; NASA(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Barr, R. Canup, R. Citron, L. Dones, H. Levison, J. Jones, H. Nekvasil, A. Morbidelli, D. Minton, S. Mojzsis, G. J. Taylor, and D. Vokouhlicky for many useful discussions and two anonymous reviewers for constructive reviews. W.F.B's and D.N.'s participation was supported by NASA's Lunar Science Institute through a grant to the Center for Lunar Origin and Evolution at the Southwest Research Institute in Boulder, Colorado. R.J.W.'s and J.M.D.D.'s work was supported by NASA's Lunar Science Institute through contract NNA09DB33A to the Center for Lunar Science and Exploration at the Lunar and Planetary Institute in Houston, Texas, and the NASA Astrobiology Program through grant NNG04GJ49A to the Goddard Center for Astrobiology in Greenbelt, Maryland.	Artemieva NA, 2008, SOLAR SYST RES+, V42, P329, DOI 10.1134/S0038094608040059; Asphaug E, 2010, CHEM ERDE-GEOCHEM, V70, P199, DOI 10.1016/j.chemer.2010.01.004; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; Bennett VC, 2002, GEOCHIM COSMOCHIM AC, V66, P2615, DOI 10.1016/S0016-7037(02)00862-1; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; BORISOV A, 1994, GEOCHIM COSMOCHIM AC, V58, P705, DOI 10.1016/0016-7037(94)90500-2; Bottke WF, 2002, ICARUS, V156, P399, DOI 10.1006/icar.2001.6788; Bottke WF, 2006, NATURE, V439, P821, DOI 10.1038/nature04536; Bottke WF, 2007, ICARUS, V190, P203, DOI 10.1016/j.icarus.2007.02.010; Brandon AD, 2000, GEOCHIM COSMOCHIM AC, V64, P4083, DOI 10.1016/S0016-7037(00)00482-8; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Chou CL, 1978, P LUNAR PLANET SCI, V9, P219; Cuzzi JN, 2010, ICARUS, V208, P518, DOI 10.1016/j.icarus.2010.03.005; Dahl TW, 2010, EARTH PLANET SC LETT, V295, P177, DOI 10.1016/j.epsl.2010.03.038; Day JMD, 2007, SCIENCE, V315, P217, DOI 10.1126/science.1133355; Day JMD, 2010, EARTH PLANET SC LETT, V289, P595, DOI 10.1016/j.epsl.2009.12.001; FARINELLA P, 1992, ICARUS, V97, P111, DOI 10.1016/0019-1035(92)90060-K; Frey HV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002449; Halliday AN, 2005, TREATISE GEOCHEM, V1, P509; HOLSAPPLE KA, 1993, ANNU REV EARTH PL SC, V21, P333, DOI 10.1146/annurev.ea.21.050193.002001; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086; JONES JH, 1986, NATURE, V323, P470, DOI 10.1038/323470a0; Jones JH, 2003, CHEM GEOL, V196, P21, DOI 10.1016/S0009-2541(02)00404-7; Levison HF, 2009, NATURE, V460, P364, DOI 10.1038/nature08094; Maier WD, 2009, NATURE, V460, P620, DOI 10.1038/nature08205; Marinova MM, 2008, NATURE, V453, P1216, DOI 10.1038/nature07070; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; Morbidelli A, 2009, ICARUS, V204, P558, DOI 10.1016/j.icarus.2009.07.011; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; Puchtel IS, 2008, GEOCHIM COSMOCHIM AC, V72, P3022, DOI 10.1016/j.gca.2008.04.006; Robert F, 2003, SPACE SCI REV, V106, P87, DOI 10.1023/A:1024629402715; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; Rubie DC, 2003, EARTH PLANET SC LETT, V205, P239, DOI 10.1016/S0012-821X(02)01044-0; Sharp ZD, 2010, SCIENCE, V329, P1050, DOI 10.1126/science.1192606; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Walker RJ, 2004, EARTH PLANET SC LETT, V224, P399, DOI 10.1016/j.epsl.2004.05.036; Ward WR, 2000, NATURE, V403, P741, DOI 10.1038/35001516; Warren PH, 2005, TREATISE GEOCHEM, V1, P559	39	159	161	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1527	1530		10.1126/science.1196874	http://dx.doi.org/10.1126/science.1196874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148387				2022-12-24	WOS:000285153500061
J	Zhang, P; Wang, JW; Shi, YG				Zhang, Peng; Wang, Jiawei; Shi, Yigong			Structure and mechanism of the S component of a bacterial ECF transporter	NATURE			English	Article							ABC TRANSPORTERS; BINDING	The energy-coupling factor (ECF) transporters, responsible for vitamin uptake in prokaryotes, are a unique family of membrane transporters(1,2). Each ECF transporter contains a membrane-embedded, substrate-binding protein (known as the S component), an energy-coupling module that comprises two ATP-binding proteins (known as the A and A' components) and a transmembrane protein (known as the T component). The structure and transport mechanism of the ECF family remain unknown. Here we report the crystal structure of RibU, the S component of the ECF-type riboflavin transporter from Staphylococcus aureus at 3.6-angstrom resolution. RibU contains six transmembrane segments, adopts a previously unreported transporter fold and contains a riboflavin molecule bound to the L1 loop and the periplasmic portion of transmembrane segments 4-6. Structural analysis reveals the essential ligand-binding residues, identifies the putative transport path and, with sequence alignment, uncovers conserved structural features and suggests potential mechanisms of action among the ECF transporters. [GRAPHICS] .	[Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Beijing 100084, Peoples R China; [Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Zhang, Peng] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; [Wang, Jiawei] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Wang, Jiawei] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Princeton University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Shi, Yigong/0000-0003-2030-168X; zhang, peng/0000-0003-0408-2923	National Institutes of Health [R01 GM084964]; Ministry of Science and Technology of China [2009CB918801]; National Natural Science Foundation of China [30888001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Yan for technical advice, A. Schmedel for administrative assistance and E. coli Genetic Resources at Yale Coli Genetic Stock Center for providing mutant E. coli strains. This work was supported by the National Institutes of Health (R01 GM084964), funds from the Ministry of Science and Technology of China (grant number 2009CB918801) and Project 30888001 supported by National Natural Science Foundation of China.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANDRIN SV, 1983, GENETIKA+, V19, P1419; Burgess CM, 2006, J BACTERIOL, V188, P2752, DOI 10.1128/JB.188.8.2752-2760.2006; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07	25	72	76	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					717	U148		10.1038/nature09488	http://dx.doi.org/10.1038/nature09488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	20972419				2022-12-24	WOS:000284836700046
J	Okie, S				Okie, Susan			A Flood of Opioids, a Rising Tide of Deaths	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; OVERDOSE		Georgetown Univ, Sch Med, Washington, DC 20057 USA	Georgetown University	Okie, S (corresponding author), Georgetown Univ, Sch Med, Washington, DC 20057 USA.							[Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P705; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; *SUBST AB MENT HLT, SUBST AB TREATM ADM	5	635	645	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2010	363	21					1981	1985		10.1056/NEJMp1011512	http://dx.doi.org/10.1056/NEJMp1011512			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	681KC	21083382				2022-12-24	WOS:000284310000001
J	Smith, AK; Cenzer, IS; Knight, SJ; Puntillo, KA; Widera, E; Williams, BA; Boscardin, WJ; Covinsky, KE				Smith, Alexander K.; Cenzer, Irena Stijacic; Knight, Sara J.; Puntillo, Kathleen A.; Widera, Eric; Williams, Brie A.; Boscardin, W. John; Covinsky, Kenneth E.			The Epidemiology of Pain During the Last 2 Years of Life	ANNALS OF INTERNAL MEDICINE			English	Article							FAMILY-MEMBERS; OF-LIFE; CANCER; OLDER; AGE; PREVALENCE; MANAGEMENT; CARE; END; INTERFERENCE	Background: The epidemiology of pain during the last years of life has not been well described. Objective: To describe the prevalence and correlates of pain during the last 2 years of life. Design: Observational study. Data from participants who died while enrolled in the Health and Retirement Study were analyzed. The survey interview closest to death was used. Each participant or proxy was interviewed once in the last 24 months of life and was classified into 1 of 24 cohorts on the basis of the number of months between the interview and death. The relationship between time before death and pain was modeled and was adjusted for age, sex, race or ethnicity, education level, net worth, income, terminal diagnosis category, presence of arthritis, and proxy status. Setting: The Health and Retirement Study, a nationally representative survey of community-living older adults (1994 to 2006). Participants: Older adult decedents. Measurements: Clinically significant pain, as indicated by a report that the participant was "often troubled" by pain of at least moderate severity. Results: The sample included 4703 decedents. Mean age (SD) of participants was 75.7 years (SD, 10.8); 83.1% were white, 10.7% were black, 4.7% were Hispanic; and 52.3% were men. The adjusted prevalence of pain 24 months before death was 26% (95% CI, 23% to 30%). The prevalence remained flat until 4 months before death (28% [CI, 25% to 32%]), then it increased, reaching 46% (CI, 38% to 55%) in the last month of life. The prevalence of pain in the last month of life was 60% among patients with arthritis versus 26% among patients without arthritis (P < 0.001) and did not differ by terminal diagnosis category (cancer [45%], heart disease [48%], frailty [50%], sudden death [42%], or other causes [47%]; P = 0.195). Limitation: Data are cross-sectional; 19% of responses were from proxies; and information about cause, location, and treatment of pain was not available. Conclusion: Although the prevalence of pain increases in the last 4 months of life, pain is present in more than one quarter of elderly persons during the last 2 years of life. Arthritis is strongly associated with pain at the end of life.	[Smith, Alexander K.] Univ Calif San Francisco, Div Geriatr, Dept Med, San Francisco, CA 94121 USA; [Smith, Alexander K.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Smith, AK (corresponding author), Univ Calif San Francisco, Div Geriatr, Dept Med, 4150 Clement St 181G, San Francisco, CA 94121 USA.	aksmith@ucsf.edu	Knight, Sara/AAJ-3818-2020		National Institute on Aging [R01AG028481, K24AG029812]; National Center for Research Resources UCSF-CTSI [UL1 RR024131]; National Palliative Care Research Center; National Institute on Musculoskeletal and Skin Diseases [P60 AR053308]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR053308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG029812, K23AG033102, R01AG028481] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Palliative Care Research Center; National Institute on Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Smith is supported by a Research Supplement to Promote Diversity in Health Related Research from the National Institute on Aging (R01AG028481), the National Center for Research Resources UCSF-CTSI (UL1 RR024131), and the National Palliative Care Research Center. Dr. Covinsky is supported by a K-24 grant from the National Institute on Aging (K24AG029812) and a grant from the National Institute on Musculoskeletal and Skin Diseases (P60 AR053308).	ADDINGTONHALL J, 1995, PALLIATIVE MED, V9, P295, DOI 10.1177/026921639500900404; *AM GER SOC, AGS CLIN PRACT GUID; American Geriatrics Society, 2009, J AM GERIATR SOC, V57, P1331, DOI [10.1111/j.1532-5415.2009.02376.x, DOI 10.1111/J.1532-5415.2009.02376.X]; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; BELLVILL.JW, 1971, J AMER MED ASSOC, V217, P1835, DOI 10.1001/jama.217.13.1835; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Christakis NA., 2001, DEATH FORETOLD PROPH; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Conill C, 1997, J PAIN SYMPTOM MANAG, V14, P328, DOI 10.1016/S0885-3924(97)00263-7; Desbiens NA, 1996, CRIT CARE MED, V24, P1953, DOI 10.1097/00003246-199612000-00005; Desbiens NA, 1997, J AM GERIATR SOC, V45, P1167, DOI 10.1111/j.1532-5415.1997.tb03765.x; DOBRATZ MC, 1991, CANCER NURS, V14, P20; Dominick Kelli L, 2004, Health Qual Life Outcomes, V2, P5; Du Pen SL, 1999, J CLIN ONCOL, V17, P361, DOI 10.1200/JCO.1999.17.1.361; Dunlop DD, 2001, ARTHRITIS RHEUM-US, V44, P212, DOI 10.1002/1529-0131(200101)44:1<212::AID-ANR28>3.0.CO;2-Q; Edwards RR, 2001, PSYCHOSOM MED, V63, P316, DOI 10.1097/00006842-200103000-00018; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; HARKINS SW, 1976, PAIN, V2, P253, DOI 10.1016/0304-3959(76)90004-X; HARKINS SW, 1986, J GERONTOL, V41, P58, DOI 10.1093/geronj/41.1.58; Helme RD, 2001, CLIN GERIATR MED, V17, P417, DOI 10.1016/S0749-0690(05)70078-1; HIGGINSON I, 1994, SOC SCI MED, V38, P553, DOI 10.1016/0277-9536(94)90251-8; *HLTH RET STUD, SURV DES; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Kutner JS, 2008, ANN INTERN MED, V149, P369, DOI 10.7326/0003-4819-149-6-200809160-00003; Lloyd-Williams M, 2004, PALLIATIVE MED, V18, P558, DOI 10.1191/0269216304pm923oa; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; McPherson CJ, 2003, SOC SCI MED, V56, P95, DOI 10.1016/S0277-9536(02)00011-4; Mercadante S, 2000, J PAIN SYMPTOM MANAG, V20, P104, DOI 10.1016/S0885-3924(00)00160-3; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Owens M R, 2001, Am J Hosp Palliat Care, V18, P124, DOI 10.1177/104990910101800211; PAPPAGALLO M, 2004, NEUROLOGIC BASIS PAI; Peat G, 2004, PAIN, V112, P397, DOI 10.1016/j.pain.2004.09.029; Reynolds KS, 2008, J PAIN SYMPTOM MANAG, V35, P388, DOI 10.1016/j.jpainsymman.2008.01.001; Scheetz J, 1988, Dimens Oncol Nurs, V2, P9; SCHLUDERMANN E, 1962, PERCEPT MOTOR SKILL, V14, P295; Silveira Maria J, 2005, J Palliat Med, V8, P827, DOI 10.1089/jpm.2005.8.827; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Stewart AL, 1999, J PAIN SYMPTOM MANAG, V17, P93, DOI 10.1016/S0885-3924(98)00131-6; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; TURK DC, 1995, PAIN, V61, P93, DOI 10.1016/0304-3959(94)00167-D; Ventafridda V, 1990, J Palliat Care, V6, P7; Weiss SC, 2001, LANCET, V357, P1311, DOI 10.1016/S0140-6736(00)04515-3; WOODROW KM, 1972, PSYCHOSOM MED, V34, P548, DOI 10.1097/00006842-197211000-00007	50	100	101	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 2	2010	153	9					563	569		10.7326/0003-4819-153-9-201011020-00005	http://dx.doi.org/10.7326/0003-4819-153-9-201011020-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	673MH	21041575	Green Accepted			2022-12-24	WOS:000283667000002
J	Goodwin, SS; Vale, RD				Goodwin, Sarah S.; Vale, Ronald D.			Patronin Regulates the Microtubule Network by Protecting Microtubule Minus Ends	CELL			English	Article							GAMMA-TUBULIN; DYNAMICS; CENTROSOME; LENGTH; NUCLEATION; DEPOLYMERIZATION; COOPERATE; KINESINS; COMPLEX; FAMILY	Tubulin assembles into microtubule polymers that have distinct plus and minus ends. Most microtubule plus ends in living cells are dynamic; the transitions between growth and shrinkage are regulated by assembly-promoting and destabilizing proteins. In contrast, minus ends are generally not dynamic, suggesting their stabilization by some unknown protein. Here, we have identified Patronin (also known as ssp4) as a protein that stabilizes microtubule minus ends in Drosophila S2 cells. In the absence of Patronin, minus ends lose subunits through the actions of the Kinesin-13 microtubule depolymerase, leading to a sparse interphase microtubule array and short, disorganized mitotic spindles. In vitro, the selective binding of purified Patronin to microtubule minus ends is sufficient to protect them against Kinesin-13-induced depolymerization. We propose that Patronin caps and stabilizes microtubule minus ends, an activity that serves a critical role in the organization of the microtubule cytoskeleton.	[Goodwin, Sarah S.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Goodwin, Sarah S.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Goodwin, Sarah/0000-0003-4686-0914	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM038499, R37 GM038499-22] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Baines AJ, 2009, MOL BIOL EVOL, V26, P2005, DOI 10.1093/molbev/msp115; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; Fan J, 1996, J MOL BIOL, V259, P325, DOI 10.1006/jmbi.1996.0322; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kwok BH, 2007, CURR OPIN CELL BIOL, V19, P36, DOI 10.1016/j.ceb.2006.12.003; Laycock JE, 2006, J CELL SCI, V119, P2354, DOI 10.1242/jcs.02957; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; MITCHISON TJ, 1993, SCIENCE, V261, P1044, DOI 10.1126/science.8102497; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Rath U, 2009, MOL BIOL CELL, V20, P4696, DOI 10.1091/mbc.E09-07-0557; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Vorobjev IA, 1999, J CELL SCI, V112, P2277; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yvon AMC, 1997, J CELL SCI, V110, P2391; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	47	165	169	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					263	274		10.1016/j.cell.2010.09.022	http://dx.doi.org/10.1016/j.cell.2010.09.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946984	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000283052200015
J	Arensburger, P; Megy, K; Waterhouse, RM; Abrudan, J; Amedeo, P; Antelo, B; Bartholomay, L; Bidwell, S; Caler, E; Camara, F; Campbell, CL; Campbell, KS; Casola, C; Castro, MT; Chandramouliswaran, I; Chapman, SB; Christley, S; Costas, J; Eisenstadt, E; Feschotte, C; Fraser-Liggett, C; Guigo, R; Haas, B; Hammond, M; Hansson, BS; Hemingway, J; Hill, SR; Howarth, C; Ignell, R; Kennedy, RC; Kodira, CD; Lobo, NF; Mao, CH; Mayhew, G; Michel, K; Mori, A; Liu, NN; Naveira, H; Nene, V; Nguyen, N; Pearson, MD; Pritham, EJ; Puiu, D; Qi, YM; Ranson, H; Ribeiro, JMC; Roberston, HM; Severson, DW; Shumway, M; Stanke, M; Strausberg, RL; Sun, C; Sutton, G; Tu, ZJ; Tubio, JMC; Unger, MF; Vanlandingham, DL; Vilella, AJ; White, O; White, JR; Wondji, CS; Wortman, J; Zdobnov, EM; Birren, B; Christensen, BM; Collins, FH; Cornel, A; Dimopoulos, G; Hannick, LI; Higgs, S; Lanzaro, GC; Lawson, D; Lee, NH; Muskavitch, MAT; Raikhel, AS; Atkinson, PW				Arensburger, Peter; Megy, Karine; Waterhouse, Robert M.; Abrudan, Jenica; Amedeo, Paolo; Antelo, Beatriz; Bartholomay, Lyric; Bidwell, Shelby; Caler, Elisabet; Camara, Francisco; Campbell, Corey L.; Campbell, Kathryn S.; Casola, Claudio; Castro, Marta T.; Chandramouliswaran, Ishwar; Chapman, Sinead B.; Christley, Scott; Costas, Javier; Eisenstadt, Eric; Feschotte, Cedric; Fraser-Liggett, Claire; Guigo, Roderic; Haas, Brian; Hammond, Martin; Hansson, Bill S.; Hemingway, Janet; Hill, Sharon R.; Howarth, Clint; Ignell, Rickard; Kennedy, Ryan C.; Kodira, Chinnappa D.; Lobo, Neil F.; Mao, Chunhong; Mayhew, George; Michel, Kristin; Mori, Akio; Liu, Nannan; Naveira, Horacio; Nene, Vishvanath; Nguyen, Nam; Pearson, Matthew D.; Pritham, Ellen J.; Puiu, Daniela; Qi, Yumin; Ranson, Hilary; Ribeiro, Jose M. C.; Roberston, Hugh M.; Severson, David W.; Shumway, Martin; Stanke, Mario; Strausberg, Robert L.; Sun, Cheng; Sutton, Granger; Tu, Zhijian (Jake); Tubio, Jose Manuel C.; Unger, Maria F.; Vanlandingham, Dana L.; Vilella, Albert J.; White, Owen; White, Jared R.; Wondji, Charles S.; Wortman, Jennifer; Zdobnov, Evgeny M.; Birren, Bruce; Christensen, Bruce M.; Collins, Frank H.; Cornel, Anthony; Dimopoulos, George; Hannick, Linda I.; Higgs, Stephen; Lanzaro, Gregory C.; Lawson, Daniel; Lee, Norman H.; Muskavitch, Marc A. T.; Raikhel, Alexander S.; Atkinson, Peter W.			Sequencing of Culex quinquefasciatus Establishes a Platform for Mosquito Comparative Genomics	SCIENCE			English	Article							AEDES-AEGYPTI; PIPIENS; VECTOR	Culex quinquefasciatus (the southern house mosquito) is an important mosquito vector of viruses such as West Nile virus and St. Louis encephalitis virus, as well as of nematodes that cause lymphatic filariasis. C. quinquefasciatus is one species within the Culex pipiens species complex and can be found throughout tropical and temperate climates of the world. The ability of C. quinquefasciatus to take blood meals from birds, livestock, and humans contributes to its ability to vector pathogens between species. Here, we describe the genomic sequence of C. quinquefasciatus: Its repertoire of 18,883 protein-coding genes is 22% larger than that of Aedes aegypti and 52% larger than that of Anopheles gambiae with multiple gene-family expansions, including olfactory and gustatory receptors, salivary gland genes, and genes associated with xenobiotic detoxification.	[Arensburger, Peter; Raikhel, Alexander S.; Atkinson, Peter W.] Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA; [Megy, Karine; Hammond, Martin; Vilella, Albert J.; Lawson, Daniel] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England; [Waterhouse, Robert M.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Abrudan, Jenica; Christley, Scott; Kennedy, Ryan C.; Lobo, Neil F.; Mori, Akio; Severson, David W.; Unger, Maria F.; Collins, Frank H.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Amedeo, Paolo; Caler, Elisabet; Chandramouliswaran, Ishwar; Eisenstadt, Eric; Hannick, Linda I.] J Craig Venter Inst, Rockville, MD 20850 USA; [Tubio, Jose Manuel C.] Univ Santiago, Complexo Hosp, Santiago De Compostela 15706, Spain; [Bartholomay, Lyric] Iowa State Univ, Ames, IA 50011 USA; [Bidwell, Shelby; Camara, Francisco; Guigo, Roderic] Univ Pompeu Fabra, Ctr Gene Regulat, E-08003 Barcelona, Catalonia, Spain; [Campbell, Corey L.] Colorado State Univ, Ft Collins, CO 80523 USA; [Campbell, Kathryn S.] Harvard Univ, Cambridge, MA 02138 USA; [Casola, Claudio] Indiana Univ, Bloomington, IN 47405 USA; [Castro, Marta T.] Hosp Llobregat, Programa Epigenet & Biol Canc, Hosp Duran & Reynals, Barcelona 08907, Spain; [Chapman, Sinead B.; Haas, Brian; Howarth, Clint; Pearson, Matthew D.; White, Jared R.; Birren, Bruce; Muskavitch, Marc A. T.] Broad Inst, Cambridge, MA 02142 USA; [Costas, Javier] Fdn Publ Galega Med Xenomica Servizo Galego Saude, Santiago De Compostela 15706, Spain; [Feschotte, Cedric; Nguyen, Nam; Pritham, Ellen J.; Sun, Cheng] Univ Texas Arlington, Arlington, TX 76019 USA; [Fraser-Liggett, Claire; White, Owen; Wortman, Jennifer] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Hansson, Bill S.] Max Planck Inst Chem Ecol, D-07749 Jena, Germany; [Hemingway, Janet; Ranson, Hilary; Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hill, Sharon R.; Ignell, Rickard] Swedish Univ Agr Sci, S-23053 Alnarp, Sweden; [Kodira, Chinnappa D.] Roche Grp, Branford, CT 06405 USA; [Mao, Chunhong; Qi, Yumin; Tu, Zhijian (Jake)] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; [Mayhew, George; Christensen, Bruce M.] Univ Wisconsin, Madison, WI 53706 USA; [Michel, Kristin] Kansas State Univ, Manhattan, KS 66506 USA; [Liu, Nannan] Auburn Univ, Auburn, AL 36849 USA; [Naveira, Horacio] Univ A Coruna, Dept Bioloxia Celular & Mol, Coruna 15071 A, Spain; [Nene, Vishvanath] Int Livestock Res Inst, Nairobi, Kenya; [Puiu, Daniela] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Ribeiro, Jose M. C.; Shumway, Martin] Natl Inst Hlth, Bethesda, MD 20892 USA; [Roberston, Hugh M.] Univ Illinois, Urbana, IL 61801 USA; [Stanke, Mario] Univ Gottingen, D-37077 Gottingen, Germany; [Cornel, Anthony] Univ Texas Galveston, Med Branch, Galveston, TX 77555 USA; [Vanlandingham, Dana L.; Zdobnov, Evgeny M.; Higgs, Stephen] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Zdobnov, Evgeny M.; Lanzaro, Gregory C.] Univ Calif Davis, Parlier, CA 93648 USA; [Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Lee, Norman H.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Muskavitch, Marc A. T.] Boston Coll, Chestnut Hill, MA 02467 USA; [Muskavitch, Marc A. T.] Harvard Sch Publ Hlth, Boston, MA 02115 USA	University of California System; University of California Riverside; European Molecular Biology Laboratory (EMBL); University of Geneva; Swiss Institute of Bioinformatics; University of Notre Dame; J. Craig Venter Institute; Universidade de Santiago de Compostela; Iowa State University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Colorado State University; Harvard University; Indiana University System; Indiana University Bloomington; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Arlington; University System of Maryland; University of Maryland Baltimore; Max Planck Society; Liverpool School of Tropical Medicine; Swedish University of Agricultural Sciences; Roche Holding; Virginia Polytechnic Institute & State University; University of Wisconsin System; University of Wisconsin Madison; Kansas State University; Auburn University System; Auburn University; Universidade da Coruna; CGIAR; International Livestock Research Institute (ILRI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; University of Illinois System; University of Illinois Urbana-Champaign; University of Gottingen; University of Texas System; University of Texas Medical Branch Galveston; Imperial College London; University of California System; University of California Davis; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Boston College; Harvard University; Harvard T.H. Chan School of Public Health	Arensburger, P (corresponding author), Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA.	arensburger@gmail.com	Naveira, Horacio/H-7249-2014; Tubio, Jose M.C./H-5076-2015; Waterhouse, Robert M/A-1858-2010; Costas, Javier/B-5016-2008; Feschotte, Cedric/C-4048-2011; Zdobnov, Evgeny M/K-1133-2012; Mayhew, George F/B-4042-2016; Wondji, Charles/AAG-1510-2020; Hansson, Bill S/G-2774-2013; Zdobnov, Evgeny/AAB-2745-2022; Sun, Cheng/AAW-7354-2021; Ferreira, Francisco Câmara/G-9841-2015; Naveira, Horacio/I-7802-2019; Tubio, Jose/AAG-7345-2019; Hill, Sharon R/A-5121-2008; Guigo, Roderic/D-1303-2010; Michel, Kristin/F-3400-2011; Stanke, Mario/P-7876-2019	Naveira, Horacio/0000-0002-3840-1569; Tubio, Jose M.C./0000-0003-3540-2459; Waterhouse, Robert M/0000-0003-4199-9052; Costas, Javier/0000-0003-0306-3990; Mayhew, George F/0000-0003-0609-6018; Hansson, Bill S/0000-0002-4811-1223; Zdobnov, Evgeny/0000-0002-5178-1498; Sun, Cheng/0000-0001-7476-9224; Ferreira, Francisco Câmara/0000-0002-1971-5466; Naveira, Horacio/0000-0002-3840-1569; Tubio, Jose/0000-0003-3540-2459; Hill, Sharon R/0000-0002-6474-0214; Guigo, Roderic/0000-0002-5738-4477; Stanke, Mario/0000-0001-8696-0384; Wortman, Jennifer/0000-0002-8713-1227; Hemingway, Janet/0000-0002-3200-7173; Casola, Claudio/0000-0003-4853-1866; Dimopoulos, George/0000-0001-6755-8111; Vilella, Albert/0000-0002-2005-2516; Fraser, Claire/0000-0003-1462-2428; Hannick, Linda/0000-0002-8018-8466; Ranson, Hilary/0000-0003-2332-8247; Lawson, Daniel/0000-0001-7765-983X; Wondji, Charles S./0000-0003-0791-3673; Megy, Karyn/0000-0002-2826-3879; Nene, Vishvanath/0000-0001-7066-4169; Ribeiro, Jose/0000-0002-9107-0818; Campbell, Corey L./0000-0002-6384-1259	NIH [HHSN266200400039C]; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services [N01-AI-30071, HHSN266200400001C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant HHSN266200400039C and by the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services under contract numbers N01-AI-30071 and HHSN266200400001C. The assembled genome was deposited in the GenBank database with accession number AAWU00000000.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P437; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Mori A, 1999, J HERED, V90, P160, DOI 10.1093/jhered/90.1.160; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Vinogradova EB, 2000, CULEX PIPIENS PIPIEN	12	337	354	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					86	88		10.1126/science.1191864	http://dx.doi.org/10.1126/science.1191864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929810	Green Accepted			2022-12-24	WOS:000282334500040
J	Sato, T; van Es, JH; Snippert, HJ; Stange, DE; Vries, RG; van den Born, M; Barker, N; Shroyer, NF; van de Wetering, M; Clevers, H				Sato, Toshiro; van Es, Johan H.; Snippert, Hugo J.; Stange, Daniel E.; Vries, Robert G.; van den Born, Maaike; Barker, Nick; Shroyer, Noah F.; van de Wetering, Marc; Clevers, Hans			Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts	NATURE			English	Article							BETA-CATENIN; ADULT-MOUSE; EPITHELIUM; DIFFERENTIATION; GENE; EXPRESSION; CANCER; MATH1; COLON; SOX9	Homeostasis of self-renewing small intestinal crypts results from neutral competition between Lgr5 stem cells, which are small cycling cells located at crypt bottoms(1,2). Lgr5 stem cells are interspersed between terminally differentiated Paneth cells that are known to produce bactericidal products such as lysozyme and cryptdins/defensins(3). Single Lgr5-expressing stem cells can be cultured to form long-lived, self-organizing crypt-villus organoids in the absence of non-epithelial niche cells(4). Here we find a close physical association of Lgr5 stem cells with Paneth cells in mice, both in vivo and in vitro. CD24(+) Paneth cells express EGF, TGF-alpha, Wnt3 and the Notch ligand Dll4, all essential signals for stem-cell maintenance in culture. Co-culturing of sorted stem cells with Paneth cells markedly improves organoid formation. This Paneth cell requirement can be substituted by a pulse of exogenous Wnt. Genetic removal of Paneth cells in vivo results in the concomitant loss of Lgr5 stem cells. In colon crypts, CD24(+) cells residing between Lgr5 stem cells may represent the Paneth cell equivalents. We conclude that Lgr5 stem cells compete for essential niche signals provided by a specialized daughter cell, the Paneth cell.	[Sato, Toshiro; van Es, Johan H.; Snippert, Hugo J.; Stange, Daniel E.; Vries, Robert G.; van den Born, Maaike; Barker, Nick; van de Wetering, Marc; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Sato, Toshiro; van Es, Johan H.; Snippert, Hugo J.; Stange, Daniel E.; Vries, Robert G.; van den Born, Maaike; Barker, Nick; van de Wetering, Marc; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Shroyer, Noah F.] Cincinnati Childrens Hosp, Div Gastroenterol, Med Ctr, MLC 2010, Cincinnati, OH 45229 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Cincinnati Children's Hospital Medical Center	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Barker, Nick/A-5535-2011; Barker, Nick/AAS-2774-2020; Sato, Toshiro/J-3522-2014; Barker, Nick/AAE-9833-2021; Stange, Daniel E/O-1837-2015	Sato, Toshiro/0000-0001-8353-8137; Barker, Nick/0000-0003-3566-4475; Stange, Daniel E/0000-0003-4246-2230; Shroyer, Noah/0000-0002-5934-2852	NATIONAL CANCER INSTITUTE [R01CA142826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK084167] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA142826-01, R01 CA142826] Funding Source: Medline; NIDDK NIH HHS [R03 DK084167-01, R03 DK084167] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTMANN GG, 1983, AM J ANAT, V167, P95, DOI 10.1002/aja.1001670109; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 2010, DEV BIOL, V345, P49, DOI 10.1016/j.ydbio.2010.06.021; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; POULSEN SS, 1986, HISTOCHEMISTRY, V85, P389, DOI 10.1007/BF00982668; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173	29	1617	1691	17	410	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					415	+		10.1038/nature09637	http://dx.doi.org/10.1038/nature09637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21113151	Green Accepted			2022-12-24	WOS:000286385600056
J	Li, L; Jose, J; Xiang, Y; Kuhn, RJ; Rossmann, MG				Li, Long; Jose, Joyce; Xiang, Ye; Kuhn, Richard J.; Rossmann, Michael G.			Structural changes of envelope proteins during alphavirus fusion	NATURE			English	Article							SEMLIKI-FOREST-VIRUS; PH-DEPENDENT FUSION; CLASS-II VIRUS; SINDBIS VIRUS; CONFORMATIONAL-CHANGE; DYNAMIC ENVELOPE; MEMBRANE-FUSION; GLYCOPROTEIN; PRECURSOR; E3	Alphaviruses are enveloped RNA viruses that have a diameter of about 700 angstrom and can be lethal human pathogens(1). Entry of virus into host cells by endocytosis is controlled by two envelope glycoproteins, E1 and E2. The E2-E1 heterodimers form 80 trimeric spikes on the icosahedral virus surface(1,2), 60 with quasi-three-fold symmetry and 20 coincident with the icosahedral three-fold axes arranged with T 54 quasi-symmetry. The E1 glycoprotein has a hydrophobic fusion loop at one end and is responsible for membrane fusion(3,4). The E2 protein is responsible for receptor binding(5,6) and protects the fusion loop at neutral pH. The lower pH in the endosome induces the virions to undergo an irreversible conformational change in which E2 and E1 dissociate and E1 forms homotrimers, triggering fusion of the viral membrane with the endosomal membrane and then releasing the viral genome into the cytoplasm(3,4). Here we report the structure of an alphavirus spike, crystallized at low pH, representing an intermediate in the fusion process and clarifying the maturation process. The trimer of E2-E1 in the crystal structure is similar to the spikes in the neutral pH virus except that the E2 middle region is disordered, exposing the fusion loop. The amino-and carboxy-terminal domains of E2 each form immunoglobulin-like folds, consistent with the receptor attachment properties of E2.	[Li, Long; Jose, Joyce; Xiang, Ye; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mr@purdue.edu	Li, Long/F-8892-2010; Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; Xiang, Ye/0000-0003-0230-9522	NIH [P01 AI055672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank S. Sun, A. Aksyuk and T. Edwards for discussions. We are also grateful to S. Kelly for help in the preparation of the manuscript. We thank F. Rey for sharing the coordinates of Chikungunya virus E2-E1 to help interpret the Sindbis virus cryo-EM density of the E2 domain B. We would like to thank the staff at the Advanced Photon Source, Argonne National Laboratory, GM/CA sector for their help in data collection. The work was supported by NIH grant P01 AI055672 to R.J.K. and M.G.R.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DUBUISSON J, 1993, J VIROL, V67, P3363, DOI 10.1128/JVI.67.6.3363-3374.1993; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferlenghi I, 1998, J MOL BIOL, V283, P71, DOI 10.1006/jmbi.1998.2066; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GRIFFIN DE, 1995, SEMIN VIROL, V6, P249, DOI 10.1006/smvy.1995.0030; HEIDNER HW, 1994, J VIROL, V68, P2683, DOI 10.1128/JVI.68.4.2683-2692.1994; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; Lehr RV, 2000, PROTEIN EXPRES PURIF, V19, P362, DOI 10.1006/prep.2000.1258; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen KE, 1996, J VIROL, V70, P2757, DOI 10.1128/JVI.70.5.2757-2763.1996; Paredes AM, 1998, J VIROL, V72, P1534, DOI 10.1128/JVI.72.2.1534-1541.1998; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sharff AJ, 2000, ACTA CRYSTALLOGR D, V56, P785, DOI 10.1107/S090744490000370X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; STRAUSS EG, 1991, J VIROL, V65, P4654, DOI 10.1128/JVI.65.9.4654-4664.1991; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; WAHLBERG JM, 1989, J VIROL, V63, P4991, DOI 10.1128/JVI.63.12.4991-4997.1989; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; WHITE J, 1980, J CELL BIOL, V87, P264, DOI 10.1083/jcb.87.1.264; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu SR, 2008, J BIOL CHEM, V283, P26452, DOI 10.1074/jbc.M801470200; Wu SR, 2007, J BIOL CHEM, V282, P6752, DOI 10.1074/jbc.M609125200; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2005, VIROLOGY, V332, P511, DOI 10.1016/j.virol.2004.11.043; Zhang W, 2002, J VIROL, V76, P11645, DOI 10.1128/JVI.76.22.11645-11658.2002; Zhang XY, 2004, VIROLOGY, V327, P287, DOI 10.1016/j.virol.2004.06.037; ZIEMIECKI A, 1978, J MOL BIOL, V122, P259, DOI 10.1016/0022-2836(78)90189-4; ZIEMIECKI A, 1980, J GEN VIROL, V50, P111, DOI 10.1099/0022-1317-50-1-111	45	220	225	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					705	U131		10.1038/nature09546	http://dx.doi.org/10.1038/nature09546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124457	Green Accepted			2022-12-24	WOS:000284836700043
J	Akiyoshi, B; Sarangapani, KK; Powers, AF; Nelson, CR; Reichow, SL; Arellano-Santoyo, H; Gonen, T; Ranish, JA; Asbury, CL; Biggins, S				Akiyoshi, Bungo; Sarangapani, Krishna K.; Powers, Andrew F.; Nelson, Christian R.; Reichow, Steve L.; Arellano-Santoyo, Hugo; Gonen, Tamir; Ranish, Jeffrey A.; Asbury, Charles L.; Biggins, Sue			Tension directly stabilizes reconstituted kinetochore-microtubule attachments	NATURE			English	Article							SINGLE KINESIN MOLECULES; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC SPINDLE; PROTEIN-KINASE; CATCH BONDS; AURORA B; COMPLEX; MITOSIS; FORCE	Kinetochores are macromolecular machines that couple chromosomes to dynamic microtubule tips during cell division, thereby generating force to segregate the chromosomes(1,2). Accurate segregation depends on selective stabilization of correct 'bi-oriented' kinetochore-microtubule attachments, which come under tension as the result of opposing forces exerted by microtubules(3). Tension is thought to stabilize these bi-oriented attachments indirectly, by suppressing the destabilizing activity of a kinase, Aurora B-4,B-5. However, a complete mechanistic understanding of the role of tension requires reconstitution of kinetochore-microtubule attachments for biochemical and biophysical analyses in vitro. Here we show that native kinetochore particles retaining the majority of kinetochore proteins can be purified from budding yeast and used to reconstitute dynamic microtubule attachments. Individual kinetochore particles maintain load-bearing associations with assembling and disassembling ends of single microtubules for >30 min, providing a close match to the persistent coupling seen in vivo between budding yeast kinetochores and single microtubules(6). Moreover, tension increases the lifetimes of the reconstituted attachments directly, through a catch bond-like mechanism that does not require Aurora B7-10. On the basis of these findings, we propose that tension selectively stabilizes proper kinetochore-microtubule attachments in vivo through a combination of direct mechanical stabilization and tension-dependent phosphoregulation.	[Akiyoshi, Bungo; Nelson, Christian R.; Arellano-Santoyo, Hugo; Biggins, Sue] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Akiyoshi, Bungo; Arellano-Santoyo, Hugo] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Sarangapani, Krishna K.; Powers, Andrew F.; Arellano-Santoyo, Hugo; Asbury, Charles L.] Univ Washington, Dept Physiol Biophys, Seattle, WA 98195 USA; [Reichow, Steve L.; Gonen, Tamir] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Gonen, Tamir] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ranish, Jeffrey A.] Inst Syst Biol, Seattle, WA 98103 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB)	Biggins, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	casbury@u.washington.edu; sbiggins@fhcrc.org		Biggins, Susan/0000-0002-4499-6319; Akiyoshi, Bungo/0000-0001-6010-394X; Reichow, Steve/0000-0001-5276-7690	NSF IGERT [DGE-0504573]; NIH [T32GM07270, T32HL007312, GM078069, GM064386]; NCI Cancer Center [CA015704]; NIGMS [PM50 GM076547, R01GM79373]; Searle Scholar Award [06-L-111]; Packard Fellowship for Science and Engineering [2006-30521]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064386, R01GM079373, P50GM076547, R01GM078069, T32GM007270] Funding Source: NIH RePORTER	NSF IGERT(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Searle Scholar Award; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Desai for antibodies, and J. Kilmartin, G. Barnes, D. Pellman, R. Tsien and the Yeast Resource Center for strains and plasmids. We also thank M. Press for constructing the Cse4-GFP strain, M. Yuan at the ISB for help, and the Seattle Mitosis Club for comments. We are grateful to T. Davis, W. Thomas, B. Zagotta, T. Tsukiyama, J. Stumpff, F. Rieke, S. Gordon and the Biggins lab for comments on the manuscript. This work was supported by an NSF IGERT fellowship (DGE-0504573) and NIH traineeship (T32GM07270) to A.F.P., an NIH Cardiovascular Pathology traineeship (T32HL007312) to K.K.S., a Beckman Young Investigator grant to S.B., NIH grants (GM078069 and GM064386) to S.B., an NCI Cancer Center Support grant (CA015704) and an NIGMS grant (PM50 GM076547/Center for Systems Biology) to J.A.R., a Searle Scholar Award (06-L-111) to C.L.A., a Packard Fellowship for Science and Engineering (2006-30521) to C.L.A. and an NIGMS grant (R01GM79373) to C.L.A. S.B. is a Scholar of the Leukemia and Lymphoma Society and T.G. is a Howard Hughes Medical Institute Early Career Scientist.	Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Enquist-Newman M, 2001, MOL BIOL CELL, V12, P2601, DOI 10.1091/mbc.12.9.2601; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Franck AD, 2010, METHODS, V51, P242, DOI 10.1016/j.ymeth.2010.01.020; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gestaut DR, 2010, METHOD CELL BIOL, V95, P641, DOI 10.1016/S0091-679X(10)95032-2; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Kitamura E, 2007, GENE DEV, V21, P3319, DOI 10.1101/gad.449407; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rose MD., 1990, METHODS YEAST GENETI; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; SIKORSKI RS, 1989, GENETICS, V122, P19; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	39	304	307	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					576	U255		10.1038/nature09594	http://dx.doi.org/10.1038/nature09594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107429	Green Accepted, Green Submitted			2022-12-24	WOS:000284584200045
J	Kidd, JM; Graves, T; Newman, TL; Fulton, R; Hayden, HS; Malig, M; Kallicki, J; Kaul, R; Wilson, RK; Eichler, EE				Kidd, Jeffrey M.; Graves, Tina; Newman, Tera L.; Fulton, Robert; Hayden, Hillary S.; Malig, Maika; Kallicki, Joelle; Kaul, Rajinder; Wilson, Richard K.; Eichler, Evan E.			A Human Genome Structural Variation Sequencing Resource Reveals Insights into Mutational Mechanisms	CELL			English	Article							DOUBLE-STRAND BREAKS; COPY-NUMBER; L1 RETROTRANSPOSITION; RECOMBINATION; REPEATS; IDENTIFICATION; DELETIONS; COMMON; TRANSDUCTION; POLYMORPHISM	Understanding the prevailing mutational mechanisms responsible for human genome structural variation requires uniformity in the discovery of allelic variants and precision in terms of breakpoint delineation. We develop a resource based on capillary end sequencing of 13.8 million fosmid clones from 17 human genomes and characterize the complete sequence of 1054 large structural variants corresponding to 589 deletions, 384 insertions, and 81 inversions. We analyze the 2081 breakpoint junctions and infer potential mechanism of origin. Three mechanisms account for the bulk of germline structural variation: microhomology-mediated processes involving short (2-20 bp) stretches of sequence (28%), nonallelic homologous recombination (22%), and L1 retrotransposition (19%). The high quality and long-range continuity of the sequence reveals more complex mutational mechanisms, including repeat-mediated inversions and gene conversion, that are most often missed by other methods, such as comparative genomic hybridization, single nucleotide polymorphism microarrays, and next-generation sequencing.	[Kidd, Jeffrey M.; Newman, Tera L.; Hayden, Hillary S.; Malig, Maika; Kaul, Rajinder; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Graves, Tina; Fulton, Robert; Kallicki, Joelle; Wilson, Richard K.] Washington Univ, Genome Sequencing Ctr, Sch Med, St Louis, MO 63108 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Washington University (WUSTL); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; Kaul, Rajinder/0000-0002-7895-9284; Kidd, Jeffrey/0000-0002-9631-1465	National Science Foundation; National Institutes of Health [HG004120]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG004120] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Smith and the staff at Agencourt Biosciences for library production, E. Kirkness and staff of the J. Craig Venter Institute for end-sequence data from the JVCI library, and L. Chen for computational assistance in the mapping of end-sequence data. We thank S. Girirajan, J. Moran, and C. Payen for thoughtful discussion; T. Brown for manuscript preparation assistance; and members of the University of Washington and Washington University Genome Centers for assistance with data generation. J.M.K. is supported by a National Science Foundation Graduate Research Fellowship. This work was supported by the National Institutes of Health Grant HG004120 to E.E.E., who is an investigator of the Howard Hughes Medical Institute. E.E.E is on the scientific advisory board for Pacific Biosciences. T.L.N. is an employee and founder of iGenix Inc.	Abe H, 2009, HEPATOL RES, V39, P1159, DOI 10.1111/j.1872-034X.2009.00566.x; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; An P, 2009, J INFECT DIS, V200, P1054, DOI 10.1086/605644; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Buard J, 2000, AM J HUM GENET, V67, P333, DOI 10.1086/303015; Chiaromonte F, 2002, Pac Symp Biocomput, P115; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lagerstedt K, 1997, HUM MOL GENET, V6, P627, DOI 10.1093/hmg/6.4.627; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Smit A, 1996, REPEATMASKER OPEN 30; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Szak ST, 2002, GENOME BIOL, V3; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Witherspoon DJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-410	62	187	191	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					837	847		10.1016/j.cell.2010.10.027	http://dx.doi.org/10.1016/j.cell.2010.10.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111241	Green Accepted, Bronze			2022-12-24	WOS:000284583500024
J	Ciocchi, S; Herry, C; Grenier, F; Wolff, SBE; Letzkus, JJ; Vlachos, I; Ehrlich, I; Sprengel, R; Deisseroth, K; Stadler, MB; Muller, C; Luthi, A				Ciocchi, Stephane; Herry, Cyril; Grenier, Francois; Wolff, Steffen B. E.; Letzkus, Johannes J.; Vlachos, Ioannis; Ehrlich, Ingrid; Sprengel, Rolf; Deisseroth, Karl; Stadler, Michael B.; Mueller, Christian; Luethi, Andreas			Encoding of conditioned fear in central amygdala inhibitory circuits	NATURE			English	Article							LONG-TERM POTENTIATION; CENTRAL NUCLEUS; SYNAPTIC PLASTICITY; PROJECTION NEURONS; RAT; COMPLEX; ORGANIZATION; FOREBRAIN; TRANSMISSION; MECHANISMS	The central amygdala (CEA), a nucleus predominantly composed of GABAergic inhibitory neurons, is essential for fear conditioning. How the acquisition and expression of conditioned fear are encoded within CEA inhibitory circuits is not understood. Using in vivo electrophysiological, optogenetic and pharmacological approaches in mice, we show that neuronal activity in the lateral subdivision of the central amygdala (CEl) is required for fear acquisition, whereas conditioned fear responses are driven by output neurons in the medial subdivision (CEm). Functional circuit analysis revealed that inhibitory CEA microcircuits are highly organized and that cell-type-specific plasticity of phasic and tonic activity in the CEl to CEm pathway may gate fear expression and regulate fear generalization. Our results define the functional architecture of CEA microcircuits and their role in the acquisition and regulation of conditioned fear behaviour.	[Ciocchi, Stephane; Herry, Cyril; Grenier, Francois; Wolff, Steffen B. E.; Letzkus, Johannes J.; Ehrlich, Ingrid; Stadler, Michael B.; Mueller, Christian; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Vlachos, Ioannis] Bernstein Ctr Computat Neurosci, D-79104 Freiburg, Germany; [Sprengel, Rolf] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Friedrich Miescher Institute for Biomedical Research; Max Planck Society; Stanford University	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	andreas.luthi@fmi.ch	Ehrlich, Ingrid/G-8551-2015; Yan, Shuo/B-8381-2009; Herry, Cyril/AAP-9902-2020	Ehrlich, Ingrid/0000-0001-9078-2429; Herry, Cyril/0000-0003-2973-0843; Letzkus, Johannes/0000-0001-5678-3030; Ciocchi, Stephane/0000-0002-5701-9250	Austrian Science Fund (FWF); Swiss National Science Foundation; Schering Foundation; European Commission [HEALTH-F2-2009-241498]; Indo Swiss Joint Research Programme; BMBF [01GQ0420]; Neurex Interreg-IV; Volkswagen Stiftung; Novartis Institutes for Biomedical Research; Novartis Research Foundation	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schering Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Indo Swiss Joint Research Programme; BMBF(Federal Ministry of Education & Research (BMBF)); Neurex Interreg-IV; Volkswagen Stiftung(Volkswagen); Novartis Institutes for Biomedical Research; Novartis Research Foundation	We thank all members of the Luthi laboratory for discussions and critical comments on the manuscript. This work was supported by grants from the Austrian Science Fund (FWF), the Swiss National Science Foundation, the Schering Foundation, the European Commission (Eurospin Project, Contract HEALTH-F2-2009-241498), the Indo Swiss Joint Research Programme, the BMBF (grant 01GQ0420 to BCCN Freiburg), Neurex Interreg-IV, the Volkswagen Stiftung, the Novartis Institutes for Biomedical Research, and the Novartis Research Foundation.	Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Davis M., 2000, AMYGDALA, P213; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fu Y, 2005, J NEUROPHYSIOL, V93, P3012, DOI 10.1152/jn.00871.2004; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Jolkkonen E, 2002, NEUROSCIENCE, V111, P133, DOI 10.1016/S0306-4522(01)00578-4; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; Lang EJ, 1997, J NEUROPHYSIOL, V77, P353, DOI 10.1152/jn.1997.77.1.353; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Linke R, 2000, EXP BRAIN RES, V134, P520, DOI 10.1007/s002210000475; Lopez de Armentia M, 2007, J PHYSIOL-LONDON, V581, P961, DOI 10.1113/jphysiol.2007.101822; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MILLHOUSE OE, 1986, J COMP NEUROL, V247, P246, DOI 10.1002/cne.902470209; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; PASCOE JP, 1985, BEHAV BRAIN RES, V16, P117, DOI 10.1016/0166-4328(85)90087-7; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Roberto M, 2003, P NATL ACAD SCI USA, V100, P2053, DOI 10.1073/pnas.0437926100; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Samson RD, 2005, REV NEUROSCIENCE, V16, P287; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; SUN N, 1994, J COMP NEUROL, V340, P43, DOI 10.1002/cne.903400105; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; THOMPSON RF, 1962, J COMP PHYSIOL PSYCH, V55, P279, DOI 10.1037/h0047856; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; VEENING JG, 1984, BRAIN RES, V303, P337, DOI 10.1016/0006-8993(84)91220-4; Veinante P, 2003, ANN NY ACAD SCI, V985, P552; Wickens JR, 2007, PROG BRAIN RES, V160, P313, DOI 10.1016/S0079-6123(06)60018-6; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	46	616	630	2	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					277	U239		10.1038/nature09559	http://dx.doi.org/10.1038/nature09559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068837				2022-12-24	WOS:000284051000045
J	Guo, Z; Kozlov, S; Lavin, MF; Person, MD; Paull, TT				Guo, Zhi; Kozlov, Sergei; Lavin, Martin F.; Person, Maria D.; Paull, Tanya T.			ATM Activation by Oxidative Stress	SCIENCE			English	Article							TELANGIECTASIA GENE-PRODUCT; ATAXIA-TELANGIECTASIA; DNA-DAMAGE; DEFICIENT MICE; PROTEIN; PHOSPHORYLATION; PURIFICATION; CELLS; ANTIOXIDANTS; MANGANESE	The ataxia-telangiectasia mutated (ATM) protein kinase is activated by DNA double-strand breaks (DSBs) through the Mre11-Rad50-Nbs1 (MRN) DNA repair complex and orchestrates signaling cascades that initiate the DNA damage response. Cells lacking ATM are also hypersensitive to insults other than DSBs, particularly oxidative stress. We show that oxidation of ATM directly induces ATM activation in the absence of DNA DSBs and the MRN complex. The oxidized form of ATM is a disulfide-cross-linked dimer, and mutation of a critical cysteine residue involved in disulfide bond formation specifically blocked activation through the oxidation pathway. Identification of this pathway explains observations of ATM activation under conditions of oxidative stress and shows that ATM is an important sensor of reactive oxygen species in human cells.	[Guo, Zhi; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Howard Hughes Med Inst, Austin, TX 78712 USA; [Guo, Zhi; Paull, Tanya T.] Univ Texas Austin, ICMB, Austin, TX 78712 USA; [Kozlov, Sergei; Lavin, Martin F.] Univ Queensland, Queensland Inst Med Res, Radiat Biol & Oncol Lab, Brisbane, Qld 4006, Australia; [Kozlov, Sergei; Lavin, Martin F.] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Person, Maria D.] Univ Texas Austin, Coll Pharm, ICMB Analyt Instrumentat Facil Core, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas Austin, Dept Mol Genet & Microbiol, Howard Hughes Med Inst, Austin, TX 78712 USA.	tpaull@mail.utexas.edu	Kozlov, Sergei/T-9779-2019; Lavin, Martin F/F-5961-2014; Kozlov, Sergei/M-2067-2014; Guo, Zhi/A-4589-2013	Lavin, Martin F/0000-0002-5940-4769; Kozlov, Sergei/0000-0001-6183-7339; Paull, Tanya/0000-0002-2991-651X	NIH [CA132813]; NHMRC [569591]; NIEHS [007784]; NATIONAL CANCER INSTITUTE [R01CA132813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to members of the Paull laboratory as well as to M. Weitzman for cell lines; to D. Johnson, G. Georgiou, J. Huibregtse, and K. Dalby for discussion; and to C. Walker for communication of data in press. This work was supported by NIH grant CA132813 (Paull laboratory), NHMRC 569591 (Lavin laboratory), and NIEHS 007784 (ICMB mass spectrometry core facility).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan DW, 2000, J BIOL CHEM, V275, P7803, DOI 10.1074/jbc.275.11.7803; CHESSA L, 1992, AM J MED GENET, V42, P741, DOI 10.1002/ajmg.1320420524; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; HaMai D, 2004, NEUROCHEM INT, V44, P223, DOI 10.1016/S0197-0186(03)00152-9; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kobayashi M, 2006, GENES CELLS, V11, P779, DOI 10.1111/j.1365-2443.2006.00976.x; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; Lee SM, 2005, J SHELLFISH RES, V24, P99; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Reliene R, 2008, FOOD CHEM TOXICOL, V46, P1371, DOI 10.1016/j.fct.2007.08.028; Reliene R, 2007, J NUTR, V137, p229S, DOI 10.1093/jn/137.1.229S; Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768; Shackelford RE, 2001, J BIOL CHEM, V276, P21951, DOI 10.1074/jbc.M011303200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Toyoshima M, 1998, AM J MED GENET, V75, P141, DOI 10.1002/(SICI)1096-8628(19980113)75:2<141::AID-AJMG4>3.0.CO;2-W; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; VOS O, 1976, INT J RADIAT BIOL, V29, P513, DOI 10.1080/09553007614550611; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277	31	770	788	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					517	521		10.1126/science.1192912	http://dx.doi.org/10.1126/science.1192912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966255	Green Submitted			2022-12-24	WOS:000283329100044
J	O'Donnell, MR; Jarand, J; Loveday, M; Padayatchi, N; Zelnick, J; Werner, L; Naidoo, K; Master, I; Osburn, G; Kvasnovsky, C; Shean, K; Pai, M; Van der Walt, M; Horsburgh, CR; Dheda, K				O'Donnell, Max R.; Jarand, Julie; Loveday, Marian; Padayatchi, Nesri; Zelnick, Jennifer; Werner, Lise; Naidoo, Kasavan; Master, Iqbal; Osburn, Garth; Kvasnovsky, Charlotte; Shean, Karen; Pai, Madhukar; Van der Walt, Martie; Horsburgh, Charles R.; Dheda, Keertan			High Incidence of Hospital Admissions With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Among South African Health Care Workers	ANNALS OF INTERNAL MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; RISK; HIV; INFECTION; TB	Background: Nosocomial transmission has been described in extensively drug-resistant tuberculosis (XDR-TB) and HIV co-infected patients in South Africa. However, little is known about the rates of drug-resistant tuberculosis among health care workers in countries with high tuberculosis and HIV burden. Objective: To estimate rates of multidrug-resistant tuberculosis (MDR-TB) and XDR-TB hospitalizations among health care workers in KwaZulu-Natal, South Africa. Design: Retrospective study of patients with drug-resistant tuberculosis who were admitted from 2003 to 2008 for the initiation of drug-resistant tuberculosis therapy. Setting: A public tuberculosis referral hospital in KwaZulu-Natal, South Africa. Participants: 231 health care workers and 4151 non-health care workers admitted for initiation of MDR-TB or XDR-TB treatment. Measurements: Hospital admission rates and hospital admission incidence rate ratios. Results: Estimated incidence of MDR-TB hospitalization was 64.8 per 100 000 health care workers versus 11.9 per 100 000 non-health care workers (incidence rate ratio, 5.46 [95% CI, 4.75 to 6.28]). Estimated incidence of XDR-TB hospitalizations was 7.2 per 100 000 health care workers versus 1.1 per 100 000 non-health care workers (incidence rate ratio, 6.69 [CI, 4.38 to 10.20]). A higher percentage of health care workers than non-health care workers with MDR-TB or XDR-TB were women (78% vs. 47%; P < 0.001), and health care workers were less likely to report previous tuberculosis treatment (41% vs. 92%; P < 0.001). HIV infection did not differ between health care workers and nonhealth care workers (55% vs. 57%); however, among HIV-infected patients, a higher percentage of health care workers were receiving antiretroviral medications (63% vs. 47%; P < 0.001). Limitation: The study had an observational retrospective design, is subject to referral bias, and had no information on type of health care work or duration of occupational exposure to tuberculosis. Conclusion: Health care workers in this HIV-endemic area were substantially more likely to be hospitalized with either MDR-TB or XDR-TB than were non-health care workers. The increased risk may be explained by occupational exposure, underlining the urgent need for tuberculosis infection-control programs.	Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa; Univ Calgary, Calgary, AB, Canada; MRC, Cape Town, South Africa; Salem State Coll, Sch Social Work, Salem, MA 01970 USA; King George V Mem Hosp, Sydenham, South Africa; Emory Univ, Sch Med, Atlanta, GA USA; Rollins Sch Publ Hlth, Atlanta, GA USA; UCL, London, England; McGill Univ, Montreal, PQ, Canada	Boston University; Boston University; University of Kwazulu Natal; University of Calgary; Massachusetts System of Public Higher Education; Salem State University; Emory University; Emory University; Rollins School Public Health; University of London; University College London; McGill University	O'Donnell, MR (corresponding author), Albert Einstein Coll Med, Div Pulm Med, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	max.odonnell@einstein.yu.edu	padayatchi, nesri/Q-2780-2019; van der Walt, Martie/CAH-0101-2022; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; Mitchell, Ellen/H-5475-2013; Loveday, Marian/M-8016-2013	padayatchi, nesri/0000-0003-2543-9071; van der Walt, Martie/0000-0001-9987-3167; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Loveday, Marian/0000-0001-9205-9314; Horsburgh, C./0000-0001-6838-7895; Naidoo, Kogieleum/0000-0002-8874-6661	National Institutes of Health, National Institutes of Allergy and Infectious Diseases [T32 AI52074]; American Thoracic Society; Centre for AIDS Programme of Research; National Institutes of Health; U.S. Department of Health and Human Services the Centre for AIDS Programme of Research [A1069469]; Fogarty International Center, National Institutes of Health [D43TW00231]; Canadian Institutes of Health Research; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052074, U01AI069469] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Thoracic Society; Centre for AIDS Programme of Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services the Centre for AIDS Programme of Research; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. O'Donnell was supported by the National Institutes of Health (T32 AI52074; National Institutes of Allergy and Infectious Diseases) and an American Thoracic Society Career Development Award. In addition, Drs. O'Donnell and Padayatchi were supported by the Centre for AIDS Programme of Research. The National Institutes of Health and the U.S. Department of Health and Human Services funds the Centre for AIDS Programme of Research (A1069469). Dr. Padayatchi was also supported by Columbia University-Southern African Fogarty AIDS International Training and Research Programme funded by the Fogarty International Center, National Institutes of Health (D43TW00231). Dr. Pai is supported by a New Investigator Award from the Canadian Institutes of Health Research. These funding sources played no role in the study design or data analysis.	Askew GL, 1997, PEDIATRICS, V100, P19, DOI 10.1542/peds.100.1.19; Basu S, 2008, EPIDEMIOL INFECT, V136, P1585, DOI 10.1017/S0950268808000964; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; BUTHELEZI S, 2008, 2 GLOB XDR TB TASK F; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P1176; CLEVELAND JL, 1995, INFECT CONT HOSP EP, V16, P7; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dimitrova B, 2005, INT J TUBERC LUNG D, V9, P43; DOOLEY SW, 1992, JAMA-J AM MED ASSOC, V267, P2632, DOI 10.1001/jama.267.19.2632; Galgalo T, 2008, INT J TUBERC LUNG D, V12, P949; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; GANDHI NR, 2006, JAMA-J AM MED ASSOC, V296, P2927; GANDHI NR, 2008, J CLIN EPIDEMIOL, V61, P344; *HLTH SYST TRUST, 2007, S AFR HLTH REV; James P, 2009, INT J TUBERC LUNG D, V13, P795; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Karim QA, 2002, INT J EPIDEMIOL, V31, P37, DOI 10.1093/ije/31.1.37; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; REISNER BS, 1995, DIAGN MICR INFEC DIS, V22, P325, DOI 10.1016/0732-8893(95)00147-7; Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006; Sotgiu G, 2008, INT J TUBERC LUNG D, V12, P606; *STAT S AFR, 2007, S AFR COMM SURV; *STAT S AFR, 2001, S AFR NAT POP CENS; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2008, GLOB TUB CONTR SURV; Zelnick J, 2005, J PUBLIC HEALTH POL, V26, P163, DOI 10.1057/palgrave.jphp.3200021	33	146	151	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					516	522		10.7326/0003-4819-153-8-201010190-00008	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956708	Green Accepted			2022-12-24	WOS:000283054600004
J	Matyas, F; Sreenivasan, V; Marbach, F; Wacongne, C; Barsy, B; Mateo, C; Aronoff, R; Petersen, CCH				Matyas, Ferenc; Sreenivasan, Varun; Marbach, Fred; Wacongne, Catherine; Barsy, Boglarka; Mateo, Celine; Aronoff, Rachel; Petersen, Carl C. H.			Motor Control by Sensory Cortex	SCIENCE			English	Article							WHISKER MOVEMENTS; BEHAVING MICE; BARREL CORTEX; CORTICAL-NEURONS; TRANSGENIC MICE; CEREBRAL-CORTEX; RAT; STIMULATION; CHANNELRHODOPSIN-2; MICROSTIMULATION	Classical studies of mammalian movement control define a prominent role for the primary motor cortex. Investigating the mouse whisker system, we found an additional and equally direct pathway for cortical motor control driven by the primary somatosensory cortex. Whereas activity in primary motor cortex directly evokes exploratory whisker protraction, primary somatosensory cortex directly drives whisker retraction, providing a rapid negative feedback signal for sensorimotor integration. Motor control by sensory cortex suggests the need to reevaluate the functional organization of cortical maps.	[Matyas, Ferenc; Sreenivasan, Varun; Marbach, Fred; Wacongne, Catherine; Barsy, Boglarka; Mateo, Celine; Aronoff, Rachel; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland; [Matyas, Ferenc] Hungarian Acad Sci, Inst Expt Med, Lab Thalamus Res, H-1450 Budapest, Hungary; [Wacongne, Catherine] INSERM, U992, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Barsy, Boglarka] Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017; Mateo, Celine/V-4619-2019	Petersen, Carl/0000-0003-3344-4495; Sreenivasan, Varun/0000-0003-0559-9713; Aronoff, Rachel/0000-0001-5813-2899	Swiss National Science Foundation; Human Frontiers in Science Program; SystemsX.ch; European Molecular Biology Organization	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank H. Bokor and L. Acsady for advice on brainstem anatomy and lesions and K. Svoboda (Addgene plasmid 20071) and C. Luscher (virus) for AAV-ChR2. This work was funded by grants from the Swiss National Science Foundation (C. C. H. P.), Human Frontiers in Science Program (C. C. H. P.), SystemsX.ch (C. C. H. P.), and a European Molecular Biology Organization long-term fellowship (F. Matyas).	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; COULTER JD, 1977, BRAIN RES, V129, P335, DOI 10.1016/0006-8993(77)90012-9; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; JACQUIN MF, 1990, J NEUROPHYSIOL, V64, P3, DOI 10.1152/jn.1990.64.1.3; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinganaud G, 1999, J COMP NEUROL, V415, P91, DOI 10.1002/(SICI)1096-9861(19991206)415:1<91::AID-CNE7>3.0.CO;2-A; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; WELKER WI, 1957, J NEUROPHYSIOL, V20, P347, DOI 10.1152/jn.1957.20.4.347; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	32	258	261	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1240	1243		10.1126/science.1195797	http://dx.doi.org/10.1126/science.1195797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109671				2022-12-24	WOS:000284613700041
J	Branch, TA; Watson, R; Fulton, EA; Jennings, S; McGilliard, CR; Pablico, GT; Ricard, D; Tracey, SR				Branch, Trevor A.; Watson, Reg; Fulton, Elizabeth A.; Jennings, Simon; McGilliard, Carey R.; Pablico, Grace T.; Ricard, Daniel; Tracey, Sean R.			The trophic fingerprint of marine fisheries	NATURE			English	Article							FOOD WEBS; ECOLOGICAL INDICATORS; GLOBAL FISHERIES; WORLD FISHERIES; GULF; BIODIVERSITY; PERSPECTIVE; AQUACULTURE; ECOSYSTEMS; IMPACTS	Biodiversity indicators provide a vital window on the state of the planet, guiding policy development and management(1,2). The most widely adopted marine indicator is mean trophic level (MTL) from catches, intended to detect shifts from high-trophic-level predators to low-trophic-level invertebrates and plankton-feeders(3-5). This indicator underpins reported trends in human impacts, declining when predators collapse ("fishing down marine food webs'')(3) and when low-trophic-level fisheries expand ("fishing through marine food webs'')(6). The assumption is that catch MTL measures changes in ecosystem MTL and biodiversity(2,5). Here we combine model predictions with global assessments of MTL from catches, trawl surveys and fisheries stock assessments(7) and find that catch MTL does not reliably predict changes in marine ecosystems. Instead, catch MTL trends often diverge from ecosystem MTL trends obtained from surveys and assessments. In contrast to previous findings of rapid declines in catch MTL3, we observe recent increases in catch, survey and assessment MTL. However, catches from most trophic levels are rising, which can intensify fishery collapses even when MTL trends are stable or increasing. To detect fishing impacts on marine biodiversity, we recommend greater efforts to measure true abundance trends for marine species, especially those most vulnerable to fishing.	[Branch, Trevor A.; McGilliard, Carey R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Watson, Reg; Pablico, Grace T.] Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada; [Fulton, Elizabeth A.] CSIRO Wealth Oceans, Hobart, Tas 7001, Australia; [Jennings, Simon] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Jennings, Simon] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Ricard, Daniel] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Tracey, Sean R.] Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Marine Res Labs, Hobart, Tas 7001, Australia	University of Washington; University of Washington Seattle; University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; Dalhousie University; University of Tasmania	Branch, TA (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	tbranch@uw.edu	Fulton, Beth/AAJ-1398-2021; Fulton, Beth/A-2871-2008; Jennings, Simon/F-5085-2012; Watson, Reg A/F-4850-2012; Ricard, Daniel/G-1814-2014; Branch, Trevor/A-5691-2009	Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917; Jennings, Simon/0000-0002-2390-7225; Watson, Reg A/0000-0001-7201-8865; McGilliard, Carey/0000-0001-5708-8283	University of California Santa Barbara; US National Science Foundation (NSF); Moore Foundation; School of Aquatic and Fishery Sciences, University of Washington; Canadian Natural Sciences and Engineering Research Council; Canadian Foundation for Innovation; Pew Charitable Trusts	University of California Santa Barbara(University of California System); US National Science Foundation (NSF)(National Science Foundation (NSF)); Moore Foundation(Gordon and Betty Moore Foundation); School of Aquatic and Fishery Sciences, University of Washington(University of Washington); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Pew Charitable Trusts	This work arose out of a working group at the National Center for Ecological Analysis and Synthesis (NCEAS), funded by the University of California Santa Barbara, the US National Science Foundation (NSF), and the Moore Foundation. T.A.B. was additionally funded by the School of Aquatic and Fishery Sciences, University of Washington. The RAM Legacy stock assessment database was funded by the Canadian Natural Sciences and Engineering Research Council and the Canadian Foundation for Innovation; the Sea Around Us Project was funded by Pew Charitable Trusts. Additional collaborators and data contributors are acknowledged in the Supplementary Information.	Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caddy J.F., 1998, SCIENCE, V282, p1383a, DOI 10.1126/science.282.5393.1383a; Caddy JF, 2000, OCEAN COAST MANAGE, V43, P615, DOI 10.1016/S0964-5691(00)00052-1; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V, 1998, J FISH BIOL, V53, P128, DOI 10.1006/jfbi.1998.0809; de Mutsert K, 2008, P NATL ACAD SCI USA, V105, P2740, DOI 10.1073/pnas.0704354105; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; JIMING Y, 1982, MAR ECOL PROG SER, V7, P247, DOI 10.3354/meps007247; Litzow MA, 2009, CAN J FISH AQUAT SCI, V66, P201, DOI 10.1139/F08-207; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 2005, PHILOS T ROY SOC B, V360, P415, DOI 10.1098/rstb.2004.1597; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Powers JE, 2010, MAR POLICY, V34, P723, DOI 10.1016/j.marpol.2009.11.009; Rochet MJ, 2003, CAN J FISH AQUAT SCI, V60, P86, DOI 10.1139/F02-164; Secretariat of the Convention on Biological Diversity, 2006, GLOB BIOD OUTL 2; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Shannon LJ, 2009, ECOL INDIC, V9, P1078, DOI 10.1016/j.ecolind.2008.12.007; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; Tacon AGJ, 2010, REV FISH SCI, V18, P94, DOI 10.1080/10641260903325680; Tacon AGJ, 2009, REV FISH SCI, V17, P305, DOI 10.1080/10641260802677074; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x	29	263	274	1	312	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					431	435		10.1038/nature09528	http://dx.doi.org/10.1038/nature09528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085178				2022-12-24	WOS:000284313100041
J	Haubensak, W; Kunwar, PS; Cai, HJ; Ciocchi, S; Wall, NR; Ponnusamy, R; Biag, J; Dong, HW; Deisseroth, K; Callaway, EM; Fanselow, MS; Luthi, A; Anderson, DJ				Haubensak, Wulf; Kunwar, Prabhat S.; Cai, Haijiang; Ciocchi, Stephane; Wall, Nicholas R.; Ponnusamy, Ravikumar; Biag, Jonathan; Dong, Hong-Wei; Deisseroth, Karl; Callaway, Edward M.; Fanselow, Michael S.; Luethi, Andreas; Anderson, David J.			Genetic dissection of an amygdala microcircuit that gates conditioned fear	NATURE			English	Article							CENTRAL EXTENDED AMYGDALA; RAT CENTRAL NUCLEUS; BACTERIAL ARTIFICIAL CHROMOSOMES; NEURONS IN-VITRO; PERIAQUEDUCTAL GRAY; NEURAL CIRCUITS; BASAL GANGLIA; RABIES VIRUS; EXPRESSION; VIVO	The role of different amygdala nuclei (neuroanatomical subdivisions) in processing Pavlovian conditioned fear has been studied extensively, but the function of the heterogeneous neuronal subtypes within these nuclei remains poorly understood. Here we use molecular genetic approaches to map the functional connectivity of a subpopulation of GABA-containing neurons, located in the lateral subdivision of the central amygdala (CEl), which express protein kinase C-delta (PKC-delta). Channelrhodopsin-2-assisted circuit mapping in amygdala slices and cell-specific viral tracing indicate that PKC-delta(+) neurons inhibit output neurons in the medial central amygdala (CEm), and also make reciprocal inhibitory synapses with PKC-delta(-) neurons in CEl. Electrical silencing of PKC-delta(+) neurons in vivo suggests that they correspond to physiologically identified units that are inhibited by the conditioned stimulus, called CEl(off) units. This correspondence, together with behavioural data, defines an inhibitory microcircuit in CEl that gates CEm output to control the level of conditioned freezing.	[Haubensak, Wulf; Kunwar, Prabhat S.; Cai, Haijiang; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Ciocchi, Stephane; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Wall, Nicholas R.; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Ponnusamy, Ravikumar; Fanselow, Michael S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Ponnusamy, Ravikumar; Fanselow, Michael S.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Biag, Jonathan; Dong, Hong-Wei] Univ Calif Los Angeles, Lab Neuroimaging, Los Angeles, CA 90095 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Friedrich Miescher Institute for Biomedical Research; Salk Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Cai, Haijiang/0000-0003-3775-903X; Biag, Jonathan/0000-0003-0891-9567; Haubensak, Wulf/0000-0002-2034-9184; Wall, Nicholas/0000-0003-2039-8258; Ciocchi, Stephane/0000-0002-5701-9250	NIH [1 R01 MH085082-01A1]; Caltech; Human Frontier Science Program; Jane Coffin Childs Memorial Fund for Medical Research; Novartis Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085082, R01MH063912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech; Human Frontier Science Program(Human Frontier Science Program); Jane Coffin Childs Memorial Fund for Medical Research; Novartis Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Heinz and X. Gong for generating BAC transgenic mice; C. Saper for providing the Cre-dependent hrGFP AAV construct; C. Xiao for training in slice electrophysiology and preliminary experiments; H. Lester for advice on the GluCl system; L. van Tright for performing in situ hybridizations; W. Lerchner for providing a CAG-driven GluCl beta construct; A. Chang for help with behavioural scoring; M. Martinez for tail genotyping; G. Mosconi for laboratory management; and J. Alex, R. Bayon and R. Sauza for animal care. This work was supported by NIH grant 1 R01 MH085082-01A1 and by funds from the Caltech 'Conscious Mouse' project. W.H. was supported by a fellowship of the Human Frontier Science Program and P.S.K. by the Jane Coffin Childs Memorial Fund for Medical Research. S.C. and A.L. were supported by the Novartis Research Foundation. D.J.A. is an Investigator of the Howard Hughes Medical Institute.	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Chieng BCH, 2006, J COMP NEUROL, V497, P910, DOI 10.1002/cne.21025; Davis M, 2003, ANN NY ACAD SCI, V985, P218; Day HEW, 1999, J COMP NEUROL, V413, P113; Day HEW, 2005, EUR J NEUROSCI, V21, P441, DOI 10.1111/j.1460-9568.2005.03865.x; De Armentia ML, 2004, J NEUROPHYSIOL, V92, P1285, DOI 10.1152/jn.00211.2004; De Oca BM, 1998, J NEUROSCI, V18, P3426; EDWARDS AL, 1972, EXPT DESIGN PSYCHOL, P249; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; Gautron L, 2010, J COMP NEUROL, V518, P2090, DOI 10.1002/cne.22323; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Marchant NJ, 2007, J COMP NEUROL, V504, P702, DOI 10.1002/cne.21464; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Schiess MC, 1999, J NEUROSCI RES, V58, P663, DOI 10.1002/(SICI)1097-4547(19991201)58:5<663::AID-JNR7>3.3.CO;2-1; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; SUN N, 1994, J COMP NEUROL, V340, P43, DOI 10.1002/cne.903400105; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tsetsenis T, 2007, NAT NEUROSCI, V10, P896, DOI 10.1038/nn1919; Veinante P, 2003, ANN NY ACAD SCI, V985, P552; Wagstaff MJD, 1998, GENE THER, V5, P1566, DOI 10.1038/sj.gt.3300754; Wickens JR, 2007, PROG BRAIN RES, V160, P313, DOI 10.1016/S0079-6123(06)60018-6; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zirlinger M, 2003, GENES BRAIN BEHAV, V2, P282, DOI 10.1034/j.1601-183X.2003.00039.x; Zirlinger M, 2001, P NATL ACAD SCI USA, V98, P5270, DOI 10.1073/pnas.091094698	53	553	565	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					270	U230		10.1038/nature09553	http://dx.doi.org/10.1038/nature09553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068836	Green Accepted, Green Submitted			2022-12-24	WOS:000284051000044
J	Alushin, GM; Ramey, VH; Pasqualato, S; Ball, DA; Grigorieff, N; Musacchio, A; Nogales, E				Alushin, Gregory M.; Ramey, Vincent H.; Pasqualato, Sebastiano; Ball, David A.; Grigorieff, Nikolaus; Musacchio, Andrea; Nogales, Eva			The Ndc80 kinetochore complex forms oligomeric arrays along microtubules	NATURE			English	Article							CHROMOSOME BI-ORIENTATION; ELECTRON-MICROSCOPY; ATTACHMENT SITE; MOLECULAR ARCHITECTURE; OUTER KINETOCHORE; STRUCTURAL BASIS; SPINDLE POLE; RESOLUTION; HEC1; VISUALIZATION	The Ndc80 complex is a key site of regulated kinetochore-microtubule attachment (a process required for cell division), but the molecular mechanism underlying its function remains unknown. Here we present a subnanometre-resolution cryo-electron microscopy reconstruction of the human Ndc80 complex bound to microtubules, sufficient for precise docking of crystal structures of the component proteins. We find that the Ndc80 complex binds the microtubule with a tubulin monomer repeat, recognizing alpha- and beta-tubulin at both intra-and inter-tubulin dimer interfaces in a manner that is sensitive to tubulin conformation. Furthermore, Ndc80 complexes self-associate along protofilaments through interactions mediated by the amino-terminal tail of the NDC80 protein, which is the site of phospho-regulation by Aurora B kinase. The complex's mode of interaction with the microtubule and its oligomerization suggest a mechanism by which Aurora B could regulate the stability of load-bearing kinetochore-microtubule attachments.	[Ball, David A.; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Alushin, Gregory M.; Ramey, Vincent H.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Pasqualato, Sebastiano; Musacchio, Andrea] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Grigorieff, Nikolaus] Brandeis Univ, Rosenstiel Basic Med Res Ctr, Howard Hughes Med Inst, Waltham, MA 02453 USA; [Musacchio, Andrea] Italian Inst Technol, Res Unit, I-20139 Milan, Italy; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; IRCCS European Institute of Oncology (IEO); Brandeis University; Howard Hughes Medical Institute; Istituto Italiano di Tecnologia - IIT; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	enogales@lbl.gov	Pasqualato, Sebastiano/G-1032-2011	Alushin, Gregory/0000-0001-7250-4484; Grigorieff, Nikolaus/0000-0002-1506-909X; Musacchio, Andrea/0000-0003-2362-8784; Pasqualato, Sebastiano/0000-0002-9038-7768	National Institute of General Medical Sciences	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to K. H. Downing for supporting the work carried out by D.A.B., to C. Ciferri for his knowledge and advice about the Ndc80 complex and critical reading of the manuscript, and to P. Grob and S. Lipscomb for electron-microscopy and computer support, respectively. We also acknowledge D. Typke and B. Glaeser for advice on data collection, and C. Sindelar for discussion of data processing strategies. This work was funded by a grant from the National Institute of General Medical Sciences (E.N.). E.N. and N.G. are Howard Hughes Medical Institute Investigators.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Hoenger A, 2008, METHOD CELL BIOL, V84, P425, DOI 10.1016/S0091-679X(07)84014-3; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Ramey VH, 2009, J STRUCT BIOL, V167, P97, DOI 10.1016/j.jsb.2009.05.002; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; WADE RH, 1990, J MOL BIOL, V212, P775, DOI 10.1016/0022-2836(90)90236-F; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3; Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170	57	214	215	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					805	U68		10.1038/nature09423	http://dx.doi.org/10.1038/nature09423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944740	Green Accepted, Green Submitted			2022-12-24	WOS:000282898700058
J	Chekeni, FB; Elliott, MR; Sandilos, JK; Walk, SF; Kinchen, JM; Lazarowski, ER; Armstrong, AJ; Penuela, S; Laird, DW; Salvesen, GS; Isakson, BE; Bayliss, DA; Ravichandran, KS				Chekeni, Faraaz B.; Elliott, Michael R.; Sandilos, Joanna K.; Walk, Scott F.; Kinchen, Jason M.; Lazarowski, Eduardo R.; Armstrong, Allison J.; Penuela, Silvia; Laird, Dale W.; Salvesen, Guy S.; Isakson, Brant E.; Bayliss, Douglas A.; Ravichandran, Kodi S.			Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis	NATURE			English	Article							ACTIVATION; CLEAVAGE; ACCUMULATION; FAMILY; CELLS	Apoptotic cells release 'find-me' signals at the earliest stages of death to recruit phagocytes(1). The nucleotides ATP and UTP represent one class of find-me signals(2), but their mechanism of release is not known. Here, we identify the plasma membrane channel pannexin 1 (PANX1) as a mediator of find-me signal/nucleotide release from apoptotic cells. Pharmacological inhibition and siRNA-mediated knockdown of PANX1 led to decreased nucleotide release and monocyte recruitment by apoptotic cells. Conversely, PANX1 overexpression enhanced nucleotide release from apoptotic cells and phagocyte recruitment. Patch-clamp recordings showed that PANX1 was basally inactive, and that induction of PANX1 currents occurred only during apoptosis. Mechanistically, PANX1 itself was a target of effector caspases (caspases 3 and 7), and a specific caspase-cleavage site within PANX1 was essential for PANX1 function during apoptosis. Expression of truncated PANX1 (at the putative caspase cleavage site) resulted in a constitutively open channel. PANX1 was also important for the 'selective' plasma membrane permeability of early apoptotic cells to specific dyes(3). Collectively, these data identify PANX1 as a plasma membrane channel mediating the regulated release of find-me signals and selective plasma membrane permeability during apoptosis, and a new mechanism of PANX1 activation by caspases.	[Chekeni, Faraaz B.; Elliott, Michael R.; Walk, Scott F.; Kinchen, Jason M.; Armstrong, Allison J.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Chekeni, Faraaz B.; Sandilos, Joanna K.; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Elliott, Michael R.; Walk, Scott F.; Kinchen, Jason M.; Armstrong, Allison J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Isakson, Brant E.] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Isakson, Brant E.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Lazarowski, Eduardo R.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Salvesen, Guy S.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario); Sanford Burnham Prebys Medical Discovery Institute	Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	Ravi@virgina.edu	Penuela, Silvia/A-6961-2010; Laird, Dale w/E-4176-2015; Kinchen, Jason/ABC-5663-2021; Laird, Dale W/AAL-2407-2020	Penuela, Silvia/0000-0003-4829-5517; Laird, Dale W/0000-0002-4568-3285; Kinchen, Jason/0000-0001-8430-2265; Ravichandran, Kodi/0000-0001-9049-1410; Elliott, Michael/0000-0002-0642-482X	NIGMS; NHLBI; AHA; National Institutes of Health; American Heart Association; American Cancer Society; American Asthma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432, T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); American Asthma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ravichandran laboratory for their comments and suggestions. We also thank R. E. Campbell for providing the construct for mBlueberry2. This work was supported by the Pharmacological Sciences Training Grant (F. B. C. andJ. K. S.) (NIGMS), a F30 pre-doctoral fellowship from the NHLBI (F. B. C.), a pre-doctoral fellowship from the AHA (J. K. S.), and grants from the National Institutes of Health (K. S. R.). J. M. K. is supported by grants from the American Heart Association (Scientist Development Grant) and the American Cancer Society. K. S. R. is a William Benter Senior Fellow of the American Asthma Foundation.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chen XD, 2009, J NEUROPHYSIOL, V101, P129, DOI 10.1152/jn.01352.2007; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Denault Jean-Bernard, 2008, V414, P191; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Johnson CE, 2008, CELL, V134, P720, DOI 10.1016/j.cell.2008.08.019; Kadl A, 2009, ARTHRITIS RHEUM-US, V60, P1362, DOI 10.1002/art.24448; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334	33	749	769	4	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					863	U136		10.1038/nature09413	http://dx.doi.org/10.1038/nature09413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944749	Green Accepted, Green Submitted			2022-12-24	WOS:000282898700071
